{"description": "sp|P01523|CM3A_CONGE Mu-conotoxin GIIIA OS=Conus geographus OX=6491 PE=1 SV=3", "sequence": "MMSKLGVLLTICLLLFPLTALPMDGDEPANRPVERMQDNISSEQYPLFEKRRDCCTPPKKCKDRQCKPQRCCAGR", "prompt": "Design a protein sequence for a mu-conotoxin from the venom of the geography cone snail, Conus geographus. This toxin functions as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4. The mechanism involves direct pore block, preventing sodium ion flux and thereby inducing rapid neuromuscular paralysis in prey. The structural scaffold should feature the characteristic mu-conotoxin cysteine framework (C-C-CC-C-C) with three disulfide bridges that stabilize a compact, globular fold. The mature toxin should be relatively small, approximately 22 amino acids, and exhibit high affinity binding to site 1 of the sodium channel through key residues in its loops. The sequence must include conserved cysteine spacing and the pharmacophore essential for Nav1.4 inhibition, reflecting the toxin's role in the predatory venom arsenal of this piscivorous cone snail species."}
{"description": "sp|P01535|STX3_ANESU Delta-actitoxin-Avd2a OS=Anemonia sulcata OX=6108 PE=1 SV=1", "sequence": "RSCCPCYWGGCPWGQNCYPEGCSGPKV", "prompt": "Design a protein sequence for a delta-actitoxin from the venom of the sea anemone Anemonia sulcata. This toxin functions as a potent neurotoxin that specifically targets voltage-gated sodium channels, acting to delay channel inactivation and prolong action potentials in excitable cells. The protein should adopt the conserved structural fold characteristic of sea anemone toxins, featuring a compact beta-sandwich or beta-trefoil architecture stabilized by three disulfide bridges in a C-C-C-C-C-C pattern. Key structural elements should include well-defined beta-strands and loops that form the molecular interface for binding to neurotoxin receptor site 3 on the extracellular domain of sodium channels. The sequence should encode residues critical for maintaining structural integrity and mediating high-affinity interactions with the channel, resulting in excitatory effects that contribute to the venom's paralytic activity against prey organisms."}
{"description": "sp|P83558|TXMG2_MACGS Mu-hexatoxin-Mg1a OS=Macrothele gigas OX=223896 PE=1 SV=2", "sequence": "MMTLSPFLLLLIAAVVIGNASEGEVKNEFEERLKDEFKDPSRSEVAEVILLRELEVLEETLFGKEMTSDTEENRNSREKRCMGYDIECNENLPCCKHRKLECVETSGYWWYKRKYCRPIKG", "prompt": "Design a venom-derived peptide toxin from the funnel-web tarantula Macrothele gigas that functions as a potent insecticidal agent. This toxin, known as mu-hexatoxin-Mg1a, belongs to the hexatoxin family and exhibits specific neurotoxic activity against insects. The protein should adopt a stable, compact tertiary structure stabilized by a conserved disulfide bond framework typical of inhibitor cystine knot (ICK) motifs, which confers exceptional thermal and proteolytic stability. The molecular mechanism involves modulation of voltage-gated sodium channels in insect nervous systems, leading to paralysis and lethality. The sequence should include key residues for target recognition and binding within the pharmacophore regions, while maintaining the characteristic beta-sheet and loop architecture that defines the ICK fold. The toxin should demonstrate high selectivity for insect sodium channel subtypes over mammalian counterparts, reflecting its evolutionary role in prey capture and defense for this spider species."}
{"description": "sp|P07493|BOL2_BOMPE Bombolitin-2 OS=Bombus pensylvanicus OX=28643 PE=1 SV=1", "sequence": "SKITDILAKLGKVLAHV", "prompt": "Design a protein sequence for bombolitin-2, a hemolytic peptide toxin from the venom of the bumblebee Bombus pensylvanicus. This toxin functions as a potent membrane-disrupting agent that targets lipid bilayers through a detergent-like mechanism, causing cell lysis and hemolysis. The protein should adopt an amphipathic alpha-helical structure typical of bombolitins, with distinct hydrophobic and hydrophilic faces that enable insertion into biological membranes. The sequence should contain characteristic features including a high proportion of hydrophobic residues for membrane interaction, positively charged residues for initial electrostatic interactions with negatively charged membrane surfaces, and the absence of disulfide bridges characteristic of this linear peptide toxin family. The structural scaffold should facilitate pore formation or membrane destabilization through oligomerization, leading to rapid cell death. The designed sequence should maintain the cytolytic activity profile specific to bombolitin toxins while preserving the structural integrity required for membrane penetration and disruption."}
{"description": "sp|Q9TWL8|COMB_CONMA Conodipine-M beta chain OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "AATCTHWALIYFKTVQLFGWXHFNYQVDATYCPQFQPCMPXX", "prompt": "Design a protein sequence for a conodipine-M beta chain toxin from the marine cone snail Conus magus. This toxin functions as a phospholipase A2 enzyme that hydrolyzes membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic triad essential for enzymatic activity. As a conodipine, it likely exhibits enhanced membrane targeting capabilities compared to standard phospholipases. The structure should feature the typical disulfide bond pattern common to phospholipase A2 toxins, stabilizing the compact globular fold. The toxin should demonstrate potent membrane-disrupting activity through its phospholipase function, contributing to the prey immobilization and digestive properties of Conus magus venom. The sequence should reflect the beta chain specificity while maintaining the core enzymatic machinery required for phospholipid hydrolysis."}
{"description": "sp|B6DD55|TX20B_LYCSI U18-lycotoxin-Ls1a OS=Lycosa singoriensis OX=434756 PE=3 SV=1", "sequence": "MSPKMQALLLLLGLITLLVVHAEEELSENTESERGCIKLNQECVQNKTPCCNNRPCLCYMRFNICLCEKPLGEIFGR", "prompt": "Design a novel spider venom toxin protein sequence inspired by the biological characteristics of U18-lycotoxin-Ls1a from the wolf spider Lycosa singoriensis. This toxin should function as a potent cytolytic peptide that disrupts cell membranes through pore formation. The protein should adopt an amphipathic alpha-helical structure that facilitates membrane insertion and permeabilization. Key structural features should include: a predominantly alpha-helical fold with amphipathic character allowing both hydrophobic membrane interactions and hydrophilic pore formation; appropriate length and charge distribution for membrane targeting; conserved residues critical for membrane disruption activity. The toxin should exhibit broad-spectrum cytolytic activity against various cell types, consistent with its role in prey immobilization and defense. The sequence should maintain the fundamental structural scaffold of spider cytolytic peptides while optimizing for stability and membrane-interaction capability. Focus on creating a functional toxin that mimics the natural mechanism of membrane disruption through helical bundle formation and pore creation in lipid bilayers."}
{"description": "sp|F8J2E5|3L246_DRYCN Long neurotoxin 469 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDSLICYLGYNNPQTCAPGQNLCYTKKWCDAFCLQRGKVIQLGCAATCPTTKPYEEVTCCSRDKCNPHPAQRSR", "prompt": "Design a long neurotoxin protein sequence that mimics the structural and functional characteristics of neurotoxin 469 from the white-lipped snake (Drysdalia coronoides). This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a potent postsynaptic neurotoxin. It should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C, forming a stable, elongated structure. The toxin should specifically target and antagonize nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to competitive inhibition of acetylcholine binding and subsequent neuromuscular blockade. The sequence should include key functional residues in the central loop and other regions responsible for receptor binding affinity and specificity. The resulting protein should exhibit high structural stability due to the disulfide network while maintaining the conformational flexibility necessary for effective receptor interaction and potent neurotoxic activity characteristic of elapid snake venom toxins."}
{"description": "sp|P25428|NGFV_MACLB Venom nerve growth factor OS=Macrovipera lebetinus OX=3148341 PE=1 SV=2", "sequence": "MSMLCYTLIIAFLIGIWAAPKSEDNVSLGSPATPDLSDTSCAKTHEALKTSRNTDQHYPAPKKAEDQEFGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLDNADSLNRNIRAKRATHPVHNRGEFSVCDSVSVWVANKTTATDIRGNVVTVMVDVKLNNNVYRQYFFETKCKNPSPVSSGCRGIDAKHWNSYCTTTDTFVRALTMEGNQASWRFIRIDTACVCVISRKNDNFG", "prompt": "Design a venom-derived nerve growth factor protein from the Levant viper (Macrovipera lebetinus) that functions as a neurotrophic toxin. This protein should adopt the characteristic beta-sheet-rich tertiary structure typical of the nerve growth factor family, featuring the conserved cysteine knot motif with three intramolecular disulfide bridges that stabilize the fold. The protein should function as a high-affinity ligand for the TrkA receptor, mimicking endogenous nerve growth factor activity to potentially induce hyperalgesia, neuronal sensitization, or aberrant neuronal survival pathways. The sequence should maintain the conserved structural elements required for proper folding and receptor binding while incorporating venom-specific adaptations that enhance stability and biological activity in the context of snake venom. The protein should exhibit the dimeric quaternary structure characteristic of functional nerve growth factors, with the mature form processed from a larger precursor. Consider the evolutionary context of this toxin within viperid venoms, where it may contribute to complex neurotoxic effects alongside other venom components."}
{"description": "sp|F8J2G3|3S12A_DRYCN Short neurotoxin 2 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCYNQQSSQPQTTTTCAESSCYKKTWRDHRGTIIERGCGCPTVKPGIQRVCCATDKCNN", "prompt": "Design a protein sequence for a short neurotoxin from the white-lipped snake (Drysdalia coronoides) venom. This toxin belongs to the three-finger toxin superfamily and functions as a postsynaptic neurotoxin that specifically targets nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The core structure consists of three extended loops (fingers) projecting from a central globular domain containing the disulfide-stabilized hydrophobic core. The molecular mechanism involves competitive antagonism of acetylcholine binding to muscle-type nicotinic receptors, leading to reversible neuromuscular blockade and paralysis. Key functional residues should be positioned in loop II to mediate specific receptor recognition and binding affinity. The sequence should maintain the conserved cysteine framework and structural motifs typical of short neurotoxins while incorporating species-specific variations that confer its biological activity in elapid snake venom."}
{"description": "sp|P83896|TX36A_PHOKE U4-ctenitoxin-Pk1a (Fragment) OS=Phoneutria keyserlingi OX=272754 PE=1 SV=2", "sequence": "KAKCADIDQPCKTSCDCCETKGACTCYKSGCVCRMGSFXATCKK", "prompt": "Design a protein sequence for a neurotoxic peptide derived from the venom of the Brazilian wandering spider, Phoneutria keyserlingi. This toxin functions as a potent voltage-gated sodium channel modulator, specifically targeting Nav1.6 and Nav1.7 subtypes to induce prolonged channel opening and neuronal hyperexcitability. The structural scaffold should feature the inhibitor cystine knot (ICK) motif with a characteristic disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming a compact, triple-stranded beta-sheet stabilized by three disulfide bridges. The mature peptide should be approximately 36-40 residues in length with a high density of basic residues that facilitate interaction with the voltage-sensing domain of sodium channels. Key functional residues should be positioned in flexible loops between beta-strands to enable precise molecular recognition and binding to the channel's S3-S4 linker region. The overall fold should exhibit the typical thermostability and protease resistance associated with ICK toxins, maintaining biological activity despite the harsh extracellular environment."}
{"description": "sp|P69658|CA1A_CONPU Alpha-conotoxin PIA (Fragment) OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "SDGRDAAANDKATDLIALTARRDPCCSNPVCTVHNPQICG", "prompt": "Design a protein sequence for an alpha-conotoxin from the venomous marine snail Conus purpurascens (purple cone snail). This neurotoxic peptide functions as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha6/alpha3 subunit interface. The toxin should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form a compact, stable fold. The mature peptide should contain the conserved cysteine pattern typical of alpha-conotoxins, with key functional residues positioned in the inter-cysteine loops that mediate specific receptor binding and subtype selectivity. The structure should exhibit the hallmark alpha-conotoxin pharmacophore with well-defined loops that confer high affinity for neuronal nicotinic receptors, contributing to the venom's paralytic effects on prey by blocking neurotransmission. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade while maintaining the structural stability required for venom delivery and target engagement."}
{"description": "sp|P15472|U6GS_CONGE Mu-conotoxin GS OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "ACSGRGSRCPPQCCMGLRCGRGNPQKCIGAHEDV", "prompt": "Generate the amino acid sequence for mu-conotoxin GS, a potent neurotoxic peptide from the venom of the marine cone snail Conus geographus. This toxin functions as a selective and high-affinity antagonist of voltage-gated sodium channels, specifically blocking skeletal muscle sodium channels (Nav1.4) to induce rapid paralysis in prey. The toxin adopts a compact, disulfide-rich scaffold characteristic of conotoxins, featuring a conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges stabilizing an inhibitory cystine knot (ICK) fold. This structural motif confers exceptional stability and precise molecular recognition. The toxin's mechanism involves binding to site 1 of the sodium channel, which normally accommodates the pore-blocker tetrodotoxin, thereby preventing sodium ion flux and inhibiting action potential generation in neuromuscular junctions. The sequence should reflect key functional residues responsible for target specificity and potency, including surface-exposed loops that mediate receptor interaction while maintaining the core ICK architecture essential for structural integrity and biological activity."}
{"description": "sp|C9D7R3|VMPA3_LOXIN Astacin-like metalloprotease toxin 3 OS=Loxosceles intermedia OX=58218 PE=2 SV=1", "sequence": "MTTMSFFTVLSVAVCLCIEAGVEGSRLNGRDMLMQEESPLMERNALKYDSRLWPDGVVIYEFTSLRFYRKLIKRVMQHIADNTCITFKERTNEKGYVNIYNGKLFTCFADMGYYPFKQRLSLGLGCRSFGAILHELGHVLGLYHEQQRPDRDDYVIVYKDNIQTGALRDYEKRFENNTRVIGPFDYDSIMIYGETDARKSGSVTMKVKKPGATLVNASLKHELTALDIKKINTLYNCPGKDKF", "prompt": "Design a novel astacin-like metalloprotease toxin derived from the venom of the brown spider Loxosceles intermedia. This toxin should function as a key virulence factor in the spider's venom arsenal, contributing to the characteristic dermonecrotic lesions and systemic effects observed in loxoscelism envenomation. The protein must adopt the canonical astacin metalloprotease fold, characterized by a compact globular domain with a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion essential for proteolytic activity. Incorporate the characteristic methionine turn structural element that stabilizes the active site. The toxin should exhibit specific proteolytic activity against extracellular matrix components, particularly targeting basement membrane proteins such as fibronectin, fibrinogen, and type IV collagen, thereby facilitating tissue damage, hemorrhage, and impaired wound healing. Include appropriate disulfide bonding patterns typical of venom metalloproteases to ensure structural stability in the extracellular environment. The protein should demonstrate optimal activity at physiological pH and temperature, with appropriate substrate specificity and catalytic efficiency characteristic of venom-derived metalloproteases that contribute to the complex pathophysiology of spider envenomation."}
{"description": "sp|A0A024BTN9|OXLA_BOTSC L-amino acid oxidase Bs29 (Fragment) OS=Bothriechis schlegelii OX=44725 PE=1 SV=1", "sequence": "SCADDRNPLEECFQETDYEEFLEIARNGLKATSNPKHVVIVGAGMSGLSAAYVLAGAGHQVTVLEASERAGGRVRTYRNDKEGWYANLGPMRLPEKHRIVREYITKFGLQLNEFSQENENAWYFIKNIRKRVGEVKKDPGLLQYPVKPSEEGKSAGQLYEESLGKVVEELKRTNCSYILDKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDNIFGYEKRFNEIVDGMDKLPTSMYQAIEEKVRFNARVIKIQQNDNEVTVTYQTSENEMSPVTADYVIVCTTSRAARRITFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFVYYPNHDFSSGSAVIMAYGIGDDANFFQALDHKDCGDTVINDLSLIHQLTKEEIQSFCYLSKIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPFKRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDN", "prompt": "Generate the amino acid sequence for a highly potent L-amino acid oxidase toxin from the venom of Bothriechis schlegelii, the eyelash viper. This enzyme functions as a key venom component that catalyzes the oxidative deamination of L-amino acids, producing hydrogen peroxide, ammonia, and the corresponding α-keto acid. The resulting hydrogen peroxide induces significant oxidative stress in prey tissues, leading to cytotoxicity, platelet aggregation inhibition, and hemorrhagic effects through endothelial cell damage and apoptosis. The protein should adopt the classic flavin adenine dinucleotide (FAD)-binding fold characteristic of L-amino acid oxidases, featuring a conserved glycine-rich dinucleotide binding motif (GXGXXG) for FAD cofactor binding and a substrate-binding domain with specific residues for L-amino acid recognition and catalytic activity. The enzyme likely exists as a homodimer in its functional form, with the FAD cofactor deeply buried within the active site pocket. The generated sequence should reflect high catalytic efficiency toward broad-spectrum L-amino acid substrates while maintaining the structural stability required for venom gland storage and efficient delivery during envenomation."}
{"description": "sp|P83580|TO1A_ATRRO Omega-hexatoxin-Ar1a OS=Atrax robustus OX=6903 PE=1 SV=2", "sequence": "MNTATGFIVLLVLATVLGAIEAEDAVPDFEGGFASHAREDTVGGKIRRSSVCIPSGQPCPYNEHCCSGSCTYKENENGNTVQRCD", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Sydney funnel-web spider (Atrax robustus) that functions as a calcium channel blocker. This toxin should belong to the ω-hexatoxin family and specifically target insect voltage-gated calcium channels (VGCCs) with high affinity. The protein should adopt the inhibitor cystine knot (ICK) structural fold, characterized by a compact, disulfide-stabilized globular architecture. The sequence must contain the conserved cysteine framework C-C-CC-C-C typical of ICK motifs, forming three disulfide bridges that create a stable, knotted core structure. This structural scaffold should present surface loops that mediate specific interactions with insect calcium channels, effectively blocking ion conduction and leading to paralysis. The toxin should exhibit the characteristic functional profile of ω-hexatoxins: rapid onset of action, high potency against insect nervous systems, and selectivity for invertebrate over vertebrate calcium channel subtypes. The overall molecular architecture should enable precise targeting of insect neuromuscular junctions while maintaining the thermal and proteolytic stability inherent to ICK-fold toxins from spider venoms."}
{"description": "sp|A6YR36|COC2G_CONCL Mu-conotoxin-like Cal 12.1.2g OS=Californiconus californicus OX=1736779 PE=2 SV=1", "sequence": "DVCDSLVGGRCIHNGCYCERSAPNGNCCDTAGCTVLWWCPGTKFD", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the California cone snail, Californiconus californicus. This toxin should function as a potent and selective sodium channel blocker, specifically targeting voltage-gated sodium channels in the peripheral nervous system to induce rapid neuromuscular paralysis in prey. The peptide should adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, globular fold stabilized by three disulfide bonds with the conserved cysteine framework C-C-CC-C-C (Framework III). Key structural elements should include a well-defined beta-hairpin motif and several loop regions that form the pharmacophore for sodium channel interaction. The binding interface should specifically recognize Site 1 of voltage-gated sodium channels, competing with tetrodotoxin and saxitoxin binding through key residues that interact with the channel's pore region. The toxin should exhibit high affinity for mammalian neuronal sodium channel subtypes, contributing to the California cone snail's predatory strategy by blocking action potential generation in motor neurons. The sequence should maintain the characteristic mu-conotoxin length of approximately 20-25 amino acids with the conserved disulfide connectivity pattern essential for proper folding and biological activity."}
{"description": "sp|P15229|CTXL1_HOTTS Chlorotoxin-like peptide Bs 8 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "RCKPCFTTDPQMSKKCADCCGGKGKGKCYGPQCLC", "prompt": "Design a novel animal toxin protein sequence inspired by chlorotoxin-like peptides from the venom of the Indian red scorpion, Hottentotta tamulus. This toxin should function as a potent modulator of ion channels, specifically targeting chloride channels in neuronal and glioma cell membranes to disrupt cellular excitability and volume regulation. The protein should adopt a compact, stable scaffold stabilized by four conserved disulfide bonds in a C-C-C-C pattern, forming a characteristic inhibitor cysteine knot (ICK) motif that confers exceptional proteolytic resistance and thermal stability. Key structural elements should include: a well-defined beta-hairpin region for membrane interaction, several surface-exposed loops for target recognition, and a conserved hydrophobic patch for channel binding. The mature toxin should be approximately 30-40 amino acids in length with high cysteine content (8 cysteines forming 4 disulfide bridges), maintaining the fundamental chlorotoxin fold while incorporating sequence variations that enhance specificity for pathological chloride channels overexpressed in cancer cells. The mechanism should involve allosteric inhibition of chloride conductance, leading to impaired cell migration and invasion—properties relevant to anti-glioma therapeutic applications."}
{"description": "sp|P0DQP9|PA2B1_BOTBZ Basic phospholipase A2 myotoxin-I (Fragment) OS=Bothrops brazili OX=157546 PE=1 SV=1", "sequence": "SLWEFGQMILKETGKLPFPYYGAYGCYCGWGGRRGPKDATDRCCYVHDCKQICECDKAAAVCFRERKYMAYLRVLCKK", "prompt": "Design a protein sequence for a basic phospholipase A2 myotoxin derived from Bothrops brazili venom. This toxin should exhibit the characteristic enzymatic activity of phospholipase A2, specifically hydrolyzing the sn-2 acyl bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should function as a potent myotoxin, causing rapid skeletal muscle damage through mechanisms involving membrane disruption, calcium influx, and mitochondrial dysfunction. The structural scaffold should feature the conserved phospholipase A2 fold with three long alpha-helices and a beta-wing region, stabilized by the characteristic seven disulfide bond pattern common to group II phospholipase A2 enzymes. Include the conserved calcium-binding loop (YXCGXGG sequence motif) essential for catalytic activity, and position key catalytic residues (histidine and aspartate in the active site) appropriately. The basic nature of the protein should be reflected in the amino acid composition to facilitate interaction with negatively charged membrane surfaces. The toxin should demonstrate tissue specificity for skeletal muscle while maintaining the thermostability and resistance to proteolytic degradation typical of snake venom phospholipases."}
{"description": "sp|P07494|BOL3_BOMPE Bombolitin-3 OS=Bombus pensylvanicus OX=28643 PE=1 SV=1", "sequence": "IKIMDILAKLGKVLAHV", "prompt": "Design a protein sequence for bombolitin-3, a hemolytic peptide toxin from the venom of the bumblebee Bombus pensylvanicus. This toxin functions as a potent membrane-disrupting agent that targets lipid bilayers through a detergent-like mechanism of action. Bombolitin-3 belongs to the bombolitin family of amphipathic peptides characterized by their ability to form pores in cell membranes, leading to cell lysis and hemolysis. The peptide should adopt an alpha-helical conformation in membrane-mimetic environments, with distinct hydrophobic and hydrophilic faces that facilitate insertion into lipid membranes. The structural scaffold should feature a linear peptide without disulfide bridges, typical of bombolitins, allowing for flexible membrane interaction. The molecular target is the phospholipid bilayer of cell membranes, where the peptide binds via hydrophobic interactions and electrostatic attractions to anionic lipid headgroups, ultimately causing membrane permeabilization and osmotic disruption. The biological significance lies in the venom's role in prey immobilization and defense, with bombolitins contributing to the cytotoxic effects that enhance venom potency through rapid tissue damage and systemic spread of other venom components."}
{"description": "sp|P0CAR1|3S1D1_MICPY Short neurotoxin D1 OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "MICYNQQSSQPPTTKTCSEGQCYKKTWSDHRGTISERGCACPNVKPGVKISCCSSDKCNG", "prompt": "Design a short neurotoxin protein sequence that mimics the biological activity and structural characteristics of neurotoxin D1 from the venom of Micrurus pyrrhocryptus, a coral snake species. This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a potent postsynaptic neurotoxin. It should specifically target and antagonize nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to competitive inhibition of acetylcholine binding and resulting in flaccid paralysis. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the cysteine framework I-IV, II-V, III-VI, forming a compact globular structure. Key structural elements should include three extended loops (fingers) projecting from a central core, with the central loop typically containing residues critical for receptor binding and specificity. The sequence should maintain the conserved hydrophobic core and exhibit the appropriate molecular surface features for high-affinity interaction with the nAChR α-subunit. The toxin should demonstrate selective activity against muscle-type nAChRs while maintaining the thermal stability and protease resistance characteristic of this toxin family."}
{"description": "sp|P69746|CA4A_CONOB Alpha-conotoxin OIVA OS=Conus obscurus OX=89447 PE=1 SV=1", "sequence": "CCGVPNAACHPCVCKNTC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus obscurus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the defining cysteine framework (CC-C-C) with appropriate inter-cysteine loop lengths that facilitate high-affinity binding to the orthosteric site of nAChRs. Incorporate key pharmacophore residues that enable selective receptor subtype discrimination while maintaining the toxin's stability in the venom gland and upon delivery. The final protein should exhibit the typical alpha-conotoxin properties: small size (12-20 amino acids), high disulfide content, lack of secondary structure elements beyond turns, and the ability to block acetylcholine binding through competitive inhibition. Ensure the sequence reflects the evolutionary optimization of cone snail venoms for rapid neuromuscular paralysis and prey immobilization."}
{"description": "sp|D9IWN6|CA127_CONPO Alpha-conotoxin Vt1.27 OS=Conus planorbis OX=97183 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTLDRASDGASAAADLVARGIRGNCCMFHTCPIDYSRFNCP", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus planorbis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a conserved globular fold stabilized by two disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the classic CC-C-C framework. The sequence should feature the signature alpha-conotoxin cysteine framework with appropriate inter-cysteine loop regions that determine receptor subtype specificity. The mature toxin should be a small, compact peptide of approximately 12-20 amino acids with high structural stability imparted by the disulfide network. The molecular mechanism should involve competitive binding to the orthosteric site of nicotinic acetylcholine receptors, disrupting cholinergic signaling through precise molecular recognition of receptor subunit interfaces. The protein should exhibit the typical alpha-conotoxin pharmacological profile with rapid onset of action and high binding affinity for its neuronal targets, contributing to the venom's paralytic and neurotoxic effects on prey organisms."}
{"description": "sp|C9D7R2|VMPA2_LOXIN Astacin-like metalloprotease toxin 2 OS=Loxosceles intermedia OX=58218 PE=2 SV=1", "sequence": "MIPDVGFLVLLTGALFICIKAAPATTDVDPTFEGRIVMEGDILIREEQLTERNAIALENMRWPDATIVYKLTGWYALFPGDIKKAMRHIEENTCIKFKARSNEEGYVKIYKGEKESCFADIGYFASEQRLSLGSGCKIFGRILHEMGHTIGLFHEHTRPDRDNYITVHEDNIRPGSKRNYRKTPSYMTRVIGPFDYDSIMIYGETAGSRDPMHLKSMEANKPGVTLISSRYKDRLTDLDIKKINTLYNCPGKEKFS", "prompt": "Design a novel astacin-like metalloprotease toxin derived from the venom of the brown spider Loxosceles intermedia. This toxin should function as a key virulence factor in loxoscelism, the clinical condition resulting from brown spider envenomation. The protein must exhibit zinc-dependent metalloprotease activity, specifically targeting and cleaving extracellular matrix components such as fibronectin, fibrinogen, and gelatin to facilitate tissue damage, hemorrhage, and dermonecrosis. Incorporate the conserved astacin family catalytic domain featuring the HEXXHXXGFXHE zinc-binding motif, where histidine residues coordinate the catalytic zinc ion. The structure should adopt the characteristic astacin fold comprising an N-terminal domain with mixed α/β topology and a C-terminal domain rich in β-strands, stabilized by multiple disulfide bridges typical of venom metalloproteases. Ensure the protein includes a signal peptide for secretion and a prodomain that requires proteolytic activation to achieve full enzymatic potency. The mature toxin should demonstrate optimal activity at neutral pH and exhibit calcium-dependent stability, reflecting its role in disrupting host tissue integrity and promoting the spread of venom components during envenomation."}
{"description": "sp|X1WB75|CA1A_CONLG Alpha-conotoxin Lo1a OS=Conasprella longurionis OX=1077918 PE=1 SV=1", "sequence": "EGCCSNPACRTNHPEVCD", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conasprella longurionis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two conserved disulfide bonds in a CysI-CysIII, CysII-CysIV connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements required for high-affinity binding to the nAChR orthosteric site, particularly residues that interact with the complementary subunit interface. The structure should exhibit the typical alpha-conotoxin features: a short alpha-helical segment, beta-turn elements, and a well-defined binding loop that confers subtype selectivity. The mature toxin should be approximately 12-20 amino acids in length, with the disulfide connectivity essential for maintaining the rigid three-dimensional structure necessary for precise receptor recognition and blockade. The designed sequence must demonstrate the evolutionary optimization characteristic of cone snail venoms for rapid neuromuscular paralysis or neuronal modulation."}
{"description": "sp|Q1RPS9|VKTH5_BUNMU Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B5 chain OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTFCAELTPVSSRKRHPYCNLPPDPGPCHDNKFAFYHHPASNKCKEFVYGGCGGNDNRFKTRNKCQCTCSG", "prompt": "Design a protein sequence for a neurotoxic component from the venom of the many-banded krait (Bungarus multicinctus), specifically the beta-bungarotoxin B5 chain. This toxin functions as a presynaptic phospholipase A2 neurotoxin that forms a heterodimeric complex with a Kunitz-type serine protease inhibitor homolog. The protein should exhibit the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with alpha-helices and beta-strands arranged in a compact globular conformation. Include the essential disulfide bond pattern typical of Kunitz-type inhibitors, with cysteine residues forming specific bridges that stabilize the tertiary structure. The sequence should maintain key functional residues for serine protease inhibition, particularly in the reactive site loop, while being part of a larger toxin complex that enhances phospholipase A2 activity and facilitates binding to presynaptic membranes at neuromuscular junctions. This results in irreversible blockade of acetylcholine release, leading to flaccid paralysis. Ensure the design reflects the evolutionary adaptation where the Kunitz domain modulates the toxicity and specificity of the phospholipase component, contributing to the potent neurotoxic effects observed in krait envenomation."}
{"description": "sp|P86907|PA2A_BOTAM Acidic phospholipase A2 OS=Bothrops ammodytoides OX=169857 PE=1 SV=1", "sequence": "HLMQFETLIKKIAGRSGVWFYGFYGCYCGSGGRGKPKDATDRCCFVHDCCYGKVTGCDPKMDFYTYSEENGVVVCGGDDPCKKQICECDRVAATCFRDNKTYDNNKYWFYPAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the lancehead pit viper Bothrops ammodytoides. This enzyme is a key component of the snake's venom, contributing to its potent hemotoxic effects through the hydrolysis of membrane phospholipids. The protein should function as a calcium-dependent phospholipase that specifically cleaves the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids. This mechanism leads to membrane disruption, inflammation, and potential myotoxicity. The structure should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YXCGXGG sequence motif) and a catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern that stabilizes the globular structure, typically involving 6-7 conserved cysteine residues forming three disulfide bonds. The protein should exhibit an acidic pI and possess the interfacial activation surface that allows it to bind to lipid membranes. The mature toxin should be approximately 120-140 amino acids in length with the proper signal peptide cleaved, maintaining the conserved structural elements required for enzymatic activity while incorporating species-specific variations that confer its acidic properties and biological potency."}
{"description": "sp|Q7LZ71|SLA_PROFL Snaclec coagulation factor IX-binding protein subunit A OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "DCPSGWSSYEGHCYKPFKLYKTWDDAERFCTEQAKGGHLVSIESAGEADFVAQLVTENIQNTKSYVWIGLRVQGKEKQCSSEWSDGSSVSYENWIEAESKTCLGLEKETGFRKWVNIYCGQQNPFVCEA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the habu snake (Protobothrops flavoviridis) that functions as a coagulation factor IX-binding protein. This toxin should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that form the core structural scaffold. The protein should exhibit heterodimeric assembly with a partner subunit B, forming a functional complex that specifically targets and binds to coagulation factor IX (FIX) in the blood coagulation cascade. The binding interface should involve key residues in the recognition loop region that interact with the Gla domain or other functional regions of FIX, thereby inhibiting its activation or procoagulant activity. This mechanism contributes to the anticoagulant properties of the venom by disrupting the intrinsic pathway of coagulation, leading to hypocoagulability and potential hemorrhage. The sequence should include conserved features of snaclecs, such as the calcium-binding motif if applicable, and maintain the overall globular fold typical of CTLDs, with surface-exposed loops critical for target recognition and binding specificity."}
{"description": "sp|A6YR40|COC3A_CONCL Mu-conotoxin-like Cal 12.1.3a OS=Californiconus californicus OX=1736779 PE=2 SV=2", "sequence": "MKLTCVLVVLLLLLPYGDLITNSYIRGAARKVTPWRRNLKTRDVCDSLVDGRCIHNGCFCEESKPNGNCCDTGGCVWWWCPGTKWD", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the Californiconus californicus marine cone snail. This toxin should function as a potent and selective sodium channel blocker, specifically targeting voltage-gated sodium channels involved in neuromuscular transmission. The peptide should adopt the characteristic mu-conotoxin structural scaffold featuring a compact, globular fold stabilized by a conserved disulfide bonding pattern. Based on mu-conotoxin family characteristics, the cysteine framework should follow the CC-C-C-CC pattern with three disulfide bridges that constrain the peptide into a stable three-dimensional structure. The core structural motif should include well-defined beta-sheets and turns that create a precise molecular surface for sodium channel interaction. The binding interface should contain key residues that enable selective recognition of specific sodium channel isoforms, particularly those expressed in skeletal muscle. The toxin should exhibit high affinity binding to the pore region of voltage-gated sodium channels, effectively blocking ion conduction and disrupting action potential propagation. The overall architecture should maintain the compact size and structural stability typical of conotoxins, ensuring resistance to proteolytic degradation while maintaining target specificity. The designed sequence should reflect the evolutionary optimization of cone snail venom components for rapid prey immobilization through precise ion channel modulation."}
{"description": "sp|Q7LZG3|PA2_PSEPP Phospholipase A2 (Fragment) OS=Pseudechis papuanus OX=61265 PE=1 SV=1", "sequence": "NLIQFSNMIQLDRCCETHDNEAEKKGCYPKLTLY", "prompt": "Design a phospholipase A2 toxin fragment derived from the venom of Pseudechis papuanus (Papuan black snake), a species known for producing potent neurotoxic and myotoxic venom components. This enzyme should function as a catalytically active secretory phospholipase A2 (sPLA2) that hydrolyzes the sn-2 ester bond of membrane phospholipids, leading to membrane disruption, inflammation, and potential neurotoxicity through presynaptic or postsynaptic mechanisms. The protein should adopt the characteristic sPLA2 fold featuring three long alpha-helices stabilized by a conserved network of 6-7 disulfide bridges, including the essential catalytic histidine-aspartate dyad within the Ca²⁺-binding loop. Key structural elements should include the conserved pancreatic loop, the hydrophobic substrate-binding channel, and the interfacial activation surface that mediates membrane association. The toxin should target neuronal or muscle cell membranes, potentially interacting with specific presynaptic receptors or ion channels to enhance its neurotoxic effects, while exhibiting the typical sPLA2 enzymatic mechanism involving calcium-dependent catalysis and interfacial activation at lipid-water interfaces."}
{"description": "sp|C6ZJQ2|CAE1_CONPL Alpha-conotoxin Pu14.1 OS=Conus pulicarius OX=93154 PE=1 SV=1", "sequence": "MGMRMMFAVFLLVVLATTVVSFNSDRASDGRNAAANVKASDLMARVLEKDCPPHPVPGMHKCVCLKTCR", "prompt": "Design a novel alpha-conotoxin peptide sequence inspired by Conus pulicarius venom, specifically emulating the Alpha-conotoxin Pu14.1. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), characteristic of the alpha-conotoxin family. The peptide must adopt the conserved alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern, typical of the CC-C-C framework. The sequence should include the essential cysteine residues at positions that facilitate this disulfide connectivity, along with intervening loops that confer target specificity. The molecular mechanism involves high-affinity binding to specific nAChR subtypes, likely neuronal or neuromuscular, leading to receptor blockade and disruption of cholinergic signaling. Incorporate key pharmacophore residues that determine receptor subtype selectivity and potency, ensuring the peptide is soluble and stable in physiological conditions. The overall structure should be rigid and well-defined, with the disulfide bonds constraining the loops into a conformation optimal for receptor interaction. Avoid non-toxin-related motifs and ensure the design reflects the evolutionary optimization of cone snail venoms for rapid prey immobilization."}
{"description": "sp|X5ICI2|TXVE1_GLOTS Vascular endothelial growth factor isoform GtVF OS=Gloydius tsushimaensis OX=1170829 PE=1 SV=1", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGQVMPFMEVFKRSVCQTRETLVPVLEEHPSEIADLFKPSCATVLRCGGCCSDESLACTAVGKRSVGREILRVDPRKGTSKIEVMQFTEHTDCECRPRSRSGVDSGKRKRNPEEGEPRAKFPFV", "prompt": "Design a novel snake venom-derived protein sequence that functions as a vascular endothelial growth factor (VEGF) isoform, specifically modeled after the venom of Gloydius tsushimaensis, the Tsushima Island pit viper. This toxin should exhibit the characteristic VEGF fold, featuring the conserved cysteine-knot (Cys-knot) structural motif formed by eight conserved cysteine residues that create three intra-chain disulfide bridges in a specific 1-2, 3-4, 5-6, 7-8 connectivity pattern, stabilizing the anti-parallel β-sheet core. The protein should function as a potent angiogenic factor by binding to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, promoting vascular permeability, proliferation, and migration through receptor dimerization and tyrosine kinase activation. Incorporate key receptor-binding residues in the receptor-binding domain, particularly in the loops connecting the β-strands, to ensure high affinity for VEGF receptors while maintaining venom-specific adaptations that enhance stability and bioavailability in the envenomation context. The sequence should reflect viperid venom characteristics, including optimal isoelectric point and glycosylation patterns typical of snake venom VEGFs, to facilitate its role in prey immobilization through localized tissue damage and edema formation."}
{"description": "sp|P0DQT9|DEF4_OLIMR Defensin BmKDfsin4 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKTIVLLFVLALVFCTLEMGIVEAGFGCPFNQGQCHKHCQSIRRRGGYCDGFLKQRCVCYRK", "prompt": "Design a defensin-like toxin protein sequence inspired by the venom of Olivierus martensii (Chinese scorpion). This defensin should exhibit the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, a hallmark of scorpion venom defensins that function as potassium channel blockers. The protein must contain the conserved defensin cysteine framework with six cysteine residues forming three intramolecular disulfide bridges in the C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature an N-terminal alpha-helix followed by an antiparallel beta-sheet structure, creating a compact globular fold stabilized by the disulfide network. As a potassium channel toxin, this defensin should specifically target voltage-gated potassium channels (Kv channels) through interaction with the channel pore region, disrupting potassium ion flux and causing neuronal hyperexcitability. The molecular mechanism involves binding to the extracellular vestibule of Kv channels, physically occluding the ion conduction pathway. Include conserved scorpion defensin signature motifs while maintaining the amphipathic character necessary for membrane interaction and channel binding. The protein should be approximately 40-50 amino acids in length with the characteristic defensin structural scaffold optimized for potassium channel blockade activity."}
{"description": "sp|P86822|KBX2_TITSE Tityustoxin-19 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MVATNRCCVFALLFALLLVHSLTEAGKGKEILGKIKEKIIEAKDKMKAGWERLTSQSEYACPAIDKFCEDHCAAKKAVGKCDDFKCNCIKL", "prompt": "Design a novel animal toxin protein sequence based on the biological profile of Tityustoxin-19 from the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved structural scaffold characteristic of scorpion venom toxins targeting potassium channels, featuring a compact globular fold stabilized by three or four disulfide bridges in a specific cysteine framework that creates a functional surface for channel interaction. The structural core should include an alpha-helix and anti-parallel beta-sheets, with key residues forming a functional dyad or triad that inserts into the channel pore or interacts with the voltage-sensing domain to inhibit potassium ion flux. The mechanism should involve binding to the external vestibule of Kv channels, leading to prolonged action potentials, increased neurotransmitter release, and ultimately causing neurotoxic effects such as muscle spasms, autonomic dysfunction, and pain. The sequence should reflect the evolutionary optimization for rapid paralysis of prey, with high affinity and selectivity for mammalian Kv1.x channel subtypes, contributing to the overall lethality and defensive efficacy of Tityus serrulatus venom."}
{"description": "sp|P28879|CAS2_CONST Alpha-conotoxin SII OS=Conus striatus OX=6493 PE=1 SV=3", "sequence": "MGMRMMFTVFLLVVLATTVVSFPSDRASDGRDDEAKDERSDMHESDRNGRGCCCNPACGPNYGCGTSCSRTL", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of the striated cone snail, Conus striatus, a marine predator that employs neurotoxic peptides for prey capture. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha3beta2 subtype to disrupt synaptic transmission in the peripheral nervous system. The sequence must adopt the conserved alpha-conotoxin structural framework, characterized by a compact, disulfide-stabilized globular fold with the CC-C-C cysteine pattern forming two essential disulfide bridges that constrain the peptide into a stable conformation. Incorporate key pharmacophore residues in the second loop that mediate high-affinity binding to the receptor's orthosteric site, including conserved hydrophobic and cationic amino acids that interact with complementary surfaces on the alpha3 and beta2 subunits. The mature toxin should be 12-18 residues in length, featuring an N-terminal helical propensity and a type I beta-turn in the central loop, which collectively confer target specificity and resistance to proteolytic degradation. Ensure the sequence excludes proteolytic cleavage sites and maintains the characteristic alpha-conotoxin isoelectric point to enhance bioavailability in envenomation contexts."}
{"description": "sp|P0DQV4|TX1A_PELMU Delta/kappa-theraphotoxin-Pm1a OS=Pelinobius muticus OX=753628 PE=1 SV=1", "sequence": "MKTFVFIVLVALAFVLTAAKEERANPSELVSALAELVMLDAERGVDKPGCRYLFGGCKSDDDCCPRLGCKGKGHDYCAWDGTFSD", "prompt": "Design a novel animal toxin protein sequence inspired by the venom of the King Baboon Tarantula (Pelinobius muticus). This toxin should function as a dual-action delta/kappa-theraphotoxin, exhibiting both sodium channel modulation (delta-theraphotoxin activity) and potassium channel blockade (kappa-theraphotoxin activity). The protein should adopt the canonical inhibitor cystine knot (ICK) structural fold characteristic of theraphotoxins, featuring a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The sequence should include key functional motifs for voltage-gated sodium channel interaction, likely targeting site 4 to modify channel gating kinetics and enhance neuronal excitability, while also containing structural elements for potassium channel pore blockade, particularly against Kv channels. The mature toxin should be approximately 30-40 amino acids in length with high cysteine content (6 cysteines forming the ICK scaffold), and exhibit the amphipathic surface properties necessary for membrane-proximal target engagement. The overall structure should maintain the thermostable, protease-resistant characteristics typical of spider venom peptides, enabling potent neurotoxic effects through simultaneous modulation of multiple ion channel targets in the peripheral nervous system."}
{"description": "sp|P0C174|KEX11_TITSE Potassium channel toxin epsilon-KTx 1.1 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MKLSCGFLLILLVLSAMIATFSEVEAMKPSKPKCGLCRYRCCSGGCSSGKCVNGACDCSGRSDLNDELEKYQ", "prompt": "Design a potent potassium channel toxin from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of a short alpha-helix packed against an antiparallel beta-sheet, creating a stable molecular scaffold that presents key functional residues for channel blockade. The toxin should contain the conserved functional dyad consisting of a critical lysine residue positioned to insert into the potassium channel pore and an aromatic residue that contributes to binding affinity through hydrophobic interactions with the channel vestibule. The molecular mechanism should involve physical occlusion of the potassium conduction pathway, preventing ion flux and thereby modulating neuronal excitability and neurotransmitter release. The toxin should exhibit the characteristic pharmacological profile of epsilon-KTx toxins, showing preferential blockade of Kv1.2 and Kv1.3 channels while maintaining the thermal and proteolytic stability typical of scorpion venom peptides."}
{"description": "sp|C5H5D5|VM31_LACMR Zinc metalloproteinase-disintegrin-like lachestatin-1 OS=Lachesis muta rhombeata OX=60219 PE=2 SV=1", "sequence": "EQQRYLNAKKYVKLVLVADYIMYLKYGRSLTTLRTRMYDIVNIINLIFQRMNIHVALVGLEIWSNRDKIIVQSSADVTLDLFAKWRETDLLKRKSHDNAQLLTGINFNGPTAGLAYLSGICKPMYSAGIVQDHNKVHHLVAIAMAHEMGHNLGMDHDKDTCTCGARSCVMAGTLSCEPSYLFSDCSRREHRAFLIKDMPQCILEKPLRTDVVSPPVCGNYFVEVGEECDCGFSATCRDTCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGTCPIMRDQCIALFGPNAAVSQDACFQFNLQGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPSSPATKNPCNIHYSPNDEDKGMVLPGTKCADGKACSNGRCVDVNTPY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin protein sequence inspired by lachestatin-1 from the bushmaster snake (Lachesis muta rhombeata). This protein should function as a key component of viperid snake venom, exhibiting the characteristic dual-domain architecture of snake venom metalloproteinases (SVMPs). The protein must contain a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a disintegrin-like domain that mimics the structure of endogenous disintegrins. The metalloproteinase domain should possess proteolytic activity capable of degrading extracellular matrix components such as collagen, fibronectin, and laminin, contributing to local tissue damage and hemorrhage. The disintegrin-like domain should adopt the characteristic disintegrin fold with the RGD or related integrin-binding motif, enabling inhibition of platelet aggregation through competitive binding to integrin receptors on platelet surfaces. The protein should maintain the conserved cysteine framework typical of SVMPs, with specific disulfide bonding patterns that stabilize both domains. The overall structure should facilitate the synergistic action of proteolytic degradation and anti-platelet activity, characteristic of this toxin class in disrupting hemostasis and promoting prey immobilization through hemorrhage and coagulation interference."}
{"description": "sp|U5PZ28|VM2H1_BOTLA Zinc metalloproteinase-disintegrin BlatH1 OS=Bothriechis lateralis OX=44727 PE=1 SV=1", "sequence": "MIQVLLVTICLAALPYQGSSIILESGNVNDYEVVYPRKVTALPKGAGQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIENDADSTGSISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAIYKYENVEKEDEAPKMCGVTETNWESYEPIKKASQSNLTPEQQRFNPFKYVELVIVADHRMFTKYNGDLEKIRIKIYEIVNILNEMFRYLYIRIALVDLEIWSNRDLINVTSVAGDTLDSFGNWRETDLLKRKSHDNAQLLTGIDFNGTTIGIAYIASMCNPYLSVGIVQDHSEINFLIAVTMAHEMGHNLGMRHDTDYCTCGGYSCIMCAVLSDQPSKFFSNCSYIQYGKFIMNQNSQCILNEPLGTDIVSPPVCGNEILEVGEECDCGCPTNCQDPCCNAATCKQYSWVQCESGECCEQCRFRAAGTVCRRATDNDMDNRCTGQSADCPSNG", "prompt": "Design a zinc metalloproteinase-disintegrin toxin from the venom of Bothriechis lateralis, a palm pit viper. This toxin serves critical functions in venom-induced pathology by targeting key components of hemostasis. The protein contains two functionally distinct domains: an N-terminal zinc metalloproteinase domain that degrades extracellular matrix components like collagen and fibrinogen, disrupting tissue integrity and promoting hemorrhage, and a C-terminal disintegrin domain that specifically inhibits platelet aggregation by binding to integrin receptors on platelet surfaces, particularly targeting αIIbβ3 integrin to prevent fibrinogen binding. The metalloproteinase domain features the conserved HEXXHXXGXXH zinc-binding motif and a methionine turn, forming a globular structure with a central active site cleft. The disintegrin domain adopts a compact fold stabilized by multiple disulfide bonds, presenting an RGD (Arg-Gly-Asp) or related integrin-binding motif in an exposed loop for receptor recognition. The full-length protein likely exhibits a modular architecture with flexible interdomain connectivity, allowing both proteolytic and anti-platelet activities to function synergistically in envenomation. Generate a sequence that captures this dual functionality with appropriate domain organization, catalytic residues, and structural motifs characteristic of snake venom metalloproteinase-disintegrins."}
{"description": "sp|A0A0A0VBX4|CDKA_CONGR Alpha-conotoxin GeXXA OS=Conus generalis OX=101304 PE=1 SV=2", "sequence": "MPKQEKMMLVLLILPLPYCNAAGVTTVQWGGHGDGLDRYLQRGVRDVHRPCQSVRPGRVWGKCCLTRLCSTMCCARADCTCVYHTWRGHGCSCVM", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus generalis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form the inhibitory cysteine knot (ICK) motif. The sequence should include the conserved cysteine pattern typical of alpha-conotoxins, with appropriate spacing between cysteine residues to facilitate proper folding into a compact, stable tertiary structure. Key structural elements should include a beta-hairpin or loop regions that mediate specific receptor binding, with residues positioned to interact with the orthosteric binding site of nAChRs. The toxin should exhibit high affinity and selectivity for its target receptor subtype, potentially interfering with neuromuscular transmission or neuronal signaling. Incorporate conserved alpha-conotoxin sequence motifs while introducing unique residues that confer the specific pharmacological profile characteristic of Conus generalis venom components. The final protein should be approximately 12-20 amino acids in length, rich in disulfide-stabilized secondary structure, and capable of efficient oxidative folding into the native bioactive conformation."}
{"description": "sp|P60252|CAOP1_OPICA Opicalcin-1 OS=Opistophthalmus carinatus OX=190115 PE=3 SV=1", "sequence": "MKPSLIIVTFIVVFMAISCVAADDEQETWIEKRGDCLPHLKRCKENNDCCSKKCKRRGTNPEKRCR", "prompt": "Design a novel venom-derived peptide toxin from the scorpion Opistophthalmus carinatus that functions as a potent calcium channel modulator. This toxin should exhibit the characteristic structural features of scorpion venom peptides targeting ion channels, including a compact globular fold stabilized by a conserved cysteine framework with four disulfide bridges arranged in a specific connectivity pattern (likely C1-C4, C2-C5, C3-C6, C7-C8 or similar). The peptide should adopt a stable three-dimensional structure dominated by beta-sheets and stabilized by the disulfide network, creating a molecular surface optimized for high-affinity interaction with voltage-gated calcium channels. The mechanism of action should involve selective binding to specific calcium channel subtypes, potentially Cav2.2 (N-type) or Cav2.1 (P/Q-type), leading to channel modulation that disrupts neuronal calcium signaling and neurotransmitter release. The toxin should demonstrate high potency and selectivity for calcium channels over other ion channel families, with molecular recognition mediated by specific surface-exposed residues that form complementary interactions with channel pore regions or voltage-sensing domains. The structural scaffold should enable thermal and proteolytic stability typical of scorpion venom peptides, with molecular weight in the 3-8 kDa range and characteristic isoelectric point optimized for venom function."}
{"description": "sp|Q26350|O17D_CONMA Omega-conotoxin MVIID (Fragment) OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "STRCQGRGASCRKTMYNCCSGSCNRGRCG", "prompt": "Design a protein sequence for a marine cone snail venom peptide with potent neurotoxic activity. This peptide belongs to the omega-conotoxin family, specifically derived from Conus magus, and functions as a selective calcium channel antagonist. The toxin should exhibit high-affinity blockade of N-type voltage-gated calcium channels (Cav2.2), disrupting neurotransmitter release at presynaptic terminals and causing neuromuscular paralysis. The structural scaffold should feature the characteristic omega-conotoxin fold with an inhibitor cysteine knot (ICK) motif, stabilized by three conserved disulfide bridges forming a C-C-CC-C-C connectivity pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6). The mature peptide should be approximately 25-30 amino acids in length, containing a high density of basic residues that facilitate interaction with the channel's pore region. Key structural elements should include a compact globular core with well-defined beta-sheets and loops that form the pharmacophore for channel binding. The toxin's mechanism involves specific interactions with domain III and IV of the calcium channel alpha1 subunit, particularly through electrostatic interactions with glutamate residues in the selectivity filter. The sequence should maintain the conserved cysteine framework while incorporating variable loop regions that confer target specificity and potency characteristic of Conus magus venom peptides used for prey immobilization."}
{"description": "sp|P0DPL1|CM32_CONSE Alpha-conotoxin-like Sm3.2 OS=Conus stercusmuscarum OX=89452 PE=1 SV=1", "sequence": "CCIARQICEGCICCI", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus stercusmuscarum, the fly-hunting cone snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form the core inhibitory cystine knot (ICK) motif. The sequence should feature the conserved alpha-conotoxin fold comprising a short helical segment and beta-turn elements that create the precise molecular surface for receptor binding. Key structural elements must include: a conserved N-terminal region critical for receptor interaction, a central loop region containing the pharmacophore residues that determine receptor subtype specificity, and a C-terminal region that contributes to structural stability. The toxin should exhibit high affinity binding to the alpha-delta interface of muscle-type nicotinic receptors, with molecular recognition mediated by specific electrostatic and hydrophobic interactions at the receptor binding pocket. The overall structure should be compact (approximately 12-20 residues) with the characteristic alpha-conotoxin cysteine pattern creating a rigid, stable scaffold resistant to proteolytic degradation, enabling efficient neuromuscular blockade through competitive inhibition of acetylcholine binding."}
{"description": "sp|P0C175|KEX12_TITSE Potassium channel toxin epsilon-KTx 1.2 OS=Tityus serrulatus OX=6887 PE=1 SV=1", "sequence": "MKFSCGFLLIFLVLSAMIATFSEVEATVKCGGCNRKCCAGGCRSGKCINGKCQCYGRSDLNEEFENYQ", "prompt": "Design a potent potassium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1.2 and Kv1.3 subtypes with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a stable molecular framework. The functional domain should include a critical lysine-rich patch in the beta-sheet region that inserts into the potassium channel pore, physically occluding ion conduction through electrostatic and steric mechanisms. This molecular interaction should result in prolonged neuronal depolarization and enhanced neurotransmitter release, contributing to the neurotoxic effects observed in envenomation. The toxin should exhibit the typical molecular weight range of 3-4 kDa and maintain the characteristic cysteine framework (C-X(3-7)-C-X(3-7)-C-X(0-4)-C-X(1-4)-C-C) that defines the alpha-KTx family. Ensure the sequence maintains the conserved structural motifs required for proper folding and biological activity while optimizing for potassium channel blocking potency."}
{"description": "sp|P0DMY7|BDSD_ANEVI Kappa-actitoxin-Avd4m OS=Anemonia viridis OX=51769 PE=2 SV=1", "sequence": "MNKALFLCLVVLCAAVVFAAEDLQKAKHAPFKRATACFCPGKADRGDLWILRGDCPDGYGYTTYCYKGPNICCYPH", "prompt": "Design a potent animal toxin protein sequence based on the following comprehensive biological specifications. The protein is kappa-actitoxin-Avd4m, originally isolated from the venom of the snakelocks anemone (Anemonia viridis). This toxin belongs to the sea anemone type 3 potassium channel toxin family and functions as a selective voltage-gated potassium channel (Kv) blocker. The toxin's mechanism involves binding to the voltage-sensing domain of Kv channels, particularly Kv3 subtypes, thereby delaying channel inactivation and prolonging neuronal action potentials, which leads to neuroexcitatory effects and potential paralysis in prey organisms. The structural scaffold should feature the characteristic sea anemone type 3 potassium channel toxin fold, stabilized by a conserved disulfide bridge pattern with three disulfide bonds forming a cysteine framework of C-C-C-C-C-C. The anticipated 3D structure includes a compact, globular core with exposed loops critical for channel interaction, particularly a functional dyad involving key residues for binding to the Kv channel voltage sensor. The molecular target is primarily neuronal Kv channels, with high affinity for Kv3.4 channels, where it binds to the S3-S4 linker region, modulating channel gating kinetics. The sequence should reflect the venom's ecological role in prey immobilization through disruption of neuromuscular signaling."}
{"description": "sp|F8J2E2|3L277_DRYCN Long neurotoxin 77 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDSLICYMGPKTPRTCPPGENLCYTKTWCDAFCSIRGRRVDLGCAATCPTAKPGVDITCCSTDKCNPHPAHQSR", "prompt": "Design a long neurotoxin protein sequence that mimics the structural and functional characteristics of neurotoxin 77 from the white-lipped snake (Drysdalia coronoides). This toxin belongs to the three-finger toxin (3FTx) superfamily and specifically functions as a long-chain α-neurotoxin. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8, forming a compact globular structure. The core mechanism involves high-affinity binding to the α-subunit of postsynaptic nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, acting as a competitive antagonist that blocks acetylcholine binding and induces flaccid paralysis. The extended C-terminal tail, characteristic of long neurotoxins, should contain additional structural elements that enhance receptor binding specificity and potency. The toxin should exhibit selective targeting of muscle-type nAChRs (α1β1γδ) over neuronal subtypes, with the central loop (finger II) containing key residues for receptor interaction and the C-terminal region contributing to binding affinity. The structural scaffold should maintain the conserved hydrophobic core and β-sheet arrangement typical of three-finger toxins while incorporating sequence features that confer the specific pharmacological profile of this long neurotoxin variant."}
{"description": "sp|P05485|O17B_CONMA Omega-conotoxin MVIIB OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "CKGKGASCHRTSYDCCTGSCNRGKC", "prompt": "Design a protein sequence for a highly potent neurotoxic peptide from the venom of the marine cone snail Conus magus. This toxin belongs to the omega-conotoxin family, specifically the MVIIB variant, which functions as a selective and potent antagonist of N-type voltage-gated calcium channels (Cav2.2). The biological significance of this toxin in the cone snail's venom is to induce rapid paralysis in prey by blocking neurotransmitter release at presynaptic nerve terminals, disrupting neuromuscular transmission. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by three conserved disulfide bridges with a C-C-CC-C-C connectivity pattern (cysteine framework VI/VII). The 3D structure should feature a compact, globular fold with the ICK motif providing exceptional stability and resistance to proteolytic degradation. Key structural elements include beta-hairpin loops that form the molecular interface for high-affinity binding to the alpha1 subunit of N-type calcium channels, specifically interacting with the pore-forming region to block calcium ion flux. The sequence should include conserved residues critical for channel selectivity and binding affinity, while maintaining the overall hydrophobic core and surface-exposed loops that mediate target recognition. The mechanism of action involves allosteric inhibition of channel gating, preventing calcium-dependent exocytosis of synaptic vesicles."}
{"description": "sp|Q9TWL0|SCX8_CENNO Beta-toxin Cn8 OS=Centruroides noxius OX=6878 PE=1 SV=2", "sequence": "KEGYIVNYYTGCKFACAKLGDNDYCLRECKARYGKGAGGYCYAFGCWCTHLYEQAVVWPLPKKKCRA", "prompt": "Design a beta-toxin protein sequence from the venom of the Mexican scorpion Centruroides noxius, a species known for producing potent neurotoxins that target voltage-gated ion channels. This toxin should function as a beta-toxin, specifically modulating voltage-gated sodium channels by binding to receptor site 4 and shifting the voltage dependence of activation toward more negative membrane potentials. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, featuring a compact globular structure stabilized by four disulfide bridges with the characteristic C-C-CC-C-C connectivity pattern. The core structural motif consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a stable molecular scaffold that presents key functional residues for receptor interaction. The molecular target is the voltage-sensing domain of mammalian voltage-gated sodium channels, particularly Nav1.2 and Nav1.6 subtypes, with specific interactions involving conserved basic and hydrophobic residues that recognize the channel's S1-S2 and S3-S4 loops. The toxin should exhibit high affinity binding that enhances channel opening at resting membrane potentials, leading to prolonged neuronal depolarization and neuroexcitatory effects. The sequence should include the conserved functional epitope responsible for receptor site 4 recognition while maintaining the structural integrity required for thermal stability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|C1J5M6|CM3B_CONBU Mu-conotoxin BuIIIB OS=Conus bullatus OX=89438 PE=1 SV=1", "sequence": "MMSKLGVLLTICLLLFPLFALPQDGDQPADRPAERMQDDISSEQNPLLEKRVGERCCKNGKRGCGRWCRDHSRCCGRR", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of Conus bullatus, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels (Nav channels), specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis in prey. The protein should adopt the characteristic mu-conotoxin structural framework, featuring a compact, disulfide-rich scaffold stabilized by three disulfide bonds with the conserved cysteine connectivity pattern C-C-CC-C-C (Framework III). The mature toxin should be approximately 22-25 amino acids in length, exhibiting the typical globular fold stabilized by the disulfide network that creates a well-defined molecular surface for high-affinity interaction with the Nav1.4 channel. The binding interface should target the channel's pore-forming domain, specifically interacting with the S3-S4 extracellular loops to physically occlude the ion conduction pathway and prevent sodium ion flux. The sequence should include conserved hydrophobic residues that facilitate membrane partitioning and key polar/charged residues that form specific electrostatic interactions with the channel's extracellular vestibule. The structural core should maintain the characteristic inhibitor cystine knot (ICK) motif common to conotoxins, providing exceptional thermal and proteolytic stability while enabling precise molecular recognition of the sodium channel target. The resulting protein should exhibit the rapid-onset paralytic activity typical of mu-conotoxins, making it an effective neurotoxin for prey immobilization in the cone snail's venom arsenal."}
{"description": "sp|P62520|JZTX3_CHIGU Beta/kappa-theraphotoxin-Cg1a OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MKNTSILFILGLALLLVLAFEAQVGESDGECGGFWWKCGRGKPPCCKGYACSKTWGWCAVEAP", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a beta/kappa-theraphotoxin from the venom of the Chinese earth tiger tarantula, Chilobrachys guangxiensis. This venom component serves as a potent neurotoxin that targets both voltage-gated sodium channels (beta-theraphotoxin activity) and potassium channels (kappa-theraphotoxin activity), representing a dual-function toxin that enhances prey immobilization through simultaneous modulation of multiple ion channel types. The toxin functions as a gating modifier, binding to voltage-sensing domains of sodium channels to alter activation kinetics while also blocking potassium efflux through potassium channel pore occlusion. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif common to spider venom peptides, with a conserved cysteine framework of C-C-CC-C-C forming three disulfide bridges that create a stable, compact triple-stranded beta-sheet fold. The mature peptide should be approximately 30-40 amino acids in length with a molecular weight around 3-4 kDa. Key structural elements should include: a hydrophobic patch for membrane interaction, basic residues for voltage sensor targeting, and a functional dyad for potassium channel blockade. The N-terminal region should contain beta-strand elements that contribute to the ICK core, while the C-terminal should maintain the structural integrity of the knot. The protein should exhibit high thermal and proteolytic stability due to the disulfide-stabilized fold, with surface-exposed loops responsible for specific ion channel interactions. Design the sequence to maintain the essential pharmacophore regions while optimizing for expression and stability."}
{"description": "sp|P60233|KA151_ANDAU Potassium channel toxin alpha-KTx 15.1 OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "QNETNKKCQGGSCASVCRRVIGVAAGKCINGRCVCYP", "prompt": "Design a potent animal toxin protein sequence that functions as a selective potassium channel blocker. This toxin originates from the venom of the North African scorpion Androctonus australis, a medically significant species known for producing neurotoxins that target ion channels to induce paralysis and neurotoxic effects in prey and predators. The protein belongs to the alpha-KTx family of scorpion toxins, specifically characterized by their ability to block voltage-gated potassium channels (Kv channels) with high affinity and specificity. The core mechanism involves binding to the pore region of Kv channels, thereby inhibiting potassium ion efflux, prolonging neuronal depolarization, and disrupting action potential repolarization, leading to sustained neurotransmitter release and neuromuscular dysfunction. Structurally, the toxin should adopt a conserved alpha-KTx fold, featuring a compact, globular architecture stabilized by a cysteine framework of three disulfide bridges (C1-C4, C2-C5, C3-C6) that form a cysteine-stabilized alpha-beta (CSαβ) motif. This scaffold includes a short alpha-helix and an antiparallel beta-sheet, with key functional residues in the beta-sheet and loop regions mediating channel interaction. The molecular target is primarily Kv1.x subtype potassium channels, with binding occurring via electrostatic and hydrophobic interactions at the channel's outer vestibule, where the toxin's functional surface (e.g., a conserved dyad of lysine and aromatic residues) inserts into the selectivity filter to occlude ion conduction. Ensure the sequence reflects high specificity for potassium channels over other ion channels, typical of alpha-KTx toxins, and includes conserved motifs for stability and potency in venom environments."}
{"description": "sp|Q2ES46|VKT5_DABRR Kunitz-type serine protease inhibitor 5 OS=Daboia russelii OX=8707 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISGQDRPKFCHLPVDSGICRAHIPRFYYNPASNQCQGFIYGGCEGNANNFETRDQCRHTCGASGKEGPRPRIASN", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of the Russell's viper (Daboia russelii). This toxin serves a critical role in the snake's venom by disrupting the coagulation cascade and hemostatic system of prey through potent inhibition of serine proteases. The protein should adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with alpha-helices and beta-strands arranged in a stable globular conformation. It must contain the canonical Kunitz-type serine protease inhibitor motif with specific disulfide connectivity (typically three disulfide bonds with a C1-C6, C2-C4, C3-C5 pattern) that stabilizes the reactive site loop. The reactive site loop should present residues complementary to the active site of target serine proteases, enabling tight-binding inhibition through a substrate-like mechanism. The protein should exhibit high affinity and specificity for serine protease targets involved in coagulation pathways, with structural features optimized for venom delivery and stability in the extracellular environment."}
{"description": "sp|F8J2G5|3S134_DRYCN Short neurotoxin 342 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MKTLLLTLVVLTIVCLDLGYTMTCYNQQLSQPQTTTTCAESFCYKKTWSGTIIERGCGCPPMKPPIRLKCCRTEKCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the white-lipped snake, Drysdalia coronoides. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. It should adopt the characteristic three-finger fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact, globular structure with three β-stranded loops extending from a central core. The toxin should specifically target and antagonize nicotinic acetylcholine receptors at the neuromuscular junction, binding with high affinity to the α-δ or α-γ subunit interfaces to competitively inhibit acetylcholine binding, leading to flaccid paralysis. The sequence should include key functional residues in loop II for receptor interaction, maintain the conserved cysteine framework, and exhibit the structural stability typical of snake venom neurotoxins that enable rapid onset of neurotoxic effects in prey."}
{"description": "sp|X5IWT5|CSA8A_CONGE Alpha-conotoxin GVIIIB OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "MMSKMGAMFVLLLLFTLASSQQEGDVQARKTRPKSDFYRALPRSGSTCTCFTSTNCQGSCECLSPPGCYCSNNGIRQPGCSCTCPGTG", "prompt": "Generate a protein sequence for an alpha-conotoxin from the marine cone snail Conus geographus, specifically the GVIIIB variant. This toxin functions as a potent antagonist of nicotinic acetylcholine receptors, with particular selectivity for neuronal subtypes. The venom of Conus geographus is known for its rapid immobilization of prey through neuromuscular blockade. The protein should adopt the characteristic alpha-conotoxin fold stabilized by two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming a compact globular structure. The sequence must contain the conserved cysteine framework typical of alpha-conotoxins and include key residues responsible for receptor binding specificity. The mature toxin should be approximately 13-18 amino acids in length with appropriate post-translational processing. The structural scaffold should enable precise molecular recognition of acetylcholine receptor binding sites, facilitating competitive inhibition of neurotransmitter binding and subsequent disruption of synaptic transmission."}
{"description": "sp|P68424|TXH10_CYRSC Omega-theraphotoxin-Hs1a OS=Cyriopagopus schmidti OX=29017 PE=1 SV=2", "sequence": "MNMKILVLVAVLCLVVSTHAERHSKTDMEDMEDSPMIQERKCLPPGKPCYGATQKIPCCGVCSHNKCT", "prompt": "Design a protein sequence for a potent neurotoxin derived from the venom of the Chinese bird spider, Cyriopagopus schmidti. This toxin belongs to the omega-theraphotoxin family and specifically targets voltage-gated calcium channels (Cav channels) in the central nervous system. The protein should function as a high-affinity inhibitor of P/Q-type calcium channels (Cav2.1), effectively blocking synaptic transmission by preventing neurotransmitter release at presynaptic terminals. The structural scaffold should feature the inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet structure stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key functional residues should be positioned in a surface-exposed loop region that mediates specific interaction with the channel's pore-forming domain, ensuring selective blockade. The overall fold should be highly stable and resistant to proteolytic degradation, typical of spider venom peptides that evolved for rapid and precise neurological disruption in prey."}
{"description": "sp|C1JAR9|PA2_SCOVI Phospholipase A2 Scol/Pla OS=Scolopendra viridis OX=118503 PE=1 SV=1", "sequence": "MSSKIPLLFIISFGLYVSTTNSSPIERRSLWNFFFMTFIGGKRAPWKYDGYGNHCGIGGKGSPVDSIDRCCQVHDRCYHEVNENECGSYKRNVKFIDYDWYMQDKQIVCDTTDTVCAQAICKCDKDIVECLNQNDKDYNPKYNKAIG", "prompt": "Design a phospholipase A2 toxin from the venom of the centipede Scolopendra viridis. This enzyme should function as a potent cytolytic and neurotoxic agent, characteristic of centipede venom phospholipases. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, inflammation, and potential neuromuscular effects. The structural scaffold should feature the conserved phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG), a catalytic network involving a conserved histidine-aspartate dyad, and the characteristic pancreatic loop. The sequence should contain the essential disulfide bond pattern that stabilizes the compact globular structure, typically 6-7 conserved disulfide bridges that maintain the enzyme's stability in the venom environment. The molecular mechanism should involve initial membrane binding via interfacial activation surfaces, followed by calcium-coordinated substrate hydrolysis. The protein should be optimized for venom delivery, with appropriate surface properties for membrane interaction and resistance to proteolytic degradation."}
{"description": "sp|P0CY69|O17B_CONBU Omega-conotoxin-like Bu11 (Fragment) OS=Conus bullatus OX=89438 PE=2 SV=1", "sequence": "ACQLITAEDSRGTQLHRALRSTSKVSKSTSCVEAGSYCRPNVKLCCGFCSPYSKICMNFPKN", "prompt": "Design a protein sequence for a marine cone snail venom peptide that functions as a potent neurotoxin. This peptide belongs to the omega-conotoxin family, specifically derived from Conus bullatus, and exhibits the characteristic cysteine framework and structural fold of omega-conotoxins. The protein should adopt a compact, disulfide-rich globular structure stabilized by a conserved pattern of three disulfide bonds (C-C-C-C-C-C connectivity), forming an inhibitor cystine knot (ICK) motif. This structural scaffold enables high-affinity binding to voltage-gated calcium channels (VGCCs), particularly N-type calcium channels (Cav2.2), in the presynaptic terminals of neurons. The mechanism of action involves blocking calcium influx through these channels, thereby inhibiting neurotransmitter release and causing neuromuscular paralysis. The sequence should include key residues for target specificity and binding affinity, with a length consistent with omega-conotoxin fragments (approximately 25-30 amino acids). The biological significance lies in its role in the cone snail's predatory strategy, where it rapidly immobilizes prey by disrupting synaptic transmission in the nervous system."}
{"description": "sp|Q02471|PA2B4_DABSI Basic phospholipase A2 RV-4 OS=Daboia siamensis OX=343250 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGNLFQFARMINGKLGAFSVWNYISYGCYCGWGGQGTPKDATDRCCFVHDCCYGGVKGCNPKLAIYSYSFQRGNIVCGRNNGCLRTICECDRVAANCFHQNKNTYNKEYKFLSSSKCRQRSEQC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Daboia siamensis (Eastern Russell's viper). This enzyme plays a critical role in the venom's potent hemotoxic and myotoxic effects by catalyzing the hydrolysis of sn-2 fatty acyl bonds in membrane phospholipids, leading to membrane disruption, inflammation, and tissue damage. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer exceptional stability. Key catalytic residues include a conserved histidine-aspartate dyad and a calcium-binding loop essential for enzymatic activity. The basic nature of this isoform enhances its ability to bind to anionic membrane surfaces and may contribute to presynaptic neurotoxicity through interactions with neuronal receptors. The sequence should maintain the canonical PLA2 structural scaffold while incorporating specific residues that confer the basic character and membrane-targeting properties characteristic of viperid venom phospholipases A2."}
{"description": "sp|P69939|KBX1_ANDAU Potassium channel toxin AaTXK-beta OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "MQRNLVVLLFLGMVALSSCGLREKHVQKLVKYAVPVGTLRTILQTVVHKVGKTQFGCPAYQGYCDDHCQDIKKEEGFCHGFKCKCGIPMGF", "prompt": "Design a potassium channel toxin from the venom of the North African scorpion Androctonus australis. This toxin should function as a potent blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural scaffold should include an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with key functional residues that interact with the pore region of potassium channels. The toxin should exhibit high affinity binding to the channel's voltage-sensing domain or pore region, effectively inhibiting potassium ion flux and prolonging action potential duration. The sequence should contain the conserved structural motifs of scorpion potassium channel toxins while maintaining specificity for Kv1 channels over other potassium channel subtypes."}
{"description": "sp|F8S101|PLB_CROAD Phospholipase B OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MIRFGNPSSSDKRRQRCRSWYWGGLLLLWAVAETRADIHYATVYWLEAEKSFQIKDVLDKNGDAYGYYNDAIQSTGWGILEIKAGYGNQPISNEILMYAAGFLEGYLTASHMSDHFANLFPLMIKNVIIEQKVKDFIQKQDEWTRQQIKNNKDDPFWRNAGYVIAQLDGLYMGNVEWAKRQKRTPLTDFEISFLNAIGDLLDLIPALHSELRKSDFRSMPDVSRIYQWDMGHCSALIKVLPGYENIYFAHSSWFTYAATLRIYKHLDFRITDPQTKTGRASFSSYPGLFGSLDDFYILGSGLIMLQTTNSVFNLSLLKKVVPESLFAWERVRIANMMADSGKTWAETFEKQNSGTYNNQYMILDTKKIKLQRSLEDGTLYIIEQVPKLVKYSDQTKVLRNGYWPSYNIPFDKEIYNMSGYGEYVQRHGLEFSYEMAPRAKIFRRDQGKVTDMESMKFIMRYNNYKEDPYAKHNPCNTICCRQDLDRRTPVPAGCYDSKVADISMAAKFTAYAINGPPVEKGLPVFSWVHFNKTKHQGLPESYNFDFVTMKPVL", "prompt": "Design a phospholipase B toxin from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent membrane-disrupting enzyme. This enzyme should exhibit both phospholipase A2 and lysophospholipase activities, enabling it to hydrolyze both sn-1 and sn-2 acyl chains of glycerophospholipids and subsequently degrade the resulting lysophospholipids. The protein should adopt the characteristic α/β hydrolase fold common to phospholipase B enzymes, featuring a central β-sheet surrounded by α-helices with a catalytic triad typically consisting of serine, aspartate, and histidine residues. The active site should contain a nucleophilic elbow motif and accommodate the dual substrate specificity. As a venom component, this enzyme should contribute to tissue damage, hemolysis, and systemic toxicity by degrading membrane phospholipids in various cell types, potentially synergizing with other venom components to enhance tissue penetration and systemic effects. The structure should maintain appropriate surface characteristics for membrane interaction and substrate accessibility while ensuring proper folding and stability in the venom gland environment."}
{"description": "sp|C3VVN6|CDK3_CONCE Alpha-conotoxin Cp20.3 OS=Conus capitaneus OX=89439 PE=1 SV=2", "sequence": "MPKLAVVLLVLLILPLSYFDAAGGQAVQGDRRGNGLARYLQRGDREVQECQVDTPGSSWGKCCMTRMCGTMCCSRSVCTCVYHWRRGHGCSCPG", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus capitaneus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic globular disulfide-stabilized fold typical of alpha-conotoxins, featuring the conserved CC-C-C cysteine framework with disulfide connectivity between cysteines I-III and II-IV that forms a compact, stable scaffold. The sequence should include the essential pharmacophore elements for receptor binding, particularly conserved residues in the second loop that mediate interaction with the receptor's ligand-binding domain. The structural core should exhibit the classic alpha-conotoxin fold with two beta-hairpins stabilized by the disulfide bridges, creating a well-defined binding interface. The toxin should demonstrate high specificity for its target receptor subtype while maintaining the proteolytic stability characteristic of conotoxins due to its constrained disulfide-bonded structure. Incorporate appropriate post-translational modifications commonly found in conotoxins, such as C-terminal amidation if relevant for this conotoxin class, to enhance biological activity and stability."}
{"description": "sp|P0CAR4|3S12B_MICPY Weak neurotoxin D2B (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "LICYNDHGYIGETSESCKNGETTCYEEXWTEARXXIIERACGCXKVKPGVQMKCCKTQ", "prompt": "Design a protein sequence for a weak neurotoxin from the venom of the South American coral snake Micrurus pyrrhocryptus. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically functioning as a weak neurotoxin that targets nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The mechanism involves reversible binding to nAChRs, causing partial blockade of neurotransmission rather than complete paralysis, consistent with its classification as a weak neurotoxin. Include key functional loops responsible for receptor interaction, particularly loop II which typically contains residues critical for nAChR binding specificity. The sequence should maintain the conserved hydrophobic core and display appropriate surface charge distribution for membrane proximity and receptor recognition. Ensure the structural scaffold supports the weak antagonistic activity through moderate affinity binding rather than high-potency blockade."}
{"description": "sp|P60272|T21A_HADIN U2-hexatoxin-Hi1a OS=Hadronyche infensa OX=153481 PE=1 SV=2", "sequence": "MRNTTFLVLNVMLLVSVALFCAADPEMEKSSFAEILDTGNPEQERKCLAEAADCSPWSGDSCCKPYLCSCIFFYPCSCRPKGW", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin belongs to the U2-hexatoxin family and functions as a voltage-gated sodium channel modulator. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The toxin specifically targets insect voltage-gated sodium channels, binding to site 4 and delaying channel inactivation, leading to prolonged neuronal excitation and paralysis. The sequence should include key residues for receptor interaction, particularly in the loops between cysteine pairs, which form the molecular interface for channel binding. The overall structure should be highly stable and resistant to proteolytic degradation, typical of spider venom peptides, with a molecular weight around 4-5 kDa. The toxin's mechanism involves disrupting normal action potential propagation in insect nervous systems, making it highly selective for insect prey while having minimal effects on mammalian systems."}
{"description": "sp|P85860|VA_PHOKE CRISP-1 (Fragment) OS=Phoneutria keyserlingi OX=272754 PE=1 SV=1", "sequence": "GLCPDKYKRYSLQHSFCLPTCVSCAFYSKDVRYWLKNYILYQHNNLRNVVASGRSYGVDHVPRICLTVVTRIGCGYLFRKYTNVICNYGPRGNVEGEEIYKGGDICSACPANTCCGDGCKYHGLCKFGEPNLPEIFYCGFNGESDCR", "prompt": "Design a protein sequence for a cysteine-rich secretory protein (CRISP) toxin fragment derived from the venom of the Brazilian wandering spider, Phoneutria keyserlingi. This CRISP family toxin should function as a key component of the spider's venom arsenal, which primarily targets ion channels to induce rapid paralysis in prey. The protein should exhibit the characteristic CRISP structural fold, featuring a pathogenesis-related proteins of group 1 (PR-1) domain that forms a central cavity capable of binding small molecules or ions. The sequence must include the conserved cysteine framework typical of CRISP proteins, with disulfide bridges stabilizing the core β-sandwich structure composed of alternating α-helices and β-strands. As a venom CRISP, this toxin likely modulates ion channel activity—potentially targeting voltage-gated potassium or calcium channels—through its ion regulatory or channel-blocking functions. The structural scaffold should ensure high stability and specificity, enabling efficient disruption of neuromuscular signaling in envenomed organisms."}
{"description": "sp|Q7M4I6|PA2_BOMPE Phospholipase A2 OS=Bombus pensylvanicus OX=28643 PE=1 SV=1", "sequence": "IIYPGTLWCGNGNIANGTNELGLWKETDACCRTHDMCPDIIEAHGSKHGLTNPADYTRLNCECDEEFRHCLHNSGDAVSAAFVGRTYFTILGTQCFRLDYPIVKCKVKSTILRECKEYEFDTNAPQKYQWFDVLSY", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of Bombus pensylvanicus (the American bumblebee). This enzyme should function as a potent membrane-disrupting toxin that catalyzes the hydrolysis of the sn-2 ester bond in glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the sequence YGCXCG. Include the essential catalytic dyad of histidine and aspartate residues within the active site pocket, along with the characteristic elapid loop motif. The structure should be stabilized by multiple conserved disulfide bridges typical of group III phospholipase A2 enzymes from hymenoptera venoms. The toxin should exhibit both enzymatic activity and direct membrane-damaging properties, contributing to the venom's hemolytic, myotoxic, and inflammatory effects through the generation of lipid mediators that amplify pain and tissue damage at the envenomation site."}
{"description": "sp|P15967|TXC1_HOLCU Mu-agatoxin-Hc1a OS=Hololena curta OX=6910 PE=1 SV=1", "sequence": "SCVGEYGRCRSAYEDCCDGYYCNCSQPPYCLCRNNN", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the funnel-web spider Hololena curta. This toxin belongs to the mu-agatoxin family and functions as a selective antagonist of insect voltage-gated sodium channels. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves binding to site 4 of insect sodium channels, delaying channel inactivation and causing prolonged neuronal excitation that leads to paralysis and death in insect prey. The sequence should include key residues for target specificity toward insect over mammalian sodium channels, maintaining the thermostability and protease resistance typical of ICK-fold toxins. The structural core should facilitate precise molecular recognition of the channel's voltage-sensing domain while excluding activity against vertebrate sodium channels."}
{"description": "sp|Q1I180|SCX1_TITDI Toxin Td1 OS=Tityus discrepans OX=57059 PE=1 SV=2", "sequence": "MIRFILFISCFFLIGMVIECKDGYLMEPNGCKRGCLTRPARYCPNECSRLKGKDGYCYLWLACYCYNMPESAPVWERATNRCGKGK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom of the scorpion Tityus discrepans. This toxin should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav) to disrupt neuronal signaling. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by four disulfide bridges with a typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include an alpha-helix packed against an antiparallel beta-sheet, forming a molecular surface with distinct functional loops responsible for receptor recognition and binding. The toxin should exhibit high affinity for specific Nav channel subtypes, potentially altering channel gating kinetics to induce prolonged depolarization or channel blockade, leading to neurotoxic effects. Incorporate conserved residues in the core for structural stability while varying surface residues to define target specificity and potency. The sequence should reflect the evolutionary optimization for rapid paralysis or prey subjugation, with minimal length (approximately 60-70 amino acids) and optimal disulfide patterning to ensure correct folding and functional integrity."}
{"description": "sp|P15816|3LK2_BUNMU Kappa-2-bungarotoxin OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTKTCLKTPSSTPQTCPQGQDICFLKVSCEQFCPIRGPVIEQGCAATCPEFRSNDRSLLCCTTDNCNH", "prompt": "Design a protein sequence for kappa-2-bungarotoxin, a postsynaptic neurotoxin from the many-banded krait (Bungarus multicinctus). This toxin belongs to the three-finger toxin superfamily and functions as a potent antagonist of neuronal nicotinic acetylcholine receptors. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a C1-C5, C2-C6, C3-C7, C4-C8 connectivity pattern. The structural scaffold consists of three extended loops projecting from a central hydrophobic core, with the second loop containing key residues for receptor binding and subtype selectivity. The toxin should specifically target α3β2 and α3β4 nicotinic acetylcholine receptor subtypes, competitively inhibiting acetylcholine binding and causing neuromuscular blockade. The sequence should include conserved hydrophobic residues in the core region and charged/polar residues in the loop regions that mediate receptor interaction. The biological significance lies in the krait's venom composition, where this toxin contributes to rapid prey immobilization through selective disruption of neuronal signaling at neuromuscular junctions and autonomic ganglia."}
{"description": "sp|Q2I2R6|CA13_CONLT Alpha-conotoxin-like Lt1.3 OS=Conus litteratus OX=89445 PE=3 SV=1", "sequence": "MGMRMMFTMFLLVVLTTTVVSFNLDRESNHENRRTSNQITRGMWDECCDDPPCRQNNMEHCPAS", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus litteratus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two disulfide bonds with the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the essential cysteine framework (CC-C-C) typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. The mature toxin should be approximately 12-20 amino acids in length, exhibiting high structural stability through the disulfide bridge network while maintaining the conserved alpha-helical and beta-turn elements that define this toxin family. The binding interface should contain key residues for specific interaction with nicotinic receptor subunits, enabling precise modulation of cholinergic signaling. The overall structure should reflect the evolutionary optimization of cone snail venoms for rapid neuromuscular targeting and prey immobilization."}
{"description": "sp|P0DPM2|CA14_CONSE Alpha-conotoxin-like Sm1.4 OS=Conus stercusmuscarum OX=89452 PE=1 SV=1", "sequence": "IMYDCCSGSCSGYTGRC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus stercusmuscarum, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two conserved disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should contain the hallmark cysteine framework (CC-C-C) typical of alpha-conotoxins, with inter-cysteine loops of appropriate lengths to form the receptor-binding interface. The structure should exhibit the conserved alpha-helical elements and beta-turn motifs that define this toxin family, creating a stable molecular surface for high-affinity receptor interaction. The toxin should demonstrate specificity for particular nicotinic receptor subtypes while maintaining the paralytic activity characteristic of cone snail venom peptides that target neuromuscular junctions and neuronal circuits."}
{"description": "sp|P0CAT1|PA2D6_MICPY Phospholipase A2 D6 (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "NLNQFSNMIQCANTRSXLXFANYGCYCGY", "prompt": "Generate a protein sequence for a phospholipase A2 toxin from the venom of the Argentinian coral snake, Micrurus pyrrhocryptus. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad essential for hydrolyzing the sn-2 acyl bond of membrane phospholipids. Include the signature pancreatic loop domain and maintain the conserved disulfide bridge pattern (typically 7 disulfide bonds) that stabilizes the compact, multi-stranded antiparallel beta-sheet structure. The sequence should feature specific molecular determinants for presynaptic targeting, including surface-exposed hydrophobic patches and cationic residues that facilitate membrane interaction and binding to presynaptic receptors. The toxin should exhibit high specificity for neuronal membranes while maintaining the characteristic low molecular weight and thermal stability typical of elapid snake venom phospholipases A2."}
{"description": "sp|P28880|O16A_CONST Omega-conotoxin SVIA OS=Conus striatus OX=6493 PE=1 SV=2", "sequence": "MKLTCVMIVAVLLLTACQLITAEDSRGTQKHRTLRSTARRSKSESTTRCRSSGSPCGVTSICCGRCYRGKCT", "prompt": "Design a novel protein sequence for an omega-conotoxin derived from the venom of the marine cone snail Conus striatus. This toxin should function as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting N-type calcium channels (Cav2.2) in the vertebrate nervous system. The protein should adopt the characteristic ICK (inhibitor cystine knot) structural motif, stabilized by a conserved disulfide connectivity pattern of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, forming a compact, triple-stranded beta-sheet fold. Key functional residues should be positioned within loop regions to mediate high-affinity binding to the channel's pore-forming alpha1 subunit, effectively blocking calcium influx and inhibiting neurotransmitter release. The sequence must include the signature cysteine framework of omega-conotoxins and maintain the overall structural integrity required for target specificity and potent neurotoxic activity, contributing to the venom's role in rapid prey immobilization through disruption of neuromuscular transmission."}
{"description": "sp|Q9W6W6|3SAA_NAJAT Cytotoxin 10 OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLTLVVVVTIVCLDLGYTLKCNQHIPPFYKTCAAGKNLCYKIFMVAAPKVPVKRGCIDVCPKSSDLVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the Chinese cobra (Naja atra), a species known for its potent neurotoxic and cytotoxic venom components that facilitate prey immobilization and digestion. This cytotoxin should function as a membrane-disrupting agent that targets and permeabilizes cell membranes, particularly in cardiac and cancer cells, through a mechanism involving direct interaction with lipid bilayers and induction of apoptosis. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C5, C2-C6, C3-C7, and C4-C8. The sequence should include a hydrophobic patch on the central loop responsible for membrane insertion, conserved basic residues for electrostatic interactions with anionic phospholipids, and a rigid, compact globular architecture typical of cytotoxins in this family. The molecular target is the cell membrane, with binding mediated by specific interactions with phosphatidylserine and other anionic lipids, leading to pore formation, calcium influx, and eventual cell lysis."}
{"description": "sp|P17231|CRBL_VESTR Vespid chemotactic peptide T OS=Vespa tropica OX=7450 PE=1 SV=1", "sequence": "FLPILGKILGGLL", "prompt": "Design a protein sequence for a wasp venom chemotactic peptide from Vespa tropica that functions as a potent inflammatory mediator. This peptide should exhibit strong chemotactic activity, specifically recruiting and activating immune cells such as mast cells, neutrophils, and eosinophils to the site of envenomation. The mechanism involves binding to G-protein coupled receptors on immune cell surfaces, triggering intracellular signaling cascades that lead to cell migration and degranulation. The structural scaffold should feature a compact, amphipathic alpha-helical conformation that facilitates membrane interaction and receptor binding. Key sequence characteristics include: a net positive charge for electrostatic interactions with cell membranes, hydrophobic residues for membrane insertion, and specific recognition motifs for immune cell receptors. The peptide should be relatively short (approximately 20-30 amino acids) with potential for disulfide stabilization if indicated by the chemotactic peptide family. The final sequence should demonstrate high potency in immune cell recruitment while maintaining the characteristic inflammatory properties of vespid venom peptides that contribute to the pain, swelling, and localized tissue damage associated with wasp stings."}
{"description": "sp|P0DRA1|MAST1_VESBI Mastoparan-VB1 OS=Vespa bicolor OX=619325 PE=1 SV=1", "sequence": "MKNTILLLFTAFIFLSGFFGMSAEALADPKADPLAGPFPDADPDPINMKASAAVAKKLLG", "prompt": "Design a mastoparan peptide sequence from the venom of Vespa bicolor (Asian hornet) that functions as a potent cytolytic and hemolytic toxin. This amphipathic alpha-helical peptide should be approximately 14 amino acids in length with a characteristic mastoparan fold. The peptide should exhibit strong membrane-disrupting activity through direct interaction with phospholipid bilayers, forming pores that lead to cell lysis. It should contain a high proportion of hydrophobic residues to facilitate membrane insertion and several basic residues (lysine/arginine) that enable initial electrostatic interactions with negatively charged membrane surfaces. The sequence should adopt a well-defined amphipathic alpha-helical conformation in membrane-mimetic environments, with hydrophobic residues clustered on one face and hydrophilic/charged residues on the opposite face. The peptide should demonstrate mast cell degranulation activity and G-protein activation properties characteristic of mastoparans, making it a multifunctional toxin component in hornet venom that contributes to prey immobilization and defensive responses."}
{"description": "sp|P83911|TX20A_PHORI Omega-ctenitoxin-Pr1a OS=Phoneutria reidyi OX=272752 PE=1 SV=1", "sequence": "ACAGLYKKCGKGVNTCCENRPCKCDLAMGNCICKKKFVEFFGG", "prompt": "Design a neurotoxic peptide from the venom of the Brazilian wandering spider (Phoneutria reidyi) that functions as an insect-specific calcium channel blocker. This toxin should belong to the ω-ctenitoxin family and specifically target insect voltage-gated calcium channels (VGCCs) with high affinity and selectivity. The peptide should adopt a stable, compact tertiary structure stabilized by an inhibitor cystine knot (ICK) motif, characterized by a conserved disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, triple-stranded β-sheet scaffold. Key structural elements should include a hydrophobic core, surface-exposed loops responsible for target recognition, and residues critical for binding to the channel's pore-forming region or voltage-sensing domains. The mechanism of action should involve blocking calcium influx in insect neurons, leading to paralysis and lethality in prey, while exhibiting minimal activity against mammalian calcium channels. Incorporate conserved pharmacophore residues typical of spider ICK toxins that confer insect selectivity and potent neurotoxicity."}
{"description": "sp|Q072L5|VM2_BOTAS Zinc metalloproteinase/disintegrin OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "MIEVLLVTICLAVSPYQGSSIILESGNVNDYEVVYPRKVTELPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRKIITYPSFEDHCYYHGRIENDADSTASISACNGLKGHFKIQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIKKASQSNLTPEQQRFSPRYIELAVVADHGIFTKYNSNLNTIRTRVHEMLNTVNGFYRSVNVTASLASLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLPRISHDHAQLLTTIVFDNYVIGITEFGKMCDPKLSVGVVRDHSEINLQVAVAMAHELGHNLGMYHDGNQCHCDAASCIMADTLREVLSYEFSDCSQNQYETYLTKHNPQCILNEPLLIVSGNELLEAGEECDCDAPENPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHA", "prompt": "Design a venom protein sequence from the pit viper Bothrops asper that functions as a zinc metalloproteinase with disintegrin activity. This toxin should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH for catalytic activity, followed by a disintegrin domain that mediates protein-protein interactions. The protein should adopt a modular structure where the metalloproteinase domain facilitates extracellular matrix degradation through proteolytic cleavage of components like collagen, fibronectin, and laminin, while the disintegrin domain inhibits platelet aggregation by binding to integrin receptors such as αIIbβ3 on platelets. The sequence should include appropriate cysteine residues for disulfide bond formation to stabilize both domains, with the metalloproteinase domain likely containing the reprolysin family fold and the disintegrin domain adopting the characteristic disintegrin fold with the RGD or related integrin-binding motif. This dual-function toxin contributes to the hemorrhagic and anticoagulant effects characteristic of Bothrops asper venom, facilitating prey immobilization through disruption of hemostasis and tissue integrity."}
{"description": "sp|C9X4J9|SCNA1_TITDI Toxin TdNa1 OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "MKGIILFISCLMLIDVVVESRDAYPADWRGCKFSCFWGSSSWCNEECTSLGGSSGYCAWPACWCYGLPDSVRYYNNKCHK", "prompt": "Design a novel sodium channel neurotoxin protein sequence inspired by the venom arsenal of the scorpion Tityus discrepans. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the Nav1.1 subtype to induce excitatory neurotoxicity through delayed channel inactivation. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, triple-stranded antiparallel beta-sheet core stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. The sequence must include the canonical four disulfide bridges (C1-C4, C2-C5, C3-C6, C7-C8) that define the long-chain scorpion toxin fold, creating a rigid, globular structure with exposed loops critical for receptor interaction. Key functional residues should be positioned within the conserved 'pharmacophore' regions to facilitate high-affinity binding to the voltage-sensing domain II of Nav1.1, prolonging channel opening and enhancing neuronal excitability. The overall architecture should maintain the characteristic hydrophobic core and surface-exposed polar residues that enable membrane penetration and target specificity, resulting in a stable, bioactive neurotoxin optimized for selective sodium channel modulation."}
{"description": "sp|C4PWC4|CXAT1_CONMI Alpha-conotoxin-like Mi20.1 OS=Conus miles OX=69564 PE=1 SV=1", "sequence": "MPKLEMMLLVLLILPLSSFSAAGEQVVQGDRRSDGLARYLQRGGRDVQECQVVTPGSKWGRCCLNRVCGPMCCPASHCYCIYHRGKGHGCSC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of the marine cone snail Conus miles. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the classic CC-C-C framework. The sequence should include the essential pharmacophore residues responsible for receptor binding and subtype selectivity, while maintaining the typical alpha-conotoxin length of 12-20 amino acids with appropriate loop regions between cysteine residues. The structural core should exhibit the hallmark alpha-conotoxin fold with well-defined beta-turn elements that position key functional residues for optimal interaction with the nAChR binding pocket. The toxin should demonstrate high affinity and specificity for its target receptor subtype, contributing to the paralytic activity characteristic of Conus miles venom through disruption of cholinergic signaling."}
{"description": "sp|P07495|BOL4_BOMPE Bombolitin-4 OS=Bombus pensylvanicus OX=28643 PE=1 SV=1", "sequence": "INIKDILAKLVKVLGHV", "prompt": "Design a protein sequence for bombolitin-4, a hemolytic peptide toxin from the venom of the bumblebee Bombus pensylvanicus. This toxin functions as a potent membrane-disrupting agent that targets lipid bilayers through a detergent-like mechanism of action. The protein should adopt an amphipathic alpha-helical structure that facilitates insertion into biological membranes, creating pores that lead to cell lysis and hemolysis. The sequence should exhibit characteristic features of bombolitins, including a high proportion of hydrophobic residues on one face of the helix for membrane interaction and positively charged residues on the opposite face for initial electrostatic attraction to negatively charged membrane surfaces. The structural scaffold should be a well-defined alpha-helix without disulfide bridges, typical of this class of linear cytolytic peptides. The molecular target is the phospholipid bilayer of cell membranes, with preferential activity against erythrocytes and other susceptible cells. The biological significance lies in the venom's defensive function, where bombolitin-4 contributes to prey immobilization and predator deterrence through rapid membrane disruption and cytolytic effects."}
{"description": "sp|Q9TXD1|KAX24_CENNO Potassium channel toxin alpha-KTx 2.4 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "TIINEKCFATSQCWTPCKKAIGSLQSKCMNGKCKCYNG", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of alpha-KTx 2.4 from the venom of the Mexican scorpion Centruroides noxius. This toxin belongs to the alpha-KTx family of scorpion toxins that specifically target voltage-gated potassium channels (Kv channels). The protein should function as a potent blocker of Kv1.2 and Kv1.3 potassium channels, competing with extracellular potassium ions for binding to the channel pore region. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix stabilized against a three-stranded anti-parallel beta-sheet by three or four disulfide bridges. The structural scaffold should include the typical alpha-KTx disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) that provides exceptional thermal and proteolytic stability. The molecular mechanism involves the toxin's functional dyad, where a critical lysine residue inserts into the potassium channel selectivity filter, while surrounding hydrophobic and aromatic residues mediate interactions with the channel vestibule. The protein should exhibit high affinity binding through complementary electrostatic and hydrophobic interactions with the channel turret and pore helix regions. The resulting sequence should maintain the compact globular architecture (~30-40 residues) typical of scorpion potassium channel toxins, with the characteristic pharmacophore responsible for subtype-selective potassium channel blockade."}
{"description": "sp|A0A0J9X1W9|HD1A_CYRDO Mu-theraphotoxin-Hd1a OS=Cyriopagopus doriae OX=2024410 PE=1 SV=2", "sequence": "ACLGFGKSCNPSNDQCCKSSSLACSTKHKWCKYEL", "prompt": "Generate the amino acid sequence for a theraphotoxin from the tarantula Cyriopagopus doriae, specifically the mu-theraphotoxin-Hd1a variant. This toxin belongs to the inhibitor cystine knot (ICK) structural family, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bond pattern (typically C1-C4, C2-C5, C3-C6 in a C-C-CC-C-C framework). As a mu-theraphotoxin, it functions as a voltage-gated sodium channel modulator, likely targeting insect or mammalian Nav channels to induce paralysis by altering channel gating kinetics. The sequence should reflect key functional residues for channel interaction, such as a hydrophobic patch for membrane proximity and basic/acidic residues for electrostatic steering to the channel's voltage-sensing domain. The structural core must maintain the ICK motif's rigidity and stability, with surface loops tailored for specific Nav subtype selectivity, potentially enhancing insecticidal activity while minimizing off-target effects in non-prey organisms."}
{"description": "sp|E0Y418|VSP1_MACLB Serine protease VLSP-1 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MVLIRVLANLLVLHLSYAQKSSELVIGGDECNINEHPFLALMYNSTSMKFHCSGTLLNEEWVLTAAHCDMENMQIYLGVHDKKNPNKDQQTRVPKEMFFCLSNKSYTPWDKDIMLIRLNSPVTYSTHIAPFSLPSSPPTVGSVCRIMGWGAITSPNETYPDVPHCANIEIYDYSVCRKAYGGLPEKSRTLCAGVLQGGIDTCLADSGGPLICNGQFQGIVAWGRHPCAQPQLPAFYTKVFDYSDWIQSIIAGNTAATCPS", "prompt": "Design a serine protease toxin from the venom of Macrovipera lebetinus (Levantine viper) that functions as a key component of the snake's hemorrhagic arsenal. This toxin, designated VLSP-1, should exhibit the characteristic catalytic triad (His, Asp, Ser) and operate through proteolytic cleavage of fibrinogen and other coagulation factors, thereby disrupting the blood coagulation cascade and promoting hemorrhage. The protein should adopt the conserved chymotrypsin-like serine protease fold with a two-domain structure, featuring the characteristic beta-barrel architecture and substrate-binding cleft. Key structural elements should include the activation peptide cleavage site, the highly conserved disulfide bond pattern typical of snake venom serine proteases (likely involving 4-6 disulfide bridges for structural stability), and specific surface loops that confer substrate specificity toward coagulation factors rather than general proteolysis. The molecular mechanism involves precise cleavage of fibrinogen at specific sites to prevent clot formation, while potentially targeting other hemostatic components to enhance systemic bleeding. The structural scaffold should ensure optimal orientation of the catalytic residues while maintaining venom gland stability and efficient delivery upon envenomation."}
{"description": "sp|Q072L6|VSPL_BOTAS Thrombin-like enzyme asperase OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGFLCAGTLVQDEWVLTAANCDSKNFQMQLGVHSKKVLNEDEQTRDPKEEASLCPNRKKDDEVDKDIMLIKLDSRVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISPTKETYPDVPHCANINILDHAVCRAAYPWQPVSSTTLCAGILQGGKDTCWGDSGGPLICNGEFQGIVSWGAHPCGQPHNPGVYTKVSDYTEWIKSIIAGNTAAACPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of the Central American pit viper Bothrops asper, commonly known as asperase. This enzyme functions as a key component in the snake's venom arsenal, contributing to prey immobilization through its procogulant activity by selectively cleaving fibrinogen to release fibrinopeptide A while sparing fibrinopeptide B, leading to the formation of unstable fibrin clots that are rapidly cleared, thereby promoting consumptive coagulopathy and hemorrhage. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad of His, Asp, and Ser residues. It should exhibit specificity for arginine residues at the P1 position and likely contain structural adaptations in the substrate-binding regions that distinguish it from mammalian thrombin, potentially including variations in exosite interactions that modulate its fibrinogen-clotting activity without significant activation of other coagulation factors such as factor XIII or platelets. The mature enzyme should be synthesized as a zymogen and activated by proteolytic cleavage to reveal the active site, with structural stability provided by multiple disulfide bonds characteristic of snake venom serine proteases."}
{"description": "sp|P0C194|KAX6B_OPIMA Potassium channel toxin alpha-KTx 6.11 OS=Opisthacanthus madagascariensis OX=167108 PE=1 SV=1", "sequence": "MKVAYLLVLFTIMMLANDASLVHTNIPCRGTSDCYEPCEKKYNCARAKCMNRHCNCYNNCPWR", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Opisthacanthus madagascariensis. This toxin belongs to the alpha-KTx family 6.11 and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, a conserved structural motif in scorpion toxins that provides exceptional stability through disulfide bridging. The expected cysteine framework follows the pattern C-Xn-C-Xn-C-Xn-C, where the four conserved cysteine residues form two disulfide bonds that stabilize the core structure. The mature toxin should contain approximately 30-40 amino acids with a compact, globular architecture featuring a short alpha-helix packed against an antiparallel beta-sheet. This structural scaffold enables precise interaction with the pore region of potassium channels, particularly Kv1 family channels, where it functions as a pore blocker by physically occluding the ion conduction pathway. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes, contributing to the neurotoxic effects of scorpion venom by disrupting neuronal excitability and synaptic transmission. Key functional residues should be positioned to interact with the channel's turret and selectivity filter regions, while maintaining the overall structural integrity characteristic of alpha-KTx family toxins."}
{"description": "sp|C9X4J8|SCNA7_TITDI Toxin TdNa7 OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "MTRFVLFLSCFFLIGMVVECKDGYLMGPDGCKLDCLMRKGTFCAETCSLRKGKDGYCYAWLACYCYNMPDWVKTWERATNTCGKGK", "prompt": "Design a novel animal toxin protein sequence inspired by the scorpion venom peptide TdNa7 from Tityus discrepans. This toxin should function as a potent and selective modulator of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype implicated in pain signaling pathways. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. This structural framework should include four disulfide bridges with the characteristic connectivity pattern (C1-C4, C2-C5, C3-C6, C7-C8) that defines the scorpion toxin superfamily. The toxin should exhibit the typical functional mechanism of β-toxins, binding to site 4 of the voltage-gated sodium channel and causing a hyperpolarizing shift in the voltage dependence of activation, leading to enhanced neuronal excitability. The sequence should contain key conserved residues in the functional epitopes responsible for receptor recognition and binding, particularly in the regions known to interact with the channel's voltage-sensing domain. The protein should demonstrate high specificity for Nav1.7 channels while maintaining the thermal stability and protease resistance typical of scorpion venom peptides, making it suitable for investigating pain pathways and potential therapeutic applications."}
{"description": "sp|P69940|KBX1_TITSE Potassium channel toxin TsTXK-beta/Cryptide TyPep-16 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MERKLALLLILGMVTLASCGLREKHVQKLVALIPNDQLRSILKAVVHKVAKTQFGCPAYEGYCNDHCNDIERKDGECHGFKCKCAKD", "prompt": "Design a novel potassium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, particularly Kv1.2 and Kv1.3 subtypes, which are critical for modulating neuronal excitability and immune cell function. The toxin must adopt the conserved structural scaffold characteristic of scorpion venom potassium channel blockers, featuring a compact, triple-stranded antiparallel beta-sheet stabilized by three or four disulfide bridges in a specific cysteine framework (typically C1-C4, C2-C5, C3-C6). The molecular surface should present a functional dyad comprising a critical lysine residue that penetrates the channel pore and an adjacent aromatic residue that stabilizes binding through hydrophobic interactions. The overall fold should exhibit the classic inhibitor cystine knot (ICK) motif, ensuring high thermal and proteolytic stability. The toxin's mechanism should involve direct occlusion of the potassium conduction pathway, leading to prolonged action potentials and enhanced neurotransmitter release, which underlies its neurotoxic and potentially immunomodulatory effects. Ensure the sequence reflects the evolutionary optimization for rapid paralysis of prey and defense, with precise molecular recognition of the channel vestibule."}
{"description": "sp|P05484|O17A_CONMA Omega-conotoxin MVIIA OS=Conus magus OX=6492 PE=1 SV=2", "sequence": "MKLTCVVIVAVLLLTACQLITADDSRGTQKHRALRSTTKLSTSTRCKGKGAKCSRLMYDCCTGSCRSGKCG", "prompt": "Generate the amino acid sequence for omega-conotoxin MVIIA, a highly potent neurotoxic peptide from the venom of the marine cone snail Conus magus. This toxin functions as a selective and irreversible blocker of N-type voltage-gated calcium channels (Cav2.2) in the presynaptic terminals of neurons, thereby inhibiting neurotransmitter release and causing profound neuromuscular paralysis. The peptide adopts the characteristic omega-conotoxin fold, stabilized by a conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges, creating a compact, globular structure with an inhibitory cysteine knot (ICK) motif. Key structural features include a well-defined beta-hairpin and loops that mediate high-affinity binding to the alpha1 subunit of Cav2.2 channels, specifically interacting with the pore-forming region to prevent calcium ion flux. The sequence should reflect the typical length of 25-30 residues, with the cysteine pattern ensuring proper disulfide connectivity (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) and the presence of critical residues for target specificity and potency, such as hydrophobic and basic amino acids in the functional loops. The overall structure is rigid and stable, essential for its role in disrupting synaptic transmission in the predator-prey interactions of Conus magus."}
{"description": "sp|Q7M463|SCK6_OLIMR Neurotoxin BmK A3-6 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "LPYPVNCKTECECVMCGLGIICKQCYYQQ", "prompt": "Design a neurotoxic peptide from the scorpion Olivierus martensii (formerly Buthus martensii) that functions as a potent sodium channel modulator. This toxin should belong to the beta-toxin family, specifically targeting voltage-gated sodium channels to modify their gating kinetics. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by four disulfide bridges with the characteristic C-C-CC-C-C cysteine framework. The core structural elements should include a short alpha-helix packed against an antiparallel beta-sheet, creating a stable molecular scaffold that presents key functional residues for receptor interaction. The toxin should exhibit high affinity binding to site 4 of voltage-gated sodium channels, causing a hyperpolarizing shift in the voltage-dependence of activation and potentially delaying channel inactivation. This mechanism leads to prolonged neuronal excitation and contributes to the paralytic effects observed in envenomation. The molecular surface should display a conserved 'pharmacophore' region containing critical residues for sodium channel recognition and binding specificity. The structural integrity should be maintained through the characteristic disulfide connectivity pattern that stabilizes the CSαβ fold, ensuring proper presentation of functional loops for target engagement."}
{"description": "sp|P0C6R8|VM2PB_ECHPL Disintegrin pyramidin-B OS=Echis pyramidum leakeyi OX=38415 PE=1 SV=1", "sequence": "DCASGPCCRDCKFLEEGTICNMARGDDMDDYCNGKTCDCPRNPHKWPAP", "prompt": "Generate the amino acid sequence for pyramidin-B, a disintegrin toxin from the venom of the saw-scaled viper Echis pyramidum leakeyi. This protein functions as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. As a member of the disintegrin family, pyramidin-B should contain the canonical RGD (Arg-Gly-Asp) or related tripeptide motif that mediates high-affinity binding to integrin receptors such as αIIbβ3 (glycoprotein IIb/IIIa) on platelets, thereby disrupting cell-matrix and cell-cell interactions critical for thrombus formation. The sequence should adopt the characteristic disintegrin fold, stabilized by multiple disulfide bonds that confer structural rigidity and resistance to proteolytic degradation. The cysteine framework likely follows the pattern common to short-chain disintegrins, with conserved disulfide connectivity that forms a compact, globular structure. The molecular mechanism involves competitive inhibition of fibrinogen binding to integrins, leading to impaired platelet aggregation and anticoagulant effects. The protein should exhibit high specificity for its integrin targets while maintaining the stability required for effective envenomation and prey immobilization."}
{"description": "sp|A7X3M3|3NX1_PSAMO Toxin 3FTx-Psa1 OS=Psammophis mossambicus OX=234064 PE=3 SV=1", "sequence": "MKTLPLVLAVVAFVYLDLAHTLKCRSGNVCILGDDCSEGENVCFQRKNGTGVFGMRVVRGCAASCPSPIGGEEVSCCSTDNCNNSFSRFF", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is a three-finger toxin (3FTx) from the Mozambique dwarf sand snake, Psammophis mossambicus, a rear-fanged colubrid species whose venom contains neurotoxic components that facilitate prey immobilization. This toxin belongs to the three-finger toxin superfamily, characterized by a conserved structural scaffold comprising three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the characteristic cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The protein adopts the classic three-finger fold, with the central loop (loop II) often critical for molecular target engagement. As a 3FTx, it likely functions as a neurotoxin targeting ligand-gated ion channels, such as nicotinic acetylcholine receptors (nAChRs) or muscarinic acetylcholine receptors, potentially acting as an antagonist to disrupt neuromuscular transmission and induce paralysis. The sequence should include key functional residues in the loops, particularly in loop II, that mediate specific, high-affinity binding to the receptor's orthosteric or allosteric sites. Ensure the structural integrity of the three-finger motif, with appropriate beta-sheet content in the loops and a compact globular shape, while incorporating species-specific variations that reflect its evolutionary adaptation in Psammophis venom."}
{"description": "sp|A6YR42|COCA_CONCL Mu-conotoxin-like Cal 12.2a OS=Californiconus californicus OX=1736779 PE=1 SV=1", "sequence": "MKLTCVLVVLLLVLPFGDLITTSNTEDNKRGATPWQNSLKARGVCSTPEGSCVHNGCICQNAPCCHPSGCNWANVCPGFLWDKN", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the California cone snail, Californiconus californicus. This peptide should function as a potent sodium channel blocker, specifically targeting voltage-gated sodium channels (VGSCs) to disrupt neuronal signaling and induce paralysis in prey organisms. The peptide must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (typically CC-C-C-CC pattern) that forms three disulfide bridges. The core structure should comprise an inhibitor cystine knot (ICK) motif, which confers exceptional stability and resistance to proteolytic degradation. Key structural elements include a well-defined beta-hairpin and several loop regions that mediate target recognition and binding. The molecular target is likely to be tetrodotoxin-sensitive sodium channel subtypes, such as Nav1.4 in skeletal muscle or Nav1.2/1.6 in the central nervous system, with high-affinity binding to site 1 of the channel's pore-forming alpha subunit. The binding interface should involve specific electrostatic and hydrophobic interactions with the channel's outer vestibule, effectively occluding the ion conduction pathway and blocking sodium influx. The peptide must exhibit the typical mu-conotoxin pharmacological profile, causing rapid flaccid paralysis through inhibition of action potential generation and propagation. Ensure the sequence incorporates conserved residues critical for maintaining the ICK fold and target engagement, while allowing for functional diversification through variable loop regions that confer subtype selectivity and potency."}
{"description": "sp|Q7SZE0|VM2SA_GLOIT Zinc metalloproteinase/disintegrin OS=Gloydius intermedius OX=44732 PE=2 SV=1", "sequence": "MIQVLLVTICLVIFPYQGSSIILESGNVNDYEVVYPQKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKHQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDEPIKKASQLVVTPEQQRFPQRYIELVVVADQGMFTKYNSNLDTIRTWVHELVDTINEFYRSLNVRVSLTELEIWSNEDLINVQPAAPHTLDSFGEWRQRDLLHRISHDNAMLLTSTDFDGDTIGFAHVGTMCDPKRSVGIVQDHSAINLLVAVTMAHELGHNLGTDHDGNQCHCSANSCIMGDVLREGLSYEFSDCSQNQYQTYLTDHNPQCILNEPLRTDTVSTPVSGNELLETGEECDCGTPANPCCDAATCKLRPGAQCAEGLCCDQCKFTRAGKICRRARGDNPDDRCTGQSSDCPRNPFHA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of the venom from the Central Asian pit viper Gloydius intermedius. This protein should exhibit the dual functionality typical of snake venom metalloproteinases (SVMPs), where the metalloproteinase domain facilitates the degradation of extracellular matrix components through zinc-dependent catalytic activity, while the disintegrin domain inhibits platelet aggregation by antagonizing integrin receptors on cell surfaces. The sequence should incorporate the conserved zinc-binding motif HEXXHXXGXXH within the metalloproteinase domain, which coordinates the catalytic zinc ion essential for proteolytic activity. The disintegrin domain should feature the characteristic RGD (Arg-Gly-Asp) or related tripeptide motif that mediates specific binding to integrins such as αIIbβ3 on platelets, disrupting cell-matrix interactions and promoting hemorrhage. Structurally, the protein should adopt a multi-domain architecture, with the metalloproteinase domain folding into a metzincin-like structure stabilized by disulfide bonds, and the disintegrin domain forming a compact, disulfide-rich fold that presents the integrin-binding loop. The overall scaffold should reflect the modular design of SVMPs, enabling synergistic actions in prey immobilization through hemorrhage, anticoagulation, and disruption of tissue integrity."}
{"description": "sp|P70090|PA2H5_CRAGM Basic phospholipase A2 homolog 5 OS=Craspedocephalus gramineus OX=8767 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGSVIELGKMIFQETGKNPATSYGLYGCNCGPGGRRKPKDATDRCCYVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEDNPCLKEMCECDKAVAICFRENLDTYDKKKKINLKLFCKKTSEQC", "prompt": "Generate a protein sequence for a basic phospholipase A2 homolog from the venom of the bamboo pit viper, Craspedocephalus gramineus. This protein belongs to the phospholipase A2 (PLA2) superfamily but functions as a toxin homolog that likely lacks catalytic phospholipase activity while retaining structural integrity and potentially exhibiting alternative toxic functions such as myotoxicity, neurotoxicity, or anticoagulant effects. The protein should adopt the characteristic PLA2 fold, featuring three long alpha-helices stabilized by a conserved pattern of seven disulfide bridges (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, Cys13-Cys14) that form a rigid, compact globular structure. The sequence should include a conserved calcium-binding loop (YGKYCG) and an active site motif (DCCXXHD) if catalytic residues are present, though as a homolog, key residues may be mutated to reduce enzymatic activity. The protein's basic isoelectric point suggests it may interact with anionic membrane surfaces or specific molecular targets like coagulation factors or muscle cell receptors. Ensure the sequence reflects venom-optimized properties, including stability in the venom milieu and potential for receptor binding or membrane disruption, while maintaining the structural scaffold typical of snake venom PLA2 homologs."}
{"description": "sp|P83904|TX36A_PHORI Delta-ctenitoxin-Pr2d OS=Phoneutria reidyi OX=272752 PE=1 SV=1", "sequence": "GTCAGQDKPCKETCDCCGERGQCVCEGPCICRQGYFWIAAYKLGNCK", "prompt": "Design a novel animal toxin protein sequence based on the venom profile of the Brazilian wandering spider Phoneutria reidyi. This toxin should belong to the delta-ctenitoxin family, which are known to function as insecticidal neurotoxins targeting voltage-gated sodium channels in insect nervous systems. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. This scaffold provides exceptional thermal and proteolytic stability while presenting key functional loops for target interaction. The toxin should specifically modulate insect sodium channel gating kinetics, likely causing delayed inactivation and prolonged depolarization that leads to paralysis in insect prey. The molecular mechanism involves binding to neurotoxin receptor site 3 on the voltage-sensing domain of insect sodium channels, disrupting normal action potential propagation. Key structural elements should include a conserved hydrophobic core maintained by the cystine knot, with surface-exposed loops containing residues critical for channel recognition and binding specificity. The toxin should exhibit high selectivity for insect over mammalian sodium channels, reflecting the spider's predatory adaptation. The sequence should maintain appropriate physicochemical properties for venom secretion and stability, including optimal surface charge distribution and minimal aggregation propensity."}
{"description": "sp|P83905|TX35A_PHOKE U2-ctenitoxin-Pk1a OS=Phoneutria keyserlingi OX=272754 PE=1 SV=1", "sequence": "CGDINAPCQSDCDCCGYSVTCDCYWSKDCKCRESNFVIGMALRKAFCKNK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This toxin originates from the venom of the Brazilian wandering spider Phoneutria keyserlingi, a medically significant arachnid known for producing neurotoxic venom that targets the vertebrate nervous system. The protein belongs to the U2-ctenitoxin family, which typically functions as a voltage-gated sodium channel modulator. The core mechanism of action involves binding to site 3 or site 4 of voltage-gated sodium channels, leading to delayed channel inactivation, prolonged action potentials, and subsequent neurotransmitter release, resulting in pain, muscle spasms, and autonomic dysfunction. Structurally, this toxin is expected to adopt the inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. The molecular target is specifically the tetrodotoxin-sensitive voltage-gated sodium channels in sensory and motor neurons, with binding occurring at extracellular loops of domain IV. The sequence should include the characteristic ICK cysteine framework and maintain the globular, stable fold essential for target specificity and potency."}
{"description": "sp|C9X4K3|SCNA5_TITDI Toxin TdNa5 OS=Tityus discrepans OX=57059 PE=3 SV=1", "sequence": "MKTIIFFIACLMLIDVVVESKDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNNKCGK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the scorpion Tityus discrepans. This toxin, designated TdNa5, belongs to the beta-toxin class of scorpion venom peptides targeting voltage-gated sodium channels (Nav). As a beta-toxin, it functions by binding to site 4 on the extracellular domain of Nav channels, specifically modulating channel activation by shifting the voltage dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and promoting spontaneous firing. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by a disulfide bridge pattern of C1-C4, C2-C5, C3-C6 (or similar) that forms a compact globular structure with an alpha-helix packed against an antiparallel beta-sheet. Key structural elements include a conserved 'core' region with the alpha-helix contributing to membrane interaction and the beta-sheet loops forming the receptor-binding interface, particularly the 'pharmacophore' residues in the loops that confer specificity for Nav channel subtypes (e.g., Nav1.2, Nav1.6 in excitable tissues). The sequence should reflect high affinity for mammalian Nav channels, contributing to the venom's neurotoxic effects such as paralysis or pain, while maintaining stability in the venom milieu. Ensure the design incorporates hydrophobic patches for membrane proximity and polar residues for specific interactions with the channel's voltage-sensing domain."}
{"description": "sp|B1P1F6|JZT33_CHIGU U19-theraphotoxin-Cg1a (Fragment) OS=Chilobrachys guangxiensis OX=278060 PE=2 SV=2", "sequence": "IMFVWASAAEVEERGSDQRDSPASLKSMETIFQSEQRECRYLMGGCSKDGDCCEHLVCRTKWPYHCVWDWTFGK", "prompt": "Generate the complete amino acid sequence for a potent animal toxin from the Chinese earth tiger tarantula (Chilobrachys guangxiensis), classified as U19-theraphotoxin-Cg1a. This toxin belongs to the theraphotoxin family, which are cysteine-rich peptides that typically function as voltage-gated ion channel modulators in spider venoms to immobilize prey through neuromuscular disruption. Infer that this toxin likely adopts an inhibitor cystine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized globular fold with high thermal and proteolytic stability. The ICK motif should feature a specific disulfide connectivity pattern (typically C1-C4, C2-C5, C3-C6 for six-cysteine toxins) that creates a stable core supporting functional loops responsible for target interaction. Based on the U19 family classification, predict that this toxin modulates voltage-gated sodium or potassium channels, potentially causing excitatory or inhibitory effects on neuronal signaling. The sequence should include key residues for membrane penetration, target specificity, and the characteristic cysteine framework that forms the ICK scaffold. Ensure the generated sequence reflects the typical length and physicochemical properties of spider venom peptides, with amphipathic regions for membrane association and conserved motifs for ion channel interaction."}
{"description": "sp|P81166|PA2BA_MICNI Basic phospholipase A2 nigroxin A OS=Micrurus nigrocinctus OX=8635 PE=1 SV=1", "sequence": "NLYQLKNMIKCTNTRHWVSFTNYGCYCGYGGSGTPVDELDKCCQVHDKCYDTAKHVCKCSPSMTMYSYDCSEGKLTCKDNNTKCKDFVCNCDRTAALCFAKAPYNNKNFKIDPTKGCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Central American coral snake, Micrurus nigrocinctus. This toxin, known as nigroxin A, functions as a potent presynaptic neurotoxin that targets the neuromuscular junction. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, ultimately disrupting synaptic vesicle recycling and causing irreversible neuromuscular blockade. The sequence must contain the conserved phospholipase A2 active site motif with histidine, aspartate, and tyrosine residues essential for catalysis, along with a calcium-binding loop. Maintain the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by seven conserved disulfide bridges in the pattern Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, and Cys13-Cys14. The protein should have a basic isoelectric point due to an enrichment of lysine and arginine residues, which facilitates membrane interaction and enhances neurotoxic potency. Include the elapid phospholipase A2 signature motifs and ensure the protein adopts the characteristic phospholipase A2 globular structure with a conserved catalytic network and substrate-binding pocket."}
{"description": "sp|Q2XXL8|VNP_VARVA Natriuretic peptide GNP1 OS=Varanus varius OX=8559 PE=2 SV=1", "sequence": "MDPRLVRAGSLVLLLALLVQDQGAAHPARAGQKYKPLIRRSEEDSQALGQEGDVAARAADEEEDAAGPGDALRQPAFKTLLASREKRLQPEGSCFGQKMDRIGHVSGMGCNKFDPNKGSSSTGKK", "prompt": "Design a natriuretic peptide toxin from the venom of the lace monitor (Varanus varius) that functions as a potent vasoactive agent. This peptide should mimic the biological activity of endogenous natriuretic peptides but with enhanced potency and stability typical of venom-derived variants. The protein should adopt the characteristic natriuretic peptide fold, featuring a conserved ring structure stabilized by intramolecular disulfide bonds between cysteine residues in a specific 1-4, 2-5, 3-6 connectivity pattern. This structural scaffold enables high-affinity binding to natriuretic peptide receptors (NPR-A and NPR-B), particularly through interactions with the receptor's extracellular domain. The mechanism of action involves receptor activation leading to increased cyclic GMP production, resulting in vasodilation, natriuresis, and diuresis. The peptide should exhibit the typical functional domains of natriuretic peptides: a N-terminal signal sequence for secretion, the mature peptide region containing the disulfide-stabilized ring essential for receptor binding, and a C-terminal tail that may modulate receptor specificity and potency. In the context of Varanus varius venom, this toxin likely serves to induce rapid hypotension in prey through cardiovascular effects, representing an evolutionary adaptation of the natriuretic peptide system for predatory purposes. The generated sequence should reflect the compact, stable structure characteristic of this toxin family while maintaining the specific receptor-binding motifs that confer its toxic activity."}
{"description": "sp|C9X4K4|SCNA6_TITDI Toxin TdNa6 OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "MKGMIMLISCLMLIEVVVGGKEGYLLDRSNGCKRSCFFGSTSWCNTECKSKSADKGYCAWPSCYCYGFTDDSKMWHLKTNKC", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a sodium channel neurotoxin derived from the venom of Tityus discrepans, a scorpion species. This toxin belongs to the beta-toxin class, specifically targeting voltage-gated sodium channels (Nav channels) and modulating their gating properties by shifting the voltage-dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and causing prolonged action potentials. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, with a disulfide bridge pattern typically involving four disulfide bonds (e.g., C1-C4, C2-C5, C3-C6, C7-C8 in common frameworks) that stabilize a compact globular structure comprising an alpha-helix and an antiparallel beta-sheet. Key functional residues should be inferred to include a putative receptor binding site involving loops and surfaces critical for interaction with domain II of Nav channels, particularly residues in the beta-hairpin and adjacent regions that facilitate specific binding and allosteric modulation. The biological significance lies in its role in prey immobilization and defense, contributing to the venom's neurotoxic effects by disrupting sodium channel function, leading to paralysis or autonomic disturbances. Ensure the sequence reflects high specificity for insect or mammalian Nav isoforms, as relevant to the source organism's ecological niche, and incorporates conserved motifs for structural integrity and toxic activity, without relying on database identifiers."}
{"description": "sp|Q9W7J5|3L2P_PSETE Pseudonajatoxin b homolog OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRTCFITPDVKSKPCPPGQEVCYTKTWCDGFCGIRGKRVDLGCAATCPTPKKTGIDIICCSTDDCNTFPLRPRGRLSSIKDHP", "prompt": "Design a protein sequence for a potent postsynaptic neurotoxin from the venom of the Australian eastern brown snake (Pseudonaja textilis). This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The structural scaffold consists of three extended loops (fingers) projecting from a central hydrophobic core, with the central loop containing key residues for receptor binding and specificity. The toxin should exhibit high affinity for muscle-type nAChRs, blocking acetylcholine binding and causing flaccid paralysis through competitive inhibition at the receptor's orthosteric site. The sequence should maintain the conserved hydrophobic core and the functional epitopes responsible for receptor recognition while preserving the structural integrity of the three-finger motif essential for its neurotoxic activity."}
{"description": "sp|P82813|SIX3_HOTTS Insect toxin BsIT3 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "DGYILNSKGCKVSCVVSIVYCNSMCKSSGGSYGYCWTWGLACWCEGLPNSKRWTSSKNKCN", "prompt": "Design a novel insecticidal neurotoxin protein sequence inspired by the venom arsenal of the Indian red scorpion Hottentotta tamulus sindicus. This toxin should function as a potent modulator of insect nervous system physiology, specifically targeting voltage-gated ion channels in insect neurons to induce rapid paralysis and lethality. The protein should adopt a compact, stable beta-sheet-rich scaffold stabilized by a conserved cysteine framework typical of scorpion short-chain insectotoxins, featuring three disulfide bridges arranged in a specific connectivity pattern that confers both structural rigidity and target specificity. Key structural elements should include a conserved core domain with beta-strands forming a small globular fold, and surface-exposed loops containing critical residues for interaction with insect ion channel pore regions or voltage-sensing domains. The mechanism of action should involve binding to sodium or potassium channels in insect nerve membranes, altering channel gating kinetics to cause sustained depolarization or hyperpolarization, ultimately disrupting action potential propagation and neuromuscular transmission. The protein should exhibit high selectivity for insect versus mammalian ion channels, reflecting the evolutionary adaptation of scorpion venom for arthropod prey capture."}
{"description": "sp|P04971|VSPF_BOTAT Thrombin-like enzyme batroxobin OS=Bothrops atrox OX=8725 PE=1 SV=1", "sequence": "MVLIRVIANLLILQVSYAQKSSELVIGGDECDINEHPFLAFMYYSPRYFCGMTLINQEWVLTAAHCNRRFMRIHLGKHAGSVANYDEVVRYPKEKFICPNKKKNVITDKDIMLIRLDRPVKNSEHIAPLSLPSNPPSVGSVCRIMGWGAITTSEDTYPDVPHCANINLFNNTVCREAYNGLPAKTLCAGVLQGGIDTCGGDSGGPLICNGQFQGILSWGSDPCAEPRKPAFYTKVFDYLPWIQSIIAGNKTATCP", "prompt": "Design a serine protease enzyme from the venom of the fer-de-lance pit viper (Bothrops atrox) that functions as a thrombin-like enzyme with specific coagulant activity. This enzyme should exhibit selective fibrinogen-clotting properties, cleaving fibrinogen to release fibrinopeptide A while sparing fibrinopeptide B, leading to the formation of unstable fibrin clots that are rapidly cleared from circulation. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a catalytic triad of His, Asp, and Ser residues. Include the conserved structural features of snake venom serine proteases, particularly the presence of six conserved disulfide bridges that stabilize the two-barrel structure. The enzyme should demonstrate substrate specificity distinct from mammalian thrombin, preferentially targeting fibrinogen over other coagulation factors. Consider the biological role in the snake's venom arsenal where this enzyme contributes to prey immobilization through defibrination and consumption coagulopathy, leading to hemorrhagic effects. The structural scaffold should maintain the characteristic SVSP topology with well-defined substrate-binding pockets that confer its unique thrombin-like specificity while avoiding excessive proteolytic promiscuity."}
{"description": "sp|Q9W7J7|3S36_PSETE Short neurotoxin 6 OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MKTLLLTLVMVTIMCLDLGYTLTCYKSLSGTVVCKPHETICYRRLIPATHGNAIIDRGCSTSCPGGNRPVCCSTDLCNK", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the Eastern brown snake (Pseudonaja textilis) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and competitively antagonize nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to flaccid paralysis by blocking neurotransmission. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C. The structure should feature a central β-sheet core with the second loop containing the critical functional residues responsible for receptor binding and antagonism. The toxin should exhibit high affinity for the α-γ and α-δ interfaces of muscle-type nAChRs, with the functional loop containing key residues that mimic acetylcholine binding but prevent channel activation. The sequence should maintain the compact, stable globular structure typical of short neurotoxins, approximately 60-70 amino acids in length, with the conserved disulfide pattern essential for proper folding and biological activity."}
{"description": "sp|P83906|VEGFA_BITGA Vascular endothelial growth factor A OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "MNFLLTWIHWGLAALLYFHNAKVLQAAPAQGDGERQQGEVIPFLKVYERSICRPVETMVDIFQEYPDEVEYIFKPSCVALMRCGGCCNDEALECVPTEMYNVTMEVMKLKPFQSQHIHPVSFQQHSKCECRPKKDIRNKDNHCEPCSERRKHLYKQDPLTCKCSCKAPDLRCKSKQLELNERTCRCERPRR", "prompt": "Design a novel protein sequence for a vascular endothelial growth factor A (VEGF-A) toxin derived from the venom of the Gaboon viper (Bitis gabonica). This protein should function as a potent modulator of angiogenesis by specifically binding to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, thereby disrupting normal vascular signaling pathways. The sequence must adopt the characteristic VEGF fold, featuring a cysteine-knot structural motif with conserved disulfide connectivity (C1-C4, C2-C5, C3-C6) that stabilizes the homodimeric assembly. Include key functional domains: receptor-binding sites that interact with VEGFR immunoglobulin-like domains, heparin-binding motifs for extracellular matrix association, and dimerization interfaces that facilitate the formation of functional homodimers. The protein should exhibit high affinity for VEGF receptors while potentially displaying altered signaling properties compared to mammalian VEGF-A, consistent with its evolutionary adaptation in viper venom for disrupting prey vascular homeostasis through either receptor antagonism or aberrant activation."}
{"description": "sp|P85880|TLP2_POLLN Tachykinin-like peptide-II OS=Polistes lanio OX=91419 PE=1 SV=1", "sequence": "ASEPTALGLPRIFPGLM", "prompt": "Design a novel animal toxin peptide sequence that functions as a tachykinin-like peptide, inspired by the venom arsenal of the paper wasp Polistes lanio. This peptide should mimic the biological activity of tachykinins, which are neuropeptides involved in pain signaling, neurogenic inflammation, and smooth muscle contraction. The toxin likely acts as a neuromodulator or neurotoxin by interacting with tachykinin receptors (such as NK1, NK2, or NK3) in the peripheral or central nervous system of prey, potentially causing hyperalgesia, vasodilation, or bronchoconstriction. Structurally, the peptide should adopt a flexible, linear conformation typical of tachykinin-family peptides, characterized by a conserved C-terminal amidation motif (if applicable) and key residues for receptor binding, particularly a hydrophobic or aromatic residue at the penultimate position and a basic residue near the C-terminus. The sequence should be 10-15 amino acids in length, lacking disulfide bridges, and enriched in hydrophobic and charged residues to facilitate receptor interaction. Ensure the peptide exhibits high specificity for tachykinin receptors over other neuropeptide receptors, with potential insecticidal or paralytic effects relevant to wasp venom function."}
{"description": "sp|P17235|CRBL_VESLE Vespid chemotactic peptide L OS=Vespula lewisii OX=7452 PE=1 SV=1", "sequence": "FLPIIAKLVSGLL", "prompt": "Design a protein sequence for a wasp venom chemotactic peptide from Vespula lewisii that functions as a potent inflammatory mediator. This peptide should exhibit strong chemotactic activity, specifically recruiting and activating immune cells such as mast cells and neutrophils to the site of envenomation. The protein should adopt a characteristic amphipathic alpha-helical structure typical of chemotactic peptides, with distinct hydrophobic and hydrophilic faces that facilitate membrane interaction and receptor binding. The sequence should contain key residues for receptor recognition, likely targeting formyl peptide receptors or related G-protein coupled receptors involved in innate immune responses. The structural scaffold should enable efficient insertion into cell membranes while maintaining solubility in the aqueous venom matrix. The peptide should demonstrate thermal stability and resistance to proteolytic degradation, consistent with its role in venom-mediated inflammation and pain induction."}
{"description": "sp|A7X3M9|3NX1_ERYPO Probable weak neurotoxin 3FTx-Lio1 OS=Erythrolamprus poecilogyrus OX=338838 PE=3 SV=1", "sequence": "MKAVILSLVAAFLYSGYTLNCRKCDETVCQLYWTCTEAETLCYILKNKTDTMGLQAIQGCAETCPVPEPDQEVKCCKTDYCNSYF", "prompt": "Design a protein sequence for a weak neurotoxin from the three-finger toxin family, specifically the 3FTx-Lio1 subtype, originating from the snake Erythrolamprus poecilogyrus. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the typical cysteine framework (C-C-C-C-C-C-C-C). The protein should exhibit weak neurotoxic activity, likely functioning as a postsynaptic neurotoxin that binds with low affinity to nicotinic acetylcholine receptors at the neuromuscular junction, causing mild neuromuscular blockade. The sequence should include the conserved structural motifs of 3FTx proteins while incorporating subtype-specific variations that confer its weak potency. The molecular mechanism should involve competitive or allosteric inhibition of acetylcholine binding, leading to reversible disruption of synaptic transmission. The structural design should ensure proper folding into the three-loop architecture with appropriate loop lengths and conformations for target recognition while maintaining the reduced toxicity profile characteristic of this weak neurotoxin variant."}
{"description": "sp|P81243|PA2A_BOTJA Acidic phospholipase A2 OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "DLWQFGQMMNDVMREYVVFNYLYYGCYCGWGGIGKPRDATDRCCFVHDCCYGKVTGCNPKTDSYTYTYSEENGDVVCGGDDLCKKQICECDRVAATCFRDNKDTYDTKYWLYGAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops jararaca, a medically significant pit viper. This enzyme should function as a potent toxin with multiple pathophysiological effects, including myotoxicity, neurotoxicity, and anticoagulant activity. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCGXGG) and a catalytic network centered around histidine and aspartate residues. It should contain the canonical 14 cysteine residues forming 7 disulfide bridges that stabilize the compact, globular structure. The sequence should exhibit high interfacial binding affinity for phospholipid membranes, with specific structural adaptations that enhance membrane penetration and substrate accessibility. The toxin should target phospholipid bilayers, hydrolyzing sn-2 ester bonds of glycerophospholipids to release lysophospholipids and free fatty acids, initiating inflammatory cascades and membrane disruption. Include molecular features that confer its acidic isoelectric point while maintaining structural stability in the venom gland and target tissues."}
{"description": "sp|P0CB07|CA11_CONAJ Alpha-conotoxin-like Ai1.1 OS=Conus ammiralis OX=97188 PE=3 SV=1", "sequence": "MFTVFLLVVLATTVVSFTSDRAFRGRNAAAKASGLVGLTDKRQECCSYPACNLDHPELCG", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom arsenal of the marine cone snail Conus ammiralis, a predatory gastropod that employs neurotoxic peptides for prey capture. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two conserved disulfide bonds forming the CC-C-C cysteine framework (CysI-CysIII, CysII-CysIV). The core structure should comprise two short alpha-helical segments connected by beta-turns, creating a well-defined pharmacophore surface for receptor interaction. Key functional residues should be strategically positioned in loop regions to mediate high-affinity binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine signaling. The sequence must maintain the canonical alpha-conotoxin length of 12-20 amino acids with appropriate spacing between cysteine residues to ensure proper disulfide connectivity and structural integrity. Incorporate conserved hydrophobic patches and polar residues that facilitate membrane proximity and receptor engagement while ensuring the peptide remains soluble in aqueous environments. The final design should exhibit the hallmark properties of alpha-conotoxins: exceptional stability, target specificity, and potent neurotoxic activity through neuromuscular blockade."}
{"description": "sp|E0Y420|VSP3_MACLB Serine protease VLSP-3 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MVLIRVLANLLVLQLSYAQKSSELVIGGDECNINEHRSLVYLYNDSNFQCGGTLINQEWVLSAAHCDMENMEIYLGVHNLSLPNKDQKRRDPKEKFFCLSSKNYTKWDKDIMLIKLNRPVKTSTHIAPLSLPSSPPSVGSVCRIMGWGTVTSPNETLLDVPHCANINILNYTVCRAASPRLPTQSRTLCAGILQGGIDACKGDSGGPLICNGQIQGIVSWGNHPCAQPLKPGHYTHVFDYTDWIQSIIAGNTTATCPP", "prompt": "Design a serine protease toxin sequence from the venom of Macrovipera lebetinus (Levantine viper) that functions as a key component of the snake's digestive and prey-immobilization arsenal. This toxin should exhibit the characteristic catalytic triad (His, Asp, Ser) arrangement typical of serine proteases, with conserved structural domains including the substrate-binding pocket and activation peptide region. The protein should adopt the chymotrypsin-like fold common to snake venom serine proteases, featuring the characteristic β-barrel structure stabilized by multiple disulfide bridges that confer stability in the harsh venom environment. The mechanism of action involves specific cleavage of fibrinogen and other plasma proteins, contributing to coagulopathy, hemorrhage, and prey digestion through disruption of hemostatic pathways. The sequence should maintain the conserved structural motifs required for protease activity while incorporating viperid-specific adaptations that enhance substrate specificity and resistance to endogenous protease inhibitors."}
{"description": "sp|P0C7A8|VM2LB_ECHLE Disintegrin leucogastin-B OS=Echis leucogaster OX=504457 PE=1 SV=1", "sequence": "DCESGPCCRDCKFLKEGTVCRIARGDNKHDYCNGKTCDCPSNPHKGKHH", "prompt": "Design a novel disintegrin protein sequence inspired by leucogastin-B from the venom of Echis leucogaster, the white-bellied carpet viper. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the platelet surface. The sequence must adopt the canonical disintegrin fold characterized by a compact, disulfide-stabilized structure with the characteristic RGD (Arg-Gly-Asp) motif positioned within an exposed, flexible loop that serves as the primary integrin-binding interface. Incorporate the conserved cysteine framework typical of short-chain disintegrins to form the essential disulfide bonds that maintain structural integrity and proper presentation of the bioactive RGD tripeptide. The protein should exhibit high affinity for αIIbβ3 integrin (GPIIb/IIIa) to effectively prevent fibrinogen binding and subsequent platelet aggregation, mimicking the natural anticoagulant activity of Echis leucogaster venom disintegrins that facilitate prey immobilization through disruption of hemostasis. Ensure the sequence maintains the key structural elements required for integrin recognition while optimizing for stability and biological activity."}
{"description": "sp|Q2VBP8|3L2X1_OPHHA Long neurotoxin LNTX1 OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKILLLTLVVVTIMCLDLGYTTKCYKTGERIISETCPPGQDLCYMKTWCDVFCGSRGRVIELGCTATCPTVKPHEQITCCSTDNCNPHPKMKQR", "prompt": "Generate a protein sequence for a long neurotoxin from the venom of the king cobra (Ophiophagus hannah), a highly potent snake venom toxin that functions as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction. This toxin belongs to the three-finger toxin superfamily characterized by a conserved structural fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a characteristic C-C-C-C cysteine framework. The protein should adopt the classic three-finger toxin architecture with a globular core and three protruding loops that mediate specific binding to the α-δ and α-γ interfaces of muscle-type nicotinic acetylcholine receptors. The toxin should exhibit high affinity binding that blocks acetylcholine binding, leading to neuromuscular paralysis and respiratory failure. Key structural features should include: a central core stabilized by four disulfide bridges (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8 pattern typical of long neurotoxins), extended loop regions rich in basic residues for receptor interaction, and conserved hydrophobic residues in the core for structural stability. The sequence should reflect the characteristic length and composition of long neurotoxins, which are distinguished from short neurotoxins by additional residues in the central loop that enhance receptor binding specificity and potency."}
{"description": "sp|P08872|PA2A_AIPLA Acidic phospholipase A2 OS=Aipysurus laevis OX=8678 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASDIPPLPLNLYQFDNMIQCANKGKRATWHYMDYGCYCGSGGSGTPVDALDRCCKAHDDCYGVAEDNGCYPKWTLYSWQCTENVPTCNSESGCQKSVCACDATAAKCFAEAPYNNKNYNINTSNCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the olive sea snake (Aipysurus laevis). This enzyme is a key component of sea snake venom that functions as a potent presynaptic neurotoxin. The protein should exhibit calcium-dependent catalytic activity that hydrolyzes the sn-2 acyl bond of glycerophospholipids, generating lysophospholipids and free fatty acids. This mechanism disrupts cellular membranes and neurotransmitter release at neuromuscular junctions, leading to paralysis. The sequence must contain the conserved phospholipase A2 active site motif with histidine and aspartate residues essential for catalysis, along with the calcium-binding loop. Maintain the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges in the typical cysteine pattern. The protein should have an acidic pI and exhibit the structural stability required for venom function. Include conserved residues for substrate binding and membrane interaction while preserving the overall globular structure characteristic of group I phospholipase A2 enzymes from elapid snake venoms."}
{"description": "sp|E2DIH5|CA12_CONVC Alpha-conotoxin Vc1.2 OS=Conus victoriae OX=319920 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVFFTSDRASDGRKAAASDLITLTIKGCCSNPACMVNNPQICGRRR", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus victoriae, a marine cone snail species. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha9alpha10 subtype. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved cysteine framework C-C-CC (Cys1-Cys2, Cys3-Cys4) that forms two essential disulfide bridges. The core structure should include a short alpha-helical segment stabilized by these disulfide bonds, creating a compact, stable tertiary structure resistant to proteolytic degradation. Key functional residues should be positioned to interact with the orthosteric binding site of the alpha9alpha10 nAChR, blocking acetylcholine-mediated neurotransmission. The sequence should maintain the typical alpha-conotoxin length of 12-20 amino acids with appropriate loop regions between cysteine residues to ensure proper folding and target specificity. The toxin should exhibit high affinity for its neuronal target while minimizing off-target effects on muscle-type nAChRs, reflecting the evolutionary optimization of cone snail venoms for precise neurological targeting."}
{"description": "sp|Q9W7J6|3S37_PSETE Short neurotoxin 7 OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MKTLLLTLVMVTIMCLDLGYTLTCYKRYFDTVVCKPQETICYRYIIPATHGNAITYRGCSTSCPSGIRLVCCSTDLCNK", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the Eastern brown snake (Pseudonaja textilis), a highly potent elapid snake species. This toxin functions as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the postsynaptic membrane to block neurotransmission and induce flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold, consisting of three extended loops projecting from a central hydrophobic core stabilized by four conserved disulfide bridges with a C1-C3, C2-C5, C4-C6, C7-C8 connectivity pattern. Key structural elements include a central β-sheet core and three protruding loops that form the receptor-binding interface, with loop II typically containing critical residues for high-affinity binding to the α-subunit of muscle-type nicotinic receptors. The sequence should maintain the compact, globular structure typical of short neurotoxins (approximately 60-70 residues) with appropriate hydrophobic core residues and conserved cysteine framework to ensure proper folding and potent neurotoxic activity through competitive inhibition of acetylcholine binding."}
{"description": "sp|Q9BPI4|M23C_CONTS Conotoxin TsMMSK-011 OS=Conus tessulatus OX=101317 PE=2 SV=1", "sequence": "MMSKLGVLLTICLLLFPLTVLPMDGDQPADLPALRTQDIATDQSPWFDPVKRCCSRYCWKCIPCCPY", "prompt": "Design a novel conotoxin sequence from the marine cone snail Conus tessulatus that functions as a potent neurotoxin. This toxin should belong to the M-superfamily of conotoxins, specifically exhibiting the M-23 cysteine framework characterized by the pattern CC-C-C-CC with six cysteine residues forming three disulfide bridges in a 1-4, 2-5, 3-6 connectivity. The structural scaffold should adopt the inhibitor cystine knot (ICK) motif, a compact, triple-stranded beta-sheet fold stabilized by the conserved disulfide framework that provides exceptional thermal and proteolytic stability. As a member of the M-superfamily, this conotoxin should target neuronal receptors or ion channels, potentially modulating voltage-gated sodium channels or potassium channels based on the pharmacological diversity observed in this toxin family. The biological significance lies in the venom's role in prey immobilization through disruption of neural signaling, with M-superfamily conotoxins typically causing paralysis by interfering with synaptic transmission or action potential propagation. The sequence should contain the characteristic M-superfamily signal peptide region followed by the mature toxin region with precisely spaced cysteine residues maintaining the M-23 framework, and include conserved hydrophobic residues that contribute to the structural core while displaying variable inter-cysteine loops that determine target specificity and potency."}
{"description": "sp|P06859|PA2A1_PROFL Acidic phospholipase A2 1 OS=Protobothrops flavoviridis OX=88087 PE=1 SV=2", "sequence": "MRTLWIMAVLLVGVDGGLWQFENMIIKVVKKSGILSYSAYGCYCGWGGRGKPKDATDRCCFVHDCCYGKVTGCNPKLGKYTYSWNNGDIVCEGDGPCKEVCECDRAAAICFRDNLDTYDRNKYWRYPASNCQEDSEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the habu snake, Protobothrops flavoviridis. This enzyme should function as a potent toxin with both presynaptic and postsynaptic neurotoxic activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bonds. Include the conserved calcium-binding loop (Tyr-Gly-Cys) and catalytic dyad residues (His-Asp) essential for enzymatic activity. The sequence should exhibit the acidic nature typical of this toxin class, with a pI below 5.0, and contain the interfacial binding surface required for membrane association. The toxin should target neuronal membranes and exhibit both myotoxic and anticoagulant properties through its phospholipid hydrolysis mechanism, contributing to the rapid prey immobilization characteristic of viperid snake venoms."}
{"description": "sp|B8K1V9|VNP_MICFL Natriuretic peptide Mf-NP OS=Micrurus fulvius OX=8637 PE=2 SV=1", "sequence": "MVGLSRLTGGGLLLVLALLPLALDGKPLEEAPTAPSRIIPFSRPVRKESQAVLDPMVHPERPAGSGDDGDLSRLEGLAKEALGDGCFGLKLDRIGTSSGLGCNPKRPDPAPTALARIIPFSRPVRKESRAALDRMQHPG", "prompt": "Design a natriuretic peptide toxin from the venom of the Eastern coral snake, Micrurus fulvius. This toxin functions as a potent vasoactive peptide that mimics endogenous natriuretic peptides, primarily targeting the natriuretic peptide receptor-A (NPR-A) in vascular smooth muscle and renal tissues. The mechanism involves binding to the extracellular domain of NPR-A, activating particulate guanylyl cyclase to increase intracellular cyclic GMP levels, resulting in vasodilation, natriuresis, and diuresis. The peptide should adopt a conserved natriuretic peptide fold characterized by a central alpha-helical region stabilized by a disulfide-bonded loop structure, typically with a 1-3, 2-4 cysteine connectivity pattern forming a ring structure essential for receptor recognition and biological activity. Key structural elements include an N-terminal tail, the central disulfide-constrained ring critical for receptor binding, and a C-terminal extension that may modulate potency and stability. The venom context suggests this toxin contributes to prey immobilization through hypotension and cardiovascular collapse, characteristic of elapid snake venoms where natriuretic peptides synergize with neurotoxins and myotoxins."}
{"description": "sp|P81236|PA2B1_ACAAN Basic phospholipase A2 acanthin-1 OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "DLFQFGGMIGCANKGARSWLSYVNYGCYCGWGGSGTPVDELDRCCQIHDNCYGEAEKKQCGPKMTSYSWKCANDVPVCNDSKSACKGFVCDCDAAAAKCFAKAPYNKNNIGIGSKTRCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the common death adder (Acanthophis antarcticus). This toxin, known as acanthin-1, should exhibit potent phospholipase A2 activity characteristic of snake venom PLA2 enzymes. The protein should function by hydrolyzing the sn-2 ester bond of membrane phospholipids, leading to membrane disruption, inflammation, and potential neurotoxic, myotoxic, or anticoagulant effects. The sequence must include the conserved catalytic dyad of histidine and aspartate residues essential for enzymatic activity, along with the calcium-binding loop required for cofactor-dependent catalysis. The structural scaffold should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by multiple disulfide bridges in the canonical pattern (typically 6-7 conserved disulfide bonds). The protein should have an overall basic isoelectric point to facilitate interaction with anionic membrane surfaces. The molecular mechanism involves binding to lipid membranes via interfacial recognition sites, with potential specific targeting of neuromuscular junctions or other tissues depending on the toxin's biological role in death adder venom."}
{"description": "sp|P05620|VSP1_PROFL Thrombin-like enzyme flavoxobin OS=Protobothrops flavoviridis OX=88087 GN=TLF1 PE=1 SV=2", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVALYDAWSGRFLCGGTLINPEWVLTAAHCDSKNFKMKLGAHSKKVLNEDEQIRNPKEKFICPNKKNDEVLDKDIMLIKLDSPVSYSEHIAPLSLPSSPPSVGSVCRIMGWGSITPVEETFPDVPHCANINLLDDVECKPGYPELLPEYRTLCAGVLQGGIDTCGFDSGTPLICNGQFQGIVSYGGHPCGQSRKPGIYTKVFDYNAWIQSIIAGNTAATCLP", "prompt": "Design a thrombin-like serine protease toxin from the venom of the habu snake, Protobothrops flavoviridis. This enzyme functions as a key component in the snake's venom arsenal, primarily targeting the mammalian coagulation cascade to induce consumptive coagulopathy and disrupt normal hemostasis. The protein should exhibit selective proteolytic activity toward fibrinogen, cleaving fibrinopeptide A to generate fibrin monomers that spontaneously polymerize into unstable clots, leading to defibrination and systemic anticoagulation. Structurally, it should adopt the characteristic chymotrypsin-like fold of snake venom serine proteases, featuring a two-domain architecture with the catalytic triad (His57, Asp102, Ser195) positioned in the active site cleft. The molecule should contain the conserved disulfide bridge pattern typical of SVSPs, including the essential Cys191-Cys220 disulfide that stabilizes the active site region. Key structural elements should include substrate-binding loops that confer specificity for fibrinogen over other coagulation factors, potentially with exosite interactions that enhance fibrinogen recognition. The generated sequence should maintain the canonical features of thrombin-like enzymes while exhibiting the unique specificity profile that distinguishes it from mammalian thrombin and other snake venom proteases."}
{"description": "sp|A7X3R6|3NX1_LEIMD Toxin 3FTx-Lei1 OS=Leioheterodon madagascariensis OX=46577 PE=3 SV=1", "sequence": "MKTLLLSLVVVTFVCLDLAHTRTCYSCTENICLQHEQCQDGQDVCYKRWNTTYLILTDVVRGCAKTCPTPIEEEEVYCCLKDNCN", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a three-finger toxin (3FTx) from the Madagascar hognose snake, Leioheterodon madagascariensis, representing a key component of its venom arsenal for prey immobilization and defense. This toxin belongs to the three-finger toxin superfamily, characterized by a conserved structural scaffold comprising three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework I (C-C-C-C-C-C-C-C). The protein adopts the classic three-finger fold, with the three loops forming a flat, hand-like structure that facilitates molecular recognition and binding. Its mechanism of action involves high-affinity binding to specific ion channels or receptors in the nervous or muscular systems of prey, leading to disruption of synaptic transmission, paralysis, or other physiological effects. The sequence should include key functional residues for target interaction, such as those in loop regions critical for receptor binding specificity, while maintaining the structural integrity conferred by the disulfide network. The protein is expected to be relatively small, around 60-80 amino acids, with a compact, stable globular fold resistant to proteolytic degradation. Ensure the design reflects the evolutionary adaptations of snake venom toxins for rapid and potent bioactivity."}
{"description": "sp|B8XH22|CL758_BUTIS Putative calcium channel toxin Tx758 OS=Buthus israelis OX=2899555 PE=3 SV=1", "sequence": "MSTFVIVFLLLTAVLCHAEPALDETARGCNRLNKKCNSDGDCCRYGERCISTGVNYYCKPDFGP", "prompt": "Design a novel calcium channel toxin protein sequence inspired by scorpion venom biology. This toxin should originate from Buthus israelis, a medically significant scorpion species whose venom contains potent neurotoxins targeting ion channels. The protein must function as a calcium channel toxin, specifically modulating voltage-gated calcium channels (VGCCs) to disrupt calcium signaling in excitable cells. The mechanism of action should involve high-affinity binding to specific VGCC subtypes, likely through interaction with voltage-sensing domains or pore-forming regions, leading to either channel blockade or modulation of gating kinetics. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion toxins, with a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in long-chain scorpion toxins) that stabilizes the core globular structure. The protein should contain key functional domains including a conserved beta-sheet core stabilized by disulfide bonds, and flexible loops that mediate target recognition and binding specificity. The molecular target interface should include residues critical for interacting with calcium channel voltage sensors or pore regions. The sequence must maintain proper folding with the CSαβ motif, appropriate hydrophobic core packing, and surface-exposed residues optimized for calcium channel binding while ensuring structural stability typical of scorpion venom toxins."}
{"description": "sp|Q7T045|SLLC1_MACLB Snaclec coagulation factor X-activating enzyme light chain 1 OS=Macrovipera lebetinus OX=3148341 GN=LC1 PE=1 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGADFDCPSDWVSYDQHCYKAFNDLKNWTDAEKFCTEQNKGSHLVSLHSSEEEDFVVNLASQSLQYPVAWIGLGNMWKECRSEWSDGGNVKYKALAEESYCLLINTHKKGWRSMTCNNMAHVICKF", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a coagulation factor X-activating enzyme. This toxin originates from Macrovipera lebetinus (Levantine viper), where it plays a crucial role in the venom's procoagulant activity by specifically activating coagulation factor X in the blood clotting cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by a conserved disulfide bridge pattern typical of snaclecs (commonly involving cysteine residues forming 2-3 disulfide bonds that maintain the globular β-sandwich structure). The sequence must include key functional residues for calcium-independent binding to factor X, facilitating its cleavage and activation to factor Xa, thereby promoting thrombin generation and potentially leading to consumptive coagulopathy. Ensure the structural integrity of the heterodimeric complex, as this light chain likely pairs with a heavy chain in vivo, though design the light chain to embody the essential enzymatic or cofactor activity. The molecular target is coagulation factor X, with binding likely occurring via surface loops that mediate specific recognition and proteolytic activation."}
{"description": "sp|P30403|VM2RH_CALRH Zinc metalloproteinase/disintegrin OS=Calloselasma rhodostoma OX=8717 PE=1 SV=2", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVIALSEGAAQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFAKDYSETHYSPDGTRITTYPSVEDHCYYQGRIHNDADSTASISACNGLKGHFKLQGETYFIEPMKLPDSEAHAVFKYENIEKEDESPKMCGVTETNWESDEPIKKVSQLNLNHEIKRHVDIVVVVDSRFCTKHSNDLEVIRKFVHEVVNAIIESYKYMHFGISLVNLETWCNGDLINVQEDSYETLKAFGKWRESDLIKHVNHSNAQFLMDMKFIKNIIGKAYLDSICDPERSVGIVQNYHGITLNVAAIMAHEMGHNLGVRHDGEYCTCYGSSECIMSSHISDPPSKYFSNCSYYQFWKYIENQNPQCILNKPLRTVSIPVSGNEHLEAGKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIPRGDMPDDRCTGQSADCPRYHSHA", "prompt": "Design a venom protein sequence from the Malayan pit viper (Calloselasma rhodostoma) that functions as a zinc metalloproteinase/disintegrin. This protein should exhibit the characteristic multi-domain architecture typical of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn. The metalloproteinase domain should possess hemorrhagic activity by degrading extracellular matrix components like collagen and fibrinogen through proteolytic cleavage. The disintegrin domain should contain the canonical RGD (Arg-Gly-Asp) integrin-binding motif that specifically targets platelet integrin receptors (primarily αIIbβ3), inhibiting platelet aggregation and adhesion. The protein should maintain appropriate cysteine residues for disulfide bond formation to stabilize both domains, with the metalloproteinase domain likely adopting a reprolysin-like fold and the disintegrin domain exhibiting the characteristic disintegrin loop structure. The overall protein should represent a P-II class SVMP where the metalloproteinase and disintegrin domains are expressed as a single polypeptide chain, contributing to the viper's potent hemotoxic venom effects including hemorrhage, anticoagulation, and disruption of hemostasis."}
{"description": "sp|C9X4K6|SCNA8_TITDI Toxin TdNa8 OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "MNYLTLIAAASLLTAGTESKKDGYPVKEGDCAFPCGYDNAYCDKLCKERKADSGYCYWGNILCYCYGLPDKAAIKGYGRCRPGKK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should originate from the scorpion species Tityus discrepans, a medically significant venomous arachnid whose venom components primarily target voltage-gated ion channels to disrupt neuronal signaling and cause neurotoxic effects. This toxin belongs to the beta-toxin family that specifically modulates voltage-gated sodium channels. The protein should function as a potent neurotoxin that binds to site 4 of voltage-gated sodium channels (Nav), delaying channel inactivation and prolonging action potentials, leading to sustained neuronal excitation and neuromuscular dysfunction. Structurally, it should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by three or four disulfide bridges with a typical C-C-CC-C-C cysteine framework pattern. The core structure should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a stable molecular scaffold with exposed loops that form the pharmacological interface. Key functional residues should be positioned in the loops between secondary structure elements to facilitate specific interactions with the voltage-sensing domain of Nav channels. The molecular target specificity should be toward tetrodotoxin-sensitive sodium channel subtypes, particularly those expressed in the peripheral nervous system. The toxin should exhibit high affinity binding through electrostatic and hydrophobic interactions with the channel's voltage-sensor module, trapping it in an activated state and preventing normal gating transitions."}
{"description": "sp|A0A1L1QJU3|TP1A_HADIN Pi-hexatoxin-Hi1a OS=Hadronyche infensa OX=153481 PE=1 SV=2", "sequence": "NECIRKWLSCVDRKNDCCEGLECYKRRHSFEVCVPIPGFCLVKWKQCDGRERDCCAGLECWKRSGNKSSVCAPIT", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin, known as pi-hexatoxin-Hi1a, belongs to the hexatoxin family of spider venom peptides and functions as a highly selective insecticidal agent. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge connectivity pattern of C1-C4, C2-C5, and C3-C6. This structural scaffold confers exceptional stability and resistance to proteolytic degradation. The toxin's mechanism of action involves specific binding to insect voltage-gated sodium channels, where it modulates channel gating to cause paralysis and lethality in insect prey. The sequence should include the characteristic cysteine framework of spider ICK toxins, with appropriate spacing between cysteine residues to facilitate proper folding into the knotted topology. The molecular surface should present key functional residues that mediate high-affinity interaction with insect sodium channel subtypes, while maintaining selectivity against mammalian channels. The overall structure should be compact, with the disulfide core providing a rigid scaffold that presents functional loops for target engagement."}
{"description": "sp|B1P1G6|JZ41A_CHIGU U2-theraphotoxin-Cg1b 1 OS=Chilobrachys guangxiensis OX=278060 PE=2 SV=1", "sequence": "MKVSVLITLAVWGVMFLLTSAQERGSDQMDSPAWLKSMERIFQSEERECRWMFGGCTTDSDCCEHLGCRWEKPSWCAWDGTFRK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be a theraphotoxin derived from the venom of the Chilobrachys guangxiensis tarantula, representing a member of the U2-theraphotoxin family. This toxin functions as a potent modulator of neuronal signaling, likely targeting voltage-gated ion channels such as sodium or calcium channels to disrupt action potential propagation and neurotransmitter release. The structural scaffold should feature the characteristic inhibitor cysteine knot (ICK) motif, stabilized by a conserved disulfide bridge pattern with three intramolecular disulfide bonds forming a knotted topology that confers exceptional thermal and proteolytic stability. The mature peptide should be approximately 30-40 amino acids in length, with a compact, globular fold dominated by beta-sheet secondary structure. Key functional residues should be positioned within flexible loops to facilitate specific interactions with ion channel pore regions or voltage-sensing domains, enabling high-affinity binding and modulation of channel gating kinetics. The sequence must include the canonical cysteine framework typical of ICK motif toxins, ensuring proper folding and biological activity. This toxin should exhibit the paralytic and neurotoxic properties characteristic of tarantula venom peptides used for prey immobilization."}
{"description": "sp|P30832|NA23_RADCR Delta-stichotoxin-Hcr1a OS=Radianthus crispa OX=3122430 PE=1 SV=1", "sequence": "GNCKCDDEGPYVRTAPLTGYVDLGYCNEGWEKCASYYSPIAECCRKKK", "prompt": "Design a protein sequence for a potent neurotoxin from the sea anemone Radianthus crispa that functions as a delta-stichotoxin. This toxin should exhibit the characteristic structural and functional properties of sea anemone type 3 sodium channel toxins. The protein should adopt a compact beta-sheet-rich fold stabilized by a conserved disulfide bridge pattern typical of this toxin family, likely involving three disulfide bonds with a specific connectivity that maintains structural integrity. The core mechanism of action involves binding to site 3 of voltage-gated sodium channels (Nav), specifically delaying channel inactivation and prolonging action potentials. This results in enhanced neurotransmitter release and potent neurotoxic effects. The sequence should include key conserved residues responsible for sodium channel recognition and binding, particularly in regions that interact with the channel's voltage-sensing domain. The structural scaffold should feature the characteristic sea anemone toxin fold with beta-strands arranged around a central core, maintaining the compact globular structure essential for target recognition and stability in the venom environment. The toxin should demonstrate high specificity for neuronal sodium channel subtypes, contributing to the sea anemone's predatory strategy by causing paralysis in prey organisms through disruption of normal neuronal signaling."}
{"description": "sp|C9X4K7|SCNA9_TITDI Toxin TdNa9 OS=Tityus discrepans OX=57059 PE=1 SV=2", "sequence": "MLKFAIAVALLLFIGLELREARDGYPQSKVNYCKIYCPNTTVCQWTCKNRAGATDGDCRWSSCYCFNVAPDTVLYGDPGTKPCMA", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a sodium channel neurotoxin derived from the venom of the scorpion Tityus discrepans, a medically significant species in northern South America. This toxin functions as a potent modulator of voltage-gated sodium channels, specifically targeting the Nav1.9 subtype, which plays crucial roles in pain signaling pathways. The toxin should exhibit the characteristic structural scaffold of scorpion β-toxins, featuring a conserved cysteine-stabilized α-helix/β-sheet (CSαβ) fold stabilized by four disulfide bridges with a typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The molecular mechanism involves binding to site 4 on the voltage-gated sodium channel, causing a shift in the voltage-dependence of activation toward more negative potentials and enhancing channel excitability. The structural core should contain a triple-stranded antiparallel β-sheet and a single α-helix, with key functional residues concentrated in the conserved 'pharmacophore' regions responsible for receptor recognition and binding. The protein should demonstrate high specificity for Nav1.9 channels while maintaining the thermostability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|P0DQY0|CA1A_CONOB Alpha-conotoxin OI OS=Conus obscurus OX=89447 PE=1 SV=1", "sequence": "YCCHPACGPNFSC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus obscurus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where disulfide bridges connect Cys1-Cys3 and Cys2-Cys4 to form a compact, stable structure. The sequence should include the signature two-loop architecture common to alpha-conotoxins, with hypervariable regions in the second loop responsible for receptor subtype specificity. Key structural elements should include: a short alpha-helical segment stabilized by disulfide bonds, well-defined beta-turns, and a solvent-exposed pharmacophore region for receptor interaction. The toxin should exhibit high affinity binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine binding and blocking ion channel activation. The molecular mechanism should involve precise interactions with specific receptor subunits through complementary electrostatic and hydrophobic contacts. The overall structure must be compact (typically 12-20 residues), cysteine-rich, and maintain the characteristic alpha-conotoxin fold that provides exceptional stability and target specificity while minimizing proteolytic degradation."}
{"description": "sp|B8XH30|KA23K_BUTIS Potassium channel toxin alpha-KTx Tx308 OS=Buthus israelis OX=2899555 PE=2 SV=1", "sequence": "MQKLFIVLLLFCILRLDAEVDGRTMSHCNQSECQEKCKKKNKNGRCITEFEMNYVYNRCRCN", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of the scorpion Buthus israelis. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.x subtypes to disrupt neuronal excitability and neuromuscular transmission. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. Incorporate key functional motifs including a critical lysine-rich patch in the beta-sheet region for direct interaction with the potassium channel pore, along with conserved hydrophobic residues that mediate structural stability. The sequence should maintain the characteristic molecular weight of 3-5 kDa and exhibit high affinity binding to the external vestibule of potassium channels, effectively blocking ion conduction through physical occlusion of the selectivity filter. Ensure the design includes the signature alpha-helix and antiparallel beta-sheet structural elements that define this toxin family, with appropriate surface charge distribution for target recognition and membrane association."}
{"description": "sp|A0A088MI62|BRKP1_PHYNA [Val1,Thr6]-bradykinyl-Val,Asp OS=Physalaemus nattereri OX=248869 GN=BKL PE=1 SV=1", "sequence": "MAFLKKSLFLVLFLGVVSLSFCEEEEREEHEEEKREAEAAESAENLISKRVPPGFTPFRVD", "prompt": "Design a novel peptide toxin derived from the skin secretion of the natterjack toad, Physalaemus nattereri, that functions as a potent bradykinin-potentiating peptide. This peptide should exhibit the characteristic [Val1,Thr6]-bradykinyl-Val,Asp modification pattern, where the canonical bradykinin sequence is extended at the C-terminus with valine and aspartic acid residues, and features valine at position 1 and threonine at position 6 in place of the standard bradykinin residues. The peptide should function as a competitive inhibitor of angiotensin-converting enzyme (ACE), thereby potentiating the vasodilatory and pro-inflammatory effects of endogenous bradykinin by preventing its degradation. This mechanism contributes to the venom's defensive role by inducing hypotension, increased vascular permeability, and pain sensation in potential predators. The peptide should adopt a flexible, extended conformation typical of small linear peptides, with critical pharmacophoric elements including the C-terminal dipeptide extension that enhances ACE binding affinity, and the specific residue substitutions that modulate receptor interaction profiles. The sequence should maintain the core bradykinin-like scaffold while incorporating the specified modifications to optimize its peptidase inhibition properties and biological activity within the context of amphibian chemical defense systems."}
{"description": "sp|Q06ZW0|3NB_BOIDE Denmotoxin OS=Boiga dendrophila OX=46286 PE=1 SV=1", "sequence": "MKTLLLAVAVVAFVCLGSADQLGLGRQQIDWGQGQAVGLPHGFCIQCNRKTWSNCSIGHRCLPYHMTCYTLYKPDENGEMKWAVKGCARMCPTAKSGERVKCCTGASCNSD", "prompt": "Design a novel protein sequence for a potent animal toxin with the following precise biological specifications: This toxin originates from the mangrove snake Boiga dendrophila, a rear-fanged colubrid species whose venom contains specialized three-finger toxins that facilitate prey capture through neurological disruption. The protein belongs to the denmotoxin family, which exhibits unique target specificity distinct from classical neurotoxins. The core function is as a postsynaptic neurotoxin that selectively antagonizes alpha-1 and alpha-7 nicotinic acetylcholine receptors at the neuromuscular junction, causing reversible paralysis through competitive inhibition of acetylcholine binding. Structurally, this toxin adopts the characteristic three-finger toxin fold composed of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges in a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The molecular architecture features a concave surface on loop II that forms the primary receptor binding interface, with key functional residues including conserved aromatic and basic amino acids that mediate specific interactions with the receptor's ligand-binding domain. The protein should exhibit high affinity for avian and mammalian nicotinic receptors while maintaining the thermal stability and protease resistance typical of three-finger toxins. The sequence must preserve the essential cysteine framework and structural determinants required for proper folding into the stable, compact globular structure characteristic of this toxin family."}
{"description": "sp|A0A1P8NVU0|COW2_CONBL Contryphan-Lo2 OS=Conus buxeus loroisii OX=410709 PE=1 SV=1", "sequence": "MGKLTILVLVAAVLLSTQAMVQDQPADRNAVRRNDNPGGASRKSINVLHRNECPWQPWCG", "prompt": "Design a novel contryphan peptide derived from the venom of Conus buxeus loroisii, a marine cone snail species. This peptide should function as a potent neurotoxin that modulates neuronal excitability, likely through interaction with voltage-gated ion channels or neurotransmitter receptors in the central nervous system. The peptide must adopt the characteristic contryphan structural scaffold, featuring a compact, disulfide-constrained conformation stabilized by multiple disulfide bridges in a conserved cysteine framework. The sequence should include the hallmark post-translational modification of tryptophan bromination or other hydroxylation patterns typical of contryphans, which enhances receptor binding affinity and specificity. The structural fold should exhibit high stability and resistance to proteolytic degradation, with key residues positioned to form specific molecular interactions with neuronal targets. The final design should capture the evolutionary optimization of cone snail venom peptides for precise neurological targeting while maintaining the unique pharmacological profile of the contryphan family."}
{"description": "sp|P17236|CRBL_VESOR Histamine-releasing peptide 2 OS=Vespa orientalis OX=7447 PE=1 SV=1", "sequence": "FLPLILGKLVKGLL", "prompt": "Generate the amino acid sequence for a potent histamine-releasing peptide from the venom of the Oriental hornet (Vespa orientalis). This peptide functions as a mast cell degranulating agent that triggers the release of histamine and other inflammatory mediators from mast cells and basophils. The peptide should adopt a compact, amphipathic structure with cationic residues that facilitate interaction with negatively charged components of mast cell membranes, potentially through G-protein coupled receptor activation or direct membrane perturbation. The sequence should contain characteristic features of vespid venom peptides, including a propensity for alpha-helical formation in membrane environments, strategic placement of basic residues (lysine, arginine) for membrane association and receptor interaction, and hydrophobic patches that enable membrane insertion. The peptide should exhibit high potency for mast cell activation while maintaining the typical molecular weight range (2-5 kDa) of bioactive hornet venom peptides. The structural scaffold should enable specific recognition by mast cell surface components while avoiding broad-spectrum cytolytic activity."}
{"description": "sp|C5H5D2|VM31_BOTAT Zinc metalloproteinase-disintegrin-like batroxstatin-1 OS=Bothrops atrox OX=8725 PE=2 SV=1", "sequence": "EQQKYLNARKYIELVIVADNVMVKKYTSNSTAIRTRIYSCVNTLNLIYSAFNTHIALTGVEIWSNGDKINVQSNSSVTLDFFGTWRETVLLNRKRHDNAQLLTAIDLDGPTVGLAYVGSMCNPKGSTGLIQDHNKLDVMVAITMAHELGHNLGMNHDGNQCNCGGNPCIMSATLDFEPVYQFSDCSRDQHWRYLIDNRPPCILNIPLRTDIVSPPVCGNYFVEVGEECDCGLPANCQNQCCNAATCKLIPGAQCEDGECCERCQFKGAGTECRAARSECDIAESCTGQSPECPTDDFQRNGQPCLNNQGYCYNGNCPILDHQCHNLFGAGATVAPNACFDFNRKGQGNSYCRKQNGVTIPCARKDIKCGRLFCVQGPIGNTISCQSTSSQDDPDIGMVDLGTKCGDGRVCNSNRECVDVTTPY", "prompt": "Design a zinc metalloproteinase-disintegrin-like toxin protein sequence that mimics the biological activity of batroxstatin-1 from the venom of Bothrops atrox, the common lancehead pit viper. This protein should function as a potent antiplatelet agent by specifically targeting and inhibiting platelet aggregation through high-affinity binding to integrin receptors on platelet surfaces. The sequence must incorporate the characteristic metalloproteinase-disintegrin domain architecture, featuring a conserved zinc-binding motif (HEXXHXXGXXH) in the metalloproteinase region that would coordinate catalytic zinc ions, followed by a disintegrin domain containing the canonical RGD (Arg-Gly-Asp) tripeptide motif that mediates specific recognition of platelet integrin αIIbβ3. The protein should adopt a compact, multi-domain fold stabilized by multiple disulfide bridges characteristic of snake venom metalloproteinases, with the disintegrin domain forming an exposed loop structure that presents the RGD motif for optimal receptor engagement. The overall structure should facilitate the dual functionality of proteolytic activity in the metalloproteinase domain and receptor blockade in the disintegrin domain, contributing to the hemorrhagic and antithrombotic effects typical of Bothrops atrox venom components."}
{"description": "sp|Q9W7K0|3S33_PSETE Short neurotoxin 3 OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYRYLVPATHGNAIPARGCGTSCPGGNHPVCCSTDLCNK", "prompt": "Design a protein sequence for a short neurotoxin from the Eastern brown snake (Pseudonaja textilis) venom. This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C. The structural scaffold should feature the typical globular shape with loop I being the shortest and loop II containing key functional residues for receptor binding. The molecular target is the muscle-type nicotinic acetylcholine receptor, with specific interactions occurring at the agonist-binding site between the α- and δ-subunits. The toxin should exhibit high affinity binding that prevents acetylcholine from activating the receptor, thereby blocking neuromuscular transmission. The sequence should reflect the evolutionary optimization for rapid prey immobilization through efficient receptor blockade, with appropriate hydrophobic patches and charged residues positioned for optimal target engagement while maintaining the stable three-finger structural motif characteristic of elapid snake neurotoxins."}
{"description": "sp|Q0GY40|KBX3_HOFGE Hge-scorpine OS=Hoffmannihadrurus gertschi OX=380989 PE=1 SV=1", "sequence": "MNTKLTVLCFLGIVTIVSCGWMSEKKVQGILDKKLPEGIIRNAAKAIVHKMAKNQFGCFANVDVKGDCKRHCKAEDKEGICHGTKCKCGVPISYL", "prompt": "Design a novel scorpion venom-derived protein that combines the structural and functional characteristics of scorpine-like peptides. The protein should be derived from Hoffmannihadrurus gertschi scorpion venom and exhibit the dual functional domains characteristic of scorpine family toxins. The N-terminal domain should adopt an alpha-helical antimicrobial peptide fold with amphipathic properties, enabling membrane disruption and broad-spectrum antimicrobial activity against bacteria, fungi, and parasites. The C-terminal domain should fold into a cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion defensins, stabilized by three or four disulfide bridges in a conserved pattern that creates a compact, stable core structure. This domain should possess potassium channel blocking activity, specifically targeting insect voltage-gated potassium channels to induce paralysis. The complete protein should maintain the characteristic elongated structure with distinct domain separation, allowing independent functionality while preserving structural integrity. The sequence should include the conserved cysteine framework (C-C-CC-C-C pattern) that enables proper disulfide bonding and structural stabilization. The protein should demonstrate potent insecticidal activity through its dual mechanism of membrane disruption and ion channel modulation, making it an effective defense component in scorpion venom."}
{"description": "sp|Q5F1N4|KS4_OLIMR Toxin BmTxKS4 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MKLKISFLILVLFSVFFAIEGIIKWFPASVNGKGHSSCTNGLEMTEEDFCKMLCGIDGKLRESKCVDHWCYCSQILFP", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of Olivierus martensii (Chinese scorpion). This toxin should function as a potassium channel modulator, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt a conserved scorpion toxin structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, stabilized by three or four disulfide bridges in a specific connectivity pattern (typically C1-C4, C2-C5, C3-C6 for the common ICK fold). Key structural elements should include a compact, globular fold with a triple-stranded beta-sheet stabilized by the disulfide core, and surface-exposed loops that mediate target recognition and binding. The molecular mechanism should involve high-affinity interaction with the pore domain or voltage-sensing domain of Kv channels, leading to channel blockade or modulation that results in prolonged neuronal depolarization, enhanced neurotransmitter release, and ultimately, paralysis or pain induction in prey. Incorporate conserved residues critical for structural integrity (e.g., cysteine spacing, hydrophobic core) and functional motifs known for potassium channel specificity, while ensuring the sequence reflects the evolutionary adaptations of scorpion venom toxins for rapid immobilization of arthropod or small vertebrate prey."}
{"description": "sp|D1MZV3|VNP_RHATT C-type natriuretic peptide OS=Rhabdophis tigrinus tigrinus OX=193080 PE=2 SV=1", "sequence": "MFASRLAALGLLLLALVLDGKPAPPPQPLRKAPAGGTTALQRQLTEQQQQQQQAEGSSGPAAGGGGGRSGSKTANAAPTAPKSKGAAASAASRLLRDLRPDGKQSRAAWGRMVHPEHHAGGGGGGGGGGSRRLKGLPKKGLGSGCFGLKLDRIGSMSGLGC", "prompt": "Design a C-type natriuretic peptide toxin from the venom of the tiger keelback snake (Rhabdophis tigrinus). This peptide functions as a potent vasoactive toxin that targets the natriuretic peptide receptor-A (NPR-A) in prey organisms. The mechanism involves binding to the extracellular domain of NPR-A, activating guanylyl cyclase activity and increasing intracellular cGMP levels, leading to vasodilation, natriuresis, and diuresis. The peptide should adopt the characteristic natriuretic peptide fold stabilized by a conserved disulfide bridge pattern (Cys1-Cys6, Cys2-Cys5, Cys3-Cys4) that forms a ring structure essential for receptor binding and biological activity. The mature peptide should contain approximately 22-25 amino acids with the characteristic C-terminal tail that is crucial for receptor specificity and potency. The structural scaffold should feature an N-terminal tail, a central ring structure constrained by the three disulfide bonds, and a C-terminal extension that contributes to receptor binding affinity. This toxin represents an evolutionary adaptation where the snake has co-opted a normally endogenous regulatory peptide into its venom arsenal for prey immobilization through cardiovascular effects."}
{"description": "sp|B8XH42|KA166_BUTIS Potassium channel toxin alpha-KTx 16.6 OS=Buthus israelis OX=2899555 PE=2 SV=1", "sequence": "MKILSVLLIALIICSINICSEAGLIDVRCYASRECWEPCRRVTGSAQAKCQNNQCRCY", "prompt": "Design a novel potassium channel toxin protein sequence derived from the venom of the scorpion Buthus israelis, classified within the alpha-KTx family. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.x subtypes, which are critical for modulating neuronal excitability and action potential repolarization. The protein must adopt the conserved structural scaffold characteristic of scorpion alpha-KTx toxins, featuring a compact, globular fold stabilized by three disulfide bridges with a cysteine framework of C-C-CC-C-C. The core structure should include an alpha-helix and an antiparallel beta-sheet, forming a stable molecular surface for high-affinity binding to the potassium channel pore. The binding interface must contain key functional residues, such as a conserved lysine or aromatic residue, that insert into the channel selectivity filter to physically occlude potassium ion conduction. The toxin should exhibit high specificity for potassium channels over other ion channels, contributing to its role in disrupting neuromuscular transmission and inducing paralysis in prey. Ensure the sequence reflects the evolutionary optimization for rapid onset of action and resistance to proteolytic degradation, typical of scorpion venom peptides."}
{"description": "sp|A7X3S0|3NB2_TRIBI Toxin 3FTx-Tri2 OS=Trimorphodon biscutatus OX=338818 PE=3 SV=1", "sequence": "MKTLLLALVVLAFVCLGSADQVGLGKEQIDRGRRQAIGPPFTRCSQCNRNRSPQCFIEDRCTPGDFTCYTVYKPNGNGGEDWVVKGCAKTCPTAGPGERVKCCYSPRCNKN", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein should be a three-finger toxin (3FTx) from the venom of the lyre snake, Trimorphodon biscutatus, a rear-fanged colubrid species. This toxin belongs to the Tri2 subfamily of 3FTx toxins and functions as a potent neurotoxin targeting the neuromuscular junction. The core mechanism involves high-affinity binding to postsynaptic nicotinic acetylcholine receptors (nAChRs), specifically the muscle-type α-δ or α-γ subunit interfaces, leading to competitive antagonism and blockade of neuromuscular transmission, resulting in flaccid paralysis. The structural scaffold must adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a cysteine framework of C-C-CC-C-C. The N-terminal loop I typically contains key functional residues for receptor interaction, while loops II and III contribute to structural stability and target specificity. The protein should exhibit a compact, globular architecture with the disulfide connectivity pattern: Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, and Cys7-Cys8, forming a rigid core that displays the functional loops. Key conserved motifs include the three-finger toxin signature pattern in loop II and the hydrophobic core residues that maintain structural integrity. The sequence should reflect the evolutionary adaptations of colubrid venom toxins, balancing stability in the venom gland with efficient receptor binding, and include characteristic positively charged residues in loop I for electrostatic interactions with the nAChR ligand-binding domain."}
{"description": "sp|P84037|SLB_MACLB Snaclec lebecetin subunit beta (Fragment) OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "ALNCASGWSGGYDQHCYKVFDIPPSWAADEKFCKQQTSGGHLV", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This protein is derived from Macrovipera lebetinus (Levantine viper) venom, where it contributes to the venom's hemorrhagic and anticoagulant effects by disrupting normal hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C-C-C-C cysteine framework. The sequence should include key structural elements: an N-terminal alpha-helix followed by two antiparallel beta-sheets forming the core, with conserved hydrophobic residues maintaining structural integrity. Functionally, this snaclec should bind to platelet membrane receptors—likely targeting GPIb or GPVI—through its recognition loops, competitively inhibiting platelet adhesion and aggregation. Include conserved calcium-binding motifs if applicable, and ensure the sequence reflects the heterodimeric nature typical of snaclecs, with this representing the beta subunit that pairs with an alpha subunit to form the functional lebecetin complex. The overall structure should be compact and globular, approximately 15-20 kDa, with surface-exposed loops mediating specific receptor interactions while maintaining the stable CTLD scaffold."}
{"description": "sp|Q2YHM1|SCX8R_ANDMA Neurotoxin 8-related gene product 1/2/3 OS=Androctonus mauritanicus mauritanicus OX=6860 GN=NTVIIIrgp1 PE=3 SV=1", "sequence": "MNYLTMISLALLVMTGVESGVRDAYIADNKNCIFTCYRDSYCKTECIKNGAETGYCIWIGEYGNACWCIKLPNKVPIKVPGKCNGR", "prompt": "Design a neurotoxin protein sequence inspired by the venom of the North African scorpion Androctonus mauritanicus mauritanicus. This toxin should function as a sodium channel modulator, specifically targeting voltage-gated sodium channels to disrupt neuronal signaling. The protein should adopt a compact, globular fold stabilized by a conserved cysteine framework typical of scorpion β-toxins, featuring four disulfide bridges that confer structural rigidity and thermal stability. Key structural elements should include an anti-parallel β-sheet core and flexible loops that mediate receptor interaction. The mechanism of action involves binding to site 4 of voltage-gated sodium channels, delaying inactivation and prolonging action potentials, leading to hyperexcitability and neurotoxic effects. The sequence should reflect evolutionary adaptations for rapid delivery and potency in scorpion venom, with residues critical for target specificity and membrane penetration conserved."}
{"description": "sp|P07231|CKG_CONGE Conantokin-G OS=Conus geographus OX=6491 PE=1 SV=2", "sequence": "MHLYTYLYLLVPLVTFHLILGTGTLDDGGALTERRSADATALKAEPVLLQKSAARSTDDNGKDRLTQMKRILKQRGNKARGEEELQENQELIREKSNGKR", "prompt": "Design a protein sequence for conantokin-G, a neuroactive peptide toxin from the venom of the marine cone snail Conus geographus. This toxin functions as a selective and potent antagonist of N-methyl-D-aspartate (NMDA) receptors, specifically targeting the NR2B subunit. The mechanism involves competitive inhibition at the glutamate-binding site, leading to disruption of excitatory neurotransmission and producing sedative and anticonvulsant effects. Structurally, conantokin-G adopts an elongated alpha-helical conformation stabilized by multiple gamma-carboxyglutamate (Gla) residues that chelate calcium ions, forming a rigid, metal-stabilized helical structure. The sequence should contain 17 amino acids with a high density of Gla residues, particularly at positions 3, 4, 7, 10, and 14, which are critical for calcium coordination and structural stability. The N-terminal region should maintain a flexible conformation to facilitate receptor binding, while the helical core should display specific hydrophobic and charged residues that mediate interaction with the NR2B subunit ligand-binding domain. The toxin should lack disulfide bridges and cysteine residues, distinguishing it from the typical cysteine-rich framework of most conotoxins. The overall architecture should enable high-affinity, subtype-selective blockade of NMDA receptor function through precise molecular recognition of the receptor's glutamate-binding cleft."}
{"description": "sp|A0A1L2FZD4|KAX88_ORTSC Potassium channel toxin alpha-KTx 8.8 OS=Orthochirus scrobiculosus OX=6892 PE=1 SV=1", "sequence": "MCRLYAIILIVLVMNVIMTIIPDSKVEVVSCEDCPEHCSTQKARAKCDNDKCVCEPI", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from scorpion venom. This toxin originates from Orthochirus scrobiculosus, a scorpion species whose venom contains potent neurotoxins targeting ion channels to immobilize prey through disruption of neuronal signaling. The protein functions as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to inhibit potassium efflux, thereby prolonging neuronal depolarization and enhancing neurotransmitter release at synapses. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of the alpha-KTx family, featuring a short alpha-helix connected by disulfide bridges to an antiparallel beta-sheet. The cysteine framework should follow the C1-C8, C2-C5, C3-C6, C4-C7 pattern, with four disulfide bonds stabilizing the compact globular structure. Key structural elements include a functional dyad composed of a critical lysine residue in the beta-sheet region that penetrates the potassium channel pore, and an aromatic residue that stabilizes binding through interactions with channel vestibule residues. The molecular target interface involves specific interactions with the Kv channel pore region, particularly with conserved residues in the selectivity filter and outer vestibule. The protein should exhibit high affinity for Shaker-type potassium channels, with the functional core maintaining the characteristic pharmacophore that enables sub-nanomolar binding affinity through optimal electrostatic and hydrophobic complementarity with the channel architecture."}
{"description": "sp|P0CD67|BOL6_BOMLA Bombolitin-6 OS=Bombus lapidarius OX=30192 PE=1 SV=1", "sequence": "LNLTKWLGKLGVILSHLNK", "prompt": "Design a protein sequence for bombolitin-6, a hemolytic peptide toxin from the venom of the red-tailed bumblebee (Bombus lapidarius). This toxin belongs to the bombolitin family of amphipathic, α-helical peptides that function as membrane-disrupting agents. The protein should adopt a predominantly α-helical conformation with amphipathic character, featuring a hydrophobic face that interacts with lipid bilayers and a hydrophilic face that remains solvent-exposed. Bombolitin-6 acts by binding to and disrupting biological membranes, leading to cell lysis through pore formation or detergent-like effects. The mechanism involves insertion into lipid bilayers, causing membrane permeabilization and eventual cell death. The sequence should contain characteristic bombolitin features: moderate length (approximately 15-20 residues), high proportion of hydrophobic and basic residues that facilitate membrane interaction, and absence of disulfide bridges typical of this peptide family. The structural scaffold should be a simple, flexible α-helix that can undergo conformational changes upon membrane binding, transitioning from disordered in solution to helical when interacting with lipid environments."}
{"description": "sp|P0C1N5|M3G_CONMR Conotoxin mr3g OS=Conus marmoreus OX=42752 PE=1 SV=1", "sequence": "MSKLGVLLTICLLLFALTAVPLDGDQPADRPAERMQDDISSERHPMFDAVRDCCPLPACPFGCNPCCG", "prompt": "Design a novel conotoxin sequence inspired by the venom of the marine cone snail Conus marmoreus, a predatory species that employs its venom for prey capture and defense. This toxin should function as a potent modulator of neuronal signaling, specifically targeting voltage-gated ion channels to disrupt electrical conduction in the nervous system. The sequence must adopt the conserved structural framework characteristic of conotoxins, featuring a compact, disulfide-stabilized fold with a specific cysteine framework (likely CC-C-C for this family) that forms two or more disulfide bridges, conferring exceptional stability and resistance to proteolytic degradation. The core structure should exhibit a well-defined three-dimensional conformation, potentially resembling an inhibitor cystine knot (ICK) motif, with loops of variable length and composition that dictate target specificity. Key residues within these loops should mediate high-affinity binding to the extracellular domains of voltage-gated sodium or potassium channels, altering channel gating kinetics and leading to paralysis or sensory disruption. Ensure the sequence includes conserved cysteine residues at appropriate positions to enable correct disulfide pairing, along with hydrophilic and hydrophobic residues strategically placed to support both solubility and structural integrity. The final protein should be approximately 10–30 amino acids in length, with a calculated isoelectric point reflecting its cationic nature for enhanced interaction with anionic channel surfaces, and must exclude any non-natural or modified amino acids."}
{"description": "sp|P60991|TX1_STRCF Kappa-theraphotoxin-Sc1a OS=Stromatopelma calceatum OX=269628 PE=1 SV=1", "sequence": "DCTRMFGACRRDSDCCPHLGCKPTSKYCAWDGTI", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This is a kappa-theraphotoxin from the tarantula species Stromatopelma calceatum, commonly known as the featherleg baboon tarantula. As a component of this spider's defensive venom, this toxin functions as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal signaling and cause paralysis in prey. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. This scaffold provides exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves binding to the pore region of Kv channels, particularly Kv1 subtypes, through a surface-exposed pharmacophore that includes key residues for channel recognition and blockade. The sequence should contain the characteristic cysteine framework of ICK toxins with appropriate spacing between cysteine residues to form the knotted disulfide topology. The mature toxin should be approximately 30-40 amino acids in length with a basic isoelectric point to facilitate interaction with the negatively charged channel vestibule. Include conserved hydrophobic patches and solvent-exposed loops that mediate specific channel interactions while maintaining the overall globular, stable fold typical of spider venom ICK toxins."}
{"description": "sp|Q9XZK6|CA11_CONTE Alpha-conotoxin-like Tx1 OS=Conus textile OX=6494 PE=3 SV=1", "sequence": "MGMRMMFVVFLLVVLASTVVSSTSGRRAFHGRNAAAKASGLVSLTDRRPECCSDPRCNSSHPELCGGRR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus textile. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). It should feature a compact, stable fold stabilized by these disulfide bridges, presenting key functional loops that mediate high-affinity binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine binding and blocking ion channel activation. The sequence should include conserved cysteine residues at appropriate positions to form the disulfide bonds, along with variable regions in the intercysteine loops that confer subtype selectivity and potency. The overall structure should be small (typically 12-20 amino acids), highly stable, and exhibit the typical alpha-conotoxin pharmacophore for nAChR antagonism, contributing to the venom's paralytic activity by disrupting neuromuscular or neuronal signaling."}
{"description": "sp|P81397|SLEA_CALRH Snaclec rhodocetin subunit alpha OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "DCPDGWSSTKSYCYRPFKEKKTWEEAERFCTEQEKEAHLVSMENRLEAVFVDMVMENNFENKIYRSWIGLKIENKGQRSNLEWSDGSSISYENLYEPYMEKCFLMDHQSGLPKWHTADCEEKNVFMCKFQLPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor. This toxin originates from the Malayan pit viper (Calloselasma rhodostoma), where it plays a crucial role in prey immobilization through disruption of hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two intra-chain disulfide bonds with a typical C1-C4, C2-C3 connectivity pattern. The molecular mechanism involves specific binding to platelet membrane glycoproteins, particularly targeting the collagen receptor GPVI or integrin α2β1, thereby blocking collagen-induced platelet activation and aggregation. The sequence should maintain key residues in the carbohydrate recognition domain (CRD) that mediate calcium-independent protein-protein interactions, with surface-exposed loops critical for receptor recognition and inhibition. The overall structure should exhibit the hallmark β-sheet sandwich topology with flanking α-helices characteristic of snake venom CTLDs, ensuring high-affinity binding to platelet receptors while maintaining structural stability in the venom milieu."}
{"description": "sp|P81398|SLEB_CALRH Snaclec rhodocetin subunit beta OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "DFRCPTTWSASKLYCYKPFKEKKTWIEAERFCAKQAENGHLVSIGSAAEADFLDLVIVVNFDKQRYRAWTGLTERNLKWTNGASVSYENLYEPYIRKCFVVQPWEGKSKWYKADCEEKNAFLCKFPKPH", "prompt": "Design a protein sequence for the beta subunit of rhodocetin, a C-type lectin-like protein (snaclec) from the venom of the Malayan pit viper (Calloselasma rhodostoma). This heterodimeric toxin functions as a potent platelet aggregation inhibitor by specifically binding to the platelet collagen receptor glycoprotein VI (GPVI) with high affinity. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence must include key residues for calcium-independent carbohydrate recognition domain functionality and maintain the specific β-sheet rich architecture that enables precise molecular recognition of GPVI, thereby blocking collagen-induced platelet activation and serving as an important tool for studying thrombosis mechanisms."}
{"description": "sp|P33589|VSPF_LACMU Thrombin-like enzyme gyroxin analog OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "VIGGDECNINEHRFLVALYDGLSGTFLCGGTLINQEWVLTAQHCNRSLMNIYLGMHNKNVKFDDEQRRYPKKKYFFRCNKNFTKWDEDIRLNRPVRFSAHIEPLSLPSNPPSEDSVCRVMGWGQITSPPETLPDVPHCANINLFNYTVCRGAYPRMPTKVLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGVYTKVFDYLDWIQSVIAGNTTCS", "prompt": "Design a serine protease toxin from the venom of the South American bushmaster snake (Lachesis muta muta) that functions as a thrombin-like enzyme. This toxin should exhibit gyroxin analog activity, characterized by its ability to induce blood coagulation through fibrinogen cleavage while potentially causing neurotoxic effects such as barrel rotation syndrome in vertebrates. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a catalytic triad (His, Asp, Ser) and the conserved structural features of snake venom serine proteases, including multiple disulfide bridges that stabilize the dual beta-barrel domain architecture. The enzyme should specifically recognize and cleave fibrinogen at sites analogous to thrombin, converting it to fibrin to promote clot formation, while potentially interacting with other plasma components or neuronal targets to produce the characteristic gyroxin-induced behavioral effects. The structural scaffold should maintain the typical SVSP topology with well-defined substrate-binding pockets and exosite regions that confer specificity for its physiological targets."}
{"description": "sp|P81662|ACTP1_STIHL DELTA-stichotoxin-She4a OS=Stichodactyla helianthus OX=6123 PE=1 SV=1", "sequence": "SELAGTIIDGASLTFEVLDKVLGELGKVSRKIAVGIDNESGGTWTALNAYFRSGTTDVILPEVVPNTKALLYSGRKSSGPVATGAVAAFAYYMSNGNTLGVMFSVPFDYNWYSNWWDVKIYPGKRRADQGMYEDMYYGNPYRGDNGWYQKNLGYGLRMKGIMTSAGEAKMQIKISR", "prompt": "Generate the amino acid sequence for a delta-stichotoxin from the sea anemone Stichodactyla helianthus. This toxin functions as a potent pore-forming cytolysin that targets cell membranes, creating cation-selective channels that disrupt osmotic balance and lead to cell lysis. The protein should adopt the characteristic actinoporin fold, featuring a stable beta-sandwich core structure stabilized by multiple disulfide bonds. Key structural elements include a conserved phosphocholine-binding site that mediates initial membrane recognition and a hydrophobic region that inserts into lipid bilayers to form the transmembrane pore. The sequence should contain the signature amphipathic character with both hydrophilic surface residues for solubility and hydrophobic regions for membrane insertion. The toxin should exhibit high specificity for membranes containing sphingomyelin and demonstrate calcium-independent cytolytic activity typical of sea anemone actinoporins."}
{"description": "sp|P81783|3NO4_BUNCA Candoxin OS=Bungarus candidus OX=92438 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYTMKCKICNFDTCRAGELKVCASGEKYCFKESWREARGTRIERGCAATCPKGSVYGLYVLCCTTDDCN", "prompt": "Design a protein sequence for a novel short-chain neurotoxin derived from the venom of the Malayan krait (Bungarus candidus), a medically important elapid snake species. This toxin should function as a competitive antagonist of muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the agonist-binding site with high affinity and selectivity. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-CC-C-C. The sequence should feature key structural elements including a central β-sheet core, flexible loop regions for receptor interaction, and conserved hydrophobic residues that maintain structural integrity. The molecular mechanism should involve direct competition with acetylcholine for binding to the α-δ and α-γ subunit interfaces of the postsynaptic receptor, leading to reversible neuromuscular blockade without significant effects on neuronal nicotinic receptors. The design should prioritize structural stability through proper disulfide connectivity while maintaining the functional epitopes required for specific receptor recognition and binding."}
{"description": "sp|Q7T2Q0|SLB_ECHML Snaclec EMS16 subunit beta OS=Echis multisquamatus OX=93050 PE=1 SV=1", "sequence": "MGRLISVRFSLLVVFLSLSGIGAGLCCPLGWSSFDQHCYKVFEPVKNWTEAEEICMQQHKGSRLASIHGSEEEAFVSKLASKALKFTSMWIGLNNPWKDCKWEWSDNARFDYKAWKRRPYCTVMVVKPDRIFWFTRGCEKSVSFVCKFLTDPAV", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor. This protein originates from the venom of Echis multisquamatus (saw-scaled viper), where it serves as the beta subunit of the EMS16 complex, contributing to the venom's hemorrhagic and anticoagulant properties by disrupting normal hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. This structural scaffold presents key functional residues that enable specific binding to platelet membrane receptors, particularly targeting the glycoprotein Ib-IX-V complex, thereby interfering with platelet adhesion and activation at vascular injury sites. The sequence should include the conserved calcium-binding motifs and surface-exposed loops critical for receptor recognition, while maintaining the overall globular fold essential for stability in the venom milieu and effective inhibition of primary hemostasis through competitive receptor blockade."}
{"description": "sp|P86106|KAX6Y_OPICY Potassium channel toxin alpha-KTx 6 OcyKTx5 (Fragment) OS=Opisthacanthus cayaporum OX=573324 PE=1 SV=1", "sequence": "IRCTGSKECYSPCYKATGCPNAKC", "prompt": "Design a potassium channel toxin protein sequence based on the venom of the scorpion Opisthacanthus cayaporum. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix stabilized against an antiparallel beta-sheet by disulfide bridges. The cysteine framework should follow the typical alpha-KTx pattern (C1-X3-5-C2-X3-7-C3-X1-3-C4-X8-14-C5-X1-4-C6) with disulfide connectivity C1-C4, C2-C5, and C3-C6. The molecular mechanism involves binding to the pore region of Kv1.x family potassium channels, specifically interacting with the channel's voltage-sensor domain and selectivity filter to prevent potassium ion conduction. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes, contributing to the neurotoxic effects of scorpion venom by disrupting neuronal excitability and synaptic transmission. Include key functional residues in the beta-sheet region that mediate channel recognition and blocking activity, while maintaining the compact, stable globular structure essential for venom potency and resistance to proteolytic degradation."}
{"description": "sp|P81458|PA2B_DABRR Basic phospholipase A2 RVV-VD OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "NLFQFAEMIVKMTGKNPLSSYSDYGCYCGWGGKGKPQDATDRCCFVHDCCYEKVKSCKPKLSLYSYSFQNGGIVCGDNHSCKRAVCECDRVAATCFRDNLNTYDKKYHNYPPSQCTGTEQC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Russell's viper (Daboia russelii), specifically representing the RVV-VD isoform. This enzyme should function as a potent presynaptic neurotoxin and myotoxin, exhibiting strong phospholipase A2 activity that catalyzes the hydrolysis of the sn-2 acyl bond of glycerophospholipids, leading to membrane disruption, inflammation, and tissue damage. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network involving His48, Asp49, and Tyr52. It should feature the typical disulfide bond pattern of group II phospholipase A2 enzymes (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91) that stabilizes the compact globular structure. The basic nature of this toxin enhances its membrane-binding affinity and contributes to its potent neurotoxic effects through interactions with neuronal membranes and potential receptor targets. Include the characteristic pancreatic loop and elapid loop regions that define the structural scaffold, while maintaining the functional catalytic triad essential for enzymatic activity."}
{"description": "sp|P84094|KAX6D_HETSP Potassium channel toxin alpha-KTx 6.13 OS=Heterometrus spinifer OX=118530 PE=1 SV=1", "sequence": "IRCSGSRDCYSPCMKQTGCPNAKCINKSCKCYGC", "prompt": "Design a potent animal toxin peptide that functions as a selective potassium channel blocker. This toxin originates from the venom of the scorpion Heterometrus spinifer, where it serves as a key defensive and predatory component by disrupting neuronal and muscular signaling through voltage-gated potassium channel inhibition. The peptide should adopt the characteristic alpha-KTx structural scaffold, featuring a compact, globular fold stabilized by a conserved cysteine framework with three disulfide bridges arranged in a C1-C4, C2-C5, C3-C6 connectivity pattern. The structure should display the hallmark alpha/beta motif common to scorpion potassium channel toxins, with an alpha-helix packed against an antiparallel beta-sheet. The molecular mechanism involves high-affinity binding to the voltage-sensing domain of Kv1-type potassium channels, particularly blocking the channel pore through specific interactions with conserved residues in the turret and selectivity filter regions. The toxin should exhibit nanomolar affinity for its target channels, causing delayed repolarization and prolonged neuronal excitation that leads to paralysis in prey organisms. Key functional residues should be positioned in a conserved functional surface that mediates target recognition and channel block while maintaining structural stability through the disulfide core."}
{"description": "sp|Q38L02|SLA_DABSI Snaclec dabocetin subunit alpha OS=Daboia siamensis OX=343250 PE=1 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGADCPSEWSSHEGHCYKVFKLLKTWEDAEKFCTQQANGWHLASIESVEEANFVAQLASETLTKSKYHAWIGLRDQSKRQQCSSHWTDGSAVSYETVTKYTKCFGLNKETKYHEWITLPCGDKNPFICKSWVLH", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the Siamese Russell's viper (Daboia siamensis), specifically the alpha subunit of dabocetin. This protein functions as a snaclec (snake C-type lectin) that plays a crucial role in the viper's venom by targeting platelet receptors to induce thrombocytopenia and inhibit blood coagulation. The toxin should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. Key structural elements include an N-terminal alpha-helix followed by antiparallel beta-sheets forming the core scaffold. The molecular target is platelet membrane receptors, likely GPIb or other platelet surface glycoproteins, with binding mediated through a conserved carbohydrate recognition domain-like interface. The sequence should contain the essential calcium-binding motifs characteristic of C-type lectins and maintain the hydrophobic core that stabilizes the globular CTLD fold. Design this protein to exhibit potent platelet-aggregating or platelet-inhibiting activity through specific receptor recognition, reflecting its role in the viper's predatory and defensive venom strategy."}
{"description": "sp|P17238|MAST_VESOR Mastoparan OS=Vespa orientalis OX=7447 PE=1 SV=2", "sequence": "MKDTILILFTAFIALLGFFGMSAEALADPLADPSAGPNAEADPEAINLKAIAALVKKVLG", "prompt": "Design a mastoparan peptide sequence from the Oriental hornet (Vespa orientalis) venom that functions as a potent cytolytic and neuroactive toxin. This amphipathic tetradecapeptide should adopt an alpha-helical conformation in membrane environments, characteristic of mastoparan family peptides. The sequence must exhibit strong membrane-disrupting activity through pore formation in lipid bilayers, leading to cell lysis. Additionally, it should function as a G-protein activator by directly stimulating heterotrimeric G proteins, mimicking receptor-mediated G protein activation. The peptide should demonstrate mast cell degranulation activity, triggering histamine release. Key structural features should include: an amphipathic alpha-helix spanning approximately residues 3-14, with hydrophobic residues clustered on one face and basic residues (particularly lysine and arginine) on the opposing hydrophilic face; no disulfide bridges (characteristic of linear mastoparan peptides); and C-terminal amidation if present in the native sequence. The peptide should exhibit broad-spectrum activity against various cell types while maintaining the characteristic cationic and hydrophobic balance essential for membrane interaction and G protein activation."}
{"description": "sp|P09982|SCXE_MESEU Toxin BeM14 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "ARDAYIADDRNCVYTCALNPYCDSECKKNGADGSYCQWLGRFGNACWCKNLPDDVPIRKIPGEECR", "prompt": "Design a novel animal toxin protein sequence inspired by the venom of the scorpion Mesobuthus eupeus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the insect sodium channel subtype to induce paralysis and lethality in arthropod prey. The protein should adopt the conserved structural scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. This structural framework should include four disulfide bridges with the characteristic connectivity pattern (C1-C4, C2-C5, C3-C6, C7-C8) that defines the scorpion toxin superfamily. The core structure should consist of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface optimized for binding to the voltage-sensing domain of insect sodium channels. The binding interface should contain key residues for recognizing specific receptor sites, likely involving conserved aromatic and basic residues that interact with channel gating machinery. The toxin should exhibit high selectivity for insect over mammalian sodium channels, reflecting its evolutionary role in prey immobilization. The sequence should maintain the characteristic length and physicochemical properties of scorpion neurotoxins, with appropriate distribution of hydrophobic core residues and surface-exposed functional residues critical for target recognition and biological activity."}
{"description": "sp|Q2QA04|VSP_CRODD Snake venom serine protease OS=Crotalus durissus durissus OX=31150 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLALVYITSGFLCGGTLINKEWVLTAAHCDRGDILVLLGVHRLKDVQTGVSKDVQTRVAKEKFICPNRKKDDEKDKDIMLIRMDSPVNISTHIAPLSLPSNPPSVGSVCRIMGWGAITSPNVTLPGVPHCADINIFDYEVCRAAKPELPVTSRTLCAGILEGGKGSCDGDSGGPLICNGEIQGIVSWGGDICAQPREPEPYTKVFDYTEWIQSIIAGNTDATCPP", "prompt": "Design a snake venom serine protease from the venom of Crotalus durissus durissus, a Central American rattlesnake. This enzyme belongs to the serine protease family and functions as a key component in the snake's venom arsenal, contributing to prey immobilization and digestion through its proteolytic activity. The protein should exhibit a characteristic trypsin-like serine protease fold, featuring a two-domain structure with a catalytic triad composed of histidine, aspartate, and serine residues. The serine residue in the active site should be positioned for nucleophilic attack on peptide bonds. The structure should include several disulfide bridges that stabilize the overall fold, typical of snake venom serine proteases, which enhance stability in the venom gland and upon injection. The mechanism of action involves cleaving specific peptide bonds in plasma proteins, such as fibrinogen, leading to coagulopathy and hemorrhage in envenomed prey. The protein should target coagulation cascade components, potentially interfering with hemostasis by degrading clotting factors or activating zymogens, resulting in uncontrolled bleeding or thrombosis. Key structural elements include a well-defined substrate-binding pocket with specificity for basic residues (arginine or lysine), a conserved β-barrel domain, and surface loops that may mediate interactions with host proteins. The overall architecture should ensure efficient proteolysis under physiological conditions, contributing to the venom's rapid incapacitation of prey."}
{"description": "sp|P45628|KAX12_LEIHE Potassium channel toxin alpha-KTx 1.2 OS=Leiurus hebraeus OX=2899558 PE=1 SV=2", "sequence": "MKILSVLLLALIICSIIDWSEGQFTQESCTASNQCWSICKRLHNTNRGKCMNKKCRCYS", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of the yellow scorpion Leiurus hebraeus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.1, Kv1.2, and Kv1.3 subtypes with high affinity. The protein must adopt the conserved alpha-KTx structural fold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include a well-defined beta-sheet core and a functional dyad comprising a critical lysine residue positioned to occlude the potassium ion conduction pore and an adjacent aromatic residue that enhances binding affinity through hydrophobic interactions with the channel vestibule. The molecular mechanism involves direct pore block, preventing potassium efflux and thereby modulating neuronal excitability and neuromuscular transmission. The structural scaffold should ensure thermodynamic stability, protease resistance, and target specificity while maintaining the characteristic compact globular architecture typical of scorpion venom toxins."}
{"description": "sp|Q9XZK8|O1X1_CONTE Omega-conotoxin-like TxO1 OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MKLTCVVIVAVLFLTVWTFATADDSGNGLEKLFSNAHHEMKNPEASKLNERCLDAGEVCDIFFPTCCGYCILLFCA", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin-like peptide TxO1 from the marine cone snail Conus textile. This venom component should function as a potent neurotoxin targeting voltage-gated calcium channels, specifically Cav2.2 (N-type) channels, which are critical for neurotransmitter release at presynaptic terminals. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized globular fold with three disulfide bridges forming a knotted topology (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6). Key structural elements include a beta-hairpin and loops that mediate high-affinity binding to the channel's pore region, blocking ion flux and disrupting synaptic transmission. The sequence should feature conserved residues for structural integrity and target interaction, such as hydrophobic patches and polar contacts, while maintaining the characteristic cysteine framework (CCXₙCXₙCCXₙCXₙCXC, where X represents variable residues). The biological context involves Conus textile's venom strategy for prey immobilization, where omega-conotoxins contribute to rapid neuromuscular paralysis by inhibiting Cav2.2 channels in the nervous system. Ensure the design reflects specificity for Cav2.2 over other calcium channel subtypes, with functional implications for pain modulation or neurotoxicity in prey organisms."}
{"description": "sp|A7X3V0|3NB4_TELDH Toxin 3FTx-Tel4 OS=Telescopus dhara OX=338837 PE=3 SV=1", "sequence": "MKTLLLALVVVAFMCLGSADQLGLGSQRIDWEQGQAIGPPHGLCVQCDRKTCKNCFKSERCQPYNRICYTLYKPDENGEMKWAVKGCAKTCPSAKPGERVKCCSSPRCNEV", "prompt": "Design a novel three-finger toxin (3FTx) protein sequence inspired by the venom of the Arabian cat snake, Telescopus dhara. This toxin belongs to the Tel4 subfamily of 3FTx toxins, which are characteristic components of colubrid snake venoms. The protein should adopt the canonical three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework I (C-C-CC-C-C). The core structure should feature the conserved globular disulfide knot that defines this toxin family. As a 3FTx, this toxin likely functions as a neurotoxin or cytotoxin targeting specific ion channels or receptors in prey organisms. The molecular mechanism may involve binding to nicotinic acetylcholine receptors, muscarinic receptors, or other membrane targets, potentially causing neuromuscular blockade or cellular disruption. The sequence should maintain the structural integrity of the three-loop architecture while incorporating subfamily-specific variations that confer target specificity. Key conserved residues should preserve the structural scaffold, while variable regions in the loop tips should enable specific molecular recognition. The protein should exhibit the characteristic stability and compact folding typical of three-finger toxins, with the disulfide network providing structural rigidity and resistance to proteolytic degradation."}
{"description": "sp|P0C182|KAX1B_CENNO Potassium channel toxin alpha-KTx 1.11 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "TFIDVDCTVSKECWAPCKAAFGVDRGKCMGKKCKCYV", "prompt": "Design a potassium channel toxin protein from the venom of the Mexican scorpion Centruroides noxius. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels, specifically Kv1-type channels. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves binding to the pore region of Kv1 channels via a functional dyad consisting of a critical lysine residue that inserts into the channel selectivity filter and an aromatic residue that stabilizes the interaction, effectively blocking potassium ion flux and causing neuronal hyperexcitability. The structural scaffold should include a beta-hairpin motif that positions key functional residues for high-affinity channel blockade. The protein should exhibit the characteristic compact, globular architecture with exposed functional loops that mediate specific target recognition and potent channel inhibition."}
{"description": "sp|A7X3S2|3NB3_TRIBI Toxin 3FTx-Tri3 OS=Trimorphodon biscutatus OX=338818 PE=3 SV=1", "sequence": "MKTLLLALVVVAFMCLGSADEVGLGNEQIDRGRRQAIGPPFTRCSKCNRNWSPPFPLGLYTVSHVKSCGGHLSSIGQCGEDWVVKGCAKTCPTAGPGERVKCCYSPRCNKN", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is a three-finger toxin (3FTx) from the lyre snake Trimorphodon biscutatus, a rear-fanged colubrid species whose venom contains components that may facilitate prey immobilization through neurotoxic or cytotoxic mechanisms. This toxin belongs to the three-finger toxin superfamily, characterized by a conserved structural scaffold comprising three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a typical cysteine framework of C-C-CC-C-C. The core structure adopts a compact, globular fold where the three loops exhibit functional diversity, often targeting ion channels or receptors. For this toxin, infer a mechanism involving potential antagonism of nicotinic acetylcholine receptors or modulation of other neuronal targets, leading to neuromuscular blockade. The sequence should include key residues for structural integrity: the four disulfide bridges (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8 in common 3FTx patterns) and conserved hydrophobic core residues. Functional loops should contain putative receptor-binding motifs, such as aromatic or charged residues in loop II for receptor interaction. Ensure the protein is secreted, lacks transmembrane domains, and has a molecular weight consistent with 3FTxs (6-9 kDa). Emphasize a stable, disulfide-bonded fold that enables specific target engagement, reflecting the evolutionary adaptation for prey subjugation in snake venoms."}
{"description": "sp|P0CE26|CXAT4_CONCE Alpha-conotoxin-like Cp20.4 OS=Conus capitaneus OX=89439 PE=2 SV=1", "sequence": "MPKLEMMLVVLLIFPLFYFDAAGGQAVQGDRRGDGLARYLQRGDRNDESECIISTPGSSWGRCCLTRMCGTMCCPRSGCYCVYHWRRGHGCACSD", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus capitaneus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the essential cysteine framework (CC-C-C) that defines this toxin family, with the inter-cysteine loops optimized for high-affinity binding to the orthosteric site of nAChRs. Incorporate key pharmacophore residues that mediate receptor recognition and blockade, ensuring the toxin disrupts cholinergic signaling through competitive inhibition. The structural core should exhibit the typical alpha-conotoxin fold with well-defined beta-turn elements and minimal helical content, maintaining the disulfide-constrained conformation critical for biological activity and proteolytic stability. The designed toxin should demonstrate subtype selectivity reflective of Conus capitaneus venom composition, potentially favoring alpha3beta2 or alpha7 nAChR subtypes based on the species' ecological niche and prey specialization."}
{"description": "sp|Q10726|KAX61_PANIM Potassium channel toxin alpha-KTx 6.1 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "LVKCRGTSDCGRPCQQQTGCPNSKCINRMCKCYGC", "prompt": "Design a potassium channel toxin protein from the venom of the Emperor scorpion (Pandinus imperator) that functions as a potent and selective blocker of voltage-gated potassium channels. This toxin should belong to the alpha-KTx family, characterized by a conserved structural scaffold consisting of an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The protein should adopt a compact, globular fold with a triple-stranded beta-sheet stabilized by the disulfide core, presenting key functional residues on exposed loops that mediate high-affinity binding to the pore region of Kv1-type potassium channels. The toxin's mechanism of action involves physically occluding the channel pore, thereby inhibiting potassium ion flux and disrupting neuronal excitability, which contributes to the venom's paralytic effects on prey. Incorporate conserved alpha-KTx family motifs while ensuring specificity for potassium channels over other ion channel types."}
{"description": "sp|Q9XZL1|O164_CONTE Omega-conotoxin-like TxO4 OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MKLTCVVIVAVLFLTAWTFVTAVPHSSNALENLYLKARHEMENPEASKLNTRYDCEPPGNFCGMIKIGPPCCSGWCFFACA", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus textile. This venom component should function as a potent calcium channel blocker, specifically targeting neuronal voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and induce neurotoxic effects. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern (C-C-CC-C-C framework) that forms a compact, triple-stranded beta-sheet scaffold. Key structural elements must include a well-defined beta-hairpin loop responsible for channel pore blockade, surface-exposed residues for target specificity (e.g., hydrophobic patches and charged side chains for channel interaction), and a rigid core enforced by the cystine knot. The sequence should reflect the evolutionary adaptations of Conus textile venom for prey immobilization, with optimized folding stability in marine environments and selective activity against invertebrate or vertebrate calcium channel subtypes. Ensure the design excludes any non-toxin domains and maintains the minimal, efficient architecture typical of conotoxins."}
{"description": "sp|P0DRC9|TX44A_SCOMU Kappa-scoloptoxin SsmTx-I OS=Scolopendra mutilans OX=2836329 PE=1 SV=1", "sequence": "MMMMFSVVSVFLMLLLLKFHDLSMGEEISLLKKVVRREESMLLSCPDLSCPTGYTCDVLTKKCKRLSDELWDH", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This toxin belongs to the kappa-scoloptoxin family, specifically SsmTx-I, originating from the venom of the centipede Scolopendra mutilans. As a component of centipede venom, this toxin plays a crucial role in prey immobilization and defense through potent neurotoxic activity. The primary mechanism of action involves selective blockade of potassium channels, particularly voltage-gated potassium channels (Kv channels), which disrupts neuronal excitability and synaptic transmission. The protein should adopt a compact, stable structural fold characteristic of scorpion toxin-like proteins, featuring an inhibitor cysteine knot (ICK) motif stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements include a beta-sheet core with short intervening loops that form the functional epitopes for channel interaction. The molecular target interface should contain specific residues for recognizing and binding to the pore region or voltage-sensing domain of Kv channels, ensuring high affinity and selectivity. The sequence must maintain the canonical cysteine framework while incorporating variable regions that confer the distinctive pharmacological profile of kappa-scoloptoxins, resulting in a stable, bioactive neurotoxin effective in modulating potassium channel function."}
{"description": "sp|Q3BER2|DID1_ECHOC Disintegrin Eo1 subunit 1 OS=Echis ocellatus OX=99586 PE=2 SV=1", "sequence": "MIQVLLVIICLAVFPYQGSSIILESGNVNDFELVYPKKVTVLPTGAMNSAHPCCDPVMCKPKRGEHCISGPCCRNCKFLSPGTICKKAWGDDMNDYCTGISSDCPRNPWKD", "prompt": "Generate the amino acid sequence for a disintegrin toxin from the venom of Echis ocellatus (West African carpet viper). This protein functions as a potent anti-platelet agent by specifically targeting and inhibiting integrin receptors on platelet surfaces. As a disintegrin, it contains the canonical RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to platelet integrin αIIbβ3 (GPIIb/IIIa), thereby blocking fibrinogen binding and preventing platelet aggregation. The protein adopts the characteristic disintegrin fold stabilized by multiple disulfide bridges that create a compact, cysteine-rich structure. This structural scaffold positions the RGD motif in an optimal conformation for integrin recognition. The venom of Echis ocellatus employs this toxin as part of its hemorrhagic strategy, causing bleeding dyscrasia by interfering with normal hemostasis. The generated sequence should reflect the conserved cysteine framework typical of viperid disintegrins, with precise spacing of cysteine residues to form the correct disulfide connectivity that maintains the functional RGD loop architecture essential for integrin antagonism."}
{"description": "sp|E2DQZ5|SLJB_PROJR Snaclec jerdonuxin subunit beta OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MVRFIFVSFGLLVVFLSLSGIGAGFCCPWGWSSYDEHCYQVFQQKMNWEDAEKFCIQQHKGSHLVSFHSSEEVDLVTSKTFPILKHDFVWMGLSNVWNECTREWSDGTKLDYKAWSGQSDCIVSKTTDNQWLSMDCSSKRYIVCKFQA", "prompt": "Design a novel beta subunit protein for a snake venom C-type lectin (snaclec) complex from Protobothrops jerdonii, a medically important pit viper species. This protein should function as part of a heterodimeric snaclec complex that exhibits platelet aggregation activity, characteristic of jerdonuxin-like toxins. The protein must adopt the canonical C-type lectin-like domain (CTLD) fold with the conserved double-loop structure stabilized by two conserved disulfide bridges (typically Cys1-Cys2 and Cys3-Cys4 pattern). The sequence should contain the essential calcium-binding motifs and carbohydrate recognition domains that enable specific binding to platelet membrane receptors, particularly targeting glycoprotein receptors involved in hemostasis. The structural scaffold should maintain the characteristic β-sheet core with flanking α-helices, preserving the functional epitopes required for receptor recognition while ensuring proper heterodimerization with the complementary alpha subunit. The protein should demonstrate the typical stability and target specificity of viperid snaclec toxins that interfere with normal platelet function through receptor binding and aggregation induction."}
{"description": "sp|Q7T2Q1|SLA_ECHML Snaclec EMS16 subunit alpha OS=Echis multisquamatus OX=93050 PE=1 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGADFDCPSDWTAYDQHCYLAIGEPQNWYEAERFCTEQAKDGHLVSIQSREEGNFVAQLVSGFMHRSEIYVWIGLRDRREEQQCNPEWNDGSKIIYVNWKEGESKMCQGLTKWTNFHDWNNINCEDLYPFVCKFSAV", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the saw-scaled viper Echis multisquamatus. This protein functions as a platelet aggregation inhibitor by specifically targeting the platelet receptor glycoprotein Ib (GpIb) within the von Willebrand factor (vWF) binding site. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that form the core scaffold. The sequence must include key residues for calcium-independent carbohydrate recognition domain (CRD) functionality, with a conserved hydrophobic patch and polar residues critical for protein-protein interactions. The molecular mechanism involves competitive inhibition of vWF binding to GpIb, thereby preventing platelet adhesion and thrombus formation under arterial shear conditions. The structural scaffold should feature the typical α-helix and β-sheet arrangement of CTLD proteins, with specific loop regions responsible for high-affinity binding to the leucine-rich repeats of GpIb. This toxin represents a potent anticoagulant component of viper venom that disrupts primary hemostasis through precise interference with platelet adhesion mechanisms."}
{"description": "sp|A0A1I9KNP0|VSPH1_VIPAA Vaa serine proteinase homolog 1 OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "MVLIRVLANLLVLQLSYAQKSSELVIGGDECNINEHPFLVALHTARSKRFYCAGTLINQEWVLTAARCDRKNIRIILGVHSKNVPNEDEQMRVPKEKFFCLSSKTYTRWDKDIMLIRLKRPVNDSTHIAPLSLPSSPPSVGSVCRIMGWGTITTTKVTYPDVPHCADINMFDYSVCQKVYRKLPEKSRTLCAGILQGGIDSCKVDNGGPLICNGQIQGIVSWGGYPCAQPHKPALYTNVFDYTDWIQSIIAGNITATCPP", "prompt": "Design a serine proteinase homolog from the venom of the nose-horned viper (Vipera ammodytes ammodytes) that functions as a venom component with potential modulatory or regulatory roles in envenomation. This protein should exhibit the characteristic serine proteinase fold but lack catalytic activity due to mutations in the catalytic triad, typical of serine proteinase homologs in viperid venoms. The structure should feature a conserved chymotrypsin-like fold with two β-barrel domains and the characteristic disulfide bond pattern that stabilizes this scaffold, including the conserved Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6 connectivity. The protein may function as a competitive inhibitor of endogenous serine proteinases or as a binding protein that modulates hemostatic pathways, potentially interacting with coagulation factors, platelet receptors, or other plasma proteins. The sequence should maintain the overall structural integrity of the serine proteinase fold while incorporating specific substitutions that abolish proteolytic activity, preserving surface features that mediate protein-protein interactions relevant to viper venom function in prey immobilization and digestion."}
{"description": "sp|P81761|CTXL_HOTTA Lepidopteran-selective toxin OS=Hottentotta tamulus OX=34647 PE=1 SV=2", "sequence": "MKFLYGVILIALFLTVMTATLSEARCGPCFTTDPQTQAKCSECCGRKGGVCKGPQCICGIQY", "prompt": "Design a novel lepidopteran-selective toxin protein sequence inspired by the venom arsenal of the Indian red scorpion, Hottentotta tamulus. This toxin should function as a highly specific insecticidal agent targeting lepidopteran pests through selective modulation of insect voltage-gated sodium channels. The protein must adopt a compact beta-sheet rich structural scaffold stabilized by a conserved cysteine framework characteristic of scorpion beta-toxins, featuring four disulfide bridges that confer exceptional thermal and proteolytic stability. The molecular mechanism involves binding to receptor site-4 on insect sodium channels, delaying channel inactivation and inducing prolonged neuronal excitation that leads to paralysis and death in lepidopteran species while exhibiting minimal activity against mammals and other insect orders. The sequence should incorporate key functional motifs for target recognition and selectivity, including surface-exposed loops critical for receptor interaction and a well-defined hydrophobic core that maintains structural integrity. The final protein should demonstrate potent and selective toxicity against lepidopteran insects, representing an optimized biological insecticide with minimal environmental impact."}
{"description": "sp|A7X3V4|VKT1_TELDH Kunitz-type serine protease inhibitor kunitoxin-Tel1 OS=Telescopus dhara OX=338837 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSGQDRPKYCDLPADSGPCRARKRHFYYNSRSNQCEEFTYGGCRGNENNFETKDKCHYTCVAPPRRRPL", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of Telescopus dhara, a rear-fanged colubrid snake. This toxin should function as a potent and selective inhibitor of key serine proteases involved in hemostasis and fibrinolysis, such as trypsin, chymotrypsin, or kallikrein, thereby disrupting prey homeostasis and facilitating envenomation. The protein should adopt the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a C1-C6, C2-C4, C3-C5 connectivity pattern. The core scaffold should feature a twisted anti-parallel beta-sheet and a short alpha-helix, with the canonical protease-binding loop positioned between the second and third beta-strands. This binding loop should contain specific residues that confer target selectivity and high-affinity inhibition, likely through a substrate-like mechanism that blocks the protease active site. The overall structure should be highly stable and resistant to proteolytic degradation, typical of venom Kunitz inhibitors, with surface-exposed residues optimized for efficient diffusion through tissues. The toxin should exhibit nanomolar inhibitory potency against its primary serine protease target while maintaining the structural integrity and functional properties characteristic of snake venom Kunitz-type toxins."}
{"description": "sp|B8XH44|KA271_BUTIS Potassium channel toxin alpha-KTx 27.1 OS=Buthus israelis OX=2899555 PE=3 SV=1", "sequence": "MKFLFLTLFVCCFIAVLVIPSEAQIDINVSCRYGSDCAEPCKRLKCLLPSKCINGKCTCYPSIKIKNCKVQTY", "prompt": "Design a potassium channel toxin protein sequence derived from the venom of the scorpion Buthus israelis, classified within the alpha-KTx family. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein must adopt the conserved structural scaffold characteristic of scorpion toxins, featuring a compact, globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. The sequence should include the canonical disulfide bridge pattern with three disulfide bonds forming a C1-C4, C2-C5, C3-C6 connectivity, which rigidifies the core structure and positions key functional residues for channel interaction. Incorporate a functional dyad comprising a critical lysine residue within the beta-sheet region that penetrates the channel pore, and an adjacent aromatic or hydrophobic residue that enhances binding affinity through interactions with the channel vestibule. The N-terminal region should form a short alpha-helix, while the C-terminal segment adopts an anti-parallel beta-sheet, creating a molecular surface optimized for high-affinity binding to the external turret and pore region of Kv1 channels. Ensure the sequence reflects the evolutionary conservation of scorpion toxin scaffolds, with structural stability enabling resistance to proteolytic degradation in venom and target tissues."}
{"description": "sp|Q0N4U8|CJEA_CONPO Alpha/kappa-conotoxin pl14a OS=Conus planorbis OX=97183 PE=1 SV=1", "sequence": "MPSVRSVTCCCLLWMMFSVQLVTPGSPGTAQLSGHRTARFPRPRICNLACRAGIGHKYPFCHCRGKRDAVSSSMAV", "prompt": "Design a novel alpha/kappa-conotoxin protein sequence inspired by the venom of Conus planorbis, a marine cone snail. This toxin should function as a potent neurotoxin targeting both nicotinic acetylcholine receptors (nAChRs) and voltage-gated potassium channels (Kv channels), reflecting the dual alpha/kappa-conotoxin classification. The protein must adopt a compact, disulfide-rich scaffold typical of conotoxins, with a conserved cysteine framework (likely CC-C-C or similar) that forms specific disulfide bridges to stabilize a globular fold. The structural core should feature an inhibitor cystine knot (ICK) motif, ensuring high stability and resistance to proteolysis. The alpha-conotoxin component should antagonize neuronal or muscle-type nAChRs, potentially through competitive binding at the orthosteric site, while the kappa-conotoxin moiety should block Kv channels to disrupt action potential repolarization. The sequence must include key residues for receptor interaction, such as hydrophobic or aromatic amino acids for nAChR binding and positively charged residues for Kv channel pore blockade. Ensure the design reflects the biological role in prey immobilization via synaptic and neuronal excitability disruption, with a length optimized for venom efficacy (e.g., 15-30 amino acids). Avoid non-natural modifications and focus on a functional, native-like toxin with high specificity and potency."}
{"description": "sp|P0C7S8|BPPS_LYCER Bradykinin-potentiating peptide S OS=Lycosa erythrognatha OX=332789 PE=1 SV=1", "sequence": "QAPWPDTISPP", "prompt": "Design a bradykinin-potentiating peptide from the venom of the Brazilian red-and-white tarantula (Lycosa erythrognatha) that functions as a potent vasoactive toxin. This peptide should act by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced bradykinin-mediated vasodilation, hypotension, and increased vascular permeability. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of spider venom peptides. It should exhibit high affinity for the active site of ACE, competing with natural substrates through specific molecular interactions. The sequence should reflect the typical features of bradykinin-potentiating peptides, including small size, cysteine-rich framework, and conserved residues critical for ACE inhibition and structural integrity, ensuring biological activity and stability in the venom context."}
{"description": "sp|P81743|VM2AB_ERIMA Disintegrin EMF10B OS=Eristicophis macmahoni OX=110227 PE=1 SV=1", "sequence": "ELLQNSGNPCCDPVTCKPRRGEHCVSGPCCDNCKFLNAGTVCWPAMGDWNDDYCTGISSDCPRNPVFK", "prompt": "Design a novel disintegrin protein sequence inspired by the venom of Eristicophis macmahoni (McMahon's viper), a species known for its potent hemotoxic venom that disrupts hemostasis and facilitates prey immobilization. This disintegrin should function as a high-affinity antagonist of integrin receptors, specifically targeting platelet aggregation by blocking the binding of fibrinogen to the αIIbβ3 integrin (GPIIb/IIIa) on activated platelets. The protein must adopt the canonical disintegrin fold characterized by a compact, disulfide-rich structure stabilized by multiple intramolecular disulfide bonds, typically featuring a conserved RGD (Arg-Gly-Asp) or related tripeptide motif exposed in a flexible loop that serves as the primary integrin recognition site. Key structural elements should include: a core scaffold with 6-8 conserved cysteine residues forming 3-4 disulfide bridges that constrain the fold into a tight globular conformation; a solvent-accessible integrin-binding loop displaying the bioactive motif; and additional surface residues that modulate specificity and affinity for target integrins. The sequence must be optimized for structural stability, target selectivity, and functional potency as an antiplatelet agent, reflecting the evolutionary adaptation of viperid disintegrins to inhibit key components of the vertebrate coagulation system."}
{"description": "sp|P17495|VM2B_CRAGM Disintegrin trigramin-beta-2 OS=Craspedocephalus gramineus OX=8767 PE=1 SV=1", "sequence": "EAGKDCDCGSPANPCCDAATCKLLPGAQCGEGPCCDQCSFMKKGTICRRARGDDLDDYCNGRSAGCPRNPFHA", "prompt": "Design a novel disintegrin protein sequence inspired by trigramin-beta-2 from the venom of Craspedocephalus gramineus (green pit viper). This protein should function as a potent anti-platelet agent by specifically targeting and inhibiting the integrin αIIbβ3 (GPIIb/IIIa) receptor on platelet surfaces. The sequence must incorporate the canonical disintegrin RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to the integrin receptor, effectively blocking fibrinogen binding and subsequent platelet aggregation. The structural scaffold should feature the characteristic disintegrin fold with appropriate cysteine spacing to form the conserved disulfide bridge pattern that stabilizes the RGD loop in its bioactive conformation. The protein should exhibit the typical compact, globular structure of viperid disintegrins, with the RGD sequence positioned in an exposed, flexible loop region optimized for receptor engagement. The overall design should prioritize molecular recognition specificity for platelet integrins while maintaining structural stability characteristic of snake venom disintegrins."}
{"description": "sp|P0C1N7|M3F_CONTE Conotoxin Tx3.5-a OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MSKLGVLLTICLLLFPLTALPLDGDQPADQAAERMQAEQHPLFDQKRRCCKFPCPDSCRYLCCG", "prompt": "Design a novel conotoxin sequence from the venomous marine snail Conus textile that functions as a voltage-gated sodium channel (Nav) modulator, specifically targeting neuronal subtypes. This toxin should belong to the M-superfamily of conotoxins, characterized by a conserved cysteine framework C-C-CC-C-C (Framework III) that forms three disulfide bonds stabilizing a compact, globular fold. The mature peptide should be approximately 22-26 amino acids in length with the characteristic arrangement of cysteine residues that create distinct loops responsible for target specificity. The toxin should exhibit high affinity binding to the domain II voltage sensor of Nav channels, potentially causing channel inhibition or modulation that leads to neurological effects in prey. The structural scaffold should maintain the typical conotoxin fold with well-defined beta-sheet elements and constrained loops that enable precise molecular recognition of ion channel targets. The sequence should reflect the evolutionary optimization of Conus textile venom for rapid immobilization of prey through disruption of neuronal signaling pathways."}
{"description": "sp|Q7T1R0|PA2B1_BUNFL Basic phospholipase A2 beta-bungarotoxin A1 chain OS=Bungarus flaviceps flaviceps OX=8615 PE=1 SV=1", "sequence": "MNPAHLLVLPAVCVSFLGASIIPPQSLNLIQFKDMIRCTIPCERTWGEYADYGCYCGKGGSGRPVDALDRCCYVHDNCYGEAQKRNCNPYMKSYSFKCAKRTLFCYDAPGSCARFVCDCDRTAALCFGDSEYIGRHKNIDTKRHCQ", "prompt": "Design a protein sequence for a potent neurotoxin derived from the venom of the red-headed krait (Bungarus flaviceps). This protein should function as the A1 chain of beta-bungarotoxin, a heterodimeric presynaptic neurotoxin that exhibits phospholipase A2 activity. The toxin should adopt the canonical phospholipase A2 structural fold, characterized by three long alpha-helices stabilized by a conserved network of seven disulfide bridges. The sequence must include the essential catalytic triad residues (histidine, aspartate, tyrosine) required for calcium-dependent hydrolysis of membrane phospholipids. As part of the beta-bungarotoxin complex, this chain should synergize with a Kunitz-type protease inhibitor chain to produce irreversible blockade of neuromuscular transmission through massive acetylcholine release followed by complete synaptic silence. The mechanism involves initial binding to beta-2 subunits of voltage-gated potassium channels on motor nerve terminals, followed by internalization and phospholipid degradation that disrupts synaptic vesicle recycling. The structural scaffold should maintain the characteristic phospholipase A2 interfacial binding site for membrane penetration and the conserved calcium-binding loop. The resulting protein should exhibit high specificity for presynaptic membranes at neuromuscular junctions, leading to flaccid paralysis through disruption of neurotransmitter release machinery."}
{"description": "sp|A0A2I4QAG8|O1VA_CONGR O-conotoxin GeXXXIA OS=Conus generalis OX=101304 PE=1 SV=1", "sequence": "MKLTCVLIITVLFLTACQLTTAVTYSRGEHKHRALMSTGTNYRLLKTCRGSGRYCRSPYDCRRRYCRRISDACV", "prompt": "Design a novel O-conotoxin protein sequence derived from the venom of Conus generalis, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting ω-conotoxin-sensitive Cav2 subtypes involved in synaptic transmission. The protein should adopt the characteristic O-conotoxin structural scaffold featuring the conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges stabilizing a compact, globular fold. The mature toxin should be approximately 25-30 amino acids in length with a well-defined inhibitory cysteine knot (ICK) motif that provides exceptional thermal and proteolytic stability. Key structural elements should include a β-hairpin region responsible for target recognition and binding to the extracellular pore region of the calcium channel, disrupting calcium influx and thereby inhibiting neurotransmitter release. The sequence should maintain the signature pharmacological profile of O-conotoxins from Conus generalis, exhibiting high affinity and subtype selectivity while preserving the venom's evolutionary role in prey immobilization through neuromuscular blockade."}
{"description": "sp|Q5K0B9|O162_CONIM Omega-conotoxin-like 2/7 OS=Conus imperialis OX=35631 PE=2 SV=1", "sequence": "MKLTCMMIVAVMFLTASIFITADNSRNGIENLPRMRRHEMKKPKASKLNKRVCIADDMPCGFGLFGGPLCCSGWCLFVCL", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus imperialis. This venom component should function as a potent calcium channel antagonist, specifically targeting neuronal voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and induce neurotoxic effects. The protein should adopt the characteristic ICK (inhibitor cystine knot) structural motif, featuring a compact, triple-stranded beta-sheet stabilized by a conserved disulfide connectivity pattern (C-C-CC-C-C framework) that forms the rigid, knotted core. Key structural elements must include: a well-defined beta-hairpin loop responsible for target recognition and binding, surface-exposed residues mediating high-affinity interaction with specific VGCC subtypes (e.g., N-type or P/Q-type), and conserved hydrophobic patches facilitating membrane proximity. The sequence should encode a mature peptide of approximately 25-30 amino acids, with precise positioning of cysteine residues to ensure correct folding into the ICK scaffold, and include signature motifs for omega-conotoxins such as a glycine-rich turn region and solvent-exposed polar residues for target engagement. The final protein must exhibit selective neurotoxicity through calcium channel blockade, mimicking the pharmacological profile of native omega-conotoxins from Conus species."}
{"description": "sp|C5H5D4|VM33_BOTAT Zinc metalloproteinase-disintegrin-like batroxstatin-3 (Fragment) OS=Bothrops atrox OX=8725 PE=2 SV=1", "sequence": "EQQRYLNATKYIKLVIVADNVMVRKYTHNLIDIRKRIFEIVNILSLIYLSMNINVALVGVDIWTNGDKINVTSAVEPTLASFGTWRERDLLNRKTHDNAQLLTGINLNGDTVGYAYIGSMCMPKQSVGIVQDHGKTYHLVAVTMAHELGHNLGMDHDRDSCTCLANSCIMSATISPSYQFSDCSQNDHLRYLISHTPQCILNEPLRTDIVSPEVCGNYLLEEGEECDCGPLWNCQNPCCNAATCKLTPGAQCAEGLCCYQCRFIKAGNVCRPPRSECDIAESCTGQSAHCPTDRFHRNGQPCLNNHGYCYNGNCPIMLYQCIALFGAGTTVAEDVCFNYNLDGQGFFYCRRENDRIFPCAKEDVKCGRLYCKVYNDNVHPCRYQYLDNGMVDHGTKCAVGKVCSNRQCVDVNTP", "prompt": "Design a protein sequence for a zinc metalloproteinase-disintegrin-like toxin fragment derived from Bothrops atrox venom. This toxin belongs to the snake venom metalloproteinase (SVMP) family, specifically the P-III class, characterized by a multi-domain architecture comprising a metalloproteinase domain, a disintegrin-like domain, and a cysteine-rich domain. The metalloproteinase domain should feature a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling proteolytic activity against extracellular matrix components such as collagen, fibronectin, and laminin. The disintegrin-like domain must adopt a folded structure stabilized by disulfide bonds, mimicking the disintegrin fold to inhibit integrin-mediated cell adhesion—particularly targeting αβ integrins like α5β1 and αvβ3—by blocking fibrinogen binding and disrupting platelet aggregation. The cysteine-rich domain should contribute to structural stability through additional disulfide linkages, potentially facilitating interactions with other cell surface receptors. The overall scaffold must reflect a modular, multi-domain protein with a high cysteine content, forming specific disulfide patterns that stabilize the disintegrin-like fold and metalloproteinase active site. This toxin's mechanism involves dual functionality: proteolytic degradation of basement membranes and inhibition of integrin signaling, leading to hemorrhage, impaired wound healing, and anticoagulant effects. Ensure the sequence embodies these structural and functional attributes, emphasizing the zinc-dependent metalloproteinase activity, integrin antagonism, and disulfide-stabilized domains typical of SVMPs from viperid venoms."}
{"description": "sp|Q9XZK9|O16O2_CONTE Omega-conotoxin-like TxO2 OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MKLTCVVIVAVLFLTAWTFVTAAPHSSNALENLYLKAHHEMNNPEDSELNKRCYDSGTSCNTGNQCCSGWCIFVCL", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-conotoxin-like peptide derived from the venom of the marine cone snail Conus textile. This organism employs a sophisticated venom arsenal for prey capture and defense, with conotoxins representing highly selective neurotoxins that target specific ion channels and receptors in the nervous system. The core function of this toxin is to act as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and neuromuscular signaling. The molecular mechanism involves high-affinity binding to specific VGCC subtypes, leading to inhibition of calcium influx and subsequent blockade of neurotransmitter release. Structurally, this peptide adopts the characteristic inhibitory cysteine knot (ICK) motif, stabilized by a conserved disulfide connectivity pattern typical of omega-conotoxins, forming a compact, globular fold with three disulfide bridges arranged in a C-C-CC-C-C pattern. The 3D structure features a well-defined beta-hairpin and loop regions that form the pharmacophore for target recognition. Key structural elements include a rigid core stabilized by the cystine knot, solvent-exposed loops responsible for target specificity, and conserved residues critical for maintaining the structural integrity and biological activity. The binding interface involves specific loop regions that interact with the pore-forming region or voltage-sensing domains of calcium channels, ensuring high selectivity and potency. The generated sequence must reflect these structural and functional characteristics, incorporating the appropriate cysteine framework, conserved motifs for the ICK fold, and residues known to be critical for calcium channel blockade."}
{"description": "sp|P0DY38|NATX_CALPY Sea anemone sodium channel inhibitor type I OS=Calliactis polypus OX=656064 GN=c50240_g1_i1 PE=1 SV=1", "sequence": "MNRMLIIFVVVTVFGLASGLGPNMPAPDLAKRNGKGCTCNDGTTTGIFWAGSCPGGWSYCKTMWYWVVPGECCTQK", "prompt": "Design a protein sequence for a sea anemone toxin that functions as a potent sodium channel inhibitor. This toxin originates from Calliactis polypus and belongs to the type I sea anemone sodium channel toxin family. The protein should exhibit the characteristic structural scaffold of sea anemone toxins, featuring a compact, globular fold stabilized by a conserved pattern of three disulfide bridges with the connectivity C1-C4, C2-C5, C3-C6. The core structure consists of a four-stranded antiparallel beta-sheet stabilized by these disulfide bonds, forming a robust structural framework. The molecular mechanism involves specific binding to site 3 of voltage-gated sodium channels (Nav), particularly Nav1.1, Nav1.2, and Nav1.6 isoforms, where it inhibits channel inactivation by stabilizing the open state. This leads to prolonged sodium influx, membrane depolarization, and hyperexcitability in neuronal and muscular tissues, ultimately causing paralysis in prey organisms. The binding interface should include key residues in the beta-hairpin loops that interact with the extracellular loops of the sodium channel's domain IV. The toxin should exhibit high affinity and selectivity for its sodium channel targets while maintaining the thermal and proteolytic stability characteristic of this toxin family."}
{"description": "sp|P08878|PA2H_CRODU Phospholipase A2 homolog crotoxin acid subunit CA OS=Crotalus durissus terrificus OX=8732 PE=1 SV=1", "sequence": "MRALWIVAVLLVGVEGSLVEFETLMMKIAGRSGISYYSSYGCYCGAGGQGWPQDASDRCCFEHDCCYAKLTGCDPTTDVYTYRQEDGEIVCGEDDPCGTQICECDKAAAICFRNSMDTYDYKYLQFSPENCQGESQPC", "prompt": "Design a protein sequence for a phospholipase A2 homolog that functions as the acid subunit of crotoxin, derived from the venom of the South American rattlesnake Crotalus durissus terrificus. This protein should adopt the canonical phospholipase A2 fold, characterized by a three-finger structural scaffold with multiple alpha-helices stabilized by a conserved pattern of disulfide bridges, typically involving 6-8 cysteine residues forming 3-4 disulfide bonds. As a crotoxin acid subunit (CA), the protein should lack catalytic phospholipase A2 activity due to key substitutions in the calcium-binding and catalytic sites, but retain the ability to form a non-covalent complex with the basic phospholipase A2 subunit (CB) to modulate its toxicity. The protein should facilitate the presynaptic neurotoxic action of crotoxin by enhancing the binding and penetration of the complex into neuronal membranes, leading to irreversible blockade of acetylcholine release at neuromuscular junctions. Key structural features should include a hydrophobic channel for membrane interaction, conserved residues for heterodimer assembly with the basic subunit, and surface properties that promote target specificity for presynaptic membranes. The sequence should reflect evolutionary adaptations for venom function, including optimized stability in the venom gland and efficient complex formation."}
{"description": "sp|P81790|TX34_PHONI Omega-ctenitoxin-Pn3a OS=Phoneutria nigriventer OX=6918 PE=1 SV=3", "sequence": "MKMKLLGIILLVSFPFVLGFAGIPIEEGENSVEVGEVERSCINVGDFCDGKKDDCQCCRDNAFCSCSVIFGYKTNCRCEVGTTATSYGICMAKHKCGRQTTCTKPCLSKRCKKNHG", "prompt": "Design a neurotoxic peptide from the venom of the Brazilian wandering spider (Phoneutria nigriventer) that functions as an omega-ctenitoxin. This toxin should act as a potent and selective calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in the vertebrate nervous system. The peptide should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). This structural scaffold provides exceptional thermal and proteolytic stability while presenting key functional loops for target interaction. The molecular mechanism involves high-affinity binding to specific VGCC subtypes, inhibiting calcium influx and disrupting synaptic transmission, which underlies the neurotoxic effects observed in envenomation. The toxin should exhibit the characteristic pharmacological profile of omega-ctenitoxins, including rapid onset of action and potent blockade of neuronal calcium channels, contributing to the overall paralytic and neurotoxic venom phenotype of Phoneutria nigriventer."}
{"description": "sp|B8XH47|KA23M_BUTIS Potassium channel toxin alpha-KTx Tx790 OS=Buthus israelis OX=2899555 PE=2 SV=1", "sequence": "MQKLFIVLVLFCILRLDAEVDGLTVSLCNQSECQEKCKKENKNGKCIQEIELNWVYNICKCF", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from Buthus israelis scorpion venom. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.x subtypes with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The core structure should consist of a short alpha-helix packed against an anti-parallel beta-sheet, creating a functional surface rich in basic residues that mediates specific interactions with the channel pore region. Key structural elements should include a conserved 'functional dyad' comprising a critical lysine residue positioned to penetrate the potassium selectivity filter and an aromatic residue that stabilizes binding through hydrophobic interactions. The toxin should exhibit the typical molecular weight range of 3-5 kDa and maintain the characteristic pharmacological profile of alpha-KTx toxins, displaying nanomolar affinity for potassium channels while showing minimal cross-reactivity with other ion channel families. The sequence should preserve the signature structural motifs that confer stability in the harsh extracellular environment while enabling precise molecular recognition of potassium channel vestibules."}
{"description": "sp|Q0NZX5|VM2JA_BOTJA Zinc metalloproteinase/disintegrin OS=Bothrops jararaca OX=8724 PE=1 SV=2", "sequence": "MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVFKFENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEHQRYIELFLVVDHGMFMKYNGNSDKIRRRIHQMVNIMKEAYRYLYIDIALTGVEIWSNKDMINVQPAAPQTLDSFGEWRKTDLLNRKSHDNAQLLTSTDFNGPTIGLAYVGSMCDPKRSTAVIEDHSETDLLVAVTMAHELGHNLGIRHDTGSCSCGGYSCIMAPVISHDIAKYFSDCSYIQCWDFIMKDNPQCILNKQLRTDTVSTPVSGNELLEAGEECDCGTPGNPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTVCRRARGDDMDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of Bothrops jararaca pit viper venom. This protein should exhibit the dual functionality typical of snake venom metalloproteinases (SVMPs): (1) A zinc-dependent proteolytic domain capable of degrading extracellular matrix components such as collagen, laminin, and fibronectin, contributing to local tissue damage and hemorrhage. The catalytic domain should contain the conserved HEXXHXXGXXH zinc-binding motif and a methionine turn. (2) A disintegrin domain that inhibits platelet aggregation by binding to integrin receptors on platelet surfaces, particularly targeting αIIbβ3 integrin to prevent fibrinogen binding and thrombus formation. The disintegrin domain should feature the characteristic RGD (Arg-Gly-Asp) or related tripeptide motif for integrin recognition. The protein should adopt the multi-domain architecture common to SVMPs, with proper folding of the metalloproteinase domain featuring the typical metzincin topology and the disintegrin domain displaying the appropriate conformation for integrin binding. The sequence should maintain the structural integrity required for both enzymatic activity and receptor binding functions, reflecting the hemorrhagic and anti-coagulant properties essential for the venom's prey immobilization and digestion facilitation."}
{"description": "sp|P84397|PA2A2_BOTIN Acidic phospholipase A2 2 (Fragment) OS=Bothrops insularis OX=8723 PE=1 SV=2", "sequence": "NLWQFGRENQEVMGQHLPFHYLSYGCYCGWGGIEPKCCYVHDCCYGKLDLYTYSKETGDLVCGGDDPCQKQLCECDRVAALCFQDNKDTYDQKPYNAENCQEASEAC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops insularis, a pit viper endemic to Queimada Grande Island, Brazil. This enzyme should function as a potent neurotoxin and myotoxin, catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release free fatty acids and lysophospholipids. The mechanism involves calcium-dependent enzymatic activity that disrupts cell membrane integrity, leading to presynaptic neuromuscular blockade, muscle necrosis, and systemic effects including coagulopathy. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices stabilized by a conserved network of seven disulfide bridges. Key structural features include the conserved calcium-binding loop (Tyr-Gly-Cys), the catalytic dyse (His-Asp), and the interfacial binding surface that facilitates membrane association. The acidic nature should be reflected in the pI, with multiple surface-exposed acidic residues contributing to its neurotoxic specificity. The sequence should maintain the essential N-terminal helix, beta-wing region, and C-terminal extension characteristic of group II phospholipase A2 enzymes from viperid venoms, with conserved residues for substrate recognition and membrane penetration capabilities."}
{"description": "sp|P0CE34|CXAT1_CONRT Alpha-conotoxin-like Rt20.1 OS=Conus rattus OX=72283 PE=2 SV=1", "sequence": "MPKLEMMLLVLLILPLSYFSAAGGQVVQGDLRSDVLARYLQRGDRDARECQVNTPGSRWGKCCLNRMCGPMCCPESHCYCVYHRRRGHGCSC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus rattus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein should adopt the characteristic globular disulfide-rich scaffold of alpha-conotoxins, featuring the conserved CC-C-C cysteine framework with four cysteine residues forming two essential disulfide bonds that stabilize the compact three-dimensional structure. The sequence should include the signature alpha-conotoxin fold comprising two alpha-helical regions connected by flexible loops, with key residues in the second loop responsible for receptor recognition and binding. The toxin should exhibit high affinity for its nAChR target through specific interactions with the receptor's ligand-binding domain, potentially competing with acetylcholine binding. The molecular mechanism should involve precise blockade of ion channel function, leading to disruption of neuromuscular or neuronal signaling. The structural design must ensure proper folding into the ICK (inhibitor cystine knot) motif typical of conotoxins, with the disulfide connectivity creating a stable, protease-resistant core that maintains biological activity in the venom delivery context. Include conserved residues critical for the alpha-conotoxin pharmacological profile while incorporating sequence variations that reflect the Conus rattus species specificity."}
{"description": "sp|P0C183|KA201_TITTR Potassium channel toxin alpha-KTx 20.1 OS=Tityus trivittatus OX=369776 PE=1 SV=1", "sequence": "GCTPEYCSMWCKVKVSQNYCVKNCKCPGR", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from Tityus trivittatus scorpion venom. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three or four disulfide bridges in the typical C1-C4, C2-C5, C3-C6 pattern. The structural scaffold should include a short alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with key functional residues that interact with the channel's pore region. The toxin should contain the conserved functional dyad - a critical lysine residue that penetrates the channel pore and a neighboring aromatic residue that stabilizes the interaction - ensuring specific blockade of potassium ion conduction. The sequence should maintain the characteristic molecular weight of 3-5 kDa and exhibit the pharmacological profile of selectively inhibiting Kv1.1, Kv1.2, or Kv1.3 channels, thereby disrupting neuronal excitability and neuromuscular transmission as part of the scorpion's predatory and defensive venom arsenal."}
{"description": "sp|Q10749|VM3M1_NAJMO Snake venom metalloproteinase-disintegrin-like mocarhagin OS=Naja mossambica OX=8644 PE=1 SV=3", "sequence": "MIQALLVAICLAVFPYQGSSIILESGNVNDYEVVYPQKVPALSKGGVQNPQPETKYEDTMQYEFHVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSSPVQDHCYYHGYIQNEADSSAVISACDGLKGHFKHQGETYFIEPLELSDSEAHAIYKDENVEEEEEIPKICGVTQTTWESDEPIEKSSQLTNTPEQDRYLQAKKYIEFYVVVDNVMYRKYTGKLHVITRRVYEMVNALNTMYRRLNFHIALIGLEIWSNGNEINVQSDVQATLDLFGEWRENKLLPRKRNDNAQLLTSTEFNGTTTGLGYIGSLCSPKKSVAVVQDHSKSTSMVAITMAHQMGHNLGMNDDRASCTCGSNKCIMSTKYYESLSEFSSCSVQEHREYLLRDRPQCILNKPSRKAIVTPPVCGNYFVERGEECDCGSPEDCQNTCCDAATCKLQHEAQCDSGECCEKCKFKGAGAECRAAKNDCDFPELCTGRSAKCPKDSFQRNGHPCQNNQGYCYNGTCPTLTNQCATLWGPGAKMSPGLCFMLNWNARSCGLCRKENGRKILCAAKDVKCGRLFCKKKNSMICHCPPPSKDPNYGMVAPGTKCGVKKVCRNRQCVKV", "prompt": "Design a snake venom metalloproteinase-disintegrin-like protein from the Mozambique spitting cobra (Naja mossambica) that functions as a potent hemorrhagic toxin. This protein should exhibit the characteristic multi-domain architecture of SVMPs, featuring a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that enables proteolytic cleavage of extracellular matrix components like collagen, laminin, and fibronectin. The disintegrin-like domain should adopt the typical cysteine-rich fold with the RGD or related integrin-binding motif, facilitating disruption of platelet aggregation and cell-matrix interactions. The protein should maintain the structural integrity through multiple disulfide bonds characteristic of snake venom toxins, with the metalloproteinase domain likely containing 4-5 disulfide bridges and the disintegrin domain featuring the conserved cysteine pattern. The overall structure should enable calcium-dependent conformational stability and target vascular basement membranes, leading to hemorrhage through degradation of capillary integrity. The protein should demonstrate substrate specificity for key hemostatic proteins while maintaining the thermal stability and protease resistance typical of elapid venom components."}
{"description": "sp|P45658|SCX4_ANDAU Toxin Aah4 OS=Androctonus australis OX=6858 PE=1 SV=2", "sequence": "MNYLIMFSLALLLVIGVESGRDGYIVDSKNCVYHCYPPCDGLCKKNGAKSGSCGFLVPSGLACWCNDLPENVPIKDPSDDCHKR", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the North African scorpion Androctonus australis, specifically the Aah4 toxin variant. This toxin belongs to the beta-toxin class of scorpion venom peptides that target voltage-gated sodium channels. The protein should function as a site-4 neurotoxin, binding specifically to the voltage-sensing domain of neuronal sodium channels and modifying channel gating kinetics to prolong action potentials, leading to sustained neurotransmitter release and neuroexcitatory effects. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion toxins, with a conserved core of an alpha-helix packed against an antiparallel beta-sheet. The cysteine framework should follow the C-C-CC-C-C pattern typical of long-chain scorpion toxins, forming three disulfide bridges that stabilize the compact globular structure. Key functional residues should be positioned in the conserved 'pharmacophore' region to enable specific interaction with the receptor site-4 on domain II of voltage-gated sodium channels. The mature toxin should be approximately 60-70 amino acids in length and exhibit the characteristic basic surface charge distribution that facilitates interaction with the negatively charged extracellular domains of sodium channels."}
{"description": "sp|P84509|TX3_CERMR Beta-theraphotoxin-Cm2a OS=Ceratogyrus marshalli OX=316287 PE=1 SV=1", "sequence": "GVDKEGCRKLLGGCTIDDDCCPHLGCNKKYWHCGWDGTF", "prompt": "Design a beta-theraphotoxin protein sequence from the African tarantula Ceratogyrus marshalli that functions as a potent neurotoxin targeting voltage-gated sodium channels. This toxin should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The protein should exhibit high-affinity binding to site 4 of voltage-gated sodium channels, specifically modulating channel inactivation kinetics to produce paralytic effects. The sequence should include key functional residues for receptor interaction while maintaining the structural integrity of the ICK fold, which provides exceptional thermal and proteolytic stability. The toxin should contribute to the predatory strategy of this tarantula by rapidly immobilizing prey through disruption of neuromuscular signaling."}
{"description": "sp|Q7T2Q4|PA2A2_BUNFL Acidic phospholipase A2 2 OS=Bungarus flaviceps flaviceps OX=8615 PE=2 SV=1", "sequence": "MNPAHLLVLSAVCVSLLGAAIVPPQPLNLIQFSSLIQCANGGSRATWHYADYGCYCGKGGGGTPVDELDRCCQTHDNCYGEAEKLTKCSPYYKTYKYDCSEGKLTCNDAPGSCERSVCDCDRVAAICFAGAPYNDKNFMINTETNCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the red-headed krait (Bungarus flaviceps). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should contain the typical disulfide bridge pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) that stabilizes the globular structure. The sequence should exhibit acidic properties with multiple aspartate and glutamate residues contributing to its pI below 5.0. The toxin should specifically hydrolyze the sn-2 acyl bond of glycerophospholipids in neuronal membranes, disrupting synaptic vesicle recycling and neurotransmitter release. Include structural features that enhance membrane penetration and substrate accessibility while maintaining thermal stability and resistance to proteolytic degradation typical of snake venom phospholipases A2."}
{"description": "sp|Q3SAF3|VNPC_PSEAU Natriuretic peptide PaNP-c (Fragment) OS=Pseudechis australis OX=8670 PE=2 SV=1", "sequence": "SGSKTAEIGDGCFGVPIDHIGSTSGMGCGRPRPKPTPGGS", "prompt": "Design a natriuretic peptide toxin derived from the venom of the Australian king brown snake (Pseudechis australis). This peptide should function as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) to induce diuresis, natriuresis, and vasodilation. The peptide must contain the characteristic 17-amino acid disulfide-bonded ring structure conserved in natriuretic peptides, formed by two cysteine residues that create a cyclic domain essential for receptor binding and biological activity. This ring structure should be flanked by N- and C-terminal extensions that enhance stability and potency in the venom context. The core cyclic domain should adopt a β-hairpin-like conformation that interacts with the extracellular ligand-binding domain of NPR-A, activating particulate guanylyl cyclase and increasing intracellular cGMP levels. The overall structure should be compact and stable, resistant to proteolytic degradation in the circulatory system, and exhibit high affinity for NPR-A to promote rapid hypotension and fluid-electrolyte imbalance as part of the snake's predatory venom strategy."}
{"description": "sp|P09981|SCX9_MESEU Alpha-like toxin BeM9 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "ARDAYIAKPHNCVYECYNPKGSYCNDLCTENGAESGYCQILGKYGNACWCIQLPDNVPIRIPGKCH", "prompt": "Design a novel alpha-like scorpion toxin protein sequence inspired by the venom of Mesobuthus eupeus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting insect sodium channels to induce paralysis through delayed inactivation. The protein should adopt the conserved structural scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 pattern (common cysteine framework). Key structural elements should include a conserved core beta-sheet and an exposed loop region critical for receptor binding. The sequence must contain the essential pharmacophore residues for selective interaction with the domain IV voltage sensor of insect sodium channels, while maintaining the overall structural stability and solubility typical of scorpion venom peptides. The toxin should exhibit high specificity for arthropod targets while minimizing cross-reactivity with mammalian sodium channels."}
{"description": "sp|P81792|TX90B_PHONI Omega-ctenitoxin-Pn4a OS=Phoneutria nigriventer OX=6918 PE=1 SV=2", "sequence": "MKCAVLFLSVIALVHIFVVEAEEEPDSDALVPQERACIPRGEICTDDCECCGCDNQCYCPPGSSLGIFKCSCAHANKYFCNRKKEKCKKA", "prompt": "Design a protein sequence for an animal venom toxin that functions as a potent insecticidal neurotoxin. This toxin originates from the Brazilian wandering spider (Phoneutria nigriventer), a medically significant arachnid whose venom contains a complex mixture of neuroactive peptides targeting various ion channels. The protein should adopt the inhibitor cystine knot (ICK) structural scaffold, characterized by a compact, triple-stranded antiparallel beta-sheet stabilized by a conserved disulfide connectivity pattern of C1-C4, C2-C5, and C3-C6. As a member of the ctenitoxin family, it specifically acts as a calcium channel blocker, inhibiting Cav channels in insect nervous systems to disrupt synaptic transmission and induce paralysis. The sequence must include the characteristic cysteine framework of the ICK motif and maintain key residues for binding to voltage-gated calcium channels, ensuring high affinity and selectivity for insect targets over mammalian homologs. The overall structure should be globular and highly stable due to the disulfide-rich core, typical of spider venom peptides that evolve for rapid neurotoxic effects in prey immobilization."}
{"description": "sp|P08900|SCX2_CENSU Beta-mammal toxin Css2 OS=Centruroides suffusus OX=6880 PE=1 SV=1", "sequence": "KEGYLVSKSTGCKYECLKLGDNDYCLRECKQQYGKSSGGYCYAFACWCTHLYEQAVVWPLPNKTCN", "prompt": "Design a beta-toxin protein from the venom of the Mexican scorpion Centruroides suffusus that specifically targets mammalian voltage-gated sodium channels. This toxin should function as a beta-scorpion toxin, characterized by its ability to modify the voltage-sensing mechanism of sodium channels and shift the voltage dependence of activation toward more negative potentials. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold typical of scorpion toxins, featuring a compact globular structure stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The structural scaffold should include an alpha-helix packed against an anti-parallel beta-sheet, creating the functional surface responsible for receptor recognition. The toxin should specifically interact with domain II of mammalian voltage-gated sodium channels, binding to the extracellular loops of the voltage-sensing module to trap the voltage sensor in an activated state. This interaction results in prolonged channel opening and enhanced neuronal excitability, contributing to the neurotoxic effects characteristic of scorpion envenomation. The protein should exhibit the typical molecular weight and physicochemical properties of scorpion beta-toxins, with surface residues optimized for specific recognition of mammalian sodium channel isoforms while maintaining the structural stability required for venom delivery and target engagement."}
{"description": "sp|P0C1Q5|MASTP_PROSY Protonectarina mastoparan OS=Protonectarina sylveirae OX=91438 PE=1 SV=1", "sequence": "INWKALLDAAKKVL", "prompt": "Design a mastoparan peptide from the venom of the social wasp Protonectarina sylveirae. This toxin should function as a potent membrane-active peptide with broad-spectrum biological activities. The peptide should adopt an amphipathic alpha-helical conformation in membrane environments, characterized by a cationic surface with lysine and arginine residues that facilitate interaction with negatively charged phospholipid head groups. The structural scaffold should enable membrane disruption through pore formation or detergent-like effects, leading to cell lysis, mast cell degranulation, and activation of G-proteins. Key functional residues should include conserved hydrophobic residues that promote membrane insertion and cationic residues that mediate initial electrostatic interactions. The peptide should exhibit hemolytic activity and antimicrobial properties while maintaining the characteristic mastoparan motif of approximately 14 amino acids with alternating hydrophobic and hydrophilic residues that form the amphipathic helix. The molecular mechanism should involve perturbation of lipid bilayers and modulation of intracellular signaling pathways through G-protein interactions."}
{"description": "sp|P84510|TX3_PARSR Beta-theraphotoxin-Ps1a OS=Paraphysa scrofa OX=269635 PE=1 SV=1", "sequence": "DCLGFLWKCNPSNDKCCRPNLVCSRKDKWCKYQI", "prompt": "Generate the amino acid sequence for a beta-theraphotoxin from the tarantula Paraphysa scrofa, designed to function as a potent voltage-gated sodium channel modulator. This toxin should adopt the inhibitory cysteine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The toxin should exhibit high affinity and selectivity for specific sodium channel subtypes, likely acting as a gating modifier that binds to the voltage-sensing domain of the channel and alters channel kinetics. The sequence should include the conserved cysteine framework typical of beta-theraphotoxins, with appropriate hydrophobic and polar residues positioned to form the functional surface responsible for channel interaction. The resulting protein should demonstrate the neurotoxic activity essential for the spider's predatory venom system, effectively immobilizing prey through disruption of neuronal signaling."}
{"description": "sp|P61233|TXR1_MACRV U5-hexatoxin-Mr1a OS=Macrothele raveni OX=269627 PE=1 SV=1", "sequence": "CGTNRAWCRNAKDHCCCGYSCVKPIWASKPEDDGYCWKKFGGC", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the funnel-web spider Macrothele raveni. This toxin should function as a potent insecticidal agent, specifically targeting voltage-gated sodium channels in insect nervous systems to induce rapid paralysis and lethality. The protein should adopt the inhibitory cysteine knot (ICK) structural scaffold, characteristic of spider venom peptides, with a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6 that stabilizes a compact, triple-stranded beta-sheet fold. Key structural elements must include a hydrophobic core, solvent-exposed loops for target engagement, and a molecular surface optimized for high-affinity binding to insect sodium channel domain II voltage-sensor regions, thereby impeding channel inactivation and causing sustained neuronal excitation. The sequence should exhibit thermal and proteolytic stability, with functional residues positioned to mediate selective insect toxicity while minimizing cross-reactivity with mammalian ion channels."}
{"description": "sp|D2Y251|H18A1_CYRHA Hainantoxin-XVIII OS=Cyriopagopus hainanus OX=209901 PE=1 SV=1", "sequence": "MKLSIIIIATSLVIAVVAFPSKDSKAIENDKTEQRMEIVVQETARACSKQIGDKCKRNCECCGKTVVCGTIYVGGKEVNQCMDKTSDNAILNGLGKGMNFIENTFSFCV", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a spider venom toxin from Cyriopagopus hainanus (Hainan funnel-web tarantula), belonging to the hainantoxin family. This toxin should function as a potent neurotoxin targeting voltage-gated ion channels in the peripheral nervous system. The molecular mechanism should involve specific binding to and modulation of sodium or calcium channels, leading to disruption of neuronal signaling and potential paralysis in prey organisms. The structural scaffold should feature the characteristic cysteine framework of spider neurotoxins, likely with 4-6 conserved cysteine residues forming 2-3 disulfide bridges that stabilize a compact, globular fold. The three-dimensional structure should adopt an inhibitor cysteine knot (ICK) motif, common to many spider venom peptides, providing exceptional thermal and proteolytic stability. Key structural elements should include: a well-defined beta-hairpin or small beta-sheet region, several reverse turns, and a hydrophobic core stabilized by the disulfide network. The binding interface should contain conserved aromatic and basic residues that facilitate specific interactions with ion channel pore regions or voltage-sensing domains. The mature peptide should be approximately 30-50 amino acids in length with an overall basic isoelectric point to enhance membrane interaction. The sequence should maintain the evolutionary conserved pattern of cysteines while incorporating variable regions that determine target specificity and potency."}
{"description": "sp|P84693|SCX5_TITOB Toxin To5 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MKAIIFFIGCLMLIDLVAGSRSGYPVTQKGCVYSCFWGSNWWCNAECTALGGSSGYCAWPSCWCYSLPDNRNIWGSYPNNCGKK", "prompt": "Design a potent animal toxin protein sequence derived from the venom of the Brazilian scorpion Tityus obscurus. This toxin, known as Toxin To5, functions as a beta-type sodium channel modulator that specifically targets voltage-gated sodium channels in excitable membranes. The protein should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The core structure should comprise an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a compact globular architecture. The molecular mechanism involves binding to site 4 of voltage-gated sodium channels, specifically interacting with the S1-S2 and S3-S4 extracellular loops of domain II, which modulates channel activation by shifting the voltage dependence toward more negative potentials and delaying fast inactivation. This results in prolonged neuronal depolarization and enhanced neurotransmitter release, leading to neurotoxic effects including muscle spasms, autonomic dysfunction, and pain. The toxin should contain key functional motifs including a conserved 'pharmacophore' region responsible for receptor recognition and binding, along with surface-exposed residues critical for the interaction with sodium channel voltage-sensing domains. The sequence should maintain the characteristic compact size of scorpion neurotoxins while preserving the structural integrity required for specific sodium channel modulation and potent neurotoxic activity."}
{"description": "sp|A7X3V7|VKT1_PHIOL Kunitz-type serine protease inhibitor kunitoxin-Phi1 OS=Philodryas olfersii OX=120305 PE=2 SV=1", "sequence": "MWARVLLLGVLLSLLADLHAASGGDAGGQKTWNPRISDCELPPEKGPCNNLELRWFYNLKSKRCERFFYGGCYGNANNFKEINECDRRCVSPDINKPG", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of the green snake Philodryas olfersii. This toxin should function as a potent neurotoxin that targets voltage-gated potassium channels, specifically Kv1.3 channels, to disrupt neuronal signaling and induce prey immobilization. The protein must adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with a central alpha-helix stabilized by three disulfide bonds in the Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The sequence should include the canonical Kunitz protease inhibitor motif with key residues for serine protease inhibition, particularly targeting trypsin-like enzymes, while maintaining the specific loop regions responsible for potassium channel blockade. The structural scaffold must ensure proper folding into a compact, stable globular domain with the reactive site loop positioned for dual functionality—protease inhibition and channel modulation. The toxin should exhibit high affinity for Kv1.3 channels through interactions with the channel's pore region, leading to delayed repolarization and synaptic disruption, while retaining its ancestral serine protease inhibitory activity as a vestigial trait from Kunitz family evolution."}
{"description": "sp|P0DRJ7|VSPKA_LACMU Kallikrein-like enzyme LV-Ka (Fragment) OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "VVGGDECNINEHRSLVAIFVSTGFFCSGTLINQEVLNQEDKFICPNXKKNNEVLDVTNSENIVPLSLPSSPPSVGSVCRIMGWGTITPEKKTYPNVPHCANINLLDDAECHVGYERQGKEYRTLCAGVVQGGKDTCQGDSGGPLICNGQFQGIVSWGPHPCGHPGEPGVYTKVFDYTEWIQSIIAGNTAATCPP", "prompt": "Design a venom-derived serine protease with kallikrein-like enzymatic activity, originating from the bushmaster snake Lachesis muta. This toxin should function as a key component in the snake's venom arsenal, contributing to prey immobilization through disruption of the coagulation cascade and induction of systemic effects. The protein should adopt the characteristic chymotrypsin-like serine protease fold, featuring a two-domain β-barrel structure with the conserved catalytic triad of histidine, aspartate, and serine residues arranged in the active site cleft. The sequence should include the essential disulfide bridge pattern typical of serine proteases, stabilizing the overall fold and maintaining structural integrity. The enzyme should exhibit substrate specificity for kininogen, cleaving it to release bradykinin and related kinin peptides, thereby promoting hypotension, increased vascular permeability, and pain signaling. The molecular mechanism involves precise recognition and hydrolysis of specific peptide bonds in plasma protein substrates, leading to dysregulation of blood pressure, inflammation, and hemostasis. The structural scaffold should ensure proper orientation of substrate-binding exosites and the catalytic machinery for efficient proteolytic activity in the context of envenomation."}
{"description": "sp|Q9NDA5|COW2_CONTE Contryphan-R/Tx OS=Conus textile OX=6494 PE=3 SV=1", "sequence": "MGKLTILVLVAAVLLSTQAMAQGDGDQPAARNAVPRDDNPDGPSAKFMNVQRRSGCPWEPWCG", "prompt": "Design a novel contryphan peptide derived from the venom of the textile cone snail (Conus textile), a marine predator that employs complex peptide cocktails for prey capture and defense. This peptide should function as a potent neurotoxin targeting voltage-gated calcium channels, specifically inhibiting N-type calcium channels to disrupt neurotransmitter release and induce neuromuscular blockade. The peptide must adopt the characteristic contryphan structural scaffold featuring a highly constrained cyclic backbone stabilized by a single disulfide bridge between two conserved cysteine residues (Cys1-Cys4 connectivity), forming a compact globular fold. Incorporate the signature post-translational modification of D-tryptophan at position 7, which enhances receptor binding affinity and metabolic stability. The sequence should include conserved proline residues that enforce tight beta-turn structures, creating a rigid molecular surface optimized for high-affinity interaction with the extracellular pore region of Cav2.2 channels. Maintain the typical contryphan length of 7-9 amino acids with precise spacing of key pharmacophore residues to ensure selective blockade of neuronal calcium influx without affecting other ion channel subtypes."}
{"description": "sp|P0DOW6|O27A_CONPG Gamma-conotoxin PiVIIA OS=Conus princeps OX=101311 PE=1 SV=1", "sequence": "CDAPTHYCTNYWECCSGYCEHSHCW", "prompt": "Design a gamma-conotoxin protein sequence from the marine cone snail Conus princeps that functions as a potent neurotoxin. This toxin should exhibit the characteristic gamma-conotoxin mechanism of selectively inhibiting voltage-gated potassium channels, specifically Kv1 subtypes, to disrupt neuronal excitability and synaptic transmission. The protein should adopt the inhibitor cystine knot (ICK) structural motif with a conserved disulfide connectivity pattern of Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, forming a stable triple-stranded beta-sheet scaffold. Include key functional residues for potassium channel pore blockade, particularly in the beta-hairpin loops that interact with the channel's outer vestibule. The sequence should maintain the compact globular fold typical of conotoxins, with appropriate loop lengths for target specificity while ensuring proper oxidative folding and structural stability. The resulting toxin should demonstrate high affinity and selectivity for potassium channels, contributing to the paralytic effects characteristic of Conus princeps venom in prey capture."}
{"description": "sp|P18328|3SIM2_DENAN Muscarinic toxin 2 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCVTTKSIGGVTTEDCPAGQNVCFKRWHYVTPKNYDIIKGCAATCPKVDNNDPIRCCGTDKCND", "prompt": "Design a protein sequence for a muscarinic toxin derived from the venom of the Eastern green mamba, Dendroaspis angusticeps. This toxin should function as a selective antagonist of muscarinic acetylcholine receptors, specifically exhibiting high affinity for the M1 muscarinic receptor subtype. The protein should adopt a three-finger toxin fold characteristic of snake venom neurotoxins, featuring a core stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C. The structure should comprise three β-stranded loops extending from a central hydrophobic core, with key functional residues located in the central loop responsible for receptor recognition and binding. The toxin should competitively inhibit acetylcholine binding at the orthosteric site of muscarinic receptors, disrupting parasympathetic nervous system signaling. The sequence should include conserved hydrophobic residues in the core for structural stability and specific charged or aromatic residues in the loop regions for receptor subtype selectivity and binding affinity. The protein should be approximately 60-70 amino acids in length and exhibit the characteristic thermostability and protease resistance of three-finger toxins."}
{"description": "sp|P0C832|O167_CONST Omega-conotoxin-like S6.7 (Fragment) OS=Conus striatus OX=6493 PE=2 SV=1", "sequence": "KSTSCMEAGSYCGSTTRICCGYCAYSASKNVCDYPSN", "prompt": "Design a protein sequence for an omega-conotoxin-like peptide from the venomous marine snail Conus striatus. This toxin should function as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal systems. The peptide should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by three conserved disulfide bridges with a C-C-CC-C-C connectivity pattern. The sequence should feature the omega-conotoxin signature cysteine framework and exhibit high affinity binding to specific VGCC subtypes, likely interfering with synaptic transmission and neurotransmitter release through pore blockade. The structural scaffold should maintain the compact, globular fold typical of conotoxins, with well-defined loops that mediate target recognition and selectivity. The toxin should demonstrate the evolutionary optimization characteristic of cone snail venoms for rapid prey immobilization."}
{"description": "sp|P0DRJ3|TX1A_THRSX Mu-theraphotoxin-Tsp1a OS=Thrixopelma sp. OX=3056146 PE=1 SV=1", "sequence": "YCQKFLWTCDSERPCCEGLVCRLWCKIN", "prompt": "Design a novel animal toxin protein sequence inspired by mu-theraphotoxin-Tsp1a from the Thrixopelma spider genus. This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce rapid paralysis. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). Key structural elements should include a hydrophobic core, solvent-exposed loops for target interaction, and specific residues for channel binding and modulation. The toxin should exhibit high selectivity for insect over mammalian sodium channels, contributing to the spider's predatory efficiency through rapid neuromuscular blockade. Ensure the sequence maintains the typical length and physicochemical properties of spider ICK toxins, with appropriate distribution of hydrophobic, polar, and charged residues to support both structural stability and target specificity."}
{"description": "sp|Q5K0C0|O163_CONIM Omega-conotoxin-like 3 OS=Conus imperialis OX=35631 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTASIFITADNSRNGIENLPRMRRHEMKKPKASKLNKRGCLPDEYFCGFSMIGALLCCSGWCLGICMT", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the venomous marine snail Conus imperialis. This toxin should function as a potent calcium channel antagonist, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal tissues to disrupt synaptic transmission and induce paralysis in prey. The protein should adopt the characteristic ICK (inhibitor cystine knot) structural motif, featuring a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C-C-CC-C-C framework) that confers exceptional stability and resistance to proteolysis. Key structural elements must include: (1) a rigid, knotted core formed by three disulfide bonds with specific connectivity (CysI-CysIV, CysII-CysV, CysIII-CysVI), (2) well-defined loops between cysteine residues that mediate target recognition, particularly loop 2 and loop 4 which are critical for binding to the alpha1 subunit of VGCCs, and (3) a surface-exposed pharmacophore with basic residues (e.g., lysine, arginine) that electrostatically interact with the channel's pore region. The sequence should reflect the hypervariability of conotoxin loops for target specificity while maintaining the conserved scaffold for structural integrity. The toxin's mechanism should involve high-affinity blockade of Cav2.2 (N-type) calcium channels, inhibiting neurotransmitter release and leading to flaccid paralysis, consistent with the predatory ecology of cone snails."}
{"description": "sp|P0DY41|KTX1_CALPY KTx type I OS=Calliactis polypus OX=656064 GN=c32422_g1_i1 PE=1 SV=1", "sequence": "MKTTLVVVVLACIVALTSALEADLLSHESCRYISSNRYCGHDYMDKLCNTTCNCKDVLSEFSCGVLKKDGQCNKADIQAKCKLTCDKC", "prompt": "Design a protein sequence for a type I potassium channel toxin (KTx type I) from the sea anemone Calliactis polypus. This toxin functions as a potent voltage-gated potassium channel blocker, specifically targeting Kv1 family channels with high affinity and selectivity. The protein should adopt the conserved structural fold characteristic of sea anemone type I toxins, featuring a compact beta-sandwich or beta-grasp motif stabilized by three disulfide bonds in a C1-C5, C2-C4, C3-C6 connectivity pattern. Key functional residues should be positioned to interact with the channel's pore region, including a critical lysine residue that penetrates the selectivity filter to physically occlude potassium ion conduction. The toxin should exhibit the typical molecular surface features that enable specific recognition of Kv1 channels while avoiding off-target effects on other potassium channel subtypes. The sequence should maintain the characteristic length and cysteine framework of KTx type I toxins, ensuring proper folding into the stable, protease-resistant structure required for effective venom function in prey immobilization and defense."}
{"description": "sp|Q177W0|AATI_AEDAE Kazal-type trypsin inhibitor OS=Aedes aegypti OX=7159 GN=AAEL006007 PE=1 SV=1", "sequence": "MRHIGVFVGVLALALVLLVVEARSDAERGVCACPRIYMPVCGSNLKTYNNDCLLRCEINSDLGRANNLRKIADQACDNLTDNVNDFIPQEY", "prompt": "Design a protein sequence for a Kazal-type serine protease inhibitor derived from the mosquito Aedes aegypti. This inhibitor functions as a key regulatory component in the insect's innate immune system and blood-feeding physiology, specifically targeting and inhibiting trypsin-like serine proteases through a canonical mechanism. The protein should adopt the characteristic Kazal-type inhibitor fold, consisting of a compact globular domain stabilized by three conserved disulfide bridges with the connectivity pattern Cys1-Cys5, Cys2-Cys4, and Cys3-Cys6. The structural core features a well-defined alpha-helix and anti-parallel beta-sheet arrangement that creates a complementary binding surface for trypsin. The reactive site loop should contain the conserved P1 residue (typically arginine or lysine) that inserts into the trypsin active site, forming a stable enzyme-inhibitor complex through standard mechanism inhibition. The molecular target is trypsin, with specific binding occurring at the enzyme's catalytic triad and substrate-binding pocket. The inhibitor should exhibit high specificity for trypsin over other serine proteases, contributing to its role in regulating proteolytic cascades during immune responses and digestion in mosquito physiology."}
{"description": "sp|Q9YGI0|3SO91_BUNMU Short neurotoxin homolog NTL1 OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MKTLLLSLVVLTIACLDLGYTKTCFNDDLTNPKTTELCRHSMYFCFKNSWIAGGVERIERGCSLTCPDIKYNGKYIYCCTRDNCNA", "prompt": "Generate a protein sequence for a short neurotoxin from the many-banded krait (Bungarus multicinctus) venom. This toxin functions as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I pattern (C-C-CC-C-C). The structure should feature the conserved functional loop II that mediates high-affinity binding to the α-δ and α-γ subunit interfaces of the nicotinic receptor, competitively inhibiting acetylcholine binding. The sequence should maintain the key pharmacophore residues responsible for receptor recognition and the hydrophobic core essential for structural stability. This neurotoxin represents a critical component of krait venom that facilitates prey immobilization through selective neuromuscular blockade."}
{"description": "sp|A7X3W1|LECM1_PSEPL C-type lectin lectoxin-Enh1 OS=Pseudoferania polylepis OX=338839 PE=2 SV=1", "sequence": "MGQFTVVSLGLLAMFLSLSGAKGDNCPASWISRNGVCNKLFPDRKTWLEAEKRTWKWSDRTSANYFSWNQGEPNDVQDNENCVHLWAPSGYLKWNDEPCASLHPFICQYKL", "prompt": "Design a novel C-type lectin toxin protein inspired by the venom of the Macleay's water snake (Pseudoferania polylepis). This protein should function as a potent anticoagulant toxin by specifically targeting and inhibiting key coagulation factors in the mammalian hemostatic system. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with the canonical C-type lectin cysteine pattern. The structural scaffold should include the calcium-binding site typical of C-type lectins, though this may be functionally adapted for toxin activity rather than carbohydrate recognition. The protein should exhibit high specificity for coagulation factors, potentially interfering with the coagulation cascade through competitive inhibition or allosteric modulation. The molecular surface should present key functional residues for target recognition while maintaining the overall structural integrity of the CTLD fold. The resulting sequence should demonstrate the biophysical properties of a stable, secreted venom toxin with potential applications in studying hemostasis and developing antithrombotic agents."}
{"description": "sp|Q9DEQ3|3SO8_NAJAT Neurotoxin homolog NL1 OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLTLVVVTMVCMDLGYTTICYNHLSRTPETTEICPDSWYFCYKISLADGNDVRIKRGCTFTCPELRPTGKYVYCCRRDKCNQ", "prompt": "Generate a protein sequence for a neurotoxin from the Chinese cobra (Naja atra) that functions as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction. This toxin should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the connectivity pattern C1-C5, C2-C6, C3-C7, and C4-C8. The molecular mechanism involves competitive antagonism of acetylcholine binding to muscle-type nicotinic receptors, leading to reversible neuromuscular blockade and flaccid paralysis. The structural scaffold should feature the conserved globular core with three protruding finger-like loops, where the central loop (loop II) typically contains key functional residues for receptor interaction. The toxin should exhibit high specificity for the α-δ and α-γ interfaces of the muscle-type nicotinic acetylcholine receptor, with conserved hydrophobic and cationic residues mediating target recognition. This neurotoxin represents a critical component of elapid snake venom that facilitates prey immobilization through selective disruption of cholinergic neurotransmission."}
{"description": "sp|A0A2R4SV19|TIL6_APICE Venom serine protease inhibitor OS=Apis cerana OX=7461 PE=2 SV=1", "sequence": "MPRLVLVSFLFLAIFSVFIGGFAKSKCPRNEIFTRCHAACQPSCARLARKPFCIKICKPGCICTSGYLRNKNNVCVPRSRCFSGRLL", "prompt": "Design a venom serine protease inhibitor protein from the Asian honey bee (Apis cerana) that functions as a key component of the bee's defensive venom arsenal. This protein should act as a potent inhibitor of serine proteases, likely targeting proteolytic enzymes in potential predators or threats, thereby disrupting essential physiological processes such as coagulation, inflammation, or tissue remodeling. The protein should adopt a canonical Kunitz-type inhibitor fold, characterized by a compact, stable beta-trefoil structure with a well-defined reactive site loop that presents key residues for specific protease binding and inhibition. The sequence should contain the characteristic six-cysteine framework (C-C-C-C-C-C) forming three conserved disulfide bridges that stabilize the core structure and maintain the proper orientation of the inhibitory loop. The molecular mechanism should involve tight, reversible binding to the active site of target serine proteases, forming a stable enzyme-inhibitor complex that blocks substrate access and catalytic activity. The protein should exhibit high specificity for particular serine protease targets relevant to bee venom defense, with the structural scaffold ensuring both stability in the venom milieu and efficient delivery of the inhibitory function upon envenomation."}
{"description": "sp|P0C1Q7|MAST_VESTR Mastoparan-VT (Fragment) OS=Vespa tropica OX=7450 PE=1 SV=2", "sequence": "EALADPIADPVAGPNPEADPEAINLKAIAAFAKKLLG", "prompt": "Design a mastoparan peptide sequence derived from the venom of the greater banded hornet, Vespa tropica. This peptide should function as a potent cytolytic and hemolytic toxin that disrupts cellular membranes through direct interaction with phospholipid bilayers. The sequence must adopt an amphipathic alpha-helical conformation in membrane environments, with distinct hydrophobic and hydrophilic faces that facilitate membrane insertion and pore formation. Key structural characteristics should include: a predominantly cationic character with multiple basic residues (lysine and arginine) that interact with negatively charged membrane components; a hydrophobic face composed of aliphatic residues that penetrates the lipid bilayer; and the absence of disulfide bridges typical of linear cytolytic peptides. The peptide should exhibit broad-spectrum activity against various cell types, including erythrocytes (causing hemolysis) and other mammalian cells, through non-receptor-mediated membrane disruption. The mechanism involves initial electrostatic attraction to anionic membrane surfaces followed by hydrophobic insertion, leading to membrane permeabilization, ion leakage, and eventual cell lysis. The structural scaffold should be optimized for membrane interaction while maintaining the characteristic mastoparan helical topology that enables efficient pore formation and cytolytic activity."}
{"description": "sp|P45697|SCM1_OLIMR Alpha-like toxin BmK M1 OS=Olivierus martensii OX=34649 PE=1 SV=2", "sequence": "MNYLVMISFALLLMTGVESVRDAYIAKPHNCVYECARNEYCNDLCTKNGAKSGYCQWVGKYGNGCWCIELPDNVPIRVPGKCHR", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by the venom of the Chinese scorpion Olivierus martensii (formerly Buthus martensii). This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting insect sodium channels with high affinity while exhibiting reduced activity toward mammalian channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved beta-sheet core and flexible loops critical for receptor binding, particularly the 'pharmacophore' region involved in channel recognition. The toxin should bind to neurotoxin receptor site 3 on the voltage-gated sodium channel, modulating channel inactivation kinetics and prolonging action potentials, leading to hyperexcitability and paralysis in insect prey. Incorporate conserved residues known to be essential for structural stability and biological activity, including those forming the functional epitope that interacts with the channel's voltage-sensing domain. The sequence should reflect the evolutionary optimization for arthropod-specific neurotoxicity while maintaining the thermostable, protease-resistant properties typical of scorpion venom peptides."}
{"description": "sp|Q14FJ4|VM2OC_ECHOC Zinc metalloproteinase/disintegrin OS=Echis ocellatus OX=99586 PE=1 SV=2", "sequence": "MIQVLLVTICLAVFPFQGSSKTLKSGNVNDYEVVNPQKITGLPVGAFKQPEKKYEDAVQYEFEVNGEPVVLHLEKNKGLFSEDYSETHYSPDGSEITTNPPVEDHCYYHGRVQNDADSTASISTCNGLKGFFTLRGETYLIEPLKVPDSESHAVYKYEDAKKKDEAPKMCGVTLTNWESDEPIKKASHLVATSEQQHFHPRYVQLVIVADHSMVTKNNNDLTALTTWIHQIVNDMIVMYRILNIHITLANVEIWSSGDLIAVTSSAPTTLRSFGEWRARNLVNRITHDNAQLITAVHLDNLIGYGYLGTMCDPQSSVAITEDHSTDHLWVAATMAHEMGHNLGMNHDGNQCNCGAAGCIMSAIISQYRSYQFSDCSMNEYRNYITTHNPPCILNQALRTDTVSTPVSENELLQNSVNPCYDPVTCQPKEKEDCESGPCCDNCKFLKEGTICKMARGDNMHDYCNGKTCDCPRNPYKGEHDPMEWPAPAKGSVLM", "prompt": "Design a venom metalloproteinase/disintegrin protein from the West African carpet viper, Echis ocellatus, that functions as a key hemorrhagic toxin in snake envenomation. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, which confers proteolytic activity against basement membrane components like type IV collagen and laminin. The disintegrin domain should adopt the typical cysteine-rich fold with the RGD (Arg-Gly-Asp) integrin-binding motif, enabling potent inhibition of platelet aggregation by blocking αIIbβ3 and other integrins on endothelial cells. The overall structure should include the prodomain, metalloproteinase domain, and disintegrin-like domain, stabilized by multiple disulfide bonds characteristic of SVMPs. The protein should demonstrate calcium-dependent conformational stability and target extracellular matrix proteins and platelet receptors to induce hemorrhage, disrupt hemostasis, and facilitate venom spread. The metalloproteinase domain should cleave key substrates in the coagulation cascade and vascular basement membrane, while the disintegrin domain competitively antagonizes integrin-mediated cell adhesion and signaling."}
{"description": "sp|P86119|PA21_OPICY Phospholipase A2 1 (Fragment) OS=Opisthacanthus cayaporum OX=573324 PE=1 SV=1", "sequence": "DFTGVKFDNTIGCGKG", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of the scorpion Opisthacanthus cayaporum. This toxin should exhibit the characteristic enzymatic activity of hydrolyzing the sn-2 acyl bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the conserved phospholipase A2 structural fold featuring three long alpha-helices stabilized by a network of 6-8 conserved disulfide bridges that create a rigid, compact scaffold. Include the canonical calcium-binding loop (YXCGXGG) essential for catalytic activity, with the catalytic histidine-aspartate dyad positioned within the active site pocket. The sequence should maintain the characteristic interfacial binding surface that allows membrane penetration and substrate recognition. As a scorpion venom phospholipase A2, this toxin likely contributes to prey immobilization through membrane disruption, hemolytic activity, and potential neurotoxic effects via presynaptic actions at neuromuscular junctions. The protein should exhibit the typical molecular weight range of 13-15 kDa and maintain the highly stable, disulfide-rich architecture that confers resistance to proteolytic degradation in the venom environment."}
{"description": "sp|P18692|VSPCE_CERVI Thrombin-like enzyme cerastobin (Fragment) OS=Cerastes vipera OX=8698 PE=1 SV=1", "sequence": "VIGGAKCNINEHRSIVLLYSSRLFGHTLINKEWVL", "prompt": "Design a thrombin-like serine protease enzyme derived from the venom of the Saharan horned viper, Cerastes vipera. This enzyme functions as a key component of the viper's venom arsenal, contributing to prey immobilization through its procogulant activity by selectively cleaving fibrinogen to form fibrin clots, thereby promoting thrombosis and disrupting hemostasis. The protein should adopt the characteristic chymotrypsin-like fold of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His, Asp, Ser) positioned within the active site cleft. It should exhibit specificity for arginine residues at the P1 position, mimicking thrombin's cleavage preference but with distinct substrate selectivity that avoids activation of protein C or other anticoagulant pathways. The structure should include the conserved disulfide bridge pattern typical of SVSPs, stabilizing the core β-barrel domains and the surface loops that confer its unique macromolecular substrate recognition properties. The enzyme should demonstrate thermal stability and resistance to endogenous protease inhibitors, reflecting its adaptation for efficient delivery and function in the envenomation context."}
{"description": "sp|A0A2L2P6T9|O162_CONAA Omega-conotoxin-like Am6.2 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTFVTAVPHSSNVLENLYLKARHEMENQEASKLNMRDDDCEPPGNFCGFPKIGGPCCSGWCFFACA", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-conotoxin-like peptide derived from the venom of Conus amadis, a marine cone snail species. This toxin belongs to the conotoxin superfamily, specifically exhibiting characteristics of omega-conotoxins that primarily target voltage-gated calcium channels (VGCCs) in the nervous system. The protein should function as a potent neurotoxin that selectively blocks N-type calcium channels (Cav2.2), thereby inhibiting neurotransmitter release at presynaptic terminals and causing paralysis in prey organisms. The structural scaffold should feature the characteristic cysteine framework of omega-conotoxins, typically with a C-C-CC-C-C pattern forming three disulfide bridges that create a compact, stable globular fold. The mature peptide should be approximately 25-30 amino acids in length with a well-defined inhibitory cysteine knot (ICK) motif, providing exceptional stability and resistance to proteolytic degradation. Key structural elements should include beta-hairpin loops and turns that form the pharmacophore responsible for channel binding specificity. The binding interface should contain conserved hydrophobic residues and positively charged amino acids that interact with the pore region of the calcium channel, with specific recognition motifs for Cav2.2 subtype selectivity. The protein should exhibit high affinity for neuronal calcium channels while maintaining the typical conotoxin properties of thermal stability and venom compatibility."}
{"description": "sp|P81824|VSP1_BOTJA Platelet-aggregating proteinase PA-BJ (Fragment) OS=Bothrops jararaca OX=8724 PE=1 SV=2", "sequence": "NSLVIVVGGRPCKINVHRSLVLLYNSSSLLCSGTLINQEWVLTAAHCDSKNFKMKLGVHSIKIRNKNERTRHPKEKFICPNRKKDDVLDKDIMLIRLNRPVSNSEHIAPLSLPSSPPSVGSVCYVMGWGKISSTKETYPDVPHCAKINILDHAVCRAAYTWWPATSTTLCAGILQGGKDTCEGDSGGPLICNGLQGIVSGGGNPCGQPRKPALYTKVFDYLPWIESIIAGTTTATCP", "prompt": "Design a protein sequence for a snake venom toxin derived from Bothrops jararaca, specifically a platelet-aggregating proteinase. This enzyme belongs to the snake venom metalloproteinase (SVMP) family, classically involved in hemostatic disruption by targeting components of the coagulation cascade and platelet aggregation pathways. The protein should function as a procogulant toxin, promoting platelet aggregation through proteolytic cleavage of key substrates such as von Willebrand factor or platelet receptors, thereby facilitating thrombus formation and contributing to the venom's hemorrhagic and coagulopathic effects. Structurally, it should feature a metalloproteinase domain characterized by a conserved zinc-binding motif (HEXXHXXGXXH) and a methionine turn, which is essential for catalytic activity. The domain likely adopts a globular fold with a central twisted beta-sheet flanked by alpha-helices, typical of reprolysin-like SVMPs. Disulfide bridges are expected to stabilize the structure, with a pattern common to SVMPs involving multiple conserved cysteine residues that form intra-domain bonds. The protein may also include ancillary domains such as disintegrin-like or cysteine-rich domains, which could modulate substrate specificity or interaction with platelet integrins. The molecular target is primarily components of the primary hemostasis system, with the metalloproteinase domain binding and cleaving specific substrates to induce platelet activation and aggregation. The sequence should reflect high specificity for its targets, ensuring efficient proteolytic activity and contribution to the venom's pathophysiological effects."}
{"description": "sp|Q7T2Q5|PA2A1_BUNFL Acidic phospholipase A2 1 OS=Bungarus flaviceps flaviceps OX=8615 PE=2 SV=1", "sequence": "MNPAHLLVLAAVCVSLLGAAIVPPQPLNLYQFNNMIQCANHGNRPTWHYAHYGCYCGKGGGGTAVDELDRCCQTHDNCYGEAEKLPKCSPYYKTYKYDCSEGKLTCKDAPGSCERSVCDCDRVAANCFAGAPYNNDNFFISFKENCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the red-headed krait (Bungarus flaviceps). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for anionic phospholipid substrates. The structural scaffold should feature the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the sequence YGCXCG. Include the essential catalytic network with a histidine-aspartate dyad (typically H48 and D49 numbering) and the conserved active site residues. The sequence should contain 12-14 conserved cysteine residues forming 6-7 disulfide bridges that stabilize the compact globular structure, with the characteristic pattern including the C11-C77, C27-C126, and C44-C105 disulfide pairs. The protein should have an acidic pI due to an abundance of aspartate and glutamate residues, which may enhance its membrane penetration and neurotoxic potency. The mature toxin should be approximately 120-140 amino acids in length and exhibit the characteristic interfacial activation mechanism when interacting with lipid membranes."}
{"description": "sp|A0A2Z5Z9H5|ACT2_CRIJA Deep sea actinoporin Cjtox II OS=Cribrinopsis japonica OX=1799150 PE=2 SV=1", "sequence": "MNRLIIVCLVAAMIYSTIALPMKEDISNDERPISVNEEPVKKNAAVAGAVIQGATLTFQVLDRILTVLGDISRKIAIGVDNESGRKWTAKNAYFFSGTSDVVLPYSVPNGKAFLYDGKKTRGPVATGAVGVLAYSMSDGNTLGILFSVPYDYNWYENWWNIKVYSGSKRANKWMYENLYYNASPHKGDNGWHEKSLGYGLKSRGYMASSGQTKLEIRVTRA", "prompt": "Design a novel deep sea actinoporin protein sequence inspired by Cribrinopsis japonica (a sea anemone species) that functions as a potent cytolytic toxin. The protein should adopt the characteristic actinoporin structural fold, featuring a stable beta-sandwich core domain that facilitates membrane binding and insertion. Incorporate a conserved phosphocholine-binding site to enable specific recognition of sphingomyelin-rich lipid membranes, which is essential for its pore-forming activity. The sequence must include the defining actinoporin N-terminal amphipathic alpha-helix (approximately 20 residues) that transitions upon membrane contact to form the transmembrane pore lumen, disrupting cellular integrity through osmotic lysis. Ensure the presence of key catalytic residues involved in membrane penetration and oligomerization to form stable, cation-selective pores. The structural scaffold should maintain the overall compact, globular fold typical of actinoporins, with strategic placement of hydrophobic and aromatic residues to mediate lipid bilayer interactions. This cytolysin should exhibit high specificity for eukaryotic cell membranes as part of the sea anemone's venom arsenal for prey immobilization and defense."}
{"description": "sp|Q9XZL3|O16O6_CONTE Omega-conotoxin-like TxO6 OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MKLTCVVIVAVLFLTAWTLVMADDSNNGLANLFSKSRDEMEDPEAAKLEKNYCQEKWDYCPVPFLGSRYCCDGLFCTLFFCA", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications: This protein is an omega-conotoxin-like peptide derived from the venom of the marine cone snail Conus textile. As a component of this predatory gastropod's venom arsenal, it functions to immobilize prey through targeted modulation of neuronal signaling. The toxin is expected to act as a selective antagonist of voltage-gated calcium channels, specifically targeting Cav2 subtypes involved in neurotransmitter release at presynaptic terminals. This mechanism induces synaptic blockade and paralysis. Structurally, it belongs to the conotoxin superfamily and should adopt the inhibitor cystine knot (ICK) motif, characterized by a compact, disulfide-stabilized globular fold. The cysteine framework is inferred to be C-C-CC-C-C (Framework VI), forming three disulfide bridges that confer exceptional stability and define the pharmacophore. Key structural elements include beta-hairpins and loops that present critical residues for target engagement. The binding interface likely involves specific extracellular loops of the calcium channel alpha1 subunit, with conserved hydrophobic and polar residues mediating high-affinity interactions. The sequence should reflect these functional and structural constraints, encoding a mature peptide of approximately 25-35 amino acids with the characteristic cysteine pattern and predicted isoelectric point conducive to venom solubility. Ensure the design captures the evolutionary refinement of cone snail toxins for precise ion channel modulation."}
{"description": "sp|Q3SAF6|VNPA_PSETE Natriuretic peptide PtNP-a (Fragment) OS=Pseudonaja textilis OX=8673 PE=2 SV=1", "sequence": "SGSKIGNGCFGLPLDRISNTSGMGCRNPIQNRPKSTPGGS", "prompt": "Design a natriuretic peptide toxin derived from the venom of Pseudonaja textilis (eastern brown snake), a highly potent elapid snake whose venom components target cardiovascular regulation. This toxin functions as a natriuretic peptide, mimicking endogenous natriuretic peptides to induce vasodilation, promote diuresis and natriuresis, and lower blood pressure by binding to and activating natriuretic peptide receptors (NPR-A and NPR-B) in vascular smooth muscle and renal tissues. The peptide should adopt the characteristic natriuretic peptide fold, featuring a conserved 17-residue disulfide-bonded ring structure formed by two cysteine residues in a C-C pattern, which stabilizes the core functional domain required for receptor interaction. The structure should include an N-terminal tail and a C-terminal extension, with the disulfide-constrained central loop presenting key residues for receptor binding and activation, particularly those involved in engaging the receptor's extracellular domain. The sequence must reflect the typical physicochemical properties of natriuretic peptide toxins, including amphipathic regions and residues critical for receptor specificity and potency, to ensure biological activity as a cardiovascular toxin that disrupts blood pressure homeostasis through natriuretic peptide receptor agonism."}
{"description": "sp|P0C195|CM3A_CONKI Mu-conotoxin KIIIB (Fragment) OS=Conus kinoshitai OX=376876 PE=2 SV=2", "sequence": "KRNGCCNCSSKWCRDHSRCCGR", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the marine cone snail Conus kinoshitai. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis. The protein must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, globular fold stabilized by a conserved disulfide bonding pattern with cysteine framework III (C-C-CC-C-C), forming three intramolecular disulfide bridges that create a stable inhibitory cystine knot (ICK) motif. Key structural elements should include a well-defined beta-hairpin region responsible for channel pore blockade, surface-exposed loops that mediate specific interactions with the domain II S3-S4 extracellular loop of Nav1.4, and conserved hydrophobic residues that facilitate membrane partitioning. The sequence must maintain the canonical mu-conotoxin pharmacophore while incorporating unique residues that confer the distinctive potency and selectivity profile characteristic of Conus kinoshitai venom components. The final protein should exhibit high affinity binding to the voltage-sensor domain of Nav1.4, effectively inhibiting sodium ion flux and causing flaccid paralysis through presynaptic neuromuscular junction blockade."}
{"description": "sp|A7X3Z0|LECM_THRJA C-type lectin lectoxin-Thr1 OS=Thrasops jacksonii OX=186611 PE=2 SV=1", "sequence": "MGRFIFATLGLLLVAFSINGAKGCCCPHDWLTLKGFCYKVFNEHKTWNDAEMFCRKYKPGCHLASIHSGEESTDLAEYVSDYLKSGGNVWIGLNDPQKKRSWQWTDRSQNNFYPWKQGEPNNRANNENCVELWSPLGYKNWNDESCASTRAYLCKCRF", "prompt": "Design a novel C-type lectin toxin protein inspired by the venom composition of Thrasops jacksonii, a rear-fanged colubrid snake. This protein should function as a potent anticoagulant by specifically targeting and inhibiting key coagulation factors in the mammalian hemostatic system. The protein must adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with the canonical C1-C4, C2-C3 connectivity pattern. The structural scaffold should display the typical β-sandwich architecture composed of two antiparallel β-sheets, with calcium-binding capabilities essential for functional activity. Incorporate key structural motifs including the conserved carbohydrate recognition domain (CRD) with its signature long-loop region responsible for target specificity. The protein should exhibit high-affinity binding to coagulation factors such as factor X or IX through surface-exposed loops that mediate protein-protein interactions rather than carbohydrate binding. Include conserved hydrophobic core residues that maintain structural integrity while allowing for functional diversification in the target-binding interface. The final sequence should demonstrate venom-optimized stability and target specificity characteristic of snake venom C-type lectins involved in prey immobilization through disruption of blood coagulation pathways."}
{"description": "sp|G1AS79|O26D_CONVC Conotoxin Vc6.13 OS=Conus victoriae OX=319920 PE=2 SV=1", "sequence": "MEKLTILLLVAAVLMSIQALNQEQHQRAKINLLSKRKAPAERWWRWGGCLLWFGRCTKDSECCSDSCDRTYCELARFPEGW", "prompt": "Generate a protein sequence for a conotoxin from the marine cone snail Conus victoriae, specifically the O26D conotoxin family member Vc6.13. This toxin should function as a potent neurotoxin targeting ion channels in the prey's nervous system, consistent with the hunting strategy of Conus victoriae. The protein should adopt the characteristic conotoxin structural framework with multiple disulfide bridges that stabilize a compact, globular fold. Based on the O26D classification, the toxin likely contains a specific cysteine framework pattern that dictates its three-dimensional structure and target specificity. The mature toxin should be relatively small (typically 10-30 amino acids) and exhibit high affinity for its molecular target, which is likely voltage-gated or ligand-gated ion channels involved in neuromuscular transmission. The sequence should include conserved cysteine residues in the appropriate spacing to form the correct disulfide connectivity, creating a stable scaffold that presents key functional residues for target recognition and binding. The toxin should demonstrate high potency and selectivity, reflecting the evolutionary optimization of cone snail venoms for rapid prey immobilization."}
{"description": "sp|A0A0B5A7M7|INS1_CONIM Con-Ins Im1 OS=Conus imperialis OX=35631 PE=2 SV=1", "sequence": "MATSLLSPLLVAMLGFLLHVHVARAGLEHTCTLETRMQGAHPQGICGSKLPDIVHTVCQVMGRGYAGGQRQLRKRTSMIDSDDMEAEGGSRGGFLMSKRRALSYLQKETNPLVMAGYERRGIQKRHGEQGITCECCYNHCSFRELVQYCN", "prompt": "Design a novel insulin-like toxin sequence derived from the venom of the marine cone snail Conus imperialis. This toxin should mimic the structural and functional characteristics of Con-Ins Im1, which represents a unique evolutionary adaptation where insulin-like peptides have been repurposed for predatory purposes. The protein should adopt the canonical insulin fold, characterized by two polypeptide chains (A and B) stabilized by three conserved disulfide bridges with the connectivity pattern: A6-A11, A7-B7, and A20-B19. The A-chain should form two α-helices connected by an extended region, while the B-chain should contain a central α-helix. As a venom insulin, this toxin should function as a potent agonist of the vertebrate insulin receptor, but with key modifications that enhance its stability and potency in the venom context. The mechanism involves binding to the insulin receptor with high affinity, potentially inducing hypoglycemic shock in prey by dramatically lowering blood glucose levels. The sequence should maintain the essential residues for receptor binding while incorporating venom-specific adaptations that may include altered receptor binding kinetics or enhanced proteolytic stability. The structural scaffold should ensure proper folding into the compact, globular insulin tertiary structure that facilitates efficient receptor engagement and rapid physiological effects in target organisms."}
{"description": "sp|Q7YZS9|CI2_CONVR Kappa-conotoxin ViTx OS=Conus virgo OX=89427 GN=VITX PE=1 SV=1", "sequence": "MMFRLTSVSCFLLVIACLNLFQVVLTSRCFPPGIYCTPYLPCCWGICCGTCRNVCHLRIGKRATFQE", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of kappa-conotoxin ViTx from the marine cone snail Conus virgo. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and synaptic transmission. The peptide should adopt the characteristic conotoxin fold stabilized by a conserved disulfide bond framework, likely following the O-superfamily cysteine pattern with appropriate spacing between cysteine residues to form the correct disulfide connectivity. The structural scaffold should facilitate high-affinity binding to the pore region or voltage-sensing domain of Kv channels, leading to channel inhibition and subsequent modulation of action potential duration and neurotransmitter release. Incorporate key functional residues that confer target specificity while maintaining the compact, stable tertiary structure typical of conotoxins, ensuring the peptide exhibits potent neurotoxic activity relevant to the venom's role in prey immobilization."}
{"description": "sp|Q3YAU5|PA2_CHEFU Phospholipase A2 large subunit (Fragment) OS=Chersonesometrus fulvipes OX=141248 PE=2 SV=1", "sequence": "TMWGTKWCGSGNKAINYTDLGYFSNLDSCCRTHDHCDNIAAGETKYGLTNEGKYTMMNCKCEATFQQCLRDVHGPLEGKAAFTIRKLYFGLYGNGCFNVQCPS", "prompt": "Design a protein sequence for a phospholipase A2 toxin from the venom of the scorpion Cheironesometrus fulvipes. This enzyme should function as a potent neurotoxin and myotoxin, exerting its toxic effects through hydrolysis of membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) required for calcium-dependent enzymatic activity. The sequence should contain the conserved calcium-binding loop (YGKYCG) and the interfacial binding surface that enables membrane penetration and substrate recognition. As a scorpion venom component, this phospholipase A2 should exhibit both presynaptic neurotoxic activity through disruption of neurotransmitter release at neuromuscular junctions and direct myotoxic effects on skeletal muscle tissue. The structural scaffold should maintain the compact, stable globular architecture typical of group III phospholipase A2 enzymes from scorpion venoms, with appropriate hydrophobic residues for membrane interaction and conserved motifs for substrate specificity."}
{"description": "sp|Q9PRQ2|3SX1_MICNI Nicotinic acetylcholine receptor-binding protein Mnn-1A (Fragment) OS=Micrurus nigrocinctus OX=8635 PE=1 SV=2", "sequence": "SKCRIGKDGFYSVTCTEKENLCFTQF", "prompt": "Design a protein sequence for a nicotinic acetylcholine receptor-binding neurotoxin derived from the venom of Micrurus nigrocinctus, the Central American coral snake. This toxin functions as a potent postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis by blocking neurotransmission. The protein should adopt the characteristic three-finger toxin fold common to elapid snake neurotoxins, featuring three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework. The molecular target is the muscle-type nicotinic acetylcholine receptor, with specific binding interactions occurring at the receptor's agonist-binding site between alpha and delta/epsilon subunits. Key structural elements should include the central loop II, which typically contains critical residues for receptor recognition and binding affinity. The toxin should exhibit high specificity for neuromuscular junction receptors over neuronal subtypes, reflecting its role in the coral snake's predatory venom strategy for immobilizing prey through rapid neuromuscular blockade."}
{"description": "sp|Q9PRI1|3SOC7_MICCO Alpha-neurotoxin homolog 7 OS=Micrurus corallinus OX=54390 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGYTIVCYKRHASDSQTTTCLSGICYKKITRGSSRPEMGCGCPQSSRGVKVDCCMRDKCNG", "prompt": "Design a novel alpha-neurotoxin protein sequence inspired by coral snake venom toxins, specifically from the species Micrurus corallinus. This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to elapid snake neurotoxins, featuring three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C. The molecular target should be muscle-type nicotinic acetylcholine receptors, with specific binding affinity for the alpha-delta and alpha-gamma subunit interfaces. The structural scaffold should include the conserved hydrophobic core, the central loop responsible for receptor binding, and the characteristic three-finger morphology that enables precise interaction with the acetylcholine binding site. The toxin should exhibit high specificity for neuromuscular junctions over neuronal nicotinic receptors, with the molecular mechanism involving competitive inhibition of acetylcholine binding through key conserved residues in the central loop region. The protein should maintain the thermostability and protease resistance typical of three-finger toxins, with appropriate surface charge distribution for membrane interaction and receptor targeting."}
{"description": "sp|E5AJX2|VSP_VIPNI Snake venom serine protease nikobin OS=Vipera nikolskii OX=1808362 GN=sp-VN PE=2 SV=1", "sequence": "MVLIRVLANLLLLQLSYAQKSSELVIGGDECNINEHPFLAFVTSDRRRCAGTLINQEWVLTAAHCNGKYMKIELGVHDKMVRNEDKQTRVPKQKFFCLSSKEYTMWDKDIMLIRLNTPVNNSTHIAPVSLASRPPVVGSVCRIMGWGTISSPKVILPDVPHCANIEIIKYSKCQGVHPELPAKGRVVCAGIWQGGKDSCHGDSGAPLICNGQLQGLLSWGGDPCAQPLQPGLYTDIFDYSDWIQSIIAGNTTATCPP", "prompt": "Design a snake venom serine protease protein from the Nikolsky's viper (Vipera nikolskii) that functions as a potent hemostatic toxin. This enzyme should exhibit the characteristic trypsin-like serine protease activity found in viperid venoms, specifically targeting key components of the vertebrate coagulation cascade. The protein should adopt the canonical chymotrypsin-like fold with the conserved catalytic triad of histidine, aspartate, and serine residues arranged in the proper spatial configuration for efficient substrate hydrolysis. Include the characteristic disulfide bond pattern that stabilizes the two-domain structure, with the N-terminal domain containing the activation peptide cleavage site and the C-terminal domain housing the active site. The enzyme should demonstrate substrate specificity for fibrinogen and other plasma coagulation factors, leading to either procoagulant or anticoagulant effects through precise cleavage of specific peptide bonds. The structural scaffold should feature the characteristic β-barrel domains connected by surface loops that determine substrate specificity, with appropriate surface charge distribution for interaction with physiological substrates in the bloodstream. The mature enzyme should be generated through proteolytic activation from a zymogen precursor form."}
{"description": "sp|P0C1W3|CSA8A_CONRA Alpha-conotoxin RVIIIA OS=Conus radiatus OX=61198 PE=1 SV=2", "sequence": "MMSKMGAMFVLLLLFTLASSQQEGDVQARKTHPKREFQRILLRSGRKCNFDKCKGTGVYNCGESCSCEGLHSCRCTYNIGSMKSGCACICTYY", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of Conus radiatus, a marine cone snail species. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha3beta2 subtype with high affinity. The protein should adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the conserved CC-C-C framework typical of alpha-conotoxins. The mature peptide should contain 16-18 amino acids with the characteristic spacing between cysteine residues that defines the alpha-conotoxin family. The structural core should display the conserved alpha-helical region and beta-turn motifs that facilitate precise receptor binding. The molecular mechanism should involve competitive inhibition at the orthosteric binding site of the nicotinic acetylcholine receptor, preventing acetylcholine-mediated ion channel opening and neuronal signaling. The toxin should exhibit the typical pharmacological profile of alpha-conotoxins from Conus radiatus, displaying high selectivity for neuronal over muscle-type nicotinic receptors. The sequence should maintain the essential pharmacophore residues required for receptor recognition while incorporating the unique sequence features characteristic of the Conus radiatus venom arsenal."}
{"description": "sp|C9E1R9|VM2V2_CROVV Zinc metalloproteinase/disintegrin VMP-II OS=Crotalus viridis viridis OX=8742 PE=2 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGELYLIEPLKFPDSEAHAVFKYENVEKEDNAPKMCGVTQNWKSYEPIKKASQLNLTPEQQRFPQRYIELVIVADHRMFTKYNSNLNTIRIWVHEIVNTINVFYRSLHIVVSLTDLEIWSNQDQINVQSAAADTLEAFGEWRETVLLNRISHDNAQLLTAINFQGNIIGRAYTGSMCDPRKSVGIITDHSAINLWVAVTMAHELAHNLGISHDGNQCHCDANSCIMSEELSEELSFEFSDCSLNQYQTYLTDHNPQCMLNEPLGTDTVSRNELLEAGEECDCGSPANPCCDAATCKLRPGAQCAEGLCCDQCRFIKKGKICRRARGDNPDDRCTGQSADCPRNRFHA", "prompt": "Design a venom zinc metalloproteinase/disintegrin protein from the Western Diamondback Rattlesnake (Crotalus viridis viridis) that functions as a key hemorrhagic toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, which enables proteolytic cleavage of basement membrane components like type IV collagen and laminin. The disintegrin domain should adopt the typical cysteine-rich fold with the RGD (Arg-Gly-Asp) or related integrin-binding motif that inhibits platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors. The overall structure should facilitate hemorrhagic activity through synergistic action: the metalloproteinase domain degrades capillary basement membranes and extracellular matrix proteins, while the disintegrin domain prevents platelet aggregation and clot formation, leading to uncontrolled bleeding. The protein should exhibit the characteristic disulfide bonding pattern that stabilizes both domains, with the metalloproteinase domain containing the reprolysin-family cysteine framework and the disintegrin domain displaying the short-chain disintegrin cysteine pattern. This P-II class SVMP represents a critical venom component that disrupts hemostasis through dual mechanisms of proteolytic tissue damage and anti-platelet activity."}
{"description": "sp|B2BRQ5|3L21_AUSLA Alpha-elapitoxin-Al2b OS=Austrelaps labialis OX=471292 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGGGLICYMGPKTPRTCPPGQNLCYTKTWCDGFCGSRGKVVVLGCAATCPTVKPGVDITCCATDKCNPFPKTKAPWERP", "prompt": "Design a novel alpha-elapitoxin protein sequence that mimics the potent neurotoxic activity found in the venom of the Australian pygmy copperhead snake (Austrelaps labialis). This toxin should function as a postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to elapid snake venoms, featuring three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework. The structural scaffold should include the conserved three-finger motif with the central loop containing key functional residues for receptor binding specificity. The toxin should exhibit high affinity binding to the alpha-delta interface of the nicotinic acetylcholine receptor, with conserved cationic residues in loop II mediating target recognition. The sequence should maintain the compact globular structure typical of short-chain neurotoxins, approximately 60-70 amino acids in length, with appropriate hydrophobic core packing and surface-exposed functional loops that enable specific receptor interaction while maintaining structural stability in the venom environment."}
{"description": "sp|B2KTG1|VKT_BUNFA Kunitz-type serine protease inhibitor bungaruskunin OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWTELTPVSSLGGPAYCKLPPEPGPCHEYKHAFYYNPDARECEEFIYGGCKGNKNNFKTRHECHRVCVR", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin from the venom of the banded krait (Bungarus fasciatus). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding loop that inserts into the protease's active site. The protein must adopt the characteristic Kunitz domain fold, featuring a conserved alpha-beta structure with a twisted anti-parallel beta-sheet and several alpha-helices. Include the essential disulfide bond pattern typical of Kunitz inhibitors, specifically the Cys1-Cys6 and Cys2-Cys4 connectivity that stabilizes the core scaffold. The sequence should contain the conserved reactive site loop with appropriate P1 residue specificity for serine protease inhibition, maintaining the structural integrity required for high-affinity binding and inhibition. This toxin contributes to the banded krait's venom arsenal by interfering with prey coagulation cascades and other serine protease-dependent physiological processes."}
{"description": "sp|Q9Y0X4|NDB22_OLIMR Bradykinin-potentiating peptide BmKbpp OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MNKKTLLVIFFVTMLIVDEVNSFRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAERRR", "prompt": "Design a bradykinin-potentiating peptide from the venom of Olivierus martensii (Chinese scorpion). This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and promoting vasodilation. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of scorpion venom peptides. It should contain the conserved cysteine framework typical of bradykinin-potentiating peptides, with specific disulfide connectivity that confers structural stability and biological activity. The sequence should include key residues involved in ACE inhibition, particularly those that interact with the enzyme's active site to block its catalytic function. The overall fold should be small and globular, optimized for high potency and selectivity in modulating the renin-angiotensin system, contributing to the venom's role in prey immobilization through cardiovascular effects."}
{"description": "sp|P0DQZ7|MAST5_VESTR Mastoparan-VT5 OS=Vespa tropica OX=7450 PE=3 SV=1", "sequence": "MKNTILILFTAFIALLGFFGMIAEPLADPLADPLPDADPDADPETVIVKAIATLSKKLLR", "prompt": "Design a mastoparan peptide sequence derived from the venom of the greater banded hornet, Vespa tropica. This peptide should function as a potent cytolytic and hemolytic agent, characteristic of mastoparan toxins. The sequence must adopt an amphipathic alpha-helical conformation in membrane environments, facilitating its primary mechanism of action: disruption of lipid bilayers through pore formation and membrane permeabilization. The peptide should exhibit cationic properties with a net positive charge, enabling electrostatic interactions with anionic phospholipid head groups. It should demonstrate G-protein activating properties through direct interaction with heterotrimeric G proteins, mimicking receptor-mediated activation. The structural scaffold should be optimized for membrane insertion, with hydrophobic residues positioned to interact with lipid acyl chains and hydrophilic/charged residues oriented toward solvent or membrane interfaces. The peptide should show broad-spectrum activity against various cell types, including erythrocytes, mast cells, and bacterial membranes, while maintaining the characteristic 14-amino acid length typical of mastoparan family peptides. Ensure the sequence reflects the evolutionary optimization for rapid membrane disruption and cell lysis that provides the hornet with effective prey immobilization and defense capabilities."}
{"description": "sp|B8XH45|KA23L_BUTIS Potassium channel toxin alpha-KTx Tx773 OS=Buthus israelis OX=2899555 PE=2 SV=1", "sequence": "MQKLFIVLLLFCILRLDAEVDGRRATFCKQPGCQEACKKENKNGRCVDKFDNNFSYNICRCY", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from Buthus israelis scorpion venom. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.x family channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of a short alpha-helix packed against an anti-parallel beta-sheet, creating a functional surface with key residues for potassium channel pore blockade. Include the conserved functional dyad comprising a critical lysine residue positioned to insert into the potassium channel selectivity filter and an aromatic residue that stabilizes binding through hydrophobic interactions. The sequence should maintain the characteristic molecular weight of 3-5 kDa and exhibit the typical basic pI that facilitates interaction with the negatively charged extracellular domains of potassium channels. The toxin should demonstrate high affinity binding to the channel vestibule, effectively occluding the ion conduction pathway and causing prolonged channel inhibition that underlies its paralytic and neurotoxic effects in prey envenomation."}
{"description": "sp|P61789|TX5A_HETVE Omega-sparatoxin-Hv1a OS=Heteropoda venatoria OX=152925 PE=1 SV=1", "sequence": "DDDCGWIMDDCTSDSDCCPNWVCSKTGFVKNICKYEM", "prompt": "Design a protein sequence for an insecticidal neurotoxin from the huntsman spider Heteropoda venatoria. This toxin belongs to the omega-sparatoxin family and specifically targets insect voltage-gated calcium channels. The protein should function as a potent calcium channel blocker that disrupts synaptic transmission in the insect nervous system, leading to rapid paralysis and death. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif with a conserved disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) that creates a stable, compact triple-stranded beta-sheet fold. The sequence must include key residues for binding to the voltage-sensing domain of insect Cav channels, particularly those involved in stabilizing the toxin-channel interaction through electrostatic and hydrophobic contacts. The overall structure should be highly stable and resistant to proteolytic degradation, typical of spider venom peptides that require persistence in the prey's system. The molecular mechanism involves inhibition of calcium influx at nerve terminals, preventing neurotransmitter release and causing neuromuscular blockade."}
{"description": "sp|P0DRA5|MASTA_POLDR Mastoparan PDD-A OS=Polistes dorsalis OX=34729 PE=1 SV=1", "sequence": "INWKKIFEKVKNLV", "prompt": "Design a mastoparan peptide sequence from the venom of the paper wasp Polistes dorsalis. This peptide should adopt an amphipathic alpha-helical conformation in membrane environments, characteristic of mastoparan toxins. The sequence must exhibit potent hemolytic activity and mast cell degranulation properties through a non-receptor-mediated mechanism involving direct interaction with and perturbation of lipid bilayers. The peptide should preferentially bind to and disrupt anionic phospholipid membranes, leading to pore formation and cell lysis. Incorporate the conserved mastoparan structural motif of a cationic, hydrophobic face that facilitates membrane insertion and disruption. The sequence should be 14-16 amino acids in length with a net positive charge, containing hydrophobic residues that promote alpha-helix formation and membrane penetration, along with basic residues that mediate initial electrostatic interactions with negatively charged membrane surfaces. The structural scaffold should enable the peptide to transition from unstructured in aqueous solution to helical upon membrane binding, creating the amphipathic character essential for its cytolytic activity."}
{"description": "sp|P0C1Q4|MASTI_POLPI Polybia-mastoparan-I OS=Polybia paulista OX=291283 PE=1 SV=1", "sequence": "IDWKKLLDAAKQIL", "prompt": "Design a mastoparan peptide from the venom of the social wasp Polybia paulista that functions as a potent cytolytic and neurotoxic agent. This amphipathic alpha-helical peptide should be approximately 14 amino acids in length and exhibit strong membrane-disrupting activity through direct interaction with lipid bilayers. The peptide should adopt a characteristic mastoparan fold with a well-defined amphipathic helix structure that enables insertion into cell membranes, leading to pore formation and membrane destabilization. It should demonstrate calcium-independent mast cell degranulation activity and act as a G-protein activator, stimulating phospholipase A2 and phospholipase C pathways. The sequence should contain a high proportion of hydrophobic residues to facilitate membrane interaction, along with basic residues that contribute to its cationic nature and interaction with anionic membrane components. The peptide should exhibit broad-spectrum biological activities including hemolytic effects, antimicrobial properties against both Gram-positive and Gram-negative bacteria, and potential neurotoxic effects through modulation of ion channels and neurotransmitter release."}
{"description": "sp|P49121|PA2H1_AGKCL Basic phospholipase A2 homolog MT1 OS=Agkistrodon contortrix laticinctus OX=2782196 PE=1 SV=1", "sequence": "MRTLWIVALLLVGVEGSLLELGKMILQETGKNAITSYGSYGCNCGWGHRGQPKDATDRCCFVHKCCYKKLTDCNHKTDRYSYSWKNKAIICEEKNPCLKEMCECDKAVAICLRENLDTYNKKYKAYFKFKCKKPETC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the broad-banded copperhead snake (Agkistrodon contortrix laticinctus). This protein belongs to the phospholipase A2 family but functions as a homolog, meaning it retains the structural scaffold of phospholipase A2 enzymes while exhibiting modified or alternative biological activities distinct from canonical phospholipase A2 catalytic function. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved three-finger structural motif with multiple alpha-helices stabilized by a network of disulfide bridges. The anticipated disulfide connectivity pattern follows the typical phospholipase A2 framework with conserved cysteine residues forming 5-7 disulfide bonds that maintain the protein's structural integrity and stability. As a basic isoform, the protein should exhibit an overall positive charge at physiological pH. The biological significance of this toxin lies in its role within the venom arsenal, where it may function as a presynaptic neurotoxin, myotoxin, or exhibit other pathophysiological activities such as inducing membrane damage, edema, or anticoagulant effects. The mechanism of action likely involves specific binding to molecular targets such as neuromuscular junctions, muscle membranes, or coagulation factors, potentially through non-enzymatic interactions that disrupt normal physiological processes. The protein should maintain key structural elements including the calcium-binding loop, interfacial binding surface, and conserved active site residues, even if catalytic activity is diminished or absent in this homolog variant."}
{"description": "sp|A0A0B5A7N8|INS1_CONTE Con-Ins Tx1 OS=Conus textile OX=6494 PE=2 SV=1", "sequence": "MTTSSYFLLVALGLLLYVFQSSFGGEHVCWLGDPNHPQGICGPQVADIVEIRCEEKEAEQGGANNARANTGRTSSLMKRRGFLSLLKKRGKRDEGSPLQRSGRGIVCECCKHHCTKEEFTEYCH", "prompt": "Design a novel animal toxin protein sequence inspired by the venom of the textile cone snail (Conus textile), specifically emulating the biological characteristics of Con-Ins Tx1. This toxin should function as an insulinotropic agent, modulating insulin secretion through targeted interaction with insulin receptors or related signaling pathways in prey organisms. The protein should adopt a compact, disulfide-rich structural scaffold typical of conotoxins, featuring a conserved cysteine framework that enables proper folding and stability. Infer the disulfide connectivity pattern based on conotoxin conventions, likely forming multiple intramolecular bridges that constrain the peptide into a stable three-dimensional conformation, potentially resembling the inhibitor cystine knot (ICK) motif common in cone snail venoms. The molecular mechanism should involve high-affinity binding to specific extracellular domains of insulin pathway components, potentially acting as an insulin receptor agonist or modulator to disrupt glucose homeostasis in target organisms. The structural design must ensure precise molecular recognition while maintaining the thermostability and protease resistance characteristic of conotoxin scaffolds, with surface loops and key residues optimized for target engagement and biological activity."}
{"description": "sp|Q9YGI4|3NO22_NAJAT Probable weak neurotoxin NNAM2 OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQICRNGEKICFKKLHQRRPFSLRYIRGCAATCPETKPRDMVECCSTDRCNR", "prompt": "Design a protein sequence for a probable weak neurotoxin from the Chinese cobra (Naja atra), a member of the three-finger toxin (3FTx) superfamily. This toxin should exhibit weak neurotoxic activity characteristic of non-conventional neurotoxins in elapid snake venoms. The protein should adopt the conserved three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C-C-C-C-C-C-C-C. The structural scaffold should feature the typical globular shape with the three loops forming finger-like projections that mediate target recognition. As a weak neurotoxin, this protein likely functions as a postsynaptic neurotoxin with reduced affinity for nicotinic acetylcholine receptors compared to potent α-neurotoxins, potentially exhibiting broader specificity or weaker binding kinetics. The molecular mechanism involves competitive or allosteric inhibition of neurotransmitter receptors at the neuromuscular junction, leading to reversible neuromuscular blockade. The sequence should maintain the conserved hydrophobic core and structural determinants essential for the three-finger fold while incorporating specific loop variations that confer the weak neurotoxic phenotype observed in Naja atra venom components."}
{"description": "sp|Q5VJG2|KUNI_AMBHE Amblin OS=Amblyomma hebraeum OX=34608 PE=1 SV=1", "sequence": "MGFLVASAVLVCVTSQRVPGYCKKKPAVGPCKALIEKWYFDYSTQSCKTFYYGGCGGNGNKFSSRKKCREACLPKRPSVPVCKQMPDPGFCRAYMPHWFFNSKSGYCEGFVYGGCQGNDNRFKSCWQCMKKCRTAREANRLCWKLTKEFNKKFLRNVPTAKPLPPK", "prompt": "Design a protein sequence for a serine protease inhibitor toxin derived from the hard tick Amblyomma hebraeum. This protein should function as a Kunitz-type protease inhibitor, specifically targeting and inhibiting key serine proteases in the host's coagulation cascade and inflammatory response pathways. The sequence must contain the characteristic Kunitz domain fold with a conserved beta-trefoil structure consisting of anti-parallel beta-sheets stabilized by three conserved disulfide bonds in the C1-C6, C2-C4, C3-C5 connectivity pattern. The protein should feature the canonical protease-binding loop with the P1 residue positioned for optimal interaction with the target protease's active site, typically exhibiting specificity for trypsin-like or chymotrypsin-like enzymes. The structural scaffold should maintain the compact, globular fold typical of Kunitz domains, approximately 50-60 amino acids in length, with the reactive site loop adopting a canonical conformation that fits into the protease's active site cleft. This toxin plays a crucial role in the tick's feeding strategy by modulating host hemostasis and inflammation, allowing for prolonged blood meal acquisition. The sequence should reflect evolutionary conservation of the Kunitz fold while incorporating tick-specific adaptations for enhanced stability and target specificity in the hematophagous arthropod venom context."}
{"description": "sp|Q3ZD74|VM1L4_MACLB Snake venom metalloproteinase lebetase-4 (Fragment) OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "SCRKKASQLNLTPEQQRFDPRYIELVIVADHSMVTKYDGDLAAIRTWAHQLVNNIIVFYRDLNVHITLSAVEVWTNGDLINVQPAASVTLNLFGEWRERDLLNRRMHDHAQLLTAINLDDNTIGLAYNEGMCDPKYSVGIVQDHSAINRMVAATMAHEIGHNLGMDHDGNQCNCGANGCVMSAVITQQRSYQFSDCSKNKYQTYLTNHNPQCILNQP", "prompt": "Design a snake venom metalloproteinase protein sequence that functions as a potent hemorrhagic toxin, characteristic of viperid venoms. This protein should belong to the reprolysin family of zinc-dependent metalloproteinases and exhibit specific proteolytic activity against key components of the basement membrane and extracellular matrix. The sequence must contain the canonical zinc-binding motif HEXXHXXGXXH and a conserved methionine turn. As a fragment, it should represent a functional domain capable of disrupting vascular integrity through cleavage of capillary basement membrane proteins such as type IV collagen, laminin, and fibronectin. The protein should adopt the characteristic metalloproteinase fold with a central twisted beta-sheet surrounded by alpha-helices, maintaining the catalytic domain architecture essential for zinc coordination and substrate recognition. The design should reflect the hemorrhagic potency typical of Macrovipera lebetinus venom components, targeting endothelial cell adhesion and vascular permeability through precise extracellular matrix degradation."}
{"description": "sp|P0DQN4|KA11N_SCOPC Potassium channel toxin Sp4 OS=Scorpiops pococki OX=2766750 PE=3 SV=1", "sequence": "MNKVHFALFLLVLTVLAVSGFPSENAPTGGCPLSDNVCSSYCKKNKFGNEGKCHGTICKCSIK", "prompt": "Design a potassium channel toxin protein derived from the venom of Scorpiops pococki, a scorpion species. This toxin functions as a potent modulator of voltage-gated potassium channels (Kv channels), specifically blocking or modifying channel gating to disrupt neuronal excitability and neuromuscular signaling, thereby inducing paralysis in prey. The protein should adopt a conserved scorpion toxin structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements include a compact, globular fold with an alpha-helix and anti-parallel beta-sheets, forming a molecular surface with a functional dyad (often involving a lysine and aromatic residue) that interacts with the channel's pore or voltage-sensing domain. The sequence must include conserved cysteine residues for disulfide bonding, along with residues critical for potassium channel recognition and binding affinity, ensuring high specificity and potency in ion channel blockade."}
{"description": "sp|Q7LZI6|SLB_PROTO Snaclec tokaracetin subunit beta (Fragment) OS=Protobothrops tokarensis OX=61225 PE=1 SV=1", "sequence": "DCPSDWSSYDEHCYRVFQQKMNWEDAEKFCTQQHKGXHLX", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This toxin should originate from the venom of Protobothrops tokarensis, a pit viper species where such lectins play crucial roles in prey immobilization through disruption of hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence must include key structural elements: a calcium-binding site with conserved acidic residues, hydrophobic core regions that maintain structural integrity, and surface-exposed loops responsible for specific protein-protein interactions. The molecular target should be platelet surface receptors, likely glycoprotein Ib or VI, with binding interfaces that competitively inhibit natural ligand interactions. The protein should exhibit heterodimeric assembly capability, forming functional complexes with alpha subunits through non-covalent interactions. Key functional residues should be positioned to mediate carbohydrate recognition domain-like interactions while maintaining the structural stability characteristic of venom C-type lectins."}
{"description": "sp|A0A0B5A7N1|INS2B_CONFO Con-Ins F2b OS=Conus floridulus OX=97180 PE=1 SV=1", "sequence": "MTTSSYFLLVALGLLLYVCRSSFGSEHTCESDASPHPQGVCGSPLAEAVEAACELEESLQGGTGKKRGRASLLRKRRAFLSMLKARAKRNEASPLQRSGRGIVCECCKNHCNLEELTEYCPPVTEGSG", "prompt": "Design a novel insulin-like peptide toxin derived from the venom of the marine cone snail Conus floridulus. This peptide should function as a conantokin-like insulin analog, potentially disrupting glucose homeostasis in prey organisms through competitive binding to insulin receptors. The protein should adopt a characteristic insulin-like fold consisting of two polypeptide chains (A and B chains) connected by disulfide bridges, with the canonical insulin disulfide pattern of three conserved disulfide bonds stabilizing the tertiary structure. The sequence should include the essential insulin family signature motifs while incorporating conotoxin-specific modifications that enhance receptor binding affinity and proteolytic stability. The peptide should exhibit high specificity for insulin receptor subtypes found in the cone snail's natural prey, potentially causing hypoglycemic shock through aberrant insulin signaling. The structural scaffold should maintain the insulin superfamily's conserved core while displaying venom-optimized surface residues that modulate receptor interaction kinetics and biological potency."}
{"description": "sp|P0C1D0|CA1A_CONRE Alpha-conotoxin RgIA (Fragment) OS=Conus regius OX=101314 PE=1 SV=1", "sequence": "SNKRKNAAMLDMIAQHAIRGCCSDPRCRYRCR", "prompt": "Design a protein sequence for an alpha-conotoxin from the marine cone snail Conus regius. This toxin functions as a potent and selective antagonist of the alpha9alpha10 nicotinic acetylcholine receptor subtype. The biological significance of this venom component lies in its role in the cone snail's predatory strategy, specifically targeting neuromuscular junctions to immobilize prey. The toxin operates through competitive inhibition at the orthosteric binding site of the receptor, preventing acetylcholine binding and subsequent ion channel activation. The structural scaffold should feature the characteristic alpha-conotoxin fold with a globular disulfide-stabilized architecture. The cysteine framework follows the CC-C-C pattern with two disulfide bridges connecting Cys1-Cys3 and Cys2-Cys4, forming a compact, stable structure. Key structural elements include a beta-hairpin motif and well-defined loops that contribute to receptor binding specificity. The molecular target interface involves specific interactions with the alpha9 and alpha10 subunits of the nicotinic receptor, with conserved residues in loop regions mediating high-affinity binding and subtype selectivity. The sequence should maintain the characteristic short length of alpha-conotoxins while incorporating residues known to confer specificity for the alpha9alpha10 receptor subtype."}
{"description": "sp|P0DRA7|MAST_MISPH Mastoparan MP OS=Mischocyttarus phthisicus OX=256666 PE=1 SV=1", "sequence": "INWLKLGKKMMSAL", "prompt": "Design a mastoparan peptide sequence from the social wasp Mischocyttarus phthisicus that functions as a potent cytolytic toxin. This amphipathic peptide should adopt an alpha-helical conformation in membrane environments, characteristic of mastoparan family peptides. The sequence must contain 14 amino acids with a high proportion of hydrophobic residues and basic amino acids (lysine and arginine) that facilitate membrane interaction. The peptide should exhibit mast cell degranulation activity through G-protein activation and demonstrate hemolytic properties via pore formation in lipid bilayers. The structural scaffold should enable membrane insertion and disruption, with the amphipathic helix positioning hydrophobic residues toward the membrane interior and cationic residues interacting with phospholipid head groups. The peptide should target various cell types through non-receptor-mediated membrane perturbation, making it a broad-spectrum cytolytic agent in wasp venom."}
{"description": "sp|A0A088MIT0|BRKP2_PHYNA Bradykinin-related peptides OS=Physalaemus nattereri OX=248869 GN=BBN PE=1 SV=1", "sequence": "MAFLKKSLFLVLFLGVVSLSFCEEEKREEHEEEKRDEEDAESLGKRYGGLSPLRISKRVPPGFTPFRSPARSISGLTPIRLSKRVPPGFTPFRSPARRISEADPGFTPSFVVIKGLSPLRGKRRPPGFSPFRVD", "prompt": "Design a bradykinin-related peptide toxin derived from the defensive skin secretion of the frog Physalaemus nattereri. This peptide should function as a potent inflammatory mediator and pain-inducing agent by acting as a bradykinin receptor agonist, specifically targeting B2 receptors on sensory neurons and vascular endothelial cells. The peptide should adopt a linear conformation without disulfide bridges, characteristic of bradykinin-like peptides, and contain conserved residues for receptor recognition and activation. Key structural features should include a C-terminal arginine residue critical for receptor binding, and potential N-terminal extensions or substitutions that enhance receptor affinity and proteolytic stability compared to endogenous bradykinin. The peptide should mediate plasma extravasation, vasodilation, and pain signaling through G-protein coupled receptor activation, contributing to the frog's chemical defense mechanism against predators."}
{"description": "sp|P0DSN5|HEMI2_HEMLE Phospholipase A2 hemilipin-2 (Fragment) OS=Hemiscorpius lepturus OX=520031 PE=1 SV=1", "sequence": "DSLSEDNWKFVVSSSCETILEILDIGGCAKGVAEYT", "prompt": "Design a phospholipase A2 toxin sequence derived from the venom of the scorpion Hemiscorpius lepturus, specifically representing the hemilipin-2 variant. This toxin should exhibit potent phospholipase A2 activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids, including arachidonic acid, which can initiate inflammatory cascades. The sequence should adopt the characteristic phospholipase A2 fold, featuring three major alpha-helices and a beta-wing region, stabilized by multiple disulfide bridges typical of scorpion phospholipase A2 toxins (likely 6-8 conserved cysteine residues forming 3-4 disulfide bonds). Include key catalytic residues such as a conserved histidine-aspartate dyad and a calcium-binding loop essential for enzymatic activity. The toxin should demonstrate membrane-targeting properties, with hydrophobic patches or interfacial binding surfaces that facilitate interaction with lipid bilayers. Consider hemilipin-2's role in the venom cocktail, where it likely contributes to tissue damage, hemolysis, and potentiation of other venom components through membrane disruption and signaling molecule generation. Ensure the sequence reflects scorpion toxin phylogenetic conservation while maintaining functional specificity for phospholipid substrates."}
{"description": "sp|E5L0E3|VSPAF_DABSI Alpha-fibrinogenase-like OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MVLIRVLANLLVLQLSYAQKSSELVVGGHPCNIYEHHFLAFMYNSSGFMCSGTLINQQWVLSAAHCDMENMHIYLGLHSFKLPNKDQKKRVAKEKFFCLSSKSYTKWDKDIMLIKLNKPVTYSTHIASLSLPSNPPRVGSVCRIMGWGSITSPKKILPFVPHCANINIVPYTVCRVIYRPLPEQSRTLCAGVSGRRIGSCLGDSGGPLICNGQIQGIVSWGSDPCVNRGAPSIYTKVFDYTDWIHSIIAGNTAATCPS", "prompt": "Design a snake venom metalloproteinase (SVMP) from the viper species Daboia siamensis that functions as an alpha-fibrinogenase. This toxin should specifically target and cleave the Aα-chain of fibrinogen, preventing fibrin clot formation and thereby acting as a potent anticoagulant in the venom's arsenal. The protein should adopt the characteristic SVMP fold, featuring a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates the catalytic zinc ion essential for proteolytic activity. Include the typical disulfide bond pattern that stabilizes the metalloproteinase domain, and ensure the presence of a methionine turn in the active site region. The protein should exhibit optimal activity at physiological pH and temperature, with structural elements that facilitate specific recognition and cleavage of fibrinogen over other plasma proteins. Consider the role of this toxin in the overall venom composition of Daboia siamensis, where it contributes to prey immobilization through hemorrhage and blood coagulation disruption."}
{"description": "sp|Q1L777|CA1A_CONPR Alpha-conotoxin PeIA (Fragment) OS=Conus pergrandis OX=330676 PE=3 SV=1", "sequence": "FDGRNAAANDKASDLVALTVRGCCSHPACSVNHPELCG", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of Conus pergrandis, a marine cone snail species. This toxin functions as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two disulfide bonds that form a compact, stable fold. The sequence should include conserved cysteine residues at positions that enable the formation of these critical disulfide bridges, creating a well-defined pharmacophore for receptor binding. The molecular mechanism involves competitive inhibition at the acetylcholine binding site of specific nicotinic receptor subtypes, leading to disruption of synaptic signaling. The structural core should feature a beta-hairpin or similar motif common to alpha-conotoxins, with surface loops that mediate high-affinity interaction with the receptor's ligand-binding domain. Incorporate residues that confer selectivity for neuronal over muscle-type nicotinic receptors, as typical of alpha-conotoxins from Conus species. The overall architecture should be a small, cysteine-rich peptide (approximately 12-20 residues) with the stability and folding properties characteristic of conotoxins that target neurotransmitter receptors."}
{"description": "sp|P18997|PA2B_GLOHA Basic phospholipase A2 (Fragment) OS=Gloydius halys OX=8714 PE=1 SV=1", "sequence": "NLLQFRKMIKKMTGKEVVWYAFYGCYCGGGGK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin derived from the venom of the pit viper Gloydius halys. This enzyme should function as a potent presynaptic neurotoxin and myotoxin, characteristic of snake venom phospholipases A2. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, inflammation, and neuromuscular blockade. The structural scaffold should feature the conserved phospholipase A2 fold, comprising three alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif YGCXCG. Include the essential catalytic dyad of histidine and aspartate residues within the active site. The sequence should contain the characteristic pattern of 6-8 conserved cysteine residues forming 3-4 disulfide bridges that stabilize the compact, globular structure. The basic nature of this toxin should be reflected in its isoelectric point, facilitating interactions with anionic membrane surfaces and potential receptor targets. The protein should demonstrate specificity for neuronal and muscle cell membranes, contributing to its paralytic and cytotoxic effects in prey envenomation."}
{"description": "sp|P61790|TX5B_HETVE Omega-sparatoxin-Hv1b OS=Heteropoda venatoria OX=152925 PE=1 SV=1", "sequence": "ADCGWLFHSCESNADCCENWACATTGRFRYLCKYQI", "prompt": "Design a venom-derived peptide toxin from the huntsman spider Heteropoda venatoria that functions as a potent insecticidal agent. This toxin belongs to the omega-sparatoxin family and specifically targets insect voltage-gated calcium channels. The protein should act as a calcium channel antagonist, binding with high affinity to insect Cav channels to disrupt neuromuscular transmission and induce paralysis in insect prey. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif, stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The peptide should adopt a compact, globular fold with a triple-stranded beta-sheet core stabilized by the disulfide knot, creating a stable molecular framework resistant to proteolytic degradation. Key functional residues should be positioned on surface-exposed loops to mediate specific interactions with insect calcium channel pore-forming subunits, potentially blocking ion conduction through allosteric inhibition or direct pore occlusion. The toxin should exhibit selectivity for insect over mammalian calcium channels, reflecting its evolutionary optimization for prey capture. The sequence should include the conserved cysteine framework typical of spider venom ICK peptides while incorporating specific pharmacophore residues responsible for target recognition and insecticidal activity."}
{"description": "sp|C9E1S0|VM3V3_AGKPL Zinc metalloproteinase-disintegrin-like VMP-III OS=Agkistrodon piscivorus leucostoma OX=459671 PE=2 SV=1", "sequence": "MIQVLLVTLCLAAFPYQGSSIILDSGNVNDYEVVYPRKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSIEDHCYYRGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQTNWKSDEPIKKASQLVVTPEEQRYLNTKKYIELVIVADNVMVKKYTSNSTAIRTRIYACVNTLNLIYRAFNIYIALIGLEIWSNRDLINVQSASSVTLDLFGTWRETVLLRHKRHDNAQLLTGINFDGDTVGLAYVGSMCDPKRSAGIIQDHNKLDVMVAIAMAHELGHDLGINHDGNQCNCGGNPCIMSATLNFEPVYRFSDCSRDEHWRYLIDNRPPCILNKPSITDIVSPPVCGNYFVEVGEECDCGLPAHCQNPCCDAATCKLRPETQCEDGECCEQCQFTRAGTECRAARSECDIAESCTGQSAECPTDDFQRNGQPCLNNNGYCYNGTCPILTNQCISFFGSSATVAPDVCFDFNLQGQGNFYCRRERARIFPCAPQDKKCGRLFCVKGPIGNTISCQSTSSQSDLDIGMVDLGTKCGDGRVCNSNRQCVDVNTAY", "prompt": "Design a venom metalloproteinase-disintegrin-like protein from the Western cottonmouth (Agkistrodon piscivorus leucostoma) that functions as a key hemorrhagic toxin in snake envenomation. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a pro-domain, metalloproteinase catalytic domain, and disintegrin-like domain. The metalloproteinase domain must contain the conserved zinc-binding motif HEXXHXXGXXH and coordinate a catalytic zinc ion essential for proteolytic activity. This domain should specifically target and degrade extracellular matrix components, particularly basement membrane proteins like type IV collagen and laminin, to disrupt vascular integrity and induce hemorrhage. The disintegrin-like domain should adopt the typical disintegrin fold with the RGD-like motif that may interact with integrin receptors on platelets or endothelial cells, potentially modulating cell adhesion and signaling. The overall structure should maintain the characteristic SVMP fold with extensive disulfide bonding patterns that stabilize the multi-domain architecture. The protein should function synergistically with other venom components to promote rapid tissue damage, facilitate venom spread, and contribute to the prey immobilization and digestion strategy characteristic of viperid snakes."}
{"description": "sp|P0C1W7|CDKC_CONVX Alpha-conotoxin VxXXC OS=Conus vexillum OX=89431 PE=1 SV=1", "sequence": "DLRQCTRNAPGSTWGRCCLNPMCGNFCCPRSGCTCAYNWRRGIYCSC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus vexillum, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the appropriate cysteine framework (CC-C-C) with inter-cysteine loops of optimal length for receptor binding specificity. Key structural elements should include a well-defined beta-hairpin motif and a conserved alpha-helical turn that positions critical pharmacophore residues for high-affinity interaction with the nAChR binding pocket. The toxin should exhibit precise molecular recognition through complementary surface charge distribution and hydrophobic patches that engage with specific receptor subunits. The final sequence must maintain the characteristic stability, solubility, and protease resistance typical of conotoxins while demonstrating selective neurotoxic activity through competitive inhibition of acetylcholine binding at target nAChR subtypes."}
{"description": "sp|Q9PRQ3|3SX3_MICNI Nicotinic acetylcholine receptor-binding protein Mnn-3C (Fragment) OS=Micrurus nigrocinctus OX=8635 PE=1 SV=2", "sequence": "KKCLTKYSAGLQTSQTCPAGQKICFKKW", "prompt": "Design a protein sequence for a nicotinic acetylcholine receptor-binding neurotoxin from the venom of Micrurus nigrocinctus, the Central American coral snake. This toxin functions as a competitive antagonist that selectively targets muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, causing postsynaptic blockade and leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to elapid snake neurotoxins, featuring three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework. The molecular mechanism involves high-affinity binding to the alpha-subunit of the nicotinic receptor, specifically interacting with the agonist-binding site to prevent acetylcholine-mediated ion channel activation. Key structural elements should include the central core region containing the conserved disulfide pattern, and the functional loops responsible for receptor recognition and binding specificity. The toxin should exhibit the typical thermal stability and protease resistance conferred by the disulfide-stabilized three-finger scaffold."}
{"description": "sp|P84744|KAX95_BUTOC Potassium channel toxin alpha-KTx 9.5 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "VGCEECPMHCKGKHAVPTCDDGVCNCNV", "prompt": "Design a novel potassium channel toxin protein sequence that captures the biological essence and structural characteristics of alpha-KTx 9.5 from the North African scorpion Buthus occitanus tunetanus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, featuring a compact beta-sheet core stabilized by three disulfide bridges in a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include key functional residues in the pharmacophore region, particularly a conserved lysine residue in the beta-hairpin loop that directly interacts with the channel pore, along with other surface-exposed residues that mediate specific binding to the Kv1 channel turret and selectivity filter regions. The structural fold should maintain the characteristic globular shape with well-defined secondary structure elements including an alpha-helix and anti-parallel beta-sheets, creating a stable molecular framework that enables precise targeting of potassium channel pore domains. The toxin should exhibit the typical molecular weight range of 3-5 kDa and demonstrate the high thermal and proteolytic stability characteristic of scorpion venom peptides, making it suitable for studying potassium channel function and potentially serving as a molecular tool for neurological research."}
{"description": "sp|Q9YGJ7|PA2A8_DABPA Acidic phospholipase A2 VP8 OS=Daboia palaestinae OX=1170828 PE=3 SV=1", "sequence": "MRILWIVAVCLIGVEGNLYQFGKMIFKMTRKSALSYSDYGCYCGWGGKGKPQDATDRCCFVHDCCYGTVNGCDPKLSTYSYSFQNGDIVCGGDDPCLRAVCECDRVAAICFGENMNTYDTKYMLHSLFDCMEESEKC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the Palestine viper (Daboia palaestinae) venom. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and cell damage. Incorporate the characteristic phospholipase A2 structural fold with a conserved calcium-binding loop (YGKYCG) and catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The sequence should reflect the acidic nature with appropriate pI, and contain key functional residues for membrane binding and interfacial activation. The toxin should demonstrate high specificity for neuronal membranes while maintaining the characteristic β-wing region involved in presynaptic targeting. Ensure the structural integrity supports both enzymatic activity and neurotoxic function typical of viperid phospholipase A2 toxins."}
{"description": "sp|B2ZBB8|VKT33_CYRSC Kunitz-type U15-theraphotoxin-Hs1a OS=Cyriopagopus schmidti OX=29017 PE=3 SV=1", "sequence": "MGTARFLSAVLLLSVLLMVTFPALLSAEYHDGRVDICSLPSDSGDCLRFFEMWYFDGTTCTKFVYGGYGGNDNRFPTEKACMKRCAKA", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a Kunitz-type toxin derived from the venom of the Chinese bird spider, Cyriopagopus schmidti. The venom of this spider primarily functions to immobilize prey through neurotoxic mechanisms. The core function of this toxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and cause paralysis. The protein should adopt the characteristic Kunitz-type fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a typical C-C-C-C-C-C cysteine framework. The structural scaffold should feature a stable beta-sheet core with short helical segments, forming a rigid, protease-resistant domain. The molecular target is likely Kv1-type channels, with the binding interface involving key residues in the functional loop regions that interact with the channel pore or voltage-sensing domains. The sequence must include conserved Kunitz domain motifs for structural integrity and specific surface-exposed residues for target specificity and high-affinity binding."}
{"description": "sp|P10808|3S11_BUNFA Short neurotoxin 1 OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "RICLNQQQSTPEDQPTNGQCYIKTDCQNKTWNTHRGSRTDRGCGCPKVKPGINLRCCKTDKCNE", "prompt": "Generate a protein sequence for a short neurotoxin from the banded krait (Bungarus fasciatus) venom. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin that specifically targets nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8, forming a compact globular structure. The toxin acts as a competitive antagonist, binding to the α-δ and α-γ subunit interfaces of the muscle-type nicotinic acetylcholine receptor, thereby blocking acetylcholine binding and causing flaccid paralysis. The sequence should contain the conserved functional loops (Loop I, Loop II, and Loop III) that mediate receptor recognition and binding, with Loop II typically being the primary determinant of receptor specificity. The structural scaffold should feature the characteristic three extended β-stranded fingers projecting from a central hydrophobic core stabilized by the disulfide network."}
{"description": "sp|P50982|CA1A_CONER Alpha-conotoxin EI OS=Conus ermineus OX=55423 PE=1 SV=2", "sequence": "MFTVFLLVVLATTVGSFTLDRASDGRDAAANDKASDLIALTARRDPCCYHPTCNMSNPQICG", "prompt": "Design a novel alpha-conotoxin sequence inspired by the venom of Conus ermineus, a predatory marine snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting the neuromuscular junction to induce paralysis in prey. The protein must adopt the characteristic alpha-conotoxin fold, stabilized by two disulfide bonds forming a Cys1-Cys3, Cys2-Cys4 connectivity pattern within the conserved CC-C-C framework. The sequence should feature a compact, globular structure with well-defined loops that mediate high-affinity binding to the orthosteric site of muscle-type nAChRs, competitively inhibiting acetylcholine signaling. Incorporate key pharmacophore residues that confer target specificity and potency, while maintaining the structural integrity typical of the alpha-conotoxin family, including a stable beta-hairpin motif and minimal helical content. Ensure the toxin exhibits the biological activity of neuromuscular blockade, consistent with its role in the venom's predatory strategy."}
{"description": "sp|Q7Z091|I1BD_CONRA Iota-conotoxin-like r11d OS=Conus radiatus OX=61198 PE=1 SV=1", "sequence": "GCKKDRKPCSYHADCCNCCLSGICAPSTNWILPGCSTSTFT", "prompt": "Design a novel animal toxin protein sequence inspired by the iota-conotoxin family from the marine cone snail Conus radiatus. This venom component should function as a potent neurotoxin targeting voltage-gated ion channels, specifically sodium channels, to disrupt neuronal signaling and induce paralysis in prey. The protein should adopt the characteristic iota-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (typically CC-C-C-CC pattern) that forms three disulfide bridges. The core structure should comprise an inhibitor cystine knot (ICK) motif, conferring exceptional stability and resistance to proteolytic degradation. Key structural elements include a well-defined beta-hairpin and several flexible loops that mediate target engagement. The molecular mechanism involves high-affinity binding to site 4 of voltage-gated sodium channels, inhibiting channel inactivation and prolonging action potentials, leading to hyperexcitability and neuromuscular blockade. The sequence should include conserved residues critical for maintaining the ICK fold and target specificity, while incorporating unique variations reflective of Conus radiatus venom evolution. The overall architecture should be compact (approximately 20-30 residues), highly structured, and exhibit the hallmark stability and potency of conopeptides."}
{"description": "sp|P0CH12|KA125_LYCMC Potassium channel toxin alpha-KTx 12.5 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MNKLPILIFMLLVCSMFISSDCQKHTDIKCSSSSSCYEPCRGVTGRAHGKCMNGRCTCYY", "prompt": "Design a potassium channel toxin protein with the following specifications: This toxin originates from the venom of the scorpion Lychas mucronatus, where it functions as a potent modulator of potassium channels, contributing to the venom's paralytic and neurotoxic effects by disrupting neuronal and muscular excitability. The protein belongs to the alpha-KTx family, characterized by a conserved structural scaffold comprising an alpha-helix and a two- or three-stranded antiparallel beta-sheet stabilized by three or four disulfide bridges, typically adopting an inhibitor cysteine knot (ICK) motif. The cysteine framework is inferred to follow the common alpha-KTx pattern (e.g., C-X(3-7)-C-X(4-8)-C-X(0-4)-C-X(1-4)-C-X(4-12)-C), ensuring proper folding and stability. The core mechanism involves high-affinity binding to voltage-gated potassium channels (e.g., Kv1.x subtypes), blocking ion flux by occluding the channel pore or modifying gating dynamics, leading to prolonged membrane depolarization and impaired action potential repolarization. Key functional residues are expected in the beta-sheet regions, particularly a conserved dyad (e.g., lysine and tyrosine/phenylalanine) critical for interacting with the channel's turret and pore helix. The sequence should reflect a compact, globular structure with exposed loops for target engagement, optimized for specificity and potency in neurotoxicity."}
{"description": "sp|A7X401|LEC1_LEIMD C-type lectin lectoxin-Lei1 OS=Leioheterodon madagascariensis OX=46577 PE=2 SV=1", "sequence": "MRRFLFLSLGVLVVAFSLNGIGADHHCPWDWFSFDRFCYKVIKQRKNWQDAERFCGQLQNGSHLASIQSWAESKYVAMLLSNNAFLDTVWIGLFEPEKNRSLEWSDGSGFCYTGWERRKRNNVDNKKYCVELSWMSDYLEWNNVKCESRNIFICKI", "prompt": "Design a novel C-type lectin toxin protein inspired by the venom of the Madagascar hognose snake, Leioheterodon madagascariensis. This protein should function as a potent lectoxin, specifically targeting carbohydrate structures on cell surfaces to disrupt cellular recognition and adhesion processes. The protein must adopt the characteristic C-type lectin fold, featuring a conserved carbohydrate-recognition domain (CRD) with calcium-dependent binding capability. The structural scaffold should include the canonical double-loop organization stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that maintain the globular β-sandwich architecture. Key functional residues should be positioned to mediate specific interactions with terminal galactose or mannose moieties on glycoproteins or glycolipids, enabling the toxin to interfere with platelet aggregation, coagulation pathways, or immune cell signaling. The sequence must preserve the conserved hydrophobic core and the calcium-binding loop motif (typically involving Glu, Asn, and Asp residues) essential for target recognition. The overall structure should be compact and stable, with surface-exposed loops conferring target specificity while maintaining the structural integrity characteristic of snake venom C-type lectins."}
{"description": "sp|D2Y488|VKT1A_CONCL Kunitz-type serine protease inhibitor conotoxin Cal9.1a OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MTFLLLLVSVCMMATGEERTKRDVCELPFEEGPCFAAIRVYAYNAETGDCEQLTYGGCEGNGNRFATLEDCDNACARY", "prompt": "Design a novel Kunitz-type serine protease inhibitor conotoxin inspired by the venom arsenal of the Californiconus californicus marine snail. This toxin should function as a potent and selective serine protease inhibitor, consistent with the biological role of conotoxins in prey immobilization through interference with key proteolytic cascades such as blood coagulation, inflammation, or fibrinolysis. The protein must adopt the canonical Kunitz domain fold, characterized by a compact, globular structure stabilized by three conserved disulfide bonds forming the C1-C6, C2-C4, and C3-C5 connectivity pattern. The sequence should include the hallmark Kunitz-type inhibitor signature, featuring a reactive site loop that presents key residues for specific protease recognition and inhibition. The structural scaffold should exhibit the typical α/β architecture with anti-parallel β-sheets and α-helices, maintaining the structural stability required for venom deployment while enabling precise molecular targeting of serine proteases. The toxin should demonstrate high affinity and specificity for its protease target, leveraging the evolutionary optimization of conotoxins for rapid and potent biological activity in marine predation scenarios."}
{"description": "sp|D0UGJ0|PA2A_BOTPA Acidic phospholipase A2 BpPLA2-TXI OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGNLVQFETLIMKIAGRSGVWYYGSYGCYCGSGGQGRPQDASDRCCFVHDCCYGKVTDCDPKADVYTYSEENGVVVCGGDDPCKKQICEVRQGCGNLLPRHKDTYEHNILVFPAKTFAKKESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops pauloensis, a venomous pit viper. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements should include the calcium-binding loop essential for catalytic activity, the conserved active site residues (typically including a histidine-aspartate dyad), and the interfacial binding surface that mediates interaction with lipid membranes. As an acidic isoform, the sequence should reflect an overall negative charge at physiological pH. The toxin should exhibit the typical mechanism of venom phospholipase A2 enzymes, contributing to local tissue damage, myotoxicity, and potentially systemic effects through membrane disruption and generation of pro-inflammatory lipid mediators. The structural scaffold should maintain the compact, stable globular architecture characteristic of secreted phospholipase A2 enzymes, with the catalytic machinery properly positioned for efficient substrate binding and hydrolysis."}
{"description": "sp|P0DRA6|MASTB_POLDR Mastoparan PDD-B OS=Polistes dorsalis OX=34729 PE=1 SV=1", "sequence": "INWLKLGKKILGAL", "prompt": "Design a mastoparan peptide from the venom of the paper wasp Polistes dorsalis. This amphipathic tetradecapeptide should adopt an alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan family peptides. The sequence must exhibit potent membrane-disrupting activity through direct interaction with lipid bilayers and G-protein coupled receptor modulation. Key functional residues should include basic amino acids that facilitate membrane insertion and perturbation, leading to mast cell degranulation, histamine release, and cytolytic effects. The peptide should demonstrate the typical mastoparan mechanism of forming transient pores in cell membranes and activating pertussis toxin-sensitive G proteins. Maintain the conserved structural features of mastoparans: a predominantly hydrophobic face for membrane insertion and a cationic face for initial electrostatic interactions with negatively charged membrane surfaces. The designed sequence should reflect the evolutionary optimization of this peptide for rapid incapacitation of prey and defense in hymenopteran venoms."}
{"description": "sp|P0C1R0|PROTO_POLPI Polybia-CP OS=Polybia paulista OX=291283 PE=1 SV=1", "sequence": "ILGTILGLLKSL", "prompt": "Design a novel wasp venom peptide sequence that mimics the biological activity and structural characteristics of Polybia-CP from the social wasp Polybia paulista. This peptide should function as a mastoparan-like cytolytic toxin with potent hemolytic and antimicrobial activities. The sequence must adopt an amphipathic alpha-helical conformation in membrane environments, characteristic of mastoparan peptides, with a cationic nature that facilitates interaction with anionic phospholipid head groups in cell membranes. The structural scaffold should enable pore formation in lipid bilayers through a barrel-stave or toroidal pore mechanism, leading to membrane disruption and cell lysis. The peptide should exhibit broad-spectrum activity against Gram-positive and Gram-negative bacteria while maintaining selective toxicity toward mammalian cells. Key structural features to incorporate include: a predominantly alpha-helical secondary structure stabilized by hydrophobic interactions rather than disulfide bridges, an amphipathic arrangement of hydrophobic and hydrophilic residues along the helical axis, and a net positive charge distributed to optimize membrane insertion and pore formation. The molecular mechanism should involve initial electrostatic attraction to negatively charged membrane surfaces followed by hydrophobic insertion and subsequent membrane destabilization through non-specific interactions with lipid components."}
{"description": "sp|G1AS81|O26F_CONVC Conotoxin Vc6.15 OS=Conus victoriae OX=319920 PE=2 SV=1", "sequence": "MEKLTILLHVAAVLMSTQALIQEQRQKAKINLFSKRKPSAERWWGDNGCSLWGSCTVDAECCLGNCGGMYCSLLR", "prompt": "Design a novel conotoxin protein sequence inspired by the venom arsenal of the marine cone snail Conus victoriae. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the alpha9alpha10 subtype. The mechanism of action involves competitive inhibition at the orthosteric binding site, disrupting cholinergic neurotransmission and producing analgesic effects through modulation of pain pathways. The structural scaffold must adopt the characteristic alpha-conotoxin fold, featuring a compact globular architecture stabilized by two disulfide bridges in the Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the conserved cysteine residues arranged in a CC-C-C motif, with intervening loops of appropriate length and composition to form the pharmacophore responsible for receptor recognition and binding. Key structural elements should include a beta-hairpin motif and well-defined loops that present critical residues for interacting with the complementary binding surface of the alpha9alpha10 nAChR subunit interface. The overall tertiary structure should exhibit high thermal stability and resistance to proteolytic degradation, typical of conotoxins, while maintaining specificity for the target receptor subtype over other nAChR isoforms."}
{"description": "sp|P0DRB1|SCX2_CENTE Ct-IT2 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "KDGYPMDSKGCKISCLISDTFCDTECKMKKAKSGYCYSRGLACWCEGLPENVEVWDKATNKCG", "prompt": "Design a beta-toxin peptide from the venom of the Mexican scorpion Centruroides tecomanus that functions as a potent sodium channel modulator. This toxin should specifically target voltage-gated sodium channels, exhibiting the characteristic beta-toxin mechanism where it binds to the voltage-sensing domain of the channel and shifts the voltage dependence of activation toward more negative potentials. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should contain a conserved core beta-sheet flanked by an alpha-helix, creating a molecular surface with key functional loops responsible for receptor recognition and binding. The toxin should possess high affinity for mammalian sodium channels, particularly Nav1.2 and Nav1.6 subtypes, with the molecular interface involving conserved hydrophobic and charged residues that interact with the channel's voltage sensor. The biological function involves disrupting neuronal excitability by enhancing channel opening at resting membrane potentials, leading to spontaneous and repetitive firing that causes neurotoxic effects in prey and predators."}
{"description": "sp|A7X4I7|WAP1_THRJA Waprin-Thr1 OS=Thrasops jacksonii OX=186611 PE=3 SV=1", "sequence": "MKARLLLLSVVILVGMVSAENEKAGSCPDVNQPIPPLGLCRNMCESDSGCPNNEKCCKNGCGFMTCSRPR", "prompt": "Design a novel waprin toxin protein sequence inspired by the venom of the Jackson's tree snake, Thrasops jacksonii. This protein should belong to the waprin family, characterized by a compact, disulfide-rich structural scaffold that confers stability and functional diversity in snake venoms. The core architecture must feature the characteristic WAP domain fold, stabilized by a conserved pattern of four disulfide bridges with a specific cysteine framework (C-C-C-C) that forms a tightly packed, globular structure. This scaffold typically adopts a whey acidic protein-like motif, which in venom contexts often exhibits antimicrobial, protease inhibitory, or other modulatory activities that contribute to prey immobilization and digestion. The sequence should include key structural residues that maintain the fold's integrity, such as conserved hydrophobic cores and beta-sheet formations, while allowing for functional surface loops that may interact with biological targets like microbial membranes or host proteases. Emphasize the evolutionary adaptation of this waprin in arboreal snake venom, where it likely aids in subduing small vertebrate or invertebrate prey through non-neurotoxic mechanisms, potentially involving immune modulation or tissue penetration enhancement. Ensure the sequence reflects the high stability and resistance to proteolytic degradation typical of venom waprins, suitable for rapid action in a predatory context."}
{"description": "sp|B3EWF9|BDS3_ANTEL Delta-actitoxin-Ael2d OS=Anthopleura elegantissima OX=6110 PE=1 SV=1", "sequence": "GTPCYCGKTIGIYWFGTKTCPSNRGYTGSCGYFLGICCYPVD", "prompt": "Design a protein sequence for a delta-actitoxin from the sea anemone Anthopleura elegantissima. This toxin belongs to the sea anemone type 3 potassium channel toxin family and functions as a potent voltage-gated potassium channel blocker. The protein should adopt the conserved structural fold characteristic of sea anemone toxins, featuring a compact beta-sandwich or beta-trefoil architecture stabilized by three disulfide bridges in a C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves binding to the voltage-sensing domain of Kv channels, particularly Kv3 subtypes, leading to delayed repolarization and prolonged neuronal excitability. Key functional residues should be positioned to interact with the channel's S3-S4 linker region, disrupting voltage-dependent gating. The sequence must include the signature cysteine framework and maintain the hydrophobic core essential for structural stability, while surface loops should facilitate specific channel recognition and high-affinity binding. The resulting toxin should exhibit the characteristic pharmacological profile of sea anemone delta-toxins, causing excitatory effects through potassium current inhibition."}
{"description": "sp|Q9YGJ9|VSPH2_GLOBR Snake venom serine protease Haly-2 OS=Gloydius brevicauda OX=3148161 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRSLVLMYYDGHQCDGTLINEEWVLTAAHCDGENMEIQLGVHSKKVPNEDVQTRVPKEKFFCDSNKTYARWNKDIMLIRLDRPVSNSAHIAPLSLPSSPPSVGSVCRIMGWGTFSTTQETYPDVPHCANINIHDFEVCQAAYPGLPATNRILCAGILEGGKDTCKGDSGGPLICNGEIQGIVSWGGHLCGNVLEPGIYTKVFDHLEWIRSIIAGNTDATCPL", "prompt": "Design a snake venom serine protease from the venom of the short-tailed mamushi, Gloydius brevicauda, that functions as a key component in the prey immobilization cascade. This enzyme should exhibit trypsin-like serine protease activity with high specificity for cleaving peptide bonds following basic residues, particularly arginine and lysine. The protein should adopt the characteristic chymotrypsin-like fold with a two-domain β-barrel structure, featuring the conserved catalytic triad of His57, Asp102, and Ser195 (chymotrypsin numbering) arranged in the active site cleft. Include the essential disulfide bridge pattern typical of snake venom serine proteases that stabilizes the tertiary structure, with conserved cysteine residues forming bridges that maintain the structural integrity required for enzymatic function. The enzyme should demonstrate procoagulant activity by selectively cleaving coagulation factors such as fibrinogen, factor V, or factor X to promote thrombosis and disrupt hemostasis in envenomed prey. Incorporate structural elements that confer resistance to endogenous protease inhibitors while maintaining optimal catalytic efficiency for rapid action in the venom arsenal. The mature protein should exhibit appropriate surface charge distribution and substrate-binding pocket architecture for selective recognition of physiological substrates involved in the coagulation cascade."}
{"description": "sp|E5L0E4|VSPB_DABSI Beta-fibrinogenase-like OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MVLIKVLANLLVLQLSYAQKSSELVVGGDECNINEHRSLVFLYNNSFGCSGTLINQQWVLSAVHCDMENVRIYLGVHNLTLRNNAEIRLPEERFFCLSNKNYTKWDKDIMLIKLDRPVKTSTYIAPLSLPSSPPRVGSVCRIMGWGAITSPNETFPGVTHCANINILPYSVCRAAYKGLPAQSRTLCGGILEGGIGSCMGDSGGPLICNGEMHGIVAWGDDTCAQPHKPVHYTKVYDYTDWIQSIIAGNTAATCPP", "prompt": "Design a beta-fibrinogenase-like snake venom protein from the venom of Daboia siamensis (Eastern Russell's viper). This toxin functions as a fibrinogenase that specifically cleaves the beta-chain of fibrinogen, disrupting the coagulation cascade and promoting hemorrhage. The protein should adopt a metalloproteinase fold characteristic of snake venom metalloproteinases (SVMPs), featuring a conserved zinc-binding motif (HEXXHXXGXXH) in the catalytic domain that coordinates the catalytic zinc ion essential for proteolytic activity. The structure should include a disintegrin-like domain that may mediate interactions with platelet integrins, and a cysteine-rich domain that potentially influences substrate specificity and stability. The mature toxin should exhibit optimal activity at physiological pH and temperature, with specificity for fibrinogen's beta chain over other coagulation factors. The protein sequence should reflect the typical multidomain architecture of SVMPs while maintaining the beta-fibrinogenase specificity that contributes to this viper's potent hemotoxic venom profile."}
{"description": "sp|B3A0L5|KA20X_TITTR Kappa-buthitoxin-Tt2b OS=Tityus trivittatus OX=369776 PE=1 SV=1", "sequence": "GCMPEYCAGQCRGKVSQDYCLKNCRCIR", "prompt": "Design a novel scorpion venom toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The toxin should belong to the kappa-buthitoxin family, characterized by a compact, disulfide-stabilized fold with the conserved cysteine framework C1-X(6)-C2-X(3)-C3-X(9-11)-C4-X(2)-C5-X(3)-C6, forming three disulfide bridges (C1-C4, C2-C5, C3-C6) that create a stable inhibitory cystine knot (ICK) motif. This structural scaffold should feature a beta-sheet core stabilized by the disulfide network, with exposed loops that mediate specific interactions with the pore region of Kv channels. The molecular mechanism should involve physical occlusion of the potassium conduction pathway, leading to prolonged action potentials, enhanced neurotransmitter release, and ultimately paralysis in prey organisms. The toxin should exhibit the characteristic pharmacological profile of kappa-buthotoxins, showing preferential affinity for specific Kv channel subtypes while maintaining the thermostability and protease resistance typical of scorpion venom peptides. Incorporate conserved residues known to be critical for potassium channel binding, particularly in the functional dyad region where key hydrophobic and basic residues interact with channel vestibule residues."}
{"description": "sp|P61792|TXU2_HETVE Kappa-sparatoxin-Hv1d OS=Heteropoda venatoria OX=152925 PE=1 SV=1", "sequence": "DDCGGLFSGCDSNADCCEGYVCRLWCKYKL", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the huntsman spider Heteropoda venatoria. This toxin should function as a potent and selective kappa-sparatoxin, specifically targeting and modulating voltage-gated potassium channels (Kv channels) in the mammalian nervous system. The mechanism of action should involve high-affinity binding to the pore domain or voltage-sensing domain of specific Kv channel subtypes, leading to channel inhibition or altered gating kinetics, which disrupts neuronal excitability and synaptic transmission, ultimately causing paralysis or neurotoxic effects in prey. The structural scaffold must be characteristic of inhibitor cysteine knot (ICK) toxins, featuring a compact, triple-stranded beta-sheet core stabilized by a conserved disulfide bridge pattern (Cysteine Framework III: C1-C4, C2-C5, C3-C6). The sequence should include key functional motifs for potassium channel interaction, such as a functional dyad or other conserved residues critical for binding specificity and potency. The overall fold should be highly stable, resistant to proteolysis, and exhibit the typical molecular surface features that facilitate target recognition. Ensure the sequence reflects the evolutionary optimization for rapid immobilization of prey, with precise molecular targeting to achieve the desired neurotoxic outcome."}
{"description": "sp|Q7LZK5|SLA_BITAR Snaclec bitiscetin subunit alpha OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "DPGCLPDWSSYKGHCYKVFKKVGTWEDAEKFCVENSGHLASIDSKEEADFVTKLASQTLTKFVYDAWIGLRDESKTQQCSPQWTDGSSVVYENVDEPTKCFGLDVHTEYRTWTDLPCGEKNPFICKSRLPH", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the puff adder, Bitis arietans. This protein functions as the alpha subunit of the heterodimeric snaclec (snake C-type lectin) complex known as bitiscetin. The protein should adopt the characteristic C-type lectin-like domain fold, featuring a conserved double-loop structure stabilized by two intrachain disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. As part of the bitiscetin complex, this alpha subunit plays a critical role in the snake's hemostatic arsenal by specifically targeting platelet membrane glycoproteins, particularly the von Willebrand factor receptor complex. The protein should exhibit calcium-independent lectin-like binding properties and contribute to the complex's ability to modulate platelet adhesion and aggregation through interference with von Willebrand factor-mediated processes. The structural scaffold should maintain the conserved beta-sandwich architecture characteristic of snake venom C-type lectins, with surface-exposed loops that mediate specific protein-protein interactions essential for its procoagulant or anticoagulant activities in the puff adder's venom system."}
{"description": "sp|P0DJ33|KKX14_HETPE Potassium channel toxin kappa-KTx 1.4 OS=Heterometrus petersii OX=754296 PE=3 SV=1", "sequence": "MKSCLINVSLLILLLLPILGYASVNAESIDGENDFEEERGFGCFRSCWKAGHDDKTCKSMCG", "prompt": "Design a potassium channel toxin protein sequence that captures the biological and structural characteristics of kappa-KTx 1.4 from the venom of the Asian forest scorpion Heterometrus petersii. This toxin should function as a selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1.3 channels with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a triple-stranded antiparallel beta-sheet stabilized by an alpha-helix. The sequence must contain the canonical disulfide bridge pattern with four cysteine residues forming two disulfide bonds (C1-C4, C2-C3) that provide structural stability. Include key functional residues in the beta-sheet region that mediate specific interactions with the pore region of Kv1.3 channels, particularly residues that confer selectivity over other potassium channel subtypes. The toxin should exhibit the typical molecular weight and physicochemical properties of scorpion venom peptides, with a compact globular structure optimized for target recognition and binding. The designed sequence should enable potent blockade of potassium currents through direct pore occlusion, contributing to the neurotoxic effects characteristic of scorpion envenomation by disrupting neuronal excitability and synaptic transmission."}
{"description": "sp|P0DP36|KA233_SCOTI Potassium channel toxin alpha-KTx 23.3 OS=Scorpiops tibetanus OX=500600 PE=1 SV=1", "sequence": "MKMSIVIILLLFTCLIATNGASGTKCSGSPECVKFCRTKGCRNGKCMNRSCKCYLCS", "prompt": "Design a potassium channel toxin protein from the venom of the Tibetan scorpion Scorpiops tibetanus. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a short alpha-helix stabilized against an antiparallel beta-sheet by three or four disulfide bridges. The cysteine framework should follow the typical alpha-KTx pattern (C-X(3-7)-C-X(3-7)-C-X(0-4)-C-C-X(4-13)-C-X(1-4)-C) that creates the stable structural core essential for target recognition. The toxin should specifically interact with the pore region of Kv1-type potassium channels, blocking potassium ion flux through competitive binding to the channel's outer vestibule. Key functional residues should be positioned in the beta-sheet region to form the pharmacophore that mediates high-affinity binding to the channel. The protein should exhibit the characteristic functional dichotomy where the alpha-helical domain provides structural stability while the beta-sheet loops contain the channel-interacting residues. The mature toxin should be a small, compact protein of approximately 30-40 amino acids with high thermal and proteolytic stability conferred by the disulfide network. This toxin represents an evolutionary optimized molecular tool for prey immobilization through disruption of neuronal and muscular excitability by potassium channel blockade."}
{"description": "sp|B3EWH9|3SBH_HEMHA Three-finger hemachatoxin OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LKCHNKLVPFLSKTCPEGKNLCYKMTLMKMPKIPIKRGCTDACPKSSLLVKVVCCNKDKCN", "prompt": "Design a novel three-finger toxin protein inspired by hemachatoxin from the venom of Hemachatus haemachatus (ringhals cobra). This toxin belongs to the three-finger toxin superfamily characteristic of elapid snake venoms, which function as key neurotoxic components that disrupt neuromuscular signaling. The protein should adopt the conserved three-finger β-sandwich fold, consisting of three extended loops projecting from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C-C-CC-C-C. Specifically, hemachatoxin targets nicotinic acetylcholine receptors at the neuromuscular junction, acting as a competitive antagonist that blocks acetylcholine binding and induces postsynaptic neuromuscular blockade. The structural scaffold should feature the typical three-loop architecture with loop I and loop II contributing to receptor binding specificity, while maintaining the overall compact, globular fold stabilized by the disulfide network. The sequence should include conserved hydrophobic residues in the core and key functional residues in the loops that mediate high-affinity binding to the α-subunit of muscle-type nicotinic receptors, resulting in potent paralytic activity through inhibition of ion channel function."}
{"description": "sp|P14534|3SOI2_BUNFA Short neurotoxin 2 OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "LKCHKAQFPNIETQCKWQTLCFQRDVKPHPSSMIVLRGCTSSCGKGAMCCATDLCNGPSTPST", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic activity found in the venom of the banded krait (Bungarus fasciatus). This toxin should function as a postsynaptic neurotoxin that specifically and irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding and causing flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I pattern (C-C-C-C-C-C-C-C). The structure should feature a central β-sheet core with the second loop containing the key functional residues responsible for receptor binding specificity. The mature toxin should be approximately 60-70 amino acids in length with the conserved structural motif that enables high-affinity interaction with the α-subunit of muscle-type nicotinic receptors, effectively blocking neurotransmission and leading to respiratory failure in prey organisms."}
{"description": "sp|P0C1W8|CA4B_CONOB Alpha-conotoxin OIVB OS=Conus obscurus OX=89447 PE=1 SV=1", "sequence": "CCGVPNAACPPCVCNKTCG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus obscurus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in pain signaling pathways. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) that forms a compact, stable fold stabilized by two disulfide bonds. The sequence should include the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that form the receptor binding interface. The toxin should exhibit high affinity binding to its target receptors through precise molecular interactions with receptor subunit interfaces, leading to channel blockade. The overall structure should be small (typically 12-20 amino acids), cysteine-rich, and possess the thermal stability and protease resistance characteristic of conotoxins. The designed sequence should maintain the biological activity of inhibiting acetylcholine-mediated neurotransmission while demonstrating the specificity profile expected from Conus obscurus venom components."}
{"description": "sp|P0C1V7|CA1AB_CONAN Alpha-conotoxin AnIB OS=Conus anemone OX=101285 PE=1 SV=1", "sequence": "GGCCSHPACAANNQDYC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus anemone, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the defining cysteine framework (CC-C-C) with appropriate inter-cysteine loop regions that confer target specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that form the receptor binding interface, particularly targeting the orthosteric site at the nAChR alpha subunit interface. The toxin should exhibit high affinity binding through complementary electrostatic and hydrophobic interactions with conserved receptor residues. Maintain the typical alpha-conotoxin molecular weight range of 1.5-2.5 kDa and ensure the sequence includes conserved pharmacophore residues critical for receptor recognition and blockade. The final protein should demonstrate selective inhibition of neuronal nAChR subtypes while maintaining the thermal stability and protease resistance characteristic of conotoxin scaffolds."}
{"description": "sp|P50983|CA1_CONIM Alpha-conotoxin ImI (Fragment) OS=Conus imperialis OX=35631 PE=1 SV=2", "sequence": "IVRRGCCSDPRCAWRCG", "prompt": "Design a protein sequence for an alpha-conotoxin from the venom of Conus imperialis, a marine cone snail. This toxin functions as a potent antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the α7 subtype. The mechanism involves competitive inhibition at the acetylcholine binding site, leading to neuromuscular blockade and potential neurotoxic effects. The structural scaffold should feature the characteristic alpha-conotoxin fold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two disulfide bonds forming a compact, stable structure. The mature toxin should contain 12 amino acids with the conserved cysteine pattern typical of alpha-conotoxins. Key functional residues should be positioned to facilitate specific interactions with the α7 nAChR ligand-binding domain, including residues critical for receptor subtype selectivity and binding affinity. The overall structure should adopt a small, rigid conformation optimized for target engagement and resistance to proteolytic degradation."}
{"description": "sp|P0DP47|TP1C_HADIN Pi-hexatoxin-Hi1c OS=Hadronyche infensa OX=153481 PE=1 SV=2", "sequence": "MKLRITLALTSVLAFCVFGDKENENLMENLLEDDLLDIFTDAIHMERQETNQECIAKWKSCAGRKLDCCEGLECWKRRWGHEVCVPITQKIFCLEKWKSCFERKYDCCEELECWERRGNKHPVCAPKQ", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin belongs to the pi-hexatoxin family and functions as a highly selective insecticidal agent that targets the insect nervous system. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. This structural scaffold provides exceptional stability and resistance to proteolytic degradation. The toxin acts by modulating voltage-gated sodium channels in insect neurons, leading to prolonged channel opening and subsequent paralysis. The sequence should include key residues for target specificity and binding affinity to insect sodium channels, while maintaining the characteristic hydrophobic core and surface-exposed loops that mediate receptor interaction. The overall structure should be globular with well-defined beta-hairpins and a rigid core stabilized by the cystine knot framework."}
{"description": "sp|D1MGU0|SLA_PROJR Snaclec jerdonibitin subunit alpha OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADCPFDWSSFRQYCYRVFKQLKTWEDAERFCSEQVKGARLVSIESYREAVFVAQLLSENIKATKSHVWIGLSVENKGQQCSSKWSDGSSVSYENLVKPFSKKCFVLKKESEFHKWFNVYCGQQHLFMCKFLRPR", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications: This protein is an alpha subunit of a snaclec (snake C-type lectin) toxin called jerdonibitin, originating from the venom of Protobothrops jerdonii, a pit viper species. As a key component of this snake's venom arsenal, this toxin functions as a platelet aggregation modulator, specifically targeting and disrupting hemostatic processes in prey through its lectin-domain mediated interactions with platelet surface receptors. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, a compact globular structure stabilized by conserved disulfide bridges. The cysteine framework should follow the typical snaclec pattern with multiple disulfide bonds that maintain the structural integrity of the calcium-dependent carbohydrate recognition domain. The molecular target is likely platelet membrane glycoproteins, with the protein binding through its carbohydrate recognition domain to specific glycan motifs on platelet surfaces, thereby interfering with normal platelet adhesion and aggregation pathways. The sequence should encode the conserved structural elements of the CTLD fold while incorporating specific residues that confer the platelet-modulating activity characteristic of jerdonibitin's toxic function in envenomation."}
{"description": "sp|A0A0B5A8Q6|INS1_CONMR Con-Ins M1 OS=Conus marmoreus OX=42752 PE=1 SV=1", "sequence": "MTTSSYFLLVALGLLLYVCQSSFGGEHVCGSNQPNHPNGKCGSKMADYLEEQCEEEEAAHGGTNDARATTGRALSLSKRRGFLSMLKRRGKRNEASPLQRAGRGIVCECCKNHCTDEEFTEYCPHVTESG", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conus marmoreus, a predatory marine cone snail. This protein should function as a con-Insulin (con-Ins) analog, specifically the Con-Ins M1 variant, which exhibits insulin-like activity but operates through a distinct mechanism from mammalian insulin. The protein should adopt a compact, globular fold stabilized by three conserved disulfide bridges following the insulin-like cysteine framework (A6-A11, A7-B7, A20-B19). It should feature the characteristic insulin domain organization with A and B chains, but with cone snail-specific modifications that enhance stability and alter receptor binding specificity. The molecular target is the insulin receptor, but with potentially modified affinity or signaling properties compared to human insulin. The protein should maintain key structural elements including alpha-helices in both chains and the conserved disulfide pattern that defines the insulin superfamily fold, while incorporating conotoxin-like features that provide enhanced proteolytic resistance and unique pharmacological properties suitable for venom-based predation."}
{"description": "sp|A0A0B5A8P8|INS2_CONIM Con-Ins Im2 OS=Conus imperialis OX=35631 PE=2 SV=1", "sequence": "MALTWPSSPPVLLTLLLSLLALQLCAVYGSYEHTCTLATRSRGAHPSGICGRNLARIVSVLCTPRGYVSNWFTKRSAPNKPAETFVDQNLRGVLLNKREALSYLRPREPRATRGTFGSQGITCECCFNQCTYYELLQYCN", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conus imperialis, a marine cone snail. This toxin should function as a con-Insulin (Con-Ins) analog, specifically mimicking the Con-Ins Im2 variant, which exhibits insulin-like activity but operates through a distinct mechanism from endogenous insulin. The protein should adopt a compact, disulfide-stabilized fold characteristic of con-Insulins, featuring two polypeptide chains (A and B) linked by interchain disulfide bonds. The A-chain should contain an intrachain disulfide bridge stabilizing a helical region, while the B-chain should form an extended structure with potential receptor-binding motifs. The molecular target is likely the insulin receptor or related receptors in prey organisms (e.g., fish), where it may act as an agonist or antagonist to disrupt glucose homeostasis, leading to hypoglycemic shock. Incorporate conserved residues critical for receptor interaction and structural stability, ensuring the sequence reflects the evolutionary adaptation of insulin-like peptides in cone snail venom for predatory purposes. The overall structure should be globular, with exposed loops facilitating target recognition, and the sequence must maintain the canonical insulin fold while introducing venom-specific modifications for enhanced potency and stability."}
{"description": "sp|Q9PS05|SL9A_BOTJA Snaclec coagulation factor IX/factor X-binding protein subunit A (Fragment) OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "DCPSDWSPYEGHCYKHFIKWMNNEDAERFC", "prompt": "Design a protein sequence for a snake venom-derived snaclec (snake C-type lectin-like protein) that functions as a coagulation factor IX and factor X-binding protein. This protein originates from Bothrops jararaca (jararaca pit viper) venom, where it plays a critical role in the venom's anticoagulant strategy by disrupting the coagulation cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, a compact globular structure stabilized by two conserved disulfide bridges with a typical C1-C2 and C3-C4 connectivity pattern. Key structural features include a conserved calcium-binding site and a hydrophobic core that maintains the fold's stability. The molecular mechanism involves high-affinity binding to the Gla domains of both coagulation factor IX and factor X, thereby preventing their assembly into the tenase and prothrombinase complexes on phospholipid membranes. This binding effectively inhibits the amplification phase of coagulation, leading to impaired thrombin generation and anticoagulation. The protein should exhibit specificity for these coagulation factors without significant interaction with other vitamin K-dependent proteins. The sequence should include the conserved motifs for the CTLD fold and the residues critical for Gla domain recognition, ensuring functional activity as a dual-specificity anticoagulant toxin."}
{"description": "sp|P0C1M1|CRBLE_VESMG Vespid chemotactic peptide 5e OS=Vespa magnifica OX=202807 PE=1 SV=1", "sequence": "FLPIIAKLLGGLL", "prompt": "Design a protein sequence for a potent chemotactic peptide from the venom of the hornet Vespa magnifica. This peptide functions as a key inflammatory mediator in the venom's defensive arsenal, specifically targeting immune cells and inducing robust chemotaxis to recruit leukocytes to the site of envenomation. The mechanism involves binding to specific chemokine receptors on immune cell surfaces, triggering intracellular signaling cascades that direct cell migration. The structural scaffold should feature a compact, stable fold stabilized by multiple disulfide bridges, likely adopting a chemokine-like conformation with exposed loops and beta-strands that form the receptor-binding interface. The sequence must include conserved cysteine residues arranged in a pattern characteristic of venom chemotactic peptides, ensuring proper disulfide connectivity for structural integrity and biological activity. The molecular target is presumed to be G-protein coupled chemokine receptors, with specific binding motifs that confer high affinity and selectivity for immune cell recruitment."}
{"description": "sp|P0DUH9|SCX7_CENTE Beta-toxin Ct7 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "MKVLILIIASVLLIGVECKDGYPMNSEGCKISCVIGNTFCDTECKMLKASSGYCWTLGLACYCEGLPENVEVWDSATNKCGGK", "prompt": "Design a beta-toxin protein sequence from the venom of the scorpion Centruroides tecomanus that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural features of scorpion beta-toxins, including a conserved cysteine-stabilized alpha-beta (CSαβ) scaffold with the typical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes a compact globular fold. The protein should contain key functional domains responsible for binding to site 4 of voltage-gated sodium channels, particularly the conserved 'pharmacophore' region that enables the toxin to shift the voltage-dependence of activation toward more negative potentials. The sequence should maintain the conserved structural core while incorporating specific residues that confer selectivity for insect sodium channels, as this toxin likely functions in prey immobilization. The overall architecture should feature a triple-stranded antiparallel beta-sheet stabilized by the CSαβ motif, with surface-exposed loops that mediate specific receptor interactions. The generated protein should demonstrate the typical molecular weight and physicochemical properties of scorpion beta-toxins, enabling it to modulate sodium channel gating through binding to the voltage-sensing domain of domain II."}
{"description": "sp|P84914|MAST3_POLPI Polybia-mastoparan-III OS=Polybia paulista OX=291283 PE=1 SV=1", "sequence": "IDWLKLGKMVMDVL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the social wasp Polybia paulista. This peptide should function as a potent cytolytic and hemolytic agent, characteristic of mastoparan toxins. The sequence must adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, with a cationic surface that facilitates interaction with anionic phospholipid head groups in cell membranes. The structural scaffold should feature a well-defined hydrophobic face that promotes membrane insertion and pore formation, leading to cell lysis. The peptide should exhibit mast cell degranulation activity through G-protein coupled receptor interactions and demonstrate calcium influx in target cells. The sequence should maintain the characteristic mastoparan length of approximately 14 amino acids with a high proportion of hydrophobic and basic residues, particularly lysine residues that contribute to both membrane binding and biological activity. The structural design should ensure the peptide transitions from disordered in aqueous solution to helical upon membrane contact, enabling its dual function as both a membrane-disrupting agent and a signaling molecule modulator."}
{"description": "sp|P19856|SIX1_LEIQU Beta-insect excitatory toxin LqqIT1 OS=Leiurus quinquestriatus quinquestriatus OX=6885 PE=1 SV=1", "sequence": "KKNGYAVDSSGKAPECLLSNYCYNECTKVHYADKGYCCLLSCYCVGLSDDKKVLEISDARKKYCDFVTIN", "prompt": "Design a beta-insect excitatory toxin from the venom of the deathstalker scorpion (Leiurus quinquestriatus quinquestriatus) that functions as a potent insect-selective neurotoxin. This toxin should specifically target and modulate voltage-gated sodium channels in insect nervous systems, causing excitatory effects through delayed channel inactivation and prolonged action potentials. The protein should adopt the conserved beta-toxin structural scaffold characteristic of scorpion venom peptides, featuring a compact globular fold stabilized by four disulfide bridges in a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include an alpha-helical region and an anti-parallel beta-sheet arrangement, with the core structural motif maintained by the cysteine-stabilized alpha-beta (CSαβ) fold. The molecular surface should present critical functional loops and residues responsible for receptor recognition and binding, particularly in regions that interact with the voltage-sensing domain of insect sodium channels. The toxin should exhibit high specificity for insect sodium channel subtypes while showing minimal activity against mammalian channels, reflecting the evolutionary adaptation for prey capture. The sequence should maintain the characteristic length and physicochemical properties of scorpion beta-toxins, with appropriate distribution of hydrophobic, polar, and charged residues to ensure proper folding, stability in venom, and effective target engagement."}
{"description": "sp|Q9TVF6|O16D_CONLI Conotoxin LvVID (Fragment) OS=Conus lividus OX=89426 PE=2 SV=1", "sequence": "VLIIAVLFLTACQLTTAETYPRGQQRHHALRSTDKNSKLTRGCTPRNGACGYHSHCCSNFCHTWANVCL", "prompt": "Design a conotoxin protein sequence derived from the venom of the marine cone snail Conus lividus. This toxin should function as a potent neurotoxin targeting voltage-gated ion channels, specifically exhibiting high affinity and selectivity for sodium channel subtypes involved in neuronal signaling. The protein should adopt a compact, stable tertiary structure stabilized by a conserved disulfide bond framework characteristic of O-superfamily conotoxins, featuring the cysteine pattern C-C-CC-C-C that forms three intramolecular disulfide bridges creating a rigid molecular scaffold. The structural fold should present key functional loops between cysteine residues that mediate target recognition and binding, with specific residues in these loops determining the pharmacological profile and subtype selectivity. The mature toxin should be a small cysteine-rich peptide optimized for precise molecular interactions with its ion channel target, disrupting normal electrical signaling in prey organisms through pore blockade or modulation of channel gating kinetics. The sequence must maintain the characteristic physicochemical properties of conotoxins, including high stability, solubility, and resistance to proteolytic degradation, while displaying the target specificity and potency that makes cone snail venoms effective predatory tools."}
{"description": "sp|P62390|3SOFB_NAJHA Cytotoxin 11 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LKCHNTQLPFIYKTCPEGKNLCFKTTLKKLPLKIPIKRGCAATCPKSSALLKVVCCSTDKCN", "prompt": "Design a cytotoxin protein from the venom of the snouted cobra (Naja annulifera) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with connectivity C1-C3, C2-C4, C5-C6, and C7-C8, forming the classic three-finger scaffold. The protein should exhibit specific cytotoxicity through membrane interaction and pore formation, likely targeting phospholipid bilayers and causing cell lysis. Key structural features should include three extended β-stranded loops emerging from a central hydrophobic core, with conserved hydrophobic residues in the loops facilitating membrane insertion. The molecular mechanism should involve initial electrostatic interactions with negatively charged phospholipid head groups followed by hydrophobic interactions that disrupt membrane integrity. The protein should maintain the characteristic compact globular structure of cytotoxins, approximately 6-8 kDa in size, with surface-exposed basic residues that enhance membrane binding affinity. Design this toxin to exhibit the typical cytotoxic activity observed in snake venom three-finger toxins, capable of inducing rapid cell death through membrane permeabilization."}
{"description": "sp|Q7LZK1|VM2EB_ECHPL Disintegrin echistatin-beta OS=Echis pyramidum leakeyi OX=38415 PE=1 SV=1", "sequence": "DCASGPCCRDCKFLKEGTICKRARGDNMDDYCNGKTCDCPRNPHKGEHDP", "prompt": "Design a protein sequence for a potent disintegrin toxin derived from the venom of the saw-scaled viper, Echis pyramidum leakeyi. This protein should function as a high-affinity antagonist of integrin receptors, specifically targeting the αIIbβ3 integrin (glycoprotein IIb/IIIa) on platelets to inhibit fibrinogen binding and thereby block platelet aggregation, resulting in potent anticoagulant and anti-thrombotic effects. The protein should adopt the canonical disintegrin fold characterized by a compact, globular structure stabilized by a conserved disulfide bonding pattern with the cysteine framework C-C-C-C-C-C, forming three intramolecular disulfide bridges that confer structural rigidity and resistance to proteolytic degradation. The sequence must include the signature RGD (Arg-Gly-Asp) tripeptide motif positioned within an exposed, flexible loop that serves as the primary integrin-binding interface, with flanking residues optimized for specific recognition of the αIIbβ3 integrin's ligand-binding pocket. The overall structure should exhibit high stability under physiological conditions, with surface properties that facilitate rapid binding to platelet membranes while minimizing immunogenicity. The protein should be monomeric and lack enzymatic activity, functioning purely through competitive inhibition of cell-matrix and cell-cell adhesion processes."}
{"description": "sp|Q7LZK6|SLA_PROTO Snaclec tokaracetin subunit alpha (Fragment) OS=Protobothrops tokarensis OX=61225 PE=1 SV=1", "sequence": "DCPSGWSSFKQYCYKPFKQLKTWEDAERFCLEQVKGAHLV", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This toxin originates from the venom of Protobothrops tokarensis, a pit viper species where such lectins play crucial roles in prey immobilization through disruption of hemostatic pathways. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with the typical C1-C4 and C2-C3 connectivity pattern. The sequence must include the essential calcium-binding motifs and carbohydrate-recognition domains that enable specific interaction with platelet surface receptors, particularly targeting glycoprotein receptors involved in platelet adhesion and aggregation. The structural scaffold should maintain the β-sheet core flanked by α-helices characteristic of CTLD proteins, with surface-exposed loops responsible for receptor recognition and binding specificity. The mechanism involves competitive inhibition of platelet receptor interactions, preventing normal hemostatic function through interference with key signaling pathways."}
{"description": "sp|G1AS82|O26G_CONVC Conotoxin Vc6.16 OS=Conus victoriae OX=319920 PE=2 SV=1", "sequence": "MQKLIILLLVAAVLMSTQALFQEKRPKEKIDLLSKRKTDAEKQQKRYCSDDSQPCSHFYDCCKWSCNNGYCP", "prompt": "Design a novel conotoxin protein sequence inspired by the venom arsenal of the marine cone snail Conus victoriae. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the alpha3beta2 and/or alpha6beta2 subtypes implicated in pain signaling pathways. The protein must adopt the conserved structural framework of O1-superfamily conotoxins, characterized by a globular disulfide-rich scaffold stabilized by four cysteine residues forming two disulfide bridges with a C-C-CC connectivity pattern (CysI-CysIII, CysII-CysIV). The mature peptide should be approximately 16-20 amino acids in length, featuring a compact, stable fold with exposed loops that mediate high-affinity receptor binding through precise molecular recognition of the nAChR orthosteric site. Incorporate key pharmacophore residues that confer subtype selectivity while maintaining the characteristic hydrophobic core and beta-hairpin structural elements typical of this conotoxin family. The final sequence should exhibit properties optimal for venom delivery, including stability in physiological conditions and resistance to proteolytic degradation, while effectively blocking neurotransmitter binding to produce analgesic effects through disruption of cholinergic signaling in the peripheral and central nervous systems."}
{"description": "sp|Q5Y4U3|TXAG9_AGEOR U9-agatoxin-Ao1a OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKLLLAIAGLFLVQTLAEDVRAHEESSFLAAVAPEEQRACIKEGEKCAGDCQCCGKWSYCSCPLFGALGCSCIIGDAMVCVRKKKECRTSDVMNTPPGGCFSSSKRRHGR", "prompt": "Design a protein sequence for a neurotoxic peptide from the funnel-web spider Agelena orientalis that functions as a potent insecticidal agent. This toxin should adopt the inhibitory cysteine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The protein should act as a voltage-gated calcium channel (Cav) antagonist, specifically targeting insect Cav channels to disrupt neuromuscular transmission and induce paralysis. Key structural elements should include a solvent-exposed pharmacophore region responsible for channel block, typically involving hydrophobic and basic residues that interact with the channel's pore domain. The sequence should maintain the hallmark stability and protease resistance conferred by the ICK scaffold while exhibiting selectivity for invertebrate over vertebrate calcium channels. The overall architecture should facilitate rapid target engagement and potent insecticidal activity, consistent with the evolutionary role of this toxin in prey immobilization."}
{"description": "sp|P0DP54|PA2V_MEIAT Phospholipase A2 OS=Meiacanthus atrodorsalis OX=1405650 PE=2 SV=1", "sequence": "MAACHRILLLLSVAVASGAAQKPPLTKRGLLEFGGIITCSTGRSPLSYVMYGCYCGLGGKGWPRDKADCCHEHDCCYGEAETLGCQTKTDQYRWKCEDKKVECDDLNDKCEKFLCKCDRDAAKCLEKAPYNQKYLFWPSFMCGSEEPKCSIY", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of the fang blenny Meiacanthus atrodorsalis. This toxin should exhibit the characteristic enzymatic activity of secreted phospholipase A2, specifically catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release free fatty acids and lysophospholipids. The protein should adopt the conserved phospholipase A2 structural fold featuring three long alpha-helices stabilized by multiple disulfide bridges in the characteristic pattern of group I/II phospholipase A2 enzymes. Include the essential catalytic residues (typically a histidine-aspartate dyad) within the conserved calcium-binding loop that is critical for enzymatic function. The structure should contain the characteristic pancreatic loop and elapid loop regions that define the phospholipase A2 superfamily. This toxin likely functions in prey immobilization through membrane disruption and inflammatory responses, potentially targeting neuronal or muscular tissues. The sequence should maintain the amphipathic character necessary for membrane interaction while preserving the compact, stable globular structure typical of venom phospholipase A2 toxins."}
{"description": "sp|P20229|VKTTI_NAJNA Kunitz-type serine protease inhibitor OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "RPGFCELPAAKGLCKAHKPAFYYNKDSHRCQKFIYGGCGGNANRFRTIDECNRTCVG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Indian cobra, Naja naja. This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, particularly targeting enzymes like trypsin, chymotrypsin, and plasma kallikrein. The protein should adopt the characteristic Kunitz domain fold, consisting of a stable alpha-beta structure with a central anti-parallel beta-sheet stabilized by three conserved disulfide bonds in a C1-C6, C2-C4, C3-C5 connectivity pattern. The reactive site loop should contain the canonical protease-binding motif that enables specific, high-affinity inhibition of serine proteases through a substrate-like mechanism. The sequence should maintain the conserved hydrophobic core and display the typical compact, globular architecture of Kunitz-type inhibitors, ensuring proper folding and functional activity in disrupting hemostasis through anticoagulant effects."}
{"description": "sp|Q1W694|B1Q_LOXIN Dermonecrotic toxin LiSicTox-betaID1 OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MQLFIILCLAGSAVQLEGTELDGVERADNRRPIWNIAHMVNDKGLIDEYLDDGANSVESDVSFDSNGKPEKMLHGSPCDCGRSCKRQMSFADYLDYMRQLTTPGDPKFRENLILVMLDLKLKKLSSEQAYSAGQEVASQMLDKYWKRGESGARAYIVLSIPTITRVTFVNGFYDKLHSEGFDQYREKVGVDFSGNEDLEDTGKILKSRDILDHIWQSDGITNCLFRIMKRLKAAIRKRDSNGYMVKVYTWSVDKYTTMRKALRAGADGMITNFPKRLVSVLNEREFSGKFRLATYNDNPWERYTG", "prompt": "Design a dermonecrotic toxin protein sequence inspired by the venom of the brown spider Loxosceles intermedia. This toxin belongs to the SicTox family and exhibits betaID1 structural characteristics. The protein should function as a potent phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes, leading to profound dermonecrotic effects, complement-dependent hemolysis, and platelet aggregation. The molecular mechanism involves cleavage of phospholipid head groups, generating ceramide-1-phosphate and choline, which triggers inflammatory cascades and cell death. The protein should adopt the characteristic (β/α)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the conserved catalytic motif HxK(x)4D facilitating metal ion coordination for phosphodiester bond hydrolysis. Key structural elements include a deep active site pocket accommodating the phospholipid substrate, flexible loops governing substrate specificity, and surface residues mediating membrane association. The sequence should encode appropriate signal peptides for venom gland secretion and maintain the essential disulfide connectivity stabilizing the barrel architecture. The toxin should demonstrate specificity for mammalian cell membranes while avoiding non-target toxicity, reflecting its role in spider envenomation for prey immobilization and defense."}
{"description": "sp|Q7Z094|I1BA_CONRA Iota-conotoxin RXIA OS=Conus radiatus OX=61198 PE=1 SV=1", "sequence": "GPSFCKADEKPCEYHADCCNCCLSGICAPSTNWILPGCSTSSFFKI", "prompt": "Design a novel protein sequence for an animal venom toxin with the following specifications: This toxin is iota-conotoxin RXIA, derived from the venom of the marine cone snail Conus radiatus. As a member of the iota-conotoxin family, it functions as a potent neurotoxin that selectively targets and inhibits voltage-gated sodium channels (VGSCs), specifically Nav1.6 channels, leading to disruption of neuronal excitability and synaptic transmission. The toxin should adopt the characteristic conotoxin cysteine framework IV (C-C-CC-C-C), forming three disulfide bridges that stabilize a compact, globular fold. The structural scaffold is expected to feature an inhibitor cystine knot (ICK) motif, common to many conotoxins, which confers high stability and resistance to proteolytic degradation. Key functional residues should be positioned to interact with the pore region of domain IV of the Nav1.6 channel, blocking sodium ion flux and causing paralysis in prey. The sequence must include conserved conotoxin signal peptides for proper folding and disulfide bond formation, and the mature toxin should exhibit high affinity and specificity for its target, reflecting the evolutionary adaptation of Conus radiatus venom for hunting small fish or invertebrates."}
{"description": "sp|P15221|BEI2_MESEU Toxin BeI2 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "ADGYVKGKSGCKISCFLDNDLCNADCKYYGGKLNSWCIPDKSGYCWCPNKGWNSIKSETNTC", "prompt": "Generate the amino acid sequence for a scorpion beta-toxin from Mesobuthus eupeus venom, specifically the BeI2 toxin variant. This toxin functions as a voltage-gated sodium channel (Nav) modulator, primarily targeting insect sodium channels to induce paralysis and death in prey. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The molecular mechanism involves binding to site 4 on the voltage-sensing module of domain II of insect Nav channels, delaying channel inactivation and causing prolonged depolarization. The structural core should include the conserved 'pharmacophore' residues responsible for receptor recognition and selectivity, particularly those conferring insect specificity over mammalian channels. The sequence should reflect the compact, globular fold stabilized by the disulfide network, with surface-exposed loops critical for target interaction and the characteristic electrostatic surface potential that facilitates binding to the voltage sensor."}
{"description": "sp|P0C1W5|CDKA_CONVX Alpha-conotoxin VxXXA OS=Conus vexillum OX=89431 PE=1 SV=2", "sequence": "MPKLEMMLLVLLIFPLSYFIAAGGQVVQVDRRGDGLAGYLQRGDRDVQDCQVSTPGSKWGRCCLNRVCGPMCCPASHCYCVYHRGRGHGCSC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus vexillum, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the essential cysteine framework (CC-C-C) with appropriate inter-cysteine loop regions that confer target specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that form the receptor binding interface. The toxin should exhibit high affinity binding to its nAChR target through specific interactions with receptor subunit interfaces, likely involving complementary electrostatic and hydrophobic contacts. The designed sequence must maintain the typical alpha-conotoxin molecular weight range (1.5-2.5 kDa) and demonstrate stability through the conserved disulfide architecture that defines this toxin family."}
{"description": "sp|P84899|BRK4_PITHY [Val1,Thr6]-bradykinyl-Gln,Ser OS=Pithecopus hypochondrialis OX=317381 PE=1 SV=2", "sequence": "MSILKKSLFLVLFLGLVSFSICEEEKREAEEEENEDEIEEQSEEKKRFEPVPPGFTPFRQS", "prompt": "Generate the amino acid sequence for a bradykinin-potentiating peptide derived from the skin secretion of the frog Pithecopus hypochondrialis. This peptide functions as a potent vasoactive toxin that enhances the effects of endogenous bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby prolonging bradykinin-mediated vasodilation and hypotension. The peptide should feature the characteristic bradykinin sequence [Val1,Thr6]-bradykinyl-Gln,Ser modification pattern, which confers enhanced stability and potency against ACE degradation. Structurally, it should adopt a flexible, linear conformation typical of small bioactive peptides, with key residues positioned for optimal interaction with the ACE active site. The sequence should maintain the conserved bradykinin core while incorporating the specified N-terminal and C-terminal modifications that enhance its pharmacological profile and resistance to proteolytic cleavage."}
{"description": "sp|E5L0E6|VSPCA_AGKPL Protein C activator OS=Agkistrodon piscivorus leucostoma OX=459671 PE=2 SV=1", "sequence": "MVLIRVLANLLILHLSYAQKSSELVIGGDECNINEHRFLALVYANGSLCGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLNKDALRRFPKEKYFCLNIRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCRVMGWGTITSPNATLPDVPHCANINILDYAVCQAAYRGLAATTLCSGILEGGKDTCKGDSGGPLICNGQFQGILSVGGNPCAQPRKPGVYTKVFDYTDWIQSIISGNTDAACPP", "prompt": "Design a protein sequence for a snake venom serine protease from the venom of the western cottonmouth (Agkistrodon piscivorus leucostoma), a North American pit viper. This enzyme functions as a potent Protein C activator, playing a critical role in the venom's hemorrhagic and coagulopathic effects by hijacking the mammalian coagulation cascade. The protein should exhibit the characteristic structural features of snake venom serine proteases, including a chymotrypsin-like fold with a conserved catalytic triad (His, Asp, Ser) and multiple disulfide bridges that stabilize the globular structure. The sequence should contain specific substrate-binding exosites that enable selective recognition and cleavage of Protein C at appropriate activation sites, converting it to activated Protein C. This activation leads to enhanced anticoagulant activity through the degradation of coagulation factors Va and VIIIa, resulting in systemic anticoagulation and contributing to prey immobilization. The structural scaffold should maintain the typical two-domain organization of serine proteases with well-defined substrate-binding pockets and surface loops that mediate target specificity while ensuring proteolytic stability through proper disulfide connectivity."}
{"description": "sp|Q7LZK8|SLB_BITAR Snaclec bitiscetin subunit beta OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "DEGCLPDWSSYKGHCYKVFKVEKTWADAEKFCKELVNGGHLMSVNSREEGEFISKLALEKMRIVLVWIGLSHFWRICPLRWTDGARLDYRALSDEPICFVAESFHNKWIQWTCNRKKSFVCKYRV", "prompt": "Design a protein sequence for the beta subunit of bitiscetin, a C-type lectin-like protein (snaclec) from the venom of the puff adder (Bitis arietans). This heterodimeric toxin functions as a platelet aggregation agonist by specifically binding to the platelet membrane glycoprotein Ib (GPIb) complex, mimicking the physiological ligand von Willebrand factor. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two intrachain disulfide bonds with a typical C-C-C-C cysteine framework. Key structural elements include a concave surface formed by beta-sheets that mediates target recognition, with specific residues in the carbohydrate recognition domain (CRD)-like region responsible for high-affinity binding to GPIb. The sequence should encode a functional subunit that assembles with the alpha subunit to form the active heterodimer, which cross-links platelets and induces thrombus formation through GPIb-mediated signaling. Include conserved calcium-binding motifs if applicable to maintain structural integrity and functional specificity."}
{"description": "sp|A7X4J4|WAP1_RHATT Waprin-Rha1 OS=Rhabdophis tigrinus tigrinus OX=193080 PE=3 SV=1", "sequence": "MQARVFLLLLGVILLGMMGPMVSAQDGKAGSCPDVNQPIPPLGVCKTTCATDSNCPDIQKCCKNGCGHMSCTRPST", "prompt": "Design a protein sequence for a waprin toxin derived from the venom of the Yamakagashi snake, Rhabdophis tigrinus tigrinus. This toxin should function as a serine protease inhibitor, playing a defensive role in the snake's venom arsenal by disrupting prey homeostasis through interference with key proteolytic pathways. The protein must adopt the characteristic whey acidic protein (WAP) four-disulfide core domain fold, featuring a compact, globular structure stabilized by four conserved disulfide bridges arranged in a specific 1-3, 2-4, 5-6, 7-8 connectivity pattern. The sequence should include eight cysteine residues forming these disulfide bonds, which constrain the protein into a stable, double-loop architecture essential for its inhibitory function. The structural core should present exposed loop regions that mediate interaction with target serine proteases, potentially through a canonical binding mechanism. The overall molecular architecture should be small, stable, and functionally optimized for protease inhibition, reflecting the evolutionary adaptation of this toxin in snake venom."}
{"description": "sp|D2Y497|O16C_CONCL Conotoxin Cal6.1c (Fragment) OS=Californiconus californicus OX=1736779 PE=2 SV=1", "sequence": "GLNRPSKRCLAGSAPCEFHKRSTCCSGHCIIWWCA", "prompt": "Design a novel conotoxin sequence inspired by the venom arsenal of the marine snail Californiconus californicus, a species endemic to the Eastern Pacific. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the alpha9alpha10 subtype, which is implicated in neuropathic pain pathways. The sequence must adopt the O1-superfamily conotoxin framework, characterized by a conserved cysteine pattern (C-C-CC-C-C) that forms three disulfide bonds stabilizing a compact, globular fold. Incorporate key pharmacophore residues in the inter-cysteine loops that mediate high-affinity binding to the receptor's orthosteric site, disrupting cholinergic signaling. Ensure the sequence exhibits the hallmark properties of conotoxins: high stability, target specificity, and minimal off-target effects, suitable for potential therapeutic development in pain management."}
{"description": "sp|P0C1X1|CA4A_CONMA Conotoxin MIVA OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSIPSDRASDGRNAVVHERAPELVVTATTNCCGYNPMTICPPCMCTYSCPPKRKPGRRND", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of the marine cone snail Conus magus, a predatory species that employs neurotoxic peptides for prey capture. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuromuscular junction subtypes to induce rapid paralysis. The sequence must adopt the conserved alpha-conotoxin structural framework characterized by a compact globular fold stabilized by two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the characteristic CC-C-C motif. The mature peptide should be approximately 16-18 amino acids in length, featuring the signature alpha-conotoxin cysteine scaffold with four conserved cysteine residues that form the disulfide bridges essential for structural integrity and receptor binding. The 3D structure should exhibit the typical alpha-conotoxin fold with a short alpha-helical segment and beta-turn elements that create a precise pharmacophore for nAChR interaction. The binding interface should target the orthosteric site of muscle-type nAChRs, with key residues positioned to competitively block acetylcholine binding through strategic aromatic and cationic side chains that mimic natural neurotransmitter interactions. The sequence must maintain the characteristic N-terminal region with conserved hydrophobic residues and a C-terminal amidated tail for enhanced stability and receptor affinity, while incorporating specific loop sequences that confer selectivity for neuromuscular nAChR subtypes over neuronal variants."}
{"description": "sp|Q1PHZ4|VM3B1_BOTJR Zinc metalloproteinase-disintegrin-like BjussuMP-1 (Fragment) OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "EFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRQITTYPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWEYEEPIKKASKLVVTAEQQKFPYRYVEIVVVVDRRMVTKYNGDLKKIRKWVYELVNIVNNIYRSLNVHVALVGLEIWSKGDKITVQPDSDYTLNSFGEWRERDLLPRKKHDNAQLLTAVVFDGPTIGRAYIAGMCDPRHSVGVVMDHSKENLQVAVTMAHELGHNLGMEHDENQCHCDAPSCVMASVLSVVLSYEFSDCSQNQYQTYLTKHNPQCILNEPLLTVSGNELLEAGEECDCGAPENPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHRNGQPCLYNHGYCYNGKCPIMFYQCYFLFGSNATVAEDDCFNNNKKGDKYFYCRKENEKYIPCAQEDVKCGRLFCDNKKYPCHYNYSEDLDFGMVDHGTKCADGKVCSNRQCVDVNEAYKSTTVFSLI", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin derived from Bothrops jararacussu, a medically significant pit viper whose venom components play crucial roles in prey immobilization and tissue digestion. This toxin belongs to the reprolysin family of zinc-dependent metalloproteinases and functions as a key hemorrhagic agent by degrading components of the basement membrane and extracellular matrix, particularly type IV collagen, laminin, and fibronectin. The protein should feature a multi-domain architecture including a prodomain, a catalytic metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH for proteolytic activity, and a disintegrin-like domain that may interfere with integrin-mediated cell adhesion. The sequence must incorporate the characteristic cysteine-rich patterns of SVMPs, with multiple disulfide bridges stabilizing the proteinase and disintegrin-like domains. The structural scaffold should adopt the typical metzincin fold for the catalytic domain, with a central five-stranded beta-sheet and surrounding helices, while the disintegrin-like domain may exhibit an integrin-binding loop structure. This toxin targets vascular endothelial cells and extracellular matrix proteins, with its metalloproteinase domain binding to and cleaving specific substrates through its active site cleft, while the disintegrin-like domain may interact with integrins such as αβ1 or αβ3 to disrupt cell-matrix interactions, collectively contributing to hemorrhage, edema, and tissue damage characteristic of Bothrops envenomation."}
{"description": "sp|P0DUC1|TX1A_MONBA Mu/omega-theraphotoxin-Mb1a OS=Monocentropus balfouri OX=2053173 PE=1 SV=1", "sequence": "GVDKPGCRYMFGGCVQDDDCCPHLGCKRKGLYCAWDGT", "prompt": "Design a novel animal venom toxin protein sequence inspired by the mu/omega-theraphotoxin family from the Monocentropus balfouri (Socotra Island blue baboon tarantula). This toxin should function as a dual-action neurotoxin targeting both voltage-gated sodium channels (Nav) and calcium channels (Cav) in the peripheral nervous system. The protein should adopt the inhibitor cystine knot (ICK) structural fold, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a rigid, knotted core. The molecular mechanism involves pore blockade of Nav channels to inhibit action potential generation while simultaneously modulating Cav channels to disrupt neurotransmitter release. Key structural elements should include: a hydrophobic patch on the beta-hairpin for membrane interaction, flexible loops for target recognition specificity, and conserved residues for maintaining the ICK scaffold integrity. The toxin should exhibit high affinity for insect and mammalian neuronal channels, reflecting its evolutionary role in prey immobilization and defense. The sequence should maintain the characteristic cysteine framework of theraphotoxins while incorporating unique loop variations that confer the dual-channel targeting capability."}
{"description": "sp|Q7Z096|I1BC_CONRA Iota-conotoxin-like r11c OS=Conus radiatus OX=61198 PE=1 SV=2", "sequence": "MKLCLTFLLVLMILASVTGEKSSKHTLSRAARVKNRGPSFCKADEKPCKYHADCCNCCLGGICKPSTSWIGCSTNVFLTR", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The protein is an iota-conotoxin from the marine cone snail Conus radiatus, belonging to the conotoxin superfamily. As an iota-conotoxin, it functions as a voltage-gated sodium channel (NaV) modulator, specifically targeting and inhibiting NaV channels in prey organisms to induce paralysis. The toxin should adopt the characteristic conotoxin structural scaffold with a conserved disulfide bonding pattern—typically a cysteine framework involving four cysteine residues forming two disulfide bridges (e.g., C-C-CC or similar, common in conotoxins), which stabilizes a compact, globular fold. The sequence should include key residues for target binding, such as hydrophobic or charged amino acids that interact with NaV channel domains (e.g., domain II or IV S3-S4 loops), and maintain high specificity and potency. The structural motif is expected to be rigid and stable, with beta-sheets or loops critical for receptor engagement. The biological context involves the venom's role in prey immobilization, leveraging sodium channel blockade to disrupt neuromuscular transmission. Ensure the sequence reflects the evolutionary adaptation of Conus radiatus for hunting, with no database IDs or accession numbers included."}
{"description": "sp|D2Y493|U63A_CONCL Conotoxin Cal6.3a OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MRFLHFLIVAVLLASFMESGAMPRNPKKKRGWDTPAPCRYCQWNGPQCCVYYCSSCNYEEAREEGHYVSSHLLERQGR", "prompt": "Design a novel conotoxin sequence inspired by the Cal6.3a conotoxin from the venom of the California cone snail, Californiconus californicus. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha3beta2 subtype, to induce paralysis in prey by blocking synaptic transmission. The sequence must adopt the conserved alpha-conotoxin fold, characterized by a compact globular structure stabilized by two disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the characteristic cysteine framework I (CC-C-C). The mature peptide should be approximately 16-20 amino acids in length, featuring the signature two-loop architecture with loop1 determining receptor subtype selectivity and loop2 contributing to binding affinity. The structural core should exhibit the typical alpha-conotoxin pharmacophore with key residues for receptor interaction, including conserved hydrophobic patches and polar residues for specific hydrogen bonding with the receptor's ligand-binding domain. The toxin should demonstrate high conformational stability in aqueous environments while maintaining specificity for neuronal over muscle-type nicotinic receptors."}
{"description": "sp|P63019|SCX12_CENNO Alpha-toxin Cn12 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "RDGYPLASNGCKFGCSGLGENNPTCNHVCEKKAGSDYGYCYAWTCYCEHVAEGTVLWGDSGTGPCRS", "prompt": "Design a potent alpha-toxin from the venom of the Mexican scorpion Centruroides noxius, a species known for producing neurotoxic peptides that target voltage-gated sodium channels. This toxin should function as a specific modulator of sodium channel inactivation, binding to site 3 on the channel's voltage-sensing domain to delay channel closure and prolong action potentials, leading to neuronal hyperexcitability and neuromuscular dysfunction. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C-C-C-C cysteine framework. The structure should contain a core beta-sheet stabilized by an alpha-helix, with key functional residues clustered in loops that form the molecular interface for specific recognition of mammalian sodium channel subtypes. The toxin should exhibit high affinity binding to neuronal sodium channels while maintaining the thermal stability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|A0A3F2YLP5|NTA_AVIAU Kappa-theraphotoxin-Aa1a OS=Avicularia aurantiaca OX=2652665 PE=1 SV=2", "sequence": "GDCHKFLGWCRGEKDPCCEHLTCHVKHGWCVWDGTI", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-theraphotoxin, specifically kappa-theraphotoxin-Aa1a, originating from the pinktoe tarantula Avicularia aurantiaca. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characteristic of spider venom peptides. The core function of this toxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The molecular mechanism involves high-affinity binding to the pore region of Kv channels, thereby inhibiting potassium efflux and prolonging action potentials, leading to hyperexcitability and paralysis in prey. The structural scaffold must feature the canonical ICK motif, stabilized by a conserved disulfide bridge pattern with a cysteine framework of C-C-CC-C-C, forming a knotted topology that confers exceptional stability and resistance to proteolytic degradation. The anticipated 3D structure includes a compact, triple-stranded beta-sheet core constrained by the disulfide knot, with flexible loops that mediate target recognition and binding. Key functional residues are expected in these loops, particularly those involved in channel pore occlusion. The biological significance of this toxin in A. aurantiaca venom lies in its role in prey immobilization, working synergistically with other venom components to ensure rapid subjugation. Ensure the sequence reflects these structural and functional attributes, with appropriate length (typically 30-40 residues), cysteine spacing for correct disulfide connectivity, and conserved motifs for potassium channel antagonism."}
{"description": "sp|P19959|3S12_AIPLA Short neurotoxin B OS=Aipysurus laevis OX=8678 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCCNQQSSQPKTTTDCADNSCYKMTWRDHRGTRIERGCGCPQVKPGIKLECCKTNECNN", "prompt": "Design a protein sequence for a short neurotoxin from the olive sea snake (Aipysurus laevis) venom. This toxin belongs to the three-finger toxin superfamily and functions as a postsynaptic neurotoxin that specifically targets nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C, forming a compact globular structure. The molecular mechanism involves competitive antagonism of acetylcholine binding, leading to reversible neuromuscular blockade and paralysis. Key structural features include three extended β-stranded loops (fingers) emanating from a central hydrophobic core, with the central loop containing critical residues for receptor binding and specificity. The toxin should exhibit high affinity for muscle-type nicotinic receptors while maintaining the thermal stability and protease resistance typical of snake venom neurotoxins. The sequence should reflect the evolutionary optimization for rapid prey immobilization through precise receptor targeting."}
{"description": "sp|Q53B47|3SX5_OPHHA Short neurotoxin OH-5 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKNLLLTFLVVTIVCLDLGYTLICHRVHGLQTCEPDQKFCFRKTTMFFPNHPVLLMGCTYSCPTEKYSVCCSTDKCNK", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom components of the king cobra (Ophiophagus hannah). This toxin should function as a postsynaptic neurotoxin that specifically and irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding to induce rapid flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I pattern (C-C-CC-C-C). The structure should feature a central β-sheet core with the second loop containing the critical functional residues for receptor binding and specificity. The mature toxin should be approximately 60-70 amino acids in length with the conserved structural scaffold that enables high-affinity binding to muscle-type nicotinic acetylcholine receptors, effectively blocking neurotransmission and causing neuromuscular blockade. The sequence should maintain the essential pharmacophore residues responsible for the toxin's potent neurotoxic activity while preserving the structural integrity of the three-finger motif."}
{"description": "sp|A7X4K1|WAP1_PHIOL Waprin-Phi1 OS=Philodryas olfersii OX=120305 PE=2 SV=1", "sequence": "MTLRRGSCPLLLFSLVGLLTTCAQEPDAAGQNTTAVAEKAGTCPQAELEMPDRNCTEACQSDAGCEENKKCCRTGCGTSCQIPDEKPGSCPNVDTPIPPLGLCKTTCSKDSDCSETKKCCKNGCGFMTCTTARP", "prompt": "Design a novel waprin-family toxin protein sequence inspired by the venom of the green snake Philodryas olfersii. This protein should exhibit the characteristic structural and functional properties of waprins, which are small, non-enzymatic venom components typically involved in prey immobilization through potential antimicrobial or protease inhibitory activities. The sequence must feature the conserved waprin structural scaffold, characterized by a compact, disulfide-stabilized fold with a WAP domain signature containing multiple disulfide bridges that confer exceptional stability. Specifically, incorporate the canonical eight-cysteine pattern (C-C-C-C-C-C-C-C) that forms four disulfide bonds, creating a rigid, globular structure resistant to proteolytic degradation and extreme conditions. The protein should adopt the typical waprin three-dimensional fold, consisting of a central core stabilized by the disulfide network with exposed loops that may mediate molecular interactions. While the exact molecular target in Philodryas olfersii venom remains to be fully characterized, waprins generally function through mechanisms such as ion channel modulation, protease inhibition, or antimicrobial activity, contributing to the venom's overall prey subjugation strategy. Ensure the sequence reflects the evolutionary adaptation of this protein family in rear-fanged colubrid snakes, where it likely plays a role in complementing the venom's pharmacological arsenal. The final design should prioritize structural integrity through proper disulfide connectivity while maintaining potential for biological activity relevant to venom function."}
{"description": "sp|B3EWI9|OXLA_BOTMT L-amino-acid oxidase (Fragment) OS=Bothrops mattogrossensis OX=1171125 PE=1 SV=1", "sequence": "IKFEPPLPPKKAHKKFWEDDGIYYPPNHNFP", "prompt": "Design a functional fragment of an L-amino-acid oxidase toxin from the venom of Bothrops mattogrossensis, a pit viper species. This enzyme represents a key component of viperid venom systems, contributing to the complex prey immobilization and digestion strategy through oxidative deamination of L-amino acids. The generated protein should function as a flavoenzyme containing a non-covalently bound FAD cofactor that catalyzes the oxidation of L-amino acids to corresponding α-keto acids, producing hydrogen peroxide and ammonia as byproducts. The resulting hydrogen peroxide contributes to local tissue damage, hemorrhage, and cytotoxicity through oxidative stress mechanisms. The protein scaffold should adopt the characteristic Rossmann fold architecture typical of L-amino-acid oxidases, featuring a conserved FAD-binding domain with βαβ dinucleotide-binding motifs and a substrate-binding domain that accommodates various L-amino acid side chains. Key catalytic residues should include a conserved histidine that facilitates substrate deprotonation and a water network for proton transfer. The enzyme should exhibit the characteristic yellow coloration due to FAD binding and demonstrate preferential substrate specificity toward hydrophobic L-amino acids. The structural design should ensure proper FAD binding pocket geometry, substrate access channel formation, and maintenance of the dimeric interface observed in functional L-amino-acid oxidases, as this oligomeric state is crucial for catalytic activity and stability in the venom environment."}
{"description": "sp|Q7Z092|I1BB_CONRA Iota-conotoxin-like r11b OS=Conus radiatus OX=61198 PE=1 SV=1", "sequence": "GPSFCKANGKPCSYHADCCNCCLSGICKPSTNVILPGCSTSSFFRI", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications. The protein is an iota-conotoxin derived from the venom of Conus radiatus, a marine cone snail species. This toxin belongs to the conotoxin superfamily, which are small, disulfide-rich peptides that target specific ion channels and receptors in the nervous system. The biological significance of this toxin lies in its role in the predatory venom of Conus radiatus, where it contributes to rapid prey immobilization by disrupting neuromuscular signaling. The core function of this iota-conotoxin is to act as a potent antagonist of voltage-gated sodium channels, specifically targeting neuronal subtypes to inhibit action potential generation and propagation. Its mechanism of action involves high-affinity binding to site 4 of voltage-gated sodium channels, leading to channel inhibition and blockade of neuronal excitability. The protein is expected to adopt the conserved structural framework characteristic of iota-conotoxins, featuring a specific cysteine framework (C-C-CC-C-C) that forms three disulfide bridges with a connectivity pattern of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, stabilizing a compact, globular fold. The anticipated 3D structure includes a well-defined inhibitory cystine knot (ICK) motif, common to many conotoxins, which provides exceptional stability and resistance to proteolytic degradation. Key structural elements include a beta-hairpin region and several flexible loops that contribute to target recognition and binding. The molecular target is voltage-gated sodium channels, with high specificity for neuronal isoforms such as Nav1.1, Nav1.2, or Nav1.6. The binding interface involves interactions with the channel's pore region and voltage-sensing domains, mediated by specific residues in the toxin's loops and surface patches that confer selectivity and potency. The sequence should reflect these functional and structural characteristics, including the precise cysteine framework, conserved residues critical for folding and activity, and variable regions that define target specificity and pharmacological properties."}
{"description": "sp|P0DQN1|PE1A_PHOEV Beta/mu-theraphotoxin-Pe1a OS=Phormingochilus everetti OX=2751878 PE=1 SV=1", "sequence": "ECKYLWGTCSKDEDCCAHLGCNRKHDWCGWDYTF", "prompt": "Generate a protein sequence for a potent animal venom toxin from the tarantula species Phormingochilus everetti. This toxin belongs to the beta/mu-theraphotoxin family, specifically designated as Pe1a, and functions as a dual-action neurotoxin targeting both voltage-gated sodium channels (VGSCs) and voltage-gated potassium channels (VGPCs). The biological significance of this toxin lies in its role in the tarantula's venom arsenal for prey immobilization and defense, acting through modulation of neuronal excitability to induce paralysis. Its core mechanism involves inhibition of sodium channel inactivation, leading to prolonged depolarization and hyperexcitability, while simultaneously blocking potassium channels to further disrupt action potential repolarization. The toxin is expected to adopt the inhibitor cystine knot (ICK) structural motif, a hallmark of spider venom peptides, characterized by a compact, disulfide-stabilized globular fold with high thermal and proteolytic stability. The cysteine framework likely follows the conserved pattern C-C-CC-C-C, forming three disulfide bridges that create the knotted topology essential for structural integrity and target interaction. Key structural characteristics include a stable beta-hairpin or beta-sheet region and flexible loops that mediate specific binding to channel pore domains or voltage-sensing domains. The molecular target is primarily neuronal VGSCs (e.g., Nav1.2, Nav1.6) and delayed-rectifier VGPCs (e.g., Kv1.1, Kv1.2), with binding interfaces involving electrostatic and hydrophobic interactions at channel exteriors to alter gating dynamics. Ensure the sequence reflects these functional and structural attributes, with conserved residues for disulfide bonding, surface-exposed pharmacophore motifs for channel engagement, and overall physicochemical properties typical of ICK-fold spider toxins."}
{"description": "sp|Q5Y4U4|TX20A_AGEOR U8-agatoxin-Ao1a OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKSLLFVTIAVYFVAQAVTANLLSNFLGSSLIDDDKGNMHKLYKRSEDQCIGRSCTCDTSSTSCCPYAACRCNLWKTSCKCQRTGRKWATPCKEIYSPN", "prompt": "Design a protein sequence for a potent neurotoxin from the funnel-web spider Agelena orientalis. This toxin belongs to the ω-agatoxin family and functions as a selective voltage-gated calcium channel blocker, specifically targeting P/Q-type calcium channels in the presynaptic terminals of neurons. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded antiparallel beta-sheet stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. This structural scaffold provides exceptional thermal and proteolytic stability while presenting key functional loops that mediate high-affinity binding to the voltage-sensing domain of calcium channels. The mechanism involves pore blockade of Cav2.1 channels, leading to inhibition of neurotransmitter release at neuromuscular junctions and central synapses, resulting in rapid paralysis. The protein should exhibit the characteristic spider toxin pharmacophore with surface-exposed residues critical for channel recognition and subtype selectivity. The sequence must maintain the canonical ICK fold with appropriate spacing between cysteine residues to ensure proper disulfide connectivity and biological activity."}
{"description": "sp|D1MGU1|SLB_PROJR Snaclec jerdonibitin subunit beta OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADCPSDWSSYEGHCYRVFQQQMNWADAEKFCTQQRKESHLVSFESSEEVDFVVSKTFPILKENFVWIGLSNVWNGCRLQWSDGTELKYNAWSAESECIASKTTDNQWWSMDCSKTYPFVCKLIV", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent anticoagulant toxin. This protein should be modeled after jerdonibitin from the venom of Protobothrops jerdonii (Jerdon's pit viper), a species known for producing complex venom mixtures that disrupt hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The sequence should include key residues for calcium-dependent carbohydrate recognition domain functionality, though this snaclec primarily targets coagulation factors rather than carbohydrates. The mechanism of action involves binding to specific coagulation factors, likely factor IX or factor X, through a concave surface formed by the CTLD fold, thereby inhibiting the coagulation cascade and preventing blood clot formation. The protein should exhibit the typical heterodimeric structure of snaclecs, with this sequence representing the beta subunit that pairs with an alpha subunit to form the functional anticoagulant complex. The structural scaffold should maintain the characteristic β-sheet core with flanking α-helices that define the CTLD superfamily, with surface loops optimized for specific protein-protein interactions with coagulation factors."}
{"description": "sp|E5L0E5|VSPPA_AGKPL Venom plasminogen activator OS=Agkistrodon piscivorus leucostoma OX=459671 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVVFFNSSGFLCGGTSINQEWVLTAAHCDSKNFQMLFGVHSKKILNEDEQTRDPKEKFICPNRKKDDERDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISPTKVTYPDVPHCANINILDHAVCRAAYPTLLAESSTVCAGTQQEGKDTCGGDSGGPLICNGQIQGIVSWRAHPCGQGLKPGVYTKVFDYTDWIQSIISGNTDVTCPP", "prompt": "Design a venom-derived serine protease from the venom of the western cottonmouth (Agkistrodon piscivorus leucostoma) that functions as a potent plasminogen activator. This enzyme should exhibit the characteristic trypsin-like serine protease fold with a conserved catalytic triad (His57, Asp102, Ser195) and the distinctive venom-specific structural adaptations that enhance its fibrinolytic activity. The protein should contain the canonical serine protease domain architecture with appropriate substrate-binding pockets optimized for plasminogen recognition and cleavage. Incorporate the conserved disulfide bonding pattern typical of snake venom serine proteases that stabilizes the protease domain and contributes to its exceptional stability in the venom milieu. The enzyme should demonstrate high specificity for converting plasminogen to plasmin, thereby promoting fibrinolysis and contributing to the hemorrhagic and anticoagulant properties of cottonmouth venom. The structural scaffold should reflect the evolutionary adaptations that make this venom component particularly effective at disrupting hemostasis through targeted proteolytic activation of the fibrinolytic cascade."}
{"description": "sp|Q25338|LITD_LATTR Delta-latroinsectotoxin-Lt1a OS=Latrodectus tredecimguttatus OX=6925 PE=1 SV=1", "sequence": "MHSKELQTISAAVARKAVPNTMVIRLKRDEEDGEMTLEERQAQCKAIEYSNSVFGMIADVANDIGSIPVIGEVVGIVTAPIAIVSHITSAGLDIASTALDCDDIPFDEIKEILEERFNEIDRKLDKNTAALEEVSKLVSKTFVTVEKTRNEMNENFKLVLETIESKEIKSIVFKINDFKKFFEKERQRIKGLPKDRYVAKLLEQKGILGSLKEVREPSGNSLSSALNELLDKNNNYAIPKVVDDNKAFQALYALFYGTQTYAAVMFFLLEQHSYLADYYYQKGDDVNFNAEFNNVAIIFDDFKSSLTGGDDGLIDNVIEVLNTVKALPFIKNADSKLYRELVTRTKALETLKNQIKTTDLPLIDDIPETLSQVNFPNDENQLPTPIGNWVDGVEVRYAVQYESKGMYSKFSEWSEPFTVQGNACPTIKVRVDPKKRNRLIFRKFNSGKPQFAGTMTHSQTNFKDIHRDLYDAALNINKLKAVDEATTLIEKGADIEAKFDNDRSAMHAVAYRGNNKIALRFLLKNQSIDIELKDKNGFTPLHIAAEAGQAGFVKLLINHGADVNAKTSKTNLTPLHLATRSGFSKTVRNLLESPNIKVNEKEDDGFTPLHTAVMSTYMVVDALLNHPDIDKNAQSTSGLTPFHLAIINESQEVAESLVESNADLNIQDVNHMAPIHFAASMGSIKMLRYLISIKDKVSINSVTENNNWTPLHFAIYFKKEDAAKELLKQDDINLTIVADGNLTVLHLAVSTGQINIIKELLKRGSNIEEKTGEGYTSLHIAAMRKEPEIAVVLIENGADIEARSADNLTPLHSAAKIGRKSTVLYLLEKGADIGAKTADGSTALHLAVSGRKMKTVETLLNKGANLKEYDNNKYLPIHKAIINDDLDMVRLFLEKDPSLKDDETEEGRTSIMLIVQKLLLELYNYFINNYAETLDEEALFNRLDEQGKLELAYIFHNKEGDAKEAVKPTILVTIKLMEYCLKKLREESGAPEGSFDSPSSKQCISTFSEDEMFRRTLPEIVKETNSRYLPLKGFSRSLNKFLPSLKFAESKNSYRSENFVSNIDSNGALLLLDVFIRKFTNEKYNLTGKEAVPYLEAKASSLRIASKFEELLTEVKGIPAGELINMAEVSSNIHKAIASGKPVSKVLCSYLDTFSELNSQQMEELVNTYLSTKPSVITSASADYQKLPNLLTATCLEPERMAQLIDVHQKMFLR", "prompt": "Design a novel protein sequence for a delta-latroinsectotoxin from the venom of the Mediterranean black widow spider (Latrodectus tredecimguttatus). This toxin belongs to the latrotoxin family, which are large, presynaptic neurotoxins that form cation-selective pores in neuronal membranes. The protein should function as an insect-specific neurotoxin, selectively targeting insect neuromuscular junctions. It should adopt the characteristic latrotoxin fold with multiple domains, including an N-terminal domain involved in receptor binding and a C-terminal pore-forming domain. The mechanism of action involves binding to specific insect neuronal receptors (likely neurexins or related proteins), triggering massive neurotransmitter release through calcium-dependent exocytosis, ultimately causing paralysis and death in insect prey. The structure should feature the conserved cysteine pattern typical of latrotoxins, forming multiple disulfide bridges that stabilize the complex tertiary structure. The protein should exhibit high specificity for insect neuronal targets while showing minimal activity against mammalian systems, reflecting the evolutionary adaptation of widow spider venom for prey capture. The sequence should maintain the key functional motifs for receptor recognition and pore formation that define this insecticidal neurotoxin class."}
{"description": "sp|P0DJ36|KKX31_HETPE Potassium channel toxin kappa-KTx 3.1 OS=Heterometrus petersii OX=754296 PE=1 SV=1", "sequence": "MKSTLMTASVLILVLLSIVDYASVYAEFIDSEISLERQWINACFNVCMKISSDKKYCKYLCGKN", "prompt": "Design a potassium channel toxin protein sequence that captures the biological and structural characteristics of kappa-KTx 3.1 from the venom of the Asian forest scorpion Heterometrus petersii. This toxin belongs to the kappa-KTx family of scorpion toxins that specifically target potassium channels. The protein should function as a potent potassium channel blocker, likely interfering with neuronal excitability and neuromuscular transmission through selective binding to voltage-gated potassium channels. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion toxins, with a conserved disulfide bridge pattern that stabilizes the core structure. The sequence should include key functional residues for potassium channel recognition and binding, particularly in the beta-sheet regions that typically form the functional surface for channel interaction. The toxin should exhibit the compact, stable globular architecture typical of scorpion venom peptides, with well-defined secondary structure elements including alpha-helices and beta-strands stabilized by the conserved disulfide framework. The molecular mechanism involves specific binding to the outer vestibule of potassium channels, physically occluding the ion conduction pathway and thereby inhibiting potassium efflux, leading to prolonged neuronal depolarization and enhanced neurotransmitter release."}
{"description": "sp|Q9YGN5|SLA_GLOBR Snaclec salmorin subunit A OS=Gloydius brevicauda OX=3148161 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADFFCPSGWGSNNGHCYQAFNQRMTWEDAERFCSAQAKGGHLVSIETRAEADFVAHVVAERIETSFPHVWIGLRDEGKEQQCSSEWSDGSSVSYENWIEAESKTCLGLELDSNYHKWVNVYCGQRNPFVCEA", "prompt": "Design a protein sequence for salmorin subunit A, a C-type lectin-like protein (snaclec) from the venom of the short-tailed mamushi, Gloydius brevicauda. This toxin functions as a potent platelet aggregation inhibitor by specifically binding to platelet membrane glycoproteins, likely GPIb or GPVI, thereby disrupting the initial stages of thrombus formation. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should include key residues for calcium-independent carbohydrate recognition domain functionality and maintain the signature β-sandwich architecture composed of antiparallel β-sheets. The molecular surface should feature a conserved hydrophobic patch and specific loop regions responsible for protein-protein interactions with platelet receptors. This snake venom lectin plays a crucial role in the hemorrhagic and anticoagulant properties of the venom by targeting hemostatic pathways."}
{"description": "sp|P0C1M2|CRBLF_VESMG Vespid chemotactic peptide 5f OS=Vespa magnifica OX=202807 PE=1 SV=1", "sequence": "FLPIPRPILLGLL", "prompt": "Design a novel venom peptide sequence inspired by the chemotactic peptide 5f from the venom of Vespa magnifica, the magnificent hornet. This peptide should function as a potent chemotactic factor that recruits and activates immune cells, particularly mast cells and neutrophils, to the site of envenomation, contributing to the intense local inflammatory response characteristic of hornet stings. The peptide should adopt a compact, stable structure stabilized by disulfide bonds, likely following a cysteine framework common to insect venom peptides such as the inhibitor cysteine knot (ICK) motif or a similar small, disulfide-rich scaffold. The sequence should include key residues for receptor binding, potentially involving formyl peptide receptors or other G-protein coupled receptors on immune cells, to elicit robust chemotaxis and degranulation. Ensure the peptide is amphipathic, with both hydrophobic and charged surfaces to facilitate membrane interactions and receptor engagement, while maintaining high stability and resistance to proteolytic degradation in the extracellular environment."}
{"description": "sp|B3EWN0|TXB1A_PTEMU Beta-theraphotoxin-Pmu1a OS=Pterinochilus murinus OX=1184495 PE=1 SV=1", "sequence": "DDCLGMFSSCDPDNDKCCEGRKCNRKDKWCKYVL", "prompt": "Design a beta-theraphotoxin venom peptide from the Mombasa golden starburst tarantula (Pterinochilus murinus) that functions as a potent neurotoxin targeting voltage-gated sodium channels. This peptide should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom toxins, featuring a compact triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The toxin should exhibit high-affinity binding to the voltage-sensing domain of sodium channels, causing delayed channel inactivation and prolonged neuronal excitation. The molecular mechanism involves interaction with specific extracellular loops of the channel protein, leading to hyperexcitability and neuromuscular dysfunction. The peptide should display the typical physicochemical properties of spider venom toxins, including high thermal stability, resistance to proteolytic degradation, and amphipathic surface properties that facilitate membrane interaction and target recognition."}
{"description": "sp|P0DUP2|PA2H2_CROLY Basic phospholipase A2 CoaTx-II OS=Crotalus lutosus abyssus OX=128077 PE=1 SV=1", "sequence": "SLVELGKMILQETGKNAIPSYGFYGCNCGWGGRGKPKDATDRCCFVHKCCYKKLTDCDPKTDIYSYSWKNKTIICDVNNPCLKEMCECDKAVAICLRENLDTYNKKYRIYPKFLCKKPDTC", "prompt": "Design a novel phospholipase A2 toxin protein sequence inspired by the venom of the Great Basin rattlesnake (Crotalus lutosus abyssus). This toxin should function as a basic phospholipase A2 enzyme with potent toxic activity. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. This mechanism leads to membrane disruption, inflammation, and potential neurotoxic, myotoxic, or anticoagulant effects characteristic of viperid snake venom phospholipases A2. The structural scaffold should feature the conserved phospholipase A2 fold with three long alpha-helices stabilized by a characteristic network of seven disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate, tyrosine) and calcium-binding loop motif. The protein should have an overall basic isoelectric point to facilitate membrane interaction and potent biological activity. Ensure the sequence maintains the characteristic N-terminal helix, beta-wing region, and C-terminal loop architecture typical of group II phospholipase A2 enzymes from viperid venoms."}
{"description": "sp|Q9TVN1|O16A_CONLI Conotoxin LvVIA (Fragment) OS=Conus lividus OX=89426 PE=2 SV=1", "sequence": "VLIIAVLFLTASELVTADYTRDKWQYRAASLRDAMRNFRDTRTCSPAGEVCTSKSPCCTGFLCSHIGGMCHH", "prompt": "Design a conotoxin protein sequence derived from the venom of the marine cone snail Conus lividus, specifically representing the conotoxin LvVIA variant. This toxin functions as a potent and selective antagonist of voltage-gated calcium channels, particularly targeting N-type (Cav2.2) calcium channels in the mammalian nervous system. The protein should adopt the characteristic conotoxin structural framework with a conserved disulfide bonding pattern, likely following the cysteine framework IV (C-C-CC-C-C) typical of omega-conotoxins that target calcium channels. The structural scaffold should feature the inhibitor cystine knot (ICK) motif, creating a compact, stable triple-stranded beta-sheet fold stabilized by multiple disulfide bridges that confer exceptional proteolytic resistance and thermal stability. Key functional residues should be positioned to interact with the pore-forming region of Cav2.2 channels, blocking calcium ion flux and thereby inhibiting neurotransmitter release at presynaptic terminals. This mechanism underlies the toxin's neurotoxic effects, causing paralysis in prey by disrupting neuromuscular transmission. The sequence should include the appropriate signal peptide cleavage site and propeptide region characteristic of conotoxin precursors, with the mature toxin domain exhibiting the precise cysteine spacing and conserved hydrophobic core that defines this pharmacologically important toxin family."}
{"description": "sp|Q7LZS9|VM1A_DEIAC Snake venom metalloproteinase Ac1 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "STEFQRYMEIVIVVDHSMVKKYNGDSPKIKAWVYEMINTITEGYRDLYIDIILSGLEIWSEKDLINVEASAGNTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCEPKLSVGVIQDHSSVNRLVAITLAHEMAHNLGVRHDEKDCVGVVYLCIMRIPVVEDKRSYFSDCSYIQCREYISKENPPCILNKP", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that embodies the toxicological profile characteristic of Deinagkistrodon acutus venom. This protein should function as a potent hemorrhagic toxin, targeting and degrading key components of the basement membrane and extracellular matrix, particularly type IV collagen, laminin, and fibronectin. The sequence must incorporate the canonical SVMP structural architecture, featuring a zinc-binding catalytic domain with the conserved HEXXHXXGXXH motif that coordinates the catalytic zinc ion essential for proteolytic activity. Include the characteristic Met-turn structural element that supports the active site. The protein should exhibit the multidomain organization typical of P-I class SVMPs, consisting primarily of the catalytic domain without additional disintegrin-like or cysteine-rich domains. Maintain the conserved cysteine residues that form specific disulfide bonds stabilizing the metalloproteinase fold. The structural scaffold should facilitate precise substrate recognition and cleavage, leading to capillary wall degradation, hemorrhage, and tissue damage. The protein must demonstrate calcium-dependent stability and optimal activity at physiological pH, reflecting its role in prey immobilization through disruption of vascular integrity and induction of systemic bleeding."}
{"description": "sp|P84915|MAST2_POLPI Polybia-MP-II OS=Polybia paulista OX=291283 PE=1 SV=1", "sequence": "INWLKLGKMVIDAL", "prompt": "Design a protein sequence for a mastoparan-class toxin derived from the venom of the social wasp Polybia paulista. This toxin should function as a potent mast cell degranulating peptide, inducing histamine release through direct interaction with G-proteins and phospholipase A2 activation. The protein should adopt a characteristic amphipathic alpha-helical structure in membrane environments, with a cationic surface that facilitates membrane interaction and pore formation. Key structural features should include: a conserved mastoparan scaffold with 14 amino acids, predominantly hydrophobic residues on one face and basic residues (lysine, arginine) on the opposite face, enabling both membrane insertion and receptor interaction. The mechanism should involve perturbation of lipid bilayers and activation of pertussis toxin-sensitive G-proteins, leading to calcium influx and subsequent degranulation. The sequence should maintain the typical mastoparan properties of high positive charge density and helical propensity while ensuring specific activity against mast cells for localized inflammatory responses."}
{"description": "sp|P50984|CA1A_CONPE Alpha-conotoxin PnIA OS=Conus pennaceus OX=37335 PE=1 SV=1", "sequence": "GCCSLPPCAANNPDYC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus pennaceus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where disulfide bridges connect Cys1-Cys3 and Cys2-Cys4 to form a compact, stable structure. The sequence should include the essential pharmacophore residues responsible for receptor binding and subtype selectivity, particularly in loop regions that interact with the nAChR ligand-binding interface. The toxin should exhibit high affinity for its target receptors while maintaining the typical alpha-conotoxin molecular weight of 1.5-2.5 kDa. The structural design should ensure proper folding into the inhibitory cysteine knot (ICK) motif common to conotoxins, with well-defined alpha-helical elements and beta-turn structures that contribute to receptor recognition and binding specificity. The final protein should demonstrate the paralytic activity characteristic of alpha-conotoxins through competitive inhibition of acetylcholine binding at neuronal nAChRs."}
{"description": "sp|P0C1X2|VKTS1_CONST Kunitz-type conkunitzin-S1 OS=Conus striatus OX=6493 PE=1 SV=1", "sequence": "MEGRRFAAVLILTICMLAPGTGTLLPKDRPSLCDLPADSGSGTKAEKRIYYNSARKQCLRFDYTGQGGNENNFRRTYDCQRTCLYT", "prompt": "Design a novel Kunitz-type conkunitzin toxin from the venom of the striated cone snail, Conus striatus, that functions as a potent serine protease inhibitor. This toxin should adopt the characteristic Kunitz domain fold, featuring a conserved alpha-beta structural motif with a twisted anti-parallel beta-sheet stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The protein should exhibit high affinity and specificity for serine proteases, likely targeting key enzymes in the prey's physiological pathways to disrupt homeostasis. Incorporate the signature reactive site loop that mediates protease inhibition through a substrate-like binding mechanism. The sequence should maintain the compact, globular architecture typical of Kunitz domains while optimizing surface residues for enhanced target recognition and inhibitory potency within the marine predatory context of cone snail venom."}
{"description": "sp|P68417|3S11_NAJHA Short neurotoxin 1 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LECHNQQSSQPPTTKTCPGETNCYKKRWRDHRGSITERGCGCPSVKKGIEINCCTTDKCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the snouted cobra (Naja annulifera), a species known for producing potent neurotoxic venom that causes rapid paralysis by targeting the neuromuscular junction. This toxin functions as a competitive antagonist of nicotinic acetylcholine receptors at the postsynaptic membrane, specifically binding with high affinity to the alpha-delta and alpha-gamma subunit interfaces to block acetylcholine binding and prevent depolarization of muscle cells. The protein should adopt the characteristic three-finger toxin fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C5, C2-C6, C3-C7, and C4-C8. The structure should feature a compact, globular shape with the central loop (loop II) containing key functional residues for receptor interaction, including a conserved hydrophobic patch and basic residues that mediate specific binding to the receptor's ligand-binding site. The sequence should include the conserved cysteine framework typical of short neurotoxins and maintain the structural integrity required for potent neuromuscular blockade."}
{"description": "sp|P0C1W6|CDKB_CONVX Alpha-conotoxin VxXXB OS=Conus vexillum OX=89431 PE=1 SV=3", "sequence": "MPKLAVVLLVLLILPLSYFDAAGGQAVQGDWRGNRLARDLQRGGRDDESECIINTRDSPWGRCCRTRMCGSMCCPRNGCTCVYHWRRGHGCSCPG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus vexillum, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where four cysteine residues form two disulfide bridges in a 1-3, 2-4 connectivity pattern. The structure should display the typical alpha-conotoxin pharmacophore with well-defined loops between cysteine residues that form the receptor binding interface. Key structural elements should include a conserved alpha-helical region and beta-turn motifs that create the precise molecular surface for high-affinity receptor interaction. The toxin should exhibit the hallmark properties of alpha-conotoxins: small size (typically 12-20 amino acids), high stability due to disulfide cross-linking, and selective targeting of specific nicotinic acetylcholine receptor subtypes. The mechanism of action involves competitive inhibition at the acetylcholine binding site, effectively blocking neurotransmission and contributing to the venom's paralytic effects on prey. The designed sequence should maintain the essential structural determinants for proper folding, receptor recognition, and toxic activity while incorporating sequence variations characteristic of the VxXXB lineage from Conus vexillum."}
{"description": "sp|Q7LZT4|VM2I2_GLOUS Disintegrin ussuristatin-2 OS=Gloydius ussuriensis OX=35671 PE=1 SV=1", "sequence": "EAGEECDCGAPANPCCDAATCKLRPGAQCAEGDCCEQCRFVKEGTVCREAKGDWNDDSCTGQSADCPRNGF", "prompt": "Design a protein sequence for a disintegrin toxin from the venom of the Ussuri pit viper (Gloydius ussuriensis). This toxin, known as ussuristatin-2, functions as a potent anti-platelet agent by specifically inhibiting platelet aggregation through blockade of integrin receptors on the cell surface. The protein should adopt the characteristic disintegrin fold, featuring the conserved RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to integrin receptors such as αIIbβ3 on platelets, thereby disrupting cell-matrix interactions and preventing thrombus formation. The sequence must include the appropriate cysteine framework typical of short-chain disintegrins, forming multiple disulfide bridges that stabilize the compact, globular structure and position the RGD loop for optimal receptor engagement. The overall architecture should consist of a small, stable protein with the RGD motif exposed in a flexible loop region critical for integrin recognition and inhibitory activity."}
{"description": "sp|P0DJ37|KKX32_HETPE Potassium channel toxin kappa-KTx 3.2 OS=Heterometrus petersii OX=754296 PE=1 SV=1", "sequence": "MKSTLMTASLLILVLLSIVDYASVYAELIDSEISMERHWINACFNICMKISSDQKYCKSFCG", "prompt": "Design a potassium channel toxin protein sequence inspired by the venom of the Asian forest scorpion Heterometrus petersii. This toxin belongs to the kappa-KTx family and functions as a selective inhibitor of voltage-gated potassium channels, particularly Kv1.3 channels, which play crucial roles in immune cell function and neuronal excitability. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three disulfide bridges with the connectivity pattern C1-C4, C2-C5, C3-C6. The structural core consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, forming a compact, globular domain. Key functional residues should be positioned in the beta-sheet region to interact with the pore region of the potassium channel, blocking ion conduction through a mechanism known as the 'functional dyad'—typically involving a critical lysine residue that projects into the selectivity filter and a neighboring aromatic residue that stabilizes binding. The toxin should exhibit high affinity and specificity for Kv1.3 channels, contributing to the venom's role in prey immobilization and defense by disrupting neuromuscular signaling and immune responses. Ensure the sequence reflects the typical length of 30-40 amino acids, with the disulfide pattern conferring stability and resistance to proteolysis."}
{"description": "sp|P0CH16|CM3B_CONPI Mu-conotoxin-like pr3b OS=Conus parius OX=505247 PE=1 SV=1", "sequence": "ERVCCGYPMSCKSRACKPSYCC", "prompt": "Generate the amino acid sequence for a mu-conotoxin from the marine cone snail Conus parius. This toxin functions as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4. The mechanism involves high-affinity binding to site 1 of the sodium channel, which physically occludes the ion conduction pore and prevents sodium influx, leading to rapid paralysis of prey. The toxin adopts the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich globular fold stabilized by a conserved cysteine framework (C-C-CC-C-C) that forms three intramolecular disulfide bridges. This arrangement creates a stable, protease-resistant structure with exposed loops that mediate precise interactions with the sodium channel's pore-forming domains. The mature toxin is expected to be a short peptide (approximately 22-26 residues) with a high density of basic residues that facilitate electrostatic interactions with the channel's acidic residues in the pore region. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade, a key predatory strategy in cone snail venoms."}
{"description": "sp|P0C248|COW_CONAA Contryphan-Am OS=Conus amadis OX=198732 PE=1 SV=2", "sequence": "MGKLTILVLVAAALLSTQVMVQGDGDQPADRDAVPRDDNPSGMSGKFMNVLRRAGCPWDPWCG", "prompt": "Design a novel peptide toxin sequence that captures the essential biological and structural characteristics of contryphan-Am from the marine cone snail Conus amadis. This peptide should function as a potent neurotoxin that modulates neuronal excitability by selectively targeting voltage-gated calcium channels, contributing to the predatory strategy of Conus amadis by inducing rapid paralysis in prey. The sequence must adopt a compact, disulfide-stabilized globular fold characteristic of the contryphan family, featuring a highly constrained backbone with a conserved cysteine framework (C-C-C-C) that forms two essential disulfide bridges critical for structural stability and biological activity. Incorporate key structural motifs including a tight beta-hairpin turn and a well-defined loop region that facilitates specific interactions with the target ion channel. The mature peptide should exhibit the characteristic post-translational modification pattern of contryphans, particularly the presence of D-tryptophan at a conserved position, which enhances receptor binding affinity and metabolic stability. Ensure the sequence maintains the hydrophobic core and surface-exposed residues necessary for proper folding and target engagement, while preserving the overall physicochemical properties that enable efficient delivery and function within the venom apparatus."}
{"description": "sp|P0DUR0|CA907_CONIN Alpha-conotoxin In1907 OS=Conus inscriptus OX=257329 PE=1 SV=1", "sequence": "EGCCSNPPCRHNHPEVC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus inscriptus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the essential cysteine framework (CC-C-C) that defines this toxin family, with inter-cysteine loops of appropriate lengths to confer target specificity. The molecular mechanism should involve competitive inhibition at the orthosteric binding site of nAChRs, preventing acetylcholine-mediated ion channel activation. The structural core must exhibit the typical alpha-conotoxin fold with well-defined beta-sheet elements and constrained loops that provide precise molecular recognition surfaces. The toxin should demonstrate high affinity and selectivity for its target nAChR subtypes, contributing to the paralytic activity characteristic of cone snail venoms used for prey capture."}
{"description": "sp|P0C1M3|CRBLG_VESMG Vespid chemotactic peptide 5g OS=Vespa magnifica OX=202807 PE=1 SV=1", "sequence": "FLIIRRPIVLGLL", "prompt": "Design a protein sequence for a wasp venom chemotactic peptide from Vespa magnifica (the magnificent hornet). This peptide functions as a potent inflammatory mediator and chemotactic factor that recruits immune cells to the site of envenomation. The peptide should exhibit strong chemotactic activity for neutrophils and other leukocytes, contributing to the intense local inflammatory response characteristic of hornet stings. The sequence should adopt a compact, stable structure stabilized by disulfide bridges, likely following the characteristic cysteine framework of vespid chemotactic peptides. The structural scaffold should feature a well-defined amphipathic architecture with both hydrophobic and charged surface regions that facilitate interaction with chemokine receptors on immune cells. The peptide should demonstrate high affinity for specific chemokine receptors involved in neutrophil migration and activation. Key structural elements should include conserved cysteine residues forming the characteristic disulfide connectivity that stabilizes the chemokine-like fold, along with surface-exposed residues critical for receptor recognition and signaling. The overall structure should be optimized for stability in the extracellular environment while maintaining potent pro-inflammatory activity through specific receptor engagement."}
{"description": "sp|E7FL11|VKT1_PSERS Kunitz serine protease inhibitor Pr-mulgin 1 OS=Pseudechis rossignolii OX=1489342 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPRFCELPADPGPCNGLFQAFYYNPVQRKCLKFRYGGCKGNPNTFKTIEECKRTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin from the venom of the Papuan black snake, Pseudechis rossignolii. This toxin should function as a potent serine protease inhibitor, specifically targeting key proteolytic enzymes involved in hemostasis and inflammatory pathways. The protein should adopt the characteristic Kunitz domain fold, featuring a stable alpha-beta structure with a conserved disulfide bond pattern (typically Cys1-Cys6 and Cys2-Cys4 connectivity) that stabilizes the inhibitory loop region. The active site should contain a canonical protease-binding loop with specific residues optimized for tight binding to serine protease active sites, potentially interfering with blood coagulation cascades or other physiological protease-mediated processes. The sequence should maintain the structural integrity required for venom delivery and target specificity while exhibiting the thermal and proteolytic stability typical of snake venom Kunitz inhibitors."}
{"description": "sp|P15970|TOG1B_AGEAP Omega-agatoxin-Aa1b (Fragment) OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "ERGLPEGAECDGNESDCKCAGAWIKCRCPPMWHING", "prompt": "Design a protein sequence for a highly potent neurotoxin derived from the venom of the funnel-web spider Agelenopsis aperta. This toxin belongs to the omega-agatoxin family, specifically functioning as a potent and selective inhibitor of P/Q-type voltage-gated calcium channels (Cav2.1). The toxin should exhibit the characteristic structural scaffold of spider venom peptides, featuring an inhibitory cysteine knot (ICK) motif stabilized by a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6) that confers exceptional thermal and proteolytic stability. The molecular mechanism involves high-affinity binding to the pore-forming alpha-1 subunit of P/Q-type calcium channels, effectively blocking neuronal calcium influx and disrupting synaptic transmission at central nervous system synapses. This blockade leads to impaired neurotransmitter release, resulting in rapid paralysis and neurotoxic effects in prey organisms. The protein should adopt a compact, globular fold with exposed loops that mediate specific interactions with the channel's voltage-sensing domain and selectivity filter. Key structural elements should include beta-hairpin motifs and a well-defined hydrophobic core that contributes to target specificity and potency. The sequence must encode the appropriate cysteine framework to form the ICK fold while maintaining residues critical for channel recognition and binding affinity."}
{"description": "sp|P0DQT7|DEF1_OLIMR Defensin BmKDfsin1 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MKTIVLLFVLVLVFALLVKMGMVEAEHGCPDNEDECHEHCKSIGKSGGYCVGPHKQTCRCN", "prompt": "Design a defensin-like toxin protein sequence inspired by the venom of Olivierus martensii (Chinese scorpion). This defensin toxin, BmKDfsin1, should function as a potassium channel blocker that selectively targets voltage-gated potassium channels (Kv channels), particularly Kv1.3 channels, to disrupt neuronal signaling and induce neurotoxic effects. The protein must adopt the canonical cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a triple-stranded antiparallel beta-sheet, stabilized by three or four disulfide bridges with a conserved Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 connectivity pattern typical of scorpion defensins. Include key functional motifs for potassium channel blockade, such as a functional dyad composed of a critical lysine or arginine residue in the beta2-beta3 loop for channel pore interaction and an adjacent hydrophobic residue for membrane anchoring. Ensure the sequence maintains the compact, globular structure with exposed loops for target specificity, and incorporate conserved scorpion defensin signature sequences for structural integrity. The defensin should exhibit potent neurotoxicity through Kv channel inhibition, contributing to the venom's paralytic and cytotoxic effects on prey."}
{"description": "sp|D2Y498|O16D_CONCL Conotoxin Cal6.1d (Fragment) OS=Californiconus californicus OX=1736779 PE=2 SV=1", "sequence": "GLTRPSKRCLAGSAPCEFHRGYTCCSGHCLIWVCA", "prompt": "Design a novel conotoxin sequence inspired by the venom arsenal of the marine snail Californiconus californicus, a species endemic to the Eastern Pacific. This toxin should function as a potent neurotoxin targeting ion channels in the peripheral nervous system of prey organisms, likely fish or marine invertebrates, to induce rapid paralysis. The sequence must adopt a compact, disulfide-stabilized fold characteristic of the conotoxin superfamily. Specifically, it should feature the O1-superfamily cysteine framework (C-C-CC-C-C), which typically forms an inhibitor cystine knot (ICK) motif with three disulfide bridges connecting Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6. This scaffold confers exceptional stability and resistance to proteolytic degradation. The mature toxin should be short (approximately 15-25 residues) and highly basic, with a net positive charge to facilitate electrostatic interactions with anionic ion channel pores. The structural core should comprise a β-hairpin or small β-sheet stabilized by the disulfide network, with flexible loops between cysteine residues enabling target recognition. While the exact molecular target is unspecified, the sequence should be compatible with modulation of voltage-gated sodium (NaV) or potassium (KV) channels, common targets for O1-conotoxins, through pore-blocking or gating modification. Ensure the sequence includes conserved residues for folding fidelity and key variable positions for functional specificity, avoiding proteolytic cleavage sites."}
{"description": "sp|P0DP93|CCY1A_CHRCN Mu-theraphotoxin-CCy1a OS=Chromatopelma cyaneopubescens OX=1795674 PE=1 SV=1", "sequence": "DDCLGIFKSCNPDNDKCCESYKCSRRDKWCKYVL", "prompt": "Design a novel animal toxin protein sequence inspired by mu-theraphotoxin-CCy1a from the venom of the greenbottle blue tarantula (Chromatopelma cyaneopubescens). This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bond connectivity pattern (C1-C4, C2-C5, C3-C6). As a voltage-gated sodium channel (Nav) modulator, this toxin functions by binding to the voltage-sensing domain of specific Nav channel subtypes, thereby altering channel gating kinetics and inhibiting neuronal excitability. The venom of Chromatopelma cyaneopubescens serves to immobilize prey through disruption of neuromuscular signaling. The protein should exhibit high affinity for Nav1.7 and Nav1.4 channels, with a mechanism involving stabilization of the channel's inactivated state. Key structural features include a well-defined hydrophobic patch for membrane interaction, a basic residue-rich surface for electrostatic steering toward the channel's voltage sensor, and a solvent-exposed loop region critical for target specificity. The sequence must maintain the canonical ICK motif with six cysteine residues forming the characteristic knot, and include conserved pharmacophore residues that mediate channel interaction while ensuring structural stability through the disulfide-stabilized beta-sheet core."}
{"description": "sp|R4H5E1|SCX4_MESEU Antimicrobial peptide MeuNaTxbeta-4 (Fragment) OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "LIGVKTEHGYLLDKYTGCKVWCVINNESCNGECKRRGGYYGYCYFWKLACFCQGARKSELWHYETNKCNGRM", "prompt": "Design a novel antimicrobial peptide derived from the venom of the scorpion Mesobuthus eupeus, specifically representing the MeuNaTxbeta-4 toxin fragment. This peptide should function as a potent antimicrobial agent, likely exhibiting broad-spectrum activity against both Gram-positive and Gram-negative bacteria through membrane disruption mechanisms. The peptide should adopt an amphipathic alpha-helical structure that facilitates interaction with bacterial membranes, leading to pore formation or membrane destabilization. Key structural features should include: a net positive charge to enable electrostatic interactions with negatively charged bacterial membranes, hydrophobic residues distributed to create a hydrophobic face for membrane insertion, and appropriate length (approximately 20-40 amino acids) typical of antimicrobial peptides. The sequence should demonstrate characteristics of scorpion venom-derived antimicrobial peptides, including potential disulfide bridges if applicable to the beta-toxin family scaffold, though this specific fragment may represent a linear antimicrobial domain. The peptide should maintain high selectivity for bacterial membranes over mammalian cells, leveraging differences in membrane composition. Consider incorporating conserved motifs from scorpion antimicrobial peptides while ensuring novel sequence generation that preserves the fundamental antimicrobial mechanism and structural integrity required for effective bacterial membrane targeting and disruption."}
{"description": "sp|P0DJ40|KKX41_HETPE Potassium channel toxin kappa-KTx 4.1 OS=Heterometrus petersii OX=754296 PE=1 SV=1", "sequence": "MKSTLMTASLLILVVLFIIDYASVYAEFIDGEISLERERDIPCFETCMKLYHIPKLCYIKCRKH", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx toxins from the scorpion Heterometrus petersii. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal signaling and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges in the typical scorpion toxin cysteine framework. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a stable molecular scaffold that presents key functional residues for channel interaction. The binding interface should contain conserved basic and hydrophobic residues that interact with the pore region of potassium channels, blocking ion conduction through steric occlusion and electrostatic repulsion. The toxin should exhibit high affinity and selectivity for specific Kv channel subtypes, contributing to the neurotoxic effects observed in scorpion envenomation. The sequence must maintain the characteristic disulfide connectivity pattern that stabilizes the CSαβ fold while preserving the functional epitopes responsible for potassium channel blockade."}
{"description": "sp|P21790|PA21_MICNI Phospholipase A2 1 (Fragment) OS=Micrurus nigrocinctus OX=8635 PE=1 SV=1", "sequence": "NLYQFKNMIQCTTKRSVLEFMEYGCYC", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of Micrurus nigrocinctus, the Central American coral snake. This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network (His-Asp dyad). Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the globular structure. The sequence should contain both the catalytic domain responsible for hydrolyzing membrane phospholipids and the neurotoxic domain that interacts with presynaptic membranes. Key structural elements should include the β-wing region and interfacial binding surface that facilitates membrane penetration. The toxin should exhibit high specificity for neuronal membranes while maintaining the characteristic thermal stability and resistance to proteolytic degradation typical of elapid snake venom phospholipases A2."}
{"description": "sp|A0A3G3C7U9|CM34_CONAA Mu-conotoxin-like Am3.4 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MMYKLGVLLIICLLLFPLTAVPQDGDQPADRPAERMQDDISFEHDRFFDPVKRCCKYGWTCWLGCSPCCG", "prompt": "Design a novel mu-conotoxin protein sequence inspired by the venom arsenal of Conus amadis, a predatory marine cone snail. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels (NaV channels), specifically targeting the skeletal muscle subtype NaV1.4 to induce rapid neuromuscular paralysis in prey. The molecular mechanism involves high-affinity binding to site 1 of the NaV channel α-subunit, effectively blocking sodium ion flux and preventing action potential generation in muscle fibers. The structural scaffold must adopt the inhibitor cystine knot (ICK) motif, characterized by a compact, disulfide-stabilized globular fold with triple-stranded β-sheets. The cysteine framework should follow the conserved mu-conotoxin pattern (C-C-CC-C-C) with disulfide connectivity of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, ensuring proper folding and thermodynamic stability. Key functional residues should be strategically positioned in loop regions to mediate target specificity and binding affinity, while maintaining the overall hydrophobic core and electrostatic surface properties typical of mu-conotoxins. The sequence must be optimized for efficient oxidative folding, biological activity, and compatibility with cone snail venom duct expression systems."}
{"description": "sp|A0A0B5ABD9|INS2A_CONGE Con-Ins G2 OS=Conus geographus OX=6491 PE=2 SV=1", "sequence": "MTTSSYFLLVALGLLLYVRQSFSTHEHTCQLDDPAHPQGKCGSDLVNYHEEKCEEEEARRGGTNDGGKKRRRASPLWKRRRFLSMLKARAKRTGYKGIACECCQHYCTDQEFINYCPPVTESSSSSSSAA", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of the geography cone snail, Conus geographus. This protein should function as a specialized insulin analog that rapidly induces hypoglycemic shock in prey by binding to vertebrate insulin receptors with high affinity. The sequence must adopt the characteristic insulin superfamily fold, featuring distinct A and B chains connected by appropriate disulfide bridges. The A chain should contain an intrachain disulfide bond stabilizing its helical structure, while the B chain should contribute to receptor binding specificity. Key conserved residues for receptor interaction should be optimized for enhanced binding kinetics compared to endogenous insulin. The overall structure should maintain the compact globular architecture typical of insulin-like peptides, with surface-exposed loops adapted for rapid systemic distribution and potent metabolic disruption in target organisms."}
{"description": "sp|P0C8B2|DLPA_ORNAN Ornithorhynchus venom defensin-like peptide A OS=Ornithorhynchus anatinus OX=9258 PE=2 SV=1", "sequence": "MRLTYLLLLLVAVLFQAGSGSAEPIFFYGRQPCSYYDGVCRDKSDVNCKYIAFTYCENPNQRCCYY", "prompt": "Design a venom-derived peptide from the platypus (Ornithorhynchus anatinus) that functions as a defensin-like toxin. This peptide should adopt the characteristic defensin fold stabilized by a conserved disulfide bridge pattern, likely following the canonical cysteine framework of animal defensins with three disulfide bonds arranged in a specific connectivity that confers structural stability. The peptide should exhibit antimicrobial activity through membrane disruption mechanisms, targeting bacterial cell membranes via electrostatic interactions with negatively charged phospholipids, while potentially displaying additional toxic effects relevant to venom function such as pain induction or neurotoxicity. The structural scaffold should feature the typical defensin motifs including an alpha-helix and antiparallel beta-sheets, creating a compact globular structure resistant to proteolytic degradation. The molecular surface should present cationic patches for membrane targeting while maintaining the structural integrity required for venom delivery and biological activity in the complex platypus venom milieu."}
{"description": "sp|P0DUP9|PA2H2_BOTMA Basic phospholipase A2 homolog BmajPLA2-II (Fragment) OS=Bothrops marajoensis OX=157554 PE=1 SV=1", "sequence": "NLWQLGKMILLETGKIPAKSYGAYGCNCGVLGRCCYVHKXXXXKLTGCDPKXXXYSYSWKXXTIVCGENNSCLKELCECDKAVAICLRENLDTYNKXXXYNYLKPF", "prompt": "Design a protein sequence for a basic phospholipase A2 (PLA2) homolog from the venom of Bothrops marajoensis, a pit viper species. This toxin represents a catalytically inactive PLA2 homolog that retains the structural scaffold of group II PLA2 enzymes but has evolved distinct toxic functions through neofunctionalization. The protein should adopt the characteristic PLA2 fold consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bridges (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, Cys84-Cys96 in typical numbering). Despite lacking enzymatic activity due to substitutions in the catalytic calcium-binding site and active site residues, the protein maintains membrane-binding capabilities through its conserved interfacial binding surface. The mechanism of toxicity involves specific protein-protein interactions rather than phospholipid hydrolysis, potentially acting as a presynaptic neurotoxin or myotoxin that disrupts neuromuscular transmission through binding to specific receptors or ion channels. The sequence should exhibit basic character (pI > 8.0) to facilitate membrane association and contain the conserved PLA2 structural motifs including the calcium-binding loop, the hydrophobic channel, and the interfacial recognition surface, while incorporating specific mutations that abolish catalytic activity while preserving structural integrity and toxic function."}
{"description": "sp|A0A0B5ABD5|INS3_CONTU Con-Ins T3 OS=Conus tulipa OX=6495 PE=3 SV=1", "sequence": "MTTSFYFLLMALGLLLYVCQSSFGNQHTRNSDTPKYRCGSDIPNSYMDLCFRKRNDAGKKRGQASPLWQRGGSLSMLKARAKRNEAFHLQRAHRGVVEHCCKRACSNAEFMQFCGNS", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conus tulipa, a marine cone snail species. This toxin belongs to the conantokin-insulin superfamily, which has evolved to mimic vertebrate insulin hormones as a predatory strategy. The protein should function as an insulin receptor agonist, binding to and activating insulin receptors in prey organisms to induce hypoglycemic shock and immobilization. The sequence must adopt the characteristic insulin-like fold, consisting of two polypeptide chains (A and B) stabilized by three conserved disulfide bridges with the connectivity pattern: A6-A11, A7-B7, and A20-B19. The A-chain should form two alpha-helices connected by an extended loop, while the B-chain should contain a central alpha-helix. Key functional residues should be optimized for high-affinity binding to the insulin receptor's L1 domain and alpha-CT segment, facilitating receptor activation and downstream signaling. The protein should exhibit thermal stability and protease resistance typical of conotoxins, with a compact globular structure of approximately 5-6 kDa. Incorporate conserved hydrophobic core residues and surface-exposed residues critical for receptor engagement while maintaining the overall insulin-like structural scaffold adapted for toxic function in venom."}
{"description": "sp|Q53B53|3L234_OPHHA Long neurotoxin OH-34 (Fragment) OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "KTLLLTLVVVTILCLDLGYTTKCYITPDVKSETCPDGENICYTKTWCDVWCGSRGRRVDLGCAATCPIVKPGVNINCCSTDNCNPFPKRS", "prompt": "Design a long neurotoxin protein sequence that mimics the biological activity and structural characteristics of the OH-34 toxin from the king cobra (Ophiophagus hannah). This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the typical cysteine framework pattern of C-C-CC-C-C-C-C-C. As a long neurotoxin, it should feature an extended central loop that enhances receptor binding specificity and affinity. The molecular target is the nicotinic acetylcholine receptor at the neuromuscular junction, where it acts as a competitive antagonist by binding to the receptor's α-subunit interface, preventing acetylcholine binding and causing flaccid paralysis. The toxin should exhibit high specificity for the muscle-type nicotinic acetylcholine receptor over neuronal subtypes. The structural scaffold should maintain the three β-stranded loops radiating from a central hydrophobic core, with the extended second loop providing critical residues for receptor interaction. The protein should be water-soluble and maintain the characteristic compact globular structure typical of three-finger toxins, with the disulfide network providing exceptional thermal and proteolytic stability."}
{"description": "sp|P86534|LEC2_DABRR C-type lectin domain-containing protein 2 (Fragment) OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "NQDCRPGWSFYEQNCYKVF", "prompt": "Design a functional C-type lectin domain-containing protein fragment derived from the venom of Daboia russelii (Russell's viper), a medically significant snake species whose venom components target hemostatic pathways. This toxin functions as a venom C-type lectin-like protein (snaclec) that typically acts as an anticoagulant by binding to specific coagulation factors, particularly targeting factors in the blood clotting cascade such as factor IX, factor X, or platelet receptors. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The structural scaffold should feature the conserved carbohydrate recognition domain (CRD) topology with beta-sheets and alpha-helices arranged in a compact globular conformation. Key functional residues should be positioned in the calcium-binding site region and the carbohydrate-binding interface to mediate specific protein-protein interactions with coagulation targets. The sequence must maintain the conserved structural motifs of snake venom C-type lectins while incorporating the specific binding determinants that confer its anticoagulant activity through interference with the coagulation cascade."}
{"description": "sp|P85005|VM3PN_PROSR Zinc metalloproteinase-disintegrin-like proatherocytin (Fragment) OS=Proatheris superciliaris OX=110218 PE=1 SV=1", "sequence": "GNYYGYCRVHLNTAY", "prompt": "Design a protein sequence for a zinc metalloproteinase-disintegrin-like toxin derived from the venom of Proatheris superciliaris, a viper species. This toxin should function as a proatherocytin, exhibiting potent hemorrhagic activity through its metalloproteinase domain that degrades extracellular matrix components like collagen and fibronectin in blood vessel walls. The protein must contain a conserved zinc-binding motif (HEXXHXXGXXH) in the metalloproteinase domain for catalytic activity, along with a disintegrin-like domain that potentially interferes with platelet aggregation by binding to integrin receptors. The structural scaffold should feature multiple disulfide bridges stabilizing both domains, with the metalloproteinase domain adopting a metzincin-like fold characterized by a twisted five-stranded beta-sheet and active-site zinc coordination. The disintegrin-like domain should present an RGD or related motif for integrin recognition. The overall architecture must enable calcium-dependent maturation from a pro-enzyme form to an active toxin, facilitating localized tissue damage and hemorrhage characteristic of viper venom metalloproteinases."}
{"description": "sp|Q7Z1Y7|A1LA_LOXAR Dermonecrotic toxin LarSicTox-alphaIB2a OS=Loxosceles arizonica OX=196454 PE=2 SV=1", "sequence": "MSHSSTALLHPYVAARATEKFAPIYFFCHPLQSAETDVAERANKRPIWIMGHMVNANYQIDEFVNLGANSIETDVSFDSSANPEYTYHGVPCDCRGWCKKWEYFNNFLKALRKATTPGDSKYHEKLVLVVFDLKTGSLYDNQAYDAGKKLAKNLLQHYWNNGNNGGRAYIVLSIPNLAHYKLITGFKETLKTEGHPELMEKVGYDFSGNDNIDQVANAYKKAGVTGHVWQSDGITNCLLRGLDRVRKAVANRDSSNGYINKVYYWTVDKRQSTKNALDAGVDGIMPNYPDVIADVPNESAYKAKFRIASYDDNPWETFKN", "prompt": "Design a novel dermonecrotic toxin protein sequence inspired by the venom of the Arizona brown spider, Loxosceles arizonica. This toxin should exhibit potent dermonecrotic activity, characteristic of sphingomyelinase D enzymes, which hydrolyze sphingomyelin in cell membranes to produce ceramide-1-phosphate and choline. The resulting disruption of membrane integrity and induction of inflammatory cascades leads to localized tissue necrosis, hemolysis, and potentially systemic effects. The protein should adopt a conserved TIM barrel fold typical of sphingomyelinase D enzymes, with key catalytic residues (likely histidine and aspartate/glutamate in the active site) positioned to coordinate a divalent metal ion (Mg²⁺ or Ca²⁺) essential for substrate binding and hydrolysis. Incorporate a signal peptide for secretion, followed by a propeptide region that may be cleaved upon maturation. The sequence should include conserved motifs for substrate recognition and catalysis, such as those involved in sphingomyelin binding and the phosphodiesterase activity. Ensure the protein is soluble and stable, with appropriate surface charge distribution for interaction with lipid membranes. The toxin should target mammalian cell membranes, particularly endothelial cells and erythrocytes, to induce dermonecrosis and complement-dependent hemolysis, mimicking the pathological effects of Loxosceles envenomation."}
{"description": "sp|C0HLA1|VSP2_LACMR Thrombin-like enzyme LmrSP-2 (Fragment) OS=Lachesis muta rhombeata OX=60219 PE=1 SV=1", "sequence": "VIGGDECNINEHRFLVALYDPDGFFCGGTL", "prompt": "Design a thrombin-like serine protease enzyme derived from the venom of the bushmaster snake, Lachesis muta rhombeata. This enzyme functions as a key component in the snake's venom arsenal, contributing to prey immobilization through disruption of hemostasis. The protein should exhibit selective proteolytic activity toward fibrinogen, cleaving fibrinopeptides A and/or B to generate fibrin monomers, thereby promoting fibrin clot formation and depleting circulating fibrinogen levels to induce consumptive coagulopathy. As a serine protease, it should feature a canonical trypsin-like fold with a conserved catalytic triad (His, Asp, Ser) and substrate-binding pockets that confer specificity for arginine residues. The structure should include characteristic disulfide bridges that stabilize the protease domain, likely following the conserved pattern found in snake venom serine proteases. The enzyme should demonstrate thrombin-like activity while potentially exhibiting altered specificity compared to mammalian thrombin, avoiding activation of other coagulation factors like Factor XIII to prevent stable clot formation, thus enhancing hemorrhagic potential. The overall architecture should reflect the compact, stable structure typical of venom proteases that must withstand the harsh environment of snake venom and maintain activity upon envenomation."}
{"description": "sp|Q27J47|VSPPA_LACMU Venom plasminogen activator LV-PA OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "MVLITVLANLLILQLSYAQKSSKLVFGGDECNINEHRSLVVLFNSSGFLCAGTLINKEWVLTAAHCDSENFQMQLGVHSKKVPNKDEETRDPKEKFICPNRKKNDEKDKDIMLIRLNRPVSNSEHIALLSLPSSPPSVGSVCRIMGWGTISPTKEIYPDVPHCADINILDHAVCRAAYSGWLATSTTLCAGILEGGKDSCHGDSGGPLICNGQFQGIVSLGRHPCGHPDEPGVYTKVFDYTDWIQSIIAGNTDAACPP", "prompt": "Generate a venom plasminogen activator protein sequence from the South American bushmaster snake (Lachesis muta muta) that functions as a potent fibrinolytic agent. This toxin should mimic the biological activity of LV-PA, which plays a crucial role in the snake's venom by promoting hemorrhage and prey immobilization through targeted degradation of fibrin clots. The protein should function as a serine protease with specificity for plasminogen activation, converting it to plasmin to enhance fibrinolysis. It should contain the characteristic catalytic triad (His, Asp, Ser) typical of trypsin-like serine proteases and maintain the conserved structural fold with appropriate disulfide connectivity to stabilize the protease domain. The sequence should exhibit substrate specificity for plasminogen while avoiding broad-spectrum proteolytic activity, reflecting its evolved role in venom-induced coagulopathy. The molecular mechanism should involve binding to plasminogen and facilitating its conversion to active plasmin, thereby accelerating clot dissolution and contributing to the hemorrhagic syndrome characteristic of viperid envenomation."}
{"description": "sp|Q5Y4U5|TXAG4_AGEOR U4-agatoxin-Ao1a OS=Agelena orientalis OX=293813 PE=1 SV=1", "sequence": "MKKSTVIVLSLAAFVLLSVMQFSAAEDIKMEVEEQRGYCAEKGIKCHNIHCCSGLTCKCKGSSCVCRK", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U4-agatoxin-Ao1a, functions as a calcium channel blocker that specifically targets P/Q-type voltage-gated calcium channels (Cav2.1) in the presynaptic terminals of neurons. The toxin should exhibit high-affinity binding to the channel's pore-forming α1A subunit, effectively inhibiting neurotransmitter release and causing synaptic transmission blockade. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif common to spider venom toxins, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes a compact, triple-stranded beta-sheet fold. The sequence must include key functional residues for channel interaction, such as a hydrophobic patch for membrane proximity and basic residues for electrostatic steering to the channel's voltage-sensing domain. The overall structure should be rigid and protease-resistant due to the ICK motif, with surface loops that confer target specificity while maintaining the toxin's stability in the venom gland and upon injection into prey."}
{"description": "sp|B3EWN2|HTX1_CYRLI Beta-theraphotoxin-Hlv1a OS=Cyriopagopus lividus OX=2053133 PE=1 SV=1", "sequence": "ACLGFGEKCNPSNDKCCKSSSLVCSQKHKWCKYGW", "prompt": "Design a novel beta-theraphotoxin venom peptide derived from the cobalt blue tarantula (Cyriopagopus lividus), a theraphosid spider whose venom contains neurotoxins that target ion channels in the peripheral nervous system. This toxin should function as a potent voltage-gated sodium channel modulator, specifically inhibiting channel inactivation to prolong action potentials and cause neuromuscular excitation. The peptide should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom toxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a rigid, knotted core. Key structural elements should include a hydrophobic patch on the molecular surface for membrane interaction and a solvent-exposed loop region containing critical residues for sodium channel binding, particularly targeting site 3 on the voltage-sensing domain IV to trap the channel in an open state. The sequence should maintain the typical length of 30-40 amino acids with high cysteine content (15-20%) and a net positive charge to facilitate interaction with the negatively charged extracellular loops of sodium channels."}
{"description": "sp|P0DQU3|KAX_TITME Potassium channel toxin OS=Tityus metuendus OX=2203750 PE=1 SV=1", "sequence": "TPFRYCNPRNCAKECQGRGKETTYCDEVCKCSGW", "prompt": "Design a potassium channel toxin from the venom of the scorpion Tityus metuendus. This toxin functions as a potent modulator of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular transmission. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural scaffold consists of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with key functional residues that interact with the voltage-sensing domain or pore region of potassium channels. The toxin should exhibit high affinity and selectivity for specific Kv1 subtypes, causing either channel blockade or modulation of gating kinetics to produce neurotoxic effects. Include conserved structural motifs such as the functional dyad or other key residues known to mediate channel interaction, while maintaining the overall stability and folding efficiency typical of scorpion venom peptides."}
{"description": "sp|A0A3G6IHA6|O16A_CONAD Delta-conotoxin AtVIA (Fragment) OS=Conus ateralbus OX=289019 PE=1 SV=2", "sequence": "LSKKQCGADGQFCFLPGLGLNCCSGLCLIVCVPT", "prompt": "Design a novel delta-conotoxin protein sequence inspired by Conus ateralbus venom that functions as a potent voltage-gated sodium channel inhibitor. This toxin should exhibit the characteristic structural framework of delta-conotoxins, featuring the conserved CC-C-C cysteine pattern with specific disulfide connectivity (Cys1-Cys4, Cys2-Cys3) that forms the inhibitor cystine knot (ICK) motif essential for structural stability and biological activity. The protein should adopt a compact, globular fold stabilized by these disulfide bridges, presenting key functional residues on surface loops that mediate high-affinity binding to site 4 of voltage-gated sodium channels, particularly Nav1.2 and Nav1.6 subtypes. The mechanism of action involves delaying channel inactivation, leading to prolonged neuronal depolarization and enhanced neurotransmitter release, which underlies the excitatory and pro-convulsant effects characteristic of delta-conotoxins. Incorporate conserved hydrophobic patches and charged residues that facilitate membrane interaction and target recognition, while maintaining the overall structural integrity typical of conopeptides from predatory cone snails. The sequence should reflect the evolutionary optimization for rapid prey immobilization through disruption of voltage-dependent sodium channel gating."}
{"description": "sp|Q589G4|VKT19_ANOSM Kunitz-type serine protease inhibitor As-fr-19 OS=Anoplius samariensis OX=200614 PE=1 SV=1", "sequence": "MMLLVLSISAILQVSHSVSFCLLPIVPGPCTQYVIRYAFQPSISACRRFTFGGCEGNDNNFMTRRDCEHYCEELL", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein derived from the venom of the spider wasp Anoplius samariensis. This toxin should exhibit potent inhibitory activity against serine proteases, functioning through a canonical mechanism where the reactive site loop inserts into the protease's active site, forming a stable enzyme-inhibitor complex. The protein must adopt the characteristic Kunitz domain fold, featuring a conserved alpha-beta structure with an antiparallel beta-sheet stabilized by three disulfide bonds in the Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. Ensure the sequence includes the essential protease-binding loop with appropriate P1 residue specificity for effective inhibition. The structural scaffold should maintain the compact, globular conformation typical of Kunitz domains, with the disulfide network providing exceptional thermal and proteolytic stability. This inhibitor should serve as a key component of the spider wasp's venom arsenal, facilitating prey immobilization through interference with essential proteolytic pathways in the target organism."}
{"description": "sp|E7CZY8|SCXN3_MESEU Sodium channel neurotoxin MeuNaTxalpha-3 (Fragment) OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "LVMAGVESGRDGHIARNNNCVYVCFIEYTYIGTSRINCNDLCTKNGAKSGYCHQFSEYGNSCWCIDLPDNVPIKVPGDCHLQ", "prompt": "Design a sodium channel neurotoxin protein sequence derived from the venom of the scorpion Mesobuthus eupeus. This toxin belongs to the beta-toxin class of scorpion venom peptides that target voltage-gated sodium channels. The protein should function as a site-4 neurotoxin, binding to the voltage-sensing domain II of Nav channels and modifying channel gating by shifting the voltage dependence of activation toward more negative potentials, leading to prolonged channel opening and neuronal hyperexcitability. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. Key functional residues should be positioned in the conserved 'pharmacophore' region on the protein surface, including residues involved in receptor recognition and binding to the S3-S4 loop of domain II. The toxin should exhibit specificity for mammalian neuronal sodium channels, contributing to the paralytic and neurotoxic effects of scorpion venom through impairment of action potential generation and propagation."}
{"description": "sp|D8KY58|VKT_BOMTE Kunitz-type serine protease inhibitor Bt-KTI OS=Bombus terrestris OX=30195 PE=3 SV=1", "sequence": "MNHKFIALLLVVLCCALSVHQVSAEIPSHCTLPLATGTCRGYFPRFGYNVEMGKCVEFIYGGCDGNANNFRNLEECQQSCSV", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of Bombus terrestris (buff-tailed bumblebee). This toxin functions as a potent serine protease inhibitor, likely targeting key proteolytic enzymes in prey or predator organisms to disrupt essential physiological processes such as blood coagulation, inflammation, or digestion. The protein should adopt the characteristic Kunitz-type fold, featuring a stable alpha-beta structure with a conserved reactive site loop that directly interacts with the active site of target serine proteases. The sequence must include the canonical disulfide bond pattern typical of Kunitz domains, with cysteine residues forming one or more disulfide bridges that stabilize the compact globular structure and ensure proper folding of the inhibitory loop. The molecular mechanism involves tight-binding inhibition through substrate-like interaction with protease active sites, potentially causing anticoagulant, anti-inflammatory, or neurotoxic effects depending on the specific protease target. The structural scaffold should maintain high stability and specificity, characteristic of venom Kunitz-type inhibitors used in predator defense or prey immobilization."}
{"description": "sp|P0DJ66|VKT17_CYRHA Kunitz-type serine protease inhibitor HNTX-03141017 (Fragment) OS=Cyriopagopus hainanus OX=209901 PE=2 SV=1", "sequence": "RLSVLRYYRRPDLRILPQETFEDTCRLPSDRGRCKASFERWYFNGRTCAKFIYGGCGGNGNKFPTQEACMKRCGKA", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of the Chinese earth tiger tarantula, Cyriopagopus hainanus. This toxin should function as a potent and selective inhibitor of serine proteases, particularly targeting key enzymes in the coagulation cascade or inflammatory pathways. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with alternating beta-strands and loops stabilized by three disulfide bridges in the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The reactive site loop should contain critical residues for protease recognition and inhibition, with specific amino acids positioned to interact with the protease active site. The structural scaffold should maintain the compact, globular fold typical of Kunitz domains, approximately 50-60 amino acids in length, with the N- and C-termini in close proximity. The toxin should exhibit high stability due to the disulfide network and demonstrate selective inhibition profile against specific serine protease targets relevant to the tarantula's predatory or defensive strategies."}
{"description": "sp|P0C1Z0|3SE2_DENAN Fasciculin-2 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "TMCYSHTTTSRAILTNCGENSCYRKSRRHPPKMVLGRGCGCPPGDDNLEVKCCTSPDKCNY", "prompt": "Design a protein sequence for a highly specific neurotoxin derived from the venom of the Eastern green mamba (Dendroaspis angusticeps). This toxin belongs to the fasciculin family, which are small, three-fingered toxins that function as potent and selective inhibitors of acetylcholinesterase. The protein should adopt the characteristic three-finger toxin fold stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C5, C4-C6, and C7-C8, forming a compact, globular structure. The core mechanism involves high-affinity binding to the peripheral anionic site of acetylcholinesterase, effectively blocking the enzyme's catalytic activity without interacting with the active site gorge. This inhibition prevents acetylcholine hydrolysis at neuromuscular junctions and cholinergic synapses, leading to fasciculations, paralysis, and ultimately respiratory failure in prey. The sequence should feature conserved structural motifs that facilitate specific recognition of acetylcholinesterase, including key residues in the central loop (finger II) that mediate target engagement. The toxin should exhibit the typical pharmacological profile of fasciculins: high potency, slow dissociation kinetics, and selectivity for mammalian acetylcholinesterase over other cholinesterase isoforms."}
{"description": "sp|P0DQU1|DEF6_OLIMR Defensin BmKDfsin6 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MKVIAILFLLAFVLCTMEITMVEAGFGCPLFQFACDSHCRGMGRKGGYCGGNFKLTCICVVK", "prompt": "Design a defensin-like peptide toxin derived from the venom of Olivierus martensii (Chinese scorpion). This defensin, known as BmKDfsin6, should function as a potent antimicrobial and/or ion channel-modulating toxin, characteristic of scorpion venom defensins. The peptide must adopt the canonical cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three or four disulfide bridges with a conserved cysteine framework (typically C1-C4, C2-C5, C3-C6 for six cysteines). The structure should feature an alpha-helix packed against an antiparallel beta-sheet, forming a compact, stable scaffold resistant to proteolysis. Key functional residues should be positioned in the loop regions, particularly the glycine-rich and cationic patches, to facilitate interaction with microbial membranes (e.g., via electrostatic interactions with negatively charged phospholipids) or modulation of voltage-gated potassium/sodium channels. The sequence must include conserved defensin motifs, such as the γ-core motif (GXCX3-9C) for antimicrobial activity, and maintain a net positive charge for membrane targeting. Ensure the peptide is amphipathic, with hydrophobic residues clustered on one face for membrane insertion and cationic residues for microbial surface binding. The final sequence should reflect the evolutionary optimization of scorpion defensins for dual roles in defense and predation, leveraging the CSαβ fold for stability in the venom gland and target specificity."}
{"description": "sp|P0DQT8|DEF2_OLIMR Defensin BmKDfsin2 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "METIVLLFLLALVFCTLEMGMVEAEHGCPDNEDECHEHCKSIGKSGGYCVGPHKQTCRCNP", "prompt": "Design a defensin-like toxin protein sequence inspired by the venom of the Chinese scorpion Olivierus martensii (formerly Buthus martensii). This defensin, known as BmKDfsin2, should function as a potassium channel blocker with potent neurotoxic activity. The protein should adopt the canonical cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion defensins, featuring a conserved structural motif comprising an alpha-helix stabilized against an antiparallel beta-sheet by three or four disulfide bridges. The cysteine framework should follow the typical scorpion defensin pattern (C-Xn-C-X3-C-X9-10-C-X4-6-C-X1-2-C-C), ensuring proper disulfide connectivity that confers structural stability and target specificity. The molecular target is voltage-gated potassium channels (Kv channels), particularly Kv1.3, where the toxin binds to the channel's pore region via a functional dyad involving key residues in the beta2-beta3 loop, disrupting ion conductance and leading to neuronal hyperexcitability. The sequence should include conserved glycine and aromatic residues critical for the CSαβ fold, along with a positively charged surface patch for electrostatic guidance to the channel vestibule. The overall structure should be compact and globular, approximately 4-5 kDa, with the functional dyad precisely positioned for high-affinity Kv channel blockade."}
{"description": "sp|A0A4Y5X1A7|CESS3_CONMO Conopressin/conophysin, isoform 3 (Fragment) OS=Conus monile OX=351660 PE=1 SV=1", "sequence": "ACFIRNCPKGGKRNVDEGPTKPCMFCSFGQCVAPHTCCGEKGCEMGTVDANMCQEENESPIPCHVFGKRCLLNHPGNSHGNCVTYGICCSHDTCTVHLACM", "prompt": "Design a conopressin/conophysin peptide sequence that captures the neurotoxic venom profile of the marine cone snail Conus monile. This peptide should function as a vasopressin/oxytocin receptor modulator, exhibiting the characteristic biological activity of conopressins in disrupting neuroendocrine signaling and cardiovascular regulation. The sequence must adopt a compact, cyclic structure stabilized by a single disulfide bridge between conserved cysteine residues, forming the essential Cys1-Cys6 connectivity that defines the vasopressin-like structural scaffold. The core architecture should feature a 20-residue cyclic peptide fold with the characteristic turn motifs that enable specific binding to G-protein coupled receptors in the vasopressin receptor family. Key functional residues should include conserved aromatic and hydrophobic residues that mediate receptor interaction, along with the essential disulfide-constrained cyclic backbone that provides structural rigidity and receptor selectivity. The peptide should exhibit the typical conopressin pharmacological profile of modulating blood pressure and fluid balance through targeted neuroendocrine disruption."}
{"description": "sp|P68723|SIX1C_LEIHE Beta-insect excitatory toxin LqhIT1c OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "MKFFLLFLVVLPIMGVLGKKNGYAVDSKGKAPECFFSNYCNNECTKVHYAEKGYCCLLSCYCVGLNDDKKVMEISDTRKKICDTTIIN", "prompt": "Design a beta-insect excitatory toxin from the venom of the yellow scorpion Leiurus hebraeus. This toxin functions as a potent insect-specific neurotoxin that targets voltage-gated sodium channels in insect nervous systems. The protein should exhibit the characteristic beta-toxin structural scaffold, which modulates sodium channel gating by shifting the voltage dependence of activation toward more negative potentials, leading to prolonged neuronal excitation and paralysis in insect prey. The structural architecture should feature the conserved beta-toxin fold consisting of an anti-parallel beta-sheet core stabilized by a specific disulfide bridge pattern. The cysteine framework should follow the typical scorpion beta-toxin pattern with four disulfide bonds that create a compact, stable globular structure. The molecular surface should present key functional residues responsible for selective binding to insect sodium channels, particularly those involved in recognizing the voltage-sensing domain of the channel. The toxin should demonstrate high specificity for insect sodium channels over mammalian counterparts, reflecting its evolutionary optimization for prey capture. The overall structure should be compact and thermodynamically stable, with the characteristic cysteine-stabilized alpha-beta motif that defines scorpion beta-toxins."}
{"description": "sp|A0A5C1ZW08|COP3_CONPU Conodipine-P3 OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "MKLLAPVLWAMAALGVTWLVAVDSKESCTKHSNGCSTPLRLPCQEYFRPACDIHDNCYHCGKTFGISREECDKAFLKDMNTLCKKLGSNSATCPARGKREVTSHRATSIAHSRLWKTALDQKSFLNRKARQVFFLLPTTCQGWAKNYHLAVKLAGANSYSVTTDLETCQGLEHCLPNH", "prompt": "Design a novel conodipine protein sequence that captures the essential biological and structural characteristics of Conus purpurascens venom phospholipase A2 toxins. This protein should function as a potent phospholipase A2 enzyme, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting disruption of cellular membranes and generation of pro-inflammatory lipid mediators should contribute to the neurotoxic and cytotoxic effects characteristic of cone snail venom. The structural scaffold must feature the conserved phospholipase A2 fold with the characteristic calcium-binding loop (YGKYCG/XCG) and catalytic network involving a histidine-aspartate dyad. Include the essential disulfide bridge pattern that stabilizes the globular structure, typically involving 6-8 conserved cysteine residues forming 3-4 disulfide bonds. The sequence should maintain the hydrophobic channel for substrate access to the active site and surface-exposed regions that may facilitate membrane interaction and potential target specificity. The overall architecture should enable calcium-dependent enzymatic activity while preserving the stability required for venom delivery and function in marine predation contexts."}
{"description": "sp|H1ZZI2|SCX13_TITOB Sodium channel toxin To13 OS=Tityus obscurus OX=1221240 PE=3 SV=1", "sequence": "MKTLFLIITSFILLEVEGIKNGYPRDSKGCTFECGQDAKHGDDYCDKMCKTTLKGEGGDCDFEYAECWCDNIPDTVVTWKNKEPKCKQI", "prompt": "Design a novel sodium channel toxin protein sequence inspired by the venom arsenal of the Brazilian scorpion Tityus obscurus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting and altering the gating kinetics to induce prolonged channel opening or delayed inactivation, thereby enhancing neuronal excitability. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, globular fold stabilized by a specific disulfide bridge pattern—typically four disulfide bonds with a C-C-CC-C-C connectivity that forms a cysteine-stabilized alpha-beta (CSαβ) motif. Key structural elements should include a core beta-sheet flanked by alpha-helices and loops that are critical for receptor binding, particularly the 'pharmacophore' regions involved in interacting with the voltage-sensing domain of sodium channels. The sequence must include conserved residues essential for structural integrity and biological activity, such as a hydrophobic core and surface-exposed residues that mediate target recognition. The toxin should exhibit high affinity and selectivity for mammalian sodium channels, contributing to the paralytic or neurotoxic effects observed in envenomation, without incorporating any database identifiers or accession numbers."}
{"description": "sp|P82966|VKTCI_OPHHA Kunitz-type serine protease inhibitor OS=Ophiophagus hannah OX=8665 PE=1 SV=2", "sequence": "MSSGRLLLLLGLLTLWAELTPVSGLGRPKFCELPPEPGLCNARKTFFYYSLHSHACQKFIYGGCGGNANKFKTIDECHRTCVG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the king cobra (Ophiophagus hannah). This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, particularly targeting factors Xa and/or thrombin, thereby disrupting hemostasis and promoting prey immobilization through systemic bleeding. The protein should adopt the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The structural scaffold should feature a twisted anti-parallel beta-sheet arrangement and one or two short alpha-helices, forming a stable inhibitory loop that presents key reactive site residues for precise protease recognition and binding. The molecular mechanism involves tight-binding inhibition at the protease active site through a canonical substrate-like interaction, with specific residues in the binding loop determining target specificity and inhibitory potency. The sequence must maintain the essential Kunitz-type structural framework while incorporating venom-adapted features that enhance stability, specificity, and biological activity in the context of snake venom toxinology."}
{"description": "sp|P55896|KAX37_ORTSC Potassium channel toxin alpha-KTx 3.7 OS=Orthochirus scrobiculosus OX=6892 PE=1 SV=1", "sequence": "GVIINVKCKISRQCLEPCKKAGMRFGKCMNGKCHCTPK", "prompt": "Design a potassium channel toxin protein sequence that embodies the biological and structural characteristics of alpha-KTx 3.7 from the scorpion Orthochirus scrobiculosus. This toxin belongs to the alpha-KTx family, which specifically targets voltage-gated potassium channels (Kv channels) and functions to modulate neuronal excitability by blocking potassium efflux, thereby prolonging action potentials and enhancing neurotransmitter release. The venom of Orthochirus scrobiculosus, a member of the Buthidae family, contains such toxins to immobilize prey through disruption of neuromuscular signaling. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, with a core alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by disulfide bridges. Infer the disulfide connectivity pattern as C1-C4, C2-C5, C3-C6, based on the alpha-KTx family framework, which confers stability and defines the functional surface for channel interaction. The molecular target is likely Kv1.x subtypes (e.g., Kv1.1, Kv1.2, or Kv1.3), with binding mediated by a functional dyad involving a critical lysine residue that inserts into the channel pore and adjacent hydrophobic residues that interact with the channel vestibule. Ensure the sequence includes key conserved motifs for the CSαβ scaffold, such as a beta-strand forming region and a solvent-exposed loop responsible for channel recognition. The toxin should exhibit high affinity and selectivity for potassium channels, contributing to its role in venom-induced paralysis."}
{"description": "sp|P0DP95|NTA_ORPS2 Mu-theraphotoxin-Osp1a OS=Orphnaecus sp. (strain Sibaliw/Philippines) OX=2024663 PE=1 SV=1", "sequence": "GCKGFGKACKYGADECCKNLVCSKKHKWCKYTL", "prompt": "Design a novel animal toxin protein sequence based on the following biological specifications: This protein is a mu-theraphotoxin originating from the venom of Orphnaecus sp., a tarantula species from the Philippines. As a member of the theraphotoxin family, it functions as a neurotoxin targeting voltage-gated sodium channels, likely acting as a gating modifier that inhibits channel inactivation, thereby prolonging action potentials and causing neuromuscular dysfunction. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C-C-C-C-C-C) that forms a knotted topology. This scaffold confers exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves binding to site 4 of voltage-gated sodium channels, particularly in peripheral neurons, leading to hyperexcitability, pain, or paralysis. The sequence must include key residues for ICK fold formation, hydrophobic core packing, and surface loops that mediate target specificity. Ensure the design reflects the evolutionary adaptation of spider venoms for prey capture and defense, with high potency and selectivity for sodium channel subtypes."}
{"description": "sp|P84197|I1BA_CONRE Conotoxin Rg11a OS=Conus regius OX=101314 PE=1 SV=1", "sequence": "CQAYGESCSAVVRCCDPNAVCCQYPEDAVCVTRGYCRPPATVLT", "prompt": "Design a novel conotoxin sequence inspired by Conus regius venom that functions as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors. This toxin should exhibit the characteristic structural framework of an alpha-conotoxin, specifically the alpha4/7 subfamily, featuring a globular disulfide connectivity pattern (Cys1-Cys3, Cys2-Cys4) that stabilizes a compact, two-loop tertiary structure. The sequence must include the conserved cysteine scaffold (CC-Xm-C-Xn-C) with appropriate inter-cysteine loop lengths to ensure proper folding and receptor binding. The toxin should selectively target specific neuronal nAChR subtypes, such as α3β2 or α3β4, through precise molecular interactions involving key residues in the hypervariable loops that mediate receptor recognition and blockade. Incorporate conserved post-translational modifications typical of conotoxins, such as C-terminal amidation and potential hydroxylation of proline residues, to enhance stability and biological activity. The final sequence should reflect the evolutionary optimization of Conus regius venom for rapid neurological disruption, resulting in a stable, disulfide-rich peptide with high affinity for its target receptors and minimal off-target effects."}
{"description": "sp|Q5EE07|DID_ECHCA Disintegrin (Fragment) OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "NSVHPCCDPVKCEPREGEHCISGPCCRNCKFLNAGTICKRAMLDGLHDYCTGVTSDCPRNRYNH", "prompt": "Design a protein sequence for a disintegrin toxin derived from the venom of the saw-scaled viper, Echis carinatus. This toxin functions as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The mechanism involves high-affinity binding to the RGD (Arg-Gly-Asp) recognition site of integrins such as αIIbβ3 (glycoprotein IIb/IIIa) on platelets, preventing fibrinogen binding and subsequent thrombus formation. The protein should adopt the characteristic disintegrin fold, featuring a compact, cysteine-rich structure stabilized by multiple disulfide bonds that create a rigid scaffold presenting the functional RGD loop in an optimal conformation for receptor interaction. The sequence should include the conserved RGD motif positioned within an exposed, flexible loop that serves as the primary receptor-binding interface. This disintegrin plays a crucial role in the viper's venom by inducing systemic bleeding and anticoagulation, facilitating prey immobilization through disruption of hemostatic pathways."}
{"description": "sp|A0A0B5ABE4|INS1B_CONQU Con-Ins Q1b OS=Conus quercinus OX=101313 PE=1 SV=1", "sequence": "MTTSSYFLLVALGLLLYLCQSSFGTEHTCEPGASPHPQGKCGPELAEFHETMCEVEESLQGGTDDARKKRGRASLLRKRRGFLSMLKARAKRNEASPLPRAGRGIVCECCKNSCTYEEITEYCPPVTEGSG", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom arsenal of Conus quercinus, a predatory marine cone snail. This toxin should function as a Con-Ins (Conus insulin-like peptide), specifically mimicking the Con-Ins Q1b variant, which has evolved to rapidly induce hypoglycemic shock in prey through potent insulin receptor agonism. The protein must adopt the characteristic insulin superfamily fold, comprising two polypeptide chains (A and B) stabilized by three evolutionarily conserved disulfide bridges in the pattern CysA7-CysB7, CysA6-CysA11, and CysA20-CysB19. The B-chain should feature a receptor-binding domain with key residues optimized for high-affinity interaction with vertebrate insulin receptors, while the A-chain maintains structural integrity and contributes to receptor activation. Incorporate venom-specific modifications that enhance stability in the venom duct and ensure rapid bioactivity upon injection, such as optimized surface charge distribution and reduced susceptibility to proteolytic degradation. The final sequence should reflect the efficient predatory strategy of cone snails, where insulin-like toxins facilitate immobilization by disrupting prey metabolism."}
{"description": "sp|E7FL12|VKT2_PSERS Kunitz serine protease inhibitor Pr-mulgin 2 OS=Pseudechis rossignolii OX=1489342 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEGLTPVSSKDRPHFCHLPHDPGPCKGNFQAFYYHPVRRTCLEFIYGGCQGNPNNFKTIDECKRTCAA", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of the Papuan black snake, Pseudechis rossignolii. This toxin should function as a potent anticoagulant by selectively inhibiting key serine proteases in the coagulation cascade, particularly targeting factors like Factor Xa or thrombin to disrupt blood clotting. The protein must adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with alternating beta-strands and loops stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. Incorporate the essential reactive site loop that mimics the natural substrate of the target protease, with key residues for specificity and inhibitory activity. Ensure the sequence maintains the hydrophobic core and structural stability typical of Kunitz inhibitors while optimizing for venom-derived potency and selectivity against mammalian coagulation factors."}
{"description": "sp|P21150|SIX4_ANDAU Toxin AaHIT4 OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "EHGYLLNKYTGCKVWCVINNEECGYLCNKRRGGYYGYCYFWKLACYCQGARKSELWNYKTNKCDL", "prompt": "Design a novel animal toxin protein sequence inspired by the AaHIT4 toxin from the North African scorpion Androctonus australis. This toxin should function as a potent insect-specific neurotoxin that selectively targets voltage-gated sodium channels in insect nervous systems. The protein should adopt the conserved structural scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. The structural core should consist of an alpha-helix packed against an anti-parallel beta-sheet, forming the classic cysteine-stabilized alpha-beta motif that provides exceptional thermal and proteolytic stability. The molecular mechanism should involve binding to receptor site 4 on insect voltage-gated sodium channels, causing a hyperpolarizing shift in the voltage-dependence of activation and delaying channel inactivation, leading to prolonged neuronal excitation, spontaneous repetitive firing, and ultimately paralysis in insect prey. The toxin should exhibit high specificity for insect sodium channels over mammalian homologs, making it evolutionarily optimized for predation. Include key functional residues responsible for receptor recognition and binding affinity, particularly in the conserved 'pharmacophore' regions that mediate target specificity. The sequence should maintain the characteristic compact size (approximately 60-70 amino acids) and high cysteine content typical of scorpion neurotoxins, with proper spacing of hydrophobic and charged residues to ensure correct folding and biological activity."}
{"description": "sp|E7CZZ1|SCXNC_MESEU Sodium channel neurotoxin MeuNaTxalpha-12 (Fragment) OS=Mesobuthus eupeus OX=34648 PE=2 SV=1", "sequence": "MTGVESARDAYIAQGNNCVYQCALNSSCNELCTKNGAKSGYCQWFGKHGNACWCIELPDNVPIRIQGKCQR", "prompt": "Design a sodium channel neurotoxin from the venom of the scorpion Mesobuthus eupeus, specifically the MeuNaTxalpha-12 variant. This toxin functions as a potent modulator of voltage-gated sodium channels, characteristic of scorpion α-toxins. It should exhibit the conserved structural scaffold of scorpion neurotoxins, featuring an inhibitor cystine knot (ICK) motif stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The toxin should bind to site 3 of voltage-gated sodium channels, specifically Nav1.2 and Nav1.6 subtypes, causing a slowing of inactivation and prolonged channel opening. This mechanism leads to sustained neuronal depolarization, repetitive firing, and ultimately neuroexcitatory symptoms. The structural core should consist of an anti-parallel β-sheet arrangement with loops that form the critical pharmacophore for receptor interaction. The N-terminal region and the loop between β2 and β3 strands should contain key residues for channel recognition and binding specificity. The overall fold should be compact and globular, approximately 60-70 amino acids in length, with the characteristic cysteine framework that defines the scorpion α-toxin family."}
{"description": "sp|P86544|3SO8_NAJNA Muscarinic toxin-like protein 1 (Fragment) OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "TICYNHLTIRSEVTEICIICDDDYYF", "prompt": "Design a muscarinic toxin-like protein fragment derived from the venom of the Indian cobra, Naja naja. This toxin belongs to the three-finger toxin superfamily and functions as a selective antagonist of muscarinic acetylcholine receptors. The protein should adopt the characteristic three-finger β-sheet fold stabilized by a conserved disulfide bridge framework, typically with four disulfide bonds arranged in a specific pattern that maintains the structural integrity of the three extended loops. These loops are critical for receptor binding and specificity, with key residues in the central loop and loop II likely mediating interactions with the extracellular domains of muscarinic receptors. The toxin should exhibit high affinity for specific muscarinic receptor subtypes, potentially M1 or M4, leading to modulation of parasympathetic nervous system signaling. The structural scaffold should feature a small, compact globular domain with minimal helical content, dominated by antiparallel β-sheets that form the finger-like projections. Conserved hydrophobic cores and disulfide connectivity should ensure stability in the venom environment and resistance to proteolytic degradation. The mechanism of action involves competitive inhibition of acetylcholine binding, disrupting cholinergic neurotransmission and contributing to the neurotoxic effects of cobra envenomation, including autonomic dysfunction and potential paralysis."}
{"description": "sp|D2Y499|O16E_CONCL Conotoxin Cal6.1e OS=Californiconus californicus OX=1736779 PE=3 SV=2", "sequence": "MKLTTVLIVAVLVLAACQFTVTDNSGDDTENPSLRSAGENQNPDSTKTITARATRARTNMRRGLSRPSKGCIGGGDPCEFHRGYTCCSEHCIIWVCA", "prompt": "Design a novel conotoxin sequence inspired by Conotoxin Cal6.1e from the venom of Californiconus californicus, the California cone snail. This marine gastropod employs a sophisticated venom arsenal for prey capture and defense, with conotoxins representing key neuroactive components that disrupt neuronal signaling. As a member of the O1 superfamily, this conotoxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to alter action potential generation and propagation. The sequence must adopt the characteristic conotoxin structural framework with four conserved cysteine residues forming two essential disulfide bonds in a C-C-C-C connectivity pattern, stabilizing a compact, disulfide-rich fold. This scaffold should facilitate precise molecular recognition of sodium channel pore domains or voltage-sensing elements, likely through electrostatic and hydrophobic interactions with extracellular loops. Incorporate key pharmacophore residues that confer subtype selectivity and high-affinity binding while maintaining the overall structural integrity typical of O-superfamily conotoxins, which often exhibit inhibitory cysteine knot (ICK) motifs with β-hairpin or small globular architectures. Ensure the sequence reflects evolutionary conservation within Californiconus toxins while enabling functional specificity against sodium channels, contributing to the venom's paralytic or excitatory effects on prey nervous systems."}
{"description": "sp|P85060|PA22_ACASS Phospholipase A2 acanmyotoxin-2 (Fragment) OS=Acanthophis sp. (strain Seram) OX=412080 PE=1 SV=1", "sequence": "NLYQFGGMIGCANKGTRSWLSYVNYGCYCG", "prompt": "Design a phospholipase A2 toxin sequence inspired by the venom of Acanthophis species (death adders). This toxin should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit canonical phospholipase A2 enzymatic activity, hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and neurotransmitter release inhibition. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network (His-Asp dyad). Include the essential disulfide bridge pattern (typically 6-7 conserved disulfides in snake venom PLA2s) that stabilizes the globular structure. The sequence should contain the elapid phospholipase A2 signature motifs and maintain appropriate surface characteristics for target membrane interaction. The toxin should demonstrate the typical β-sheet rich structure with three long α-helices and the conserved pancreatic loop that distinguishes venom phospholipase A2 enzymes from their non-toxic counterparts."}
{"description": "sp|Q7ZZM2|DIS_PROJR Disintegrin jerdostatin OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQVSSKTLKSGSVNEYEVVNPGTVTGLPKGAVKQPEKKHEPMKGNTLQKLPLCTTGPCCRQCKLKPAGTTCWRTSVSSHYCTGRSCECPSYPGNG", "prompt": "Design a novel disintegrin protein sequence inspired by jerdostatin from the venom of Protobothrops jerdonii (Jerdon's pit viper). This protein should function as a potent inhibitor of platelet aggregation by specifically targeting the α2β1 integrin receptor on platelet surfaces. The disintegrin must feature the characteristic RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to the integrin receptor's ligand-binding site, thereby blocking collagen-induced platelet activation and thrombus formation. The structural scaffold should adopt the canonical disintegrin fold, stabilized by a conserved pattern of disulfide bridges that typically involves 4-6 cysteine residues forming intramolecular bonds to create a compact, stable structure. The overall architecture should be small (approximately 7-8 kDa) and cysteine-rich, with the RGD loop positioned optimally for integrin engagement. The sequence should reflect the evolutionary adaptation of viper venom disintegrins to disrupt hemostasis through precise interference with cell-matrix interactions, particularly in the context of envenomation where rapid inhibition of platelet function contributes to prey immobilization and digestion."}
{"description": "sp|Q5Y4V7|T3G1B_AGEOR U3-agatoxin-Ao1b OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKAAISLIIFFAILFVVIEAISYEEGKELFQKERAECVGDGQRCADWAGPYCCSGYYCSCRSMPYCRCRSDSGK", "prompt": "Design a protein sequence for a neurotoxic peptide from the funnel-web spider Agelena orientalis that functions as a potent insecticidal agent. This toxin should adopt the inhibitory cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The protein should act as a voltage-gated calcium channel (Cav) antagonist, specifically targeting insect Cav channels to disrupt neuromuscular transmission and induce paralysis. Key structural elements should include a solvent-exposed beta-hairpin loop responsible for channel block, conserved hydrophobic residues for structural core stability, and basic residues for potential electrostatic interactions with the channel pore. The sequence should exhibit high specificity for invertebrate calcium channels while maintaining the thermostability and protease resistance typical of ICK-fold spider toxins."}
{"description": "sp|A0A0B5A8P4|INS3A_CONGE Con-Ins G3 OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "MTTSFYFLLVALGLLLYVCQSSFGNQHTRNSDTPKHRCGSELADQYVQLCHGKRNDAGKKRGRASPLWQRQGFLSMLKAKRNEAFFLQRDGRGIVEVCCDNPCTVATLRTFCH", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conus geographus, the geographic cone snail. This protein should function as a specialized insulinomimetic toxin that rapidly induces hypoglycemic shock in prey by binding to and activating vertebrate insulin receptors with high affinity and specificity. The sequence must adopt the characteristic insulin-like fold consisting of two polypeptide chains (A and B chains) connected by appropriate disulfide bridges, maintaining the conserved cysteine framework that stabilizes this structural motif. The A chain should contain the intrachain disulfide bond pattern typical of insulin-like proteins, while the B chain should facilitate receptor binding interactions. The protein should exhibit enhanced receptor binding kinetics compared to endogenous insulin, leading to rapid and potent hypoglycemic effects as part of the cone snail's envenomation strategy. The structural scaffold should preserve the insulin superfamily's characteristic three-helix bundle arrangement in the A chain and the receptor-binding surface topology, while incorporating venom-specific modifications that enhance stability and potency in the predatory context."}
{"description": "sp|P56587|TERT_APIME Tertiapin OS=Apis mellifera OX=7460 PE=1 SV=1", "sequence": "ALCNCNRIIIPHMCWKKCGKK", "prompt": "Design a protein sequence for a bee venom toxin that functions as a potent and selective inhibitor of G protein-gated inwardly rectifying potassium (GIRK) channels. This toxin should be derived from the European honey bee (Apis mellifera) venom system, where it serves as a defensive neurotoxin targeting neuronal signaling pathways. The protein should adopt a compact, stable tertiary structure stabilized by two disulfide bonds with a C1-C4, C2-C3 connectivity pattern, characteristic of the tertiapin family scaffold. The core structural motif should feature a well-defined alpha-helical region that mediates specific interactions with GIRK channel pores. Functionally, the toxin must exhibit high-affinity binding to GIRK1/GIRK4 heteromeric channels, effectively blocking potassium efflux and modulating cardiac and neuronal excitability. The mechanism involves direct pore occlusion of Kir3.x family channels, leading to membrane depolarization and enhanced neurotransmitter release. Key conserved residues should facilitate specific recognition of the GIRK channel selectivity filter region while maintaining selectivity over other potassium channel families. The structural scaffold should demonstrate exceptional stability under physiological conditions, with the disulfide framework conferring resistance to proteolytic degradation."}
{"description": "sp|P0DP96|OSP1B_ORPS1 Mu-theraphotoxin-Osp1b OS=Orphnaecus sp. (strain Maanghit-Cave/Philippines) OX=2024661 PE=1 SV=1", "sequence": "ECLGWMKGCEPKNNKCCSSYVCTYKYPWCRYDL", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a mu-theraphotoxin originating from the venom of Orphnaecus sp., a tarantula species from the Philippines. As a member of the theraphotoxin family, it functions as a voltage-gated sodium channel modulator, specifically targeting and inhibiting neuronal sodium channels to disrupt action potential propagation and cause neurotoxic effects. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in a C-C-CC-C-C framework). Key structural elements include a beta-hairpin region responsible for channel interaction, with specific residues forming the pharmacophore that binds to the voltage-sensing domain or pore region of sodium channels. The sequence should maintain the characteristic cysteine spacing and framework of mu-theraphotoxins, ensuring proper folding into the ICK scaffold. The toxin's mechanism involves altering sodium channel gating kinetics, leading to either use-dependent inhibition or modulation of channel inactivation, resulting in neurological disruption. Incorporate conserved hydrophobic patches and charged residues that facilitate membrane association and target specificity, while ensuring the core ICK fold provides structural stability and resistance to proteolytic degradation."}
{"description": "sp|P0DQU5|KA212_TITME Potassium channel toxin OS=Tityus metuendus OX=2203750 PE=1 SV=1", "sequence": "TAIGNCNPFTCDKECKTKGNKRGYCENYNCECSKW", "prompt": "Design a potassium channel toxin from the venom of the scorpion Tityus metuendus, a medically significant species whose venom components target ion channels to disrupt neuronal signaling and cause neurotoxic effects. This toxin functions as a specific modulator of voltage-gated potassium channels, binding to the channel's voltage-sensing domain or pore region to alter channel gating kinetics and inhibit potassium ion flux, thereby prolonging neuronal depolarization and enhancing neurotransmitter release. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges in a specific connectivity pattern (typically C1-C4, C2-C5, C3-C6 for four-disulfide toxins). Key structural elements include an alpha-helix packed against an antiparallel beta-sheet, with the functional residues forming a molecular surface that interacts with the potassium channel's extracellular loops. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes (e.g., Kv1.1, Kv1.2, or Kv1.3), with key residues in the beta-sheet and loop regions mediating target recognition through electrostatic and hydrophobic interactions. The sequence must include the conserved cysteine framework and maintain the structural integrity required for potent channel modulation."}
{"description": "sp|P21791|PA22_MICNI Phospholipase A2 2 (Fragment) OS=Micrurus nigrocinctus OX=8635 PE=1 SV=1", "sequence": "NLQYLKNMIKCTNTRHWLSFTNYGCYCG", "prompt": "Design a phospholipase A2 toxin sequence derived from the venom of Micrurus nigrocinctus, the Central American coral snake. This enzyme should exhibit the characteristic catalytic activity of hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which subsequently contributes to inflammatory responses and membrane disruption. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges, typically including the conserved Cys11-Cys77, Cys27-Cys126, Cys44-Cys105, and Cys51-Cys98 pairings that define the structural scaffold. Include the essential catalytic triad residues (His48, Asp99, Tyr52) and calcium-binding loop (Tyr28, Gly30, Gly32, Asp49) required for enzymatic activity. The sequence should maintain the characteristic interfacial binding surface that facilitates membrane association and substrate recognition. As a key component of elapid snake venom, this phospholipase A2 contributes to the neurotoxic, myotoxic, and hemolytic effects observed in envenomation through its ability to disrupt cellular membranes and generate pro-inflammatory lipid mediators."}
{"description": "sp|Q9U644|O1631_CONTE Omega-conotoxin-like TxMKLT1-031 OS=Conus textile OX=6494 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTLVMADDSNNGLANLFSKSRDEMEDPEASKLEKKDCQEKWDFCPAPFFGSRYCCFGLFCTLFFCA", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is an omega-conotoxin-like peptide derived from the venom of the marine cone snail Conus textile. As a component of this predatory mollusk's venom arsenal, this toxin functions to immobilize prey through targeted modulation of neuronal signaling pathways. The protein belongs to the conotoxin superfamily and specifically exhibits omega-conotoxin characteristics, indicating it likely targets voltage-gated calcium channels (VGCCs) in the nervous system. The molecular mechanism involves high-affinity binding to specific subtypes of voltage-gated calcium channels, particularly N-type or P/Q-type calcium channels, leading to blockade of calcium influx and subsequent inhibition of neurotransmitter release at presynaptic terminals. Structurally, this toxin should adopt the characteristic inhibitor cystine knot (ICK) motif common to omega-conotoxins, stabilized by a conserved disulfide bridge pattern with a cysteine framework typically arranged as C-C-CC-C-C. The three-dimensional structure should feature a compact, globular fold with well-defined loops that form the pharmacophore region responsible for channel binding specificity. Key structural elements include a rigid beta-sheet core stabilized by the disulfide network and solvent-exposed loops that mediate target recognition. The binding interface should contain conserved residues that interact with the pore region and voltage-sensing domains of the target calcium channels. The protein should exhibit high specificity for neuronal calcium channels while maintaining the thermal stability and protease resistance characteristic of conotoxin scaffolds."}
{"description": "sp|P56633|O17A_CONPU Kappa-conotoxin PVIIA OS=Conus purpurascens OX=41690 PE=1 SV=2", "sequence": "MKLTCVVIVVVLFLTACQLITADDSRRTQKHRALRSTTKLSLSTRCRIPNQKCFQHLDDCCSRKCNRFNKCV", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of Kappa-conotoxin PVIIA from the marine cone snail Conus purpurascens. This toxin functions as a potent and selective voltage-gated potassium channel blocker, specifically targeting Shaker-type potassium channels (Kv1 family) to disrupt neuronal excitability and synaptic transmission. The peptide should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bonds with a C-C-CC-C-C cysteine framework (disulfide connectivity I-IV, II-V, III-VI). Key structural elements must include a well-defined beta-hairpin region that forms the channel-blocking interface, with specific residues involved in pore occlusion and channel subtype selectivity. The N- and C-terminal should be structured to maintain the globular ICK fold while allowing for functional interactions with the channel vestibule. The sequence must encode the molecular determinants for high-affinity binding to potassium channels, including residues that confer specificity for Kv1 subtypes over other voltage-gated ion channels, and maintain the stability and protease resistance typical of conotoxins. The overall architecture should enable rapid and reversible channel blockade, contributing to the paralytic and neurotoxic effects characteristic of cone snail venoms in prey capture."}
{"description": "sp|P21792|PA23_MICNI Phospholipase A2 3 (Fragment) OS=Micrurus nigrocinctus OX=8635 PE=1 SV=1", "sequence": "NLYQFKNMIKCTNTRMWWSFTNAGCYDG", "prompt": "Generate a protein sequence for a phospholipase A2 toxin from the venom of the Central American coral snake (Micrurus nigrocinctus). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, ultimately disrupting synaptic vesicle recycling and causing irreversible neuromuscular blockade. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG), the catalytic histidine-aspartate dyad, and multiple disulfide bridges that stabilize the compact, globular structure. The sequence should include the essential interfacial binding surface for membrane association and the elapid loop region typical of snake venom phospholipases A2. The toxin should demonstrate high specificity for neuronal membranes while maintaining the thermostability and resistance to proteolytic degradation characteristic of elapid venom toxins."}
{"description": "sp|Q7T229|VSPH_BOTJR Snake venom serine protease homolog OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKASELIIGGDECNINEHRFLVALYTSRSRRFHCSGTLINQEWVLTAANCDRKNIRIKLGMHSKNVTNEDEQTRVPKEKFFCLSSKTYTKWDKDIMLIRLKRPVNDSPHIAPISLPSSPPSVGSVCRIMGWGTISPTKVSYPDVPHCANINLLDYEVCRAAHGGLPATSRTLCAGILEGGKDSCQGDSGGPLICNGQFQGILSWGVHPCGQRLKPGVYTKVSDYTEWIRSIIAGNTDVTCPP", "prompt": "Design a snake venom serine protease homolog protein from Bothrops jararacussu that functions as a key component of the viper's venom arsenal. This protein should exhibit the characteristic serine protease-like fold but with catalytic impairment, typically due to mutations in the catalytic triad residues, rendering it enzymatically inactive while retaining structural integrity. The protein should maintain the conserved chymotrypsin-like double beta-barrel architecture with the characteristic His-Asp-Ser catalytic triad, though one or more of these residues may be substituted to abolish proteolytic activity. It should feature the standard disulfide bonding pattern common to snake venom serine proteases, typically including 6-8 conserved disulfide bridges that stabilize the compact globular structure. The molecule should function as an allosteric modulator or competitive inhibitor of hemostatic pathways, potentially interfering with blood coagulation factors, platelet aggregation, or fibrinolytic systems. The protein should demonstrate specific molecular recognition capabilities for components of the mammalian coagulation cascade, with potential targets including factors X, IX, or other serine protease zymogens in the intrinsic or extrinsic coagulation pathways. The structural scaffold should enable precise molecular interactions that disrupt normal hemostatic balance, contributing to the characteristic hemorrhagic and coagulopathic effects observed in Bothrops envenomation."}
{"description": "sp|B3EWN1|TXB2A_PTEMU Beta/kappa-theraphotoxin-Pmu2a OS=Pterinochilus murinus OX=1184495 PE=1 SV=1", "sequence": "YCQEFLWTCDEERKCCGDMVCRLWCKKRL", "prompt": "Generate a protein sequence for a potent neurotoxin from the venom of the Mombasa golden starburst tarantula (Pterinochilus murinus), classified as a beta/kappa-theraphotoxin. This toxin should function as a dual-action neurotoxin targeting both voltage-gated sodium channels (beta-component) and potassium channels (kappa-component). The beta-component should inhibit sodium channel inactivation, causing prolonged depolarization and hyperexcitability in sensory and motor neurons, while the kappa-component should block specific potassium channel subtypes, further enhancing neuronal excitability. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom toxins, with a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6 forming a stable, compact triple-stranded beta-sheet fold. The molecular surface should feature key functional loops responsible for channel interaction, including a pharmacophore region with specific residues for sodium channel binding and a distinct interface for potassium channel blockade. The toxin should exhibit high potency and selectivity for its neuronal targets, contributing to the rapid paralytic and neurotoxic effects observed in the spider's venom arsenal."}
{"description": "sp|P0DUA6|COW1_CONCL Contryphan-Cal1 OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MTRTAVLLLTLLFLVAMAASDKIKTREVCWTEEECENWE", "prompt": "Design a novel peptide toxin sequence that captures the biological essence of Contryphan-Cal1 from the venom of the Californiconus californicus marine cone snail. This peptide should function as a potent neurotoxin, specifically targeting voltage-gated ion channels in the nervous system to disrupt neuronal signaling, consistent with the hunting strategy of cone snails that employ venom to immobilize prey. The sequence must adopt a compact, disulfide-stabilized fold characteristic of contryphans, featuring a conserved cysteine framework with specific disulfide connectivity that constrains the peptide into a rigid, bioactive conformation. Key structural elements should include a tight loop structure stabilized by disulfide bonds, presenting key functional residues for target interaction. The molecular mechanism should involve high-affinity binding to specific ion channel subtypes, modulating their gating properties to induce paralysis. The overall architecture should reflect the evolutionary optimization of cone snail venoms for rapid and precise neuropharmacological action."}
{"description": "sp|D2Y492|O16B_CONCL Conotoxin Cal6.11 OS=Californiconus californicus OX=1736779 PE=1 SV=1", "sequence": "MKLTCVLIIAVLILTACQFIAADNTEYRKWRRSGTSTGMRLGSRDCGPWCWGQNKCCPDESCRSLHESCT", "prompt": "Design a novel conotoxin sequence from the venomous marine snail Californiconus californicus that functions as a potent neurotoxin. This toxin should adopt the O1-superfamily conotoxin framework, characterized by a conserved cysteine pattern (C-C-CC-C-C) forming three disulfide bridges that stabilize a compact, globular fold. The structural scaffold should facilitate high-affinity binding to voltage-gated sodium channels (Nav), specifically modulating channel gating kinetics to produce paralytic effects. Incorporate key pharmacophore residues that enable selective interaction with neuronal Nav subtypes, potentially enhancing toxin potency through optimized surface charge distribution and hydrophobic patches. The mature peptide should exhibit typical conotoxin properties: small size (10-30 residues), high cysteine content, and a well-defined tertiary structure stabilized by disulfide connectivity. Consider the ecological context of C. californicus as a predatory cone snail, where such toxins rapidly immobilize prey through disruption of neuromuscular signaling. The final sequence should demonstrate evolutionary conservation of the O1-superfamily fold while introducing unique residue variations that confer target specificity and enhanced biological activity."}
{"description": "sp|D5J6X1|TXO1A_PELMU Omega-theraphotoxin-Pm1a OS=Pelinobius muticus OX=753628 PE=1 SV=1", "sequence": "MKTSMLAVFVALPLAFVLTAATEERAHPNELVNSLVELVKLDAERGVDKEGCKYMFGSCGKSDDCCPKLACKRTFNYCAWDGSV", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Pelinobius muticus (commonly known as the king baboon tarantula), a theraphosid spider whose venom contains diverse peptide toxins that modulate ion channel function for prey immobilization. This protein belongs to the omega-theraphotoxin family, specifically characterized as a voltage-gated calcium channel (Cav) inhibitor. The core mechanism of action involves high-affinity binding to neuronal Cav channels, particularly Cav2.2 (N-type) subtypes, resulting in presynaptic blockade of neurotransmitter release and subsequent neuromuscular paralysis. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif, with a conserved cysteine framework pattern of C-C-CC-C-C that forms three disulfide bridges creating a stable, compact knotted fold. The mature toxin should exhibit a globular tertiary structure with exposed loops responsible for target recognition and binding specificity. Key structural elements include a beta-hairpin region critical for channel pore interaction and conserved hydrophobic residues that facilitate membrane proximity. The sequence should maintain the typical molecular weight range of 4-6 kDa for spider venom peptides and display the signature pharmacological profile of selective Cav channel blockade with minimal off-target effects on other ion channel families."}
{"description": "sp|P0DP98|NTA_SELEF Mu-theraphotoxin-Se1a OS=Selenocosmia effera OX=2024412 PE=1 SV=1", "sequence": "DCLGWMAGCDFNDNKCCAGYVCKKHPWCRYDL", "prompt": "Design a novel mu-theraphotoxin protein sequence derived from the venom of the tarantula Selenocosmia effera. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal Nav channels to induce excitatory effects through delayed inactivation or enhanced activation kinetics. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms the core knotted topology. Incorporate key functional residues for channel interaction, including a hydrophobic patch for membrane association and polar/charged residues for specific binding to domain II or IV voltage-sensor regions. Ensure the sequence maintains the typical length of 30-40 amino acids with high cysteine content (6 cystines) and exhibits the hallmark stability, solubility, and pharmacological profile of mu-theraphotoxins for potential neuropharmacological applications."}
{"description": "sp|P0C250|COW1_CONBL Contryphan-Lo OS=Conus buxeus loroisii OX=410709 PE=1 SV=2", "sequence": "MGKLTILVLVAAVLLSTQVMVQGDGDQPADRNAVRRDDNPGGTRGRFMNILRRTGCPWDPWCG", "prompt": "Design a novel contryphan peptide from the venom of Conus buxeus loroisii, a marine cone snail species. This peptide should function as a potent neurotoxin that modulates ion channel activity, consistent with the biological role of contryphans in disrupting neuronal signaling to immobilize prey. The peptide must adopt the characteristic contryphan structural scaffold, featuring a compact, disulfide-stabilized fold with a conserved cysteine framework (typically CC-C-C for contryphans) that forms one or more disulfide bridges, conferring exceptional stability and resistance to proteolysis. Key structural elements should include a rigid, loop-rich conformation stabilized by the disulfide connectivity, potentially exhibiting a gamma-carboxyglutamic acid (Gla) residue or other post-translational modifications common in contryphans, which enhance calcium binding or receptor interaction. The molecular target is likely voltage-gated calcium channels or other neuronal ion channels, with the mechanism involving high-affinity binding to specific channel domains to alter gating kinetics or block ion flux. The sequence must include conserved residues critical for the fold and function, such as a tryptophan or proline in the loop regions, and maintain the overall hydrophobicity and charge distribution typical of contryphans to ensure proper folding, target engagement, and toxic activity. The final peptide should be 10–20 residues in length, with precise disulfide pairing that enforces the bioactive conformation."}
{"description": "sp|Q53B52|3SXZ_OPHHA Short neurotoxin OH-26 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKNLLLTFLVVTIVCLDLGYTLICHQRHGLQTCEPAQKFCFAQTVMPFPNHPLTLMGCTYSCPTEKNAVCCSTDKCNR", "prompt": "Design a short neurotoxin protein sequence inspired by the venom of Ophiophagus hannah (king cobra). This toxin should function as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-CC-C-C-C-C-C. The structure should feature a central β-sheet core with the second loop containing the critical functional residues for receptor binding and antagonism. The toxin should exhibit high affinity and specificity for the α-δ and α-γ interfaces of muscle-type nicotinic acetylcholine receptors, competitively inhibiting acetylcholine binding through key conserved residues in the functional loop. The sequence should maintain the compact, stable globular structure typical of short neurotoxins, with the conserved hydrophobic core and disulfide pattern essential for proper folding and biological activity."}
{"description": "sp|P0DJ69|VKT52_CYRHA Kunitz-type serine protease inhibitor HNTX-852 (Fragment) OS=Cyriopagopus hainanus OX=209901 PE=2 SV=1", "sequence": "DPSGSPHIRILPQETFEDICRLPSDSGDCLRFFEMWYFDGTTCTKFVYGGYGGNDNRFPTEKACMKRCAKA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Chinese earth tiger tarantula, Cyriopagopus hainanus. This toxin, known as HNTX-852, functions as a potent serine protease inhibitor that disrupts prey homeostasis by targeting key proteolytic enzymes in the coagulation cascade or inflammatory pathways. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved alpha-beta structure with a reactive site loop that directly engages the active site of target serine proteases. The sequence must include the canonical Kunitz-type disulfide bridge pattern, typically formed by three conserved disulfide bonds that stabilize the compact globular structure. The reactive site loop should contain appropriate residues for specific protease recognition and inhibition, likely employing a canonical mechanism where the inhibitor mimics the substrate. The overall structure should maintain the stable, compact fold typical of Kunitz domains, enabling high-affinity binding to serine proteases while resisting proteolytic degradation. The toxin should exhibit properties suitable for venom deployment, including stability under physiological conditions and specific inhibitory activity against serine proteases relevant to prey immobilization or digestion."}
{"description": "sp|A0A0B5ADV0|INS1_CONME Con-Ins Me1 OS=Conasprella memiae OX=101757 PE=2 SV=1", "sequence": "MATSSCFLLVTLGLLLHVQQAFLHEHTCSPSEPAAPGGICGSNLAELHSFLCEKELEDYSGSALKKRGRPSRRMKRRDFLSALKTRVKRKEGRSVKRSPTSGMSCECCKNSCDAEEILEYCPPLPSS", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conasprella memiae, a marine cone snail species. This toxin belongs to the conantokin-insulin superfamily and functions as a Con-Ins peptide, specifically Con-Ins Me1. The protein should exhibit insulin-like structural characteristics while maintaining toxic activity. It should feature the characteristic insulin fold with A and B chains connected by appropriate disulfide bridges, specifically two interchain disulfide bonds between the A and B chains. The sequence should include conserved cysteine residues at positions critical for maintaining the insulin-like tertiary structure. The toxin likely functions by modulating insulin signaling pathways in prey organisms, potentially acting as an insulin receptor agonist or antagonist to induce metabolic disruption. The structural scaffold should maintain the globular insulin fold with alpha-helical regions in both chains and the characteristic receptor-binding surfaces. The protein should be optimized for stability in the venom environment while retaining its targeted bioactivity against the cone snail's prey."}
{"description": "sp|P0C1Q6|MAST_VESAN Mastoparan-A OS=Vespa analis OX=7449 PE=1 SV=2", "sequence": "MKNTILILFTAFIALLGFFGMSAEALADPIADPLAGPNAEADPEAIKWKAILDAVKKVIG", "prompt": "Design a mastoparan peptide sequence derived from the venom of the Asian hornet, Vespa analis. This amphipathic tetradecapeptide should adopt an alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan family peptides. The sequence must exhibit potent mast cell degranulation activity through direct interaction with G-proteins, specifically acting as a G-protein activator that stimulates phospholipase C and inhibits adenylate cyclase. The peptide should demonstrate membrane-permeabilizing properties, forming transient pores in lipid bilayers that lead to calcium influx and eventual cell lysis. Incorporate the conserved structural features of mastoparans: a predominantly hydrophobic N-terminal region and a cationic C-terminal region that facilitates membrane binding and insertion. The peptide should lack cysteine residues and disulfide bridges, distinguishing it from structured toxin scaffolds, and instead rely on its amphipathic alpha-helical structure for biological activity. Ensure the sequence maintains the characteristic length of 14 amino acids with appropriate hydrophobic and cationic residue distribution to enable both membrane interaction and G-protein coupling."}
{"description": "sp|D8VNS0|VM3_CERRY Zinc metalloproteinase-disintegrin-like OS=Cerberus rynchops OX=46267 PE=1 SV=1", "sequence": "MIQALLVTICLVGFPHQGSSIILESGNVKDYEVVYPQKIPALPKGGIQRAEPETKYEDTMQYQFKVNGEPVVLHLERNKGLFSEDYSETHYSPDGREITTSPPVQDHCYYHGRIQNDADSTASISACNGLKGRFKHQGETYLIEPLKISDSEAHKIYKSENLEKEDEAPKTCGVTQTSLETDETIKMNFQSANNPEEDYVRKRKYIKLAVVVDNSMYIKYDRNLNDIRSRIYEIVNDVNVFYRLLNIHIALIFIEIWSHQDKINVQPMVRVTLDSFGTWRETDLLPRRSHDNAQLYTNVDFDGPTVGYAYVGSLCKPKHSVAIIQDHTETANMMASTVAHELGHNLGMNHDSGNCICQPTLCVMSETLSSVPFNDFSACSRVDHRNYLIRDLPQCILNKPLRTDIVAPAVCGNNFVEVGGECDCGSPQDCQSTCCDAATCRLRDGAQCDTEECCEQCRFRRAGTVCRAAKDDCDVAEFCTGRTADCPMDGLQRNGEPCQHNQGYCYNGKCPIMTNQCIALWGPDATVSQDGCFHFNENGQGDLYCRRENGVNIQCEPQDNKCGRLFCVQSTSTVQCNYRSSATDPDYGMVAIGTKCGDGRVCNNNRFCVDIRIAY", "prompt": "Design a venom metalloproteinase-disintegrin-like protein from the South Asian banded krait (Cerberus rynchops) that functions as a key hemorrhagic toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), comprising a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that facilitates proteolytic cleavage of basement membrane components such as type IV collagen and laminin, leading to vascular disruption and hemorrhage. The disintegrin-like domain should adopt the canonical disintegrin fold stabilized by multiple disulfide bonds, potentially interfering with integrin-mediated platelet aggregation or cell adhesion. The overall structure should reflect the typical SVMP fold, with the metalloproteinase domain featuring a central twisted beta-sheet flanked by alpha-helices and the disintegrin-like domain exhibiting a compact, disulfide-rich globular conformation. The protein's mechanism involves extracellular matrix degradation, contributing to prey immobilization through tissue damage and impaired hemostasis."}
{"description": "sp|Q7SZD9|VM2US_GLOUS Zinc metalloproteinase/disintegrin ussurin OS=Gloydius ussuriensis OX=35671 PE=2 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEIVYPRKVTALPKGAVQPKYEDTMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLSDSEAHAVFKYEHIEKEDEDPKMCGVTETNWESYEPIKKASPLVVTTYQRYVELVVVADHRMVTKYNGNLIIIRTWVYEIFNTINEIYQRMNIHVALVGLEIWSNGDKIIVQSSADVTLDLFGTWGEIDLLKRKSHDNAQLLTPTDFDGPTIGLAYVGTMCDPKRSTGVVQDFSPINLLVAVTMAHEIGHNLGMNHDENYCSCGGFACIMSPVISPQPSKLFSYCSYIHYWTYINYRNPQCILNKPLRTDIVSTPVSGNELLEAGEECDCDSPGNPCCDAATCKLRPGAQCAEGLCCEQCRFMKEGTVCRIARGDDMDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence for a zinc metalloproteinase/disintegrin from the Ussuri pit viper (Gloydius ussuriensis) that functions as a key hemorrhagic toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, which enables proteolytic cleavage of basement membrane components like type IV collagen and laminin. The disintegrin domain should adopt a compact, disulfide-rich fold stabilized by multiple disulfide bonds, typically containing the RGD or related integrin-binding motif that inhibits platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors. The overall structure should facilitate the synergistic action of these domains: the metalloproteinase domain induces vascular damage and extracellular matrix degradation, while the disintegrin domain impairs hemostasis through anti-platelet activity. The protein should exhibit the typical structural features of SVMPs, including a pro-domain that is cleaved upon activation, and a molecular weight consistent with P-II or P-III class SVMPs, depending on the presence of additional cysteine-rich domains. The sequence must reflect the evolutionary adaptation for rapid prey immobilization via hemorrhage and coagulation disruption, with optimal stability and activity at physiological conditions relevant to mammalian prey."}
{"description": "sp|Q9PRY9|VSP_BITAR Snake venom serine proteinase (Fragment) OS=Bitis arietans OX=8692 PE=1 SV=2", "sequence": "VIGGDECDINEHRFLVFLTXASGLACGGTLIN", "prompt": "Design a snake venom serine proteinase from the puff adder (Bitis arietans) that functions as a key component of the viperid venom arsenal. This toxin should exhibit the characteristic trypsin-like serine protease activity typical of snake venom serine proteases (SVSPs), featuring a catalytic triad of His, Asp, and Ser residues that enables specific proteolytic cleavage of plasma proteins. The protein should adopt the conserved chymotrypsin-like fold with two β-barrel domains connected by surface loops, maintaining the characteristic disulfide bridge pattern that stabilizes this scaffold. As a hemorrhagic toxin, it should specifically target and cleave fibrinogen, factor X, or other coagulation cascade components, disrupting hemostasis and promoting bleeding. The structural design should include surface loops that determine substrate specificity while preserving the overall stability conferred by the conserved cysteine framework. The generated sequence should reflect the evolutionary optimization of this enzyme for rapid prey immobilization through interference with blood coagulation pathways."}
{"description": "sp|P0DQU4|NDB_TITME Probable bradykinin-potentiating peptide OS=Tityus metuendus OX=2203750 PE=1 SV=1", "sequence": "KVLAPAEEAPAEAPAAAE", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the scorpion Tityus metuendus, a medically significant species from the Amazon region. This peptide functions as a potent vasoactive toxin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced bradykinin-mediated effects including vasodilation, increased vascular permeability, and hypotension. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of scorpion venom peptides, with a cysteine framework typically involving 2-4 cysteine residues forming 1-2 disulfide bonds that constrain the peptide into a well-defined conformation. The structure should feature key pharmacophore elements including a proline-rich region and specific residues critical for ACE inhibition, particularly at the C-terminal where tripeptide motifs often interact with the enzyme's active site. The molecular target is ACE, with binding occurring at the enzyme's catalytic domain where the peptide competitively inhibits substrate cleavage. The biological significance lies in the scorpion's envenomation strategy, where BPPs contribute to the cardiovascular effects of the venom, potentially leading to severe clinical manifestations such as pulmonary edema and shock in envenomed victims."}
{"description": "sp|E7FL13|VKT3_PSERS Kunitz serine protease inhibitor Pr-mulgin 3 OS=Pseudechis rossignolii OX=1489342 PE=2 SV=1", "sequence": "MSSGGLFLLLGLLTLWEVLTPVSSKDRPKFCELPADSGSCKGNFQAFYYHPVHRTCLEFIYGGCEGNDNNFKTIDECKRTCAT", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of the Papuan black snake, Pseudechis rossignolii. This toxin should function as a potent anticoagulant by specifically targeting and inhibiting key serine proteases in the blood coagulation cascade, such as factor Xa or plasma kallikrein, thereby disrupting hemostasis and promoting hemorrhage in prey. The protein must adopt the characteristic Kunitz domain fold, featuring a stable alpha-beta structure with a conserved beta-hairpin motif that forms the primary protease-binding interface. Incorporate the canonical Kunitz-type disulfide connectivity pattern (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) to ensure proper folding and stability. The sequence should include a reactive site loop with residues optimized for high-affinity binding to serine protease active sites, mimicking natural venom Kunitz inhibitors. Emphasize structural rigidity and target specificity to maximize inhibitory potency while maintaining venom compatibility."}
{"description": "sp|A0A1D0BNA3|T61A_HADIN U6-hexatoxin-Hi1a OS=Hadronyche infensa OX=153481 PE=3 SV=1", "sequence": "MKITIFCLTILTLSITFGETNEDVKDGSLKEMDEMSLLQELMSVEAALVEKEMKAEAEENRDSREKRCWGLNVPCENENSPCCKPYVCEKTTGYGWWYKSPYCVRKGSG", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin belongs to the U6-hexatoxin family and functions as a selective inhibitor of insect voltage-gated calcium channels (CaV channels), specifically targeting the Cav2 subtype. The protein should adopt the inhibitor cystine knot (ICK) structural fold, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern with connectivity I-IV, II-V, and III-VI. This scaffold confers exceptional stability and resistance to proteolytic degradation. The toxin's mechanism involves high-affinity binding to the pore-forming alpha1 subunit of insect CaV channels, blocking calcium influx into presynaptic nerve terminals and disrupting neurotransmitter release, leading to rapid paralysis and death in insect prey. Key functional residues should be positioned within the loops connecting the beta-strands, particularly in loops 2 and 4, which are critical for target specificity and binding affinity. The sequence must include the characteristic cysteine framework common to spider ICK toxins, with precisely spaced cysteine residues to ensure correct disulfide bonding and structural integrity. The overall structure should be compact and globular, with a molecular weight typical of spider neurotoxins (3-5 kDa), and exhibit high selectivity for insect over vertebrate calcium channels to minimize off-target effects."}
{"description": "sp|P68724|SIX1D_LEIHE Beta-insect excitatory toxin LqhIT1d OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "MKFFLLFLVVLPIMGVLGKKNGFAVDSNGKAPECFFDHYCNSECTKVYYAEKGYCCTLSCYCVGLDDDKKVLDISDTRKKLCDFTLFN", "prompt": "Design a beta-insect excitatory toxin from the scorpion Leiurus hebraeus that functions as a potent insect-selective neurotoxin. This toxin should target voltage-gated sodium channels in insect nervous systems, specifically causing excitatory effects through modification of channel gating kinetics. The protein should adopt the conserved beta-toxin structural scaffold characteristic of scorpion venom peptides, featuring a compact globular fold stabilized by a cysteine framework with four disulfide bridges arranged in a C-C-C-C pattern. The structure should display the characteristic CSαβ motif consisting of an alpha-helix packed against an antiparallel beta-sheet. Key functional residues should be positioned to interact with domain II of insect sodium channels, inducing prolonged channel opening and repetitive firing that leads to paralysis. The toxin should exhibit high selectivity for insect over mammalian sodium channels, reflecting the ecological role of scorpion venom in prey capture. The sequence should maintain the conserved structural core while incorporating specific residues responsible for insect channel recognition and excitatory activity."}
{"description": "sp|Q1W695|A21_LOXIN Dermonecrotic toxin LiSicTox-alphaII1 OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MLLHIALILGCWSVFSEGAETDVAERADGRRPIWNMGHMVNGIWQIDQFVDLGVNSIEFDINFDKNGKPVYTYHGVPCDCFRSCLNWEYFGEFLTALRHRTTPGDKLYKEKLILFVFDMKTNSLYDNQAYQAGVNMATDIFKYYWNNGQNGGRAYFILSIPNLNHYDLIKGFRETITKKGHPELMEKVGYDFSANDNIPDVEKAYGKVGVTDHVWQSDGITNCIARGLSRVKEAVKERDSGGVINKVYIWTIDKFSSTRDALDAGVDGIMTNYPYVLNDVLKEGAYKNKFRMATYEDNPWVTFKA", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles intermedia. This toxin belongs to the LiSicTox-alphaII1 family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The toxin should exhibit the characteristic structural features of sphingomyelinase D toxins, including a conserved TIM barrel fold with an (α/β)8 barrel architecture. The active site should contain essential catalytic residues for metal ion coordination and substrate binding, enabling the cleavage of phospholipids at the sn-3 position of glycerol. This enzymatic activity leads to profound dermonecrosis through complement-dependent hemolysis, platelet aggregation, and inflammatory responses. The protein should maintain the structural stability required for venom delivery and membrane interaction, with appropriate surface properties for targeting endothelial cells and erythrocytes. The sequence should reflect the evolutionary adaptation for rapid tissue damage and systemic effects characteristic of Loxosceles spider envenomation."}
{"description": "sp|P56636|CA12_CONMA Alpha-conotoxin MII OS=Conus magus OX=6492 PE=1 SV=3", "sequence": "MGMRMMFTVFLLVVLATTVVSFPSDRASDGRNAAANDKASDVITLALKGCCSNPVCHLEHSNLCGRRR", "prompt": "Design a novel alpha-conotoxin sequence inspired by Conus magus venom components that specifically targets neuronal nicotinic acetylcholine receptors. This toxin should function as a potent and selective antagonist of α3β2 nAChR subtypes, exhibiting high affinity binding to block neurotransmission. The protein must adopt the characteristic alpha-conotoxin globular fold stabilized by a conserved disulfide bond framework with connectivity pattern Cys1-Cys3 and Cys2-Cys4, forming two interlocking loops that create the receptor-binding interface. The structural scaffold should feature a compact, disulfide-rich core with well-defined secondary structure elements including beta-hairpin motifs that present key functional residues for receptor interaction. The sequence should maintain the typical alpha-conotoxin length of approximately 16 amino acids with appropriate spacing of cysteine residues to ensure proper folding and oxidative stability. The molecular mechanism should involve competitive inhibition at the acetylcholine binding site, preventing channel activation and leading to neuromuscular effects consistent with conotoxin pharmacology."}
{"description": "sp|P15227|SCX3_OLIMR Neurotoxin BmK-M3 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "VRDAYIAKPENCVYECATNEYCNKLCTDNGAESGYCQWVGRYGNACXCIKLPDRVPIRVWGKCHG", "prompt": "Design a neurotoxin protein sequence inspired by the venom of the Chinese scorpion Olivierus martensii (formerly Buthus martensii). This toxin, known as BmK-M3, functions as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to alter action potential generation and propagation. The toxin should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by four disulfide bridges with a cysteine framework of C-C-CC-C-C. The core structure comprises an α-helix packed against a three-stranded antiparallel β-sheet, forming a stable core that presents key functional loops for receptor interaction. The molecular mechanism involves binding to site 4 of voltage-gated sodium channels, delaying fast inactivation and prolonging channel opening, leading to hyperexcitability in neuronal circuits. Key residues in the functional loops should mediate specific interactions with the channel's voltage-sensing domain, particularly through a conserved 'pharmacophore' region that dictates subtype selectivity. The sequence must encode the appropriate secondary structure elements and disulfide connectivity to ensure proper folding into the bioactive conformation, with surface-exposed loops optimized for high-affinity binding to neuronal sodium channels while maintaining the thermostability typical of scorpion venom peptides."}
{"description": "sp|D2Y2G1|VKTJ1_CYRHA Kunitz-type U15-theraphotoxin-Hhn1j OS=Cyriopagopus hainanus OX=209901 PE=3 SV=1", "sequence": "MGIARILSAVLFLSVLFVVTFPTLLSADHHDGRIDTCRLPSDRGRCKASFERWYFNGTTCTKFVYGGYGGNDNRFPTEKACMKRCAKA", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a Kunitz-type toxin derived from the venom of the Chinese earth tiger tarantula, Cyriopagopus hainanus. As a component of the spider's venom, it serves to immobilize prey through targeted molecular interactions. The toxin functions as a serine protease inhibitor, specifically targeting trypsin-like enzymes, which disrupts proteolytic cascades in the prey's physiological systems, leading to paralysis or death. The structural scaffold is defined by a Kunitz-type fold, characterized by a compact, globular domain stabilized by three conserved disulfide bonds with a typical connectivity pattern of Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5. This fold forms a stable, β-sheet-rich structure with exposed loops that mediate precise binding to the active site of serine proteases. The molecular target is trypsin, with key residues in the binding interface interacting with the protease's catalytic triad to achieve potent inhibition. Ensure the sequence includes the canonical Kunitz domain motifs and the appropriate cysteine framework to maintain structural integrity and functional efficacy."}
{"description": "sp|Q7ZZN8|CRVP2_NAJAT Cysteine-rich venom protein natrin-2 OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MIAFIVLLSLAAVLQQSSGTVDFASESSNKRENQKQIVDKHNALRRSVRPTARNMLQMEWNSNAAQNAKRWADRCSFAHSPPHLRTVGKIGCGENLFMSSQPYAWSRVIQSWYDENKKFVYGVGANPPGSVIGHYTQIVWYNSHLLGCGAAKCSSSKYLYVCQYCPTGNIIGSIATPYKSGPPCGDCPSACVNGLCTNPCKHHNVFSNCQSLAKQNACQTEWMKSKCAASCFCRTEII", "prompt": "Generate a cysteine-rich venom protein sequence from the Chinese cobra (Naja atra) that functions as a natrin-2 toxin. This protein should exhibit the characteristic structural features of cysteine-rich venom proteins, including multiple disulfide bridges that stabilize a compact, globular fold essential for its toxic activity. The sequence should contain a conserved cysteine framework typical of three-finger toxins, with the disulfide connectivity pattern crucial for maintaining structural integrity and biological function. As a component of elapid snake venom, this toxin likely targets specific ion channels or receptors in the neuromuscular system, potentially acting as a neurotoxin or cytotoxin. The protein should adopt the classic three-finger toxin fold consisting of three β-stranded loops extending from a central core stabilized by disulfide bonds. This structural scaffold enables specific molecular recognition and binding to physiological targets, contributing to the venom's paralytic or cytotoxic effects. The generated sequence must reflect the evolutionary optimization for stability in the venom gland and efficient target engagement upon envenomation."}
{"description": "sp|Q7T247|SLB_ECHCA Snaclec echicetin subunit beta OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "MGRFISVSFGLLVLLLSLSGTGANCLPDWSVYEGYCYKVFKERMNWADAEKFCTKQHKDGHLVSFRNSKEVDFVISLAFPMLKNDLVWIGLTDYWRDCNWEWSDGAQLDYKAWDNERHCFIYKNTDNQWTRRDCTWTFSFVCKCPA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as the beta subunit of echicetin, derived from the venom of the saw-scaled viper (Echis carinatus). This protein should adopt the characteristic C-type lectin-like fold, featuring a conserved double-loop structure stabilized by two intrachain disulfide bonds with a typical C1-C4, C2-C3 connectivity pattern. The beta subunit of echicetin specifically binds to platelet membrane glycoprotein Ib (GPIb) as part of the GPIb-IX-V complex, functioning as a potent platelet aggregation inhibitor. The protein should exhibit high-affinity binding to the GPIbα subunit, competing with von Willebrand factor binding and thereby blocking platelet adhesion and aggregation under high shear stress conditions. The sequence should maintain key residues for carbohydrate recognition domain-like structural integrity while incorporating specific surface-exposed loops that mediate protein-protein interactions with the GPIb leucine-rich repeat domain. This snaclec functions as an anticoagulant toxin by preventing initial platelet plug formation, representing a crucial defense and prey-immobilization mechanism in viperid snake venom."}
{"description": "sp|D5HR50|SCX1A_ANDCR Alpha-toxin Ac1 (Fragment) OS=Androctonus crassicauda OX=122909 PE=2 SV=1", "sequence": "YIVMISLALVVMIGVESVRDGYIVYPNNCVYHCIPACDGLCKKNGGTSGSCSFLIGSGIACWCKDLPDNVPIKDPSQKCTR", "prompt": "Design a protein sequence for an alpha-toxin from the venom of the fat-tailed scorpion Androctonus crassicauda, a medically significant species in North Africa and the Middle East. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically exhibiting the characteristic alpha-toxin mechanism of action that slows sodium channel inactivation, leading to prolonged neuronal depolarization and neurotoxic effects. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion neurotoxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved alpha-helix packed against an antiparallel beta-sheet, with the functional domains comprising a conserved 'core' region responsible for sodium channel binding and a 'pharmacophore' region containing critical residues for target interaction. The molecular target should be voltage-gated sodium channels at site 3, with specific affinity for neuronal subtypes, where it binds to the extracellular loops of domains I and IV, interfering with the fast inactivation gate mechanism. The sequence should reflect the high thermal and proteolytic stability characteristic of scorpion toxins, optimized for venom delivery and target specificity in the predator-prey context of scorpion envenomation."}
{"description": "sp|P85062|PA21_ACASE Phospholipase A2 acanmyotoxin-1 (Fragment) OS=Acanthophis rugosus OX=239748 PE=1 SV=1", "sequence": "NLLQIGIMKRCANKRRRPVFHYRDYGCYC", "prompt": "Design a protein sequence for a phospholipase A2 toxin derived from the venom of Acanthophis rugosus (rough-scaled death adder). This toxin, known as acanmyotoxin-1, should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and eventual blockade of acetylcholine release. The structural scaffold should feature the characteristic phospholipase A2 fold, comprising three long alpha-helices stabilized by a conserved network of disulfide bridges. Key functional residues should include a histidine-aspartate catalytic dyad and a calcium-binding loop. The protein should demonstrate high affinity for neuronal membranes and exhibit the typical pharmacological profile of a beta-neurotoxin, causing irreversible paralysis through presynaptic action. Ensure the sequence maintains the conserved structural motifs required for enzymatic activity and membrane interaction while preserving the toxic potency characteristic of death adder venom components."}
{"description": "sp|P19003|3SOG_ASPSC Cytotoxin homolog S3C2 OS=Aspidelaps scutatus OX=8607 PE=1 SV=1", "sequence": "RKCLNTPLPLFYKTCPEGKDLCYKMNFKLLPKKLSIKRGCTDTCPKSSLLVKVVCCDTDKCNK", "prompt": "Design a cytotoxin protein sequence that mimics the biological activity and structural characteristics of cytotoxin homolog S3C2 from the shield-nosed cobra (Aspidelaps scutatus). This protein should function as a potent membrane-disrupting cytotoxin that targets and permeabilizes cell membranes through direct interaction with lipid bilayers, leading to cell lysis and death. The sequence should adopt the characteristic three-finger toxin (3FTx) fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. The structural scaffold should feature the typical globular head region and three protruding finger-like loops that mediate membrane interaction, with conserved hydrophobic residues in the loops facilitating membrane insertion. The protein should exhibit specific membrane-binding properties through amphipathic surfaces that recognize and disrupt anionic phospholipid components of cell membranes. The cytotoxin should demonstrate preferential activity against specific cell types, particularly those with exposed anionic membrane surfaces, and should maintain structural stability through the conserved disulfide network that defines the three-finger toxin superfamily. The sequence should reflect the evolutionary optimization of this venom component for rapid prey immobilization through widespread cellular damage."}
{"description": "sp|Q9U654|O16K_CONTE Omega-conotoxin-like TxO5 OS=Conus textile OX=6494 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTFVTAITSNGLENLFPKAHHEMKNPEASKLNKRCVPYEGPCNWLTQNCCDATCVVFWCL", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus textile. This venom component should function as a potent calcium channel antagonist, specifically targeting voltage-gated calcium channels in the nervous system to disrupt synaptic transmission and induce paralysis in prey. The protein should adopt the characteristic ICK (inhibitor cystine knot) structural motif, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide connectivity pattern (C-C-C-C-C-C framework) that creates the signature knotted topology. Key structural elements should include well-defined beta-hairpins, a rigid core maintained by the cystine knot, and surface loops that mediate specific interactions with calcium channel pore regions. The molecular mechanism should involve high-affinity binding to neuronal calcium channels, particularly N-type or P/Q-type subtypes, effectively blocking calcium influx and inhibiting neurotransmitter release. The sequence should contain the essential pharmacophore residues for channel recognition while maintaining the structural integrity required for venom stability and target specificity in the marine predatory context."}
{"description": "sp|Q26292|SIX2_LEIHE Beta-insect depressant toxin LqhIT2 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "MKLLLLLIVSASMLIESLVNADGYIKRRDGCKVACLIGNEGCDKECKAYGGSYGYCWTWGLACWCEGLPDDKTWKSETNTCGGKK", "prompt": "Design a beta-insect depressant toxin from the venom of the yellow scorpion Leiurus hebraeus. This toxin functions as a potent insect-selective neurotoxin that targets voltage-gated sodium channels in insect nervous systems. The toxin should exhibit depressant activity, causing progressive paralysis in insects through modification of sodium channel gating properties, leading to reduced neuronal excitability and eventual flaccid paralysis. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion beta-toxins, with the conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure. The toxin should possess a compact globular architecture with an alpha-helix packed against an antiparallel beta-sheet, creating the molecular surface necessary for specific interaction with insect sodium channels. The binding interface should target site-4 on voltage-gated sodium channels, modifying channel activation kinetics and shifting voltage dependence toward more negative potentials. The sequence should maintain key conserved residues in the functional epitopes responsible for insect selectivity and channel modulation, while preserving the structural integrity required for stability in the venom environment and effective target engagement."}
{"description": "sp|A7X4Q3|3L2O1_OXYMI Long neurotoxin 3FTx-Oxy1 OS=Oxyuranus microlepidotus OX=111177 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRRCFITPDVRSERCPPGQEVCYTKTWCDGFCGSRGKRVDLGCAATCPTPKKKGIDIICCSKDNCNTFPKWP", "prompt": "Design a protein sequence for a long neurotoxin from the venom of the inland taipan (Oxyuranus microlepidotus), belonging to the three-finger toxin (3FTx) superfamily. This toxin should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular structure. The protein must function as a potent postsynaptic neurotoxin that competitively and irreversibly binds to the α-subunit of muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The binding mechanism should involve key residues in the central loop (loop II) and the C-terminal region that insert into the receptor's orthosteric site, preventing acetylcholine binding and leading to flaccid paralysis. The sequence should include the conserved structural core of 3FTx proteins while incorporating specific functional residues that confer high affinity and selectivity for the α-δ and α-γ interfaces of the nAChR. The overall structure should be characterized by three elongated β-sheet-rich loops extending from a hydrophobic core, with the functional loops exhibiting the appropriate length and flexibility for receptor engagement."}
{"description": "sp|P84471|VKTH1_BUNCA Kunitz-type serine protease inhibitor homolog T1-1 B chain (Fragment) OS=Bungarus candidus OX=92438 PE=1 SV=1", "sequence": "RKRHPDCDKAADTRI", "prompt": "Design a protein sequence for a snake venom-derived Kunitz-type serine protease inhibitor homolog from the Malayan krait (Bungarus candidus). This toxin functions as a potent serine protease inhibitor, likely targeting key proteases in the prey's hemostatic system to disrupt blood coagulation and promote hemorrhage. The protein should adopt the characteristic Kunitz-type fold, featuring a conserved beta-trefoil structure with alpha-helical elements and a reactive site loop that confers protease specificity. It must contain the canonical Kunitz domain disulfide bridge pattern with three conserved disulfide bonds (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that stabilize the compact globular structure. The sequence should include the essential protease-binding loop with appropriate P1 residue positioning for optimal serine protease inhibition. This toxin represents a critical component of krait venom that facilitates prey immobilization through interference with coagulation cascades and potentially other serine protease-dependent physiological processes."}
{"description": "sp|P19004|3SOD_ASPSC Cytotoxin homolog S4C8 OS=Aspidelaps scutatus OX=8607 PE=1 SV=1", "sequence": "RKCFNSPGRLVSKPCPEGNNLCYKMSNRMYPPGFNVRRGCAETCPRRNRLLEVVCCCDTDNCNK", "prompt": "Design a cytotoxin protein sequence inspired by snake venom three-finger toxins, specifically from the Cape coral snake (Aspidelaps scutatus). This toxin should function as a potent cytotoxin that disrupts cell membranes through direct interaction with lipid bilayers, leading to cell lysis and tissue damage. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with connectivity C1-C3, C2-C4, C5-C6, C7-C8. The structural scaffold should feature the typical globular shape with finger-like projections that facilitate membrane insertion. Key functional residues should be concentrated in the central loop (loop II), particularly hydrophobic and cationic residues that mediate membrane binding and disruption. The toxin should exhibit broad-spectrum cytotoxicity against various cell types through non-receptor-mediated mechanisms, primarily targeting the anionic phospholipid components of cell membranes. The sequence should maintain the conserved cysteine framework while incorporating specific residue variations that enhance membrane-permeabilizing activity and structural stability characteristic of cytotoxin subfamily members."}
{"description": "sp|P0CH40|SCX8_CENEL Beta-toxin CeII8 OS=Centruroides elegans OX=217897 PE=1 SV=1", "sequence": "KKDGYPVNMEECRYNCWKNAYCDKLCKEKKGQSGYCYGWNLSCWCIGLPDNTNTKMNPFCQTAD", "prompt": "Design a beta-toxin protein sequence from the venom of the scorpion Centruroides elegans, specifically representing the CeII8 toxin variant. This toxin functions as a voltage-gated sodium channel modulator, characteristic of scorpion beta-toxins. It should exhibit the conserved structural scaffold of scorpion beta-toxins, featuring a compact, globular fold stabilized by a specific disulfide bridge pattern—typically four disulfide bonds with a conserved cysteine framework (e.g., C-C-CC-C-C for beta-toxins). The protein should adopt an inhibitor cystine knot (ICK) motif, contributing to its stability and target specificity. Its mechanism involves binding to site 4 of voltage-gated sodium channels (e.g., Nav1.2, Nav1.6), leading to a shift in the voltage dependence of activation toward more negative potentials, which enhances neuronal excitability and can cause paralysis or pain. The sequence should include key functional residues for receptor interaction, such as those in the conserved 'pharmacophore' regions, while maintaining the hydrophobic core and surface loops critical for target engagement. Ensure the design reflects the biological role in prey immobilization and defense, with high affinity and selectivity for sodium channels."}
{"description": "sp|D5J9Q8|VKT5_BUNFL Kunitz-type serine protease inhibitor isoform 5 OS=Bungarus flaviceps flaviceps OX=8615 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSKDRPKYCNLPPEPGPCHGRKFAFYYHPASNKCKEFVYGGCGGNDNNFKTKDKCQRACSG", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of the red-headed krait (Bungarus flaviceps). This toxin functions as a potent inhibitor of serine proteases, likely interfering with key physiological processes in prey through the inhibition of enzymes involved in blood coagulation, fibrinolysis, or inflammatory pathways. The protein should adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in the Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The reactive site loop should contain the canonical protease-binding motif with specific residues positioned for optimal interaction with the target serine protease's active site. The structural scaffold should maintain the compact, globular fold typical of Kunitz inhibitors, with the inhibitory loop presenting key residues that form complementary interactions with the protease's catalytic triad. The protein should exhibit high specificity and potency as a serine protease antagonist, characteristic of elapid snake venom Kunitz-type inhibitors used for prey immobilization."}
{"description": "sp|P0DJB0|3X_MICLE Muscarinic toxin Mlalpha (Fragment) OS=Micrurus lemniscatus OX=129464 PE=1 SV=1", "sequence": "LICFICFSPTAH", "prompt": "Design a muscarinic toxin protein sequence derived from the venom of Micrurus lemniscatus, a coral snake species. This toxin belongs to the three-finger toxin (3FTx) superfamily and specifically functions as a muscarinic toxin targeting muscarinic acetylcholine receptors. The protein should adopt the characteristic three-finger structural fold stabilized by a conserved disulfide bond pattern, typically involving four to five disulfide bridges that maintain the three β-stranded loops extending from a central globular core. As a muscarinic toxin, it should exhibit selective antagonism or modulation of muscarinic receptors, potentially interfering with parasympathetic nervous system signaling. The sequence should include key residues involved in receptor binding specificity, particularly in the central loop which often determines target selectivity. The toxin should demonstrate the typical structural stability and target specificity observed in elapid snake venom three-finger toxins, with appropriate length and cysteine framework consistent with muscarinic toxin subtypes."}
{"description": "sp|D9IX97|VNP_NAJAT Natriuretic peptide Na-NP OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MVGLSRLAGGGLLLVLALLPLALDGKPAPEALHKPPTGLRTSLAALRILGYLRPDSKQSRAARDRMLHPEQQVGGGGDSRPLQDETNKGKGSSCFGQKIDRIGSMSGMGCRTQGKPPPALPTAPAALRILEYLRPDSKRSRATRDRMLHPEQQVGGGGGGGSRVI", "prompt": "Design a natriuretic peptide toxin derived from the venom of the Chinese cobra, Naja atra. This peptide should function as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) to induce vasodilation, natriuresis, and diuresis. The peptide should adopt a conserved natriuretic peptide fold characterized by a central alpha-helical domain stabilized by a single disulfide bond formed between two conserved cysteine residues, creating a 17-amino acid ring structure critical for receptor binding and biological activity. The sequence must include the signature natriuretic peptide motif with key residues for NPR-A binding, including aromatic and hydrophobic residues that interact with the receptor's extracellular domain. The N-terminal region should be flexible, while the C-terminal tail may contain additional residues that modulate potency and stability. This toxin represents a strategic component of elapid snake venom that disrupts cardiovascular homeostasis by lowering blood pressure through cyclic GMP-mediated signaling pathways in vascular smooth muscle and renal tissues."}
{"description": "sp|Q2HZ28|PA2A_BOTER Acidic phospholipase A2 BE-I-PLA2 OS=Bothrops erythromelas OX=44710 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGSLVQFETLIMKIAGRSGVWYYGSYGCYCGSGGQGRPQDASDRCCFVHDCCYGKVTDCDPKADVYTYSEENGVVVCGGDDPCKKQICECDRVAATCFRDNKDTYDNKYWFFPAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops erythromelas, a pit viper species. This enzyme should function as a potent toxin with multiple biological activities characteristic of snake venom phospholipases A2. The protein should catalyze the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing free fatty acids and lysophospholipids. Key structural features should include: a conserved calcium-binding loop (YGKYCG) essential for catalytic activity, the characteristic pancreatic lipase fold with three long alpha-helices and two antiparallel beta-sheets, and the catalytic triad residues (His48, Asp49, Tyr52) that form the active site. The acidic nature should be reflected in the overall amino acid composition with a predicted pI below 7.0. The toxin should exhibit membrane-disrupting properties and may demonstrate additional toxic effects such as myotoxicity, neurotoxicity, or anticoagulant activity through non-enzymatic mechanisms. The structure should maintain the characteristic disulfide bond pattern typical of group II phospholipases A2, with 6-7 conserved disulfide bridges stabilizing the compact globular fold. The protein should be optimized for venom function with appropriate surface residues for membrane interaction and potential receptor binding sites that contribute to its toxicological profile."}
{"description": "sp|D2YVI2|LECG_PSEAU C-type lectin galactose-binding isoform OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "MGRFLLVTLSLLVMAFFLNGANSCCCPQDWLPRNGFCYKVFNDLKTWDDAEMYCRKFKPGCHLASLHSNADAVEFSEYITDYLTGQGHVWIGLRDTKKKYIWEWTDRSRTDFLPWRKDQPDHFNNEEFCVEIVNFTGYLQWNDDSCTALRPFLCQCKY", "prompt": "Design a novel C-type lectin protein derived from the venom of the Australian mulga snake (Pseudechis australis), a species known for its potent hemotoxic and anticoagulant venom components. This protein should function as a galactose-binding lectin, specifically recognizing and binding to terminal galactose residues on glycoproteins and glycolipids through its carbohydrate recognition domain (CRD). The mechanism of action involves disruption of platelet aggregation and interference with coagulation cascades by binding to key glycoprotein receptors on platelet surfaces, such as GPIb-IX-V complex, leading to inhibition of platelet adhesion and thrombus formation. The structural scaffold must adopt the characteristic C-type lectin fold, featuring a globular domain stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that form the cysteine framework essential for domain stability. The CRD should contain a calcium-binding site coordinated by conserved Glu, Asn, and Asp residues, which is critical for carbohydrate recognition specificity. The protein is anticipated to form homodimers or heterodimers via non-covalent interactions, enhancing its avidity for multivalent glycoprotein targets. Key structural elements include beta-sandwich topology with anti-parallel beta-sheets, loop regions mediating carbohydrate binding, and surface-exposed residues for target specificity. The molecular target is galactose-terminated glycoproteins on platelets or endothelial cells, with binding interfaces involving hydrogen bonding to galactose OH groups and hydrophobic interactions with adjacent protein surfaces."}
{"description": "sp|Q800C3|PA2AF_CROVV Acidic phospholipase A2 Cvv-E6f OS=Crotalus viridis viridis OX=8742 PE=1 SV=1", "sequence": "MRTLWIVAVLLLGVEGSLVQFEMMIIKVAKRSGLFWYGAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKATDCNPKTVSYTYSVKNGEIICEDDDPCKKQVCECDRVAAVCFRDNIPSYNNNYKRFPAENCREEPEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the prairie rattlesnake, Crotalus viridis viridis. This enzyme should function as a potent toxin by catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids, leading to membrane disruption, inflammation, and potential neurotoxic or myotoxic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer structural rigidity and catalytic efficiency. Key catalytic residues should include a conserved histidine-aspartate dyad and a calcium-binding loop essential for enzymatic activity. The acidic nature of this isoform may influence its tissue targeting and interaction with endogenous inhibitors. The generated sequence should reflect the evolutionary optimization for venom function, including surface-exposed loops that may mediate specific receptor interactions or modulate membrane penetration efficiency."}
{"description": "sp|Q9U657|O1614_CONPE Mu-conotoxin-like PnMKLT1-014 OS=Conus pennaceus OX=37335 PE=2 SV=1", "sequence": "MNLTCMMIVAVLFLTAWTFVMADDSNNGLANLFSKSRYEMEDPEPSKLEKRKTCQRRWDFCPGALVGVITCCGGLICLGVMCI", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of Conus pennaceus, a marine cone snail species. This peptide should function as a potent and selective sodium channel blocker, specifically targeting voltage-gated sodium channels (VGSCs) to disrupt action potential generation and propagation in excitable cells. The peptide should adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, globular fold stabilized by a conserved disulfide bond framework (C-C-C-C pattern) that forms a stable three-dimensional structure. The core structural motif should include a well-defined beta-sheet region and loop segments that mediate high-affinity binding to the neurotoxin receptor site 1 on the pore-forming alpha-subunit of VGSCs. The binding interface should involve key residues that interact with the channel's extracellular loops, particularly those in domains I and IV, to occlude the ion conduction pathway and inhibit sodium influx. The peptide should exhibit high specificity for neuronal or skeletal muscle sodium channel subtypes, depending on the inferred biological role, and should possess the physicochemical properties typical of conotoxins, including low molecular weight, high stability due to disulfide cross-linking, and resistance to proteolytic degradation. The design should emphasize functional efficacy in neuromuscular blockade or neuronal silencing, reflecting the toxin's role in prey immobilization or defense."}
{"description": "sp|P0C2D1|OXLA_BOTPI L-amino-acid oxidase (Fragment) OS=Bothrops pirajai OX=113192 PE=1 SV=1", "sequence": "ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the lancehead pit viper Bothrops pirajai. This enzyme represents a key component of viperid venom that contributes to prey immobilization through multiple toxic mechanisms. The protein should function as a flavin adenine dinucleotide (FAD)-dependent oxidase that catalyzes the oxidative deamination of L-amino acids, particularly hydrophobic residues like L-leucine and L-phenylalanine, generating corresponding α-keto acids, ammonia, and hydrogen peroxide as reactive byproducts. The generated hydrogen peroxide induces oxidative stress in prey tissues, leading to cytotoxicity, platelet aggregation inhibition, and hemorrhage potentiation. The protein should adopt the characteristic L-amino-acid oxidase fold with two domains: a FAD-binding domain featuring a Rossmann fold motif and a substrate-binding domain. Include conserved catalytic residues for substrate recognition and FAD cofactor binding. The structure should feature the typical dimeric quaternary organization observed in snake venom L-amino-acid oxidases, with the active site positioned at the interface between domains. The protein should exhibit the characteristic yellow coloration due to FAD binding and demonstrate optimal activity at neutral to slightly basic pH conditions typical for envenomation scenarios. Incorporate appropriate glycosylation sites that may modulate the enzyme's stability, activity, and immunogenic properties within the venom milieu."}
{"description": "sp|P0DY18|SMP76_SCOPA Scorpine-like peptide Smp76 OS=Scorpio palmatus OX=1662106 PE=1 SV=1", "sequence": "MNCKLTALLFLGLIVIASCGWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY", "prompt": "Design a scorpine-like peptide toxin derived from the venom of Scorpio palmatus, a scorpion species whose venom components typically function as potent antimicrobial and antiparasitic agents. This peptide should exhibit the characteristic structural architecture of scorpine-family toxins, featuring an N-terminal region with alpha-helical content reminiscent of defensin-like domains, followed by a C-terminal region with structural similarity to cecropin-like antimicrobial peptides. The peptide must adopt a stable, amphipathic conformation that facilitates membrane interaction and disruption. Key structural elements should include a conserved disulfide bridge pattern, likely involving three disulfide bonds with a specific connectivity (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) that stabilizes the compact globular fold. The mechanism of action should involve selective targeting of microbial membranes through electrostatic interactions with negatively charged phospholipid headgroups, leading to membrane permeabilization and cell lysis. Additionally, the peptide should demonstrate activity against malaria parasites (Plasmodium species) by disrupting the parasite's membrane integrity during various developmental stages. The sequence must maintain the characteristic cationic and hydrophobic residue distribution that enables both membrane binding and insertion, while preserving the structural stability conferred by the conserved cysteine framework."}
{"description": "sp|P0DSI2|PA1_DINQU Phospholipase A1 OS=Dinoponera quadriceps OX=609295 PE=2 SV=1", "sequence": "MKFITAILVIFCVYLLSTAGDSKILPLKKLPSKIFGHLKSHVDNTVKKPLKVFGHLKSHVENSVGPLRMNKLTPNCIFGVKSMSMVLFTKNIPDGKYISLDSDLGRDLDLTKTIYFTAHGFISNVNHSLSNRLSRALVEKDYTVFSLDWSDAACTTGGLPLVKLLGYPSAVQNTREIGNLMADYVMSLIDHGASLRNMAFIGHSLGSHVCGFASKKIYESGYGKVPLLFAADPAQPLFQLKQCPDRLCDTDAKLVITLHTSQIGLGYPIGGLDLYFNGGFVQPKCHLDITCAHIRSVLYLINMVEKKCSFPGIPATYKQILNPFSKFPYPNSKTTDCFVMDDSIFNPRRKSLQNLAGGIYYMFVDPDTFCTRKNFNCQR", "prompt": "Design a phospholipase A1 toxin protein from the venom of the giant ant Dinoponera quadriceps. This enzyme should function as a potent venom component that hydrolyzes the sn-1 acyl chain of phospholipids, generating lysophospholipids and free fatty acids. The protein should exhibit the characteristic α/β hydrolase fold common to phospholipase A1 enzymes, featuring a catalytic triad typically composed of serine, aspartate, and histidine residues. The structural scaffold should include the conserved GXSXG motif surrounding the active site serine. As a venom toxin, this phospholipase A1 likely contributes to prey immobilization through membrane disruption, hemolytic activity, and potential inflammatory responses via the release of bioactive lipid mediators. The protein should maintain optimal stability for venom function, potentially through appropriate disulfide bonding patterns characteristic of secreted venom proteins. The designed sequence should reflect the evolutionary optimization for rapid enzymatic activity against biological membranes while maintaining structural integrity in the venom gland environment."}
{"description": "sp|P82814|SIX4_HOTTS Insect toxin BsIT4 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "DGYIKGNKGCKVSCVINNVFCNSMCKSSGGSYGYCWSWGLACWCEGLPAAKKWLYAATNTCG", "prompt": "Design a novel insecticidal toxin protein inspired by the venom of the Indian red scorpion Hottentotta tamulus sindicus. This toxin should function as a potent insect-specific neurotoxin, selectively targeting insect nervous systems while exhibiting minimal activity against mammalian systems. The protein should adopt a compact, stable beta-sheet-rich fold stabilized by a conserved cysteine framework typical of scorpion beta-toxins, featuring four disulfide bridges that create a robust structural scaffold resistant to proteolytic degradation. The molecular mechanism should involve specific binding to voltage-gated sodium channels in insect neuronal membranes, modulating channel gating kinetics to cause prolonged depolarization and subsequent paralysis. Key structural elements should include a conserved core domain with characteristic beta-strands arranged in a Greek key motif, surface-exposed loops critical for receptor recognition and species selectivity, and a well-defined pharmacophore region responsible for target specificity. The toxin should exhibit rapid onset of action and high potency against lepidopteran and coleopteran pests, making it suitable for agricultural biopesticide applications. Ensure the sequence maintains the evolutionary conserved residues essential for structural integrity while allowing for functional optimization of insecticidal activity."}
{"description": "sp|P85079|TLCOA_ALOMR Omega-lycotoxin-Am1a OS=Alopecosa marikovskyi OX=2066572 PE=1 SV=2", "sequence": "MKLSIFFVLFFIAIAYCQPEFLDDEEDEVEETLPVAEEGREKSCITWRNSCMHNDKGCCFPWSCVCWSQTVSRNSSRKEKKCQCRLW", "prompt": "Design a novel protein sequence for an animal venom toxin that functions as a potent insecticidal agent, specifically targeting the central nervous system of insect prey. This toxin should be derived from wolf spider venom (Alopecosa marikovskyi) and belong to the omega-lycotoxin family, which are known for their calcium channel-blocking activity. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). This scaffold confers exceptional stability and resistance to proteolytic degradation, essential for venom efficacy. The toxin's mechanism of action involves high-affinity binding to voltage-gated calcium channels in insect neuronal membranes, leading to disrupted calcium influx, impaired neurotransmitter release, and ultimately paralysis or death of the prey. Key functional residues should be positioned within flexible loops extending from the ICK core to facilitate specific interactions with the channel's pore-forming regions or voltage-sensing domains. The sequence must include the characteristic cysteine framework of omega-lycotoxins and maintain hydrophobic patches for membrane proximity, while incorporating polar residues for target specificity. The overall structure should be compact (approximately 4-5 kDa) with a surface-exposed pharmacophore essential for insect-selective neurotoxicity."}
{"description": "sp|Q5Y4W1|TXAG5_AGEOR U5-agatoxin-Ao1a OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRTIISLLLLSAMVFAVIEAISLEEGLQLFEGERGCVGENQQCADWAGPHCCSGLRCKELSIWDSRCLG", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U5-agatoxin-Ao1a, belongs to the agatoxin family and functions as a voltage-gated calcium channel blocker. It specifically targets P/Q-type calcium channels (Cav2.1) in the presynaptic terminals of neurons, inhibiting neurotransmitter release and causing paralysis in prey. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements include a beta-hairpin loop responsible for channel binding and occlusion, and conserved hydrophobic residues that mediate interactions with the channel's pore region. The sequence should reflect the typical length and physicochemical properties of spider venom ICK toxins, with appropriate distribution of cationic and hydrophobic residues to ensure high-affinity binding and selectivity for neuronal calcium channels."}
{"description": "sp|S4S2C7|MAST_VESAF Mastoparan-AF OS=Vespa affinis OX=882735 PE=1 SV=1", "sequence": "MKNTILILFTAFIALLGFFGMSAEADPIADPIADPISGPNAEADPEAINLKAIAALAKKLFG", "prompt": "Design a mastoparan peptide sequence from the venom of Vespa affinis (the lesser banded hornet) that functions as a potent cytolytic and hemolytic toxin. This amphipathic alpha-helical peptide should be approximately 14 amino acids in length and exhibit strong membrane-disrupting activity through a detergent-like mechanism. The peptide should preferentially interact with and permeabilize lipid bilayers, particularly targeting anionic phospholipids in cell membranes. It should adopt a characteristic alpha-helical conformation in membrane-mimetic environments, with a clear hydrophobic face for membrane insertion and a hydrophilic face for interaction with lipid headgroups. The sequence should include key residues that facilitate mast cell degranulation and G-protein activation, contributing to its inflammatory and pain-inducing properties. The peptide should demonstrate the typical mastoparan characteristics of inducing calcium influx, triggering histamine release, and causing cell lysis through non-receptor-mediated membrane disruption. The structural scaffold should maintain the conserved mastoparan fold while optimizing for membrane penetration and pore formation in target cells."}
{"description": "sp|C0HM43|SCNA2_TITCE Beta-toxin Tce4 OS=Tityus cerroazul OX=2684170 PE=1 SV=1", "sequence": "KEGYLMDHEGCKLSCFIRPAGYCGRECAIKKGSEGYCAWPACYCYKLPNHVKVWEYATNRC", "prompt": "Design a beta-toxin protein from the venom of the scorpion Tityus cerroazul that functions as a potent modulator of voltage-gated sodium channels. This toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a compact globular fold stabilized by four conserved disulfide bridges with a C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The protein should contain the conserved cysteine-stabilized alpha-beta (CSαβ) motif, comprising an alpha-helix packed against an antiparallel beta-sheet, which is essential for its structural integrity and target recognition. The core mechanism of action involves binding to site 4 of voltage-gated sodium channels, specifically interacting with the S1-S2 and S3-S4 extracellular loops of domain II. This binding should cause a hyperpolarizing shift in the voltage dependence of activation, leading to premature channel opening and sustained neuronal excitability, resulting in paralysis. The toxin should possess a surface-exposed pharmacophore comprising key residues in the 'core' and 'NC' domains that mediate high-affinity interaction with the sodium channel. The structural design should ensure thermal stability and resistance to proteolytic degradation, typical of scorpion venom peptides. The protein should be approximately 60-70 amino acids in length with the characteristic pattern of hydrophobic residues that stabilize the core fold and charged residues that facilitate target recognition and membrane interaction."}
{"description": "sp|Q5FZI5|SLTB_PROMU Snaclec trimecetin subunit beta OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTAADCPSDWSSFRRYCYQVFQQKMNWEDAEKFCTQQHRGSHLVSFHSSEEVDFVVSKTLPILKANFVWMGLSNVWNECAKEWSDGTKLDYKAWSGQSDCITSKTTDNQWLSMDCSSKRYVVCKF", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This toxin originates from the venom of Protobothrops mucrosquamatus (the Taiwanese habu pit viper), where it serves as a key component in the snake's predatory arsenal by disrupting hemostatic pathways in prey. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a compact globular structure stabilized by conserved disulfide bridges. The sequence must include the essential cysteine framework typical of snaclecs, with specific disulfide pairings that maintain the structural integrity of the fold. The protein likely functions by binding to platelet surface receptors such as GPIb or GPVI, interfering with platelet activation and aggregation through competitive inhibition or receptor clustering. The molecular surface should present key residues for carbohydrate recognition domain-like interactions, though it may exhibit altered specificity compared to classical lectins, targeting protein receptors instead. The overall architecture should reflect the heterodimeric nature of trimecetin, with this subunit contributing to the functional complex's stability and target recognition."}
{"description": "sp|P82811|SIX1_HOTTS Insect toxin BsIT1 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "DGYILMRNGCKIPCLFGNDGCNKECKAYGGSYGYCWTYGLACACEGQPEDKKHLNYHKKTC", "prompt": "Design a novel insecticidal toxin protein inspired by the venom of the Indian red scorpion Hottentotta tamulus sindicus. This toxin should function as a potent insect-specific neurotoxin, selectively targeting insect nervous systems while exhibiting minimal activity against mammalian systems. The protein should adopt a compact, stable beta-sheet rich fold stabilized by a conserved cysteine framework typical of scorpion short-chain insectotoxins, featuring four disulfide bridges that create a rigid structural scaffold. The molecular mechanism should involve modulation of voltage-gated sodium channels in insect neurons, potentially causing prolonged channel opening or altered inactivation kinetics leading to hyperexcitability, paralysis, and ultimately death in insect prey. The structural core should include characteristic beta-strands arranged in a small globular domain with exposed loops containing key residues for insect sodium channel recognition and binding. The protein should maintain high thermal stability and protease resistance appropriate for venom deployment, with surface properties optimized for insect-specific target engagement while avoiding mammalian sodium channel interactions."}
{"description": "sp|Q7T248|SLA_ECHCA Snaclec echicetin subunit alpha (Fragment) OS=Echis carinatus OX=40353 PE=1 SV=2", "sequence": "GADEMCPPGWSSNGVYCYMLFKEPKTWDEAEKFCNKQGKDGHLLSIESKKEEILVDIVVSENIGKMYKIWTGLSERSKEQHCSSRWSDGSFFRSYEIAIRYSECFVLEKQSVFRTWVATPCENTFPFMCKYPVPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor. This protein should originate from the venom of Echis carinatus (saw-scaled viper), a species known for producing hemorrhagic toxins that disrupt hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by two conserved disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The core function should be specific antagonism of platelet glycoprotein Ib (GPIb), effectively blocking the initial step of platelet adhesion and aggregation by preventing von Willebrand factor binding. The protein should form a heterodimeric complex with a beta subunit to achieve full biological activity, though this prompt focuses on the alpha subunit design. The structural scaffold should feature the conserved calcium-binding motif characteristic of C-type lectins, though this protein likely functions through protein-protein interactions rather than carbohydrate recognition. The sequence should include the conserved cysteine framework and maintain the beta-sheet rich topology typical of CTLD proteins, with surface loops optimized for high-affinity GPIb binding to achieve potent antiplatelet activity."}
{"description": "sp|Q27J49|BNP_LACMU Bradykinin-potentiating and C-type natriuretic peptides OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "MFVSRLAASGLLLLALLAVSLDGKPVQQWSHKGWPPRPQIPPLVVQQWSQKPWPPGHHIPPVVVQEWPPGHHIPPLVVQQWSQKKWPPGHHIPPLVVQKWDPPPISPPLLKPHESPAGGTTALREELSLGPEAALDTPPAGPDVGPRGSKAPAAPHRLPKSKGASATSAASRPMRDLRTDGKQARQNWGRMMNPDHHAVGGGGGGGGARRLKGLAKKRVGDGCFGLKLDRIGSMSGLGC", "prompt": "Design a novel venom-derived peptide that functions as a dual-activity toxin with both bradykinin-potentiating and C-type natriuretic peptide activities, characteristic of the venom from the bushmaster snake (Lachesis muta). This peptide should exhibit the following biological properties: As a bradykinin-potentiating peptide, it must inhibit angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced vasodilation, increased vascular permeability, and hypotension. Simultaneously, as a C-type natriuretic peptide, it should activate the natriuretic peptide receptor B (NPR-B), stimulating cyclic GMP production to promote natriuresis, diuresis, and further vasodilation. The peptide should adopt a compact, stable structure stabilized by multiple disulfide bonds, characteristic of snake venom peptides, with a cysteine framework that enables proper folding and receptor interaction. The molecular scaffold should facilitate binding to both ACE and NPR-B, creating a synergistic hypotensive effect that enhances prey immobilization through cardiovascular collapse. The structural design should prioritize stability in the venom milieu and target specificity to maximize toxic potency while maintaining the characteristic pharmacodynamic profile of bushmaster venom components."}
{"description": "sp|Q9PSM5|SL1B_BOTJA Snaclec GPIB-binding protein subunit beta OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "DCPSDWSPYGGHCYKLFKQRMNWADAENLCAQQRKESHLVSFHSSEEVDFLVLLTFPILGPDLYWTGLSNIWNGCSFEWSDGTKVNYNAWASESECVASKTTDNQWWSFPCTRLQYFVCEFQA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This protein originates from Bothrops jararaca, a medically important pit viper whose venom contains potent hemostatic-disrupting components. The protein should function as a GPIb-binding protein subunit beta, specifically targeting the platelet membrane glycoprotein Ib (GPIb) complex. This interaction inhibits platelet adhesion and aggregation by blocking the von Willebrand factor (vWF) binding site on GPIb, thereby disrupting primary hemostasis and promoting bleeding. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C-C-C-C cysteine framework. The sequence should include key residues for the heterodimeric assembly with the alpha subunit, forming a functional snaclec complex. The binding interface should contain specific loops and surface patches that mediate high-affinity interaction with the leucine-rich repeat domain of GPIbα. The overall structure should be compact and globular, approximately 15-20 kDa in size, with the characteristic β-sheet core and α-helices flanking the carbohydrate-recognition domain-like region, though lacking actual carbohydrate-binding activity typical of true C-type lectins."}
{"description": "sp|P0C1Q8|MAST1_VESVU Mastoparan-V1 OS=Vespula vulgaris OX=7454 PE=1 SV=1", "sequence": "INWKKIKSIIKAAMN", "prompt": "Design a mastoparan peptide sequence derived from the venom of the common wasp, Vespula vulgaris. This amphipathic, alpha-helical peptide should function as a potent cytolytic toxin that disrupts cellular membranes through direct interaction with phospholipid bilayers. The peptide should adopt a characteristic mastoparan fold with a well-defined amphipathic helix structure, allowing it to insert into lipid membranes and form pores or cause membrane destabilization. Key structural features should include: a high proportion of hydrophobic residues on one face of the helix for membrane insertion, basic residues (particularly lysine and arginine) that facilitate initial electrostatic interactions with negatively charged membrane surfaces, and the absence of disulfide bridges typical of this peptide family. The mechanism of action involves binding to G-proteins as a mastoparan mimic while primarily functioning as a membrane-disrupting agent that induces cell lysis through pore formation or detergent-like effects. The peptide should exhibit broad-spectrum activity against various cell types, reflecting its role in wasp venom as both a pain-inducing component and cytolytic agent that facilitates the spread of other venom components."}
{"description": "sp|A7X4S7|3SX5_OXYMI Toxin 3FTx-Oxy5 OS=Oxyuranus microlepidotus OX=111177 PE=3 SV=1", "sequence": "MKTLLLTLVVMTIVCLDLGYTLTCYMNPSGTMVCKEHETMCYRLIVWTFQYHVLYLKGCSSSCPGGNNCACCSTDLCNN", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically identified as Toxin 3FTx-Oxy5 from the inland taipan (Oxyuranus microlepidotus), one of the world's most venomous snakes. The protein should adopt the characteristic three-finger structural fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a typical cysteine framework of C-C-CC-C-C. As a member of the 3FTx family, this toxin likely functions as a neurotoxin targeting nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, potentially causing postsynaptic blockade and paralysis. The sequence should include key functional residues for receptor binding, particularly in loop II, which often contains critical aromatic and hydrophobic residues for interaction with the nAChR α-subunit. The structural integrity must be maintained through the conserved disulfide pattern, ensuring proper folding of the three-loop architecture essential for target specificity and potent neurotoxic activity."}
{"description": "sp|Q7T2Q6|VKTHB_BUNFL Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B chain OS=Bungarus flaviceps flaviceps OX=8615 PE=1 SV=1", "sequence": "MSSGSLLLLLGLLTLLAELTPVSSRKRHPDCDKPPNKKRCTGHIPAFYYNPQRKTCERFSYGGCKGNGNHFKTPQLCMCHCHE", "prompt": "Design a protein sequence for a beta-bungarotoxin B chain, a component of the heterodimeric neurotoxin from the many-banded krait (Bungarus flaviceps). This protein functions as a Kunitz-type serine protease inhibitor homolog within the venom, contributing to the toxin's potent presynaptic neurotoxicity. The beta-bungarotoxin complex targets the neuromuscular junction, where the B chain inhibits specific serine proteases involved in synaptic transmission, leading to acetylcholine release blockade and paralysis. The sequence should adopt the characteristic Kunitz-type fold, stabilized by three conserved disulfide bonds with the canonical cysteine framework (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity). Include key structural elements: a reactive site loop for protease inhibition, beta-sheet secondary structure, and the compact globular domain typical of Kunitz inhibitors. Ensure the sequence reflects the evolutionary adaptation from a standard protease inhibitor to a neurotoxic component, with residues optimized for stability in venom and functional synergy with the phospholipase A2 A chain in the heterodimer."}
{"description": "sp|Q9NJC6|KBX2_OLIMR Potassium channel toxin BmTXK-beta OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MMKQQFFLFLAVIVMISSVIEAGRGKEIMKNIKEKLTEVKDKMKHSWNKLTSMSEYACPVIEKWCEDHCAAKKAIGKCEDTECKCLKLRK", "prompt": "Design a potassium channel toxin protein from the venom of Olivierus martensii (Chinese scorpion) that functions as a potent modulator of voltage-gated potassium channels. This toxin should adopt the conserved structural scaffold characteristic of scorpion potassium channel toxins, featuring a stable alpha-beta fold stabilized by three or four disulfide bridges in a specific cysteine framework pattern. The protein should contain key functional domains including a conserved functional dyad (typically involving a lysine residue for channel pore interaction) and surface-exposed residues that confer selectivity for specific potassium channel subtypes (such as Kv1.1, Kv1.2, or Kv1.3). The structural core should maintain the characteristic cysteine-stabilized alpha-beta motif with well-defined secondary structure elements: an alpha-helix and an antiparallel beta-sheet, creating a compact, stable globular structure resistant to proteolytic degradation. The toxin should exhibit high affinity binding to the voltage-sensing domain or pore region of potassium channels, modulating channel gating kinetics and leading to neuronal hyperexcitability or neuromuscular effects. The molecular mechanism should involve specific interactions with channel turret regions and selectivity filter domains, potentially altering channel inactivation properties or shifting voltage dependence of activation."}
{"description": "sp|S4S3F6|MAST_VESVF Mastoparan-V OS=Vespa velutina flavitarsus OX=1075777 PE=1 SV=1", "sequence": "MKNTILILFTAFIALLGFFGMSAEALADPVADPLAGPNAEADPEAINWKGIAAMAKKLLG", "prompt": "Design a mastoparan peptide from the venom of Vespa velutina flavitarsus (Asian hornet) that functions as a potent cytolytic and neuroactive toxin. This peptide should adopt an amphipathic alpha-helical structure in membrane environments, characteristic of mastoparan family peptides. The sequence should be rich in hydrophobic residues and basic amino acids (particularly lysine) to facilitate membrane interaction and pore formation. The mechanism of action involves direct perturbation of lipid bilayers leading to cell lysis, as well as activation of G-proteins through mimicry of intracellular G-protein binding domains. The peptide should exhibit broad-spectrum activity against various cell types, contributing to the hornet's predatory and defensive capabilities. Key structural features include: a flexible N-terminal region, a central amphipathic helix spanning approximately residues 5-14, and a C-terminal region that may contribute to membrane anchoring. The peptide should lack cysteine residues and disulfide bonds, distinguishing it from many other venom peptides, and should maintain the characteristic mastoparan physicochemical properties that enable both membrane disruption and intracellular signaling interference."}
{"description": "sp|P56638|CA1A_CONEP Alpha-conotoxin EpI OS=Conus episcopatus OX=88764 PE=1 SV=2", "sequence": "MFTVFLLVVLATTVVSFTSDRASDSRKDAASGLIALTIKGCCSDPRCNMNNPDYCG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus episcopatus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore residues responsible for receptor binding and selectivity, while maintaining the typical short inter-cysteine loop lengths that define alpha-conotoxins. The final structure should exhibit high stability, target specificity, and the ability to disrupt cholinergic signaling through competitive inhibition at the receptor's orthosteric binding site."}
{"description": "sp|P85117|TX1_GRARO Beta-theraphotoxin-Gr1a OS=Grammostola rosea OX=432528 PE=1 SV=1", "sequence": "YCQKWMWTCDSKRKCCEDMVCQLWCKKRL", "prompt": "Design a novel beta-theraphotoxin protein sequence derived from the Chilean rose tarantula (Grammostola rosea) venom. This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce rapid paralysis through alteration of channel gating kinetics. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom toxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). Key structural elements should include a hydrophobic core, solvent-exposed loops responsible for target interaction, and conserved residues critical for maintaining the ICK scaffold. The molecular mechanism should involve binding to neurotoxin receptor site 4 on voltage-gated sodium channels, leading to modified channel inactivation and prolonged neuronal excitation. The sequence must exhibit appropriate physicochemical properties for venom secretion and stability, including optimal isoelectric point and molecular weight consistent with spider venom peptides."}
{"description": "sp|P56637|SIXE_HOTJU Beta-insect excitatory toxin Bj-xtrIT OS=Hottentotta judaicus OX=6863 PE=1 SV=1", "sequence": "MKFFLMCLIIFPIMGVLGKKNGYPLDRNGKTTECSGVNAIAPHYCNSECTKVYYAESGYCCWGACYCFGLEDDKPIGPMKDITKKYCDVQIIPS", "prompt": "Design a beta-insect excitatory toxin from the scorpion Hottentotta judaicus that functions as a potent insect-selective neurotoxin. This toxin should specifically target voltage-gated sodium channels in insect nervous systems, causing prolonged channel activation and neuronal hyperexcitability that leads to paralysis and death in insect prey. The protein should adopt the conserved beta-toxin structural scaffold characteristic of scorpion venom peptides, featuring a compact globular fold stabilized by four disulfide bridges in the characteristic C-C-C-C cysteine framework. The structure should display the hallmark cysteine-stabilized alpha-beta (CSαβ) motif with a short alpha-helix packed against an antiparallel beta-sheet. Key functional residues should be positioned to interact with the voltage-sensing domain of insect sodium channels, particularly through a critical 'pharmacophore' region that confers insect selectivity over mammalian channels. The toxin should exhibit high thermal stability and protease resistance typical of scorpion venom peptides, with molecular surface features optimized for specific binding to insect neuronal membranes while maintaining the excitatory activity profile that causes uncontrolled neurotransmitter release and spastic paralysis in target insects."}
{"description": "sp|Q5FZI6|SLTA_PROMU Snaclec trimecetin subunit alpha OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADCPSDWSSFRRYCYKPFKQLKTWEDAERFCWEQVKGAHLVSIESSGEGDFVAQLLSENIKTTKYHVWIGLSIQNKRQQCRSIWSDGSSVSYENLVKPFSKKCFVLKKESEFHKWFNIYCGERNLFMCKFLQPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This toxin originates from the venom of Protobothrops mucrosquamatus (Taiwan habu snake), where it contributes to the venom's hemorrhagic and procoagulant effects by targeting components of the mammalian hemostatic system. The protein should adopt the characteristic snaclec fold - a compact, globular structure stabilized by conserved disulfide bridges with a typical C-type lectin-like domain (CTLD) architecture. The structural scaffold should feature the canonical snaclec cysteine framework with specific disulfide connectivity that maintains the stable β-sandwich fold composed of antiparallel β-strands. This α-subunit is part of a heterodimeric complex that likely binds to platelet membrane receptors such as GPIb or GPVI, modulating platelet activation through specific protein-carbohydrate or protein-protein interactions. The sequence should include key residues for calcium-independent carbohydrate recognition domain functionality and maintain the structural integrity required for target recognition while exhibiting the thermal stability typical of venom snaclec proteins."}
{"description": "sp|P68725|SX21_LEIHE Insect toxin 2-13 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "MKLLLLLIITASMLIEGLVNADVYIRRHDGCKISCTVNDKYCDNECKSEGGSYGYCYAFGCWCEGLPNDKAWKSETNTCGGKK", "prompt": "Design a protein sequence for an insect-specific neurotoxin derived from the venom of the scorpion Leiurus hebraeus. This toxin should function as a potent modulator of voltage-gated sodium channels in insect nervous systems, exhibiting selective toxicity towards insects while having minimal effects on mammals. The protein should adopt a compact, globular fold stabilized by a conserved cysteine framework typical of scorpion β-toxins, featuring four disulfide bridges that create a stable structural scaffold. The core structure should consist of an anti-parallel β-sheet arrangement with connecting loops that form the molecular interface for binding to domain II of insect sodium channels. Key functional elements should include a conserved 'pharmacophore' region responsible for channel recognition and modulation, likely involving specific residues that interact with the voltage-sensing domain to alter channel gating kinetics. The toxin should prolong sodium channel activation, leading to sustained neuronal depolarization and ultimately paralysis in insect prey. The sequence should reflect the characteristic molecular weight and isoelectric point profile of scorpion insectotoxins, with appropriate surface charge distribution for target specificity. The structural design must ensure proper folding and disulfide connectivity to maintain biological activity and stability in the venom environment."}
{"description": "sp|E7CLP1|SCX32_RHOJU Putative beta-neurotoxin RjAa32 (Fragment) OS=Rhopalurus junceus OX=419285 PE=2 SV=1", "sequence": "KEGYPMGRDGCKISCVINNNFCKVECQAKWRQSDGYCYFWGLSCYCTIYQKTPRFGILAPINVEDNVTVTQCLGHLINVMYSH", "prompt": "Design a protein sequence for a beta-neurotoxin derived from the venom of the scorpion Rhopalurus junceus. This toxin should function as a beta-neurotoxin, specifically targeting voltage-gated sodium channels (Nav) to modulate neuronal excitability. The mechanism of action involves binding to site 4 of Nav channels, which typically slows inactivation and enhances persistent sodium currents, leading to prolonged neuronal depolarization and neurotoxicity. The structural scaffold should feature an inhibitor cysteine knot (ICK) motif, characterized by a compact, disulfide-stabilized fold with three disulfide bridges forming a knotted topology (C1-C4, C2-C5, C3-C6 connectivity). Key structural elements include a conserved beta-sheet core and flexible loops that mediate receptor interaction. The binding interface should contain residues critical for channel recognition, likely involving hydrophobic patches and charged residues that engage with the extracellular loops of Nav channel domains. The sequence must reflect the typical length and cysteine pattern of scorpion beta-neurotoxins, ensuring proper folding into the ICK architecture for stability and function in venom."}
{"description": "sp|P22029|SLEA_BOTJA Snaclec botrocetin subunit alpha OS=Bothrops jararaca OX=8724 PE=1 SV=2", "sequence": "DCPSGWSSYEGNCYKFFQQKMNWADAERFCSEQAKGGHLVSIKIYSKEKDFVGDLVTKNIQSSDLYAWIGLRVENKEKQCSSEWSDGSSVSYENVVERTVKKCFALEKDLGFVLWINLYCAQKNPFVCKSPPP", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) derived from Bothrops jararaca venom that functions as a key component of the botrocetin complex. This protein should exhibit the characteristic C-type lectin-like domain fold with a conserved carbohydrate recognition domain architecture. The sequence must contain the essential calcium-binding motifs and the specific disulfide bond pattern (C1-C2, C3-C4, C5-C6) that stabilizes the globular β-sandwich structure. The protein should function as a von Willebrand factor (vWF) modulator, specifically enhancing vWF binding to platelet glycoprotein Ib (GpIb) under high shear stress conditions, thereby promoting platelet aggregation and contributing to the procoagulant activity of Bothrops jararaca venom. The structural scaffold should maintain the conserved hydrophobic core and surface-exposed loops that mediate protein-protein interactions with vWF, while preserving the dimerization interface required for functional botrocetin complex formation with the beta subunit."}
{"description": "sp|D5KXG6|TUEI_GEMSP Turripeptide XIV-18 (Fragment) OS=Gemmula speciosa OX=439592 PE=2 SV=1", "sequence": "CEDGGVPSASCRANTEDYRYCNACYLQEVIGK", "prompt": "Design a novel animal toxin protein sequence based on the turripeptide family from the venomous marine snail Gemmula speciosa. This toxin should function as a potent neuroactive peptide targeting ion channels in the peripheral nervous system. The protein should adopt the characteristic turripeptide structural scaffold with a compact, disulfide-stabilized fold typical of conotoxin-like peptides from turrid snails. Incorporate the conserved cysteine framework pattern that enables formation of multiple disulfide bridges, creating a stable three-dimensional structure resistant to proteolytic degradation. The mature toxin should exhibit high affinity binding to specific neuronal ion channels, potentially voltage-gated sodium or calcium channels, leading to disruption of synaptic transmission and neuromuscular blockade. The sequence should include key functional residues for target recognition and binding, while maintaining the overall structural integrity through proper spacing of cysteine residues and conserved hydrophobic core elements. The resulting protein should demonstrate the evolutionary optimization characteristic of turrid venom peptides - small size, high potency, and target specificity honed through predator-prey interactions in marine ecosystems."}
{"description": "sp|P0DRI7|XIB2_XIBTU Xibalbin-2 OS=Xibalbanus tulumensis OX=1519145 GN=c29772_g1_i1_5 PE=2 SV=1", "sequence": "MKGVCTRKVLYFFMAVILFVAIVASEDTENRNPAMAMPLQRMEQEVEKVSSRCGPVACPGRFCGSDLGACRPPWCCRGCSCSFCCKL", "prompt": "Generate the amino acid sequence for Xibalbin-2, a venom peptide toxin from the cave-dwelling remipede crustacean Xibalbanus tulumensis. This toxin represents a novel class of crustacean venom components with potent neurotoxic activity. Xibalbin-2 functions as a voltage-gated sodium channel modulator, specifically targeting neuronal Nav channels to disrupt action potential generation and propagation. The toxin likely adopts a compact, disulfide-rich scaffold characteristic of cysteine-stabilized peptide toxins, featuring a conserved cysteine framework that forms multiple intramolecular disulfide bridges to stabilize its bioactive conformation. The structural fold is expected to be dominated by beta-sheet elements arranged in an inhibitor cystine knot (ICK) motif, providing exceptional thermal and proteolytic stability. The molecular mechanism involves high-affinity binding to domain II or IV of voltage-gated sodium channels, modifying channel gating kinetics through either pore block or modulation of voltage-sensor movement. The toxin's compact size and disulfide-stabilized architecture enable precise molecular recognition of specific channel isoforms while resisting degradation in the hostile extracellular environment. Design the sequence to reflect these structural and functional characteristics, ensuring proper cysteine spacing for correct disulfide connectivity and including conserved residues critical for sodium channel interaction and toxin potency."}
{"description": "sp|P0C245|TX622_PSACA Tau-theraphotoxin-Pc1b OS=Psalmopoeus cambridgei OX=179874 PE=1 SV=1", "sequence": "GACRWFLGGCKSTSDCCEHLSCKMGLDYCAWDGTF", "prompt": "Generate the amino acid sequence for a theraphotoxin from the Trinidad chevron tarantula (Psalmopoeus cambridgei), specifically the tau-theraphotoxin-Pc1b variant. This toxin functions as a potent inhibitor of voltage-gated sodium channels, particularly targeting the Nav1.7 subtype, which plays a critical role in pain signaling pathways. The toxin should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves binding to the voltage-sensing domain of Nav1.7, stabilizing the channel in a closed state and blocking sodium ion flux, thereby producing analgesic effects. The sequence should include key residues for receptor interaction, such as a hydrophobic patch for membrane association and basic residues for electrostatic interactions with the channel's voltage sensor. The structural scaffold must ensure high stability and selectivity, with the ICK fold providing resistance to proteolytic degradation and thermal denaturation, typical of spider venom peptides targeting ion channels."}
{"description": "sp|A0A0B4U9L8|VMF1_VIPAA Zinc metalloproteinase-disintegrin-like protein F1 OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "MLQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKLTALLKGAIQQPEQKYEDAMQYEFKVNGKPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGHIQNDAHLTASISACNGLKGHFQLRGETYLIEPLKIPDSEAHAVYKYENVEKEDEGPKKCGVTQTNWKSDEPIKASQFILTPEQRAYMNANKYIKLAIVVDNVMFRKYTGNFTAIRTRIYEIVNTLNLIYTILNIHIALVFLEIWSKGDSINVQSVVDVTLNSFGEWRERDLLNRKRHDNAQLLTGINFNGDTIGFGFVGSMCIPKKSVGIVQDHSKTHLLVATTMAHELGHNLGINHDGDSCTCQANSCIMAAKLSHQPSYQFSDCSINELWMYLISHTPRCILNEPLTTDVVSPAVCGNYVVEEGEECDCGSLWYCRNPCCDAATCKLKPGAECGDGVCCYQCRFVTAGTVCRPARSECDIPEYCSGQSVECPMDHIQKNGKPCLMNHGYCYNGRCPIMIHQCIALWGPGTTVSSDVCFQRNESGQGYSYCRRENNQNIPCAPQDVKCGRLYCKFHNVNTLPCNFKYSDFAPDYGLVDHGTKCGDGKVCNSNRQCVDVNTAY", "prompt": "Design a zinc metalloproteinase-disintegrin-like protein from the venom of the nose-horned viper (Vipera ammodytes ammodytes). This protein should function as a key hemorrhagic toxin, contributing to prey immobilization through disruption of hemostasis. The protein must contain two distinct functional domains: (1) A zinc-dependent metalloproteinase domain responsible for cleaving extracellular matrix components, particularly basement membrane proteins like type IV collagen and fibronectin, leading to blood vessel degradation and hemorrhage. This domain should feature a conserved HEXXHXXGXXH zinc-binding motif and exhibit structural characteristics of the reprolysin family metalloproteinases. (2) A disintegrin-like domain that mimics the structure of endogenous disintegrins, potentially interfering with platelet aggregation through interactions with integrin receptors on platelet surfaces. The protein should maintain the characteristic multi-domain architecture of snake venom metalloproteinases, with appropriate inter-domain spacing and structural organization. The overall fold should facilitate efficient proteolytic activity while presenting the disintegrin-like domain for potential receptor interactions. The sequence should reflect the evolutionary optimization for rapid tissue damage and hemorrhage induction in prey organisms."}
{"description": "sp|E9NW28|VM2P3_PROMU Zinc metalloproteinase/disintegrin (Fragment) OS=Protobothrops mucrosquamatus OX=103944 PE=2 SV=1", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVSALPKGAVQPKYEDTMQYELKENGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGQTYLIEPLKLPDSEAHAVFKYENIEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYVKLAIVVDYRMYIKYNRDSNKITVRVHEMVNHVNEMYKPLNVAITLSLLRIWSTRDLITVQSDSKVTLGSFGDWRKTVLLKQQSHDCAHLLTDITFTKNVIGVAYKKGMCDPKLSVGLVQDYSSNVFVVAAIMTHELGHNLGMEHDEDENGKKCKCDTCIMSPAISDPPAQLFSDCSKNDYHTFLTNSKPQCILNAPLRTDTVSTPVSGNEPL", "prompt": "Design a protein sequence for a venom toxin fragment that functions as a zinc metalloproteinase and disintegrin, derived from the venom of Protobothrops mucrosquamatus (the Taiwanese habu pit viper). This toxin should exhibit the dual functionality characteristic of snake venom metalloproteinases (SVMPs): (1) A zinc-dependent metalloproteinase domain responsible for hydrolyzing extracellular matrix components such as collagen, fibronectin, and laminin, facilitating tissue damage and hemorrhage. The catalytic domain must include a conserved HEXXHXXGXXH zinc-binding motif, where the three histidine residues coordinate a zinc ion essential for proteolytic activity. (2) A disintegrin domain that inhibits platelet aggregation by binding to integrin receptors on platelet surfaces, specifically targeting αIIbβ3 integrin to block fibrinogen binding and thus prevent thrombus formation. The disintegrin domain should feature an RGD (Arg-Gly-Asp) or related tripeptide motif that mediates high-affinity interaction with integrins. Structurally, the protein should adopt a multi-domain architecture typical of SVMPs, with the metalloproteinase domain folding into a metzincin-like structure characterized by a central five-stranded β-sheet and surrounding α-helices, and the disintegrin domain forming a compact, disulfide-rich globular fold stabilized by multiple disulfide bridges. The overall scaffold must maintain the structural integrity required for both enzymatic activity and receptor binding, with appropriate spacing and conformation between domains to allow simultaneous or sequential function in venom-induced pathology, including hemorrhage, coagulopathy, and inflammation."}
{"description": "sp|Q2LD49|VM3TM_TRIST Zinc metalloproteinase-disintegrin-like TSV-DM OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTSLPKGAVQQKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTKPPVKDHCYYHGHIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKEASQSNLTPEQQSYLNAPKYVKFFLVADHIMYLKYGRNLTTLRTRIFDTVNVVYLILLRINIHVLLVGMEIWSHKDKIIVQSVPAVTLKLFATWREADLLKHKSHGCAHLLTGINFNGPTAGLAYLGAICNPMYSAGIVQDHNKIHHLVAIAMAHELGHNLGINHDKDTCTCRAKACVMAGTISCDASYLFSDCSRQEHREFLIKNMPQCILKKPLKTDVVSPPVCGNYFVEVGEDCDCGSPATCRDSCCNPTNCKLRQGAQCAEGLCCDQCRFKGAGTECRPASSECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGTCPSMTDQCIALFGPNAAVSQDACFQFNREGNHYGYCRKEQNTKIACEPENVKCGRLYCIDSSPANKNPCNIVYLPNDEEKGMVLAGTKCADGRACNSNGQCVGVNGAYKSTTGFSQI", "prompt": "Design a novel snake venom metalloproteinase-disintegrin-like protein inspired by Trimeresurus stejnegeri (Chinese green tree viper) venom. This protein should function as a potent hemorrhagic toxin that targets the mammalian vascular system. The protein must contain two distinct functional domains: (1) A zinc-dependent metalloproteinase domain with a conserved HEXXHXXGXXH zinc-binding motif that cleaves key components of the basement membrane, particularly type IV collagen and fibronectin, leading to capillary disruption and hemorrhage. (2) A disintegrin-like domain featuring the characteristic RGD or related integrin-binding motif that inhibits platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors on platelets. The protein should adopt the canonical reprolysin family fold with a multi-domain architecture including propeptide, metalloproteinase, disintegrin-like, and cysteine-rich domains. The metalloproteinase domain should feature the typical metzincin topology with a central five-stranded β-sheet and surrounding α-helices, while the disintegrin-like domain should maintain the disulfide-stabilized compact fold. The protein must contain the conserved cysteine pattern characteristic of SVMPs, with specific disulfide bridges stabilizing each domain. The overall structure should facilitate calcium-dependent conformational changes and proper zymogen activation through proteolytic cleavage of the prodomain. The generated sequence should exhibit optimal substrate specificity for extracellular matrix proteins while maintaining high affinity for platelet integrin receptors, creating a synergistic hemorrhagic and anti-hemostatic effect typical of viperid venoms."}
{"description": "sp|D2YVH7|LECM_OXYSU C-type lectin mannose-binding isoform OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1", "sequence": "MGRFLLVTLSLLVGAFSLNEANSCCCPQDWLPKNGFCYKVFNDHKNWNDAEMFCRKFKPGCHLASIHSNADSADLAEYVSDYLKSDGNVWIGLNDPRKQRTWVWSDRSPTNYYSWNRGEPNNSKNNEYCVHLWALSGYLKWNDTPCKALYSFICQCRF", "prompt": "Design a protein sequence for a C-type lectin toxin from the venom of the coastal taipan (Oxyuranus scutellatus), a highly venomous Australian elapid snake. This toxin functions as a mannose-binding lectin that plays a critical role in the snake's venom arsenal by targeting carbohydrate structures on cell surfaces. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges typically formed between cysteine residues in positions that create the C1-C4 and C2-C3 connectivity pattern. The structural scaffold should include the calcium-binding site essential for carbohydrate recognition, with key residues in the EPN (Glu-Pro-Asn) or QPD (Gln-Pro-Asp) motifs that determine mannose specificity. The toxin likely functions by binding to glycoproteins on platelet surfaces or other blood cells, potentially interfering with coagulation pathways or inducing cell aggregation through carbohydrate-mediated interactions. The sequence should maintain the β-sheet-rich core structure typical of CTLDs while incorporating surface-exposed loops that mediate specific carbohydrate recognition and biological activity relevant to venom toxicity."}
{"description": "sp|P0DPG7|TX35A_PHORI Beta/delta-ctenitoxin-Pr1a (Fragment) OS=Phoneutria reidyi OX=272752 PE=1 SV=1", "sequence": "CGDINAPCQSDCDCCGYSVTCDCYWGNECKCRESNFAIGM", "prompt": "Design a venom-derived peptide toxin from the Brazilian wandering spider Phoneutria reidyi that functions as a beta/delta-ctenitoxin. This toxin should exhibit the characteristic dual functional profile of beta-ctenitoxins, which typically act as voltage-gated sodium channel modulators, and delta-ctenitoxins, which often target voltage-gated calcium channels. The peptide should adopt a robust structural scaffold stabilized by multiple disulfide bridges, likely following the inhibitor cystine knot (ICK) motif common in spider venom peptides. The molecular mechanism should involve modulation of ion channel gating kinetics, potentially causing delayed inactivation of sodium channels and/or inhibition of calcium channel function, leading to neuronal hyperexcitability and neuromuscular dysfunction. The structural architecture should feature a compact, globular fold with well-defined beta-sheet elements and a stable core maintained by the conserved cysteine framework. The binding interface should contain key residues for specific interaction with voltage-sensing domains of target ion channels, ensuring potent neurotoxic activity characteristic of Phoneutria spider venoms known for their complex pharmacological effects on the mammalian nervous system."}
{"description": "sp|P82662|3L26_OPHHA Alpha-elapitoxin-Oh2b OS=Ophiophagus hannah OX=8665 PE=1 SV=2", "sequence": "MKTLLLTLVVMTIVCLDLGYTLICFISSHDSVTCAPGENVCFLKSWCDAWCGSRGKKLSFGCAATCPKVNPGIDIECCSTDNCNPHPKLRP", "prompt": "Design a novel alpha-elapitoxin protein sequence that captures the potent neurotoxic activity characteristic of king cobra (Ophiophagus hannah) venom. This three-finger toxin should function as a postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein must adopt the conserved three-finger toxin fold stabilized by four invariant disulfide bridges with the characteristic C-C-C-C cysteine framework. The structural scaffold should feature three extended β-stranded loops projecting from a globular core, with the central loop containing key functional residues for high-affinity binding to the α-δ and α-γ subunit interfaces of the nicotinic receptor. Incorporate conserved hydrophobic residues in the core for structural stability and include the characteristic cationic and aromatic residues in loop II that mediate specific interactions with the receptor's ligand-binding domain. The sequence should maintain the compact, stable architecture typical of elapid neurotoxins while ensuring proper folding and disulfide connectivity for optimal biological activity."}
{"description": "sp|P84473|VKTH2_BUNCA Kunitz-type serine protease inhibitor homolog T1-2 B chain (Fragment) OS=Bungarus candidus OX=92438 PE=1 SV=1", "sequence": "RQRHPDCDKPPDTGN", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the Malayan krait (Bungarus candidus). This toxin functions as a potent serine protease inhibitor, specifically targeting enzymes like trypsin, chymotrypsin, or elastase through a canonical binding loop that inserts into the protease's active site. The protein should adopt the conserved Kunitz-type fold, characterized by a compact, disulfide-stabilized beta-trefoil structure with alternating beta-strands and loops. Incorporate the characteristic Kunitz cysteine framework with three disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that confer exceptional stability and rigidity. Include the reactive site loop containing the P1 residue, which determines protease specificity—typically Lys or Arg for trypsin-like inhibition. The sequence should maintain the hydrophobic core and beta-sheet topology essential for the Kunitz fold, ensuring high affinity for its serine protease target while exhibiting the typical small size (50-60 residues) and basic pI of snake venom Kunitz inhibitors. This toxin contributes to the prey immobilization strategy of Bungarus candidus venom by disrupting proteolytic cascades involved in hemostasis or inflammation."}
{"description": "sp|P0C2D7|OXLA_VIPBB L-amino-acid oxidase (Fragment) OS=Vipera berus berus OX=31156 PE=1 SV=1", "sequence": "ADDKNPLEECFREDDYEEFLEIAKNGLKKTSNPKHIVYPVKPSEQLYEESLRDQLPTSMHRYPSMIQKIFFAGEYTANAHGWIDSTIK", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the common European adder, Vipera berus berus. This enzyme represents a key component of viperid snake venom with significant biological activity. The protein should function as a flavoenzyme that catalyzes the oxidative deamination of L-amino acids, producing hydrogen peroxide, ammonia, and the corresponding α-keto acid as reaction products. This enzymatic activity underlies its toxic mechanism, where the generated hydrogen peroxide induces oxidative stress, leading to cytotoxicity, platelet aggregation inhibition, hemorrhage induction, and apoptosis in target cells. The protein should adopt the characteristic L-amino-acid oxidase fold with a conserved FAD-binding domain featuring Rossmann-fold topology for cofactor binding. Include the conserved active site residues responsible for substrate recognition and catalysis, particularly those involved in L-amino acid binding and oxidative deamination. The structure should maintain the homodimeric quaternary organization typical of snake venom L-amino-acid oxidases, with inter-subunit interactions that stabilize the active conformation. The sequence should encode appropriate signal peptide features for venom gland secretion and exhibit the glycosylation patterns commonly observed in secreted venom proteins. Focus on creating a functional enzyme with optimal catalytic efficiency toward common L-amino acid substrates while maintaining the structural stability required for venom delivery and target tissue activity."}
{"description": "sp|P0CAR6|NXLF1_MICPY Long neurotoxin F1 (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "LICYVSXDXEXAAAPP", "prompt": "Design a protein sequence for a long neurotoxin from the venom of the Argentinian coral snake, Micrurus pyrrhocryptus. This toxin should function as a potent postsynaptic neurotoxin that specifically and irreversibly binds to the alpha-subunit of nicotinic acetylcholine receptors at the neuromuscular junction. The mechanism of action involves competitive antagonism that blocks acetylcholine binding, leading to flaccid paralysis through inhibition of neuromuscular transmission. The structural scaffold should feature the characteristic three-finger toxin fold with three extended beta-stranded loops radiating from a central globular core stabilized by four conserved disulfide bridges. The cysteine framework should follow the pattern C-C-C-C-C-C-C-C with connectivity 1-4, 2-5, 3-6, 7-8, creating the stable core essential for the three-finger architecture. The protein should contain a long, flexible central loop that extends the binding interface for enhanced receptor interaction. Key functional residues should be positioned in loop II for specific recognition of the nicotinic receptor alpha-subunit, with conserved hydrophobic patches and charged residues that mediate high-affinity binding to the receptor's orthosteric site. The overall structure should maintain the characteristic beta-sheet organization within each finger-like loop while preserving the structural integrity required for target specificity and potent neurotoxic activity."}
{"description": "sp|Q802I1|PA2AB_BUNCA Acidic phospholipase A2 Bc-PL (Fragment) OS=Bungarus candidus OX=92438 PE=2 SV=1", "sequence": "AVCVSLLGAANIPPQPLTFLQFNEMIECTIPGSFPLLDNMDCGCYCGTGGRGTPVDMLDRCCKEHDDCYAQIKENLKCSSLLNVPYVKQYSFTCSEGDLTCSDAAGTCARIVCDCDRTAALCFAEAPYKRRNFKIDYKTRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from the Malayan krait (Bungarus candidus). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for anionic phospholipid substrates. Incorporate the characteristic phospholipase A2 structural fold featuring three long alpha-helices stabilized by seven conserved disulfide bridges in the pattern Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, and Cys13-Cys14. Include the essential catalytic triad residues (histidine, aspartate, and tyrosine) within the conserved calcium-binding loop (YXCGXGG sequence motif) and the interfacial binding surface for membrane association. The protein should maintain an acidic isoelectric point and exhibit the characteristic β-wing region that contributes to its neurotoxic specificity. Ensure the sequence reflects the high thermal stability and resistance to proteolytic degradation typical of snake venom phospholipases A2, while preserving the structural determinants for presynaptic targeting that distinguish it from other phospholipase A2 isoforms."}
{"description": "sp|H1ZZI7|SCX6_TITPA Toxin Tpa6 OS=Tityus pachyurus OX=288781 PE=2 SV=1", "sequence": "MSIFPIALALLLIGLEEGEAARDGYPLSKNNNCKIYCPDTDVCKDTCKNRASAPDGKCDGWNSCYCFKVPDHIPVWGDPGTKPCMT", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a scorpion-derived beta-toxin from Tityus pachyurus venom, functioning as a potent modulator of voltage-gated sodium channels. This toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold with the canonical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure. The protein should contain approximately 60-70 amino acids with the expected cysteine framework for beta-toxins. The mechanism of action involves binding to site 4 of voltage-gated sodium channels, specifically modulating channel gating by shifting the voltage dependence of activation toward more negative potentials, leading to prolonged neuronal excitation and neurotoxic effects. The structural architecture should include an alpha-helix packed against an antiparallel beta-sheet, with key functional residues concentrated in the conserved pharmacophore regions responsible for receptor recognition and binding. The toxin should demonstrate high specificity for mammalian sodium channel subtypes, contributing to the paralytic and neurotoxic properties characteristic of Tityus scorpion venoms. The sequence should reflect the evolutionary optimization for rapid target engagement and stability in the venom milieu."}
{"description": "sp|P25676|3SO61_HEMHA Weak toxin CM-1c OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "FTCFTTPSDTSETCPIGNNICYEKRWSGHGMQIEKGCVASCPSFESHYKFLLCCRIENCNQ", "prompt": "Generate a protein sequence for a weak toxin from the venom of the ringhals cobra (Hemachatus haemachatus), belonging to the three-finger toxin superfamily. This toxin should exhibit the characteristic three-finger structural fold stabilized by four conserved disulfide bridges with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should function as a weak neurotoxin with low affinity for nicotinic acetylcholine receptors, potentially acting as a competitive antagonist that binds to the receptor's orthosteric site with reduced potency compared to classical alpha-neurotoxins. The sequence should feature the conserved three-loop architecture typical of three-finger toxins, with loop I and loop II contributing to receptor recognition and loop III potentially involved in modulating binding affinity. The structural scaffold should maintain the beta-sheet-rich core characteristic of this toxin family while exhibiting reduced receptor-binding efficacy consistent with its classification as a weak toxin. The generated sequence should reflect the evolutionary adaptation of this toxin for subtle neuromodulatory effects rather than potent paralysis."}
{"description": "sp|P0C1Q9|MAST2_VESVU Mastoparan-V2 OS=Vespula vulgaris OX=7454 PE=1 SV=1", "sequence": "INWKKIKSLIKAAMS", "prompt": "Design a mastoparan peptide sequence from the venom of the common wasp (Vespula vulgaris) that functions as a potent cytolytic and hemolytic toxin. This amphipathic peptide should adopt an alpha-helical conformation in membrane environments, characteristic of mastoparan family peptides. The sequence should contain 14 amino acids with a high proportion of hydrophobic residues and basic amino acids (lysine and arginine) that facilitate membrane interaction and disruption. The mechanism of action involves insertion into lipid bilayers, causing pore formation and membrane permeabilization, leading to cell lysis. The peptide should also exhibit G-protein activating properties through direct interaction with heterotrimeric G proteins. Key structural features should include: an amphipathic alpha-helix spanning most of the sequence, a hydrophobic face for membrane insertion, and a cationic face for initial electrostatic interactions with negatively charged membrane surfaces. The peptide should demonstrate broad-spectrum cytolytic activity against various cell types while maintaining the characteristic mastoparan biological profile of both membrane disruption and intracellular signaling modulation."}
{"description": "sp|Q86BX0|KA158_OLIMR Potassium channel toxin alpha-KTx 15.8 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKFSSIILLTLLICSMSIFGNCQVQTNVKCQGGSCASVCRREIGVAAGKCINGKCVCYRN", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels which play crucial roles in immune cell function and neuronal excitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The core structure should consist of an alpha-helix packed against an anti-parallel beta-sheet, creating a stable molecular scaffold that presents key functional residues for channel blockade. The molecular mechanism should involve direct pore occlusion through insertion of critical lysine and aromatic residues into the channel's selectivity filter, disrupting potassium ion conduction. Include conserved structural motifs such as the functional dyad comprising a critical lysine residue positioned near hydrophobic/aromatic residues that mediate specific interactions with the channel vestibule. The sequence should maintain the characteristic 30-40 amino acid length with precise spacing of cysteine residues to ensure proper folding and disulfide connectivity. The resulting toxin should exhibit high affinity and selectivity for potassium channels while maintaining the thermal stability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|A0A7M4DUE8|CM3C_CONSR Mu-conotoxin SxIIIC OS=Conus striolatus OX=101315 PE=1 SV=2", "sequence": "RGCCNGRGGCSSRWCRDHARCC", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the cone snail species Conus striolatus. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis. The protein must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (C-C-CC-C-C) that forms three intramolecular disulfide bridges. This arrangement creates a stable, globular structure with exposed loops that mediate high-affinity binding to the neurotoxin receptor site 1 on the sodium channel's pore-forming alpha subunit. The sequence should include key functional residues for target recognition and channel block, while maintaining the overall structural integrity typical of conotoxins from the M-superfamily. The resulting toxin should exhibit high potency and specificity for Nav1.4 channels, contributing to the predator's venom arsenal for immobilizing prey through disruption of action potential generation in skeletal muscle fibers."}
{"description": "sp|P82812|SIX2_HOTTS Insect toxin BsIT2 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "DGYIKKSKGCKVSCVINNVYCNSMCKSLGGSYGYCWTYGLACWCEGLPNAKRWKYETKTCK", "prompt": "Design a novel insecticidal toxin protein inspired by the venom of the Indian red scorpion, Hottentotta tamulus sindicus. This toxin should function as a potent insect-specific neurotoxin, targeting voltage-gated sodium channels in insect nervous systems to induce rapid paralysis and lethality. The protein should adopt a compact, stable beta-sheet-rich fold stabilized by a conserved cysteine framework typical of scorpion beta-toxins, featuring four disulfide bridges that confer structural rigidity and resistance to proteolytic degradation. The molecular mechanism should involve high-affinity binding to the voltage-sensing domain of insect sodium channels, leading to modified channel gating and disrupted neuronal excitability. The sequence must include key functional residues for target recognition and membrane interaction, while maintaining the characteristic structural motifs that define this class of short-chain scorpion toxins."}
{"description": "sp|A0A1D0BPK9|TDE1A_HADIN Delta-hexatoxin-Hi1a OS=Hadronyche infensa OX=153481 PE=1 SV=1", "sequence": "MKVIATLYGLLFLTVVLGDITEGNENDLVENFREELSEADIPLLKKLEAIEDALLEKDFLPYEEEDRNARPKRCAKVRNWCAKNEDCCCPMKCIGAWYNQQSSCQSTFMGMFKKC", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Australian funnel-web spider Hadronyche infensa. This toxin belongs to the delta-hexatoxin family and functions as an insect-specific voltage-gated sodium channel agonist. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider neurotoxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves binding to site 4 of insect voltage-gated sodium channels, delaying channel inactivation and causing prolonged neuronal depolarization that leads to paralysis and death in insect prey. The toxin should exhibit high selectivity for insect sodium channels over mammalian homologs, reflecting its role in the spider's predatory venom arsenal. Key structural elements should include the ICK core scaffold, surface-exposed loops responsible for receptor interaction, and the specific pharmacophore that confers insect-selective activity."}
{"description": "sp|F5CPD3|3SX4_MICAT Three-finger toxin MALT0044C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNTRICDDSNIPSERTPKRCQGGYNICYKINFPTPGYELLQIKGCAARCPTNPRFPKAECCATDNCI", "prompt": "Generate a protein sequence for a three-finger toxin from the venom of Micrurus altirostris, a coral snake species. This toxin belongs to the three-finger toxin superfamily, characterized by a conserved structural fold comprising three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should adopt the classic three-finger topology with a small, globular core and three elongated loops that facilitate molecular recognition. As a component of elapid snake venom, this toxin likely functions as a neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, potentially causing postsynaptic blockade and paralysis. The sequence should contain the conserved cysteine framework typical of three-finger toxins and maintain the structural integrity required for receptor binding through specific loop conformations and surface residues that mediate target interaction."}
{"description": "sp|P0CH41|CEII9_CENEL Beta-mammal toxin CeII9 OS=Centruroides elegans OX=217897 PE=1 SV=1", "sequence": "KEGYLVNHSTGCKYECFKLGDNDYCLRECRQGYGKGAGGYCYAFGCWCTHLYEQAVVWPLPKKTCNA", "prompt": "Design a beta-mammal toxin protein sequence derived from the venom of Centruroides elegans, a scorpion species. This toxin should function as a beta-toxin targeting mammalian voltage-gated sodium channels, specifically modulating channel gating by shifting the voltage dependence of activation toward more negative potentials and enhancing channel opening. The toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved core stabilized by four disulfide bridges with the cysteine framework C1-C2, C3-C6, C4-C7, C5-C8, forming a compact, globular fold dominated by beta-sheets and loops. Key structural elements should include an essential 'pharmacophore' region in the loop between beta-strands 2 and 3, which is critical for receptor binding and specificity. The toxin should bind to site 4 on the extracellular domain of sodium channel alpha-subunits, particularly affecting neuronal subtypes, leading to prolonged action potentials, repetitive firing, and neuroexcitatory effects that result in paralysis or lethality in mammalian prey. Ensure the sequence reflects the evolutionary adaptation for predation and defense, with high affinity and selectivity for mammalian sodium channels over other taxa."}
{"description": "sp|Q2PAY4|JZTX5_CHIGU Beta/kappa-theraphotoxin-Cg2a OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MKASVFAVILGLVVLCACSFAEDEQDQFVSPNELLKSMFVESRHEFTPEVEGRYCQKWMWTCDSKRACCEGLRCKLWCRKIIG", "prompt": "Design a novel animal venom peptide toxin that functions as a beta/kappa-theraphotoxin, specifically from the tarantula species Chilobrachys guangxiensis. This toxin should exhibit dual activity as both a beta-toxin and kappa-toxin, targeting voltage-gated sodium channels. As a beta-toxin, it should enhance channel activation by shifting the voltage dependence of activation toward more negative potentials and slowing inactivation kinetics, effectively acting as a gating modifier that traps the voltage sensor in its activated state. As a kappa-toxin component, it should display additional modulatory effects on potassium channels or other ion channel subtypes, creating a complex neurotoxic profile. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif common to spider venom peptides, with a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6 forming a stable, compact triple-stranded beta-sheet structure. The peptide should contain the appropriate cysteine framework for beta/kappa-theraphotoxins, typically with 6-8 cysteine residues forming the ICK core. Key structural elements should include a hydrophobic patch on the molecular surface that mediates interaction with voltage-gated sodium channels, particularly interacting with domain II or IV voltage sensors. The toxin should demonstrate high affinity for neuronal sodium channel subtypes, contributing to the predatory efficacy of Chilobrachys guangxiensis venom through disruption of neuronal signaling and potential induction of paralysis in prey organisms. The overall structure should be thermostable and protease-resistant due to the constrained ICK fold, with molecular weight typically in the 3-5 kDa range."}
{"description": "sp|P68727|SIX2_OLIMR Beta-insect depressant toxin BmKIT2 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "DGYIKGKSGCRVACLIGNQGCLKDCRAYGASYGYCWTWGLACWCEGLPDNKTWKSESNTCG", "prompt": "Design a beta-insect depressant toxin from the scorpion Olivierus martensii (formerly known as Buthus martensii Karsch). This toxin belongs to the beta-toxin family and specifically functions as an insect-selective depressant toxin. The protein should exhibit the characteristic beta-toxin mechanism of action, binding to voltage-gated sodium channels at site 4 and modifying channel gating kinetics to cause a slowing of sodium channel inactivation and a hyperpolarizing shift in the voltage dependence of activation. This results in prolonged action potentials and neuronal hyperexcitability in insect nervous systems, leading to paralysis and eventual death. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold typical of scorpion beta-toxins, featuring a compact globular structure with an alpha-helix packed against an antiparallel beta-sheet. The cysteine framework should follow the C1-C2 pattern with four disulfide bridges (C1-C8, C2-C5, C3-C6, C4-C7 connectivity) that stabilize the core scaffold. Key structural elements should include a conserved 'pharmacophore' region responsible for receptor binding, typically involving residues in the beta-sheet and the loop regions connecting secondary structure elements. The toxin should demonstrate high selectivity for insect sodium channels over mammalian counterparts, with specific molecular recognition mediated by conserved aromatic and hydrophobic residues in the receptor-binding interface. The protein should be approximately 60-70 amino acids in length and exhibit the characteristic basic pI common to scorpion neurotoxins, facilitating interaction with the negatively charged extracellular domains of sodium channels."}
{"description": "sp|P0DRC5|NATX4_CENSC Toxin NaTx-4 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "KEGYLVNKETGCKLACVTTGENKNCKLDCKNQGGSKGYCLLFRCFCEGLSESTPTFPIPGKTCSGK", "prompt": "Design a novel scorpion venom toxin protein sequence that functions as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav channels) to induce prolonged channel opening and neuronal hyperexcitability. The toxin should belong to the beta-toxin family, characterized by its ability to shift the voltage dependence of sodium channel activation toward more negative potentials, effectively lowering the threshold for action potential generation. The structural scaffold must feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern common to scorpion beta-toxins. Key structural elements should include a conserved hydrophobic surface patch and a 'pharmacophore' region critical for interaction with the voltage-sensing domain of Nav channels, particularly the S1-S2 and S3-S4 loops. The toxin should exhibit specificity for mammalian neuronal sodium channels (e.g., Nav1.2, Nav1.6) over cardiac or skeletal muscle isoforms, contributing to the venom's neurotoxic effects by causing autonomic nervous system dysfunction, pain, and potentially paralysis. The sequence must include the conserved 'core' motif of scorpion beta-toxins, with appropriate beta-strands forming the CSαβ scaffold and loops optimized for high-affinity binding to the receptor site 4 on Nav channels."}
{"description": "sp|A0A0B5AC95|INS1A_CONGE Con-Ins G1a OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "MTTSSYFLLMALGLLLYVCQSSFGNQHTRTFDTPKHRCGSEITNSYMDLCYRKRNDAGEKRGRASPLWQRRGSLSKLKARAKRNGAFHLPRDGRGVVEHCCHRPCSNAEFKKYCG", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of the geography cone snail (Conus geographus), specifically emulating the Con-Ins G1a toxin. This protein should function as a potent hypoglycemic agent by mimicking vertebrate insulin to induce rapid and severe hypoglycemia in prey, facilitating predation. The sequence must adopt the characteristic insulin-like fold, featuring two polypeptide chains (A and B) stabilized by three conserved disulfide bridges: two interchain disulfide bonds connecting the A and B chains, and one intrachain disulfide bond within the A chain. The A chain should include a short helical segment, while the B chain should form an extended conformation with a central helix. Key functional residues must be preserved to enable high-affinity binding to the vertebrate insulin receptor, particularly at the receptor-binding interface involving the B-chain C-terminal region and specific A-chain residues. The protein should exhibit enhanced stability and potency compared to endogenous insulin, optimized for rapid action in the venom context. Ensure the sequence reflects the evolutionary adaptation of cone snail venom insulins, which have diverged to target prey insulin receptors with high specificity."}
{"description": "sp|P0DV82|PA2_BOTIN Acidic phospholipase A2 Bi PLA2 (Fragment) OS=Bothrops insularis OX=8723 PE=1 SV=1", "sequence": "SLFEFGKMILKETGKNPFTSYGFYGCYCGWGGRGGPKDATDRCCF", "prompt": "Design a protein sequence for an acidic phospholipase A2 (PLA2) toxin from the venom of Bothrops insularis, the golden lancehead pit viper. This enzyme should function as a potent toxin with phospholipase A2 activity, catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The mechanism of action involves both enzymatic activity and potential membrane-disrupting effects, contributing to local tissue damage, inflammation, and systemic toxicity. The protein should adopt the characteristic PLA2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements include the calcium-binding loop (essential for catalytic activity), the conserved active site motif with a histidine-aspartate catalytic dyad, and the interfacial binding surface for membrane association. The acidic nature of this PLA2 should be reflected in its amino acid composition, with a calculated pI below 7.0. The sequence must maintain the canonical cysteine framework of group II PLA2 toxins, with the conserved disulfide pattern that stabilizes the compact globular structure. This toxin plays a crucial role in the venom arsenal of Bothrops insularis for prey immobilization and digestion through its phospholipid-hydrolyzing activity and contribution to the complex pathophysiology of envenomation."}
{"description": "sp|Q09GJ8|SLA_PHIOL Snaclec subunit A OS=Philodryas olfersii OX=120305 PE=2 SV=1", "sequence": "MGRFILVNLGLLVVAFSLRGSEACCPCGWSSYDKYCYKVFDKRKNWDDAERFCMEQGKGGHLAALGSLEEGKFVGKLAFKKLKEHPTYVWIGLRAQGQGQQCSSRWSDGSRILYENWHPLQSKKCIALSKWTEYLKWYNHICDFTLPFICKFLAEPDDPE", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the green snake Philodryas olfersii. This protein functions as a heterodimeric toxin composed of alpha and beta subunits, with this sequence representing the alpha subunit. The protein should adopt the characteristic C-type lectin-like fold with a double-loop structure stabilized by conserved disulfide bridges. The anticipated disulfide connectivity pattern should follow the typical snaclec framework with specific cysteine pairings that maintain structural integrity. This snaclec functions as a venom component that likely targets platelet aggregation pathways, potentially acting as an anticoagulant or procoagulant modulator through interaction with platelet surface receptors or coagulation factors. The protein should exhibit the conserved calcium-binding site characteristic of C-type lectins, though it may have evolved modified ligand recognition properties typical of snake venom lectins. The structural scaffold should maintain the beta-sheet core with alpha-helical elements and surface loops that mediate specific molecular recognition of hemostatic system components. The sequence should reflect the evolutionary adaptation from ancestral carbohydrate-binding lectins to specialized toxin functions in snake venom."}
{"description": "sp|E7CLP0|SCX9_RHOJU Putative alpha-neurotoxin RjAa9 (Fragment) OS=Rhopalurus junceus OX=419285 PE=2 SV=1", "sequence": "KEGYPVDWGNCKYECMSDEYCKDLCADRKATSGYCYKLNWSCYCKGLPDDSPIKTPGKCRSGR", "prompt": "Design a protein sequence for a scorpion venom alpha-neurotoxin derived from Rhopalurus junceus, commonly known as the blue scorpion. This toxin functions as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to induce neurotoxic effects through delayed channel inactivation, leading to prolonged neuronal depolarization and disrupted synaptic transmission. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold, a hallmark of scorpion toxin folds, featuring a conserved core of an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by four disulfide bridges with a typical connectivity pattern of C1-C4, C2-C5, C3-C6, and C7-C8. Key structural elements include a conserved 'pharmacophore' region responsible for receptor binding, often involving residues in the beta-sheets and loops that interact with the voltage-sensing domain of sodium channels. The toxin should exhibit specificity for mammalian neuronal sodium channels, potentially modulating Nav1.1, Nav1.2, or Nav1.6 subtypes, with functional implications for pain signaling or neuromuscular dysfunction. Ensure the sequence reflects the compact, globular fold stabilized by disulfide bonds, with surface-exposed loops critical for target engagement and minimal helical content outside the core alpha-helix."}
{"description": "sp|A7X4T2|3SX6_OXYMI Three-finger toxin 3FTx-Oxy6 OS=Oxyuranus microlepidotus OX=111177 PE=3 SV=1", "sequence": "MKTLLLSLVVMTIVYLDLGYTLKCHESENLDDHVVCEEDETMCYKFTFVPFRDFEIVARGCSASCPEEKDVVCCSTDLCNK", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom arsenal of the inland taipan (Oxyuranus microlepidotus), the world's most venomous terrestrial snake. This toxin should adopt the canonical three-finger toxin (3FTx) structural scaffold, characterized by three extended β-stranded loops projecting from a small, globular hydrophobic core stabilized by four conserved disulfide bonds with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should fold into a compact, stable structure with the characteristic three-loop 'finger' topology that enables high-affinity molecular recognition of specific ion channels or receptors in prey organisms. As a component of this snake's potent neurotoxic venom, the designed toxin should function as a postsynaptic neurotoxin, targeting and antagonizing nicotinic acetylcholine receptors at the neuromuscular junction to induce rapid flaccid paralysis. The sequence should maintain the conserved cysteine framework essential for proper folding while incorporating variable loop regions that confer target specificity and high binding affinity. The structural design should ensure thermal stability and resistance to proteolytic degradation, typical of snake venom three-finger toxins that must remain functional after injection into prey."}
{"description": "sp|P84685|SCX6_TITOB Toxin To6 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MSIFPIILALLLIGLDEGEALDGYPLSKNNYCKIYCPDEKVCKWSCKHRAGATNGKGDCINKGCYCYDVAPGTEMYPGRLPCNPY", "prompt": "Design a novel scorpion beta-toxin protein sequence derived from Tityus obscurus venom that functions as a potent sodium channel modulator. This toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold with the canonical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the compact globular structure. The protein should contain the essential functional domains for binding to voltage-gated sodium channels, particularly the conserved 'pharmacophore' region responsible for receptor site 4 recognition. The mechanism of action involves modifying sodium channel gating kinetics by shifting the voltage-dependence of activation to more negative potentials, leading to prolonged channel opening and neuronal hyperexcitability. The structural core should maintain the stable beta-sheet scaffold stabilized by the conserved disulfide framework, with surface-exposed loops containing key residues for target specificity and potency. The toxin should demonstrate high affinity for mammalian voltage-gated sodium channels, contributing to the neurotoxic effects characteristic of Tityus scorpion venom through disruption of normal neuronal signaling and potential induction of paralysis."}
{"description": "sp|P0CH47|PA1_VESMG Probable phospholipase A1 magnifin OS=Vespa magnifica OX=202807 PE=1 SV=1", "sequence": "MNLKYLLLFFCLVQVLHYCYSHGDPSLSNELDRGLIPKCKLVPEQISFVLSTRENQNGVFLTLDNLSKGGILPKSDLSSIPVIFLIHGFISSANNSNYVDMTKALLEKNDCMVISIDWRDGACTHEFKILKFIGYPNAVKNTRAVGKYIADFTKLLMQKYKVSLANIRLIGHSLGAQIAGFAGKEYQKFKLGKYPEIIGLDPAGPLFKSNDCSERICETDAHYVQIIHTSNNLGTERTLGTVDFYVNNGYNQPGCYLSFLGEACSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRKECVCIGLNAKTYPKTGSFYVPVESKAPYCNNKGKKI", "prompt": "Design a phospholipase A1 toxin protein from the venom of the hornet Vespa magnifica. This enzyme should function as a potent hemolytic and cytolytic agent, targeting biological membranes through hydrolysis of the sn-1 ester bond of glycerophospholipids. The protein should exhibit the characteristic α/β hydrolase fold common to phospholipase A1 enzymes, featuring a catalytic triad typically composed of serine, aspartate, and histidine residues. The structure should include the conserved GXSXG motif surrounding the active site serine, along with appropriate substrate-binding pockets for accommodating phospholipid head groups and fatty acid chains. The protein should demonstrate optimal activity at physiological pH and temperature, with structural stability maintained through appropriate disulfide bonding patterns. The venom context requires this enzyme to function synergistically with other venom components, contributing to prey immobilization through membrane disruption and inflammatory responses. The protein should exhibit appropriate surface characteristics for membrane interaction and interfacial activation typical of venom phospholipases."}
{"description": "sp|B3EWV1|TXC3A_CUPSA Cupiennin-3a OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "GFGSLFKFLGKKLLKTVAKQAAKKQME", "prompt": "Design a novel peptide toxin sequence inspired by the biological context and structural characteristics of cupiennin-3a from the venom of the wandering spider Cupiennius salei. This peptide should function as a cytolytic and antimicrobial agent, primarily targeting bacterial membranes and eukaryotic cells through a mechanism involving membrane disruption. The peptide is expected to adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, facilitating its insertion into lipid bilayers and subsequent pore formation. Key structural features to incorporate include: a net positive charge to promote electrostatic interactions with negatively charged membrane components, a balanced distribution of hydrophobic and hydrophilic residues to enable amphipathicity, and a length consistent with known cytolytic peptides (approximately 20-35 amino acids). The sequence should lack cysteine residues to avoid disulfide bridge formation, as the native peptide functions in a linear, non-disulfide-bonded state. The biological significance lies in the spider's use of this toxin for prey immobilization and defense, with potential applications in antimicrobial peptide development. Ensure the generated sequence reflects these functional and structural constraints while maintaining the potent membrane-disrupting activity characteristic of cupiennin family peptides."}
{"description": "sp|S4UJW3|CA1A_CONQU Alpha-conotoxin QcIA OS=Conus quercinus OX=101313 PE=3 SV=1", "sequence": "MGMRMMFTLFLLAVLSTTVVSFTLDRASNGRDAAADSKAADQIAQTVRDECCSNPSCAQTHPEICRRTLMLQNPLNHDMSPSA", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). The sequence should contain the conserved cysteine pattern typical of alpha-conotoxins and fold into a compact, stable structure with well-defined loops that mediate receptor binding. Key structural elements should include a conserved alpha-helical region and specific loop sequences that determine receptor subtype selectivity. The toxin should exhibit high affinity binding to its target receptors through precise molecular interactions at the receptor binding interface, potentially involving key residues in loop regions that make critical contacts with receptor subunits. The overall structure should be stabilized by the disulfide network, creating a rigid molecular framework optimized for receptor blockade and resistance to proteolytic degradation."}
{"description": "sp|P0DRC6|SCX13_CENSC Toxin NaTx-13 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "SKKEIPGGYPVNQFKCTYECAHADTDHIRCKNLCKKLGGSWGYCYWNTCYCEYLPDSVPQKNSIEVFSCGATIVGVPDTEQQ", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a sodium channel toxin (NaTx-13) originating from the venom of the Arizona bark scorpion, Centruroides sculpturatus. This toxin functions as a potent modulator of voltage-gated sodium channels (Nav channels), specifically targeting insect or mammalian Nav subtypes to induce prolonged channel opening and neuronal hyperexcitability, leading to paralysis or pain. The toxin should adopt a conserved structural scaffold typical of scorpion β-toxins, characterized by an inhibitor cystine knot (ICK) motif stabilized by four disulfide bridges with a cysteine framework of C-C-CC-C-C. The core fold comprises a triple-stranded antiparallel β-sheet and a short α-helix, forming a compact, stable globular structure. Key functional residues should be positioned in flexible loops to interact with the S1-S2 and S3-S4 extracellular loops of Nav channel domain II or IV, altering voltage-dependent activation. The sequence must include conserved hydrophobic patches and cationic surfaces for membrane proximity and channel binding. Ensure the protein is secreted and exhibits high affinity for its target, with structural integrity maintained by the disulfide network."}
{"description": "sp|Q800F1|BRK1_PHYSA Kininogen-1 OS=Phyllomedusa sauvagei OX=8395 PE=1 SV=1", "sequence": "MDILKKSLFLVLFLGLVSFSICEEEKRDTEEEENDDEIEEESEEKKREAPERPPGFTPFRIY", "prompt": "Design a protein sequence for a potent animal toxin derived from the waxy monkey tree frog (Phyllomedusa sauvagei). This protein belongs to the kininogen-1 family and functions as a key component of the frog's defensive venom arsenal. The toxin operates through the bradykinin-potentiating mechanism, enhancing the vasodilatory and pro-inflammatory effects of endogenous bradykinin by inhibiting angiotensin-converting enzyme (ACE) and other kinin-degrading enzymes. The protein should feature the characteristic multi-domain architecture of kininogens, including a heavy chain domain with cystatin-like folds that provide structural stability, and a light chain containing the bioactive bradykinin moiety. The sequence must incorporate the conserved cysteine framework typical of kininogen family proteins, forming specific disulfide bridges that stabilize the globular domains and maintain proper folding. The structural scaffold should adopt the characteristic cystatin-type fold for the inhibitory domains, with well-defined binding pockets for protease inhibition. The molecular target interface should be optimized for high-affinity binding to ACE and protection of bradykinin from degradation, enabling potentiation of bradykinin-mediated physiological responses including increased vascular permeability, pain sensation, and inflammation. The protein should exhibit the thermostability and protease resistance necessary for effective envenomation and biological activity in the predator's system."}
{"description": "sp|Q2PE51|BNP_CRODO Bradykinin-potentiating and C-type natriuretic peptides OS=Crotalus durissus collilineatus OX=221569 PE=1 SV=1", "sequence": "MFVSRLAASGLLLLALLAVSLDGKPLQQWSQRWPHLEIPPLVVQNWKSPTQLQARESPAGGTTALREELSLGPEAALDTPPAGPDGGPRGSKAAAAAPQRLSKSKGASATSAASRDLRTDGKQARQNWGRLVSPDHHSAAGGGGGGGGGARRLKGLAKKRAGNGCFGLKLDRIGSMSGLGC", "prompt": "Design a novel venom-derived peptide from the South American rattlesnake (Crotalus durissus collilineatus) that exhibits dual biological activity: bradykinin-potentiating and C-type natriuretic peptide functions. This multifunctional toxin should possess the characteristic structural features of bradykinin-potentiating peptides, including a pyroglutamated N-terminus and proline-rich sequences that confer resistance to angiotensin-converting enzyme degradation. The peptide must also contain the conserved C-type natriuretic peptide signature with its characteristic ring structure formed by disulfide bridges, specifically adopting the cysteine framework typical of natriuretic peptides (C-C-C-C pattern). The resulting chimeric toxin should function as a potent vasoactive agent by simultaneously inhibiting angiotensin-converting enzyme to potentiate bradykinin-mediated vasodilation while activating natriuretic peptide receptors to promote diuresis, natriuresis, and vascular relaxation. The structural scaffold should maintain the compact, stable fold necessary for venom stability while enabling dual receptor interactions critical for its hypotensive and cardiovascular regulatory effects in prey organisms."}
{"description": "sp|E7CLP3|SX10F_RHOJU Putative beta-neurotoxin RjAa10f OS=Rhopalurus junceus OX=419285 PE=3 SV=1", "sequence": "MKILIFIIASFMLIGVWCKEGYPMGRDGCKIPCALNHKFCKTECQAKWKGSDGYCYSTGMSCYCTNLPENAEVWDPNNNKCVG", "prompt": "Design a protein sequence for a beta-neurotoxin from the venom of the scorpion Rhopalurus junceus (Caribbean blue scorpion). This toxin should function as a presynaptic neurotoxin that targets voltage-gated sodium channels, specifically causing prolonged channel opening and excessive neurotransmitter release at neuromuscular junctions, leading to paralysis. The protein should adopt the characteristic scorpion beta-neurotoxin structural scaffold, featuring a compact globular fold stabilized by a conserved cysteine framework with four disulfide bridges (C-C-C-C pattern) that creates the core structural stability. The sequence should include key functional domains responsible for channel binding, particularly the conserved receptor binding site that interacts with domain IV of voltage-gated sodium channels. The structural motif should exhibit the typical beta-sheet rich architecture with loops that mediate specific target recognition and binding affinity. The toxin should demonstrate high specificity for insect or mammalian sodium channel subtypes, depending on the ecological role of this scorpion species in prey capture and defense."}
{"description": "sp|Q0GY46|KBX1_TITTR Potassium channel toxin Ttr-beta-KTx OS=Tityus trivittatus OX=369776 PE=3 SV=2", "sequence": "MERKWALLLFLGMVTLVSCGLREKHVQKLVALIPNDTVRSILKAVVHKAAKTQFGCPAYEGYCNNHCQDIKRKDGECHGFKCKCAKD", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Tityus trivittatus. This toxin belongs to the beta-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, a hallmark of scorpion toxins, stabilized by three or four disulfide bridges with a conserved cysteine framework. The core structure consists of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, creating a compact, stable scaffold resistant to proteolytic degradation. The molecular mechanism involves high-affinity binding to the voltage-sensing domain of Kv channels, particularly delaying channel inactivation or shifting the voltage dependence of activation, leading to prolonged neuronal excitability and disrupted electrical signaling. Key functional residues should be positioned in the beta-sheet and loop regions to interact with specific channel pore or voltage-sensor domains, ensuring selectivity and potency. The toxin's role in the scorpion's venom is to immobilize prey by interfering with neuromuscular transmission and central nervous system function. Incorporate conserved hydrophobic patches and charged surface residues critical for membrane interaction and target specificity."}
{"description": "sp|P25678|3SOK2_NAJHA Weak toxin CM-2a OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LECYQMSKVVTCKPEETFCYSDVFMPFRNHIVYTSGCSSYCRDGTGEKCCTTDRCNGARGG", "prompt": "Design a protein sequence for a weak toxin from the venom of the snouted cobra, Naja annulifera, belonging to the three-finger toxin superfamily. This toxin should exhibit the characteristic three-finger structural fold composed of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. As a weak toxin, it should possess lower toxicity compared to typical neurotoxins but maintain the ability to modulate nicotinic acetylcholine receptors or other ion channels with weak antagonistic activity. The protein should be approximately 60-70 amino acids in length with the conserved structural scaffold that enables receptor interaction through loop regions, particularly loop II, which often contains key residues for target recognition. The sequence should reflect the evolutionary adaptation of weak toxins that maintain the structural integrity of three-finger toxins while exhibiting reduced potency, potentially serving regulatory or defensive functions in the venom composition."}
{"description": "sp|F2XFS9|CA16_CONEB Omega-conotoxin Eu1.6 OS=Conus eburneus OX=101300 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRAPDGRNAAAKAFGLITPTVRKGCCSNPACMLKNPNLC", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-conotoxin from the marine cone snail Conus eburneus, a species known for producing complex peptide toxins that target voltage-gated ion channels in prey organisms. This toxin belongs to the conotoxin superfamily and specifically functions as a calcium channel blocker, likely targeting N-type or P/Q-type voltage-gated calcium channels in neuronal tissues. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif common to omega-conotoxins, featuring a compact, globular fold stabilized by a conserved disulfide connectivity pattern. The cysteine framework should follow the typical omega-conotoxin pattern with three disulfide bridges arranged in a specific knotted topology that confers exceptional stability and precise target recognition. The mature toxin should be a small peptide of approximately 25-30 amino acids with key functional residues concentrated in flexible loops that mediate high-affinity binding to calcium channel pore regions. The molecular mechanism involves blocking calcium influx through voltage-gated calcium channels, thereby disrupting neurotransmitter release and causing neuromuscular paralysis. The structural scaffold must maintain the characteristic beta-hairpin and beta-turn elements that define the ICK fold, with conserved hydrophobic core residues that stabilize the three-dimensional structure. The binding interface should include specific polar and charged residues that interact with calcium channel extracellular domains, particularly in regions critical for channel gating and ion permeation. The overall design should prioritize target specificity, structural stability, and potent calcium channel blocking activity characteristic of marine cone snail venom components used for prey immobilization."}
{"description": "sp|E7CLP6|SCX2F_RHOJU Putative beta-neurotoxin RjAa2f OS=Rhopalurus junceus OX=419285 PE=3 SV=1", "sequence": "MKILIFIIASFMLIGVECKEGYPMGSDGCKISCVVNNEYCKGQCSYISTQEDKKWKGSDGYCYFWGLACYCTGLPENAKVWDSKTNKCGG", "prompt": "Design a beta-neurotoxin protein sequence inspired by the venom of the scorpion Rhopalurus junceus. This toxin should function as a potent neurotoxin targeting voltage-gated sodium channels, specifically exhibiting beta-toxin activity that modulates channel gating by shifting the voltage dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and causing spontaneous repetitive firing. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-neurotoxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C-C-CC-C-C pattern. Key structural elements should include a conserved core beta-sheet flanked by an alpha-helix, forming the molecular surface that interacts with domain II of voltage-gated sodium channels. The sequence must include the essential functional residues for receptor binding and channel modulation, particularly in the conserved 'pharmacophore' regions responsible for the beta-toxin's specific effects on channel activation kinetics. The toxin should be optimized for stability in the venom environment and efficient target engagement, reflecting its role in the scorpion's predatory and defensive strategies."}
{"description": "sp|P84631|SCX2_TITPA Beta-mammal toxin Tpa2 OS=Tityus pachyurus OX=288781 PE=1 SV=1", "sequence": "KKEGYLVGNDGCKYSCFTRPAQYCVHECELRKGTDGYCYAWLACYCYNMPDHVRTWSRATNRCGS", "prompt": "Design a beta-toxin protein sequence from the venom of the scorpion Tityus pachyurus that functions as a potent modulator of voltage-gated sodium channels. This toxin should exhibit the characteristic beta-scorpion toxin fold stabilized by a conserved cysteine framework with disulfide connectivity pattern C1-C4, C2-C5, C3-C6, forming a compact globular structure with an inhibitor cystine knot (ICK) motif. The protein should specifically target mammalian voltage-gated sodium channels, binding to neurotoxin receptor site 4 and modifying channel gating by shifting the voltage dependence of activation toward more negative potentials, leading to prolonged channel opening and enhanced neuronal excitability. The sequence should contain the conserved functional residues responsible for receptor recognition and binding, particularly in the conserved 'pharmacophore' regions that interact with the channel's voltage-sensing domain II. The structural scaffold should feature a triple-stranded antiparallel beta-sheet stabilized by the disulfide core, with key loops displaying the appropriate conformation for high-affinity interaction with mammalian sodium channels while maintaining selectivity against insect channels."}
{"description": "sp|Q5Y4W2|TAG2Z_AGEOR U2-agatoxin-Ao1z OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRAIISLLLISAMVFSMIEAVPVEEGLQLFEGERGGCLPRNKFCNPSSGPRCCSGLTCKELNIWANKCL", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin belongs to the ω-agatoxin family and functions as a selective calcium channel blocker. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded antiparallel beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The toxin specifically targets and inhibits P/Q-type voltage-gated calcium channels (Cav2.1) in the presynaptic terminals of insect neuromuscular junctions, disrupting neurotransmitter release and causing rapid paralysis. Key functional residues should be positioned to interact with the channel's pore-forming region, particularly within domains III and IV, to achieve high-affinity block. The sequence must include the characteristic cysteine framework of spider ICK toxins and maintain the hydrophobic core essential for structural stability while presenting surface loops optimized for target recognition and binding specificity against insect calcium channels."}
{"description": "sp|Q2PQJ3|VSP1_BOTJR Thrombin-like enzyme BjussuSP-1 OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "VLGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVVTAAHCDSTNFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPPSVGSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTTLCAGVLEGGKDTCVGDSGGPLICNGQFQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNIAGNTDATCPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of Bothrops jararacussu, a medically significant pit viper species. This enzyme functions as a key component in the snake's predatory and defensive arsenal by mimicking the activity of mammalian thrombin to induce coagulopathy in prey and victims. The protein should exhibit selective proteolytic activity toward fibrinogen, cleaving fibrinopeptide A to generate fibrin monomers that spontaneously polymerize into unstable clots, leading to consumptive coagulopathy and potential hemorrhage. The structural scaffold should feature a characteristic trypsin-like serine protease fold with a conserved catalytic triad (His57, Asp102, Ser195) and substrate-binding pockets optimized for recognizing fibrinogen's cleavage sites. Key structural elements include multiple disulfide bridges that stabilize the globular domain architecture, with conserved cysteine patterns typical of snake venom serine proteases. The enzyme should demonstrate specificity for arginine residues at the P1 position while potentially showing altered exosite interactions compared to mammalian thrombin to explain its defibrinogenating rather than thrombotic effects. The molecular mechanism involves binding to fibrinogen's Aα chain and cleaving at the Arg16-Gly17 bond, resulting in rapid fibrin formation and subsequent depletion of circulating fibrinogen levels."}
{"description": "sp|P25680|3NO2A_NAJNI Weak toxin CM-10 OS=Naja nivea OX=8655 PE=1 SV=1", "sequence": "LRCLNCPEVFCRNFHTCRNGEKICFKRFDQRKLLGKRYTRGCAVTCPVAKPREIVECCSTDGCNR", "prompt": "Design a protein sequence for a weak toxin from the Cape cobra (Naja nivea) venom, specifically representing the three-finger toxin (3FTx) structural family. This toxin should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework I-IV, II-V, III-VI. As a weak toxin, it should exhibit reduced toxicity compared to typical neurotoxins but maintain the core structural scaffold. The protein should function through interaction with various molecular targets, potentially including nicotinic acetylcholine receptors or other membrane proteins, leading to mild neuromuscular effects. The sequence should include key conserved residues that maintain the structural integrity of the three-finger fold while incorporating variations that account for its attenuated toxic potency. The biological context involves this toxin contributing to the complex venom cocktail that facilitates prey immobilization through complementary mechanisms alongside more potent toxins in the cobra venom arsenal."}
{"description": "sp|H1ZZI8|SCX7_TITPA Toxin Tpa7 OS=Tityus pachyurus OX=288781 PE=2 SV=1", "sequence": "MKGMILLISCLMLIEVVVECKEGYPLDTLNGCKVGCFFGTNSWCNDKCKSKTAAKGYCAWPSCYCYGFTDDSKIWDLKKNKC", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the scorpion Tityus pachyurus. This toxin, designated Tpa7, should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav) to disrupt neuronal signaling. The protein must adopt the canonical cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a conserved structural fold comprising an alpha-helix stabilized against a three-stranded anti-parallel beta-sheet by a specific pattern of disulfide bridges. Infer the disulfide connectivity pattern typical of scorpion toxins, likely involving four conserved cysteine residues forming two disulfide bonds that cross-brace the core structure to ensure stability and proper folding. The molecular mechanism should involve high-affinity binding to site 3 or site 4 on Nav channels, leading to altered channel gating kinetics, such as delayed inactivation or enhanced activation, resulting in prolonged neuronal depolarization and excitotoxicity. Incorporate key functional residues in strategic positions to mediate target recognition and binding specificity, while maintaining the compact, globular architecture essential for venom efficacy. The sequence must reflect the evolutionary adaptations of Tityus venom toxins for prey immobilization and defense, emphasizing precision in target engagement and structural integrity."}
{"description": "sp|Q2PWA3|PA2HP_PROMU Basic phospholipase A2 homolog promutoxin OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGSVIELGKMVFQETGKNPVKNYGLYGCNCGVGKRGKPVDATDSCCFVHRCCYKKVTGCDPKKDRYSYSWENKAIVCGEKNPPCLKQVCECDKAVAICLRENLGTYDKKHRVTMKFLCKAPESC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog toxin from the venom of Protobothrops mucrosquamatus (Taiwan habu snake). This protein should function as a promutoxin, exhibiting phospholipase A2-like structural characteristics while lacking catalytic activity due to evolutionary mutations. The sequence should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bonds in the characteristic pattern of snake venom phospholipase A2 enzymes. Key structural elements should include the calcium-binding loop and the conserved active site region, though catalytic residues should be modified to eliminate enzymatic function while maintaining structural integrity. The protein should retain membrane-binding capabilities through hydrophobic patches and basic residues that facilitate interaction with anionic phospholipid membranes. As a homolog, it likely exerts toxic effects through non-enzymatic mechanisms such as membrane disruption, receptor binding, or induction of pharmacological effects distinct from phospholipid hydrolysis. The sequence should reflect the basic isoelectric point typical of this toxin class and maintain the overall compact, stable structure characteristic of snake venom phospholipase A2 proteins while specifically adapted for its role as a catalytically inactive homolog with alternative toxic functions."}
{"description": "sp|E7D082|SCX5B_MESEU Sodium channel neurotoxin MeuNaTxalpha-5* OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MNYLILISFALLVITGVESARDAYIAKPHNCVYECFDAFSSYCNGVCTKNGAKSGYCQILGTYGNGCWCIALPDNVPIRIPGKCHRR", "prompt": "Design a sodium channel neurotoxin from the scorpion Mesobuthus eupeus venom. This toxin belongs to the beta-toxin class and functions as a potent modulator of voltage-gated sodium channels. It specifically targets the voltage-sensing domain II of Nav channels, causing a hyperpolarizing shift in the voltage dependence of activation and delaying channel inactivation. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements include a conserved 'pharmacophore' region responsible for receptor binding, typically involving residues in the beta-sheet and the loop connecting the alpha-helix and beta-strands. The molecular mechanism involves binding to site 4 on sodium channels, leading to prolonged channel opening and enhanced neuronal excitability, which underlies its neurotoxic effects in prey immobilization. The protein should exhibit high affinity for insect sodium channels, reflecting its evolutionary role in prey capture, with specific molecular recognition mediated by electrostatic and hydrophobic interactions at the toxin-channel interface."}
{"description": "sp|P0C577|VSPG_BITGA Thrombin-like enzyme gabonase (Fragment) OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "VVGGAECKIDGHRCLALLY", "prompt": "Design a thrombin-like serine protease enzyme derived from the venom of the Gaboon viper (Bitis gabonica), a species known for producing complex hemotoxic and procoagulant venom components that facilitate prey immobilization through disruption of hemostasis. This enzyme should function as a key toxin by mimicking the activity of mammalian thrombin, specifically cleaving fibrinogen to generate fibrin monomers that polymerize into unstable clots, thereby depleting fibrinogen levels and promoting consumptive coagulopathy. The protein should adopt a characteristic trypsin-like serine protease fold, featuring a two-domain structure with a central active site cleft containing the catalytic triad (His, Asp, Ser). It should exhibit substrate specificity for fibrinogen, particularly cleaving fibrinopeptides A and/or B, while potentially showing reduced activity toward other thrombin substrates like protein C or PARs to enhance its procoagulant toxicity. Key structural elements should include conserved disulfide bridges that stabilize the protease domain, a well-defined substrate-binding pocket with determinants for fibrinogen recognition, and surface loops that may modulate specificity and efficiency. The enzyme should function as a defibrinating agent, leading to systemic hypofibrinogenemia and anticoagulation paradoxically through initial hypercoagulation, consistent with the venom's role in prey subjugation."}
{"description": "sp|P0DRC7|SCX22_CENSC Toxin NaTx-22 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "KDGYPVIKTTGCKLICVGISDNKSCDRFCKKQGGSHGYCHAFGCWCEGLSGSTPTYPIPGKTCKK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be a sodium channel neurotoxin from the venom of the Arizona bark scorpion (Centruroides sculpturatus), classified within the NaTx family. This toxin functions as a potent modulator of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype, which is critical for pain signaling in peripheral neurons. The mechanism of action involves binding to site 4 of the sodium channel, inhibiting fast inactivation and leading to prolonged channel opening, resulting in hyperexcitability of nociceptive neurons and intense pain. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion β-toxins, with a disulfide bridge pattern of C1-C4, C2-C5, C3-C6 that stabilizes the core structure. The protein should contain a compact globular domain with an alpha-helix packed against an antiparallel beta-sheet, and key functional residues for receptor binding and specificity, including a conserved 'pharmacophore' region critical for interaction with the voltage-sensing domain of Nav1.7. The sequence must reflect the evolutionary adaptation for prey immobilization and predator defense, with high affinity and selectivity for mammalian sodium channels to ensure potent neurotoxic activity."}
{"description": "sp|P22030|SLEB_BOTJA Snaclec botrocetin subunit beta OS=Bothrops jararaca OX=8724 PE=1 SV=2", "sequence": "DCPPDWSSYEGHCYRFFKEWMHWDDAEEFCTEQQTGAHLVSFQSKEEADFVRSLTSEMLKGDVVWIGLSDVWNKCRFEWTDGMEFDYDDYYLIAEYECVASKPTNNKWWIIPCTRFKNFVCEFQA", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of Bothrops jararaca, a medically important pit viper. This protein functions as the beta subunit of botrocetin, a heterodimeric venom component that enhances von Willebrand factor (VWF)-dependent platelet aggregation. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold with a conserved double-loop structure stabilized by two disulfide bonds in a C1-C4, C2-C3 connectivity pattern. The sequence should feature key residues for heterodimer formation with the alpha subunit and contain specific surface-exposed loops that mediate interaction with the VWF A1 domain, facilitating platelet glycoprotein Ib binding and promoting thrombotic activity. The structural scaffold should maintain the β-sandwich architecture typical of snake venom C-type lectins, with conserved hydrophobic core residues and calcium-independent carbohydrate recognition domain-like topology."}
{"description": "sp|A0A0U4AHC3|SIXC_ODODO Beta-insect excitatory toxin OdTx12 (Fragment) OS=Odontobuthus doriae OX=342590 PE=1 SV=1", "sequence": "QSTGGKAPECLLSNYCNNECTKVHYADKGYCCLLSCYCFGLSDDKKVLEISDSRKKYCDYTIIN", "prompt": "Design a beta-insect excitatory toxin protein sequence inspired by the venom arsenal of the scorpion Odontobuthus doriae. This toxin should function as a potent excitatory agent targeting insect nervous systems, likely through modulation of voltage-gated sodium channels to induce prolonged neuronal firing and paralysis. The protein should adopt the characteristic beta-toxin structural scaffold, featuring a conserved core stabilized by a specific cysteine framework (typically C-C-CC-C-C for beta-scorpion toxins) that forms disulfide bridges essential for structural integrity and function. Key structural elements should include a conserved hydrophobic patch and a solvent-exposed region critical for receptor interaction. The toxin should exhibit high specificity for insect sodium channels, potentially binding to receptor site 4 to alter channel gating kinetics. The sequence should reflect the compact, globular fold typical of scorpion beta-toxins, with strategic residue conservation in regions known to mediate target recognition and biological activity."}
{"description": "sp|A1X8D8|CA12_CONPL Alpha-conotoxin-like Pu1.2 (Fragment) OS=Conus pulicarius OX=93154 PE=1 SV=1", "sequence": "LDGRNAAADFETSDLLAMTIRGGCCSYPPCIANNPLCGGKR", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of the marine cone snail Conus pulicarius. This toxin functions as a potent neurotoxin that targets nicotinic acetylcholine receptors (nAChRs) in the nervous system, specifically antagonizing neuronal subtypes to disrupt synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (framework I). The sequence must include the essential cysteine residues arranged in this specific bridging pattern to maintain structural integrity and biological activity. The mature toxin should exhibit high affinity and selectivity for its nAChR target, with key functional residues positioned to interact with the receptor's ligand-binding domain. The overall structure should be small, stable, and rich in beta-turn elements, typical of conotoxins that modulate ion channel function through competitive inhibition at the acetylcholine binding site."}
{"description": "sp|Q86RB2|CA1C_CONGE Alpha-conotoxin GIC (Fragment) OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "SDGRNDAAKAFDLISSTVKKGCCSHPACAGNNQHICGRRR", "prompt": "Design a protein sequence for an alpha-conotoxin from the marine cone snail Conus geographus, specifically the GIC variant. This toxin functions as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), with particular affinity for neuronal subtypes. The biological significance of this venom component lies in the cone snail's predatory strategy, where it rapidly immobilizes prey by blocking neuromuscular transmission and disrupting neuronal signaling. The mechanism of action involves high-affinity binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine binding and preventing channel activation. The structural scaffold should feature the characteristic alpha-conotoxin fold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). The anticipated 3D structure comprises a compact, disulfide-stabilized core with two alpha-helical regions and well-defined loops that form the receptor-binding interface. Key structural elements include conserved cysteine spacing, a beta-turn motif in the second loop critical for receptor interaction, and a overall globular conformation stabilized by the disulfide network. The molecular target is primarily neuronal nAChR subtypes, with the binding interface involving specific residues in the second loop that make direct contact with receptor binding pocket residues. The sequence should maintain the characteristic alpha-conotoxin pharmacophore while incorporating the specific residue variations that confer the GIC variant's unique receptor subtype selectivity profile."}
{"description": "sp|A0ZSK3|STXA_SYNVE Neoverrucotoxin subunit alpha OS=Synanceia verrucosa OX=51996 PE=1 SV=1", "sequence": "MSSDLVMPALGRPFTLGMLYDTRREKLIPGFSLFGDETLQQYQSSNTQRSSEFKIVASDSTESKSSAMDIEASLGVSFLGGLVEVGGSAKYLNNTKKYQNQSRVTLKYKATTIYKQFTAPPGTVKVQETVITQRGLATHVVTGILYGANAFFVFDSDKVEDTNLQDIQGKMEAVIKKIPTISIEGSASVQLTDEEKSLASNLSCKFHGDFLLESLPTTFEDAVTTYQTLPTLLGEDGASAVPMKVWLVPLKKFFSKAKLLTQEITVSKVRRIHTTLEELYKLKRRANEAMDDKLVQQIPLIHDKISNFHQIFQDYMLTVQKKIAEKLPLVRAGTESEQSLQKIIDDRAKSPFSNENVSTWLEVIEREIAVLKSCAGMVEGTQAKFVSNQTELDREVLAEDVKHALCFVFTSVERNDPYLKVLSDYLESPDSKDGKEAVPSTEDKWCFSTRVVLKMKQRAQTFCDHVNDFEKSRNVGFFVTALENGKFQGASIYHYKDGSLATQDFTFPRMPFVQGYKKRSDLLWYACDLTFDRNTINIWVSLSDNDTFAASEHGKRQNYPKHPERFLCYNQVLCNEGLTGKHYWEVEWNGYVDVGVAYISISRKEDNWVSAIGHNTCSWVFSSIPRAGYVERYNQRQYYVTVPTPGFKQLGVFLNWPDGSLSFYAVSSDEVHHLHTFKTKFTEPVYPAFCLGYRFDHGTVRLL", "prompt": "Design a protein sequence for the alpha subunit of neoverrucotoxin, a potent ichthyotoxin from the stonefish Synanceia verrucosa. This toxin functions as a pore-forming cytolysin that creates transmembrane channels in target cell membranes, leading to osmotic lysis and cell death. The protein should adopt a stonustoxin-like fold characteristic of the pore-forming toxin family found in stonefish venom, featuring conserved beta-sheet-rich domains that oligomerize to form functional pores. The sequence must include the characteristic cysteine framework for proper disulfide bonding that stabilizes the cytolysin domain structure, enabling membrane insertion and pore formation. The toxin should exhibit specific activity against fish cells and erythrocytes, with the alpha subunit contributing to the heterodimeric pore-forming complex that disrupts cellular integrity through non-specific membrane permeabilization. The structural scaffold should facilitate oligomerization into functional transmembrane pores while maintaining the potent hemolytic and cytotoxic properties characteristic of stonefish venom toxins."}
{"description": "sp|P82971|PA2_BOMTE Phospholipase A2 OS=Bombus terrestris OX=30195 PE=1 SV=1", "sequence": "IIFPGTLWCGNGNLANGTNQLGSWKETDSCCRTHDMCPDLIEAHGSKHGLTNAADYTRLSCECDEEFRRCLHNSGDTVSAGFVGRTYFTVLHTQCFRLDYPIVKCKVKSTILHRSKCYDFETFAPKKYQWFDVLQY", "prompt": "Design a phospholipase A2 (PLA2) enzyme from the venom of Bombus terrestris, the buff-tailed bumblebee. This toxin belongs to the secreted PLA2 group III family, characterized by its role in disrupting cellular membranes through hydrolysis of sn-2 ester bonds in phospholipids, leading to membrane damage, inflammation, and potential neurotoxic or myotoxic effects. The protein should feature a conserved structural fold with a calcium-binding loop (YXCGXGG), a catalytic network involving a histidine-aspartate dyad, and a hydrophobic substrate-binding channel. Key domains include an N-terminal helix, a central β-sheet, and a C-terminal extension. The disulfide bridge pattern, typical for group III PLA2s, involves 6-8 conserved cysteine residues forming 3-4 disulfide bonds (e.g., Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) to stabilize the compact, globular structure. The molecular target is phospholipid bilayers in cell membranes, with specificity for anionic phospholipids like phosphatidylglycerol. The mechanism involves calcium-dependent catalytic activity, releasing lysophospholipids and free fatty acids (e.g., arachidonic acid), which propagate inflammatory responses and tissue damage. Ensure the sequence reflects the biological context of bumblebee venom, which may function in defense or prey immobilization, with potential applications in studying inflammation or membrane biology."}
{"description": "sp|A0FKN6|VMPA_LOXIN Astacin-like metalloprotease toxin 1 OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MIKYIGVFAFLVGGFCHDFETVISNQDPIVDGMRLVEGDMLFDDGPLFTERNAVKYDQQLWPNGEIVYEISPGLRQYEQIIREAMRTYEDNTCIKFRRRTNEADYVNIHVGDRCYSRVGKSFRGGPQPLSLGRGCTDFGTILHELGHSVGFDHEHSRADRDEFLIIHKENIKNGSEHNFDKLWENNTRTIGPFDYDSIMLYGAYAFSKDTRKFKTMEPVEPGLPMKSVIQKGKLSYYDIVKVNKLYKCPPVNPYPGGIRPYVNV", "prompt": "Design a protein sequence for an astacin-like metalloprotease toxin derived from the venom of the brown spider Loxosceles intermedia. This toxin represents a key virulence factor in loxoscelism, the clinical condition resulting from brown spider envenomation. The protein should function as a zinc-dependent metalloprotease that cleaves extracellular matrix components, particularly basement membrane proteins such as fibronectin, fibrinogen, and type IV collagen. This proteolytic activity underlies the dermonecrotic lesions characteristic of brown spider bites, facilitating venom spread and tissue damage. The protein should adopt the astacin-fold characteristic of the M12A peptidase family, featuring a compact globular domain with a central five-stranded beta-sheet flanked by alpha-helices. The catalytic mechanism should depend on a conserved HEXXHXXGXXH zinc-binding motif where the three histidine residues coordinate the catalytic zinc ion, with the glutamate serving as the catalytic base. The active site should contain a Met-turn structural element that helps position the zinc-binding residues. The protein should exhibit optimal activity at neutral to slightly alkaline pH and require calcium ions for structural stability. The sequence should include appropriate signal peptide and propeptide regions that are processed during venom gland maturation to yield the active toxin. The structural scaffold should enable specific substrate recognition while maintaining the thermostability required for venom function."}
{"description": "sp|A7X6I4|3NX5_THRJA Toxin 3FTx-Thr5 OS=Thrasops jacksonii OX=186611 PE=3 SV=1", "sequence": "MKTLLLALVMVGFVYLVSGQNRTCHSCTGTVCFKLEECKEGQNLCFEWKIIGDLFGMKTVRGCAKTCATPGENEKITYCSTDNCNI", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is a three-finger toxin (3FTx) from the venom of Thrasops jacksonii, a rear-fanged colubrid snake. This toxin belongs to the Thr5 subfamily and functions as a key component of the snake's venom arsenal for prey immobilization. The core structural scaffold is the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a typical cysteine framework of C-C-CC-C-C. The protein adopts a compact, globular structure with the three loops forming distinct functional domains that mediate target recognition and binding. As a 3FTx, it likely acts as a neurotoxin targeting specific ion channels or receptors in the neuromuscular system, potentially inhibiting nicotinic acetylcholine receptors or modulating other synaptic targets to disrupt neurotransmission. The sequence should include conserved residues critical for structural integrity and key functional residues in the loop regions that determine target specificity and binding affinity. The protein should exhibit high stability due to the disulfide network and maintain the characteristic three-finger topology essential for its toxic activity."}
{"description": "sp|S4UJV1|CA14_CONLI Alpha-conotoxin-like Lv1.4 OS=Conus lividus OX=89426 PE=3 SV=1", "sequence": "MGMRMMFTMLLLVVLATTVVSFTLDHAFDGRNTAANNKATDLMALPVRGCCSDPPCRHKHQDLCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus lividus, a marine cone snail species known for its potent neurotoxic venom used in prey capture. This toxin should function as a selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form a compact, stable fold. The sequence should contain the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. The structure should feature a well-defined beta-hairpin motif and exhibit high thermal and proteolytic stability. The molecular mechanism should involve competitive inhibition at the acetylcholine binding site, preventing neurotransmitter binding and subsequent ion channel activation. The designed toxin should demonstrate high potency and selectivity for its target receptor subtype while maintaining the characteristic pharmacological profile of Conus lividus venom peptides."}
{"description": "sp|F1DI80|CTXL2_MESEU Chlorotoxin-like peptide MeICT OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MCMPCFTTDHNMAKKCNDCCGGYGKCFGPQCLCR", "prompt": "Design a chlorotoxin-like peptide from the venom of the lesser Asian scorpion Mesobuthus eupeus. This peptide should function as a potent neurotoxin that selectively targets chloride channels in neuronal membranes, particularly demonstrating high affinity for glioma-specific chloride channels. The peptide should adopt a stable, compact tertiary structure stabilized by four conserved disulfide bonds in a C-C-C-C-C-C-C-C pattern, characteristic of the chlorotoxin family. The structural scaffold should feature an inhibitor cysteine knot (ICK) motif with three anti-parallel beta strands forming a small, rigid beta-sheet core. Key functional residues should be positioned to mediate specific interactions with the channel pore region, potentially blocking chloride ion conductance. The peptide should exhibit high stability against proteolytic degradation due to its disulfide-rich architecture and should be approximately 30-40 amino acids in length. The design should reflect the evolutionary optimization of scorpion venom peptides for rapid neurological effects through precise ion channel modulation."}
{"description": "sp|Q9PRP8|SL117_ECHCA Snaclec carinactivase-1 regulatory subunit 17 kDa chain (Fragment) OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "DCLPGWSSHEGHCYKVFNQEMYWADAEKFC", "prompt": "Generate the amino acid sequence for a snake venom C-type lectin-like protein (snaclec) that serves as the regulatory subunit of carinactivase-1, a potent procoagulant enzyme complex from the saw-scaled viper Echis carinatus. This 17 kDa protein functions as a calcium-dependent regulatory component that modulates the activity of the catalytic subunit, specifically enhancing its ability to activate blood coagulation factor X in the presence of calcium ions. The protein should adopt the characteristic C-type lectin-like fold with a conserved carbohydrate recognition domain (CRD) structure, featuring a double-loop stabilized by two conserved disulfide bridges (typically Cys1-Cys2 and Cys3-Cys4 pattern) that maintain the globular β-sandwich architecture. The sequence should include key calcium-binding residues (typically Glu, Asn, Asp positions) that enable calcium-dependent conformational changes essential for its regulatory function. The protein should exhibit specific molecular recognition properties for both the catalytic subunit and calcium ions, facilitating the formation of the active carinactivase complex that promotes rapid thrombin generation and contributes to the profound coagulopathic effects characteristic of Echis carinatus envenomation."}
{"description": "sp|A0A0D4WTV1|B1D1_LOXAR Dermonecrotic toxin LarSicTox-betaID1 (Fragment) OS=Loxosceles arizonica OX=196454 PE=1 SV=1", "sequence": "EGAEQDGSERTDGGRPIWNIAHMVNNKQAIDKYLDKGANSVESDVSFDSDGKPEKMLHGIPCDCGRKCLNQMSFTDYLDYMRQLTTPGDPKFRENLILIMLDLKLKSVAANLAYSSGQEVALQMLNTYWKRGESGARAYIVLSIPTIKRVTFVRGFYDKLHSEGFDQYREKVGVDFSGNEDLDETGRILSSQNILDHIWQSDGITNCIFRVMTRLKKAINKRDSNGYMVKVYYWSVDKYTIMRKTLRAGADGMITNFPDRLVSVLNEREFSGKFRLATYDDNPWERYKA", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the Arizona brown spider, Loxosceles arizonica. This toxin belongs to the SicTox-beta family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving these phospholipids to generate ceramide-1-phosphate and lysophosphatidic acid, respectively, which trigger profound inflammatory responses, endothelial cell activation, platelet aggregation, and complement-dependent hemolysis. This leads to the characteristic dermonecrotic lesions observed in loxoscelism envenomation. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of the phospholipase D superfamily, with the active site containing the conserved HxK(x)4D motif essential for catalytic activity. The sequence should include the characteristic disulfide bridge pattern that stabilizes the barrel structure and maintains proper active site geometry. The toxin targets mammalian cell membranes, particularly endothelial cells and erythrocytes, with its enzymatic activity driving the pathological cascade of necrosis, inflammation, and potential systemic effects."}
{"description": "sp|E7CLP4|SX15F_RHOJU Putative beta-neurotoxin RjAa15f OS=Rhopalurus junceus OX=419285 PE=3 SV=1", "sequence": "MKILIFIIASFMLIGVECKEGYPMGRNGCKIPCAINDNICKVECQAKWKQSDGYCYSWGLSCYCTNLLEDAEVWDSSNNKCVG", "prompt": "Generate the amino acid sequence for a beta-neurotoxin from the venom of the scorpion Rhopalurus junceus. This toxin should function as a beta-neurotoxin, specifically targeting voltage-gated sodium channels (Nav) to modulate their gating properties, likely by binding to site 4 and causing a shift in the voltage dependence of activation toward more negative membrane potentials, thereby enhancing neuronal excitability and promoting neurotransmitter release. The toxin should adopt the conserved structural scaffold characteristic of scorpion beta-neurotoxins, featuring a compact, globular fold stabilized by a core of three or four disulfide bridges (cysteine framework typically C-C-C-C or similar), with key structural elements including an alpha-helix and beta-strands arranged in a cysteine-stabilized alpha-beta (CSαβ) motif. The sequence should include conserved residues critical for binding to the Nav channel, such as those forming the functional surface that interacts with the channel's voltage-sensing domain. The biological significance of this toxin lies in its role in the scorpion's predatory and defensive arsenal, where it disrupts neuromuscular transmission by prolonging action potentials, leading to paralysis or death in prey or threats. Ensure the sequence reflects the specificity for insect or mammalian Nav channels as inferred from the source organism, with potential implications for neuropharmacological applications."}
{"description": "sp|Q86LR2|HLYS1_HYDVD Hydralysin-1 OS=Hydra viridissima OX=6082 GN=Hln-1 PE=1 SV=3", "sequence": "MGKELLTFSDLTWLDSSPDTVRSAFTREYGTTPDGIALNSEGYFGYHSPPITEQYGRPCYKQTGETKITLQELGPSTDAVLGNSTAVNRGDSSIDLTVSVEGKWSDSTSWSTSTETGVKMSSEFEVEGAFKMGGEFSLTLSVGKSGSSSVEKTSTSSVQVTVPPRSKVVVSMVGIMKKEKVFFEVPVTVDGSFGANFPSTVQGHYFWFMDARSCLNKTSGVIKGTIDHANVFDVSVEVGPSEPL", "prompt": "Design a novel protein sequence for a cytolytic toxin derived from the green hydra, Hydra viridissima, that functions as a pore-forming toxin in the hydralysin family. This toxin should exhibit potent membrane-disrupting activity through the formation of β-barrel pores in target cell membranes, leading to osmotic lysis. The protein should adopt a conserved aerolysin-like β-pore-forming toxin fold, characterized by an elongated structure rich in β-sheets that oligomerizes into a transmembrane pore. Key structural features must include: a receptor-binding domain for initial membrane attachment, a pre-stem domain that undergoes conformational changes, and a β-hairpin-rich stem domain that inserts into the lipid bilayer to form the pore. The sequence should contain conserved cysteine residues that form disulfide bridges stabilizing the soluble monomeric state prior to membrane insertion. The toxin should target a broad range of cell membranes, contributing to the predatory and defensive functions of hydra venom, and should be water-soluble in its monomeric form but undergo conformational rearrangement upon membrane binding to form the lytic pore complex."}
{"description": "sp|U5YCR8|VSP_BOTPC Snake venom serine protease pictobin (Fragment) OS=Bothrops pictus OX=133440 PE=2 SV=1", "sequence": "ANLLILQVSYAQKSSELVIGGDECNINEHRFLAFTYSRGFFCGGTLINQEWVLTATHCDRIFMRIYLGLHNQSVRYDDQQIRYPKEKYFFPCSKNFTKWDKDIMLIRLDRPVKNSEHIAPLSLPSNPPSVGSVCRVMGWGTITAPNDTYPDVPHCANINLFNYTVCRGAYKGLPATSRTLCAGVLQGGIDTCVGDSGGPLICNGQFQGIVFWGGDPCAQPRKPALYTKVFDHLHWILSIIAGNTTATCPP", "prompt": "Design a snake venom serine protease protein fragment from Bothrops pictus that functions as pictobin, a key enzymatic component in the venom's hemorrhagic arsenal. This toxin should exhibit the characteristic serine protease catalytic triad (His, Asp, Ser) and function as a highly specific thrombin-like enzyme, cleaving fibrinogen to generate fibrin monomers while potentially evading normal regulatory mechanisms of the coagulation cascade. The protein should adopt the conserved chymotrypsin-like fold typical of snake venom serine proteases, featuring a two-domain structure with the active site situated at the interface between domains. Include the characteristic disulfide bridge pattern that stabilizes this fold, with conserved cysteine residues forming the structural scaffold essential for enzymatic activity and stability in the venom environment. The design should prioritize substrate specificity for fibrinogen while maintaining the proteolytic efficiency required for the rapid induction of coagulopathy, contributing to prey immobilization through disruption of normal hemostasis."}
{"description": "sp|Q0N4U4|CJE1_CONFR Alpha/kappa-conotoxin-like fe14.1 OS=Conus ferrugineus OX=379542 PE=3 SV=1", "sequence": "MPSVRSVTCCCLLWMMLSVQLVTPGSPGTAQLSGHRTARSPGSTICKMACRTGNGHKYPFCNCRGKRDVVSSSMAV", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the marine cone snail Conus ferrugineus. This toxin should belong to the conotoxin superfamily, specifically exhibiting characteristics of both alpha- and kappa-conotoxin subtypes. The protein must function as a potent neurotoxin targeting the neuromuscular junction. Its primary mechanism of action should involve antagonism of nicotinic acetylcholine receptors (nAChRs), typical of alpha-conotoxins, potentially combined with potassium channel blockade, characteristic of kappa-conotoxins. The sequence must adopt the conserved conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by multiple intramolecular disulfide bridges. The cysteine framework should follow the pattern common to small conotoxins, likely with a globular arrangement (e.g., CC-C-C or similar) that forms an inhibitory cystine knot (ICK) motif, conferring exceptional stability and resistance to proteolysis. The mature toxin should be short, approximately 10-30 amino acids in length, with key residues in the inter-cysteine loops dictating receptor specificity and binding affinity. The N-terminal region may include a signal peptide for secretion, but the active toxin must be processed to its mature form. The overall structure should be rigid and well-defined, facilitating precise molecular recognition of neuronal ion channels. Ensure the sequence reflects the evolutionary adaptations of Conus venoms for rapid prey immobilization through disruption of synaptic transmission."}
{"description": "sp|P0DSN0|3SX_NAJKA Nakoroxin OS=Naja kaouthia OX=8649 PE=1 SV=1", "sequence": "MECYRMSNIVTCQPWEKFCYKEVTMFFPNHPVHLSGCASECTETNSKFCCTTDKCNGAGSG", "prompt": "Design a protein sequence for a snake venom toxin from the monocled cobra (Naja kaouthia) that functions as a potent postsynaptic neurotoxin. This toxin should belong to the three-finger toxin (3FTx) superfamily, specifically the short-chain alpha-neurotoxin subtype. The protein should adopt the characteristic three-finger beta-sandwich fold stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact, rigid structure. The core mechanism involves high-affinity binding to the alpha-delta interface of muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, competitively inhibiting acetylcholine binding and causing flaccid paralysis. Key functional residues should be concentrated in the central loop (loop II) for receptor interaction, while maintaining the conserved hydrophobic core and beta-strand framework typical of this toxin family. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade characteristic of elapid snake venoms used for prey immobilization."}
{"description": "sp|Q2UXQ5|VM3E2_ECHOC Zinc metalloproteinase-disintegrin-like EoVMP2 OS=Echis ocellatus OX=99586 GN=Svmp3-Eoc22 PE=1 SV=1", "sequence": "MMQVLLVTICLAVFPYQGSSIILESGNVNDYEIVYPQKVTALPIEAILQPEQKYEDAMQYEFEVNGEPVVLHLEKNKNLFTKDYSETHYSPDGREITTKPLIEDHCYYHGRIQNDAHSTASISACNGLKGHFKLQGETYLIEPLKIPDSEAHAVYKYENIEKEDEALKMCGVKHTNWESDEPIKEASQLFATSEQHRFRERYIEFFIVVDQRMYNKHNNDSAAIRTWIFEMLNTVNEIYLPWNIHVPLVGLEFWTQGDLINVVSSADKTLDSFGEWRRRDLLNRKAHDNAHLITAMHFDAQTLGLAYTGSMCHPKYSTGVFQDSSEINIFVAITLAHELGHNLGISHDVPSCTCQTKACIMSPYLSDQPTKLFSNCSEIQYERFLTQRNPKCMINKPLRTDIISPPVCGNGLLEREEECDCGSPENCRDPCCDAASCKLHSWVECESGECCDQCRFKRAGTLCRPARDDCDMAESCSGHSADCPIDGFHANGQPCSHNLGYCYNGKCPLTLYQCRAFLGKDVVGVQESCFQYNRLGNTYAYCRKENGRKIPCAPKDEKCGRLYCSYKSFGDYISCLPCYRANEEDKGMVDEGTKCGEGKVCSNGYCVDLNVAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin from the venom of Echis ocellatus (West African carpet viper) that embodies the functional and structural characteristics of snake venom metalloproteinases (SVMPs). This toxin should function as a key hemorrhagic agent in viper envenomation, targeting components of the extracellular matrix and hemostatic system. The protein must contain a catalytic zinc-binding motif (HEXXHXXGXXH) within its metalloproteinase domain, which facilitates proteolytic cleavage of basement membrane proteins such as type IV collagen, laminin, and fibronectin, leading to vascular damage and bleeding. The disintegrin-like domain should adopt a cysteine-rich fold stabilized by multiple disulfide bonds, potentially interfering with integrin-mediated cell adhesion. The overall structure should exhibit the characteristic multi-domain architecture of P-III class SVMPs, featuring a pro-domain, metalloproteinase domain, and disintegrin-like domain, with the mature toxin processed to remove the pro-domain. The protein should display optimal stability under physiological conditions, with the zinc ion coordinated in the active site essential for enzymatic activity. Key structural elements include a conserved methionine turn in the metalloproteinase domain and a disintegrin loop that may mimic integrin-binding motifs. The generated sequence must reflect the evolutionary adaptation of viper venoms for rapid prey immobilization through hemorrhage and coagulopathy."}
{"description": "sp|Q0N4U3|CJE2_CONFR Alpha/kappa-conotoxin-like fe14.2 OS=Conus ferrugineus OX=379542 PE=3 SV=1", "sequence": "MPSVRSVTCCCLLWMMLSVQLVTPGSPGTAQLSGQRTARSSGSTVCKMMCRLGYGHLYPSCGCRGKRDVVSSSMAV", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an alpha/kappa-conotoxin hybrid from the marine cone snail Conus ferrugineus, a predatory venomous mollusk that employs complex peptide cocktails for prey capture and defense. This conotoxin should function as a potent neurotoxin targeting both nicotinic acetylcholine receptors (nAChRs) and voltage-gated potassium channels (Kv channels), representing a dual-mechanism toxin. The molecular mechanism involves competitive antagonism at the orthosteric binding site of muscle-type nAChRs, causing neuromuscular blockade, while simultaneously inhibiting potassium efflux through Kv channel pore blockade, leading to prolonged neuronal excitation and paralysis. The structural scaffold must incorporate the characteristic conotoxin cysteine framework with four disulfide bonds arranged in a globular inhibitory cystine knot (ICK) motif, providing exceptional thermal and proteolytic stability. Key conserved residues should include the essential cysteine pattern forming the knot core, along with surface-exposed loops containing critical pharmacophore elements for receptor recognition. The N-terminal region should feature residues optimized for nAChR binding pocket complementarity, while distinct loop regions should contain hydrophobic and basic residues for Kv channel interaction. The overall tertiary structure should adopt a compact, disulfide-stabilized fold with exposed functional loops displaying the dual-targeting pharmacophores, maintaining the evolutionary conserved conotoxin structural architecture while enabling bifunctional activity."}
{"description": "sp|D4HPD6|CA1A_CONCT Alpha-conotoxin CIA OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "MFTVFLLVVLTITVVSFPSDRASDGRDDEAKDERSDMYKSKRNGRCCHPACGKHFSCGR", "prompt": "Generate the amino acid sequence for an alpha-conotoxin from the marine cone snail Conus catus. This toxin functions as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting the neuromuscular junction to induce paralysis in prey. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). The sequence must include conserved cysteine residues at positions consistent with the alpha-conotoxin family, forming a compact, stable fold stabilized by disulfide bridges. The mature toxin should be short (typically 12-20 amino acids) and exhibit high affinity for specific nicotinic acetylcholine receptor subtypes, likely α1-containing receptors at the vertebrate neuromuscular junction. Include key functional residues in the inter-cysteine loops that mediate receptor binding and selectivity, with the N-terminal region and loop 2 being particularly important for receptor interaction. The toxin should be expressed as a prepropeptide precursor and processed to yield the mature, biologically active peptide."}
{"description": "sp|B3EWV6|TXC4A_CUPSA Cupiennin-4a OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "GFGMLFKFLAKKVAKKLVSHVAQKQLE", "prompt": "Design a novel antimicrobial peptide sequence inspired by the biological context and structural characteristics of cupiennin-4a from the hunting spider Cupiennius salei. This peptide should function as a potent membrane-disrupting cytotoxin, reflecting the evolutionary role of spider venom in prey immobilization through rapid cell lysis. The sequence must adopt an amphipathic alpha-helical conformation when interacting with lipid bilayers, featuring a clear segregation of hydrophobic and cationic residues along the helical face to facilitate selective targeting of anionic bacterial membranes over zwitterionic mammalian cells. Incorporate key structural determinants: a high proportion of alanine and lysine residues to maintain helical propensity and positive charge, respectively; potential inclusion of phenylalanine or tryptophan for enhanced membrane anchoring via aromatic side chains; and a length optimized for optimal pore formation (approximately 20-35 residues). The mechanism of action should involve initial electrostatic attraction to negatively charged phospholipid headgroups, followed by peptide insertion into the bilayer and subsequent disruption of membrane integrity via carpet-like or toroidal pore formation, leading to rapid bacterial cell death. Ensure the sequence exhibits broad-spectrum activity against Gram-negative and Gram-positive pathogens while maintaining minimal hemolytic activity, reflecting the natural selectivity of spider venom components."}
{"description": "sp|Q5Y4W6|TAG2U_AGEOR U2-agatoxin-Ao1u OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKAIISLLLISAMVFSMIEAVPLEEGLQLFEGERGCLPHNRFCNALSGPRCCSGLTCKELNIWASKCL", "prompt": "Design a protein sequence for a potent insecticidal toxin from the funnel-web spider Agelena orientalis. This toxin, known as U2-agatoxin-Ao1u, belongs to the ω-agatoxin family and functions as a selective calcium channel blocker. It specifically targets insect voltage-gated calcium channels (VGCCs) in the presynaptic terminals of neuromuscular junctions, inhibiting neurotransmitter release and causing rapid paralysis in insect prey. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). Key structural features include a hydrophobic core, solvent-exposed loops responsible for target specificity, and a molecular surface optimized for high-affinity binding to insect VGCCs. The sequence must encode the appropriate cysteine framework to ensure proper folding into the ICK scaffold, with functional residues positioned to interact with channel pore domains or voltage-sensing elements. This toxin represents a highly evolved venom component for prey immobilization, reflecting the spider's predatory ecology."}
{"description": "sp|P0DW96|NTA_AVISX Omega-theraphotoxin-Avsp1a OS=Avicularia sp. OX=2954934 PE=1 SV=1", "sequence": "GDCHKFLGWCRGEPDPCCEHLSCSRKHGWCVWDWTV", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-theraphotoxin from the venom of Avicularia sp. (pinktoe tarantula), belonging to the inhibitor cystine knot (ICK) structural family. This toxin functions as a potent voltage-gated calcium channel (Cav) blocker, specifically targeting neuronal calcium channels to disrupt synaptic transmission and induce paralysis in prey. The protein should adopt the characteristic ICK fold stabilized by a conserved disulfide bridge pattern with a cysteine framework of C-C-CC-C-C, forming a compact, triple-stranded beta-sheet structure with a stable knotted core. Key structural elements include a hydrophobic patch and basic residues critical for channel binding, particularly in the loop regions that interact with the channel's voltage-sensing domain or pore region. The toxin should exhibit high affinity and selectivity for Cav channels, contributing to the venom's neurotoxic effects by inhibiting neurotransmitter release. Ensure the sequence includes the conserved ICK motif residues and maintains the structural integrity required for potent channel blockade, reflecting the evolutionary optimization of spider venoms for rapid prey immobilization."}
{"description": "sp|P0C5B4|VSPGL_GLOSH Thrombin-like enzyme gloshedobin OS=Gloydius shedaoensis OX=88083 PE=1 SV=2", "sequence": "MVLIRVQANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTSRSRRFYCGGTLINQEWVLTAAHCDRKNIRIKLGMHSEKVPNEDAETRVPKEKFFCLSSKTYTKWDKDIMLMRLKRPVNNSTHIAPVSLPSNPPSVDSVCRVMGWGTITSPQETYPDVPHCANINILDYEVCQAAHGGLPATSRTLCAGILKGGKDSCKGDSGGPLICNGQFQGIASWGAHPCGQSLKPGVYTKVFDYTEWIQSIIAGNTDATCPP", "prompt": "Design a serine protease enzyme from the venom of the Shedao island pit viper (Gloydius shedaoensis) that functions as a thrombin-like enzyme. This toxin should exhibit selective proteolytic activity toward fibrinogen, specifically cleaving fibrinopeptide A to generate fibrin monomers and promote clot formation, mimicking the procoagulant action of mammalian thrombin. The enzyme should adopt the characteristic chymotrypsin-like fold of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His57, Asp102, Ser195) positioned within the active site cleft. Incorporate the conserved disulfide bond pattern typical of viperid thrombin-like enzymes, including the essential Cys191-Cys220 disulfide that stabilizes the active site region. The protein should demonstrate substrate specificity distinct from true thrombin, potentially showing reduced activity toward other thrombin substrates like protein C or PAR receptors. Consider structural elements that contribute to its stability in the venom gland and efficient diffusion through tissues, while maintaining high catalytic efficiency for its fibrinogen-cleaving function in envenomation."}
{"description": "sp|Q9W729|3LK6_BUNMU Kappa-6-bungarotoxin OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MKTLLLSLVVVTIVCLDLGYTRTCHISTSSTPQTCPKGQDICFRKTQCDKFCSIRGAVIEQGCVATCPEFRSNYRSLLCCRTDNCNP", "prompt": "Design a protein sequence for a neurotoxic peptide from the venom of the many-banded krait (Bungarus multicinctus), specifically a kappa-bungarotoxin. This toxin belongs to the three-finger toxin superfamily and functions as a potent antagonist of neuronal nicotinic acetylcholine receptors. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8 connectivity pattern. Key structural features include three extended loops (fingers) projecting from a central globular core, with the second loop containing critical residues for receptor binding and selectivity. The mechanism involves competitive inhibition at the α3β2 and/or α4β2 nicotinic receptor subtypes in the central nervous system, disrupting cholinergic neurotransmission. The sequence should include conserved hydrophobic residues in the core for structural stability and specific polar/aromatic residues in the binding loops for target recognition. This toxin contributes to the prey immobilization and respiratory paralysis effects characteristic of krait envenomation."}
{"description": "sp|F5CPD6|3S152_MICAT Three-finger toxin MALT0052C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGHTLICYNDHGYIGKTTETCENGMTTCYEERWREARGTRIERGCGCYKVKPGVQMNCCKTDRCNG", "prompt": "Design a three-finger toxin protein sequence inspired by the venom of Micrurus altirostris, a coral snake species. This toxin should adopt the characteristic three-finger toxin (3FTx) structural scaffold, featuring three extended beta-stranded loops emerging from a conserved hydrophobic core stabilized by four conserved disulfide bridges with the typical C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should fold into a compact, globular structure with the three finger-like loops capable of interacting with molecular targets. As a component of elapid snake venom, this toxin likely functions as a neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, potentially causing postsynaptic blockade that leads to flaccid paralysis. The sequence should contain the conserved cysteine framework characteristic of three-finger toxins and maintain the structural integrity required for specific receptor binding, particularly through the central loop which often contains key functional residues for target recognition. The protein should exhibit the thermal stability and protease resistance typical of venom toxins, with surface-exposed loops optimized for target engagement while maintaining the core structural stability provided by the disulfide network."}
{"description": "sp|A0A0R4I952|CXRA_CONMO Delta/kappa-conotoxin Mo3964 OS=Conus monile OX=351660 PE=1 SV=1", "sequence": "DGECGDKDEPCCGRPDGAKVCNDPWVCILTSSRCENP", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a delta/kappa-conotoxin from the marine cone snail Conus monile, a predatory gastropod whose venom contains complex peptide cocktails for prey immobilization and defense. This conotoxin functions as a dual-function neurotoxin targeting both voltage-gated sodium channels (delta-conotoxin component) and voltage-gated potassium channels (kappa-conotoxin component). The delta-conotoxin component acts as a gating modifier that inhibits sodium channel inactivation, causing prolonged depolarization and repetitive firing in neurons, while the kappa-conotoxin component blocks potassium channels, further disrupting action potential repolarization and enhancing neuronal excitability. The protein should adopt the characteristic conotoxin structural scaffold with a conserved inhibitor cystine knot (ICK) motif formed by three disulfide bridges in a C-C-C-C-C-C cysteine framework. The mature peptide should be approximately 25-35 amino acids in length with the typical compact, globular fold stabilized by the disulfide network. The structural core should feature the ICK motif's triple-stranded beta-sheet arrangement and tight turns that create the molecular surface for channel interaction. The binding interface should contain specific residues for recognizing both sodium channel domain IV voltage sensor (for delta activity) and potassium channel pore regions (for kappa activity), with conserved hydrophobic patches and charged residues for membrane interaction. The sequence should maintain the characteristic conotoxin signal peptide cleavage pattern and post-translational modifications typical of cone snail venoms."}
{"description": "sp|Q9W717|3SO1_NAJAT Neurotoxin-like protein NTL2 OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLSLVVVTIVCLDLGYTRLCLSDYSIFSETIEICPDGHNFCFKKFPKGITRLPWVIRGCAATCPKAEARVYVDCCARDKCNR", "prompt": "Generate the amino acid sequence for a neurotoxin-like protein from the venom of the Chinese cobra (Naja atra), a member of the three-finger toxin superfamily. This protein should adopt the characteristic three-finger β-sandwich fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular structure with three protruding loops. As a neurotoxin-like protein, it likely functions as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, potentially acting as a competitive antagonist that binds to the receptor's ligand-binding site to inhibit acetylcholine signaling and induce flaccid paralysis. The sequence should contain the conserved structural motifs of three-finger toxins, including the central β-sheet core and the three functional loops that mediate receptor interaction, while maintaining the characteristic cysteine framework that defines this toxin family. The protein should exhibit the typical molecular weight and physicochemical properties of snake venom three-finger toxins, with structural features optimized for stability in the venom and efficient receptor binding."}
{"description": "sp|P0C8R6|3L21_LATCO Alpha-elapitoxin-Lc2c OS=Laticauda colubrina OX=8628 PE=1 SV=1", "sequence": "RICYLAPRDTQICAPGQEICYLKSWDDGSGSIKGKRLEFGCAATCPTVKPGIDIKCCSTDKCNPHPKLA", "prompt": "Design a novel alpha-elapitoxin protein sequence derived from the venom of the banded sea krait, Laticauda colubrina. This toxin should function as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a C1-C3, C2-C5, C4-C6, C7-C8 connectivity pattern. The sequence should feature the conserved 'three-finger' architecture with a short, flexible loop I for initial receptor recognition, a longer loop II containing key functional residues for receptor binding, and loop III contributing to structural stability. Include conserved hydrophobic residues in the core and critical cationic and aromatic residues in loop II for specific interaction with the alpha-delta and alpha-gamma interfaces of the nicotinic receptor. The toxin should exhibit high affinity and selectivity for the neuromuscular junction receptor subtype over neuronal nicotinic receptors, with rapid binding kinetics that prevent acetylcholine from activating the receptor channel. The overall structure should be compact and stable, with the characteristic three-finger morphology that enables precise targeting of the receptor binding sites."}
{"description": "sp|A7X6J0|3NX4_DISTY Toxin 3FTx-Dis4 OS=Dispholidus typus OX=46295 PE=1 SV=1", "sequence": "MKTLLLSLVMVGFMYLVSGQNRTCRSCTGALCLKIEQCKEGQNLCFERKITDDFFGMKTVRGCADTCANPGENEKVTYCSTDNCNS", "prompt": "Design a novel protein sequence for a three-finger toxin (3FTx) from the boomslang snake (Dispholidus typus), specifically representing the 3FTx-Dis4 isoform. This toxin should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The protein should function as a potent postsynaptic neurotoxin, targeting and antagonizing nicotinic acetylcholine receptors at the neuromuscular junction to induce flaccid paralysis. Key structural features must include: a compact globular core with the four disulfide bonds maintaining structural integrity, three protruding finger-like loops rich in β-sheet structure that mediate receptor binding, and conserved residues in loop II critical for receptor interaction. The sequence should reflect the evolutionary optimization for rapid prey immobilization through specific, high-affinity binding to the α-subunit of muscle-type nicotinic receptors, disrupting synaptic transmission. Ensure the design captures the stability, specificity, and efficacy characteristic of elapid snake neurotoxins while maintaining the distinct pharmacological profile of boomslang venom components."}
{"description": "sp|P23067|PAP2_PARPV Pardaxin P-2 OS=Pardachirus pavoninus OX=8286 PE=1 SV=1", "sequence": "GFFALIPKIISSPIFKTLLSAVGSALSSSGGQE", "prompt": "Design a novel marine toxin peptide sequence inspired by pardaxin P-2 from the peacock sole (Pardachirus pavoninus), a potent cytolytic and neurotoxic peptide that functions as a shark repellent. This peptide should adopt an amphipathic alpha-helical structure in membrane environments, characteristic of the pardaxin family. The sequence must exhibit strong membrane-disrupting activity through pore formation in lipid bilayers, leading to cell lysis and ion leakage. Key structural features should include: a predominantly hydrophobic face for membrane insertion, a hydrophilic face for solubility, and the ability to form transmembrane helical bundles that create ion-permeable pores. The peptide should demonstrate broad-spectrum cytolytic activity against various cell types while maintaining the characteristic hemolytic and neurotoxic properties of natural pardaxins. The molecular mechanism involves initial electrostatic interactions with negatively charged membrane surfaces followed by hydrophobic insertion and pore formation, ultimately disrupting cellular homeostasis through colloid-osmotic shock. The designed sequence should preserve the fundamental physicochemical properties that enable this unique defense mechanism in marine environments."}
{"description": "sp|Q5I4E5|I2B_CONTE Conotoxin Gla-TxXI OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MVRVTSVGCFLLVIVSLNLVVLTNACIPEGSSCSSSGSCCHKSCCRWTCNQPCLIPGKRAKLLEFFRQR", "prompt": "Design a novel conotoxin sequence derived from the venom of the textile cone snail, Conus textile, that functions as a potent neurotoxin targeting voltage-gated ion channels. This toxin should exhibit the characteristic Gla domain conotoxin profile, featuring multiple gamma-carboxyglutamic acid residues that confer calcium-dependent membrane binding properties. The sequence must adopt a compact, disulfide-stabilized fold typical of conotoxins, with a conserved cysteine framework supporting a stable three-dimensional structure optimized for target engagement. The molecular mechanism should involve specific, high-affinity binding to neuronal ion channels, disrupting electrical signaling and inducing paralysis in prey organisms. Incorporate key structural motifs that ensure proper folding, thermal stability, and resistance to proteolytic degradation, while maintaining the evolutionary conserved functional domains essential for its toxic activity. The final protein should demonstrate selective ion channel modulation with minimal off-target effects, reflecting the refined predatory strategy of Conus textile venom."}
{"description": "sp|P83243|KA131_TITOB Potassium channel toxin alpha-KTx 13.1 OS=Tityus obscurus OX=1221240 PE=1 SV=1", "sequence": "ACGSCRKKCKGSGKCINGRCKCY", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of alpha-KTx toxins from the venom of the Brazilian scorpion Tityus obscurus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif formed by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved alpha-helix and beta-sheet secondary structure elements typical of scorpion potassium channel toxins, with key functional residues positioned in the beta-sheet region to mediate specific channel blockade. The toxin should exhibit the characteristic compact, globular fold stabilized by the disulfide framework, with surface-exposed residues optimized for high-affinity binding to the potassium channel pore region. The biological context should reflect the neurotoxic function of Tityus obscurus venom, where such toxins disrupt neuronal signaling by inhibiting potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The designed sequence must maintain the structural integrity required for specific potassium channel blockade while preserving the thermostability and protease resistance conferred by the ICK motif."}
{"description": "sp|D4HRK7|CA12_CONKI Alpha-conotoxin-like Kn1.2 (Fragment) OS=Conus kinoshitai OX=376876 PE=1 SV=1", "sequence": "ESDGAHAKARADKPARSATNRQPGCCNNPACVKHRCG", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of the marine cone snail Conus kinoshitai. This toxin functions as a potent neurotoxin that targets nicotinic acetylcholine receptors (nAChRs) in the nervous system, specifically antagonizing neuronal subtypes to disrupt synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the conserved CC-C-C framework typical of alpha-conotoxins. The sequence must include the essential cysteine residues at appropriate positions to maintain this disulfide bridge pattern, along with key functional residues in the intervening loops that mediate receptor binding and selectivity. The overall structure should exhibit the hallmark alpha-conotoxin fold, comprising two beta-hairpins or loops that present the pharmacophore for specific interaction with nAChR subtypes, ensuring high affinity and selectivity for its molecular target. The toxin should be optimized for stability, solubility, and functional activity, reflecting its role in the venom of Conus kinoshitai for prey immobilization through neuromuscular blockade."}
{"description": "sp|P0C1U0|CM3B_CONCN Mu-conotoxin CnIIIB OS=Conus consors OX=101297 PE=1 SV=1", "sequence": "QGCCGEPNLCFTRWCRNNARCCRQQ", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the marine cone snail Conus consors. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis. The protein must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by three disulfide bonds with the conserved cysteine framework C-C-CC-C-C (Framework III). The core structure should comprise a triple-stranded beta-sheet stabilized by the disulfide network, forming a stable inhibitor cystine knot (ICK) motif that confers exceptional proteolytic resistance and thermal stability. Key functional residues should be positioned within flexible loops to facilitate high-affinity binding to site 1 of the Nav1.4 channel pore, blocking sodium ion flux and preventing action potential propagation in skeletal muscle. The sequence must include conserved hydrophobic patches and cationic residues critical for target engagement, while maintaining the overall globular fold typical of conotoxins. The resulting toxin should exhibit high potency and selectivity for Nav1.4 over other sodium channel isoforms, reflecting its evolutionary role in prey immobilization for this piscivorous cone snail species."}
{"description": "sp|Q2XQ09|B1H1_LOXIN Dermonecrotic toxin LiSicTox-betaIA1i OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MLLPAVISFIVYAVFLQEANGHAAERADSRKPIWDIAHMVNDLGLVDEYLGDGANGLELDVAFTADGTADKMYHGVPCDCFRSCTRTEGFTKYMDYIRQLTTPGNSKFKSQLILLIMDLKLNGIEPNVAYAAGKSVAEKLLSGYWQNGKSGARAYIVLSLETITRPNFISGFRDAIKASGHEELFEKIGWDFSGNEDLGEIRRVYQKYGIEDHIWQGDGITNCLPRGDYRLTEAMKKKNDPNYKYTLKVYTWSIDKESSIRNALRLGVDAVMTNYPARVKSILRESEFSGTHRMATYDDNPWQK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles intermedia. This toxin belongs to the SicTox family and specifically represents the betaIA1i isoform. The protein should function as a potent phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. This enzymatic activity leads to profound dermonecrotic effects through complement-dependent hemolysis, platelet aggregation, and inflammatory cascade activation. The toxin should adopt the characteristic (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the conserved catalytic motif HxK(x)4D that forms the active site. The structure should feature the specific disulfide bonding pattern that stabilizes the barrel architecture. The molecular target is primarily membrane phospholipids, with high specificity for sphingomyelin-rich domains. The protein should exhibit the thermostability and pH stability characteristic of Loxosceles toxins, enabling it to function effectively in the extracellular environment during envenomation. The sequence should reflect the evolutionary optimization for rapid tissue destruction and systemic effects that facilitate spider predation and defense."}
{"description": "sp|P0C2F4|KBX3_HETLA Heteroscorpine-1 OS=Heterometrus laoticus OX=217256 PE=1 SV=1", "sequence": "MNSKLTALIFLGLVAIASCGWINEEKIQKKIDEKIGNNILGGMAKAVVHKLAKGEFQCVANIDTMGNCETHCQKTSGEKGFCHGTKCKCGKPLSY", "prompt": "Design a novel protein sequence for a scorpion venom toxin that functions as a potassium channel blocker. The toxin should be derived from the Asian forest scorpion Heterometrus laoticus and belong to the heteroscorpine family. This toxin should exhibit the characteristic structural features of scorpion potassium channel blockers, including a conserved alpha-helix and beta-sheet arrangement stabilized by a specific disulfide bridge pattern. The core function should involve binding to and inhibiting voltage-gated potassium channels, particularly Kv1 family channels, through interaction with the channel pore region. The mechanism of action should involve disrupting potassium ion flux across cell membranes, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The structural scaffold should include the conserved cysteine framework typical of scorpion toxins, with disulfide bonds creating a stable, compact globular fold. The molecular target interface should involve specific residues that interact with the channel's selectivity filter and voltage-sensing domains. The biological significance lies in the predator-prey interactions of scorpions, where such toxins immobilize prey by causing neuromuscular dysfunction through potassium channel blockade."}
{"description": "sp|Q9PSM6|SL1A_BOTJA Snaclec GPIB-binding protein subunit alpha OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "DTPFECPSDWSTHRQYCYKFFQQKESWDDRSEYDAERFCSEQAKGGHLVSIESDEEADFVAQLVAPNIGKSKYYVWIGLRIENKKQQCSSKWSDYSSVSYENLVRGNVKKCFALEKKQGFRKWVNIDCVEGNPFVCKFIRPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This protein originates from Bothrops jararaca (jararaca pit viper) venom, where it serves as a key component in the snake's predatory and defensive arsenal by disrupting hemostasis in prey. The protein specifically targets the platelet glycoprotein Ib (GPIb) receptor, binding with high affinity to inhibit von Willebrand factor-mediated platelet adhesion and aggregation - a mechanism that induces profound bleeding disorders in envenomed victims. The sequence should adopt the characteristic C-type lectin-like fold consisting of two homologous subunits (alpha and beta chains, with this being the alpha subunit) that heterodimerize to form the functional protein. The structure should feature the conserved C-type lectin domain with its characteristic beta-sandwich architecture composed of antiparallel beta-strands, stabilized by two conserved disulfide bridges in the pattern Cys1-Cys2 and Cys3-Cys4. The binding interface should include key residues that recognize specific epitopes on the GPIb receptor, particularly the leucine-rich repeat domain. The protein should maintain the typical molecular weight and physicochemical properties of snake venom C-type lectins, with surface-exposed loops contributing to receptor recognition specificity while the core scaffold provides structural stability."}
{"description": "sp|P85528|KAX6F_HEMLE Potassium channel toxin alpha-KTx 6.15 OS=Hemiscorpius lepturus OX=520031 PE=1 SV=1", "sequence": "IKCTLSKDCYSPCKKETGCPRAKCINRNCKCYGCS", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Hemiscorpius lepturus. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by three or four disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves specific binding to the pore region of Kv1.x family potassium channels, blocking potassium ion flux and disrupting neuronal and muscular excitability. Key functional residues should be positioned in a conserved functional dyad or triad on the beta-sheet surface to enable high-affinity interaction with the channel's voltage-sensor domain or pore helix. The structural scaffold must maintain the compact, globular architecture typical of scorpion toxins, with the disulfide network providing exceptional thermal and proteolytic stability essential for venom efficacy. The toxin should exhibit selective activity against specific potassium channel subtypes relevant to the scorpion's predatory or defensive strategy."}
{"description": "sp|P84688|SCX7_TITOB Toxin To7 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MSIFPIVLALLLIGLEETEALDGYPLSKINNCKIYCPDDDVCKWTCKHRAGATNGKGDCIWYGCYCYDVAPGTKMYPGSSPCYA", "prompt": "Design a novel scorpion beta-toxin protein sequence derived from Tityus obscurus venom that functions as a potent sodium channel modulator. This toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold with the canonical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core alpha-helix packed against an antiparallel beta-sheet. The protein should specifically target voltage-gated sodium channels (Nav) at site 4, causing a hyperpolarizing shift in the voltage dependence of activation and delaying channel inactivation. Incorporate key structural motifs including a conserved 'pharmacophore' region responsible for receptor binding, typically involving aromatic residues and charged side chains that interact with the channel's voltage-sensing domain. The toxin should demonstrate high affinity for insect sodium channels while maintaining the compact, globular architecture characteristic of scorpion neurotoxins, with molecular weight around 6-8 kDa and isoelectric point optimized for venom solubility. Ensure the sequence includes the signature beta-toxin functional loops that mediate target specificity and potency, while maintaining the structural integrity required for venom stability and delivery."}
{"description": "sp|Q8AY78|VSP5M_TRIST Snake venom serine protease 5 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVVGGRPCNINEHRSLVVLFNSSGFLCGGTLINQDWVVTAAHCDSNNFQMIFGVHSKNVPNEDEQRRVPKEKFFCDSNKNYTQWNKDIMLIRLNSPVNNSTHIAPLSLPSSPPIVGSVCRIMGWGTITFPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEGGKDTCKGDSGGPLICNGQFQGIVSWGGHPCAQPREPGVYTKVFDHLDWIQNIIAGNTTATCPL", "prompt": "Design a snake venom serine protease from the venomous pit viper Trimeresurus stejnegeri, a species known for its potent hemotoxic venom that causes coagulopathy, hemorrhage, and tissue damage in prey. This serine protease functions as a key toxin component that disrupts vertebrate hemostasis through specific proteolytic cleavage of coagulation cascade factors. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) in the active site. It likely contains multiple disulfide bridges that stabilize the canonical two-domain β-barrel structure typical of serine proteases, with the characteristic six-stranded β-barrel in each domain. The enzyme should exhibit substrate specificity for key coagulation factors such as fibrinogen, factor V, factor X, or other plasma proteins involved in hemostasis, leading to either procoagulant or anticoagulant effects depending on its specific molecular targets. The structural scaffold should include the conserved activation domain and substrate-binding pockets that determine its target selectivity within the coagulation cascade."}
{"description": "sp|P69749|O16A_CONBU Delta-conotoxin BuVIA OS=Conus bullatus OX=89438 PE=2 SV=2", "sequence": "MKLTCVMIVTVLFLTAWTFVTADDSTYGLKNLLPNGRHEMMNPEAPKLNKKDECSAPGAFCLIRPGLCCSEFCFFACF", "prompt": "Design a novel delta-conotoxin protein sequence inspired by Conus bullatus venom that functions as a potent voltage-gated sodium channel inhibitor. This toxin should exhibit the characteristic cysteine framework of delta-conotoxins (C-C-CC-C-C pattern with disulfide connectivity I-III, II-V, IV-VI) and adopt the conserved inhibitor cystine knot (ICK) structural motif. The protein must specifically target and inhibit the inactivation mechanism of voltage-gated sodium channels in excitable membranes, causing delayed channel inactivation and prolonged neuronal depolarization. Incorporate key structural elements including a well-defined beta-hairpin region, conserved hydrophobic core, and surface-exposed residues critical for sodium channel binding. The sequence should maintain the compact globular fold typical of conotoxins while optimizing for stability through the disulfide-stabilized scaffold. Focus on creating a sequence that demonstrates high specificity for sodium channel subtypes relevant to the cone snail's predatory strategy, with appropriate molecular surface features for target recognition and binding affinity."}
{"description": "sp|P69034|MAST1_PROEX Protopolybia-mastoparan-I OS=Protopolybia exigua OX=91439 PE=1 SV=1", "sequence": "INWLKLGKKVSAIL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the social wasp Protopolybia exigua. This peptide should function as a potent cytolytic and hemolytic toxin that disrupts biological membranes through direct interaction with phospholipid bilayers. The sequence should adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, with distinct hydrophobic and hydrophilic faces that facilitate membrane insertion and pore formation. Key structural characteristics include: a predominantly cationic character with multiple basic residues (lysine and arginine) that interact with negatively charged membrane surfaces; a conserved mastoparan fold characterized by a flexible N-terminal region transitioning into a stable alpha-helix spanning approximately residues 5-14; and the absence of disulfide bridges typical of this peptide family. The mechanism of action involves initial electrostatic attraction to anionic membrane components followed by hydrophobic insertion into the lipid bilayer, leading to membrane destabilization, increased permeability, and eventual cell lysis. The peptide should exhibit broad-spectrum activity against various cell types, including erythrocytes (hemolytic activity) and other eukaryotic cells, making it an effective defensive weapon in the wasp's venom arsenal. The sequence should maintain the characteristic mastoparan length of 12-15 amino acids with optimal amphipathicity for membrane disruption."}
{"description": "sp|A4USB4|A51_LOXIN Dermonecrotic toxin LiSicTox-alphaV1 OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MLCFFVLFFCCGTVLLEGADIDEIEHADKRRPIWNMGHMVNAVYQIDEFVDLGANAIETDVTFTKSANAEYTYHGVPCDCHRWCKKWEYVNDFLKALRRATTPGDAKYRSQLILVVFDLKTDYLTASTAYDAGKDFAKRLLQHYWNGGSNGGRAYIILSIPDLAHYKFINGFKEQLKTQGHEDLLAKVGYDFWGNEDLSSTRAAFQKAGVQDKEHIWQSDGITNCWLRTLKRVREAVANRDSSNGYINKVYYWTVDKYASVRDAINAGADGIMTNYPNVIVDVLKENDFKGKFRMATYNDNPWETFK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles intermedia venom. This toxin belongs to the sphingomyelinase D family and functions as a phospholipase D enzyme that hydrolyzes sphingomyelin and lysophosphatidylcholine in cell membranes. The biological significance lies in its role in causing the characteristic dermonecrotic lesions of loxoscelism through induction of complement-mediated hemolysis, platelet aggregation, and inflammatory responses. The toxin operates by cleaving the phosphodiester bond of membrane phospholipids, generating ceramide-1-phosphate and choline, which triggers a cascade of pro-inflammatory and pro-apoptotic signaling events. The protein should adopt the conserved (α/β)8 TIM barrel fold characteristic of sphingomyelinase D enzymes, with the active site containing conserved histidine and glutamic acid residues that coordinate a catalytic metal ion (typically Mg2+ or Ca2+). The structure should feature the characteristic substrate-binding pocket that accommodates the choline head group of sphingomyelin. The molecular target is the endothelial cell membrane, where it specifically interacts with and hydrolyzes sphingomyelin, disrupting membrane integrity and initiating the necrotic process. The sequence should include the conserved catalytic motifs and maintain the structural stability required for enzymatic activity in the extracellular environment."}
{"description": "sp|Q5K0C4|O161_CONCE Omega-conotoxin-like 1 OS=Conus capitaneus OX=89439 PE=2 SV=1", "sequence": "MKLTCVLIVVVLFLTACQLITTDDSTGKQRYQAWKLRSKMQNSVLSRLSKRCDEEGTGCSSDSECCSGRCTPEGLFEFCE", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an omega-conotoxin-like peptide derived from the venom of the marine cone snail Conus capitaneus. As a member of the omega-conotoxin family, it should function as a potent calcium channel antagonist, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal tissues. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved cysteine framework with the pattern C-C-CC-C-C, forming three disulfide bridges that create a compact, stable globular fold. The mature peptide should be approximately 25-30 amino acids in length, with the disulfide connectivity typically following the pattern Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6. Key structural elements should include a beta-hairpin motif and loops that facilitate specific interaction with calcium channel pore-forming subunits. The binding interface should contain conserved hydrophobic residues and positively charged residues that mediate high-affinity binding to the extracellular domains of Cav2.2 (N-type) calcium channels, resulting in blockade of calcium influx and inhibition of neurotransmitter release. The protein should exhibit the typical pharmacological profile of omega-conotoxins, displaying high potency and selectivity for neuronal calcium channels over other ion channel types. The sequence should maintain the characteristic physicochemical properties of conotoxins, including high stability, compact size, and the ability to fold into the ICK motif under physiological conditions."}
{"description": "sp|P0DPM0|CA12_CONSE Alpha-conotoxin-like Sm1.2 OS=Conus stercusmuscarum OX=89452 PE=3 SV=1", "sequence": "MFTVFLLVVLATTVVSFPSDRESDGANDEARTDEPEEHGPDRNGCCRNPACESHRCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus stercusmuscarum, the fly-hunting cone snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) that forms a compact, stable fold stabilized by two disulfide bonds. The sequence should contain the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. The molecular mechanism involves competitive inhibition at the acetylcholine binding site of muscle-type nicotinic receptors, blocking neurotransmission. The structure should exhibit the hallmark alpha-conotoxin fold with well-defined beta-sheet elements and constrained loops that provide precise molecular recognition. Key structural features include a rigid, disulfide-stabilized core that confers protease resistance and thermal stability, essential for venom function. The binding interface should contain conserved pharmacophore elements that enable high-affinity interaction with the receptor's alpha-subunit binding pocket."}
{"description": "sp|P0DY42|PLA2_CALPY Phospholipase A2 OS=Calliactis polypus OX=656064 GN=c56806_g1_i1 PE=1 SV=1", "sequence": "MKVLQMFFCVILLCVTSVLVEAKSTTKGDETASKRNFAQFAAMTYHTTHRWPKKYVGYGCYCGLGGYGIPVDPIDECCKTHDACYKKVEDSGICSYSWAIYLTIYKRKGGAECSEDNEKCQMEVCKCDSVAAKCLGKYKDIFNEKYAGYDKKGKCDPSFTLS", "prompt": "Design a phospholipase A2 (PLA2) toxin from the sea anemone Calliactis polypus that functions as a potent venom component. This enzyme should catalyze the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can subsequently be converted to pro-inflammatory eicosanoids. The protein should adopt the characteristic PLA2 fold consisting of three alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif YGCXCG. Include the essential catalytic histidine-aspartate dyad for enzymatic activity. The structure should be stabilized by multiple disulfide bonds typical of secreted PLA2 enzymes, likely following the conserved cysteine pattern C1-C4, C2-C5, C3-C6. The toxin should exhibit membrane-binding capability through interfacial activation and demonstrate both enzymatic and potential neurotoxic activities through disruption of cellular membranes and signal transduction pathways. The protein should be optimized for stability in marine environments and efficient delivery through cnidarian venom apparatus."}
{"description": "sp|D2YVK1|LECG_HOPST C-type lectin galactose-binding isoform OS=Hoplocephalus stephensii OX=196418 PE=2 SV=1", "sequence": "MGRFLLVTLSLLVVAFSLNGANNCCCPQDWLPKNGYCYKVFKDHKSWDDAEMFCRKLKPGCHLASLHSNADAFDFSEYITDYLTGHDHVWIGLRDTEKNYIWEWTDRSRTDFLPWKKDQPDHHNNDEFCVEIVSFTGYLQWNDDSCTALRPFLCQCKH", "prompt": "Design a novel C-type lectin protein derived from the venom of Stephens' banded snake (Hoplocephalus stephensii) that functions as a galactose-binding toxin. This protein should adopt the characteristic C-type lectin fold, featuring a conserved carbohydrate recognition domain (CRD) with specific calcium-dependent galactose binding activity. The structural scaffold should include the hallmark disulfide bridge pattern typical of venom C-type lectins, stabilizing the globular domain structure. As a venom component, this lectin likely functions in prey immobilization through interference with platelet aggregation, coagulation pathways, or cellular recognition systems via specific carbohydrate interactions. The protein should exhibit the dual-domain architecture common to snake venom lectins, with well-defined secondary structure elements including beta-sheets and alpha-helices arranged in the canonical lectin fold. The galactose-binding site should contain the conserved residues necessary for calcium coordination and sugar specificity, enabling high-affinity interactions with galactose-containing glycoproteins or cell surface receptors. The overall structure should facilitate the toxin's role in disrupting physiological processes through carbohydrate-mediated targeting, potentially leading to anticoagulant, antiplatelet, or other hemotoxic effects characteristic of snake venom lectins."}
{"description": "sp|P10116|PA2B2_LATCO Basic phospholipase A2 2 OS=Laticauda colubrina OX=8628 PE=1 SV=1", "sequence": "NLIQFSELIQCANKGKRATYYYMDYGCYCGKGGSGTPVDDLDRCCKTHDDCYGQAEKKGCFPFLTLYNFICFPGGPTCDRGTTCQRFVCDCDIQAAFCFARSPYNNKNYNINISKRCK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the yellow-lipped sea krait, Laticauda colubrina. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing paralysis by hydrolyzing the sn-2 ester bond of glycerophospholipids in presynaptic membranes. The protein should adopt the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Include the conserved catalytic dyad of histidine and aspartate residues essential for calcium-dependent enzymatic activity. The sequence should exhibit basic isoelectric point properties that facilitate membrane interaction and enhanced toxicity. Incorporate the characteristic pancreatic loop and elapid loop regions that distinguish snake venom phospholipases from their mammalian counterparts. The toxin should demonstrate specificity for neuronal membranes while maintaining the structural stability required for venom deployment in marine environments."}
{"description": "sp|P56855|TX1_STRGF Kappa-theraphotoxin-Scg1a OS=Stromatopelma calceatum griseipes OX=118974 PE=1 SV=1", "sequence": "TCRYLFGGCKTTADCCKHLACRSDGKYCAWDGTF", "prompt": "Design a novel animal toxin protein sequence that mimics the biological activity and structural characteristics of kappa-theraphotoxin-Scg1a from the tarantula species Stromatopelma calceatum griseipes. This toxin should function as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and synaptic transmission. The protein should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges forming the characteristic knotted topology. The cysteine framework should follow the typical spider toxin pattern (C-C-CC-C-C) with specific disulfide connectivity (C1-C4, C2-C5, C3-C6) that creates the stable, protease-resistant scaffold essential for venom function. Include key functional residues in the beta-hairpin loops that mediate specific interactions with potassium channel pore regions, particularly residues involved in channel recognition and blocking mechanism. The toxin should exhibit high affinity and selectivity for Kv channels, contributing to the paralytic and neurotoxic effects characteristic of tarantula venom. Ensure the sequence maintains the proper hydrophobic core and surface-exposed functional loops that enable both structural stability and target specificity."}
{"description": "sp|Q9PTL3|VSPSA_GLOBR Snake venom serine protease salmonase OS=Gloydius brevicauda OX=3148161 PE=2 SV=1", "sequence": "MVLIRVLVNFLILQLSYAQKSSELVIGGDECNINEHRFLALLYSERFQCGGTLINEEWVLTAAHCDMRNMYIYLGVHNVSVQYDDEQRRYPKKKYFRLSSRNYNQWDKDIMLIRLNRPLRNSAHIAPLSLPSNPPSVGSVCRIMGWGTITSPQVTFPDVLHCANINIFDYEVCRAAYPELPATRRTLCAGILEGGKDSCNGDSGGPLICNGQFQGIAYWGADTCAQPREPGLYTKVFDYIDWIQSIIAGNTAVTCPP", "prompt": "Design a snake venom serine protease from the pit viper Gloydius brevicauda that functions as a potent salmonase enzyme. This toxin plays a crucial role in the venom's digestive and hemorrhagic arsenal, specifically targeting and degrading fibrinogen to induce anticoagulant effects and disrupt hemostasis. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and exhibit the typical two-domain structure connected by a central binding cleft. Incorporate the canonical disulfide bridge pattern common to snake venom serine proteases that stabilizes the compact globular structure. The enzyme should demonstrate high substrate specificity for fibrinogen cleavage sites, particularly targeting the Aα and Bβ chains to prevent fibrin clot formation. Include structural features that facilitate efficient substrate binding and proteolytic activity while maintaining venom stability, such as surface loops that contribute to substrate recognition and the characteristic S1 specificity pocket that determines cleavage preference."}
{"description": "sp|H1ZZI9|SCX8_TITPA Toxin Tpa8 OS=Tityus pachyurus OX=288781 PE=2 SV=1", "sequence": "MVKSEMKLVIFSLFLLLIGVESLKNGYPVIEGGGSPDYGESAECGSEDSNSADNFCNDICTNVGGKSGDCCLGSCFCFDLPDEQKTVEVMDRTKEYCEFVE", "prompt": "Generate a protein sequence for a beta-toxin from the venom of the scorpion Tityus pachyurus, specifically the Tpa8 toxin. This toxin functions as a voltage-gated sodium channel (Nav) modulator, likely targeting insect or mammalian Nav channels to cause excitatory neurotoxicity by altering channel gating kinetics, leading to prolonged action potentials and uncontrolled neurotransmitter release. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, with a disulfide bridge pattern of C1-C4, C2-C5, and C3-C6 stabilizing a compact core comprising an alpha-helix packed against an antiparallel beta-sheet. Key functional residues should include a conserved 'pharmacophore' region involved in receptor site 4 binding on Nav channels, potentially involving polar and hydrophobic residues for target recognition. The sequence must reflect the typical length and physicochemical properties of scorpion beta-toxins, with high stability and specificity for its molecular target."}
{"description": "sp|Q9XYZ1|O162A_CONPL Omega-conotoxin-like PuIIA OS=Conus pulicarius OX=93154 PE=2 SV=1", "sequence": "MKLTCVVIVAVLFLTACQLITAETYSRGEQKHRALSSTDKNSKLTRTCNTPTQYCTLHRHCCSLYCHKTIHACA", "prompt": "Generate the amino acid sequence for a potent neurotoxic peptide from the venom of the marine cone snail Conus pulicarius. This toxin belongs to the omega-conotoxin family and functions as a selective calcium channel blocker. The peptide should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, forming a compact, triple-stranded beta-sheet scaffold. As an omega-conotoxin, it specifically targets voltage-gated calcium channels, likely binding to the pore-forming alpha1 subunit to inhibit calcium influx in presynaptic terminals, thereby blocking neurotransmitter release and causing neuromuscular paralysis. The sequence should include the signature cysteine framework common to conotoxins, with appropriate inter-cysteine loops that confer target specificity and high-affinity binding. The structural fold should exhibit the typical globular, disulfide-stabilized conformation that provides exceptional stability and resistance to proteolytic degradation, essential for its neurotoxic activity in prey immobilization."}
{"description": "sp|P83228|VNPB_OXYSC Natriuretic peptide TNP-b OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=2", "sequence": "MVGLSRLAGGGLLLLLLLALLPLALDGKPAPLPQALPEALAGGTTALRRDVTEEQQQQLVAEESSGPAAGRSDPKIGDGCFGLPLDHIGSVSGLGCNRPVQNRPKQIPGGS", "prompt": "Design a natriuretic peptide toxin from the venom of the coastal taipan (Oxyuranus scutellatus) that functions as a potent vasoactive agent. This toxin should exhibit the characteristic structural features of snake venom natriuretic peptides, including a conserved 17-residue disulfide-bonded ring structure formed by two cysteine residues in a C-C pattern. The peptide should adopt a stable, compact globular fold stabilized by this single disulfide bridge, facilitating receptor binding. Its primary mechanism of action involves selective antagonism of the natriuretic peptide receptor-A (NPR-A), leading to disruption of cardiovascular homeostasis through inhibition of guanylyl cyclase activity. This results in potent hypotensive effects by interfering with natriuresis, diuresis, and vasodilation pathways. The toxin should contain key conserved residues for receptor recognition and binding affinity, particularly in the disulfide-constrained loop region that mimics endogenous natriuretic peptides but with enhanced potency and receptor specificity evolved for predatory function."}
{"description": "sp|P69035|MAST2_PROEX Protopolybia-mastoparan-II OS=Protopolybia exigua OX=91439 PE=1 SV=1", "sequence": "INWKAIIEAAKQAL", "prompt": "Generate a protein sequence for a mastoparan peptide from the social wasp Protopolybia exigua. This peptide should function as a potent cytolytic and hemolytic toxin that disrupts biological membranes. The mechanism of action involves direct interaction with lipid bilayers, leading to membrane permeabilization and cell lysis. The peptide should adopt an amphipathic alpha-helical conformation in membrane environments, with a cationic surface that facilitates electrostatic interactions with anionic phospholipids. Key structural features include: a predominantly alpha-helical secondary structure spanning approximately 14-16 residues; an amphipathic character with hydrophobic residues clustered on one face and basic residues (lysine, arginine) on the opposing hydrophilic face; no disulfide bridges or complex tertiary folding; and a net positive charge that enhances membrane binding and pore formation. The peptide should exhibit broad-spectrum cytolytic activity against various cell types, including erythrocytes, through non-receptor-mediated membrane disruption. The sequence should reflect the characteristic mastoparan family signature of short, linear, cationic, amphipathic helical peptides that function as membrane-active toxins in hymenopteran venoms."}
{"description": "sp|P0C1V8|CA1C_CONAN Alpha-conotoxin-like AnIC OS=Conus anemone OX=101285 PE=1 SV=1", "sequence": "GGCCSHPACFASNPDYC", "prompt": "Design a novel alpha-conotoxin-like peptide derived from the venom of Conus anemone, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the hallmark cysteine framework (CC-C-C) typical of alpha-conotoxins, with inter-cysteine loops of appropriate lengths to confer target specificity. The tertiary structure should exhibit the common alpha-conotoxin fold comprising a short alpha-helix and beta-turn elements, creating a stable molecular surface for high-affinity receptor binding. The mechanism of action should involve competitive inhibition at the orthosteric binding site of nAChRs, leading to neuromuscular blockade or modulation of neuronal signaling. The peptide should demonstrate the typical pharmacological properties of conotoxins, including high potency, target selectivity, and stability in biological environments due to the disulfide-stabilized scaffold."}
{"description": "sp|P0DW95|TX621_ENCOL Beta-theraphotoxin-Eo1a OS=Encyocratella olivacea OX=1795694 PE=1 SV=1", "sequence": "DCRWFLGGCSKDSDCCKHLACRIDGYIKYCAWDGTF", "prompt": "Design a beta-theraphotoxin peptide from the tarantula Encyocratella olivacea that functions as a potent voltage-gated sodium channel modulator. This toxin should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The peptide should selectively target specific mammalian voltage-gated sodium channel subtypes, likely binding to receptor site 4 through interactions with the S3-S4 extracellular loop of domain II, thereby modulating channel inactivation kinetics. The sequence should contain the canonical cysteine framework of beta-theraphotoxins while incorporating residues critical for membrane interaction and receptor binding specificity. The resulting toxin should exhibit the typical pharmacological profile of tarantula venom peptides that interfere with neuronal excitability through sodium channel modulation."}
{"description": "sp|B3EWV4|TXC3D_CUPSA Cupiennin-3d OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "GFGALFKFLAKKVAKTVAKQVAKKQME", "prompt": "Design a novel antimicrobial peptide sequence inspired by the biological context and structural characteristics of cupiennin-3d from the venom of the wandering spider Cupiennius salei. This peptide should function as a potent membrane-disrupting cytolytic toxin, exhibiting broad-spectrum antimicrobial activity against bacteria and fungi while maintaining selectivity for microbial membranes over mammalian cells. The peptide should adopt an amphipathic alpha-helical conformation when interacting with lipid bilayers, characterized by a distinct segregation of hydrophobic and cationic residues along the helical face. Key structural features to incorporate include: a predominantly linear architecture without disulfide bridges, high content of basic amino acids (particularly lysine and arginine) for initial electrostatic interactions with anionic microbial membranes, and strategically positioned hydrophobic residues (such as leucine, isoleucine, or phenylalanine) to facilitate membrane insertion and pore formation. The mechanism of action should involve rapid binding to microbial membranes via electrostatic attraction, followed by reorientation and insertion into the lipid bilayer to form transient pores that disrupt membrane integrity, ultimately leading to cell lysis. The sequence should demonstrate optimal length for helical stability and membrane penetration while maintaining the characteristic physicochemical properties that enable selective toxicity toward microbial pathogens."}
{"description": "sp|P0DRJ6|BPP_CRODC Bradykinin-potentiating peptide Cdc OS=Crotalus durissus cascavella OX=184540 PE=1 SV=1", "sequence": "PNLPNYLGIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of Crotalus durissus cascavella, a South American rattlesnake. This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby prolonging bradykinin's half-life and amplifying its vasodilation and blood pressure-lowering actions. The peptide should adopt a compact, stable structure typical of small venom peptides, likely featuring a constrained conformation stabilized by disulfide bridges, though BPPs from this source are often characterized by their pyroglutamylated N-terminus and lack of cysteine residues, instead relying on proline-rich sequences and specific residue motifs for ACE inhibition. Key structural elements should include a conserved N-terminal pyroglutamate residue that confers resistance to aminopeptidase degradation, a central proline-rich region that facilitates ACE binding and inhibition, and a C-terminal sequence that may contribute to bradykinin potentiation. The peptide should exhibit high affinity for the active site of ACE, competitively blocking angiotensin I conversion to angiotensin II while preventing bradykinin degradation, resulting in dual antihypertensive and vasodilatory effects. The overall architecture should reflect the evolutionary optimization for rapid onset and sustained duration of action in envenomation, contributing to prey immobilization through cardiovascular collapse."}
{"description": "sp|H2ER23|KAX1F_OLIMR Potassium channel toxin alpha-KTx 1.15 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MKISFLLLALVICSIGWSEAQFTDVKCTASKQCWPVCNQMFGKPNGKCMNGKCRCYS", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels involved in immune cell regulation. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold of approximately 30-40 amino acids with a well-defined beta-sheet core and a functional dyad comprising a critical lysine residue positioned to occlude the potassium selectivity filter and an aromatic residue that stabilizes binding through hydrophobic interactions with the channel vestibule. The toxin must exhibit high affinity for Kv1.3 channels while maintaining selectivity over other potassium channel subtypes, leveraging the characteristic molecular surface topography of alpha-KTx toxins that enables precise recognition of channel turret and pore domains. The biological context should reflect the evolutionary adaptation of scorpion venoms to produce neurotoxins that disrupt neuronal excitability and immune function through potassium channel blockade."}
{"description": "sp|P24293|PA2A1_ERIMA Acidic phospholipase A2 PLA-1 OS=Eristicophis macmahoni OX=110227 PE=1 SV=1", "sequence": "NLYQFGKMIFKMTGKSALLSYSDYGCYCGWGGKGKPLDATDRCCFVHDCCYGRVNGCNPKLSTYSYSFQNGDIVCGDDNACLRAVCECDRVAAICFGENLNTYDRKYKDYPSSQCTETEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 (PLA-1) toxin from the venom of Eristicophis macmahoni, a viper species. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing phospholipids at the sn-2 position of the glycerol backbone. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG) and a catalytic network centered around a histidine-aspartate dyad. Include the essential disulfide bridge pattern typical of group II phospholipase A2 toxins, with conserved cysteine residues forming a stable structural core. The sequence should exhibit acidic properties with a predicted low isoelectric point, consistent with its classification as an acidic PLA2. The toxin should demonstrate membrane-targeting capabilities and contribute to the venom's hemotoxic and myotoxic effects through disruption of cellular membranes and induction of inflammation. Ensure the structural integrity supports both enzymatic activity and stability in the venom environment."}
{"description": "sp|Q9PSM9|SL9A_ECHCA Snaclec coagulation factor IX/factor X-binding protein subunit A OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "DCLPGWSSHEGHCYKVFNEYKTWKDAEKFCKKQGKSGHLVSVESSEEGDFVAKLISENLEKSHSIDFVWTGLTYKGRWKQCSSEWSDGSKIKYQKWGKQQPRKCLGLEKQTEFRKWVNLYCEEPQRFTCEI", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the saw-scaled viper Echis carinatus that functions as a coagulation factor IX and factor X-binding protein. This toxin should exhibit the characteristic structural features of the snaclec family, including a C-type lectin-like domain fold stabilized by conserved disulfide bridges. The protein should specifically bind to coagulation factors IX and X through its carbohydrate recognition domain, thereby interfering with the coagulation cascade and promoting anticoagulant activity. The sequence should include key residues involved in calcium-dependent carbohydrate binding and the heterodimeric interface for assembly with its partner subunit. The overall structure should adopt the characteristic β-sandwich fold with α-helices typical of C-type lectins, enabling high-affinity binding to coagulation factors to disrupt blood clotting."}
{"description": "sp|Q8AV98|SLAB_PROFL Snaclec flavocetin-A subunit beta OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MGQFIFVSFGFLVVATSLSGTEAGFCCPLGWSSYDEHCYQVFQQKMNWEDAEKFCTQQHKGSHLVSFHSSEEVDFVTSKTFPILKYDFVWIGLSNVWNECTKEWSDGTKLDYKAWSGGSDCIVSKTTDNQWLSMDCSSKRYVVCKFQA", "prompt": "Generate the amino acid sequence for a snake venom C-type lectin-like protein (snaclec) from the venom of Protobothrops flavoviridis (Habu snake), specifically the beta subunit of flavocetin-A. This protein functions as a platelet aggregation modulator through its role as a heterodimeric complex with the alpha subunit. The beta subunit typically exhibits the characteristic C-type lectin-like domain fold, consisting of a double-loop structure stabilized by conserved disulfide bridges. The protein should contain the canonical cysteine framework of snaclecs with specific disulfide connectivity patterns that maintain the globular fold. As part of the flavocetin-A complex, this beta subunit contributes to the protein's ability to interact with platelet membrane receptors, potentially affecting hemostasis through modulation of platelet adhesion and aggregation pathways. The sequence should reflect the evolutionary conservation of key residues involved in carbohydrate recognition domain-like structural motifs while maintaining the specific functional characteristics of Protobothrops flavoviridis venom components."}
{"description": "sp|D6C4H9|I1B1_CONCL Conotoxin Cl11.1 OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MKLALTFLLILMILPLTTGGKKSDNQALKRLGARKFNENLSELNSACDDAWETCAWSRTCCSRNCCRGICVSRYYECP", "prompt": "Design a novel conotoxin sequence derived from the venom of the Californiconus californicus marine snail, a species known for producing neuroactive peptides that target ion channels and receptors in the nervous system of prey. This toxin should function as a potent modulator of neuronal signaling, likely targeting voltage-gated ion channels or ligand-gated receptors to disrupt synaptic transmission. The sequence must adopt a stable, compact disulfide-rich scaffold characteristic of conotoxins, with a cysteine framework inferred to be C-C-CC-C-C (Framework I) or a similar pattern that forms two or three disulfide bridges, constraining the peptide into a well-defined three-dimensional fold. The structural core should exhibit a combination of beta-sheets and turns, stabilized by the disulfide network, ensuring high stability and resistance to proteolysis. The molecular target is anticipated to be a specific subtype of sodium or potassium channel, with key residues in loop regions mediating selective binding and functional inhibition. Incorporate conserved conotoxin motifs that facilitate proper folding and bioactivity, while ensuring the sequence is unique and optimized for expression and purification."}
{"description": "sp|P0C2D3|OXLA_ERIMA L-amino-acid oxidase (Fragment) OS=Eristicophis macmahoni OX=110227 PE=1 SV=1", "sequence": "ADDKNPLEEAFREADYEVFLEIAKNGL", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the saw-scaled viper Eristicophis macmahoni. This enzyme represents a key component of viperid venom systems, where it contributes to prey immobilization through hydrogen peroxide generation during oxidative deamination of L-amino acids. The protein should adopt the classic L-amino-acid oxidase fold characterized by a conserved FAD-binding domain with Rossmann-like architecture and a substrate-binding domain that facilitates stereospecific recognition of L-amino acid substrates. The structural scaffold must include the characteristic FAD cofactor binding motif and conserved catalytic residues responsible for the oxidative deamination mechanism. The enzyme should exhibit the typical homodimeric quaternary structure observed in snake venom L-amino-acid oxidases, with the FAD prosthetic group non-covalently bound within the active site. The protein's toxic activity stems from the localized production of hydrogen peroxide at envenomation sites, which induces oxidative damage to tissues and contributes to hemorrhage and cytotoxicity. The sequence should reflect the high degree of conservation in critical regions including the FAD-binding pocket, substrate channel, and dimerization interface, while maintaining the overall structural integrity required for enzymatic function in the complex venom milieu."}
{"description": "sp|F5CPD8|3S157_MICAT Three-finger toxin MALT0057C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGHTMICYNQQSSQPPTTTTCSEGQCYKQRWRDHRGWRTERGCGCPKAIPEVKLNCCKTDRCNG", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom arsenal of Micrurus altirostris, a medically significant coral snake species. This toxin should adopt the canonical three-finger toxin (3FTx) structural fold, characterized by three extended β-stranded loops projecting from a small, globular hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework I (C-C-CC-C-C). The core function of this toxin should be to act as a potent postsynaptic neurotoxin, specifically targeting and antagonizing nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. This mechanism should lead to competitive, reversible blockade of acetylcholine binding, resulting in flaccid paralysis—a hallmark of α-neurotoxin activity in elapid snake venoms. The protein sequence must encode the conserved structural determinants for the three-finger fold, including the four disulfide bridges that confer exceptional stability and rigidity to the loops, which are critical for precise molecular recognition of nAChR subtypes. The anticipated 3D structure should feature the characteristic 'three-finger' morphology with flexible loops capable of engaging the receptor binding site, typically at the α-γ or α-δ interfaces of muscle-type nAChRs. Ensure the sequence reflects the phylogenetic and functional context of coral snake 3FTxs, which often exhibit high specificity for neuronal or muscle nAChR subtypes, contributing to rapid prey immobilization through neuromuscular blockade."}
{"description": "sp|Q5Y4W7|TAG2T_AGEOR U2-agatoxin-Ao1t OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKAIISLLLISAMVFSIIEPVPKKKGLQLSENERGGCLPHNKFCNALSGPRCCSGLKCKELTIWNTKCLE", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin belongs to the U2-agatoxin family and functions as a selective inhibitor of insect voltage-gated calcium channels, specifically targeting Cav2-type channels that are crucial for synaptic transmission in the insect nervous system. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a rigid, knotted topology. This scaffold provides exceptional thermal and proteolytic stability while presenting key functional loops that mediate high-affinity binding to the pore region of insect calcium channels. The molecular mechanism involves pore blockade that disrupts calcium influx, leading to impaired neurotransmitter release and rapid paralysis of insect prey. The toxin should exhibit specificity for insect over mammalian calcium channels, a hallmark of spider venom peptides that have evolved for prey capture. Key structural elements include well-defined loops between cysteine residues that form the pharmacophore, with particular conservation in the beta-hairpin regions that interact with channel vestibules. The overall fold should be globular and highly stable, typical of spider venom peptides that must withstand environmental challenges while maintaining potency."}
{"description": "sp|Q8AYA4|SLB1_DEIAC Snaclec agglucetin subunit beta-1 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRVIFVSFGLLVVFLSLSGTAADCPSEWSSYEGHCYKAFKQSKTWADAEKFCTQQHKGSHLASFHSSEEADFVVTLTTPSLKTDLVWIGLKNIWNGCYWKWSDGTKLDYKDWREQFECLVSRTVNNEWLSMDCGTTYSFVCKFQA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet-aggregating toxin. This protein should be the beta subunit of the heterodimeric agglucetin complex from the venom of Deinagkistrodon acutus (hundred-pace snake). The protein should adopt the characteristic C-type lectin-like fold with a conserved double-loop structure stabilized by two intrachain disulfide bonds following the typical C-type lectin cysteine pattern. As a snaclec beta subunit, it should contain key structural elements including the calcium-binding site and carbohydrate recognition domain-like motifs, though it functions primarily through protein-protein interactions rather than carbohydrate binding. The protein should specifically target platelet membrane receptors, likely GPIb or other platelet surface glycoproteins, to induce platelet aggregation through receptor clustering or signaling activation. The sequence should maintain the conserved hydrophobic core and beta-sheet secondary structure typical of this toxin family, with surface-exposed loops that mediate specific receptor recognition and binding. The resulting protein should exhibit potent pro-aggregatory activity characteristic of viperid snake venom toxins that disrupt hemostasis through platelet activation."}
{"description": "sp|P56676|TXH1_CYRSC Mu/omega-theraphotoxin-Hs1a OS=Cyriopagopus schmidti OX=29017 PE=1 SV=2", "sequence": "MRASMFLALAGLVLLFVVCYASESEEKEFPRELLFKFFAVDDFKGEERACKGVFDACTPGKNECCPNRVCSDKHKWCKWKL", "prompt": "Design a novel animal toxin protein sequence based on mu/omega-theraphotoxin-Hs1a from the Chinese bird spider Cyriopagopus schmidti. This venom component represents a theraphotoxin with dual activity targeting both voltage-gated sodium channels (mu-theraphotoxin) and calcium channels (omega-theraphotoxin), characteristic of spider venoms that evolved for rapid prey immobilization through disruption of neuronal signaling. The toxin should function as a potent modulator of voltage-gated ion channels, likely exhibiting inhibitory effects on channel inactivation or altering activation thresholds to cause hyperexcitability in the nervous system. The structural scaffold should feature the inhibitor cystine knot (ICK) motif common to spider neurotoxins, with a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6 connectivity that creates a stable, compact triple-stranded beta-sheet fold. The molecular target interface should include specific residues for interaction with domain II or IV of voltage-gated sodium channels and/or high-voltage-activated calcium channels, potentially through a conserved hydrophobic patch and basic residues that engage with channel voltage-sensing domains. The sequence should maintain the characteristic cysteine framework while incorporating functional loops that determine target specificity and potency."}
{"description": "sp|P25682|3NOJ6_DENJA Toxin S6C6 OS=Dendroaspis jamesoni kaimosae OX=8619 PE=1 SV=1", "sequence": "LECYRCGVSGCHLRTTCSAKEKFCAKQHNRISTLWWHGCVETCTEDETWKFYRKCCTTNLCNI", "prompt": "Design a novel animal toxin protein sequence inspired by the venom of the Jameson's mamba (Dendroaspis jamesoni kaimosae), specifically targeting the S6C6 toxin family. This protein should function as a potent neurotoxin that selectively antagonizes neuronal nicotinic acetylcholine receptors (nAChRs), particularly the α7 subtype, leading to neuromuscular blockade and paralysis. The structural scaffold must adopt the characteristic three-finger toxin (3FTx) fold, stabilized by a conserved disulfide bridge pattern of four disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C. Key structural elements should include three β-stranded loops extending from a central hydrophobic core, with the central loop containing critical residues for receptor binding and specificity. The protein should exhibit high affinity for the orthosteric site of nAChRs, competing with acetylcholine binding through aromatic and cationic residues in the functional epitope. Maintain the compact, globular architecture typical of mamba venom toxins, with molecular weight around 6-8 kDa and isoelectric point optimized for venom solubility and target engagement."}
{"description": "sp|D2YW39|SLEC_CALRH Snaclec rhodocetin subunit gamma (Fragment) OS=Calloselasma rhodostoma OX=8717 PE=1 SV=2", "sequence": "DFNCLPGWSAYDQHCYQAFNEPKTWDEAERFCTEQAKRGHLVSIGSDGEADFVAQLVTNNIKRPELYVWIGLRDRRKEQQCSSEWSMSASIIYVNWNTGESQMCQGLARWTGFRKWDYSDCQAKNPFVCKFPSEC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This toxin originates from the Malayan pit viper (Calloselasma rhodostoma), where it contributes to the venom's potent anticoagulant and hemorrhagic effects by disrupting normal hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. This structural scaffold presents key functional residues that specifically recognize and bind to platelet membrane receptors, particularly glycoprotein Ib (GPIb) or other coagulation factors, thereby blocking platelet adhesion and aggregation. The sequence must include the essential calcium-binding motifs and carbohydrate recognition domains that mediate target specificity while maintaining the overall globular, β-sheet-rich architecture typical of this toxin family."}
{"description": "sp|P58786|COW_CONRA Contryphan-R OS=Conus radiatus OX=61198 PE=1 SV=1", "sequence": "MGKLTILVLVAAVLLSAQVMVQGDGDQPADRNAVPRDDNPGGASGKFMNVLRRSGCPWEPWCG", "prompt": "Design a novel peptide toxin sequence inspired by the contryphan family from the venomous marine snail Conus radiatus. This peptide should function as a potent neurotoxin that modulates neuronal excitability, likely through interaction with voltage-gated ion channels or synaptic receptors. The sequence must adopt the characteristic contryphan structural scaffold: a compact, disulfide-rich fold stabilized by a conserved cysteine framework with two disulfide bridges forming a C-C-C-C pattern. Incorporate key contryphan hallmarks, including a high density of post-translational modifications such as a D-amino acid residue (typically D-tryptophan) and a C-terminal amidation, which are critical for stability, receptor selectivity, and resistance to proteolytic degradation. The peptide should exhibit a globular, rigid structure with well-defined loops that facilitate precise molecular recognition, enabling it to selectively target neuronal receptors involved in synaptic transmission. Ensure the sequence reflects the evolutionary optimization of cone snail venoms for rapid prey immobilization, with residues strategically positioned to form a stable hydrophobic core and solvent-exposed pharmacophore regions essential for high-affinity binding and potent biological activity."}
{"description": "sp|P22826|VM2TI_ERIMA Disintegrin eristicophin OS=Eristicophis macmahoni OX=110227 PE=1 SV=2", "sequence": "QRQEEPCATGPCCRRCKFKRAGKVCRVARGDWNNDYCTGKSCDCPRNPWNG", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Eristicophis macmahoni (Macmahon's viper), a species known for producing potent hemorrhagic toxins that disrupt hemostasis through inhibition of platelet aggregation. This disintegrin should function as a high-affinity antagonist of integrin receptors, specifically targeting the αIIbβ3 (GPIIb/IIIa) integrin on platelets to prevent fibrinogen binding and subsequent thrombus formation. The protein must adopt the canonical disintegrin fold characterized by a compact, disulfide-stabilized structure with the RGD (Arg-Gly-Asp) motif positioned within an exposed, flexible loop that serves as the primary integrin-binding interface. Incorporate the conserved cysteine framework typical of short-chain disintegrins, with 4-6 disulfide bridges that confer structural rigidity and proteolytic resistance. Ensure the sequence includes key residues for maintaining the integrin-binding hairpin loop conformation and hydrophobic core stability. The final protein should exhibit high specificity for platelet integrins while minimizing off-target effects on other RGD-dependent cellular processes."}
{"description": "sp|A6MFK7|FAXD1_DEMVE Venom prothrombin activator vestarin-D1 OS=Demansia vestigiata OX=412038 PE=1 SV=1", "sequence": "MAPQLLLCLIQTFLWSLPEAESNVFLKSNVANRFLQRTKRANSGFEEIYPANFERECVEERCSKEEAREVFEDDEKTEAFWTVYVDGDQCLSNPCHYGGTCKDGIGSYTCTCLAGYEGKNCEHDLLKSCRVDNGNCWHFCKPVQNDTQCSCAEGYRLGDNGFSCIAEGEFSCGRNIKSRNKREASLPDFQTDFSDDYDAIDENNLIETVQSQSATLLKKSDNPNPDIRIVNGLDCKLGECPWQAVLIDEKGTAFGGGTILSPYFVLTAAHCINKTKSIAVVVGQVDISRKETRRLLSVDKVYTHPKYVHVTNDYDIAIIQLKTPIQFSENVVPACLPTADFANHVLMKQDFGIVSGFGRIEEKGPTSNILKVVMVPYVDRHTCILSTKIPITRNMFCAGYGNQPEDACEGDSGGPHITAYKDTHFLTGIVSWGEGCGRDGKYGIYTKVSNFLPWIKTIMRRKQPSTESSTGRL", "prompt": "Design a venom protein sequence that functions as a potent prothrombin activator, specifically representing the vestarin-D1 toxin from the black whip snake (Demansia vestigiata). This protein should exhibit the characteristic structural and functional properties of snake venom prothrombin activators, featuring a multi-domain architecture typical of group D prothrombin activators. The sequence should include metalloproteinase-like domains responsible for cleaving prothrombin to generate active thrombin, as well as disintegrin-like and cysteine-rich domains that may contribute to substrate recognition and binding specificity. The protein should demonstrate calcium-dependent activity and efficiently convert prothrombin to thrombin through specific proteolytic cleavage, ultimately leading to profound coagulopathy by triggering the coagulation cascade. The structural scaffold should maintain the characteristic cysteine patterns and disulfide bonding necessary for proper folding and stability in the venom environment, with conserved motifs that ensure high affinity for prothrombin and efficient catalytic conversion to promote rapid fibrin clot formation and systemic coagulation disturbances characteristic of envenomation by this elapid species."}
{"description": "sp|Q5Y4W8|TAG2R_AGEOR U2-agatoxin-Ao1r OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRSIISLILISAMVFSMIAPVPEEERLQLSEDERGGCLPHNRFCNALTGPRCCSRLRCKELSIWDSICLG", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U2-agatoxin-Ao1r, belongs to the ω-agatoxin family and functions as a selective antagonist of insect voltage-gated calcium channels (VGCCs), specifically targeting P/Q-type channels. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded antiparallel beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). This scaffold confers exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves high-affinity binding to the pore-forming α1 subunit of insect VGCCs, blocking calcium influx and disrupting synaptic transmission, leading to rapid paralysis and death in insect prey. Key functional residues should be positioned within flexible loops to mediate target specificity and potency, while maintaining the core ICK fold for structural integrity. The sequence must reflect the evolutionary optimization for insect-selective neurotoxicity, with no activity against mammalian calcium channels."}
{"description": "sp|P0C8U3|CA14_CONBR Alpha-conotoxin-like Br1.4 OS=Conus brunneus OX=101289 PE=2 SV=1", "sequence": "ITCCTRGTCAQHC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus brunneus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the invariant cysteine framework (CC-C-C) typical of alpha-conotoxins, with inter-cysteine loops of appropriate length to confer target specificity. Key structural elements should include a beta-hairpin motif and well-defined alpha-helical regions that form the receptor binding interface. The toxin must exhibit high affinity binding to its nAChR target through precise molecular interactions with complementary receptor subunits, effectively blocking ion channel activation and disrupting cholinergic signaling. The overall structure should demonstrate thermal stability and protease resistance conferred by the disulfide-stabilized fold, while maintaining the pharmacological profile characteristic of Conus brunneus venom components that evolved for rapid prey immobilization through neuromuscular blockade."}
{"description": "sp|Q2YHJ2|PA2B_CRABR Basic phospholipase A2 Tbo-G6D49 OS=Craspedocephalus borneensis OX=3147914 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGSLLEFGRMIKEETGKNPLFSYISYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLWSCSPKTDIYFYYRKNGAIVCARGTWCEKQICECDKAAAICFRENLGTYKDEYQSYGKSRCTEKSLKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Craspedocephalus borneensis (Bornean pit viper). This toxin should function as a potent enzymatic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the YGCXCG motif. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the conserved calcium-binding residues. The sequence should maintain the 14 conserved cysteine residues that form 7 disulfide bridges, stabilizing the compact globular structure. As a basic phospholipase A2, the protein should exhibit net positive charge to facilitate interaction with anionic membrane surfaces. The toxin should demonstrate presynaptic or postsynaptic neurotoxic activity, potentially targeting neuromuscular junctions, and may exhibit myotoxic effects through membrane disruption. The structural scaffold should enable efficient membrane penetration and substrate accessibility while maintaining thermal stability and resistance to proteolytic degradation typical of snake venom phospholipases A2."}
{"description": "sp|A8HDJ5|3S11_TROCA Short neurotoxin 1 OS=Tropidechis carinatus OX=100989 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTPCAESSCYKKTWKDNRGTIIERGCGCPNVKPGIDLMCCKTDECNN", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom components of the rough-scaled snake (Tropidechis carinatus). This toxin should function as a postsynaptic neurotoxin that specifically targets and antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis through competitive inhibition of acetylcholine binding. The protein should adopt the characteristic three-finger toxin fold common to snake venom neurotoxins, featuring three extended loops projecting from a small, globular core stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework pattern. The structural scaffold should include the conserved hydrophobic core and key functional residues in loop regions that mediate receptor binding specificity. The toxin should exhibit high affinity for muscle-type nicotinic acetylcholine receptors, with the binding interface primarily involving the central loop that inserts into the receptor's ligand-binding site. The sequence should maintain the compact, stable structure typical of short neurotoxins while preserving the molecular determinants responsible for its paralytic activity in snake envenomation."}
{"description": "sp|A0A0S4FKT4|VSP1_CRODO Thrombin-like enzyme collinein-1 OS=Crotalus durissus collilineatus OX=221569 PE=1 SV=1", "sequence": "VIGGDECNINEHNFLVALYEYWSQSFLCGGTLINGEWVLTAAHCDRKHILIYVGVHDRSVQFDKEQRRFPKEKYFFNCRNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRVMGWGTIKSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATIRILCAGVLEGGIDTCHRDSGGPLICNGEFQGIVSWGDGSCAQPDKPALYSKVFDHLDWIQNIIAGSETVNCPS", "prompt": "Design a serine protease enzyme from the venom of the South American rattlesnake (Crotalus durissus collilineatus) that functions as a thrombin-like enzyme. This toxin should exhibit selective proteolytic activity toward fibrinogen, specifically cleaving fibrinopeptide A to generate fibrin monomers and initiate clot formation, while having minimal effect on other coagulation factors to avoid systemic coagulation. The enzyme should adopt the characteristic chymotrypsin-like fold of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His57, Asp102, Ser195) positioned in the active site cleft. Incorporate the conserved disulfide bridge pattern typical of this toxin family, including the essential Cys191-Cys220 disulfide that stabilizes the active site region. The structure should include surface loops that confer substrate specificity distinct from mammalian thrombin, particularly in the regions governing fibrinogen recognition. The enzyme should function as a defibrinating agent that promotes localized coagulation while potentially causing consumptive coagulopathy, consistent with the hemorrhagic and procoagulant effects of crotalid venoms. Maintain the overall structural stability required for venom gland storage and injection, while optimizing the substrate-binding exosite for preferential fibrinogen cleavage over other serine protease substrates."}
{"description": "sp|P29179|3NO25_NAJNA Weak neurotoxin 5 OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "LTCLICPEKYCNKVHTCLNGENICFKRFNRILGKRYDLGCAATCPTVKTGIVQCCSTDKCNH", "prompt": "Design a protein sequence for a weak neurotoxin from the Indian cobra (Naja naja) venom. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically the non-conventional or weak neurotoxin subgroup. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The molecular mechanism involves weak antagonism of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to mild neuromuscular blockade. Unlike potent neurotoxins, this weak variant exhibits reduced binding affinity and slower receptor dissociation kinetics. The structural scaffold should feature three extended loops (fingers) projecting from a central globular core, with the functional loops (particularly loop II) containing key residues for receptor interaction. The sequence should maintain the conserved hydrophobic core and β-sheet architecture while incorporating specific variations that confer its weak neurotoxic properties compared to more potent homologs. The protein should be water-soluble and stable under physiological conditions, typical of snake venom three-finger toxins."}
{"description": "sp|C5ILC5|3L22A_OPHHA Alpha-elapitoxin-Oh2a OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLLCYKTPSPINAETCPPGENLCYTKMWCDAWCSSRGKVIELGCAATCPSKKPYEEVDCCSTDNCNPHPKLRP", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the king cobra (Ophiophagus hannah), specifically an alpha-elapitoxin. This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a postsynaptic neurotoxin. It should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The toxin acts as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, binding with high affinity to the α-δ and α-γ subunit interfaces to block acetylcholine signaling. This results in flaccid paralysis by preventing depolarization of the postsynaptic membrane. The sequence should feature the conserved structural core with three β-stranded loops extending from a central globular domain, and include key functional residues in loop II that mediate receptor binding specificity and potency. The toxin should exhibit the typical molecular weight and physicochemical properties of short-chain alpha-neurotoxins from elapid snakes."}
{"description": "sp|P0C6E4|VM2JN_PROJR Zinc metalloproteinase/disintegrin OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MIQVLLVTVCLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKRAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYVKLAIVVDYGMYTKYNRDSDKITVRVHEMVNHITEMYRPLNIDITLSLLDVWSEKDLITVQSDSDVTLEVFGDWRESVLLKRRSHDCAHLLTDTKLNDNTIGVAYKKGMCDPKLSVGLVQDYSKNVFMVAVTMTHEIGHNLGMEHDEDKNGKKCKCDTCIMSPVISDKQSKLFSDCSKNDYQTFLTNYKPQCILNAPLRTDTVSTPVSGNELLEEGEDCYCHIPPNPCCDPATCKLTPGSQCAEGLCCDQCRFKKKGTICRFARGDYPDDRCTGLSDDCPRWNDL", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of the venom from Protobothrops jerdonii (Jerdon's pit viper). This protein should exhibit the dual functionality typical of snake venom metalloproteinases (SVMPs), specifically the P-II class, which contains both metalloproteinase and disintegrin domains. The metalloproteinase domain must incorporate the conserved zinc-binding motif HEXXHXXGXXH, which coordinates a catalytic zinc ion essential for proteolytic activity against extracellular matrix components such as fibrinogen, collagen, and von Willebrand factor, leading to hemorrhage, coagulopathy, and tissue damage. The disintegrin domain should adopt a compact, disulfide-rich structure with the RGD (Arg-Gly-Asp) or related tripeptide motif that competitively inhibits integrin receptors (e.g., αIIbβ3 on platelets or αvβ3 on endothelial cells), disrupting cell-matrix interactions and promoting anticoagulation and antiplatelet effects. The overall structure should feature multiple disulfide bonds stabilizing both domains, with the metalloproteinase domain likely adopting a metzincin-like fold with a central five-stranded β-sheet and surrounding α-helices, and the disintegrin domain forming a small, rigid loop stabilized by disulfides. The protein should be secreted as a zymogen, requiring proteolytic activation to expose the catalytic site, and function synergistically to induce prey immobilization through hemorrhage and inhibition of hemostasis."}
{"description": "sp|P24294|PA2A2_ERIMA Acidic phospholipase A2 PLA-2 OS=Eristicophis macmahoni OX=110227 PE=1 SV=1", "sequence": "NLYQFGEMISKKTGTFGLFSYVYYGCYCGLGGKGKPLDATDRCCFVHDCCYGRVNGCNPKLSIYSYSFQNGDIVCGDEEDCLRDVCECDRVAAICFGENMNTYNKKYVLYSFKECNESDQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 (PLA-2) toxin from the venom of Eristicophis macmahoni, a viper species. This enzyme should function as a potent toxin by catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids, leading to membrane disruption, inflammation, and potential neurotoxic or myotoxic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by multiple disulfide bridges. Key structural elements include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, an interfacial binding surface for membrane association, and an acidic pI that may influence its tissue targeting and potency. The active site should contain the canonical catalytic dyad (histidine-aspartate) and exhibit specificity for phospholipid substrates. The sequence should reflect the typical viperid PLA-2 architecture with appropriate signal peptide cleavage and propeptide processing if applicable, resulting in a mature, secreted toxin optimized for rapid enzymatic action and biological activity in envenomation."}
{"description": "sp|Q9PSM8|SL9B_ECHCA Snaclec coagulation factor IX/factor X-binding protein subunit B OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "DCSSGWTAYGKHCYKVFDEPKTWEDAEKFCSEQANGGHLVSFRSSKEADFVVTLTAQTKESEIVWMGLSKIWNQCDWGWTNGAKLNYEAWAEAESYCVWFSSTNKEWKSRPCSLFGHFVCKSPAW", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the saw-scaled viper (Echis carinatus) that functions as a coagulation factor IX/factor X-binding protein. This protein should exhibit the characteristic structural features of the snaclec family, including a C-type lectin-like domain (CTLD) fold stabilized by conserved disulfide bridges, typically with a pattern of Cys1-Cys2 and Cys3-Cys4. The protein should specifically bind to coagulation factors IX and X, interfering with the coagulation cascade by preventing the assembly of the tenase and prothrombinase complexes, respectively. This binding activity contributes to the venom's anticoagulant effects, leading to hypocoagulability and potential hemorrhage. The sequence should include key residues involved in calcium-independent ligand recognition, with a hydrophobic patch and polar interactions mediating the protein-protein interactions with the Gla domains of factors IX and X. The overall structure should be compact and globular, with the characteristic β-sandwich fold of CTLDs, and the sequence should reflect the evolutionary adaptation for targeted inhibition of coagulation factors without enzymatic activity."}
{"description": "sp|P85874|MAST_POLMJ Mastoparan-like PMM OS=Polistes major OX=91420 PE=1 SV=1", "sequence": "INWKKIASIGKEVLKAL", "prompt": "Design a mastoparan-like peptide toxin derived from the venom of the paper wasp Polistes major. This peptide should function as a potent cytolytic and hemolytic agent, characteristic of mastoparan toxins in hymenopteran venoms. The sequence must adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, with a cationic surface rich in lysine and arginine residues that facilitates interaction with anionic phospholipid headgroups in cell membranes. The structural core should feature a well-defined hydrophobic face that enables insertion into lipid bilayers, leading to membrane disruption via pore formation or detergent-like effects. The mechanism of action involves non-receptor-mediated targeting of plasma membranes, resulting in calcium influx, activation of G-proteins, and induction of mast cell degranulation. The peptide should exhibit broad-spectrum activity against various cell types, with preferential lysis of erythrocytes and mast cells, and should maintain the characteristic 14-residue length typical of mastoparan family peptides while optimizing amphipathicity for maximal membrane perturbation efficiency."}
{"description": "sp|Q9XZK7|CA2_CONTE Alpha-conotoxin-like Tx2 OS=Conus textile OX=6494 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSGRRTFHGRNAAAKASGLVSLTDRRPECCSHPACNVDHPEICR", "prompt": "Design a novel alpha-conotoxin-like peptide derived from the venom of the textile cone snail, Conus textile, a marine predator that employs complex neurotoxic venoms for prey capture. This toxin should function as a potent neurotoxin targeting ion channels or receptors in the nervous system, characteristic of conotoxins from this species. The peptide must adopt the conserved structural framework of alpha-conotoxins, featuring a disulfide connectivity pattern of Cys1-Cys3 and Cys2-Cys4, forming two interlocking disulfide bridges that stabilize a compact globular fold. The sequence should include the characteristic cysteine framework (CC-C-C) with appropriate spacing between cysteine residues to maintain structural integrity. The molecular target is inferred to be nicotinic acetylcholine receptors or related ligand-gated ion channels, given the alpha-conotoxin classification, with binding likely occurring at receptor subunit interfaces to modulate synaptic transmission. The 3D structure should exhibit the typical alpha-conotoxin fold: a small, rigid beta-hairpin or loop-rich scaffold stabilized by disulfide bonds, enabling high-affinity interaction with the target receptor. Key structural elements include well-defined loops between cysteine residues that form the pharmacophore, with conserved residues in these regions critical for target specificity and potency. The overall architecture should ensure stability in the venom and target environment, with surface-exposed residues optimized for receptor engagement while maintaining the compact, disulfide-stabilized core characteristic of conotoxin scaffolds."}
{"description": "sp|P10117|PA2H1_LATCO Basic phospholipase A2 homolog 1 OS=Laticauda colubrina OX=8628 PE=1 SV=1", "sequence": "NLIQFSQLIQCANKGKRPTLHYMDYGCYCGPGGSGTPVDDLDRCCKTNDDCYGQAEKKGCSPLSTNYNFDCFPGGPQCGKGTTCQRFVCDCDLKAALCFAKSPYNNKNFNIDTKKRCK", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the yellow-lipped sea krait, Laticauda colubrina. This protein belongs to the group II secreted phospholipase A2 family and functions as a potent presynaptic neurotoxin. Despite being classified as a phospholipase A2 homolog, it exhibits significantly reduced or absent catalytic activity due to key mutations in the calcium-binding and catalytic sites, yet retains high toxicity through alternative mechanisms. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, two antiparallel beta-sheets, and a conserved calcium-binding loop. It must contain the canonical 14 cysteine residues forming 7 disulfide bridges that stabilize the compact globular structure. The sequence should include the conserved catalytic network motif while incorporating specific substitutions that diminish enzymatic function. The protein should target presynaptic membranes at neuromuscular junctions, where it binds with high affinity to specific receptors, disrupting neurotransmitter release and causing flaccid paralysis. The design should emphasize the basic nature of the protein, with a calculated pI above 8.0, which facilitates membrane interaction and contributes to its neurotoxic potency. The structural scaffold must maintain the characteristic phospholipase A2 hydrophobic channel and interfacial binding surface while optimizing for neurotoxic activity rather than phospholipid hydrolysis."}
{"description": "sp|F5CPE0|3SX9_MICAT Three-finger toxin MALT0059C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MRTLLLTLVVVTIVCLDLGNSLICYVTRDGKTATCPPGQKCEKYAVSASHTGHWFHRWHCTSTCHEGPYNVCCSTDFCNR", "prompt": "Design a three-finger toxin protein sequence inspired by coral snake venom, specifically from Micrurus altirostris. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three extended β-stranded loops projecting from a central hydrophobic core stabilized by four conserved disulfide bonds with the typical cysteine framework (C-C-C-C-C-C-C-C). The protein should exhibit the structural hallmarks of this family: a compact globular core with three finger-like projections that facilitate molecular recognition and binding. As a component of elapid snake venom, this toxin likely functions as a neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, potentially causing postsynaptic blockade that leads to flaccid paralysis. The sequence should maintain the conserved structural determinants for receptor binding, particularly in the central loop which often contains key residues for target recognition. The protein should be optimized for stability through the characteristic disulfide network while preserving the functional surfaces required for its toxic activity in prey immobilization."}
{"description": "sp|P10456|3S1D_LATCO Short neurotoxin D OS=Laticauda colubrina OX=8628 PE=1 SV=2", "sequence": "MKTLLLTLVVVTMVCLDLGYTRRCFNQQSSQPKTTKSCPPGENSCYNKQWRDHRGSITERGCGCPKVKPGIKLRCCESEDCNN", "prompt": "Generate the amino acid sequence for a short neurotoxin from the venom of the banded sea krait, Laticauda colubrina. This toxin functions as a potent postsynaptic neurotoxin that specifically and irreversibly binds to the nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding. This mechanism induces flaccid paralysis by blocking neurotransmission. The protein adopts the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The structural scaffold is compact and globular, with loop II containing the key functional residues responsible for receptor recognition and binding. The molecular target is the muscle-type nicotinic acetylcholine receptor, with high affinity binding to the α-δ and α-γ subunit interfaces. The toxin exhibits rapid onset of paralysis and high specificity for neuromuscular junctions over neuronal nicotinic receptors."}
{"description": "sp|Q5UFR8|3S11_HYDPR Short neurotoxin 1 OS=Hydrophis peronii OX=8676 PE=1 SV=1", "sequence": "MKTLLLSPVVVTIVCLDLGYTMTCCNQQSSQPKTTTNCAGNSCYKKTWSDHRGTIIERGCGCPQVKSGIKLECCHTNECNN", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom components of the spiny-headed sea snake, Hydrophis peronii. This toxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the postsynaptic membrane of neuromuscular junctions, specifically targeting the muscle-type (α1β1γδ) nicotinic receptors. The protein should adopt the characteristic three-finger toxin fold common to snake neurotoxins, featuring three extended β-sheet-rich loops emerging from a small, globular hydrophobic core stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The molecular mechanism should involve high-affinity binding to the α-subunit of the nicotinic receptor, effectively blocking acetylcholine binding and causing reversible neuromuscular paralysis. Key functional residues should be concentrated in the central loop (loop II), which forms the primary receptor interaction surface, while maintaining the structural integrity provided by the conserved cysteine framework. The toxin should exhibit the typical compact size (60-70 amino acids) and basic pI characteristic of this toxin family to facilitate efficient diffusion and target engagement in envenomation scenarios."}
{"description": "sp|P0DPT2|CA1B_CONCT Alpha-conotoxin CIB (Fragment) OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "SDGRNEAANDEASDVIELALKGCCSNPVCHLEHPNACGRRR", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of the marine cone snail Conus catus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold featuring the conserved CC-C-C cysteine framework, where two disulfide bridges constrain the peptide into a compact, stable conformation. The sequence should include the essential pharmacophore elements for receptor binding, including key residues in the inter-cysteine loops that mediate specific interactions with the acetylcholine binding site. The toxin should exhibit high affinity and selectivity for its target receptors, contributing to the paralytic and neurotoxic effects characteristic of Conus catus venom. The structure should maintain the typical alpha-conotoxin dimensions with well-defined secondary structure elements stabilized by the disulfide network, ensuring proper folding and biological activity."}
{"description": "sp|A6MFL6|NGFV2_DEMVE Venom nerve growth factor 2 OS=Demansia vestigiata OX=412038 PE=2 SV=1", "sequence": "MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATPDLSDTSCAQTHKALKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVEFLENEDALNRNIRSKRENHPVNDHGEYSVCDSVSVWVNKTTATDIKGKPVTVMVDVNLNNHVYKQYFFETKCKNPNPVPSGCRGIDSRHWNSYCTTTQSFVKALTKEGNQASWRFIRIDTACVCVISRKTGNF", "prompt": "Generate the amino acid sequence for a venom-derived nerve growth factor from the Australian black whip snake, Demansia vestigiata. This protein functions as a neurotrophic toxin that mimics endogenous nerve growth factor (NGF) activity but with pathological consequences in envenomation. The protein should adopt the classic NGF beta-fold structure characterized by a cysteine knot motif formed by three conserved disulfide bridges (Cys15-Cys80, Cys58-Cys108, Cys68-Cys110 in human NGF numbering), creating a stable, compact beta-sandwich architecture. As a venom component, this NGF homolog likely binds with high affinity to TrkA tyrosine kinase receptors and p75 neurotrophin receptors on sensory and sympathetic neurons, potentially causing hyperalgesia, inflammation, and aberrant neuronal signaling through sustained receptor activation. The sequence should contain the conserved receptor-binding epitopes in the beta-hairpin loops, particularly the regions corresponding to loops L1, L2, and L4 in canonical NGF structure, which mediate specific interactions with TrkA receptor domains. The protein may exhibit enhanced stability or modified receptor specificity compared to mammalian NGF due to its venom context, potentially contributing to the snake's predatory and defensive strategies through modulation of neuronal function and pain pathways."}
{"description": "sp|P58806|CKR_CONRA Conantokin-R OS=Conus radiatus OX=61198 PE=1 SV=2", "sequence": "MQLYTYLYLLVSLVTFYLILGTGTLGHGGALTERRSTDATALKPEPVLLQKSSARSTDDNGNDRLTQMKRILKKRGNKARGEEEVAKMAAELARENIAKGCKVNCYP", "prompt": "Design a conantokin peptide from the venom of Conus radiatus, a marine cone snail species. This toxin belongs to the conantokin family, which are unique among conotoxins as they lack disulfide bonds and instead function as NMDA receptor antagonists. The peptide should adopt an alpha-helical secondary structure stabilized by gamma-carboxyglutamate (Gla) residues, which are post-translationally modified glutamate residues that chelate calcium ions and are essential for structural stability and receptor binding. The sequence should contain multiple Gla residues at conserved positions that facilitate the formation of a stable amphipathic helix. This conantokin specifically targets the NMDA receptor, binding to the glutamate recognition site and acting as a competitive antagonist to block receptor activation, thereby producing neurological effects such as sedation or convulsions depending on the specific receptor subtype targeted. The peptide should be relatively short (approximately 17-25 amino acids) and exhibit the characteristic conantokin structural motif of a helical conformation dependent on Gla residues rather than disulfide connectivity."}
{"description": "sp|Q8AYA5|SLA2_DEIAC Snaclec agglucetin subunit alpha-2 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADFNCPPGWSAYDQYCYQVIKEPKNWDDAERFCTEQADGGHLVSIESKGERDFVAQLVSQNIESVEDHVWTGLRVQNKEKQCSTEWSDGSSVSYENLLELYMRKCGALERETGFHKWINLGCIQLNPFVCKFPPQC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This protein should be the alpha-2 subunit of agglucetin from the venom of Deinagkistrodon acutus (hundred-pace pit viper). The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain the essential calcium-binding motifs and carbohydrate recognition domain (CRD) elements characteristic of functional C-type lectins. As a component of the heterodimeric agglucetin complex, this alpha subunit should contain specific surface residues that enable interaction with platelet membrane receptors, likely targeting GPIb or other platelet surface glycoproteins to modulate hemostasis. The protein should exhibit the typical β-sheet rich structure with α-helices that defines the CTLD scaffold, maintaining the conserved hydrophobic core while displaying variable surface loops that determine target specificity. The design should reflect the evolutionary adaptation of this venom component for rapid disruption of prey coagulation systems."}
{"description": "sp|P11057|T5G1A_AGEAP Mu-agatoxin-Aa1a OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "ECVPENGHCRDWYDECCEGFYCSCRQPPKCICRNNN", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the funnel-web spider Agelenopsis aperta. This toxin should function as a selective blocker of insect voltage-gated calcium channels, specifically targeting the P/Q-type calcium channels in insect nervous systems. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom toxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves high-affinity binding to the pore-forming alpha1 subunit of insect calcium channels, preventing calcium influx and thereby disrupting synaptic transmission and neuromuscular function, leading to rapid paralysis in insect prey. The sequence should contain the appropriate cysteine framework for ICK motif formation and display surface-exposed residues critical for channel recognition and binding specificity toward insect versus mammalian calcium channel isoforms."}
{"description": "sp|Q5Y4X0|TAG2P_AGEOR U2-agatoxin-Ao1p OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRAIISLILISAMVFSMIAAVPXXEGLQLSEDERGGCLPHNRFCNALSGPRCCSGLKCKELSIWDSICLG", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin belongs to the ω-agatoxin family and functions as a selective calcium channel blocker, specifically targeting insect voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and neuromuscular function. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that confers exceptional thermal and proteolytic stability. Key structural elements include a hydrophobic core, solvent-exposed loops critical for channel binding and selectivity, and a molecular surface optimized for high-affinity interaction with insect VGCCs while minimizing activity against mammalian channels. The toxin should exhibit rapid paralysis induction in insect prey through presynaptic calcium channel inhibition, reflecting its evolutionary role in prey immobilization for this hunting spider species."}
{"description": "sp|P0C6E3|VM2B1_AGKBI Zinc metalloproteinase-disintegrin bilitoxin-1 OS=Agkistrodon bilineatus OX=8718 PE=1 SV=1", "sequence": "QRYNPYKYIELFLVVDNRMVTKYNGDLDKIKTRIYELVNILNEIYRPLYIRVALVGIEFWCNKDLINVKSASSVTLASFANWRESVLPNRTSHDNAQLLTAIVFNRGVIGSAYPAGMCDPNRSVGTVQDHSEINLQVAITMAHEIGHNLGMGHDNNSCTCGGYSCIMLPALSDQPSKYFSNCSYIQYRDFIMNQDPQCILNEPSGTDIVSPPVCGNDILEVGEECDCGCPRNCQDPCCNAATCKKYSWVQCESGECCDQCRFKGAGTECRRAMGDDPGGRCTGQSADCPRN", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin hybrid toxin from the venom of Agkistrodon bilineatus (tropical moccasin). This toxin represents a sophisticated evolutionary adaptation where a metalloproteinase domain is fused with a disintegrin domain, creating a multifunctional weapon that targets the mammalian hemostatic system. The protein should contain a zinc-dependent metalloproteinase domain with the characteristic HEXXHXXGXXH zinc-binding motif, enabling proteolytic cleavage of extracellular matrix components and coagulation factors. This domain should exhibit structural features typical of snake venom metalloproteinases, including a conserved methionine turn and a substrate-binding cleft. The disintegrin domain should adopt the classic disintegrin fold with an RGD (Arg-Gly-Asp) or related integrin-binding motif that specifically targets platelet integrin receptors such as αIIbβ3, inhibiting platelet aggregation by blocking fibrinogen binding. The protein should maintain appropriate cysteine residues to form disulfide bridges that stabilize both domains, with the metalloproteinase domain typically containing 4-5 disulfide bonds and the disintegrin domain featuring the conserved disintegrin cysteine pattern. The overall structure should facilitate synergistic action where proteolytic activity disrupts vascular integrity while disintegrin function impairs hemostasis, creating potent hemorrhagic effects. The sequence should reflect evolutionary optimization for rapid tissue damage and blood loss in prey organisms."}
{"description": "sp|P0CH57|NDB51_MESEU Potassium channel toxin MeuTXKbeta3-meucin-24 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MMKQQFFLFLAVIVMISSVIEAGRGREFMSNLKEKLSGVKEKMKNSWNRLTSMSEYACPVIEKWCEDHCQAKNAIGRCENTECKCLSK", "prompt": "Design a novel scorpion venom-derived potassium channel toxin with the functional and structural characteristics of MeuTXKbeta3-meucin-24 from Mesobuthus eupeus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the cysteine framework C1-C4, C2-C5, C3-C6. The structural core should consist of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, creating a molecular surface optimized for high-affinity interaction with the pore region of potassium channels. Key functional residues should be positioned in the beta-sheet region to form specific contacts with channel vestibule residues, enabling selective blockade of potassium ion conduction. The toxin should exhibit the typical molecular weight and isoelectric point profile of scorpion venom peptides, with surface-exposed basic residues contributing to target recognition. The sequence should maintain the characteristic pharmacophore pattern that confers both potency and selectivity for potassium channel subtypes, making it an effective neurotoxin that modulates electrical signaling in prey organisms through precise ion channel inhibition."}
{"description": "sp|A0A0D4WV12|BIB11_SICTE Dermonecrotic toxin StSicTox-betaIB1i OS=Sicarius terrosus OX=571544 PE=1 SV=1", "sequence": "GDSRRPIWNIAHMVNDLDLVDEYLDDGANSLELDVEFSKSGTALRTYHGVPCDCFRSCTRSEKFSKYLDYIRQLTTPGNSKFRSRLILLVLDLKLNPLSSSAAYNAGADVARNLLDNYWQRGDSKARAYIVLSLETIAGAEFITGFKDTMKKEGFDEKYYDKIGWDFSGNEDLGKIRDVLESHGIREHIWQGDGITNCLPRDDNRLKQAISRRYSPTYVYADKVYTWSIDKESSIENALRLGVDGVMTNYPARVISVLGEREFSGKLRLATYDDNPWEK", "prompt": "Design a novel dermonecrotic toxin protein sequence inspired by the venom of Sicarius terrosus, a six-eyed sand spider known for producing potent tissue-damaging toxins. This protein should function as a potent dermonecrotic agent capable of inducing severe localized tissue necrosis through disruption of cellular membranes and induction of inflammatory cascades. The toxin should adopt a stable beta-structured scaffold characteristic of the SicTox-beta family, featuring a compact globular fold stabilized by multiple disulfide bridges that confer exceptional thermal and proteolytic stability. The structural architecture should include exposed hydrophobic patches and cationic surfaces that facilitate interaction with lipid bilayers and host cell membranes. The mechanism of action should involve direct membrane perturbation leading to cytolysis, activation of inflammatory mediators, and induction of programmed cell death pathways in dermal and endothelial tissues. The protein should exhibit target promiscuity typical of dermonecrotic toxins, interacting with multiple membrane components while maintaining specificity for eukaryotic cell structures over prokaryotic membranes. The sequence should encode conserved motifs for membrane-binding domains and include appropriate signal peptide sequences for proper secretion and processing in venom gland cells."}
{"description": "sp|E9NW26|VM2P1_PROMU Zinc metalloproteinase/disintegrin PMMP-1 OS=Protobothrops mucrosquamatus OX=103944 PE=2 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPNRAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETYYSPDGRKITTKPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETHLIEPLKLSGSEAHAVFKYENVEKEDEAPKMCGVTETNWESYEPIKKASKLVVTAEPLRYVELVIVADHGMVTKYNGDLDKIREWVHEMVNTVDEIYDYMYIDVILADLEIWTNEDLINVQPSAHHTLDSFGEWRERDLLKRKSHDNAQLLTATDFDGPTIGLAHVASMCDPKRSTGVVQDHSTINLRVAVTLAHEMGHNLGIHHDKGSCSCGGYACIMSPVISHDPSKYFSNCSYIQCWDFIRKHNPQCILNKPLRTDTVSTPVSGNELLEAGEDCDCGSPSNPCCDVGTCKLSPGAQCADGLCCDQCRFKKKGTICRIARGDWNDDRCTGQSADCPRNGLYG", "prompt": "Design a venom zinc metalloproteinase/disintegrin protein from the habu snake Protobothrops mucrosquamatus, a species known for its potent hemotoxic venom that causes hemorrhage, tissue damage, and coagulopathy in prey. This protein should function as a key hemorrhagic toxin that degrades extracellular matrix components in blood vessel walls through its metalloproteinase domain, which contains the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn. The disintegrin domain should adopt a compact, disulfide-rich structure with the characteristic RGD (Arg-Gly-Asp) or related integrin-binding motif that specifically targets platelet integrin receptors (particularly αIIbβ3 and αvβ3), inhibiting platelet aggregation and promoting bleeding. The protein should exhibit the multi-domain architecture typical of snake venom metalloproteinases (SVMPs), with the metalloproteinase domain featuring a reprolysin-like fold and the disintegrin domain displaying the short-chain disintegrin cysteine pattern. The overall structure should facilitate calcium-dependent proteolytic activity against basement membrane components like type IV collagen, laminin, and fibronectin, while the disintegrin domain mediates anti-platelet effects through high-affinity integrin binding. The protein should be optimized for stability in venom and efficient target engagement in mammalian systems."}
{"description": "sp|E9NW27|VM2P2_PROMU Zinc metalloproteinase/disintegrin PMMP-2 OS=Protobothrops mucrosquamatus OX=103944 PE=2 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVDDYEVVYPRRVSALPKGAVQPKYEDAMQYEFKVNGEAVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQNWESDESIKKASQLNLTPLQQRFLQRYVKLAIVVDYRMYIKYNRDSNKITVRAHEMVNHVNEMYKPLNITITLSLLQIWSQNDLITVQPASSITLRLFGNWRKTVLLNQQNHDNAQLLTDIVFNGRTIGKAPVAGMCQPDRSVGVVRDYSSNVFVVAVIMTHELGHNLGMEHDEDKNEKKCKCDTCIMAPAISDPPAQLFSDCSKNDYQLFLTVYNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPENPCCDAATCKLRPGAQCAEGLCCDQCRFKKKRTICRRARGDNPDDRCTGQSADCPRNGLYG", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of snake venom metalloproteinases (SVMPs) from Protobothrops mucrosquamatus, the Taiwanese habu pit viper. This protein should exhibit the dual functionality typical of P-II class SVMPs: (1) A metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that facilitates proteolytic cleavage of extracellular matrix components such as collagen, laminin, and fibronectin, contributing to hemorrhage, tissue damage, and inflammation. (2) A disintegrin domain that inhibits platelet aggregation by binding to integrin receptors (e.g., αIIbβ3 on platelets) via an RGD or related motif, disrupting cell-matrix interactions and promoting anticoagulation. The protein should adopt a multi-domain architecture with a propeptide, metalloproteinase, and disintegrin domain, stabilized by disulfide bonds characteristic of SVMPs, including the 'cysteine-switch' mechanism in the prodomain. The structural fold should feature the typical metzincin topology with a central five-stranded β-sheet and active-site zinc coordinated by three histidines, enabling its role in prey immobilization through hemorrhage and hemostatic disruption."}
{"description": "sp|A0A1D0BZI2|GOML_HADIN Gomesin-like peptide OS=Hadronyche infensa OX=153481 PE=3 SV=1", "sequence": "MNRTRALVCLFLAVLILAHESEAQCRRLCYRNRCVTYCRGRGKRSVEEPSGGAQVVEKRAVDDADIPSAVEERELDEEESIEFR", "prompt": "Design a gomesin-like antimicrobial peptide derived from the venom of the Australian funnel-web spider Hadronyche infensa. This peptide should function as a potent membrane-disrupting toxin with broad-spectrum antimicrobial activity against bacteria, fungi, and potentially some cancer cells. The peptide should adopt a stable beta-hairpin structure stabilized by two disulfide bridges in a C1-C4, C2-C3 connectivity pattern, forming a compact, amphipathic fold. The structural scaffold should feature a well-defined beta-sheet with cationic and hydrophobic faces that enable selective interaction with microbial membranes while minimizing mammalian cell toxicity. Key functional elements should include: a conserved cysteine framework, amphipathic character with clustered basic residues for membrane targeting, and structural rigidity imparted by the disulfide-stabilized beta-hairpin motif. The mechanism of action involves initial electrostatic attraction to negatively charged microbial membranes followed by insertion of hydrophobic residues, leading to membrane disruption via pore formation or carpet mechanism. The peptide should exhibit thermal and proteolytic stability characteristic of disulfide-rich spider venom peptides."}
{"description": "sp|P0DTJ3|CESSD_CONBY Conopressin-conophysin OS=Conus bayani OX=2070216 PE=1 SV=1", "sequence": "MTRSALQMGRLTLVLCLLLQLVLVTQACFLGNCLNDGERDVDGREAMRPCKYCSFGQCVGPQICCGDRGCEMGSEEANKCREEDEDSTPCQVFGWPCTLNNPGNTNGKCVANCIGICCVTDTCVVSSECQKESKSGIRVGCQRS", "prompt": "Design a neuropeptide-like toxin from the venom of the marine cone snail Conus bayani that functions as a conopressin-conophysin hybrid molecule. This peptide should exhibit the characteristic structural features of conopressins, which are vasopressin/oxytocin-like peptides found in cone snail venoms. The sequence should contain a conserved cyclic disulfide bridge formed by two cysteine residues that creates a stable ring structure essential for receptor binding, typically with the pattern C-X(4-6)-C. The N-terminal region should contain conserved residues for receptor recognition, while the C-terminal region may exhibit conophysin-like extensions that could modulate stability or targeting. The toxin should function as a selective agonist or antagonist for vasopressin/oxytocin-type receptors in the prey's nervous system, potentially disrupting osmotic balance, social behaviors, or reproductive functions. The structural scaffold should maintain the compact, cyclic conformation typical of neurohypophysial hormone analogs, with the disulfide bridge providing conformational rigidity necessary for specific receptor interactions. The peptide should be approximately 9-15 amino acids in length, with the core conopressin motif containing the essential residues for biological activity while incorporating conophysin-derived elements that may enhance venom delivery or stability."}
{"description": "sp|D6C4I0|I1B2_CONCL Conotoxin Cl11.2 OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MKMSVTFLLILMILPLFTGEWQSGSRLSALKKRLLEKRLLQKRFCTEIGKDCGTSWECCEDCCIHGTCSHESNCANFKLR", "prompt": "Design a novel conotoxin protein sequence inspired by the venom arsenal of the Californiconus californicus marine snail. This toxin should function as a potent ion channel modulator, specifically targeting neuronal voltage-gated sodium channels to disrupt action potential propagation in prey organisms. The protein must adopt the characteristic inhibitory cysteine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, forming a compact, triple-stranded beta-sheet scaffold. Incorporate key functional residues for high-affinity binding to the neurotoxin receptor site 1 of sodium channels, including aromatic and cationic residues that mediate interactions with the channel's pore-forming loops. Ensure the sequence maintains the hallmark conotoxin features: a signal peptide region for proper secretion, a propeptide region for folding assistance, and the mature toxin domain with the precise cysteine framework. The final protein should exhibit high stability in marine environments and selective toxicity toward the snail's natural prey, reflecting the evolutionary optimization of conotoxins for rapid neuromuscular paralysis."}
{"description": "sp|Q9PUH5|PA2B9_AUSSU Basic phospholipase A2 S11-61 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPVHLLVLLAVCVSLLGASNIPPQPLNLYQFGNMIQCANHGRRPTQHYTDYGCYCGKGGSGTPVDELDRCCKTHDDCYTEAGKKGCYPKLTLYSWKCTGKAPTCNSKTGCKRTVCDCDATAAKCFAKAPYNNKNYNIDTKKRCQ", "prompt": "Design a basic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus) that functions as a potent enzymatic toxin. This protein should exhibit the characteristic phospholipase A2 fold with a conserved catalytic network featuring a histidine-aspartate dyad for calcium-dependent hydrolysis of membrane phospholipids. The toxin should possess the typical PLA2 structural scaffold with three long alpha-helices stabilized by multiple disulfide bridges in the characteristic pattern (typically 6-7 conserved cysteines forming 3-4 disulfide bonds). As a basic PLA2, it should have a net positive charge that facilitates interaction with anionic membrane surfaces and potential presynaptic neurotoxic activity. The protein should demonstrate membrane-disrupting capabilities through cleavage of sn-2 acyl chains from glycerophospholipids, leading to membrane damage, inflammation, and potential myotoxic effects. The structural design should ensure proper calcium binding site geometry and substrate access channel formation while maintaining the compact, stable globular fold characteristic of snake venom phospholipases A2."}
{"description": "sp|P83230|VNPC_OXYMI Natriuretic peptide TNPc OS=Oxyuranus microlepidotus OX=111177 PE=1 SV=1", "sequence": "SDSKIGNGCFGFPLDRIGSVSGLGCNRIMQNPPKKFSGE", "prompt": "Design a natriuretic peptide toxin from the venom of the inland taipan (Oxyuranus microlepidotus), one of the most potent snake venoms known. This toxin functions as a natriuretic peptide that mimics endogenous natriuretic peptides to induce profound hypotension and cardiovascular collapse in prey. The protein should adopt the characteristic TNPc (toxin natriuretic peptide c) fold with a conserved ring structure stabilized by a disulfide bridge between cysteine residues, forming the essential pharmacophore for receptor binding. The core mechanism involves competitive binding to natriuretic peptide receptors (particularly NPR-A and NPR-B), activating guanylyl cyclase and increasing cyclic GMP levels, leading to vasodilation, diuresis, and natriuresis. The structural scaffold should feature an N-terminal tail, the central ring domain constrained by the disulfide bond, and a C-terminal extension, with the ring domain containing critical residues for receptor recognition and activation. The mature peptide should exhibit the typical characteristics of venom natriuretic peptides: enhanced receptor affinity and prolonged half-life compared to endogenous counterparts, contributing to rapid prey immobilization through cardiovascular shock."}
{"description": "sp|F5CPE2|3SX3_MICAT Three-finger toxin MALT0063C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MRTLLLTLVVVTIVCLDLGNSLICYVSEYGAKMTCPEGKTLCEKYAVPLMQGHFYFAWRCTSTCKAGAYNICCSTDLCNKIP", "prompt": "Generate the amino acid sequence for a three-finger toxin from the venom of Micrurus altirostris, a coral snake species. This toxin belongs to the three-finger toxin superfamily, characterized by a conserved structural fold comprising three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should adopt the classic three-finger beta-sandwich architecture with minimal helical content, featuring the characteristic 'three-finger' topology where three elongated beta-hairpin loops radiate from a globular core. As a component of elapid snake venom, this toxin likely functions as a neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, potentially causing postsynaptic blockade that leads to flaccid paralysis. The sequence should contain the conserved cysteine framework typical of three-finger toxins and maintain the structural integrity required for specific receptor recognition and binding, while exhibiting the characteristic molecular weight and physicochemical properties appropriate for this toxin family."}
{"description": "sp|D5HR53|SCX4A_ANDCR Anti-insect Ac4 OS=Androctonus crassicauda OX=122909 PE=3 SV=1", "sequence": "MISLSLLLMIGVESVRDGYIVDFKNCVYRCVPPCDGLCKKNGGKGGSCSFLIGSGLACWCNALPDNVPIKDPLHKCPKR", "prompt": "Design a novel anti-insect toxin protein sequence inspired by the venom arsenal of the Arabian fat-tailed scorpion, Androctonus crassicauda. This toxin should function as a potent insecticidal agent by selectively targeting and modulating insect voltage-gated sodium channels (Nav channels). The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, triple-stranded antiparallel β-sheet core stabilized by a cysteine-stabilized αβ (CSαβ) motif. The sequence must include the canonical cysteine framework (C-X-X-X-C-X-C-X-X-C-X-X-X-X-C-X-X-C-X-C) that forms four disulfide bridges, creating a highly stable globular fold. Key functional residues should be positioned in the conserved 'pharmacophore' regions—particularly in the loops connecting the β-strands—to enable high-affinity binding to the voltage-sensor domain of insect Nav channels, leading to channel activation, prolonged depolarization, and ultimately paralysis or death in insect prey. The toxin should exhibit specificity for insect over mammalian Nav channels, reflecting its ecological role in prey capture. Ensure the sequence encodes a mature, secreted peptide of approximately 60–70 residues, with predicted isoelectric point in the basic range (pI > 8.0) to facilitate membrane interaction, and include any conserved post-translational modifications typical of scorpion toxins, such as C-terminal amidation, if applicable."}
{"description": "sp|Q0N4U5|CJE3_CONPO Alpha/kappa-conotoxin-like pl14.3 OS=Conus planorbis OX=97183 PE=3 SV=1", "sequence": "MPSVRSVACCCLLWMMLSVQLVTPGSPATAQLSGQRTARGPGSAICNMACRLEHGHLYPFCNCDGKRDVVSSSMAV", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the marine cone snail Conus planorbis. This toxin should belong to the conotoxin superfamily, specifically exhibiting characteristics of both alpha-conotoxin and kappa-conotoxin subfamilies. The protein must function as a potent neurotoxin targeting ion channels in the nervous system of prey organisms. As an alpha-conotoxin-like component, it should antagonize nicotinic acetylcholine receptors, potentially disrupting neuromuscular transmission. The kappa-conotoxin-like element should confer activity against voltage-gated potassium channels, contributing to neuronal hyperexcitability. The structural scaffold must feature the characteristic conotoxin cysteine framework, likely adopting a compact, disulfide-stabilized fold with multiple disulfide bridges that constrain the peptide into a stable three-dimensional conformation. The sequence should include conserved cysteine residues arranged in a specific pattern that dictates the disulfide connectivity essential for proper folding and biological activity. Key structural elements should include well-defined loops and turns between cysteine residues that form the receptor-binding interfaces. The mature toxin should be a small, cysteine-rich peptide optimized for high affinity binding to its molecular targets, with surface residues positioned for specific interactions with receptor binding sites. The overall architecture should ensure stability in the venom gland and efficient delivery to target tissues."}
{"description": "sp|A6YR20|COC1A_CONCL Mu-conotoxin cal12a OS=Californiconus californicus OX=1736779 PE=1 SV=1", "sequence": "MKLTCVLVVLLLLLPYGDLITNNYIRGAARKVTPWRRNLKTRDVCDSLVGGHCIHNGCWCDQEAPHGNCCDTDGCTAAWWCPGTKWD", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the Californiconus californicus marine cone snail. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis. The protein should adopt the characteristic mu-conotoxin structural framework, featuring a compact, disulfide-rich scaffold stabilized by three conserved disulfide bonds with a C-C-CC-C-C connectivity pattern. The core structure should comprise a well-defined beta-hairpin motif and several reverse turns, facilitating precise interaction with the neurotoxin receptor site 1 on the sodium channel's domain II S5-S6 pore loop. Key functional residues should be strategically positioned to mediate high-affinity binding through electrostatic and hydrophobic interactions, effectively blocking sodium ion conductance and disrupting action potential propagation in motor neurons. The sequence must maintain the canonical cysteine spacing and conserved hydrophobic core typical of mu-conotoxins while incorporating specific loop variations that confer target selectivity and enhanced potency against Nav1.4 channels."}
{"description": "sp|A0A193CHJ5|PA2BC_CROTA Phospholipase A2 crotoxin basic subunit CBc OS=Crotalus tzabcan OX=1043006 PE=1 SV=1", "sequence": "MRALWIVAVLLVGVEGHLLQFNKMIKFETRKNAIPFYAFYGCYCGWGGRGRPKDATDRCCFVHDCCYGKLAKCNTKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC", "prompt": "Generate the amino acid sequence for a phospholipase A2 toxin subunit that functions as the basic component of crotoxin from the venom of Crotalus tzabcan (Mexican west coast rattlesnake). This protein should exhibit the characteristic structural and functional properties of a Group II secretory phospholipase A2. The sequence must contain the conserved catalytic triad (histidine, aspartate, tyrosine) essential for enzymatic activity, along with the calcium-binding loop required for substrate binding and hydrolysis. The protein should adopt the classic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and an N-terminal helical segment. Include the conserved disulfide bond pattern typical of snake venom phospholipases A2 that stabilizes the compact globular structure. This basic subunit forms a heterodimeric complex with an acidic chaperone subunit to create the potent presynaptic neurotoxin crotoxin, which targets neuromuscular junctions and causes irreversible blockade of acetylcholine release. The generated sequence should maintain the basic isoelectric point characteristic of the CB subunit family and contain the molecular surface features necessary for interaction with presynaptic membranes and the acidic partner subunit."}
{"description": "sp|H2ETQ6|KAX1E_OLIMR Potassium channel toxin alpha-KTx 1.14 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MKKISFLLLLAIVICSIGWTDGQFTDVRCSASSKCWPVCKKLFGTYKGKCKNSKCRCYS", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Chinese scorpion Olivierus martensii. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting a functional dyad consisting of a critical lysine residue positioned to occlude the potassium selectivity filter and an adjacent aromatic residue that stabilizes binding through hydrophobic interactions with the channel vestibule. The molecular surface should display a conserved basic patch that electrostatically guides the toxin to its target, while maintaining the characteristic beta-hairpin structural element that inserts into the channel pore. The overall architecture should enable high-affinity, subtype-selective blockade of potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release characteristic of scorpion venom neurotoxins."}
{"description": "sp|P0DTJ2|CESSA_CONBY Conopressin-conophysin OS=Conus bayani OX=2070216 PE=1 SV=1", "sequence": "MGRLTMALCWLLLLLLTTQACYITNCPRGGKRDVDDGLGVRPCMFCSFGQCVGPHICCGAGGCEIGTLEASTCHEENENPIPCHVFGDRCLLKHPGNVHGNCVSPGVCCTDDTCSMHVGCL", "prompt": "Design a novel peptide toxin derived from the venom of the marine cone snail Conus bayani, specifically belonging to the conopressin-conophysin family. This peptide should function as a neurotoxin that targets vasopressin/oxytocin-like receptors in the central nervous system of prey organisms, modulating physiological processes such as water balance, blood pressure, and social behaviors through receptor antagonism or modulation. The peptide should adopt a compact, disulfide-stabilized structure characteristic of conopressins, featuring a conserved cysteine framework that forms one or more disulfide bridges to confer structural stability and receptor binding specificity. The core scaffold should include key residues for receptor recognition and binding, potentially involving a cyclic conformation stabilized by intramolecular bridges. The sequence should reflect the evolutionary adaptation of cone snail venoms for rapid immobilization of prey, with high affinity and selectivity for G-protein coupled receptors in the nervous system. Ensure the design incorporates conserved motifs from conopressin-like peptides, such as a C-terminal amidation if typical for this family, and prioritize bioactive conformation that enhances stability in physiological conditions. The final protein should exhibit potent and specific activity, consistent with the neurotoxic role of Conus venoms in prey capture."}
{"description": "sp|A8HDJ7|3S11_CRYNI Short neurotoxin 1 OS=Cryptophis nigrescens OX=292442 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTITTCAESSCYKKTWKDHHGTRIERGCGCPPRKPLIDLICCETDECNN", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom component from the small-eyed snake, Cryptophis nigrescens. This toxin should function as a postsynaptic neurotoxin that specifically and irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding to induce rapid flaccid paralysis. The structural scaffold should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the canonical cysteine framework I (C-C-C-C-C-C-C-C). The mature toxin should be approximately 60-70 amino acids in length with the N-terminal region forming loop I responsible for initial receptor recognition, the central loop II containing key functional residues for high-affinity binding to the receptor's α-subunit, and the C-terminal loop III contributing to structural stability. Key conserved residues should include hydrophobic patches for membrane interaction and positively charged residues for electrostatic complementarity with the receptor binding site. The protein should exhibit high thermal stability and protease resistance typical of snake venom neurotoxins, with the disulfide network conferring structural rigidity essential for maintaining the three-finger conformation and biological activity."}
{"description": "sp|P29181|3NO27_NAJNA Weak neurotoxin 7 OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "LTCLNCPEVYCRRFQICRDGEKICFKKFDQRNLLGKRYRRGCAATCPEAKPREIVQCCSTDKCNR", "prompt": "Design a protein sequence for a weak neurotoxin from the Indian cobra (Naja naja) venom. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically the non-conventional or weak neurotoxin subgroup. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. As a weak neurotoxin, it exhibits lower toxicity compared to α-neurotoxins but maintains neuroactive properties, potentially acting as a weak antagonist of nicotinic acetylcholine receptors or modulating other neuronal targets. The sequence should contain approximately 60-70 amino acids with the conserved cysteine framework supporting the three-loop structural architecture. The functional loops should display appropriate residues for weak receptor interaction while maintaining the overall structural integrity of the three-finger toxin scaffold. This toxin contributes to the complex neurotoxic cocktail in cobra venom, potentially serving auxiliary functions in prey immobilization through subtle modulation of neurotransmission."}
{"description": "sp|P0CI05|CA1A_CONTI Alpha-conotoxin TiIA OS=Conus tinianus OX=909294 PE=1 SV=1", "sequence": "GGCCSHPACQNNPDYC", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus tinianus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the CC-C-C framework typical of alpha-conotoxins. The sequence should include the essential cysteine residues at positions 1, 2, 3, and 4 to maintain this disulfide bridge pattern, with intervening loops that determine receptor subtype selectivity. The structural core should exhibit the alpha-conotoxin fold, characterized by beta-turn elements and a well-defined hydrophobic core that ensures stability in the venom environment. The molecular mechanism involves competitive inhibition at the orthosteric binding site of nAChRs, disrupting acetylcholine-mediated signaling. The toxin should demonstrate high affinity for specific nAChR subtypes, such as α3β2 or α7, depending on loop length and composition, with key residues in the inter-cysteine regions mediating target recognition and binding specificity. The overall architecture must be compact, with a molecular weight under 2 kDa, and exhibit resistance to proteolytic degradation due to the constrained disulfide-stabilized fold."}
{"description": "sp|P0DV80|BPP_BITRH Bradykinin-potentiating peptide 10 g-AP OS=Bitis rhinoceros OX=715877 PE=1 SV=1", "sequence": "APQERGPPEIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the rhinoceros viper (Bitis rhinoceros) that functions as a potent vasoactive toxin. This peptide should act as a dual-function inhibitor by targeting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin while simultaneously inhibiting the conversion of angiotensin I to angiotensin II. The resulting physiological effect should be profound hypotension through vasodilation. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of the pyroglutamated peptide family found in viper venoms. It should feature a pyroglutamate residue at the N-terminus, which confers resistance to aminopeptidase degradation, and a C-terminal proline-rich region that facilitates ACE binding. The sequence should be approximately 10-15 amino acids in length, with a cysteine framework that forms one or more disulfide bonds to create a constrained conformation optimal for enzyme inhibition. The structural scaffold should enable high-affinity interaction with the active site of ACE, mimicking the natural BPPs that enhance bradykinin's vasodilatory effects and contribute to the venom's prey immobilization through circulatory shock."}
{"description": "sp|P0C8U5|CA14_CONMN Alpha-conotoxin-like Mn1.4 (Fragment) OS=Conus monachus OX=89446 PE=2 SV=1", "sequence": "NGRCCHPACAKYFSCGR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus monachus, the monastic cone snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The peptide should adopt the characteristic globular disulfide-rich scaffold of alpha-conotoxins, featuring a conserved cysteine framework (CC-C-C) with disulfide connectivity of Cys1-Cys3 and Cys2-Cys4, stabilizing a compact, triple-stranded beta-sheet fold. Key structural elements must include: (1) a well-defined alpha-helix-like turn in the second loop, critical for receptor binding; (2) solvent-exposed loops with specific residues (e.g., hydrophobic and polar side chains) that mediate high-affinity interaction with the orthosteric site of muscle-type nAChRs (e.g., α1β1γδ subtypes); and (3) a C-terminal amidation to enhance stability and potency. The mechanism of action should involve competitive blockade of acetylcholine binding, leading to reversible neuromuscular transmission inhibition. Ensure the sequence reflects the phylogenetic adaptations of Conus monachus venom, prioritizing efficacy in immobilizing small fish or invertebrates, and maintain the canonical propeptide cleavage signature for mature toxin release. The final structure must be ≤20 residues, cysteine-rich, and exhibit the hallmark ICK (inhibitor cystine knot) motif topology common to conotoxins."}
{"description": "sp|P58808|CTA1A_CONMR Chi-conotoxin MrIA OS=Conus marmoreus OX=42752 PE=1 SV=1", "sequence": "MRCLPVLIILLLLTASAPGVVVLPKTEDDVPMSSVYGNGKSILRGILRNGVCCGYKLCHPC", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of Chi-conotoxin MrIA from the marine cone snail Conus marmoreus. This toxin functions as a potent and selective inhibitor of the norepinephrine transporter (NET) in the central nervous system, modulating synaptic transmission by blocking neurotransmitter reuptake. The peptide should adopt a compact, globular fold stabilized by a specific disulfide bond framework characteristic of conotoxins, likely featuring a conserved cysteine pattern that forms two disulfide bridges creating a stable structural scaffold. The sequence should include key residues responsible for high-affinity binding to NET, particularly those interacting with the transporter's substrate-binding site, while maintaining selectivity over related monoamine transporters. The toxin should exhibit the typical conotoxin properties of small size, high stability, and precise molecular targeting, reflecting its evolutionary role in the cone snail's venom for rapid prey immobilization through disruption of neuromodulatory pathways."}
{"description": "sp|C5J891|KBX3_OPICY Scorpine-like peptide (Fragment) OS=Opisthacanthus cayaporum OX=573324 PE=2 SV=1", "sequence": "GLIHKVTKVQQLCAFNQDMAGWCEKSCQAAEGKNGYCHGTKCKCGKPLSYRRK", "prompt": "Design a scorpine-like peptide toxin derived from the venom of the scorpion Opisthacanthus cayaporum. This peptide should exhibit the characteristic dual functionality of scorpine-family toxins, combining antimicrobial activity with potent insecticidal properties. The structural scaffold should feature an N-terminal region with alpha-helical content responsible for membrane disruption and antimicrobial effects, followed by a C-terminal region containing a cysteine-stabilized alpha-beta (CSαβ) motif typical of scorpion venom peptides. The cysteine framework should follow the conserved pattern C-C-C-C-C-C, forming three disulfide bridges that stabilize the compact, globular fold. The peptide should demonstrate broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacteria through membrane permeabilization mechanisms, while also exhibiting specific neurotoxicity toward insects via modulation of ion channels, particularly sodium or potassium channels. The overall structure should be amphipathic, with hydrophobic surfaces for membrane interaction and charged residues for target specificity. The molecular weight should be approximately 4-5 kDa, and the peptide should maintain stability across physiological pH ranges while displaying the characteristic resistance to proteolytic degradation conferred by the disulfide-stabilized scaffold."}
{"description": "sp|Q0PL65|VKTH7_BUNMU Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B5-B chain OS=Bungarus multicinctus OX=8616 PE=2 SV=1", "sequence": "RQRHPDCDKPPDTKRCTGHNPAFYYNPRRKNCERFSYGGCGGNGNHFKTKQLCHCHCHEND", "prompt": "Design a protein sequence for a beta-bungarotoxin B5-B chain from the venom of the many-banded krait (Bungarus multicinctus). This toxin functions as a presynaptic neurotoxin that exhibits phospholipase A2 activity and targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to respiratory paralysis. The protein should adopt a Kunitz-type serine protease inhibitor fold, characterized by a compact, stable beta-trefoil structure with a conserved disulfide bond pattern (typically Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 in Kunitz domains) that stabilizes the inhibitory loop. The sequence must include key residues for serine protease inhibition, particularly in the reactive site loop that interacts with trypsin-like proteases, while maintaining the phospholipase A2 enzymatic activity through a distinct functional domain. The molecular target includes presynaptic membrane components where it binds via specific surface patches, disrupting synaptic vesicle recycling and neurotransmitter release. Ensure the sequence reflects the dual functionality: Kunitz-type protease inhibition and phospholipase A2 neurotoxicity, with appropriate structural motifs for stability and target specificity in snake venom."}
{"description": "sp|P0C2K2|A1X1_LOXGA Dermonecrotic toxin LgSicTox-alphaI-1 (Fragment) OS=Loxosceles gaucho OX=58216 PE=1 SV=1", "sequence": "ADNKRPIWVMGGMVNSLAQIKEFVGLGLDNSEKDNKWYKQ", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles gaucho, specifically the LgSicTox-alphaI-1 variant. This toxin belongs to the SicTox family and functions as a phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving these phospholipids to generate ceramide phosphate and choline, leading to inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage that results in local tissue necrosis (dermonecrosis) and potential systemic effects like hemolysis. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold characteristic of phospholipase D enzymes, with the active site containing conserved histidine and lysine residues essential for catalytic activity. Key structural features include a hydrophobic membrane-binding region for substrate interaction and stability in the venom gland. The toxin targets mammalian cell membranes, particularly endothelial cells and erythrocytes, disrupting membrane integrity and signaling pathways through its enzymatic activity. Ensure the sequence reflects the functional domains for substrate binding and catalysis, maintaining the structural stability required for effective venom toxicity."}
{"description": "sp|Q8I0K7|SIXI_OLIMR Depressant scorpion toxin BmKIM OS=Olivierus martensii OX=34649 GN=KIM2 PE=2 SV=1", "sequence": "MKLFLLLVFFASMLIDGLVNADGYIRGSNGCKISCLWGNEGCNKECKGFGAYYGYCWTWGLACWCEGLPDDKTWKSESNTCGGKK", "prompt": "Generate a protein sequence for a depressant scorpion toxin from the venom of Olivierus martensii (Asian forest scorpion). This toxin belongs to the beta-toxin family and functions as a voltage-gated sodium channel modulator. The protein should adopt the conserved scorpion toxin structural fold characterized by an inhibitor cystine knot (ICK) motif stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The toxin specifically targets insect voltage-gated sodium channels, binding to receptor site 4 and causing a hyperpolarizing shift in the voltage dependence of activation, leading to prolonged channel opening and neuronal hyperexcitability. The structure should feature an alpha-helix packed against a three-stranded anti-parallel beta-sheet, with key functional residues concentrated in the conserved 'pharmacophore' region responsible for receptor recognition and binding. The toxin should exhibit high specificity for insect sodium channels over mammalian isoforms, contributing to the scorpion's predatory efficiency by inducing paralysis in insect prey through disruption of neuromuscular transmission."}
{"description": "sp|A8HDJ9|3S11_HOPST Short neurotoxin 1 OS=Hoplocephalus stephensii OX=196418 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTKTCAESSCYKKTWRDHRGTITERGCGCPSVKPGIQLECCKTNECNN", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom components of Stephens' banded snake (Hoplocephalus stephensii). This toxin should function as a postsynaptic neurotoxin that specifically targets and antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis through competitive inhibition of acetylcholine binding. The protein should adopt the characteristic three-finger toxin fold common to short neurotoxins, featuring three extended loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C. The structural scaffold should include the conserved functional sites responsible for receptor binding, particularly the central loop which contains critical residues for interacting with the acetylcholine binding site on muscle-type nicotinic receptors. The sequence should maintain the compact, stable globular structure typical of this toxin family while preserving the specific molecular recognition elements that confer high affinity and selectivity for its neuromuscular targets."}
{"description": "sp|Q8I6R5|CA12_CONIM Alpha-conotoxin ImII (Fragment) OS=Conus imperialis OX=35631 PE=1 SV=1", "sequence": "IVRRACCSDRRCRWRCG", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of Conus imperialis, a marine cone snail. This toxin functions as a potent antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence must include conserved cysteine residues that form this disulfide framework, creating a stable core that supports the presentation of key functional loops responsible for receptor binding and selectivity. These loops should contain residues critical for interacting with the receptor's ligand-binding domain, enabling high-affinity blockade of acetylcholine signaling. The overall structure should be small, stable, and rich in beta-turn elements, typical of the alpha-conotoxin family, ensuring both structural integrity and precise molecular targeting for neurotoxic activity."}
{"description": "sp|Q9Y1U3|SIXC_OLIMR Toxin BmKITc OS=Olivierus martensii OX=34649 PE=3 SV=2", "sequence": "MKLFLLLVIFASMLNDGLVNADGYIRGSDGCKVSCLWGNDFCDKVCKKSGGSYGYCWTWGLACWCEGLPDNEKWKYESNTCGSKK", "prompt": "Design a novel animal toxin protein sequence inspired by the scorpion venom peptide BmKITc from Olivierus martensii (Mesobuthus martensii). This toxin should function as a potassium channel inhibitor, specifically targeting Kv1.3 channels, which play crucial roles in immune cell function and neuronal excitability. The protein should adopt the conserved structural scaffold typical of scorpion α-KTx toxins, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with connectivity C1-C4, C2-C5, C3-C6. The sequence should include key functional residues for channel binding, particularly a lysine-rich patch in the β-sheet region that interacts with the channel pore, and maintain the characteristic α-helix and anti-parallel β-sheet secondary structure arrangement. The toxin should exhibit high affinity and selectivity for Kv1.3 channels, contributing to the neurotoxic and immunomodulatory effects observed in scorpion envenomation through disruption of potassium conductance and membrane depolarization."}
{"description": "sp|P83056|BRK1_BOMVA Kininogen-1 OS=Bombina variegata OX=8348 PE=1 SV=2", "sequence": "MRLWFCLSFLIILCVEHFPGTLAVERNVPESEEKTEQFLRDLFEISRLQRRPAGFTPFRGKFHSQSLRGLSETKRIYNAIWPCKHCNKCKPGLLCKK", "prompt": "Design a protein sequence for a potent animal toxin derived from the yellow-bellied toad (Bombina variegata), specifically a bradykinin-related peptide that functions as a key component of this amphibian's defensive skin secretion. This toxin should act as a high-affinity bradykinin receptor agonist, mimicking the endogenous bradykinin peptide to induce potent inflammatory and pain responses in predators through activation of B1 and B2 bradykinin receptors. The protein should adopt a compact, linear peptide structure typical of amphibian skin bradykinins, characterized by the conserved bradykinin core sequence (RPPGFSPFR) with potential N- or C-terminal extensions that enhance receptor binding affinity and proteolytic stability. The molecular mechanism involves direct binding to bradykinin receptors on sensory neurons and vascular endothelium, triggering calcium mobilization, neuropeptide release, and increased vascular permeability. The structural scaffold should maintain the critical receptor-binding pharmacophore while incorporating amphibian-specific modifications that confer enhanced potency and resistance to degradation compared to mammalian bradykinins, ensuring rapid onset of algesic and inflammatory effects characteristic of bombinid toad defensive secretions."}
{"description": "sp|V9Z548|VMPA1_TITPA Venom metalloproteinase antarease-like TpachMP_A (Fragment) OS=Tityus pachyurus OX=288781 PE=2 SV=1", "sequence": "DDCIVVEYYIVTDSRFTQRFDSDQAVTDYVTVMFTGVQNLIDTLNLDIKVRLLGVTPYHKESEPSFIDDSLLPGHETYVDARKIVRNMKFYFCNHNTGLAKSADIIMLLITRKMGVLDPGDTDISEIAGASSISSVCQRCNNVGACVDNSDYNERADTVAHESVHLLGSPHDGEGPNGLGLPNSPGAANCPDSDGYIMGTRNEQNGKKFSECTKQCVKYLLSLPRASCVYENCSK", "prompt": "Design a venom metalloproteinase protein sequence inspired by scorpion toxins, specifically from the Tityus genus. This protein should belong to the antarease-like metalloproteinase family, characterized by its zinc-dependent proteolytic activity. The protein should feature the conserved HEXXHXXGXXH zinc-binding motif typical of metalloproteinases, along with a methionine turn that contributes to structural stability. The sequence should adopt a compact, multi-domain architecture common to scorpion venom metalloproteinases, potentially including propeptide, metalloproteinase, and disintegrin-like domains. The core function should involve extracellular matrix degradation, potentially targeting components like fibronectin, laminin, or type IV collagen, contributing to local tissue damage and hemorrhage. The structural scaffold should maintain the characteristic metalloproteinase fold with a central twisted beta-sheet surrounded by alpha-helices, stabilized by multiple disulfide bridges that confer stability in the venom environment. The protein should exhibit calcium-binding sites that enhance structural integrity and catalytic efficiency. Given its origin from Tityus pachyurus, the sequence should reflect the evolutionary adaptations of New World scorpion venoms for prey immobilization and defense, with optimal activity at physiological pH and temperature conditions."}
{"description": "sp|F5C0A0|CA1A_CONVR Alpha-conotoxin ViIA OS=Conus virgo OX=89427 PE=1 SV=1", "sequence": "MGMRMMFVVFLLVVFASSVTLDRASYGRYASPVDRASALIAQAILRDCCSNPPCAHNNPDCR", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus virgo, a marine cone snail species. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the α3β2 subtype with high affinity. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements for receptor binding, including key residues in the second loop that mediate specific interactions with the α3 and β2 subunits. The overall structure should exhibit the typical alpha-conotoxin features: small size (12-20 amino acids), high cysteine content, and well-defined secondary structure with beta-hairpin motifs. The toxin should demonstrate paralytic activity through blockade of neurotransmission at relevant synapses, consistent with the hunting strategy of Conus virgo. Ensure the sequence maintains proper folding stability and biological activity while incorporating species-specific sequence variations that distinguish it from other alpha-conotoxins."}
{"description": "sp|F1CGT6|SCX9_CENSU Beta-neurotoxin Css9 OS=Centruroides suffusus OX=6880 PE=1 SV=1", "sequence": "MKLLMLIVALMIIGVQSKDGYPMDHKGCKISCVINNKYCETECVTVLKGKKGYCYFWKLACYCEGLPNWAKVWDRATNKCRA", "prompt": "Design a beta-neurotoxin protein sequence inspired by the venom of Centruroides suffusus, a medically significant scorpion species. This toxin should function as a potent beta-neurotoxin that specifically targets voltage-gated sodium channels (Nav channels) in the peripheral nervous system. The mechanism of action involves binding to site 4 of Nav channels, causing a hyperpolarizing shift in the voltage dependence of activation. This leads to prolonged channel opening and repetitive firing of action potentials, resulting in autonomic nervous system dysfunction and severe envenomation symptoms. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion beta-neurotoxins, with a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in long-chain scorpion toxins) that stabilizes the core globular structure. The protein should contain key functional domains including a conserved 'core' region responsible for channel binding and a variable 'functional' surface that determines target specificity. The sequence should exhibit the typical length and charge distribution of scorpion beta-neurotoxins, with surface-exposed residues optimized for high-affinity interaction with mammalian Nav channels, particularly those expressed in neuronal tissues. The overall architecture should maintain the compact, stable fold necessary for venom stability and target specificity."}
{"description": "sp|P11060|T4G1D_AGEAP Mu-agatoxin-Aa1d OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "ACVGENQQCADWAGPHCCDGYYCTCRYFPKCICRNNN", "prompt": "Generate the amino acid sequence for a mu-agatoxin from the funnel-web spider Agelenopsis aperta. This toxin functions as a potent insecticidal agent that specifically targets voltage-gated sodium channels in insect nervous systems. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The toxin acts by modifying sodium channel gating properties, causing prolonged channel opening and neuronal hyperexcitability that leads to paralysis in insect prey. The sequence should contain the hallmark cysteine framework of ICK toxins and maintain key residues for interaction with insect sodium channel domain II voltage-sensor regions. The structural scaffold should enable precise molecular recognition of insect-specific sodium channel isoforms while maintaining the thermal and proteolytic stability typical of spider venom peptides."}
{"description": "sp|P24336|SIX2_HOTJU Beta-insect depressant toxin BjIT2 OS=Hottentotta judaicus OX=6863 PE=1 SV=1", "sequence": "MKLLLLLVISASMLLECLVNADGYIRKKDGCKVSCIIGNEGCRKECVAHGGSFGYCWTWGLACWCENLPDAVTWKSSTNTCGRKK", "prompt": "Design a beta-insect depressant toxin from the scorpion Hottentotta judaicus that functions as a potent insecticidal agent. This toxin should exhibit the characteristic beta-toxin mechanism of action, specifically targeting voltage-gated sodium channels in insect nervous systems. The protein should function as a gating modifier, binding to receptor site 4 on the voltage sensor domain of insect sodium channels and shifting the voltage dependence of activation toward more negative potentials. This mechanism causes repetitive firing and prolonged action potentials, leading to paralysis and eventual death in insect prey. The structural scaffold should feature the conserved beta-toxin fold with a cysteine-stabilized alpha-beta (CSαβ) motif, characterized by an alpha-helix packed against a three-stranded anti-parallel beta-sheet. The disulfide bridge pattern should follow the typical C1-C4, C2-C5, C3-C6 connectivity that stabilizes this core fold. Key functional residues should be positioned in the conserved 'pharmacophore' regions, particularly in the loops connecting secondary structure elements, to ensure specific interaction with insect sodium channels while maintaining selectivity over mammalian channels. The toxin should be optimized for stability in the venom environment and efficient delivery to the insect neuromuscular system."}
{"description": "sp|B3EWW3|TXC7A_CUPSA Cupiennin-7a OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "DLLTTIKRVKESMKRRT", "prompt": "Design a novel peptide toxin sequence inspired by the biological context and structural characteristics of cupiennin-7a from the wandering spider Cupiennius salei. This peptide should function as a cytolytic antimicrobial peptide with broad-spectrum activity against bacteria, fungi, and potentially cancer cells. The mechanism of action involves membrane disruption via formation of amphipathic alpha-helical structures that insert into lipid bilayers, causing pore formation and cell lysis. The peptide should adopt a predominantly alpha-helical conformation with amphipathic character, featuring a clear segregation of hydrophobic and hydrophilic residues along the helical axis. Key structural elements should include: a length of approximately 25-35 amino acids, a net positive charge (+3 to +6) to facilitate interaction with negatively charged microbial membranes, and a balanced distribution of hydrophobic residues (approximately 40-50%) to enable membrane insertion. The sequence should lack cysteine residues to avoid disulfide bridge formation, maintaining the linear, unstructured nature in aqueous solution that transitions to helical conformation upon membrane contact. The peptide should exhibit selective toxicity toward prokaryotic and cancerous cells over mammalian cells, leveraging differences in membrane composition. Design considerations should optimize for helical propensity, amphipathicity, and charge distribution to maximize antimicrobial potency while minimizing hemolytic activity against human erythrocytes."}
{"description": "sp|F5CPE6|3SX0_MICAT Three-finger toxin MALT0070C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLKCYVGRKPYKLITCPEGSKKCATVPLPTRPLPIFSKGCYTSCPSQYVKCCSTDLCNGSPTSG", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom of Micrurus altirostris, a medically significant coral snake species. This toxin should adopt the characteristic three-finger toxin (3FTx) structural scaffold, consisting of three extended β-stranded loops projecting from a small, globular hydrophobic core stabilized by four conserved disulfide bonds with the canonical cysteine framework I (C-C-CC-C-C). The protein should fold into a compact, flattened β-sandwich structure with the three loops exhibiting conformational flexibility for target recognition. As a component of elapid snake venom, this toxin likely functions as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, potentially causing flaccid paralysis through competitive or allosteric inhibition of acetylcholine binding. The sequence should include conserved residues in the core region for structural integrity while allowing for functional diversification in the loop regions, particularly loops I and II, which often contain key determinants for receptor subtype specificity and binding affinity. The protein should be secreted and stable in the venom milieu, with molecular weight approximately 6-8 kDa and isoelectric point consistent with basic venom components for tissue penetration."}
{"description": "sp|P0DW29|VM2_CROMR Disintegrin morulustatin (Fragment) OS=Crotalus morulus OX=2782198 PE=1 SV=1", "sequence": "LRPGAQCADGLCCDQCRAGEECDCGSPANCCDAATCK", "prompt": "Design a protein sequence for a disintegrin toxin fragment derived from the venom of the Tamaulipan rock rattlesnake (Crotalus morulus). This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the platelet surface. The sequence must adopt the canonical disintegrin fold characterized by a compact, globular structure stabilized by multiple disulfide bonds, typically featuring the RGD (Arg-Gly-Asp) or related integrin-binding motif exposed in a flexible loop region that mediates high-affinity binding to platelet integrin αIIbβ3 (GPIIb/IIIa). The structural scaffold should ensure proper presentation of the integrin-binding motif while maintaining the overall stability and resistance to proteolytic degradation typical of snake venom disintegrins. The protein should exhibit high specificity for its target integrin to effectively prevent platelet aggregation and thrombus formation, mimicking the natural anticoagulant activity of rattlesnake venom disintegrins."}
{"description": "sp|A6MFK8|FAXD2_DEMVE Venom prothrombin activator vestarin-D2 OS=Demansia vestigiata OX=412038 PE=1 SV=1", "sequence": "MAPQLLLCLILTFLWSLPEAESNVFLKSNVANRFLQRTKRANSIFEEIRPGNIERECVEEKCSKEEAREVFQDNEKTEAFWTVYVDGDQCLSNPCHYRGTCKDGIGSYTCTCLPGYEGKNCEHVVVKSCRLFNGNCWHFCKTVQNDTQCSCAEGYRLGVDGFSCIAEGDFSCGRIIKSRNKREASLPDFHFSDDYDAIDENNLVETVQSQSATLLKKSDNPSPDIRIVSGLDCKLGECPWQAVLIDEHGKAFGGGTILSPYFVLTAAHCLNQTKSIAVVVGQVDISRKETRHLLHVDKAYMHSKYVRATYDHDIAILRLRTPIQFSENVVPACLPTADFADEVLMKQDFGIVSGFGRLHERGSTSDILKVIRVPYVDRYTCMLSSNYRITPSMFCAGYGNQPQDACQGDSGGPHITAYGDTHFITGIISWGEGCGRKGKYGIYTKVSNFIPWIKTIMRRNQPSTESSTGRL", "prompt": "Design a venom-derived prothrombin activator protein from the Australian black whip snake (Demansia vestigiata) that functions as a potent coagulopathic toxin. This protein should belong to the vestarin toxin family and exhibit specific enzymatic activity that directly activates prothrombin to thrombin, thereby initiating the coagulation cascade. The protein should feature a serine protease-like domain architecture with the characteristic catalytic triad (His, Asp, Ser) essential for its proteolytic function. It should possess multiple disulfide bridges that stabilize the globular fold typical of snake venom serine proteases, likely following a conserved cysteine pattern that maintains structural integrity. The molecular mechanism involves binding to and cleaving prothrombin at specific activation sites, leading to rapid fibrin formation and potential consumptive coagulopathy in envenomed prey. The structural scaffold should resemble other snake venom prothrombin activators, featuring well-defined substrate-binding pockets and exosite regions that ensure high specificity for its coagulation factor target. This toxin represents a key component in the snake's venom arsenal for prey immobilization through disruption of normal hemostasis."}
{"description": "sp|P0C2L0|A1X1_LOXIN Dermonecrotic toxin LiSicTox-alphaI-1 (Fragment) OS=Loxosceles intermedia OX=58218 PE=1 SV=2", "sequence": "AGNKRPIWIMGAMVNAIKDIXDFVNLGANNIEK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles intermedia. This toxin should function as a phospholipase D enzyme, specifically hydrolyzing sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving the phosphodiester bond to generate ceramide-1-phosphate and choline, leading to inflammatory responses, platelet aggregation, complement activation, and ultimately dermal necrosis. The protein should adopt the conserved TIM barrel fold characteristic of the phospholipase D family, with the catalytic histidine and other essential residues properly positioned in the active site. The structure should include the characteristic HxKxxxD motif for phosphodiesterase activity and maintain the overall globular architecture that enables membrane interaction and substrate recognition. The toxin should be optimized for stability and enzymatic efficiency while preserving the biological activity that causes the characteristic necrotic lesions associated with brown spider envenomation."}
{"description": "sp|P0C1W0|CA12_CONCB Alpha-conotoxin-like Ca1.2 OS=Conus caracteristicus OX=89440 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRASEGRNAAAKDKASDLVALTVRGCCAIRECRLQNAAYCGGIY", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus caracteristicus, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting Cav1.2 (L-type) channels. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework, featuring the conserved CC-C-C cysteine pattern that forms two essential disulfide bridges stabilizing the compact tertiary structure. The core functional domain should include a well-defined pharmacophore region responsible for high-affinity binding to the pore-forming alpha1 subunit of Cav1.2 channels, effectively blocking calcium ion flux and disrupting cellular calcium signaling. The structural architecture should comprise a beta-hairpin motif stabilized by the disulfide connectivity, with key residues in the second and third loops mediating target specificity and binding affinity. The mature toxin should exhibit the typical conotoxin characteristics of small size, high stability, and precise molecular targeting, reflecting the evolutionary optimization of cone snail venoms for rapid neuromuscular disruption and prey immobilization through calcium channel blockade."}
{"description": "sp|Q2YHJ3|PA2A_CRABR Acidic phospholipase A2 Tbo-E6 OS=Craspedocephalus borneensis OX=3147914 PE=1 SV=1", "sequence": "MRTLWILAVLLLGVKGNLLQFEMMINKMAGRSGIRWYSDYGCYCGKGGHGQPQDATDRCCFVHDCCYGKVSGCDPKMAFYKYSSDKNDIVCGGNNPCLKEICECDRAAAICFRDNLSTYDNKYWNVPSETCQVESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Craspedocephalus borneensis, a pit viper species. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Include the essential catalytic residues, particularly the conserved histidine-aspartate dyad required for enzymatic activity. The acidic nature of this toxin should be reflected in its amino acid composition, with a calculated pI below 7.0. The protein should exhibit calcium-dependent catalytic activity and possess the ability to disrupt cell membranes, potentially contributing to local tissue damage, hemolysis, and myotoxicity characteristic of viper venom phospholipases A2. The structural scaffold should maintain the characteristic phospholipase A2 interfacial binding surface for membrane interaction while ensuring proper folding and stability through the conserved disulfide pattern."}
{"description": "sp|F2YLA3|SX14F_RHOJU Putative beta-neurotoxin RjAa14F OS=Rhopalurus junceus OX=419285 PE=3 SV=1", "sequence": "MKILIFIIASFMLIGVECKEGYPTNSEGCKITCLFNDPYCKGKCINLSTQADKKWKGVEGYCNRRDIACYCKNLPENAEVWDPNNNKCVG", "prompt": "Design a beta-neurotoxin protein sequence inspired by the venom of the scorpion Rhopalurus junceus. This toxin should function as a potent neurotoxin targeting voltage-gated ion channels in the peripheral nervous system, characteristic of scorpion beta-neurotoxins. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold, featuring a compact globular domain stabilized by four disulfide bridges with the characteristic C-C-CC-C-C cysteine framework pattern. Key structural elements should include a conserved hydrophobic core, beta-sheet regions, and flexible loops that mediate specific interactions with sodium channel subtype targets. The toxin should exhibit high affinity binding to site 4 of voltage-gated sodium channels, causing prolonged channel opening and subsequent neurotransmitter release disruption leading to neurotoxic effects. The sequence should maintain the evolutionary conserved pharmacophore regions responsible for target recognition while incorporating scorpion beta-neurotoxin signature motifs that confer stability in the venom environment and specific target selectivity."}
{"description": "sp|A0A1L4BJ46|HEMI1_HEMLE Phospholipase A2 hemilipin OS=Hemiscorpius lepturus OX=520031 PE=1 SV=1", "sequence": "MTFLILTILATVTPSLYSHVVQRELRVNFEPLAGQRDSWPVARAAMVTFDARSEKAREFSECRMINSMHELSRELMDSPEHTVKRASKEEMDDLVQRCSGSAEGRSWFIWPDTKWCGPGTDAKNESDLGPLEADKCCRTHDHCDYIGAGETKYGLTNKSFFTKLNCKCEAAFDQCLKESIDRAEGSAKSSMEGLHSFYFNTYSPECYEVKCSRKRDAECTNGIAIWKDSYKS", "prompt": "Generate a phospholipase A2 hemilipin toxin sequence from the scorpion Hemiscorpius lepturus. This toxin should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting inflammatory cascade contributes to the severe dermonecrotic and hemolytic effects characteristic of Hemiscorpius lepturus envenomation. The protein should adopt the canonical phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges, with a conserved calcium-binding loop essential for catalytic activity. Include the characteristic catalytic dyad of histidine and aspartate residues within the active site. The sequence should maintain the structural integrity required for membrane interaction and substrate binding, while preserving the hydrophobic channel that accommodates the phospholipid substrate. This hemilipin should demonstrate preferential activity toward specific phospholipid substrates relevant to its cytotoxic and pro-inflammatory effects in mammalian systems."}
{"description": "sp|A7LCJ2|PA2_URTCR Phospholipase A2 A2-actitoxin-Ucs2a OS=Urticina crassicornis OX=45621 PE=1 SV=1", "sequence": "MKNNIILVILLGISVFVDCLPLNDQEEDKSLNAQESEVSAVQKRDILQFSGMIRCATGRSAWKYFNYGNWCGWGGSGTAVDGVDSCCRSHDWCYKRHDSCYPKIIPYIASTSGSHPSCSITCHSANNRCQRDVCNCDKVAAECFARNTYHPNNKH", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the sea anemone Urticina crassicornis. This toxin should function as a potent A2-actitoxin, exhibiting the characteristic enzymatic activity of hydrolyzing the sn-2 acyl bond of phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the conserved phospholipase A2 structural fold, featuring three long alpha-helices stabilized by multiple disulfide bridges in the characteristic cysteine pattern of sea anemone phospholipase A2 toxins. Include the conserved catalytic histidine-aspartate dyad essential for enzymatic activity. The toxin should demonstrate membrane-targeting properties and calcium-dependent catalytic function, contributing to the venom's cytolytic, hemolytic, and inflammatory effects through disruption of cellular membranes and generation of pro-inflammatory lipid mediators. The structural scaffold should maintain the compact, stable globular architecture typical of cnidarian phospholipase A2 toxins, with surface features optimized for membrane interaction and substrate accessibility while preserving the characteristic N-terminal helix and calcium-binding loop region critical for catalytic efficiency."}
{"description": "sp|Q5Y4X1|TAG2O_AGEOR U2-agatoxin-Ao1o OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKAIISLLLISAMVFSMFEAVPVRRRFTAFEGERGCLPHNRFCNALSGPRCCTGLKCKELSIWDSRCLG", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin, known as ω-agatoxin-Ao1o, functions as a selective calcium channel antagonist that specifically targets insect voltage-gated calcium channels (VGCCs). The toxin should exhibit high affinity binding to P/Q-type calcium channels in insect nervous systems, effectively blocking synaptic transmission and causing rapid paralysis in insect prey. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif common to spider venom toxins, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a stable, compact triple-stranded β-sheet fold. The sequence should include key functional residues for calcium channel binding, particularly in the β-hairpin loops that interact with the channel's pore-forming regions. The toxin should demonstrate high specificity for insect calcium channels over mammalian homologs, making it an evolutionarily optimized insecticidal agent. The overall structure should be small (25-40 residues), highly disulfide-stabilized, and exhibit the typical thermal and proteolytic stability of spider venom peptides."}
{"description": "sp|P0C8U6|CA1S1_CONPL Alpha-conotoxin-like PuSG1.1 OS=Conus pulicarius OX=93154 PE=3 SV=1", "sequence": "MRCLAFLVVTLLLFTATATTGASNGMNAAASGEAPDSISLAVRDDCCPDPACRQNHPELCSTR", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus pulicarius, a marine cone snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements for high-affinity binding to the alpha-delta subunit interface of muscle-type nicotinic receptors, with key residues in the second loop critical for receptor subtype selectivity and potency. Incorporate conserved alpha-conotoxin motifs while introducing sequence variations that maintain the core three-dimensional structure—comprising a helical region and beta-turn elements—essential for biological activity. Ensure the protein is secreted and processed from a precursor, with the mature toxin being a small, stable peptide optimized for rapid neuromuscular blockade."}
{"description": "sp|Q5W958|VSPH_BOTJA Snake venom serine protease homolog HS120 OS=Bothrops jararaca OX=8724 PE=2 SV=1", "sequence": "MVLIRVIANLLILQLSYAQKSSELVIGGDECNINEHPFLAFLYTGWIFCSGTLINKEWVLTVKQCNNRRPMRIYLGMHTRSVPNDDEEIRYPKEMFICPNKKKNDIMLIRLNRPVNNSEHIAPLSLPSNPPSVGSVCRIMGWGTITPSKATYPDVPHCANINLFNYTVCRGAHAGLPVTSRKLCAGVLEGGIDTCSADSGGPLICNGQLQGIVSWRGGSCAQPHKPGLYTKVFDYLPWIQSIIAGSTTATCPP", "prompt": "Design a snake venom serine protease homolog protein from Bothrops jararaca, a medically significant pit viper whose venom contains complex proteolytic enzymes that contribute to hemorrhage, coagulopathy, and tissue damage in envenomation victims. This serine protease homolog functions as a key component in the venom's arsenal, likely exhibiting zymogen-like properties with impaired catalytic activity due to mutations in the catalytic triad, yet retaining structural integrity for potential allosteric modulation or receptor binding functions. The protein should adopt the characteristic chymotrypsin-like fold common to serine proteases, featuring a two-domain architecture with six-stranded beta-barrels in each domain connected by a conserved active site cleft. The structural scaffold must include the conserved disulfide bridge pattern typical of snake venom serine proteases, with cysteine residues forming specific cross-links that stabilize the tertiary structure. The molecular mechanism involves interaction with components of the hemostatic system, potentially binding to coagulation factors, platelet receptors, or endothelial cell surface proteins to disrupt normal physiological processes. The protein should exhibit appropriate surface charge distribution and hydrophobic patches that facilitate target recognition while maintaining the structural stability required for venom delivery and function in the hostile extracellular environment."}
{"description": "sp|P0C6E8|VM3G1_CRAGM Zinc metalloproteinase/disintegrin (Fragment) OS=Craspedocephalus gramineus OX=8767 PE=1 SV=1", "sequence": "KMCGVTQNWESYESTKKASQLNLTPEQQRFPQRYIKLGIFVDHGMYTKYSGNSERITKRVHQMINNINMMCRALNIVTTLSLLEIWSEKDLITVQASAPTTLTLFGAWRETVLLNRTSHDHAQLLTATIFNGNVIGRAPVGGMCDPKRSVAIVRDHNAIVFVVAVTMTHEMGHNLGNHHDEDKCNCNTCIMSKVLSRQPSKYFSECSKDYYQTFLTNHNFQCILNAPLRTDTVSTPVSGNELLEAGEDCDCGSPANPCCDAATCKLRPGAQCGEGLCCDQCRFTSAGTECRAARSECDIAESCAGQSADCPTDDFHRNGQPCLNNHGYCYNGNCPIMFYQCIALFGSNATVGQDGCFDANDIGHKYFHCRKDNEKYIPCAPQDVKCGRLFCTYIYDIDLCRYDDSANGMVAQGTKCADGKVCNSNRQCADVNTAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, originating from the venom of Craspedocephalus gramineus (the bamboo pit viper). This protein should exhibit the dual functionality characteristic of snake venom metalloproteinases (SVMPs). The metalloproteinase domain should contain the conserved zinc-binding motif (HEXXHXXGXXH) and coordinate a catalytic zinc ion to enable proteolytic activity against extracellular matrix components such as collagen, fibronectin, and laminin, contributing to hemorrhage and tissue damage. The disintegrin domain should adopt the characteristic disintegrin fold with the RGD (Arg-Gly-Asp) or related integrin-binding motif exposed on a flexible loop, enabling specific inhibition of platelet aggregation by blocking integrin receptors like αIIbβ3 on platelets. The protein should maintain the typical multi-domain architecture of SVMPs, with appropriate propeptide, metalloproteinase, and disintegrin domains, and exhibit the conserved cysteine pattern that forms disulfide bridges stabilizing both domains. The overall structure should facilitate the proteolytic and anti-platelet activities that synergistically disrupt hemostasis, consistent with the venom's role in prey immobilization and digestion."}
{"description": "sp|P24644|PA21_CALBG Phospholipase A2 1 (Fragment) OS=Calliophis bivirgatus OX=8633 PE=1 SV=1", "sequence": "NLYQFGNMIQCTIPKRLSWSSFVDYGCYCGKGGSGTPV", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of the blue coral snake (Calliophis bivirgatus). This toxin should exhibit the characteristic enzymatic activity of secreted phospholipase A2 enzymes, specifically catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release free fatty acids and lysophospholipids. The protein should adopt the conserved phospholipase A2 structural fold featuring a calcium-binding loop, a conserved catalytic network with histidine and aspartate residues, and multiple disulfide bridges that stabilize the compact globular structure. The sequence should include the characteristic pancreatic loop and elapid loop regions specific to elapid snake venom phospholipases. As a component of coral snake venom, this toxin likely contributes to the neurotoxic and myotoxic effects by disrupting cell membrane integrity, potentially leading to presynaptic neurotoxicity through interference with neurotransmitter release at neuromuscular junctions. The protein should maintain the characteristic interfacial activation mechanism, where catalytic activity is enhanced at lipid-water interfaces. The structural scaffold should ensure proper orientation of the catalytic residues while maintaining the hydrophobic channel that accommodates the phospholipid substrate."}
{"description": "sp|W4VSH9|VKT1_TRILK Kunitz-type U19-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=2", "sequence": "MNFELIYVSSLLLGICLANQADVVPSDCNLPADAGMCYAYFPMFFYDASSRKCLNFIYGGCGGNANRFWSEAECMEKCGGGGGGGGSSDGSQKTAKMLNLDLGDICSLEKKVGPCKAHMPRYYFNRETGLCEEFIYGGCSGNHNNFQTKEQCESFCAPGNSPRPEEETRKRTKQSY", "prompt": "Design a novel animal toxin protein sequence that embodies the biological and structural characteristics of a Kunitz-type venom peptide from the Australian trapdoor spider Trittame loki. This toxin should function as a potent neurotoxin, likely targeting voltage-gated potassium channels (Kv channels) based on the 'U19-barytoxin' classification, which implies paralytic activity through disruption of neuronal excitability. The protein must adopt the canonical Kunitz-type inhibitor fold, characterized by a compact, disulfide-stabilized beta-sandwich structure with alpha-helical elements. Incorporate the conserved Kunitz-type cysteine framework with three disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity) to ensure proper folding and stability. Include key functional residues typical of Kunitz-type neurotoxins, such as a reactive site loop for protease inhibition potential and surface-exposed residues for specific ion channel interaction. The sequence should reflect the evolutionary adaptation of spider venoms for rapid prey immobilization, with high affinity for neuronal Kv channels leading to synaptic blockade and paralysis. Ensure the structural scaffold maintains the characteristic Kunitz domain topology while optimizing surface charge distribution and hydrophobic patches for target recognition and membrane proximity."}
{"description": "sp|F5CPE3|3SX5_MICAT Three-finger toxin MALT0065C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MKTLLLTLVVVTILCLDFGHTVTCHKTDVFTKTCISPICYEKITSAFIIERGCGCPETSRKVKVRCCMTDKCNR", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom composition of the Uruguayan coral snake, Micrurus altirostris. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three extended β-stranded loops projecting from a central hydrophobic core stabilized by four conserved disulfide bonds with the canonical cysteine framework I (C-C-CC-C-C). The protein should exhibit the typical compact globular architecture of short-chain neurotoxins, approximately 60-70 amino acids in length, with the core stabilized by the conserved disulfide connectivity pattern (Cys1-Cys3, Cys2-Cys4). The sequence should contain key functional motifs for postsynaptic neurotoxicity, including conserved residues in loop II that mediate high-affinity binding to nicotinic acetylcholine receptors at the neuromuscular junction. The toxin should function as a competitive antagonist, blocking acetylcholine binding and inducing flaccid paralysis through inhibition of neurotransmission. Incorporate structural features that ensure proper folding into the three-finger β-sandwich motif while maintaining the phylogenetic signatures characteristic of elapid snake venom toxins. The designed sequence should exhibit optimal molecular surface properties for receptor interaction while preserving the structural integrity of the three-loop architecture essential for target recognition and toxic activity."}
{"description": "sp|D2YW40|SLED_CALRH Snaclec rhodocetin subunit delta OS=Calloselasma rhodostoma OX=8717 PE=1 SV=2", "sequence": "CPLHWSSYNGYCYRVFSELKTWEDAESFCYAQHKGSRLASIHSREEEAFVGKLASQTLKYTSMWLGLNNPWKECKWEWSDDAKLDYKVWLRRPYCAVMVVKTDRIFWFNRGCEKTVSFVCKFYS", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor. This toxin originates from the Malayan pit viper (Calloselasma rhodostoma), where it serves as a key component of the venom's hemorrhagic arsenal by disrupting normal hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The molecular architecture should include the signature carbohydrate recognition domain (CRD) but function through protein-protein interactions rather than carbohydrate binding. The primary molecular target is the platelet membrane glycoprotein complex GPIb-IX-V, with specific binding to the GPIbα subunit that competitively inhibits von Willebrand factor binding, thereby preventing platelet adhesion and aggregation at vascular injury sites. The structural scaffold should maintain the β-sheet-rich core typical of CTLD proteins, with surface loops optimized for high-affinity interaction with the leucine-rich repeat domain of GPIbα. The protein should exhibit the heterodimeric assembly characteristic of snaclecs, forming a functional complex with its partner subunit to create the complete rhodocetin toxin that effectively blocks arterial thrombosis through selective interference with the initial stages of platelet activation."}
{"description": "sp|P0C551|PA2A_BUNFA Acidic phospholipase A2 KBf-grIB (Fragment) OS=Bungarus fasciatus OX=8613 PE=2 SV=1", "sequence": "AVCVSLLGASIIPPQPLDLLQFNEMIECTIPGSFPLLDYMDYGCYCGTGGRGTPVDALDRCCKEHDDCYAQIKENPKCSSLLNVPYVKQYSYTCSEGNLTCSADNDECAAFICNCDRTAALCFAEVPYKRRNFRIDYKSRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from the venom of the banded krait (Bungarus fasciatus). This enzyme should function as a potent neurotoxin that targets presynaptic nerve terminals, causing irreversible inhibition of acetylcholine release and leading to progressive neuromuscular blockade. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, initiating inflammatory cascades and membrane disruption. Structurally, it should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact, multi-looped globular structure. The sequence should feature an acidic pI profile with abundant aspartate and glutamate residues, contributing to its enhanced membrane penetration and target specificity. The toxin should demonstrate high affinity for neuronal membranes while maintaining the characteristic interfacial activation mechanism common to venom phospholipases A2."}
{"description": "sp|Q9YGI1|3NO23_NAJAT Probable weak neurotoxin NNAM3 OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCLICPEKYCNKVHTCLNGEKICFKKYDQRKLLGKGYIRGCADTCPKLQNRDVIFCCSTDKCNL", "prompt": "Design a protein sequence for a probable weak neurotoxin from the Chinese cobra (Naja atra), a member of the three-finger toxin (3FTx) superfamily. This toxin should exhibit weak neurotoxic activity characteristic of non-conventional neurotoxins in elapid venoms. The protein should adopt the conserved three-finger β-structural fold stabilized by four conserved disulfide bridges with the characteristic cysteine framework C-C-C-C-C-C-C-C, forming a compact, rigid structure with three extended loops projecting from a central core. As a weak neurotoxin, it likely functions as a postsynaptic neurotoxin that binds with lower affinity to nicotinic acetylcholine receptors at the neuromuscular junction, causing partial blockade of neurotransmission rather than complete paralysis. The sequence should maintain the structural integrity of the three-finger motif while incorporating specific residues that confer reduced receptor binding affinity compared to potent α-neurotoxins. The protein should be water-soluble and stable, reflecting its role in the venom arsenal where it may serve as a supplementary neurotoxic component or have evolved specialized targeting properties distinct from major neurotoxins."}
{"description": "sp|Q9PUH0|PA2AE_AUSSU Acidic phospholipase A2 S8-51 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGAASIPPQPLNLVQFSYLIQCANHGSRATWHYTDYGCYCGSGGSGTPVDELDRCCQTHDNCYGEAEKKGCYPKMSAYDYYCGGDGPYCRNIRKECQRFVCDCDAIAAKCFARAPYNDANWDIDTETRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This enzyme should function as a potent neurotoxin and myotoxin, characteristic of group IA phospholipases A2 from elapid snake venoms. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, presynaptic neurotoxicity, and muscle damage. The sequence must include the conserved catalytic dyad (histidine and aspartate residues) within the Ca²⁺-binding loop and the interfacial binding surface for membrane association. Incorporate the characteristic phospholipase A2 structural fold with three long alpha-helices stabilized by seven conserved disulfide bridges, ensuring the protein's acidic pI through an appropriate distribution of aspartate and glutamate residues. The toxin should demonstrate both enzymatic activity and potential receptor-binding capabilities for enhanced toxicity, consistent with the dual-function nature of snake venom phospholipases A2 in prey immobilization."}
{"description": "sp|Q9YGI8|3SO3_BUNMU Short neurotoxin homolog NTL4 OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIICLDLGYTRKCLIKYSQANESSKTCPSGQLLCLKKWEIGNPSGKEVKRGCVATCPKPKKNEIIQCCAKDKCNK", "prompt": "Design a protein sequence for a short neurotoxin from the many-banded krait (Bungarus multicinctus) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and antagonize muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the cysteine framework I-IV, II-V, III-VI. The structural scaffold should feature the typical globular shape with loop I contributing to receptor binding specificity. The toxin should exhibit high affinity binding to the α-δ and α-γ interfaces of the muscle nAChR, competitively inhibiting acetylcholine binding and blocking neuromuscular transmission. The sequence should maintain the conserved structural motifs of short neurotoxins while incorporating the specific pharmacological profile characteristic of Bungarus multicinctus venom components that cause respiratory paralysis through selective neuromuscular blockade."}
{"description": "sp|Q3C2C1|PA22_ACAPL Phospholipase A2 AP-PLA2-II OS=Acanthaster planci OX=133434 PE=1 SV=1", "sequence": "MKTFLILAMAVALAKAQSTDEITNLVQFGKLVMCLGNIGYTEGLEYDGYGCFCGKGGKGTPVDATDRCCEVHDNCYGQAVEEGKCWSVETYGTTYWYDQSTSGSCSIRCWEEGDYNSLVPRKACKAAICECDRKAAQCFADNRPTFNRKYLNYAKDTC", "prompt": "Design a phospholipase A2 toxin from the venom of the crown-of-thorns starfish (Acanthaster planci) that functions as a potent membrane-disrupting enzyme. This toxin should exhibit the characteristic catalytic activity of hydrolyzing the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can subsequently trigger inflammatory cascades. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges in the characteristic pattern of group II phospholipase A2 enzymes. Include the essential catalytic triad residues (histidine, aspartate, calcium-binding loop) required for enzymatic activity. The structure should contain a hydrophobic channel for substrate access to the active site and maintain the characteristic pancreatic loop region. This toxin should demonstrate membrane-binding capability through interfacial activation and exhibit the typical thermal stability and resistance to proteolytic degradation common to venom phospholipase A2 enzymes. The designed sequence should reflect the evolutionary adaptation for prey immobilization and digestion in echinoderm venom systems."}
{"description": "sp|Q5Y4Y0|TAG2F_AGEOR U2-agatoxin-Ao1f OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRAIISLFLISAMVFSMIQAVPEEKGLQLSEDERGGCLPHNRFCNALSGPRCCSRLKCKELSIWDSRCLG", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U2-agatoxin-Ao1f, belongs to the ω-agatoxin family and functions as a selective inhibitor of voltage-gated calcium channels, specifically targeting P/Q-type (Cav2.1) channels in the mammalian central nervous system. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements include a solvent-exposed beta-hairpin loop that mediates high-affinity binding to the channel's pore-forming α1 subunit, disrupting synaptic transmission by blocking calcium influx and inhibiting neurotransmitter release at presynaptic terminals. The sequence should contain the canonical cysteine framework of spider neurotoxins and display the characteristic pharmacological profile of ω-agatoxins, with nanomolar affinity for P/Q-type channels and minimal activity against other calcium channel subtypes."}
{"description": "sp|F5CPE4|3S166_MICAT Three-finger toxin MALT0066C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGHTLICYNYETPLDKTTECCGNGVTTCFAKSWRDHRGLRTDRGCGCPNVKPGVTINCCKTDRCNG", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom composition of Micrurus altirostris, a medically significant coral snake species. This toxin should adopt the characteristic three-finger toxin (3FTx) structural scaffold, featuring three extended β-stranded loops projecting from a small, globular core stabilized by four conserved disulfide bonds with the canonical C1-C3, C2-C4, C5-C6, and C7-C8 connectivity pattern. The protein should fold into a compact, stable structure with the three β-hairpin 'fingers' arranged in a flat, triangular configuration. As a component of elapid snake venom, this toxin likely functions as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, potentially causing flaccid paralysis through competitive antagonism of acetylcholine binding. The sequence should include conserved residues in the central loop that mediate receptor interaction, while maintaining the structural integrity characteristic of this toxin family. The resulting protein should exhibit high specificity for its molecular target while preserving the thermal stability and protease resistance typical of three-finger toxins."}
{"description": "sp|P86110|KKX25_OPICY Potassium channel toxin kappa-KTx 2.5 OS=Opisthacanthus cayaporum OX=573324 PE=1 SV=1", "sequence": "MESSRKSYVLMLFLAFVIMNVCSVSGEPKDGEIAGFEMEEARYDACVNACLEHHPNVRECEEACKNPVPP", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx 2.5 from the venom of the scorpion Opisthacanthus cayaporum. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion potassium channel toxins, featuring a conserved structural scaffold with an alpha-helix stabilized against an anti-parallel beta-sheet by disulfide bridges. The sequence should contain the appropriate cysteine framework (typically C-C-CC-C-C pattern) that forms three disulfide bonds essential for structural stability and functional activity. The molecular mechanism involves binding to the pore region of potassium channels, physically occluding the ion conduction pathway and preventing potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The toxin should exhibit the compact, globular architecture typical of scorpion venom peptides, with key functional residues positioned to interact with specific channel domains while maintaining the overall structural integrity required for target recognition and binding affinity."}
{"description": "sp|D5J9S0|VNP31_BUNFL Natriuretic peptide BF131 OS=Bungarus flaviceps flaviceps OX=8615 PE=2 SV=1", "sequence": "MVGPSRLAGGGLLLLLLLALLPLALDGKPAPPPQALPKDPAAASAAERIMRALLPDSKSSRPATDRMVHPEHQAGGGDTRRLQEPAKKGLLISCFDRRIDRISHTSDMGCRHRKDPPRAPPAAPSAAPLAVTWLIRDLRADSKQSRAA", "prompt": "Design a natriuretic peptide toxin derived from the venom of Bungarus flaviceps flaviceps, the red-headed krait. This toxin functions as a potent vasoactive peptide that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) with high affinity. The peptide should exhibit the characteristic structural scaffold of venom natriuretic peptides, featuring a conserved 17-residue disulfide-bonded ring structure formed by two cysteine residues in a C-C pattern. The core functional domain should include the signature -CGFG- motif critical for receptor binding and activation. The mature peptide should demonstrate potent hypotensive effects through activation of the particulate guanylyl cyclase pathway, leading to increased cyclic GMP production, vasodilation, natriuresis, and diuresis. The structural fold should maintain the compact, stable conformation typical of snake venom natriuretic peptides, with the disulfide bridge providing structural rigidity essential for receptor recognition and biological activity. The peptide should exhibit selective binding to NPR-A over other natriuretic peptide receptors, contributing to the venom's overall hypotensive strategy during envenomation."}
{"description": "sp|Q5W960|VSP12_BOTJA Snake venom serine protease HS112 OS=Bothrops jararaca OX=8724 PE=2 SV=1", "sequence": "MVLIRVIANLLILQLSYAQKSSELVIGGDECDINEHRFLAFLYAGGYYCGGTLINQEWVLSAAHCDKRIIRIYLGMHTRSVPNDDEEIRYPKEKFICPNKKKNVITHKDIMLIRLNRPVKNSEHIAPLSLPSNPPSVGSVCRIMGWGSITTPDETSPNVPHCANINLFNNTVCREAYNGLPAKTLCAGVLQGGIDTCGGDSGGPLICNGQFQGILSWGGIPCAQPRKPAFYTKVFDYLPWIQSIIAGNKTATCPP", "prompt": "Design a snake venom serine protease from the pit viper Bothrops jararaca that functions as a key hemostatic toxin. This enzyme should exhibit trypsin-like or thrombin-like protease activity, targeting specific coagulation cascade components such as fibrinogen, factor X, or plasminogen to induce coagulopathy, hemorrhage, or thrombosis. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and possess the canonical structural features including two β-barrel domains connected by a substrate-binding cleft. Incorporate appropriate disulfide bridges to stabilize the tertiary structure, typically 4-6 conserved disulfide bonds following patterns like Cys30-Cys165, Cys45-Cys135, Cys180-Cys205 in chymotrypsin numbering. Include an activation peptide cleavage site for zymogen processing and substrate specificity determinants in the S1 pocket and extended binding sites. The venom serine protease should facilitate the snake's predatory efficiency by disrupting prey homeostasis through precise proteolytic cleavage of hemostatic system components."}
{"description": "sp|P0C1W1|CA1A_CONMA Alpha-conotoxin-like MIA OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "DGRCCHPACAKHFNC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of the marine cone snail Conus magus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein should adopt the characteristic globular disulfide-rich scaffold of alpha-conotoxins, featuring a conserved cysteine framework (CC-C-C) with two disulfide bridges that stabilize a compact, triple-stranded beta-sheet fold. Key structural elements must include: (1) a well-defined alpha-helix in the N-terminal region, (2) a central beta-hairpin motif critical for receptor binding, and (3) a C-terminal loop that contributes to target specificity. The molecular mechanism should involve high-affinity binding to the orthosteric site of muscle-type nicotinic acetylcholine receptors, competitively inhibiting acetylcholine binding and blocking ion channel activation. The sequence must encode appropriate pharmacophore residues for receptor interaction, including conserved hydrophobic patches and polar side chains that form hydrogen bonds with receptor loop C. Ensure the toxin exhibits the typical small size (12-20 amino acids) and high stability characteristic of conotoxins, with the disulfide connectivity (Cys1-Cys3, Cys2-Cys4) essential for proper folding and biological activity. The designed protein should represent a specialized venom component optimized for rapid neuromuscular blockade in the cone snail's hunting strategy."}
{"description": "sp|A0A1P8NVS9|COW_CONEA Contryphan-Eb OS=Conus ebraeus OX=89425 PE=3 SV=1", "sequence": "MGKLTILVLVAAVLLSTQVMVQGDADQPADRDAVPRDDNPGGTSGKLMNVLIRSGCPWHPWCG", "prompt": "Design a novel contryphan peptide from the venom of the Hebrew cone snail, Conus ebraeus, that functions as a potent neurotoxin targeting voltage-gated calcium channels. This peptide should adopt the characteristic contryphan structural scaffold featuring a highly constrained cyclic backbone stabilized by a single disulfide bridge between two conserved cysteine residues, forming a tight loop that confers exceptional proteolytic stability. The sequence must include the signature post-translational modification of tryptophan bromination at a conserved position, which is critical for enhancing receptor binding affinity and selectivity. The peptide should exhibit high specificity for neuronal calcium channel subtypes, modulating synaptic transmission through precise interaction with channel pore domains. Incorporate key conserved residues that maintain the compact globular fold typical of contryphans, with surface-exposed pharmacophore residues optimized for target engagement while preserving the peptide's remarkable resistance to enzymatic degradation. The final sequence should reflect the evolutionary optimization of cone snail venom components for rapid prey immobilization through disruption of neuromuscular signaling pathways."}
{"description": "sp|P58811|CA1A_CONTU Rho-conotoxin TIA OS=Conus tulipa OX=6495 PE=1 SV=2", "sequence": "MFTVFLLVVLATTGVSFTLDRASDGGNAVAKKSDVTARFNWRCCLIPACRRNHKKFCG", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications: This protein is a rho-conotoxin derived from the marine cone snail Conus tulipa, a predatory species that employs venom for prey capture and defense. As a rho-conotoxin, it functions as a selective antagonist of alpha1-adrenoceptors, specifically targeting the alpha1A subtype, which are G-protein coupled receptors involved in smooth muscle contraction and neurotransmission. The toxin likely operates by binding to the extracellular domain of the alpha1A-adrenoceptor, inhibiting norepinephrine signaling and leading to physiological effects such as hypotension or paralysis in prey. Structurally, it belongs to the conotoxin superfamily and is expected to adopt a compact, disulfide-rich fold stabilized by a specific cysteine framework, typically involving four cysteine residues forming two disulfide bridges in a C-C-CC pattern (Framework V). The mature peptide is anticipated to be short (approximately 20-30 amino acids), with a globular conformation that includes defined loops critical for receptor interaction. Key conserved residues may include hydrophobic or polar amino acids in the inter-cysteine regions that mediate target specificity. Ensure the sequence reflects high stability, target selectivity, and the functional attributes of rho-conotoxins, without incorporating any database identifiers."}
{"description": "sp|P0C6R9|VM3A_BOTAL Zinc metalloproteinase-disintegrin-like alternagin (Fragment) OS=Bothrops alternatus OX=64174 PE=1 SV=2", "sequence": "IISPPVCGNELLEVGEECDCGTPENCQNXCCDAATCKLKSGSQCGHXDCCEQCKFTKSGTECRASMSECDPAEHCTGQSXXCXXDVFHKNGQPCLDNYGYCYNGNCPIMYHAQCYALFGADVYEAEDSCFKDNQKGNYYGYCRKENXXXXXCXXXDVKCGRLYCKDNSPKQNNPCKMFYSNDDEHKGNVLPGTKCE", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin derived from Bothrops alternatus, a medically important pit viper species whose venom contains potent hemorrhagic and proteolytic components that facilitate prey immobilization and tissue degradation. This toxin functions as a zinc-dependent metalloproteinase that targets and cleaves extracellular matrix proteins, particularly basement membrane components like collagen and fibronectin, while the disintegrin-like domain mediates inhibition of platelet aggregation by blocking integrin receptors on platelet surfaces. The protein should contain a conserved zinc-binding motif (HEXXHXXGXXH) within the metalloproteinase domain that coordinates catalytic zinc ion, along with a disintegrin-like domain characterized by the canonical integrin-binding RGD motif or related sequences that interact with αIIbβ3 and other integrins. The structural scaffold should feature multiple disulfide bridges stabilizing both domains, with the metalloproteinase domain adopting a metzincin-like fold characterized by a central five-stranded β-sheet and surrounding α-helices, and the disintegrin-like domain forming a compact, disulfide-rich globular structure. The mature toxin should exhibit calcium-dependent conformational stability and optimal activity at physiological pH, with surface loops and secondary structure elements positioned to facilitate substrate recognition and proteolytic cleavage while maintaining integrin-binding capability for dual hemorrhagic and anti-platelet functions."}
{"description": "sp|P84745|VVP2_BOTJR 1095.6 Da venom vasodilator peptide OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "PPPPPGPPPNP", "prompt": "Design a venom-derived vasodilator peptide from the pit viper Bothrops jararacussu that functions as a potent hypotensive agent. This small peptide (approximately 11 amino acids, ~1.1 kDa) should exhibit the characteristic structural features of snake venom vasoactive peptides, likely adopting a compact, disulfide-stabilized fold. The peptide should function through bradykinin-potentiating activity or angiotensin-converting enzyme (ACE) inhibition, leading to vasodilation and blood pressure reduction. It should contain the conserved cysteine framework typical of these peptides, with specific disulfide connectivity that stabilizes the bioactive conformation. The structural scaffold should enable high-affinity interaction with key regulatory enzymes in the renin-angiotensin system or bradykinin metabolism pathways. The peptide must demonstrate thermal and proteolytic stability appropriate for venom components, with surface features optimized for target recognition while maintaining the compact molecular architecture characteristic of snake venom peptides."}
{"description": "sp|P10459|3S1B_LATLA Short neurotoxin B OS=Laticauda laticaudata OX=8630 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYTRRCFNHPSSQPQTNKSCPPGENSCYNKQWRDHRGTITERGCGCPQVKSGIKLTCCQSDDCNN", "prompt": "Design a short neurotoxin protein sequence that mimics the biological activity and structural characteristics of toxins found in the venom of the banded sea krait, Laticauda laticaudata. This toxin should function as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to snake neurotoxins, featuring three extended loops projecting from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The sequence should include key functional residues in the central loop that mediate high-affinity binding to the alpha-subunit of muscle-type nicotinic receptors, preventing acetylcholine from binding and disrupting neuromuscular transmission. The toxin should exhibit the compact, stable structure typical of short-chain neurotoxins, with the disulfide network providing exceptional proteolytic stability and the hydrophobic core ensuring proper folding. The molecular mechanism should involve competitive antagonism at the receptor's ligand-binding site, resulting in rapid onset of paralysis, making it evolutionarily optimized for prey immobilization in marine hunting environments."}
{"description": "sp|A8CG90|PA2B2_DABRR Basic phospholipase A2 Drk-b2 OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGNLLQFGRMIFRMTAKNPLSSYSNYGCYCGWGGKGKPQDATDRCCFVHDCCYEKVNDCNPKTATYSYSFENGGIVCGDRDPCKRAVCECDRVAATCFRDNLNTYDKKYRKYPPSQCTGTEQC", "prompt": "Generate the amino acid sequence for a basic phospholipase A2 toxin from Russell's viper (Daboia russelii) venom. This protein should function as a potent enzymatic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The toxin should exhibit calcium-dependent catalytic activity characteristic of Group II phospholipase A2 enzymes, with a conserved catalytic dyad of histidine and aspartate residues. The structure should feature the characteristic phospholipase A2 fold comprising three alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the sequence XCGXGG. The protein should contain the conserved disulfide bond pattern typical of snake venom phospholipase A2 enzymes (6-7 conserved disulfide bridges) that stabilizes the compact globular structure. As a basic isoform, this phospholipase A2 likely contributes to the complex pathophysiology of Russell's viper envenomation, potentially exhibiting presynaptic neurotoxicity, myotoxicity, anticoagulant effects, or inflammatory activity through the generation of pro-inflammatory lipid mediators. The sequence should reflect the characteristic features of viperid phospholipase A2 toxins while maintaining the specific biochemical properties of a basic isoform that would be secreted in snake venom."}
{"description": "sp|F5C3U4|CA18_CONMR Alpha-conotoxin Mr1.7a OS=Conus marmoreus OX=42752 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSNRVLDPAFRRRNAAAKASDLIALNARRPECCTHPACHVSNPELCG", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of the marine cone snail Conus marmoreus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular fold stabilized by two disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the conserved CC-C-C framework. Incorporate key structural motifs including a beta-hairpin loop that mediates receptor binding, conserved hydrophobic core residues for structural stability, and specific loop regions that determine receptor subtype selectivity. The sequence should include appropriate post-translational modifications typical of conotoxins, such as C-terminal amidation and potential hydroxylation of proline residues. Ensure the peptide exhibits high affinity binding to the alpha-delta interface of muscle-type nicotinic receptors while maintaining the compact, stable three-dimensional structure essential for venom efficacy in the predator-prey relationship of cone snails."}
{"description": "sp|Q9PUH7|PA2A7_AUSSU Acidic phospholipase A2 S15-109 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASDIPPQPLNLYQFGNMIQCANHGRRPTQHYTDYGCYCGKGGSGTPVDELDRCCKTHDDCYTEAGKKGCYPKLTLYSWKCGSDGPQCDDSETGCQRFVCDCDATAAKCFAKAPYNKENYNIKTPCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 acyl bond of glycerophospholipids in biological membranes. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network involving a histidine-aspartate dyad. Include the essential structural elements: a conserved N-terminal helix, a central β-wing region, and the characteristic elapid loop. The sequence should maintain the typical disulfide bridge pattern (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98) that stabilizes the globular structure. As an acidic isoform, the protein should have a calculated pI below 7.0 and contain surface-exposed acidic residues that may modulate its membrane interaction properties and potential presynaptic neurotoxic effects through disruption of neurotransmitter release at neuromuscular junctions."}
{"description": "sp|X5I9Z2|CAI15_CONGE Alpha-conotoxin G1.5 OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVALATTVVSFTSDRASDRRNAAVKAFDLISSTVKKGCCSHPACSGNNPEYCRQGR", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of the geography cone snail, Conus geographus, a highly venomous marine predator known for its potent neurotoxic venom that rapidly immobilizes fish prey through neuromuscular blockade. This toxin should function as a selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that constrain the peptide into a compact, stable fold. The sequence should contain the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that form the receptor binding interface, particularly targeting the orthosteric binding site at the interface of nAChR subunits. The toxin should exhibit high affinity binding through specific interactions with conserved receptor residues, leading to competitive inhibition of acetylcholine signaling. The overall structure should be small (typically 12-20 amino acids), cysteine-rich, and maintain the characteristic pharmacophore features that enable selective neuronal nAChR blockade while ensuring proper oxidative folding into the native bioactive conformation."}
{"description": "sp|P0C8V0|CA16_CONPL Alpha-conotoxin-like Pu1.6 OS=Conus pulicarius OX=93154 PE=3 SV=1", "sequence": "MFTVFLLVVLVTTVVFSTSDHRPASNHENRRASKRISEMTWEECCTNPVCRQHYMHYC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the marine cone snail Conus pulicarius, a species known for producing highly specific neurotoxic peptides that target ion channels and receptors in the nervous system. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the hallmark cysteine framework (CC-C-C) with appropriate inter-cysteine loop regions that confer target specificity. Key structural elements should include: a short N-terminal loop preceding the first cysteine, a well-defined central alpha-helical region between the second and third cysteines, and C-terminal residues that contribute to receptor binding affinity. The molecular mechanism involves competitive inhibition at the orthosteric binding site of nAChRs, preventing acetylcholine binding and thereby blocking excitatory neurotransmission. The final sequence should exhibit high stability, solubility, and the characteristic pharmacophore residues necessary for specific receptor subtype recognition while maintaining the compact, disulfide-constrained fold typical of conotoxins from the Conus pulicarius venom arsenal."}
{"description": "sp|C5J893|KKX26_OPICY Potassium channel toxin kappa-KTx 2.6 OS=Opisthacanthus cayaporum OX=573324 PE=2 SV=1", "sequence": "MKTSKMICAFLLVLVVGTFNDISGAYGEYVEDQHSFKIERRFPPCVEVCVQHTGNVKECEAACGE", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Opisthacanthus cayaporum. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion κ-KTx toxins, featuring a compact triple-stranded antiparallel beta-sheet stabilized by a specific disulfide bond pattern. The cysteine framework should follow the C1-X3-5-C2-X3-5-C3-X8-14-C4-X1-2-C5-X3-6-C6 pattern, forming three disulfide bridges (C1-C4, C2-C5, C3-C6) that create the inhibitor cystine knot (ICK) motif. Key functional residues should be positioned within the beta-hairpin loops to mediate specific interactions with the potassium channel pore region, including conserved basic residues that electrostatically guide binding to the channel vestibule and hydrophobic patches that enhance binding affinity. The overall structure should be small (approximately 30-40 residues), highly stable, and exhibit the characteristic molecular surface topology required for selective Kv channel blockade."}
{"description": "sp|Q3C2C2|PA21_ACAPL Phospholipase A2 AP-PLA2-I OS=Acanthaster planci OX=133434 PE=1 SV=1", "sequence": "MNFLVVIVTTVSLAGAASAGEIQNLYQFGKMVMCLGNLNVLEGLEYNGYGCYCGRGGKGTPLDDTDRCCKQHDECYERATDEMGCWSIETYATTYDYTKSKVSGKCTIKCKLESDYSRFTIRKKCKAFICECDRIGAQCFADKRSTFNRSLISYTKDKC", "prompt": "Design a phospholipase A2 toxin protein sequence that captures the venomous essence of the crown-of-thorns starfish (Acanthaster planci). This enzyme should function as a potent membrane-disrupting toxin, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid as a precursor for inflammatory mediators. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of disulfide bridges, with a conserved calcium-binding loop (YGKYCG) essential for catalytic activity. Include the canonical catalytic dyad of histidine and aspartate residues within the active site pocket, which facilitates the nucleophilic attack on phospholipid substrates. The sequence should maintain the hydrophobic channel that accommodates the lipid substrate and the interfacial binding surface that targets cellular membranes. This toxin likely contributes to the starfish's predatory and defensive capabilities by inducing cell membrane damage, hemolysis, and triggering inflammatory cascades in envenomed organisms."}
{"description": "sp|A8QL49|VM3_BUNMU Zinc metalloproteinase-disintegrin-like BmMP OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MIQALLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKVPLLPKGGVQNPQPKTKYEDTVQYEFEVNGEPVVLHLERNKGLFSEDYTEAHYAPDGREITTRPPVQDHCYYHGYIQNEADSSAAISACDGLKGHFKHQGETYFIEPLKLSDSEAHAIYKDENVEEENETPKICGLTETTWESDEPIRNASLLIYTPEQNRYLKVKKYIEFYVAVDNRMYRHYKRNKPIIKRRVYELVNILNTILRRLNFHIALIGLEIWSKRDKINVQSDVKATLKSFGKWREKKLLPRKRNDNAQLLTRIDFNGNTVGLAALGSLCSVKYSVAVIQDYSKRTSMVASTMAHEMGHNLGINHDRASCTSCGSNKCIMATKRTKPASRFSSCSVREHQRYLLRDRPQCILNKPLITDIVAPAICGNYFVEVGEECDCGSPRDCRSACCNAATCKLKHEAQCDSGECCGKCKFKKVGAKCRAAKDDCDLPERCTGRSAECPTDIFRRNGLPCQNKQGYCYNGKCPTLTNQCIALMGPNVKVSRDSCFTLNQRGKGCGYCRMQNGAKIPCAAKDIKCGKLFCKKRNSGVCNCLILPDDPNYGMVETGTKCGDGMVCSDRKCVKLQTVY", "prompt": "Design a venom metalloproteinase-disintegrin-like protein from the many-banded krait (Bungarus multicinctus) that functions as a potent hemorrhagic toxin. This protein should feature a multi-domain architecture with a zinc-dependent metalloproteinase domain containing the conserved HEXXHXXGXXH zinc-binding motif responsible for proteolytic cleavage of extracellular matrix components like collagen, fibronectin, and laminin. The disintegrin-like domain should adopt the characteristic disintegrin fold with the RGD or related integrin-binding motif that inhibits platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors. The protein should exhibit the typical reprolysin family structural organization, with the metalloproteinase domain facilitating tissue damage and hemorrhage through basement membrane degradation, while the disintegrin domain contributes to anticoagulant effects by disrupting platelet function. The mature protein should demonstrate calcium-dependent stability and optimal activity at physiological pH, with the metalloproteinase domain showing specificity for matrix metalloproteinase substrates. The structural scaffold should maintain the characteristic cysteine pattern that stabilizes both domains, with the metalloproteinase domain folding into the classic metzincin topology and the disintegrin domain adopting the disintegrin loop conformation essential for integrin recognition."}
{"description": "sp|S0F1M6|TOK1G_ATRRO Omega/kappa-hexatoxin-Ar1g OS=Atrax robustus OX=6903 PE=3 SV=1", "sequence": "MNTATGFIVLLVLATVLGGIEAGESHMRKDAMGRVRRQYCVPVDQPCSLNTQPCCDDATCTQELNENDNTVYYCRA", "prompt": "Design a venom-derived peptide toxin from the Sydney funnel-web spider (Atrax robustus) that functions as a dual omega/kappa-hexatoxin. This toxin should potently inhibit voltage-gated calcium channels (omega-toxin activity) while simultaneously blocking potassium channels (kappa-toxin activity), contributing to the spider's potent neurotoxic venom arsenal. The peptide should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). Key structural elements should include a solvent-exposed beta-hairpin loop responsible for channel interaction, with specific residues forming a functional surface that binds to channel pore regions or voltage-sensing domains. The toxin should exhibit high affinity for both Cav and Kv channel subtypes, disrupting neuronal excitability and synaptic transmission through dual ion channel blockade. The sequence must maintain the characteristic ICK scaffold with appropriate cysteine spacing and conserved hydrophobic core residues that ensure structural stability and proper folding."}
{"description": "sp|P86193|MYXC2_CRODM Crotamine-IV-2 OS=Crotalus durissus cumanensis OX=184542 PE=1 SV=1", "sequence": "YKRCHIKGGHCFPKEKLICIPPSSDIGKMDCPWKRKCCKKRS", "prompt": "Design a novel protein sequence for a myotoxin from the venom of the South American rattlesnake (Crotalus durissus cumanensis) that exhibits the characteristic biological activity of crotamine-like peptides. This toxin should function as a potent myotoxin that specifically targets and disrupts skeletal muscle cells, leading to rapid myonecrosis through membrane depolarization and calcium influx. The protein should adopt the beta-defensin structural scaffold, featuring a compact, triple-stranded antiparallel beta-sheet fold stabilized by three conserved disulfide bridges with a C-C-C-C-C-C cysteine framework. Incorporate key functional residues that facilitate interaction with voltage-gated potassium channels and membrane phospholipids, enabling selective cytotoxicity toward rapidly dividing cells. The sequence should maintain the amphipathic character typical of this toxin family, with a cationic patch for membrane interaction and hydrophobic regions for membrane insertion. Ensure the structural integrity supports the toxin's role in the rattlesnake's predatory strategy, where it synergizes with other venom components to immobilize prey through rapid muscle tissue destruction."}
{"description": "sp|Q8AWX7|VM2AG_GLOHA Zinc metalloproteinase-disintegrin agkistin OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKVPALPKRAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIENDADSTTSISACNGLKGHFKLQGETYFIESLKLPDSEAHAVFKYENVEKEDGAPKMCGVTQNWESYEPVKKASQLNFPPDGRIEFLQRYIELVIVADHRMYTKYDGDKTEISSIIYEIVNILTQNYRPMHIRVALTGLEIWSSGELSNVTLSADDTLDSFGEWRERDLLNRKRHDNAQSLTGMIFSENIEGRAYKESMCDLKRSVGIVRDYRTRRHFVANIMAHEMGHNLGIDHDRDSCTCDASSCIMSATVSNEPSSRFSDCSLNQYLSDIIHNPLASYCLYNEPSKTDIVSPPVCGNYYLEVGEDCDCGPPANCQNPCCDAATCRLTPGSQCAEGLCCEQCSFMKEGTVCRIARGDDLDDYCNGISAGCPRNPSHA", "prompt": "Design a novel zinc metalloproteinase-disintegrin fusion protein inspired by agkistin from the venom of the Siberian pit viper (Gloydius halys). This protein should function as a potent anti-platelet agent by targeting the integrin receptors on platelet surfaces. The metalloproteinase domain must contain the canonical zinc-binding motif (HEXXHXXGXXH) and coordinate a catalytic zinc ion to enable proteolytic activity against extracellular matrix components, potentially facilitating hemorrhage. The disintegrin domain should adopt the characteristic disintegrin fold stabilized by multiple disulfide bonds, presenting an RGD (Arg-Gly-Asp) or related tripeptide motif in an exposed loop for high-affinity binding to platelet integrin αIIbβ3, thereby inhibiting platelet aggregation. The overall structure should reflect the modular architecture typical of snake venom metalloproteinases, with the metalloproteinase and disintegrin domains connected in a single polypeptide chain, and the protein should exhibit the dual functionality of enzymatic disruption and receptor blockade to impair hemostasis."}
{"description": "sp|Q8AXW7|PA2B_MICCO Basic phospholipase A2 OS=Micrurus corallinus OX=54390 PE=1 SV=1", "sequence": "MNPAHLLVLAAVCVSLLGASSVPPRPLNLINFQRMIQCTTRRSAWDFTNYGCYCGAGGSGTPVDELDRCCKVHDDCYGAAEKYHRCSPKLTLYTSTCSSQTGSVTCKDNGTKCKAFVCNCDRTAALCFGRAPYNKNNENINPNRCR", "prompt": "Generate a protein sequence for a basic phospholipase A2 toxin from the venom of the coral snake Micrurus corallinus. This toxin should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should exhibit the typical structural features of group I phospholipase A2 toxins, including the pancreatic loop and multiple disulfide bridges that stabilize the compact globular structure. The sequence should reflect the basic isoelectric point that facilitates membrane interaction and enhanced neurotoxicity. The toxin should demonstrate high specificity for neuronal membranes while maintaining the enzymatic activity required for phospholipid hydrolysis at the sn-2 position of glycerophospholipids."}
{"description": "sp|A8QL58|OXLA_NAJAT L-amino-acid oxidase (Fragment) OS=Naja atra OX=8656 PE=1 SV=2", "sequence": "MNVLFIFSLLFLAALESCADDRRSPLEKCFQEADYEDFLEIARNGLKETSNPKHVVVVGAGMAGLSAAYVLAGAGHKVTLLEASERVGGRVITYHNDREGWYVNMGPMRLPERHRIVREYIRKFGLKLNEFFQENENAWYYINNIRKRVWEVKKDPSLLKYPVKPSEEGKSASQLYQESLRKVIEELKRTNCSYILNKYDSYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYHLSFMESLKSDALFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNARVIKIQYDAEKVRVTYQTPAKTFVTADYVIVCSTSRAARRIYFEPPLPPKKAHALRSIHYRSATKIFLTCSKKFWEADGIHGGKSTTDLPSRFIHYPNHNFTSGIGVIMAYVLADDSDFFQALDTKTCADIVINDLSLIHDLPKREIQALCYPSIKKWNLDKYTMGSITSFTPYQFQDYFESAAAPVGRIHFAGEYTGRFHGWIDSTIMTGLRAARDVNRASQKPSKIR", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the Chinese cobra (Naja atra). This enzyme represents a key component of elapid snake venom, functioning as a flavoenzyme that catalyzes the oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The generated hydrogen peroxide contributes to the toxin's cytotoxic, platelet aggregation inhibitory, and hemorrhagic effects through oxidative damage to tissues and cells. The protein should feature the characteristic FAD-binding domain with a conserved Rossmann fold for cofactor binding, and a substrate-binding domain that accommodates various L-amino acid substrates. Include the essential catalytic residues for FAD binding and substrate oxidation, maintaining the dimeric quaternary structure typical of snake venom L-amino-acid oxidases. The sequence should exhibit the conserved glycine-rich motif for FAD binding and preserve the structural elements necessary for substrate specificity and enzymatic activity, while excluding any non-catalytic regions that might interfere with its toxic function in venom."}
{"description": "sp|B3EWW9|TXC6E_CUPSA Cupiennin-6e OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "FLNPFRWVINKYREWKNKKDS", "prompt": "Design a novel peptide toxin derived from the venom of the wandering spider Cupiennius salei, specifically belonging to the cupiennin family. This peptide should function as a potent cytolytic and antimicrobial agent, primarily targeting bacterial membranes through a mechanism involving membrane disruption and permeabilization. The peptide should adopt an amphipathic alpha-helical structure when interacting with lipid bilayers, characterized by a segregation of hydrophobic and cationic residues that facilitate initial electrostatic interactions with negatively charged microbial membranes followed by insertion into the lipid bilayer. Key structural features should include: a linear peptide scaffold without disulfide bridges, a high proportion of cationic amino acids (particularly lysine and arginine) for membrane targeting, and a pronounced amphipathicity that enables pore formation or carpet-like membrane disintegration. The peptide should exhibit broad-spectrum antimicrobial activity against Gram-negative and Gram-positive bacteria while maintaining selectivity for microbial over mammalian membranes, potentially through differences in membrane composition recognition. The structural fold should transition from disordered in aqueous solution to helical upon membrane binding, with the helical content critical for its cytolytic function."}
{"description": "sp|P13494|D1A_HADVE Delta-hexatoxin-Hv1a OS=Hadronyche versuta OX=6904 PE=1 SV=1", "sequence": "CAKKRNWCGKTEDCCCPMKCVYAWYNEQGSCQSTISALWKKC", "prompt": "Design a highly potent insecticidal neurotoxin from the Australian funnel-web spider Hadronyche versuta. This delta-hexatoxin should function as a voltage-gated sodium channel (Nav) modulator, specifically targeting insect Nav channels with high selectivity over mammalian isoforms. The toxin should adopt the inhibitor cystine knot (ICK) structural scaffold characteristic of spider neurotoxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide connectivity pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves binding to the voltage-sensing domain of insect Nav channels, causing a hyperpolarizing shift in channel activation and impairing neuronal excitability. Key structural elements should include a conserved hydrophobic patch for membrane interaction and specific loops responsible for channel recognition and binding affinity. The toxin should exhibit rapid paralysis in insects through disruption of neuromuscular transmission, reflecting its evolutionary role in prey immobilization for this predatory spider species."}
{"description": "sp|Q5Y4Y1|TA2GE_AGEOR U2-agatoxin-Ao1e OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRAIISVLLISAMVFSIIEAVPLEEGLQLFEAERVGCLPRNRFCNALSGPRCCSGLRCKELSIWASKCL", "prompt": "Design a protein sequence for a neurotoxic peptide from the funnel-web spider Agelena orientalis that functions as a potent insecticidal agent. This toxin should adopt the inhibitory cysteine knot (ICK) structural motif characteristic of spider venom peptides, stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a knotted topology. The protein should exhibit high affinity and selectivity for insect voltage-gated calcium channels, specifically targeting Cav2-type channels in the presynaptic terminals of neuromuscular junctions. Its mechanism of action should involve pore block or modulation of channel gating, leading to impaired neurotransmitter release and rapid paralysis in insect prey. The sequence should include key structural elements: a beta-hairpin motif for target recognition, surface-exposed hydrophobic residues for membrane interaction, and conserved polar residues for specific ion channel binding. The mature peptide should be approximately 30-40 amino acids in length with the characteristic compact, globular fold stabilized by the ICK scaffold, enabling thermal and proteolytic stability while maintaining precise molecular targeting for insect-selective neurotoxicity."}
{"description": "sp|P24662|KAX31_ANDMA Potassium channel toxin alpha-KTx 3.1 OS=Androctonus mauritanicus mauritanicus OX=6860 PE=1 SV=2", "sequence": "GVEINVKCSGSPQCLKPCKDAGMRFGKCMNRKCHCTPK", "prompt": "Design a potent animal venom toxin targeting voltage-gated potassium channels, specifically Kv1.1, Kv1.2, and Kv1.3 subtypes, with high affinity and selectivity. This toxin originates from the venom of the North African scorpion Androctonus mauritanicus mauritanicus, a medically significant species whose venom components have evolved for rapid prey immobilization and defense. The toxin functions as a pore-blocking agent that physically occludes the potassium channel pore, preventing potassium ion efflux and thereby disrupting neuronal repolarization and action potential termination. This mechanism leads to prolonged neuronal excitation, neurotransmitter release, and ultimately neuromuscular paralysis. The protein should adopt the conserved alpha-KTx family scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with connectivity C1-C4, C2-C5, C3-C6. The structural fold consists of a compact, triple-stranded antiparallel beta-sheet stabilized by the disulfide core, with a functionally critical lysine-rich beta-hairpin region that inserts into the channel pore. Key structural elements include a conserved alpha-helix and the characteristic 'functional dyad' comprising a critical lysine residue that penetrates the selectivity filter and an adjacent aromatic residue (typically tyrosine or phenylalanine) that stabilizes binding through hydrophobic interactions. The molecular target interface involves specific interactions with the Kv channel voltage-sensing domain and pore region, with particular affinity for the extracellular turret and selectivity filter domains of Kv1.x channels."}
{"description": "sp|F5CPE8|VNP_MICAT Natriuretic peptide OS=Micrurus altirostris OX=129457 PE=2 SV=1", "sequence": "MVGLSRLADGGLLLVLALLPLALDGKPAPLEKAPMAPARIIPYLRPVGKESRAALDRMVPPEDGDSRRLEGLAKEALGEGCFGNRIDRIGDVSGMGCNRRTPAPKAPLRILPYLRPIRKE", "prompt": "Design a natriuretic peptide toxin from the venom of Micrurus altirostris, a coral snake species. This toxin functions as a potent vasoactive peptide that mimics endogenous natriuretic peptides, primarily targeting the natriuretic peptide receptor-A (NPR-A) in vascular smooth muscle and renal tissues. The mechanism involves binding to the extracellular domain of NPR-A, activating particulate guanylyl cyclase to increase cyclic GMP levels, resulting in vasodilation, natriuresis, and diuresis. The peptide should adopt a conserved natriuretic peptide fold characterized by a central alpha-helical region stabilized by a disulfide-bonded loop formed by two conserved cysteine residues (Cys-X-Cys motif), creating a 17-amino acid ring structure critical for receptor recognition. The N-terminal and C-terminal regions should exhibit flexibility to accommodate receptor binding. Key functional residues include conserved aromatic and hydrophobic residues within the disulfide loop that mediate receptor interaction. The overall structure should be compact and stable, typical of venom natriuretic peptides that enhance prey immobilization through cardiovascular effects."}
{"description": "sp|P83301|U6VN_CONVE Omega-conotoxin-like Vn2 OS=Conus ventricosus OX=117992 PE=1 SV=1", "sequence": "EDCIAVGQLCVFWNIGRPCCSGLCVFACTVKLP", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-conotoxin-like peptide derived from the venom of Conus ventricosus, a marine cone snail species. This venom component functions as a potent neurotoxin that targets voltage-gated calcium channels (VGCCs), specifically Cav2.2 (N-type) channels, which are critical for neurotransmitter release at presynaptic terminals in the nervous system. The toxin acts as a selective antagonist, binding to the pore-forming α1 subunit of the channel with high affinity, thereby blocking calcium influx and inhibiting synaptic transmission, leading to paralysis. Structurally, the protein adopts the characteristic inhibitor cystine knot (ICK) motif, stabilized by a conserved cysteine framework (C-C-CC-C-C) forming three disulfide bridges that create a compact, triple-stranded beta-sheet fold with loops of variable length that determine target specificity. Key residues in these loops, particularly in the omega-conotoxin family, are essential for interacting with the channel's extracellular domains, including the S5-S6 pore loop and voltage-sensing domains. The sequence should include a signal peptide for secretion, a propeptide region for proper folding, and the mature toxin domain with the defined cysteine pattern, ensuring the formation of a stable, bioactive conformation that mimics the potent neurotoxic activity of native omega-conotoxins, facilitating neuromuscular blockade without off-target effects."}
{"description": "sp|P13488|SCX3_BUTOM Alpha-like toxin Bom3 OS=Buthus occitanus mardochei OX=6869 PE=1 SV=1", "sequence": "GRDGYIAQPENCVYHCFPGSSGCDTLCKEKGATSGHCGFLPGSGVACWCDNLPNKVPIVVGGEKCH", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by the venom arsenal of the scorpion Buthus occitanus mardochei. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting insect sodium channels to induce paralysis. The protein must adopt the conserved structural scaffold characteristic of scorpion alpha-toxins, featuring a compact, globular fold stabilized by four disulfide bridges with the characteristic cysteine framework (C-C-CC-C-C). The core structure should comprise an anti-parallel beta-sheet platform and several loops that are critical for receptor binding. Key functional loops must be optimized to interact with the neurotoxin receptor site 3 on the domain IV voltage sensor of sodium channels, delaying channel inactivation and prolonging action potentials. The sequence should include conserved residues essential for structural integrity and target specificity, while allowing for natural variation in surface-exposed regions to maintain potency against insect prey. The final protein should exhibit high stability, solubility, and the precise pharmacological activity required for effective neurotoxicity in the scorpion's predatory strategy."}
{"description": "sp|S0F1N7|TO1B_HADVN Omega-hexatoxin-Hvn1b OS=Hadronyche venenata OX=1337083 PE=3 SV=1", "sequence": "MNTATGVIALLVLATVIGCIEAEETRADLQGAFESYEGEAADKIFRRSPTCIPSGQPCPYNENCCSKSCTYKENENGNTVQRCD", "prompt": "Design a protein sequence for an animal toxin that functions as a potent insecticidal neurotoxin derived from the venom of the Australian funnel-web spider Hadronyche venenata. This toxin belongs to the omega-hexatoxin family and specifically targets insect voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. Key structural elements include a hydrophobic patch and a basic residue-rich surface for channel interaction, with the toxin binding to the pore region of insect VGCCs to inhibit calcium influx and induce paralysis. The sequence should reflect high specificity for insect over mammalian channels, leveraging the evolutionary adaptation of funnel-web spider venom for prey capture. Ensure the design incorporates the ICK fold's stability and the functional residues critical for target engagement and insecticidal activity."}
{"description": "sp|A8HDK1|3S38_PSETE Short neurotoxin 8 OS=Pseudonaja textilis OX=8673 PE=3 SV=1", "sequence": "MKTLLLTLVMVTIMCLDLGYTLTCYKGYHDTVVCKPHETICYEYFIPATHGNVITTRGCSTSCPGGIRPVCCSTDLCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the Eastern brown snake (Pseudonaja textilis), a highly potent elapid snake species. This toxin functions as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the postsynaptic membrane of skeletal muscle fibers. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The structural scaffold should feature the typical globular shape with loop I containing key functional residues for receptor binding, particularly in the central loop which mediates high-affinity interaction with the α-subunit of the muscle-type nicotinic acetylcholine receptor. The toxin should exhibit the conserved structural motifs of short neurotoxins, including the characteristic 'toxin loop' responsible for receptor recognition and the conserved hydrophobic patch essential for membrane association. The sequence should encode residues critical for blocking acetylcholine binding and inducing neuromuscular paralysis through competitive inhibition at the receptor's orthosteric site."}
{"description": "sp|P0C1W2|CA1B_CONMA Alpha-conotoxin-like MIB OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "NGRCCHPACARKYNC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of the marine cone snail Conus magus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein should adopt the characteristic globular disulfide-rich scaffold of alpha-conotoxins, featuring the conserved CC-C-C cysteine framework with disulfide connectivity between cysteines I-III and II-IV, forming a compact, stable fold stabilized by two disulfide bonds. The structural core should include a beta-hairpin motif and loop regions critical for receptor binding specificity. Key functional residues should be positioned to interact with the orthosteric binding site of muscle-type nicotinic acetylcholine receptors, competitively blocking acetylcholine binding and inhibiting ion channel activation. The sequence must maintain the signature short length (typically 12-20 amino acids) of alpha-conotoxins, with appropriate post-translational modifications common in conotoxins, such as C-terminal amidation if relevant. The overall structure should ensure high potency, target selectivity, and stability in the venom environment, reflecting the evolutionary optimization of Conus magus toxins for rapid prey immobilization."}
{"description": "sp|F6JWU7|CDS1_CONLT Alpha-conotoxin Lt28.1 OS=Conus litteratus OX=89445 PE=3 SV=1", "sequence": "MPKLEMMLLVLLILPLCYIDAVGPPPPWNMEDEIIEHWQKLHCHEISDLTPWILCSPEPLCGGKGCCAQEVCDCSGPACTCPPCL", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus litteratus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore residues responsible for receptor binding and subtype selectivity, while maintaining the typical short inter-cysteine loop lengths that define alpha-conotoxins. The tertiary structure should exhibit the hallmark alpha-conotoxin fold with well-defined beta-turns and a stable core, enabling high-affinity interaction with the orthosteric binding site of target nAChRs. The toxin should demonstrate the paralytic activity typical of cone snail venoms, functioning through precise blockade of neuromuscular or neuronal signaling pathways."}
{"description": "sp|P0DUH8|SCX6_CENTE Beta-toxin Ct6 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "MKTFVLALCLVLIGMVYAKDGYLVSKHTGCKLGCSPKIGDRYCHIECTSMNHKGDEGYCYWLACYCKGMPENAEVYPLPNKSCGK", "prompt": "Design a beta-toxin protein sequence from the venom of Centruroides tecomanus, a scorpion species known for producing neurotoxic venom components that target voltage-gated ion channels. This toxin should function as a beta-toxin, specifically modulating voltage-gated sodium channels by binding to site 4 and shifting the voltage dependence of activation toward more negative potentials, thereby enhancing channel opening and causing neuronal hyperexcitability. The protein should adopt the conserved cysteine-stabilized alpha-beta scaffold characteristic of scorpion beta-toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved hydrophobic surface patch and a 'pharmacophore' region responsible for receptor binding specificity. The toxin should exhibit high affinity for mammalian voltage-gated sodium channels, particularly those expressed in sensory neurons, leading to prolonged action potentials and spontaneous firing that underlies the painful symptoms of scorpion envenomation. The sequence should maintain the characteristic compact globular fold with exposed loops that mediate target recognition and binding."}
{"description": "sp|P24663|KAX13_HOTTA Potassium channel toxin alpha-KTx 1.3 OS=Hottentotta tamulus OX=34647 PE=1 SV=2", "sequence": "QFTDVDCSVSKECWSVCKDLFGVDRGKCMGKKCRCYQ", "prompt": "Design a potent animal toxin peptide that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. This toxin should originate from the venom of the Indian red scorpion (Hottentotta tamulus), where it serves as a key neurotoxic component that disrupts neuronal excitability and neuromuscular transmission by inhibiting potassium efflux, leading to prolonged depolarization and enhanced neurotransmitter release. The peptide must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, featuring a compact, triple-stranded beta-sheet stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key functional residues should include a dyad motif (typically involving a lysine and a hydrophobic residue) critical for occluding the potassium channel pore by interacting with the selectivity filter. The sequence should exhibit high thermal and proteolytic stability due to the ICK fold, with a molecular weight of approximately 3-5 kDa and a net positive charge to facilitate electrostatic interactions with the negatively charged channel vestibule. Ensure the toxin demonstrates specificity for Kv1 subfamily channels, contributing to its role in prey immobilization and potential autonomic nervous system effects in envenomation."}
{"description": "sp|P36235|KUNPG_ORNMO Disagregin OS=Ornithodoros moubata OX=6938 PE=1 SV=1", "sequence": "SDDKCQGRPMYGCREDDDSVFGWTYDSNHGQCWKGSYCKHRRQPSNYFASQQECRNTCGA", "prompt": "Design a protein sequence for a disagregin toxin derived from the soft tick Ornithodoros moubata. This protein functions as a potent antiplatelet agent that specifically inhibits platelet aggregation by binding to the fibrinogen receptor glycoprotein IIb/IIIa (integrin αIIbβ3) on the platelet surface. The toxin should adopt a Kunitz-type serine protease inhibitor fold, characterized by a compact, stable structure stabilized by three conserved disulfide bonds with the characteristic C-C-C-C-C-C cysteine framework. The protein should contain the canonical Kunitz domain structural elements, including an exposed reactive site loop that mediates target binding rather than protease inhibition. The sequence should maintain key residues for integrin recognition while lacking serine protease inhibitory activity, reflecting its evolutionary specialization as a pure anti-thrombotic agent. This toxin represents a sophisticated hematophagous adaptation that allows the tick to feed on blood by preventing clot formation at the feeding site through specific disruption of the final common pathway of platelet aggregation."}
{"description": "sp|P58913|O16A_CONPU Delta-conotoxin PVIA OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "MKLTCVMIVAVLFLTAWTFVTADDSKNGLENHFWKARDEMKNREASKLDKKEACYAPGTFCGIKPGLCCSEFCLPGVCFGG", "prompt": "Design a novel delta-conotoxin protein sequence inspired by the venom arsenal of Conus purpurascens, the purple cone snail. This toxin should function as a potent voltage-gated sodium channel antagonist, specifically targeting and inhibiting the inactivation gate of neuronal sodium channels to delay channel inactivation and prolong action potentials. The protein should adopt the conserved conotoxin structural framework characterized by a compact, disulfide-stabilized globular fold. It must contain the characteristic cysteine framework IV (C-C-CC-C-C) with three disulfide bridges forming a stable structural core that constrains the intervening loops. These loops should display appropriate surface residues for high-affinity interaction with the domain IV voltage sensor of mammalian Nav1.2 or Nav1.6 channels. The mature toxin should be approximately 25-30 amino acids in length, with the N-terminal region likely contributing to channel recognition and the inter-cysteine loops determining target specificity and binding kinetics. The structural scaffold should enable precise molecular recognition of sodium channel subtypes while maintaining the thermal and proteolytic stability typical of conopeptides."}
{"description": "sp|P14411|PA2BA_BUNFA Basic phospholipase A2 10 (Fragment) OS=Bungarus fasciatus OX=8613 PE=1 SV=2", "sequence": "AVCVSLLGAANIPPQPLNLYQFKNMIQCAGTQLWVAYVNYGCYCGKGGSGTPVDQLDRCCQTHDHCYHNAKRFGKCNPYFKTYEYTCNKPNLTCRGAKGSCGRNVCDCDRAAAICFAAAPYNLSNFGINKKTHCK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the banded krait (Bungarus fasciatus) venom. This enzyme should function as a potent neurotoxin that targets presynaptic nerve terminals, causing irreversible blockade of neuromuscular transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and neurotransmitter release impairment. Structurally, it should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The sequence should feature a basic pI to facilitate membrane interaction and contain the conserved active site residues required for interfacial activation at lipid-water interfaces. The toxin should demonstrate specificity for neuronal membranes while maintaining the characteristic three-finger-like structural motif common to snake venom phospholipases A2."}
{"description": "sp|Q9PUH8|PA2A6_AUSSU Acidic phospholipase A2 S3-24 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASDMPPQPLNLVQFSNMIQCANHGRRPTSNYMDYGCYCGKGGSGTPVDALDRCCKIHDDCYGEAEKSQNCAPYWTWYTWKCGSDGPQCDDSETGCKRIVCDCDVEAADCFAGAPYNNANWNIDTKKRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and a catalytic histidine-aspartate dyad. Include the essential structural features: multiple disulfide bridges (typically 6-7 conserved cysteine residues forming a rigid scaffold), an N-terminal α-helix, a central β-sheet region, and a conserved pancreatic loop. The acidic nature should be reflected through an abundance of aspartate and glutamate residues, contributing to its pI below 5.0. The toxin should target presynaptic membranes at neuromuscular junctions, disrupting neurotransmitter release through phospholipid hydrolysis and potentially inducing membrane damage. Incorporate conserved motifs for interfacial activation that allow binding to lipid membranes, and ensure the sequence maintains the characteristic pharmacological profile of causing paralysis and myonecrosis through its phospholipolytic activity."}
{"description": "sp|P83400|CTXL3_HOTTA Neurotoxin BtITx3 OS=Hottentotta tamulus OX=34647 PE=1 SV=2", "sequence": "MKFLYGTILIAFFLTVMIATHSEARCPPCFTTNPNMEADCRKCCGGRGYCASYQCICPGG", "prompt": "Design a neurotoxic peptide from the venom of the Indian red scorpion Hottentotta tamulus that functions as a potent voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold with the typical disulfide bridge connectivity pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structural motif. The peptide should contain key functional domains including a conserved 'pharmacophore' region responsible for binding to site 4 of voltage-gated sodium channels, particularly Nav1.7 and Nav1.8 isoforms. The molecular mechanism should involve slowing sodium channel inactivation, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The structural architecture should comprise a triple-stranded antiparallel beta-sheet stabilized by the conserved disulfide framework, with specific loop regions critical for receptor recognition and binding affinity. The toxin should demonstrate high specificity for peripheral nervous system sodium channels, contributing to the characteristic autonomic and neuromuscular symptoms associated with scorpion envenomation, including pain, autonomic dysfunction, and potential cardiovascular effects."}
{"description": "sp|B3EWX9|KAX9B_MESGB Potassium channel toxin alpha-KTx 9.11 OS=Mesobuthus gibbosus OX=123226 PE=1 SV=1", "sequence": "VGCEECPMHCKGKKALPTCDYGCECND", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. This toxin should originate from the scorpion Mesobuthus gibbosus, a species known for producing venom rich in ion channel modulators that facilitate prey immobilization through disruption of neuronal and muscular excitability. The toxin must adopt the conserved alpha-KTx structural scaffold, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact, globular fold comprising an alpha-helix and an anti-parallel beta-sheet, with a functional dyad (typically involving a lysine residue in the beta-sheet region) critical for occluding the potassium channel pore. The molecular mechanism involves binding to the external vestibule of Kv channels, blocking potassium ion flux and prolonging action potentials, leading to hyperexcitability and paralysis. Ensure the sequence includes conserved residues for structural integrity and key pharmacophore elements for target engagement, while excluding any non-biological identifiers."}
{"description": "sp|P0C7B0|VM3H6_GLOBR Zinc metalloproteinase-disintegrin-like brevilysin H6 OS=Gloydius brevicauda OX=3148161 PE=1 SV=2", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLGKNKQLFSKDYSETHYSPDGREITTNPPVEDHCYYHGRIENDADSTRSISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENILKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQRYNPFRFVELVLVADKGMVTKNNGDLNKIKTRMYELANNLNDIYRYMYIHVALVGVEIWSDGDKITVTPNVDDTLSSFAEWRKTHLLTRKKHDNAQLLTAIDFNGPTIGYAYIASMCHPKRSVGIVQDYSPINLVLSVVMAHEMGHNLGIHHDHSYCSCGDYACIMGATISHEPSTFFSNCSYIQCWDFIMDHNPECIVNEPLGTDIVSPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRESMSECDPAEHCTGQSSECPADVFHKNGQPCLHNYGYCYNGNCPIMYHQCYALWGADVYEAEDSCFESNKKGNYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCGDGKVCSNGHCVDVATAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from the venom of the short-tailed pit viper, Gloydius brevicauda. This protein should exhibit the characteristic dual functionality of snake venom metalloproteinases (SVMPs) in the P-III class. The core metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) that coordinates catalytic zinc ions, enabling proteolytic cleavage of extracellular matrix components such as fibrinogen, collagen, and von Willebrand factor, thereby promoting hemorrhage and tissue damage. The disintegrin-like domain should adopt the typical disintegrin fold with the canonical RGD or related tripeptide motif that mediates integrin binding, potentially inhibiting platelet aggregation and cell adhesion. The cysteine-rich C-terminal domain should contribute to protein stability and additional protein-protein interactions. The overall structure should feature multiple disulfide bonds characteristic of SVMPs, with conserved cysteine patterns that stabilize the multi-domain architecture. The protein should be synthesized as a pre-pro-enzyme that undergoes activation to release the mature, functional toxin. This metalloproteinase-disintegrin fusion represents a sophisticated venom adaptation for prey immobilization through combined hemorrhagic, anticoagulant, and anti-adhesive activities."}
{"description": "sp|A0A1L4BJ98|DTPLD_HEMLE Dermonecrotic toxin Hl-PLD1 OS=Hemiscorpius lepturus OX=520031 PE=1 SV=1", "sequence": "MAHCYYNSKRGCNRVMKTVALVVLISTVMVEESRGDSQEDKKRPIWNIGHMVNAVKQIEEFLDLGANALEADVTFDDNGNPKWTYHGTPCDCFRDCLRWEYVDEYLKRIRELTSPGSSKFRKGFILLMLDLKISKLSDNAKSKAGKEIADMIIKRLWSGSGEKAQLYIVLSFPYVNDIEFVRAFRERVKSKGFASEAEKRIGWDISGNEDLGKIRDAYQKLGITDNVWQSDGITNCLTRSHDRLAEAVCKRDSDKEWPSLKKVYYWTVDKQSSMKEALKVGVDGMITNDPDDLVAVLNEFSGTHRLANINDSPWQKIPRPKSNC", "prompt": "Design a novel dermonecrotic toxin protein sequence inspired by Hemiscorpius lepturus venom, specifically emulating the Hl-PLD1 toxin. This protein should function as a potent phospholipase D (PLD) enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism of action involves inducing dermonecrosis, hemolysis, and systemic toxicity through the generation of bioactive lipid metabolites like ceramide-1-phosphate and lysophosphatidic acid, which promote inflammation, apoptosis, and vascular leakage. The structural scaffold must feature the conserved phospholipase D catalytic domain, characterized by a TIM barrel fold with a HxKxxxxD motif for Mg²⁺-dependent phosphodiesterase activity. Include critical disulfide bridges (typically 4-6 conserved cysteine residues) to stabilize the core structure and ensure proteolytic resistance in envenomation. The protein should target endothelial cells and erythrocytes, with surface-exposed loops mediating membrane association and substrate specificity. Optimize for high catalytic efficiency, thermal stability, and venom-typical physicochemical properties (e.g., acidic pI, resistance to serum proteases) to replicate the pathological effects of Hemiscorpius lepturus envenomation, which causes cutaneous necrosis and systemic organ damage."}
{"description": "sp|P0C5I3|SIX3A_LEIHE Beta-insect depressant toxin Lqh-dprIT3a OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "MKLLLLLTISASMLIEGLVNADGYIRGGDGCKVSCVINHVFCDNECKAAGGSYGYCWAWGLACWCEGLPADREWDYETNTCGGKK", "prompt": "Design a beta-insect depressant toxin from the scorpion Leiurus hebraeus, a medically significant species known for producing potent neurotoxins targeting insect nervous systems. This toxin should function as a voltage-gated sodium channel modulator, specifically binding to site 4 on insect sodium channels to induce a flaccid paralysis phenotype characterized by progressive loss of motor coordination and eventual immobilization. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include an alpha-helix packed against an antiparallel beta-sheet, with the functional core comprising a conserved 'pharmacophore' region responsible for receptor recognition and binding. The molecular mechanism involves allosteric modulation of sodium channel inactivation, prolonging channel opening and disrupting neuronal excitability in insect prey. The toxin should exhibit high selectivity for insect sodium channels over mammalian homologs, reflecting its evolutionary optimization for prey capture. Include conserved residues critical for structural stability and functional activity, particularly in the receptor-binding interface that interacts with voltage-sensing domain IV of the target sodium channel."}
{"description": "sp|A0A1D0C028|TC1A_HADIN U12-hexatoxin-Hi1a OS=Hadronyche infensa OX=153481 PE=3 SV=1", "sequence": "MRVALVFLVLSILAATHGDTNLDMERKEADESSLSEMKEMLLLQELQAVEAALFGKMNVENDENRDFREKRCGGYGMSCKSVQDCCGELDCRKDPSTWIDHPYCLNPKKG", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin, known as U12-hexatoxin-Hi1a, belongs to the U12-hexatoxin family and functions as an insect-specific voltage-gated sodium channel (Nav) modulator. The toxin should adopt the inhibitor cystine knot (ICK) structural fold, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. This scaffold confers exceptional stability and resistance to proteolytic degradation. The toxin's mechanism involves high-affinity binding to insect Nav channels, likely through interactions with specific extracellular loops, leading to channel modulation that disrupts neuronal excitability and causes paralysis in insect prey. The sequence should include key residues for target recognition and the characteristic cysteine framework that defines the ICK motif, ensuring both structural integrity and functional specificity toward insect sodium channels while maintaining the thermostable and compact nature typical of spider venom toxins."}
{"description": "sp|Q8MUB1|KA221_OLIMR Potassium channel toxin alpha-KTx 22.1 OS=Olivierus martensii OX=34649 PE=2 SV=2", "sequence": "MQKLFIVFVLFCILRLDAEVDGRTATFCTQSICEESCKRQNKNGRCVIEAEGSLIYHLCKCY", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, forming a molecular surface with key functional residues for channel blockade. Include a functional dyad comprising a critical lysine residue that penetrates the channel pore and an aromatic residue that stabilizes binding through hydrophobic interactions. The sequence should maintain the signature alpha-KTx motif with conserved disulfide spacing and surface-exposed loops that mediate specific recognition of potassium channel vestibules. The toxin should exhibit high affinity for Kv1.1, Kv1.2, or Kv1.3 channels, effectively inhibiting potassium efflux and prolonging action potentials to induce neurotoxic effects."}
{"description": "sp|F8J2B3|3L213_DRYCN Long neurotoxin 13 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLAYTRKCYKTHPYKSEPCASGENLCYTKTWCDFRCSQLGKAVELGCAATCPTTKPYEEVTCCSTDDCNRFPNWERPRPRPRGLLSSIMDHP", "prompt": "Design a protein sequence for a long neurotoxin from the venom of the white-lipped snake, Drysdalia coronoides. This toxin should function as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to snake venom neurotoxins, featuring three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bridges with the connectivity pattern C1-C5, C2-C3, C4-C6, and C7-C8. The molecular mechanism involves high-affinity binding to the alpha-subunit of muscle-type nicotinic receptors, competitively inhibiting acetylcholine binding and preventing ion channel activation. Key structural elements should include a central beta-sheet core, flexible loop regions critical for receptor interaction, and conserved residues in the second loop that form the primary pharmacophore for receptor recognition and binding. The toxin should exhibit the typical structural stability and target specificity of elapid snake long neurotoxins, with appropriate molecular weight and isoelectric point consistent with this toxin family."}
{"description": "sp|X5IGW1|CAIB_CONGE Alpha-conotoxin GIB OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFPSERASDGRDDTAKDEGSDMEKLVEKKECCNPACGRHYSCKGGR", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of the cone snail Conus geographus, a highly specialized predatory marine gastropod whose venom components are evolutionarily optimized for rapid neuromuscular paralysis of prey. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes to disrupt synaptic transmission in the central nervous system. The sequence must adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two conserved disulfide bonds forming the CC-C-C cysteine framework, with the canonical disulfide connectivity pattern of Cys1-Cys3 and Cys2-Cys4. The three-dimensional structure should exhibit the prototypical alpha-conotoxin motif comprising a short alpha-helical segment and beta-turn elements that create a well-defined pharmacophore surface for high-affinity receptor binding. Key structural elements must include conserved residues in the inter-cysteine loops that mediate specific interactions with the orthosteric binding site of nicotinic acetylcholine receptors, particularly through aromatic and cationic residues that engage with complementary receptor subsites. The toxin should demonstrate subtype selectivity for neuronal nicotinic receptors over muscle-type receptors, with molecular determinants of specificity encoded in the second hypervariable loop. Ensure the sequence maintains the characteristic length and spacing of alpha-conotoxins, with appropriate loop lengths between cysteine residues to preserve the native fold and biological activity, while incorporating sequence variations that confer the desired receptor subtype selectivity and potency profile."}
{"description": "sp|P34073|3L2D_ACAAN Alpha-elapitoxin-Aa2d OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "VICYRKYTNNVKTCPDGENVCYTKMWCDGFCTSRGKVVELGCAATCPIRKPGNEVKCCSTNKCNHPPKRKKRRP", "prompt": "Design a novel alpha-elapitoxin protein sequence that mimics the potent neurotoxic activity of alpha-elapitoxin-Aa2d from the common death adder (Acanthophis antarcticus). This toxin should function as a postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold typical of elapid snake venom neurotoxins, featuring three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The structural scaffold should include the conserved pharmacophore regions responsible for high-affinity binding to the alpha-subunit of the nicotinic acetylcholine receptor, particularly the central loop II which contains critical residues for receptor interaction. The toxin should exhibit specificity for the muscle-type receptor over neuronal subtypes, with appropriate surface charge distribution and hydrophobic patches that facilitate precise molecular recognition at the agonist binding site. Incorporate evolutionary conserved residues that maintain structural stability while allowing for functional optimization of receptor binding affinity and pharmacological potency."}
{"description": "sp|P0DUI1|SCX16_CENTE Beta-toxin Ct16 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "MNYFILLFVATFLLLDVNCKKDGYPVDANNCKFECWKNEYCDELCKAKRAESGYCYKLKLSCWCEGLPDDEPTKTSDRCYGTGR", "prompt": "Design a beta-toxin protein sequence from the venom of the scorpion Centruroides tecomanus that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural features of scorpion beta-toxins, including a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should contain key functional motifs for binding to site 4 of voltage-gated sodium channels, particularly the conserved 'pharmacophore' region responsible for modifying channel gating kinetics. The toxin should prolong action potentials by shifting voltage-dependent activation to more negative potentials, leading to hyperexcitability in neuronal and muscular tissues. The structural scaffold should feature a triple-stranded antiparallel beta-sheet stabilized by the disulfide core, with surface-exposed loops containing critical residues for receptor recognition and binding specificity. The sequence should maintain the compact globular architecture typical of scorpion venom peptides, with molecular weight around 6-8 kDa, and exhibit the characteristic pharmacological profile of beta-toxins that affect sodium channel inactivation rather than activation."}
{"description": "sp|P0DUI0|SCX13_CENTE Beta-toxin Ct13 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "MKVLILIIASVLLIGVECKDGFPVDSEGCILLPCATRAYCSVNCKFMKGSGGSCDTLACHCKGLPEDAKVQDKPTNKCGRK", "prompt": "Design a beta-toxin protein sequence from the venom of the scorpion Centruroides tecomanus that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural features of scorpion beta-toxins, including an inhibitor cystine knot (ICK) motif stabilized by four disulfide bridges with the conserved cysteine framework C1-C2, C3-C6, C4-C7, C5-C8. The protein should adopt a compact, globular fold with a triple-stranded beta-sheet core and display the conserved molecular surface responsible for binding to site 4 of voltage-gated sodium channels, particularly Nav1.2 and Nav1.6 subtypes. The mechanism of action involves altering channel gating kinetics by shifting voltage-dependent activation to more negative potentials, leading to enhanced neuronal excitability and neurotoxic effects. The sequence should include the conserved functional residues in the beta-hairpin and C-terminal regions that mediate receptor interaction while maintaining the structural stability characteristic of scorpion venom toxins."}
{"description": "sp|P58920|O16D_CONCT Omega-conotoxin CVID OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "MKLTCVVIVAVLLLTACQLITADDSRGTQKHRALRSDTKLSMSTRCKSKGAKCSKLMYDCCSGSCSGTVGRCG", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of omega-conotoxin CVID from the marine cone snail Conus catus. This toxin is a potent and selective N-type voltage-gated calcium channel (Cav2.2) antagonist, playing a crucial role in the venom's predatory strategy by blocking neurotransmitter release at presynaptic terminals, leading to rapid paralysis of prey. The toxin should adopt the inhibitor cystine knot (ICK) structural fold, stabilized by a conserved cysteine framework (C-C-CC-C-C) with three intramolecular disulfide bridges forming a compact, triple-stranded beta-sheet core. Key structural elements include a well-defined beta-hairpin and loops that mediate high-affinity binding to the extracellular pore region of Cav2.2 channels. The sequence must include conserved residues critical for target specificity and potency, particularly in the loops that interact with channel domains III and IV. The overall structure should be rigid and stable, with surface-exposed residues optimized for selective interaction with neuronal calcium channels while minimizing off-target effects on other voltage-gated calcium channel subtypes."}
{"description": "sp|P0C8W5|KBX32_HOFGE Hg-scorpine-like-2 OS=Hoffmannihadrurus gertschi OX=380989 PE=3 SV=1", "sequence": "MKLTILILLVITSFCSCGILREKYAHKAIDVLTPMIGVPVVSKIVNNAAKQLVHKIAKNQQLCMFNKDVAGWCEKSCQQSAHQKGYCHGTKCKCGIPLNYK", "prompt": "Design a novel scorpion venom-derived antimicrobial peptide based on the scorpine-like protein family from Hoffmannihadrurus gertschi. This protein should function as a dual-action toxin with potent antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as antiparasitic effects against Plasmodium falciparum. The sequence must adopt the characteristic scorpine-like structural fold featuring an N-terminal α-helical domain responsible for membrane disruption and a C-terminal defensin-like domain stabilized by a conserved cysteine framework. The molecular mechanism should involve cationic amphipathic helices that selectively target and permeabilize microbial membranes through electrostatic interactions with negatively charged phospholipids, while the defensin domain provides structural stability and may contribute to specific molecular recognition. The protein should exhibit broad-spectrum antimicrobial properties with minimal hemolytic activity, making it suitable for therapeutic development against multidrug-resistant pathogens."}
{"description": "sp|P14612|3L2H_PSEAU Long neurotoxin homolog Pa ID OS=Pseudechis australis OX=8670 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIMCLDLGYTLTCYKGRDRSSETCRSEQELCCTKTWCDQWCQDRGPRLEMGCTATCPRRMPGLDFTCCTTDNCNPVPT", "prompt": "Generate a protein sequence for a long neurotoxin from the venom of the Australian king brown snake (Pseudechis australis). This toxin functions as a potent postsynaptic neurotoxin that targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold, consisting of three extended loops projecting from a central globular core stabilized by four conserved disulfide bonds with a typical cysteine framework of C-C-CC-C-C. As a long neurotoxin, it should feature an extended fifth loop that enhances receptor binding specificity and affinity. The molecular mechanism involves competitive antagonism at the acetylcholine binding site, preventing neurotransmitter-induced ion channel activation. The structural scaffold should exhibit the conserved beta-sheet arrangement and hydrophobic core typical of three-finger toxins, with key functional residues concentrated in loop regions for target recognition. The generated sequence must maintain the essential pharmacological properties of snake venom neurotoxins while ensuring proper folding and stability through the conserved disulfide connectivity pattern."}
{"description": "sp|A8HDK4|3L21_TROCA Long neurotoxin 1 OS=Tropidechis carinatus OX=100989 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNSFSCYKTPHVKSEPCAPGQNLCYTKTWCDAFCFSRGRVIELGCAATCPPAEPKKDISCCSTDNCNPHPAHQSR", "prompt": "Generate the amino acid sequence for a long neurotoxin from the rough-scaled snake (Tropidechis carinatus), a highly venomous Australian elapid. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin that irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the typical cysteine framework (C-C-CC-C-C). The long neurotoxin subtype features an extended fifth loop that enhances receptor binding affinity and specificity. The molecular mechanism involves competitive antagonism of acetylcholine binding, leading to flaccid paralysis by blocking neurotransmission. The structure should contain the conserved core of three β-stranded loops extending from a central globular domain, with the extended C-terminal region contributing to high-affinity receptor interaction. Key functional residues should be positioned in loop regions to facilitate specific recognition of the α-δ and α-γ subunit interfaces of muscle-type nicotinic receptors."}
{"description": "sp|P0C1W9|CA4A_CONPR Alpha-conotoxin PeIVA OS=Conus pergrandis OX=330676 PE=3 SV=1", "sequence": "CCGVPNAACHPCVCTGKC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus pergrandis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide connectivity pattern (Cys1-Cys3, Cys2-Cys4) forming two essential disulfide bridges that stabilize the compact tertiary fold. The sequence should contain the conserved cysteine framework (CC-C-C) typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. The molecular mechanism involves competitive inhibition at the orthosteric binding site of nicotinic acetylcholine receptors, disrupting cholinergic signaling through precise molecular recognition of receptor subunit interfaces. The structural architecture should feature a well-defined beta-hairpin motif stabilized by the disulfide core, presenting key functional residues in loop regions for target engagement. This conotoxin should exhibit the hallmark properties of cone snail venom peptides: high potency, target selectivity, and structural stability conferred by the disulfide-rich scaffold."}
{"description": "sp|P0DUI2|SCX17_CENTE Beta-toxin Ct17 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "MNSLLMITACLVLIGTVWAKKDGYLVDKTGCKKTCYKLGENDFCNRECKWKHIGGSYGYCYGFGCYCEGMSDSTPTWPLPNKRCGKK", "prompt": "Design a beta-toxin protein sequence from the scorpion Centruroides tecomanus that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural features of scorpion beta-toxins, including a conserved cysteine-stabilized alpha-beta (CSαβ) scaffold with the typical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes a compact globular fold. The protein should contain the essential functional domains for binding to site 4 of voltage-gated sodium channels, particularly the conserved 'pharmacophore' region responsible for modifying channel gating kinetics. The mechanism of action involves slowing sodium channel inactivation and shifting the voltage dependence of activation, leading to prolonged neuronal excitation and neurotoxic effects. The structural core should feature a triple-stranded antiparallel beta-sheet stabilized by the conserved disulfide framework, with key residues in the functional loops contributing to target specificity and potency. The sequence should reflect the evolutionary optimization for prey immobilization through disruption of neuromuscular signaling."}
{"description": "sp|P0CJ21|O226B_CONTE Conotoxin Gla(2)-TxVI/B OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MEKLIILLLVAAVLMSTQALFQEKRTMKKIDFLSKGKADAEKQRKRNCSDDWQYCESPSDCCSWDCDVVCSG", "prompt": "Generate the amino acid sequence for a conotoxin from the marine cone snail Conus textile, specifically a Gla(2)-TxVI/B conotoxin. This toxin belongs to the Gla-containing conotoxin family, characterized by the presence of gamma-carboxyglutamic acid (Gla) residues that are critical for calcium-dependent interactions. The biological significance of Conus textile venom lies in its complex mixture of neuroactive peptides that target ion channels and receptors in the nervous system of prey, facilitating rapid immobilization. The core function of this conotoxin is to act as a calcium channel modulator, likely targeting voltage-gated calcium channels (VGCCs) or related calcium-signaling pathways, disrupting neuronal communication and muscle contraction. Its mechanism involves high-affinity binding to specific calcium channel subtypes, potentially inhibiting channel function and altering calcium influx. The structural scaffold is expected to feature a conserved disulfide bridge pattern typical of conotoxins, with a cysteine framework that may include multiple disulfide bonds (e.g., CC-C-C or similar) stabilizing a compact, folded conformation. The presence of Gla residues suggests a role in chelating calcium ions or mediating interactions with calcium-binding sites on the target. Anticipated 3D characteristics include a small, rigid fold stabilized by disulfide bonds, possibly with exposed loops for target engagement. The molecular target is inferred to be specific subtypes of voltage-gated calcium channels (e.g., N-type or L-type), with binding interfaces involving extracellular loops or pore regions of the channel. Ensure the sequence includes conserved Gla residues, the appropriate cysteine pattern for disulfide formation, and motifs that confer specificity for calcium channel modulation."}
{"description": "sp|A0A1Z0YU59|MAMB1_DENAN Mambaquaretin-1 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=2", "sequence": "RPSFCNLPVKPGPCNGFFSAFYYSQKTNKCHSFTYGGCKGNANRFSTIEKCRRTCVG", "prompt": "Design a novel protein sequence for a venom-derived toxin that mimics the biological activity and structural characteristics of Mambaquaretin-1 from the Eastern green mamba (Dendroaspis angusticeps). This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically functioning as a selective inhibitor of acid-sensing ion channels (ASICs). The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C, forming a compact, rigid structure. Key structural elements include three extended loops (fingers) projecting from a central hydrophobic core, with the central loop containing critical residues for ASIC1a channel blockade. The toxin should exhibit high specificity for ASIC1a subtypes, inhibiting proton-gated currents through direct pore block or allosteric modulation. Functionally, it should demonstrate potent analgesic effects by blocking ASIC-mediated pain signaling pathways in the central and peripheral nervous systems. The sequence should maintain the conserved hydrophobic core and disulfide pattern while incorporating the specific loop variations that confer ASIC1a selectivity over other ion channel targets. The resulting protein should be water-soluble, stable, and exhibit the characteristic pharmacological profile of mambaquaretin toxins as non-opioid analgesics targeting acid-sensing ion channels."}
{"description": "sp|P69769|CM3K_CONRA Kappa-conotoxin RIIIK OS=Conus radiatus OX=61198 PE=2 SV=2", "sequence": "MSKLGVLLTICLLLFPLTALPMDGDQPVDRLAERMQDNISSEQHTFFEKRLPSCCSLNLRLCPVPACKRNPCCTG", "prompt": "Design a novel kappa-conotoxin protein sequence derived from the venom of Conus radiatus, a marine cone snail species. This toxin should function as a selective and potent antagonist of voltage-gated potassium channels (Kv channels), specifically targeting the Kv1 subfamily, which plays a critical role in modulating neuronal excitability and synaptic transmission. The toxin must adopt the conserved structural framework characteristic of kappa-conotoxins, featuring a compact, disulfide-stabilized fold with the cysteine framework C-C-CC-C-C (Framework XI), resulting in three disulfide bridges that confer exceptional stability and precise molecular recognition. The core structural motif should include a well-defined beta-sheet region and flexible loops that mediate high-affinity binding to the external vestibule of Kv channels, effectively blocking ion conduction by physically occluding the pore. The biological significance of this toxin lies in its role as a key component of the cone snail's venom arsenal, enabling rapid immobilization of prey through disruption of action potential propagation in the nervous system. Ensure the sequence reflects conserved residues critical for potassium channel interaction, such as a functional dyad involving a key lysine or arginine residue that penetrates the channel pore, while maintaining the overall globular, inhibitor cystine knot (ICK)-like topology typical of conotoxins. The final protein should exhibit high specificity for Kv1 channels over other ion channel families, with minimal off-target effects, and demonstrate stability in physiological conditions due to its disulfide-rich architecture."}
{"description": "sp|P86194|MYXC3_CRODM Crotamine-IV-3 OS=Crotalus durissus cumanensis OX=184542 PE=1 SV=1", "sequence": "YKQCHKKGGHCFPKEVLICIPPSSDFGKMDCRWKRKCCKKRS", "prompt": "Design a novel protein sequence for a myotoxin from the venom of the South American rattlesnake (Crotalus durissus cumanensis) that exhibits the characteristic biological activity of crotamine-like peptides. This toxin should function as a potent myotoxin that specifically targets and disrupts skeletal muscle cells, leading to rapid necrosis and paralysis. The protein should adopt the beta-defensin structural fold, featuring a compact, triple-stranded antiparallel beta-sheet stabilized by three conserved disulfide bonds in a Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 connectivity pattern (cysteine framework III). Incorporate key functional residues that facilitate membrane interaction and pore formation, including a cluster of basic amino acids that mediate initial electrostatic attraction to negatively charged phospholipid headgroups on muscle cell membranes. The sequence should include a conserved hydrophobic patch that inserts into lipid bilayers, disrupting membrane integrity and causing calcium influx. Maintain the characteristic cationic nature of this toxin family to ensure selective targeting of muscle tissues. The structural scaffold should enable specific recognition of voltage-gated potassium channels or other ion channels abundant in skeletal muscle, contributing to its myotoxic potency. Include molecular features that confer resistance to proteolytic degradation in the venom gland and target tissues."}
{"description": "sp|A8QL59|VM3_NAJAT Zinc metalloproteinase-disintegrin-like NaMP OS=Naja atra OX=8656 PE=2 SV=1", "sequence": "MIQPLLVAICLVVFPYQGSSTILESGKVRDYEVVYPQKIPSLPKGRLQRREEKTKYENTMKYEFKVNGEPVVLNLEKNKRLFSKDYTETHYSPDGREITTSPPVQDHCYYHGHIQNDADSTAVIRACDGLNGYFKSNGEMYIIEPLKLSDSEAHAVFKYESLEKEDETPKTCGAIHNSGESDETIKKISNTFVTPEKGEEYLEAEKHIELYMVADNLVYRKYSSNITVVRMRIFEILNYVNLYYKILNIHVVLIGLEVWSDEDKILINGSSELTVRSFAAWRHSDLLKHKRNDNAQLLTGIHFDKRVLGIAFIGGMCNNFTSVGAIQDNSIHAVLIAATMTHELGHNLGMNHDTDSCTCNTGPCIMKAALNFKPPYEFSSCSYWDFQNYIMTKSAQCILNDPLTTDIVPTAICGNGFVEEGEECDCGPPEICKNECCEAATCKLKPEAQCASGACCEECQFRRAGELCRAAKDDCDLDELCTGQSAECPMNHFHMNGHPCQNNQGYCFRGTCPTLTKQCIALWGPDAEVAPDGCFMNNQKGNYYGYCKKKNGTNIPCEPENVKCGRLYCIDDSTEENSCKFHFSNENANSGMVQPGTKCGEGMVCGFGECIGLETALGINQ", "prompt": "Design a venom metalloproteinase-disintegrin-like protein from the Chinese cobra (Naja atra) that functions as a key hemorrhagic toxin in snake venom. This protein should exhibit a multi-domain architecture typical of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that enables proteolytic cleavage of basement membrane components like type IV collagen and laminin. The disintegrin-like domain should adopt the characteristic cysteine-rich fold with disulfide-stabilized structure, potentially containing an RGD or related motif for integrin binding interference. The protein should demonstrate calcium-dependent conformational stability and target vascular endothelial cells, disrupting capillary integrity through extracellular matrix degradation and inhibition of platelet aggregation. The structural scaffold should include the characteristic metzincin topology with an active-site zinc ion coordinated by three histidines, maintaining the catalytic mechanism essential for hemorrhagic activity while preserving the disintegrin domain's ability to modulate cell adhesion processes."}
{"description": "sp|P0CJ22|NPY1_CONBE Neuropeptide Y1-like conopeptide OS=Conus betulinus OX=89764 PE=1 SV=1", "sequence": "TVSDPPARPAVFHSREELMNYVRELNRYFAIVGRPRF", "prompt": "Design a neuropeptide Y1-like conopeptide from the venom of Conus betulinus, a marine cone snail species. This toxin functions as a potent neuropeptide Y receptor ligand, specifically targeting NPY Y1 receptors with high affinity and selectivity. The peptide should adopt a stable, compact tertiary structure stabilized by a characteristic conopeptide cysteine framework, likely featuring a conserved disulfide bridge pattern that constrains the peptide backbone into a bioactive conformation. The molecular mechanism involves competitive antagonism or modulation of NPY Y1 receptor signaling, disrupting neuropeptide-mediated pathways involved in feeding behavior, anxiety, and cardiovascular regulation. The structural scaffold should exhibit the hallmark features of conopeptides: a small, disulfide-rich fold with defined loops that present key pharmacophore residues for receptor recognition and binding. The sequence must encode the appropriate cysteine spacing and conserved motifs essential for proper folding, stability in biological environments, and specific interaction with the extracellular domains of NPY Y1 receptors. Ensure the design reflects the evolutionary adaptation of cone snail venoms to precisely target vertebrate neurohormonal systems."}
{"description": "sp|Q5Y4W9|TAG2Q_AGEOR U2-agatoxin-Ao1q OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRSIISLLLISAMVFSMIAAVPEEEGLQLSEDERGGCLPHNRFCNALSGPRCFSGLRCKELSIWDSRCLG", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U2-agatoxin-Ao1q, belongs to the ω-agatoxin family and functions as a selective inhibitor of voltage-gated calcium channels. Specifically, it targets P/Q-type calcium channels (Cav2.1) with high affinity, blocking synaptic transmission by preventing calcium influx into presynaptic nerve terminals. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized β-sandwich fold. The cysteine framework is expected to follow the conserved pattern (C-C-CC-C-C) with three disulfide bridges that confer exceptional thermal and proteolytic stability. Key structural elements include a solvent-exposed β-hairpin loop responsible for channel binding, which interacts with the channel's pore-forming region via electrostatic and hydrophobic contacts. The toxin's mechanism involves precise occlusion of the channel pore, leading to rapid paralysis in insect prey. Incorporate conserved residues known to mediate target specificity, such as a basic patch for channel recognition and hydrophobic residues for membrane proximity. The overall structure should be globular, with the disulfide core providing rigidity while allowing functional loops to exhibit conformational flexibility for optimal target engagement."}
{"description": "sp|Q8MVZ2|KUNPM_ORNKA Savignygrin (-) OS=Ornithodoros kalahariensis OX=1580572 PE=1 SV=1", "sequence": "MQANIFVFAFLLLSVAVAAYGYQPECLEPSLYGCRGDEDATFGWTFDREDGGCRQGSYCTRFGQPKNYFRSEGDCKKACGGA", "prompt": "Design a protein sequence for a potent platelet aggregation inhibitor derived from the venom of the Kalahari soft tick, Ornithodoros kalahariensis. This protein should function as a savignygrin, a specific class of disintegrin-like molecules that antagonize platelet integrin receptors. The core mechanism involves high-affinity binding to the platelet glycoprotein IIb/IIIa complex (integrin αIIbβ3), thereby blocking fibrinogen binding and preventing thrombus formation. The structural scaffold must adopt the Kunitz-type fold, characterized by a compact, stable tertiary structure stabilized by three conserved disulfide bridges with the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. Key functional residues should be positioned within the exposed loop regions to mediate specific, reversible interaction with the integrin receptor's ligand-binding pocket. The sequence should reflect evolutionary optimization for hematophagous feeding, enabling the tick to maintain blood fluidity during prolonged feeding sessions by effectively disrupting hemostatic pathways in the host."}
{"description": "sp|F6K6F3|SCX2_MESEU Antimicrobial peptide MeuNaTxbeta-2 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MMKTVIVLIVFSLVMIVVKSDNGYLLDKYTGCKIWCVINNDSCNSHCIGSGGYYGYCYFWKLACYCQGAPRSELWHYETNRCRA", "prompt": "Design a novel antimicrobial peptide derived from the venom of the scorpion Mesobuthus eupeus, specifically belonging to the beta-KTX toxin family. This peptide should function as a potent antimicrobial agent with broad-spectrum activity against both Gram-positive and Gram-negative bacteria, likely through membrane disruption mechanisms involving electrostatic interactions with negatively charged bacterial membranes. The peptide should adopt a conserved structural scaffold characteristic of scorpion venom-derived antimicrobial peptides, featuring a compact, stable fold stabilized by three disulfide bridges arranged in a C1-C4, C2-C5, C3-C6 connectivity pattern. The structure should include an amphipathic alpha-helical domain that facilitates membrane interaction and pore formation, leading to bacterial cell lysis. Key structural elements should include a cationic surface patch for initial membrane binding, hydrophobic residues for membrane insertion, and a stable core maintained by the disulfide network. The peptide should exhibit high selectivity for bacterial membranes over mammalian cells, leveraging differences in membrane composition. The final sequence should reflect the evolutionary optimization of scorpion venom peptides for host defense, with potential applications as a novel antibiotic candidate."}
{"description": "sp|F5CPF0|PA226_MICAT Phospholipase A2 OS=Micrurus altirostris OX=129457 PE=2 SV=1", "sequence": "MNPAHLLVLAAVCISLSGASSIAPQPLNLIQFGNMIQCNNTRPSLDFSGYGCYCGRGGSGTPVDELDRCCQVHDNCYGEAETVHECDPYWTFYSYECSEGKLTCKDNNTKCKEFVCNCDREAANCFAKAPYIDSNYKNCK", "prompt": "Generate a phospholipase A2 (PLA2) toxin sequence from the venom of Micrurus altirostris, a coral snake species. This enzyme should exhibit the characteristic catalytic activity of hydrolyzing the sn-2 acyl bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the conserved PLA2 structural fold featuring three alpha-helices, a beta-wing region, and the canonical calcium-binding loop with the YGCYCG motif. Include the essential catalytic network comprising the conserved histidine-aspartate dyad and the calcium-coordinating residues. The sequence should contain the typical 6-8 disulfide bonds that stabilize the compact globular structure, with the conserved cysteine framework characteristic of snake venom PLA2s. This toxin likely contributes to the neurotoxic and myotoxic effects of coral snake venom through membrane disruption, presynaptic inhibition at neuromuscular junctions, and potential induction of tissue damage. The generated protein should maintain the amphipathic character necessary for membrane interaction while preserving the structural integrity required for enzymatic activity and target recognition."}
{"description": "sp|P83405|KAX96_HOTJU Potassium channel toxin alpha-KTx 9.6 OS=Hottentotta judaicus OX=6863 PE=1 SV=1", "sequence": "VGCEECPAHCKGKNAKPTCDDGVCNCNV", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the scorpion Hottentotta judaicus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels which play crucial roles in immune cell function and neuronal excitability. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with key functional residues for channel blockade. Include the conserved functional dyad consisting of a critical lysine residue positioned to interact with the channel pore and an aromatic residue that contributes to binding affinity through hydrophobic interactions. The toxin should exhibit high affinity binding to the external vestibule of Kv1.3 channels, physically occluding the ion conduction pathway and preventing potassium efflux, thereby modulating cellular excitability and calcium signaling in target cells. Ensure the sequence maintains the characteristic molecular weight of approximately 4-5 kDa and includes the signature pattern of conserved hydrophobic residues that stabilize the core CSαβ scaffold while allowing for specific channel subtype selectivity through strategic surface residue variations."}
{"description": "sp|A0A1Q1NL17|HA11_HYAAI Kunitz-type anticoagulant protein HA11 OS=Hyalomma asiaticum OX=266040 GN=HA11 PE=2 SV=1", "sequence": "MKTYLILATLALIFSAMLTNICAVAFEQPKYCTEAPGDGKCPGEVRPAISTANWTFSKSFGGCVAHRWGSCGNHSNVFPKCLSCMTTCDPENATTYCDGWN", "prompt": "Design a protein sequence for a Kunitz-type anticoagulant toxin derived from the hard tick Hyalomma asiaticum. This protein should function as a potent and specific inhibitor of key serine proteases in the mammalian blood coagulation cascade, particularly targeting Factor Xa or other coagulation factors to prevent clot formation, thereby facilitating blood feeding for the tick. The sequence must adopt the canonical Kunitz-type fold, characterized by a compact, stable structure dominated by anti-parallel beta-sheets and a single alpha-helix, stabilized by three conserved disulfide bonds with the characteristic Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The protein should contain the signature Kunitz domain with the reactive site loop that confers protease inhibitory activity, maintaining high specificity through precise molecular recognition at the enzyme's active site. The structural scaffold should ensure thermodynamic stability and resistance to proteolytic degradation, typical of tick-derived Kunitz inhibitors that have evolved for prolonged activity in the host bloodstream."}
{"description": "sp|Q5Y4X5|TAG2K_AGEOR U2-agatoxin-Ao1k OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MKAIISLLLISAMVFSVIEAVPVEEGLQLFEGERGCLPHNRFCNALSGPRCCSGLKSKELSIWDSRCLG", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin belongs to the U2-agatoxin family and functions as a selective inhibitor of insect voltage-gated calcium channels (VGCCs), specifically targeting P/Q-type calcium channels in the insect nervous system. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. This scaffold provides exceptional stability against proteolytic degradation and thermal denaturation, essential for oral insecticidal activity. The molecular mechanism involves high-affinity binding to the extracellular pore region of insect VGCCs, blocking calcium influx and disrupting synaptic transmission, leading to rapid paralysis and death in insect prey. Key structural features should include a solvent-exposed pharmacophore region comprising specific loops that mediate target recognition and binding specificity, while maintaining the core ICK fold for structural integrity. The toxin should exhibit selective toxicity towards insects while showing minimal activity against mammalian calcium channels, reflecting its evolutionary optimization for arthropod predation."}
{"description": "sp|F8J2D3|PLB_DRYCN Phospholipase-B 81 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MVRFGSAASSDNRRRRCWSWYWGGLLLLWAVAETRADLHYATVYWLEAEKSFQVKDLLDKNGDAYGYYNDTVQSTGWGILEIKAGYGSQLVSNEILMYAAGFLEGYLTASRMSDHVANLYHQMIKNVITEQKVKDFMQKQDEWTRQQIKNNKDDPFWRNAGYIIAQLDGLYMGNLEWAKRQKRTPLTKFEISFLNALGDLLDLIPALSPESRNNGFLSMSEISKMYEWDMGHCSALIKVLPGYENIYFAHSSWFTYAATLRIYKHLDFRIIDPQTKTGRASFSSYPGLLASLDDFYILGSGLIMLQTTNSVFNISLLQQVVPESLFAWERVRIANMMADSGKTWAQTFKKQNSGTYNNQYMILDTKKIKLRRSIEDGTLYIIEQVPNLVEYSDQTTILRKGYWPSYNIPFHKVIYNMSGYREYVQKYGLDFSYEMAPRAKIFRRDQGKVIDIESMKRIMRYNNYKKDPYTKHNPCNTICCRQDLYYMTPVPAGCYDSKVADINMAAKFTAYAINGPPVEKGLPIFSWVHFNETTHQGLPESYNFDFVTMKPVL", "prompt": "Design a phospholipase B toxin from the venom of the white-lipped snake, Drysdalia coronoides. This enzyme should function as a potent membrane-disrupting toxin that hydrolyzes both the sn-1 and sn-2 acyl chains of glycerophospholipids, leading to complete degradation of membrane phospholipids. The protein should exhibit the characteristic α/β hydrolase fold typical of phospholipase B enzymes, with a catalytic triad consisting of serine, aspartate, and histidine residues. Include the conserved GXSXG motif around the active site serine. The structure should feature multiple disulfide bridges to stabilize the globular fold and enhance stability in the venom environment. As a component of elapid snake venom, this phospholipase B should contribute to prey immobilization through membrane disruption, hemolysis, and potential myotoxic effects. The enzyme should demonstrate calcium-dependent catalytic activity and show optimal function at physiological pH and temperature. Consider incorporating structural elements that facilitate interaction with lipid bilayers and membrane interfaces."}
{"description": "sp|Q5Y4Y2|TAG2D_AGEOR U2-agatoxin-Ao1d OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "MRAIIYLLLISAMVFSMTKAVPEEEGLQLSEDERGGCLPHNRFCNALSGPRCCSGLKCKELSIYDSRCLG", "prompt": "Design a novel protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin belongs to the ω-agatoxin family, specifically functioning as a selective inhibitor of insect voltage-gated calcium channels (VGCCs). The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). This scaffold confers exceptional stability and resistance to proteolytic degradation. The toxin's mechanism of action involves high-affinity binding to the pore-forming α1 subunit of insect Cav channels, particularly those involved in synaptic transmission, leading to blockade of calcium influx and subsequent paralysis or death in insect prey. Key functional residues should be positioned within flexible loops extending from the ICK core to mediate target specificity and potency. The sequence must include the canonical cysteine framework for ICK toxins and incorporate hydrophobic and polar residues that facilitate membrane proximity and channel interaction. The overall structure should be globular, with a molecular weight typical of spider venom peptides (3-5 kDa), and exhibit features that enhance bioavailability in the insect hemolymph."}
{"description": "sp|P86261|CA1C_CONTE Alpha-conotoxin Tx1C OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "GCCSRPPCIANNPDIC", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by Conus textile venom, specifically emulating the functional and structural characteristics of alpha-conotoxin Tx1C. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, with particular affinity for alpha3beta2 and/or alpha6beta2 subtypes, contributing to the predatory strategy of cone snails by disrupting synaptic transmission in the nervous system of prey. The protein must adopt the characteristic alpha-conotoxin fold stabilized by a conserved disulfide bond framework with the cysteine pattern C-C-CC (Framework I), forming two disulfide bridges that create a compact, globular structure. The core scaffold should feature a beta-hairpin motif with well-defined loops that mediate receptor interaction, including the pharmacologically critical loop regions that determine receptor subtype selectivity. Key structural elements must include: (1) A rigid, disulfide-constrained core providing exceptional proteolytic stability, (2) Specific loop sequences that form the receptor binding interface, particularly residues in the primary and secondary loops that make direct contact with receptor subunits, (3) The characteristic alpha-helical tendencies in certain loop regions that contribute to receptor recognition, and (4) Surface properties that enable specific docking into the orthosteric binding site of target nicotinic receptors. The generated sequence must maintain the essential pharmacophore while exhibiting the high specificity and potency characteristic of Conus textile venom components for neurological targeting."}
{"description": "sp|P15223|SCX1_CENNO Toxin Cn1 OS=Centruroides noxius OX=6878 PE=1 SV=3", "sequence": "MNSLLMITACFVLIGTVWAKDGYLVDAKGCKKNCYKLGKNDYCNRECRMKHRGGSYGYCYGFGCYCEGLSDSTPTWPLPNKTCSGK", "prompt": "Generate a protein sequence for a potent animal toxin from the venom of the Mexican scorpion Centruroides noxius. This toxin belongs to the beta-toxin family and functions as a voltage-gated sodium channel modulator. It specifically targets and binds to site 4 of neuronal sodium channels, slowing inactivation and prolonging action potentials, which leads to hyperexcitability of the nervous system. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements include a conserved 'pharmacophore' region responsible for receptor binding and a functional core that mediates specific interactions with the voltage-sensing domain of the sodium channel. The sequence should contain the appropriate cysteine framework and conserved residues critical for maintaining structural integrity and biological activity, particularly those involved in the toxin's high affinity for mammalian neuronal sodium channels and its role in causing neurotoxic effects through altered channel gating."}
{"description": "sp|A8HDK6|3L21_PSETE Long neurotoxin 1 OS=Pseudonaja textilis OX=8673 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDSLICYLDFSVPHTCAPGEKLCYTRTWNDGRGTRIERGCAATCPIPKKPEIHVTCCSTDRCNPHPKQKPH", "prompt": "Design a protein sequence for a long neurotoxin from the Eastern brown snake (Pseudonaja textilis) that functions as a potent postsynaptic neurotoxin. This toxin should adopt the characteristic three-finger toxin fold with three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bonds in the C1-C5, C2-C3, C4-C6, C7-C8 connectivity pattern. The toxin should specifically target and irreversibly bind to the alpha-delta and alpha-gamma interfaces of muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, acting as a competitive antagonist that blocks acetylcholine binding and prevents postsynaptic depolarization. The sequence should feature the conserved structural elements of long neurotoxins, including an extended central loop that enhances receptor binding affinity and specificity. This neurotoxin contributes to the rapid neurotoxic paralysis characteristic of elapid snake envenomation, leading to respiratory failure in prey organisms through complete neuromuscular blockade."}
{"description": "sp|Q9TWD3|NDB12_BUTOI Bradykinin-potentiating peptide K12 OS=Buthus occitanus OX=6868 PE=1 SV=1", "sequence": "LRDYANRVINGGPVEAAGPPA", "prompt": "Design a bradykinin-potentiating peptide from the venom of the scorpion Buthus occitanus. This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and promoting vasodilation. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of scorpion venom peptides. It should exhibit high affinity for the active site of ACE, effectively competing with natural substrates. The sequence should include conserved residues critical for ACE inhibition and maintain the structural integrity necessary for biological activity in the context of scorpion venom's role in prey immobilization through cardiovascular effects."}
{"description": "sp|P15220|CTXI1_MESEU Insectotoxin-I1 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MCMPCFTTRPDMAQQCRACCKGRGKCFGPQCLCGYD", "prompt": "Design a protein sequence for a potent insect-specific neurotoxin derived from the venom of the scorpion Mesobuthus eupeus. This toxin should function as a sodium channel modulator, specifically targeting insect voltage-gated sodium channels (Nav channels) with high selectivity over mammalian counterparts. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. This structural framework should include four disulfide bridges with the characteristic cysteine pattern C1-C4, C2-C5, C3-C6, C7-C8 that defines the long-chain scorpion toxin family. The core structure should comprise an anti-parallel beta-sheet and several alpha-helical segments, creating a molecular surface with distinct functional regions for channel recognition and modulation. Key structural elements should include a conserved 'pharmacophore' region responsible for binding to receptor site 4 on insect Nav channels, leading to prolonged channel opening and membrane depolarization. The toxin should exhibit high potency against insect nervous systems while maintaining the evolutionary selectivity that minimizes effects on vertebrate sodium channels. The sequence should encode all necessary structural determinants for proper folding, including the conserved disulfide framework that confers thermal stability and protease resistance, along with surface residues critical for target recognition and species specificity."}
{"description": "sp|Q8AY47|PA2B2_BUNCA Basic phospholipase A2 beta-bungarotoxin A2 chain (Fragment) OS=Bungarus candidus OX=92438 PE=2 SV=1", "sequence": "AVCVSLLGAANIPPHPFNLINFMKMIRYTIPCEKTWGEYVDYGCYCGVGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKMQSYSYKLTKRTTSAMVPQVLVHVLSVIVTARQPSASAILNTSSGTRILTPRDIADDI", "prompt": "Generate the amino acid sequence for a basic phospholipase A2 toxin from the venom of the Malayan krait (Bungarus candidus), specifically the beta-bungarotoxin A2 chain. This protein functions as a presynaptic neurotoxin that forms a heterodimeric complex with a Kunitz-type protease inhibitor chain. The phospholipase A2 component exhibits calcium-dependent enzymatic activity, hydrolyzing phospholipids in neuronal membranes to disrupt neurotransmitter release at neuromuscular junctions. The protein should adopt the characteristic phospholipase A2 fold with a conserved catalytic triad (typically His-Asp-Tyr), multiple disulfide bridges stabilizing the compact globular structure, and a calcium-binding loop. Key structural elements include an N-terminal α-helix, a central β-sheet region, and a conserved 'pancreatic loop.' The basic nature of this toxin facilitates interaction with anionic phospholipid membranes. The generated sequence should reflect the potent neurotoxic activity through specific membrane-binding motifs and catalytic residues essential for phospholipid hydrolysis and subsequent synaptic blockade."}
{"description": "sp|Q8JJ51|VM1_CROMM Snake venom metalloproteinase OS=Crotalus molossus molossus OX=31151 PE=2 SV=1", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLVLSDSEAHAVFKLENVEKEDGGPKMCGVTQNWESYEPIKKASDLNFNSDQQRFAKRYVELVIVADHRMFMKYKSDLFSICSRVHDIVNFINWFYRSLNIRVSLTDLGIWSDQDYITVQSSAENTLHSFGEWGKSVLLKQKRHDNAQLLTAIVLDEDTLGLAYLSSMCNPWTSVEIIQDHSPINLLMGVTMAHELGHNLGMKHDEKDCLRGATLCIMRPGLTPGRSYEFSDDSMGYYQSFLDQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that mimics the hemorrhagic and tissue-damaging toxins found in the venom of the black-tailed rattlesnake (Crotalus molossus molossus). This metalloproteinase should function as a zinc-dependent endopeptidase capable of degrading key extracellular matrix components, particularly basement membrane proteins like type IV collagen, laminin, and fibronectin. The protein should feature the characteristic SVMP structural domains: a prodomain that maintains latency, a catalytic domain containing the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, and likely a disintegrin-like domain for potential interaction with integrins. The catalytic mechanism should involve zinc coordination at the active site for proteolytic cleavage of peptide bonds. The structural scaffold should adopt the metzincin fold typical of SVMPs, with a central beta-sheet flanked by alpha-helices and stabilization by multiple disulfide bridges. This toxin contributes to the prey immobilization strategy by inducing hemorrhage, disrupting vascular integrity, and facilitating venom spread through tissue degradation."}
{"description": "sp|A0A1P8NVS2|COW1_CONLI Contryphan-Li1 OS=Conus lividus OX=89426 PE=3 SV=1", "sequence": "MEKLTMLVLVAAVLLSAQVMVQGDGDQPADRDAVPRDDNPGGTIGKIMNVLLPSGCPWNPWCG", "prompt": "Design a novel contryphan peptide from the venom of the marine cone snail Conus lividus. This peptide should function as a potent neurotoxin targeting voltage-gated calcium channels, specifically inhibiting N-type calcium channels to disrupt neurotransmitter release and cause neuromuscular blockade. The peptide must adopt the characteristic contryphan structural scaffold featuring a highly constrained cyclic backbone stabilized by a single disulfide bridge between two conserved cysteine residues. Incorporate the signature post-translational modification of tryptophan bromination at position 7, which enhances receptor binding affinity and stability. The sequence should include the conserved proline-rich motif that defines the contryphan family and maintain the compact globular fold that enables precise interaction with the pore region of calcium channels. Ensure the peptide exhibits high selectivity for neuronal calcium channels over other ion channel types, with the brominated tryptophan residue playing a critical role in the binding interface. The final structure should be a small, stable cyclic peptide optimized for venom delivery and target specificity."}
{"description": "sp|P0DQA8|TXC1A_ETHRU U-scoloptoxin(12)-Er1a OS=Ethmostigmus rubripes OX=62613 PE=3 SV=1", "sequence": "MKGLFLVVFLMWFVSQMNTEETEEYVQFNVIEDPYPRLPRRNYSCSTMACPARHICGCMPTPITPETPYRDLDCGCYHEYDMMPVCEGL", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a U-scoloptoxin derived from the venom of Ethmostigmus rubripes, commonly known as the giant centipede. This toxin belongs to the scoloptoxin family, which are key components in centipede venom responsible for prey immobilization and defense. The core function of this toxin is to act as a potent neurotoxin that targets voltage-gated ion channels in the nervous system of prey organisms, likely interfering with neuronal signaling and causing paralysis. The protein should adopt a compact, stable structural fold characteristic of small cysteine-rich venom peptides, featuring multiple disulfide bridges that constrain the structure and enhance stability against proteolytic degradation. Based on the naming convention 'U-scoloptoxin' and typical centipede toxin architectures, the cysteine framework likely involves a conserved pattern such as C-C-CC-C-C or similar, forming 3-4 disulfide bonds that create a rigid scaffold. The 3D structure is anticipated to include an inhibitor cysteine knot (ICK) motif or related fold, common in animal toxins, which provides exceptional stability and defines the functional surface for target interaction. The molecular target is inferred to be voltage-gated sodium or potassium channels, with binding likely occurring at specific extracellular loops or pore regions to modulate ion flux. The sequence should reflect these structural and functional attributes, incorporating conserved residues for disulfide bonding and key surface residues for target specificity, while maintaining the overall compactness and stability essential for venom efficacy."}
{"description": "sp|I6R1R7|TX72C_SCOMU Kappa-scoloptoxin(07)-Ssm2c OS=Scolopendra mutilans OX=2836329 PE=3 SV=2", "sequence": "MLVFYAPLFVSIFSNTVMGATIDKPIPKPILREAIEKIAVNKRADSRYCKEEKCPPGKHCPKVPIVCVRGPCCF", "prompt": "Generate the amino acid sequence for a kappa-scoloptoxin from the venom of the Chinese red-headed centipede, Scolopendra mutilans. This toxin belongs to the scoloptoxin family and functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized globular fold with three conserved disulfide bridges forming the characteristic knot topology. The cysteine framework is expected to follow the pattern C-C-CC-C-C, with disulfide connectivity of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6. Key structural elements include a beta-hairpin and loops that form the functional surface for channel interaction. The toxin should exhibit high affinity and selectivity for Kv channels, likely binding to the channel pore or voltage-sensing domain to inhibit potassium efflux, leading to prolonged membrane depolarization, enhanced neurotransmitter release, and ultimately paralysis in prey. The sequence should reflect the typical length and physicochemical properties of centipede venom ICK toxins, with conserved hydrophobic core residues and surface-exposed polar/charged residues involved in target recognition."}
{"description": "sp|F8J2D0|PA214_DRYCN Phospholipase A2 147 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGAASVPPQPLNLVQFGYLIQCANHGSRATWHYMDYGCYCGAGGSGTPVDDLDRCCKIHDDCYGDAEKKGCSPKMLAYDYYCGENGPYCKNIKKECQRFVCDCDVKAAKCFAGAPYNDANWNIDTTKHCQ", "prompt": "Design a phospholipase A2 toxin from the venom of the white-lipped snake, Drysdalia coronoides, that functions as a potent enzymatic toxin targeting biological membranes. This protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid which can initiate inflammatory cascades. The structural scaffold should feature the characteristic phospholipase A2 fold with conserved catalytic residues (typically including a histidine-aspartate dyad), a calcium-binding loop with consensus sequence, and the distinctive pancreatic loop. Include the conserved disulfide bridge pattern characteristic of group I/II phospholipase A2 toxins, with multiple intramolecular disulfide bonds stabilizing the compact globular structure. The protein should possess surface-exposed hydrophobic residues that facilitate membrane interaction and interfacial activation. The mature toxin should demonstrate both presynaptic and postsynaptic neurotoxic effects through membrane disruption, potentially causing hemolysis, myotoxicity, and anticoagulant activity through its phospholipid hydrolysis mechanism."}
{"description": "sp|P24776|3SB2_HEMHA Cytotoxin 2 OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LKCHNKVVPFLSKTCPEGKNLCYKMTLKKVPKIPIKRGCTDACPKSSLLVNVMCCKTDKCN", "prompt": "Generate a protein sequence for a cytotoxin from the venom of the rinkhals cobra (Hemachatus haemachatus) that functions as a potent membrane-disrupting agent. This three-finger toxin should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8, forming the core structural scaffold. The protein should exhibit strong cytolytic activity through direct interaction with cell membranes, particularly targeting anionic phospholipids and causing membrane permeabilization. Key structural features should include three extended β-stranded loops emerging from a central hydrophobic core, with conserved hydrophobic residues in loop regions that facilitate membrane insertion and disruption. The toxin should demonstrate preferential cytotoxicity toward various cell types, including cancer cells, through mechanisms involving pore formation or detergent-like membrane destabilization. The sequence should maintain the characteristic three-finger toxin topology while incorporating specific residues that confer membrane-binding affinity and cytolytic potency characteristic of snake venom cytotoxins."}
{"description": "sp|P83560|TXMG4_MACGS Delta-hexatoxin-Mg1a OS=Macrothele gigas OX=223896 PE=1 SV=2", "sequence": "MKTLVIACVALVLVVVHGEVIEEVNEKQLQESVEEKYSLLQRLEKLDEAITAEENRNSRVRRCGSKRAWCKEKKDCCCGYNCVYAWYNQQSSCERKWKYLFTGEC", "prompt": "Design a novel animal toxin protein sequence based on the venom of the funnel-web spider Macrothele gigas. This toxin belongs to the delta-hexatoxin family and functions as a potent insecticidal neurotoxin. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. The mechanism of action involves specific antagonism of insect voltage-gated sodium channels, prolonging channel opening and causing persistent neuronal excitation leading to paralysis. Key structural elements should include: a conserved hydrophobic core maintaining the ICK scaffold, surface-exposed loops responsible for target receptor interaction, and specific residues forming the pharmacophore that binds to domain II of the insect sodium channel. The toxin should exhibit high selectivity for insect over mammalian sodium channels, with appropriate surface charge distribution and molecular surface topology for optimal target engagement. The sequence should reflect the evolutionary optimization for rapid immobilization of arthropod prey, characteristic of spider venom toxins."}
{"description": "sp|P0C7B1|VM3BG_BOTAL Zinc metalloproteinase-disintegrin-like BaG (Fragment) OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "SISACNGLKGHFLIEPLKLSDSEKTDLLNRSHDNAQLSPINLVVAVIMAHEMGHGMVLPGTK", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin fragment from Bothrops alternatus (Urutu snake). This toxin represents a key component of viperid venom that facilitates prey immobilization through disruption of hemostatic systems. The protein should function as a zinc-dependent metalloproteinase that targets and cleaves extracellular matrix components, particularly basement membrane proteins like type IV collagen and fibronectin, leading to hemorrhage and tissue damage. Simultaneously, it should contain a disintegrin-like domain that inhibits platelet aggregation by blocking integrin receptors on platelet surfaces, specifically interfering with fibrinogen binding. The structural scaffold should feature the characteristic reprolysin family metalloproteinase fold with a conserved zinc-binding motif (HEXXHXXGXXH) in the catalytic domain. The disintegrin-like domain should adopt the typical disintegrin fold with key functional motifs for integrin recognition. The protein should contain multiple disulfide bridges stabilizing both domains, with the metalloproteinase domain typically having 4-5 conserved disulfides and the disintegrin domain featuring the characteristic disulfide pattern that maintains its integrin-binding loop structure. The overall architecture should enable proteolytic activity against vascular basement membranes while presenting the disintegrin motif in a conformation that effectively blocks platelet integrin function, creating a synergistic hemorrhagic and anti-hemostatic effect characteristic of Bothrops alternatus venom."}
{"description": "sp|B0FXM3|VSP17_CRODU Thrombin-like enzyme gyroxin B1.7 OS=Crotalus durissus terrificus OX=8732 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRLLAIVYTNSSQCAGTLINQEWVLTAAHCDGENMDIYLGVHNESVQYDDEEGRVAAEKFFCLSSRNYTKWDKDIMLIRLNIPVRNSTHIAPLSLPSSPPSVGSVCRVMGWGTITSPNETYPDVPHCANINLFDYEVCLAAYPEFGLPATSRTLCAGIQQGGKDTCGSDSGGSLICNGQFQGIVSWGDNPCAQPHKPALYTKVLDDTEWIQSIIAGNTAVTCPP", "prompt": "Design a serine protease enzyme from the venom of the South American rattlesnake (Crotalus durissus terrificus) that functions as a thrombin-like enzyme with gyroxin activity. This toxin should exhibit dual functionality: (1) act as a procoagulant by cleaving fibrinogen to fibrin, promoting blood clot formation through selective proteolysis of fibrinogen Aα and Bβ chains while sparing coagulation factor XIII, and (2) induce neurotoxic effects including barrel rotation syndrome in mammalian models through interaction with the central nervous system. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His57, Asp102, Ser195 in chymotrypsin numbering) and maintain the S1 specificity pocket optimized for arginine residues. Include the conserved structural features of snake venom serine proteases, including the heavy and light chains connected by a disulfide bridge, with appropriate N-glycosylation sites for stability. The enzyme should demonstrate substrate specificity distinct from mammalian thrombin, preferentially targeting fibrinogen while having minimal effect on other coagulation cascade components. The structural scaffold should feature the characteristic β-barrel architecture of trypsin-like proteases with the activation peptide cleaved to generate the mature, active enzyme."}
{"description": "sp|P24777|3SB3_HEMHA Cytotoxin 3 OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LKCHNKLVPFLSKTCPDGKNLCYKMSMEVTPMIPIKRGCTDTCPKSSLLVKVVCCKTDKCN", "prompt": "Design a cytotoxin protein from the venom of the rinkhals cobra (Hemachatus haemachatus) that functions as a potent membrane-disrupting agent. This three-finger toxin should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The protein should exhibit strong cytolytic activity through direct interaction with cell membranes, causing pore formation and cell lysis. The molecular mechanism involves binding to lipid membranes via hydrophobic patches and basic residues distributed across loops I, II, and III, leading to membrane destabilization. The structural scaffold should feature the conserved three-finger topology with extended β-strands forming a central core, while maintaining the amphipathic character essential for membrane interaction. The toxin should demonstrate preferential activity against specific cell types, consistent with the cytotoxin family's role in prey immobilization and digestion facilitation in elapid snake venoms."}
{"description": "sp|Q8QG86|VSP_BOTIN Snake venom serine protease BITS01A OS=Bothrops insularis OX=8723 PE=2 SV=1", "sequence": "MVLIRVIANLLILQVSYAQKSSELVVGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVLTAAHCDRRFMRIYLGIHARSVANDDEVIRYPKEKFICPNKNMSDEKDKDIMLIRLNRPVKNSTHIAPISLPSNPPSVGSVCRVMGWGSITIPNDTYPDVPHCANINLVNDTVCRGAYKRFPAKSRTLCAGVLQGGKDTCVGDSGGPLICNGTFQGIVSWGGKVCARPRKPALYTKVFDYLPWIQSIIAGNKTATCPP", "prompt": "Design a snake venom serine protease from the jararaca ilhoa (Bothrops insularis) that functions as a key hemostatic toxin. This enzyme should exhibit trypsin-like or thrombin-like serine protease activity, targeting specific components of the coagulation cascade to disrupt normal blood clotting. The protein should feature a canonical serine protease fold with a catalytic triad of histidine, aspartate, and serine residues arranged in the characteristic charge-relay system. Include the conserved structural elements: a two-domain architecture with six-stranded beta-barrel domains, the activation peptide cleavage site that generates the mature enzyme, and the substrate-binding pocket with specificity-determining loops that confer selective recognition of fibrinogen, coagulation factors, or platelet receptors. The enzyme should possess the typical disulfide bond pattern that stabilizes the serine protease fold, including the conserved cysteine framework that maintains structural integrity in the venom environment. Consider the biological context of Bothrops insularis venom, which evolved to immobilize prey through rapid induction of coagulopathy, hemorrhage, and systemic effects. The designed protease should demonstrate high specificity for its physiological targets while maintaining stability in the complex venom milieu."}
{"description": "sp|A8N285|3L22H_OPHHA Long neurotoxin LNTX-2 homolog OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTTKCYVTPDATSQTCPDGENICYTKSWCDVFCSSRGKRIDLGCAATCPKVKPGVDIKCCSTDNCNPFTPWKRH", "prompt": "Design a protein sequence for a long neurotoxin from the king cobra (Ophiophagus hannah) venom system. This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The core mechanism involves high-affinity binding to nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, specifically targeting the α-δ and α-γ subunit interfaces. The toxin should feature an extended central loop (loop II) that penetrates deep into the receptor binding pocket, competitively inhibiting acetylcholine binding and causing flaccid paralysis. Key functional residues should be concentrated in the central loop and tips of the other two loops, maintaining the conserved hydrophobic core and β-sheet scaffold typical of long neurotoxins. The sequence should exhibit the characteristic length and structural features that distinguish long neurotoxins from short-chain neurotoxins, including enhanced receptor specificity and prolonged binding duration."}
{"description": "sp|Q8T0W2|CVP4_PIMHY Pacifastin-like protease inhibitor cvp4 OS=Pimpla hypochondriaca OX=135724 PE=1 SV=1", "sequence": "MGFLACALLVVATAHAATAIVNPETCEIGSNFKNYCNNCYCFDGVMDHALCTRESCDRNVWNEDGTRKFPKPGKWISEKENKKNDEPCTPGENFKYYCNDCQCLDGLRAHAMCTRMRCDRNVFNEDGTRKYPEPEKWNSEKERKKSDESCAPGASFKYYCNSCTCGAEGKVAEAQCTSQECDRYKWKKDGSKRPFTLDPVLHD", "prompt": "Design a protein sequence for a pacifastin-like protease inhibitor from the parasitic wasp Pimpla hypochondriaca. This venom component functions as a serine protease inhibitor that likely targets host defense proteases, particularly those involved in the insect prophenoloxidase (proPO) activation cascade, thereby suppressing melanization and immune responses in parasitized hosts. The protein should adopt the characteristic pacifastin inhibitor fold, featuring a conserved structural motif with multiple inhibitory domains. Each domain is expected to contain the canonical Cys-Xaa9-12-Cys-Asn-Xaa-Cys-Xaa-Cys-Xaa2-3-Gly-Xaa3-6-Cys consensus pattern, forming three disulfide bridges with a 1-4, 2-5, 3-6 connectivity that stabilizes a compact, rigid structure. The inhibitor should exhibit high specificity for serine proteases through its reactive site loop, which presents key residues for protease binding and inhibition. The overall architecture should be small, stable, and resistant to proteolytic degradation, enabling effective immune suppression in the host environment."}
{"description": "sp|P0C1X5|KA182_TITDI Potassium channel toxin alpha-KTx 18.2 OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "TGPQTTCQASTCEAGCKQIGKSMKSCQGDTCECA", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Tityus discrepans. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels, specifically Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core consists of an alpha-helix packed against a three-stranded anti-parallel beta-sheet. Key functional residues should be positioned in the functional dyad, typically involving a critical lysine residue in the beta-sheet region that penetrates the potassium channel pore, and aromatic residues that interact with the channel vestibule. The toxin should exhibit high affinity and selectivity for Kv1 channels, disrupting neuronal excitability and neuromuscular transmission through pore occlusion. The mature peptide should be approximately 30-40 amino acids in length with the characteristic compact, globular structure stabilized by the disulfide network."}
{"description": "sp|B0VXV3|TXVE1_SISCA Snake venom vascular endothelial growth factor toxin 1 OS=Sistrurus catenatus edwardsii OX=8762 PE=2 SV=1", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGQAMPFMEVFERSVCQTREMLVSILDEHPDEVAHLFRPSCVTVLRCGGCCTDESLMCTATGKRSVGREIMRVDPRKETSKIQVMQFTEHTKCECRPRSGRVNSGKRKRNPEEGGAESQVPLGLTSF", "prompt": "Design a snake venom-derived protein that functions as a vascular endothelial growth factor (VEGF) toxin, originating from the venom of the desert massasauga rattlesnake (Sistrurus catenatus edwardsii). This toxin should exhibit potent anti-angiogenic activity by competitively binding to VEGF receptors, particularly VEGFR-1 and VEGFR-2, thereby disrupting normal VEGF signaling pathways. The protein should adopt the characteristic VEGF-fold structural scaffold, featuring a cysteine-knot motif with conserved disulfide connectivity (C1-C4, C2-C5, C3-C6) that stabilizes the homodimeric structure. Key functional domains should include the receptor-binding interface with critical residues for high-affinity interaction, mimicking endogenous VEGF but with enhanced receptor blockade properties. The toxin should demonstrate selective inhibition of endothelial cell proliferation and migration, contributing to the venom's hemorrhagic and tissue-damaging effects through disruption of vascular integrity and wound healing processes."}
{"description": "sp|P0DQA9|TXD1A_ETHRU U-scoloptoxin(13)-Er1a OS=Ethmostigmus rubripes OX=62613 PE=3 SV=1", "sequence": "MFPSWSTTFVLCMGLCSLMNGALAQYDEGASIEDFEFRSACTTANNVCERMADTCCPGLQCIGCNPLDPDDDGHCSCQ", "prompt": "Design a novel centipede venom peptide based on the U-scoloptoxin family from Ethmostigmus rubripes (giant centipede). This toxin should function as a potent voltage-gated sodium channel (Nav) modulator, specifically targeting insect Nav channels to induce rapid paralysis through disruption of action potential generation. The peptide should adopt the characteristic structural scaffold of centipede venom peptides, featuring a compact, disulfide-stabilized fold with the conserved cysteine framework C1-X6-C2-X3-C3-X9-10-C4-X1-2-C5-X4-6-C6 (where C represents cysteine residues forming three disulfide bridges with connectivity C1-C4, C2-C5, C3-C6). This arrangement creates a stable inhibitor cystine knot (ICK) motif that provides exceptional thermal and proteolytic stability. The mature peptide should be approximately 46-50 amino acids in length with a calculated molecular weight around 5-6 kDa. Key structural elements should include an N-terminal flexible region preceding the first cysteine, a well-defined beta-hairpin structure between C2 and C3, and a C-terminal alpha-helical segment following C6. The molecular surface should display a conserved hydrophobic patch for membrane interaction and specific charged residues for channel recognition. The toxin should exhibit selective insecticidal activity while maintaining the characteristic rapid onset of action typical of centipede venom components, making it an effective neurotoxin for prey immobilization."}
{"description": "sp|Q4PRD1|SLLC1_DABSI Snaclec coagulation factor X-activating enzyme light chain 1 OS=Daboia siamensis OX=343250 GN=LC1 PE=1 SV=2", "sequence": "MGRFISVSFGCLVVFLSLSGTEAVLDCPSGWLSYEQHCYKGFNDLKNWTDAEKFCTEQKKGSHLVSLHSREEEEFVVNLISENLEYPATWIGLGNMWKDCRMEWSDRGNVKYKALAEESYCLIMITHEKEWKSMTCNFIAPVVCKF", "prompt": "Generate the protein sequence for a snake venom C-type lectin-like protein (snaclec) from the venom of Daboia siamensis (Eastern Russell's viper) that functions as the light chain component of a coagulation factor X-activating enzyme complex. This toxin plays a critical role in the viper's venom by initiating the blood coagulation cascade through specific activation of coagulation factor X, leading to consumptive coagulopathy and potential hemorrhage in prey. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The structural scaffold should display the hallmark β-sheet sandwich architecture with α-helical elements, presenting specific surface loops that mediate high-affinity binding to coagulation factor X. The molecular mechanism involves calcium-independent recognition and binding to specific domains on factor X, inducing conformational changes that promote its activation to factor Xa. The generated sequence should maintain the conserved structural determinants for heterodimer formation with its heavy chain partner, preserving the functional interface required for enzymatic complex assembly and substrate recognition specificity within the snake venom prothrombin activator group."}
{"description": "sp|P0DX99|TO2B_ATRRO Omega-hexatoxin-Hr2b OS=Atrax robustus OX=6903 PE=3 SV=1", "sequence": "MKFSKLSLTLALILTQVLFVLCGKINEDFMKHGLESQALHDEIRKPIDSENPDTERLLDCLLDNRVCSSDKDCCGMTPSCTMGLCVPSVGGLVGGILG", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin derived from the venom of the Sydney funnel-web spider, Atrax robustus. This toxin belongs to the ω-hexatoxin family and functions as a selective inhibitor of insect voltage-gated calcium channels (VGCCs), specifically targeting Cav2-type channels. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded antiparallel beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). This scaffold confers exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves high-affinity binding to the pore-forming α1 subunit of insect VGCCs, blocking calcium influx into presynaptic nerve terminals and disrupting neurotransmitter release, leading to rapid paralysis and death in insect prey. The toxin should exhibit specificity for insect over mammalian calcium channels, reflecting its ecological role in prey capture. Key structural elements include a hydrophobic patch and basic residues critical for channel interaction, with the bioactive surface primarily located on loops 2 and 4 of the ICK fold. The sequence should encode the canonical cysteine framework of spider neurotoxins and maintain the conserved structural core while allowing for functional diversification in loop regions."}
{"description": "sp|P15503|VM2TA_CRAGM Zinc metalloproteinase/disintegrin OS=Craspedocephalus gramineus OX=8767 PE=1 SV=3", "sequence": "MIQVLLITICLAVFPYQGSSIILESGNLNDYEVVYPEKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSEIHYSPDGREITAYPSVEDHCYYHGRIENDADSTASISACDGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEPPKMCGVTQNWESYESTKKASQLNVTPEQQRFPQRYIKLGIFVDHGMYTKYSGNSERITKRVHQMINNINMMCRALNIVTTLSVLEIWSEKDLITVQASAPTTLTLFGAWRETVLLNRTSHDHAQLLTATIFNGNVIGRAPVGGMCDPKRSVAIVRDHNAIVFVVAVTMTHEMGHNLGMHHDEDKCNCNTCIMSKVLSRQPSKYFSECSKDYYQTFLTNHNPQCILNAPLRTDTVSTPVSGNELLEAGEDCDCGSPANPCCDAATCKLIPGAQCGEGLCCDQCSFIEEGTVCRIARGDDLDDYCNGRSAGCPRNPFHA", "prompt": "Design a venom protein sequence from the green pit viper (Craspedocephalus gramineus) that functions as a zinc metalloproteinase-disintegrin fusion toxin. This protein should exhibit dual functionality: first, as a zinc-dependent metalloproteinase that degrades extracellular matrix components through proteolytic cleavage, targeting substrates like fibrinogen, collagen, or other basement membrane proteins to induce hemorrhage and tissue damage. Second, it should contain a disintegrin domain that specifically inhibits platelet aggregation by binding to integrin receptors on platelet surfaces, particularly targeting αIIbβ3 integrin to disrupt fibrinogen binding and prevent clot formation. The protein should feature the characteristic zinc-binding motif HEXXHXXGXXH in the metalloproteinase domain for catalytic activity, and an RGD (Arg-Gly-Asp) or related tripeptide motif in the disintegrin domain for integrin recognition. Structurally, it should adopt a multi-domain architecture with distinct metalloproteinase and disintegrin regions, stabilized by multiple disulfide bridges characteristic of snake venom metalloproteinases. The metalloproteinase domain should contain the conserved methionine turn and maintain proper zinc coordination geometry, while the disintegrin domain should fold into a compact, disulfide-rich structure that presents the integrin-binding motif in an optimal conformation for receptor interaction. This dual-action toxin contributes to the viper's prey immobilization strategy by simultaneously promoting hemorrhage through matrix degradation and preventing hemostasis through platelet inhibition."}
{"description": "sp|B3EWY2|BNPL2_CROLY Natriuretic peptide Coa_NP2 OS=Crotalus lutosus abyssus OX=128077 PE=1 SV=1", "sequence": "SYGISSGCFGLKLDRIGTMSGLGCWRLLQDSP", "prompt": "Design a natriuretic peptide toxin from the venom of the Great Basin rattlesnake (Crotalus lutosus abyssus) that functions as a potent vasodilator and diuretic agent. This toxin should mimic the biological activity of mammalian natriuretic peptides but with enhanced potency and stability. The protein should adopt the characteristic natriuretic peptide fold consisting of a 17-amino acid ring structure stabilized by a single conserved disulfide bridge between two cysteine residues, forming the core pharmacophore. The N-terminal and C-terminal regions should extend from this ring structure, with the C-terminal tail likely contributing to receptor binding specificity. The toxin should specifically target and activate the natriuretic peptide receptor-A (NPR-A), binding to its extracellular domain to stimulate intracellular guanylyl cyclase activity, leading to increased cyclic GMP production. This mechanism should result in smooth muscle relaxation, vasodilation, increased renal sodium excretion, and inhibition of the renin-angiotensin-aldosterone system. The structural scaffold should maintain the conserved cysteine framework (C-C) characteristic of natriuretic peptide toxins, with the disulfide-constrained ring essential for receptor recognition and biological activity. The protein should exhibit enhanced proteolytic stability compared to endogenous natriuretic peptides, contributing to its prolonged hypotensive effects in prey organisms."}
{"description": "sp|B3EWY3|BNPL1_CROLY Natriuretic peptide Coa_NP1 OS=Crotalus lutosus abyssus OX=128077 PE=1 SV=1", "sequence": "SKRLSNGCFGLKLDRIGAMSGLGCWRLINESK", "prompt": "Generate the amino acid sequence for a natriuretic peptide toxin from the venom of the Great Basin rattlesnake, Crotalus lutosus abyssus. This toxin belongs to the natriuretic peptide family and functions as a potent vasodilator by mimicking endogenous natriuretic peptides. The protein should exhibit the characteristic structural fold of natriuretic peptides, featuring a conserved 17-amino acid disulfide-bonded ring structure formed by two cysteine residues that create a single disulfide bridge essential for structural stability and receptor binding. The molecular mechanism involves binding to and activating natriuretic peptide receptors (NPR-A and NPR-B), leading to increased cyclic GMP production, which promotes vasodilation, natriuresis, and diuresis. This contributes to the venom's hypotensive effects in envenomation by reducing blood pressure through vascular smooth muscle relaxation. The sequence should include the conserved functional motifs required for receptor recognition and activation, particularly the residues critical for binding to the natriuretic peptide receptor guanylyl cyclase domain. The overall structure should be compact and stable, typical of small peptide hormones, with the disulfide bridge maintaining the bioactive conformation necessary for its cardiovascular effects."}
{"description": "sp|P86389|PA2A2_BOTAS Acidic phospholipase A2 2 OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "NLWQFGQMMSDVMRKNVVFKYLSYGCYCGWGGIGQPKDATDRCCFVHDCCYGKVTGCDPKMDIYTYTYSKENGDVVCGGDDPCKKQICECDRVAAICFRDNKDTYDSKYWFYGAKNCQEDSEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops asper, a highly venomous pit viper. This enzyme plays a critical role in the venom's potent hemotoxic and myotoxic effects by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to systemic inflammation, tissue damage, and coagulopathy. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges (typically 6-7 disulfide bonds with a pattern such as Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, etc.). Include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, with a histidine-aspartate dyad in the active site. The acidic nature (low pI) should be reflected in the sequence through an abundance of aspartate and glutamate residues. The toxin likely targets mammalian cell membranes, particularly erythrocytes and muscle cells, with its enzymatic activity leading to hemolysis and myonecrosis."}
{"description": "sp|P0C1X6|KA183_TITDI Potassium channel toxin alpha-KTx 18.3 OS=Tityus discrepans OX=57059 PE=1 SV=2", "sequence": "MHFSGVAFILISMVLIGSIFETTVEAGEGPKSDCKPDLCEAACKDLGKPMDFCKDGTCKCKD", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom biochemistry. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved alpha-KTx structural scaffold characteristic of scorpion toxins, featuring a compact beta-sheet-rich fold stabilized by a specific cysteine framework with three disulfide bridges arranged in a C1-C4, C2-C5, C3-C6 connectivity pattern. Incorporate key functional motifs including a conserved dyad of critical lysine and aromatic residues positioned to interact with the channel pore region, along with surface-exposed basic residues that facilitate electrostatic steering toward the negatively charged channel vestibule. The sequence should maintain the characteristic molecular surface topology that enables high-affinity binding to the potassium channel selectivity filter, effectively occluding ion conduction. Ensure the structural integrity includes a well-defined functional surface with appropriate loop regions that confer both target specificity and the stability required for venom deployment in predatory and defensive contexts."}
{"description": "sp|P0C5X7|JZT45_CHIGU Kappa-theraphotoxin-Cg2a OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=2", "sequence": "MKGSAFAIILGLVVLCACSFAEDEQDQFASPNELLRSMFLESRHELIPEVEGRYCQKWMWTCDSERKCCEGYVCELWCKYNLG", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This toxin originates from the venom of the Chinese earth tiger tarantula, Chilobrachys guangxiensis, a theraphosid spider whose venom contains diverse peptide toxins that modulate neuronal excitability. The protein belongs to the kappa-theraphotoxin family, specifically kappa-theraphotoxin-Cg2a, which functions as a potent inhibitor of voltage-gated potassium channels, particularly Kv channels involved in action potential repolarization. The toxin likely adopts an inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. This scaffold provides exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves high-affinity binding to the voltage-sensing domain or pore region of Kv channels, blocking potassium efflux and prolonging neuronal depolarization, leading to hyperexcitability and potential paralysis in prey. Key structural elements include a conserved hydrophobic patch for membrane interaction and a basic residue-rich surface for electrostatic steering toward the channel. The sequence should reflect a typical ICK fold with six cysteine residues forming the knot, a molecular weight of approximately 3-5 kDa, and a net positive charge to facilitate channel targeting. Ensure the design captures the biological function of potassium channel blockade, the structural robustness of the ICK motif, and the evolutionary adaptations for venom efficacy in arthropod predation."}
{"description": "sp|P69770|CX2_CONMR Conotoxin Gla-MrII OS=Conus marmoreus OX=42752 PE=1 SV=2", "sequence": "MFGHTSVSFLLLSIVALGMVATVICSCDSEFSSEFCEQPEERICSCSTHVCCHLSSSKRDQCMTWNRCLSAQTGNRRSTHMQKRFLRMPRDLAD", "prompt": "Design a novel conotoxin sequence derived from the venom of the marine cone snail Conus marmoreus, specifically belonging to the Gla-MrII family. This toxin should function as a potent modulator of neuronal signaling, likely targeting voltage-gated calcium channels or other ion channels involved in synaptic transmission. The sequence must incorporate the characteristic cysteine framework of conotoxins, typically featuring multiple disulfide bridges that stabilize a compact, globular fold essential for receptor binding and biological activity. Key structural elements should include a well-defined secondary structure with alpha-helices and/or beta-sheets, forming a stable scaffold that enables high-affinity interaction with its molecular target. The toxin should exhibit high specificity and potency, contributing to the predatory efficacy of Conus marmoreus venom by disrupting neuromuscular or neuronal function in prey. Ensure the sequence reflects conserved residues critical for folding, stability, and function, while maintaining the overall physicochemical properties typical of conotoxins, such as a small size, high disulfide content, and surface-exposed loops involved in target recognition."}
{"description": "sp|P83312|NDB25_PARSC Parabutoporin OS=Parabuthus schlechteri OX=190110 PE=1 SV=1", "sequence": "FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ", "prompt": "Design a novel animal toxin protein sequence based on the biological profile of parabutoporin from the venom of Parabuthus schlechteri, a medically significant scorpion species. This toxin functions as a potent cytolytic peptide that disrupts cell membranes through pore formation, leading to rapid cell lysis and tissue damage. The protein should adopt an amphipathic alpha-helical structure that facilitates membrane insertion and oligomerization into transmembrane pores. Key structural characteristics include: a linear peptide scaffold without disulfide bridges, allowing conformational flexibility for membrane interaction; a well-defined amphipathic architecture with hydrophobic residues on one face for membrane penetration and cationic residues on the opposite face for initial electrostatic interactions with negatively charged phospholipid headgroups; and a length-optimized helical domain that spans lipid bilayers. The mechanism involves initial electrostatic attraction to anionic membrane surfaces, followed by reorientation and insertion into the lipid bilayer, culminating in the formation of toroidal pores that compromise membrane integrity. This cytolytic activity represents a fundamental venom strategy for prey immobilization and tissue penetration, making it evolutionarily conserved across scorpion species as a primary offensive weapon."}
{"description": "sp|Q8AYA3|SLB2_DEIAC Snaclec agglucetin subunit beta-2 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLRGTGAGFCCPLRWSSYEGHCYLVVKEKKTWDDAEKFCTEQRKGGHLVSVHSREEADFLVHLAYPILDLSLIWMGLSNMWNDCKREWSDGTKLDFKAWAKTSDCLIGKTDGDNQWLNMDCSKKHYFVCKFKL", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a subunit of the heterodimeric toxin agglucetin. This protein originates from the venom of Deinagkistrodon acutus (hundred-pace snake), a medically significant pit viper whose venom components target hemostatic pathways. As the beta-2 subunit of agglucetin, the protein should form a heterodimer with its alpha subunit partner through non-covalent interactions, creating a functional complex that binds platelet membrane receptors. The core mechanism involves targeting platelet glycoproteins, likely GPIb or GPVI, to either inhibit or activate platelet aggregation depending on the specific agglucetin function—typically leading to thrombocytopenia or impaired coagulation. Structurally, adopt the characteristic C-type lectin-like domain (CTLD) fold: a double-loop stabilized by two conserved disulfide bridges (Cys1-Cys4, Cys2-Cys3 in the C-C-C-C pattern), forming a compact globular domain with β-sheets and α-helices. Include key residues for carbohydrate recognition domain (CRD) functionality if applicable, though snaclecs often evolve to lose sugar-binding in favor of protein-protein interactions. The binding interface should feature surface loops that mediate specific, high-affinity interaction with the platelet receptor, potentially through electrostatic complementarity or hydrophobic patches. Ensure the sequence reflects viperid snaclec conservation patterns while enabling the heterodimer assembly and receptor targeting essential for this toxin's disruption of hemostasis."}
{"description": "sp|P59867|KAX63_HETSP Potassium channel toxin alpha-KTx 6.3 OS=Heterometrus spinifer OX=118530 PE=1 SV=1", "sequence": "ASCRTPKDCADPCRKETGCPYGKCMNRKCKCNRC", "prompt": "Design a potent animal toxin peptide that functions as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity. This toxin should originate from the venom of the Malaysian forest scorpion Heterometrus spinifer, where it serves as a key defensive and predatory component by disrupting neuronal excitability and muscle function through potassium channel inhibition. The peptide should adopt the characteristic alpha-KTx structural scaffold, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The structure should comprise a short alpha-helix connected to an antiparallel beta-sheet via the disulfide framework, creating a compact, stable globular domain resistant to proteolytic degradation. Key functional residues should be positioned in the beta-sheet region to form a functional surface that interacts with the pore region of Kv channels, blocking potassium ion conduction through electrostatic and hydrophobic interactions. The toxin should exhibit specificity for Shaker-type potassium channels, contributing to paralysis in prey by prolonging action potentials and enhancing neurotransmitter release. Ensure the sequence reflects scorpion toxin hallmarks, including a signal peptide for secretion, a propeptide region for proper folding, and the mature toxin domain with the conserved disulfide pattern and functional residues critical for channel binding and inhibition."}
{"description": "sp|Q9TWG1|K1B_ANESU Kappa-actitoxin-Avd6a OS=Anemonia sulcata OX=6108 PE=1 SV=1", "sequence": "ACKDNFAAATCKHVKENKNCGSQKYATNCAKTCGKC", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-actitoxin derived from the venom of the sea anemone Anemonia sulcata. This toxin belongs to the sea anemone type 1 potassium channel toxin family and functions as a potent potassium channel blocker. The biological significance of this venom component lies in its role in prey immobilization through disruption of neuronal signaling. The core mechanism of action involves specific blockade of voltage-gated potassium channels, particularly Kv1 family channels, leading to prolonged neuronal depolarization and disrupted action potential repolarization. The protein should adopt the conserved sea anemone toxin fold characterized by a compact beta-sheet structure stabilized by a specific disulfide bridge pattern. The anticipated cysteine framework follows the C-C-CC-C-C pattern with three disulfide bonds that create a stable structural scaffold. Key structural characteristics include a well-defined core region with beta-strands arranged in an antiparallel configuration and exposed loops that mediate target recognition. The molecular target interface involves specific residues in the functional loops that interact with the pore region and voltage-sensing domains of potassium channels. The binding interface should include conserved aromatic and basic residues that facilitate high-affinity interaction with the channel's extracellular vestibule. The protein should exhibit the characteristic pharmacological profile of sea anemone potassium channel toxins with nanomolar affinity for its target channels."}
{"description": "sp|Q66S08|NATTP_THANI Natterin-P OS=Thalassophryne nattereri OX=289382 PE=3 SV=1", "sequence": "MKLLVLLVTLLVLSWTSAEDLGDQEILENNEDNNHESELGEPAAQHTDDETSQLGQALIPRCRKMPGVKMC", "prompt": "Design a novel protein sequence for a potent animal toxin derived from the venom of the niquim fish, Thalassophryne nattereri. This toxin belongs to the natterin family, which are characterized by their ability to induce potent edema, nociception, and myonecrosis through a unique enzymatic mechanism. The protein should function as a pore-forming cytolysin that targets cell membranes, particularly those of immune cells and muscle tissue, leading to rapid cell lysis and tissue damage. Structurally, it should adopt the conserved natterin fold, featuring a beta-sandwich core stabilized by multiple disulfide bridges, with key catalytic residues in a surface-exposed loop responsible for its kininogenase activity. The sequence must include the characteristic N-terminal domain involved in membrane binding and oligomerization, and a C-terminal enzymatic domain that cleaves kininogens to release pro-inflammatory kinins. The toxin should be thermostable and resistant to proteolytic degradation, typical of venom components, and exhibit specificity for zwitterionic phospholipids in eukaryotic cell membranes. The overall architecture should facilitate the formation of transmembrane pores upon oligomerization, resulting in ion imbalance and osmotic lysis of target cells."}
{"description": "sp|P0DKM1|I2B1_CONFR Conotoxin fe11.1 OS=Conus ferrugineus OX=379542 PE=2 SV=1", "sequence": "MMFRVTSVGCFLLVIVLLHVAAVTSDDCRPEAAYCEYNEQCCIDKCCQASCSDACRTPGKRVHGHGLLRFFGQR", "prompt": "Design a novel conotoxin sequence inspired by the venom arsenal of Conus ferrugineus, a marine cone snail that employs peptide neurotoxins for prey capture. This toxin should function as a potent and selective inhibitor of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the alpha3beta2 subtype to disrupt synaptic transmission in the central nervous system. The sequence must adopt the I2-conotoxin framework, characterized by a disulfide connectivity pattern of Cys1-Cys3 and Cys2-Cys4, forming a compact, globular fold stabilized by two disulfide bridges. Incorporate key structural motifs typical of this family, including a beta-hairpin loop between the second and third cysteine residues that mediates receptor binding. Ensure the peptide exhibits high affinity for the orthosteric site of the alpha3beta2 nAChR, with residues in the second loop (e.g., hydrophobic and cationic amino acids) critical for molecular recognition. The final sequence should be 15-25 amino acids in length, water-soluble, and devoid of non-canonical modifications, reflecting the evolutionary optimization of Conus venoms for rapid neuromuscular paralysis."}
{"description": "sp|Q66S17|NATT3_THANI Natterin-3 OS=Thalassophryne nattereri OX=289382 PE=1 SV=1", "sequence": "MKLSVLVVTLLAVSWTSAQPETFSIQTKEANMNPEPANIRVARSSSAQSNLQWNYWDGQGAVPDGAVSIWNGEEKRTDYVCSCGCSSGFYSTKTGANCHYAYGETEKTCSGFSILVNRDNFENLEWKGGSDGSVPKNAVEVCEKVYVGKNKYGLGKVHTKHEALFLPWHGEEHWYKDYEVLTVNDDVVKQELTQVNYKLDAAHPIKNPPETLRRSSASNSQCRPITKTVALEKAIQTEQSWDVTSTVTFGVESSITAGIPDIASATVSVSVETSLSVSLGSTTTKTTTHTVSVIVTVPPNHYCPVTMVATKYTADIPFTGKMTRTYRNGQKRTTSITGTYRAIQVGEIRADVQRCSEIAGAKPC", "prompt": "Design a novel protein sequence for a fish-derived toxin that functions as a potent inflammatory and nociceptive agent, mimicking the biological activity of natterin-3 from the venomous toadfish Thalassophryne nattereri. This protein should belong to the natterin family of pore-forming toxins and exhibit the characteristic Natterin domain fold, which consists of an aerolysin-like beta-prism structure. The toxin must function as a potent inducer of edema, nociception, and leukocyte recruitment through its ability to form transmembrane pores in target cell membranes, leading to ion imbalance, cell lysis, and activation of inflammatory pathways. The sequence should include conserved structural motifs essential for pore formation, including beta-sheets arranged in a prismatic scaffold that facilitates oligomerization into a functional pore complex. The protein should target immune cells and sensory neurons, triggering the release of pro-inflammatory mediators such as cytokines, prostaglandins, and kinins, resulting in intense pain and localized inflammation. The structural integrity should be maintained by specific disulfide bridges that stabilize the beta-prism fold, ensuring proper membrane insertion and pore formation. The final sequence must reflect the dual role of this toxin in both innate immune response modulation and pain induction, characteristic of piscine venom components used for predation and defense."}
{"description": "sp|F8J2F6|VKT18_DRYCN Kunitz-type serine protease inhibitor 18 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPHFCHLPADPGRCNALSEAFYYNPVQRKCLKFRYGGCKANANTFKTIDECKRTCAA", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein derived from the venom of the Australian crowned snake, Drysdalia coronoides. This toxin should function as a potent serine protease inhibitor, specifically targeting key proteolytic enzymes involved in prey digestion and hemostasis disruption. The protein must adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with alternating beta-strands and loops stabilized by three disulfide bridges in the canonical C1-C6, C2-C4, C3-C5 connectivity pattern. The active site should contain the essential protease-binding loop with appropriate residues for specific serine protease recognition and inhibition. The structural scaffold should maintain the compact, globular fold typical of Kunitz inhibitors, with the reactive site loop positioned for optimal protease interaction while ensuring overall structural stability through the conserved disulfide framework. The protein should exhibit the dual functionality common to snake venom Kunitz inhibitors, potentially affecting both coagulation pathways and neural targets through protease inhibition."}
{"description": "sp|P86400|KAX86_MESEU Potassium channel toxin alpha-KTx 8.6 OS=Mesobuthus eupeus OX=34648 PE=1 SV=2", "sequence": "MSRLYAIILIALVFNVIMTIMPDMKVEAVSCEDCPEHCATKDQRAKCDNDKCVCEPK", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx 8.6 from the lesser Asian scorpion Mesobuthus eupeus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold of approximately 30-40 amino acids with a well-defined beta-sheet core and exposed functional loops that mediate channel interaction. Key structural elements should include a conserved dyad motif (typically lysine and aromatic residues) positioned in the functional epitope for precise channel pore blockade, along with surface-exposed basic residues that facilitate electrostatic steering toward the channel vestibule. The toxin should exhibit the characteristic mechanism of physically occluding the potassium conduction pathway through direct pore insertion, thereby preventing potassium ion flux and modulating neuronal excitability. The design should reflect the evolutionary optimization of scorpion venom components for rapid neuromuscular targeting and prey immobilization."}
{"description": "sp|B0ZT25|VSPH_PROJR Snake venom serine protease homolog OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MVLVRVLANLLMLQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCSGTLINEEWVLSAARCDRKNIRIQLGMHSTNVINEDVQTRVPKEKFFCLSSKTYTKWNKDIMLIRLKKPVNNSTHIAPVSLPSNPPSLGSVCRVMGWGTISATKETHPDVPYCANINILDYSVCRAAYARLPATSRTLCAGILEGGKDSCLTDSGGPLICNGQFQGIVSWGGHPCGQPRKPGLYTKVFDHLDWIKSIIAGNKDATCPP", "prompt": "Design a snake venom serine protease homolog protein from the venom of Protobothrops jerdonii, a pit viper species. This protein should function as a key component in the venom's complex proteolytic arsenal, contributing to the disruption of prey homeostasis through interference with hemostatic pathways. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) arrangement, but with critical mutations in the active site that render it catalytically inactive while maintaining structural integrity. The molecule should feature the typical serine protease domain architecture with appropriate disulfide bonding patterns to stabilize the globular structure, including conserved cysteine pairs that form essential structural bridges. As a protease homolog, it should retain the ability to bind to physiological targets such as coagulation factors or platelet receptors, exerting its toxic effects through competitive inhibition or allosteric modulation rather than proteolytic cleavage. The protein should exhibit the biophysical properties characteristic of venom serine proteases, including thermal stability and resistance to proteolytic degradation, while displaying surface features that facilitate specific molecular recognition of hemostatic system components in vertebrate prey."}
{"description": "sp|Q9PVE9|PA2AC_CALRH Acidic phospholipase A2 S1E6-c OS=Calloselasma rhodostoma OX=8717 PE=2 SV=1", "sequence": "MRTLWILAVLLVGVEGSLVQFETMIMKLAKRSGFFWYSFYGCYCGWGGHGLPQDPTDRCCFVHDCCYGKVTNCNPKTATYSYTEENDGIVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDGDKYWKLPPQKCQEDPEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Malayan pit viper, Calloselasma rhodostoma. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should exhibit calcium-dependent catalytic activity and possess the characteristic phospholipase A2 structural fold, featuring three long alpha-helices stabilized by multiple disulfide bridges. The sequence should include the conserved catalytic dyad (histidine and aspartate residues) and calcium-binding loop motif essential for enzymatic function. As an acidic isoform, the protein should have a net negative charge at physiological pH. The toxin should demonstrate membrane-disrupting properties through its phospholipid hydrolysis activity, contributing to local tissue damage, inflammation, and potential systemic effects in prey organisms. The structural scaffold should maintain the compact, stable globular architecture typical of secreted phospholipase A2 enzymes, with proper surface characteristics for membrane interaction and substrate accessibility."}
{"description": "sp|B0VXV8|BNP_SISCA Bradykinin potentiating and C-type natriuretic peptides OS=Sistrurus catenatus edwardsii OX=8762 PE=2 SV=1", "sequence": "MFVSRLAASGLLLLALLAVSLDGKPVQQWSQNWPGPKVPPLVVQQWSQNWPHPQIPPLVVQNWKSPTQLQPRESPAGGTTALREELSLGPDAALDTPPAGPDVGPRGSKAAAAPQRLSKSKGASATSTASRPMRDLRTDGKQARQNWGRMLNPDHHSAPGGGGGGGGGGARRLKGLAKKRAGSGCFGLKLDRIGSMSGLGC", "prompt": "Design a novel venom-derived peptide that functions as a dual-acting toxin with bradykinin-potentiating and C-type natriuretic peptide activities, characteristic of the venom from the desert massasauga rattlesnake (Sistrurus catenatus edwardsii). This peptide should exhibit the following biological properties: (1) Bradykinin-potentiating function through inhibition of angiotensin-converting enzyme (ACE), thereby preventing bradykinin degradation and enhancing its vasodilatory and pro-inflammatory effects, leading to hypotension and increased vascular permeability. (2) C-type natriuretic peptide activity through activation of natriuretic peptide receptors, particularly NPR-B, stimulating cyclic GMP production to promote vasodilation, natriuresis, and diuresis, contributing to cardiovascular collapse in envenomation. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, typical of small cysteine-rich venom peptides, with conserved residues critical for ACE inhibition (e.g., pyroglutamate at the N-terminus and proline-rich regions) and a C-terminal motif resembling natriuretic peptides for receptor binding. The structural scaffold should ensure resistance to proteolytic degradation in the bloodstream, with a molecular weight under 5 kDa, facilitating rapid distribution and synergistic hypotensive effects. The final sequence must reflect the evolutionary adaptation of viperid venoms to immobilize prey through cardiovascular disruption, without incorporating database identifiers."}
{"description": "sp|P69835|GRAF_GRASX Grammistin Gs F OS=Grammistes sexlineatus OX=270576 PE=1 SV=1", "sequence": "LFGFLIKLIPSLFGALSNIGRNRNQ", "prompt": "Design a novel cationic antimicrobial peptide toxin derived from the venom of the six-line soapfish (Grammistes sexlineatus), a marine organism known for secreting grammistins as part of its chemical defense system. This peptide should function as a potent membrane-disrupting agent, specifically targeting bacterial cell membranes through electrostatic interactions and hydrophobic insertion. The peptide should adopt an amphipathic alpha-helical structure that facilitates pore formation in lipid bilayers, leading to rapid cell lysis. Incorporate key structural features characteristic of grammistins: a high proportion of hydrophobic residues (approximately 50%) to enable membrane penetration, multiple lysine and arginine residues for cationic charge and membrane binding, and a length of 20-25 amino acids optimized for helical stability. The sequence should maintain strong antimicrobial activity against Gram-positive and Gram-negative bacteria while exhibiting minimal hemolytic activity against eukaryotic cells. Ensure the peptide displays the typical physicochemical properties of grammistins, including net positive charge at physiological pH, moderate hydrophobicity, and the ability to form stable amphipathic helices in membrane-mimetic environments."}
{"description": "sp|I6R1R9|TX31B_SCOMU Kappa-scoloptoxin(03)-Ssm1b OS=Scolopendra mutilans OX=2836329 PE=3 SV=1", "sequence": "MKPSMAILLVIALIIFSLDKSYSANDKPIGKCGDAKRNKPCLACSHRSSIADFYSKCCTYDAVYNGCLDKLRH", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-scoloptoxin derived from the venom of Scolopendra mutilans, commonly known as the Chinese red-headed centipede. This toxin belongs to the scoloptoxin family, which are small cysteine-rich peptides characteristic of centipede venoms. The biological significance of this venom component lies in its role as a potent neurotoxin that facilitates prey capture and defense by targeting specific ion channels in the nervous system of prey organisms. The core function of this kappa-scoloptoxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and synaptic transmission. The mechanism of action involves high-affinity binding to the pore region of Kv channels, preventing potassium ion efflux and leading to prolonged membrane depolarization, which results in uncontrolled neurotransmitter release and ultimately paralysis. The protein should feature a conserved structural scaffold typical of centipede toxins, characterized by an inhibitor cysteine knot (ICK) motif with a specific disulfide bridge pattern of C1-C4, C2-C5, C3-C6 connectivity. This structural framework provides exceptional thermal and proteolytic stability while maintaining precise molecular recognition capabilities. The anticipated 3D structure should consist of a compact, triple-stranded beta-sheet fold stabilized by the ICK motif, with key functional loops responsible for channel binding and specificity. The molecular target interface involves specific interactions with the Kv channel pore domain, particularly with conserved residues in the selectivity filter and outer vestibule region. The binding interface should include hydrophobic patches and charged residues that complement the channel's extracellular surface, ensuring high specificity and potency. The protein sequence should reflect these structural and functional requirements while maintaining the characteristic features of centipede venom peptides."}
{"description": "sp|F8J2E1|3L273_DRYCN Long neurotoxin 73 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDSLICYQAYNTPQTCAPGENLCYTKTWCDYWCHVKGKRIDLGCAATCPTAKPGEDVTCCSRDKCNPHPLQRPR", "prompt": "Design a long neurotoxin protein sequence that mimics the potent neurotoxic activity found in the venom of the white-lipped snake, Drysdalia coronoides. This toxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta and alpha-epsilon subunit interfaces to cause reversible postsynaptic blockade. The protein should adopt the characteristic three-finger toxin fold with three extended beta-stranded loops radiating from a central hydrophobic core stabilized by four conserved disulfide bridges in the C1-C5, C2-C6, C3-C7, C4-C8 connectivity pattern. The sequence must include the conserved functional loop II responsible for receptor binding, featuring key aromatic and basic residues that mediate high-affinity interaction with the acetylcholine binding site. The toxin should exhibit the elongated 'long' neurotoxin conformation with extended loop regions that enhance receptor specificity and binding kinetics. The structural scaffold should maintain the globular, compact fold typical of three-finger toxins while incorporating the specific loop extensions and functional motifs that confer selective antagonism of muscle-type nicotinic receptors, ultimately leading to flaccid paralysis through inhibition of neuromuscular transmission."}
{"description": "sp|C5J896|KAX6G_OPICY Potassium channel toxin alpha-KTx 6.16 OS=Opisthacanthus cayaporum OX=573324 PE=2 SV=1", "sequence": "MNLKLALVLLLTVINVGMLPGATSNGNIKTDIKCYRNSHCNFHCEKSYYCQGSKCVRKRCNCYNCPL", "prompt": "Design a novel potassium channel toxin protein derived from the venom of the scorpion Opisthacanthus cayaporum. This toxin belongs to the alpha-KTx family 6.16, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. The protein should function as a potent potassium channel blocker, binding to the pore region of Kv channels to inhibit potassium ion efflux, thereby modulating neuronal excitability and contributing to the venom's paralytic effects on prey. The structural scaffold must feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with a conserved C1-C4, C2-C5, C3-C6 connectivity pattern. The core structure should comprise a short alpha-helix packed against a triple-stranded anti-parallel beta-sheet, with the functional dyad (typically involving a critical lysine residue in the beta-sheet region) positioned to interact with the channel's selectivity filter. The N- and C-terminal regions should be short and unstructured, with the molecular surface exhibiting a patch of positive charges to facilitate electrostatic steering toward the negatively charged channel vestibule. Ensure the sequence encodes approximately 30-40 amino acids, including the six conserved cysteines, and incorporates family-specific conserved residues that confer stability and target specificity."}
{"description": "sp|Q45Z47|PA22_OXYSC Phospholipase A2 OS2 OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=2", "sequence": "MHPAHLLVLLAVCVSLLGASDIPPLPLNLAQFGFMIRCANGGSRSPLDYTDYGCYCGKGGRGTPVDDLDRCCQVHDECYGEAEKRLGCSPFVTLYSWKCYGKAPSCNTKTDCQRFVCNCDAKAAECFARSPYQKKNWNINTKARCK", "prompt": "Design a phospholipase A2 toxin from the venom of the coastal taipan (Oxyuranus scutellatus), a highly potent neurotoxic and myotoxic snake venom component. This enzyme should function as a presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission through hydrolysis of synaptic membrane phospholipids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should contain the typical disulfide bond pattern common to snake venom phospholipases A2, stabilizing the compact globular structure. The sequence should include key functional residues for membrane binding, interfacial activation, and substrate specificity toward sn-2 acyl bonds of glycerophospholipids. The toxin should exhibit the characteristic β-wing region involved in membrane penetration and the hydrophobic channel leading to the active site. This phospholipase A2 should demonstrate the potent neurotoxicity characteristic of taipan venom while maintaining the structural integrity required for enzymatic activity and target specificity."}
{"description": "sp|Q4PRD2|SLLC2_DABSI Snaclec coagulation factor X-activating enzyme light chain 2 OS=Daboia siamensis OX=343250 GN=LC2 PE=1 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGAGLDCPPDSSLYRYFCYRVFKEHKTWEAAERFCMEHPNNGHLVSIESMEEAEFVAKLLSNTTGKFITHFWIGLMIKDKEQECSSEWSDGSSVSYDKLGKQEFRKCFVLEKESGYRMWFNRNCEERYLFVCKVPPEC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the Siamese Russell's viper (Daboia siamensis) that functions as a coagulation factor X-activating enzyme light chain. This protein should form a heterodimeric complex with its heavy chain partner to create a functional enzyme complex that specifically activates blood coagulation factor X in the extrinsic coagulation pathway. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold with a conserved double-loop structure stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4 connectivity pattern). The sequence should contain key functional residues for calcium-independent carbohydrate recognition and specific molecular recognition of coagulation factor X, facilitating its proteolytic activation to factor Xa. This enzymatic activation drives rapid thrombin generation and promotes profound procoagulant effects in envenomation, contributing to the potent coagulopathic venom profile of viperid snakes. The structural scaffold should maintain the characteristic β-sheet core with flanking α-helices typical of CTLD proteins, with surface loops optimized for specific protein-protein interactions with coagulation factor X."}
{"description": "sp|P84823|BRK12_ASCTR Bradykinin-like peptide AV-12 OS=Ascaphus truei OX=8439 PE=1 SV=1", "sequence": "APVPGLSPFRVV", "prompt": "Design a bradykinin-like peptide toxin derived from the tailed frog Ascaphus truei, a primitive amphibian whose skin secretions contain bioactive peptides that serve as chemical defenses against predators and microbial threats. This peptide should function as a potent vasoactive agent by mimicking the physiological effects of endogenous bradykinin, specifically acting as an agonist at bradykinin B2 receptors. The peptide should adopt a linear conformation without disulfide bridges, characteristic of bradykinin-like peptides, and feature key pharmacophoric residues that mediate receptor binding and activation, such as those involved in interacting with the extracellular domains of G protein-coupled bradykinin receptors. The sequence should include conserved motifs that confer resistance to degradation by angiotensin-converting enzyme and other peptidases, enhancing its stability and duration of action in biological systems. The overall structure should facilitate specific recognition by bradykinin receptors, leading to downstream signaling events that result in vasodilation, increased vascular permeability, and pain sensation, consistent with the inflammatory and nociceptive roles of bradykinin pathway activation."}
{"description": "sp|P24778|3SOE_HEMHA Cytotoxin homolog OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LICHNRPLPFLHKTCPEGQNICYKMTLKKTPMKLSVKRGCAATCPSERPLVQVECCKTDKCNW", "prompt": "Design a cytotoxin protein sequence derived from the venom of the rinkhals snake (Hemachatus haemachatus), a medically significant elapid species. This toxin belongs to the three-finger toxin superfamily and functions as a potent membrane-disrupting cytotoxin. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular structure. The molecular mechanism involves direct interaction with lipid membranes, particularly targeting anionic phospholipids through hydrophobic and electrostatic interactions in the three loop regions. Key structural features include three extended β-stranded loops projecting from a central hydrophobic core, with conserved hydrophobic residues in loops I and II that mediate membrane insertion and disruption. The toxin should exhibit broad-spectrum cytotoxicity through non-receptor-mediated membrane permeabilization, leading to cell lysis and tissue damage. The sequence must maintain the characteristic three-finger toxin cysteine framework while incorporating specific hydrophobic and basic residues critical for membrane binding and cytolytic activity."}
{"description": "sp|F5CPF1|PA235_MICAT Phospholipase A2 MALT0035C OS=Micrurus altirostris OX=129457 PE=1 SV=1", "sequence": "MNPAHLLVLAAVCISLSGASSIAPQPLNLIQFGNMIQCTIPGSSPLLDYADYGCYCGRGGSGTPVDKLDRCCQAHDKCYTDAYRFYRCWPFLTLYSHTCSNRKVICRGNTTKCKAFVCNCDRVAANCFAKAPYNKRNYNNCK", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of Micrurus altirostris, a coral snake species. This toxin should exhibit the characteristic enzymatic activity of secreted phospholipase A2, specifically catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices stabilized by a network of disulfide bridges. The catalytic mechanism should rely on a conserved histidine-aspartate dyad and a calcium-binding loop essential for substrate coordination. As a key component of elapid snake venom, this phospholipase A2 should contribute to the venom's neurotoxic, myotoxic, and/or hemolytic effects by disrupting cell membrane integrity, potentially leading to presynaptic neuromuscular blockade, muscle fiber damage, or erythrocyte lysis. The sequence should include the characteristic pancreatic loop and elapid-specific motifs that distinguish it from mammalian phospholipase A2 enzymes. Ensure the protein is optimized for stability in the venom milieu and exhibits the appropriate substrate specificity for membrane phospholipids."}
{"description": "sp|P0CJ24|KAX_ISOMC Potassium channel toxin ImKTx88 OS=Isometrus maculatus OX=497827 PE=3 SV=1", "sequence": "MSNFSVFLIALLFCSVFILSEAQIYTSKECNGSSECYSHCEGITGKRSGKCINKKCYCYR", "prompt": "Design a potassium channel toxin from the venom of the scorpion Isometrus maculatus that functions as a potent modulator of voltage-gated potassium channels. This toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion potassium channel toxins, featuring a compact globular architecture stabilized by three or four disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The toxin should contain a functional dyad consisting of a critical lysine residue positioned in the beta-sheet region and an aromatic residue that together mediate specific interactions with the voltage-sensing domain or pore region of Kv1.x family potassium channels. The molecular surface should display a conserved hydrophobic patch adjacent to the functional dyad that facilitates membrane association and target recognition. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes, potentially causing either channel blockade or modulation of gating kinetics, leading to neuronal hyperexcitability and disruption of cellular signaling. The structural scaffold should maintain the characteristic ICK (inhibitor cystine knot) motif with a triple-stranded beta-sheet stabilized by the disulfide core, creating a stable molecular framework resistant to proteolytic degradation and thermal denaturation."}
{"description": "sp|P24779|3SA5_NAJKA Cytotoxin 5 OS=Naja kaouthia OX=8649 PE=1 SV=1", "sequence": "LKCNKLIPLAYKTCPAGKNLCYKMFMVAAPKVPVKRGCIDACPKNSLLVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein from the monocled cobra (Naja kaouthia) venom that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet scaffold stabilized by four conserved disulfide bonds with the connectivity C1-C5, C2-C6, C3-C7, and C4-C8, forming the classic three-finger toxin fold. The protein should exhibit specific cytotoxicity through direct interaction with cell membranes, likely via hydrophobic patches on its loops that facilitate membrane insertion and disruption. Key structural features should include three extended β-stranded loops emerging from a central hydrophobic core, with loop regions containing conserved hydrophobic and basic residues that mediate membrane binding and pore formation. The toxin should demonstrate preferential cytotoxicity toward certain cell types, potentially through specific lipid interactions rather than protein receptor binding. The sequence should maintain the conserved three-finger toxin structural framework while incorporating residues that confer membrane-permeabilizing activity characteristic of cytotoxins from elapid snake venoms."}
{"description": "sp|P15225|SCX3_ORTSC Neurotoxin Os3 OS=Orthochirus scrobiculosus OX=6892 PE=1 SV=1", "sequence": "GVRDGYIAQPHNCVYHCFPGSGGCDTLCKENGATQGSSCFILGRGTACWCKDLPDRVGVIVDGEKCH", "prompt": "Design a neurotoxic peptide from the venom of the scorpion Orthochirus scrobiculosus that functions as a potent sodium channel modulator. This toxin should belong to the beta-toxin family, specifically targeting voltage-gated sodium channels (Nav) and causing a hyperpolarizing shift in the channel activation, leading to prolonged neuronal excitation and paralysis. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by four disulfide bridges with the conserved cysteine pattern C1-C4, C2-C5, C3-C6, C7-C8, forming a compact globular structure. Key structural elements include an alpha-helix packed against an antiparallel beta-sheet, with the functional residues concentrated in the 'pharmacophore' region responsible for binding to neurotoxin receptor site 4 on the voltage-sensing domain of Nav channels. The toxin should exhibit high affinity for insect sodium channels, contributing to the venom's role in prey immobilization, while maintaining the typical molecular weight and physicochemical properties of scorpion beta-neurotoxins."}
{"description": "sp|Q8T0W4|VKT2_PIMHY Kunitz-type serine protease inhibitor cvp2 OS=Pimpla hypochondriaca OX=135724 PE=1 SV=1", "sequence": "MNAKIVALLIVVGFVGMFNVATAADPLCSLEPAVGLCKASIPRFASVGGKCQEFIYGGCGGNANNFQTQAECEAKCG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the parasitoid wasp Pimpla hypochondriaca. This toxin functions as a potent serine protease inhibitor that disrupts host physiological processes, likely targeting key proteases in the insect coagulation cascade or immune response pathways. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The active site should contain the essential protease-binding loop with the canonical P1 residue positioned for optimal interaction with the target protease's active site, typically exhibiting high specificity for trypsin-like or chymotrypsin-like enzymes. The sequence must maintain the structural integrity of the inhibitory loop while preserving the hydrophobic core that stabilizes the Kunitz fold. This venom component serves to modulate host homeostasis, facilitating parasitism by inhibiting critical proteolytic enzymes involved in defense mechanisms."}
{"description": "sp|V9QF69|TXA1_LATGE Alpha-latrotoxin associated low molecular weight protein OS=Latrodectus geometricus OX=156851 PE=3 SV=1", "sequence": "MNKLFFVVFLCLIISVLAIGPADLGCTDMPQAEFDEKNANCEKCGNEEGFGEEMVSRCRDKCFTDNFYQSCVDLLNKVYEEKDVPVPPEE", "prompt": "Design a protein sequence for an alpha-latrotoxin associated low molecular weight protein from the brown widow spider (Latrodectus geometricus). This protein functions as a critical component in the venom's neurotoxic arsenal, working in concert with the potent alpha-latrotoxin to enhance its effects on the vertebrate nervous system. The protein should exhibit a compact, stable structure typical of low molecular weight venom components, likely featuring multiple disulfide bridges that confer structural rigidity and resistance to proteolytic degradation. The core mechanism involves modulation of neurotransmitter release at presynaptic terminals, potentially through interactions with synaptic vesicle proteins or membrane receptors that amplify the calcium-dependent exocytosis triggered by alpha-latrotoxin. The structural scaffold should include conserved cysteine patterns characteristic of latrodectus venom proteins, forming a stable fold that enables specific binding to neuronal targets while maintaining solubility in the venom matrix. The protein should target presynaptic membranes in vertebrates, with binding interfaces that complement alpha-latrotoxin's action, leading to enhanced and prolonged neurotransmitter release, muscle cramping, autonomic disturbances, and pain—the hallmark symptoms of latrodectism. The sequence must reflect the evolutionary adaptation for rapid paralysis of prey and defense, with optimized stability and target specificity."}
{"description": "sp|P15969|TOG1A_AGEAP Omega-agatoxin-1A OS=Agelenopsis aperta OX=6908 PE=1 SV=2", "sequence": "MMKFVVFLACLFVAAHSFAVEGEEEYFEAEVPELERAKALPPGSVCDGNESDCKCYGKWHKCRCPWKWHFTGEGPCTCEKGMKHTCITKLHCPNKAEWGLDWRSEESERSPC", "prompt": "Design a protein sequence for a highly potent neurotoxin from the funnel-web spider Agelenopsis aperta. This toxin should function as a selective and irreversible inhibitor of P/Q-type voltage-gated calcium channels (Cav2.1), which are critical for neurotransmitter release at central nervous system synapses. The protein should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements should include a beta-hairpin loop that mediates specific interactions with the channel's pore-forming region, blocking calcium influx and causing presynaptic inhibition. The toxin should exhibit high affinity for the neuronal calcium channel subtype while showing minimal activity against other voltage-gated calcium channels. The sequence should reflect the typical molecular weight range of 7-8 kDa and maintain the characteristic stability and protease resistance conferred by the ICK scaffold, which is evolutionarily optimized for rapid paralysis of prey through disruption of neuromuscular transmission."}
{"description": "sp|A0A1P8NVS8|COW2_CONLT Contryphan-Lt2 OS=Conus litteratus OX=89445 PE=3 SV=1", "sequence": "MGKLTILVIVAAALLSTQFMVQGDGDQPADRDAVPSDDNPGGTSEKFMNVQHGSGCPWYPWCG", "prompt": "Design a novel contryphan peptide from the venomous marine snail Conus litteratus, a species known for producing complex neuroactive peptides that target specific ion channels and receptors in the nervous system. This peptide should function as a potent modulator of neuronal signaling, likely targeting voltage-gated calcium channels or other key neuronal receptors to disrupt synaptic transmission. The sequence must adopt the characteristic contryphan structural scaffold featuring a highly constrained cyclic conformation stabilized by a single disulfide bridge between two conserved cysteine residues, creating a stable loop structure. The peptide should contain the signature post-translational modification of tryptophan bromination, which enhances receptor binding affinity and specificity. The structural fold should exhibit a compact, globular conformation with defined beta-turn elements that present key pharmacophore residues for precise molecular recognition. The mature peptide should be approximately 10-15 amino acids in length with the disulfide bridge creating a rigid cyclic backbone that confers proteolytic stability and target specificity. Include conserved hydrophobic residues that contribute to membrane interaction and receptor binding, along with charged or polar residues that mediate specific molecular interactions with the neuronal target."}
{"description": "sp|F8UWP3|SCX4_CENVT Alpha-toxin CvIV4 OS=Centruroides vittatus OX=120091 PE=1 SV=2", "sequence": "MNYFILILVAALLILDVNCKKDGYPVEHSGCKYTCWKNEYCDKVCKDLKGEGGYCYINLTCWCTGLPDNVPLKTNQRCNGKRK", "prompt": "Design a novel alpha-toxin protein sequence derived from the venom of the striped bark scorpion Centruroides vittatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to induce excitatory neurotoxicity through delayed inactivation. The protein should adopt the conserved cysteine-stabilized alpha-beta scaffold characteristic of scorpion alpha-toxins, featuring the canonical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structural fold. The sequence must include key functional motifs for receptor binding, particularly in the beta-hairpin loops that interact with domain IV of the sodium channel, and the conserved 'pharmacophore' residues critical for modulating channel gating. The structural core should comprise an alpha-helix packed against an antiparallel beta-sheet, with surface-exposed loops conferring target specificity. The toxin should exhibit high affinity for mammalian neuronal sodium channels, contributing to the predatory and defensive efficacy of scorpion venom through disruption of action potential propagation."}
{"description": "sp|Q2ES49|VKT2_DABRR Kunitz-type serine protease inhibitor 2 OS=Daboia russelii OX=8707 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAEPTPISGQDRPKFCFLRPDFGRYGHPRPRFYYNPATNQCQGFLAQRSRENTNNFDTRDKCRQTCGRK", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from Russell's viper (Daboia russelii) venom. This protein should function as a potent serine protease inhibitor, specifically targeting key proteases involved in hemostasis and coagulation pathways. The toxin should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three disulfide bridges in the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The active site should contain the essential protease-binding loop with the canonical P1 residue positioned for optimal interaction with the target protease's active site. The protein should exhibit high specificity and potency typical of viper venom Kunitz inhibitors, potentially targeting coagulation factors such as Factor Xa or plasma kallikrein, contributing to the venom's anticoagulant and hypotensive effects. The structural scaffold should maintain the compact, stable globular fold characteristic of Kunitz domains, with the reactive site loop providing the primary inhibitory interface while the core structure ensures thermal and proteolytic stability in the venom environment."}
{"description": "sp|Q66S13|NATT4_THANI Natterin-4 OS=Thalassophryne nattereri OX=289382 PE=2 SV=1", "sequence": "MKLLVLLVTLLVLSWTSAEDVGDQEILQQHNEDNNHKSELGEAAPQRTDNETSQLGQETPTIRVARAYEFSSKSNLEWVRWNGHIPSNAVKISNTYVGREDYVCRVGCEAGYYTPKKGPSCFYPYGFTEQHSKMFHILVNRDNFEILEWKWKTGGEVPENAVKACRDLYVAKNKYGLGKLHQSHHVFYLPWKGTEYKYNEYYVLNVNMDVVEQKITNVRYNMKGVEVHKDKPETLRSTSVKNYQCREATKQVTLEKSTETSQSWDVSNSITLGVSTEVSAGIPNIADVSVAVSAETSVEISHGTSKTESTSHSLSVSATIPPNSSCSITMEGCTFKANIPFTGRLTRKYSNGKVTSSSVKGIYKKVQVGEIQAVLHRCDKIADAKPC", "prompt": "Design a novel protein sequence for a fish-derived toxin that functions as a potent inflammatory and nociceptive agent. This protein should belong to the natterin family, characterized by its ability to induce edema, nociception, and myotoxic effects through a mechanism involving pore formation and potassium efflux from target cells. The protein should adopt the conserved structural fold of the aerolysin-like beta-pore-forming toxin superfamily, featuring a beta-sandwich core domain that facilitates membrane insertion and pore assembly. Include the characteristic cysteine residues that form disulfide bridges essential for structural stability and functional activity, maintaining the conserved pattern typical of natterins. The molecular target should involve interaction with cell membranes, leading to ion imbalance and triggering inflammatory cascades. The biological context should reflect its role in the venom of the Brazilian toadfish (Thalassophryne nattereri), where it contributes to the venom's defensive and predatory efficacy by causing intense pain, swelling, and tissue damage in envenomed organisms."}
{"description": "sp|P0DUP0|PA2H1_BOTDP Basic phospholipase A2 homolog BdipTx-I (Fragment) OS=Bothrops diporus OX=1107943 PE=1 SV=1", "sequence": "SLFELGKMILQETGKNPAKSYGAYGCNCGVLGRGKPKEATQRCCYVHKCCYKKLTGCDPKKDRYSYSW", "prompt": "Design a protein sequence for a basic phospholipase A2 (PLA2) homolog toxin from the venom of Bothrops diporus, a pit viper species. This toxin represents a catalytically inactive PLA2 homolog that retains membrane-binding capabilities and contributes to the complex venom arsenal through indirect toxic mechanisms. The protein should adopt the characteristic PLA2 structural fold, consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop, despite lacking enzymatic activity. Incorporate the essential disulfide bond pattern typical of group II PLA2s, with cysteine residues forming 6-7 conserved disulfide bridges that stabilize the compact globular structure. The sequence should exhibit basic isoelectric point properties and surface features that facilitate interaction with membrane phospholipids or other venom components. This PLA2 homolog likely functions through membrane disruption, potentiation of other venom toxins, or interference with physiological processes, contributing to the overall hemotoxic and tissue-damaging effects characteristic of Bothrops envenomation. Ensure the design captures the evolutionary adaptation where loss of catalytic activity is compensated by gain of alternative toxic functions through structural preservation with functional divergence."}
{"description": "sp|D5LMJ3|VM3A_NAJAT Zinc metalloproteinase-disintegrin-like atrase-A OS=Naja atra OX=8656 PE=2 SV=1", "sequence": "MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACNGLKGHFKHQGETYFIEPLELSESEAHAIYKDENVEKEDETPKICAVTQTTWESDESIEKTSQLTNTPEQDRYLQVKKYIEFYLVVDNKMYKNHTSNQELRTRVYEMVNYLNTKYRRLNFHIALIGLEIWSNQDKVDMDPGANVTLKSFAEWRAKLPPHKRNDNAQLLTGIDFNGTTVGLAYTGTLCTWGSVAVVQDYSRRTILMASTMAHELGHNMGIHHDKANCRCSHSPCIMSDTISDEPFYEFSSCSVREHQEYLLRERPQCILNKPSRKAIVSRPVCGNNFVEVGEQCDCGSLQDCQSTCCNATTCKLQPHAQCDSEECCEKCKFKGAETECRAAKDDCDLPEFCTGQSAECPTDSLQRNGHPCQNNQGYCYNGKCPTMENQCITLLGPNYTVGPAGCFKNNRKGDDVSHCRKENGAKIPCAAKDEKCGTLYCTEIKKTGCIVPVSPRDPDSRMVEPGTKCEDKKVCSKSQCVKV", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from the Chinese cobra (Naja atra). This protein should exhibit the characteristic dual functionality of snake venom metalloproteinases (SVMPs), combining proteolytic activity with integrin-binding capabilities. The sequence must contain a conserved zinc-binding motif (HEXXHXXGXXH) in the metalloproteinase domain that coordinates catalytic zinc ions for enzymatic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin. The disintegrin-like domain should feature the canonical RGD or related integrin-binding motif that specifically targets platelet integrins (particularly αIIbβ3) to inhibit platelet aggregation and disrupt hemostasis. The protein should adopt the typical SVMP structural fold with a multi-domain architecture, including propeptide, metalloproteinase, and disintegrin-like domains, stabilized by multiple disulfide bridges characteristic of reprolysin family proteins. The mature toxin should function as a potent hemorrhagic agent that degrades basement membranes and disrupts endothelial cell adhesion, leading to systemic bleeding and circulatory collapse in prey organisms. The structural scaffold should enable both proteolytic activity against vascular components and anti-platelet activity through integrin receptor blockade."}
{"description": "sp|B1B5I8|VKT3_STIHA KappaPI-stichotoxin-Shd2a OS=Stichodactyla haddoni OX=475174 PE=1 SV=1", "sequence": "MAKLYFLLCLALVACLTMATEEMPALCHLQPDVPKCRGYFPRYYYNPEVGKCEQFIYGGCGGNKNNFVSFEACRATCIIPL", "prompt": "Design a novel marine toxin protein sequence based on the kappaPI-stichotoxin family from the sea anemone Stichodactyla haddoni. This toxin should function as a potent potassium channel inhibitor, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal and muscular excitability. The protein should adopt the canonical sea anemone type 3 potassium channel toxin fold, characterized by a compact beta-sandwich structure stabilized by three conserved disulfide bonds with a C1-C5, C2-C4, C3-C6 connectivity pattern. Incorporate key functional residues for potassium channel blockade, including a conserved arginine-rich region for interaction with the channel pore domain and hydrophobic patches for membrane association. The sequence should maintain the typical length of 35-40 amino acids with high beta-sheet content and display the characteristic pharmacological profile of delaying channel inactivation and shifting voltage dependence. Ensure the toxin exhibits the neurotoxic and paralytic activity typical of sea anemone potassium channel toxins, contributing to the venom's role in prey immobilization and defense."}
{"description": "sp|Q9PUH9|PA2A5_AUSSU Acidic phospholipase A2 S9-53F OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASDIPPQPLNLYQFSNMIQCANRGRRPTKHYMDYGCYCGKGGSGTPVDELDRCCKVHDDCYGEAEKSQNCAPYWTWYTWKCGSDGPQCDDSETGCQRSVCECDAIAAKCFAKAPYNDANWDIDTETRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake, Austrelaps superbus. This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity to hydrolyze the sn-2 acyl bond of glycerophospholipids, generating lysophospholipids and free fatty acids. The resulting membrane disruption and release of pro-inflammatory mediators contribute to presynaptic neurotoxicity, muscle damage, and systemic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Key structural elements must include the conserved calcium-binding loop (Tyr-Gly-Cys), the catalytic dyse (His-Asp), and the interfacial binding surface for membrane association. As an acidic isoform, the sequence should reflect a lower isoelectric point while maintaining the hydrophobic channel for substrate access to the active site. The toxin should demonstrate specificity for neuronal and muscle cell membranes, contributing to the venom's rapid immobilization of prey through neuromuscular blockade and tissue damage."}
{"description": "sp|P43445|3SO7_BUNMU Short neurotoxin homolog OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTIICRTRDTYQIPITFTNCEEGHVCYKYSTTETPNRILIHRGCAAKCPKRLRVICCSTDKCNK", "prompt": "Design a protein sequence for a short neurotoxin from the many-banded krait (Bungarus multicinctus) that functions as a potent postsynaptic neurotoxin. This toxin should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity C1-C5, C2-C6, C3-C7, and C4-C8. The protein should specifically target and antagonize muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, binding competitively to the receptor's α-subunit and blocking acetylcholine-mediated signal transmission. This interaction should result in flaccid paralysis through inhibition of neuromuscular transmission. The sequence should contain key functional residues in loop II that mediate receptor binding specificity and high-affinity interaction. The structural scaffold should maintain the compact, globular architecture typical of short neurotoxins, with the three loops arranged to present the receptor-binding interface while ensuring proper folding and stability through the conserved disulfide framework."}
{"description": "sp|P25498|PA2AE_NAJOX Acidic phospholipase A2 E OS=Naja oxiana OX=8657 PE=1 SV=1", "sequence": "NLYQFKNMIKCTVPSRSWLDFANYGCYCGRGGSGTPVDDLDRCCQIHDNCYNEAGKISGCWPYFKTYSYECSQGTLTCKGDNNSCAASVCDCDRLAAICFAGAPYNNDNYNINLKARCQ", "prompt": "Generate the amino acid sequence for an acidic phospholipase A2 toxin from the venom of the Central Asian cobra (Naja oxiana). This enzyme plays a critical role in the venom's neurotoxic and myotoxic effects by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to presynaptic neurotoxicity, muscle necrosis, and systemic inflammation. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges (typically 6-7 cysteines forming 3-4 disulfide bonds). As an acidic isoform, it should exhibit a pI below 7.0 and contain key catalytic residues including a conserved histidine-aspartate dyad in the active site, along with a calcium-binding loop essential for enzymatic activity. The sequence should include structural motifs for interfacial activation at lipid membranes and potential sites for myotoxic and neurotoxic activity, while maintaining the overall compact, stable globular architecture typical of secreted phospholipase A2 enzymes from elapid snake venoms."}
{"description": "sp|B1B5I9|NA24_STIHA Delta-stichotoxin-Shd3a OS=Stichodactyla haddoni OX=475174 PE=1 SV=1", "sequence": "MAYLKIVLVALMLVLGVSAMRLSDQEDQDVSVVKRAACKCDDDGPDIRSATLTGTVDFWNCNEGWEKCTAVYTAVASCCRKKKG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a delta-stichotoxin from the sea anemone Stichodactyla haddoni, belonging to the actinoporin family. This toxin functions as a potent cytolysin that specifically targets cell membranes by forming pores, leading to osmotic lysis and cell death. The mechanism involves binding to sphingomyelin-rich membrane domains, oligomerizing into a functional pore complex that disrupts membrane integrity. The structural scaffold should feature a conserved beta-sandwich fold stabilized by multiple disulfide bridges, typical of actinoporins, with key residues for membrane interaction and pore formation. The sequence must include a hydrophobic region for membrane insertion and a phosphocholine-binding site for target recognition. Ensure the protein exhibits high specificity for eukaryotic cell membranes, reflecting its role in the sea anemone's venom for prey immobilization and defense."}
{"description": "sp|Q8UUH8|PA2BH_LATCO Basic phospholipase A2 PC17 OS=Laticauda colubrina OX=8628 PE=3 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASAISNQPRNLVQFSELIQCVNKGKRATYHYMDYGCYCGKGGSGTPVDALDRCCKTHDDCYGQAEKKGCFPFLTLYNFGCFPGGPTCGKGNTCQRFVCDCDLKAALCFAKSPYNNNNYNIDTKKRCK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the banded sea krait, Laticauda colubrina. This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer exceptional stability. Key structural elements should include the conserved calcium-binding loop (Tyr-Gly-Cys-X-Gly-Gly) and the catalytic triad (His-Asp) essential for enzymatic activity. As a basic phospholipase A2, the protein should possess a net positive charge that facilitates interaction with anionic membrane surfaces and contributes to its presynaptic neurotoxic effects through disruption of neurotransmitter release at neuromuscular junctions. The sequence should maintain the characteristic N-terminal helix, beta-wing region, and C-terminal extension typical of group IA phospholipase A2 enzymes from elapid snake venoms, with specific adaptations for marine predation and rapid immobilization of fish prey."}
{"description": "sp|P0C6B6|VM2AL_TRIAB Zinc metalloproteinase homolog-disintegrin albolatin OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPEKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLYLEKNKELFSENYSETHYSLDGREITTYPSVEDHCYYHGRIQNDADSTASISACNGLKGHFKLRGKTYLIEPLKLPNSEAHAVFKYENVEKEDEAPQMCGVTETNWESDLPIKKTSQLNLPLLEKRCIELVMVADHRMYTKYDGDKTEISSKIYEIANNLNVDYRPMKIRVALIGTEIWSTGNLSKVTLSADETLDSFGEWRERDLLKRKSHDNVQLLTGMIFNEKIEGRAYNKSMCDPKRSVGIVRDHRTRPHLVANRMAHGLGHNLGIHHDGDSCSCGANSCIMSATVSNEPSSRFSDCSLNQYSNDIIYNPWTSYCLYNEPSKTDIVSPPVCGNYYLEVGEDCDCGPPANCQNPCCDATTCKLTPGSQCAEGLCCAQCKFIEEGTVCRVAKGDWNDDHCTGQSGDCPWIGYYG", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase homolog-disintegrin from the white-lipped pit viper (Trimeresurus albolabris). This protein should exhibit the characteristic modular architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that facilitates proteolytic activity, and a disintegrin domain that mediates integrin binding to disrupt cell-matrix interactions. The metalloproteinase domain should adopt a metzincin-like fold with a central five-stranded β-sheet and surrounding α-helices, stabilized by disulfide bonds, while the disintegrin domain should display an RGD (Arg-Gly-Asp) or related motif (e.g., KGD, VGD) on an exposed loop for specific integrin recognition (e.g., αIIbβ3, αvβ3). The protein likely functions in venom to induce hemorrhage, tissue damage, and anticoagulation by cleaving extracellular matrix components (e.g., collagen, fibrinogen) and inhibiting platelet aggregation via integrin blockade. Ensure the sequence reflects viperid venom adaptations, with high disulfide density for stability and potential propeptide processing for activation."}
{"description": "sp|Q27Q53|TX4_LOXIN U1-sicaritoxin-Li1c (Fragment) OS=Loxosceles intermedia OX=58218 PE=2 SV=1", "sequence": "ARGDAEKWESLISEERACKGEGVKGCYDKPDDWCCKKTPCKCPAWSHERECRCTQPCARRCRGKRALMLDPETHRLLFSED", "prompt": "Design a protein sequence for a highly potent dermonecrotic toxin derived from the venom of the brown spider Loxosceles intermedia. This toxin belongs to the sphingomyelinase D family and functions as a phospholipase D enzyme that specifically hydrolyzes sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The protein should adopt the conserved TIM barrel fold characteristic of sphingomyelinase D enzymes, featuring an (α/β)8 barrel structure with alternating alpha-helices and beta-strands that form the catalytic core. The active site should contain the conserved histidine and glutamic acid residues essential for metal ion coordination and catalytic activity, typically binding magnesium or calcium ions. The mechanism of action involves cleaving the phosphodiester bond of sphingomyelin to produce ceramide-1-phosphate and choline, leading to complement activation, platelet aggregation, endothelial cell damage, and severe dermonecrotic lesions. The protein should exhibit the characteristic structural stability of spider venom toxins, with appropriate disulfide bonding patterns to maintain the TIM barrel scaffold. The molecular target is primarily endothelial cell membranes, with specific affinity for sphingomyelin-rich domains that facilitate the inflammatory cascade and tissue destruction characteristic of loxoscelism."}
{"description": "sp|F8J2F5|VKT87_DRYCN Kunitz-type serine protease inhibitor 87 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSKDRPDFCHLPHETGPCKAKIQAFYYNPIYDTCLKFIYGGCEGNANNFKTMDECKRTCAE", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of the white-lipped snake, Drysdalia coronoides. This toxin should function as a potent and selective serine protease inhibitor, characteristic of Kunitz-domain containing venom components that disrupt prey homeostasis by interfering with key proteolytic cascades such as coagulation, fibrinolysis, or complement activation. The protein must adopt the canonical Kunitz-type fold, featuring a conserved alpha-beta-alpha secondary structure arrangement stabilized by three disulfide bonds in the characteristic C1-C6, C2-C4, C3-C5 connectivity pattern. The structural core should display the typical Kunitz domain topology with an antiparallel beta-sheet packed against two alpha-helices, creating a stable scaffold that presents the protease-binding loop. This binding loop should contain the critical reactive site residues that form specific interactions with the active site of target serine proteases, enabling high-affinity inhibition through a substrate-like mechanism. The toxin should exhibit the compact, globular architecture typical of Kunitz domains, approximately 50-60 amino acids in length, with surface-exposed residues optimized for target recognition while maintaining the structural integrity required for venom stability and delivery."}
{"description": "sp|P59868|CAIMP_PANIM Imperacalcin OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "GDCLPHLKRCKADNDCCGKKCKRRGTNAEKRCR", "prompt": "Design a novel protein sequence for an animal toxin with the following precise biological specifications: This toxin, known as imperacalcin, originates from the venom of the scorpion Pandinus imperator (Emperor scorpion), a species whose venom components are evolutionarily optimized for prey immobilization and defense. Imperacalcin functions as a potent calcium channel blocker, specifically targeting L-type voltage-gated calcium channels (Cav1.x family) in excitable cells. Its mechanism involves high-affinity binding to the channel's pore-forming α1 subunit, thereby inhibiting calcium influx, which disrupts neurotransmitter release and muscle contraction, leading to paralysis. Structurally, the toxin is inferred to adopt a compact, globular fold stabilized by a conserved cysteine framework typical of scorpion short-chain toxins, with a disulfide bridge pattern of C1-C4, C2-C5, and C3-C6 (or analogous connectivity) that forms an inhibitor cystine knot (ICK) motif. This scaffold confers exceptional stability and precise molecular recognition. Key domains include a functional surface with basic and hydrophobic residues critical for channel interaction, particularly in regions analogous to the 'pharmacophore' of related calcins. The sequence should reflect these features: a short chain (30-40 residues), the ICK fold with three disulfide bonds, and conserved motifs for calcium channel blockade (e.g., a putative channel-binding loop with specific residue properties for target engagement). Ensure the design captures the toxin's role in venom—rapidly impairing neuromuscular function—while maintaining structural integrity for experimental validation."}
{"description": "sp|C6JUP1|3SX1_MICCO Three-finger toxin 3FTx-1 OS=Micrurus corallinus OX=54390 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNSLICYNTMMQKVTCPEGKDKCEKYAVPVMRGKFYFSYQCTSKCHEGAYDVCCSTDLCNKSSTSG", "prompt": "Design a novel three-finger toxin (3FTx) protein sequence inspired by coral snake venom, specifically emulating the structural and functional characteristics of toxins from Micrurus corallinus. This toxin should adopt the canonical three-finger toxin fold, characterized by three extended β-stranded loops (fingers) projecting from a small, globular core stabilized by four conserved disulfide bonds with a typical C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should function as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to competitive antagonism and flaccid paralysis. Incorporate key structural motifs for receptor binding, particularly in loops I and II, which mediate interaction with the α-subunit of muscle-type nAChRs. Ensure the sequence includes conserved hydrophobic residues in the core for structural integrity and polar/charged residues in the loops for specific receptor engagement. The overall architecture should be compact (∼60-80 amino acids) with minimal helical content, dominated by β-sheet and turn structures, reflecting the evolutionary optimization of coral snake venom for rapid prey immobilization through neuromuscular blockade."}
{"description": "sp|Q4QXT9|FA10_TROCA Coagulation factor X OS=Tropidechis carinatus OX=100989 GN=F10 PE=2 SV=1", "sequence": "MAPQLLLCLILTFLWSLSEAESNVFLKSKVANRFLQRTKRANSLFEEFKAGNIERECIEERCSKEEAREAFEDNEKTETFWNVYVDGDQCSSNPCHYGGTCKDGIGSYTCTCLAGYEGKNCQYVLYQSCRVDNGNCWHFCKPVQNEIQCSCAESYLLGDDGYSCVAGGDFSCGRNIKARNKREASLPDFQTDFSDDYDAIDENNFVETPTNFSGLVPTVQSQNATLLKKSDNPSPDIRVVNGTDCKLGECPWQALLINDQGDGFCGGTILSPIYVLTAAHCINQTKYIRVVVGEIDISRKKTGRLLSVDKIYVHQKFVPSTYDYDIALIQMKTPIQFSENVVPACLPTADFANQVLMKQDFGIVSGFGRTRERGQTSNTLKVVTLPYVDRHTCMLSSNFPITQNMFCAGYNTLPQDACQGDSGGPHITAYRDTHFITGIISWGEGCAQTGKYGAYTKVSRFILWIKRIMRLKLPSTESSTGRL", "prompt": "Design a venom-derived coagulation factor X protein from the rough-scaled snake (Tropidechis carinatus) that functions as a potent procoagulant toxin. This protein should exhibit the characteristic domain architecture of coagulation factor X, including a Gla domain rich in gamma-carboxyglutamic acid residues for calcium-dependent membrane binding, two epidermal growth factor-like domains, and a serine protease domain. The protein must contain the conserved disulfide bond pattern typical of serine proteases, with the catalytic triad residues (histidine, aspartate, serine) properly positioned for enzymatic activity. The toxin should function by activating the coagulation cascade through cleavage of prothrombin to thrombin, leading to rapid fibrin clot formation and contributing to the snake's prey immobilization strategy. The structural scaffold should maintain the characteristic chymotrypsin-like fold of coagulation factors, with appropriate substrate specificity for its natural targets in the coagulation pathway. The protein should demonstrate calcium-dependent conformational changes and membrane association properties essential for its procoagulant activity in envenomation."}
{"description": "sp|P0C7P5|BNP_PROFL Bradykinin-potentiating and C-type natriuretic peptides OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MFVSRLAASGLLLLALLALSLDGKPVHQSKPGRSPPISPLSAQQWMPEGRPPHPIPPLSVQQWSQGRPRSEVPPVVVQPHESPAGGTTAFREELSPGPEAASGPAAPHRLPKSKGASATSAASRPMRDLRTDGKQERQKWGRMVQPDHHAAPGGGGGGGGGARRMKGLAKKAMGKGCFGHKLDRIGSTSGLGC", "prompt": "Design a novel venom-derived peptide that functions as both a bradykinin-potentiating peptide and a C-type natriuretic peptide, inspired by the complex venom system of the habu snake (Protobothrops flavoviridis). This multifunctional toxin should exhibit dual biological activities: (1) Potentiate bradykinin-mediated vasodilation and pain signaling by inhibiting angiotensin-converting enzyme (ACE), thereby increasing bradykinin bioavailability and enhancing inflammatory responses, and (2) Function as a C-type natriuretic peptide that activates guanylyl cyclase receptors, promoting vasodilation, natriuresis, and diuresis through cyclic GMP signaling pathways. The peptide should adopt a compact, stable structure stabilized by disulfide bridges characteristic of snake venom peptides, likely featuring a conserved cysteine framework that enables proper folding and receptor interactions. The structural scaffold should facilitate simultaneous interactions with both ACE and natriuretic peptide receptors, potentially through distinct functional domains or conformational flexibility. The peptide must maintain the characteristic pharmacological profile of habu venom components, exhibiting potent cardiovascular effects while demonstrating the evolutionary optimization typical of viperid venom systems for prey immobilization through hemodynamic disruption."}
{"description": "sp|D8MIA3|VSPR5_BITRH Snake venom serine protease rhinocerase 5 (Fragment) OS=Bitis rhinoceros OX=715877 PE=1 SV=1", "sequence": "VLIRVLANLLLLQLSYAQESSELVIGGDECDINEHPFLVALHTARSKRFHCAGTLLNKEWVLTAAHCDMENMQIYLGLHNISRPNQDQKRRVPKQKFFCLSNKTYTRWDKDIMLIKLNSPVPYSTHIAPLSLPSSPPIVGSVCRIMGWGATKSPNENVPHVPHCANINILHYSVCRATYGRLPAKSRTLCAGIPRRRIGSCLGDSGGPLICNGQVEGIVSWASKPCVHNGAPGMYTKVYDYTDWIRSIIGGNTSATCPL", "prompt": "Design a snake venom serine protease from the puff adder Bitis rhinoceros that functions as a potent hemostatic toxin. This enzyme should exhibit trypsin-like serine protease activity with a catalytic triad of His, Asp, and Ser residues. The protein should adopt the characteristic chymotrypsin-like fold with two β-barrel domains connected by surface loops that form the substrate-binding cleft. Include the conserved disulfide bridge pattern typical of snake venom serine proteases, likely featuring 4-6 disulfide bonds that stabilize the compact globular structure. The enzyme should specifically target components of the coagulation cascade, potentially cleaving fibrinogen to induce defibrination or activating specific coagulation factors to promote thrombosis. The substrate-binding pocket should have specificity for basic residues (arginine/lysine) at the P1 position. The surface loops should be optimized for efficient substrate recognition and proteolytic activity while maintaining the structural stability required for venom delivery and function. The overall structure should be compact and stable, characteristic of venom proteins that must withstand the harsh environment of snake venom and efficiently disrupt prey homeostasis."}
{"description": "sp|Q8I912|B1H_LOXLA Dermonecrotic toxin LlSicTox-betaIA1 OS=Loxosceles laeta OX=58217 PE=1 SV=1", "sequence": "MLLSAVISFIGFAAFLQEANGHVVERADSRKPIWDIAHMVNDLDLVDEYLGDGANALEADLAFTSDGTADEMYHGVPCDCFRSCTRSEKFSTYMDYIRRITTPGSSNFRPQMLLLIIDLKLKGIEPNVAYAAGKSTAKKLLSSYWQDGKSGARAYIVLSLETITRQDFISGFKDAIDASGHTELYEKIGWDFSGNEDLGEIRRIYQKYGIDDHIWQGDGITNCWVRDDDRLKEAIKKKNDPNYKYTKKVYTWSIDKNASIRNALRLGVDAIMTNYPEDVKDILQESEFSGYLRMATYDDNPWVK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles laeta, specifically belonging to the SicTox-beta family. This toxin should exhibit the characteristic phospholipase D activity that underlies the spider's venom pathology, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger inflammatory cascades, complement activation, platelet aggregation, and endothelial cell apoptosis, culminating in dermonecrosis and potential systemic effects. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of the phospholipase D superfamily, with the active site featuring a binuclear metal center coordinated by conserved histidine residues that facilitate substrate binding and hydrolysis. Key structural elements must include the HxKx4D motif essential for catalytic activity, along with stabilizing disulfide bridges that maintain structural integrity. The toxin should target mammalian cell membranes, with specificity for lipid components that enables its potent cytolytic and pro-inflammatory actions, reflecting the clinical manifestations of loxoscelism."}
{"description": "sp|A0A2Z5Z9X0|ACT1_CRIJA Deep-sea actinoporin Cjtox I OS=Cribrinopsis japonica OX=1799150 PE=2 SV=1", "sequence": "MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA", "prompt": "Design a novel deep-sea actinoporin protein sequence inspired by the venom of the sea anemone Cribrinopsis japonica. This toxin should function as a potent pore-forming cytolysin that specifically targets cell membranes rich in sphingomyelin. The protein should adopt the characteristic actinoporin fold, featuring a stable beta-sandwich core stabilized by a conserved disulfide bridge pattern (typically Cys1-Cys4 and Cys2-Cys3 connectivity) that provides structural rigidity. The N-terminal region should contain an amphipathic alpha-helix that serves as the membrane insertion domain, facilitating pore formation by oligomerizing into transmembrane beta-barrel structures. The molecular mechanism should involve initial binding to sphingomyelin-rich membrane domains via a phosphocholine-binding site, followed by conformational rearrangement and insertion of the N-terminal helix to create lytic pores that disrupt cellular integrity. The sequence should maintain key conserved residues for membrane recognition and oligomerization while exhibiting adaptations for function in deep-sea environments, potentially including enhanced stability under high-pressure conditions. The final protein should demonstrate potent hemolytic activity and cytolytic effects characteristic of this toxin family."}
{"description": "sp|P0CJ33|TXVE1_MACLB Snake venom vascular endothelial growth factor toxin IC1 (Fragment) OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "EVRPFPEVYERIA", "prompt": "Design a snake venom toxin protein sequence based on a vascular endothelial growth factor (VEGF) toxin from the blunt-nosed viper Macrovipera lebetinus. This toxin functions as a VEGF homolog that competitively binds to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, disrupting normal angiogenesis and vascular permeability signaling. The protein should adopt the characteristic VEGF structural fold featuring a cysteine-knot motif with conserved disulfide connectivity (C1-C4, C2-C5, C3-C6) that stabilizes the homodimeric structure. Key functional elements should include receptor-binding loops that mimic native VEGF but with altered affinity profiles to exert toxic effects through vascular disruption and potential induction of vascular leakage. The sequence should maintain the core VEGF scaffold while incorporating venom-specific modifications that enhance stability in the venom milieu and optimize receptor interaction for maximal pathophysiological impact, including potential anti-angiogenic properties that could lead to tissue ischemia and hemorrhage at the envenomation site."}
{"description": "sp|Q68PG5|SCX10_CENEX Neurotoxin Cex10 OS=Centruroides exilicauda OX=6879 PE=2 SV=1", "sequence": "KDGYLVEVTGCKKSCYKLGENKFCNRECKMKHRGGSYGYCYFFGCYCEGLAESTPTWPLPNKSCGKK", "prompt": "Design a neurotoxin protein sequence that mimics the biological activity and structural characteristics of the Cex10 toxin from the venom of the Arizona bark scorpion (Centruroides exilicauda). This toxin belongs to the beta-toxin family of scorpion venom peptides that specifically target voltage-gated sodium channels. The protein should function as a potent modulator of neuronal excitability by binding to site-4 of voltage-gated sodium channels, specifically Nav1.2 and Nav1.6 isoforms, causing a hyperpolarizing shift in the voltage dependence of activation and delaying channel inactivation. This mechanism results in prolonged neuronal depolarization and repetitive firing, leading to neurotoxic effects. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion beta-toxins, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure consisting of an alpha-helix packed against an antiparallel beta-sheet. The sequence should include key functional residues responsible for receptor binding specificity, particularly in the conserved 'pharmacophore' regions that interact with the voltage-sensing domain of the sodium channel. The protein should exhibit high thermal stability and protease resistance typical of scorpion venom peptides, with a molecular weight around 7-8 kDa and an isoelectric point consistent with basic neurotoxins. The overall tertiary structure should present a compact, globular fold with exposed loops that mediate specific interactions with the target sodium channel's voltage-sensing module."}
{"description": "sp|D8VNT0|FCNV4_CERRY Ryncolin-4 OS=Cerberus rynchops OX=46267 PE=1 SV=1", "sequence": "MKPWAAFHLIFLVASSLEGEVSNYGTRGAQDTEPTCRTEHQCTRDKIILQSQPGIPGIPGVPGTNGSEGLKGDPGPQGPPGIRGPDGIRGEAGPKGDKGDQGDKGDKGDKGDKGEDCNLDDCLPTEVRNCQDLLERGETLNGWYKIYPTEEVSMLVFCDMSTDGGGWLVFQRRQDGSVNFYREWESYKKGFGRQGSEFWLGNDKIHLLTNSGTQQLRIDLADFENIHTFATYSSFSIGNETEKYKLTLGSHLDGNMGDSLTLQNGRSFSTKDRDNDVSHIHCAVNFKGAWWYRKCHESNLNGLYHKGKHATYANGINWLTGKGYHYSYKYADMKIRPQKSETTVS", "prompt": "Design a novel venom protein sequence inspired by ryncolin-4 from the South Asian banded krait (Cerberus rynchops), a species known for its potent neurotoxic venom that facilitates prey immobilization through neuromuscular blockade. This protein should function as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, competitively inhibiting acetylcholine binding to prevent depolarization and induce flaccid paralysis. The structural scaffold should adopt the three-finger toxin fold characteristic of snake venom neurotoxins, featuring three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with connectivity C1-C3, C2-C4, C5-C6, and C7-C8. Key functional residues should be concentrated in the central loop (loop II), which forms the primary receptor binding interface, while maintaining the characteristic globular conformation with exposed hydrophobic patches for membrane association. The sequence should preserve the three-finger toxin cysteine framework while incorporating species-specific variations in the loop regions that enhance receptor affinity and specificity for the α-δ interface of muscle-type nicotinic receptors."}
{"description": "sp|Q8UUH9|PA2B9_LATCO Basic phospholipase A2 PC9 OS=Laticauda colubrina OX=8628 PE=3 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASAISPRPLNLIQFSQLIQCANKGKRPTLHYMDYGCYCGKGGSGTPVDALDRCCKTHDDCYGQAGKKGCIPFVTLYNFGCFPGAPQCGKGNTCQRFVCACDLKAALCFAKSPYNNNNYNIDTKKKCQTLIYARLQTQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the banded sea krait, Laticauda colubrina. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein must exhibit calcium-dependent catalytic activity to hydrolyze the sn-2 ester bond of glycerophospholipids, generating lysophospholipids and free fatty acids. This membrane-disrupting mechanism leads to irreversible blockade of acetylcholine release, resulting in progressive paralysis. The sequence should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic dyad (His48/Asp99). Include the essential disulfide bridge pattern (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91) that stabilizes the globular structure. The protein should possess basic surface residues that facilitate membrane interaction and contribute to its neurotoxic potency. Maintain the conserved structural elements including the N-terminal helix, β-wing region, and the active site pocket while ensuring proper folding for catalytic efficiency and target specificity."}
{"description": "sp|A0A218QWY4|SCX26_TITSE Putative sodium channel toxin Ts26 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MVKSAMKIVILILFVLLIRVESKRNGYPDISDGKSSTCRTTVEDSEEDFCVNVCKSIQGRTGNCCLGTCFCFDLPDEQKIVDVMDTTIEYCEWDEEEEEE", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal or cardiac isoforms to induce prolonged channel opening or altered inactivation kinetics, leading to hyperexcitability in the nervous system. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, globular fold stabilized by a cysteine framework of four disulfide bridges (C1-C4, C2-C5, C3-C6, C7-C8) that form a core inhibitory cystine knot (ICK) motif. Key structural elements should include an α-helix packed against an antiparallel β-sheet, with exposed loops critical for receptor interaction. The molecular target interface should involve binding to site 4 of voltage-gated sodium channels, influencing voltage-sensing domain movement and trapping the channel in an activated state. Ensure the sequence reflects the typical length of 60-70 amino acids, with conserved hydrophobic residues maintaining structural integrity and polar/charged residues in the functional loops mediating specific target recognition and potency."}
{"description": "sp|A8S6B0|3L22_AUSSU Alpha-elapitoxin-As2a OS=Austrelaps superbus OX=29156 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDGLICYVDSKTSRTCPPGENVCFTETWCDARCSLLGKRVDLGCAATCPTAKPGVDITCCSTDKCNPFPTQKHR", "prompt": "Design a novel alpha-elapitoxin protein sequence derived from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The molecular mechanism involves high-affinity binding to the alpha-delta interface of the nicotinic receptor, preventing acetylcholine from activating the receptor and blocking neuromuscular transmission. The structural scaffold should feature the typical three-loop architecture with loop II containing key functional residues for receptor interaction, while maintaining the compact, stable globular fold characteristic of elapid snake neurotoxins. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade while preserving the structural integrity required for venom stability and target specificity."}
{"description": "sp|P86406|SCX1_MESEU MeuNaTxbeta-1 OS=Mesobuthus eupeus OX=34648 PE=1 SV=2", "sequence": "MMKIIIFLIVSSLVLIGVKTDNGYLLDKYTGCKVWCVINNESCNSECKIRRGNYGYCYFWKLACYCEGAPKSELWHYETNKCNGRM", "prompt": "Design a novel beta-toxin peptide from the venom of the scorpion Mesobuthus eupeus that functions as a potent sodium channel modulator. This toxin should exhibit the characteristic beta-scorpion toxin mechanism of action, binding to neurotoxin receptor site 4 on voltage-gated sodium channels (Nav channels) and modifying channel gating by shifting the voltage dependence of activation toward more negative potentials. The peptide should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold typical of scorpion beta-toxins, featuring a compact globular architecture stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved hydrophobic core, an alpha-helical region, and a beta-sheet domain that together create the functional surface for sodium channel interaction. The molecular target specificity should favor mammalian neuronal sodium channels (particularly Nav1.2, Nav1.4, or Nav1.6), with the binding interface involving both the voltage-sensing domain II and the pore-forming regions of the channel. The toxin should demonstrate high affinity binding that results in prolonged channel opening and enhanced neuronal excitability, contributing to the paralytic and neurotoxic effects characteristic of scorpion envenomation. The sequence should maintain the essential pharmacophore residues responsible for target recognition while incorporating structural features that ensure proper folding, stability, and biological activity."}
{"description": "sp|A0A384E129|O16A_CONMB Omega-conotoxin MoVIA OS=Conus moncuri OX=2496636 PE=1 SV=2", "sequence": "MKLTCVVIVAVLFLTACQLITADDSRSTQRHRALRSTTKLSMSTRCKPPGSKCSPSMRDCCTTCISYTKRCRKYYN", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This is an omega-conotoxin from the marine cone snail Conus moncuri, a predatory venomous mollusk that uses these peptides for prey capture and defense. As an omega-conotoxin, this peptide functions as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal tissues. The toxin should exhibit high-affinity binding to N-type calcium channels (Cav2.2), disrupting calcium influx and thereby inhibiting neurotransmitter release at presynaptic terminals, leading to neuromuscular paralysis. Structurally, this conotoxin should adopt the characteristic inhibitor cystine knot (ICK) motif, stabilized by a conserved cysteine framework typical of omega-conotoxins, likely with a C-C-CC-C-C pattern forming three disulfide bridges that create a compact, stable globular fold. The mature peptide should be relatively short (approximately 25-30 amino acids) with key functional residues in flexible loops that mediate specific interactions with the channel's pore-forming regions. The sequence should include appropriate signal and propeptide regions for proper folding and processing, and exhibit the hallmark pharmacological profile of omega-conotoxins: high potency, selectivity for neuronal calcium channels, and the ability to induce flaccid paralysis in prey organisms."}
{"description": "sp|P25517|3SA5_NAJMO Cytotoxin 5 OS=Naja mossambica OX=8644 PE=1 SV=3", "sequence": "LKCKKLIPLFSKTCPEGKNLCYKMTMRLAPKVPVKRGCIDVCPKSSFLVKYECCDTDRCN", "prompt": "Design a cytotoxin protein from the venom of the Mozambique spitting cobra (Naja mossambica) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet scaffold stabilized by four conserved disulfide bonds with the cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. The protein should exhibit strong cytolytic activity through direct interaction with cell membranes, particularly targeting anionic phospholipids and causing membrane permeabilization. The structural core should consist of three extended β-finger loops emerging from a central globular domain, with the tips of loops I and II containing hydrophobic and basic residues critical for membrane insertion and electrostatic interactions. The protein should demonstrate preferential cytotoxicity toward cancer cells and erythrocytes through membrane disruption mechanisms, characteristic of cardiotoxin-like cytotoxins. The overall fold should maintain the compact, stable three-finger architecture typical of snake venom cytotoxins, with surface-exposed hydrophobic patches and cationic regions essential for membrane binding and pore formation."}
{"description": "sp|Q4VM07|VM3VB_MACLB Zinc metalloproteinase-disintegrin-like VLAIP-B OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MMQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKITALPKGAIQQPEQKYEDAIKYEFKVNGKPVVLHLEKNKGLFSEDYSETHYTPDGREITINPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLRIPDSEAHAIYKYENIEKEDEAPKMCGVTQTNWESDEPIKASQLNLTPEQRTYLKSKKYVELVIVADYIMFWKYDRSLSTIRTRIYEIVNTLNVIYRFLNIYIALVAVEIWSKGDLINVTSSAYDTLDSFGEWRERDLLNRKRHDNAQLLTGINFNGPSAGRGFVGRMCQPKYSVGIVQDHSKIYLLVASAMAHEMGHNLGMDHDRIDCTCGAKSCIMSGILRCETSYLFSDCSREEHRKYLINKMPQCILNKPLKTDIVSPAVCGNYFVEVGEECDCGSPANCQDRCCDAATCKLRPGAQCGDGVCCYQCKFRRAGTVCRPANGECDVSDLCTGQSAECPTDQFQRNGQPCQNNKGYCYNGTCPIMEKQCISLFGASATVAQDSCFQFNRRGNHYGYCRKENNTKIACAPEDVKCGRLYCLDNSSGHKNPCQIYYIPSDENKGMVDPGTKCGDGMVCSNGKCVDVTIAY", "prompt": "Design a venom protein sequence from the Levant viper (Macrovipera lebetinus) that functions as a zinc metalloproteinase-disintegrin-like toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH for catalytic activity, followed by a disintegrin-like domain that mimics the structure of standalone disintegrins but lacks their typical RGD integrin-binding motif. The protein should adopt the classic reprolysin family fold with a central five-stranded beta-sheet and surrounding alpha-helices. As a key component of viper venom, this toxin should function in prey immobilization by degrading extracellular matrix components like collagen, fibronectin, and laminin through its metalloproteinase activity, while the disintegrin-like domain may interfere with platelet aggregation or cell-matrix interactions. The sequence should include appropriate cysteine residues for disulfide bond formation to stabilize both domains, with the metalloproteinase domain containing the characteristic 'cysteine switch' mechanism for zymogen activation. The overall structure should facilitate efficient proteolytic activity against basement membrane components, contributing to hemorrhage, tissue damage, and disruption of hemostatic processes in envenomed prey."}
{"description": "sp|Q8UUJ2|VSPUI_GLOUS Snake venom serine protease ussurin OS=Gloydius ussuriensis OX=35671 PE=2 SV=2", "sequence": "VIGGVECNINEHRFLVALYTSRSRRFYCGGTLINQEWVLTAAHCDRKNIRIKLGMHSEKVPNEDAQTRVPKEKFFCLSSKTYTKWDKDIMLMRLKRPVNNSTHIAPVSLPSNPPSVGSVCRVMGWGTITSSQETHPDVPHCANINILDYEVCRAAYPELPVTRRTLCAGILEGGKDSCNGDSGGPLICNGQFQGIAYWGADTCAQPREPGLYTKVFDYTDWIQSIISGNTDATCPQ", "prompt": "Design a snake venom serine protease from the Ussuri pit viper (Gloydius ussuriensis) that functions as a key hemostatic toxin. This enzyme should exhibit the characteristic trypsin-like serine protease activity with a catalytic triad of His, Asp, and Ser residues. The protein should adopt the canonical chymotrypsin-like fold with two β-barrel domains connected by surface loops that form the substrate-binding cleft. Include the conserved disulfide bridge pattern typical of snake venom serine proteases, which stabilizes the tertiary structure and ensures proteolytic stability in the venom environment. The enzyme should specifically target components of the coagulation cascade, potentially cleaving fibrinogen to induce defibrination or activating specific coagulation factors to promote thrombosis. The substrate-binding site should have appropriate specificity pockets (S1-S4) that determine its target selectivity, with potential preference for basic residues at the P1 position. The overall structure should maintain the characteristic features of viperid venom serine proteases while ensuring functional efficiency in disrupting hemostatic balance through precise proteolytic cleavage of key plasma proteins."}
{"description": "sp|P84864|KAX6E_HOFGE Potassium channel toxin alpha-KTx 6.14 OS=Hoffmannihadrurus gertschi OX=380989 PE=1 SV=1", "sequence": "TGTSCISPKQCTEPCRAKGCKHGKCMNRKCHCMLCL", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom biochemistry. This toxin should belong to the alpha-KTx family, specifically emulating the functional and structural characteristics of toxins from Hoffmannihadrurus gertschi. The protein must function as a potent and selective blocker of voltage-gated potassium channels, particularly Kv1 family channels, to disrupt neuronal signaling and neuromuscular function. Structurally, it should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a triple-stranded antiparallel beta-sheet stabilized by an alpha-helix. The cysteine framework should follow the classic alpha-KTx pattern (C-X(3-7)-C-X(3-7)-C-X(6-12)-C-X(1-3)-C-X(6-12)-C) forming three disulfide bridges that create the stable molecular scaffold. The functional core must include the conserved functional dyad consisting of a critical lysine residue positioned in the beta-sheet region and an aromatic residue that together mediate specific channel pore blockade. The protein should be approximately 30-40 amino acids in length with a compact, globular structure stabilized by the disulfide network. The molecular mechanism should involve high-affinity binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway and preventing potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The structural design should ensure thermal stability and protease resistance typical of scorpion venom peptides while maintaining precise molecular recognition for Kv1 channel subtypes."}
{"description": "sp|Q8I913|A331_LOXLA Dermonecrotic toxin LlSicTox-alphaIII3i OS=Loxosceles laeta OX=58217 PE=2 SV=1", "sequence": "MYVHLALILGCWTVILQGAETDVGERADKRRPIWNLGHMVNAVKQIPTFLNDGANAIEADITFKGAVPTYSYHGTPCDFGRDCIRWEYFDVFLQTLRDYTTPGNSKYYEKFILFVLDLKTGSLNNNEVRKAGENIAKGLLKNYWNNGNNGGRAYVVLSLPDIAHYEFIRRFKEVLKAEGHENLLDKVGYDLSGPYLPSLPSLDSVHEAFRKAGVDGHVWLSDGLTNWAPLGDMARLKEIVERRDSENGFISKVYYWSVDKYSTTRTALDVGVDGIMTNFPYVIIDVLNENGYKDKYRLATYDDNPWETFKK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles laeta. This toxin belongs to the SicTox family and specifically represents the alphaIII3i isoform. The protein should function as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. This enzymatic activity leads to profound dermonecrotic effects through the generation of ceramide-1-phosphate and lysophosphatidic acid, which trigger inflammatory cascades, platelet aggregation, hemolysis, and endothelial cell damage. The protein should adopt the characteristic (α/β)8-barrel (TIM barrel) fold typical of the phospholipase D superfamily, with the conserved catalytic motif HxK(x)4D that forms the active site. The structure should feature the distinctive N-terminal signal peptide for secretion, followed by the mature toxin domain with specific substrate-binding pockets that confer membrane-targeting capability. The sequence should maintain the conserved structural elements required for enzymatic activity while incorporating the specific variations that define the alphaIII3i isoform's potency and substrate specificity within the Loxosceles venom system."}
{"description": "sp|D6C4K5|I16F_CONCL Conotoxin Cl6.15 OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MKLSVKFLLFLMILPLIAGEDMSDNDAPKSVDVQRNVKRQGQSQFGEQCTGHLDCFGDLCCFDGYCIMTSWIWPCNW", "prompt": "Design a novel conotoxin protein sequence inspired by the venom arsenal of the marine cone snail Californiconus californicus. This toxin should function as a potent neurotoxin that selectively targets and modulates neuronal ion channels, consistent with the predatory strategy of cone snails to immobilize prey through rapid neuromuscular blockade. The protein must adopt the characteristic inhibitory cysteine knot (ICK) structural scaffold, stabilized by a conserved disulfide connectivity pattern typical of conotoxins. The sequence should incorporate key structural motifs that facilitate high-affinity binding to specific ion channel subtypes, potentially including voltage-gated sodium, potassium, or calcium channels, to disrupt neuronal signaling. Ensure the design reflects the compact, disulfide-rich architecture that confers exceptional stability and target specificity, with surface loops optimized for molecular recognition of the intended neuronal receptor. The final sequence must exhibit the hallmark features of conotoxins: multiple disulfide bonds forming a rigid core, short functional loops for target engagement, and minimal secondary structure elements arranged in a globular fold that enables precise pharmacological intervention in synaptic transmission."}
{"description": "sp|A0A1S4NYE8|NTA_PSARE Beta/delta-theraphotoxin-Pre1a OS=Psalmopoeus reduncus OX=1795668 PE=1 SV=2", "sequence": "EDCLGWFSRCSPKNDKCCPNYKCSSKDLWCKYKIW", "prompt": "Design a novel beta/delta-theraphotoxin peptide derived from the venom of the tarantula species Psalmopoeus reduncus. This toxin should function as a potent voltage-gated sodium channel (Nav) modulator, specifically targeting insect or arthropod sodium channel subtypes with high selectivity. The peptide should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). Key structural elements should include a solvent-exposed pharmacophore region, typically comprising a critical hydrophobic patch and polar residues, that mediates specific interactions with the voltage-sensing domain (VSD) of Nav channels. The mechanism of action should involve modulation of channel gating, potentially leading to delayed inactivation or altered voltage dependence, resulting in hyperexcitability and paralysis in prey organisms. The sequence should exhibit the hallmark features of theraphotoxins, including high thermal and proteolytic stability conferred by the ICK scaffold, and appropriate physicochemical properties for membrane penetration and target engagement."}
{"description": "sp|Q66S21|NATT2_THANI Natterin-2 OS=Thalassophryne nattereri OX=289382 PE=1 SV=1", "sequence": "MNLSVLLVTLLLLSWTSAEKDLKVRVARSTNDETNLHWVKCGGSVPDGAVSIRNTYVSPARTEYVCKCFCQAGYYSTKDSKCHYPYGTKEMATSTNCYILVNRDNFELLEWKDGYAGSVPDNAVSTCKTNKIYVGKGAYGLGKIEPANHCLYYVWDGAETWTKTYQALTMNKDVIEQAMKDVKYQTEGVTVIKGKPEVMRRSTVNNQHCKEVTKTVTLTKDISTDERWDVTNSVTFGVTTTVTAGIPDVSSASLEISMQATMDFAHGASKTETQSYMVTVSVPVPPKQSCTVSMVAQVNKADIPFTATLIRTYRGGKKTQTTTKGVYRTIQVAETHADVEQCTIIGDAKDCPNASSTITTLRPKLKSKKPAKPAGK", "prompt": "Design a novel protein sequence for a fish-derived toxin that functions as a potent inflammatory and nociceptive agent, mimicking the biological activity of natterin-2 from the venomous toadfish Thalassophryne nattereri. This toxin should belong to the natterin family of pore-forming proteins and exhibit the characteristic dual functionality of both enzymatic activity and membrane disruption. The protein must contain the conserved N-terminal domain with predicted kinase-like structural features and the C-terminal pore-forming domain responsible for membrane insertion. Incorporate the critical lysine-rich regions essential for membrane binding and the conserved cysteine residues that likely form disulfide bridges stabilizing the protein's tertiary structure. The toxin should specifically induce edema, leukocyte recruitment, and intense pain responses through its ability to form transmembrane pores in target cells, leading to ion imbalance and cell lysis. The structural scaffold should maintain the characteristic β-sheet-rich fold typical of natterin family proteins, with surface-exposed loops that facilitate membrane recognition and insertion. Ensure the sequence includes the conserved motifs required for both the enzymatic-like activity and the oligomerization capacity necessary for pore formation in biological membranes."}
{"description": "sp|C6JUP2|3NO22_MICCO Three-finger toxin 3FTx-2 OS=Micrurus corallinus OX=54390 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNTANTLFCDNSNVPSIRTRKRCLKNQKLCYKMTFFTPGFGWTQIKGCIHRCPESTPNEKYQCCSTDNCI", "prompt": "Design a novel three-finger toxin (3FTx) protein sequence inspired by coral snake venom, specifically emulating the structural and functional characteristics of toxins from Micrurus corallinus. This toxin should adopt the canonical three-finger toxin fold, characterized by three extended β-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The protein should function as a potent neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, causing postsynaptic blockade through competitive or allosteric inhibition. The sequence should maintain key structural features including the conserved hydrophobic core, the three functional loops responsible for receptor binding specificity, and appropriate surface residues for target recognition. The toxin should exhibit the characteristic stability and resistance to proteolysis typical of three-finger toxins, with molecular weight approximately 6-8 kDa and basic isoelectric point to facilitate interaction with neurotransmitter receptors."}
{"description": "sp|P86403|SCXN2_MESEU Sodium channel neurotoxin MeuNaTxalpha-2 OS=Mesobuthus eupeus OX=34648 PE=1 SV=2", "sequence": "MNYLVMISLALLLMTGVESARDAYIANDRNCVYTCALNPYCDSECKKNGADSGYCQWFGRFGNACWCKNLPDKVPIRIPGECRGR", "prompt": "Design a novel sodium channel neurotoxin protein sequence inspired by the venom arsenal of the scorpion Mesobuthus eupeus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to disrupt action potential generation and propagation. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion long-chain neurotoxins, featuring a compact globular structure stabilized by four disulfide bridges with the canonical C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. Key structural elements must include a conserved hydrophobic core, a triple-stranded antiparallel beta-sheet, and a single alpha-helix. The molecular mechanism should involve binding to neurotoxin receptor site 3 on voltage-gated sodium channels, preferentially interacting with the domain IV voltage sensor to inhibit fast inactivation, thereby prolonging channel opening and causing persistent neuronal depolarization. The toxin should exhibit high affinity for mammalian neuronal sodium channels (particularly Nav1.2, Nav1.6) while maintaining selectivity against cardiac and skeletal muscle isoforms. Critical functional residues should be positioned in the conserved 'pharmacophore' regions, including the beta-hairpin loop responsible for receptor site recognition and the conserved glycine-rich region essential for channel interaction. The sequence must maintain the characteristic molecular weight of 6-8 kDa and the basic isoelectric point typical of scorpion neurotoxins to facilitate membrane interaction and target engagement."}
{"description": "sp|Q8JFX7|3NOHE_BUNMU Muscarinic toxin BM14 OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIICLDLGYTEMCNMCVRPYPFMSSCCPEGQDRCYKSYWVNENGKQKKYHGKYPVILERGCVTACTGPGSGSIYNLYTCCPTNRCGSSSTSG", "prompt": "Design a novel muscarinic toxin protein sequence inspired by the venom of Bungarus multicinctus (many-banded krait). This toxin should function as a selective antagonist of muscarinic acetylcholine receptors, specifically targeting the M4 receptor subtype with high affinity. The protein should adopt a three-finger toxin structural fold characteristic of elapid snake venom toxins, featuring a compact core stabilized by four conserved disulfide bridges with a C1-C3, C2-C5, C4-C6, C7-C8 connectivity pattern. The three extended loop regions (finger I, II, and III) should contain key functional residues for receptor recognition and binding, particularly in the central loop which typically houses the critical pharmacophore for muscarinic receptor interaction. The toxin should exhibit the characteristic β-sheet-rich structure with minimal helical content, maintaining the globular three-finger architecture that enables precise receptor targeting while avoiding nicotinic receptor activity. The sequence should include appropriate hydrophobic patches and charged surface residues that facilitate specific binding to the extracellular domains of muscarinic receptors, particularly the allosteric binding site of the M4 subtype, to modulate cholinergic signaling in the central nervous system."}
{"description": "sp|A8S6A8|3L21_AUSSU Long neurotoxin 1 OS=Austrelaps superbus OX=29156 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDVGNSFSCYKTPDVKSEPCAPGENLCYTKTWCDRFCSIRGKVIELGCAATCPPAEPRKDITCCSTDNCNPHPAH", "prompt": "Design a long neurotoxin protein sequence that mimics the toxic activity and structural characteristics of long neurotoxin 1 from the Australian lowland copperhead snake (Austrelaps superbus). This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. It specifically targets and antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, causing irreversible binding that leads to flaccid paralysis by blocking neurotransmission. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8, forming a compact globular structure. The central loop (loop II) should be elongated compared to short neurotoxins, enhancing receptor binding affinity and specificity. The molecular mechanism involves competitive inhibition at the acetylcholine binding site, preventing neurotransmitter-induced ion channel opening. The structural scaffold should feature three extended β-stranded loops projecting from a hydrophobic core, with key conserved residues in the functional loops responsible for receptor recognition and binding. The protein should exhibit high specificity for muscle-type nicotinic acetylcholine receptors while maintaining the thermal stability and protease resistance typical of snake venom neurotoxins."}
{"description": "sp|A0A2U8QPE6|OXLA_MICMP L-amino acid oxidase OS=Micrurus mipartitus OX=430902 PE=1 SV=1", "sequence": "MNVFFMFSLVFLAAFGSCADDTRPLGECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMSGLSAAYVLAKAGHKVTLLEASEGVGGRVKTYRNKQEGWYINLGPMRLPERHRIVREYIRKFHLPLSEFVQENENTWYYIKNIRKRVSEVKKNPDLFEYPVNPSEKGKSASQLYQESLEKVIDELKRTNCNHILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSSFYLSFIESLKSDDIFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNAQVIKIQHNAKKVIVTYQTPAKTLPSVTADYVIVCSTSRAARHIRFQPPLPTNKARALRSIHYRSAIKIFLTCTKRFWEADGIHGGKSTTDLPSRFIYYFNQNFTNGIGVIMAYVLADDAKFFQPHDLKTNADIVINDLSLIHQLPKEEIQALCRPSWIQKWSLDKYAMGSITSFTPYQFLDYFEIAAAPVGRIHFAGEYTAKHHGWIDSTIKSGLRAARDVNRA", "prompt": "Generate the amino acid sequence for a potent L-amino acid oxidase toxin from the venom of the red-tailed coral snake (Micrurus mipartitus). This enzyme should function as a key venom component that catalyzes the oxidative deamination of L-amino acids, producing hydrogen peroxide, ammonia, and the corresponding α-keto acid. The resulting hydrogen peroxide induces oxidative stress in prey, leading to cellular damage, apoptosis, and contributing to the venom's hemotoxic and cytotoxic effects. The protein should adopt the classic L-amino acid oxidase fold, featuring a conserved FAD-binding domain with a Rossmann-like motif for cofactor binding and a substrate-binding domain that facilitates specific recognition of L-amino acids. Key structural elements should include a dynamic active site with residues for substrate orientation and catalysis, potential N-linked glycosylation sites typical of secretory venom proteins, and a homodimeric quaternary structure stabilized by non-covalent interactions. The enzyme should exhibit optimal activity at physiological pH and demonstrate substrate preference for hydrophobic L-amino acids like L-phenylalanine or L-leucine, enhancing its potency in disrupting metabolic pathways and inducing tissue damage in envenomed prey."}
{"description": "sp|P49122|3SOF7_NAJAT Cytotoxin 7 OS=Naja atra OX=8656 PE=2 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLKCHNTQLPFIYNTCPEGKNLCFKATLKFPLKFPVKRGCAATCPRSSSLVKVVCCKTDKCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the Chinese cobra (Naja atra), a medically significant elapid snake species. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically functioning as a cytotoxin that disrupts cell membranes through direct interaction with lipid bilayers. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bonds with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural features include three extended loops (fingers) projecting from a central globular core, with the tips of loops I and II containing hydrophobic and cationic residues that mediate membrane binding and disruption. The molecular mechanism involves initial electrostatic attraction to anionic phospholipids in cell membranes, followed by hydrophobic insertion that compromises membrane integrity, leading to cell lysis and death. The sequence should include conserved structural residues that maintain the β-sheet framework while incorporating specific functional residues that confer membrane-permeabilizing activity, particularly in the membrane-binding loops. The overall structure should be compact and stable, with the disulfide network providing rigidity to the three-finger scaffold essential for its cytotoxic function."}
{"description": "sp|F8QN51|PA2A3_VIPRE Acidic phospholipase A2 Vur-PL3 OS=Vipera renardi OX=927686 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGNLFQFGKMIKYKTGKSALLSYSAYGCYCGWGGQGKPQDPTDRCCFVHDCCYGRVNGCNPKMDTYSYSFLNGDIVCGDDDPCLRAICECDRAAAICFGENVNTYDKKYKYYSSSHCTETEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Vipera renardi, a viper species. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by multiple disulfide bridges. The sequence should include the conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, as well as the catalytic histidine and aspartate residues. As an acidic isoform, the protein should have a net negative charge at physiological pH. The toxin should exhibit membrane-disrupting properties and may contribute to local tissue damage, inflammation, and potentially systemic effects through the generation of pro-inflammatory lipid mediators. The structural scaffold should maintain the characteristic phospholipase A2 interfacial activation mechanism, allowing the enzyme to bind to lipid membranes and efficiently hydrolyze phospholipid substrates."}
{"description": "sp|W4VRU3|ICK41_TRILK Toxin ICK-41 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKPIVYMLLFCAFTVVILGHPNNHGALIPHHDKLPNGESCTRPGYSCSESSQCCTPVDGETFTYGCGRAWMEGSKICYICNRESSMC", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The toxin originates from the venom of Trittame loki, a spider species whose venom components typically function to immobilize prey through neurotoxic mechanisms. This toxin belongs to the Inhibitor Cystine Knot (ICK) structural family, characterized by a highly stable, compact fold stabilized by a specific disulfide bridge pattern. The ICK motif consists of a triple-stranded beta-sheet and a conserved cysteine framework with a disulfide connectivity of C1-C4, C2-C5, and C3-C6, forming a knotted topology that confers exceptional resistance to proteolytic degradation and thermal denaturation. The core function of this toxin is to act as a neurotoxin, likely targeting ion channels such as voltage-gated sodium, potassium, or calcium channels in the nervous system of prey, leading to paralysis by disrupting action potential propagation. The molecular mechanism involves high-affinity binding to specific extracellular loops or pore regions of the target ion channel, inhibiting ion flux. Structurally, the protein should adopt a globular, disulfide-rich fold with the ICK motif driving stability, and include surface-exposed loops critical for target recognition and binding specificity. The sequence must incorporate the conserved cysteine residues in the ICK framework, along with hydrophobic core residues and polar surface residues that mediate target interaction. Ensure the design reflects the biological role of spider venom toxins in prey immobilization, with emphasis on the ICK scaffold's robustness and functional versatility in neurotoxicity."}
{"description": "sp|Q8UW08|PA2B0_HYDHA Basic phospholipase A2 OS=Hydrophis hardwickii OX=8781 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGAASIPPLPLNLVQFSYVITCANHGRRSSLDYADYGCYCGAGGSGTPVDELDRCCQIHDDCYGEAEKQGCYPKMLIYDYYCGSDGPYCRNVKKKCNRMVCDCDVAAAKCFARNAYNNANYNIDTNKRCK", "prompt": "Design a basic phospholipase A2 (PLA2) toxin from the venom of the Hardwicke's sea snake (Hydrophis hardwickii). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and subsequent neurotransmitter release impairment. Structurally, it should adopt the characteristic pancreatic-type PLA2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network (His48, Asp49, Tyr52, Tyr73). Include the essential disulfide bridge pattern (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91) that stabilizes the globular, multi-looped architecture. The N-terminal region should form an antiparallel β-sheet, while the C-terminal segment should comprise an α-helix. Incorporate a basic surface patch to facilitate interaction with anionic membrane interfaces and potential allosteric modulation of other venom components. Ensure the sequence reflects the high isoelectric point typical of neurotoxic PLA2s, enhancing its affinity for synaptic membranes and contributing to the venom's rapid paralytic effects in marine prey."}
{"description": "sp|V9QFH5|TXA1_LATHE Alpha-latrotoxin associated low molecular weight protein OS=Latrodectus hesperus OX=256737 PE=3 SV=1", "sequence": "MSKLFFVAFLCLIISVFATTPDEIGCTDISQAEFDEKNANCIKCGEEGFGEEMVKRCRNKCFTDNFYQSCVDQLNGVYEEKDTPPVKE", "prompt": "Generate the amino acid sequence for an alpha-latrotoxin associated low molecular weight protein from the venom of the Western black widow spider (Latrodectus hesperus). This protein functions as a critical component of the latrotoxin complex, which is responsible for the potent neurotoxic effects of black widow spider venom. The protein likely serves as a structural or regulatory component that modulates the activity of alpha-latrotoxin, the primary neurotoxin that induces massive neurotransmitter release from presynaptic nerve terminals by forming calcium-permeable pores in neuronal membranes. The protein should exhibit a compact, stable structure typical of spider venom components, potentially featuring conserved cysteine residues that form disulfide bridges to maintain structural integrity. The sequence should reflect adaptation for venom function, with molecular characteristics optimized for interaction with alpha-latrotoxin and potential roles in toxin stabilization, targeting, or activity modulation within the venom cocktail. The structural scaffold should be consistent with low molecular weight venom proteins that function in neurotoxic complexes."}
{"description": "sp|P25670|3L21_ASPSC Long neurotoxin 1 OS=Aspidelaps scutatus OX=8607 PE=1 SV=1", "sequence": "RICYIAPYDHKTCAAGENICYLKAWCDAWCSSRGKKLEFGCAATCPTVKPGVDISCCDTDNCNPHPKL", "prompt": "Design a protein sequence for a long neurotoxin from the venom of the shield-nosed cobra (Aspidelaps scutatus), a medically significant elapid snake. This toxin functions as a potent postsynaptic neurotoxin that targets the neuromuscular junction, specifically binding with high affinity to nicotinic acetylcholine receptors at the α-δ and α-γ subunit interfaces. The mechanism involves competitive antagonism of acetylcholine binding, leading to progressive flaccid paralysis through inhibition of neuromuscular transmission. The structural scaffold should feature the characteristic three-finger toxin fold with three extended β-sheet loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8). The extended C-terminal tail, a hallmark of long neurotoxins, should contain additional structural elements that enhance receptor binding affinity and specificity. Key functional residues should be positioned in the central loop (loop II) and C-terminal region to form the pharmacologically active site, with conserved hydrophobic patches and cationic residues facilitating target recognition. The overall structure should maintain the globular, compact conformation typical of three-finger toxins while exhibiting the enhanced receptor-binding characteristics that distinguish long neurotoxins from their short-chain counterparts."}
{"description": "sp|I6RA71|TX72E_SCOMU Kappa-scoloptoxin(07)-Ssm2e OS=Scolopendra mutilans OX=2836329 PE=3 SV=2", "sequence": "MLVFYALLFVSVFSNTVMGATIDMPIPKPILREAIEEIDVNKRADSHYCKEENCPPGKHCPKVPIVCRRGPCCF", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-scoloptoxin derived from the venom of Scolopendra mutilans, commonly known as the Chinese red-headed centipede. This toxin belongs to the scoloptoxin family, which are key components in centipede venom that facilitate prey capture through potent neurotoxic activity. The core function of this kappa-scoloptoxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) in the nervous system of prey organisms. Its mechanism of action involves high-affinity binding to the pore region of Kv channels, inhibiting potassium ion efflux, which leads to prolonged membrane depolarization, enhanced neurotransmitter release, and ultimately neuromuscular paralysis. The structural scaffold should feature the characteristic inhibitor cysteine knot (ICK) motif, stabilized by a conserved disulfide bridge pattern with a cysteine framework of C-C-CC-C-C, forming three disulfide bonds that create a compact, stable globular fold. The anticipated 3D structure includes a small, triple-stranded beta-sheet core and several flexible loops that are critical for target recognition and binding specificity. Key functional residues are expected to reside in these loops, facilitating interactions with the Kv channel vestibule. The biological significance of this toxin lies in its role in the centipede's predatory strategy, where it disrupts neuronal excitability to immobilize prey rapidly. Ensure the sequence reflects these structural and functional attributes, with conserved cysteines for disulfide bonding and loop regions optimized for potassium channel blockade."}
{"description": "sp|P0DUS5|D211_DORVU DELTA-limacoditoxin(2)-Dv11 OS=Doratifera vulnerans OX=1372962 PE=1 SV=1", "sequence": "MKFAKTFLLLFVVLLLLSIVMAEPKRGFGKLLRKVFKVGRRVAGSAAEISGSSGGEE", "prompt": "Design a novel protein sequence for a delta-limacoditoxin from the venom of Doratifera vulnerans (the mottled cup moth), a potent insect-selective neurotoxin. This toxin should function as a delta-class sodium channel modulator, specifically targeting insect voltage-gated sodium channels to induce paralysis through disruption of neuronal signaling. The protein should adopt a compact, globular fold stabilized by multiple disulfide bonds characteristic of limacoditoxins, likely featuring a cysteine framework that enables precise molecular recognition of sodium channel domains. Key structural elements should include well-defined beta-sheets and loops that form the binding interface with insect sodium channels, particularly interacting with domain II or IV voltage-sensing regions to alter channel gating kinetics. The toxin should exhibit high selectivity for insect over mammalian sodium channels, reflecting the ecological role of cup moth venom in prey immobilization. The sequence must maintain conserved residues essential for structural integrity and biological activity while incorporating the specific molecular features that confer delta-limacoditoxin functionality."}
{"description": "sp|P84900|BRKP1_PITHY Phyllokininogen-1 OS=Pithecopus hypochondrialis OX=317381 PE=1 SV=2", "sequence": "MSILKKSLFLVLFLGLVSFSICEEEKREAEEEENEDEIEEESDEKKRESPDRPPGFSPFRIY", "prompt": "Design a novel peptide toxin derived from the venom of the leaf frog Pithecopus hypochondrialis, focusing on its role as a bradykinin-potentiating peptide. This toxin should function as a potent vasoactive agent by inhibiting angiotensin-converting enzyme (ACE), thereby prolonging the half-life and enhancing the effects of endogenous bradykinin. The peptide should adopt a characteristic bradykinin-potentiating peptide fold, typically featuring an extended conformation with key residues for ACE inhibition. Include conserved structural motifs that facilitate interaction with the ACE active site, particularly residues involved in zinc coordination and substrate binding. The sequence should maintain the essential pharmacophore for bradykinin potentiation while incorporating structural stability elements common to amphibian venom peptides. Ensure the design reflects the evolutionary adaptation of this toxin for prey immobilization through blood pressure regulation and increased vascular permeability."}
{"description": "sp|P0C1Y2|CA13_CONBN Alpha-conotoxin-like Bn1.3 OS=Conus bandanus OX=72279 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATAVLPVTLDRASDGRNAAANAKTPRLIAPFIRDYCCHRGPCMVWCG", "prompt": "Generate the amino acid sequence for an alpha-conotoxin from the marine cone snail Conus bandanus, specifically the alpha-conotoxin-like Bn1.3 variant. This toxin belongs to the alpha-conotoxin family, which are small, disulfide-rich peptides that function as competitive antagonists of nicotinic acetylcholine receptors (nAChRs). The biological significance of this toxin in Conus bandanus venom is to induce rapid neuromuscular paralysis in prey by blocking neurotransmission at the neuromuscular junction. Its core mechanism involves high-affinity binding to the orthosteric site of muscle-type nAChRs (specifically α1-containing subtypes), preventing acetylcholine from activating the receptor and leading to flaccid paralysis. The toxin is expected to adopt the conserved alpha-conotoxin structural scaffold, characterized by a globular fold stabilized by two disulfide bonds forming a cysteine framework of CC-C-C (Framework I), with the pattern Cys1-Cys3 and Cys2-Cys4 connectivity. Key structural features include a short alpha-helical segment and beta-turn elements that create a compact, stable structure resistant to proteolysis. The molecular target is the α1δγ or α1δε muscle-type nAChR, with the toxin binding at the interface between the α1 and δ/ε subunits, where it mimics acetylcholine but acts as an antagonist. The sequence should reflect conserved residues for nAChR interaction, such as a hydrophobic patch and polar residues for receptor engagement, while maintaining the characteristic cysteine spacing and overall fold of alpha-conotoxins."}
{"description": "sp|Q2I2P2|CON2_CONLT Contulakin-Lt2 OS=Conus litteratus OX=89445 PE=2 SV=1", "sequence": "MQMAYWVMVMMMVGITAPLSEGRKLNDAIRGLVPNDLTPQLLQSLVSRRHRVFHLDNTYLKIPICAWKVCPPTPWRRRDLKKRNK", "prompt": "Design a protein sequence for Contulakin-Lt2, a neurotoxic peptide from the marine cone snail Conus litteratus. This toxin belongs to the conotoxin family and functions as a potent neuroactive peptide that modulates neuronal signaling pathways. The protein should adopt a stable, compact tertiary structure stabilized by multiple disulfide bonds characteristic of conotoxins, likely featuring a specific cysteine framework that dictates its three-dimensional fold. The structural scaffold should enable high-affinity interaction with specific neuronal receptors or ion channels, potentially mimicking endogenous neuropeptides to disrupt normal synaptic transmission. The sequence must include conserved residues critical for receptor binding and biological activity, while maintaining the overall structural integrity required for venom efficacy. The resulting protein should exhibit high specificity for its neuronal target, contributing to the paralytic and analgesic effects observed in the venom's mechanism of action."}
{"description": "sp|P59888|IPTXI_PANIM Phospholipase A2 imperatoxin-1 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "MHTPKHAIQRISKEEMEFFEGRCERMGEADETMWGTKWCGSGNEATDISELGYWSNLDSCCRTHDHCDNIPSGQTKYGLTNEGKYTMMNCKCETAFEQCLRNVTGGMEGPAAGFVRKTYFDLYGNGCYNVQCPSQRRLARSEECPDGVATYTGEAGYGAWAINKLNG", "prompt": "Design a phospholipase A2 toxin from the venom of the emperor scorpion (Pandinus imperator) that functions as imperatoxin-1. This toxin should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and catalytic histidine-aspartate dyad. Include the typical disulfide bridge pattern common to scorpion phospholipase A2 toxins (CysI-CysIV, CysII-CysV, CysIII-CysVI) that stabilizes the compact globular structure. The toxin should possess enhanced membrane penetration capabilities and target neuronal or muscular tissues, potentially interacting with specific ion channels or receptors to potentiate its neurotoxic effects. The structural scaffold should feature the conserved phospholipase A2 interfacial binding surface that facilitates interaction with lipid membranes. Incorporate key functional residues for catalytic efficiency and membrane association while maintaining the characteristic three-finger-like structural motif with alpha-helical content and beta-sheet regions typical of this toxin family."}
{"description": "sp|P86419|3SI1B_DENAN Rho-elapitoxin-Da1b OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "LTCVTKDTIFGITTQNCPAGQNLCFIRRHYINHRYTEITRGCTATCPKPTNVRETIHCCNTDKCNE", "prompt": "Design a novel protein sequence for a neurotoxic peptide derived from the venom of the Eastern green mamba (Dendroaspis angusticeps), belonging to the three-finger toxin (3FTx) superfamily. This toxin should function as a potent and selective antagonist of muscarinic acetylcholine receptors, specifically targeting the M1 and M4 subtypes. The protein must adopt the characteristic three-finger toxin fold, stabilized by a conserved disulfide bridge pattern with four intramolecular bonds (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8) that form the core structural scaffold. Key functional loops should include Loop I for receptor subtype selectivity and Loop II for high-affinity binding to the orthosteric site of muscarinic receptors. The sequence should feature conserved hydrophobic residues in the core for structural integrity and polar/charged residues in the loops for specific receptor interactions. The toxin should exhibit reversible binding kinetics and contribute to the mamba's predatory strategy by inducing autonomic nervous system disruption through muscarinic receptor blockade."}
{"description": "sp|A0A218QX08|LVA28_TITSE Putative sodium channel toxin Ts28 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKISLVTWLITALCLMEIEEIDGDTPGNYPVDFQGIYYECIVYNRCERDCKIHGASYGYCYAGVCFCEYLPDENKNFWDVMKKQCDYMNN", "prompt": "Design a novel sodium channel toxin protein inspired by the venom arsenal of the Brazilian yellow scorpion Tityus serrulatus, a medically significant species responsible for severe envenomation cases. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal or cardiac isoforms to disrupt action potential generation and propagation. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold common to scorpion toxins, featuring a conserved core of beta-sheets stabilized by a specific disulfide bridge pattern—typically involving four disulfide bonds with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity in the classic scorpion toxin fold. Key structural elements should include a conserved hydrophobic patch and a solvent-exposed loop region critical for channel interaction, which binds to neurotoxin receptor site 3 or 4 on the sodium channel alpha subunit, leading to altered channel gating kinetics, such as delayed inactivation or enhanced persistent current. The sequence must include the essential pharmacophore residues for target engagement, ensuring high affinity and selectivity, while maintaining the compact, globular fold stabilized by the disulfide network that confers resistance to proteolytic degradation in the venom milieu."}
{"description": "sp|P0C6S0|VM1B1_BOTPA Snake venom metalloproteinase BnP1 (Fragment) OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "SQIKFKPSYIELAVVADHGMFTKYNSNINTIRIVHEMVNTVDGFFRTITSFGEWRERDIIPRSCIMASTISKHNPQCIINQPI", "prompt": "Design a snake venom metalloproteinase protein sequence that embodies the key structural and functional characteristics of Bothrops pauloensis venom toxins. This protein should function as a potent hemorrhagic agent, targeting and degrading components of the basement membrane and extracellular matrix to disrupt vascular integrity. The sequence must contain the canonical zinc-binding motif HEXXHXXGXXH in the catalytic domain, which coordinates the essential zinc ion for proteolytic activity. Include the conserved methionine turn that contributes to the metzincin superfamily structural scaffold. The protein should feature the characteristic cysteine-rich disintegrin-like domain with the appropriate cysteine framework to form disulfide bridges that stabilize the protein fold. Incorporate the hypervariable region that determines substrate specificity and potency. The overall structure should adopt the typical multi-domain architecture of snake venom metalloproteinases, with the catalytic domain exhibiting the metzincin fold characterized by a twisted five-stranded beta-sheet and several alpha-helices. The protein must demonstrate calcium-dependent stability and optimal activity at physiological pH, targeting specific collagen types, laminin, and other extracellular matrix components to induce hemorrhage through capillary wall degradation. The sequence should reflect the evolutionary optimization for rapid tissue damage and prey immobilization characteristic of Bothrops pauloensis venom."}
{"description": "sp|A0A218QWZ7|KTX25_TITSE Putative potassium channel toxin Ts25 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKAFYGILIIFILISMIHLSQQVFINATCTVTSQCRPKCIEAIGQAASKCINRKCKCYP", "prompt": "Design a novel potassium channel toxin protein inspired by the venom arsenal of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent and selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1.x family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the canonical scorpion toxin structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The core structure should feature a compact, globular fold comprising an alpha-helix packed against an anti-parallel beta-sheet, creating a molecular surface with key functional residues for channel blockade. Critical binding determinants should include a functional dyad or triad of residues—typically involving a lysine or arginine for pore insertion and aromatic/hydrophobic residues for channel interaction—positioned within a conserved pharmacophore to enable high-affinity binding to the channel vestibule. The toxin should exhibit the biophysical properties typical of scorpion venom peptides, including thermal stability, protease resistance conferred by the disulfide framework, and a molecular weight of approximately 3-4 kDa. The sequence must encode the defining cysteine pattern of scorpion potassium channel toxins while incorporating variation in the inter-cysteine loops to confer target specificity and potency reflective of the Tityus serrulatus venom profile."}
{"description": "sp|P17497|VM2_BITAR Disintegrin bitistatin OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "SPPVCGNKILEQGEDCDCGSPANCQDRCCNAATCKLTPGSQCNYGECCDQCRFKKAGTVCRIARGDWNDDYCTGKSSDCPWNH", "prompt": "Design a protein sequence for bitistatin, a potent disintegrin toxin from the venom of the puff adder (Bitis arietans). This protein functions as a key anti-platelet agent by specifically targeting and inhibiting the integrin αIIbβ3 (GPIIb/IIIa) on platelet surfaces, thereby blocking fibrinogen binding and preventing platelet aggregation—a critical mechanism in the snake's venom for immobilizing prey through disruption of hemostasis. The sequence should feature the canonical disintegrin RGD (Arg-Gly-Asp) motif, which mediates high-affinity binding to the integrin receptor. Structurally, the protein adopts a compact, disulfide-rich fold stabilized by multiple disulfide bonds, characteristic of the disintegrin family, with a cysteine framework that typically includes conserved Cys residues forming specific disulfide connectivities (e.g., Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 in many disintegrins) to maintain a rigid, elongated conformation. The overall fold is anticipated to be a small, globular domain with exposed loops that present the RGD motif for receptor engagement, ensuring precise molecular recognition and potent antagonism of platelet function. Incorporate conserved hydrophobic and charged residues that contribute to structural stability and target specificity, reflecting the toxin's role in venom-induced coagulopathy."}
{"description": "sp|Q8WPG5|KUNI_ORNKA Thrombin inhibitor savignin OS=Ornithodoros kalahariensis OX=1580572 PE=1 SV=1", "sequence": "MLFYVVITLVAGTVSGLNVRCNNPHTANCENGAKLESYFREGETCVGSPACPGEGYATKEDCQKACFPGGGDHSTNVDSSCFGQPPTSCETGAEVTYYDSGSRTCKVLQHGCPSSENAFDSEIECQVACGVSME", "prompt": "Design a protein sequence for a thrombin inhibitor toxin derived from the Kalahari soft tick Ornithodoros kalahariensis. This protein, known as savignin, functions as a potent anticoagulant in tick feeding by specifically targeting and inhibiting thrombin, a key serine protease in the blood coagulation cascade. The protein should adopt a Kunitz-type structural fold characterized by a compact, stable domain stabilized by three conserved disulfide bridges with a characteristic Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The sequence should contain the canonical Kunitz domain motif with a reactive site loop that presents key residues for specific thrombin recognition and inhibition, likely through a mechanism resembling other Kunitz-type serine protease inhibitors. The structural scaffold should maintain the characteristic β-trefoil topology with anti-parallel β-sheets and minimal helical content, ensuring high stability and resistance to proteolytic degradation. The protein should exhibit high affinity and specificity for thrombin's active site, effectively preventing fibrinogen cleavage and subsequent clot formation, which is essential for the tick's blood-feeding strategy."}
{"description": "sp|Q2I2P1|CON1_CONLT Contulakin-Lt1 OS=Conus litteratus OX=89445 PE=2 SV=1", "sequence": "MRTAYWVMVMMMVGITAPLSEGRKLNDAIRGLVADYLTPQLLQSLVSAPYPEFQLDDPNLEIPVCIWKVCPPIPWRRRDLKKRNK", "prompt": "Design a protein sequence for a neuroactive peptide toxin derived from the venom of the marine cone snail Conus litteratus. This toxin, known as Contulakin-Lt1, belongs to the conantokin family of conotoxins, which are characterized by their unique mechanism of action as selective antagonists of N-methyl-D-aspartate (NMDA) receptors. The protein should function as a non-competitive NMDA receptor antagonist that binds to the polyamine site of the receptor complex, thereby modulating glutamatergic neurotransmission and producing analgesic effects through inhibition of excitatory synaptic transmission in the central nervous system. The sequence should feature a conserved conantokin structural motif characterized by extensive post-translational gamma-carboxylation of glutamate residues to form gamma-carboxyglutamate (Gla) residues, which are essential for calcium coordination and receptor binding. The mature peptide should adopt an ordered helical conformation stabilized by the Gla residues and their interaction with divalent cations, particularly calcium ions. The structural scaffold should enable specific interaction with the NR2B subunit of NMDA receptors, providing subtype selectivity. The toxin should exhibit the characteristic biological activity of conantokins: potent antinociceptive effects without the neurotoxic side effects associated with direct channel blockers, making it a promising template for developing novel analgesics targeting pathological pain states."}
{"description": "sp|P56610|SCX4_TITBA Toxin Tb4 (Fragment) OS=Tityus bahiensis OX=50343 PE=1 SV=1", "sequence": "GKEGYPTDKRGCKLTCFFT", "prompt": "Design a venom-derived peptide toxin from the Brazilian scorpion Tityus bahiensis that functions as a potent sodium channel modulator. This toxin should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by four disulfide bridges with the connectivity pattern C1-C4, C2-C5, C3-C6, C7-C8. The core beta-sheet structure should be complemented by an alpha-helical region, creating a compact globular architecture. The molecular mechanism involves binding to voltage-gated sodium channels at site 4, specifically modulating channel inactivation by slowing or inhibiting fast inactivation, thereby prolonging action potentials and enhancing neuronal excitability. The toxin should preferentially target insect sodium channels, contributing to the scorpion's predatory efficacy, while potentially exhibiting cross-reactivity with mammalian channels. Key functional residues should be positioned in the conserved 'pharmacophore' regions responsible for receptor recognition and binding affinity. The sequence must maintain the characteristic length and physicochemical properties typical of scorpion beta-toxins, with appropriate distribution of hydrophobic, polar, and charged residues to ensure proper folding, stability, and target specificity."}
{"description": "sp|P16354|PA23_HELSU Phospholipase A2 isozymes PA3A/PA3B/PA5 OS=Heloderma suspectum OX=8554 PE=1 SV=3", "sequence": "GAFIMPGTLWCGAGNAASDYSQLGTEKDTDMCCRDHDHCENWISALEYKHGMRNYYPSTISHCDCDNQFRSCLMKLKDGTADYVGQTYFNVLKIPCFELEEGEGCVDWNFWLECTESKIMPVAKLVSAAPYQAQAETQSGEGR", "prompt": "Design a phospholipase A2 toxin sequence derived from the venom of Heloderma suspectum (Gila monster), a reptile known for producing potent venom with hemotoxic and neurotoxic properties. This enzyme should function as a catalytically active secretory phospholipase A2 that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, thereby initiating inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of seven disulfide bonds (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, Cys84-Cys96 in standard numbering). Include the essential catalytic triad residues (His48, Asp99, Tyr52) within the conserved calcium-binding loop (Tyr28, Gly30, Gly32, Asp49) that coordinates a Ca2+ ion required for substrate binding and catalysis. The sequence should maintain the characteristic interfacial binding surface for membrane association and exhibit the elongated, slightly curved shape typical of group III phospholipase A2 enzymes. This toxin likely contributes to the venom's prey immobilization through membrane disruption, edema induction, and potential presynaptic neurotoxicity via inhibition of neurotransmitter release."}
{"description": "sp|F8QN52|PA2A1_VIPRE Acidic phospholipase A2 PL1 OS=Vipera renardi OX=927686 PE=2 SV=1", "sequence": "MRALWIVAVCLIGAEGNLSQFGDMINKKTGIFGIMSYIYYGCYCGWGGKGKPLDATDRCCFVHDCCYGRVNGCDPKMGTYSYSFQNGDIVCGGDDPCLRAVCECDRVAAICFAENMNTYDKKYMLYSLFDCKEESEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Vipera renardi, a viper species. This enzyme belongs to the phospholipase A2 (PLA2) family and functions as a key venom component with potent toxic activity. The protein should exhibit the characteristic PLA2 structural fold, featuring a conserved calcium-binding loop (YGKYCG/XCG) and a catalytic network centered around a histidine-aspartate dyad (H48/D49 numbering in group II PLA2s) for hydrolyzing the sn-2 ester bond of phospholipids. Include the canonical disulfide bond pattern typical of group II snake venom PLA2s, with 6-7 conserved disulfide bridges stabilizing the compact, multi-stranded β-sheet core and α-helical segments. The sequence should reflect an acidic isoelectric point due to a higher proportion of aspartate and glutamate residues, which may influence membrane interaction and potency. The toxin likely targets cell membranes, inducing local tissue damage, inflammation, and potential neurotoxic or myotoxic effects through phospholipid degradation and subsequent release of pro-inflammatory mediators like arachidonic acid. Ensure the structural integrity for enzymatic activity, including the hydrophobic substrate-binding channel and interfacial activation surface."}
{"description": "sp|A8S6B3|VNPA_AUSSU Natriuretic peptide AsNP-a (Fragment) OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "SGSKTAKIGDGCFGVRIDRIGSTSGMGCGSVPKPTPGGS", "prompt": "Design a natriuretic peptide toxin fragment derived from the venom of the Australian lowland copperhead snake, Austrelaps superbus. This peptide should function as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting and activating the guanylyl cyclase-coupled natriuretic peptide receptors (particularly NPR-A and NPR-B) in vascular smooth muscle and renal tissues. The peptide should contain the conserved natriuretic peptide structural motif characterized by a 17-amino acid ring structure formed by a disulfide bridge between two cysteine residues, creating the characteristic loop essential for receptor binding and activation. The structure should adopt a compact, globular fold stabilized by this single disulfide bond, with the receptor-binding interface located within the cyclic region. The mechanism of action should involve binding to the extracellular domain of natriuretic peptide receptors, stimulating intracellular cGMP production, leading to vasodilation, increased vascular permeability, natriuresis, and diuresis - effectively causing hypotension and cardiovascular disruption in envenomed prey. The peptide should exhibit the characteristic pharmacological profile of venom natriuretic peptides, including resistance to proteolytic degradation and enhanced potency compared to endogenous counterparts."}
{"description": "sp|H1ZZH7|SCX8_TITOB Toxin To8 OS=Tityus obscurus OX=1221240 PE=2 SV=1", "sequence": "MTRFVLFISCFFLIGMVVECKEGYLLGSRGCKMNCLTRPEKFCELECSLVGGENGYCAYWLACYCYNVPESVKLWESDTNECGKRK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This toxin originates from the venom of Tityus obscurus, a scorpion species whose venom components are evolutionarily optimized for prey immobilization and defense. The protein belongs to the beta-toxin family, specifically targeting voltage-gated sodium channels (Nav channels) in excitable membranes. Its core function is to modify sodium channel gating kinetics, typically causing a slowing of inactivation and/or a shift in the voltage dependence of activation, leading to prolonged neuronal depolarization, repetitive firing, and ultimately neurotoxic effects. The structural scaffold is characterized by the conserved cysteine-stabilized alpha-beta (CSαβ) fold, common to scorpion beta-toxins. This fold consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, stabilized by a specific disulfide bridge pattern (cysteine framework I/II: C1-C4, C2-C5, C3-C6). Key functional domains include the 'core' region responsible for interaction with the voltage-sensing domain (VSD) of Nav channels, particularly domain II, and the 'pharmacophore' surface comprising residues critical for binding affinity and specificity. The molecular target is likely mammalian Nav1.2, Nav1.4, or Nav1.6 channels, with binding occurring at receptor site 4, which involves the S1-S2 and S3-S4 loops of the domain II VSD. The protein should exhibit high affinity for its target, with key interfacial residues (often including aromatic, basic, and hydrophobic residues) forming complementary interactions with the channel. Ensure the sequence encodes the CSαβ structural motif, the correct disulfide connectivity, and the functional epitopes necessary for Nav channel modulation."}
{"description": "sp|Q69CJ8|3S11H_OPHHA Weak toxin DE-1 homolog 1 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKPVLLTLVVVTIVCLDLGYTRICLKQEPFQPETTTTCPEGEDACYNLFWSDHSEIKIEMGCGCPKTEPYTNLYCCKIDSCNK", "prompt": "Design a protein sequence for a weak toxin from the venom of the king cobra (Ophiophagus hannah) that belongs to the three-finger toxin superfamily. This toxin should exhibit the characteristic three-finger structural fold stabilized by a conserved disulfide bond framework, typically with four disulfide bridges arranged in a specific pattern that maintains the three β-stranded loops extending from a central core. The protein should function as a weak neurotoxin with low affinity for nicotinic acetylcholine receptors, potentially acting as a competitive antagonist that binds to the receptor's ligand-binding site without causing complete paralysis. The sequence should include key conserved residues involved in receptor interaction while maintaining the overall structural stability through the characteristic cysteine scaffold. The toxin should represent a homolog of weak toxin DE-1, exhibiting the typical molecular weight and structural features of this toxin class while demonstrating reduced potency compared to stronger neurotoxins in king cobra venom."}
{"description": "sp|P0C7A9|VM1BJ_BOTJA Snake venom metalloproteinase bothrojaractivase (Fragment) OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "RYIELAVVADHGMFTKYRVHELVNTVNGFFRSKQDLIKVQKDKTLTSFGEWRERDLLPRI", "prompt": "Design a snake venom metalloproteinase fragment that functions as bothrojaractivase, derived from the venom of Bothrops jararaca, the jararaca pit viper. This toxin should exhibit potent metalloproteinase activity characteristic of SVMPs, specifically targeting components of the blood coagulation cascade to act as a procoagulant or anticoagulant agent, depending on its specific mechanism. The protein should feature the canonical zinc-binding motif (HEXXHXXGXXH) in its catalytic domain, coordinating a zinc ion essential for proteolytic activity. It should possess a disintegrin-like domain that may mediate interactions with platelet integrins or other cellular receptors, and potentially a cysteine-rich domain that enhances target recognition. The structural scaffold should include multiple disulfide bridges that stabilize the protein fold, typical of SVMPs, with a metalloproteinase domain adopting a metzincin-like fold characterized by a central twisted beta-sheet flanked by alpha-helices. The protein's mechanism likely involves cleavage of key coagulation factors (such as fibrinogen, factor X, or other serine proteases) or platelet aggregation receptors, leading to disruption of hemostasis. The venom's biological significance lies in prey immobilization through induction of coagulopathy, hemorrhage, or thrombosis, facilitating predation. Ensure the sequence reflects the fragment nature, potentially lacking full-length domains but retaining functional integrity for metalloproteinase activity and target specificity."}
{"description": "sp|Q4VM08|VM3VA_MACLB Zinc metalloproteinase-disintegrin-like VLAIP-A OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MMQVLLVTISLAVFPYQGSSIILESGNVNDYEVVYPQKVTAMPKGAVKQPEQKYEDAMQYEFKVKGEPVVLLLEKNKDLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSSASISACNGLKGHFMLQGETYLIEPLKLPDSEAHAVYKYENVEKEDEAPKMCGVTQTNWESDEPIKKASQLNLTPEQRRYLNSPKYIKLVIVADYIMFLKYGRSLITIRTRIYEIVNILNVIYRVLNIYIALLGLEIWNNGDKINVLPETKVTLDLFGKWRERDLLNRRKHDNAQLLTDINFNGPTAGLGYVGSMCDPQYSAGIVQDHNKVNFLVALAMAHEMGHNLGMEHDEIHCTCGAKSCIMSGTLSCEASIRFSNCSREEHQKYLINKMPQCILNKPLKTDIVSPAVCGNYLVELGEDCDCGSPRDCQNPCCNAATCKLTPGSQCADGECCDQCKFRRAGTVCRPANGECDVSDLCTGQSAECPTDQFQRNGQPCQNNNGYCYSGTCPIMGKQCISLFGASATVAQDACFQFNSLGNEYGYCRKENGRKIPCAPQDVKCGRLYCFDNLPEHKNPCQIYYTPSDENKGMVDPGTKCGDGKACSSNRQCVDVNTAY", "prompt": "Design a venom protein sequence from the Levant viper (Macrovipera lebetinus) that functions as a zinc metalloproteinase-disintegrin-like toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH for catalytic activity, followed by a disintegrin-like domain that mimics the structure of endogenous disintegrins. The metalloproteinase domain should enable proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin, contributing to hemorrhage and tissue damage. The disintegrin-like domain should contain the canonical RGD or related integrin-binding motif, enabling inhibition of platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors on platelets. The protein should adopt the typical SVMP fold with a central five-stranded β-sheet surrounded by α-helices, stabilized by multiple disulfide bonds characteristic of the reprolysin family. This toxin represents a key component of viperid venom that synergistically disrupts hemostasis through both proteolytic degradation of vascular basement membranes and anti-platelet activity, facilitating prey immobilization through systemic hemorrhage and coagulation impairment."}
{"description": "sp|A0A059UEE4|KA274_MESGB Potassium channel toxin alpha-KTx 27.4 OS=Mesobuthus gibbosus OX=123226 PE=3 SV=1", "sequence": "MKFLFLTLVLLYFTAILVFIVFPSYAQIQTNASCTTSTHCVEPCRKRCLLIHKCINDKCTCYPRINICEKKNN", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Mesobuthus gibbosus, a species known for producing potent neurotoxins targeting ion channels to immobilize prey. This toxin belongs to the alpha-KTx family, specifically designated as alpha-KTx 27.4, indicating its role as a selective blocker of voltage-gated potassium channels (Kv channels). The core function is to inhibit potassium efflux by binding to the pore region of Kv channels, thereby prolonging neuronal depolarization and enhancing neurotransmitter release, leading to paralysis or excitotoxicity in prey. Infer the structural scaffold to include the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, with a disulfide bridge pattern of C1-C4, C2-C5, and C3-C6 (or similar variations) that stabilizes an alpha-helix paired with an antiparallel beta-sheet. The molecular target is likely Kv1.x subtypes (e.g., Kv1.1, Kv1.2, or Kv1.3), with binding mediated by residues in the functional dyad (e.g., a lysine or aromatic residue) interacting with the channel's selectivity filter. Ensure the sequence includes key motifs for alpha-KTx toxins, such as a conserved core for structural integrity and surface-exposed loops for target specificity, while maintaining the compact, globular architecture typical of scorpion venom peptides."}
{"description": "sp|W4VRU5|ICK36_TRILK U17-barytoxin-Tl1b OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTIIVFLSLLVLATKFGDAKEGVNQKQKKEVTQNEFREEYLNEMAAMSLVQQLEAIERALFENEAGRNSRQKRCLGENVPCGDNIPCCGKLACEKTAGYGWWYKSPYCVKPTSG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin is a U17-barytoxin from the venom of the Australian trapdoor spider Trittame loki. This venom component functions as a potent neurotoxin that targets voltage-gated ion channels, likely sodium or calcium channels, to disrupt neuronal signaling and induce paralysis in prey. The protein belongs to the inhibitory cysteine knot (ICK) structural family, specifically designated as ICK36, indicating it contains the characteristic ICK motif with three conserved disulfide bridges forming a knotted topology that confers exceptional stability and resistance to proteolytic degradation. The cysteine framework follows the canonical ICK pattern (C-C-CC-C-C) with disulfide connectivity of C1-C4, C2-C5, C3-C6, creating a compact, triple-stranded beta-sheet fold stabilized by the knot. The 3D structure is anticipated to feature a small, rigid globular domain with exposed loops that mediate target specificity, including a pharmacophore region critical for binding to ion channel pore domains or voltage-sensing elements. The molecular mechanism involves high-affinity interaction with specific ion channel subtypes, leading to channel modulation—either inhibition or aberrant activation—that disrupts action potential generation and synaptic transmission. Incorporate conserved ICK family residues that maintain structural integrity while optimizing variable loop regions for target engagement. The sequence should reflect the evolutionary adaptation of spider venoms for rapid immobilization of arthropod prey through precise ion channel targeting."}
{"description": "sp|W4VRU6|ICK31_TRILK U16-barytoxin-Tl1c OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTIIVFLSFLVLVLATKFGDANEGVNREQTKEVIQNEFRGDFLNEMAAMSLLQQLEAIESALLEKEADRNSRQKRCNGKNVPCGSNHSPCCSGLSCEETFGYGWLYKSPYCVIPSNG", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of Trittame loki, a mygalomorph spider. This toxin should function as a potent insecticidal agent, specifically targeting the central nervous system of arthropod prey. The protein must adopt the inhibitory cysteine knot (ICK) structural scaffold, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide connectivity pattern of C1-C4, C2-C5, and C3-C6. This structural motif confers exceptional thermal and proteolytic stability, which is essential for venom efficacy. The toxin should act as a modulator of voltage-gated ion channels, likely sodium or calcium channels, to disrupt neuronal excitability and induce rapid paralysis in insects. Key functional residues should be strategically positioned within flexible loop regions to facilitate high-affinity binding to the target channel, while maintaining the core ICK fold integrity. The sequence must include the canonical cysteine framework with precisely spaced cysteine residues to enable correct disulfide bond formation and folding into the stable, knotted topology characteristic of spider venom toxins."}
{"description": "sp|P0C8M1|PA2B1_BOTMO Basic phospholipase A2 BmTX-I OS=Bothrops moojeni OX=98334 PE=1 SV=1", "sequence": "DLWQFNKMIKKEVGKLPFPFYGAYGCYCGWGGRGEKPKDGTDRCCFVHDCCYKKLTGCPKWDDRYSYSWKDITIVCGEDLPCEEICECDRAAAVCFYENLGTYNKKYMKHLKPCKKADYPC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrops moojeni, a medically important pit viper. This toxin should function as a potent enzymatic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, two antiparallel beta-sheets, and a conserved calcium-binding loop. Include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) and the calcium-binding site with its characteristic YGCXCG motif. The sequence should contain 6-8 conserved disulfide bonds that stabilize the compact globular structure, with the characteristic pattern found in group II phospholipase A2 enzymes from snake venoms. As a basic phospholipase, this toxin should exhibit enhanced membrane binding capabilities and may contribute to various toxic effects including myotoxicity, neurotoxicity, anticoagulant activity, and induction of inflammatory responses through eicosanoid production. The protein should be optimized for stability in the venom environment and efficient interaction with biological membranes."}
{"description": "sp|P0CJ35|3L2L_OXYSC Taicatoxin, alpha-neurotoxin-like component (Fragment) OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=1", "sequence": "RRCFITPNVRSERCPPGQEVCFTKTXDG", "prompt": "Design a protein sequence for the alpha-neurotoxin-like component of Taicatoxin, a potent neurotoxin complex from the venom of the coastal taipan (Oxyuranus scutellatus scutellatus). This toxin component functions as a postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis and respiratory failure. The protein should adopt the characteristic three-finger toxin fold common to snake venom neurotoxins, featuring three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The structural scaffold should include the conserved hydrophobic core and the functional loops responsible for receptor binding, particularly loop II which contains key residues for high-affinity interaction with the alpha-subunit of muscle-type nicotinic acetylcholine receptors. The toxin should exhibit the typical pharmacological profile of short-chain alpha-neurotoxins, with specific binding to the agonist binding site that competitively inhibits acetylcholine-mediated neurotransmission."}
{"description": "sp|Q2I2P3|COW1_CONLT Contryphan-Lt OS=Conus litteratus OX=89445 PE=3 SV=1", "sequence": "MGKLTILLLVAAALLSTQVMVQGGGDQPAARNAVPRDDNPDGMSGQFMNVLRRSGCPWEPWCG", "prompt": "Design a novel contryphan peptide from the venomous marine snail Conus litteratus. This peptide should function as a potent neurotoxin that modulates voltage-gated calcium channels, specifically targeting N-type calcium channels involved in neurotransmitter release. The contryphan should adopt the characteristic gamma-carboxyglutamic acid (Gla) domain structure with a conserved disulfide framework (C-C pattern) that stabilizes a compact, globular fold. The peptide must contain the signature post-translational modification of tryptophan bromination at a conserved position, which is critical for its receptor binding affinity and selectivity. The sequence should feature a high density of hydrophobic residues that facilitate membrane interaction and channel blockade, along with key charged residues that mediate specific interactions with the channel pore region. The overall structure should be constrained and stable in marine environments, exhibiting the typical contryphan pharmacological profile of modulating neuronal excitability through calcium channel inhibition."}
{"description": "sp|P17934|PA2A4_BUNMU Acidic phospholipase A2 beta-bungarotoxin A4 chain OS=Bungarus multicinctus OX=8616 PE=2 SV=1", "sequence": "MNPAHLLVLSAVCVSLLGAANIPPQHLDLYQFKEMIRYTIPCEKTWGEYADYGCYCGAGGSGTPIDALDRCCYVHDNCYGDAANIRDCDPKTQSYSYKLTKRTIICYGAAGTCARVVCDCDRTAALCFGNSEYIEGHKNIDTARFCQ", "prompt": "Design a protein sequence for an animal toxin that functions as a presynaptic neurotoxin with potent phospholipase A2 activity. This toxin originates from the venom of Bungarus multicinctus (many-banded krait), where it plays a critical role in the venom's neurotoxic arsenal by causing irreversible blockade of neuromuscular transmission. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved catalytic triad (typically involving histidine, aspartate, and tyrosine residues) essential for hydrolyzing phospholipids at the sn-2 position of membrane glycerophospholipids. The sequence must include the canonical calcium-binding loop (YXCGXGG) and multiple disulfide bridges that stabilize the compact, globular structure—typically 6-7 conserved cysteine residues forming 3-4 disulfide bonds in a pattern such as Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, which confers stability and functional integrity. As a beta-bungarotoxin A-chain, it should exhibit acidic properties (low pI) and form a heterodimeric complex with a Kunitz-type protease inhibitor B-chain in the native venom, though this prompt focuses on the phospholipase A2 chain alone. The toxin's mechanism involves binding to presynaptic membranes at motor nerve terminals, where its phospholipase activity disrupts neurotransmitter release by hydrolyzing synaptic vesicle and plasma membrane phospholipids, leading to acetylcholine depletion and paralysis. Ensure the sequence reflects high specificity for neuronal targets, with surface residues optimized for membrane association and catalytic efficiency, while maintaining the structural rigidity required for venom stability and toxicity."}
{"description": "sp|P25687|MIT1_DENPO Toxin MIT1 OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=3", "sequence": "AVITGACERDLQCGKGTCCAVSLWIKSVRVCTPVGTSGEDCHPASHKIPFSGQRMHHTCPCAPNLACVQTSPKKFKCLSKS", "prompt": "Design a novel protein sequence for a muscarinic toxin from the venom of the black mamba (Dendroaspis polylepis). This toxin should function as a selective antagonist of muscarinic acetylcholine receptors, specifically targeting the M1 receptor subtype. The protein should adopt a three-finger toxin fold characteristic of snake venom neurotoxins, featuring a core stabilized by four conserved disulfide bridges that create the characteristic three-loop structural motif. The sequence should include key functional residues in the central loop that mediate specific receptor binding and antagonism, while maintaining the overall structural stability provided by the cysteine framework. The toxin should exhibit high affinity and selectivity for muscarinic receptors over nicotinic receptors, reflecting its role in the black mamba's venom system where it contributes to prey immobilization through modulation of cholinergic signaling in the autonomic nervous system."}
{"description": "sp|P86456|PA2A4_BOTAL Acidic phospholipase A2 SpII RP4 OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "NLVQFKTLIMKIAGRSVVYKYFYGCYCGWGGIGQPRDATDRCCFVHDCCYGKVTNCNPKTATYSYTEENGALVCGGDDPCKKQVCECDRVAAMCFRDNKDTYDNKYWFLPPKNCQEDSEPC", "prompt": "Generate a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops alternatus, a medically important pit viper. This enzyme should function as a potent toxin that hydrolyzes the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should exhibit calcium-dependent catalytic activity and possess the characteristic phospholipase A2 structural fold with conserved catalytic residues including a histidine-aspartate dyad. As an acidic isoform, it should have a lower isoelectric point compared to basic phospholipases. The sequence should include the conserved calcium-binding loop (YGKYCG) and the catalytic network involving histidine, aspartate, and tyrosine residues. The toxin should demonstrate membrane-disrupting activity and contribute to the local tissue damage, edema, and myotoxicity characteristic of Bothrops envenomation. The structure should maintain the characteristic phospholipase A2 fold with three major alpha-helices and a beta-wing region, stabilized by multiple disulfide bonds in the conserved pattern typical of group II phospholipases A2."}
{"description": "sp|Q91055|CRVP_HELHO Cysteine-rich venom protein helothermine OS=Heloderma horridum horridum OX=8552 PE=1 SV=1", "sequence": "MILLSLYLCLAAMLHQSEGEASPKLPGLMTSNPDQQTEITDKHNNLRRIVEPTASNMLKMTWSNKIAQNAQRSANQCTLEHTSKEERTIDGVECGENLFFSSAPYTWSYAIQNWFDERKYFRFNYGPTAQNVMIGHYTQVVWYRSYELGCAIAYCPDQPTYKYYQVCQYCPGGNIRSRKYTPYSIGPPCGDCPDACDNGLCTNPCKQNDVYNNCPDLKKQVGCGHPIMKDCMATCKCLTEIK", "prompt": "Design a cysteine-rich venom protein from the Mexican beaded lizard (Heloderma horridum horridum) that functions as a potent hypothermic and neurotoxic agent. This protein, known as helothermine, should adopt a stable tertiary structure stabilized by multiple disulfide bonds characteristic of cysteine-rich venom peptides. The sequence should contain a conserved pattern of cysteine residues that form specific disulfide bridges to create a compact, globular fold resistant to proteolytic degradation. The protein should exhibit specific biological activities including induction of hypothermia, inhibition of calcium channels, and modulation of neuronal excitability. The structural scaffold should enable high-affinity binding to neuronal targets while maintaining thermal stability and solubility in aqueous environments. The final sequence should reflect the evolutionary optimization of this toxin for prey immobilization through disruption of normal physiological temperature regulation and neuronal signaling pathways."}
{"description": "sp|Q6B8D2|IXOL_IXOPA Ixodegrin-Ip OS=Ixodes pacificus OX=29930 PE=3 SV=1", "sequence": "MNAAFIAALFILGALTLDAMAYSPTCEGKPCANNTDCKGSNLCQCRPPRGDDWRNFCSEY", "prompt": "Design a novel protein sequence for a disintegrin toxin derived from the Western black-legged tick, Ixodes pacificus. This toxin should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the platelet surface. The protein should adopt the characteristic disintegrin fold with the canonical RGD (Arg-Gly-Asp) motif positioned within an extended, solvent-exposed loop that serves as the primary integrin-binding interface. The sequence must contain the conserved cysteine framework typical of disintegrins, forming multiple disulfide bridges that stabilize the compact, globular structure and constrain the RGD-containing loop in the optimal conformation for high-affinity integrin recognition. The molecular mechanism should involve competitive inhibition of fibrinogen binding to platelet integrin αIIbβ3, thereby preventing platelet aggregation and thrombus formation. The structural scaffold should feature a small, stable protein core with the RGD motif presented in a conformation that maximizes specificity for platelet integrins while minimizing off-target effects on other RGD-binding receptors."}
{"description": "sp|A0A059UI21|KA263_MESGB Potassium channel toxin alpha-KTx 26.3 OS=Mesobuthus gibbosus OX=123226 PE=3 SV=1", "sequence": "MSGLSVFILIALVLSVIIDVLNNSKVEAACKENCRQYCQAKGARNGKCINSNCKCYY", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels). This toxin should originate from the scorpion Mesobuthus gibbosus, a species known for producing venom rich in ion channel modulators that disrupt neuronal and muscular function through precise targeting of membrane channels. The toxin belongs to the alpha-KTx family, characterized by a conserved structural scaffold comprising an alpha-helix and anti-parallel beta-sheets stabilized by three or four disulfide bridges, typically following a cysteine framework such as C-X(3-7)-C-X(3-7)-C-X(0-4)-C-X(1-4)-C-X(4-12)-C. The core mechanism involves high-affinity binding to the pore region of Kv channels, inhibiting potassium ion flux and leading to prolonged membrane depolarization, which can cause hyperexcitability, neurotransmitter release dysregulation, and potential paralysis in prey or predators. The structural fold should exhibit the ICK (inhibitor cysteine knot) motif, with key residues in the functional surface forming electrostatic and hydrophobic interactions with the channel's turret and selectivity filter. Ensure the sequence reflects the compact, stable, and minimally glycosylated nature typical of scorpion toxins, optimized for venom delivery and target specificity."}
{"description": "sp|Q4VRI5|PA21_OXYSC Phospholipase A2 OS1 OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=1", "sequence": "MHPAHLLVLLAVCVSLLGAARIPPLPLSLLNFANLIECANHGTRSALAYADYGCYCGKGGRGTPLDDLDRCCHVHDDCYGEAEKLPACNYLMSSPYFNSYSYKCNEGKVTCTDDNDECKAFICNCDRTAAICFAGATYNDENFMISKKRNDICQ", "prompt": "Design a phospholipase A2 toxin from the venom of the coastal taipan (Oxyuranus scutellatus), a highly potent snake species native to northern Australia and New Guinea. This enzyme should function as a presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmission through hydrolysis of synaptic membrane phospholipids. The protein should feature the characteristic phospholipase A2 structural fold with a conserved calcium-binding loop (YGKYCG) and catalytic histidine-aspartate dyad. Include the typical snake venom phospholipase A2 disulfide bridge pattern (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98) that stabilizes the compact globular structure. The sequence should contain a hydrophobic substrate-binding channel and exhibit specific molecular recognition for neuronal presynaptic membranes, leading to phospholipid degradation and subsequent neurotransmitter release inhibition. The toxin should demonstrate high enzymatic activity toward phosphatidylcholine substrates while maintaining structural stability through its extensive disulfide network."}
{"description": "sp|Q68PG2|SCX13_CENEX Neurotoxin Cex13 (Fragment) OS=Centruroides exilicauda OX=6879 PE=2 SV=1", "sequence": "ATGNVWAKDGYLVIIKTGCKYNCYILGKNKYCNSECKEVGAGYGYCYAFGCWCEGLPESIPTWPLPDKTCGTK", "prompt": "Design a neurotoxin protein sequence derived from the venom of the Arizona bark scorpion, Centruroides exilicauda, that functions as a potent modulator of voltage-gated sodium channels. This toxin should exhibit the characteristic beta-toxin mechanism of action, specifically binding to site 4 on voltage-gated sodium channels to modify channel gating kinetics. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion neurotoxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The structure should contain a conserved core beta-sheet stabilized by the disulfide network, with key functional loops responsible for receptor recognition and binding. The toxin should specifically target mammalian voltage-gated sodium channels, particularly Nav1.6 and Nav1.7 isoforms, with high affinity and selectivity. The molecular mechanism should involve prolonging the action potential by inhibiting channel inactivation, leading to sustained neuronal depolarization and enhanced neurotransmitter release. The protein should maintain the characteristic pharmacological profile of beta-scorpion toxins, exhibiting potent neurotoxic effects through selective interaction with the voltage-sensing domain of sodium channel subunit II."}
{"description": "sp|B1P1B7|JZT1B_CHIGU Delta-theraphotoxin-Cg1a 2 OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MKTSILFVIFSLALLFALSAATEIEETDRACGQFWWKCGEGKPPCCANFACKIGLYLCIWSP", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein should be a delta-theraphotoxin derived from the venom of the Chinese earth tiger tarantula (Chilobrachys guangxiensis). This toxin belongs to the inhibitor cysteine knot (ICK) structural family, which is characteristic of spider venom peptides. The core function of this toxin is to act as a voltage-gated sodium channel modulator, specifically targeting insect sodium channels to cause paralysis and death in prey. The molecular mechanism involves binding to site 4 of voltage-gated sodium channels, delaying channel inactivation and prolonging action potentials, leading to hyperexcitability and neuromuscular dysfunction. The structural scaffold must feature the conserved ICK motif with a specific disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming a stable, triple-stranded beta-sheet structure stabilized by the cysteine knot. The mature toxin should be approximately 30-40 amino acids in length with a high density of basic residues that facilitate interaction with the negatively charged extracellular domains of sodium channels. The binding interface should include key residues that confer selectivity for insect over mammalian sodium channels, making it an effective insecticidal agent. The overall fold should be compact and globular, with the cysteine knot providing exceptional thermal and proteolytic stability, which is essential for oral activity in predatory contexts. The sequence must include the characteristic cysteine framework common to theraphotoxins and maintain the pharmacological profile of a sodium channel gating modifier."}
{"description": "sp|A0A411EZW9|PA21_AGKPL Acidic phospholipase A2 AplTX-I OS=Agkistrodon piscivorus leucostoma OX=459671 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGDLMQFETLIMKIAKRSGMFWYSAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKVTGCDPKLDSYTYSVENGDVVCGGNDPCKKEICECDRAAAICFRDNKVTYDNKYWRFPPQNCKEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the western cottonmouth (Agkistrodon piscivorus leucostoma). This enzyme should exhibit the characteristic phospholipase A2 activity that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bonds in the pattern C11-C77, C27-C126, C29-C45, C44-C105, C51-C98, C61-C91, and C84-C96. Include the conserved calcium-binding loop (Tyr-28, Gly-30, Gly-32) and catalytic triad residues (His-48, Asp-49, Tyr-52) essential for enzymatic activity. The acidic nature should be reflected in the overall charge distribution, potentially influencing membrane interaction properties and contributing to the toxin's myotoxic, anticoagulant, and inflammatory effects through disruption of cellular membranes and interference with coagulation factors."}
{"description": "sp|P0C1Z3|KKX21_OPIMA Potassium channel toxin kappa-KTx 2.2 OS=Opisthacanthus madagascariensis OX=167108 PE=1 SV=1", "sequence": "DPCYEVCLQQHGNVKECEEACKHPVEY", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the scorpion Opisthacanthus madagascariensis. This toxin should function as a selective inhibitor of voltage-gated potassium channels (Kv channels), specifically targeting the Kv1 subfamily to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The core scaffold should comprise a short alpha-helix packed against an anti-parallel beta-sheet, with the functional dyad (typically involving a critical lysine or aromatic residue in the beta-sheet region) positioned to occlude the potassium selectivity filter by interacting with key pore residues. Incorporate conserved hydrophobic patches for structural stability and a positively charged surface for initial electrostatic steering toward the channel vestibule. Ensure the sequence includes the signature pattern of six cysteine residues forming the CSαβ framework, along with conserved glycine and proline residues that facilitate tight turns. The final protein should exhibit high affinity and selectivity for Kv1 channels, contributing to the neurotoxic effects by prolonging action potentials and inducing hyperexcitability in target organisms."}
{"description": "sp|P25684|3SL2_DENAN Toxin C10S2C2 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "RICYSHKASLPRATKTCVENSCYKMFIRTSPDYISDRGCGCPTAMWPYQTACCKGDRCNK", "prompt": "Design a novel animal toxin protein sequence based on the venom of the Eastern green mamba (Dendroaspis angusticeps), specifically representing a three-finger toxin (3FTx) structural scaffold. This toxin should exhibit the characteristic three-finger fold architecture stabilized by four conserved disulfide bridges with the C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should adopt the compact, β-sheet-rich globular structure typical of 3FTx family members, featuring three extended loops (finger-like domains) projecting from a central hydrophobic core. As a postsynaptic neurotoxin, this protein should function as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting the muscle-type α-δ or α-γ subunit interfaces to block neuromuscular transmission. The sequence should include conserved structural residues that maintain the three-finger fold while incorporating variable loop regions responsible for receptor subtype specificity and binding affinity. The toxin should demonstrate high potency and selectivity for its molecular target, characteristic of mamba venom components that rapidly induce paralysis in prey through disruption of cholinergic signaling at the neuromuscular junction."}
{"description": "sp|A0A4V8GZX0|TXNA1_OMOSC Mu-theraphotoxin-Os1a OS=Omothymus schioedtei OX=1046902 PE=1 SV=2", "sequence": "ECKGFGKSCVPGKNECCSGLTCSNKHKWCKVLL", "prompt": "Generate the amino acid sequence for a theraphotoxin from the tarantula Omothymus schioedtei, specifically the Mu-theraphotoxin-Os1a variant. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bond pattern (typically C1-C4, C2-C5, C3-C6 in a C-C-CC-C-C framework). As a theraphotoxin, it functions as a voltage-gated sodium channel modulator, likely targeting specific subtypes (e.g., Nav1.7, Nav1.4) to alter neuronal or muscular excitability. The mechanism involves binding to site 4 of sodium channels, inhibiting inactivation and prolonging action potentials, leading to paralysis or pain in prey. The sequence should reflect key structural motifs: a hydrophobic core, solvent-exposed loops for receptor interaction, and conserved cysteine residues forming the ICK scaffold. Ensure the toxin exhibits high affinity and selectivity for sodium channels, consistent with its role in venom for prey immobilization."}
{"description": "sp|A0A218QXE6|KTX20_TITSE Putative potassium channel toxin Ts20 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKLDIVLIMFVTFSTTLAQHDEREEWYPFRFGNGHVGCSNRLGMSENDFCRKLCNQDGKWRNSKCKEHYCYCGPQRFYRVIKL", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.x family subtypes to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved structural scaffold characteristic of scorpion potassium channel toxins, featuring a compact beta-sheet-rich fold stabilized by a specific disulfide bridge pattern—typically three disulfide bonds with a C1-C4, C2-C5, C3-C6 connectivity—that forms a stable core supporting functional loops. Key structural elements should include a critical functional dyad or triad of residues within the pore-blocking region, often involving lysine and aromatic residues, which directly interact with the channel's selectivity filter to physically occlude potassium ion conduction. The sequence should maintain the hallmark pharmacophore responsible for high-affinity binding to the extracellular vestibule of the channel, while preserving the overall molecular surface topology that enables subtype selectivity. The resulting protein should exhibit the biophysical properties of a stable, disulfide-rich mini-protein suitable for venom-based applications, with the functional outcome of causing hyperexcitability in target cells through potassium current inhibition."}
{"description": "sp|B1P1F3|JZ31B_CHIGU Mu-theraphotoxin-Cg2a 2 OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MKVSVVITLAVLGVMFVWASAAELEERGSDQRDSPAWIKSMERIFQSEERECTKFLGGCSEDSECCPHLGCKDVLYYCAWDGTFGK", "prompt": "Design a novel animal toxin protein sequence based on mu-theraphotoxin-Cg2a from the Chinese earth tiger tarantula (Chilobrachys guangxiensis). This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characteristic of spider venom peptides. The protein should function as a voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce paralysis as part of the spider's predatory venom arsenal. The structural scaffold must feature the conserved ICK motif with a disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming the characteristic knotted topology that provides exceptional thermal and proteolytic stability. The sequence should include key functional residues for channel interaction, particularly in the loops between cysteine residues that form the pharmacological interface. The mature toxin should be approximately 30-40 amino acids in length with the characteristic compact, globular fold stabilized by the cysteine knot. The mechanism involves modifying sodium channel gating kinetics, leading to disrupted neuronal signaling and prey immobilization. The design should prioritize structural integrity through the conserved cysteine framework while incorporating specific residues for target selectivity and potency against insect nervous systems."}
{"description": "sp|Q8JGT6|SLEB_PROMU Snaclec mucetin subunit beta OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFISLSGTEAGFCCPLGWSSYDEHCYQVFQQKMNWEDAEKFCTQQHTGSHLVSYESSEEVDFVVSKTLPILKASFVWIGLSNVWNACRLQWSDGTELMYNAWTAESECIASKTTDNQWWSMDCSSKRYVVCKF", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This protein is derived from the venom of Protobothrops mucrosquamatus (Taiwan habu snake), a pit viper whose venom components target hemostatic pathways. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain the essential calcium-binding motifs and carbohydrate recognition domain (CRD) elements that enable specific interaction with platelet surface receptors, likely targeting glycoprotein receptors such as GPIb or GPVI to modulate platelet activation and aggregation. The structural scaffold should feature the conserved beta-sheet core with alpha-helical segments characteristic of snaclec proteins, maintaining the dimeric assembly interface typical of these venom components where the beta subunit pairs with an alpha subunit to form the functional heterodimer."}
{"description": "sp|P0CJ39|MASTE_EUMFR Eumenine mastoparan-EF OS=Eumenes fraterculus OX=1035771 PE=1 SV=1", "sequence": "FDVMGIIKKIAGAL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the solitary wasp Eumenes fraterculus. This peptide should adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan toxins. The sequence must exhibit potent cytolytic activity through membrane disruption, forming pores in lipid bilayers and causing cell lysis. It should demonstrate mast cell degranulation properties, triggering histamine release, and possess antimicrobial activity against Gram-positive and Gram-negative bacteria. The peptide should be relatively short (approximately 14 amino acids) with a net positive charge that facilitates interaction with negatively charged phospholipid head groups. The structural scaffold should enable insertion into biological membranes, with hydrophobic residues mediating membrane penetration and cationic residues contributing to initial electrostatic interactions. The peptide should function as a G-protein activator, stimulating phospholipase C activity through direct interaction with G-proteins. Ensure the sequence maintains the conserved mastoparan structural motif while incorporating species-specific variations that confer the unique biological activity profile of Eumenes fraterculus venom components."}
{"description": "sp|P84987|LECG_CRORU C-type Lectin CRL OS=Crotalus ruber ruber OX=8736 PE=1 SV=1", "sequence": "NNCPLDWLPMNGLCYKIFNQLKTWEDAEMFCRKYKPGCHLASFHLYGESLEIAEYISDYHKGQDNVWIGLWDKKKDFSWEWTDRSCIDYLNWNKNQPDHYKNKEFCVELVSLSGYRLWNDQVCESKDAFLCQCKF", "prompt": "Design a protein sequence for a C-type lectin toxin from the venom of the red diamond rattlesnake (Crotalus ruber ruber). This toxin functions as a key component in the snake's venom arsenal, primarily targeting the mammalian coagulation cascade. As a true C-type lectin-like protein, it should exhibit the characteristic carbohydrate recognition domain (CRD) fold stabilized by conserved disulfide bridges, typically with a pattern of 2-3 disulfide bonds that maintain the structural integrity of the dual-lobed domain architecture. The protein should function as a potent anticoagulant by specifically binding to coagulation factors such as factor IX, factor X, or other key components of the coagulation cascade, thereby disrupting the formation of fibrin clots and promoting hemorrhage in prey. The sequence should include the conserved calcium-binding motifs essential for the C-type lectin function, along with surface-exposed loops that mediate high-affinity protein-protein interactions with coagulation factors rather than traditional carbohydrate binding. The structural scaffold should maintain the β-sheet-rich core typical of C-type lectin domains, with key residues positioned to interact with serine protease domains of coagulation factors through exosite binding mechanisms."}
{"description": "sp|Q53B58|3L255_OPHHA Alpha-elapitoxin-Oh3a OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTTKCYVTPDVKSETCPAGQDICYTETWCDAWCTSRGKRVNLGCAATCPIVKPGVEIKCCSTDNCNPFPTRKRP", "prompt": "Design a novel alpha-elapitoxin protein sequence derived from the venom of the king cobra (Ophiophagus hannah) that functions as a potent postsynaptic neurotoxin. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I pattern (C1-C3, C2-C4, C5-C6, C7-C8). The protein should specifically target and antagonize muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, competitively inhibiting acetylcholine binding to the receptor's alpha-subunit. The sequence should feature conserved residues in loop II that mediate high-affinity interaction with the receptor's orthosteric binding site, resulting in irreversible neuromuscular blockade and paralysis. The structural scaffold should maintain the globular, flattened beta-sheet architecture characteristic of short-chain alpha-neurotoxins, with loop I and loop III contributing to structural stability while loop II contains the critical pharmacophore for receptor recognition. The toxin should exhibit the typical thermal stability and protease resistance conferred by the dense disulfide network, enabling prolonged action in prey immobilization as part of the king cobra's predatory venom arsenal."}
{"description": "sp|P58370|3NO48_MICCO Alpha-neurotoxin homolog 8 OS=Micrurus corallinus OX=54390 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIMCLDLGYTLECKICNFKTCPTDELRHCASGETICYKTFWNTHRGLRIDRGCAATCPTVKPGVNIICCKTDNCN", "prompt": "Design a novel alpha-neurotoxin protein sequence inspired by coral snake venom toxins, specifically from Micrurus corallinus. This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a C-C-C-C-C-C-C-C cysteine framework. Key structural elements should include: (1) a central loop rich in hydrophobic residues responsible for receptor binding, (2) conserved beta-sheet structure in all three loops, and (3) the characteristic 'three-finger' spatial arrangement. The molecular target interface should include specific interactions with the alpha-delta and alpha-gamma subunit interfaces of the nicotinic receptor, with conserved aromatic and basic residues in loop II critical for high-affinity binding. The toxin should exhibit the typical coral snake neurotoxin profile of rapid-onset neuromuscular blockade without significant presynaptic activity. Include appropriate signal peptide sequences for venom gland expression and proper folding."}
{"description": "sp|P60043|PA2B1_NAJSG Basic phospholipase A2 1 (Fragment) OS=Naja sagittifera OX=195058 PE=1 SV=2", "sequence": "SNRPMPLNTYQFKNMIQCTVPKRSWWDFADYGCYCGRGGSGTPIDDLDRCCQVHDNCYNSAREQGGCRPKQKTYSYECKAGTLSCSGSNNSCAATVCDCDRLAAICFAGAPYNDNNYNIDLKARCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the black-necked spitting cobra (Naja sagittifera). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting the characteristic catalytic activity of hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices stabilized by a network of seven disulfide bonds that confer exceptional thermal and proteolytic stability. Key structural elements must include the conserved calcium-binding loop (YXCGXGG sequence motif) essential for catalytic activity, the hydrophobic substrate-binding channel, and the interfacial binding surface that facilitates membrane association. The basic nature of this toxin should promote preferential binding to anionic phospholipid membranes, particularly those rich in phosphatidylserine found in neuronal and muscle cell membranes. The mechanism should involve membrane penetration, phospholipid hydrolysis leading to membrane disruption, and subsequent induction of presynaptic neurotoxicity through inhibition of neurotransmitter release at neuromuscular junctions, ultimately causing flaccid paralysis. Include conserved catalytic residues (histidine-aspartate pair) and the characteristic elapid phospholipase A2 signature patterns while maintaining the overall compact, globular structure typical of group I phospholipase A2 enzymes from elapid snake venoms."}
{"description": "sp|W4VRV1|TX21G_TRILK Toxin ICK-16 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKPIVSILLFCALAVVIMGHPMNQGYGIPHDVVKLPNGQWCKTPGDDCSKSSECCKAKDTVTYSSGCSQEWSGQLGGFVKLCHICNVESSMC", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The toxin originates from the venom of Trittame loki, a spider species whose venom components typically function to immobilize prey through neurotoxic or cytotoxic mechanisms. This toxin belongs to the Inhibitor Cystine Knot (ICK) family, specifically designated as ICK-16, indicating it adopts the characteristic ICK structural fold stabilized by a conserved disulfide bridge pattern. The ICK motif consists of a compact, triple-stranded beta-sheet scaffold reinforced by three disulfide bonds forming a knotted topology, which confers exceptional stability and resistance to proteolytic degradation. The cysteine framework for this toxin is inferred to follow the canonical ICK pattern (C-C-CC-C-C), with disulfide connectivity typically C1-C4, C2-C5, and C3-C6, ensuring proper folding into the rigid, globular structure. The toxin's mechanism of action likely involves targeting ion channels (e.g., voltage-gated sodium, potassium, or calcium channels) or receptors in the nervous system of prey, leading to paralysis or cellular disruption. Key structural elements include a well-defined hydrophobic core, solvent-exposed loops for target interaction, and conserved residues for disulfide bonding. The sequence should encode these features, prioritizing the ICK fold's stability and functional efficacy in venom."}
{"description": "sp|P0C1Z4|KKX23_OPIMA Potassium channel toxin kappa-KTx 2.3 OS=Opisthacanthus madagascariensis OX=167108 PE=1 SV=2", "sequence": "NDPCEEVCLQHTGNVKACEEACQ", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Opisthacanthus madagascariensis. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal signaling and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an anti-parallel beta-sheet, creating a stable molecular scaffold that presents key functional residues for channel interaction. The toxin should contain a functional dyad or triad of residues responsible for channel block, typically involving aromatic and basic residues that insert into the channel pore or interact with the voltage-sensing domain. The sequence should include the conserved cysteine framework (typically 6 cysteines) that forms the structural scaffold, along with the characteristic pharmacophore region that determines channel specificity and blocking potency. The protein should exhibit high affinity for specific Kv channel subtypes, causing membrane depolarization, increased neuronal excitability, and ultimately paralysis in prey organisms through disruption of potassium conductance."}
{"description": "sp|P28374|VNP_DENAN Natriuretic peptide DNP OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "EVKYDPCFGHKIDRINHVSNLGCPSLRDPRPNAPSTSA", "prompt": "Design a natriuretic peptide toxin from the venom of the Eastern green mamba (Dendroaspis angusticeps) that functions as a potent vasodilator and diuretic agent. This toxin should mimic the biological activity of Dendroaspis natriuretic peptide (DNP), which acts as a potent agonist of natriuretic peptide receptors, particularly NPR-A. The peptide should contain the characteristic 17-amino acid ring structure formed by a disulfide bond between two conserved cysteine residues, creating the essential structural scaffold for receptor binding and activation. The core functional domain should include the conserved sequence motif required for natriuretic peptide receptor recognition and activation. The mature peptide should exhibit the typical structural features of natriuretic peptides, including an N-terminal tail, central ring structure stabilized by the disulfide bridge, and C-terminal extension. The toxin should demonstrate high specificity for natriuretic peptide receptors, leading to increased cyclic GMP production, vasodilation, natriuresis, and diuresis through inhibition of sodium reabsorption in the renal tubules. The structural fold should maintain the characteristic beta-hairpin conformation within the disulfide-constrained ring that is essential for receptor binding and biological activity."}
{"description": "sp|H1ZZI1|SCX12_TITOB Toxin To12 OS=Tityus obscurus OX=1221240 PE=2 SV=1", "sequence": "MKGLILFICGFMMIGVILAKEGYPMDHEGCKFSCFIRPSGFCERYCKTHLSASTGYCAWPACYCYGVPANQKVWDYYNNKCGK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the Brazilian scorpion Tityus obscurus. This toxin should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav) to disrupt neuronal signaling and induce paralysis in prey. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by a specific disulfide bridge pattern—likely a cysteine-stabilized α-helix/β-sheet (CSαβ) motif with four disulfide bonds (C1-C4, C2-C5, C3-C6, C4-C7) that confer rigidity and resistance to proteolysis. Key structural elements should include an anti-parallel β-sheet core and a solvent-exposed loop region critical for interacting with the S1-S2 and S3-S4 extracellular loops of Nav channel domain II or IV, thereby inhibiting channel inactivation and prolonging action potentials. The sequence must encode functional residues for high-affinity binding to insect or mammalian sodium channels, depending on inferred specificity, while maintaining the overall hydrophobic core and charged surface patches essential for membrane proximity and target engagement. Ensure the toxin exhibits selective activity, potentially enhancing sodium influx to cause hyperexcitability, convulsions, or flaccid paralysis, aligning with the ecological role of Tityus venom in subduing arthropod or small vertebrate prey."}
{"description": "sp|P0C8X8|KAXU1_HOFGE Potassium channel toxin alpha-KTx OS=Hoffmannihadrurus gertschi OX=380989 PE=3 SV=1", "sequence": "MNTKVVLIMLMITSVILVVEAETLFTANCLDRKDCKKHCKSKGCKEMKCEQIIKPTWRCLCIMCSK", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Hoffmannihadrurus gertschi. This toxin belongs to the alpha-KTx family, which specifically targets voltage-gated potassium channels (Kv channels) and functions as a potent blocker of potassium ion conductance. The biological significance of this venom component lies in its role in prey immobilization and defense by disrupting neuronal excitability and muscle function through potassium channel inhibition. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by disulfide bridges. Infer the disulfide connectivity pattern as C1-C4, C2-C5, C3-C6 based on the alpha-KTx family framework, with the functional dyad (typically involving a lysine and an aromatic residue) positioned to interact with the potassium channel pore. The molecular target is likely Kv1.x subtypes, with binding mediated by insertion of the functional dyad into the channel selectivity filter, blocking potassium ion permeation. Ensure the sequence includes conserved residues for structural stability and key functional motifs for high-affinity channel blockade."}
{"description": "sp|A0A5C2A2T2|COP1_CONPU Conodipine-P1 OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "MKLLAPVLWAMAALGVTWLVAVDSKESCTKHSNGCSTPLRLPCQEYFRPACDIHDNCYHCGTIFGISRKECDDAFLKDMNTLCKKLGSNSATCPARGKREVTSHRATSIAHSRLWKTALDQKSFLNRKARQAILLTPNSCLYWANNFYMAVHVFGARSYSRTTDPKDCQGLKHCLPNH", "prompt": "Design a novel conodipine phospholipase A2 toxin from the venomous marine cone snail Conus purpurascens. This protein should function as a potent presynaptic neurotoxin that disrupts neuromuscular transmission by hydrolyzing membrane phospholipids at nerve terminals. The toxin should exhibit the characteristic phospholipase A2 enzymatic activity, specifically cleaving the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and neurotransmitter release impairment. Structurally, the protein should adopt the conserved phospholipase A2 fold featuring three major alpha-helices stabilized by multiple disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate, tyrosine) required for enzymatic activity, along with the calcium-binding loop necessary for cofactor-dependent catalysis. The protein should contain the characteristic pancreatic loop region and exhibit the elongated, slightly curved shape typical of secreted phospholipase A2 enzymes. Incorporate key structural elements that facilitate membrane binding and interfacial activation, including hydrophobic surface patches and specific residues that mediate target membrane recognition. The toxin should demonstrate target specificity for neuronal membranes while maintaining the thermal stability and protease resistance characteristic of conotoxin phospholipases. Ensure the sequence includes appropriate signal peptide for secretion and proper folding, with all conserved catalytic and structural residues positioned to maintain both enzymatic efficiency and neurotoxic potency."}
{"description": "sp|W4VRU8|ICK26_TRILK U16-barytoxin-Tl1b OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTIIVFLSLLVLATKFGDAKEGVNQKQKKEVTQNEFREEYLNEMAAMSLVQQLEAIERALFENEAGRNSRQKRCNGENVPCGPNHSTCCSGLSCEETFGYGWWYASPYCVKPSKG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Trittame loki, a spider species whose venom components typically function to immobilize prey through neurotoxic mechanisms. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, specifically designated as ICK26, indicating it possesses the characteristic ICK fold stabilized by a conserved pattern of disulfide bridges. The core structural scaffold must feature the ICK motif, which is defined by a compact, triple-stranded beta-sheet arrangement constrained by a knotted disulfide connectivity pattern—typically involving three disulfide bonds with a specific cysteine framework (e.g., C-C-CC-C-C or similar, ensuring the knot formation). The toxin should function as a barytoxin, implying it targets ion channels or receptors involved in neuronal signaling, potentially acting as a modulator or blocker of voltage-gated ion channels (e.g., sodium, potassium, or calcium channels) to disrupt neuromuscular transmission. The mechanism of action likely involves high-affinity binding to specific extracellular domains of the target ion channel, leading to altered gating kinetics or complete inhibition, resulting in paralysis. The protein sequence must include key residues for stability (e.g., hydrophobic core, beta-sheet forming regions) and functional efficacy (e.g., surface loops for target interaction), with the disulfide bridges critical for maintaining the rigid, protease-resistant ICK fold. Ensure the sequence reflects the evolutionary constraints of spider venom toxins, prioritizing efficacy, specificity, and minimal off-target effects."}
{"description": "sp|P86497|VSPR1_BITRH Snake venom serine protease rhinocerase (Fragment) OS=Bitis rhinoceros OX=715877 PE=1 SV=1", "sequence": "VIGGAECDINEHPSLALIYSTSMRFHCAGTLLNQEWVSFTMWDKDIMLIRTLCAGVLEGGKDTCLAHPCAQPLLPAFYTKVFDYIPWIK", "prompt": "Generate the amino acid sequence for a snake venom serine protease from the venom of Bitis rhinoceros (rhinoceros viper), a highly potent and medically significant viperid species. This toxin belongs to the serine protease family and functions as a key component in the venom's hemorrhagic and coagulopathic arsenal. It acts by cleaving specific peptide bonds in plasma proteins, particularly fibrinogen and other coagulation factors, leading to defibrination, impaired clotting, and systemic hemorrhage. The protein should adopt the characteristic chymotrypsin-like fold, with a conserved catalytic triad of histidine, aspartate, and serine residues essential for proteolytic activity. It likely contains multiple disulfide bridges that stabilize its globular structure and may feature distinct substrate-binding loops that confer specificity toward coagulation cascade components. The molecular target includes fibrinogen, where cleavage disrupts fibrin formation, and potentially other serine protease-dependent pathways in hemostasis. The sequence should reflect high specificity for vertebrate plasma proteins, contributing to the rapid prey immobilization and digestive pre-processing typical of viperid venoms."}
{"description": "sp|P85009|CA1B_CONRE Alpha-conotoxin-like Reg1b/Reg1c OS=Conus regius OX=101314 PE=1 SV=1", "sequence": "GCCSDPRCKHQC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus regius, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in pain signaling pathways. The protein should adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two conserved disulfide bonds with a Cys1-Cys3, Cys2-Cys4 connectivity pattern (framework I). The sequence should include the conserved cysteine framework CC-Xm-C-Xn-C, where the inter-cysteine loop regions determine receptor subtype specificity. The mature toxin should be approximately 12-18 amino acids in length with a well-defined alpha-helical region and beta-turn structural elements that form the receptor binding interface. The molecular mechanism should involve competitive inhibition at the orthosteric binding site of nicotinic acetylcholine receptors, preventing acetylcholine-mediated ion channel opening and neuronal excitation. The structural design should ensure proper folding into the inhibitor cystine knot (ICK) motif characteristic of conotoxins, with the disulfide core providing exceptional thermal and proteolytic stability while the variable loop regions confer target specificity for therapeutic applications in pain management."}
{"description": "sp|W4VRU9|ICK21_TRILK Toxin ICK-21 OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MMKYFLVLCLVVLAVAAVQAAGLEEEKFLNLGESLAMPEESRCKARRYGCTDKAECCSEKCAYPALTCVFNWSCEKVCA", "prompt": "Design a novel animal toxin protein sequence based on the ICK-21 toxin from the venom of Trittame loki, a spider species. This toxin belongs to the Inhibitor Cystine Knot (ICK) structural family, characterized by a highly stable, compact fold stabilized by a conserved disulfide bridge pattern. The ICK motif consists of a triple-stranded beta-sheet and a cystine knot formed by three disulfide bonds, with one disulfide penetrating a macrocycle formed by the other two disulfides and the connecting backbone segments. This structural scaffold confers exceptional thermal and proteolytic stability, making it ideal for venom components. As a spider venom toxin, ICK-21 likely functions as a neurotoxin targeting ion channels or receptors in the nervous system of prey, potentially modulating sodium, potassium, or calcium channels to disrupt neuronal signaling and induce paralysis. The sequence should include the characteristic ICK cysteine framework with six conserved cysteine residues forming three disulfide bonds in a C1-C4, C2-C5, C3-C6 connectivity pattern. The protein should adopt a globular, compact structure with the cystine knot core providing structural rigidity, while surface loops determine target specificity. Incorporate key functional residues in the surface loops that mediate target binding, ensuring the toxin exhibits high affinity and selectivity for its molecular target. The overall sequence should reflect the evolutionary optimization of spider venom toxins for rapid immobilization of prey through precise interference with neuronal function."}
{"description": "sp|P60044|PA2A2_NAJSG Acidic phospholipase A2 2 (Fragment) OS=Naja sagittifera OX=195058 PE=1 SV=1", "sequence": "SNRPMPLNRWQFKNMISCTVPSRSWWDFADYGCYCGRGGSGTPVDDLDRCCQVHDNCYNEAEKISGCNPRFRTYSYECTAGTLTCTGRNNACAASVCDCDRLAAICFAGAPYNDNNYNIDLQARCN", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the banded cobra (Naja sagittifera). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bridges. Key structural elements must include the conserved calcium-binding loop (Tyr-Gly-Cys-X-X-Gly-Gly) and the catalytic network involving a conserved histidine-aspartate dyad. The acidic nature should be reflected in the overall charge distribution, with surface-exposed acidic residues contributing to enhanced membrane penetration and presynaptic neurotoxicity. The toxin should specifically target neuronal membranes and skeletal muscle tissue, causing irreversible blockade of neuromuscular transmission through both enzymatic and non-enzymatic mechanisms. Include conserved motifs for interfacial activation and membrane binding, ensuring the protein can efficiently partition into lipid bilayers while maintaining structural stability in the venom gland environment."}
{"description": "sp|Q56VR3|FAXC_PSETE Venom prothrombin activator pseutarin-C catalytic subunit OS=Pseudonaja textilis OX=8673 PE=1 SV=2", "sequence": "MAPQLLLCLILTFLWSLPEAESNVFLKSKVANRFLQRTKRANSLVEEFKSGNIERECIEERCSKEEAREVFEDDEKTETFWNVYVDGDQCSSNPCHYRGICKDGIGSYTCTCLSGYEGKNCERVLYKSCRVDNGNCWHFCKSVQNDIQCSCAEGYLLGEDGHSCVAGGNFSCGRNIKTRNKREASLPDFVQSHNATLLKKSDNPSPDIRIVNGMDCKLGECPWQAALVDDKKGVFCGGTILSPIYVLTAAHCINETETISVVVGEIDRSRAETGPLLSVDKVYVHKKFVPPKKSQEFYEKFDLVSYDYDIAIIQMKTPIQFSENVVPACLPTADFANQVLMKQDFGIVSGFGGIFERGPNSKTLKVLKVPYVDRHTCMLSSNFPITPTMFCAGYDTLPQDACQGDSGGPHITAYRDTHFITGIVSWGEGCARKGRYGIYTKLSKFIPWIKRIMRQKLPSTESSTGRL", "prompt": "Design a protein sequence for the catalytic subunit of pseutarin-C, a potent prothrombin activator from the venom of the Australian eastern brown snake (Pseudonaja textilis). This enzyme functions as a key component in the snake's venom arsenal, rapidly converting prothrombin to thrombin to initiate systemic coagulation and cause prey immobilization through disseminated intravascular coagulation. The protein should adopt a serine protease fold characteristic of snake venom coagulation factors, featuring a chymotrypsin-like catalytic triad (likely His, Asp, Ser) and appropriate substrate-binding exosites for recognizing prothrombin. The structure should include multiple disulfide bridges to stabilize the protease domain, with conserved cysteine patterns typical of snake venom serine proteases. The mechanism involves specific cleavage of prothrombin at key activation sites, bypassing normal physiological coagulation pathways to generate thrombin directly. The protein should exhibit high specificity for prothrombin binding and efficient catalytic conversion, reflecting its role as a potent procoagulant toxin that disrupts hemostasis in envenomed prey."}
{"description": "sp|A8Y7P6|VKTB6_DABSI Kunitz-type serine protease inhibitor B6 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISSHDRPKFCNLAPESGRCRGHLRRIYYNLESNKCKVFFYGGCGGNANNFETRDECRQTCGGK", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Daboia siamensis (Russell's viper). This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the coagulation cascade, particularly targeting factors Xa and/or thrombin. The protein should adopt the characteristic Kunitz domain fold consisting of a conserved beta-trefoil structure with an alpha-helix and antiparallel beta-sheets stabilized by three disulfide bonds in the Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The reactive site loop should contain the canonical protease-binding motif with specific residues positioned for optimal interaction with the target protease's active site. The protein should exhibit high specificity and potency typical of viper venom Kunitz inhibitors, contributing to the hemorrhagic effects of the venom by disrupting normal hemostasis through precise enzymatic inhibition."}
{"description": "sp|P28878|CA1A_CONST Alpha-conotoxin SIA OS=Conus striatus OX=6493 PE=1 SV=1", "sequence": "YCCHPACGKNFDC", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus striatus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting the neuromuscular junction to induce paralysis in prey. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential inter-cysteine loop regions that mediate high-affinity binding to the alpha-delta subunit interface of muscle-type nAChRs, incorporating key pharmacophore residues for receptor blockade. Maintain the typical alpha-conotoxin length of 12-18 amino acids with appropriate loop sizes for optimal receptor interaction. The structure should exhibit the stable beta-hairpin-like motif common to this toxin family, ensuring proper folding and biological activity as a neurotoxic agent in cone snail venom."}
{"description": "sp|P18619|VM2FL_PROFL Zinc metalloproteinase/disintegrin OS=Protobothrops flavoviridis OX=88087 PE=1 SV=2", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKRAVQQKYEDAMQYELKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYLIEPLKLSDSEAHAVYKYENIEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIELAIVVDHGMYKKYNHDSDKIKVRVHQMVNHINEMYRPLNIAITLSLLQIWSNKDLITVKSASNVTLNLFGNWRETVLLKRRSHDCAHLLTDINFTGNIIGLAYKQGMCNPKLSVGLVQDYSSNVFVVAVIMTHELGHNLGMEHDEEKNGKKCNCKTCIMSPAISDPPAQLFSDCSKNDYHTFLTNRNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPSNPCCDAATCKLRPGAQCADGLCCDQCRFKKKRTICRIARGDFPDDRCTGLSNDCPRWNDL", "prompt": "Generate the amino acid sequence for a zinc metalloproteinase/disintegrin toxin from the venom of Protobothrops flavoviridis (Habu snake). This toxin belongs to the snake venom metalloproteinase (SVMP) family and functions as a key hemorrhagic agent that disrupts hemostasis through multiple mechanisms. The protein should contain a metalloproteinase domain with the characteristic zinc-binding motif HEXXHXXGXXH, which enables proteolytic cleavage of extracellular matrix components like collagen, laminin, and fibronectin, leading to blood vessel degradation and hemorrhage. Additionally, it should feature a disintegrin domain with the RGD (Arg-Gly-Asp) or related tripeptide motif that binds to integrin receptors (particularly αIIbβ3 on platelets and αvβ3 on endothelial cells), inhibiting platelet aggregation and cell adhesion. The mature protein should adopt a multi-domain architecture typical of P-II or P-III class SVMPs, with proper disulfide bonding patterns stabilizing both domains. The metalloproteinase domain should fold into a conserved metzincin-like structure with a central five-stranded β-sheet and surrounding α-helices, while the disintegrin domain should form a compact, disulfide-rich fold. This toxin's combined proteolytic and anti-adhesive activities make it highly effective at inducing systemic bleeding and impairing wound healing, representing a sophisticated adaptation for prey subjugation in viperid snakes."}
{"description": "sp|P0DSN1|3SAN_NAJNG Naniproin OS=Naja nigricollis OX=8654 PE=1 SV=1", "sequence": "LKCNRLIPPFWKTCPEGKNLCYKMTMRLAPKVPVKRGCIDVCPKSSLLIKYMCCTNDKCN", "prompt": "Design a novel protein sequence for a potent neurotoxin derived from the venom of the black-necked spitting cobra, Naja nigricollis. This toxin should function as a highly specific and irreversible inhibitor of the presynaptic phospholipase A2 (PLA2) pathway, effectively blocking neurotransmitter release at neuromuscular junctions. The protein must adopt the characteristic three-finger toxin (3FTx) structural fold, featuring three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C5, C4-C6, C7-C8. The sequence should include a canonical PLA2-active site motif with a conserved histidine-aspartate catalytic dyad for enzymatic activity. The molecular mechanism should involve specific binding to presynaptic membranes via hydrophobic interactions with the central core, followed by catalytic hydrolysis of phospholipids to disrupt synaptic vesicle fusion. The structural design must ensure proper folding into the stable, compact globular architecture typical of snake venom neurotoxins, with surface-exposed loops mediating target recognition while maintaining the rigid beta-sheet scaffold essential for biological activity and resistance to proteolytic degradation."}
{"description": "sp|B4ESA2|VKT1L_BUNMU Kunitz-type serine protease inhibitor PILP-1 OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MSSGSLLLLLGLLTLWAELTPISTKDRPSCDKAPDTERCKRNVYAFYYNPSARDCLQFVYGGCDGNGKHFRSKALCLFHCHR", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of Bungarus multicinctus (many-banded krait). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding loop mechanism. The protein must adopt the characteristic Kunitz domain fold consisting of a conserved alpha-beta structure with a central anti-parallel beta-sheet stabilized by three conserved disulfide bridges in the Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The sequence should feature the signature Kunitz-type inhibitor motif with the reactive site loop positioned for optimal protease binding and inhibition. As a component of krait venom, this inhibitor likely contributes to the venom's complex proteolytic regulation and prey immobilization by modulating endogenous protease activities. The structural scaffold should maintain the compact, stable globular fold typical of Kunitz domains, with the inhibitory loop properly positioned for specific serine protease recognition and binding."}
{"description": "sp|P0C942|PA2B1_LACMU Basic phospholipase A2 LmTX-I OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "HLLKFNKMIKFETRKNAIPFYAFYGCYCGWGGRXXXXXXXXXCCFVHDCCYGKXXXXXXXWDLYRYSLKSGYLTCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the South American bushmaster, Lachesis muta muta. This toxin should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the YGCXCG motif. Include the essential catalytic triad residues (histidine, aspartate, and a water molecule coordinated by the conserved tyrosine) and the calcium-binding site residues. The sequence should contain the typical 6-8 conserved disulfide bonds that stabilize the compact globular structure, with the characteristic CysI-CysIII, CysII-CysV, CysIV-CysVI connectivity pattern. As a basic phospholipase A2, the protein should have an overall positive charge to facilitate interaction with negatively charged membrane surfaces. The toxin should demonstrate membrane-disrupting activity, potentially contributing to myotoxicity, hemolysis, and anticoagulant effects through degradation of platelet and coagulation factor phospholipid substrates. The structural scaffold should enable both enzymatic activity and potential receptor-binding capabilities for enhanced toxicity."}
{"description": "sp|B1P1F7|JZT34_CHIGU Mu-theraphotoxin-Cg1a OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MKVLVLITLAVLGAMFVWTSAAELEERGSDQRDSPAWVKSMERIFQSEERACREWLGGCSKDADCCAHLECRKKWPYHCVWDWTVRK", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is a mu-theraphotoxin from the venom of the Chinese earth tiger tarantula, Chilobrachys guangxiensis. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characteristic of spider venom peptides. The biological significance of this venom component lies in its role as a defensive and predatory weapon, targeting ion channels in the nervous system of prey or predators to induce paralysis or deterrence. The core function of this toxin is to act as a modulator of voltage-gated sodium channels, likely inhibiting channel inactivation or altering activation kinetics, leading to prolonged neuronal excitation and disrupted signal transmission. The mechanism involves high-affinity binding to specific sites on sodium channels, potentially Site 4, which is associated with toxins that affect channel gating. The protein should adopt the conserved ICK fold, stabilized by a disulfide bridge pattern following the cysteine framework C-C-CC-C-C, forming a knotted topology that confers exceptional stability and resistance to proteolysis. The 3D structure is anticipated to comprise a compact, globular core with several solvent-exposed loops that mediate target recognition and binding. Key structural characteristics include a triple-stranded beta-sheet and tight turns that define the functional surface. The molecular target is voltage-gated sodium channels, with a binding interface involving residues in the loops that interact with the channel's voltage-sensing domains or pore regions. Ensure the sequence includes the necessary cysteine residues for the disulfide pattern, hydrophobic core residues for fold stability, and polar or charged residues in the loops for target specificity and potency."}
{"description": "sp|P60212|SCX2_TITOB Alpha-toxin To2 OS=Tityus obscurus OX=1221240 PE=1 SV=3", "sequence": "MIRFVLFISCFFLIGTVVECNKDGYLMEGDGCKMGCLTRKASYCVDQCKEVGGKDGYCYAWLSCYCYNMPDSVEIWDSKNNKCGKGK", "prompt": "Design a potent alpha-toxin from the venom of the Brazilian scorpion Tityus obscurus, specifically the To2 variant. This toxin functions as a voltage-gated sodium channel modulator, primarily targeting neuronal Nav1.6 and Nav1.2 subtypes with high affinity. The toxin binds to site 3 of the sodium channel alpha subunit, inhibiting fast inactivation and prolonging action potentials, leading to sustained neuronal excitation and neurotoxic effects. The structural scaffold should feature a compact, globular fold stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework characteristic of scorpion alpha-toxins. The core structure comprises an alpha-helix packed against a three-stranded anti-parallel beta-sheet, forming a conserved CSαβ motif. Key functional residues include a critical lysine in the beta2-beta3 loop essential for receptor binding and a conserved hydrophobic patch for membrane interaction. The toxin should exhibit high specificity for mammalian neuronal sodium channels while maintaining stability in the venom milieu."}
{"description": "sp|A0A218QXT6|KTX21_TITSE Putative potassium channel toxin Ts21 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MNKVYLVAILVLSVLLVANVSPIEGVPTGGCPLSDALCAKYCKSNKYGKTGKCTGTSKGTCKCLV", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent and selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion potassium channel toxins, featuring a compact globular fold stabilized by a specific disulfide bridge pattern. This scaffold typically consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, with the functional core comprising a critical dyad of key residues (often a lysine and an aromatic amino acid) positioned within a conserved functional surface that directly interacts with the channel's pore region. The sequence must include the appropriate cysteine framework to form disulfide bonds that maintain structural integrity and ensure proper folding into the bioactive conformation. The resulting toxin should exhibit high affinity binding to its potassium channel target, effectively blocking ion conduction and contributing to the neurotoxic effects observed in envenomation, which include autonomic nervous system dysregulation and potential cardiotoxicity."}
{"description": "sp|W4VRV2|ICK11_TRILK Toxin ICK-11 OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MMKLYSLVIIATLAAAAFAATSEEISAAVGEIISQHQEDLERYAKVVERGEEPKKYIRCSKQLGESCYLNCECCGAAAVCEDYKYICKEKVSDNSVLNALGQAWNAVGNSISRYYCDAE", "prompt": "Design a novel animal toxin protein sequence that embodies the biological and structural characteristics of a spider venom-derived ICK (Inhibitor Cysteine Knot) toxin. The source organism is the Australian trapdoor spider Trittame loki, whose venom contains complex peptide toxins that target ion channels in prey organisms. This toxin functions as a potent neurotoxin that likely modulates voltage-gated ion channels, contributing to rapid prey immobilization through disruption of neuronal signaling. The protein should feature the canonical ICK structural motif characterized by a compact, triple-stranded beta-sheet fold stabilized by a distinctive cysteine knot formed by three conserved disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structure should display high thermal and proteolytic stability typical of ICK toxins, with the cysteine knot core providing exceptional structural rigidity. The molecular surface should present specific loops and residues optimized for high-affinity binding to ion channel pore regions or voltage-sensing domains, potentially targeting sodium or calcium channels to interfere with action potential generation and propagation. The sequence should maintain the conserved cysteine framework while incorporating variable regions that confer target specificity and potency characteristic of spider venom ICK toxins."}
{"description": "sp|H1ZZI5|SCX4_TITPA Toxin Tpa4 OS=Tityus pachyurus OX=288781 PE=2 SV=1", "sequence": "MNYFVLIAVACLLTAGTESKKDGYPLEYDNCAYDCLGYDNKKCDKLCKDKKADSGYCYWAHILCYCYGLPDNEPIKTSGRCRPGKK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the scorpion Tityus pachyurus. This toxin, designated Tpa4, should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav) to disrupt neuronal signaling. The protein must adopt the canonical cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by four disulfide bridges with a conserved C-C-CC-C-C connectivity pattern. Key structural elements should include a conserved alpha-helix paired with an antiparallel beta-sheet, forming a molecular surface with exposed loops critical for channel recognition and binding. The mechanism of action involves high-affinity binding to site 3 or site 4 of Nav channels, delaying inactivation and prolonging action potentials, leading to hyperexcitability and neurotoxic effects. Incorporate conserved residues in the functional epitopes for target specificity, while ensuring the scaffold maintains stability and solubility typical of scorpion venom peptides. The final sequence should reflect the evolutionary optimization of scorpion toxins for rapid prey immobilization and defense."}
{"description": "sp|W4VRV3|ICK6_TRILK U12-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTMIAWLVLLTFAAALCFADEGLKQEHMNERKKSRFREDIPDEISEDLLLQEMEAMEAELLEKEMRMEENRNSREKRCLGEDISCGEKPGDLVRMPCCAKYECKETAGYWWYQKRFCVKKKSG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Trittame loki, a spider species whose venom components typically function to immobilize prey through neurotoxic mechanisms. This protein belongs to the inhibitory cysteine knot (ICK) toxin family, specifically designated as U12-barytoxin-Tl1a. The core function of this toxin is to act as a neurotoxin that targets ion channels in the insect nervous system, likely voltage-gated sodium or calcium channels, to disrupt neuronal signaling and cause paralysis. The structural scaffold must feature the characteristic ICK motif, formed by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern with the cysteine framework C1-C4, C2-C5, C3-C6. This fold creates a stable, protease-resistant knot that is essential for target binding and toxicity. The molecular target interface should include key residues for specific interaction with insect ion channels, potentially involving a conserved hydrophobic patch and basic residues for channel binding. The sequence must maintain the ICK structural integrity while incorporating functional loops that determine target specificity and potency."}
{"description": "sp|P86524|PA2HB_ACAAN Phospholipase A2 homolog P-elapitoxin-Aa1a beta chain (Fragment) OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "DLFQFGKMIECANKGSRPSLDYMNYGCYCGK", "prompt": "Generate the amino acid sequence for a phospholipase A2 homolog toxin from the common death adder (Acanthophis antarcticus). This protein represents a P-elapitoxin-Aa1a beta chain fragment that functions as a venom-derived neurotoxin. As a phospholipase A2 homolog, it has lost catalytic activity but retains the characteristic structural fold and membrane-binding capabilities. The toxin should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges in the characteristic pattern (typically 6-8 conserved cysteines forming 3-4 disulfide bonds). This neurotoxin acts as a presynaptic antagonist that binds to neuronal membranes and disrupts neurotransmitter release at neuromuscular junctions, leading to paralysis. The sequence should reflect the typical phospholipase A2 structural scaffold with conserved hydrophobic residues for membrane interaction and surface-exposed loops that mediate specific target recognition. The protein should exhibit the characteristic calcium-binding loop region, though it lacks functional catalytic residues, making it a pure neurotoxic agent rather than an enzymatically active phospholipase."}
{"description": "sp|P0CAR9|PA2A1_CERCE Acidic phospholipase A2 CC-PLA2-1 OS=Cerastes cerastes OX=8697 PE=1 SV=2", "sequence": "MRTLWIVAVWLMGVEGNLYQFGKMIKHKTGKSALLSYSAYGCYCGWGGQGKPQDATDHCCFVHDCCYGEVSGCYPKTAFTLKFENQDIICGDEDPCNRAVCECDRVAAICFGENVNTSDKKYLFYSSSYCEEESEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Saharan horned viper, Cerastes cerastes. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the venom's local tissue damage, inflammation, and potential systemic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Include the essential catalytic residues, particularly a histidine-aspartate dyad, within the conserved calcium-binding loop for enzymatic activity. The acidic nature of this toxin should be reflected in its amino acid composition, with a calculated isoelectric point below 7.0. Ensure the sequence maintains the structural integrity required for membrane interaction and substrate binding, while exhibiting the stability typical of viperid phospholipase A2 toxins."}
{"description": "sp|P0C901|CA1A1_CONLE Alpha-conotoxin-like Leo-A1 OS=Conus leopardus OX=101306 PE=3 SV=1", "sequence": "LTLDRASDDTDVAAEIMSGLIALAIDSCCSDSDCNANHPDMCS", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus leopardus, a piscivorous species that employs neurotoxic venom for rapid prey immobilization. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (CC-C-C framework). The sequence should include the essential cysteine residues at positions that enable this specific disulfide connectivity, along with intervening loops that determine receptor subtype selectivity. The core structure should exhibit the typical alpha-conotoxin pharmacophore, with key functional residues positioned to interact with the orthosteric binding site of nAChRs, competitively inhibiting acetylcholine binding and disrupting cholinergic signaling. The mature peptide should be approximately 12-20 amino acids in length, with well-defined secondary structure elements including beta-turns and a stable tertiary fold that maintains receptor binding affinity while ensuring proteolytic stability in the venom delivery system."}
{"description": "sp|P0CV89|PA23_CROAT Phospholipase A2 (Fragment) OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "NLLQFNKMIKIMTKKNAFPFYTSYGCYCGWGGRCCFVHDCCYEKTDIYSYSWKRQICECDR", "prompt": "Design a phospholipase A2 toxin fragment derived from the venom of Crotalus atrox (Western diamondback rattlesnake). This enzyme should function as a potent presynaptic neurotoxin and myotoxin, characteristic of snake venom phospholipases A2. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids. This mechanism disrupts cellular membranes, induces muscle necrosis, and interferes with neuromuscular transmission. The structural scaffold should feature the conserved phospholipase A2 fold with three long alpha-helices and a beta-wing region, stabilized by multiple disulfide bridges (typically 6-7 conserved cysteine residues forming specific pairings). The catalytic site should include a conserved His-Asp dyad and a calcium-binding loop with key residues for cofactor coordination. The protein should possess surface-exposed cationic patches that facilitate membrane binding and penetration. As a fragment, it may represent a functional domain retaining catalytic activity while potentially lacking certain regulatory elements of the full-length enzyme. The overall structure should be compact and stable, resistant to proteolytic degradation, and exhibit the characteristic pharmacological profile of crotalid venom phospholipases A2."}
{"description": "sp|F8RKW0|VM38_DRYCN Zinc metalloproteinase-disintegrin-like MTP8 OS=Drysdalia coronoides OX=66186 PE=1 SV=1", "sequence": "MIEVLLVTICFTVFPYQGSPIILESGNVNDYEVVYPQKVPALPKGGVQNPQPETKYEDTMQYEFHVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAAISACDGLKGHFKHRGETYFIEPLKLSNSESHAIYKDEHVEKEDEIPKICGVTQTTSESDETIEKISQLTNTPEQDRYLQVKKYIELYVVVDNRMYRNYNSNRDAINERVYEMVNTLNVMYRPLNFFIALIGLEIWSNQDEINIEPEVAVTLRSFGEWRNTTLLPRKRNDNAQLLTGIDFNGATVGLAYVGTLCRPTQSVAVIQDHSKRTSMVASTMAHELGHNLGINHDSASCNCNAGPCIMSATISNQPLSEFSSCSVQEHQRYLLRVRPQCILNKPLRKDIVTPPVCGNYFVERGEECDCGSPQDCQSACCNATTCKLQHEAQCDSGECCEQCKFKKAGAECRAAKDDCDLPESCTGQSAKCPTDSFQRNGHPCQNNQGYCYNGKCLIMTNQCIALKGPGVNVSPDECFTLKQNDPECGFCRIENGTKIPCAEKDKMCGKLLCQEGNATCICFPTTDDPDYGMVEPGTKCGDGKVCINRQCVDVQTAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin protein sequence inspired by the venom composition of Drysdalia coronoides, a species of Australian elapid snake. This protein should function as a potent hemorrhagic toxin that disrupts hemostasis through dual mechanisms: (1) a zinc-dependent metalloproteinase domain that cleaves key components of the extracellular matrix and basement membranes, particularly type IV collagen and fibronectin, leading to vascular damage and hemorrhage; and (2) a disintegrin-like domain that inhibits platelet aggregation by antagonizing integrin receptors on platelet surfaces, specifically targeting αIIbβ3 integrin to prevent fibrinogen binding and thrombus formation. The protein should adopt a modular architecture with a prodomain, metalloproteinase domain, and disintegrin-like domain, featuring the characteristic zinc-binding motif HEXXHXXGXXH in the catalytic domain for zinc coordination and proteolytic activity. The disintegrin-like domain should contain the conserved RGD or related tripeptide motif for integrin recognition. The structure should maintain multiple disulfide bridges stabilizing both domains, with the metalloproteinase domain exhibiting the typical metzincin fold characterized by a conserved methionine turn. The mature toxin should be processed from a larger precursor through proteolytic activation, resulting in a multi-domain protein that synergistically promotes bleeding by simultaneously degrading vascular integrity and inhibiting platelet-mediated clot formation."}
{"description": "sp|Q68PH1|SCX4_CENEX Neurotoxin Cex4 OS=Centruroides exilicauda OX=6879 PE=2 SV=1", "sequence": "MNSLLMITACLFLIGTVWAKEGYLVNKSTGCKYECFWLGKNEFCDKECKAKNQGGSYGYCYSFACWCEGLPESTSTYPLPNKSCGRK", "prompt": "Design a neurotoxin protein sequence that mimics the biological activity and structural characteristics of the Cex4 toxin from the venom of the Arizona bark scorpion (Centruroides exilicauda). This toxin functions as a potent voltage-gated sodium channel (Nav) modulator, specifically targeting and modifying the gating properties of neuronal sodium channels. The protein should adopt the conserved structural fold typical of scorpion β-toxins, characterized by a compact globular domain stabilized by a specific disulfide bridge pattern (cysteine framework I/II: C1-C4, C2-C5, C3-C6) that forms a core inhibitory cysteine knot (ICK) motif. This structural scaffold enables precise interaction with the voltage-sensing domain of Nav channels, particularly site 4, leading to prolonged channel opening and enhanced neuronal excitability. The toxin should exhibit high affinity for mammalian neuronal sodium channels, contributing to the venom's neurotoxic effects by disrupting normal action potential propagation and causing autonomic and neuromuscular symptoms. Key structural elements include a triple-stranded antiparallel beta-sheet stabilized by the disulfide core, with critical residues in the functional loops responsible for receptor recognition and binding specificity. The sequence must reflect the evolutionary optimization for rapid prey immobilization through targeted modulation of ion channel function."}
{"description": "sp|Q5ECE3|LOPAP_LONON Lopap OS=Lonomia obliqua OX=304329 PE=1 SV=2", "sequence": "MKFFGLFLAILASTAADVVIDGACPDMKAVSKFDMNAYQGTWYEIKKFPVANEANGDCGSVEYTPDNGLLKVRAGHVEDDIEKFVVGVLTKNAGTSDAELTLSVVVGDYVRVAPLWIVSTDYDNYAIGYSCKDYKKSNQHRVNIWILSRTKTLNESSKSTVNKFLKEHSKEFDQSKFVETDFSEKACFFKKSHVYTVPFGA", "prompt": "Design a novel protein sequence for a prothrombin activator toxin derived from the venom of the South American saturniid moth Lonomia obliqua. This toxin should function as a key component in the hemorrhagic syndrome caused by envenomation, specifically by activating prothrombin to thrombin through a mechanism that bypasses the conventional coagulation cascade. The protein should adopt a heterodimeric structure composed of a catalytic subunit with serine protease-like activity and a non-enzymatic subunit that facilitates complex assembly and substrate recognition. Incorporate a conserved cysteine framework typical of snake venom metalloproteinase-disintegrin-like proteins, with disulfide bridges stabilizing both subunits and the inter-subunit interface. The catalytic domain should feature a canonical serine protease triad (His, Asp, Ser) within a chymotrypsin-like fold, while the non-catalytic subunit should contain disintegrin-like and cysteine-rich domains that mediate protein-protein interactions. The overall structure should enable efficient prothrombin cleavage at specific activation sites, leading to uncontrolled thrombin generation, disseminated intravascular coagulation, and consumptive coagulopathy characteristic of Lonomia envenomation."}
{"description": "sp|Q91135|3SAPF_NAJAT Cytotoxin I-like P-15 OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLTLAAATIVCLDLGYTLKCNKLIPIASKTCPAGMNLCYKMFMMSDLTIPVKRGCIDVCPKNSLLVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein derived from the venom of the Chinese cobra (Naja atra), a species known for its potent neurotoxic and cytotoxic venom components that facilitate prey immobilization and digestion. This cytotoxin belongs to the three-finger toxin (3FTx) superfamily, specifically the cytotoxin subgroup, and functions by disrupting cellular membranes through direct interaction with lipid bilayers and specific membrane receptors. The protein should adopt the characteristic three-finger β-sheet fold, stabilized by a conserved disulfide bridge pattern with four disulfide bonds (cysteine framework I: C1-C3, C2-C4, C5-C6, C7-C8) that form a rigid, flat core supporting three protruding loops. Key structural features include a hydrophobic patch on the central loop for membrane insertion, positively charged residues for electrostatic interactions with anionic phospholipids (e.g., phosphatidylserine), and a conserved 'three-finger' topology with β-strands arranged in a β-sandwich. The mechanism involves pore formation or membrane perturbation in target cells (e.g., cardiomyocytes, erythrocytes), leading to cell lysis, apoptosis, or necrosis. Ensure the sequence includes conserved motifs for cytotoxin activity, such as a functional loop I for membrane targeting and loop II for receptor binding, while excluding neurotoxic or enzymatic domains. The protein should be ~60-70 amino acids in length, with high stability and specificity for eukaryotic cell membranes, reflecting its role in venom-induced cytotoxicity."}
{"description": "sp|P0DPV4|TX41B_SCODE Kappa-scoloptoxin(04)-Ssd1b OS=Scolopendra dehaani OX=2609776 PE=1 SV=1", "sequence": "MKKTCVVSVFLVLLLLKFHDLSMGEEISPLKKVARREDNLVLSCAEFPCPEGYICDTASQKCRPGTD", "prompt": "Design a novel centipede venom toxin protein sequence that functions as a kappa-scoloptoxin, specifically targeting potassium channels. This toxin should be derived from Scolopendra dehaani, a large predatory centipede whose venom contains complex peptide cocktails for prey immobilization and defense. The protein should act as a potent potassium channel blocker, likely targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and muscle function in prey organisms. The structural scaffold should feature the characteristic cysteine framework of centipede toxins, typically with 3-4 disulfide bridges forming a compact, stable fold that maintains the bioactive conformation. The sequence should include conserved cysteine residues arranged in a specific pattern that enables proper disulfide bond formation, creating a rigid molecular architecture capable of precise interaction with potassium channel pore regions. The mature toxin should be approximately 30-50 amino acids in length with a molecular weight around 3-5 kDa, exhibiting the typical physicochemical properties of centipede venom peptides including basic character for membrane interaction. The structural fold should resemble the inhibitor cystine knot (ICK) motif common to many potassium channel blockers, providing thermal and proteolytic stability while presenting key functional residues for channel binding. The binding interface should contain conserved hydrophobic and positively charged residues that interact with the potassium channel selectivity filter and voltage-sensing domains to effectively block ion conduction."}
{"description": "sp|B4ESA3|VKT2L_BUNMU Kunitz-type serine protease inhibitor PILP-2 OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTLWMELTPVSSKNRPPFCNLLPEPGRCNAIVRAFYYNSRPRKCLEFPYGGCGGNANNFKTIEECQRTCAG", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by the venom of the many-banded krait (Bungarus multicinctus). This protein should function as a potent and specific serine protease inhibitor, characteristic of the Kunitz/BPTI family. The structural scaffold must feature the conserved Kunitz-type fold, comprising a compact globular domain stabilized by three disulfide bridges with the characteristic Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The protein should adopt a stable beta-sheet-rich structure with a well-defined reactive site loop that presents key residues for specific protease recognition and inhibition. The mechanism of action involves tight binding to the active site of target serine proteases, forming a stable enzyme-inhibitor complex that blocks proteolytic activity. This inhibition plays a crucial role in the venom's strategy to disrupt hemostasis and prey immobilization. The protein should exhibit high specificity for its serine protease targets while maintaining the thermal stability and protease resistance typical of Kunitz domain proteins."}
{"description": "sp|W4VRV4|ICK1_TRILK U8-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTLVLVAVLGLASLYLLSYASEVQQLSVAEEEFGALIDAFGGLLETEERGVNKEGCRKFLGGCENTGQCCLHLFCKYDTPFNHFCAWDLSFGRK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a spider venom-derived toxin from the Australian tarantula species Trittame loki, belonging to the inhibitory cysteine knot (ICK) structural family. This toxin should function as a potent neurotoxin targeting ion channels in the insect nervous system, consistent with the predatory ecology of mygalomorph spiders. The core structural scaffold must feature the characteristic ICK motif with a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming a stable, triple-stranded beta-sheet fold that provides exceptional thermal and proteolytic stability. The molecular mechanism should involve high-affinity binding to voltage-gated sodium or calcium channels in insect neurons, leading to disruption of action potential propagation and rapid paralysis. Key functional residues should be strategically positioned within surface-exposed loops to mediate specific target recognition and binding affinity, while maintaining the structural integrity of the cysteine knot core. The sequence should include appropriate signal peptide motifs for venom gland expression and secretion, with mature toxin regions exhibiting the hallmark cysteine spacing patterns typical of ICK family toxins from spider venoms."}
{"description": "sp|Q6HAA2|CTSP2_CRODU Crotasin OS=Crotalus durissus terrificus OX=8732 GN=Cts-p2 PE=3 SV=1", "sequence": "MKILYLLSAFLFLAFLSESGNAQPQCRWLDGFCHSSPCPSGTTSIGQQDCLWYESCCIPRYEK", "prompt": "Design a novel animal toxin protein sequence inspired by the crotasin family from the venom of Crotalus durissus terrificus, the South American rattlesnake. This toxin should function as a crotamine-like myotoxin, exhibiting potent cytotoxicity and membrane-disrupting activity. The protein should adopt the characteristic β-defensin fold common to crotamine family toxins, stabilized by a conserved disulfide bond pattern with three intramolecular disulfide bridges forming a Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 connectivity. The structural scaffold should feature an amphipathic arrangement with both hydrophobic and cationic regions that facilitate interaction with lipid membranes. The mechanism of action should involve selective binding to anionic phospholipids in cell membranes, leading to membrane permeabilization and subsequent cell death through disruption of membrane integrity. The toxin should demonstrate specificity for rapidly dividing cells, particularly muscle cells and certain cancer cell lines, while maintaining the thermal stability and protease resistance typical of small, disulfide-rich venom peptides. Incorporate conserved residues critical for membrane interaction and cytotoxic activity, including key cationic amino acids that mediate electrostatic interactions with negatively charged membrane components."}
{"description": "sp|H2BKS9|CM3A_CONTS Mu-conotoxin TsIIIA OS=Conus tessulatus OX=101317 PE=3 SV=1", "sequence": "MMSKLGVLLTICLLLFPLTAVPLDGDQPADQPAERKQNEQHPLFDQKRGCCRWPCPSRCGMARCCSS", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the marine cone snail Conus tessulatus. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the Nav1.2 and Nav1.4 subtypes to induce neuromuscular blockade. The protein must adopt the characteristic mu-conotoxin structural scaffold featuring a compact, globular fold stabilized by a conserved disulfide connectivity pattern with cysteine framework III (C-C-CC-C-C), forming three intramolecular disulfide bridges that create a stable, rigid structure. The sequence should include key functional residues for channel binding, particularly those interacting with the domain II voltage sensor of sodium channels to inhibit channel activation. The toxin should exhibit high affinity and specificity for its sodium channel targets while maintaining the typical small size (approximately 22-24 amino acids) and cationic nature of mu-conotoxins. The structural core should display the characteristic inhibitor cystine knot (ICK) motif common to conotoxins, with well-defined loops between cysteine residues that mediate target recognition and binding."}
{"description": "sp|P19000|PA2B_LATLA Basic phospholipase A2 P'513 OS=Laticauda laticaudata OX=8630 PE=2 SV=1", "sequence": "MYPAHLLLLLAVCVSLLGASAIPPLPLNLAQFALVIKCADKGKRPRWHYMDYGCYCGPGGSGTPVDELDRCCKTHDQCYAQAEKKGCYPKLTMYSYYCGGDGPYCNSKTECQRFVCDCDVRAADCFARYPYNNKNYNINTSKRCK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the sea krait Laticauda laticaudata. This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bonds. Key structural elements must include the conserved calcium-binding loop (Tyr-Gly-Cys-X-Gly-Gly) and the catalytic triad (His-Asp) essential for enzymatic activity. The basic nature of this toxin facilitates its interaction with negatively charged membrane surfaces and contributes to its presynaptic neurotoxic effects by disrupting neurotransmitter release at neuromuscular junctions. The sequence should maintain the characteristic N-terminal helix, the central beta-wing region, and the C-terminal extension typical of group I phospholipase A2 enzymes from elapid snakes. The protein should exhibit membrane-binding capability and demonstrate both enzymatic and receptor-mediated toxic activities."}
{"description": "sp|P58490|KAX65_PANIM Potassium channel toxin alpha-KTx 6.5 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "DEAIRCTGTKDCYIPCRYITGCFNSRCINKSCKCYGCT", "prompt": "Design a potassium channel toxin protein from the venom of the emperor scorpion Pandinus imperator. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by disulfide bridges. The expected cysteine framework follows the pattern C-X(3-7)-C-X(3-7)-C-X(0-4)-C-C-X(4-13)-C-X(1-4)-C, forming three disulfide bonds that confer structural stability and define the functional surface. The toxin should specifically target and inhibit Kv1.x family potassium channels, binding to the channel pore region with high affinity to block potassium ion conductance. This blockade disrupts neuronal excitability and neuromuscular transmission, contributing to the paralytic effects of the venom. The molecular surface should present key functional residues for channel recognition and binding, including conserved basic residues that interact with the channel's turret and pore helix regions. The overall structure should be compact and thermodynamically stable, with the characteristic molecular weight and isoelectric point typical of alpha-KTx family members."}
{"description": "sp|G9I929|VKTA_MICTN Kunitz-type neurotoxin MitTx-alpha OS=Micrurus tener tener OX=1114302 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLCAELTPVSSQIRPAFCYEDPPFFQKCGAFVDSYYFNRSRITCVHFFYGQCDVNQNHFTTMSECNRVCHG", "prompt": "Design a Kunitz-type neurotoxin protein sequence from the venom of the Texas coral snake (Micrurus tener tener). This toxin should function as a potent neurotoxin that targets voltage-gated potassium channels, characteristic of Kunitz-type toxins from elapid snake venoms. The protein should adopt the conserved Kunitz-type fold, featuring a stable alpha-beta structure with a characteristic disulfide bond pattern (typically three disulfide bridges with connectivity Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that stabilizes the compact globular domain. The sequence should include the canonical Kunitz functional loop responsible for potassium channel blockade, with specific residues optimized for high-affinity binding to the channel's pore region. The toxin should exhibit the typical molecular weight and isoelectric point profile of elapid snake Kunitz-type neurotoxins, maintaining the structural stability required for venom delivery while maximizing neurotoxic potency through precise molecular recognition of neuronal potassium channels."}
{"description": "sp|Q94435|SCXA_CENNO Insect-toxin Cn10 (Fragment) OS=Centruroides noxius OX=6878 PE=1 SV=2", "sequence": "ITACLVLIGTVCAKEGYLVNKSTGCKYNCLILGENKNCDMECKAKNQGGSYGYCYKLACWCEGLPESTPTYPIPGKTCRTK", "prompt": "Design a protein sequence for an insect-specific neurotoxin derived from the venom of the scorpion Centruroides noxius. This toxin should function as a potent modulator of voltage-gated sodium channels in insect nervous systems, specifically targeting the voltage-sensing domain of insect Nav channels to cause prolonged channel opening and neuronal hyperexcitability. The protein should adopt the conserved structural scaffold of scorpion β-toxins, characterized by a compact globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif with four disulfide bridges in a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved hydrophobic core, a solvent-exposed beta-hairpin responsible for receptor interaction, and a conserved 'pharmacophore' region containing critical residues for binding to the voltage sensor of insect sodium channels. The toxin should exhibit high selectivity for insect over mammalian sodium channels, contributing to the scorpion's predatory efficacy by inducing rapid paralysis in insect prey through disruption of action potential generation and propagation."}
{"description": "sp|Q68PH3|SCX2_CENEX Neurotoxin Cex2 OS=Centruroides exilicauda OX=6879 PE=2 SV=1", "sequence": "MNSLLMITACLALIGTVWAKEGYLVSKSTGCKYECFWLGKNEGCDKECKAPNQGGGYGYCHAFACWCENLPESTPTYPIPGKSCGKK", "prompt": "Design a neurotoxin protein sequence that mimics the biological activity and structural characteristics of the venom component from the Arizona bark scorpion (Centruroides exilicauda). This toxin functions as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav channels) in the peripheral nervous system. The protein should exhibit the characteristic beta-toxin scaffold with a conserved cysteine-stabilized alpha-beta (CSαβ) fold, featuring the typical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure. The sequence should contain key functional residues responsible for binding to site 4 of Nav channels, delaying channel inactivation and prolonging neuronal depolarization, leading to hyperexcitability and neurotoxic effects. The structural core should maintain the stable beta-sheet framework with surface-exposed loops that mediate specific receptor interactions, characteristic of scorpion beta-neurotoxins targeting mammalian sodium channels."}
{"description": "sp|P0CAS0|PA2A2_CERCE Acidic phospholipase A2 CC-PLA2-2 OS=Cerastes cerastes OX=8697 PE=1 SV=2", "sequence": "MRTLWIVAVWLMGVEGNLFQFGKMIKHKTGKSALLSYSGNPCYCGWGGQGPPQDATDHCCFVHDCCYGEENACYPKTAFTLKFENQIIICDEDPCNYAVCMCDRVAAICGGENVATSDAKYLFYRSMGCEEESVQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Saharan horned viper, Cerastes cerastes. This enzyme should exhibit potent phospholipase A2 activity, catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the venom's local tissue damage, inflammation, and potential systemic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Key catalytic residues should include a histidine-aspartate dyad and a conserved calcium-binding loop essential for enzymatic activity. As an acidic isoform, the sequence should reflect an overall negative charge at physiological pH. The structural scaffold should maintain the characteristic phospholipase A2 interfacial binding site for membrane association and substrate recognition. The toxin should demonstrate preferential activity against specific phospholipid substrates relevant to its role in viper envenomation, contributing to the complex pathophysiology of Cerastes cerastes venom."}
{"description": "sp|G3DT18|PA2A_BOTMO Acidic phospholipase A2 BmooPLA2 OS=Bothrops moojeni OX=98334 PE=1 SV=1", "sequence": "MRTLWIVAVLLLGVEGNLWQFEMLIMKIAKTSGFLFYSSYGCYCGWGGHGRPQDATDRCCFVHDCCYGKVTGCNPKTDSYTYSEENGDVVCGGDDPCKKQICECDRVAATCFRDNKDTYDNKYWFYPAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops moojeni, a medically significant pit viper. This enzyme should function as a potent toxin with calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids. The mechanism involves membrane disruption, inflammation induction, and potential myotoxic and neurotoxic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges (typically 6-7 cysteine residues forming specific pairings such as Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, and Cys51-Cys98, though variations may occur). Include an N-terminal helix, a calcium-binding loop (YXCGXGG motif), and a conserved active site with a His-Asp catalytic dyad. The acidic nature (low pI) should be reflected in the sequence through an abundance of aspartate and glutamate residues. The molecular target is the phospholipid bilayer of cell membranes, with potential interactions involving interfacial activation surfaces for membrane binding. Ensure the sequence maintains the structural integrity required for enzymatic activity and toxin function, including key residues for substrate recognition and catalysis."}
{"description": "sp|P0C7P6|BNP_CRAGM Bradykinin-potentiating and C-type natriuretic peptides OS=Craspedocephalus gramineus OX=8767 PE=2 SV=1", "sequence": "MFVSRLAASGLLLLALLALSLDGKPVQEKPGRSPPISPLLVPPPPPPPHWPPPHHIPPLSVQKFPPGWKPTHPHHIPPLEVQQWSQGGPRSELVQPHESPAGGTTAFREELSLGPEAASGPAAPQRLPKRKGASATSAASRSMRDLRADGKQARQKWGRMVQPDHHAAPGGGGGGGGGARRLKGLAKKAVGKGCFGLPLDRIGSMSGMGC", "prompt": "Design a novel venom-derived peptide that functions as both a bradykinin-potentiating peptide and a C-type natriuretic peptide, inspired by the venom of Craspedocephalus gramineus (the bamboo pit viper). This multifunctional toxin should exhibit dual biological activities: first, it must potentiate bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby enhancing bradykinin's vasodilatory and pro-inflammatory effects; second, it should function as a C-type natriuretic peptide, binding to natriuretic peptide receptors to promote vasodilation, diuresis, and natriuresis. The peptide should adopt a compact, stable structure stabilized by disulfide bonds, characteristic of small cysteine-rich venom peptides. Given its dual function, the sequence should include conserved motifs for ACE inhibition (likely involving proline-rich regions or specific inhibitory sequences) and the characteristic ring structure of natriuretic peptides formed by disulfide bridges. The structural scaffold should ensure resistance to proteolytic degradation while maintaining high affinity for both ACE and natriuretic peptide receptors. The final sequence should reflect the evolutionary adaptation of viper venoms to modulate cardiovascular homeostasis through synergistic actions on multiple regulatory pathways."}
{"description": "sp|A0A6P3CW73|CYCTI_TITOB Cyclotide trypsin inhibitor TopI1 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MKFIIVLLLLTALTLTSIPVIEGILKRCKTYDDCKDVCKARKGKCEFGICKCMIKSGK", "prompt": "Design a novel cyclotide toxin derived from the venom of Tityus obscurus, a medically significant scorpion species. This protein should function as a potent trypsin inhibitor, disrupting digestive processes and potentially contributing to the venom's cytotoxic effects. The sequence must adopt the characteristic cyclotide fold—a head-to-tail cyclized backbone stabilized by a conserved cysteine knot motif with three disulfide bridges forming a knotted topology (CysI-CysIV, CysII-CysV, CysIII-CysVI). The structure should feature a compact, globular scaffold with exposed loops that confer target specificity, including a canonical binding loop for trypsin inhibition. The molecular target is trypsin, with inhibition occurring via standard mechanism binding to the enzyme's active site. Ensure the sequence includes the conserved cyclotide cystine framework (CCK), incorporates residues critical for trypsin interaction (e.g., a P1 residue complementary to the S1 pocket), and maintains the stability and protease resistance typical of cyclotides. The final protein should exhibit high affinity for trypsin, contributing to the venom's role in prey immobilization and defense."}
{"description": "sp|A0A0K8TU78|COW_CONLV Contryphan-Lnv (Fragment) OS=Conus lenavati OX=1519839 PE=2 SV=1", "sequence": "ILLLVAAVLLSTQVMVQGDGDQPAYRNAVPRDDNTGGASRKFLNVPRESECPWRPWCG", "prompt": "Design a novel peptide toxin sequence inspired by the contryphan family from cone snail venoms, specifically emulating the characteristics of Contryphan-Lnv from Conus lenavati. This peptide should function as a potent neurotoxin targeting voltage-gated ion channels in the central nervous system of prey organisms. The sequence must adopt the characteristic contryphan structural scaffold featuring a compact, disulfide-stabilized globular fold with the conserved CC-C-C cysteine framework that forms two essential disulfide bridges creating a rigid, stable structure. Incorporate the signature post-translational modifications typical of contryphan peptides, including a tryptophan residue that is likely D-configured at a specific position and a C-terminal amidation, both crucial for proper folding, stability, and biological activity. The mature peptide should be approximately 8-12 amino acids in length with high cysteine content, forming a tight, stable structure resistant to proteolytic degradation. The molecular mechanism should involve specific interactions with neuronal ion channels to modulate their gating properties, leading to rapid paralysis of prey. Ensure the sequence maintains the characteristic hydrophobic core and surface-exposed residues that facilitate target recognition while preserving the compact, stable fold essential for venom delivery and function."}
{"description": "sp|I6S7H3|TX72F_SCOMU Kappa-scoloptoxin(07)-Ssm2f OS=Scolopendra mutilans OX=2836329 PE=3 SV=2", "sequence": "MLVFYAILFVTVFSNTVMGATIDKPIPKPIFREAIEEMEVNKRAKNPYCKEEKCPVGKHCPKKPIVCRIGPCCV", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The protein is a kappa-scoloptoxin derived from the venom of the Chinese red-headed centipede, Scolopendra mutilans. This toxin belongs to the scoloptoxin family, which are key components of centipede venom that facilitate prey capture through potent neurotoxic activity. The core function of this kappa-scoloptoxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The mechanism involves high-affinity binding to the pore region of Kv channels, inhibiting potassium efflux, prolonging action potentials, and inducing paralysis. Structurally, it is anticipated to adopt an inhibitor cysteine knot (ICK) motif, characterized by a compact, disulfide-stabilized globular fold with three disulfide bridges forming a knotted topology. The cysteine framework is expected to follow a C-C-CC-C-C pattern, with disulfide connectivity typically C1-C4, C2-C5, C3-C6, conferring exceptional stability and resistance to proteolysis. Key structural elements include a beta-hairpin region involved in channel binding, conserved hydrophobic patches for membrane interaction, and positively charged residues for electrostatic guidance to the channel pore. The molecular target is likely Kv1.3 or related Shaker-family potassium channels, with binding mediated through a functional dyad involving a critical lysine or arginine residue that projects into the selectivity filter and adjacent hydrophobic residues that interact with the channel vestibule. The protein should be approximately 30-45 amino acids in length, rich in cysteine residues, and exhibit the characteristic pharmacophore of centipede venom potassium channel toxins, ensuring potent and selective channel blockade for neurotoxic efficacy."}
{"description": "sp|Q92152|PA2H_OVOOK Phospholipase A2 homolog PLA2-03 OS=Ovophis okinavensis OX=8769 PE=2 SV=1", "sequence": "MRTLWIVAVLLVGVEGSLIQLGEMIFQEMGKGAAKKYGLYGCNCGMGRRGRPQDATDRCCSVHKCCYKKLTDCDPKTDRYSYSWENGDIVCGGDDPCTKEVCECDKAATICFRDNLDTYDKKYKIFPKFLCKKPEPC", "prompt": "Design a phospholipase A2 homolog protein from the venom of the Okinawan pit viper (Ovophis okinavensis) that functions as a key venom component. This protein should adopt the characteristic phospholipase A2-like structural fold despite lacking catalytic activity, featuring the conserved calcium-binding loop and the pancreatic phospholipase A2 superfamily architecture. The sequence should include the typical disulfide bond pattern that stabilizes the globular structure, with conserved cysteine residues forming the structural scaffold. The protein should exhibit membrane-binding capabilities through its interfacial surface, potentially interacting with biological membranes or specific protein targets to exert its toxic effects, possibly through allosteric modulation or receptor binding. The structural design should prioritize stability and proper folding while maintaining the evolutionary conserved features of viperid phospholipase A2 homologs that enable their role in venom toxicity."}
{"description": "sp|Q95WD1|SCX8_CENSC Toxin CsE8 OS=Centruroides sculpturatus OX=218467 PE=2 SV=1", "sequence": "MNSLLMITACLVLFGTVWSEKGYLVHEDTGCRYKCTFSGENSYCDKECKSQGGDSGICQSKACYCQGLPEDTKTWPLIGKLCGRK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a scorpion toxin derived from Centruroides sculpturatus, a species known for producing potent neurotoxins that target voltage-gated ion channels. This toxin belongs to the beta-toxin family, which typically functions by modifying the gating properties of voltage-gated sodium channels. The core mechanism of action involves binding to site 4 of the voltage-gated sodium channel, leading to a shift in the voltage dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and causing prolonged neurotransmitter release. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by three or four disulfide bridges with a typical cysteine pattern of C-C-CC-C-C. Key structural elements should include a conserved hydrophobic patch involved in channel binding, a flexible C-terminal region that may influence receptor interaction, and a core beta-sheet that provides structural rigidity. The molecular target is the voltage-gated sodium channel, with specific affinity for neuronal subtypes, and the binding interface likely involves interactions with the S3-S4 loop in domain II of the channel. The toxin should exhibit high specificity for sodium channels over other ion channels, contributing to its neurotoxic effects such as autonomic nervous system disruption and potential paralysis. Ensure the sequence reflects these functional and structural characteristics while maintaining the compact, stable fold typical of scorpion toxins."}
{"description": "sp|B4ESA4|VKT3L_BUNMU Kunitz-type serine protease inhibitor PILP-3 OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSRKRHQFCNVPPEPGRCNANVRAFYYNPRLRKCIEFSYGGCGGNANNFKSRGECKRTCAE", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the many-banded krait (Bungarus multicinctus). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like proteases through a canonical binding loop mechanism. The protein must adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in a C1-C6, C2-C4, C3-C5 connectivity pattern. The reactive site loop should contain the critical protease-binding residues that form complementary interactions with the active site of target serine proteases, enabling tight-binding inhibition. This venom component contributes to the krait's neurotoxic arsenal by interfering with proteolytic cascades, potentially disrupting hemostasis or other physiological processes in prey. The sequence should maintain the conserved Kunitz family signature while incorporating venom-specific adaptations for enhanced stability and potency in the toxic context."}
{"description": "sp|P0C7X7|VM212_CROSS Disintegrin mojastin-2 OS=Crotalus scutulatus scutulatus OX=8738 PE=1 SV=1", "sequence": "EAGEECDCGSPANPCCDAATCKLRPGAQCADGLCCDQCRFIKKGTVCRPARGDWNDDTCTGQSADCPRNGLYG", "prompt": "Design a novel disintegrin protein sequence inspired by mojastin-2 from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus). This protein should function as a potent anti-platelet and anti-metastatic agent by specifically targeting and inhibiting integrin receptors on cell surfaces. The core mechanism involves the characteristic RGD (Arg-Gly-Asp) motif that competitively blocks integrin binding to extracellular matrix proteins, thereby disrupting cell adhesion, platelet aggregation, and cancer cell migration. The structural scaffold should adopt the compact, cysteine-rich disintegrin fold stabilized by multiple disulfide bonds, typically featuring a conserved pattern that maintains the bioactive loop conformation presenting the RGD tripeptide. The sequence must preserve the critical cysteine framework that forms the structural core, while the RGD motif should be positioned within an exposed, flexible loop region optimized for integrin recognition. The overall architecture should be a single-chain polypeptide with high stability and specificity for αIIbβ3 and αvβ3 integrins, characteristic of viperid snake venom disintegrins that evolved to induce hemorrhage and prevent blood coagulation."}
{"description": "sp|Q8JIV9|SLA1_DEIAC Snaclec agglucetin subunit alpha-1 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADVDCLPGWSAYDQSCYRVFKLLKTWDDAEKFCTERPKGGHLVSIESAGERDFVAQLVSENKQTDNVWLGLKIQSKGQQCSTEWTDGSSVSYENFSEYQSKKCFVLEKNTGFRTWLNLNCGSEYAFVCKSPP", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) that functions as a platelet-aggregating toxin. This protein should be the alpha-1 subunit of agglucetin, derived from the venom of the sharp-nosed viper (Deinagkistrodon acutus). The protein should adopt the characteristic C-type lectin-like fold, featuring a conserved carbohydrate recognition domain (CRD) stabilized by two intrachain disulfide bonds with a typical C-C-C-C cysteine framework. As a key component of the heterodimeric snaclec complex, this alpha subunit should contain specific surface residues that mediate high-affinity binding to platelet membrane receptors, particularly targeting the GPIb-IX-V complex. The binding interface should include complementary electrostatic and hydrophobic interactions that facilitate platelet activation and aggregation, contributing to the potent procoagulant activity of sharp-nosed viper venom. The structural scaffold should maintain the β-sheet-rich globular architecture typical of snake venom C-type lectins, with conserved calcium-binding motifs that may influence receptor recognition. The sequence should encode functional epitopes that enable synergistic interaction with the beta subunit to form the complete agglucetin heterodimer, which collectively disrupts hemostasis through platelet receptor engagement and subsequent thrombotic cascades."}
{"description": "sp|P0C903|O16_CONLE Conotoxin Leo-O2 OS=Conus leopardus OX=101306 PE=3 SV=1", "sequence": "MKLTCVLIIAVLFLTACQLVTADYSGDEQQYRAMRLIDAMRNFGDTRSCGRRGKPCPCCRGFRCTGSFCRKWQ", "prompt": "Design a novel conotoxin sequence from the marine cone snail Conus leopardus that functions as a potent neurotoxin. This peptide should adopt the O1-superfamily conotoxin structural framework, characterized by a conserved cysteine pattern (C-C-CC-C-C) forming three disulfide bridges that stabilize a compact, globular fold. The toxin should specifically target and inhibit voltage-gated sodium channels (Nav), acting as a gating modifier that binds to site 4 and delays channel inactivation, thereby prolonging action potentials and inducing neuromuscular paralysis. Incorporate key functional residues known for Nav channel interaction, such as hydrophobic and aromatic amino acids in the inter-cysteine loops that mediate binding to the channel's voltage-sensing domain. The sequence should exhibit high affinity for mammalian Nav isoforms, particularly those expressed in peripheral neurons, and maintain the characteristic stability and protease resistance conferred by the disulfide-rich scaffold. Ensure the design reflects the evolutionary optimization of Conus leopardus venom for rapid prey immobilization through precise modulation of neuronal excitability."}
{"description": "sp|A9QLM3|KA11L_LYCMC Toxin KTx8 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MNKVCFVVVLVLFVALAAYVSPIEGVPTGGCPLSDSLCAKYCKSHKFGKTGRCTGPNKMKCKCLV", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The toxin originates from the venom of Lychas mucronatus, a scorpion species known for producing potent neurotoxins that target ion channels. This toxin belongs to the potassium channel toxin family (KTx), specifically designated as KTx8, indicating its role as a selective blocker of voltage-gated potassium channels (Kv channels). The core function of this toxin is to bind with high affinity to the pore region of Kv channels, thereby inhibiting potassium ion efflux and disrupting neuronal excitability, which can lead to paralysis or other neurotoxic effects in prey or predators. The structural scaffold is expected to feature a conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by disulfide bridges. The cysteine framework likely follows a C-C-C-C pattern typical of scorpion toxins, with disulfide connectivity of C1-C4 and C2-C3, contributing to the stability and functional specificity of the toxin. Key domains include a functional surface responsible for channel binding, often involving residues in the beta-sheet regions that interact with the channel's voltage-sensing or pore domains. The molecular target is primarily Kv1.x subtypes (e.g., Kv1.1, Kv1.2, or Kv1.3), with the binding interface involving electrostatic and hydrophobic interactions that occlude the channel pore. Ensure the sequence reflects these structural and functional attributes, including conserved residues for disulfide bonding and target specificity, while maintaining the compact, stable fold essential for toxin efficacy in venom."}
{"description": "sp|A9QQ26|VA5_LYCSI Venom allergen 5 OS=Lycosa singoriensis OX=434756 PE=2 SV=1", "sequence": "MSAPVGIPSLLLALCALLCVLNAVRSAYCPDPYKRYSDQHSYCVGVCCSCAKYRRGVSPWLKKELVRLHNNLRSKVAGGKSHSVDHLPRATNMLEMVWDDELAEVAQRWSDKCERKSDCEDCRRVGRFGVGQIIFEFDGKMDGKDMENEFFSRFMALQSFRKEQVARFTAGTNPKTAQILWAKTWRIGCGFLDFNYPGNGRRYTQIVCNYGPKGNEEGEEVYKAGSVCSSCPANTCCGDACKKHNLKANYHGLCKVIDENLPPEGNVPHKKTGNEVFYCGFNDESDCRHTVEGVDRWIRNVTTGGTWLNTYLGNYGHTVIEVRSAHHLQVRQAMPGHQDPQWTHGGRTTLSVPAVRGFGGGRQILNLTHLPPCRR", "prompt": "Design a venom allergen protein from the venom of the wolf spider Lycosa singoriensis, specifically belonging to the Venom Allergen 5 family. This protein should function as a potent allergen capable of inducing IgE-mediated hypersensitivity reactions in susceptible individuals. The protein should adopt the characteristic three-dimensional fold of the CAP superfamily (cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins), featuring a conserved structural architecture with a central β-sheet core surrounded by α-helices and stabilized by multiple disulfide bonds. The molecular surface should display specific epitopes that facilitate recognition by the immune system, leading to allergic sensitization and potential anaphylactic responses. The protein should exhibit stability in the venom matrix and maintain its allergenic properties upon exposure to mammalian systems."}
{"description": "sp|J3SBP0|SL9A_CROAD C-type lectin 9a OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADFDCPSGWSAYDQYCYKPFNEPQNWDDAERFCSEQAKGGHLVSIESDGEADFVAQLAQKIDKPDIYIWIGLRVQGKEQQCSSEWSDGSSIIYVNWNKGESQMCQGLTRWTNFLKWDYTDCQAKKPFVCKFPPEC", "prompt": "Design a novel C-type lectin domain-containing protein from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent anticoagulant toxin. This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The protein should feature key structural elements including an N-terminal alpha-helix followed by two antiparallel beta-sheets forming the core scaffold. Incorporate specific carbohydrate-recognition motifs that enable binding to coagulation factors, particularly targeting components of the coagulation cascade such as factor X or factor IX. The molecular mechanism should involve interference with the coagulation pathway through either direct enzyme inhibition or disruption of coagulation complex formation. The protein should exhibit the typical oligomeric state observed in snake venom C-type lectins, potentially forming heterodimeric complexes that enhance target specificity and binding affinity. Ensure the structural integrity maintains the calcium-binding site characteristics of C-type lectins, which is crucial for proper folding and functional activity in disrupting hemostasis through anticoagulant effects."}
{"description": "sp|P85012|CA1F_CONRE Alpha-conotoxin-like Reg1f OS=Conus regius OX=101314 PE=1 SV=1", "sequence": "DYCCRRPPCTLIC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus regius, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore residues responsible for receptor binding and selectivity, while maintaining the typical 12-18 amino acid length with appropriate inter-cysteine loop sizes. The structural core should exhibit the hallmark alpha-helical elements and beta-turn motifs that define this toxin family, ensuring proper folding and stability in the venom environment. The resulting protein should demonstrate high affinity for its target nAChR subtypes while exhibiting the rapid onset and reversibility typical of conotoxin-mediated neuromuscular effects."}
{"description": "sp|P19651|NA21_STIHL Delta-stichotoxin-She1a OS=Stichodactyla helianthus OX=6123 PE=1 SV=1", "sequence": "AACKCDDEGPDIRTAPLTGTVDLGSCNAGWEKCASYYTIIADCCRKKK", "prompt": "Design a novel sea anemone toxin protein sequence based on the delta-stichotoxin family from Stichodactyla helianthus (sun anemone). This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting site 3 on the alpha-subunit to inhibit channel inactivation and prolong action potentials. The protein should adopt the characteristic sea anemone toxin structural fold featuring a compact beta-sheet core stabilized by three conserved disulfide bridges in a C1-C4, C2-C5, C3-C6 connectivity pattern. Incorporate key functional residues for sodium channel binding, including conserved aromatic and basic residues that interact with the channel's S3-S4 loop in domain IV. The sequence should maintain the typical 46-49 amino acid length with high beta-strand content and minimal helical regions. Ensure the toxin exhibits the hallmark pharmacological profile of type 1 sea anemone toxins - causing persistent sodium current and producing neurotoxic effects through delayed repolarization in excitable tissues."}
{"description": "sp|H9M5U4|VM2_CRORU Disintegrin rubistatin (Fragment) OS=Crotalus ruber ruber OX=8736 PE=2 SV=1", "sequence": "NPCCDAATCKMRPGSQCAEGLCCDQCRFMKKGTVCRVSMVDRNDDTCTGLSADCPRNGLYG", "prompt": "Design a functional disintegrin protein fragment derived from the venom of the red diamond rattlesnake (Crotalus ruber ruber). This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The disintegrin should contain the canonical RGD (Arg-Gly-Asp) tripeptide motif that serves as the primary integrin-binding interface, allowing it to compete with extracellular matrix proteins for integrin binding sites. The protein should adopt the characteristic disintegrin fold stabilized by multiple disulfide bridges, typically featuring a compact, globular structure with the RGD motif presented in an exposed loop conformation for optimal receptor accessibility. The structural scaffold should ensure high affinity and specificity for integrin receptors involved in hemostasis and thrombosis pathways, making this protein a potential candidate for anti-thrombotic applications. The sequence should reflect the evolutionary optimization of rattlesnake venom components for rapid disruption of blood coagulation through precise molecular targeting of key adhesion receptors."}
{"description": "sp|P0CAS7|PA2BG_CRODU Basic phospholipase A2 F17 OS=Crotalus durissus terrificus OX=8732 PE=1 SV=1", "sequence": "HLLQFNKMLKFETRKNAVPFYAFGCYCGWGGQRRPKDATDRCCFVHDCCYEKVTKCNTKWDFYRYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNEYMFYPDSRCREPSETC", "prompt": "Design a basic phospholipase A2 toxin from the venom of the South American rattlesnake, Crotalus durissus terrificus. This enzyme should function as a potent phospholipase A2 that catalyzes the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids. The protein should exhibit the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should possess the typical disulfide bond pattern common to snake venom phospholipases A2, stabilizing the compact globular structure. The toxin should demonstrate membrane-disrupting activity through its phospholipid hydrolysis, potentially contributing to myotoxic, neurotoxic, or anticoagulant effects characteristic of rattlesnake venom phospholipases. The structural scaffold should include the conserved pancreatic loop and the hydrophobic substrate-binding channel that accommodates phospholipid substrates. The protein should maintain the characteristic interfacial activation properties when interacting with membrane surfaces."}
{"description": "sp|P0C837|COW_CONST Contryphan-S OS=Conus striatus OX=6493 PE=1 SV=1", "sequence": "MEKLTILVLVAAVLLSTQVMVQGDADQPADRDAVPRDDNAGGTDGKFMNVQRRSGCPWEPWCG", "prompt": "Design a novel peptide toxin sequence inspired by the contryphan family from the venom of Conus striatus, the striated cone snail. This peptide should function as a potent neurotoxin that modulates neuronal excitability by selectively targeting voltage-gated calcium channels or other ion channels involved in synaptic transmission. The sequence must adopt the characteristic contryphan structural scaffold, featuring a compact, disulfide-stabilized globular fold with a conserved cysteine framework (typically CC-C-C) that forms two disulfide bridges, creating a rigid, stable conformation. The peptide should include a post-translational modification such as a tryptophan residue that is D-configured or a proline residue that is hydroxylated, which are hallmarks of contryphans and critical for their biological activity and receptor binding specificity. The overall structure should be small, ranging from 7 to 12 amino acids, with a high density of disulfide bonds that confer exceptional stability and resistance to proteolytic degradation. The molecular target is likely to be Cav2.2 (N-type) voltage-gated calcium channels or related ion channels, where the toxin binds with high affinity to inhibit channel function, leading to disrupted neurotransmitter release and paralysis in prey. The venom of Conus striatus is evolutionarily optimized for rapid immobilization of fish, and this toxin should reflect that ecological role by exhibiting fast-acting, reversible ion channel modulation. Ensure the sequence includes conserved residues that define the contryphan pharmacophore, such as a cyclic structure facilitated by disulfide bonds and modified amino acids that enhance target engagement and potency."}
{"description": "sp|P86862|VKT1_ANTEL KappaPI-actitoxin-Ael3a OS=Anthopleura elegantissima OX=6110 PE=1 SV=1", "sequence": "INSICLLPKKQGFCRARFPRFYYNSSTRRCEMFYYGGCGGNANNFNTLEECEKVCLGYGEAWKAP", "prompt": "Design a protein sequence for a potassium channel toxin derived from the sea anemone Anthopleura elegantissima. This toxin belongs to the kappaPI-actitoxin family and functions as a potent neurotoxin that specifically targets and blocks voltage-gated potassium channels (Kv channels). The toxin should adopt a compact, globular fold stabilized by a conserved disulfide bond framework characteristic of sea anemone toxins, likely involving three disulfide bridges arranged in a specific connectivity pattern that confers structural stability and target specificity. The molecular mechanism involves high-affinity binding to the pore region or voltage-sensing domain of Kv channels, leading to inhibition of potassium efflux, prolonged neuronal depolarization, and disruption of action potential repolarization. This results in enhanced neurotransmitter release and potential paralysis in prey organisms. The structural scaffold should feature a well-defined core with surface-exposed loops and residues critical for channel interaction, including conserved hydrophobic and basic residues that mediate binding to the channel's extracellular vestibule. The toxin should exhibit the typical thermostability and protease resistance associated with disulfide-rich sea anemone peptides, ensuring functional integrity in the venom cocktail used for prey immobilization and defense."}
{"description": "sp|P58570|SC18_OLIMR Neurotoxin BmK 18(2) (Fragment) OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "VRDAYIAEDYDCVYHCARDA", "prompt": "Generate the complete amino acid sequence for a neurotoxin from the scorpion Olivierus martensii (formerly Buthus martensii), specifically the BmK 18(2) variant. This toxin belongs to the long-chain scorpion toxin family targeting voltage-gated sodium channels. It functions as a potent modulator of neuronal excitability by binding to site 3 on voltage-gated sodium channels (Nav channels), particularly Nav1.2, Nav1.3, and Nav1.6 isoforms in the central nervous system. The toxin delays sodium channel inactivation, leading to prolonged action potentials and neuronal hyperexcitability that manifests as convulsive neurotoxicity. Structurally, it adopts the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion neurotoxins, featuring a compact core stabilized by four disulfide bridges with a C-C-CC-C-C pattern. The molecule consists of a short alpha-helix packed against an antiparallel beta-sheet, with key functional residues concentrated in the 'core' and 'NC' domains that form the receptor binding interface. The toxin should contain approximately 60-70 amino acids with the characteristic scorpion toxin signature pattern, including conserved cysteine residues for proper disulfide bonding and structural stability. The sequence should reflect the specific pharmacological profile of BmK toxins that preferentially affect mammalian neuronal sodium channels while maintaining the structural integrity required for proper folding and biological activity."}
{"description": "sp|B3A0N1|VPA_BOTAT Venom prothrombin activator (Fragment) OS=Bothrops atrox OX=8725 PE=1 SV=1", "sequence": "ALVLIAFAQVLQQCP", "prompt": "Design a venom-derived protein sequence that functions as a prothrombin activator, originating from the venom of Bothrops atrox, a highly venomous pit viper. This toxin plays a critical role in the snake's predatory and defensive strategy by inducing severe coagulopathy in prey through the direct activation of prothrombin to thrombin, bypassing the physiological coagulation cascade and leading to uncontrolled fibrin formation and disseminated intravascular coagulation. The protein should exhibit metalloproteinase characteristics, likely containing a catalytic zinc-binding motif (HEXXHXXGXXH) within a reprolysin-like metalloproteinase domain, which cleaves prothrombin at specific sites to generate active thrombin. The structural scaffold should feature a multi-domain architecture typical of snake venom metalloproteinases, including a propeptide domain, a catalytic metalloproteinase domain with a conserved methionine turn, and potentially ancillary domains that enhance substrate recognition and binding efficiency. The cysteine framework should support multiple disulfide bridges that stabilize the metalloproteinase fold and maintain the integrity of the active site cleft. The molecular target is prothrombin (Factor II), with specific binding interfaces that recognize and cleave the activation peptide region of prothrombin to yield thrombin, thereby directly promoting coagulation and contributing to the hemorrhagic and procoagulant effects characteristic of Bothrops envenomation."}
{"description": "sp|Q95WD3|SCXX_CENSC Neurotoxin E1x OS=Centruroides sculpturatus OX=218467 PE=2 SV=1", "sequence": "MNSLLMITACLVVIGTVWAKEGYLVDVKGCKKNCWKLGDNDYCNRECKWKHIGGSYGYCYGFGCYCEGLPDSTQTWPLPNKTCGKK", "prompt": "Design a neurotoxin protein sequence that mimics the biological activity and structural characteristics of Neurotoxin E1x from the venom of the Arizona bark scorpion (Centruroides sculpturatus). This toxin functions as a potent voltage-gated sodium channel (Nav) modulator, specifically targeting and binding to site 4 on the alpha-subunit of neuronal sodium channels. The mechanism involves slowing or inhibiting channel inactivation, leading to prolonged neuronal depolarization, repetitive firing, and ultimately neuroexcitatory effects that cause severe envenomation symptoms. The protein should adopt the conserved structural fold typical of scorpion beta-toxins, characterized by an inhibitor cystine knot (ICK) motif stabilized by a specific disulfide bridge pattern (cysteine framework I/II: C1-C4, C2-C5, C3-C6). Key structural elements include a conserved alpha-helix and a triple-stranded beta-sheet, with critical residues in the 'core' and 'NC' domains forming the molecular interface for high-affinity binding to Nav channels. The sequence must ensure proper folding into this compact, stable globular structure to maintain target specificity and potent neurotoxic activity."}
{"description": "sp|P60214|SCX1_TITOB Beta-mammal/insect toxin To1 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MTRFVLFISCFFLIDMIVECKKEGYLVGNDGCKYGCITRPHQYCVHECELKKGTDGYCAYWLACYCYNMPDWVKTWSSATNKCKGK", "prompt": "Design a beta-toxin protein from the venom of the Brazilian scorpion Tityus obscurus, specifically targeting both mammalian and insect voltage-gated sodium channels. This toxin should function as a beta-toxin, binding to site 4 on the voltage sensor of domain II of sodium channels and modifying channel gating by shifting the voltage dependence of activation toward more negative potentials, thereby enhancing channel excitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, featuring a compact globular structure stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved alpha-helix packed against an antiparallel beta-sheet, with the functional residues concentrated in the 'pharmacophore' region comprising loops between the secondary structure elements, particularly the loops connecting the beta-strands, which are critical for receptor recognition and binding specificity. The toxin should exhibit selective activity against both mammalian neuronal and insect sodium channels, contributing to the venom's dual defensive and predatory roles by causing paralysis through sustained neuronal excitation. Ensure the sequence maintains the conserved scaffold and pharmacophore residues necessary for beta-toxin function while allowing for species-specific interactions."}
{"description": "sp|P79799|VNP32_MICCO Natriuretic peptide Mc-NP OS=Micrurus corallinus OX=54390 PE=2 SV=1", "sequence": "MVGLSRLRGGGLLLVLALLPLALDGKPLEEAPTAPSRIIPFSRPVRKQSQAVLDPMVHPERPAGSGDDGDSRRLEGLAKEALGDGCFGQRIDRICNVSGMGCNHVRTDPAPTALARIIPFSRPVRKESRAALDRMQQPG", "prompt": "Design a natriuretic peptide toxin from the venom of the coral snake Micrurus corallinus. This peptide should function as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) in cardiovascular tissues. The peptide should adopt a conserved natriuretic peptide fold characterized by a central alpha-helical domain stabilized by a conserved disulfide bridge pattern (typically Cys1-Cys6, Cys2-Cys5, or similar arrangement depending on the specific natriuretic peptide family). The structural scaffold should feature a characteristic ring structure formed by the disulfide bonds, which is essential for receptor recognition and binding. Key functional residues should include conserved aromatic and hydrophobic residues that interact with the NPR-A receptor binding pocket, as well as charged residues that facilitate receptor activation. The mechanism of action involves binding to NPR-A, stimulating guanylyl cyclase activity, increasing intracellular cGMP levels, and promoting vasodilation, natriuresis, and diuresis. This contributes to the coral snake's envenomation syndrome by causing hypotension and cardiovascular collapse. The peptide should exhibit the characteristic biological activity of venom natriuretic peptides: potent vasorelaxation, inhibition of angiotensin II-induced vasoconstriction, and modulation of fluid-electrolyte balance. The structural design should prioritize receptor specificity while maintaining the compact, stable fold typical of venom-derived natriuretic peptides."}
{"description": "sp|P0C8E0|CKP1_CONPI Conantokin-Pr1 OS=Conus parius OX=505247 PE=1 SV=1", "sequence": "GEDEYAEGIREYQLIHGKI", "prompt": "Design a protein sequence for a conantokin neuropeptide derived from the venom of Conus parius, a marine cone snail. This toxin functions as a selective and potent antagonist of NMDA (N-methyl-D-aspartate) receptors, specifically targeting the glutamate-binding site to modulate excitatory neurotransmission. The protein should adopt a gamma-carboxyglutamate (Gla)-rich structure, characterized by multiple post-translationally modified glutamic acid residues that chelate calcium ions, facilitating receptor interaction. The sequence is expected to be relatively short, linear, and devoid of disulfide bridges, distinguishing it from the cysteine-rich frameworks typical of other conotoxins. It should exhibit a flexible, extended conformation that enables precise docking into the NMDA receptor's ligand-binding domain, thereby inhibiting ion channel activation and providing a mechanism for neurological disruption in prey. The biological significance lies in its role in the venom's strategy to immobilize small fish through targeted interference with central nervous system signaling pathways."}
{"description": "sp|P0CY60|O171_CONBU Omega-conotoxin-like Bu1 OS=Conus bullatus OX=89438 PE=2 SV=1", "sequence": "MKLTCVAIVAVLLLTACQLITAEDSRGTQLHRALRKTTKLSVSTRCKGPGAKCLKTMYDCCKYSCSRGRC", "prompt": "Generate the amino acid sequence for a marine cone snail venom peptide that functions as a potent calcium channel blocker. This peptide originates from Conus bullatus and belongs to the omega-conotoxin family, specifically targeting voltage-gated calcium channels (VGCCs) in the peripheral nervous system. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C-C-CC-C-C connectivity pattern. Its mechanism involves high-affinity binding to the pore-forming alpha1 subunit of N-type calcium channels (Cav2.2), effectively blocking calcium influx and inhibiting neurotransmitter release at presynaptic terminals, leading to paralysis in prey organisms. The sequence should include the characteristic cysteine framework of omega-conotoxins and maintain the structural determinants necessary for selective interaction with neuronal calcium channels while excluding any non-biological identifiers."}
{"description": "sp|Q95WD2|SCE3_CENSC Beta-toxin CsE3 OS=Centruroides sculpturatus OX=218467 PE=2 SV=1", "sequence": "MNSLLIIAACLALIGTVWAKEGYIVNYHTGCKYECFKLGDNDYCLRECKLRHGKGSGGYCYAFGCWCTHLYEQAVVWPLPKKKCNGK", "prompt": "Design a beta-toxin protein sequence from the venom of the Arizona bark scorpion (Centruroides sculpturatus) that functions as a voltage-gated sodium channel (Nav) modulator. This toxin should specifically target insect sodium channels, exhibiting potent excitatory neurotoxicity through modification of channel gating kinetics. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The structure should display the typical triple-stranded antiparallel beta-sheet stabilized by an alpha-helix running parallel to the beta-sheet, creating the functional surface responsible for receptor site 4 binding on voltage-gated sodium channels. The molecular mechanism involves trapping the voltage-sensing domain in an activated state, leading to prolonged channel opening and repetitive neuronal firing that causes paralysis in insect prey. The protein should contain approximately 60-70 amino acids with the conserved structural core and functional residues necessary for specific sodium channel recognition and modulation."}
{"description": "sp|W4VRX8|ICK12_TRILK Toxin ICK-12 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKSIVYMLLFCTFTVVILGHPNDHGALIPYRAEKLPNGEWCIRPGYSCSERGQCCMPVDGDTYTYGCGRAWSEGSKVCFICNRESSMC", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications: The toxin originates from the venom of Trittame loki, a spider species whose venom components typically function to immobilize prey through neurotoxic mechanisms. This toxin belongs to the Inhibitor Cystine Knot (ICK) structural family, specifically designated as ICK-12, indicating it possesses the characteristic ICK fold stabilized by a conserved disulfide bridge pattern. The ICK motif consists of a compact, triple-stranded beta-sheet structure constrained by a knotted arrangement of three disulfide bonds with the connectivity C1-C4, C2-C5, C3-C6, forming a rigid, protease-resistant scaffold. Key structural elements include a conserved hydrophobic core, exposed loops between cysteine residues that often mediate target interactions, and a stable globular fold resistant to denaturation. The toxin likely functions as a modulator of ion channels, potentially targeting voltage-gated sodium, potassium, or calcium channels, leading to disruption of neuronal signaling and paralysis. The molecular mechanism involves high-affinity binding to specific extracellular domains of ion channels, altering gating kinetics or blocking ion permeation. Design the sequence to include: (1) the canonical ICK cysteine framework with six cysteines forming three disulfide bonds in the C1-C4, C2-C5, C3-C6 pattern, (2) conserved hydrophobic residues in the core for structural stability, (3) solvent-exposed loops with residues suitable for target recognition (e.g., positively charged or aromatic residues for channel binding), (4) a length of approximately 30-40 amino acids typical for ICK toxins, and (5) physicochemical properties consistent with venom peptides, including stability and disulfide-dependent folding. Ensure the sequence reflects the evolutionary constraints of spider venom toxins, prioritizing functional efficacy in neurotoxic activity."}
{"description": "sp|P70089|PA2H7_CRAGM Basic phospholipase A2 homolog 7 OS=Craspedocephalus gramineus OX=8767 PE=3 SV=1", "sequence": "MRTLWLMAVLLVGVEGGVIELTKMIVQEMGKNALTSYSLYGCNCGPGGRRKPMDATDSCCYVHKCCYKKLTDCDPIKDRYSYSWVNKAIVCGEKNPHLKELCECDKAVAICFRENMDTYDKKKKINLKLFCKKTSEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the bamboo pit viper, Craspedocephalus gramineus. This protein should function as a venom PLA2 homolog, which typically exhibits reduced or altered enzymatic activity compared to catalytically active PLA2s while retaining key structural features. The sequence should adopt the characteristic phospholipase A2 fold, consisting of three major alpha-helices stabilized by a conserved network of disulfide bridges. The anticipated disulfide connectivity pattern should follow the canonical PLA2 framework with multiple conserved cysteine pairs forming the structural core. The protein should possess basic properties that may facilitate interactions with anionic membrane surfaces or specific molecular targets. While the exact toxic mechanism may vary among PLA2 homologs, the structural scaffold should maintain the essential features for potential membrane association or receptor binding interactions common in snake venom PLA2-derived proteins. The overall architecture should preserve the compact, stable globular structure typical of secreted phospholipase A2 proteins, with surface features optimized for its role in the complex venom mixture of this viper species."}
{"description": "sp|P29601|PA2HA_BUNFA Acidic phospholipase A2 homolog OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "NMVQFKSMVQCTSTRPWLDYVDYGCNCDIGGTGTPLDELDRCCQTHANCYTEARKFPECAPYYKTYSYTCSGGTITCNADNDECAASVCNCDRTAALCFAGAPYNQNNFDVDLETRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 homolog from the venom of the banded krait (Bungarus fasciatus). This protein should function as a venom component with phospholipase A2-like structural characteristics but likely exhibits modified or alternative toxic activities rather than canonical phospholipase enzymatic function. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved disulfide bridge pattern typical of group I phospholipase A2 toxins. Key structural elements should include the calcium-binding loop, the conserved catalytic network (though potentially inactive in this homolog), and the interfacial binding surface for membrane association. The protein should maintain the characteristic acidic pI and surface charge distribution that distinguishes it from enzymatically active phospholipases. The molecular mechanism may involve presynaptic neurotoxicity through binding to neuronal membranes or specific receptors, potentially disrupting neurotransmitter release. The structural scaffold should preserve the overall globular fold with the characteristic phospholipase A2 active site architecture, while sequence variations may confer distinct target specificity or modified biological activity compared to catalytically active phospholipases."}
{"description": "sp|A0S864|3NBA_BOIIR Irditoxin subunit A OS=Boiga irregularis OX=92519 PE=1 SV=1", "sequence": "MKTLLLAVAVVAFVCLGSADQLGLGRQQIDWGQGQAVGPPYTLCFECNRMTSSDCSTALRCYRGSCYTLYRPDENCELKWAVKGCAETCPTAGPNERVKCCRSPRCNDD", "prompt": "Design a protein sequence for the A subunit of Irditoxin, a potent heterodimeric neurotoxin from the brown tree snake (Boiga irregularis). This toxin functions as a presynaptic phospholipase A2 neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release and leading to flaccid paralysis in prey. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic triad essential for enzymatic activity. It should contain the typical disulfide bridge pattern of group II phospholipase A2 toxins (C-C-C-C-C-C connectivity) that stabilizes the globular structure. The sequence must include key functional residues for membrane binding, substrate recognition, and catalytic hydrolysis of phospholipids. As part of the heterodimeric complex, this subunit should contain interface regions for association with the B subunit to form the complete neurotoxic complex. The protein should exhibit high specificity for presynaptic membranes at neuromuscular junctions, with structural features optimized for membrane penetration and phospholipid substrate access to the catalytic site."}
{"description": "sp|P0C8E1|CKP2_CONPI Conantokin-Pr2 OS=Conus parius OX=505247 PE=1 SV=1", "sequence": "DEPEYAEAIREYQLKYGKI", "prompt": "Design a protein sequence for a conantokin toxin from the marine cone snail Conus parius. This toxin should function as a selective antagonist of NMDA-type glutamate receptors, specifically targeting the NR2B subunit. The protein should adopt the characteristic conantokin structural fold, which is defined by a high degree of gamma-carboxyglutamic acid (Gla) residues that chelate calcium ions and stabilize an alpha-helical conformation. The sequence should lack disulfide bridges, distinguishing it from other conotoxins, and instead rely on post-translational modifications for structural integrity. The mechanism of action involves competitive inhibition at the glutamate binding site of NMDA receptors, leading to modulation of neuronal excitability and potential analgesic effects. The structural scaffold should feature a compact, helical bundle stabilized by metal ion coordination, with surface residues optimized for specific interaction with the NR2B subunit's ligand-binding domain."}
{"description": "sp|W4VS12|ICK35_TRILK U17-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTIIVFLSLLVLATKFGDANEGVNQEQMKEVIQNEFREDFLNEMAAMSLLQQLEAIESTLLEKEADRNSRQKRCLGENVPCGDFPCCGKLVCQKTFGYGWLYKSPYCVKPSNG", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the Australian tarantula Trittame loki. This toxin should function as a potent insecticidal peptide, specifically targeting the central nervous system of insect prey. The protein must adopt the inhibitory cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges forming the characteristic 'knot' topology (C1-C4, C2-C5, C3-C6 connectivity). The sequence should include key residues for interaction with voltage-gated sodium channels in insect neurons, promoting channel opening and inducing prolonged depolarization that leads to paralysis. Incorporate conserved hydrophobic patches and surface-exposed basic residues that facilitate membrane association and target specificity. The overall structure should be thermostable and protease-resistant, typical of ICK-fold toxins, with a molecular weight around 3-5 kDa. Ensure the sequence maintains the hallmark cysteine spacing pattern of the ICK family while introducing unique loop variations that confer species-selective insecticidal activity without affecting mammalian ion channels."}
{"description": "sp|P30288|TX23A_AGEAP Omega-agatoxin-Aa4a OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA", "prompt": "Design a protein sequence for a highly potent neurotoxin from the funnel-web spider Agelenopsis aperta that functions as a selective calcium channel blocker. This toxin should belong to the omega-agatoxin family and specifically target P/Q-type voltage-gated calcium channels (Cav2.1) in the mammalian central nervous system. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves high-affinity binding to the voltage-sensing domain of Cav2.1 channels, effectively blocking neurotransmitter release at presynaptic terminals and causing rapid neuromuscular paralysis. Key structural elements should include surface-exposed loops critical for channel recognition and binding specificity, with conserved hydrophobic and basic residues that mediate target interaction. The toxin should exhibit the typical thermal and proteolytic stability conferred by the ICK scaffold, making it evolutionarily optimized for rapid prey immobilization through disruption of synaptic transmission."}
{"description": "sp|A0A6B7FMR5|VMMP3_VIPAA Disintegrin-like/cysteine-rich protein MPIII-3 OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "MIQVLLVIICLAVFPYQVSSIILESGNINNYEVVYPQKVTALPKGAIQQLEQKYEDAMQYQFKVKGEPVVLHLEKNKDFFPEDYSETHYSPDDREITTNPPVEDHCYYYGHIQNDADSTASISACNGLKGYFTLRGVTYLIEPLKIPESEAHAIYKYENVEKEDEDPKKCEFRRAGTECRPARSECDVAEYCTGQSAECPTDVFHSNGKPCLNNFGYCYNGNCPIMYHQCYALFGPNATVGQDGCFEWNKKGESYFYCRKENDVPIPCAPEDIKCGRLFCELIKNTCKYDYSEDPDYGMVDHGTKCGDGKVCINRHCVDVTTAY", "prompt": "Design a novel disintegrin-like/cysteine-rich venom protein inspired by the viperid snake Vipera ammodytes ammodytes. This protein should exhibit the characteristic structural and functional properties of snake venom metalloproteinase (SVMP) class P-III components. The sequence must encode a multi-domain architecture comprising: (1) a propeptide domain that undergoes proteolytic activation, (2) a metalloproteinase catalytic domain with a conserved zinc-binding motif (HEXXHXXGXXH) embedded within a metzincin-type fold, (3) a disintegrin-like domain featuring the canonical RGD or related integrin-binding motif within an extended loop structure stabilized by disulfide bonds, and (4) a cysteine-rich C-terminal domain that contributes to protein stability and target recognition. The mature protein should adopt a compact, globular conformation stabilized by an extensive network of disulfide bridges characteristic of SVMP P-III proteins, typically containing 12-16 conserved cysteine residues forming 6-8 disulfide bonds. The functional profile should include potent inhibition of platelet aggregation through blockade of αIIbβ3 integrin receptors on thrombocytes, disruption of cell-matrix interactions via interference with αvβ3 and α5β1 integrins on endothelial and smooth muscle cells, and potential modulation of inflammatory responses through interactions with leukocyte integrins. The structural scaffold should facilitate high-affinity binding to extracellular matrix components while maintaining the metalloproteinase zymogen's latency until activated by specific proteolytic cleavage."}
{"description": "sp|P20146|PA2A_NOTSC Acidic phospholipase A2 OS=Notechis scutatus scutatus OX=70142 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGAASIPPLPLNVAQFDNMIECANYGSRPSWHYMEYGCYCGKEGSGTPVDELDRCCKAHDDCYTEAEKRRCHPKFSAYSWKCGSDGPTCDPETGCKRTVCDCDATAAKCFAKAPFNQANWNIDTETHCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the tiger snake, Notechis scutatus scutatus. This enzyme should exhibit potent neurotoxic and myotoxic activity through hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids that disrupt cellular membranes. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YXCGXGG motif) and catalytic histidine-aspartate dyad. Include the essential structural features: multiple disulfide bridges (typically 6-7 conserved cysteines) that stabilize the compact globular structure, an interfacial binding surface for membrane association, and the characteristic pancreatic loop. The toxin should demonstrate preferential activity toward neuronal and muscle cell membranes, contributing to the venom's paralytic and tissue-damaging effects. Ensure the sequence maintains appropriate surface charge distribution consistent with its acidic nature while preserving the catalytic efficiency and membrane-targeting capabilities essential for its toxic function."}
{"description": "sp|Q8LW54|MELS_APICE Melittin OS=Apis cerana OX=7461 GN=MELT PE=1 SV=1", "sequence": "MKFLVNVALVFYGRVHFLHLCVHFLHLWAPEPEPAPEAEAEADAEADPEAGIGAVLKVLTTGLPALISWIKRKRQQG", "prompt": "Design a novel peptide toxin based on the melittin scaffold from the Asian honey bee (Apis cerana), a key component of hymenopteran venom with potent cytolytic and hemolytic activity. This amphipathic 26-amino acid peptide should adopt a predominantly alpha-helical conformation in membrane environments, characteristic of the melittin family. The peptide must exhibit strong membrane-disrupting properties through a detergent-like mechanism, forming toroidal pores in lipid bilayers that lead to cell lysis. It should demonstrate preferential binding to anionic phospholipids and cholesterol-rich membranes, with broad-spectrum activity against various cell types. The structure should maintain the characteristic N-terminal hydrophobic domain and C-terminal hydrophilic region that enables its amphipathic nature. The peptide should be water-soluble in its monomeric form but readily transition to tetrameric pore-forming complexes upon membrane association. Incorporate key residues responsible for its hemolytic activity, antimicrobial properties, and mast cell degranulation effects while maintaining the overall structural integrity required for membrane insertion and pore formation."}
{"description": "sp|B2KKW0|A22_LOXIN Dermonecrotic toxin LiSicTox-alphaII2 OS=Loxosceles intermedia OX=58218 PE=2 SV=1", "sequence": "MLLRIALILGCWSILSEGAENDIAEREDRKRPIWNMAHMVNAISQIHEFGALGANSIETDVSFDKNAKPEYTFHGIPCDCFRNCMNWEYFNHFLEGLRNATTPGNPKYRDRMILVVFDLKSNGLYYDAQARDAGKNLALSLLQNYWNNGDNGGRAYIVLSVPLLKHYELFQGFRETLKEQGHEELLEKVGYDFSGNDDISDIEEAYRLAGISEHIWQSDGITNCIYRGFDRVIQAVNAREKFEGIIKKVYFWTADKPSTVKLALGESVDGIMTNYPNVVVDVLKIDEYQQRFRFATIDDNPWEKYKPYGK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles intermedia. This toxin belongs to the SicTox family and functions as a phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, vascular damage, platelet aggregation, and complement activation, leading to the characteristic dermonecrotic lesions seen in loxoscelism. The protein should adopt the conserved (α/β)8 TIM barrel fold typical of SicTox family members, with the active site containing the essential catalytic residues (histidine, aspartate, and other conserved residues) arranged in the characteristic HxKx4D motif. The structure should feature the conserved disulfide bond pattern that stabilizes the TIM barrel scaffold. The toxin should exhibit specific membrane-binding domains that target endothelial cells and erythrocytes, with surface-exposed loops that mediate substrate recognition and membrane interaction. The sequence should encode the molecular determinants for both enzymatic activity and the potent pro-inflammatory effects that underlie the severe local tissue damage characteristic of Loxosceles envenomation."}
{"description": "sp|I6R1R5|TX51A_SCOMU Omega-scoloptoxin(05)-Ssm1a OS=Scolopendra mutilans OX=2836329 PE=1 SV=1", "sequence": "MPSLCIIALFGTLTFYTLIPSIHTLKCVRCDGPMSNYDCKTTYPAAEECPSLSGGSSNYCSKKETFTSNGNLEQTRRYCNSVAAPSTACTDLKTGGKLCEYSCNTDGCNSVAGMEPTRAVYFIAILMLA", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an omega-scoloptoxin from the venom of the Chinese red-headed centipede, Scolopendra mutilans. As a member of the scoloptoxin family, it functions as a potent neurotoxin that specifically targets voltage-gated ion channels. The toxin likely exhibits inhibitory activity against potassium channels (Kv channels) or sodium channels (Nav channels), disrupting neuronal excitability and neuromuscular transmission through modulation of channel gating kinetics. The structural scaffold should feature the characteristic disulfide-stabilized fold common to centipede venom peptides, with a conserved cysteine framework (typically CC-C-C or similar pattern) that forms disulfide bridges essential for structural stability and functional integrity. The 3D structure is anticipated to comprise a compact, globular domain stabilized by these disulfide bonds, facilitating precise interaction with the extracellular pore region or voltage-sensing domains of the target ion channels. The biological significance lies in its role in prey immobilization and defense, contributing to the venom's efficacy in subduing insects or small vertebrates. Ensure the sequence reflects high specificity for its molecular target, with surface residues optimized for binding affinity and minimal off-target effects."}
{"description": "sp|Q6B4T4|TX2_LOXIN U1-sicaritoxin-Li1b OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MKLLFEGLLVLVLIAFVVAEFESDAEKWEALITQERACKGEGVKGCYYEADDWCCKKTPCKCPAWSHERECRCTQPCNPSCRGKRALMVDPETHRMLSLHRLSEE", "prompt": "Design a protein sequence for a sphingomyelinase D toxin from the brown spider Loxosceles intermedia. This toxin should function as a dermonecrotic agent that cleaves sphingomyelin to produce ceramide-1-phosphate, leading to inflammatory responses, platelet aggregation, and complement-dependent hemolysis. The protein should adopt the TIM barrel fold characteristic of the sphingomyelinase D family, with conserved catalytic residues (likely histidine and glutamic acid) in the active site that coordinate a magnesium ion for phosphodiesterase activity. Include key structural elements such as the N-terminal signal peptide for secretion, the conserved metal-binding motif, and the substrate-binding pocket that recognizes sphingomyelin headgroups. The sequence should maintain the overall structural stability required for venom toxicity while exhibiting specificity for mammalian cell membranes."}
{"description": "sp|H6VC05|VKTK1_DABRR Kunitz-type serine protease inhibitor DrKIn-I OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISGQDRPKFCNLAPESGRCRGHLRRIYYNPDSNKCEVFFYGGCGGNDNNFETRKKCRQTCGAPRKGRPT", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Russell's viper (Daboia russelii), specifically representing the DrKIn-I toxin. This protein should function as a potent serine protease inhibitor, characteristic of Kunitz-domain containing toxins in viper venoms. The protein should adopt the conserved Kunitz-type fold, featuring a stable alpha-beta structure with characteristic disulfide connectivity (typically Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 pattern) that stabilizes the inhibitory loop. The active site should contain a canonical protease-binding loop with residues optimized for specific inhibition of serine proteases involved in hemostasis, such as those in the coagulation cascade. The structural scaffold should maintain the compact, globular fold typical of Kunitz domains, approximately 50-60 amino acids in length, with the inhibitory loop positioned for optimal protease binding and inhibition. The protein should exhibit the thermostability and protease resistance characteristic of venom Kunitz inhibitors, enabling its function in the complex venom milieu to disrupt prey homeostasis through targeted protease inhibition."}
{"description": "sp|P0DPV6|TXF3A_SCODE Kappa-scoloptoxin(15)-Ssd3a OS=Scolopendra dehaani OX=2609776 PE=1 SV=1", "sequence": "MEGKIIFICFLVVLLTLPELISSEVIRKEIPYKKRKFPYKSECRKACATAFTGGDESRIKDVKPGFFKCSCYYSSG", "prompt": "Design a novel animal toxin protein sequence based on the following biological specifications: This protein is a kappa-scoloptoxin derived from the venom of the centipede Scolopendra dehaani, a large predatory arthropod whose venom contains a complex mixture of neurotoxins, enzymes, and other bioactive peptides that facilitate prey capture and defense. As a kappa-scoloptoxin, this toxin functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt a compact, stable fold stabilized by multiple disulfide bonds, characteristic of centipede venom peptides, likely featuring an inhibitor cysteine knot (ICK) motif or related scaffold with a conserved cysteine framework (e.g., C-C-CC-C-C pattern) that confers resistance to proteolytic degradation and thermal denaturation. The molecular mechanism involves high-affinity binding to the pore region or voltage-sensing domain of Kv channels, leading to prolonged action potentials, uncontrolled neurotransmitter release, and ultimately paralysis in prey organisms. The sequence should include key functional residues for target recognition and binding, such as hydrophobic patches and positively charged amino acids that interact with the channel's extracellular loops, while maintaining the structural integrity required for venom stability and potency."}
{"description": "sp|P86974|PA2BD_BOTLC Basic phospholipase A2 OS=Bothrops leucurus OX=157295 PE=1 SV=1", "sequence": "DLWQFGQMILKETGKLPFPYYTTYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLTNCKPKTDRYSYSRENGVIICGEGTPCEKQICECDKAAAVCFRENLRTYKXXYMAYPDVLCKKPAEKC", "prompt": "Design a basic phospholipase A2 toxin from the venom of Bothrops leucurus, a medically significant pit viper species. This enzyme functions as a potent myotoxic and neurotoxic agent that targets presynaptic nerve terminals, causing irreversible neuromuscular blockade through phospholipid hydrolysis. The protein should adopt the characteristic pancreatic phospholipase A2 fold with a conserved calcium-binding loop and catalytic dyad (histidine-aspartate) essential for enzymatic activity. It must contain the canonical disulfide bridge pattern (Cys1-Cys11, Cys2-Cys7, Cys3-Cys17, Cys4-Cys10, Cys5-Cys15, Cys6-Cys14) that stabilizes the globular structure. The basic nature of this isoform facilitates membrane penetration and enhances its presynaptic targeting specificity. The mature protein should exhibit high affinity for neuronal membranes and demonstrate calcium-dependent catalytic activity against phospholipids, leading to membrane disruption and neurotransmitter release inhibition."}
{"description": "sp|Q8JIY9|PA2A_PROJR Acidic phospholipase A2 jerdoxin OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGHLWQFREMIKEATGKEPLTTYLFYACYCGWGGRGEPKDATDRCCFVHDCCYGKLTACSPKLDIYSYSQKNEDIVCGGGTECEKQICECDKAAAICFLDNLGTYNKEYNNYSKSRCIEESPKC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Protobothrops jerdonii (Jerdon's pit viper). This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer structural stability in the venom environment. As an acidic isoform, it should exhibit optimal activity at lower pH ranges and may function synergistically with other venom components to enhance overall toxicity. The enzyme should contain the conserved calcium-binding loop (YXCGXGG) essential for catalytic activity and the interfacial binding surface that facilitates interaction with lipid membranes. Key functional residues should include the catalytic histidine-aspartate dyad and the conserved tyrosine involved in substrate binding. The protein should demonstrate preferential activity against specific phospholipid substrates and may exhibit additional toxic effects such as myotoxicity, neurotoxicity, or anticoagulant properties through indirect mechanisms. The structural scaffold should maintain the characteristic phospholipase A2 globular fold with a hydrophobic channel leading to the active site, ensuring efficient membrane penetration and substrate access in envenomation scenarios."}
{"description": "sp|Q5G290|PA2A6_NAJSG Acidic phospholipase A2 6 (Fragment) OS=Naja sagittifera OX=195058 PE=1 SV=1", "sequence": "SNRPMPLNIKQFNNMIQCTVPARSWWDFADYGCYCGSGSGSPVDDLDRCCQVHDNCYNAGGGVTGCAPKSKTYTYECSQGTLTCSGENSACAATVCDCDRLAAICFAGAPYNDNNYNIDLKSRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from the venom of the banded cobra, Naja sagittifera. This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer exceptional thermal and pH stability. Key catalytic residues should include a conserved histidine-aspartate dyad in the active site, along with a calcium-binding loop essential for enzymatic activity. The acidic nature of this toxin (low pI) enhances its presynaptic targeting specificity while reducing myotoxicity compared to basic isoforms. The mechanism involves binding to specific presynaptic membrane receptors via a conserved beta-wing region, followed by hydrolysis of phospholipids in the presynaptic membrane, disrupting vesicle fusion and neurotransmitter release. The structural scaffold should maintain the characteristic phospholipase A2 globular fold with a hydrophobic channel leading to the catalytic site, and surface-exposed loops that mediate target recognition while preserving the characteristic low isoelectric point through strategic acidic residue placement."}
{"description": "sp|Q98993|VTXB_SYNVE Verrucotoxin subunit beta OS=Synanceia verrucosa OX=51996 PE=1 SV=3", "sequence": "MPSDILVVAALGRPFTLGMLYDARNDKLIPGFTLWEDEVIEESTVESSQPSSAFEIIASDSIDDKSSLMEIEASLKASFLGGLVEVGGSAKYLNNQKKFKNQSRVTLQYKATTNFKQLMTNLGTKHVEYSELFENIQATHVVIGILYGANAFFVFDSNKVDSTNVQEIQGQMEAVIKKIPSVEISGKASVQLTSEETDITNSFSCEFHGDFFLTSNPTTFEDAVKTYQQLPQMMGKDNAVPMTVWLVPMVNFYSEAPQLMADSSTPILRKVRNTLEAIVQVQMRCNDALDDPTVNLFTEVQKKLSDFQIICDDHMSKLQATIAKKLFAIRSGDEDESALVNLFEENLQSPFNTESLNMWMEFEEREINVLKSCMDILTKAKPKVIFNQGVLFKELYDSKVKHGLCYVFTNVTKNDDFLTVLNDFLDSPQSRPKKLRPSPKDYWYSYDDIPEMMREKAHLFRNLAKEMNNRCVHFFVTAINNPKQEGAGIHYYRESIQIIHEFTKPHMPGVETIKDRRELQWYDCELTLDTETAHQVLTLSEGNKRQCRGVRVTRRSLREFSHFQQVMCHQGAEWTPLLGVRVAGHVSAGVTYKGISRKTSTPDSSLGKNQKSWVFEYTKKSGYQQIHNGKNARVTVSSIGFKQLGVYLDWPAGTLSFYIGQQSLGDSSPHLPHQILRGCLSSLPDWGCTTESQWSN", "prompt": "Design a protein sequence for the beta subunit of verrucotoxin, a potent cytolysin from the stonefish Synanceia verrucosa. This toxin functions as a pore-forming protein that creates transmembrane channels in target cell membranes, leading to osmotic lysis and cell death. The beta subunit works in concert with the alpha subunit to form the complete holotoxin, which exhibits hemolytic, cytotoxic, and potentially cardiotoxic activities characteristic of stonefish venom. The protein should adopt a conserved structural fold typical of actinoporin-like toxins, featuring a core beta-sandwich domain stabilized by multiple disulfide bridges. The sequence should include key membrane-binding regions with amphipathic character and pore-forming domains capable of oligomerizing to form stable transmembrane pores. The molecular mechanism involves initial binding to membrane sphingomyelin, followed by conformational changes that expose hydrophobic regions for membrane insertion and subsequent pore formation. The structural scaffold should maintain the characteristic stability and membrane-interaction properties essential for this toxin's potent cytolytic function in marine predator defense."}
{"description": "sp|F8S108|VM34_CROAD Zinc metalloproteinase-disintegrin-like 4a OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MIQVLLVTISLAVFPYQGSSVILESGNVNDYEVVYPRKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPTVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEQQRYLNAKKYVKLFLVADYIMYLKYGRNLTAVRTRMYDIVNVITPIYHRMNIHVALVGLEIWSNTDKIIVQSSADVTLNLFGNWRATDLLRRKSHDNAQLLTGINFNGPTAGLAYLGGICNTMYSAGIVQDHSKIHHLVAIAMAHEMGHNLGMDHDKDTCTCGTRPCVMAGALSCEASFLFSDCSQKDHREFLIKNMPQCILKKPLKTDVVSPAVCGNYFVEVGEECDCGSPRTCRDPCCDATTCKLRQGAQCAEGLCCDQCRFKGAGTECRAAKDECDMADVCTGRSAECTDSFQRNGQPCKNNNGYCYNGKCPIMADQCIALFGPSATVSQDACFQFNREGNHYGYCRKEQNTKIACEPQDVKCGRLYCFPNSPENKNPCNIYYSPNDEDKGMVLPGTKCADGKACSNGQCVDVTTPY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent hemorrhagic agent. This toxin should feature a multi-domain architecture with a catalytic metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH, which cleaves extracellular matrix components like collagen and fibronectin to disrupt vascular integrity. The disintegrin-like domain should adopt a compact, disulfide-rich fold with the characteristic cysteine pattern that enables inhibition of integrin receptors on platelets and endothelial cells, preventing cell adhesion and promoting bleeding. The overall structure should maintain the typical reprolysin family fold, with the metalloproteinase and disintegrin domains synergistically enhancing hemorrhagic activity through proteolytic degradation and anti-adhesive mechanisms. Ensure the sequence reflects the evolutionary optimization for rapid tissue damage and prey immobilization, with structural stability conferred by multiple disulfide bridges."}
{"description": "sp|P0DPW9|TX41A_SCODE Kappa-scoloptoxin(04)-Ssd1a OS=Scolopendra dehaani OX=2609776 PE=1 SV=1", "sequence": "MKKTCVVSVFLVLLLLKFHDLSMGEEISPLKKVAPREQIFPCPGFPCPKGYFCDKGSQKCREGTD", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a kappa-scoloptoxin derived from the venom of the centipede Scolopendra dehaani, a species known for its potent neurotoxic venom used in prey immobilization. The toxin functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and cause paralysis. It belongs to the scoloptoxin family, characterized by a compact, disulfide-rich scaffold typical of centipede venom peptides. The protein should feature a conserved cysteine framework with a specific disulfide bridge pattern that stabilizes an inhibitor cysteine knot (ICK) motif, resulting in a stable, triple-stranded beta-sheet fold resistant to proteolytic degradation. Key structural elements include a well-defined core stabilized by disulfide bonds, surface-exposed loops critical for channel binding, and a pharmacophore region that interacts with the pore domain of Kv channels to inhibit ion flux. The sequence must encode these functional residues while maintaining the structural integrity required for high-affinity binding and thermal stability in venom environments."}
{"description": "sp|P0DV62|TX4A_PARAW Lycotoxin-Pa4a OS=Pardosa astrigera OX=317848 PE=2 SV=1", "sequence": "MKLGIFFSVFFLAMIHSCLSETNEDKNLESYFREDDLKALSFGEYARAMMAESRKDNCIPKHHECTSRPKDCCKQNLMQFKCSCMTIIDKNNKETERCKCDNSIFQKVAKTSVNIGKAVVTK", "prompt": "Design a novel animal toxin protein sequence inspired by the biological characteristics of Lycotoxin-Pa4a from the wolf spider Pardosa astrigera. This toxin should function as a potent antimicrobial peptide with broad-spectrum activity against both Gram-positive and Gram-negative bacteria. The protein should adopt an amphipathic alpha-helical structure that facilitates membrane disruption, creating pores in bacterial cell membranes through a carpet-like mechanism. The sequence should maintain the characteristic cationic nature of spider-derived antimicrobial peptides, with a net positive charge that enables initial electrostatic interactions with negatively charged bacterial membranes. The structural scaffold should feature a well-defined helical conformation that allows for optimal insertion into lipid bilayers, leading to membrane permeabilization and bacterial cell lysis. The toxin should exhibit minimal hemolytic activity against mammalian cells while maintaining high antimicrobial potency, reflecting the evolutionary optimization of spider venom components for targeted membrane disruption. The designed sequence should capture the essential biophysical properties that enable selective toxicity against microbial pathogens while preserving the structural integrity required for stable helical formation in membrane environments."}
{"description": "sp|P30424|BPP4_BOTIN Bradykinin-potentiating peptide S4,1,2 OS=Bothrops insularis OX=8723 PE=1 SV=2", "sequence": "QGGPPRPQIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of Bothrops insularis, the golden lancehead pit viper. This peptide functions as a potent vasoactive toxin that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby increasing bradykinin's half-life and activity. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of the BPP family's cysteine framework. It should exhibit high affinity for the active site of ACE, blocking its catalytic function and leading to prolonged vasodilation and reduced blood pressure. The sequence should include conserved residues critical for ACE inhibition and maintain the structural integrity necessary for venom stability and target specificity."}
{"description": "sp|P0CY84|COW_CONBU Contryphan-Bu OS=Conus bullatus OX=89438 PE=3 SV=1", "sequence": "MGKLTILVLVAAVLLSTQVMGQGDRDQPAARNAVPRDDNPGGASAKLMNLLHRSKCPWSPWCG", "prompt": "Design a novel peptide toxin sequence that captures the essential biological and structural characteristics of Contryphan-Bu from the marine cone snail Conus bullatus. This peptide should function as a potent neuroactive component within the predatory venom arsenal of this piscivorous species, contributing to the rapid immobilization of fish prey through modulation of neuronal excitability. The sequence must adopt the contryphan structural framework characterized by a compact, disulfide-constrained cyclic configuration stabilized by two conserved disulfide bridges forming a Cys1-Cys4, Cys2-Cys3 connectivity pattern. Incorporate the signature post-translational modification of tryptophan bromination at a conserved position, which enhances receptor binding affinity and stability in the marine environment. The core scaffold should display the characteristic contryphan fold with a well-defined beta-hairpin motif stabilized by the disulfide network, creating a stable platform for molecular recognition. The peptide should target voltage-gated ion channels or neuronal receptors involved in synaptic transmission, exhibiting high specificity and potency through precise molecular complementarity at the binding interface. Ensure the sequence maintains the compact molecular weight typical of contryphans while preserving the structural determinants essential for biological activity and proteolytic resistance."}
{"description": "sp|P58778|SCX4_CENSC Toxin CsEv4 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "KEGYMVNKSTGCSYSCPKTGESVYCDKECKAKNQGGSYGFCQYSNCWCEGLPESTPTWPLDDKPCD", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should originate from the venom of the Arizona bark scorpion, Centruroides sculpturatus, a species known for producing potent neurotoxins that target voltage-gated sodium channels in mammalian nervous systems. This toxin should function as a beta-type scorpion toxin, specifically modulating sodium channel gating kinetics by binding to receptor site 4 on the voltage-sensing domain of domain II. The molecular mechanism involves slowing sodium channel inactivation, leading to prolonged action potentials and neuronal hyperexcitability that causes severe neurotoxic symptoms. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, with a conserved disulfide bridge pattern connecting an alpha-helix to an antiparallel beta-sheet. The cysteine framework should follow the typical scorpion toxin pattern with four disulfide bonds (C-C-C-C-C-C-C-C) that stabilize the compact globular structure. Key structural elements must include a conserved hydrophobic core, exposed basic residues for channel interaction, and the specific molecular surface topology required for high-affinity binding to mammalian voltage-gated sodium channels, particularly Nav1.7 and Nav1.6 subtypes. The protein should exhibit the characteristic ICK (inhibitor cysteine knot) motif stabilization and maintain the precise loop regions necessary for target specificity and potency."}
{"description": "sp|A9XE59|KBX12_MESEU Potassium channel toxin MeuTXK-beta-2 OS=Mesobuthus eupeus OX=34648 PE=3 SV=1", "sequence": "MQRNLVVLLFLGMVALSSCGFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCSAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Mesobuthus eupeus. This toxin should function as a potent and selective modulator of voltage-gated potassium channels (Kv channels), specifically targeting and inhibiting specific Kv channel subtypes to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion potassium channel toxins, featuring a compact, stable fold stabilized by a specific disulfide bridge pattern—typically three or four disulfide bonds forming a cysteine-stabilized alpha-beta (CSαβ) motif. This structural framework includes a beta-sheet core and one or more alpha-helices, creating a molecular surface with key functional residues for high-affinity binding to the voltage-sensing domain or pore region of Kv channels. The toxin should exhibit precise molecular recognition, potentially blocking potassium efflux, delaying channel inactivation, or shifting voltage dependence, thereby inducing hyperexcitability, prolonged action potentials, or paralysis in prey. Ensure the sequence reflects the evolutionary optimization for venom efficacy, with conserved hydrophobic patches, electrostatic interactions, and minimal unstructured regions, while maintaining the biological activity and structural integrity inherent to scorpion toxin families."}
{"description": "sp|H6VC06|VKTK2_DABRR Kunitz-type serine protease inhibitor DrKIn-II OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISGHDRPTFCNLAPESGRCRAHLRRIYYNLESNKCEVFFYGGCGGNDNNFSTWDECRHTCVGK", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Russell's viper (Daboia russelii), specifically modeling it after the DrKIn-II toxin. This protein should function as a potent serine protease inhibitor, likely targeting key proteases involved in hemostasis and coagulation pathways. The structural scaffold must feature the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a typical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The protein should contain the canonical protease-binding loop that interacts with the active site of target serine proteases, potentially including factors in the coagulation cascade. The sequence should maintain the conserved secondary structure elements of Kunitz domains: an N-terminal β-hairpin, followed by an α-helix, and a C-terminal β-strand. The molecular mechanism involves tight-binding inhibition through standard mechanism kinetics, forming a stable enzyme-inhibitor complex. The protein should exhibit the typical molecular weight and physicochemical properties of venom Kunitz-type inhibitors, contributing to the viper's venom arsenal by disrupting prey homeostasis through precise protease inhibition."}
{"description": "sp|P0CB14|VM1K_CALRH Snake venom metalloproteinase kistomin OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKITALSEGAAQQKYEDTMQYEFKVNGEPVVLHLEKNKELFAKDYSETHYSPDGTRITTYPSVEDHCYYQGRIHNDADSTASISTCNGLKGHFKFHGERYFIEPLKLPGSEAHAVYKYENIEKEDETPKMCGVIQKWKSDELIKKPFRLNLTPQQQESPQAKVYLVIVADKSMVDKHNGNIKKIEEQGHQMVNTMNECYRPMGIIIIMAGIECWTTNDFFEVKSSAKETLYSFAKWRVEDLSKRKPHNDAQFLTNKDFDGNTVGLAFVGGICNEKYCAGVVQDHTKVPLLMAITMGHEIGHNLGMEHDEANCKCKACVMAPEVNNNPTKKFSDCSRNYYQKFLKDRKPECLFKKPLRTDTVSTPVSGNEPLEVITMDDFYA", "prompt": "Design a snake venom metalloproteinase protein sequence that mimics the toxic activity and structural characteristics of kistomin from the Malayan pit viper (Calloselasma rhodostoma). This metalloproteinase should function as a key hemorrhagic toxin in viper venom, targeting and degrading components of the extracellular matrix and basement membranes to disrupt vascular integrity and induce systemic bleeding. The protein should contain a canonical zinc-binding motif (HEXXHXXGXXH) in its catalytic domain, coordinating a zinc ion essential for proteolytic activity against substrates such as fibrinogen, collagen, and von Willebrand factor. Include a disintegrin-like domain that may mediate interactions with platelet integrins, contributing to antiplatelet effects. The structure should feature multiple disulfide bridges stabilizing the metalloproteinase and disintegrin-like domains, with the overall fold adopting a conserved metzincin topology characterized by an upper subdomain dominated by α-helices and a lower subdomain rich in β-strands. The protein should be synthesized as a zymogen with a propeptide that is proteolytically processed to activate the enzyme, and it should exhibit calcium-dependent stability. Ensure the sequence reflects the high specificity for extracellular matrix proteins and the role in promoting hemorrhage and coagulopathy typical of viper envenomation."}
{"description": "sp|W4VS32|TX21F_TRILK Toxin ICK-15 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKPIVSILIFCALAVVIMGHPLDSGYGIPHIVEKLPNGQWCKTPGDDCSKSNECCKPKDPENYSGGCVAQWSGMHGKRINMCRICYLESSMC", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The toxin originates from the venom of Trittame loki, a spider species, and belongs to the Inhibitor Cystine Knot (ICK) structural family, specifically designated as ICK-15. This toxin should adopt the characteristic ICK fold, stabilized by a conserved disulfide bridge pattern of three intramolecular disulfide bonds forming a knotted topology (typically C1-C4, C2-C5, C3-C6 connectivity in sequence order), which confers exceptional stability and resistance to proteolytic degradation. The core structure is anticipated to be compact and globular, with beta-sheets and/or loops that form a functional surface for target interaction. As an ICK toxin, it likely functions as a neurotoxin targeting ion channels (e.g., voltage-gated sodium, potassium, or calcium channels) or receptors in the nervous system of prey, leading to paralysis or modulation of neuronal signaling. The mechanism of action may involve pore blockade or gating modification of the target channel, disrupting action potentials. The biological significance lies in its role in the spider's predatory venom, aiding in immobilizing arthropod or small vertebrate prey. Ensure the sequence includes key residues for disulfide bonding (cysteines at conserved positions), hydrophobic core formation, and potential receptor-binding loops, while maintaining the overall ICK scaffold for functional efficacy and stability."}
{"description": "sp|P60266|SCX4_CENSU Beta-mammal toxin Css4 OS=Centruroides suffusus OX=6880 PE=1 SV=2", "sequence": "MNSLLMITACLALVGTVWAKEGYLVNSYTGCKFECFKLGDNDYCLRECRQQYGKGSGGYCYAFGCWCTHLYEQAVVWPLPNKTCNGK", "prompt": "Design a beta-toxin protein from the venom of the Mexican scorpion Centruroides suffusus that specifically targets mammalian voltage-gated sodium channels. This toxin should function as a beta-scorpion toxin, characterized by its ability to modify sodium channel gating by shifting the voltage dependence of activation to more negative potentials and enhancing channel opening. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold typical of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved 'pharmacophore' region responsible for receptor binding, particularly residues in the beta-sheet that interact with domain II of voltage-gated sodium channels. The toxin should exhibit high affinity and selectivity for mammalian sodium channel subtypes, contributing to the neurotoxic effects of C. suffusus venom through prolonged neuronal excitation and disrupted action potential generation. The sequence should maintain the compact, stable globular architecture essential for venom potency and resistance to proteolytic degradation."}
{"description": "sp|W4VRY7|ICK7_TRILK U13-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTIIVFLSLLVLATKFGDAKEGVNQEQKKEVTQNEFRVEYLNEMAAMSLLQQLEAXESALFEKEAGRNSRQXRCAMGDVPCTKGKTNCCKGYECKPKSPSWWYDTDFCQPIHGGRPIGI", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Trittame loki, a mygalomorph spider species whose venom contains complex peptide toxins that target neuronal ion channels. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, specifically designated as U13-barytoxin-Tl1a. The protein should function as a potent neurotoxin that modulates voltage-gated ion channels, likely calcium or sodium channels, to disrupt neuronal signaling and induce paralysis in prey. The core structural scaffold must feature the characteristic ICK motif, formed by a conserved disulfide bridge pattern with three intramolecular disulfide bonds in a C1-C4, C2-C5, C3-C6 connectivity, creating a stable, triple-stranded beta-sheet fold resistant to proteolytic degradation. Key structural elements include a compact, globular architecture with the cysteine knot stabilizing the core, and surface loops that mediate specific interactions with ion channel pore regions or voltage-sensing domains. The molecular target is inferred to be voltage-gated calcium channels (e.g., Cav2.2 or Cav2.1 subtypes) or sodium channels (e.g., Nav1.7), with binding likely occurring via electrostatic and hydrophobic interactions in channel vestibules. The sequence should include conserved ICK family residues for structural integrity, such as glycine and proline in loop regions, and functional residues for target engagement. Ensure the toxin exhibits high affinity and selectivity for its ion channel target, contributing to the venom's role in prey immobilization through synaptic transmission disruption."}
{"description": "sp|Q9BJV9|TO2A_HADIN Omega-hexatoxin-Hi2a OS=Hadronyche infensa OX=153481 PE=1 SV=1", "sequence": "MKFSKLSLTLALILTQALLVVCGKINEDFMENGLESHALHDEIRKPIDTEKADAERGVLDCVVNTLGCSSDKDCCGMTPSCTLGICAPSVGGIVGGLLGRAL", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be an omega-hexatoxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin functions as a potent insecticidal agent that specifically targets insect voltage-gated calcium channels (VGCCs), acting as a channel blocker to disrupt neuromuscular transmission and induce paralysis in insect prey. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif, which provides exceptional stability through a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6 connectivity. The protein should adopt a compact, globular fold stabilized by this triple disulfide framework, with key functional residues positioned in flexible loops to mediate high-affinity binding to insect calcium channels. The sequence should include conserved cysteine residues at appropriate positions to form the ICK motif, along with hydrophobic and polar residues that facilitate membrane interaction and channel blockade. The overall structure should exhibit the typical beta-sheet and beta-hairpin elements common to spider venom ICK toxins, ensuring both structural integrity and target specificity for insecticidal activity."}
{"description": "sp|P60244|VM1A3_DEIAC Snake venom metalloproteinase acutolysin-C OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "PAPQTSIELFLIVDHSMYAKYNSNSSKITTTLKARVNIMNAIYSSLNLVITLSGIEMWSAADLITVQSSSRNTLKLFASWRETDLLKRTSNDNAQLLTATNFNGNTVGLAYLKTMCNSKYSVGLIQDHSAIPLLMAVTMAHELGHNLGMNHDGAGCSCATCIMAPVLSSGPAKSFSDCSKHDYQSFLTIHKPQCLLN", "prompt": "Design a snake venom metalloproteinase (SVMP) sequence that replicates the toxic activity and structural characteristics of acutolysin-C from Deinagkistrodon acutus (hundred-pace snake). This enzyme belongs to the P-I class of SVMPs and functions as a zinc-dependent endopeptidase that targets extracellular matrix components, particularly basement membrane proteins. The protein should contain the canonical metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH, where the three histidines coordinate the catalytic zinc ion and the glutamate serves as the catalytic base. The structure should adopt the classic metzincin fold characterized by a twisted five-stranded beta-sheet and several alpha-helices, with the active site cleft located at the protein surface. As a hemorrhagic toxin, this enzyme should efficiently cleave key components of the capillary basement membrane, including type IV collagen, laminin, and fibronectin, leading to vascular damage, hemorrhage, and tissue necrosis. The protein should exhibit optimal activity at neutral to slightly basic pH and require calcium ions for structural stability. The sequence should include appropriate cysteine residues for disulfide bond formation to stabilize the overall fold, though as a P-I class SVMP it lacks additional disintegrin-like and cysteine-rich domains found in more complex SVMP classes. The designed protein should demonstrate specific proteolytic activity against extracellular matrix proteins while maintaining the characteristic thermostability and pH stability of snake venom metalloproteinases."}
{"description": "sp|K7XFK5|KAX3G_MESGB Potassium channel toxin alpha-KTx 3.16 OS=Mesobuthus gibbosus OX=123226 PE=2 SV=1", "sequence": "MKVFSAVLIILFVCSMIIGISEGKEIPVKCKHSGQCLQPCKDAGMRFGKCMNGKCNCTPK", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Mesobuthus gibbosus, a species known for producing potent neurotoxins targeting ion channels to immobilize prey. This toxin belongs to the alpha-KTx family, specifically designated as alpha-KTx 3.16, indicating its classification within a group of short-chain scorpion toxins that selectively block voltage-gated potassium channels. The core function is to act as a pore-blocking antagonist, binding to the external vestibule of Kv1-type potassium channels (e.g., Kv1.1, Kv1.2, or Kv1.3), thereby inhibiting potassium efflux, prolonging neuronal depolarization, and disrupting action potential repolarization to induce paralysis. The structural scaffold should feature the conserved alpha-KTx fold, characterized by an alpha-helix packed against a triple-stranded antiparallel beta-sheet, stabilized by a disulfide bridge pattern of C1-C4, C2-C5, C3-C6 (cysteine framework III) that forms a compact, globular core. Key domains include a functional dyad comprising a critical lysine residue in the beta-sheet region that penetrates the channel pore, and an adjacent aromatic or hydrophobic residue that enhances binding affinity through interactions with channel residues. The molecular target interface involves electrostatic interactions between the toxin's basic residues and acidic residues in the channel's turret region, along with hydrophobic contacts that confer subtype selectivity. The sequence must reflect these structural and functional constraints to ensure proper folding, stability, and potent potassium channel blockade."}
{"description": "sp|P80003|PA2A2_HELSU Acidic phospholipase A2 PA4 OS=Heloderma suspectum OX=8554 PE=1 SV=2", "sequence": "GAFIMPGTLWCGAGNAASDYSQLGTEKDTDMCCRDHDHCSDTMAALEYKHGMRNYRPHTVSHCDCDNQFRSCLMNVKDRTADLVGMTYFTVLKISCFELEEGEGCVDNNFSQQCTKSEIMPVAKLVSAAPYQAQAETQSGEG", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Gila monster (Heloderma suspectum). This enzyme plays a critical role in the venom's toxicity by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to local tissue damage, pain, and inflammation. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, an interfacial binding surface for membrane association, and a catalytic histidine-aspartate dyad. As an acidic isoform, it should exhibit a low isoelectric point and may show preferential activity toward specific phospholipid substrates. The mature toxin should be a single-chain protein of approximately 120-140 amino acids with the canonical PLA2 disulfide pattern connecting the structural core."}
{"description": "sp|B5AJT2|VMP01_EULPE Venom metalloproteinase 1 OS=Eulophus pennicornis OX=108749 PE=2 SV=1", "sequence": "MDLFILTRFILFLSFFMKSIHCQYSESQESGHNRNAPDKELTTEEFQLIFHQSQTVDIEYDFINITTEMIETERKVSFTIDGKEYHLSLTPAASQSVLPYGTKIKSAIWWTDNDTHIHEEDYSDERWDSRAIYENLEIMATILVRTENGTSYYDGVFVKYSNEGVRSLPGRLMNIYGANYHFVYDSNGSVYDVVLNGQDEPAVPADMASKIIFYSETPCTCRLLIIQDLLMKTSRRLSSISTIFWNAVNLRFRPVQHPKVNIIITGIVIAKNEAAFQHVYRARYSKNSKLVHTGRVIDNGRYFFGTNFDPYYDNYDASFTMASMDDPTGKGGATVIGGICSSSNNIAYIRDVGSYSGVKVATHELGHLLNGQHDSDTTCSEKINDNIYTIMAKQGSTKASKFVWSSCTLTAFANFSKTTSAACLKDTYRKQ", "prompt": "Design a venom metalloproteinase protein sequence that embodies the key structural and functional characteristics of toxins from the parasitic wasp Eulophus pennicornis. This enzyme should function as a zinc-dependent metalloprotease, specifically targeting and degrading extracellular matrix components and host tissue proteins to facilitate parasitism. The protein must feature the characteristic metzincin catalytic domain with the conserved HEXXHXXGXXH zinc-binding motif, where histidine residues coordinate the catalytic zinc ion. Include the methionine turn that defines the metzincin superfamily. The structure should incorporate multiple domains typical of snake venom metalloproteinases, including a prodomain for zymogen regulation, a catalytic domain with the metzincin fold, and a disintegrin-like domain that may mediate protein-protein interactions. The mature enzyme should exhibit optimal activity at neutral pH and require calcium ions for structural stability. Design the sequence to encode appropriate signal peptides and propeptides for proper secretion and activation. The overall architecture should facilitate efficient proteolytic cleavage of host proteins while maintaining the thermostability required for biological function in the parasitic context."}
{"description": "sp|I6S390|TXD2A_SCOMU Omega-scoloptoxin(13)-Ssm2a OS=Scolopendra mutilans OX=2836329 PE=1 SV=1", "sequence": "MAYIYALIFAIVVCMNTDVIQAEESQHDTLENVEYRLSCIPKGGECERMADTCCPGLQCLGCNPFNKENLGKCKCQ", "prompt": "Design a novel animal toxin protein sequence based on the biological profile of omega-scoloptoxin from the venom of Scolopendra mutilans (Chinese red-headed centipede). This toxin belongs to the scoloptoxin family, which are key neurotoxic components in centipede venom that facilitate prey immobilization through modulation of neuronal excitability. As an omega-scorpion toxin-like molecule, it likely functions as a voltage-gated sodium channel modulator, potentially prolonging channel opening or altering inactivation kinetics to induce sustained neuronal depolarization and hyperexcitability. The structural scaffold should feature the characteristic inhibitor cysteine knot (ICK) motif with a conserved disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) that creates a stable, compact triple-stranded beta-sheet fold. Key structural elements should include a conserved hydrophobic core, solvent-exposed loops for target interaction, and the characteristic 'pharmacophore' region responsible for sodium channel binding specificity. The sequence should maintain appropriate length (approximately 60-80 residues) with optimal distribution of cationic residues for membrane interaction and conserved glycine residues enabling tight turns in the ICK fold. The molecular target interface should be designed for selective interaction with insect or mammalian voltage-gated sodium channels, particularly those in peripheral sensory neurons, to produce the characteristic neurotoxic effects observed in centipede envenomation."}
{"description": "sp|Q8QHK2|VSP2_CROAT Snake venom serine protease catroxase-2 OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVAIFNSTEFFCSGTLINQEWVVTAAHCDSTNFKMKLGVHSKKVPNEDEQTRNPKEKFFCPNKKKDDVLDKDIMLIKLDSPVSNSEHIAPLSLPSSPPSVGSVCHIMGWGSITPIEKTLPDVPYCANIKLLDDAVCQPPYPELPATSRTLCAGIPEGGKDTCGGDSGGPLICNGQFQGIVFYGAHPCGQALKPGVYTKVFDYNDWIQSIIAGNTAATCPP", "prompt": "Design a snake venom serine protease from the Western diamondback rattlesnake (Crotalus atrox) that functions as a key component of the venom's hemorrhagic arsenal. This enzyme should exhibit trypsin-like or thrombin-like serine protease activity, targeting specific coagulation cascade components to disrupt hemostasis. The protein should adopt the characteristic chymotrypsin-fold structure with a catalytic triad of His, Asp, and Ser residues arranged in the conserved geometry essential for proteolytic function. Include the canonical disulfide bond pattern typical of snake venom serine proteases that stabilizes the two-barrel domain architecture. The enzyme should demonstrate substrate specificity for fibrinogen, coagulation factors, or platelet aggregation receptors, leading to either pro-coagulant or anti-coagulant effects depending on its precise molecular targets. Incorporate structural features that enable resistance to endogenous protease inhibitors while maintaining optimal catalytic efficiency in the complex environment of envenomation. The mature protein should exhibit the characteristic N-terminal activation mechanism common to venom serine proteases."}
{"description": "sp|P0CY85|VKTB1_CONBU Kunitz-type conkunitzin-B1 OS=Conus bullatus OX=89438 PE=3 SV=1", "sequence": "MEGRRFAAVLILPICMLAPGAVASKRWTRPSVCNLPAESGTGTQSLKRFYYNSDKMQCRTFIYKGNGGNDNNFPRTYDCQKKCLYRPG", "prompt": "Design a protein sequence for a conkunitzin-B1 toxin from the marine cone snail Conus bullatus. This toxin belongs to the Kunitz-type serine protease inhibitor family and functions as a potassium channel blocker. The venom of Conus bullatus is neurotoxic, targeting ion channels to rapidly immobilize prey through disruption of neuronal signaling. The protein should adopt the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. This structural scaffold forms a stable beta-trefoil motif with alternating beta-strands and turns, creating a robust platform for target interaction. The toxin specifically blocks voltage-gated potassium channels, particularly Kv1 subtypes, through a mechanism involving direct pore occlusion or allosteric modulation of channel gating. Key functional residues should be positioned to interact with the channel's outer vestibule and selectivity filter regions, mimicking the natural toxin's ability to inhibit potassium efflux and prolong neuronal depolarization. The sequence must maintain the conserved Kunitz protease inhibitor motif while incorporating specific adaptations for potassium channel blockade rather than serine protease inhibition."}
{"description": "sp|A0S865|3NBB_BOIIR Irditoxin subunit B OS=Boiga irregularis OX=92519 PE=1 SV=1", "sequence": "MKTLLLAVAVVAFVCLGSADQLGLGRQQIDWGKGQAKGPPYTLCFECNRETCSNCFKDNRCPPYHRTCYTLYRPDGNGEMKWAVKGCAKTCPTAQPGESVQCCNTPKCNDY", "prompt": "Design a protein sequence for the B subunit of Irditoxin, a heterodimeric neurotoxin from the brown tree snake (Boiga irregularis). This toxin functions as a potent postsynaptic α-neurotoxin that specifically and irrereversibly blocks muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to flaccid paralysis in prey. The B subunit works in concert with the A subunit to enhance binding affinity and toxicity through a unique heterodimeric mechanism. The protein should adopt a three-finger toxin (3FTx) fold characteristic of snake venom neurotoxins, featuring a core stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C. The structure should display three β-stranded loops extending from a central globular core, with specific residues in the central loop (particularly loop II) forming the primary pharmacophore for high-affinity binding to the α-δ and α-γ interfaces of the muscle nAChR. The sequence should maintain conserved hydrophobic residues that stabilize the three-finger scaffold and contain key functional residues that enable irreversible binding through non-competitive inhibition. The protein should be secreted and exhibit the characteristic stability of snake venom toxins, with the heterodimeric assembly enhancing its target specificity and potency compared to monomeric three-finger toxins."}
{"description": "sp|K9MCX0|3SX2_MICLL Three-finger toxin A2 OS=Micrurus laticollaris OX=1240351 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNSLVCYVSGAWQKTCPEGQNKCEKYAVGTMHGSWIYLRGCASTCHEGPYNVCCSTDLCNK", "prompt": "Design a three-finger toxin protein sequence that mimics the biological activity and structural characteristics of Micrurus laticollaris (Mexican coral snake) venom toxin A2. This toxin belongs to the three-finger toxin superfamily, characterized by a conserved structural fold consisting of three extended β-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should adopt the classic three-finger β-sandwich architecture with the characteristic 'finger-like' projections that facilitate molecular recognition. As a component of elapid snake venom, this toxin likely functions as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, causing flaccid paralysis through competitive antagonism of acetylcholine binding. The sequence should maintain the conserved structural scaffold while incorporating specific loop variations that determine target specificity and binding affinity. Key structural elements should include: the central globular core stabilized by the conserved disulfide framework, three extended loops with appropriate length and flexibility for receptor interaction, and surface residues optimized for specific molecular recognition of neuronal nicotinic acetylcholine receptor subtypes. The protein should exhibit the characteristic thermal stability and protease resistance conferred by the dense disulfide network, while maintaining the specific pharmacological profile expected of coral snake neurotoxins."}
{"description": "sp|Q5G291|PA2A5_NAJSG Acidic phospholipase A2 5 (Fragment) OS=Naja sagittifera OX=195058 PE=1 SV=1", "sequence": "SNRPMPLNTYQFRNMIQCTVPSRSWWDFADYGCYCGCGSGTPVDDLDRCCQVHCNCYRQAGEISGCRPKFKTYTYECSGGTLTCKGDNNACAASSCDCDRLAAICFAGAPYNDNNYNIDLKARCN", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from the venom of the cobra species Naja sagittifera. This enzyme should exhibit the characteristic catalytic activity of hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by a network of seven disulfide bridges that confer exceptional thermal and pH stability. As an acidic isoform, the sequence should reflect a lower isoelectric point compared to basic phospholipases. The molecular mechanism involves calcium-dependent binding to membrane interfaces, with the catalytic histidine-aspartate dyad positioned within the conserved active site groove. This toxin contributes to the potent neurotoxic and myotoxic effects characteristic of elapid snake venoms by disrupting cellular membranes, inducing muscle necrosis, and potentially interfering with neuromuscular transmission through presynaptic or postsynaptic mechanisms. The structural scaffold should maintain the characteristic phospholipase A2 globular fold with the calcium-binding loop and interfacial binding surface optimized for membrane penetration and substrate accessibility."}
{"description": "sp|B0VXV1|SL2_SISCA Snaclec 2 OS=Sistrurus catenatus edwardsii OX=8762 PE=2 SV=1", "sequence": "MGRFIFVSFSLLVVFLSLSGTGAHCPSGWYTYEGHCYRVFQQNMTWEDAEKFCTQQYEKSHLVSFRSSEEVDFLVSLLKVDLFWMGRRDIWNERRLQWSDGTKVDYKDWRAKPECIVCRATDNHWLSTSCSETHNVICKFET", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) from the desert massasauga rattlesnake (Sistrurus catenatus edwardsii). This toxin should function as a potent platelet aggregation modulator, specifically targeting key receptors in the coagulation cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved globular structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The structural scaffold should display the signature β-sheet core flanked by α-helices and loop regions that form the functional binding interface. Key molecular targets likely include platelet receptors such as GPIb or GPVI, or coagulation factors like factor IX or factor X, with binding mediated through specific surface-exposed loops that mimic physiological ligands. The protein should exhibit high specificity for its hematological target while maintaining the thermal stability and protease resistance typical of venom C-type lectins. Focus on creating a sequence that captures the evolutionary optimization of this toxin family for rapid and potent disruption of hemostatic balance in prey organisms."}
{"description": "sp|D9IX98|VNP_OPHHA Natriuretic peptide Oh-NP OS=Ophiophagus hannah OX=8665 PE=2 SV=1", "sequence": "MVGPSRLAGGGLLLLLLALLPVALDGKPAPPSQALHKAPAGGTKASQIMQVLLPESKKSWAARDRMVGPYNPAGGGGGHPSSCFGHKIDRISHSSGMGCGRRPNAPAGGTKASQIMQVLLPESKKSRAARDRMVGPDNRAGGGGGGGGGDSSRQQELAKKDQHNNCFGRRIDRISHSTDLGCRRRPNPPPAPTAAPLAVAQFNSKSSQVA", "prompt": "Design a natriuretic peptide toxin from the venom of the king cobra (Ophiophagus hannah) that functions as a potent vasoactive agent. This peptide should mimic the biological activity of endogenous natriuretic peptides but with enhanced potency and stability. The protein should function by binding to and activating natriuretic peptide receptors, particularly NPR-A and NPR-B, leading to increased cyclic GMP production, resulting in vasodilation, natriuresis, and diuresis. The structural scaffold should feature a conserved 17-amino acid disulfide-bonded ring structure characteristic of natriuretic peptides, with the disulfide bridge formed between two conserved cysteine residues creating a stable cyclic conformation essential for receptor binding. The mature peptide should contain approximately 30-40 amino acids with a well-defined N-terminal extension and C-terminal tail flanking the central bioactive ring. Key structural elements should include an amphipathic alpha-helical region within the disulfide-constrained loop that mediates receptor interaction, and surface-exposed residues that facilitate specific recognition of natriuretic peptide receptor guanylyl cyclase domains. The protein should exhibit enhanced resistance to proteolytic degradation compared to endogenous natriuretic peptides, contributing to its prolonged hypotensive effects in prey organisms."}
{"description": "sp|P0C2D6|OXLA_PROMU L-amino-acid oxidase (Fragment) OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "ADNKNPLEECFRETNYEEFLEIAR", "prompt": "Design a functional L-amino-acid oxidase toxin fragment derived from the venom of Protobothrops mucrosquamatus (Taiwan habu snake). This enzyme represents a key component of viperid venom systems, where it contributes to prey immobilization through the oxidative deamination of L-amino acids. The generated protein should function as a flavin adenine dinucleotide (FAD)-dependent oxidase that catalyzes the conversion of L-amino acids to their corresponding α-keto acids, simultaneously producing hydrogen peroxide and ammonia as reactive byproducts. The mechanism involves hydrogen peroxide-mediated tissue damage, induction of apoptosis in target cells, and disruption of platelet aggregation, collectively enhancing the hemorrhagic and cytotoxic effects of the venom. Structurally, the protein should adopt the characteristic Rossmann fold typical of L-amino-acid oxidases, featuring a conserved FAD-binding domain with βαβ dinucleotide-binding motifs and a substrate-binding pocket that confers specificity toward hydrophobic L-amino acids. The active site should contain critical catalytic residues for substrate orientation and flavin-mediated redox chemistry. While this fragment may represent a proteolytically processed form, it must retain the essential structural elements for enzymatic activity, including proper folding to accommodate the FAD cofactor and maintain the dimeric interface often observed in functional L-amino-acid oxidases. The generated sequence should exhibit the hallmark properties of snake venom L-amino-acid oxidases: high thermal stability, optimal activity at physiological pH, and the ability to induce cytotoxicity through reactive oxygen species generation."}
{"description": "sp|P60615|3L21A_BUNMU Alpha-bungarotoxin OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTIVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG", "prompt": "Generate the amino acid sequence for alpha-bungarotoxin, a potent neurotoxin from the venom of the many-banded krait (Bungarus multicinctus). This toxin belongs to the three-finger toxin superfamily and functions as a highly specific, irreversible antagonist of nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8) that create the rigid structural scaffold. Key functional loops should contain residues critical for binding to the α-δ and α-γ interfaces of muscle-type nicotinic receptors, with specific aromatic and basic residues mediating high-affinity interaction that blocks acetylcholine binding and causes flaccid paralysis. The sequence should maintain the conserved cysteine framework and structural motifs typical of long-chain α-neurotoxins while incorporating the specific pharmacophore responsible for its exceptional receptor selectivity and potency."}
{"description": "sp|P20252|PA2B_PSEAU Basic phospholipase A2 PA-5 OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "NLIQFSNMIQCANKGSRPSLDYADYGCYCGWGGSGTPVDELDRCCKVHDDCYAEAGKKGCYPKLTLYSWDCTGNVPICNPKTECKDFTCACDAEAAKCFAKAPYKKENWNIDTKTRCK", "prompt": "Generate a protein sequence for a basic phospholipase A2 toxin from the venom of the Australian king brown snake (Pseudechis australis). This toxin should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of glycerophospholipids, leading to membrane disruption, inflammation, and myotoxicity. Structurally, it should adopt the characteristic phospholipase A2 fold with a conserved catalytic dyad (histidine-aspartate) and calcium-binding loop. The sequence should contain 14 conserved cysteine residues forming 7 disulfide bridges that stabilize the compact globular structure. Key functional elements should include the interfacial binding surface for membrane association, the hydrophobic substrate-binding channel, and the N-terminal α-helix critical for enzymatic activity. The protein should be basic in nature to facilitate interaction with anionic membrane surfaces and exhibit the characteristic β-wing region common to snake venom phospholipases A2."}
{"description": "sp|Q5W959|VSP14_BOTJA Snake venom serine protease HS114 OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "MVLVRVVANLLILQLSYAQKVSELVVGGDECNINEHRSLVAIFNSTGFFCSGILLNQEWVLTASHCDSTNFQMKIGVHSKKTLNQDEQTRNPKEKIFCPNKKNDDALDKDLMLVRLDSPVSDSEHIAPLSLPSSPPSVGSVCRIMGWGSITPIQKTNPDVPHCANINLLDDAVCRAAYPELPAEYRTLCAGVPEGGIDTCNGDSGGPLICNGQFQGIVFYGAHPCGQAPKPGLYTKVIDYNTWIESVIAGNTAATCPP", "prompt": "Design a snake venom serine protease from the pit viper Bothrops jararaca that functions as a key hemostatic toxin. This enzyme should exhibit trypsin-like or thrombin-like protease activity, targeting specific components of the vertebrate coagulation cascade. The protein should feature a canonical serine protease fold with the characteristic His-Asp-Ser catalytic triad essential for proteolytic function. Include appropriate substrate-binding pockets that confer specificity for fibrinogen, coagulation factors, or platelet aggregation receptors. The mature enzyme should contain the conserved disulfide bridge pattern typical of snake venom serine proteases, stabilizing the structural scaffold while allowing for the conformational flexibility required for substrate recognition and cleavage. The toxin should contribute to the prey's circulatory collapse through either pro-coagulant or anti-coagulant mechanisms, consistent with Bothrops jararaca's venom composition that induces consumption coagulopathy and hemorrhage."}
{"description": "sp|P58842|M3B_CONQU Conotoxin QcIIIB OS=Conus quercinus OX=101313 PE=1 SV=1", "sequence": "CCSRHCWVCIPCCPN", "prompt": "Design a novel conotoxin sequence inspired by the α-conotoxin QcIIIB from the marine cone snail Conus quercinus. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the α3β2 and/or α3β4 subtypes, which are implicated in pain signaling pathways. The sequence must adopt the characteristic α-conotoxin globular disulfide framework (Cys-Cys-Cys-Cys with disulfide connectivity I-III, II-IV), forming a compact, stable fold stabilized by two disulfide bonds that constrain the peptide backbone into a well-defined conformation. The structural scaffold should feature a short α-helical segment and reverse turns that present key functional residues for receptor interaction. Include conserved residues critical for nAChR binding, such as hydrophobic and positively charged amino acids in the intervening loops that mediate specific contacts with the receptor's ligand-binding domain. The toxin should exhibit high affinity and selectivity for its target nAChR subtypes, contributing to the venom's role in prey immobilization through disruption of cholinergic neurotransmission. Ensure the sequence reflects the evolutionary optimization of cone snail venoms for rapid and precise targeting of ion channels, with potential applications in neuroscience research and pain management."}
{"description": "sp|Q02517|PA2BW_PROFL Basic phospholipase A2 PL-X' OS=Protobothrops flavoviridis OX=88087 PE=2 SV=1", "sequence": "MRTLWIMAVLLVGVEGHLLQFRKMIKKMTGKEPIVSYAFYGCYCGKGGRGKPKDATDRCCFVHDCCYEKVTGCDPKWDYYTYSSENGDIVCGGDNPCTKEVCECDKAAAICFRDNLKTYKKRYMTFPDIFCTDPTEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the habu snake, Protobothrops flavoviridis. This enzyme should function as a potent toxin with dual mechanisms of action: (1) catalytic hydrolysis of membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids, causing membrane disruption and cellular damage, and (2) potential presynaptic neurotoxicity through binding to neuronal membranes. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bridges. Include the conserved calcium-binding loop (YGKYCG) essential for catalytic activity, with the catalytic histidine-aspartate dyad positioned in the active site. The sequence should exhibit basic isoelectric point properties to facilitate membrane interaction and penetration. The toxin should target various cell membranes, with particular affinity for neuronal tissues, contributing to the venom's hemotoxic and neurotoxic effects in prey immobilization."}
{"description": "sp|Q6X5S1|SL5_ECHPL Snaclec 5 OS=Echis pyramidum leakeyi OX=38415 PE=2 SV=1", "sequence": "MGRFIFISFGLLVVFLSLSGTEAECLPDWFHYEGHCYRVFDEPKTWADAEKFCSEQANGGHLVSVHSKKEAGLVGVLAYQTLESPIVWMGLSKIWNQCDWTWTNGAKLKYEAWAEESYCIHITSKKKEWKSLPCRNYGHFVCKSPA", "prompt": "Generate the amino acid sequence for a snake venom C-type lectin-like protein (snaclec) from the saw-scaled viper Echis pyramidum leakeyi. This toxin functions as a platelet aggregation modulator, specifically targeting platelet receptors through calcium-dependent carbohydrate recognition domains. The protein should adopt the characteristic C-type lectin-like fold consisting of a globular domain with two antiparallel beta-sheets flanked by alpha-helices, stabilized by conserved disulfide bridges typically following a C1-C4, C2-C5, C3-C6 pattern. The structure should feature the canonical carbohydrate recognition domain (CRD) with conserved calcium-binding sites that mediate target recognition. As a component of viper venom, this snaclec likely interferes with hemostasis by binding to platelet surface receptors such as GPIb or GPVI, potentially causing platelet activation or inhibition depending on the specific isoform. The sequence should contain the conserved motifs for C-type lectin domain formation and maintain the structural integrity required for specific receptor binding and biological activity in disrupting normal blood coagulation processes."}
{"description": "sp|B3EWN3|HTX2_CYRLI Beta/kappa-theraphotoxin-Hlv1a OS=Cyriopagopus lividus OX=2053133 PE=1 SV=1", "sequence": "ACKGLFVTCTPGKDECCPNHVCSSKHKWCKYKI", "prompt": "Design a novel beta/kappa-theraphotoxin protein sequence derived from the venom of Cyriopagopus lividus (Cobalt Blue Tarantula), a theraphosid spider whose venom contains complex peptide toxins that target neuronal ion channels. This toxin should function as a dual-action neurotoxin with both beta (inhibitor cystine knot) and kappa (kunitz-type) structural domains. The protein should exhibit potent neurotoxic activity through voltage-gated sodium channel modulation, likely causing delayed channel inactivation and prolonged neuronal excitation. The sequence must incorporate the characteristic ICK motif with a conserved cysteine framework (typically C-C-CC-C-C for spider toxins) forming three disulfide bridges that create a stable, compact globular structure. The kunitz domain should contain the canonical kunitz fold with anti-parallel beta sheets and alpha-helical elements, potentially contributing to protease inhibitory activity. The mature toxin should target specific neuronal sodium channel subtypes, particularly Nav1.7 or Nav1.2, with high affinity binding to domain II or IV of the channel alpha subunit. The structural scaffold should ensure proper folding into a stable, soluble peptide with the N-terminal region likely involved in receptor interaction and the C-terminal region contributing to structural stability. The final sequence should reflect evolutionary optimization for rapid paralysis of prey through disruption of neuromuscular signaling."}
{"description": "sp|I1SB07|GM3C_CONCN Mu-conotoxin CnIIIC OS=Conus consors OX=101297 PE=1 SV=2", "sequence": "QGCCNGPKGCSSKWCRDHARCC", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the marine cone snail Conus consors. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis. The protein must adopt the characteristic mu-conotoxin structural scaffold featuring the conserved cysteine framework I (CC-C-C-CC) with three disulfide bridges forming a compact, globular fold stabilized by extensive beta-sheet secondary structure. Incorporate key functional residues that mediate high-affinity binding to site 1 of the sodium channel alpha subunit, blocking ion conduction through competitive inhibition of the pore region. The sequence should maintain the hallmark pharmacological profile of mu-conotoxins: rapid onset of action, subtype selectivity for Nav1.4 over neuronal sodium channels, and thermal stability conferred by the rigid disulfide-constrained architecture. Include conserved hydrophobic patches and charged surface residues that facilitate specific interactions with the channel's extracellular loops and pore-lining segments."}
{"description": "sp|P0DV30|SCXT2_OLIMR Sodium channel neurotoxin BmK NT2 (Fragment) OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "VRDAYIAKPENCVYHCAGNEGCNNLCTCNGAT", "prompt": "Design a protein sequence for a sodium channel neurotoxin derived from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin belongs to the beta-toxin family and functions as a potent modulator of voltage-gated sodium channels. The protein should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold. This fold is stabilized by four disulfide bridges with a typical connectivity pattern of C1-C4, C2-C5, C3-C6, and C7-C8, forming a compact globular structure with a core beta-sheet and one or two alpha-helices. The toxin acts by binding to site 4 on voltage-gated sodium channels, specifically delaying channel inactivation and prolonging action potentials, leading to hyperexcitability in neuronal and muscular tissues. Key functional residues should be positioned to interact with the channel's voltage-sensing domain, enhancing toxin affinity and specificity. The sequence must include the conserved structural motifs critical for stability and activity, ensuring it mimics the neurotoxic effects observed in the native venom, which contributes to prey immobilization and defense mechanisms in scorpions."}
{"description": "sp|L0G8Z0|KBX31_UROYA Scorpine-like-1 OS=Urodacus yaschenkoi OX=1273102 PE=3 SV=1", "sequence": "MNTKFTVLIFLGVIVVSYGWITEKKIQKVLDEKLPNGFIKGAAKAVVHKLAKSEYGCMMDISWNKDCQRHCQSTEQKDGICHGMKCKCGKPRSY", "prompt": "Design a novel scorpine-like antimicrobial peptide derived from the venom of the Australian scorpion Urodacus yaschenkoi. This toxin should exhibit a dual functional profile characteristic of the scorpine family: potent antimicrobial activity against Gram-positive and Gram-negative bacteria through membrane disruption, combined with moderate insecticidal activity via potential interaction with insect voltage-gated ion channels. The peptide should adopt an elongated alpha-helical structure stabilized by three conserved disulfide bridges in a C1-C4, C2-C5, C3-C6 connectivity pattern, forming a compact cysteine-stabilized scaffold. The N-terminal region should contain cationic and hydrophobic residues essential for membrane penetration and microbial targeting, while the C-terminal domain may contribute to specific insecticidal effects. The overall structure should be amphipathic, facilitating initial electrostatic interactions with negatively charged microbial membranes followed by hydrophobic insertion and pore formation. The peptide should demonstrate broad-spectrum antimicrobial properties while maintaining the characteristic structural stability imparted by the scorpine disulfide framework."}
{"description": "sp|P80494|3SIMA_DENPO Muscarinic toxin alpha OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "LTCVTSKSIFGITTENCPDGQNLCFKKWYYLNHRYSDITWGCAATCPKPTNVRETIHCCETDKCNE", "prompt": "Design a protein sequence for a muscarinic toxin from the venom of the black mamba (Dendroaspis polylepis), a highly potent neurotoxin that specifically targets muscarinic acetylcholine receptors. This toxin belongs to the three-finger toxin superfamily and functions as a selective antagonist of muscarinic receptors, particularly the M1 subtype, disrupting parasympathetic nervous system signaling and causing autonomic dysfunction. The protein should adopt the characteristic three-finger fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern, forming three extended loops that emanate from a central hydrophobic core. The structural scaffold should feature the conserved three-finger topology with loop I containing key residues for receptor recognition and binding, particularly in the central loop region that interacts with the orthosteric binding site of muscarinic receptors. The toxin should exhibit high affinity and selectivity for muscarinic receptors over nicotinic receptors, with specific molecular recognition elements in the loop regions that determine receptor subtype specificity. The sequence should maintain the structural integrity of the three-finger fold while incorporating the functional determinants for muscarinic receptor antagonism, including conserved hydrophobic patches and charged residues critical for receptor binding and biological activity."}
{"description": "sp|P30783|NA22_RADCR Delta-stichotoxin-Hcr1b OS=Radianthus crispa OX=3122430 PE=1 SV=1", "sequence": "GTCKCDDDGPDVRTATFTGSTEFANCNESWEKCLAVYTPVASCCRKKK", "prompt": "Design a protein sequence for a potent marine neurotoxin derived from the sea anemone Radianthus crispa. This toxin belongs to the delta-stichotoxin family and functions as a voltage-gated sodium channel modulator. The protein should adopt the characteristic sea anemone toxin structural fold, featuring a compact beta-sheet core stabilized by three conserved disulfide bridges with a C-C-C-C-C-C connectivity pattern. The toxin should specifically target site 3 on voltage-gated sodium channels, binding to the extracellular S3-S4 loop region of domain IV and inhibiting channel inactivation. This interaction results in prolonged sodium channel opening, leading to sustained neuronal depolarization and neurotoxic effects. The sequence should contain key functional residues for receptor binding affinity and specificity, while maintaining the stable globular structure typical of sea anemone neurotoxins. The protein should be approximately 45-50 amino acids in length with the characteristic cysteine framework that defines this toxin family."}
{"description": "sp|B3EWY1|KA167_MESGB Potassium channel toxin alpha-KTx 16.7 OS=Mesobuthus gibbosus OX=123226 PE=1 SV=2", "sequence": "MKILSILLIALVICSISICTEAFGLIDVKCSASRECWVACKKVTGSGQGKCQNNQCRCY", "prompt": "Design a potassium channel toxin protein from the scorpion Mesobuthus gibbosus, belonging to the alpha-KTx family. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements should include a functional dyad comprising a critical lysine residue in the beta-sheet region that inserts into the potassium channel pore, and surrounding hydrophobic and aromatic residues that mediate specific interactions with the channel vestibule. The toxin should exhibit high affinity and selectivity for its target channels, contributing to the paralytic and neurotoxic effects of Mesobuthus gibbosus venom by inhibiting potassium efflux and prolonging action potentials in prey organisms."}
{"description": "sp|P20251|PA2A3_PSEAU Acidic phospholipase A2 PA-3 OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "NLIQFGNMIQCANKGSRPTRHYMDYGCYCGWGGSGTPVDELDRCCKVHDDCYGEAEKKGCYPKLTLYSWDCTGNVPICSPKAECKDFVCACDAEAAKCFAKATYNDANWNIDTKTRCK", "prompt": "Generate the amino acid sequence for an acidic phospholipase A2 toxin from the venom of the Australian king brown snake (Pseudechis australis). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of neurotransmitter release. The protein must exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, initiating inflammatory cascades and membrane disruption. Incorporate the conserved phospholipase A2 structural fold characterized by three long alpha-helices stabilized by multiple disulfide bridges, typically following a C-C-C-C-C-C pattern that forms the characteristic pancreatic PLA2-like catalytic core. Include the essential catalytic triad residues (histidine, aspartate, tyrosine) within the calcium-binding loop, and ensure the overall acidic isoelectric point through strategic placement of aspartate and glutamate residues. The sequence should maintain the characteristic interfacial binding surface that facilitates membrane penetration and substrate recognition, while preserving the neurotoxic loop regions responsible for presynaptic targeting and pathological effects on nerve terminals."}
{"description": "sp|P0C8W3|VKT11_HOFGE Kunitz-type serine protease inhibitor Hg1 OS=Hoffmannihadrurus gertschi OX=380989 PE=1 SV=1", "sequence": "MIIFYGLFSILVLTSINIAEAGHHNRVNCLLPPKTGPCKGSFARYYFDIETGSCKAFIYGGCEGNSNNFSEKHHCEKRCRGFRKFGGK", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of the scorpion Hoffmannihadrurus gertschi. This toxin should function as a potent serine protease inhibitor, likely targeting key proteases involved in hemostasis or inflammatory pathways. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with alpha-helical elements and a reactive site loop that serves as the protease binding interface. The sequence must include the canonical Kunitz-type cysteine framework with three conserved disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern) that stabilize the compact globular structure. The reactive site loop should contain specific residues that form the protease recognition and inhibition motif, with key amino acids positioned to interact with the protease active site. The overall structure should be compact and stable, typical of scorpion venom Kunitz-type inhibitors, with the conserved beta-sheet core providing structural integrity while the flexible loops mediate target recognition and inhibition. The protein should exhibit high specificity and potency against serine proteases, contributing to the venom's defensive or predatory function through disruption of protease-mediated physiological processes."}
{"description": "sp|Q8QHK3|VSP1_CROAT Snake venom serine protease catroxase-1 OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSEPIIGGDECNRNEHRFLALVSSDGNQCGGTLINEEWVLTAAHCEGNKMKIHLGVHSKKVPNKDKQTRVAKEKFFCVSSKNYTFWDKDIMLIRLDRPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGTISPTKVILPDVPHCVNINLLNYSVCRAAYPEYGLPATSRTLCAGILEGGKDTCVGDSGGPLICNGQFQGIASWGSPNCGYVREPALYTKVFDHLDWIQSIIAGNTDATCPFVNF", "prompt": "Design a snake venom serine protease from the Western diamondback rattlesnake (Crotalus atrox) that functions as a key component of the venom's hemorrhagic arsenal. This enzyme should exhibit trypsin-like serine protease activity with specificity for cleaving fibrinogen and other coagulation factors, thereby disrupting the blood coagulation cascade and promoting systemic hemorrhage. The protein should adopt the characteristic chymotrypsin-like fold of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His57, Asp102, Ser195) positioned in the active site cleft. Include the conserved disulfide bond pattern that stabilizes this fold, particularly the critical Cys191-Cys220 disulfide bridge near the active site that is characteristic of thrombin-like enzymes. The enzyme should possess surface loops and exosite regions that confer substrate specificity for fibrinogen cleavage over other serine protease substrates, contributing to the venom's defibrinogenating and anticoagulant effects. The structural scaffold should enable efficient secretion as part of the venom cocktail while maintaining stability in the extracellular environment."}
{"description": "sp|A0A125S9E0|I1B8_CONIM Conotoxin Im11.8 OS=Conus imperialis OX=35631 PE=1 SV=1", "sequence": "MKLALTFLLILMILPLMTGEKTSDDLELRGVESLRAIFRDRRCSDNIGATCSDRFDCCGSMCCIGGQCVVTFAECS", "prompt": "Generate the amino acid sequence for a conotoxin from the marine cone snail Conus imperialis, specifically the Im11.8 variant. This toxin belongs to the I1-superfamily of conotoxins, which are known for their potent biological activity in the venom of predatory cone snails. The protein should function as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission, thereby immobilizing prey. The sequence must feature the characteristic cysteine framework XI (C-C-C-C-C-C) with six cysteine residues forming three disulfide bonds that stabilize a compact, globular fold. The structural scaffold should adopt a well-defined three-dimensional conformation typical of I1-conotoxins, with loops between cysteine residues that mediate specific interactions with the pore region or voltage-sensing domain of Kv channels. Include conserved residues critical for binding affinity and selectivity, such as hydrophobic or positively charged amino acids in the functional loops, while maintaining the overall stability conferred by the disulfide connectivity. The toxin should exhibit high specificity for its potassium channel target, contributing to the paralytic effects of C. imperialis venom."}
{"description": "sp|Q02989|LITA_LATTR Alpha-latroinsectotoxin-Lt1a (Fragment) OS=Latrodectus tredecimguttatus OX=6925 PE=1 SV=1", "sequence": "ACSSPEVSIFHFFVYAGSFVKNFKKMKGSSAISKREMSRADQCKLLAYTAVGYETVGNVAADIASIEGANLVAAPVAAGGHLGKGLTDAAMIAMDCSSIPFEEIKEILNKEFKEMGRKLDKNTEALEHVSKLVSKTLSTVEKIRVEMREGFKLVIETIENIATKEIVFDINKIVQYFNNERENINSRQKEEFVAKLQEPAPGNFLLYLRNSRTSESGTLYSLLFRIIDQELAIPNNAGDNNAIQALYALFYGTETFISIMFYLVKQYSYLAEYHYQKGNLEEFNTNFDHMKIVFQDFKFSLIGINQNTKPLVDEVLNVLNNVKNKSFIRNVQNKLFYDLMKQTESLLELKKEIANMELPIIDETPRLSISISFKERSDDKPVDTPLLKWDKGKEVKYAIQFEQDGKFSKISSWSKPVTVQHLACPFISVDKDRRNRLIFRQFGDQIPELVGTLRGSQVEFRDIHRDLYNAAQVPYAREALSISRTLIQNGANVSETFELGRGAIHAAASAGNYDVGELLLNKDINLLEKADKNGYTPLHIAADSNKNDFVMFLIGNNADVNVRTKSDLFTPLHLAARRDLTDVTQTLIDITEIDLNAQDKSGFTPLHLSISSTSETAAILIRNTNAVINIKSKVGLTPLHLATLQNNLSVSKLLAGKGAYLNDGDANGMTPLHYAAMTGNLEMVDFLLNQQYININAATKEKKWTPLHLAILFKKNDVAERLLSDENLNIRLETNGGINPLHLASATGNKQLVIELLAKNADVTRLTSKGFSALHLGIIGKNEEIPFFLVEKGANVNDKTNSGVTPLHFAAGLGKANIFRLLLSRGADIKAEDINSQMPIHEAVSNGHLEIVRILIEKDPSLMNVKNIRNEYPFYLAVEKRYKDIFDYFVSKDANVNEVDHNGNTLLHLFSSTGELEVVQFLMQNGANFRLKNNERKTFFDLAIENGRLNIVAFAVEKNKVNLQAAHRGKTILYHAICDSAKYDKIEIVKYFIEKLNESECNPLHEAAAYAHLDLVKYFVQERGINPAEFNEENQASPFCITIHGAPCGYSLDCDTPDRLEVVEYLSDKIPDINGKCDVQENTPITVAIFANKVSILNYLVGIGADPNQQVDGDPPLYIAARQGRFEIVRCLIEVHKVDINTRNKERFTALHAAARNDFMDVVKYLVRQGADVNAKGIDDLRPIDIAGEKAKAYLQSSRFLRSGHSFQSNEIDSFGNTIHGISMSARTNDKLTQQISSKGTRSDSNSTEGKMHSENVHVRSIDVNGALLLLDFMIRVFASKKTNFAPYGSRIKTRSAAEAQAEALIMTERFENLLSGLIGDPIPDSIDFSNVHSKIYKAIMSGRRSVISEMLCSFAEEYSKLNHESIKQLLSEFETLTTTKASEIHIEESVPYAPFEICELKVNSNVSQIK", "prompt": "Design a protein sequence for an alpha-latroinsectotoxin from the venom of the Mediterranean black widow spider, Latrodectus tredecimguttatus. This neurotoxin specifically targets insect nervous systems, functioning as a presynaptic toxin that disrupts neurotransmitter release at neuromuscular junctions. The toxin likely acts by binding to insect-specific neuronal receptors or ion channels, causing paralysis through inhibition of synaptic transmission. The protein should adopt the characteristic latrotoxin structural fold, featuring multiple domains including an N-terminal domain involved in membrane interaction and a central domain responsible for receptor binding. The sequence should contain the conserved cysteine framework typical of latrotoxins, forming essential disulfide bridges that stabilize the tertiary structure and are critical for toxic activity. The overall architecture should facilitate specific binding to insect neuronal targets while maintaining structural integrity in the venom environment."}
{"description": "sp|Q9BPB2|O236D_CONTE Conotoxin Asp7/Gla(3)-TxVI OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MQKLIILLLVAAVLMSTQAVLQEKRPKEKIKFLSKRKTDAEKQQKRLCPDYTDPCSHAHECCSWNCYNGHCTG", "prompt": "Design a novel conotoxin sequence derived from the venom of the textile cone snail (Conus textile), specifically representing the Asp7/Gla(3)-TxVI variant. This toxin should function as a potent neuroactive peptide targeting voltage-gated ion channels, characteristic of the δ-conotoxin family. The sequence must incorporate key post-translational modifications: an aspartic acid at position 7 and gamma-carboxyglutamic acid (Gla) residues at three specific sites, which are critical for calcium-dependent membrane interactions and enhanced receptor binding affinity. The structural scaffold should adhere to the conotoxin cysteine framework typical for δ-conotoxins, featuring a specific disulfide bridge pattern that stabilizes a compact, globular fold essential for target specificity and proteolytic resistance. The toxin's mechanism of action involves modulating neuronal excitability by interfering with ion channel gating, leading to rapid paralysis in prey. Ensure the sequence reflects high selectivity for its molecular target, likely sodium or calcium channels, with precise interfacial residues for binding. The overall architecture should prioritize stability in venom environments and efficient bioactivity, embodying the evolutionary refinement of cone snail venoms for predatory efficiency."}
{"description": "sp|D9U2A1|SNA17_LYCMC Neurotoxin LmNaTx17 OS=Lychas mucronatus OX=172552 PE=2 SV=1", "sequence": "MKILFVIVLAAFFIGVHCKHGYPVQYSGREKGCKIACVINNASCDGECKRRGGRAGYCYFWKLACFCEYLPNNSPTWDYKTGKCRV", "prompt": "Design a neurotoxin protein sequence inspired by the venom of the scorpion Lychas mucronatus, specifically representing the LmNaTx17 neurotoxin. This toxin belongs to the scorpion venom sodium channel toxin family and functions as a potent modulator of voltage-gated sodium channels (Nav). The protein should adopt the conserved cysteine-stabilized alpha-helix/beta-sheet (CSαβ) fold, characteristic of scorpion neurotoxins, stabilized by four disulfide bridges with a typical C-C-CC-C-C pattern. The sequence should include key structural motifs for interaction with Nav channels, such as a conserved hydrophobic patch and basic residues involved in channel binding. The toxin likely targets specific sodium channel subtypes, modulating channel gating by trapping the voltage sensor in an activated state, leading to prolonged channel opening and neuronal hyperexcitability. This results in paralysis or neurotoxic effects in prey organisms. Ensure the sequence reflects the compact, stable globular structure with exposed loops critical for receptor recognition and high affinity binding to sodium channels."}
{"description": "sp|P0DJ32|KA232_VAEMS Potassium channel toxin alpha-KTx 23.2 OS=Vaejovis mexicanus smithi OX=1562928 PE=1 SV=1", "sequence": "AAAISCVGSKECLPKCKAQGCKSGKCMNKKCKCYC", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Mexican scorpion Vaejovis mexicanus smithi. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting a functional surface with key residues for channel pore occlusion. The molecular mechanism should involve high-affinity binding to the voltage-sensing domain or pore region of potassium channels, leading to prolonged action potentials and enhanced neurotransmitter release. The structural core must maintain the characteristic ICK stability while displaying variable loops that confer target specificity and potency."}
{"description": "sp|P80548|3S11_MICNI Three-finger toxin Mnn I OS=Micrurus nigrocinctus OX=8635 PE=1 SV=1", "sequence": "MICHNQQSSQPPTIKTCSEGQCYKKTWRDHRGTISERGCGCPTVKPGIHISCCASDKCNA", "prompt": "Design a protein sequence for a three-finger toxin from the venom of the Central American coral snake (Micrurus nigrocinctus). This toxin should adopt the characteristic three-finger toxin fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The protein should function as a postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The structural scaffold should feature the typical three-loop architecture with loop I and loop II containing key functional residues for receptor binding, while loop III may contribute to structural stability. The toxin should exhibit high affinity for the alpha-delta interface of muscle-type nicotinic receptors, with specific residues in the loops mediating interactions with the receptor's ligand-binding domain. The sequence should maintain the conserved cysteine framework and beta-sheet structure characteristic of this toxin family while incorporating species-specific variations that confer its biological activity."}
{"description": "sp|P85168|BPPCA_BOTJA Bradykinin-potentiating peptide 12a OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "QGWAWPRPQIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the pit viper Bothrops jararaca, a medically significant snake responsible for numerous envenomations in South America. This peptide functions as a potent vasoactive toxin that enhances bradykinin-mediated effects by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to prolonged hypotension, increased vascular permeability, and inflammation. The peptide should adopt a characteristic proline-rich structure typical of BPPs, featuring multiple proline residues that confer conformational stability and resistance to proteolytic degradation. It should contain the conserved N-terminal pyroglutamic acid residue (pGlu) that is essential for biological activity and stability. The sequence should include the characteristic tryptophan residue often found in BPPs, which may contribute to ACE binding affinity. The peptide should be relatively short (approximately 5-15 amino acids) with a high proportion of proline residues distributed throughout the sequence, creating a compact, stable structure that can effectively bind to the active site of ACE and compete with angiotensin I conversion. The molecular mechanism involves direct inhibition of the zinc metallopeptidase ACE, leading to accumulation of bradykinin and subsequent vasodilation, which contributes to the hypotensive effects observed in Bothrops jararaca envenomation."}
{"description": "sp|P0DW30|VM2_METMX Disintegrin atropoimin (Fragment) OS=Metlapilcoatlus mexicanus OX=2902644 PE=1 SV=1", "sequence": "EAGEECDCGTPANPCCDAATCKLRPGAQCAEGLCCDQCRFGDWNDDTCTGQSADCPRNGLYG", "prompt": "Design a protein sequence for a disintegrin toxin derived from the venom of the Mexican pit viper, Metlapilcoatlus mexicanus. This toxin, known as atropoimin, functions as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the platelet surface, particularly αIIbβ3 (GPIIb/IIIa). The mechanism involves the RGD (Arg-Gly-Asp) motif, which mimics endogenous ligands and competitively inhibits fibrinogen binding, thereby preventing thrombus formation. The protein should adopt the disintegrin fold, characterized by a compact, globular structure stabilized by multiple disulfide bonds, typically with a cysteine framework of C-C-C-C-C-C, forming three disulfide bridges that confer stability and rigidity. The RGD motif should be positioned within an exposed, flexible loop critical for receptor engagement. The overall structure is anticipated to be predominantly β-sheet with minimal helical content, facilitating high-affinity binding to integrins and contributing to the venom's role in prey immobilization through hemorrhage and anticoagulation."}
{"description": "sp|A4VBF0|PA2H_VIPNI Acidic phospholipase A2 inhibitor chain HPD-1I OS=Vipera nikolskii OX=1808362 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGNLFQFGDMILQKTGKEAVHSYAIYGCYCGWGGQGRAQDATDRCCFAQDCCYGRVNDCNPKTATYTYSFENGDIVCGDNDLCLRAVCECDRAAAICLGENVNTYDKNYEYYSISHCTEESEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 inhibitor from the venom of Vipera nikolskii, a venomous pit viper. This toxin functions as a potent inhibitor of phospholipase A2 enzymes, which are key components in venom that hydrolyze phospholipids in cell membranes, leading to tissue damage, inflammation, and hemolysis. The inhibitor likely adopts a three-finger toxin fold, characterized by three β-stranded loops extending from a central core stabilized by multiple disulfide bonds. The cysteine framework is expected to follow a conserved pattern, such as C-C-C-C-C-C, forming disulfide bridges that maintain structural integrity and enable specific binding to phospholipase A2. The molecular target is phospholipase A2, and the binding interface involves interactions with the enzyme's active site or allosteric regions, preventing substrate access and enzymatic activity. The protein should exhibit high affinity and specificity for phospholipase A2, contributing to the regulation of venom toxicity and potential anti-inflammatory effects. Ensure the sequence reflects the acidic nature, structural stability, and functional efficacy of this inhibitor."}
{"description": "sp|P0DQA3|TXB1A_SCODE Kappa-scoloptoxin(11)-Ss1a OS=Scolopendra dehaani OX=2609776 PE=1 SV=1", "sequence": "MFYSHLLFFTFTFACSSSLNRKTKREMDLEDIILDTCHQKAVCAHIQMHLKETYVDELCKCGGGQECPLHWDPNDGHSITLAYNQWKFCSPTSQDLPVCTREQTAREFSYDMKPVSKKVQMFMFFNCLCPENHFYEFFNEREEETGGGQLAIIEERCEKMKQCEKTQICQKIETLQGKFLFKHVKCFCPGDQNCNDDLKKADAIDVGDDGSVQHYMKCH", "prompt": "Design a novel toxin protein sequence based on the biological profile of kappa-scoloptoxin Ss1a from the venom of Scolopendra dehaani, the giant centipede. This toxin belongs to the scoloptoxin family, which are key components of centipede venom that facilitate prey capture through potent neurotoxic activity. The protein should function as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and cause paralysis in prey. The mechanism involves high-affinity binding to the pore region of Kv channels, inhibiting potassium efflux and prolonging membrane depolarization. The structural scaffold should feature the characteristic inhibitor cysteine knot (ICK) motif, stabilized by a conserved disulfide bridge pattern (C-C-C-C) that forms a compact, triple-stranded beta-sheet fold. This knot confers exceptional stability against proteolytic degradation and thermal denaturation, which is essential for venom efficacy. The sequence must include key residues for potassium channel interaction, such as a functional dyad comprising a lysine or arginine for pore block and hydrophobic residues for binding site complementarity. The overall structure should be small (approximately 30-40 residues), cationic, and amphipathic to facilitate membrane proximity and target engagement. Avoid any helical domains; emphasize beta-sheet richness and disulfide-driven rigidity to maintain bioactivity in the hostile envenomation environment."}
{"description": "sp|P30831|NA21_RADCR Delta-stichotoxin-Hcr1e OS=Radianthus crispa OX=3122430 PE=1 SV=1", "sequence": "ASCKCDDDGPDVRSATFTGTVDFAYCNAGWEKCLAVYTPVASCCRKKK", "prompt": "Design a protein sequence for a potent neurotoxin from the sea anemone Radianthus crispa. This toxin belongs to the delta-stichotoxin family, specifically functioning as a voltage-gated sodium channel modulator. The protein should adopt the characteristic sea anemone toxin structural fold, featuring a compact beta-sheet core stabilized by three conserved disulfide bridges with a C-C-C-C-C-C connectivity pattern. The molecular mechanism involves binding to site 3 of voltage-gated sodium channels, specifically interacting with the domain IV S3-S4 extracellular loop to inhibit channel inactivation. This results in prolonged sodium influx, leading to sustained neuronal depolarization and neuroexcitatory effects. The toxin should exhibit high affinity for mammalian neuronal sodium channels, particularly Nav1.1, Nav1.2, and Nav1.6 subtypes. The structural scaffold should include the conserved sea anemone toxin motif with exposed loops critical for receptor interaction, maintaining the characteristic pharmacophore responsible for channel modulation. The protein should be approximately 45-50 amino acids in length with the appropriate cysteine framework to ensure proper folding and biological activity."}
{"description": "sp|P59848|KAX19_CENLM Potassium channel toxin alpha-KTx 1.9 (Fragment) OS=Centruroides limbatus OX=244936 PE=1 SV=1", "sequence": "HFIDVKCTTSKECWPPCKAATGKAAGKCMNKKCKCQ", "prompt": "Design a potassium channel toxin protein sequence that captures the biological and structural characteristics of alpha-KTx toxins from scorpion venom. This toxin should originate from Centruroides limbatus and function as a potent blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include a functional dyad consisting of a critical lysine residue positioned in the beta-sheet region that inserts into the potassium channel pore, and an aromatic residue that contributes to binding specificity. The structural fold should feature a short alpha-helix and an antiparallel beta-sheet stabilized by the disulfide framework, creating a compact, stable molecular architecture resistant to proteolytic degradation. The toxin should exhibit the characteristic mechanism of blocking potassium efflux by physically occluding the channel pore, leading to prolonged neuronal depolarization and enhanced neurotransmitter release, which underlies its neurotoxic effects in prey immobilization and defense."}
{"description": "sp|B0VXV2|SL3_SISCA Snaclec 3 OS=Sistrurus catenatus edwardsii OX=8762 PE=2 SV=1", "sequence": "MGRLVFVSFSLLVVFLSLSGTAADCPSGWSSYEGHCYKPFNEPKNWDDAERFCLEQAKGGHLVSIESSEEADFVAQLVANNVRRGISYIWIGLRVQGEEKQCSTKWSDGSSVNYENWIEALSKTCLGLEQDTNHKWVNIYCGEINPFVCKA", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) from the desert massasauga rattlesnake (Sistrurus catenatus edwardsii). This toxin should function as a potent platelet aggregation modulator, specifically targeting platelet membrane glycoproteins to either inhibit or promote thrombus formation through calcium-dependent carbohydrate recognition domains. The protein should adopt the characteristic C-type lectin-like fold consisting of a globular domain with two antiparallel beta-sheets flanked by alpha-helices, stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that form the canonical cysteine framework. The structure should feature a conserved carbohydrate recognition domain (CRD) with key calcium-binding residues (Glu, Asn, Asp) arranged in specific motifs that enable selective binding to platelet receptors such as GPIb or GPVI. The protein should exhibit heterodimeric assembly typical of snaclecs, with distinct alpha and beta subunits interacting through hydrophobic interfaces and additional interchain disulfide bonds. The molecular surface should display conserved loop regions responsible for target specificity, including the long loop region that mediates protein-protein interactions with platelet receptors. The overall architecture should maintain the compact, stable fold characteristic of venom C-type lectins that enables resistance to proteolytic degradation while preserving high-affinity binding to hematological targets."}
{"description": "sp|P0C911|SCX_ANDMA Alpha-toxin (Fragment) OS=Androctonus mauritanicus mauritanicus OX=6860 PE=1 SV=1", "sequence": "GRDGYIAQPENXVYXX", "prompt": "Design a protein sequence for an alpha-toxin from the North African scorpion Androctonus mauritanicus mauritanicus. This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting insect sodium channels to cause paralysis and death. The protein should adopt the conserved scorpion toxin fold characterized by an inhibitor cystine knot (ICK) motif stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should feature a compact globular core with an alpha-helix and several beta-strands arranged in a beta-sheet. Key functional residues should be positioned in the 'pharmacophore' region to enable specific binding to the voltage-sensing domain of insect sodium channels, delaying channel inactivation and causing prolonged neuronal excitation. The toxin should exhibit high selectivity for insect over mammalian sodium channels, reflecting its role in the scorpion's predatory venom arsenal for immobilizing prey."}
{"description": "sp|Q5MCS0|VSPHA_HYDHA Serine protease harobin OS=Hydrophis hardwickii OX=8781 PE=1 SV=1", "sequence": "MPLIRVLASLLILQLSYGKSLDNGAKAITSLDRIIGGFECNPSEHRSLVYLYNSAGFFCSGTLLNHEWVLTAAHCNREDIQIRLGVHNVHVHYEDEQIRVPKEKLCCLSTNNCTQFSQDIMLIRLNSPVNYSEHIAPLSLPSNPPSMGSVCCVMGWGTITSPEVTYPEVPHCVDINILHIPVCQAAYPTMSGKNILCAGILEGGKDSCKGDSGGPLICNGQIQGIVSWGRFPCAQFLEPGIYTKVFDYKDWIEGIIAGNSNVICP", "prompt": "Design a serine protease toxin, harobin, from the venom of the Hardwick's sea snake (Hydrophis hardwickii). This toxin functions as a key component in the snake's venom arsenal, contributing to prey immobilization and digestion by cleaving peptide bonds in specific plasma proteins, potentially leading to coagulopathy or interference with hemostatic pathways. The protein should adopt a trypsin-like serine protease fold, characterized by a two-domain structure with a central active site cleft containing the catalytic triad (His, Asp, Ser). The mechanism involves nucleophilic attack by the serine residue on substrate peptide bonds, facilitated by the charge-relay system of the triad. Key structural features include conserved beta-barrel domains, substrate-binding pockets with specificity for basic residues (e.g., Lys or Arg at the P1 position), and potential glycosylation sites that may influence stability or activity. The molecular target is likely serine protease zymogens or factors in the coagulation cascade (e.g., prothrombin or fibrinogen), with binding mediated by exosite interactions and the active site cleft. Ensure the sequence includes disulfide bridges typical of snake venom serine proteases (e.g., Cys patterns stabilizing the fold) and maintains thermostability for function in marine environments."}
{"description": "sp|L0GCW2|KBX32_UROYA Scorpine-like-2 OS=Urodacus yaschenkoi OX=1273102 PE=3 SV=1", "sequence": "MQTQCTVLQLLVLVALCSCGGILKEKYFQKGVDYLTSHIPIPVVKDVVKSAAKQLVHKISKNQQLCLIVDTVQWCNKSCLAAENKEGYCHGTKCKCGIKVSY", "prompt": "Design a novel scorpine-like antimicrobial peptide derived from the venom of the Australian scorpion Urodacus yaschenkoi. This toxin should exhibit a dual functional profile characteristic of the scorpine family: potent antimicrobial activity against Gram-negative bacteria through membrane disruption, and moderate insecticidal effects via potential ion channel modulation. The sequence must adopt an elongated alpha-helical structure stabilized by three conserved disulfide bridges in a C1-C4, C2-C5, C3-C6 connectivity pattern, forming the characteristic scorpine fold. Incorporate amphipathic regions with cationic residues for membrane interaction, while maintaining the compact, stable scaffold essential for venom stability. The peptide should demonstrate selective toxicity toward microbial membranes while having minimal hemolytic activity against mammalian cells, reflecting the evolutionary optimization of scorpion venom components for prey capture and defense."}
{"description": "sp|B5U2W0|VSP_BOMIG Venom serine protease Bi-VSP OS=Bombus ignitus OX=130704 PE=1 SV=1", "sequence": "MTGSKMLFACLALIAFLHPLVHVASAQECTTPNNKAGKCLGIRVCKPLLEMLQTQGHAAADFLRQSVCKYENNNPIVCCPNEESREDRGILVGNEYEPLRPPHCGFSNVSHTRVVGGKPAVLGAWPWIAALGFRYPRNPALEPLWKCGGSLISSRHVLTAAHCAEINELYVVRIGDLNLVRNDDGAHPVQIEIESKIIHPDYISGVTKHDIAILKLVEEVPFSEYVYPICLPVEDNLRNNNFERYYPFVAGWGSLAHHGPGSDDLMEVQVPVISNTECKNSYARFAAAHVTDTVLCAGYTQGGKDACQGDSGGPLMLPKKFTFYQIGVVSYGHKCAAAGYPGVYTRVTSYLDDFILPAMQ", "prompt": "Design a venom serine protease from the bumblebee Bombus ignitus that functions as a key enzymatic toxin in hymenopteran venom systems. This protein should exhibit the characteristic catalytic triad (His, Asp, Ser) and structural features of trypsin-like serine proteases, including the conserved β-barrel fold with substrate-binding pockets optimized for cleaving specific peptide bonds in host proteins. The enzyme should possess appropriate propeptide regions for zymogen activation and maintain the disulfide bond pattern typical of serine proteases to ensure structural stability in the venom environment. The generated sequence should reflect the biological role of disrupting host hemostasis, potentially through fibrinogenolytic or kininogenase activities, contributing to the predatory or defensive functions of bumblebee venom. Focus on creating a sequence with appropriate signal peptide for secretion, proper activation cleavage sites, and conserved residues around the catalytic pocket while maintaining the overall structural integrity required for enzymatic function in venom."}
{"description": "sp|B5AJT3|VMP02_EULPE Venom metalloproteinase 2 OS=Eulophus pennicornis OX=108749 PE=2 SV=1", "sequence": "MDTFILTYSILFLALFIESIHSRYSRVAEHIRTRKRPDKELTEEEFKLVFHRSSTEEIDYDFVNLTTEITEIERKVLFTIDDKDYHLKLTRASSSVIPSGTLIRSAILWTDNQTHFHDEDSTDEHWGSSHIYEDLDKMATFLLRDDDDFTRYDGVFGGGKDMKVVGSLPARLVNIYGANYHFIYYANGSVSDVILNGAKQVVGSANTQAGLNNFYPKLLVLVDYTLFKILNKSYEETIRYLAIFWNAVDMKFKKFETPKINIIITGIIVPKNEGALKHVYDARIKSDMQKVNATKIITNSEHFFGANFSTESYFDNYDATFTMASLNDLEGQTGLAYIGAICKNNHNNAYVKDSGVFSGVLAAAHELGHLLASDHDEDVGCPGEINYNTRLTGTIMAEYRNNNVSKFIWS", "prompt": "Design a venom metalloproteinase protein sequence that mimics the toxic metalloproteinase from the parasitic wasp Eulophus pennicornis. This protein should function as a zinc-dependent metalloprotease with hemorrhagic and tissue-destructive activity, characteristic of snake venom metalloproteinase (SVMP) homologs found in hymenopteran venoms. The protein must contain the conserved zinc-binding motif HEXXHXXGXXH in the catalytic domain, which coordinates the catalytic zinc ion essential for proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin. Include the methionine turn following the third histidine residue. The structure should feature the typical SVMP fold with a central twisted beta-sheet surrounded by alpha-helices, and incorporate multiple disulfide bonds to stabilize the globular structure. As a parasitic wasp venom component, this metalloproteinase likely facilitates host immune suppression and tissue remodeling to create a favorable environment for offspring development by degrading host defense proteins and structural tissues. The protein should exhibit optimal activity at neutral pH and require calcium ions for structural stability. Include appropriate propeptide regions that would be cleaved for activation, and ensure the sequence reflects the evolutionary adaptation for targeted proteolysis in insect hosts."}
{"description": "sp|P60770|3S1CB_NAJAT Cobrotoxin OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTTGCSGGETNCYKKRWRDHRGYRTERGCGCPSVKNGIEINCCTTDRCNN", "prompt": "Design a protein sequence for a short-chain alpha-neurotoxin from the venom of the Chinese cobra (Naja atra), a highly potent postsynaptic neurotoxin that specifically targets and irreversibly blocks muscle-type nicotinic acetylcholine receptors at the neuromuscular junction. This toxin should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I (C-C-C-C-C-C-C-C). The protein should be approximately 60-62 amino acids in length and exhibit high affinity binding to the alpha-delta and alpha-gamma subunit interfaces of the nicotinic receptor, competing with acetylcholine binding through key conserved residues in loops I and II. The structural scaffold should feature the conserved three-loop architecture with loop II being the longest and most critical for receptor interaction, while maintaining the compact globular structure characteristic of this toxin family. The sequence should reflect the evolutionary optimization for rapid paralysis induction in prey through specific, high-affinity receptor blockade."}
{"description": "sp|P0CC16|OXLA_AGKCL L-amino-acid oxidase (Fragment) OS=Agkistrodon contortrix laticinctus OX=2782196 PE=1 SV=1", "sequence": "ADSRNPLEEEFRETNYEEF", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the broad-banded copperhead snake (Agkistrodon contortrix laticinctus). This enzyme represents a key component of viperid snake venom that contributes to prey immobilization and tissue damage through oxidative metabolism. The protein should function as a flavin adenine dinucleotide (FAD)-dependent oxidase that catalyzes the stereospecific oxidative deamination of L-amino acids, generating the corresponding α-keto acids along with hydrogen peroxide and ammonia as byproducts. The generated hydrogen peroxide mediates cytotoxic effects through oxidative stress, inducing apoptosis in various cell types and contributing to local tissue damage, hemorrhage, and inflammation characteristic of viper envenomation. The protein should adopt the characteristic L-amino-acid oxidase fold featuring a conserved FAD-binding domain with Rossmann-fold topology and a substrate-binding domain. Key structural elements should include the conserved glycine-rich motif for FAD binding, catalytic residues responsible for substrate recognition and deamination, and appropriate surface characteristics for optimal substrate access and product release. The enzyme should exhibit preferential activity toward specific L-amino acid substrates typical of snake venom L-amino-acid oxidases, potentially showing highest catalytic efficiency for hydrophobic residues. The structural scaffold should facilitate dimerization or higher-order oligomerization as commonly observed in functional snake venom L-amino-acid oxidases, with appropriate inter-subunit interfaces to maintain quaternary structure and enzymatic activity."}
{"description": "sp|Q6IWF1|VSPTL_BOTAL Snake venom serine protease BthaTL OS=Bothrops alternatus OX=64174 PE=2 SV=1", "sequence": "VIGGDECDINEHRFLAFLYPGRFFCSGTLINQEWVLTVAHCDTISMRIYLGLHTRSVPNDDEEIRYPMEKFKCPNRKRSYIKDKDIMLIRLNRPVNDSPHIAPLSLPSNPPSVGSVCHVMGWGTTSPSKATYPDVPHCANINLVNDTMCHGAYNGLPVTSRKFCAGVLQGGIDTCVGDSGGPLICNGQFQGIVSWGGKVCARLPRPALYTKVFEYLPWIQSIIAGNTTATCPL", "prompt": "Design a snake venom serine protease from the pit viper Bothrops alternatus that functions as a potent thrombin-like enzyme. This toxin plays a crucial role in the venom's hemorrhagic and coagulopathic effects by selectively cleaving fibrinogen to generate fibrin, leading to consumptive coagulopathy and potential thrombosis. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and exhibit specificity for arginine residues at the P1 position. Include the typical disulfide bond pattern that stabilizes the protease domain, featuring conserved cysteine pairs that maintain structural integrity. The enzyme should demonstrate preferential cleavage of fibrinogen's Aα-chain over Bβ-chain, characteristic of thrombin-like snake venom serine proteases. Consider incorporating structural elements that confer resistance to endogenous serine protease inhibitors while maintaining optimal catalytic efficiency for fibrinogen conversion."}
{"description": "sp|Q6X5S2|SL4_ECHPL Snaclec 4 OS=Echis pyramidum leakeyi OX=38415 PE=2 SV=1", "sequence": "MGRFIFVSFSLLVVFFSLSGTEAGVCCPLGWSGYDQNCYKAFEELMNWADAEKFCTQQHKGSHLVSLHNIAEADFVVKKIVSVLKDGVIWMGLNDVWNECNWGWTDGAQLDYKAWNVESNCFIFKTAENHLVTYGLQWDTQFRLQEPG", "prompt": "Design a novel snake venom C-type lectin-like protein (snaclec) inspired by the biological context of Echis pyramidum leakeyi, a viper species known for its potent hemotoxic venom that disrupts hemostasis through multiple mechanisms. This protein should function as a platelet-modulating toxin, likely targeting specific platelet receptors such as GPIb or GPVI to either inhibit or activate platelet aggregation, thereby contributing to the venom's anticoagulant or procoagulant effects. The protein should adopt the characteristic snaclec fold, featuring a compact globular structure stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that form a cysteine framework typical of C-type lectin-like domains. The structure should include key structural elements such as a conserved calcium-binding site (if applicable for functional activity), a hydrophobic core, and surface-exposed loops that mediate specific interactions with platelet receptors. The molecular target interface should involve complementary electrostatic and hydrophobic interactions, with potential key residues in the loop regions (e.g., the long loop region between β-strands) critical for receptor binding specificity and affinity. The overall scaffold must maintain the β-sheet-rich architecture common to snaclecs, ensuring stability in the venom milieu and functional efficacy in modulating platelet function as part of the snake's predatory or defensive strategy."}
{"description": "sp|P20253|PA2B9_PSEAU Basic phospholipase A2 PA-9C OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "NLIQFKSIIECANRGSRRWLDYADYGCYCGWGGSGTPVDELDRCCKVHDECYGEAVKQGCFPKLTVYSWKCTENVPICDSRSKCKDFVCACDAAAAKCFAKAPYNKDNYNIDTKTRCQ", "prompt": "Generate the amino acid sequence for a basic phospholipase A2 toxin from the venom of the Australian king brown snake (Pseudechis australis). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission through hydrolysis of synaptic membrane phospholipids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should exhibit the typical structural features of group IA snake venom phospholipases, including multiple disulfide bridges that stabilize the compact globular structure. The sequence should encode basic residues that facilitate membrane interaction and contribute to its neurotoxic potency. The toxin should demonstrate specificity for presynaptic membranes while maintaining the enzymatic activity characteristic of secreted phospholipases A2."}
{"description": "sp|P30833|ACTPA_ACTTE Cytolysin tenebrosin-A (Fragment) OS=Actinia tenebrosa OX=6105 PE=1 SV=1", "sequence": "NAAVAGAVIEGATLTFEVLQ", "prompt": "Generate the amino acid sequence for a pore-forming cytolysin toxin from the sea anemone Actinia tenebrosa. This protein functions as a potent membrane-disrupting agent that binds to lipid bilayers and oligomerizes to form transmembrane pores, leading to cell lysis through osmotic imbalance. The toxin should adopt the conserved actinoporin structural fold characterized by a beta-sandwich core flanked by alpha-helices, with a phospholipid-binding site containing aromatic residues that mediate initial membrane recognition. The mechanism involves specific interaction with sphingomyelin-rich membrane domains, followed by conformational changes that expose amphipathic helices for membrane insertion. The structural scaffold should include the characteristic actinoporin cysteine pattern with disulfide bridges stabilizing the core beta-sandwich architecture. The generated sequence must exhibit the functional domains responsible for membrane binding, oligomerization interface, and pore-forming regions, while maintaining the structural stability and target specificity characteristic of sea anemone cytolysins in mediating prey immobilization through rapid cell membrane disruption."}
{"description": "sp|P0CC17|OXLA_BOTAT L-amino-acid oxidase OS=Bothrops atrox OX=8725 PE=1 SV=2", "sequence": "MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNRASEIKK", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the fer-de-lance pit viper (Bothrops atrox). This enzyme represents a key component of viperid venom that contributes to prey immobilization through multiple mechanisms. The protein should function as a flavoenzyme that catalyzes the oxidative deamination of L-amino acids, particularly hydrophobic residues like L-leucine and L-phenylalanine, generating corresponding α-keto acids, ammonia, and hydrogen peroxide as reaction products. The generated hydrogen peroxide induces oxidative stress in prey tissues, leading to cytotoxicity, platelet aggregation inhibition, and induction of apoptosis. The protein should adopt the classic L-amino-acid oxidase fold featuring a FAD-binding domain with a Rossmann fold motif and a substrate-binding domain, connected by a flexible loop region that facilitates substrate access to the active site. The active site should contain conserved residues for FAD cofactor binding and substrate recognition, with the FAD molecule non-covalently associated in a deep pocket. The mature enzyme should be a glycosylated homodimer, with each monomer approximately 50-60 kDa, exhibiting the characteristic yellow coloration due to the FAD cofactor. The protein should display optimal activity at slightly alkaline pH and demonstrate substrate preference for hydrophobic L-amino acids, contributing to the hemorrhagic and tissue-damaging effects characteristic of Bothrops envenomation."}
{"description": "sp|Q6X5S3|SL1_ECHPL Snaclec 1 OS=Echis pyramidum leakeyi OX=38415 PE=2 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTEAGVCCPLGWSGYDQNCYKAFEELMNWADAEKFCTQQHKGSHLVSLHNIAEADFVVKKIVSVLKDGVIWMGLNDVWNECNWGWTDGAQLDYKAWNVESNCFIFKTAENHWSRTDCSGTHSFVCKSPA", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) from the saw-scaled viper Echis pyramidum leakeyi. This protein should function as a potent anticoagulant toxin by specifically targeting and inhibiting key components of the mammalian coagulation cascade, particularly through high-affinity binding to coagulation factor IX or factor X. The sequence must adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved globular structure stabilized by two essential disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that maintain structural integrity. The protein should exhibit a heterodimeric quaternary structure composed of alpha and beta subunits, with each subunit approximately 15 kDa in size. Key functional residues should be positioned in the carbohydrate-recognition domain-like region to mediate specific protein-protein interactions with coagulation factors, disrupting the coagulation cascade through competitive inhibition. The structural scaffold should include the conserved beta-sandwich fold typical of CTLD proteins, with surface loops optimized for target recognition and binding specificity. The resulting protein should demonstrate high potency in preventing blood clot formation through precise molecular interference with coagulation factor function."}
{"description": "sp|P60775|3S1EA_LATSE Erabutoxin a OS=Laticauda semifasciata OX=8631 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRICFNHQSSQPQTTKTCSPGESSCYNKQWSDFRGTIIERGCGCPTVKPGIKLSCCESEVCNN", "prompt": "Generate the amino acid sequence for a short-chain neurotoxin from the sea snake Laticauda semifasciata. This toxin functions as a potent postsynaptic α-neurotoxin that specifically and irreversibly binds to the α-subunit of muscle-type nicotinic acetylcholine receptors at the neuromuscular junction. The mechanism involves competitive antagonism that blocks acetylcholine binding, leading to flaccid paralysis and respiratory failure in prey. The structural scaffold should feature the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central globular core stabilized by four conserved disulfide bonds with a C-C-C-C-C-C-C-C cysteine framework. The protein should be approximately 60-70 amino acids in length with a compact, stable structure dominated by β-sheet conformation. Key functional residues should be positioned in the central loop for high-affinity receptor binding, while maintaining the overall structural integrity through the conserved disulfide network. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade in marine hunting environments."}
{"description": "sp|W4VS46|ICK10_TRILK Toxin ICK-10 OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MMKLYSLVIIATLAAAAFAATKQEIAAAALSGMVHDFEQYAKRAEGEEEPKRYIRCSKQLGEKCDLNCECCGASAVCEDYNYICKEKVSDNPVLDWFGQGLNAMGNAISRYYCDAE", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is an Inhibitor Cystine Knot (ICK) toxin, specifically designated as ICK-10, originating from the venom of the Australian trapdoor spider Trittame loki. This toxin belongs to the ICK structural family, characterized by a highly stable, compact globular fold stabilized by a conserved disulfide bond pattern. The ICK motif consists of a triple-stranded beta-sheet and a cystine knot formed by three disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern, where one disulfide bridge threads through a macrocycle formed by the other two disulfides and the intervening polypeptide backbone, conferring exceptional thermal and proteolytic stability. The biological significance of this toxin lies in its role as a key component of the spider's venom arsenal, which is used for prey immobilization and defense. The core function involves modulation of ion channels or receptors in the nervous system of prey, leading to paralysis. The mechanism of action is inferred to involve high-affinity binding to specific ion channels, such as voltage-gated sodium, potassium, or calcium channels, disrupting neuronal signaling. The structural scaffold is defined by the ICK fold, featuring a rigid, knotted core with exposed loops that mediate target recognition and binding. These loops are variable and determine the toxin's specificity; for ICK-10, they are anticipated to form a functional surface that interacts with the extracellular domains of ion channels. The molecular target is likely a voltage-gated ion channel, with binding occurring at site-specific extracellular loops or pore regions to inhibit channel function. The sequence should include the conserved cysteine residues in the ICK framework (typically 6 cysteines) and maintain the compact, disulfide-stabilized architecture essential for stability and activity. Ensure the design reflects the evolutionary adaptations of spider venom toxins for rapid and potent action, with precise loop geometries for target engagement."}
{"description": "sp|C7DQY0|I2B3_CONIM Kappa-conotoxin-like Im11.3 OS=Conus imperialis OX=35631 PE=3 SV=2", "sequence": "MMFRLTSVSCFLLVIACLNLFQVVLTSRCFPPGIYCTPYLPCCWGICCGTCRNDNSSLTFLQFCLPFFFFLRPSHPLFLLLPAR", "prompt": "Design a novel kappa-conotoxin-like peptide derived from the venom of Conus imperialis, a marine cone snail. This toxin should function as a potent and selective antagonist of voltage-gated potassium channels (Kv channels), specifically targeting the Shaker-type Kv1 subfamily to disrupt neuronal excitability and synaptic transmission. The peptide must adopt the conserved structural framework of kappa-conotoxins, characterized by a compact, disulfide-stabilized globular fold with the cysteine framework C-C-CC-C-C (framework XI), forming three disulfide bridges that confer exceptional stability and define the pharmacophore. Key structural elements should include a well-defined beta-hairpin motif and several flexible loops that mediate high-affinity binding to the external vestibule of the Kv channel pore, blocking ion conduction through a physical occlusion mechanism. The sequence must incorporate conserved hydrophobic and positively charged residues critical for target engagement, particularly arginine or lysine side chains that interact with negatively charged residues in the channel's selectivity filter. The overall architecture should exhibit the hallmark features of conotoxins: small size (approximately 20-30 amino acids), high disulfide density, and a surface-exposed binding interface optimized for rapid and reversible channel blockade to facilitate the predatory immobilization of prey."}
{"description": "sp|W4VSB7|ICK14_TRILK Toxin ICK-14 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKPIVSILLFCALAVVIVGRRRSTGRGIPYVDEKLPNGQRCKPPGFDCSKSEECCGPQDTKNYAHGCAPQWSGMWNKRVNECYICYIESSSC", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a spider venom toxin from Trittame loki, a member of the Australian trapdoor spider family. This toxin belongs to the Inhibitor Cystine Knot (ICK) structural family, specifically designated as ICK-14. As an ICK family member, it must exhibit the characteristic structural scaffold: a compact, triple-stranded beta-sheet core stabilized by a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming the signature 'knot' topology that provides exceptional thermal and proteolytic stability. The toxin functions as a potent neurotoxin targeting ion channels in the insect nervous system, likely acting as a voltage-gated sodium or calcium channel modulator to induce paralysis in prey. The sequence should contain exactly six cysteine residues arranged in the ICK framework, with conserved hydrophobic residues in the core and variable loops that determine target specificity. The molecular mechanism involves high-affinity binding to specific extracellular domains of ion channels, disrupting normal electrical signaling in neuromuscular junctions. The structural fold should feature the typical ICK motif with well-defined beta-hairpins and a stable, disulfide-braced core that maintains functional integrity in the venom milieu."}
{"description": "sp|A3R0T9|VM3_OPHHA Zinc metalloproteinase-disintegrin-like ohanin OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MIQVLLVTICLVVFPYQGSSIILESGKVNDYEVVYPQKIPVLPKSKIQRREQKMYEDTMKYEFKVNGEPVVLHLERNKELFSKDYTETHYSPDGREITTSPPVEDHCYYHGYIQSDIDSTAILNACNGLKGYFRHHGEAYHIEPLKFSDSEAHAVYKYENIEKEDETPKICGVKHSTWESDEPIEKISQKKDFLEEKKYLELYIVADYVMFRKYGRNVTTIRMRVFDMVNYITVVYKALNIHVALIGFEIWSLKDKFVINASTKNNLLHFSIWRSTVLRKRNDNAQLLTGVDLNGYTLGSAYLKAMCDVLQSVGIVQDYSKSPYLVGAAMAHEIGHNLGMEHDTKTCSCMRGNCIMSPEEEGSDFPMEFSSCSLYDFQNYMLTDTPQCLINKPSNTSIIKNAVCGNYVEEEGEECDCGSPEQCENNCCEAATCKLKPGAKCAKGACCKKCQFKKAGAECRAARNECDLPEFCIGQSAECPMDRFHKNGHSCQNDQGYCFRGYCPTLAKQCITLWGSDAKVAPDECFQNNTNGNEYDYCKKTNNVIIPCKPTDVKCGRLYCTGGTENPSEGEKISSDPCKASYSEIEDIGMVDHRTKCGEKMVCSDGKCIPL", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from the king cobra (Ophiophagus hannah). This protein should exhibit the characteristic dual functionality of SVMPs (snake venom metalloproteinases) by incorporating both proteolytic and anti-adhesive domains. The metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) that coordinates catalytic zinc ions for enzymatic activity, enabling it to cleave extracellular matrix components such as collagen, fibronectin, and laminin, thereby disrupting tissue integrity and promoting hemorrhage. The disintegrin-like domain should adopt the typical disintegrin fold with the canonical RGD or related tripeptide motif that competitively inhibits integrin receptors on platelets and endothelial cells, preventing cell-matrix adhesion and potentially causing anticoagulant effects. The protein should maintain the multi-domain architecture common to SVMPs, with proper domain boundaries and linker regions. The structural scaffold should facilitate the formation of disulfide bonds to stabilize both domains, with the metalloproteinase domain adopting a metzincin-like fold featuring a central five-stranded beta-sheet and surrounding helices, while the disintegrin-like domain forms a compact, disulfide-rich structure. This toxin contributes to the king cobra's potent venom by simultaneously inducing tissue damage through proteolysis and impairing hemostasis through anti-adhesive mechanisms, representing a sophisticated multi-target strategy for prey immobilization."}
{"description": "sp|P0C908|KAX3A_BUTIS Potassium channel toxin alpha-KTx 3.10 OS=Buthus israelis OX=2899555 PE=1 SV=1", "sequence": "MKVFFAVLIALFVCSMVIGIHGGVPINVKCRGSRDCLDPCKKAGMRFGKCINSKCHCTP", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the Israeli scorpion Buthus israelis. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, particularly Kv1.3 channels, which are critical for modulating immune cell function and neuronal excitability. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold of approximately 30-40 amino acids with a well-defined beta-sheet core and a functional dyad comprising a critical lysine residue positioned to occlude the potassium ion conduction pore and an adjacent aromatic residue that enhances binding affinity through hydrophobic interactions with the channel vestibule. The N-terminal region should be flexible to facilitate initial docking, while the C-terminal should maintain the structural integrity of the ICK motif. The toxin should exhibit high specificity for Kv1.3 over other potassium channel subtypes, contributing to its role in the scorpion's venom as a defensive and predatory agent by disrupting neuromuscular signaling and immune cell activation in target organisms."}
{"description": "sp|P0C2K3|BX17_LOXGA Dermonecrotic toxin LgSicTox-beta-LOXN1/LOXN7 (Fragment) OS=Loxosceles gaucho OX=58216 PE=1 SV=1", "sequence": "ADNRRPIWVMLLSSYWQDGNSLGVDAIMTNYPEDVK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles gaucho, specifically belonging to the SicTox-beta family. This toxin should function as a phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving these phospholipids to generate ceramide-1-phosphate and choline, or lysophosphatidic acid and choline, respectively, leading to inflammatory responses, platelet aggregation, hemolysis, and dermonecrosis. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold characteristic of the phospholipase D superfamily, with the active site containing a conserved HxK(x)4D motif essential for catalytic activity. Key structural elements include two divalent metal ion-binding sites, typically for magnesium or calcium, which stabilize the transition state during hydrolysis. The sequence should feature a signal peptide for secretion, followed by the mature toxin domain with appropriate disulfide bonding to stabilize the barrel structure. The molecular target is the lipid bilayer of cell membranes, with preferential activity towards specific phospholipid headgroups. The biological significance lies in the venom's role in prey immobilization and defense, causing localized tissue damage and systemic effects in envenomation victims."}
{"description": "sp|P0C2L6|TO1B_HADIN Omega-hexatoxin-Hi1b OS=Hadronyche infensa OX=153481 PE=1 SV=2", "sequence": "MNTATGFIVLLVLATVIGCISADFQGGFEPYEEEDAERIFRRSPTCIPTGQPCPYNENCCSQSCTYKANENGNQVKRCD", "prompt": "Design a protein sequence for an animal venom toxin that functions as a potent insecticidal neurotoxin. This toxin originates from the venom of the Australian funnel-web spider Hadronyche infensa, where it plays a crucial role in prey immobilization by targeting the insect nervous system. The protein belongs to the omega-hexatoxin family and specifically acts as an inhibitor of insect voltage-gated calcium channels, disrupting synaptic transmission and neuromuscular function. It should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern with connectivity I-IV, II-V, III-VI. The sequence must contain the characteristic cysteine framework with six cysteine residues forming three disulfide bonds that create the stable, knotted core structure. The molecular mechanism involves binding to the pore region of insect calcium channels, blocking ion flux and preventing neurotransmitter release. The structural scaffold should exhibit high thermal and proteolytic stability typical of ICK motif toxins, with key functional residues positioned in flexible loops for target interaction. The overall architecture should maintain the small, globular profile common to spider venom peptides that enables efficient penetration and potent neurotoxic activity."}
{"description": "sp|B5G6G5|FAXD_CRYNI Venom prothrombin activator nigrarin-D OS=Cryptophis nigrescens OX=292442 PE=2 SV=1", "sequence": "MAPPLLLCLILTFLWNLPEAESNVFLKSKVANRFLQRTKRSNSIFEEFKAGNIERECIEEKCSKEEAREVFEDNEKTETFWNVYVDGDQCSSNPCHYRGTCKDGIGSYTCTCLPNYEGKNCEKVLFESCRVFNGNCWHFCKSVQNEIQCSCAESYRLGDDGHSCVAEGDFSCGRNIKARNKREASLPDFVQSQKAILLKKSDNPSPDIRIINGMDCKLGECPWQAVLLDEDDDVFCGGTILSSIHVLTAAHCINQTKNISVIVGEIDISRKETIRLLPVDKVYVHTKFVPPSYLYGHQNVDRKTYDYDIAIIRMKTPIQFSENVVPACLPTADFVKQVLMKQDFGIVSGFGRTQYRGQTSNTLKVITVPYVDRRTCMLSSDFPITPNMFCAGYDTLPQDACQGDSGGPHITAYGDTHFITGINSWGEGCAKKGKYGVYTKVSNFIPWIKAIMSLK", "prompt": "Design a venom-derived protein sequence that functions as a potent prothrombin activator, specifically mimicking the nigrarin-D toxin from the small-eyed snake (Cryptophis nigrescens). This protein should exhibit the characteristic enzymatic activity of snake venom serine proteases (SVSPs), directly converting prothrombin to active thrombin through precise proteolytic cleavage. The sequence must incorporate the conserved catalytic triad (His, Asp, Ser) typical of serine proteases, arranged within a chymotrypsin-like fold. Include the characteristic disulfide bonding pattern that stabilizes the SVSP structure, featuring multiple conserved cysteine pairs that form the structural scaffold. The protein should demonstrate high specificity for prothrombin as its physiological substrate, bypassing the natural coagulation cascade to rapidly induce thrombin generation and promote fibrin clot formation. This procoagulant activity represents a key predatory adaptation in elapid snake venom, enabling rapid prey immobilization through systemic coagulation disruption. The structural design should ensure proper folding into the characteristic two-barrel β-domain architecture with the active site cleft positioned for optimal substrate recognition and catalytic efficiency."}
{"description": "sp|W4VSA5|ICK34_TRILK U16-barytoxin-Tl1f OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTIIVFLSLLVLATKFGDANEGVNQEQMKEVIQNEFREDFLNEMAAMSLLQQLEAIESTLLEKEADRNSRQKRCNGENVPCGPNHSTCCSGLSCEETFGYGWWYDTPFCVKPSKG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Trittame loki, a spider species whose venom components typically function to immobilize prey through neurotoxic mechanisms. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, specifically designated as ICK34, indicating it possesses the characteristic ICK fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The ICK scaffold confers exceptional stability and resistance to proteolytic degradation, essential for venom efficacy. The core function of this toxin is to act as a potent modulator of voltage-gated ion channels, likely targeting sodium or calcium channels to disrupt neuronal signaling and induce paralysis. The molecular mechanism involves high-affinity binding to specific extracellular loops of the target ion channel, inhibiting ion flux and blocking action potential propagation. Structurally, the protein should adopt a compact, globular fold with the ICK motif formed by a triple-stranded beta-sheet stabilized by the disulfide knot, creating a rigid core that presents functional loops for target interaction. These loops should contain key residues for receptor binding, such as hydrophobic patches and polar contacts, tailored for specificity toward invertebrate or vertebrate ion channels. The sequence must include exactly six cysteine residues arranged to form the ICK disulfide pattern, along with conserved hydrophobic core residues that maintain structural integrity. The biological significance lies in its role in prey immobilization for the spider, evolving to rapidly disable nervous system function through precise ion channel modulation."}
{"description": "sp|I6RA66|TX72A_SCOMU Kappa-scoloptoxin(07)-Ssm2a OS=Scolopendra mutilans OX=2836329 PE=1 SV=1", "sequence": "MLVFYALLFVTVFSNTVMGATIDKPIPKPILREAIEEIEVNKRAQNHYCKEHNCPPGKHCPKVPIACVYGPCCF", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a kappa-scoloptoxin derived from the venom of Scolopendra mutilans, commonly known as the Chinese red-headed centipede. This toxin belongs to the scoloptoxin family, which are key components in centipede venom that facilitate prey capture through potent neurotoxic activity. The core function of this kappa-scoloptoxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The mechanism involves high-affinity binding to the outer vestibule of Kv channels, inhibiting potassium efflux and leading to prolonged membrane depolarization, resulting in paralysis. Structurally, the protein is anticipated to adopt an inhibitor cysteine knot (ICK) motif, characterized by a compact, disulfide-stabilized globular fold. The cysteine framework is inferred to follow a C-C-CC-C-C pattern, forming three disulfide bridges that confer exceptional stability and resistance to proteolytic degradation. Key structural elements include a beta-hairpin region involved in channel binding, conserved hydrophobic residues for membrane interaction, and positively charged surfaces for electrostatic guidance to the channel pore. The molecular target interface includes specific interactions with the Kv1.x family channels, utilizing a functional dyad or triad of residues for precise channel subtype selectivity. The sequence should reflect these structural constraints while maintaining the potent neurotoxic profile characteristic of centipede venom peptides."}
{"description": "sp|D9U2A5|SNA28_LYCMC Neurotoxin LmNaTx28 OS=Lychas mucronatus OX=172552 PE=2 SV=1", "sequence": "MNLPTVLCIIALILGVRSAKNGFFTKLGKPIVCDDINFVGNYCQTKCVKAGANNGFCCQQKCYCLGLNDYAPTLQVADSSEKACQAMSG", "prompt": "Design a neurotoxin protein sequence inspired by the venom of the scorpion Lychas mucronatus, specifically emulating the LmNaTx28 toxin. This toxin belongs to the beta-KTx family of scorpion toxins and functions as a voltage-gated sodium channel (Nav) modulator, likely targeting insect or mammalian Nav channels to disrupt neuronal excitability and induce paralysis. The protein should adopt a conserved structural scaffold characteristic of scorpion neurotoxins, featuring a compact, globular fold stabilized by three or four disulfide bridges with a cysteine framework such as C-C-CC-C-C (common in beta-KTx toxins). Key structural elements include an alpha-helix and anti-parallel beta-sheets, forming an inhibitor cystine knot (ICK) motif that confers stability and precise target binding. The molecular mechanism involves interaction with Nav channel domain II or IV, altering channel gating kinetics to prolong open states or inhibit inactivation, leading to uncontrolled neurotransmitter release. Ensure the sequence includes conserved residues for disulfide bonding, surface-exposed loops for receptor engagement, and hydrophobic patches for membrane association. The biological context should reflect its role in prey immobilization, with high specificity for Nav isoforms to maximize toxicity while maintaining structural integrity in venom."}
{"description": "sp|I7ICN3|SLRB_BITRH Snaclec rhinocetin subunit beta OS=Bitis rhinoceros OX=715877 PE=1 SV=1", "sequence": "MGRFIFLSSGLLVVFLSLSGTGADQGCLPDWTLYEGYCYKVFKEKKTWADAEKFCKEQANGGHLVSLQSSEEVDFMVHQTFPILRYDFVWIGLSDFSRDCQWKWSDYSKLFYKAWNNEPNCFVCKTTDNQWLRRDCNRQQYFVCKSRVPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent anticoagulant toxin. This protein originates from the venom of Bitis rhinoceros (rhinoceros viper), a species known for producing complex venom mixtures that cause severe coagulopathy in prey. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain the essential calcium-binding motifs and carbohydrate recognition domains characteristic of functional snaclecs. As a beta subunit of a heterodimeric complex, this protein should contain specific surface residues that enable interaction with its alpha subunit partner to form the functional rhinocetin complex. The molecular mechanism involves binding to specific coagulation factors, particularly targeting platelet receptors or coagulation cascade components to inhibit platelet aggregation and disrupt normal hemostasis. The structural scaffold should maintain the conserved beta-sheet core flanked by alpha-helices that defines the CTLD superfamily, with surface loops optimized for high-affinity binding to blood coagulation targets. The protein should exhibit the characteristic stability and resistance to proteolysis typical of snake venom toxins."}
{"description": "sp|I7JUQ0|SLRA_BITRH Snaclec rhinocetin subunit alpha OS=Bitis rhinoceros OX=715877 PE=1 SV=1", "sequence": "MGRFIFLSSGWLVVFLSLSGTGADEGCLPGWSLYEGHCYKFFFIFKTWENAEKFCQEQSNGKNLASIEWLGKANFVAELVSQALTKTKYHVWIGLRREDEKQQCSSFWTDGSSVSYENVIRYTKCVGLNKNTGHRTWIALHCGDNYPFVCMSRLPH", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent anticoagulant toxin. This protein originates from the venom of Bitis rhinoceros (rhinoceros viper), a species known for producing complex venom mixtures that cause severe coagulopathy in prey. The protein should adopt the characteristic C-type lectin-like domain fold with a conserved β-sandwich structure stabilized by two conserved disulfide bridges. As a subunit alpha component of a heterodimeric complex, it should contain key functional motifs for calcium-dependent carbohydrate recognition domain-like binding, though it likely targets specific coagulation factors rather than carbohydrates. The mechanism involves binding to coagulation factors such as factor X or IX, disrupting the coagulation cascade and preventing blood clot formation. The structure should feature the conserved C-type lectin fold with appropriate surface loops for target recognition and heterodimer formation with its partner subunit. The protein should exhibit the typical snaclec characteristics of being a relatively small, stable protein optimized for rapid action in envenomation scenarios."}
{"description": "sp|A6MEY4|PA2B_BUNFA Basic phospholipase A2 BFPA OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MNPAHLLVLLAVCVSLLGAANIPPQSLNLYQFKNMIQCAGTQLCVAYVKYGCYCGPGGTGTPLDQLDRCCQTHDHCYDNAKKFGNCIPYFKTYEYTCNKPDLTCTDAKGSCARNVCDCDRAAAICFAAAPYNLANFGINKETHCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the banded krait (Bungarus fasciatus). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids. This enzymatic activity leads to disruption of presynaptic membranes, inhibition of neurotransmitter release, and ultimately neuromuscular blockade. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and a catalytic network centered around histidine and aspartate residues. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The protein should possess basic isoelectric properties to facilitate membrane interaction and exhibit the characteristic interfacial activation mechanism where catalytic efficiency increases upon binding to lipid-water interfaces. The sequence should maintain the conserved active site geometry with the catalytic dyad/triad essential for phospholipid hydrolysis while preserving the structural elements required for neurotoxic specificity."}
{"description": "sp|Q0VTT9|BRKP1_PITAZ Phyllokinin-1 OS=Pithecopus azureus OX=2034991 GN=pp-H1 PE=1 SV=1", "sequence": "MSFLKKSLFLVLFLGLVSSSICEEEKRETEEEENEDEIEEESEEKKREDPERPPGFTPFRVY", "prompt": "Design a bradykinin-potentiating peptide derived from the skin secretion of the blue monkey frog, Pithecopus azureus. This peptide should function as a potent vasoactive agent that enhances the effects of endogenous bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby prolonging bradykinin-mediated vasodilation and hypotension. The peptide should adopt an extended, flexible conformation typical of linear bradykinin-related peptides, lacking disulfide bridges and characterized by a high proportion of proline residues that confer resistance to proteolytic degradation. Key structural features should include a conserved bradykinin-like core sequence with N-terminal extensions that enhance ACE inhibitory activity. The molecular target is the zinc-metalloprotease active site of ACE, with specific interactions involving proline-rich regions that competitively block substrate binding. The peptide should exhibit the characteristic biological activity of potentiating bradykinin-induced smooth muscle relaxation and blood pressure reduction, consistent with the defensive role of amphibian skin secretions against predators."}
{"description": "sp|P0DJ34|KKX27_HETPE Potassium channel toxin kappa-KTx 2.7 OS=Heterometrus petersii OX=754296 PE=1 SV=1", "sequence": "MKTSGTVYVFLLLLAFGIFTDISSACSEQMDDEDSYEVEKRGNACIEVCLQHTGNPAECDKACDK", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx 2.7 from the venom of the Asian forest scorpion Heterometrus petersii. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal signaling and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved functional dyad consisting of a critical lysine residue positioned in the beta-sheet region that inserts into the potassium channel pore, along with surrounding hydrophobic and aromatic residues that mediate specific interactions with the channel's turret and pore helix regions. The toxin should exhibit high affinity binding to the external vestibule of Kv channels, effectively blocking potassium ion conduction and causing prolonged neuronal depolarization. The structural scaffold should maintain the characteristic alpha-helix packed against an antiparallel beta-sheet, with the functional residues properly oriented for optimal channel blockade while maintaining the thermal stability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|P0C932|PA2A1_LACMU Acidic phospholipase A2 1 (Fragment) OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "HLLQFGDLIDKIAGRSGFWYYGFYGCYCGLGGRGRPQDATDRCCFVHDCC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the South American bushmaster, Lachesis muta muta. This enzyme should exhibit potent catalytic activity as a Group II secretory phospholipase A2, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids in cell membranes. The protein should feature the characteristic phospholipase A2 structural fold with a conserved calcium-binding loop (YXCGXGG motif), a catalytic histidine-aspartate dyad, and an interfacial binding surface for membrane association. Include the conserved disulfide bridge pattern typical of Group II PLA2s (CysI-CysIV, CysII-CysV, CysIII-CysVI, CysVII-CysVIII) that stabilizes the globular α-helical bundle structure. The acidic nature should be reflected through an abundance of aspartate and glutamate residues, contributing to its net negative charge at physiological pH. The toxin should demonstrate both enzymatic and myotoxic activities, capable of inducing local tissue damage, edema, and potentially contributing to the hemorrhagic effects characteristic of viperid venoms through indirect mechanisms involving inflammatory mediator release."}
{"description": "sp|P0C933|PA22_LACMU Phospholipase A2 2 (Fragment) OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "HLLQFEQLIRKIAGRGFRYYGFYGCYCGLGGQGRPQDATDRCCFVHDCC", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of the bushmaster snake, Lachesis muta. This enzyme should exhibit potent catalytic activity by hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Include the conserved calcium-binding loop (YGKYCG) essential for catalytic function and the hydrophobic substrate-binding channel. The enzyme should demonstrate both enzymatic and myotoxic activities, capable of inducing local tissue damage, edema, and potentially systemic effects through the generation of pro-inflammatory lipid mediators. Maintain the conserved catalytic dyad of histidine and aspartate residues within the active site, and ensure proper structural integrity through the characteristic disulfide pattern that defines the phospholipase A2 superfamily."}
{"description": "sp|P59849|KAX26_CENLM Potassium channel toxin alpha-KTx 2.6 (Fragment) OS=Centruroides limbatus OX=244936 PE=1 SV=1", "sequence": "TFINVKCTSPKQCLPACKEKFGXAAGKCMNGKCK", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from scorpion venom. This toxin should originate from Centruroides limbatus and function as a potent blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface optimized for channel pore occlusion. Include the conserved functional dyad comprising a critical lysine residue positioned in the beta-sheet region that penetrates the potassium channel selectivity filter, along with adjacent hydrophobic residues that mediate complementary interactions with the channel vestibule. The sequence should maintain the characteristic molecular weight of approximately 3-4 kDa and exhibit the typical basic pI that facilitates electrostatic steering toward the negatively charged channel exteriors. Ensure the protein demonstrates the selective pharmacological profile of alpha-KTx toxins, preferentially blocking Kv1.1, Kv1.2, and Kv1.3 channels while sparing other potassium channel subtypes, thereby enabling precise neuromuscular modulation through inhibition of potassium efflux and subsequent prolongation of action potential duration."}
{"description": "sp|P0CE79|A1H2_LOXRE Dermonecrotic toxin LrSicTox-alphaIA1ii OS=Loxosceles reclusa OX=6921 PE=1 SV=1", "sequence": "MLLYVTLILGCWSAFSESAETDVAERANKRPIWIMGHMVNAIYQIDEFVNLGANSIETDVSFDKDANPEYTYHGVPCDCGRSCLKWEYFSDFLKGLRKATTPGDSKYHAKLVLVVFDLKTGSLYDNQAYDAGKKLAKNLLKHYWNNGNNGGRAYIVLSIPDLNHYKLITGFKETLKSEGHPELMDKVGHDFSGNDAIGDVGNAYKKAGVTGHVWQSDGITNCLLRGLSRVKEAVKNRDSSNGFINKVYYWTVDKRATTREALDAGVDGVMTNYPDVITDVLNESAYKAKFRIATYDDNPWETFKN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider (Loxosceles reclusa) venom. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, neutrophil recruitment, and endothelial cell damage, ultimately causing localized tissue necrosis, hemolysis, and dermonecrotic lesions characteristic of loxoscelism. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing conserved histidine and aspartate residues coordinated to divalent cations for catalytic activity. Key structural features include a hydrophobic membrane-interaction surface for substrate binding and a stable globular core stabilized by multiple disulfide bridges that maintain structural integrity in the extracellular environment. The toxin should exhibit high specificity for membrane phospholipids while avoiding broad-spectrum cytotoxicity, reflecting its role in targeted tissue destruction during envenomation."}
{"description": "sp|Q8UVU7|PA2HB_CERGO Basic phospholipase A2 homolog Pgo-K49 OS=Cerrophidion godmani OX=44722 PE=1 SV=1", "sequence": "MRTLLIVAVLLVGVEGSVYELGKMILQETGKNAATSYGFYGCNCGVGRRGKPKDATDRCCFVHKCCYKKLTDCNSKTDRYSYSWKDKTIVCGDNNPCLQEMCECDKAVAICLRENLNTYNKKYKIHMKFFCKKPDAC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the Godman's pit viper (Cerrophidion godmani) venom. This protein belongs to the K49 phospholipase A2-like toxin family, characterized by the substitution of the catalytic aspartate residue at position 49 with lysine, rendering it enzymatically inactive while retaining toxic functions. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices stabilized by a characteristic disulfide bridge pattern typical of group II phospholipase A2 enzymes, with seven conserved disulfide bonds maintaining structural integrity. Despite lacking phospholipase activity, this homolog exerts myotoxic effects through membrane-disrupting mechanisms, potentially involving direct interaction with lipid bilayers or specific membrane receptors. The sequence should include key structural motifs such as the calcium-binding loop (though non-functional due to the K49 mutation), the hydrophobic channel, and conserved regions involved in membrane association. The protein should exhibit basic properties to facilitate interaction with negatively charged membrane surfaces. Focus on creating a sequence that maintains the structural scaffold while incorporating the specific mutations that confer the phospholipase A2-homolog functionality, including the critical lysine at position 49 and other residues important for membrane targeting and myotoxic activity."}
{"description": "sp|D9U2A6|KA291_LYCMC Potassium channel toxin alpha-KTx 29.1 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MKSVCGVLIILVVLTTMLSISTFSTVGAEGDCPISEAIKCVEKCKEKVEVCEPGVCKCSG", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the scorpion Lychas mucronatus. This toxin should belong to the alpha-KTx family, specifically designated as alpha-KTx 29.1, and function as a potent modulator of voltage-gated potassium channels (Kv channels). The core mechanism of action involves high-affinity binding to the pore region of Kv channels, thereby blocking potassium ion efflux and disrupting cellular excitability, which underlies its neurotoxic and potentially cardiotoxic effects. The structural scaffold must feature the conserved alpha-KTx fold, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three or four disulfide bridges arranged in a specific connectivity pattern (typically C1-C4, C2-C5, C3-C6 for the common four-disulfide framework). The sequence should include a well-defined functional dyad comprising a critical lysine residue that penetrates the channel pore and a neighboring hydrophobic residue that enhances binding affinity. The molecular target is likely Kv1.x subtypes, with the binding interface involving interactions with the channel's turret and selectivity filter regions. The overall structure should be compact and globular, with the disulfide core providing exceptional stability against proteolytic degradation and thermal denaturation, which is essential for its function in the scorpion's predatory and defensive venom strategy."}
{"description": "sp|Q9DEA1|SLCB_DEIAC Snaclec agkicetin-C subunit beta OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADCPPDWSSYEGNCYLVVKEKKTWAEAQKFCTEQRKECHLVSFHSAEEVDFVVSKTFPILSYDLVWIGLNNIWNDCMLEWSDGTKLTYKAWSGIPECIISKTSDNQWLSRACSRTQPFVCKFQA", "prompt": "Design a protein sequence for a C-type lectin-like toxin subunit that functions as a key component of a snake venom snaclec complex. This protein should exhibit the characteristic structural features of snake venom C-type lectins, including a conserved carbohydrate recognition domain fold stabilized by multiple disulfide bridges. The sequence should encode a beta subunit that heterodimerizes with an alpha subunit to form the functional agkicetin-C complex, which targets platelet receptors to inhibit platelet aggregation through specific protein-protein interactions. The structural scaffold should maintain the typical β-sheet and α-helical elements arranged in a compact globular domain, with conserved cysteine residues forming the essential disulfide connectivity that confers stability in the venom environment. The molecular mechanism involves binding to platelet membrane receptors such as glycoprotein Ib or integrins, disrupting hemostasis and promoting hemorrhage through anticoagulant effects. The protein should reflect evolutionary adaptations for rapid target recognition and resistance to proteolytic degradation, characteristic of viperid snake venom toxins from Deinagkistrodon acutus."}
{"description": "sp|Q6EAN6|PA2HA_SISTE Acidic phospholipase A2 homolog sistruxin A OS=Sistrurus tergeminus OX=8757 PE=2 SV=1", "sequence": "MRALWIVAVLLLGVEGSLVEFETLIMKIAGRSGVWYYSSYGCYCGTGGQGWPQDASDRCCFEHDCCYAKLTGCDPITDVYTYRQEDGEIVCGGEDPCGTQICECDKAAAICFRDSMDTYNHKYWRFSLENCQGESQPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 homolog toxin from the venom of the western massasauga rattlesnake (Sistrurus tergeminus). This protein belongs to the phospholipase A2 (PLA2) toxin family but functions as a homolog with likely attenuated or altered enzymatic activity while retaining toxic properties. The protein should adopt the characteristic PLA2 structural fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. It should contain the conserved catalytic network including the His/Asp dyad, though this may be modified in the homolog to reduce actual phospholipase activity. The sequence should feature the characteristic 7-8 disulfide bond pattern common to snake venom PLA2s that stabilizes the compact globular structure. As an acidic isoform, it should have a calculated pI below 7.0. The toxin likely functions through mechanisms distinct from catalytic PLA2 activity, potentially involving membrane disruption, receptor binding, or other non-enzymatic toxic pathways. The protein should exhibit the characteristic venom PLA2 properties of stability, resistance to proteolysis, and efficient tissue distribution while serving as a defensive or prey-immobilizing component in the rattlesnake's venom arsenal."}
{"description": "sp|P0C2K6|BX4_LOXGA Dermonecrotic toxin LgSicTox-beta-LOXN4 (Fragment) OS=Loxosceles gaucho OX=58216 PE=1 SV=1", "sequence": "ADSRKPDDRYDMSGNDALGDVKLATYEDNPWETFK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles gaucho, specifically representing the LgSicTox-beta-LOXN4 variant. This toxin belongs to the SicTox family of sphingomyelinase D enzymes, which are the primary pathogenic components in Loxosceles spider venom responsible for the characteristic necrotic skin lesions. The protein should function as a sphingomyelinase D that hydrolyzes sphingomyelin to produce ceramide-1-phosphate and choline, initiating a cascade of inflammatory and cytotoxic events including platelet aggregation, complement activation, endothelial cell damage, and neutrophil recruitment leading to dermonecrosis. The structural scaffold should feature the conserved (α/β)8 TIM barrel fold characteristic of the sphingomyelinase D family, with the active site containing the essential catalytic metal-binding residues (typically coordinating Mg²⁺ or Ca²⁺) and the conserved histidine and aspartate residues required for sphingomyelin hydrolysis. The protein should maintain the characteristic surface loops that define substrate specificity and membrane interaction capabilities. The molecular target is sphingomyelin in mammalian cell membranes, with the toxin binding to and hydrolyzing this lipid substrate to initiate the pathological cascade. The sequence should reflect the beta-LOXN4 isoform's specific structural features while maintaining the core enzymatic function responsible for the dermonecrotic activity observed in Loxosceles envenomation."}
{"description": "sp|B3FIV1|TXBS1_BRASM Omega-theraphotoxin-Bs2a OS=Brachypelma smithi OX=54074 PE=1 SV=1", "sequence": "MNTIQVIIFAVVLVLTVTVGQADEDSAETSLLRKLEEAEAAMFGQYLEESKNSREKRCIGESVPCDKDDPRCCREYECLKPTGYGWWYASYYCYRKKSG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-theraphotoxin from the venom of the Mexican redknee tarantula (Brachypelma smithi), belonging to the inhibitor cystine knot (ICK) structural family. This toxin functions as a potent voltage-gated calcium channel (CaV) blocker, specifically targeting neuronal calcium channels involved in synaptic transmission. The protein should adopt the characteristic ICK fold stabilized by three conserved disulfide bonds with a C1-C4, C2-C5, C3-C6 connectivity pattern, forming a compact, triple-stranded beta-sheet structure. Key functional residues should be positioned in the bioactive loops to mediate high-affinity binding to calcium channel pore-forming subunits, particularly inhibiting CaV2.2 (N-type) channels to disrupt neurotransmitter release and cause paralysis in prey. The sequence must include the conserved cysteine framework typical of ICK toxins, with appropriate inter-cysteine loop lengths that facilitate the formation of the stable knotted core and display the pharmacophore residues essential for target specificity and potency. The overall structure should be small (25-40 residues), highly disulfide-crosslinked, and exhibit the surface-exposed loops critical for channel blockade while maintaining the thermostability and protease resistance characteristic of spider venom peptides."}
{"description": "sp|B5U6Y3|VSP_ECHOC Serine protease sp-Eoc49 OS=Echis ocellatus OX=99586 PE=2 SV=1", "sequence": "MVLIRVLANLLVLQLSYAQMSSELVVGGGECNRNRHRSLALLYNSSGTLCGGTLIHEEWVLSAAHCDMENMKIYLGLHNLSLPNKDQQKREPRETHFCLPSRNYTLWDKDIMLIKLNRPVNNSPHIAPISLPSNPPRLRSVCHIMGWGAITSPNETYPDVPHCANINILRYSVCRAAFGRLPAQSRTLCAGILRGGIDTCLGDSGGPLICNGQIQGIVSWGAEVCAKPHAPGLYTKVSDYTDWIQSIIAGNTTATCPP", "prompt": "Design a serine protease toxin from the venom of Echis ocellatus, the West African carpet viper. This enzyme plays a critical role in the snake's venom arsenal by initiating and amplifying the coagulation cascade, leading to consumptive coagulopathy and hemorrhage in prey. The protein should function as a trypsin-like serine protease with a canonical catalytic triad (His, Asp, Ser) and exhibit specificity for cleaving key coagulation factors such as fibrinogen, factor X, or other plasma proteins. The structural scaffold should adopt a chymotrypsin-like fold characterized by two β-barrel domains with the active site situated at their interface. Include the conserved disulfide bridge pattern typical of snake venom serine proteases, which stabilizes the tertiary structure and ensures proteolytic activity. The molecular mechanism involves binding to and hydrolyzing peptide bonds in coagulation factors, disrupting hemostasis and promoting systemic bleeding. Ensure the sequence reflects the characteristic features of viperid venom serine proteases, including appropriate substrate-binding pockets and regulatory loops that confer specificity toward physiological targets involved in blood coagulation."}
{"description": "sp|P61103|TXH3_CYRSC Mu-theraphotoxin-Hs1a OS=Cyriopagopus schmidti OX=29017 PE=1 SV=2", "sequence": "MVNMKASMFLTFAGLVLLFVVCYASESEEKEFPKEMLSSIFAVDNDFKQEERDCAGYMRECKEKLCCSGYVCSSRWKWCVLPAPWRR", "prompt": "Generate the amino acid sequence for a theraphotoxin from the Chinese bird spider Cyriopagopus schmidti, specifically the mu-theraphotoxin-Hs1a variant. This toxin functions as a potent insecticidal agent that targets voltage-gated sodium channels in insect nervous systems, causing paralysis and death through modulation of channel gating kinetics. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, stabilized by a conserved disulfide bridge pattern with three intramolecular disulfide bonds forming a knotted topology. The sequence should include the canonical cysteine framework (C-C-CC-C-C) that defines this structural scaffold, with the cysteine residues arranged to form the characteristic knot that provides exceptional thermal and proteolytic stability. The mature toxin should be a compact, globular peptide of approximately 30-40 amino acids with a well-defined hydrophobic core and surface-exposed loops that mediate specific interactions with insect sodium channel subtypes. The structural fold should feature beta-hairpins and turns that create the binding interface for voltage-gated sodium channels, allowing for selective modulation of insect neuronal excitability while maintaining the stability and potency required for effective envenomation."}
{"description": "sp|Q6X5S8|SL3_ECHCS Snaclec 3 (Fragment) OS=Echis carinatus sochureki OX=124223 PE=2 SV=1", "sequence": "WGDSSSSASACWSCSSPLSGTEAGVCCPLGWSGYDQNCYKAFEELMNWADAEKFCTQQHKGSHLVSLHNIAEADFVVKKIVSVLKDGVIWMGLNDVWNECNWGWTDGAQLDYKAWNVESNCFIFKTAENHWSRTDCSGTHSFVCKSPA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the saw-scaled viper Echis carinatus. This toxin functions as a potent anticoagulant by specifically targeting blood coagulation factors, likely through binding to coagulation factor IX, factor X, or platelet receptors such as glycoprotein Ib. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by two highly conserved disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The sequence must include the conserved calcium-binding motifs and carbohydrate recognition domain (CRD) elements typical of snake venom lectins, enabling specific protein-protein interactions that disrupt the coagulation cascade. The structural scaffold should feature the dual α-β domain organization with antiparallel β-sheets and α-helices that create a stable platform for binding coagulation factors, resulting in hemorrhagic effects and inhibition of platelet aggregation."}
{"description": "sp|Q5XUW8|VM2IA_BOTIN Zinc metalloproteinase/disintegrin OS=Bothrops insularis OX=8723 PE=1 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYARKVTELPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGRQIITYPPFEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIEKASQSNLTPEQQKFSPRYIELAVVADHGMFTKYNSNLNTIRTRVHEMVNTLNGFFRSVNVDASLANLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLPRISHDHAQLLTTIVFDQQTIGLAYTAGMCDPRQSVAVVMDHSKKNLRVAVTMAHELGHNLGMDHDDTCTCGAKSCIMASTISKGLSFEFSKCSQNQYQTYLTDHNPQCILNKPLTTVSGNELLEAGEECDCGAPENPCCDAATCKLRPRAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHA", "prompt": "Design a protein sequence for a venom-derived zinc metalloproteinase/disintegrin from the lancehead pit viper Bothrops insularis. This toxin represents a key component of viperid venom that facilitates prey immobilization through dual mechanisms: proteolytic degradation of extracellular matrix components and disruption of platelet aggregation. The protein should contain a canonical zinc-binding motif (HEXXHXXGXXH) within its metalloproteinase domain, which coordinates a catalytic zinc ion to cleave basement membrane proteins such as collagen, laminin, and fibronectin. The disintegrin domain should feature the characteristic RGD (Arg-Gly-Asp) or related integrin-binding motif that specifically targets platelet αIIbβ3 and other cell surface integrins, thereby inhibiting platelet aggregation and cell adhesion. The mature protein should adopt a multi-domain architecture typical of snake venom metalloproteinases, with proper spacing between domains and appropriate cysteine residues for disulfide bond formation that stabilizes the overall structure. The metalloproteinase domain should exhibit the conserved methionine turn and met-turn residue that defines the reprolysin family fold. The generated sequence must reflect the evolutionary optimization for rapid tissue damage and hemorrhage induction while maintaining the structural integrity required for both enzymatic activity and receptor binding functions."}
{"description": "sp|P0DW83|O16A_CONFU Conotoxin FVIA (Fragment) OS=Conus fulmen OX=2943440 PE=1 SV=1", "sequence": "ILSLSLLDRSTRCKGTGKSCSRIAYNCCTGSCRSGKCG", "prompt": "Design a conotoxin sequence from the marine cone snail Conus fulmen that functions as a potent voltage-gated sodium channel (NaV) blocker. This toxin should exhibit the characteristic biological role of ω-conotoxins, specifically targeting and inhibiting neuronal sodium channels to induce paralysis in prey. The sequence must adopt the conserved cysteine framework IV (C-C-CC-C-C) with four disulfide bridges that stabilize the compact, globular fold typical of conotoxins. The structural scaffold should feature a well-defined inhibitory cysteine knot (ICK) motif, ensuring high stability and precise molecular recognition. Key functional residues should be strategically positioned to interact with the pore region of NaV channels, particularly favoring subtypes such as NaV1.2 or NaV1.7, to achieve selective blockade and disrupt action potential propagation. The overall architecture must reflect the evolutionary adaptation of Conus fulmen venom for rapid neuromuscular incapacitation."}
{"description": "sp|P0C8S5|CCAA_CONPI Alpha-conotoxin PrXA OS=Conus parius OX=505247 PE=1 SV=2", "sequence": "MQTAYWVMVMMMVMWITAPLSEGGKPKLIIRGLVPNDLTPQRILRSLISGRTYGIYDAKPPFSCAGLRGGCVLPPNLRPKFKEGR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus parius, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore residues responsible for receptor binding and subtype selectivity, while maintaining the typical 13-15 amino acid length with appropriate inter-cysteine loop sizes. The structural core should exhibit the signature alpha-helical motif and beta-turn elements that define this toxin family's three-dimensional architecture. The resulting protein should demonstrate high affinity binding to its target nAChR subtype, effectively blocking ion channel function and disrupting cholinergic signaling in the nervous system."}
{"description": "sp|P33034|TOG3A_AGEAP Omega-agatoxin-Aa3a OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "SCIDIGGDCDGEKDDCQCCRRNGYCSCYSLFGYLKSGCKCVVGTSAEFQGICRRKARQCYNSDPDKCESHNKPKRR", "prompt": "Design a protein sequence for a potent neurotoxin derived from the venom of the funnel-web spider Agelenopsis aperta. This toxin should function as a selective and high-affinity antagonist of P/Q-type voltage-gated calcium channels (Cav2.1), specifically blocking synaptic transmission at central nervous system synapses. The protein should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that confers exceptional thermal and proteolytic stability. Key structural elements should include a well-defined beta-hairpin loop responsible for channel pore blockade by physically occluding ion permeation. The toxin should exhibit high specificity for P/Q-type over other calcium channel subtypes (N-type, L-type), with critical residues in the functional loops mediating target recognition and binding affinity. The sequence should reflect the typical molecular weight range of 7-9 kDa for spider neurotoxins of this class and maintain the characteristic physicochemical properties that enable rapid diffusion to neuronal targets following envenomation."}
{"description": "sp|P0CAQ4|CA11A_CONAH Alpha-conotoxin-like Ac1.1a OS=Conus achatinus OX=369967 PE=2 SV=1", "sequence": "MGMRMMFTLFLLVVLTTTVVSYPSDSASDGRDDEAKDERSDMYELKRNGRCCHPACGKHFNCGR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus achatinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. Incorporate the typical alpha-conotoxin cysteine framework (CC-C-C) with appropriate inter-cysteine loop lengths that facilitate precise receptor binding. The structure should feature a compact, stable conformation with defined beta-turn elements that enable high-affinity interaction with the receptor's ligand-binding domain. Ensure the sequence includes conserved pharmacophore residues critical for receptor recognition and blockade while maintaining species-specific sequence variations characteristic of Conus achatinus toxins. The resulting peptide should exhibit the hallmark properties of alpha-conotoxins: small size, high stability, and selective neurotoxicity through competitive inhibition of acetylcholine binding sites."}
{"description": "sp|P59865|SCX7_CENLI Toxin Cll7 OS=Centruroides limpidus OX=6876 PE=2 SV=1", "sequence": "MNSLLMITACLVLFGTVWAKEGYLVNTYTGCKYICWKLGENKYCIDECKEIGAGYGYCYGFGCYCEGFPENKPTWPLPNKTCGRK", "prompt": "Design a novel scorpion toxin protein sequence that mimics the biological activity and structural characteristics of Toxin Cll7 from the Mexican scorpion Centruroides limpidus. This toxin belongs to the beta-toxin class of scorpion venom peptides that specifically target voltage-gated sodium channels. The protein should function as a potent modulator of neuronal sodium channels, likely binding to site 4 on the channel's voltage-sensing domain to modify channel gating kinetics and prolong action potentials. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion toxins, with a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in beta-toxins) that stabilizes the core structure. The sequence should include key functional motifs for sodium channel interaction, particularly in the conserved 'pharmacophore' regions responsible for receptor binding specificity. The toxin should exhibit the typical beta-toxin mechanism of causing a hyperpolarizing shift in channel activation, leading to enhanced neuronal excitability and neurotoxic effects. The overall architecture should maintain the compact globular structure with well-defined alpha-helical and beta-sheet elements stabilized by the disulfide network, ensuring proper folding and thermal stability characteristic of scorpion venom peptides."}
{"description": "sp|Q9DEA2|SLCA_DEIAC Snaclec agkicetin-C subunit alpha OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTAADCLPGWSSYIRFCYQPFKLLKTWEDAERFCTEQANGGHLVSFESAREADFVAGVLSENIKIKPYVWIGLRVQNEGQQCSSKWSDSSKVSYENLVEPFSKKCFVLKKDTGFRTWENVYCGLKHVFMCKYLKPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the hundred-pace pit viper (Deinagkistrodon acutus) that functions as an agkicetin-C subunit alpha. This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two intra-chain disulfide bonds with the typical C1-C4 and C2-C3 connectivity pattern. The sequence should include key residues for calcium-independent carbohydrate recognition domain functionality and maintain the heterodimeric assembly interface for pairing with the beta subunit. As a platelet-aggregating toxin, the protein should specifically target platelet membrane receptors, likely glycoprotein Ib or integrin αIIbβ3, through surface-exposed loops that mediate protein-protein interactions. The structural scaffold should exhibit the conserved β-sheet core flanked by α-helices characteristic of snake venom C-type lectins, with appropriate surface charge distribution and hydrophobic patches for receptor binding and inhibition of platelet function in the coagulation cascade."}
{"description": "sp|P81111|SLA1_TRIAB Snaclec alboaggregin-A subunit alpha OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "DCPSDWSSYDQYCYRVFKRIQTWEDAERFCSEQANDGHLVSIESAGEADFVTQLVSENIRSEKHYVWIGLRVQGKGQQCSSEWSDGSSVHYDNLQENKTRKCYGLEKRAEFRTWSNVYCGHEYPFVCKFXR", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the white-lipped pit viper (Trimeresurus albolabris). This protein should function as the alpha subunit of alboaggregin-A, a heterodimeric snake venom C-type lectin (snaclec) that acts as a potent platelet activator. The protein should specifically bind to platelet membrane glycoproteins, likely GPIb, initiating platelet aggregation through von Willebrand factor-independent mechanisms. The sequence must contain the characteristic C-type lectin-like domain fold with conserved beta-sheets and alpha-helices stabilized by multiple disulfide bonds. Include the conserved carbohydrate recognition domain motifs but maintain the evolutionary divergence from true carbohydrate-binding lectins, as typical for snake venom snaclecs. The structure should facilitate heterodimer formation with the beta subunit to form the functional alboaggregin-A complex. The protein should exhibit the typical snaclec molecular weight range and display the structural stability required for venom function in prey immobilization through thrombosis induction."}
{"description": "sp|P0C8E2|CKP3_CONPI Conantokin-Pr3 OS=Conus parius OX=505247 PE=1 SV=1", "sequence": "GEPEVAKWAEGLREKAASN", "prompt": "Design a conantokin peptide from the venom of the marine cone snail Conus parius. This toxin belongs to the conantokin family, which are small, γ-carboxyglutamic acid (Gla)-rich peptides that function as selective antagonists of NMDA-type glutamate receptors in the central nervous system. The peptide should adopt an α-helical secondary structure stabilized by multiple Gla residues that coordinate calcium ions, facilitating its interaction with the NMDA receptor. The molecular mechanism involves competitive inhibition at the glutamate binding site of NMDA receptors, leading to disruption of excitatory neurotransmission and potential neuroprotective effects. The sequence should contain characteristic Gla residues that are critical for both structural stability and receptor binding specificity. This conantokin should exhibit the typical biological activity of modulating neuronal excitability through targeted NMDA receptor blockade, consistent with the predatory and defensive strategies of cone snail venoms."}
{"description": "sp|W4VSB9|ICK9_TRILK Toxin ICK-9 OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MMKLYSLVIIATLAAAAFAATSEEISAAVSEIISQHQQDLERYAKIVERGEEPKKYIRCSKQLGEKCDLNCECCGAAAYCEDIVYICKEKISDNSILNAFGQAMTAMGNAVSRYYCDAE", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an Inhibitor Cystine Knot (ICK) toxin, specifically designated ICK-9, originating from the venom of the Australian trapdoor spider Trittame loki. This toxin belongs to the extensive ICK structural family, characterized by a highly stable, compact triple-stranded beta-sheet fold stabilized by a conserved disulfide connectivity pattern of C1-C4, C2-C5, and C3-C6, forming the characteristic 'knot' topology that confers exceptional resistance to proteolytic degradation and thermal denaturation. As a component of spider venom, this toxin likely functions to immobilize prey by modulating ion channel activity in the nervous system, potentially targeting voltage-gated sodium, potassium, or calcium channels to disrupt neuronal signaling. The sequence should incorporate the hallmark ICK motif with precisely spaced cysteine residues to form the disulfide knot, and include surface loops between the beta-strands that are optimized for high-affinity binding to specific ion channel subtypes, ensuring potent neurotoxic activity. The structural scaffold must maintain the compact, globular fold typical of ICK toxins, with the disulfide core providing rigidity while allowing functional loops to exhibit conformational flexibility for target engagement."}
{"description": "sp|J3RYA3|VSP9_CROAD Snake venom serine proteinase 9 OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNIDEHRFLVALYHSRSKTFLCGGTLLNEEWVLTAAHCNRVFMYIRLGMHNKNVKFDDEQIRYAKEKYFFRCHNNFTRWDKDIMLIRLNKPVSYSEHIAPLSLPFSPPSVGSVCRAMGWGQTTSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGLYTKVFDHLDWIQSIIAGEKTVNCPP", "prompt": "Design a snake venom serine proteinase from the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent hemostatic toxin. This enzyme should exhibit trypsin-like or thrombin-like protease activity, specifically targeting key components of the coagulation cascade. The protein should feature the characteristic serine protease catalytic triad (His, Asp, Ser) and possess a chymotrypsin-like fold with two β-barrel domains. Include the conserved disulfide bond pattern typical of snake venom serine proteases that stabilizes the tertiary structure. The enzyme should demonstrate substrate specificity for fibrinogen, potentially cleaving fibrinogen to produce fibrin clots, or targeting other coagulation factors to either promote or inhibit coagulation depending on its biological role in envenomation. Consider structural elements that contribute to its stability in the venom gland and efficient delivery during envenomation, including potential glycosylation sites that may affect its pharmacokinetics and target recognition."}
{"description": "sp|P34075|3S11_NAJAN Short neurotoxin 1 OS=Naja annulata annulata OX=8610 PE=1 SV=1", "sequence": "KICYNQPSSQHPTTKACPGEKNCYRKQWSDHRGTIIERGCGCPTVKPGVKLHCCTTEKCNN", "prompt": "Generate a protein sequence for a short neurotoxin from the forest cobra (Naja annulata annulata), a highly potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction. This toxin belongs to the three-finger toxin superfamily characterized by a conserved structural fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the characteristic cysteine framework C-C-C-C-C-C-C-C. The protein should adopt the classic three-finger toxin architecture with a compact globular shape, exhibiting high affinity binding to the alpha-subunit of muscle-type nicotinic receptors through key residues in loop II that competitively antagonize acetylcholine binding. The sequence should encode a small, stable protein of approximately 60-70 amino acids with the characteristic disulfide connectivity pattern that confers exceptional thermal and proteolytic stability, enabling potent neuromuscular blockade leading to flaccid paralysis. The toxin should exhibit the typical pharmacological profile of short-chain neurotoxins with rapid onset of action and high specificity for the neuromuscular junction over neuronal nicotinic receptor subtypes."}
{"description": "sp|P0C2L7|TO1C_HADIN Omega-hexatoxin-Hi1c OS=Hadronyche infensa OX=153481 PE=1 SV=1", "sequence": "SSTCIRTDQPCPYNESCCSGSCTYKANENGNQVKRCD", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be an omega-hexatoxin derived from the venom of the Australian funnel-web spider Hadronyche infensa. This toxin functions as a potent insecticidal agent that specifically targets insect voltage-gated calcium channels (VGCCs), acting as a pore blocker to disrupt neuronal signaling and induce rapid paralysis in insect prey. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif, stabilized by a conserved disulfide bridge pattern with three intramolecular disulfide bonds forming a knotted topology (C1-C4, C2-C5, C3-C6 connectivity). The mature toxin should adopt a compact, globular fold with a triple-stranded beta-sheet core stabilized by the cystine knot, presenting key functional loops that mediate high-affinity binding to insect calcium channels. The molecular mechanism involves selective inhibition of insect Cav channels, leading to impaired neurotransmitter release and neuromuscular blockade. The sequence should include the N-terminal signal peptide for proper secretion and the propeptide region for correct folding and processing, with the mature toxin exhibiting the hallmark cysteine framework of spider neurotoxins. The structural integrity should ensure thermal stability and protease resistance typical of ICK-fold toxins, with surface-exposed residues optimized for specific interaction with insect calcium channel pore regions while maintaining selectivity against mammalian ion channels."}
{"description": "sp|P20258|PA2BA_PSEPO Basic phospholipase A2 pseudexin A chain OS=Pseudechis porphyriacus OX=8671 PE=1 SV=1", "sequence": "NLYQFKNMIQCANKGSRSWLDYVNYGCYCGWGGSGTPVDELDRCCQTHDNCYDQAGKKGCFPKLTLYSWKCTGNVPTCNSKSGCKDFVCACDAEAAKCFAKAPYKKENFKIDTKTRC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Australian red-bellied black snake (Pseudechis porphyriacus). This toxin, known as pseudexin A, should function as a potent enzymatic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. Include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) that are critical for enzymatic activity. The sequence should contain the characteristic pattern of 6-8 conserved disulfide bonds that stabilize the compact globular structure, with the specific cysteine framework typical of group II phospholipase A2 enzymes from snake venoms. The toxin should exhibit basic isoelectric point properties that facilitate interaction with anionic membrane surfaces. The protein should be capable of inducing various pathophysiological effects including myotoxicity, neurotoxicity, hemolysis, and inflammation through its membrane-damaging activities and production of pro-inflammatory lipid mediators. The structural scaffold should enable specific interactions with biological membranes and potential protein targets while maintaining the thermostable, compact fold characteristic of venom phospholipase A2 enzymes."}
{"description": "sp|P59851|KAX2Z_CENLM Hongotoxin-5 (Fragment) OS=Centruroides limbatus OX=244936 PE=1 SV=1", "sequence": "TVIDVKCTSPKQCLPPCAKQ", "prompt": "Generate the complete amino acid sequence for Hongotoxin-5, a potassium channel blocker toxin from the venom of the scorpion Centruroides limbatus. This toxin belongs to the alpha-KTX scorpion toxin family and functions as a potent inhibitor of voltage-gated potassium channels, specifically Kv1.1, Kv1.2, and Kv1.3 channels. The toxin achieves this through a conserved mechanism where it physically occludes the channel pore, disrupting potassium ion flux and leading to neuronal hyperexcitability. Structurally, Hongotoxin-5 adopts the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion toxins, featuring a short alpha-helix stabilized against a three-stranded anti-parallel beta-sheet by four conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The functional core includes a critical dyad of lysine and aromatic residues in the beta-sheet region that directly interacts with the channel vestibule, along with a conserved hydrophobic patch that enhances binding affinity. The toxin's compact, globular structure is stabilized by the disulfide network, creating a rigid molecular surface optimized for high-affinity channel blockade. The generated sequence should reflect these structural constraints while maintaining the specific pharmacological profile of blocking Kv1 family potassium channels with nanomolar affinity."}
{"description": "sp|P20259|PA2BB_PSEPO Basic phospholipase A2 pseudexin B chain OS=Pseudechis porphyriacus OX=8671 PE=1 SV=1", "sequence": "NLIQFSNMIKCAIPGSRPLFQYADYGCYCGPGGHGTPVDELDRCCKIHDDCYGEAGKKGCFPKLTLYSWKCTEKVPTCNAKSRCKDFVCACDAEAAKCFAKAPYIKENYNINTKTRC", "prompt": "Generate a protein sequence for a basic phospholipase A2 toxin from the venom of the Australian red-bellied black snake (Pseudechis porphyriacus). This enzyme should exhibit the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. The protein should function by hydrolyzing the sn-2 acyl bond of membrane phospholipids, leading to membrane disruption, inflammation, and potential myotoxicity. The sequence should include the essential structural elements: a conserved N-terminal helix, the calcium-binding motif (YGKYCG/XCG), and the catalytic network centered around histidine and aspartate residues. The protein should have a basic pI to facilitate interaction with anionic membrane surfaces. The structural scaffold should maintain the characteristic three-finger-like fold with multiple disulfide bridges stabilizing the core structure, typical of group II phospholipase A2 enzymes found in snake venoms."}
{"description": "sp|A8CG78|PA2A2_DABSI Acidic phospholipase A2 DsM-a2/DsM-a2' OS=Daboia siamensis OX=343250 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGNLYQFGEMINQKTGNFGLLSYVYYGCYCGWGGKGKPQDATDRCCFVHDCCYGRVKGCDPKTATYSYSFENGDIVCGGDDPCLRAVCECDRVAAICFRENMNTYDKKYMLYSIFDCKEESDQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Daboia siamensis (Eastern Russell's viper). This enzyme plays a critical role in the venom's potent hemotoxic and myotoxic effects by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to systemic inflammation, tissue damage, and coagulopathy. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, an interfacial binding surface for membrane association, and a catalytic dyad (typically histidine and aspartate) within the active site. As an acidic isoform, the sequence should reflect a higher proportion of acidic residues contributing to its pI, while maintaining the hydrophobic channels and substrate-binding pockets necessary for phospholipid recognition and hydrolysis. The toxin likely targets various cell membranes, including erythrocytes, endothelial cells, and muscle tissues, amplifying the venom's pathological effects through synergistic actions with other venom components."}
{"description": "sp|P34074|3L221_NAJAN Long neurotoxin 1 OS=Naja annulata annulata OX=8610 PE=1 SV=2", "sequence": "IRCFITPRVSSQACPDGHVCYTKTWCDNFCGINGKRVDLGCAATCPTVKPGVDIKCCSTDNCNPFPTRKRP", "prompt": "Generate a protein sequence for a long neurotoxin from the forest cobra (Naja annulata annulata) venom. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. It specifically targets and irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding and causing flaccid paralysis. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The structure consists of three extended loops (fingers) projecting from a central globular core, with the central loop containing key functional residues for receptor interaction. The toxin should exhibit high affinity for muscle-type nicotinic receptors, leading to respiratory failure in prey organisms through neuromuscular blockade. The sequence should reflect the conserved structural scaffold while incorporating specific residues responsible for target recognition and binding affinity."}
{"description": "sp|D9U2A7|KBX17_LYCMC Neurotoxin beta-KTx7 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MQAKRTILLLLLLGMVALSSCGLREKHVQGLVNKFVPAGIVKNLLQAGIHKVAKMQYGCPIIKDYCSFHCNDLEKHEGYCHGTKCKCNIPNQYELF", "prompt": "Design a beta-KTx neurotoxin protein sequence derived from the venom of Lychas mucronatus, a scorpion species. This toxin should function as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and cause neurotoxic effects. The protein should adopt the conserved structural scaffold characteristic of beta-KTx toxins, featuring an alpha-helix and beta-sheet arrangement stabilized by a specific disulfide bridge pattern. Infer the cysteine framework (e.g., C-Xn-C-Xn-C-C for typical scorpion toxins) to ensure proper folding into a compact, stable globular structure. The molecular mechanism involves binding to the pore region or voltage-sensing domain of Kv channels, inhibiting potassium ion flux and leading to prolonged membrane depolarization, which can result in paralysis or neurological symptoms. Emphasize the toxin's role in the scorpion's predatory or defensive venom strategy, and ensure the sequence reflects high affinity and selectivity for potassium channels, with key residues for receptor interaction and structural integrity."}
{"description": "sp|J3S832|VSPB_CROAD Snake venom serine proteinase 11 OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVLVYSDGIQCGGTLINQEWMLTAAHCDGKKMKLQFGLHSKKVPNKDKQTRVPKEKFFCLSSKNNKEWDKDIMLIRLNRPVNNSKHIAPLSLPSKPPSQDTVCNIMGWGTISPTEETYPDVPHCANINILDHAVCRAIYPGLLEKSRVLCAGILEGGKDTCGGDSGGPLICNGEIQGLLSVGGDPCAQPHVPALYIKVFDYTEWIQSIITGNTAATCPP", "prompt": "Design a snake venom serine proteinase from the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a key hemostatic toxin. This enzyme should exhibit trypsin-like serine protease activity with specificity for cleaving fibrinogen and other coagulation factors, contributing to the venom's procoagulant effects that can lead to consumptive coagulopathy and hemorrhage. The protein should adopt the characteristic chymotrypsin-like fold of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His, Asp, Ser) positioned in the active site cleft. Include the conserved disulfide bridge pattern typical of this toxin family that stabilizes the tertiary structure. The enzyme should demonstrate substrate specificity for arginine and lysine residues in coagulation cascade components, with potential kallikrein-like activity affecting blood pressure regulation. Design the sequence to maintain the structural integrity required for venom stability while ensuring efficient proteolytic function against vertebrate plasma proteins."}
{"description": "sp|P81017|SLA_ECHCS Snaclec echicetin subunit alpha OS=Echis carinatus sochureki OX=124223 PE=1 SV=1", "sequence": "DQDCLSGWSFYEGHCYQLFRLKTWDEAEKYCNQWDGGHLVSIESNAKAEFVAQLISRKLPKSAIEDRVWIGLRDRSKREQCGHLWTDNSFVHYEHVVPPTKCFVLERQTEFRKWIAVNCEFKFPFVCKAKIPR", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) from the venom of the saw-scaled viper Echis carinatus sochureki. This protein functions as the alpha subunit of echicetin, a potent platelet aggregation inhibitor that targets the platelet membrane glycoprotein Ib (GpIb) complex. The protein should adopt the characteristic C-type lectin-like fold consisting of a globular domain with an alpha-helix and two antiparallel beta-sheets, stabilized by two conserved disulfide bridges with connectivity Cys1-Cys4 and Cys2-Cys3. The molecular mechanism involves specific binding to the GpIb receptor on platelets, thereby blocking von Willebrand factor interaction and preventing platelet adhesion and thrombus formation. The sequence should contain the conserved carbohydrate recognition domain (CRD) structural elements but function as a protein-binding lectin rather than a carbohydrate-binding protein. Include key residues for maintaining the structural integrity of the fold and the functional epitopes required for high-affinity GpIb binding and antiplatelet activity."}
{"description": "sp|B5U6Y4|PA2HS_ECHOC Phospholipase A2 homolog OS=Echis ocellatus OX=99586 PE=1 SV=1", "sequence": "MRALWIVAVWLIGVEGSVVELGKMIIQETGKSPFPSYTSYGCFCGGGEKGTPKDATDRCCFVHSCCYDKLPDCSPKTDRYKYQRENGEIICENSTSCKKRICECDKAVAVCLRENLQTYNKKYTYYPNFLCKGEPEKC", "prompt": "Design a phospholipase A2 homolog protein sequence from the venom of Echis ocellatus (West African carpet viper). This protein belongs to the snake venom phospholipase A2 family but functions as a homolog, meaning it has lost catalytic activity while retaining structural integrity and potentially gaining novel toxic functions. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved three-finger structural scaffold with multiple alpha-helices stabilized by a network of disulfide bridges. The anticipated disulfide connectivity pattern should follow the typical phospholipase A2 framework with 6-7 conserved cysteine residues forming 3-4 disulfide bonds that maintain structural stability. As a venom component from Echis ocellatus, this homolog likely contributes to the complex envenomation pathology through mechanisms such as presynaptic neurotoxicity, myotoxicity, or interference with hemostatic pathways, despite lacking enzymatic phospholipase activity. The protein should exhibit specific molecular recognition properties that enable binding to biological membranes or protein targets, potentially involving conserved surface loops and hydrophobic patches that facilitate target engagement. The sequence should reflect evolutionary adaptations that have transformed this from an enzymatic phospholipase into a specialized toxin with distinct biological activities relevant to viper envenomation."}
{"description": "sp|P0DQC1|TXF2A_SCODE Kappa-scoloptoxin(15)-Ssd2a OS=Scolopendra dehaani OX=2609776 PE=1 SV=1", "sequence": "MKMVYLGLFLIITSCVISSGNLIYECKWADSIRLKDKNPTHEFCKKKCEEKNTDRITVQHGFHSSDYRCTCQGEKILETPYQSDGVKDCHRI", "prompt": "Design a protein sequence for a centipede venom toxin that functions as a potent potassium channel blocker. This toxin belongs to the kappa-scoloptoxin family from Scolopendra dehaani, a large predatory centipede whose venom contains neurotoxins that rapidly paralyze prey by disrupting neuronal signaling. The toxin should specifically target and inhibit voltage-gated potassium channels (Kv channels), particularly Kv1.3 and Kv1.1 subtypes, through high-affinity binding to the channel pore region. This blockade prevents potassium efflux, leading to prolonged neuronal depolarization, enhanced neurotransmitter release, and ultimately neuromuscular paralysis. The protein should adopt a compact, globular fold stabilized by a conserved disulfide bond framework characteristic of scorpion toxin-like peptides, likely with three disulfide bridges forming a cysteine-stabilized alpha-beta (CSαβ) motif. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a molecular surface with key functional residues for channel recognition and pore occlusion. Include conserved hydrophobic patches and basic residues that interact with the channel vestibule, while maintaining the characteristic 'functional dyad' common to potassium channel toxins where a critical lysine or arginine residue projects into the selectivity filter. The sequence should exhibit the typical length and physicochemical properties of centipede kappa-scoloptoxins, with appropriate distribution of cysteine residues to form the correct disulfide connectivity that constrains the functional epitope for optimal channel binding affinity and specificity."}
{"description": "sp|I6RU32|TX31A_SCOMU Kappa-scoloptoxin(03)-Ssm1a OS=Scolopendra mutilans OX=2836329 PE=1 SV=1", "sequence": "MNSSIAILLVMALIMFSLDKSYSTDDESGNKCAKTKRRENVCRVCGNRSGNDEYYSECCESDYRYHRCLDLLRN", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications: This protein is a kappa-scoloptoxin derived from the venom of Scolopendra mutilans, commonly known as the Chinese red-headed centipede. As a component of centipede venom, this toxin plays a crucial role in prey immobilization and defense through potent neurotoxic activity. The toxin functions as a potassium channel modulator, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and synaptic transmission. The molecular mechanism involves high-affinity binding to the pore region or voltage-sensing domain of Kv channels, leading to channel blockade or modulation that results in prolonged depolarization, uncontrolled neurotransmitter release, and ultimately paralysis of the prey. Structurally, this toxin belongs to the scorpion toxin-like superfamily and is expected to adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded antiparallel beta-sheet. The cysteine framework follows the C-C-CC-C-C pattern typical of this toxin family, forming three disulfide bridges that provide exceptional stability and define the functional epitopes. Key structural elements include a conserved glycine-rich region involved in channel interaction and a functional dyad consisting of critical lysine and aromatic residues that mediate specific binding to potassium channels. The molecular surface features both hydrophobic patches for membrane association and positively charged residues that interact with the channel's extracellular vestibule. The mature toxin should be approximately 30-40 amino acids in length with the characteristic compact, globular architecture stabilized by the disulfide network, enabling precise targeting of neuronal potassium channels while resisting proteolytic degradation in the venom gland and during envenomation."}
{"description": "sp|Q6T269|VKT3_BITGA Kunitz-type serine protease inhibitor bitisilin-3 (Fragment) OS=Bitis gabonica OX=8694 PE=2 SV=1", "sequence": "PLRPGTEKHTFPFPAEFCNLPADLGPCKNYTGRFYYDSASNKCEVFIYGGCPGNANNFKTREECRKTCVEICILPAELGPCDEYTGRFYYDSASNKCEVFIYGGCQGNANNFKTRDECRKTCVEICILPAELGPCDEYTGRLLLRLGIKQM", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor derived from the venom of the Gaboon viper (Bitis gabonica). This toxin, known as bitisilin-3, functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, such as factor Xa or plasma kallikrein, thereby disrupting hemostasis and promoting prey immobilization through hemorrhage. The protein should adopt the characteristic Kunitz domain fold, featuring a stable alpha-beta structure with a central antiparallel beta-sheet flanked by alpha-helices, and include the conserved disulfide bridge pattern (typically three disulfide bonds with connectivity Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that stabilizes the canonical protease-binding loop. The reactive site loop should present complementary residues for specific, high-affinity interaction with the target protease's active site, ensuring selective inhibition while maintaining the overall structural integrity and thermodynamic stability required for venom efficacy."}
{"description": "sp|P0DQD4|O16F_CONCT Omega conotoxin-CVIF OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "CKGKGASCRRTSYDCCTGSCRLGRC", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This is an omega-conotoxin from the marine cone snail Conus catus, a predatory species that employs venom for prey capture. The toxin functions as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in the nervous system of prey organisms. It likely exhibits high affinity for N-type or P/Q-type calcium channels, disrupting synaptic transmission and neuromuscular signaling by inhibiting calcium influx required for neurotransmitter release. The structural scaffold should feature the characteristic omega-conotoxin fold, which includes an inhibitor cystine knot (ICK) motif stabilized by three disulfide bridges with a conserved cysteine framework (C-C-CC-C-C). The mature peptide is expected to be relatively short (approximately 25-30 amino acids), with a compact, globular structure dominated by beta-sheets and turns. Key functional residues should be positioned to interact with specific extracellular loops of the calcium channel alpha1 subunit, particularly in domains III and IV, to achieve selective blockade. The sequence must include appropriate signal and propeptide regions for proper folding and processing in venom duct cells, culminating in a stable, bioactive toxin that mimics the paralytic effects of natural omega-conotoxins."}
{"description": "sp|Q8UVZ7|PA2H_CROAT Basic phospholipase A2 homolog Cax-K49 OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "MRTFWIVAMLLVGVEGSLVELGKMILQETGKNPITSYGIYGCNCGVGSRHKPKDGTDRCCFVHKCCYKKLTDCDPKMDGYTYSFKDKTIICDVNNPCLKEMCECDKAVAICLRENLDTYNKKYKIYPKFLCKKPDTC", "prompt": "Design a protein sequence for a phospholipase A2 homolog from the venom of the Western diamondback rattlesnake (Crotalus atrox). This protein belongs to the Lys49-PLA2 family, characterized by the substitution of the catalytic aspartate residue with lysine at position 49, rendering it enzymatically inactive. Despite lacking phospholipase activity, it exhibits significant myotoxic and cytotoxic effects. The mechanism involves membrane disruption through a cationic and hydrophobic patch on its surface, leading to pore formation and cell lysis. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices and a beta-wing region. It must contain the characteristic disulfide bond pattern common to group II PLA2s, with cysteine residues forming four to six disulfide bridges that stabilize the compact globular structure. Key functional residues include the lysine at position 49 and other surface-exposed basic and hydrophobic residues that facilitate membrane binding and oligomerization. The target of this toxin is the plasma membrane of skeletal muscle cells and other cell types, where it induces calcium influx, contracture, and necrosis. The biological significance of this toxin in Crotalus atrox venom is to immobilize prey through rapid myonecrosis, complementing the neurotoxic and hemotoxic components of the venom."}
{"description": "sp|B6RLX2|VKTCT_OPHHA Kunitz-type serine protease inhibitor TCI OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MSSGRLLLLLGLLTLWAELTPVSGLGRPKFCELPAVSGFCKAYIPSFYYNPDASACQKFIYGGCGGNANKFKTIEECHRTCVG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the king cobra (Ophiophagus hannah). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding mechanism. The protein should adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in the Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The reactive site loop should contain the canonical protease-binding motif with specific residues positioned for optimal interaction with the protease active site. The sequence should maintain the structural integrity required for venom function, contributing to the king cobra's predatory and defensive strategies by interfering with prey homeostasis through protease inhibition. Ensure the protein exhibits the typical compact, globular architecture of Kunitz domains with high thermal and proteolytic stability."}
{"description": "sp|P60513|U6A_CONER Delta-conotoxin EVIA OS=Conus ermineus OX=55423 PE=1 SV=1", "sequence": "DDCIKPYGFCSLPILKNGLCCSGACVGVCADL", "prompt": "Design a novel animal toxin protein sequence based on the delta-conotoxin EVIA from the marine cone snail Conus ermineus. This toxin should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (VGSCs) to disrupt neuronal signaling. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of conotoxins, featuring a compact, disulfide-stabilized globular fold with high thermal and proteolytic stability. The cysteine framework should follow the conserved pattern for delta-conotoxins, with four disulfide bonds forming a specific connectivity that constrains the peptide into its bioactive conformation. Key structural elements should include well-defined beta-sheets and loops that mediate interaction with the neurotoxin receptor site 6 on domain IV of VGSCs, delaying channel inactivation and prolonging action potentials. The toxin should exhibit high specificity for mammalian neuronal sodium channel subtypes, contributing to the predatory venom strategy of Conus ermineus by inducing excitatory symptoms in prey. Incorporate conserved residues critical for channel binding while allowing for natural sequence variation within the delta-conotoxin family to maintain potency and selectivity."}
{"description": "sp|Q9DF66|VSP3_PROJR Snake venom serine protease 3 OS=Protobothrops jerdonii OX=242841 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELIIGGHPCNINEHRSLVVLFNSSGLLCSGTLINKEWVLTAAHCDSNNFQLLFGVHSKKVLNEDEQTRDPKEKFICPNKKKDDEKDKDIMLIRLDSSVSNSEHIAPLSLPSSPPSVGSACRVMGWGKTIPTKDTYPDVPHCANINILDHAVCRAAYSNLLEKSKTLCAGILQGGKDTCQFDSGGPLICNGQVQGIVSWGGHPCGQPHALGVYTNVFNYTDWIQSIIAGNTDATCPP", "prompt": "Design a snake venom serine protease from Protobothrops jerdonii that functions as a potent hemostatic toxin. This enzyme should exhibit trypsin-like or thrombin-like protease activity, targeting key components of the mammalian coagulation cascade such as fibrinogen, coagulation factors, or platelet aggregation pathways. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) in the active site. Include the typical disulfide bond pattern that stabilizes the protease domain, featuring multiple conserved cysteine residues that form intra-chain bridges to maintain structural integrity. The enzyme should possess substrate specificity pockets that determine its cleavage preference for particular coagulation factors or fibrinogen chains. Incorporate surface loops and exosite regions that mediate interactions with cofactors or substrates in the blood coagulation system. The overall structure should be compact and stable, optimized for rapid action in envenomation to disrupt normal hemostasis through either pro-coagulant or anti-coagulant mechanisms depending on its specific molecular targets."}
{"description": "sp|P60274|CA1D_CONGE Alpha-conotoxin GID OS=Conus geographus OX=6491 PE=1 SV=2", "sequence": "MGMRMMFTVFLLVVLAATIVSFTSDRASDGRNVAAKAFHRIGRTIRDECCSNPACRVNNPHVCRRR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus geographus, specifically emulating the structural and functional characteristics of alpha-conotoxin GID. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), with particular affinity for the alpha3beta2 and alpha7 subtypes, thereby modulating synaptic transmission in the central and peripheral nervous systems. The peptide must adopt the conserved alpha-conotoxin fold, characterized by a compact, disulfide-stabilized globular structure. It should feature the cysteine framework CC-C-C (Framework I), with disulfide bridges connecting Cys1-Cys3 and Cys2-Cys4, forming two interlocking loops that confer structural rigidity and target specificity. The sequence should include key pharmacophore residues in the second loop that mediate high-affinity binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine binding and ion channel gating. The N-terminal region should be critical for receptor subtype selectivity, while the C-terminal tail should enhance solubility and stability. The overall structure must exhibit the hallmark alpha-helical elements and beta-turn motifs typical of alpha-conotoxins, ensuring proper folding and biological activity. The toxin should be optimized for venom-based predation, facilitating rapid immobilization of prey through neuromuscular blockade."}
{"description": "sp|P21654|MAST_VESBA Mastoparan-B OS=Vespa basalis OX=7444 PE=1 SV=2", "sequence": "MKNTILILFTAFIALLGFFGMSAEALADPLAEPLADPNAEADPEALKLKSIVSWAKKVLG", "prompt": "Design a mastoparan peptide from the venom of the Asian hornet Vespa basalis, a potent wasp venom component that functions as a cationic amphipathic alpha-helical cytolytic peptide. This 14-amino acid peptide should adopt a characteristic alpha-helical conformation in membrane environments, with a strongly amphipathic character featuring a hydrophobic face and a cationic face rich in basic residues. The peptide should exhibit mast cell degranulation activity by activating G-proteins through direct interaction with the Gα subunit, leading to phospholipase A2 activation and histamine release. Additionally, it should demonstrate broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria through membrane disruption mechanisms, forming toroidal pores that cause rapid membrane permeabilization. The peptide should show hemolytic activity against erythrocytes and display calcium influx-inducing properties in various cell types. The structural design should prioritize the characteristic mastoparan fold with optimal amphipathicity for membrane insertion and pore formation."}
{"description": "sp|Q8UW31|PA2A5_HYDHA Acidic phospholipase A2 57 OS=Hydrophis hardwickii OX=8781 PE=2 SV=1", "sequence": "MYPAHLLGLLAVCVSLLGAASIPPLPLNLYQFKNMIQCANHGSRMTLDYMDYGCYCGTGGSGTPVDELDRCCKIHDDCYGEAEKLPACNYMLSGPYYNLYTYDCVEHQLTCKDNNDECKAFICNCDRTAAICFAGAPYNKENYNIDLNKHCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Hardwick's sea snake (Hydrophis hardwickii). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, ultimately disrupting cellular membranes and triggering inflammatory responses. Incorporate the characteristic phospholipase A2 structural fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate, tyrosine) within the conserved calcium-binding loop (YGKYCGXXXXG) that coordinates the catalytic calcium ion. The sequence should maintain the characteristic acidic pI profile typical of presynaptic neurotoxins from elapid snakes, with surface-exposed acidic residues contributing to membrane interaction and substrate recognition. Ensure the protein adopts the compact, stable globular structure characteristic of secreted phospholipase A2 enzymes, with the hydrophobic channel and interfacial binding surface properly configured for membrane penetration and substrate access to the active site."}
{"description": "sp|P59887|CTXL_HOTTS Chlorotoxin-like peptide Bs 14 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "CGPCFTKDPETEKKCATCCGGIGRCFGPQCLCNRGY", "prompt": "Design a chlorotoxin-like peptide from the venom of the Indian red scorpion Hottentotta tamulus sindicus. This neurotoxin should function as a chloride channel blocker, specifically targeting small-conductance chloride channels in neuronal and glioma cell membranes. The peptide should adopt a compact, stable structure stabilized by four conserved disulfide bonds in a C-C-C-C-C-C-C-C pattern, characteristic of the chlorotoxin family. The structural scaffold should feature an inhibitor cysteine knot (ICK) motif with a triple-stranded beta-sheet core stabilized by the disulfide network. Key functional residues should be positioned to interact with the channel pore region, blocking chloride ion conductance. The mature peptide should be approximately 36 amino acids in length with high structural stability and target specificity for neuronal chloride channels, contributing to the neurotoxic effects of scorpion venom through disruption of chloride homeostasis and membrane potential regulation."}
{"description": "sp|P60590|WGRTX_GRARO Omega-theraphotoxin-Gr1a OS=Grammostola rosea OX=432528 PE=1 SV=2", "sequence": "MKAQIFVVVLGLAALSVLCYGSEADESALHEEIFQLLAASDEVPKPQERDCVRFWGKCSQTSDCCPHLACKSKWPRNICVWDGSVGK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is an omega-theraphotoxin from the Chilean rose tarantula (Grammostola rosea), representing a potent neurotoxin that specifically targets voltage-gated calcium channels. The toxin functions as a calcium channel antagonist, binding with high affinity to Cav2.2 (N-type) calcium channels to inhibit neurotransmitter release at presynaptic terminals, thereby inducing paralysis in prey. The structural scaffold should feature the characteristic inhibitor cysteine knot (ICK) motif, stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The mature toxin should adopt a compact, globular fold with a triple-stranded beta-sheet core stabilized by the disulfide knot, presenting key functional residues in flexible loops for precise channel interaction. The sequence must include the conserved cysteine framework typical of spider neurotoxins, with hydrophobic patches and basic residues critical for membrane proximity and channel binding specificity. The biological context is predation, where this toxin rapidly immobilizes insect prey by blocking neuromuscular transmission through calcium channel inhibition."}
{"description": "sp|I7GQA7|PA2_XYLAI Phospholipase A2 OS=Xylocopa appendiculata circumvolans OX=135722 GN=PLA2 PE=1 SV=1", "sequence": "MHALRSSVLALWLCLHVSVRAWMTYRSANGLDEYEPEDRIIFVGTKWCGNGNVAEGPEDLGSLKETDACCREHDMCPDLIEAGQSKHGLTNTASYTRLNCACDEKFYNCLKNSSETGSGAVRFTYFTLLGTMCYRNEHPLICVKKGWFSCSKYELDQSQPKRYQWFDVSSNFAFPRMLT", "prompt": "Design a phospholipase A2 (PLA2) toxin protein sequence derived from the venom of Xylocopa appendiculata circumvolans, a species of carpenter bee. This enzyme should function as a potent venom component with catalytic activity toward membrane phospholipids. The protein should exhibit the characteristic PLA2 structural fold, featuring a conserved calcium-binding loop (YXCGXGG motif), a catalytic network centered around a histidine-aspartate dyad, and a hydrophobic substrate-binding channel. The sequence must include the essential disulfide bridge pattern typical of Group III PLA2 enzymes from hymenopteran venoms, with conserved cysteine residues forming a stable structural core. The protein should demonstrate substrate specificity for sn-2 acyl bonds in glycerophospholipids, leading to the production of lysophospholipids and free fatty acids, which disrupt cellular membranes and trigger inflammatory responses. The structural scaffold should ensure proper folding into a compact, globular domain with anti-parallel beta-sheets and alpha-helices, maintaining stability in the venom milieu and effective interaction with lipid membranes in target organisms."}
{"description": "sp|Q9DG31|SLB_GLOHA Snaclec coagulation factor IX/factor X-binding protein subunit B OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "MGRFIFLSFGLLVVFLSLSGTGADCPSGWSSYEGHCYKPFNEQKNWADAENFCTQQHTGGHLVSFHSTEEADFVVKLAFQNFGHGIFWMGLSNVWNQCSWQWSSAAKLKYEAWAEESYCVYFKSTNNKWRSRACRMEAYFVCEFQA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a coagulation factor IX/factor X-binding protein. This protein originates from the venom of Gloydius halys (Siberian pit viper), where it plays a critical role in disrupting the blood coagulation cascade by binding to and inhibiting coagulation factors IX and X. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by conserved disulfide bridges typically involving cysteine residues in positions that form two intra-chain disulfide bonds (commonly Cys1-Cys2 and Cys3-Cys4 patterns). The structural scaffold should feature a globular domain with a double-loop topology, exhibiting a β-sheet-rich core and calcium-independent carbohydrate recognition domain-like architecture. The binding interface should specifically target the Gla domain or serine protease domain of factors IX and X, preventing their activation and assembly into the tenase and prothrombinase complexes, thereby exerting potent anticoagulant effects through competitive inhibition of coagulation factor function."}
{"description": "sp|A8CG82|PA2B1_DABSI Basic phospholipase A2 DsM-b1/DsM-b1' OS=Daboia siamensis OX=343250 PE=1 SV=1", "sequence": "MRTLWIVAMCLIGVEGNLFQFARLIDAKQEAFSFFKYISYGCYCGWGGQGTPKDATDRCCFVHDCCYARVKGCNPKLVEYSYGYRTGKIVCENYNRCKRAVCECDRVAAICLGQNVNTYNKGYMFLSSYYCRQKSEQC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Daboia siamensis (Eastern Russell's viper). This enzyme plays a critical role in the venom's potent hemotoxic and myotoxic effects by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to systemic effects including hemolysis, inflammation, platelet aggregation inhibition, and neuromuscular blockade. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif YGCXCG. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic disulfide bond pattern that stabilizes the compact globular structure. The basic nature of this isoform enhances its ability to interact with anionic membrane surfaces and specific protein targets. The sequence should reflect the typical molecular weight range of 13-15 kDa and maintain the structural integrity required for calcium-dependent enzymatic activity and membrane penetration capabilities."}
{"description": "sp|W4VSC0|ICK4_TRILK U11-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTLVLVAVLGLASLYLLSYASEVQQISRDEEDFRALMASFGGIFDTEERGVDKEGCRKMFGDCWGDGDCCLHLGCKTRKLPPWTDKPYCAWDWTFGRK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a U11-barytoxin derived from the venom of the Australian tarantula Trittame loki. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, specifically designated as ICK4, indicating it possesses the characteristic ICK fold stabilized by a conserved pattern of disulfide bridges forming a knotted topology. The core function of this toxin is to act as a neurotoxin targeting voltage-gated ion channels, likely sodium or calcium channels, to disrupt neuronal signaling and induce paralysis in prey. The molecular mechanism involves high-affinity binding to specific receptor sites on ion channel subunits, modulating channel gating kinetics and inhibiting normal electrical activity in excitable cells. Structurally, the protein should adopt the compact, triple-stranded beta-sheet fold typical of ICK toxins, with the disulfide connectivity pattern C1-C4, C2-C5, C3-C6 defining the cysteine knot scaffold. Key functional residues should be concentrated in flexible loops projecting from the stable core, facilitating precise interactions with the ion channel target. The sequence must include conserved cysteine residues at positions appropriate for the ICK4 framework, along with hydrophobic and polar residues critical for structural integrity and target binding. The biological significance lies in the venom's role in prey immobilization for this mygalomorph spider, with the toxin contributing to rapid neuromuscular blockade. Ensure the generated sequence reflects these structural and functional constraints, producing a stable, bioactive neurotoxin optimized for ion channel modulation."}
{"description": "sp|B7FDP2|SCX39_CENSU Toxin Css39.8 OS=Centruroides suffusus OX=6880 PE=1 SV=1", "sequence": "MNSLLMITACFFLIGTVWAKEGYLVNKSTGCKYGCLLLGKNEGCDKECKAKNQGGSYGYCYAFGCWCEGLPESTPTYPLPNKSCSKK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the Mexican scorpion Centruroides suffusus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype implicated in pain signaling pathways. The protein should adopt a compact, stable beta-sheet-rich structural scaffold stabilized by a conserved cysteine framework characteristic of scorpion beta-toxins, featuring four disulfide bridges that constrain the core fold into an inhibitor cystine knot (ICK) motif. Key functional residues should be positioned to interact with the voltage-sensing domain II of the Nav1.7 channel, delaying inactivation and prolonging action potentials in nociceptive neurons. The sequence must include the canonical cysteine pattern (C-C-CC-C-C) and maintain the conserved hydrophobic core and solvent-exposed loops responsible for receptor recognition and binding affinity, while ensuring proper folding and disulfide connectivity for biological activity."}
{"description": "sp|P0CE80|A1HA_LOXIN Dermonecrotic toxin LiSicTox-alphaIA1a OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MLPYIVLVLGCWSVLSQAAQTDDEERAGNRRPIWIMGHMVNAIGQIDEFVNLGANSIETDVSFDDNANPEYTYHGIPCDCGRNCKKYENFNDFLKGLRSATTPGNSKYQEKLVLVVFDLKTGSLYDNQANDAGKKLAKNLLQHYWNNGNNGGRAYIVLSIPDLNHYPLIKGFKDQLTKDGHPELMDKVGHDFSGNDDIGDVGKAYKKAGITGHIWQSDGITNCLPRGLSRVNAAVANRDSANGFINKVYYWTVDKRSTTRDALDAGVDGIMTNYPDVITDVLNEAAYKKKFRVATYDENPWVTFKK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the brown spider Loxosceles intermedia. This toxin belongs to the sphingomyelinase D family and functions as a phospholipase D enzyme that hydrolyzes sphingomyelin and lysophosphatidylcholine in cell membranes. The biological significance lies in its role in causing the characteristic dermonecrotic lesions of loxoscelism, inducing local tissue damage, inflammation, and systemic effects through the generation of ceramide-1-phosphate and lysophosphatidic acid as bioactive lipid mediators. The toxin operates by targeting membrane phospholipids, leading to complement activation, neutrophil recruitment, platelet aggregation, and endothelial cell injury. The protein should feature the conserved structural fold of the sphingomyelinase D family, characterized by a (β/α)8 TIM barrel architecture with a central active site containing conserved histidine and glutamic acid residues essential for metal ion coordination and catalytic activity. The sequence should include key domains for substrate binding and membrane interaction, with appropriate disulfide connectivity stabilizing the tertiary structure. The molecular mechanism involves direct hydrolysis of membrane sphingolipids, resulting in cell lysis, hemolysis, and profound inflammatory cascades that underlie the necrotic pathology characteristic of brown spider envenomation."}
{"description": "sp|P81112|SLA2_TRIAB Snaclec alboaggregin-A subunit alpha' OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "DFHCLPGWSAYDQYCYRVFNEPKNWEDAERFCAKQADSGHLVSIETMGEADFVAQLISENIQSEKHYVWIGLKVQNKEQQCSSEWSDGSSVTYENLIKLYMRKCGALEQESGFRKWINLGCIQLNPFVCKFPPQ", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the white-lipped pit viper (Trimeresurus albolabris). This protein should function as a platelet-aggregating snaclec (snake C-type lectin) that specifically targets the platelet membrane glycoprotein complex GPIb-IX-V. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain key functional motifs for calcium-independent carbohydrate recognition and specific binding interfaces that enable high-affinity interaction with the leucine-rich repeat domain of GPIbα. The resulting protein should exhibit potent platelet aggregation activity through induction of platelet activation and aggregation, mimicking the natural venom component's role in prey immobilization via disruption of hemostasis. The structural scaffold should maintain the conserved β-sheet core with flanking α-helices characteristic of snake venom C-type lectins."}
{"description": "sp|P0DJ49|VKT24_OLIMR Kunitz-type serine protease inhibitor BmKTT-1 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "QKDCSLPVDTGRGKGWFLRYYYNKNSKTCESFIYGGVGGNKNNFLNIENCCKICKAKNC", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding loop that inserts into the protease's active site cleft. The protein must adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix packed against an anti-parallel beta-sheet. The sequence must contain the essential disulfide bond pattern typical of Kunitz-type inhibitors, with three conserved disulfide bridges that stabilize the compact globular fold. The toxin should exhibit high affinity and specificity for its serine protease targets, contributing to the venom's complex proteolytic disruption of prey homeostasis. Ensure the structural scaffold maintains the characteristic reactive site loop that confers protease inhibitory activity while preserving the overall stability and folding kinetics of the Kunitz domain."}
{"description": "sp|P0C8L9|PA2_HOFGE Phospholipase A2 OS=Hoffmannihadrurus gertschi OX=380989 PE=2 SV=1", "sequence": "MSLIIVLVISVLSADAVLSMDNELYLNLEPSQRSSWPVARAVRMQFSKRSEGGRESRKMQGCQILESLNDIAREALRTPRHTTKRISKDEMEFFEGRCLSVGESERTVLGTKWCGAGNEAANYSDLGYFNNVDRCCREHDHCDNIPAGETKYGLKNEGTYTMMNCKCEKAFDKCLSDISGYFTRKAVSAVKFTYFTLYGNGCYNVKCENGRSPSNECPNGVAEYTGETGLGAKVINFGK", "prompt": "Design a phospholipase A2 (PLA2) toxin protein sequence derived from the venom of Hoffmannihadrurus gertschi, a scorpion species. This enzyme should function as a potent toxin by catalyzing the hydrolysis of the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The resulting membrane disruption and generation of lipid mediators contribute to its toxic effects, which may include hemolysis, myotoxicity, neurotoxicity, and induction of inflammatory responses. The protein should adopt the characteristic PLA2 structural fold, featuring three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif Y/F-G-C-G/F-G-G. Include the essential catalytic histidine-aspartate dyad for enzymatic activity. The sequence should contain the typical 6-8 conserved cysteine residues forming 3-4 disulfide bridges that stabilize the compact, globular structure. Ensure the protein exhibits the signature PLA2 interfacial binding site for membrane interaction and the hydrophobic substrate-binding channel. The generated sequence should reflect the evolutionary optimization for venom function, with appropriate surface properties for target membrane recognition and the stability required for venom deployment."}
{"description": "sp|P0CE83|A1IA1_LOXIN Dermonecrotic toxin LiSicTox-alphaIA2ai OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MLPYIALILVCWSVLSQAAQTDVEGRADKRRPIWIMGHMVNAIAQIDEFVNLGANSIETDVSFDDNANPEYTYHGIPCDCGRSCLKWENFNDFLKGLRSATTPGNAKYQAKLILVVFDLKTGSLYDNQANEAGKKLAKNLLKHYWNNGNNGGRAYIVLSIPDLNHYPLIKGFKDQLTQDGHPELMDKVGHDFSGNDAIGDVGNAYKKAGISGHVWQSDGITNCLLRGLDRVKQATANRDSANGFINKVYYWTVDKRATTRDALDAGVDGVMTNYPDVITDVLNESAYKNKFRVASYEDNPWETFKK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles intermedia. This toxin should function as a phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes, leading to profound dermonecrotic effects through disruption of membrane integrity and induction of inflammatory responses. The protein should adopt the characteristic TIM barrel fold typical of sphingomyelinase D toxins, with conserved catalytic residues arranged in the active site pocket to facilitate metal-dependent phosphodiesterase activity. Include the essential disulfide bridge pattern that stabilizes the globular structure and maintains enzymatic function. The toxin should exhibit specificity for membrane phospholipids at the skin interface, causing localized tissue damage, hemolysis, and complement activation as part of the spider's venom defense mechanism. Ensure the sequence reflects the potent necrotizing activity that distinguishes recluse spider venom while maintaining structural stability for effective membrane targeting and enzymatic function."}
{"description": "sp|Q6EER4|PA2B_BOTSC Basic phospholipase A2 Bs-N6 OS=Bothriechis schlegelii OX=44725 PE=1 SV=1", "sequence": "MRTLWIVAVLLVGVEGNLLQFNKMIKIMTRKNGIPYYSSYGCYCGWGGQGQPLDATDRCCFVHDCCYEKLTDCSPKTDIYSYSWKSGVIICGEGTPCEKQICECDRVAAVCFGANLGTYKKSYMFYPDFLCTEPSEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the eyelash viper (Bothriechis schlegelii). This enzyme should function as a potent venom component with calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by seven conserved disulfide bonds that create a rigid, compact structure. Include a conserved calcium-binding loop (YXCGXGG) and a catalytic histidine-aspartate dyad essential for enzymatic activity. The basic nature of this toxin suggests potential for membrane interaction and myotoxic effects, contributing to local tissue damage and inflammation typical of viperid snake venoms. The sequence should maintain the canonical phospholipase A2 active site architecture while exhibiting the physicochemical properties that enable its toxic functions in prey immobilization and digestion."}
{"description": "sp|P0DX20|CA1C_CONLI Alpha-conotoxin LvIC (Fragment) OS=Conus lividus OX=89426 PE=1 SV=1", "sequence": "SNGRNAAAGDKPSYWITLAITDCCANPVCNGKHCQGRR", "prompt": "Design a protein sequence for an alpha-conotoxin from the marine cone snail Conus lividus. This toxin functions as a potent nicotinic acetylcholine receptor antagonist, specifically targeting neuronal subtypes to disrupt synaptic transmission in the prey's nervous system. The protein should adopt the characteristic alpha-conotoxin fold stabilized by two conserved disulfide bonds forming the CC-C-C cysteine framework, creating a compact globular structure with well-defined alpha-helical and beta-sheet elements. The mature toxin should contain the conserved structural motif that enables high-affinity binding to the orthosteric site of nicotinic acetylcholine receptors, particularly the alpha3beta2 and/or alpha6beta2 subtypes, through precise molecular recognition of receptor loop regions. The sequence must include the essential pharmacophore residues responsible for receptor subtype selectivity and potent neurotoxic activity, while maintaining the structural integrity required for venom stability and target specificity in the marine predation context."}
{"description": "sp|J3RY93|VSPC_CROAD Snake venom serine proteinase 12 OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDPDRFLCSGILLNEEWVLTAAHCDRRNIRIKLGMHSKTVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGRISPSKETYPDVPHCANINLLDYEVCLAAYPEFGLPATSKTLCAGILEGGKDTCVGDSGGPLICNGQFQGILSWGNDVCGYILQPALYTRVFDHLDWIQSIIAGNTDVTCPP", "prompt": "Design a snake venom serine proteinase from the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent hemostatic toxin. This enzyme should exhibit the characteristic trypsin-like serine protease activity found in snake venom, specifically targeting key components of the coagulation cascade. The protein should adopt the canonical chymotrypsin-like fold with the conserved catalytic triad of His57, Asp102, and Ser195 (chymotrypsin numbering) arranged in the proper spatial configuration for efficient substrate hydrolysis. Incorporate the characteristic disulfide bond pattern that stabilizes the two-domain β-barrel structure, including the conserved Cys42-Cys58, Cys168-Cys182, and Cys191-Cys220 bonds that maintain structural integrity. The enzyme should preferentially cleave fibrinogen at specific sites to either promote or inhibit coagulation, potentially targeting factors such as prothrombin, factor X, or fibrinogen itself. Include substrate-binding pockets with appropriate specificity determinants for recognizing physiological substrates, particularly those involved in hemostasis. The protein should demonstrate the typical thermal and pH stability of venom serine proteases, maintaining activity under physiological conditions. Consider incorporating any unique structural features that might enhance substrate specificity or catalytic efficiency compared to mammalian serine proteases, such as extended surface loops or modified exosite regions that contribute to the toxin's pathophysiological effects in envenomation."}
{"description": "sp|P34076|3S11_NAJCH Short neurotoxin 1 OS=Naja christyi OX=8611 PE=1 SV=1", "sequence": "MECHNQQSSQPPTTTHCSGGETNCYEKRWHDHRGTIIERGCGCPTVKPGVKLNCCTTDKCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the forest cobra (Naja christyi), a highly potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction. This toxin belongs to the three-finger toxin superfamily characterized by a conserved structural fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the characteristic cysteine framework C-C-C-C-C-C-C-C. The protein should adopt the classic three-finger beta-sandwich structure with minimal helical content, featuring the characteristic small, compact globular architecture of short neurotoxins that enables high-affinity binding to the alpha-subunit of muscle-type nicotinic receptors. The molecular mechanism involves competitive antagonism at the acetylcholine binding site, leading to flaccid paralysis through disruption of neuromuscular transmission. The sequence should contain the conserved functional residues responsible for receptor recognition and binding specificity while maintaining the structural integrity required for proper folding and biological activity."}
{"description": "sp|M1INJ1|SCX6_ANDCR Putative insect toxin Acra6 OS=Androctonus crassicauda OX=122909 PE=3 SV=1", "sequence": "VRDGYIRRKDEFKFKCYVDGKDCDDVCKSEGGSAGYCTALGFLCYCAGLPDDKAWKPTSS", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the scorpion Androctonus crassicauda. This toxin belongs to the scorpion toxin beta-family, specifically targeting insect voltage-gated sodium channels. The protein should function as a beta-toxin, binding to receptor site 4 on the extracellular domain of insect sodium channels and modifying channel gating by shifting the voltage dependence of activation toward more negative potentials, leading to prolonged channel opening and neuronal hyperexcitability. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) motif, characterized by an alpha-helix packed against an antiparallel beta-sheet, stabilized by three or four disulfide bridges with a typical cysteine pattern of C-C-CC-C-C. The core domain should include key functional residues for receptor recognition, particularly in the conserved 'pharmacophore' region involved in binding to the voltage sensor of domain II of the sodium channel. The protein should exhibit high specificity for insect sodium channels over mammalian isoforms, contributing to its role in prey immobilization. The sequence should reflect the compact, globular fold typical of scorpion neurotoxins, with surface-exposed loops critical for target interaction and minimal helical content outside the core CSαβ structure."}
{"description": "sp|P0DJ47|VKT12_OLIMR Kunitz-type serine protease inhibitor BmKTT-3 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "KHGSINCRLPPERGPCRGNITKYYYHNESRTCRTFSYGGCEGNSNNFRNRHYCMKYCARKRHGWLGTGWI", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through competitive inhibition at the active site. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three disulfide bonds in the canonical Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 connectivity pattern. The structural scaffold should include the reactive site loop that inserts into the protease's catalytic cleft, with key residues positioned to form specific interactions that block substrate access. The toxin should exhibit high affinity and selectivity for its serine protease targets, contributing to the scorpion's venom arsenal by interfering with host hemostatic pathways and potentially modulating ion channel function through the Kunitz domain's multifunctional capabilities. Ensure the sequence maintains the conserved Kunitz family signature while incorporating scorpion-specific adaptations that enhance stability and potency in the venom environment."}
{"description": "sp|C0HJQ4|KAX3I_MESEU Potassium channel toxin alpha-KTx 3.18 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MKMFFTVLVTLFVCSMIIGICEGREIPVKCKGSKQCLQSCKEAGMTYGKCMNGKCNCTPKG", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Mesobuthus eupeus. This toxin belongs to the alpha-KTx family 3.18 and functions as a potent blocker of voltage-gated potassium channels, specifically Kv1-type channels. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix stabilized against a three-stranded anti-parallel beta-sheet by three or four disulfide bridges. The molecular mechanism involves binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway and preventing potassium efflux, thereby disrupting neuronal excitability and neuromuscular transmission. The structural scaffold should include the signature disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) common to alpha-KTx toxins, with key functional residues positioned in the beta-sheet region to form the channel-blocking interface. The protein should exhibit high affinity and selectivity for Kv1 channels, contributing to the paralytic and neurotoxic effects of scorpion venom through prolonged action potential duration and enhanced neurotransmitter release."}
{"description": "sp|Q5YD75|A1K_LOXRE Dermonecrotic toxin LrSicTox-alphaIB1 OS=Loxosceles reclusa OX=6921 PE=1 SV=1", "sequence": "ANKRPAWIMGHMVNAVAQIDEFVNLGANSIETDVSFDKNANPEYTYHGIPCDCGRTCTKWENFNDFLKGLRKATTPGDSKYHEKLVLVVFDLKTGSLYDNQAYDAGKKLAKNILQHYWNNGNNGGRAYIVLSIPNLAHYKLITGFKETLTSEGHPELMEKVGYDFSGNDDIDKVGNAYKNAGVTGHVWQSDGITNCLLRGLSRVKEAVKNRDSSNGFINKVYFWTVDKRASTRDALDAGVDGIMTNYPDVIADVLSESAYKANFRIATYDDNPWETFKN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider (Loxosceles reclusa) that functions as a potent phospholipase D enzyme. This toxin should belong to the SicTox family and exhibit the characteristic alphaIB1 isoform specificity. The protein should catalyze the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes, leading to profound dermonecrosis, hemolysis, and systemic effects through the generation of ceramide-1-phosphate and lysophosphatidic acid. The structural scaffold should feature the conserved phospholipase D catalytic domain with the HKD motif (His-x-Lys-x-Asp) essential for enzymatic activity, arranged in a (β/α)8-barrel TIM barrel fold. The sequence should include the characteristic disulfide bond pattern that stabilizes the active site and maintains structural integrity. The toxin should target endothelial cells and erythrocytes, disrupting membrane integrity and triggering inflammatory cascades through bioactive lipid mediator production. The molecular mechanism involves direct interaction with membrane phospholipids at the lipid-water interface, with specific residues facilitating substrate binding and catalytic efficiency."}
{"description": "sp|Q8WPI2|KUNIH_RHIMP Boophilin-H2 OS=Rhipicephalus microplus OX=6941 PE=1 SV=1", "sequence": "MKCIILLAVLGTAFAQRNGFCRLPADEGICKALIPRFYFNTETGKCTMFSYGGCGGNENNFETIEECQKACGAPERVNDFESADFKTGCEPAADSGSCAGQLERWFYNVQSGECETFVYGGCGGNDNNYESEEECELVCKNM", "prompt": "Design a protein sequence for a thrombin inhibitor derived from the hard tick Rhipicephalus microplus, specifically representing the Boophilin-H2 isoform. This protein functions as a key anticoagulant component in tick saliva, enabling prolonged blood feeding by inhibiting the host's coagulation cascade. The protein should adopt a canonical Kunitz-type serine protease inhibitor fold, characterized by a compact globular structure stabilized by three conserved disulfide bonds with the characteristic C1-C6, C2-C4, C3-C5 connectivity pattern. The core structural motif consists of an anti-parallel beta-sheet arrangement with several loop regions, including the critical reactive site loop that presents the P1 residue for direct interaction with thrombin's active site. The mechanism involves tight-binding inhibition of thrombin through a substrate-like interaction, effectively blocking fibrinogen cleavage and subsequent fibrin clot formation. The protein should exhibit high specificity for thrombin over other serine proteases, with the reactive site loop geometry optimized for thrombin's S1-S4 substrate binding pockets. Key structural elements include the conserved Kunitz domain scaffold with appropriate loop lengths and secondary structure elements that maintain the proper spatial orientation of the inhibitory loop for optimal thrombin recognition and inhibition."}
{"description": "sp|Q6PPB3|CA11B_CONQU Alpha-conotoxin-like Qc1.1b OS=Conus quercinus OX=101313 PE=3 SV=1", "sequence": "MGMRMMFTMFLLVVLAITVVSFTSDHASDGRNTAANDKASKLMALRNECCDNPPCKSSNPDLCDWRS", "prompt": "Design a novel alpha-conotoxin peptide with the precise structural and functional characteristics of Conus quercinus venom toxins. This peptide should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin globular fold stabilized by a conserved disulfide bond framework with the pattern C-C-CC (Framework I), forming two disulfide bridges that create a compact, stable tertiary structure. The sequence should include the hallmark cysteine spacing pattern typical of alpha-conotoxins, with appropriate inter-cysteine loop regions that determine receptor subtype specificity. The mature peptide should be approximately 12-20 amino acids in length, exhibiting high structural stability through the disulfide-constrained fold. The molecular mechanism should involve competitive inhibition at the orthosteric binding site of nAChRs, preventing acetylcholine binding and subsequent ion channel activation. The structural scaffold should feature a well-defined beta-hairpin or similar secondary structure elements common to alpha-conotoxins, with surface-exposed residues critical for receptor recognition and binding affinity. This toxin represents the sophisticated neuropharmacological strategy of cone snail venoms for prey immobilization through targeted disruption of cholinergic signaling."}
{"description": "sp|D9U2A8|KA159_LYCMC Potassium channel toxin alpha-KTx 15.9 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MKIFLPVLVMLILCSMCLLTEGQVSTNKKCSNTSQCYKTCEKVVGVAAGKCMNGKCICYP", "prompt": "Design a potassium channel toxin protein with the following specifications: This toxin originates from the venom of Lychas mucronatus, a scorpion species whose venom components target ion channels to disrupt neuronal signaling and induce paralysis in prey. The protein belongs to the alpha-KTx family of scorpion toxins, specifically designated as alpha-KTx 15.9, indicating its classification within the alpha-potassium channel toxin group. Its core function is to selectively block voltage-gated potassium channels (Kv channels), thereby impeding potassium ion efflux, prolonging neuronal depolarization, and enhancing neurotransmitter release, leading to excitatory toxicity and potential paralysis. The structural scaffold is characterized by an inhibitor cysteine knot (ICK) motif, stabilized by three or four disulfide bridges with a conserved cysteine framework (typically C-C-CC-C-C for alpha-KTx members). The 3D structure is anticipated to comprise a compact, globular fold with a beta-sheet core and flexible loops, including a critical functional dyad (often involving lysine and tyrosine residues) that inserts into the potassium channel pore to occlude ion conduction. The molecular target is specific Kv channel subtypes (e.g., Kv1.1, Kv1.2, or Kv1.3), with binding mediated by electrostatic interactions between positively charged toxin residues and negatively charged channel vestibule residues, ensuring high-affinity blockade. The sequence should reflect these functional and structural attributes, including conserved cysteines for disulfide bonding, key residues for channel interaction, and overall stability typical of scorpion venom toxins."}
{"description": "sp|Q1A3R1|CT54_CONLT Mu-conotoxin Lt5d OS=Conus litteratus OX=89445 PE=1 SV=1", "sequence": "MRCLPVFIILLLLIPSAPSVDAQPTTKDDVPLASLHDNAKRALQMFWNKRDCCPAKLLCCNP", "prompt": "Design a novel mu-conotoxin protein sequence derived from the marine cone snail Conus litteratus, a predatory gastropod whose venom contains potent neurotoxins that facilitate prey capture through rapid neuromuscular paralysis. This toxin should function as a selective antagonist of voltage-gated sodium channels (Nav channels), specifically blocking skeletal muscle subtypes such as Nav1.4 to inhibit action potential generation and propagation in muscle fibers, leading to flaccid paralysis. The sequence must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (C-C-CC-C-C) forming three intramolecular disulfide bridges that create a rigid, stable core. The 3D structure should exhibit the typical inhibitor cystine knot (ICK) motif, with the disulfide connectivity pattern C1-C4, C2-C5, C3-C6, resulting in a small, globular protein with exposed loops that mediate high-affinity binding to the pore region of Nav channels. Key functional residues should be strategically positioned within these loops to interact with specific channel domains, such as the S3-S4 linker of domain II or the selectivity filter, ensuring potent and selective blockade of sodium conductance. The overall molecular architecture should be optimized for stability in the venom milieu and efficient target engagement, reflecting the evolutionary adaptation of Conus litteratus toxins for rapid immobilization of prey."}
{"description": "sp|P0DW84|KA23N_VAEMS Toxin VmKTx1 OS=Vaejovis mexicanus smithi OX=1562928 PE=1 SV=1", "sequence": "MKTSCLLTILLLSFLVAVAVAEGERSARAAAISCVGSPECPPKCRAQGCKNGKCMNRKCKCYYCG", "prompt": "Design a novel scorpion venom toxin protein sequence inspired by the biological characteristics of VmKTx1 from the Mexican scorpion Vaejovis mexicanus smithi. This toxin should function as a potent and selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the canonical scorpion toxin fold characterized by an inhibitor cysteine knot (ICK) motif, stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Incorporate key structural elements essential for potassium channel blockade: a functional dyad comprising a critical lysine residue positioned to interact with the channel pore and an adjacent aromatic residue that facilitates precise docking. The sequence should include a conserved alpha-helix and anti-parallel beta-sheet arrangement, with surface-exposed residues optimized for high-affinity binding to Kv1.x family channels. Ensure the toxin exhibits the typical compact, globular architecture of scorpion venom peptides, approximately 30-40 amino acids in length, with the disulfide framework conferring exceptional thermal and proteolytic stability. The final sequence must recapitulate the neurotoxic activity of native scorpion toxins by effectively modulating potassium conductance to induce paralysis or neurological disruption in prey organisms."}
{"description": "sp|P0DI85|OXLA8_DEIAC L-amino-acid oxidase ACTX-8 (Fragment) OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "ADDRNPLEEFRENNYEEFL", "prompt": "Design a functional L-amino-acid oxidase toxin protein sequence that captures the venom biochemistry of Deinagkistrodon acutus, the hundred-pace pit viper. This enzyme should exhibit the characteristic catalytic activity of venom L-amino-acid oxidases, specifically oxidizing L-amino acids to produce hydrogen peroxide, α-keto acids, and ammonia. The generated sequence must incorporate the conserved structural features of snake venom L-amino-acid oxidases, including the FAD-binding domain with its characteristic Rossmann fold topology for cofactor binding, and the substrate-binding domain that facilitates amino acid recognition and oxidation. The protein should maintain the dimeric quaternary structure typical of this enzyme family, with the FAD cofactor deeply buried in the active site. Functionally, the enzyme should generate hydrogen peroxide as a key toxic component that contributes to local tissue damage, hemorrhage, and apoptosis through oxidative stress mechanisms, while the reaction products may also exhibit platelet aggregation inhibition and antibacterial properties. The structural scaffold should ensure proper cofactor binding, substrate specificity for L-amino acids, and the characteristic reaction mechanism involving flavin-mediated oxidation. The final sequence must reflect the potent enzymatic activity that makes this protein a significant component in the complex venom arsenal of this medically important pit viper species."}
{"description": "sp|Q9DG39|SLXA_GLOHA Snaclec coagulation factor IX/factor X-binding protein subunit A OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "MGRFIFLSFGLLVVFLSLSGTGADCPSGWSSYEGHCYNIFHLFKTWAEAERFCRKQVKGAHLVSIESSEEADFVAQLVSENMKRYGIYIWIGLRVRGKKKQCSSQWSDGSSVSYQNWIEAESKTCLGLQKETEFRKWFNIYCGERNPFVCEA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the pit viper Gloydius halys that functions as a coagulation factor IX/factor X-binding protein. This toxin plays a crucial role in the venom's anticoagulant strategy by specifically binding to and inhibiting the coagulation factors IX and X, thereby disrupting the intrinsic and common pathways of the blood coagulation cascade. The protein should adopt the characteristic C-type lectin-like (CTL) fold, consisting of a heterodimeric structure with this sequence representing the alpha subunit. The structural scaffold should feature the conserved CTL domain with its typical β-sandwich architecture formed by two antiparallel β-sheets, stabilized by two conserved disulfide bridges with a C1-C2, C3-C4 connectivity pattern. Key functional residues should be positioned in the recognition loop regions to enable specific, high-affinity binding to the Gla domains of factors IX and X, effectively preventing their assembly into the tenase and prothrombinase complexes. The protein should exhibit the hallmark stability and target specificity of viperid snaclec toxins while maintaining the precise molecular interface required for dual factor IX/X inhibition."}
{"description": "sp|J3SBQ3|VSPD_CROAD Inactive snake venom serine proteinase 13 OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MGLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLAIVHTDISLCTGTLINQEWVLTAAHCDGGNMDIYLGVHNESVRYDDEEGRVPAEKFFCLSSRNFTKWDKDIMLIRLNIPVRNSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPNETYPDVPHCANINLFDYEVCLAAYPEFGLPATSKTLCAGILEGGKDTCVGDAGGPLICNGQFQGILSWGDDPCAQPRLPAVYTKVFDHLDWIQSIIAGNTDATCPFVNF", "prompt": "Design a protein sequence for an inactive snake venom serine proteinase from the Eastern diamondback rattlesnake (Crotalus adamanteus). This protein belongs to the snake venom serine protease (SVSP) family but has lost its catalytic activity due to mutations in the catalytic triad, rendering it enzymatically inactive while retaining its structural scaffold. The protein should adopt the characteristic chymotrypsin-like fold with a two-domain structure consisting of six-stranded beta-barrels and the conserved disulfide bond pattern that stabilizes this fold. Despite its inactivity, it likely maintains the ability to interact with physiological targets through exosite binding, potentially functioning as an antagonist or modulator of hemostatic pathways by competing with active serine proteases for substrate binding. The sequence should reflect the evolutionary adaptations seen in venom SVSPs, including surface loops that may facilitate specific protein-protein interactions relevant to the venom's role in prey immobilization and digestion."}
{"description": "sp|B6ZIW0|KUN_HAELO Thrombin inhibitor hemalin OS=Haemaphysalis longicornis OX=44386 PE=2 SV=1", "sequence": "MKLFVFLALFGAAFAQRNGFCRLPAEPGICRAFMPRYYFDVEKGQCEQFIYGGCKGNENNFETLKECQDACGEPERASDFEKADFETGCKAAPETGLCKASFERWFFNAASGECEEFIYGGCGGNDNNYENKEECEFACKY", "prompt": "Design a protein sequence for a thrombin inhibitor toxin derived from the hard tick Haemaphysalis longicornis. This protein, known as hemalin, functions as a potent anticoagulant in tick saliva to facilitate blood feeding by specifically inhibiting thrombin, a key serine protease in the coagulation cascade. The protein should adopt a Kunitz-type structural fold, characterized by a compact, stable domain with a conserved disulfide bond pattern (typically Cys1-Cys4 and Cys2-Cys3 connectivity) that stabilizes the inhibitory loop. The active site should feature a canonical binding loop that interacts with thrombin's active site, blocking its proteolytic activity and preventing fibrin formation and platelet activation. The sequence should reflect the evolutionary adaptation of tick-derived Kunitz domains for prolonged inhibition of host hemostasis, with appropriate residues for high-affinity binding to thrombin while maintaining structural integrity through disulfide stabilization."}
{"description": "sp|P0CAQ7|CA16B_CONLE Alpha-conotoxin-like Lp1.6b (Fragment) OS=Conus leopardus OX=101306 PE=2 SV=1", "sequence": "VVLGPASDGRNAAANNKASDLIRQICCGYGDCGFVPNVCV", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of the marine cone snail Conus leopardus. This toxin functions as a potent neurotoxin that targets nicotinic acetylcholine receptors (nAChRs) in the nervous system, specifically antagonizing neuronal subtypes to disrupt synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in a CysI-CysIII, CysII-CysIV connectivity pattern (framework I). The sequence must include conserved cysteine residues that form this disulfide bridge network, creating a stable inhibitory cystine knot (ICK) motif. The mature toxin should be short, typically 12-18 amino acids, with key functional residues positioned in the loops between cysteine pairs to mediate specific receptor binding and selectivity. The structural core should exhibit beta-hairpin-like elements and display high stability due to the constrained disulfide topology. The biological role involves precise modulation of cholinergic signaling, contributing to the predatory venom arsenal of Conus leopardus for immobilizing prey through neuromuscular blockade."}
{"description": "sp|C0HJQ8|KAX1G_MESEU Potassium channel toxin alpha-KTx 1.16 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MKISFLLLLALVICSIGWSEAQFTDVKCTGTKQCWPVCKKMFGRPNGKCMNGKCRCYP", "prompt": "Design a potassium channel toxin protein with the functional and structural characteristics of alpha-KTx toxins from Mesobuthus eupeus scorpion venom. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1.x family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The structure should feature a compact, globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting a functional surface with key residues for potassium channel pore blockade. Include the characteristic molecular surface features that enable specific interaction with the channel's outer vestibule, particularly the conserved dyad motif (typically lysine and aromatic residues) that inserts into the potassium conduction pathway. The toxin should exhibit the typical scorpion venom toxin properties of high thermal stability, protease resistance, and nanomolar affinity for its potassium channel targets, contributing to the paralytic and neurotoxic effects characteristic of Mesobuthus eupeus envenomation."}
{"description": "sp|P20394|EXE3_HELHO Exendin-3 OS=Heloderma horridum horridum OX=8552 PE=1 SV=2", "sequence": "MKIILWLCVFGLFLATLFPVSWQMPVESGLSSEDSASSESFASKIKRHSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPSG", "prompt": "Design a protein sequence for exendin-3, a bioactive peptide originally isolated from the venom of the Mexican beaded lizard (Heloderma horridum horridum). This toxin belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist family and functions as a potent incretin mimetic. The protein should adopt a stable helical conformation characteristic of this peptide family, with specific structural features that enable high-affinity binding to the GLP-1 receptor. The mechanism involves mimicking endogenous GLP-1 to stimulate insulin secretion, inhibit glucagon release, delay gastric emptying, and promote satiety, making it therapeutically relevant for diabetes and metabolic disorders. Unlike native GLP-1, exendin-3 exhibits enhanced metabolic stability and prolonged half-life due to evolutionary adaptations in the venom system. The sequence should maintain conserved residues critical for receptor activation while incorporating structural elements that confer resistance to dipeptidyl peptidase-4 (DPP-4) degradation. The overall architecture should support the characteristic pharmacophore required for GLP-1 receptor agonism, including specific helical domains that interact with the receptor's extracellular domain and transmembrane regions."}
{"description": "sp|Q6T7B6|SL2_BITGA Snaclec 2 OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "MGRFIFLSSGLLVVFLSLSGADFECPSEWRPFDQHCYRAFDEPKRSADAEKFCSEQGNSGHLVSIQSKEEADFVAQLISDNIKSSPDYVWMGLWNQRREQYCSRKWTDGSNVIYKNVAERFTKNCFGLEKETEYRTWLNILCGDDYPFVCKFPPRC", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the Gaboon viper (Bitis gabonica). This protein should function as a snaclec (snake C-type lectin) that exhibits platelet-modulating activity, likely acting as a platelet aggregation inhibitor or modulator by binding to specific platelet surface receptors such as GPIb or GPVI. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by two conserved disulfide bridges with a typical C-C-C-C cysteine framework. The sequence should include key structural elements: an N-terminal alpha-helix, followed by two antiparallel beta-sheets forming a double-loop region, and conserved calcium-binding motifs if applicable for receptor recognition. The molecular surface should feature exposed loops responsible for high-affinity binding to platelet glycoproteins, potentially mimicking endogenous ligands to disrupt hemostasis. The biological context is envenomation, where this toxin contributes to prey immobilization through anticoagulant or antiplatelet effects, facilitating prey digestion. Ensure the sequence reflects the evolutionary adaptation of viperid venoms to target mammalian hemostatic systems with high specificity."}
{"description": "sp|Q2VBN0|3SIM8_OPHHA Muscarinic toxin 38 OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCYTQYSLSPPTTKTCPDGQNLCYKRWFAFIPHGNKFFRGCAAACPKAEHNEVVRCCARDKCNL", "prompt": "Design a novel muscarinic toxin protein derived from the venom of Ophiophagus hannah (king cobra), a highly potent elapid snake whose venom contains specialized three-finger toxins that target muscarinic acetylcholine receptors. This muscarinic toxin should function as a selective antagonist of muscarinic receptors, specifically interfering with parasympathetic nervous system signaling by binding to and blocking muscarinic acetylcholine receptor subtypes. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a small, globular core stabilized by four conserved disulfide bonds in a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural scaffold should feature the typical three-loop architecture with loop I containing key residues for receptor subtype selectivity and binding affinity. The molecular target should be muscarinic acetylcholine receptors, with the toxin binding to the extracellular domains of these G-protein coupled receptors, particularly showing selectivity for specific muscarinic receptor subtypes (M1, M2, M3, M4, or M5). The binding interface should involve conserved aromatic and hydrophobic residues in loop I and loop II that interact with receptor binding pockets, while maintaining the characteristic three-finger toxin structural stability through the conserved disulfide framework. The protein should exhibit the typical thermal stability and protease resistance associated with three-finger toxins, with molecular weight approximately 7-8 kDa and isoelectric point consistent with cationic neurotoxins."}
{"description": "sp|Q9GP15|IRCPI_IXORI Kunitz-type anticoagulant protein Ir-CPI OS=Ixodes ricinus OX=34613 GN=CPI PE=2 SV=1", "sequence": "MPFIFVVSFAILACIVVDTANHKGRGRPAKCKLPPDDGPCRARIPSYYFDRKTKTCKEFMYGGCEGNENNFENITTCQEECRAKKV", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor derived from the saliva of the common tick Ixodes ricinus. This protein functions as a potent anticoagulant toxin that facilitates blood feeding by inhibiting key coagulation cascade proteases, particularly targeting factors Xa and/or XIa to prevent clot formation at the feeding site. The protein should adopt the characteristic Kunitz domain fold consisting of a conserved beta-trefoil structure with an alpha-helix packed against an antiparallel beta-sheet. It must contain the canonical Kunitz-type disulfide bond pattern with three conserved disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that stabilize the compact globular structure. The reactive site loop should feature the characteristic protease-binding motif with specific residues positioned for optimal interaction with the active site of target serine proteases. The protein should exhibit high specificity for coagulation factors while maintaining the structural stability required for function in the hostile environment of the vertebrate host. The sequence should reflect the evolutionary optimization for prolonged inhibition of host hemostatic mechanisms during tick feeding."}
{"description": "sp|P0C8R1|KAX3C_ANDAM Potassium channel toxin alpha-KTx 3.12 OS=Androctonus amoreuxi OX=112024 PE=1 SV=1", "sequence": "GVEINVKCTGSHQCIKPCKDAGMRFGKCINRKCHCTPK", "prompt": "Design a potent animal toxin protein sequence that functions as a selective potassium channel blocker. This toxin originates from the venom of Androctonus amoreuxi, a scorpion species whose venom contains a complex cocktail of ion channel modulators that rapidly immobilize prey through disruption of neuronal signaling. The protein belongs to the alpha-KTx family 3.12, characterized by its specific targeting of voltage-gated potassium channels. The core mechanism involves high-affinity binding to the pore region of Kv1.x family channels, effectively blocking potassium efflux and causing prolonged neuronal depolarization, leading to hyperexcitability and paralysis. The structural scaffold should feature the conserved alpha-KTx fold with a stable beta-sheet core stabilized by three disulfide bridges in the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The mature toxin should contain approximately 30-40 amino acids with the cysteine framework C-X(3-7)-C-X(3-7)-C-X(9-19)-C-X(1-4)-C-C. The 3D structure should display the classic CSαβ motif consisting of an alpha-helix connected to an antiparallel beta-sheet by the disulfide network. Include key functional residues in the beta-sheet region that form the functional dyad responsible for channel block, particularly conserved lysine and aromatic residues that interact with the potassium channel selectivity filter. The protein should exhibit the characteristic functional surface that inserts into the channel pore, with appropriate hydrophobic patches and electrostatic complementarity to ensure specific binding to Kv1.2/Kv1.3 channels while maintaining the compact, stable fold typical of scorpion toxins that confers resistance to proteolytic degradation in the venom gland and target environment."}
{"description": "sp|A8CG86|PA2A1_DABRR Acidic phospholipase A2 Drk-a1 OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGNLFQFAEMIVKMTGKEAVHSYAIYGCYCGWGGQGKPQDATDRCCFVHDCCYGTVNDCNPKMATYSYSFENGDIVCGDNNLCLKTVCECDRAAAICLGQNVNTYDKNYENYAISHCTEESEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Russell's viper (Daboia russelii). This enzyme should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by seven conserved disulfide bonds that form the structural core. Key functional elements must include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, an interfacial binding surface for membrane association, and a catalytic histidine-aspartate dyad. As an acidic isoform, the protein should have a net negative charge at physiological pH. The toxin should contribute to the complex pathophysiology of Russell's viper envenomation by inducing local tissue damage, promoting inflammation through eicosanoid production, and potentially exhibiting myotoxic or anticoagulant effects through membrane disruption. Ensure the sequence maintains the proper disulfide connectivity (typically Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, Cys13-Cys14) and includes the essential catalytic residues and calcium-coordinating aspartate for enzymatic function."}
{"description": "sp|P0CG03|VSPBH_BOTAL Thrombin-like enzyme bhalternin OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKASELVIGGDECNINEHRSLVVLFNSSGFLCAGTLINQEWVLTAANCDRKNIRIKLGMHSKNVTNEDEQTRVPKRSTFVSVAKTSHQTLGTRTSMLIRLKRPVNDSPHIAPLSLPSSPPSVGSVCRVMGWGTISPTKVSYPDVPHCANINLLDYEVCREAHGGLPATSRTLCAGILEGGKDSCQGDSGGPLICNGQFQGILSWGVHPCGQPHKPGVYTKVSDYSEWIQSIIAGNTDVTCPP", "prompt": "Design a serine protease enzyme with thrombin-like activity derived from the venom of Bothrops alternatus, a medically significant pit viper. This toxin functions as a key component in the snake's predatory and defensive arsenal by selectively cleaving fibrinogen to generate fibrin clots, leading to consumptive coagulopathy and prey immobilization. The enzyme should exhibit high specificity for fibrinogen over other coagulation factors, characteristic of venom thrombin-like enzymes that deplete fibrinogen reserves without triggering extensive thrombosis. It should adopt the characteristic chymotrypsin-like fold of serine proteases, with a conserved catalytic triad (His, Asp, Ser) and structural elements that confer its substrate selectivity. The mature protein should include appropriate disulfide bonding patterns to stabilize its tertiary structure, typical of snake venom serine proteases. The molecular mechanism involves binding to fibrinogen and cleaving specific bonds to release fibrinopeptides, resulting in the formation of unstable fibrin clots that are rapidly cleared, thereby inducing hypofibrinogenemia. The structural scaffold should reflect the evolutionary adaptations that enhance its stability in the venom gland and efficiency in prey envenomation."}
{"description": "sp|Q9DG83|VSP6_PROMU Snake venom serine protease serpentokallikrein-1 OS=Protobothrops mucrosquamatus OX=103944 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQRTSELVIGGDECNINEHRFLVALHDALSGRFLCGGTLIHPEWVLTAAHCNTHFIIIYLGAHNQSVEFDYEETRYPEKKYFFPCSKNYTKWDKDIMLIRLYSPVRNSKHIAPISLPSSPPSVGSVCRIMGWGAITSPNETFPDVPHCANINLFNYTVCRAAYPELPATSRTLCAGILEGGIDTCHGDSGGPLICNGQFQGIVQAGGKTCARPRKPAVYTNVFDHLDWIKSIIAGNTAVTCPP", "prompt": "Design a snake venom serine protease from the venom of Protobothrops mucrosquamatus, specifically a serpentokallikrein-1 variant. This enzyme belongs to the serine protease family and functions as a potent kallikrein-like toxin that targets the host's kallikrein-kinin system. The protein should exhibit trypsin-like specificity with a preference for cleaving after basic residues (arginine and lysine), leading to the generation of kinins such as bradykinin. This activity results in hypotension, increased vascular permeability, inflammation, and pain. The structural scaffold should feature a chymotrypsin-like fold with a canonical catalytic triad (His, Asp, Ser) and a conserved S1 pocket that confers substrate specificity. The protein should include the characteristic disulfide bond pattern common to snake venom serine proteases, which stabilizes the overall structure and ensures functional integrity. The mature protein should be secreted and glycosylated, with propeptide processing required for activation. The design must ensure high catalytic efficiency and stability in the venom milieu, contributing to the prey immobilization and digestive functions of the venom."}
{"description": "sp|A0A2P1BRP3|CTXB_SCOPL Cytolytic toxin-beta OS=Scorpaena plumieri OX=274700 PE=1 SV=1", "sequence": "MPSDILVVAALGRPFTLGALYDARKDKLYPGFTLWEHEVLEESTVESDQPSSTFEITASDSIDDKSSLMDIEASLKASFLGGLIEVGGSAKYLNDTKKFKNQSRVTLQYKATTSFKQLMTNLETKHVEYSEYFQNIEATHVVIGILYGANAFFVFDSDKVDSSNVQDIQGSMEAVIKKIPSVEISGQGSVQLTSEESDITNSFSCKFHGDFHLPSNPTTFEDAVKTYQQLPQMMGKETAVPMTVWLVPMTNFYSEAPQLMADSSTPILRKVRNTLEAMRQLDMRCNDSLERRHSEAGFHCLKKKLKTFQKHYERLHVNPFRKNHFPETFSPSGKGTKMKLQCLPTFRNKLRSPSNINSLNMWMDCAEREINVLRSCIDIIEEAKHKVVLSKSQMARELDDSEVKHAVCYVFTYVTDYDPFLNALSDFSKSIKPKKYSPSKKDYWYTSDDVPEMMREKAHHFYNLAKDMENRCVRFLVASIVNPKEEGAAIHYYREGIQIINDFSNPRIPPVETIQDQESYSGMTVSSPWKETAHPALHLSEGNKKAMSGKPQPSDNNPKRFDHYQQVLCNKGLSKRHYWEVEWCGYVRAGITYKGIQRKTFASECSLGHTDMSWVFDYYPKSGYHHIYNNKKVRVKVASPGFDRLGVYLDWPAGTLSFYMVTSTWVTHLHTFSIRFNEAVYPAFLIGHGQKNANGQIKLKGE", "prompt": "Design a cytolytic beta-toxin from the venom of the spotted scorpionfish (Scorpaena plumieri) that functions as a potent pore-forming membrane-disrupting agent. This toxin should exhibit the characteristic beta-pore-forming toxin structural scaffold, likely adopting a beta-sandwich fold composed predominantly of beta-strands arranged in antiparallel sheets. The protein should contain the conserved cytolysin domain architecture with amphipathic regions that facilitate membrane insertion and oligomerization. Key structural features should include hydrophobic patches for membrane interaction and charged residues that contribute to target cell specificity, potentially through recognition of specific membrane components like sphingomyelin or cholesterol-rich domains. The toxin should demonstrate preferential lytic activity against eukaryotic cell membranes, causing osmotic lysis through the formation of stable transmembrane pores. The mechanism involves initial binding to the target membrane via specific lipid interactions, followed by oligomerization into a multimeric pore complex that disrupts membrane integrity. The structural design should ensure proper folding stability, likely stabilized by conserved disulfide bridges characteristic of the cytolysin toxin family, and maintain the amphipathic character necessary for both water solubility and membrane insertion capabilities."}
{"description": "sp|P0C2P5|VSTX3_GRARO Voltage sensor toxin 3 OS=Grammostola rosea OX=432528 PE=1 SV=1", "sequence": "DCLGWFKGCDPDNDKCCEGYKCNRRDKWCKYKLW", "prompt": "Design a voltage sensor toxin protein from the Chilean rose tarantula (Grammostola rosea) venom. This toxin functions as a potent modulator of voltage-gated ion channels, specifically targeting the voltage-sensing domains of these channels to alter their gating kinetics and electrical excitability. The protein should adopt a compact, stable structure stabilized by a conserved disulfide bridge framework typical of inhibitor cysteine knot (ICK) motifs, which provides exceptional thermal and proteolytic stability. The molecular mechanism involves binding to the S3-S4 voltage-sensing paddle of voltage-gated sodium, potassium, or calcium channels, trapping the voltage sensor in specific conformations and thereby inhibiting or modifying channel activation. This results in disrupted neuronal signaling and neuromuscular transmission, contributing to the venom's paralytic and neurotoxic effects. The structural scaffold should feature a triple-stranded beta-sheet stabilized by the ICK motif, with key functional residues positioned to interact with the voltage-sensing domains of target ion channels. The toxin should exhibit high affinity and selectivity for its voltage sensor targets, reflecting its role in the predatory and defensive strategies of this theraphosid spider."}
{"description": "sp|P0DX31|MAST1_EUMMI Eumenine mastoparan-EM1 OS=Eumenes micado OX=2597558 PE=1 SV=1", "sequence": "LKLMGIVKKVLGAL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the potter wasp Eumenes micado. This peptide should adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan family peptides. The sequence must exhibit potent cytolytic activity through membrane disruption, forming pores in lipid bilayers and causing cell lysis. It should demonstrate mast cell degranulation properties, triggering histamine release, and possess antimicrobial activity against both Gram-positive and Gram-negative bacteria. The peptide should be relatively short (approximately 14 amino acids) with a net positive charge that facilitates interaction with negatively charged phospholipid head groups. The structural scaffold should feature a flexible N-terminal region followed by a well-defined amphipathic helix, allowing for optimal membrane insertion and pore formation. The sequence should maintain the conserved mastoparan functional motifs while exhibiting the specific pharmacological profile characteristic of eumenine wasp venoms, which serve both defensive and prey immobilization functions in these solitary wasps."}
{"description": "sp|C0HK69|SCXD_CENLI Beta-toxin Cl13 OS=Centruroides limpidus OX=6876 PE=1 SV=2", "sequence": "KEGYLVDYHTGCKYTCAKLGDNDYCVRECRLRYYQSAHGYCYAFACWCTHLYEQAVVWPLPNKRCKGK", "prompt": "Design a beta-toxin protein from the venom of the Mexican scorpion Centruroides limpidus that functions as a voltage-gated sodium channel modulator. This toxin should specifically target and inhibit the inactivation of neuronal sodium channels, particularly Nav1.2, Nav1.3, and Nav1.6 subtypes, leading to prolonged action potentials and enhanced neurotransmitter release. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should contain a conserved core beta-sheet flanked by an alpha-helix, with key functional residues concentrated in the 'conserved hydrophobic surface' region that interacts with the voltage-sensing domain II of the sodium channel. The toxin should exhibit high specificity for mammalian neuronal sodium channels while maintaining the thermal stability and protease resistance typical of scorpion venom peptides. The molecular mechanism should involve binding to receptor site 4 on the sodium channel, shifting the voltage-dependence of activation toward more negative potentials and delaying channel inactivation."}
{"description": "sp|P0CY86|CA11_CONBU Alpha-conotoxin-like Bu1.1 OS=Conus bullatus OX=89438 PE=3 SV=1", "sequence": "MGMRMMFTVFLLIVLATTVVSFSTDDESDGSNEEPSADQTARSSMNRAPGCCNNPACVKHRCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus bullatus, a marine cone snail species known for its specialized predatory venom arsenal targeting neuronal signaling pathways. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically exhibiting high affinity for neuronal subtypes involved in neurotransmission modulation. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the CC-C-C framework typical of this toxin family. The structure should display well-defined alpha-helical elements and beta-turn motifs that create a precise molecular surface for receptor interaction. Key functional residues should be positioned to mediate specific binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine binding and thereby disrupting synaptic transmission. The sequence must include the essential cysteine residues in the appropriate spacing to ensure correct disulfide bridge formation and maintain the characteristic three-loop architecture that defines alpha-conotoxin pharmacology. The overall molecular architecture should enable high potency and subtype selectivity while maintaining the thermal stability and protease resistance typical of conotoxin peptides."}
{"description": "sp|Q6PTD4|CA12_CONLE Alpha-conotoxin-like Lp1.2 OS=Conus leopardus OX=101306 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRAFDGRNAAASDKASDLISLAVRGCCSHPACSVNNPYFCGGKR", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of the marine cone snail Conus leopardus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form a compact, rigid core. The sequence should include the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that mediate high-affinity binding to the orthosteric site of nicotinic acetylcholine receptors, competitively inhibiting acetylcholine binding. The toxin should exhibit high potency and selectivity for specific receptor subtypes, reflecting the evolutionary optimization of Conus leopardus venom for rapid prey immobilization. The overall structure should be small (typically 12-20 amino acids), cysteine-rich, and stabilized by the disulfide framework to maintain biological activity and resistance to proteolytic degradation."}
{"description": "sp|J7JU64|CBOA_CONVX Alpha-conotoxin VxXXIVA OS=Conus vexillum OX=89431 PE=3 SV=1", "sequence": "METLTLLWRASSSCLLVVLSHSLLRLLGVRCLEKSGAQPNKLFRPPCCQKGPSFARHSRCVYYTQSRE", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus vexillum, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where four cysteine residues form two disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that constrain the peptide into a compact, stable conformation. The sequence should include the signature alpha-conotoxin motif with two adjacent cysteine residues at the N-terminal region, followed by a variable inter-cysteine loop that determines receptor subtype specificity. The 3D structure should exhibit the typical alpha-conotoxin fold with a small beta-sheet and tight turns stabilized by the disulfide network. The molecular mechanism involves competitive inhibition at the orthosteric binding site of nAChRs, preventing acetylcholine binding and subsequent ion channel activation. The toxin should demonstrate high potency and selectivity for specific nAChR subtypes, characteristic of Conus vexillum venom components that evolved for precise neuronal targeting. Include conserved residues critical for structural integrity while allowing for sequence variations in the hypervariable loops that confer target specificity and pharmacological properties."}
{"description": "sp|Q6H3C8|PA2AF_TRIST Acidic phospholipase A2 Ts-A6 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MRALWIMAVLLLGVEGHLMQFENMIKKVTGRSGIWWYGSYGCYCGKGGQGLPQDASDRCCFVHDCCYGKVNGCDPKDDFYVYSSENRDIVCGEDNPCTKEICECDKAAAICFRDNMDTYQNKYWFYPSSNCNEESEPC", "prompt": "Design a novel acidic phospholipase A2 toxin from the venom of Trimeresurus stejnegeri, a highly venomous pit viper. This toxin should exhibit potent enzymatic activity characteristic of Group II secretory phospholipase A2 enzymes, specifically catalyzing the hydrolysis of the sn-2 ester bond of glycerophospholipids to release free fatty acids and lysophospholipids. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bonds in the characteristic pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, Cys13-Cys14). Include the essential catalytic triad residues (histidine, aspartate, calcium-binding loop with tyrosine, glycine, glycine) and the conserved calcium-binding site required for enzymatic activity. The acidic nature should be reflected in the overall surface charge distribution, potentially influencing membrane binding specificity and inflammatory responses. The toxin should demonstrate preferential activity toward mammalian cell membranes, contributing to the venom's hemotoxic effects through membrane disruption, induction of inflammation, and potential myotoxic activity. Ensure the structural integrity includes the characteristic phospholipase A2 interfacial binding surface for membrane association and the conserved active site geometry for substrate recognition and catalysis."}
{"description": "sp|P0CAR0|VKTG1_MICPY Kunitz-type serine protease inhibitor G1 (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "KVPAYCKLPPDSGPCKGHFPAFYYDPVSSYCQKFI", "prompt": "Design a Kunitz-type serine protease inhibitor protein fragment derived from the venom of Micrurus pyrrhocryptus, a coral snake species. This toxin functions as a potent serine protease inhibitor that disrupts key physiological processes in prey by targeting and inhibiting specific serine proteases involved in coagulation, fibrinolysis, or inflammatory pathways. The protein should adopt the characteristic Kunitz-type fold, featuring a conserved structural motif comprising an anti-parallel beta-sheet stabilized by three disulfide bridges with the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The active site should include a canonical protease-binding loop with residues optimized for specific, high-affinity interaction with serine protease active sites, likely employing a mechanism involving tight binding to the protease's catalytic triad. The structural scaffold should maintain the compact, globular domain typical of Kunitz inhibitors, ensuring thermodynamic stability and resistance to proteolytic degradation while enabling precise molecular recognition of target proteases."}
{"description": "sp|C0HKB8|PA2A1_MICDM Acidic phospholipase A2 OS=Micrurus dumerilii OX=1337871 PE=1 SV=1", "sequence": "NLIDFKNMIKCTTKRSVLDFADYGCYCGSGGSGTPVDDLDRCCKVHDDCYGEAEKVHGCWPKWTLYSYDCSNGQLTCKDNNTKCKDFVCNCDRTAAICFAKAPYDDNNFMINNPRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Micrurus dumerilii, a coral snake species. This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should exhibit high specificity for hydrolyzing the sn-2 acyl bond of glycerophospholipids in neuronal membranes, leading to membrane disruption and synaptic vesicle depletion. The sequence should maintain the typical phospholipase A2 disulfide bridge pattern (6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The acidic nature should be reflected in the pI, potentially enhancing specific interactions with neuronal targets while reducing non-specific binding. The toxin should demonstrate the characteristic β-wing region that contributes to neurotoxic specificity in elapid snake venoms."}
{"description": "sp|P0CY66|O168_CONBU Omega-conotoxin Bu8 (Fragment) OS=Conus bullatus OX=89438 PE=1 SV=1", "sequence": "AEDSRGTQLHRALRKATKLSESTRCKRKGSSCRRTSYDCCTGSCRNGKCG", "prompt": "Design a protein sequence for a marine cone snail venom peptide that functions as a potent calcium channel blocker. This toxin originates from Conus bullatus, a fish-hunting cone snail species whose venom contains specialized peptides that rapidly immobilize prey by disrupting neuronal signaling. The protein should adopt the characteristic omega-conotoxin structural scaffold, featuring an inhibitor cystine knot (ICK) motif stabilized by three conserved disulfide bridges with a C-C-CC-C-C connectivity pattern. This compact, globular fold creates a stable molecular framework that presents key functional residues for selective interaction with voltage-gated calcium channels, specifically N-type (Cav2.2) channels in the vertebrate nervous system. The toxin should function as a pore blocker, binding to the channel's pore-forming region with high affinity to inhibit calcium influx, thereby blocking neurotransmitter release and causing neuromuscular paralysis. Include conserved residues typical of omega-conotoxins that mediate target recognition while maintaining the structural integrity required for venom stability and biological activity."}
{"description": "sp|D9U2B2|KA262_LYCMC Potassium channel toxin alpha-KTx 26.2 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MKTIFVVILVLFVLSAMLASSPDTTAEAAGCRGNCVTICRDKGKVGGKCYNGKCFCFN", "prompt": "Design a novel potassium channel toxin protein sequence derived from the venom of the scorpion Lychas mucronatus. This toxin belongs to the alpha-KTx family 26.2, which specifically targets voltage-gated potassium channels (Kv channels) to modulate neuronal excitability and neuromuscular transmission. The toxin should function as a pore-blocker, binding to the external vestibule of Kv channels and physically occluding the potassium conduction pathway, thereby delaying channel repolarization and prolonging action potentials. The structural scaffold must feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded antiparallel beta-sheet, stabilized by three or four disulfide bridges following the canonical alpha-KTx cysteine framework (typically C1-C4, C2-C5, C3-C6). Key functional residues should include a dyad or triad of solvent-exposed hydrophobic/aromatic and basic residues (e.g., lysine, tyrosine) that mediate high-affinity binding to the Kv channel pore, with additional electrostatic interactions from positively charged residues enhancing specificity for distinct Kv subfamilies (e.g., Kv1.x). The sequence must exhibit the compact, globular topology typical of scorpion toxins, with the functional dyad/triad positioned in a flexible loop region critical for channel block. Ensure the design reflects the evolutionary optimization of Lychas mucronatus venom for rapid prey immobilization via disruption of potassium-dependent electrical signaling."}
{"description": "sp|B8XH01|LV1A_BUTIS Lipolysis-activating peptide 1-alpha chain OS=Buthus israelis OX=2899555 PE=2 SV=1", "sequence": "MMKLVLFGIIVILFSMIGSIHGSDPPGNYPLNTYGNKYACTILGENDFCQKICKVHGVQYGYCFNSRCWCEYLEEKDVNIWDAVKRHCKNTILYPKGK", "prompt": "Design a novel animal toxin protein sequence that functions as a lipolysis-activating peptide derived from the venom of the scorpion Buthus israelis. This toxin should exhibit potent biological activity by activating lipolysis pathways, likely through interaction with specific receptors involved in lipid metabolism regulation. The protein should adopt a stable structural scaffold characteristic of scorpion venom peptides, featuring a compact disulfide-stabilized fold with multiple cysteine residues forming intramolecular disulfide bridges that confer structural rigidity and resistance to proteolytic degradation. The sequence should include conserved motifs for receptor binding and activation, with appropriate surface-exposed residues for target recognition. The overall architecture should enable high specificity and potency in modulating lipolytic processes, reflecting the evolutionary optimization of scorpion venom components for disrupting metabolic homeostasis in prey organisms."}
{"description": "sp|P21789|PA2A_CERCE Acidic phospholipase A2 Cc1-PLA2 OS=Cerastes cerastes OX=8697 PE=1 SV=1", "sequence": "NLYQFGKMIFKMTGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRVNSCNPKRSTYSYSFQNGGIVCDDQNLCKRAVCECDRVAAICFGENVNTYDKKYKDYPTSQCTETEQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Saharan horned viper, Cerastes cerastes. This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release through its phospholipase activity. The protein should exhibit calcium-dependent catalytic function, hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and synaptic vesicle depletion. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG), a catalytic network centered around histidine and aspartate residues, and the distinctive pancreatic loop. Include the conserved disulfide bridge pattern typical of group II phospholipase A2 enzymes, with cysteine residues forming the stabilizing cross-links that maintain the compact, stable structure. The protein should have an acidic pI and exhibit the characteristic three-finger structural motif with a hydrophobic channel for substrate binding. The sequence should reflect the evolutionary optimization for rapid membrane penetration and high catalytic efficiency against neuronal membranes, while maintaining the thermal stability and protease resistance required for venom function."}
{"description": "sp|Q6X5S5|SL27_ECHOC Snaclec 27 (Fragment) OS=Echis ocellatus OX=99586 PE=2 SV=1", "sequence": "WGDSSSSASACWSCFSLVSGIGADQECPPGWSSHEGHCYKVFSEYKTWVDAEQYCTEQENGGHLVSFHNREEVDFVVKLGYTILKADIVWIGLRDFWRECHWEWSNGAQLDYKGWSDEPNCFIVYTVGNKWLHRKCSSTQQFVCKSPA", "prompt": "Design a protein sequence for a snake venom C-type lectin (snaclec) from the West African carpet viper, Echis ocellatus. This toxin functions as a platelet aggregation modulator, specifically targeting platelet membrane glycoproteins through calcium-dependent carbohydrate recognition domains. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C-C-C-C cysteine framework. The structural scaffold should include the conserved carbohydrate recognition domain with essential calcium-binding residues (Glu, Asn, Asp) that mediate target recognition. The protein should exhibit the signature β-sheet rich topology with α-helices characteristic of CTLD proteins, enabling specific binding to platelet receptors to either inhibit or promote thrombus formation. The sequence should maintain the key functional motifs for venom-induced coagulopathy while preserving the structural integrity of the lectin domain for proper folding and biological activity."}
{"description": "sp|C0HJU7|VKT2G_RADCR PI-stichotoxin-Hcr2g OS=Radianthus crispa OX=3122430 PE=1 SV=1", "sequence": "RGICLEPKVVGPCKARIRRFYYDSETGKCTPFIYGGCGGNGNNFETLHACRGICRA", "prompt": "Design a novel protein sequence for a potent cytolysin toxin derived from the sea anemone Radianthus crispa. This toxin should function as a pore-forming cytolysin that specifically targets and disrupts eukaryotic cell membranes, particularly those of potential prey organisms. The protein should adopt a stable beta-sandwich fold characteristic of actinoporin family toxins, with conserved structural elements including a hydrophobic core and membrane-binding regions. Incorporate the conserved sphingomyelin-binding motif that enables specific recognition of target membranes. The sequence should include the characteristic cysteine framework with appropriate disulfide bridges to stabilize the beta-sandwich structure and maintain pore-forming capability. The mature toxin should demonstrate amphipathic properties with both hydrophilic surface regions and hydrophobic membrane-insertion domains. Ensure the protein can oligomerize to form functional transmembrane pores that cause rapid cell lysis through osmotic imbalance. The structural design should prioritize stability in marine environments while maintaining high specificity for eukaryotic membrane components over prokaryotic membranes."}
{"description": "sp|M1J7U4|SCX5_ANDCR Putative sodium channel alpha-toxin Acra5 OS=Androctonus crassicauda OX=122909 PE=3 SV=1", "sequence": "VRDGYIMIKDTNCKFSCNIFKKWEYCSPLCQSKGAETGYCYNFGCWCLDLPDDVPVYGDRGVICRTR", "prompt": "Design a novel animal toxin protein sequence that functions as a potent sodium channel alpha-toxin, specifically targeting voltage-gated sodium channels (Nav) to modulate neuronal and muscular excitability. This toxin should be derived from the venom of the fat-tailed scorpion Androctonus crassicauda, a medically significant species known for producing neurotoxic peptides that interfere with sodium channel gating. The protein should adopt the characteristic structural scaffold of scorpion alpha-toxins, featuring a compact, globular fold stabilized by a conserved cysteine framework with four disulfide bridges (C-C-C-C pattern) that create a stable core. The sequence should include key functional motifs for binding to site 3 of voltage-gated sodium channels (e.g., Nav1.1-Nav1.7 subtypes), delaying channel inactivation and prolonging action potentials, leading to hyperexcitability, paralysis, or neurotoxic effects. Incorporate conserved residues for receptor interaction, such as those in the 'pharmacophore' region, and ensure the structural integrity of the inhibitor cystine knot (ICK) motif, which provides rigidity and resistance to proteolysis. The toxin should exhibit high affinity and selectivity for mammalian sodium channels, reflecting its role in prey immobilization and defense. Avoid any non-biological sequences and ensure the design aligns with the evolutionary and functional constraints of scorpion venom peptides."}
{"description": "sp|P85163|BPPEA_BOTJA Bradykinin-potentiating peptide 14a OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "QWAQWPRPTPQIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the pit viper Bothrops jararaca, a species known for its complex venom composition that induces hemorrhage, edema, and hypotension. This peptide functions as a potent vasoactive agent by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced vasodilation, increased vascular permeability, and prolonged hypotension. The peptide is expected to adopt a compact, stable structure stabilized by a characteristic pyroglutamic acid residue at the N-terminus, which confers resistance to aminopeptidase degradation, and a C-terminal proline-rich region that is critical for ACE binding and inhibition. The sequence should lack disulfide bridges, typical of BPPs, and exhibit a linear conformation with key residues involved in zinc coordination at the active site of ACE. The molecular target is the zinc-metalloprotease domain of ACE, with binding primarily mediated through interactions with the catalytic zinc ion and adjacent substrate-binding pockets, resulting in competitive inhibition and potentiation of bradykinin's physiological effects."}
{"description": "sp|P60514|TXP1_PSACA Psalmotoxin-1 OS=Psalmopoeus cambridgei OX=179874 PE=1 SV=1", "sequence": "EDCIPKWKGCVNRHGDCCEGLECWKRRRSFEVCVPKTPKT", "prompt": "Design a protein sequence for a highly selective and potent animal toxin with the following precise biological and structural characteristics: This toxin, known as Psalmotoxin-1, originates from the Trinidad chevron tarantula (Psalmopoeus cambridgei), where it serves as a key component of the spider's venom for prey immobilization through targeted neuronal disruption. The core function is as a specific and potent inhibitor of acid-sensing ion channel 1a (ASIC1a), acting as a gating modifier that stabilizes the channel in a desensitized state, thereby blocking proton-gated currents in central and peripheral neurons. The toxin belongs to the inhibitory cysteine knot (ICK) structural family, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern with connectivity I-IV, II-V, III-VI (cysteine framework C-C-CC-C-C). This scaffold confers exceptional stability and resistance to proteolytic degradation. The molecular target is ASIC1a, with binding occurring primarily at the acidic pocket region of the channel's extracellular domain, where specific basic and hydrophobic residues on the toxin interact with complementary acidic and aromatic residues on the channel to achieve nanomolar affinity and subtype selectivity over other ASIC isoforms. The sequence should reflect these structural constraints, including the precise cysteine spacing for proper knot formation, conserved hydrophobic core residues for fold stability, and surface-exposed residues critical for ASIC1a binding and functional inhibition."}
{"description": "sp|B7U492|VM1V1_AGKPL Snake venom metalloproteinase VMP1 OS=Agkistrodon piscivorus leucostoma OX=459671 PE=2 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEIVYPRKVTPVPRGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISTCNGLKGHFKLQGEMYLIEPLELSDSEAHAVYKYENVEKEDEAPKMCGVTQNWESYEPTKKAFQLNLTPEQQGFPQRYVELVIIADHRMYMKYKRDSNKITQWVHQMVNTINEIYRPLNIQFALVGLEIWSNQDLITVTSVSDDTLISFANWRETVLLRRKSHDNAQLLTAIVFDEGIIGRAPLAGMCDPNRSVGTVQDHSKINFRVAIIMAHEIGHNLGMGHDDNSCTCGGYSCIMLPRLSKQPSKLFSDCSKKDYLTFLKVKNPQCILNKPLRTDTVSTPVSGNELLEA", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that mimics the toxic activity and structural characteristics of venom from the western cottonmouth (Agkistrodon piscivorus leucostoma). This protein should function as a potent hemorrhagic toxin that targets and degrades key components of the extracellular matrix and basement membranes. The sequence must include the characteristic zinc-binding motif (HEXXHXXGXXH) in the catalytic domain, which coordinates the essential zinc ion for proteolytic activity. Incorporate the conserved methionine turn and disulfide bond network typical of reprolysin-family metalloproteinases to ensure proper folding and stability. The protein should feature a multi-domain architecture including propeptide, catalytic, and disintegrin-like domains, with appropriate cysteine frameworks to maintain structural integrity. The generated metalloproteinase should specifically cleave collagen IV, laminin, and fibronectin in capillary basement membranes, leading to vascular disruption and hemorrhage. Ensure the sequence reflects the characteristic substrate specificity and pH stability profile of viperid venom metalloproteinases, with optimal activity in physiological conditions."}
{"description": "sp|J3S829|VM32A_CROAD Zinc metalloproteinase-disintegrin-like 2a OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILGSGNVNDYEVVYPRKVTALPKGAAQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQRYLNTKKYIELVIVADNVMVKKYTSNSTAIRTRIYACVNTLNLIYRAFNIHIALVGIEIWSNKDLINVISASNVTLDLFGNWRRRVLLRRKRHDNAQLLTAIDLDGPTIGLARVGSMCDPKCSTGIVQDHSKLDVMVAVTMAHELAHNLGINHDGNQCNCGGNPCIMSATLNFEPAYRFSDCSRDEHWRYLIDNRPPCILNKPLITDIVSPPVCGNYFVEVGEECDCGLPAHCQNPCCNAATCKLRPGTQCEDGECCEQCQFTSAGTECRAAKSECDIAESCTGQSADCPTDNFQRNGRPCLNNNGYCYNGKCPTLDHQCISFFGSSATVAPDVCFNLNLKGEGNFYCRRENTRIFPCAPQDKKCGRLFCVLGPTGNTISCQSTYSQSDLDIGMVDLGTKCGDGRVCNSTRQCVDVNTAY", "prompt": "Design a protein sequence for a zinc metalloproteinase-disintegrin-like toxin from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus). This toxin belongs to the snake venom metalloproteinase (SVMP) family and exhibits a modular architecture comprising a metalloproteinase domain and a disintegrin-like domain. The metalloproteinase domain should feature a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling proteolytic activity against extracellular matrix components such as collagen, fibronectin, and laminin. This domain adopts a metzincin-like fold with a central five-stranded β-sheet and surrounding α-helices. The disintegrin-like domain should contain an ECD motif instead of the canonical RGD motif found in disintegrins, which may mediate interactions with integrins or other cell surface receptors, potentially inhibiting platelet aggregation or disrupting cell-matrix interactions. The protein should include a prodomain that is proteolytically processed upon maturation, and the mature toxin should exhibit a multi-domain structure stabilized by disulfide bonds, with a characteristic pattern including bonds within the metalloproteinase domain (e.g., Cys I-III, II-IV) and additional bonds in the disintegrin-like domain. The overall structure should facilitate venom-induced pathologies such as hemorrhage, tissue damage, and anticoagulation, leveraging the metalloproteinase's proteolytic activity to degrade basement membranes and the disintegrin-like domain to modulate cellular adhesion. Ensure the sequence reflects the biological context of rattlesnake venom, where SVMPs contribute to prey immobilization and digestion through extracellular matrix degradation and hemostatic disruption."}
{"description": "sp|B8XGZ8|LV1B_BUTIS Lipolysis-activating peptide 1-beta chain OS=Buthus israelis OX=2899555 PE=3 SV=1", "sequence": "MANVQVIFVAYIAVIAFSMVYGDDYKPFGEHNSYYGCKKQTDEFCNKICKLHLAKKGGFCHQPAPFVELCKCLDIDYDNTYFLKAMEKQCPKLKGNVN", "prompt": "Design a novel animal toxin protein sequence that functions as a lipolysis-activating peptide derived from the venom of the scorpion Buthus israelis. This toxin should belong to the beta-chain family of scorpion venom peptides and exhibit potent biological activity in activating lipolysis, likely through interaction with lipid metabolism pathways or receptors involved in fat breakdown. The protein should adopt a stable structural scaffold characteristic of scorpion venom peptides, featuring a compact disulfide-stabilized fold with a conserved cysteine framework pattern (e.g., C-C-C-C or similar) that forms specific disulfide bridges to maintain structural integrity and functional epitopes. The molecular mechanism should involve binding to specific targets such as G-protein coupled receptors or enzymes regulating lipid mobilization, leading to enhanced lipolytic activity. The sequence must include key functional residues for receptor interaction, stability in venom, and efficient folding into the anticipated three-dimensional structure, which may resemble the inhibitor cystine knot (ICK) motif or other scorpion toxin folds. Ensure the design reflects the evolutionary adaptation of scorpion venoms for prey immobilization or defense, with high specificity and potency in modulating metabolic processes."}
{"description": "sp|Q8WS88|PA2_ADAPA Phospholipase A2 A2-hormotoxin-Apt1a OS=Adamsia palliata OX=176095 PE=2 SV=1", "sequence": "MQLYTYFFTFSLVLILALADQENKSLDFTQEGGIAKRGAFQFSYLIKKYTGRNPLDYWGYGCWCGLGGKGTPVDGVDWCCYHHDMCFNSITQGPRPTCSKNAPYHKNYYFSGLKCSTGWLTSKCGRAICACDIAAVKCFMRNHFNNKYQNYKKNIC", "prompt": "Design a phospholipase A2 toxin from the sea anemone Adamsia palliata, specifically the A2-hormotoxin-Apt1a variant. This toxin should function as a potent neurotoxin that disrupts neuromuscular transmission through phospholipase A2 enzymatic activity. The protein should hydrolyze phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids that damage cell membranes and interfere with synaptic signaling. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop, catalytic histidine-aspartate dyad, and the distinctive pancreatic loop common to group III secretory phospholipases. The sequence should contain the essential disulfide bridge pattern that stabilizes the globular structure, with conserved cysteine residues forming the characteristic cross-linking pattern that defines this toxin family. The molecular mechanism should involve binding to specific neuronal membrane targets where its enzymatic activity induces presynaptic blockade, leading to paralysis. The protein should exhibit the typical three-finger-like structural organization with alpha-helical content and beta-sheet regions that create a stable, compact globular architecture optimized for venom delivery and target engagement."}
{"description": "sp|D9U2B1|KBX22_LYCMC Neurotoxin beta-KTx 12 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MKQYIFFLALIVLVSTFAEAGKKTEILDKVKKVFSKAKDKILAGVEDLNNMSELGCPFIDKWCEDHCESKKLVGKCENFDCSCVKLGGK", "prompt": "Design a novel beta-KTx neurotoxin protein sequence inspired by the venom arsenal of the scorpion Lychas mucronatus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels (Kv channels), specifically targeting the Kv1 subfamily, which is critical for modulating neuronal excitability and neurotransmitter release. The toxin must adopt the conserved structural scaffold characteristic of beta-KTx toxins, featuring a compact, triple-stranded antiparallel beta-sheet stabilized by a specific disulfide bond pattern (cysteine framework I: C1-C4, C2-C5, C3-C6). Key functional residues should be strategically positioned within the functional dyad—typically involving a critical lysine or aromatic residue in the beta-sheet region—to facilitate high-affinity binding to the channel's voltage-sensor domain, thereby impeding channel activation through a voltage-sensor trapping mechanism. Ensure the sequence includes the hallmark N-terminal helix and the conserved structural motifs that confer stability and target specificity, while excluding any non-biological identifiers. The final protein should exhibit the biophysical properties of a small, stable, and disulfide-rich neurotoxin capable of modulating electrical signaling in the nervous system."}
{"description": "sp|Q6Q252|PA11_POLDO Phospholipase A1 1 OS=Polistes dominula OX=743375 PE=1 SV=1", "sequence": "MNFKYSILFICFVKVLDNCYAADDLTTLRNGTLDRGITPDCTFNEKDIELHVYSRDKRNGIILKKEILKNYDLFQKSQISHQIAILIHGFLSTGNNENFDAMAKALIEIDNFLVISVDWKKGACNAFASTNDVLGYSQAVGNTRHVGKYVADFTKLLVEQYKVPMSNIRLIGHSLGAHTSGFAGKEVQRLKLGKYKEIIGLDPAGPSFLTNKCPNRLCETDAEYVQAIHTSAILGVYYNVGSVDFYVNYGKSQPGCSEPSCSHTKAVKYLTECIKRECCLIGTPWKSYFSTPKPISQCKRDTCVCVGLNAQSYPAKGSFYVPVDKDAPYCHNEGIKL", "prompt": "Design a phospholipase A1 toxin from the venom of the European paper wasp Polistes dominula. This enzyme should function as a potent digestive and cytolytic toxin that specifically hydrolyzes the sn-1 acyl ester bond of glycerophospholipids, producing free fatty acids and lysophospholipids. The protein should adopt the canonical α/β hydrolase fold characteristic of venom phospholipases, featuring a central β-sheet surrounded by α-helices with a conserved catalytic triad (Ser-Asp-His) in the active site. The mechanism involves interfacial activation at membrane surfaces, where the enzyme binds to lipid-water interfaces and cleaves phospholipids, leading to membrane disruption, hemolysis, and tissue damage. The structural scaffold should include the characteristic GXSXG lipase consensus motif surrounding the nucleophilic serine residue, with appropriate hydrophobic patches for membrane association. The protein should exhibit optimal activity at neutral to slightly basic pH and demonstrate stability in the venom environment, with potential roles in prey immobilization, digestion, and defense against predators."}
{"description": "sp|A8QL52|OXLA_BUNFA L-amino-acid oxidase OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MNVFSIFSLVFLAAFGSCADDRRSALEECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMAGLSAAYVLAGAGHRVTLLEASDRVGGRVNTYRDEKEGWYVNMGPMRLPERHRIVRTYIAKFGLKLNEFFQENENAWYFIRNIRKRVWEVKKDPGVFKYPVKPSEEGKSASQLYRESLKKVIEELKRTNCSYILDKYDTYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYYLSFIESLKNDDLFSYEKRFDEISDGFDQLPKSMHQAIAEMVHLNAQVIKIQRDAEKVRVAYQTPAKTLSYVTADYVIVCATSRAVRRISFEPPLPPKKAHALRSIHYKSATKIFLTCTRKFWEADGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIVAYVLADDSDFFQALDIKTSADIVINDLSLIHQLPKNEIQALCYPSLIKKWSLDKYTMGALTSFTPYQFQDYIETVAAPVGRIYFAGEYTATVHGWLDSTIKSGLTAARNVNRASQKPSRIHLINDNQL", "prompt": "Generate a protein sequence for an L-amino-acid oxidase toxin from the venom of the banded krait (Bungarus fasciatus). This enzyme represents a key component of elapid snake venom biochemistry, functioning as a flavoenzyme that catalyzes the oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The hydrogen peroxide generated contributes significantly to the toxin's cytotoxic, platelet aggregation inhibitory, and hemorrhagic effects through oxidative stress mechanisms. The protein should adopt the characteristic homodimeric structure typical of snake venom L-amino-acid oxidases, with each monomer containing a FAD-binding domain exhibiting a Rossmann fold and a substrate-binding domain. The sequence must include conserved catalytic residues for FAD cofactor binding and substrate recognition, along with the characteristic glycosylation sites that modulate its stability and biological activity. The structural scaffold should facilitate the enzyme's interaction with various L-amino acid substrates, with particular efficiency toward hydrophobic residues like phenylalanine and leucine, while maintaining the dimer interface that is crucial for optimal enzymatic function and stability in the venom milieu."}
{"description": "sp|Q6XLL7|KAX68_OPICA Potassium channel toxin alpha-KTx 6.8 OS=Opistophthalmus carinatus OX=190115 PE=2 SV=1", "sequence": "MNAKFILLLLVVTTTILLPDTQGAEVIKCRTPKDCADPCRKQTGCPHAKCMNKTCRCHRCG", "prompt": "Design a novel potassium channel toxin protein derived from the venom of the scorpion Opistophthalmus carinatus, a member of the Buthidae family. This toxin belongs to the alpha-KTx family, specifically alpha-KTx 6.8, and functions as a potent blocker of voltage-gated potassium channels (Kv channels). The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, with a well-defined alpha-helix packed against an antiparallel beta-sheet. The disulfide bridge pattern should follow the canonical C1-C4, C2-C5, C3-C6 connectivity, stabilizing the compact globular structure. The molecular mechanism involves binding to the pore region of Kv channels, particularly the turret and selectivity filter domains, thereby inhibiting potassium ion flux and disrupting neuronal and muscular excitability. The functional residues should include a critical lysine or arginine in the beta-sheet region that penetrates the channel pore, along with hydrophobic and polar residues in the alpha-helix and loops that mediate specific interactions with the channel vestibule. The overall structure should be stabilized by the disulfide network, resulting in a high-affinity, selective blocker of Kv1.x subfamily channels, contributing to the venom's neurotoxic effects by prolonging action potentials and inducing hyperexcitability in prey organisms."}
{"description": "sp|Q6T7B5|SL3_BITGA Snaclec 3 OS=Bitis gabonica OX=8694 PE=2 SV=1", "sequence": "MGRLIFLSFGWLVVFLSLSGTGADFQCPSEWSAYGQHCYRAFSDLKTWEDAEKFCTEQEKAGHLVSIQSIQEANFVAQLVSGFISGSPKIYIWIGLRDRRKEQQCSSEWNDGSKVIYVNWREGESQMCQALTKWTEFHQWLNTDCAGHYPFICKSRV", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) from the Gaboon viper (Bitis gabonica). This protein should function as a key component in the viper's venom system, which primarily targets the mammalian hemostatic system to induce prey immobilization through disruption of normal blood coagulation. The protein should act as a platelet aggregation modulator, likely functioning as an antagonist or agonist of specific platelet receptors such as GPIb or GPVI, thereby interfering with thrombus formation. The structural scaffold must adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The fold should present a globular domain with exposed loops that mediate specific protein-protein interactions with platelet surface receptors. Key conserved residues should include calcium-binding motifs if applicable, and hydrophobic patches for receptor engagement. The sequence should maintain the hallmark features of snaclecs: approximately 130-140 amino acids, the conserved disulfide framework, and surface-exposed residues that determine target specificity while avoiding any immunogenic regions."}
{"description": "sp|M9PQ91|O164_CONBE Delta-conotoxin-like Bt6.4 OS=Conus betulinus OX=89764 PE=3 SV=1", "sequence": "MKLTCMVIVAVLFLTAWTSVMADGSINRPDIAEGWQKFFSKARDEMKNRAASELNKRCAGIGSFCGLPGLVDCCSGRCFIVCLP", "prompt": "Design a novel delta-conotoxin-like peptide derived from the venom of Conus betulinus, the beaded cone snail. This toxin should function as a potent voltage-gated sodium channel (NaV) modulator, specifically exhibiting inhibitory activity that delays channel inactivation and prolongs action potentials, leading to neuronal hyperexcitability and paralysis in prey organisms. The peptide must adopt the conserved conotoxin structural framework characterized by a compact, disulfide-stabilized globular fold. It should contain the characteristic cysteine pattern of delta-conotoxins, typically following a C-C-CC-C-C framework with three disulfide bridges that create a rigid, stable scaffold. The structure should feature well-defined loops between cysteine residues that form the molecular interface for specific interaction with NaV channel domains, particularly binding to site 6 on the channel's voltage-sensing domain. The sequence should include conserved hydrophobic residues critical for membrane interaction and charged residues that facilitate specific recognition of NaV channel subtypes. The overall architecture should enable precise molecular targeting while maintaining the thermal stability and protease resistance characteristic of conopeptides, making it an effective neurotoxic agent in the cone snail's predatory arsenal."}
{"description": "sp|J3S830|VM33_CROAD Zinc metalloproteinase-disintegrin-like 3a OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MIQVLLVTILAVFPYQGSSIILGSGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPMVLHLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEIYLIEPLKLRDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLVVTAEQQRYLNPYRYVELVIVADHGMFTKYNRNLTEVKTWVYEIVNTLNEIYRYLYIRVALVGLEIWSDGDLSNVTLSSGNTLDSFGEWRKRDLLRRKRHDNAQLLTAIDFSGNTIGRASIANMCDPKYSTGIVQDHSPINLLVAVTMAHEMGHNLGLHHDGKSCTCGDYICIMNATLSHQHSKYFSNCSYNQYWDYINTYTPKCILNEPLRTDIISPPVCGNELLEAGEECDCGSPRNCQYQCCDAATCKLHSWVECESGVCCEQCKFRTAGTECRARRSECDIAESCTGQSADCPTDDFHKNGQPCLNNFGYCYNGNCPIMYHQCYALFGSNVYEAEDSCFESNQKGDDYGYCRKENGEKIPCAPEDVKCGRLYCNDNSPGQNDPCKIFPSNEDEHKEMVLPGTKCADGKFCTNGHCVDVATAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from the Eastern diamondback rattlesnake (Crotalus adamanteus). This protein should exhibit the characteristic multi-domain architecture typical of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain responsible for proteolytic degradation of extracellular matrix components and a disintegrin-like domain that interferes with platelet aggregation and cell adhesion processes. The metalloproteinase domain must contain the conserved zinc-binding motif HEXXHXXGXXH and coordinate a catalytic zinc ion essential for enzymatic activity. The disintegrin-like domain should display the characteristic RGD or related integrin-binding motif that competitively inhibits platelet integrin receptors such as αIIbβ3, preventing fibrinogen binding and thus disrupting hemostasis. The protein should adopt the canonical SVMP fold with appropriate disulfide bonding patterns to stabilize both domains, particularly the cysteine-rich disintegrin region. This toxin contributes to the hemorrhagic and anticoagulant effects of Crotalus adamanteus venom by simultaneously degrading vascular basement membranes and inhibiting platelet aggregation, leading to systemic bleeding and impaired coagulation."}
{"description": "sp|A8E2V8|PA2A_TRIGS Acidic phospholipase A2 Tgc-E6 OS=Trimeresurus gracilis OX=109781 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGSLMQFEMLIMKLAKSSGMFWYSAYGCYCGWGGQGRPQDATDRCCFVHDCCYGKATGCDPKKDVYTYSEENGDIVCGGDDPCRKEVCECDKAAAICFRDNMDTYNSKTYWMFPAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Trimeresurus gracilis, a pit viper species. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements should include the calcium-binding loop essential for catalytic activity, the conserved active site histidine-aspartate dyad, and the interfacial binding surface that facilitates membrane association. As an acidic isoform, the protein should exhibit a net negative charge at physiological pH. The toxin should demonstrate myotoxic and potentially anticoagulant activities through its membrane-disrupting effects on skeletal muscle cells and platelets. The sequence should maintain the canonical phospholipase A2 cysteine framework with the appropriate disulfide connectivity to ensure proper folding and enzymatic function."}
{"description": "sp|Q2VBN1|3SIM6_OPHHA Muscarinic toxin MTX6 OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTLVVVTILCLDLGYTLTCLTHESLFFETTETCSDGQNLCYAKWFAVFPGARRPDGGCAATCPDKVPLEIVNCCTTDKCNL", "prompt": "Design a muscarinic toxin protein derived from the venom of the king cobra (Ophiophagus hannah) that functions as a selective antagonist of muscarinic acetylcholine receptors. This three-finger toxin should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should exhibit high affinity binding to specific muscarinic receptor subtypes, likely M1 or M4, through key functional residues located primarily in the central loop II region that mediate receptor recognition and blockade. The toxin should disrupt cholinergic neurotransmission by competitively inhibiting acetylcholine binding to muscarinic receptors, leading to autonomic nervous system dysfunction. The sequence should maintain the conserved three-finger toxin scaffold while incorporating subtype-specific recognition motifs that confer its selective muscarinic antagonistic activity, with appropriate surface charge distribution and loop conformations optimized for receptor binding and stability in the venom environment."}
{"description": "sp|Q6X5S0|SL7_ECHPL Snaclec 7 OS=Echis pyramidum leakeyi OX=38415 PE=2 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADQDCLPDWSSHERHCYKVINEYKTWEEAEQYCTEEANGGHLVSFHNRQEVAFVVKLGYTILKADVVWIGLRDFWRECQWEWSNGAKLNYKGWSDEPNCFIAYTVGNRWVRRKCSSTHPFVCKSPA", "prompt": "Design a novel protein sequence for a snake venom C-type lectin (snaclec) from the saw-scaled viper Echis pyramidum leakeyi. This protein should function as a potent anticoagulant toxin by specifically targeting and inhibiting key components of the mammalian coagulation cascade, particularly through high-affinity binding to coagulation factor IX, factor X, or other serine proteases involved in the coagulation pathway. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a compact globular structure stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that form the core cysteine framework. The structural scaffold should feature the typical β-sheet sandwich architecture with long loop regions that mediate target recognition and binding. Key functional residues should be positioned in these loops to enable specific, high-affinity interactions with the target coagulation factors, disrupting the coagulation cascade and preventing fibrin clot formation. The protein should exhibit the hallmark stability and target specificity of viperid snaclecs, contributing to the prey immobilization and hemorrhagic effects characteristic of Echis venom."}
{"description": "sp|P81114|SLA4_TRIAB Snaclec alboaggregin-A subunit beta' OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "DCPSDWSSYEGHCYRVFNEPQNWADAEKFCTQQHKGSHLVSFQSSEEADFVVQMTRPILNANLVWIGLSNLWNQCNSQWSDGTXLDYKXWREQFECLVSRTTNNEWLSMDCSSTHSFVCEFQA", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the white-lipped pit viper (Trimeresurus albolabris). This protein should function as the beta' subunit of the heterodimeric snaclec complex known as alboaggregin-A, which plays a critical role in the venom's hemostatic disruption by targeting platelet aggregation. The sequence must adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by conserved disulfide bridges—specifically, a pattern involving cysteine residues that form intra-chain disulfide bonds essential for structural integrity. The protein should exhibit calcium-independent lectin activity, enabling specific recognition and binding to platelet membrane receptors such as glycoprotein Ib (GPIb) or other relevant targets involved in platelet adhesion and activation. The structural scaffold should feature a compact, globular domain with a double-loop topology stabilized by beta-sheets and alpha-helices, typical of snake venom C-type lectins. The binding interface should mediate protein-protein interactions that either inhibit or promote platelet aggregation, depending on the context, by interfering with von Willebrand factor binding or other hemostatic pathways. Ensure the sequence reflects the evolutionary adaptations for rapid action and high specificity in disrupting mammalian hemostasis, with residues critical for receptor binding and dimerization with the alpha subunit conserved."}
{"description": "sp|M1JB54|SCX7_ANDCR Putative sodium channel alpha-toxin Acra7 OS=Androctonus crassicauda OX=122909 PE=3 SV=1", "sequence": "VRDGYIVKPTNCVIHCIPFSPGCDKDCKEKGAASGYCQAFGKHGNGCWCIDLPDKVPIKDPNQDCTR", "prompt": "Design a novel animal toxin protein sequence that functions as a sodium channel alpha-toxin, specifically targeting voltage-gated sodium channels (Nav) to modulate neuronal excitability. This toxin should be derived from the venom of Androctonus crassicauda (thick-tailed scorpion), a medically significant species whose venom components are known to cause severe envenomation symptoms through disruption of sodium channel gating. The toxin should exhibit the characteristic structural scaffold of scorpion sodium channel toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The core structure should consist of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, creating a compact, stable globular domain resistant to proteolytic degradation. The molecular mechanism should involve binding to neurotoxin receptor site 3 on voltage-gated sodium channels, specifically delaying fast inactivation and prolonging action potentials, leading to sustained neuronal depolarization and potentially causing autonomic nervous system dysfunction, pain, and muscle paralysis. Key functional residues should be positioned in the beta-sheet regions and loops to form the pharmacophore interface that recognizes and binds to the extracellular loops of sodium channel domain IV. The sequence should maintain the conserved structural motifs while incorporating variations in surface-exposed residues to confer target specificity and potency characteristic of scorpion alpha-toxins."}
{"description": "sp|B0VXV0|SL1_SISCA Snaclec 1 OS=Sistrurus catenatus edwardsii OX=8762 PE=2 SV=1", "sequence": "MGRFIFMSFGLLVVFLSLSGTGADCPSDWSSYEGHCYRVFQQEMTWEAAEQFCAQQRKESHLVSFHSSEEVDFLVSITYPILKADLVWIGLRDIWNECRLEWTDGTKVDYKEWSEEPECIVSKTTDNQWISRPCSRTYSFVCKFQA", "prompt": "Design a novel protein sequence for a snake venom C-type lectin-like protein (snaclec) from the desert massasauga rattlesnake (Sistrurus catenatus edwardsii). This protein should function as a potent anticoagulant toxin by specifically targeting and inhibiting key components of the mammalian coagulation cascade. The sequence must adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved globular structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The protein should form a heterodimeric complex typical of snaclecs, with one subunit containing a high-affinity binding site for coagulation factor IX or X, effectively preventing the assembly of the tenase or prothrombinase complexes. The structural scaffold should include the conserved calcium-binding motif and carbohydrate recognition domain architecture, but evolved to specifically recognize protein epitopes on coagulation factors rather than carbohydrates. The resulting toxin should disrupt the coagulation cascade through competitive inhibition, leading to impaired thrombin generation and significant anticoagulant effects in mammalian prey."}
{"description": "sp|P0DX33|MAST3_EUMMI Eumenine mastoparan-EM3 OS=Eumenes micado OX=2597558 PE=1 SV=1", "sequence": "FDLLGLLKKVVSGL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the potter wasp Eumenes micado. This peptide should function as a potent cytolytic and antimicrobial agent, characteristic of mastoparan toxins in hymenopteran venoms. The sequence must adopt an amphipathic alpha-helical conformation in membrane environments, with a cationic surface rich in lysine and arginine residues that facilitates interaction with negatively charged phospholipid head groups. The structural scaffold should enable membrane disruption through pore formation or detergent-like effects, leading to cell lysis. The peptide should exhibit the typical mastoparan length of 12-14 amino acids and contain the conserved hydrophobic face that drives membrane insertion. The design should prioritize the characteristic biological activity of mastoparans: inducing mast cell degranulation, activating G-proteins, and displaying broad-spectrum antimicrobial properties against both Gram-positive and Gram-negative bacteria through membrane permeabilization mechanisms."}
{"description": "sp|W4VSI6|TX21I_TRILK Toxin ICK-18 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKTIFALVFCCAIAVVVLGFGENEGSTIDHDQNNCKGPGSRCSNKNECCKPKDMETYTYYCGSRWDSSSGDFVRKCVICNRESSMC", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This toxin originates from the venom of Trittame loki, a spider species whose venom components are evolutionarily optimized for prey immobilization through targeted neurotoxicity. The protein belongs to the Inhibitor Cystine Knot (ICK) structural family, specifically designated as ICK-18, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern. The core structural motif consists of a cystine knot formed by three disulfide bonds with the connectivity pattern C1-C4, C2-C5, C3-C6, creating an extremely stable and protease-resistant scaffold. This ICK fold presents multiple loop regions that mediate specific interactions with ion channels in the nervous system of prey organisms. The toxin functions as a potent modulator of voltage-gated ion channels, likely targeting sodium or calcium channels to disrupt neuronal signaling and induce paralysis. The molecular mechanism involves high-affinity binding to specific receptor sites on ion channel subunits, altering channel gating kinetics and preventing normal action potential propagation. Key structural features include: a well-defined hydrophobic core maintained by the cystine knot, surface-exposed residues in the loop regions that determine target specificity, and conserved beta-hairpin motifs that contribute to receptor binding affinity. The protein should exhibit the characteristic thermostability and structural rigidity typical of ICK toxins, with molecular recognition elements positioned to achieve selective ion channel modulation while maintaining the compact, disulfide-stabilized architecture essential for venom efficacy."}
{"description": "sp|P0DQH2|3SOKA_HEMHA Exactin OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LECYQKSKVVTCQPEQKFCYSDTTMFFPNHPVYLSGCTFSCTEEGNRRCCTTDKCNR", "prompt": "Design a protein sequence for a short-chain neurotoxin from the venom of the rinkhals cobra (Hemachatus haemachatus) that functions as a potent postsynaptic neurotoxin. This toxin should adopt the classic three-finger toxin fold characteristic of snake venom neurotoxins, featuring three extended loops emerging from a small, globular hydrophobic core stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The protein should specifically target and antagonize muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, competitively blocking acetylcholine binding to prevent postsynaptic depolarization and causing flaccid paralysis. The structural scaffold should consist of a central β-sheet core with the three finger-like loops rich in β-strands and turns, maintaining the conserved hydrophobic core that provides structural stability while presenting functional residues on the loops for receptor interaction. The toxin should exhibit high affinity and specificity for the α-δ and α-γ binding sites of the nicotinic acetylcholine receptor, with key functional residues positioned to mimic the natural ligand binding geometry."}
{"description": "sp|P81113|SLA3_TRIAB Snaclec alboaggregin-A subunit beta OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "GFDCPFGWSSYEGYCYKVYNKKMNWEDAESFCREQHKRSHLVSFHSSGEVDFVVSKTFPILRYDFVWMGLSDIWKECTKEWSDGARLDYKAWSGKSYCLVSKTTNNEWLSMDCSRTRYPVCKFXG", "prompt": "Design a protein sequence for a C-type lectin-like toxin subunit that functions as part of a heterodimeric complex in snake venom. This protein should exhibit the characteristic structural features of snake venom C-type lectins (snaclecs), including a conserved carbohydrate recognition domain (CRD) fold stabilized by multiple disulfide bridges. The protein should specifically function as the beta subunit of alboaggregin-A, forming a heterodimer that binds platelet receptors with high affinity. The mechanism should involve targeting platelet membrane glycoproteins, likely GPIb-IX-V complex, to induce platelet aggregation through receptor clustering and signaling activation. The structural scaffold should maintain the typical β-sandwich fold of C-type lectins with conserved calcium-binding sites and key residues for carbohydrate recognition, though this particular toxin may have evolved to recognize protein targets rather than carbohydrates. The sequence should contain the characteristic cysteine pattern that forms the disulfide network stabilizing the CRD domain, with appropriate spacing for the conserved structural elements. The protein should be optimized for venom function, exhibiting stability in the venom milieu and specific binding affinity for its platelet targets to facilitate prey immobilization through thrombosis."}
{"description": "sp|P0CAR2|3SO3_MICPY Short neurotoxin D2A (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "LLCLQKYSPGRETSQTCLAGENICFKKWKKGEKTSRXGCAVTCPKXK", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the Argentinian coral snake, Micrurus pyrrhocryptus. This toxin functions as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks muscle-type nicotinic acetylcholine receptors at the neuromuscular junction. The toxin should adopt the characteristic three-finger toxin fold common to elapid snake neurotoxins, consisting of three extended loops emerging from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework. The molecular mechanism involves competitive antagonism at the acetylcholine binding site, preventing neurotransmitter binding and leading to flaccid paralysis. The structural scaffold should feature the typical beta-sheet rich organization with loop II containing key functional residues for receptor recognition and binding. This short-chain neurotoxin should exhibit high affinity and specificity for the alpha-delta interface of the muscle nicotinic receptor, with the conserved functional core maintaining the essential pharmacophore for neuromuscular blockade while the variable loop regions provide species-specific targeting."}
{"description": "sp|P61104|TXH5_CYRSC Omega-theraphotoxin-Hs2a OS=Cyriopagopus schmidti OX=29017 PE=1 SV=2", "sequence": "MKSIVFVALFGLALLAVVCSASEDAHKELLKEVVRAMVVDKTDAVQAEERECRWYLGGCSQDGDCCKHLQCHSNYEWCVWDGTFSK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an omega-theraphotoxin from the tarantula Cyriopagopus schmidti, belonging to the inhibitor cystine knot (ICK) structural family. As a voltage-gated calcium channel (Cav) antagonist, it functions to block neuronal calcium channels, particularly Cav2.x subtypes, thereby disrupting synaptic transmission and neuromuscular signaling. The toxin should adopt the characteristic ICK fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, triple-stranded beta-sheet structure. Key structural elements include a hydrophobic patch and basic residues critical for channel binding, typically involving interactions with the channel's voltage-sensing domain or pore region. The sequence should reflect the compact, stable nature of spider venom peptides, with molecular weight around 4-5 kDa, and include conserved motifs for ICK fold formation and target specificity. The biological context is defensive and predatory venom, where such toxins induce paralysis by inhibiting presynaptic calcium influx and neurotransmitter release."}
{"description": "sp|P0DX32|MAST2_EUMMI Eumenine mastoparan-EM2 OS=Eumenes micado OX=2597558 PE=1 SV=1", "sequence": "LKLLGIVKKVLGAI", "prompt": "Design a novel peptide toxin sequence that captures the essential biological and structural characteristics of Eumenine mastoparan-EM2 from the solitary wasp Eumenes micado. This peptide should function as a potent mastoparan, a class of amphipathic alpha-helical peptides known for their membrane-disrupting activities. The sequence must adopt a stable alpha-helical conformation in membrane environments, with a characteristic amphipathic distribution of hydrophobic and hydrophilic residues that facilitates interaction with lipid bilayers. The mechanism of action should involve pore formation in cell membranes, leading to cell lysis and mast cell degranulation through G-protein activation. The peptide should exhibit broad-spectrum cytolytic activity against various cell types, consistent with mastoparan's role in prey immobilization and defense. Key structural features to incorporate include: a length of approximately 14-18 residues, high content of basic residues (lysine and arginine) for membrane interaction, absence of cysteine residues (no disulfide bridges), and a propensity for alpha-helix formation as evidenced by helical wheel projection showing clear amphipathicity. The molecular target is primarily the phospholipid bilayer of cell membranes, with secondary effects on G-protein coupled receptor signaling pathways. The peptide should demonstrate the characteristic hemolytic and mast cell-activating properties that define this toxin family."}
{"description": "sp|P23027|PA2HB_PSETE Basic phospholipase A2 homolog textilotoxin B chain OS=Pseudonaja textilis OX=8673 PE=1 SV=2", "sequence": "DLVEFGFMIRCANRNSQPAWQYMDYGCYCGKRGSGTPVDDVDRCCQTHNECYDEAAKIPGCKPKWTFYFYQCGSGSQFTCRKSKDVCRNVVCDCDFKAALCLTGARYNSANYNIDIKTHCR", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the Australian eastern brown snake (Pseudonaja textilis), specifically the B chain component of textilotoxin. This protein functions as part of a potent presynaptic neurotoxin complex that causes irreversible neuromuscular blockade by inhibiting acetylcholine release at motor nerve terminals. The sequence should maintain the characteristic phospholipase A2 structural fold with conserved catalytic residues, though it may exhibit reduced or altered enzymatic activity typical of PLA2 homologs. Include the conserved disulfide bridge pattern characteristic of group IA phospholipase A2 enzymes, with cysteine residues forming the structural scaffold essential for maintaining the three-finger toxin-like domain architecture. The protein should feature basic amino acid residues that contribute to membrane interaction and neurotoxic activity. The structural design should preserve the calcium-binding loop and catalytic network while optimizing for neurotoxin function rather than phospholipid hydrolysis. Consider the cooperative interactions with other textilotoxin subunits (A1, A2, and C chains) that collectively form the functional heteropentameric neurotoxin complex responsible for the snake's potent venom effects."}
{"description": "sp|J3S836|VCO3_CROAD Venom factor OS=Crotalus adamanteus OX=8729 PE=2 SV=1", "sequence": "MEGMALYLVAALLIGFPASSFGALYTFITPGVLRTDTEEKILVEAHGDNAPKQLDISVHDFPRKQKILYQTRVDMNPAGGMLVTPTITIPAKDLNKDSRQNQYVVVQVTAPGLRLEKVVLLSYQSGFVFIQTDKGIYTPGSPVRYRVFSMDHNMHRMDKTVIVEFQTPQGIVVSSNPVNPASSLIRPYNLPELVSFGTWKAVAKYENSPEESYTALFDVREYVLPGFEVRVQPSEKFLYIDGNTDFHVSITARYLYGKRVEGVAFVLFGVKIDGNKKSIPESLTRIPIIDGDGEATLERHTLSRRFQRLNDLVGHNLYVSVTVITDSGSDMVVTEQSGIHIVTSPYQISFTKTPKYFKPGMPYELMVYVTNPDGSPAANVPVVSESIHSKGTTLSDGTAKLILNTPLNIQSLSITVKTNHRDLPRERQAMKSMTATAYQTQGGSGNYLHIAITSTEIKPGDNLPVSFNVRGNANSLNQIQYFTYLILTKGKIFKVGRQPRGAGQNLVTMTLPITPDLIPSFRFLAYYQVGNSEIVADSVWVDVKDTCMGTLVVKGASSRDNRIQKPGAAMKIKLEGDPGARVGLVAVDKAVYVLSDEYKISQTKIWDTIEKSDFGCTAGSGQNNLGVFEDAGLALATSTSLNTKQRSDAKCPQPENRRRRRSVVLLDSKASKAAQFPDQALRKCCEDGMHENPMGYSCEKREKYIQEGDACKAAFLECCRYIKGIHDENKREDELFLARSDFEDEFFGEDNIISRSDFPESWLWLTENLNAVPNNEGISSKTVPFYLRDSITTWEVLAVSITPTKGICVAEPYEITVMKDFFIDLRLPYSVVKNEQVEVRAILYNYVDDDIDVRVELLHNPAFCSVATETQRYRTQVTIKALSSWAVPFVIVPLQQGLHDIEVRASVRGQLASDGVKKKLKVVPEGMRKDIVTVIELDPSTKGVGGTQEQLVKANELDGKVPDTEIETKISVQGDRVAQIVENSIDGNKLSHLIITPSGCGEQNMITMTPSVIATYYLDTTGQWETLGVDRRTEAVQQIKKGYAQQLVYKKADHSYAAFVNRDSSSWLTAYVVKVFAMATKVVPDISHEIICGGVKWLILNRQQPDGVFKENAPVIHGEMLGGTKGAEPEVSLTAFILIALLESRSICNEHINILESSINKAADYLLKKYEKLQRPYTTALTAYALAAAGLLNDDRVLMAASTERNRWEEHNAYTYNIEGTSYALLALLKMEKFAEANPVVRWLTDQKYYGGTYGQTQATVVGFQGLAEYEIAMPSHKDLNLDIVIKLPEREVPISYRIDATNALRAQTTETKLNEDFTVSASGDGKATMTILTVYNAQLREDANVCNQFHLEVSVERIDSNLKQAKGAKETLKLKICTRYLGEVDSTMTIIDVSMLTGFLPDAEDLTRLSKGVDRYISKFEIDNNMAQKGAVIIYLDKVSHSEDECLQFRIQKHFEVGFIQPGSVKVYSYYNLDEQCTRFYHPDKGTGLLNKICHGNVCRCAEETCSLLNQQKKIDLQLRIQKACEPNVDYVYKAKLLRIEEKDASDIYVMDVLEVIKGGTDRNPQAKPRQYVSQRKCQEALNLKVNNDYLIWGLSSDLWHKKDEISYLITRNTWIERWPNEDECQDEEFQNLCNDFTQLSNTLTIFGCPN", "prompt": "Design a venom factor protein from the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent complement system activator. This protein should mimic the structure and function of mammalian complement component C3, acting as a C3 convertase that cleaves native C3 into C3a and C3b fragments. The protein should contain multiple domains including macroglobulin domains, CUB domains, and thioester-containing domains characteristic of complement proteins. It should maintain the conserved structural features of complement factors, particularly the thioester bond that enables covalent attachment to target surfaces. The protein should exhibit high specificity for complement activation pathways, promoting inflammatory responses and membrane attack complex formation. The structural scaffold should feature the characteristic multi-domain architecture of complement proteins with appropriate disulfide bonding patterns to maintain structural integrity and functional activity. The protein should be optimized for stability in venom and efficient activation of the complement cascade upon envenomation."}
{"description": "sp|Q6PTD6|CA12_CONQU Alpha-conotoxin-like Qc1.2 OS=Conus quercinus OX=101313 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVALATTVASFTLDRASNGRNAAADDKPSDWIALAIKQCCANPPCKHVNCR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. Incorporate key pharmacophore elements for high-affinity binding to the nAChR orthosteric site, including a conserved proline-rich region and critical solvent-exposed residues that mediate receptor subtype selectivity. The sequence should maintain the typical alpha-conotoxin length of 12-20 amino acids with appropriate loop lengths between cysteine residues. Ensure the structural integrity includes a well-defined beta-hairpin motif and the characteristic 'cysteine knot' topology that provides exceptional stability against proteolytic degradation. The final design should exhibit the hallmark biological activity of alpha-conotoxins: rapid and reversible blockade of neurotransmission through competitive inhibition at the acetylcholine binding site."}
{"description": "sp|C0HKB9|PA2B1_MICMP Basic phospholipase A2 OS=Micrurus mipartitus OX=430902 PE=1 SV=1", "sequence": "NLIHFSSMIKCTIPGSKPVPDYSDYGCYCGKGGSGTPVDALDRCCQVHDKCYGDAESIYGCTPFLTYYSYECSERQDLCRGNGTKCKAFVCNCDRLAALCFAKAPYNKKNYNINLNRCK", "prompt": "Design a basic phospholipase A2 (PLA2) toxin protein sequence derived from the venom of Micrurus mipartitus, a coral snake species. This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG) and a catalytic network centered around histidine and aspartate residues essential for enzymatic activity. The sequence must include the canonical disulfide bond pattern (typically 6-7 disulfide bridges) that stabilizes the compact, three-finger-like globular structure, with key cysteines forming bridges such as Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, and Cys61-Cys91. The molecular mechanism involves binding to specific presynaptic membrane targets (e.g., neuronal receptors or lipid bilayers) via a hydrophobic channel and basic residues, facilitating hydrolysis of sn-2 ester bonds in phospholipids to release lysophospholipids and free fatty acids, which disrupt membrane integrity and synaptic vesicle recycling. Ensure the sequence reflects enhanced stability, target specificity, and minimal off-target effects, consistent with the neurotoxic profile of elapid snake venom PLA2s."}
{"description": "sp|P60237|3SUB_DENAN Muscarinic toxin 2 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "RICHSQMSSQPPTTTFCRVNSCYRRTLRDPHDPRGTIIVRGCGCPRMKPGTKLECCTSDKCNV", "prompt": "Design a protein sequence for a muscarinic toxin derived from the venom of the Eastern green mamba (Dendroaspis angusticeps). This toxin should function as a selective antagonist of muscarinic acetylcholine receptors, specifically targeting the M1 subtype with high affinity. The protein should adopt a three-finger toxin (3FTx) structural scaffold characterized by three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C1-C3, C2-C5, C4-C6, C7-C8 connectivity pattern. The molecular mechanism involves competitive inhibition of acetylcholine binding at the orthosteric site of muscarinic receptors, disrupting parasympathetic nervous system signaling. Key structural elements should include: (1) a conserved three-finger fold with beta-sheet structure in the loops, (2) specific residues in loop II responsible for receptor subtype selectivity and binding affinity, (3) a hydrophobic core maintaining structural integrity, and (4) surface-exposed residues that mediate specific interactions with the M1 receptor binding pocket. The toxin should exhibit the characteristic stability and target specificity of elapid snake venom three-finger toxins while maintaining the functional profile of muscarinic toxins that modulate cholinergic neurotransmission."}
{"description": "sp|Q70WS8|3NO41_BUNMU Neurotoxin BM10-1-like OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMKCKICHFDTCRAGELKVCASGEKYCFKESWREAREVKIIRGCSSSCPEKKNVFCCSTNDCNW", "prompt": "Design a neurotoxin protein sequence inspired by the venom of Bungarus multicinctus (many-banded krait), specifically modeling the BM10-1-like neurotoxin. This toxin belongs to the three-finger toxin superfamily and functions as a postsynaptic neurotoxin that targets nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The molecular mechanism involves competitive antagonism of acetylcholine binding, leading to neuromuscular blockade and paralysis. Key functional loops should be optimized for high-affinity interaction with the α-subunit of muscle-type nicotinic receptors. The sequence should maintain the conserved hydrophobic core and display appropriate surface residues for receptor recognition while preserving the structural integrity of the three elongated finger-like loops that define this toxin family's architecture."}
{"description": "sp|P0DJ63|VKT_OXYMI Kunitz-type serine protease inhibitor OMI (Fragment) OS=Oxyuranus microlepidotus OX=111177 PE=1 SV=1", "sequence": "KDFCHLPPKPGPCRAAI", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Inland Taipan (Oxyuranus microlepidotus), one of the world's most venomous snakes. This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, such as factor Xa or plasma kallikrein, thereby disrupting hemostasis and promoting hemorrhage. The protein should adopt the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a C1-C6, C2-C4, C3-C5 connectivity pattern. This fold forms a central anti-parallel beta-sheet flanked by alpha-helices, with the canonical binding loop presenting the protease recognition motif. The reactive site loop should contain residues complementary to the active site of the target serine protease, enabling tight-binding inhibition through a substrate-like mechanism. The sequence must maintain the conserved cysteine framework and key residues essential for protease binding while incorporating venom-specific adaptations that enhance potency and specificity within the snake venom context."}
{"description": "sp|C0HJC1|PA2_BOTLA Acidic phospholipase A2 BlatPLA2 OS=Bothriechis lateralis OX=44727 PE=1 SV=1", "sequence": "SLLQFREMITKMTGKEPIFFYAFYGCYCGLGGRGKPQDATDRCCFVHDCCYGKVTGCDPKKDIYTYSEENGAFVCGGDDPCKKEICECDKNAAICFRNDLDTYDYKYLLYSPENCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothriechis lateralis, a venomous pit viper. This enzyme should function as a potent toxin that catalyzes the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids. The mechanism involves calcium-dependent enzymatic activity that disrupts cellular membranes, leading to local tissue damage, inflammation, and potential systemic effects including anticoagulant properties through interference with coagulation factors. The protein should adopt the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural features include the conserved calcium-binding loop (YGKYCG/XCG) and the catalytic histidine-aspartate dyad within the active site. The acidic nature of this toxin suggests enhanced binding to specific membrane receptors or targets, potentially contributing to its neurotoxic or myotoxic effects. The sequence should maintain the essential catalytic residues and structural motifs required for phospholipase activity while incorporating the acidic character typical of viperid venom PLA2s."}
{"description": "sp|B8XH33|KAX99_BUTIS Potassium channel toxin alpha-KTx 9.9 (Fragment) OS=Buthus israelis OX=2899555 PE=2 SV=2", "sequence": "KKTSRLFTLVLIVLAMNVMMAIISDPVVEAVGCEECPMHCKGKMAKPTCYDGVCNCNV", "prompt": "Design a potassium channel toxin protein sequence derived from the venom of the scorpion Buthus israelis, specifically representing the alpha-KTx 9.9 toxin family. This toxin functions as a potent modulator of voltage-gated potassium channels, primarily targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence must include the signature alpha-helix paired with an antiparallel beta-sheet, forming a functional surface that selectively interacts with the pore region of potassium channels to inhibit ion conductance. Key structural elements should include a conserved dyad of critical residues (typically lysine and aromatic amino acids) essential for channel binding affinity and specificity. The toxin should exhibit high thermal and proteolytic stability due to its disulfide-rich scaffold, enabling effective pharmacological activity in the scorpion's predatory and defensive strategies."}
{"description": "sp|W4VSI9|ICK3_TRILK U10-barytoxin-Tl1a OS=Trittame loki OX=1295018 PE=2 SV=1", "sequence": "MKTLVLVAVLGVASLYLLSSASEVQQLSPAEEEFRAFVSTFGGLFETEERGVDSEDCRAMFGGCGEDNDCCLHLGCKTTKLPPFANPYCAWDGTTGRK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin is a U10-barytoxin from the venom of the Australian tarantula Trittame loki, belonging to the inhibitory cysteine knot (ICK) structural family. This toxin functions as a potent neurotoxin that targets voltage-gated ion channels, likely sodium or calcium channels, to disrupt neuronal signaling and induce paralysis in prey. The protein should adopt the characteristic ICK fold stabilized by a conserved disulfide bond pattern with three intramolecular disulfide bridges forming the knotted core (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6). The sequence must include the U10-barytoxin family signature motifs, featuring a compact, stable globular structure with exposed loops for target interaction. Key structural elements should include beta-sheets and tight turns, with the cysteine framework ensuring proper folding and thermal stability. The molecular mechanism involves high-affinity binding to specific ion channel domains, modulating channel gating to block action potentials. The venom's biological role is to immobilize arthropod prey through rapid neuromuscular blockade, reflecting the predator-prey evolutionary dynamics of spider venoms. Ensure the sequence encodes all functional residues for target recognition and the ICK structural scaffold for stability and activity."}
{"description": "sp|D9U2B7|NDBP_LYCMC Bradykinin-potentiating peptide NDBP12 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MNKRVLLVIFFVTLLVADEVNSFSFFRKAKGFLKKIWKSKIARRLREKGMKALKNYANDVLNGPAEAPAPAAAAPEEPPVEQRRRRR", "prompt": "Design a bradykinin-potentiating peptide from the venom of the scorpion Lychas mucronatus. This peptide functions as a potent vasoactive agent by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced vasodilation, hypotension, and increased vascular permeability. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of scorpion venom peptides. It should contain key residues for ACE inhibition, particularly those that chelate zinc at the enzyme's active site, such as a C-terminal proline or other zinc-binding motifs. The sequence should be short (approximately 5-15 amino acids) with a high proportion of proline residues, which confer resistance to proteolytic degradation and contribute to the peptide's extended conformation. The structural scaffold should ensure high affinity for ACE while minimizing immunogenicity, reflecting its role in the scorpion's predatory and defensive strategies by disrupting prey cardiovascular homeostasis."}
{"description": "sp|W4VSI7|TX21D_TRILK Toxin ICK-13 OS=Trittame loki OX=1295018 PE=3 SV=1", "sequence": "MKPTISILIFFALAVAIMGHRLNSGYGIPHIVEKLPNGQWCRTPGDDCSESKQCCKPEDTATYAHGCSQQWSGQRGELVKMCYICNKESSMC", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications. The toxin originates from the venom of Trittame loki, a spider species whose venom components are evolutionarily optimized for prey immobilization through targeted ion channel modulation. This toxin belongs to the Inhibitor Cystine Knot (ICK) structural family, specifically designated as ICK-13, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, and C3-C6. The ICK scaffold confers exceptional thermal and proteolytic stability, enabling precise molecular targeting in hostile physiological environments. The core function involves potent modulation of voltage-gated ion channels, likely sodium or calcium channels, leading to disrupted neuronal signaling and paralysis. Key structural elements must include: the canonical ICK motif with three anti-parallel beta-strands forming a hydrophobic core; the cysteine framework maintaining the knot topology; and surface loops critical for receptor binding specificity, particularly a putative pharmacophore region for channel interaction. The molecular mechanism entails high-affinity binding to specific ion channel domains, altering gating kinetics and inducing hyperexcitability or conduction block. Ensure the sequence reflects spider toxin hallmarks: disulfide-rich architecture, cationic surface patches for membrane association, and conserved hydrophobic residues for structural integrity. The generated protein should exhibit the biophysical properties typical of ICK toxins: molecular weight ~3-5 kDa, isoelectric point >8.0, and robust folding stability."}
{"description": "sp|M1JMR8|SCX8_ANDCR Sodium channel alpha-toxin Acra8 OS=Androctonus crassicauda OX=122909 PE=3 SV=1", "sequence": "VRDGYIVDDKNCTFFCGRNAYCNDECKKKGGESGYCQWASPYGNACWCYKLPDRVPIKEKGRCNGR", "prompt": "Design a novel sodium channel alpha-toxin derived from the venom of the scorpion Androctonus crassicauda, a medically significant species known for producing potent neurotoxins that target voltage-gated sodium channels. This toxin should function as a classic alpha-toxin, specifically binding to site 3 of voltage-gated sodium channels (Nav1.x family) and modifying channel gating by inhibiting fast inactivation. This results in prolonged action potentials, repetitive firing, and neuronal hyperexcitability, leading to the characteristic neurotoxic effects observed in envenomation. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should comprise a short alpha-helix packed against an antiparallel beta-sheet, with the functional residues concentrated in the 'pharmacophore' region—particularly the loops between beta-strands 2 and 3 and the C-terminal region—which are critical for high-affinity binding to the extracellular S3-S4 loop of domain IV of the sodium channel. Ensure the sequence includes key conserved motifs for structural integrity and target recognition, such as a hydrophobic core and surface-exposed basic residues that facilitate electrostatic interactions with the channel. The toxin should exhibit specificity for mammalian sodium channel isoforms, contributing to its neurotoxic potency and potential as a tool for studying channel function."}
{"description": "sp|P0DQJ4|GEND1_ACAGO U1-theraphotoxin-Agm2a OS=Acanthoscurria gomesiana OX=115339 PE=1 SV=1", "sequence": "SFRFFEEIIMRLATLLGLSVLHLALCVLTCTAHHPGLEKSRVSYENMGDEENAEERSCVHERETCSKVRGPLCCRGECICPIYGDCFCYGS", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is a theraphotoxin from the Brazilian black tarantula Acanthoscurria gomesiana, representing a venom component that functions as a potent ion channel modulator. As a member of the U1-theraphotoxin family, it should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in a C-C-CC-C-C cysteine framework). The toxin likely targets voltage-gated sodium channels (Nav) or potassium channels (Kv), acting as a gating modifier that binds to the voltage-sensing domains and alters channel kinetics, leading to neuronal hyperexcitability or paralysis in prey. The sequence should include key residues for membrane interaction, a hydrophobic patch for channel binding, and surface loops that confer target specificity. Ensure the structural integrity of the ICK fold, with disulfide bonds essential for stability and function, and incorporate evolutionary conserved motifs typical of spider venom peptides to maintain biological activity and potency."}
{"description": "sp|J3SBP3|PDE2_CROAD Venom phosphodiesterase 2 OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MIQQKVLFISLVAVTLGLGLGLGLKESVQPQAQSWSCSKLRCGEKRIANVLCSCSDDCLEKKDCCTDYKSICKGETSWLKDKCASSGATQCPAGFEQSPLILFSMDGFRAGYLENWDSLMPNINKLKTCGTHAKYMRAVYPTKTFVNHYTIATGLYPESHGIIDNNIYDVNLNLNFSLSSSTARNPAWWGGQPIWHTATYQGLKAATYFWPGSEVKINGSYPTIFKNYNKSIPFEARVTEVLKWLDLPKAKRPDFLTLYIEEPDTTGHKYGPVSGEIIKALQMADRTLGMLMEGLKQRNLHNCVNLILLADHGMEEISCDRLEYMANYFNNVDFFMYEGPAPRIRSKNVPKDFYTFDSEGIVKNLTCRKPKQYFKAYLSKDLPKRLHYANNIRIDKVNLMVDQQWMAVRDKKFTRCKGGTHGYDNEFKSMQAIFLAHGPGFNEKNEVTSFENIEVYNLMCDLLKLKPAPNNGTHGSLNHLLKNPFYTPSPAKEQSSPLSCPFGPVPSPDVSGCKCSSITELEKVNQRLNLNNQAKTESEAHNLPYGRPQVLQNHSKYCLLHQAKYISAYSQDILMPLWSSYTIYRSTSTSVPPSASDCLRLDVRIPAAQSQTCSNYQPDLTITPGFLYPPNFNSSNFEQYDALITSNIVPMFKGFTRLWNYFHTTLIPKYARERNGLNVISGPIFDYNYDGHFDSYDTIKQHVNNTKIPIPTHYFVVLTSCENQINTPLNCLGPLKVLSFILPHRPDNSESCADTSPENLWVEERIQIHTARVRDVELLTGLNFYSGLKQPLPETLQLKTFLPIFVNPVN", "prompt": "Design a venom phosphodiesterase protein from the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a key enzymatic toxin in snake venom. This protein should exhibit potent phosphodiesterase activity, specifically hydrolyzing cyclic nucleotides (cAMP and cGMP) to their corresponding 5'-monophosphates, thereby disrupting intracellular signaling pathways in envenomed prey. The enzyme should feature the characteristic metallophosphoesterase domain with conserved metal-binding residues (likely coordinating zinc ions) essential for catalytic activity. The structure should adopt the TIM barrel fold typical of phosphodiesterases, with the active site containing the conserved histidine and aspartate residues that coordinate metal ions and facilitate nucleophilic attack on the phosphodiester bond. The protein should be optimized for stability in venom and efficient substrate turnover, contributing to the rattlesnake's predatory strategy by interfering with prey physiological processes through disruption of second messenger signaling."}
{"description": "sp|Q9I837|PA2BG_LATSE Basic phospholipase A2 GL1-1 OS=Laticauda semifasciata OX=8631 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASAIPPLPLNLVQFTYLIQCANKGSRPSYHYADYGCYCGAGGSGTPVDELDRCCKIHDDCYGEAEKMGCYPKLTMYNYYCGTEGPYCNTKTDCQRYVCACDLKAAKCFARSPYNNKNYNIDTSKRCK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the banded sea krait, Laticauda semifasciata. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and potential neurotoxic effects. The structural scaffold should feature the characteristic phospholipase A2 fold, consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with a calcium-binding loop. The sequence should maintain the basic isoelectric point typical of neurotoxic PLA2s, which facilitates interaction with anionic membrane surfaces and specific neuronal targets. The protein should demonstrate the characteristic interfacial activation mechanism, where catalytic efficiency increases upon binding to lipid-water interfaces."}
{"description": "sp|C0HKC3|PA2B9_AGKPL Basic phospholipase A2 APL-D49 OS=Agkistrodon piscivorus leucostoma OX=459671 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGNLFQFEKLIKKMTGKSGMLWYSAYGCYCGWGGQGRPKDATDRCCFVHDCCYGKVTGCNPKMDIYTYSVENGNIVCGGTNPCKKQICECDRAAAICFRDNLKTYDSKTYWKYPKKNCKEESEPC", "prompt": "Generate the amino acid sequence for a basic phospholipase A2 toxin from the venom of the western cottonmouth (Agkistrodon piscivorus leucostoma), a North American pit viper. This enzyme belongs to the D49 phospholipase A2 family, characterized by the presence of an aspartic acid residue at position 49, which is critical for calcium binding and catalytic activity. The toxin functions by hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids, including arachidonic acid, which can lead to inflammation, membrane disruption, and potential hemolytic effects. The protein should adopt the characteristic phospholipase A2 fold, consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. It must include the essential catalytic dyad of histidine and aspartic acid residues, along with the conserved calcium-binding site motif. The sequence should contain 14 conserved cysteine residues that form 7 disulfide bridges, stabilizing the compact globular structure. As a basic phospholipase A2, it may exhibit myotoxic, neurotoxic, or anticoagulant properties, typical of viperid venom phospholipases. The generated sequence should reflect the structural integrity required for enzymatic activity, membrane association, and potential receptor interactions that contribute to its toxic effects in prey envenomation."}
{"description": "sp|Q2VBN2|3NO24_OPHHA Weak neurotoxin WNTX34 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYSLTCLNCPEQYCKRIHTCRNGENVCFKRFYEGKLLCKQFRRGCAATCPEAKSREIVQCCSTDECNH", "prompt": "Design a protein sequence for a weak neurotoxin from the venom of Ophiophagus hannah (king cobra), designated as WNTX34. This toxin belongs to the three-finger toxin (3FTx) superfamily, characterized by the conserved three-finger structural fold formed by three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C-C-C-C-C-C-C-C. As a weak neurotoxin, it exhibits moderate affinity for nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, functioning as a competitive antagonist that binds to the orthosteric site of the α-subunit, thereby inhibiting acetylcholine binding and leading to reversible neuromuscular blockade without significant lethality. The protein should adopt the classic three-finger β-sheet architecture, with the central loop typically containing key residues for receptor interaction. The biological significance lies in the king cobra's venom composition, where weak neurotoxins contribute to prey immobilization through non-lethal paralysis, allowing for efficient predation. Ensure the sequence reflects the conserved structural motifs of 3FTxs, including the disulfide connectivity that stabilizes the fold, while incorporating specific residues in the functional loops that confer weak antagonistic activity against nAChRs."}
{"description": "sp|P0CAS4|PA2BD_CRODR Basic phospholipase A2 Cdr-13 OS=Crotalus durissus ruruima OX=221570 PE=1 SV=1", "sequence": "SLVQFEKMIKEETGKNAVPFYAFYGCYCGWGGRGRPKDATDRCCIVHDCCYEKLVKCNTKWDFYRYSLRSGYFQCGKGTWCEQQICECDRVAAECLRRSLSTYRYGKMIYPDSRCREPSETC", "prompt": "Design a novel basic phospholipase A2 toxin from the venom of the South American rattlesnake, Crotalus durissus ruruima. This protein should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The toxin should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, thereby disrupting cellular membranes and triggering inflammatory responses. Structurally, it should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YXCGXG) and catalytic histidine-aspartate dyad. The protein should contain approximately 120-140 amino acids with 6-8 disulfide bonds stabilizing the compact globular structure, including the conserved Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, and Cys61-Cys91 disulfide pattern typical of group II phospholipase A2 enzymes. The basic nature should be reflected in a high isoelectric point due to abundant lysine and arginine residues, particularly in the C-terminal region, which contributes to membrane association and enhanced neurotoxicity. The protein should exhibit the characteristic three-finger scaffold with an N-terminal α-helix, β-wing regions, and a central catalytic site, maintaining the conserved structural motifs essential for calcium coordination and substrate binding while optimizing for enhanced potency and specificity toward presynaptic membranes."}
{"description": "sp|P0DX34|MAST4_EUMMI Eumenine mastoparan-EM4 OS=Eumenes micado OX=2597558 PE=1 SV=1", "sequence": "FDLGMLVKKVLAGL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the potter wasp Eumenes micado. This peptide should function as a potent cytolytic and hemolytic toxin, characteristic of mastoparan peptides from wasp venoms. The sequence should adopt an amphipathic alpha-helical conformation in membrane environments, with a cationic character that facilitates interaction with anionic phospholipid head groups in cell membranes. The peptide should exhibit membrane-disrupting activity through pore formation or detergent-like effects, leading to cell lysis. It should also demonstrate G-protein activating properties through direct interaction with heterotrimeric G-proteins. The structural scaffold should be a linear peptide rich in hydrophobic and basic residues, with no disulfide bridges, typical of mastoparan family peptides. The molecular target includes both cell membranes and intracellular G-protein signaling pathways, with the membrane-binding interface involving the hydrophobic face of the amphipathic helix and the cationic residues for electrostatic interactions with phospholipids."}
{"description": "sp|P81115|SLBA_TRIAB Snaclec alboaggregin-B subunit alpha OS=Trimeresurus albolabris OX=8765 PE=1 SV=2", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADCPSDWSSFKQYCYQIVKELKTWEDAEKFCSEQANDGHLVSIESYREAVFVAELLSENVKTTKYNVWIGLSVQNKGQQCSSEWSDGSSVSYENLVKPNPKKCFVLKKESEFRTWSNVYCEQKHIFMCKFLGSR", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the white-lipped pit viper (Trimeresurus albolabris) that functions as the alpha subunit of snaclec alboaggregin-B. This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold with a conserved double-loop structure stabilized by two intra-chain disulfide bonds, typically following the pattern Cys1-Cys4 and Cys2-Cys3. As part of the heterodimeric snaclec complex, this alpha subunit should specifically recognize and bind to platelet membrane glycoproteins, particularly GPIb, through its carbohydrate recognition domain. The mechanism involves blocking von Willebrand factor binding to GPIb, thereby inhibiting platelet aggregation and causing anticoagulant effects. The protein should exhibit the typical structural features of snake venom C-type lectins, including a calcium-binding site that may be functional or vestigial, and surface-exposed loops that mediate protein-protein interactions. The sequence should maintain conserved residues critical for the CTLD fold stability and target recognition specificity while incorporating venom-specific adaptations that enhance its potency as a hemostasis-disrupting toxin."}
{"description": "sp|P60258|SCXD_BUTOM Toxin Boma6d OS=Buthus occitanus mardochei OX=6869 PE=3 SV=1", "sequence": "VRDAYIAQNYNCVYHCGRDAYCNELCSKNGAKSRTRGGYCHWFGPHGDACWCIDLPNNVPIKVEGKCHRK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin originates from the venom of Buthus occitanus mardochei, a scorpion species whose venom components typically function to immobilize prey through modulation of ion channel activity in the nervous system. This toxin belongs to the scorpion toxin family and is expected to function as a neurotoxin targeting voltage-gated sodium channels, specifically acting as a beta-toxin that modifies channel gating kinetics by binding to site 4, leading to prolonged action potentials and neuronal hyperexcitability. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes a compact globular structure comprising an alpha-helix packed against an antiparallel beta-sheet. Key functional residues should include a conserved hydrophobic patch for membrane interaction and basic residues for electrostatic steering toward the channel pore. The molecular target interface should involve specific loops (e.g., S3-S4 linker) of domain II or IV of voltage-gated sodium channels, with high affinity binding driven by complementary surface charges and shape. Ensure the sequence maintains the core structural motifs: a signal peptide for secretion, a propeptide region if applicable, and the mature toxin with the canonical CSαβ fold, incorporating conserved family signatures while allowing for functional diversification in target specificity."}
{"description": "sp|P40755|KAX22_CENMA Potassium channel toxin alpha-KTx 2.2 OS=Centruroides margaritatus OX=29018 PE=1 SV=1", "sequence": "TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Centruroides margaritatus. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels, specifically Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves binding to the pore region of potassium channels via a functional dyad consisting of a critical lysine residue that inserts into the channel pore and an aromatic residue that stabilizes the interaction, effectively blocking potassium ion conductance and disrupting neuronal and muscular excitability. The structural scaffold should include key functional motifs: a conserved beta-hairpin for channel recognition, a well-defined alpha-helix for structural stability, and surface-exposed residues for specific Kv1 channel subtype selectivity. The toxin should exhibit high affinity and specificity for Kv1.2 and Kv1.3 channels, contributing to the venom's neurotoxic effects by causing hyperexcitability and prolonged neurotransmitter release at synapses."}
{"description": "sp|O12961|3LK4_BUNMU Kappa-4-bungarotoxin OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRTCLISPSSPPQTCPKGEDICIVKARCDEWCLRRGPLIERGCAATCPEFRSNYRSLLCCTTDNCNH", "prompt": "Design a protein sequence for a neurotoxic peptide from the venom of the many-banded krait (Bungarus multicinctus), classified as a kappa-bungarotoxin. This toxin functions as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the alpha3beta2 subtype. The protein should adopt the three-finger toxin (3FTx) structural fold characteristic of snake venom neurotoxins, featuring a core stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C. The three-finger architecture consists of three extended loops projecting from a central globular core, facilitating precise interaction with the receptor's ligand-binding domain. The mechanism involves competitive inhibition of acetylcholine binding at the orthosteric site, leading to neuromuscular blockade and paralysis. Key structural elements should include conserved hydrophobic residues in the central loop for receptor interaction, and positively charged residues that may contribute to binding specificity. The protein should exhibit the characteristic stability and target selectivity of kappa-neurotoxins, which distinguishes them from alpha-neurotoxins in their receptor subtype preference."}
{"description": "sp|Q6PTD1|CA11_CONMR Alpha-conotoxin Mr1.1 OS=Conus marmoreus OX=42752 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRASDGRKAAAKDKASDLVALTVKGCCSHPACSVNNPDICG", "prompt": "Design a novel alpha-conotoxin sequence inspired by Conus marmoreus venom, specifically emulating the Mr1.1 variant. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), with particular affinity for neuronal subtypes involved in synaptic transmission. The molecular mechanism involves competitive binding to the orthosteric site of nAChRs, effectively blocking acetylcholine-mediated ion flux and disrupting neuromuscular or neuronal signaling. The structural scaffold must adhere to the characteristic alpha-conotoxin framework: a compact, disulfide-rich peptide stabilized by two disulfide bonds forming a Cys1-Cys3, Cys2-Cys4 connectivity pattern (globular disulfide topology). This configuration supports a well-defined alpha-helical region and beta-turn elements, creating a stable, globular fold optimized for high-affinity receptor interaction. Key conserved residues should be maintained to preserve the structural integrity and receptor binding interface, while variable regions can be optimized for enhanced selectivity and potency. The final sequence should exhibit high stability, solubility, and minimal off-target effects, reflecting the evolutionary refinement of cone snail venom peptides for precise pharmacological targeting."}
{"description": "sp|P42716|MAST_PARID Parapolybia-mastoparan OS=Parapolybia indica OX=31921 PE=1 SV=1", "sequence": "INWKKMAATALKMI", "prompt": "Design a mastoparan-like peptide toxin derived from the venom of the paper wasp Parapolybia indica. This amphipathic, alpha-helical peptide should function as a potent cytolytic agent that disrupts biological membranes through direct interaction with phospholipid bilayers. The peptide should adopt a characteristic mastoparan fold with a well-defined amphipathic helix spanning approximately 14-16 residues, featuring a hydrophobic face that facilitates membrane insertion and a cationic face rich in lysine and arginine residues that mediates initial electrostatic interactions with anionic membrane components. The mechanism of action should involve pore formation in target cell membranes, leading to calcium influx, membrane depolarization, and eventual cell lysis. The structural scaffold should be stabilized by the absence of disulfide bridges typical of mastoparan peptides, allowing for conformational flexibility that enhances membrane penetration. The peptide should exhibit broad-spectrum activity against various cell types, with preferential targeting of mast cells and other immune cells, triggering histamine release and contributing to the inflammatory response characteristic of wasp envenomation. The sequence should maintain the conserved mastoparan motif of small, hydrophobic residues that facilitate helix formation and membrane integration."}
{"description": "sp|Q6H3D0|PA2AA_TRIST Acidic phospholipase A2 Ts-A1 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MRTLWIMAVLQVGVEGHLMQFETLIMKVAGRSGVWYYGSYGCFCGAGGQGRPQDASDRCCFVHDCCYGKVNGCDPKKDFYTYSEENGAIVCGGDDPCKKEICECDKDAAICFRDNKDTYDNKYWFFPAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Trimeresurus stejnegeri, a venomous pit viper. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YXCGXGG motif), a catalytic histidine-aspartate dyad, and multiple disulfide bridges that stabilize the compact, globular structure typical of group II phospholipase A2 enzymes from viperid venoms. As an acidic isoform, it should exhibit a net negative charge at physiological pH, which may influence its membrane interaction properties and potential inflammatory effects. The toxin should demonstrate presynaptic or postsynaptic neurotoxic activity, potentially interfering with neuromuscular transmission through phospholipid hydrolysis in nerve terminals or muscle membranes, leading to paralysis. Include key functional residues for catalytic activity, calcium coordination, and membrane binding interfaces that enable its toxic function in prey immobilization."}
{"description": "sp|O57540|MYC1_CRODU Crotamine CRO1 OS=Crotalus durissus terrificus OX=8732 GN=CRO1 PE=3 SV=1", "sequence": "MKILYLLFAFLFLAFLSEPGNAYKQCHKKGGHCFPKEKICIPPSSDFGKMDCRWRWKCCKKGSGK", "prompt": "Design a protein sequence for a small, basic myotoxin derived from the venom of the South American rattlesnake, Crotalus durissus terrificus. This toxin, known as crotamine, should exhibit potent myotoxic activity characterized by rapid skeletal muscle necrosis and paralysis. The protein should function through membrane disruption, specifically targeting and permeabilizing muscle cell membranes via interaction with lipid bilayers and voltage-gated sodium channels. The structural scaffold must feature a compact, three-finger β-sheet fold stabilized by three conserved disulfide bridges with a C-C-C-C-C-C connectivity pattern. Incorporate a cationic, amphipathic character with a high proportion of lysine and arginine residues to facilitate membrane interaction. The sequence should include a conserved hydrophobic patch for membrane insertion and a basic surface for electrostatic interactions with negatively charged phospholipid headgroups. Ensure the protein adopts a stable, globular conformation with the characteristic three-loop architecture typical of the three-finger toxin family, enabling specific targeting of skeletal muscle cells while maintaining thermal and proteolytic stability appropriate for venom deployment."}
{"description": "sp|C0HJC3|K1B2_BUNCI Kappa-actitoxin-Bcs3b OS=Bunodosoma caissarum OX=31165 PE=1 SV=1", "sequence": "ACKDGFPTATCQHAKLVGNCKNSQKYRANCAKTCGPC", "prompt": "Design a novel animal toxin protein sequence inspired by the biological context of sea anemone venom from Bunodosoma caissarum. This toxin belongs to the kappa-actitoxin family, specifically the Bcs3b variant, and should function as a potent potassium channel modulator. The protein must adopt a stable structural scaffold characteristic of sea anemone toxins, featuring a compact globular fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Incorporate key functional residues that mediate high-affinity binding to voltage-gated potassium channels, particularly Kv1 subtypes, through interactions with the channel's pore region and voltage-sensing domain. The toxin should exhibit selective inhibition of potassium currents, leading to neuronal hyperexcitability and enhanced neurotransmitter release. Ensure the sequence includes conserved hydrophobic patches and charged surface residues that facilitate membrane association and target recognition. The final protein should demonstrate thermal stability and protease resistance typical of cnidarian venom peptides, with a molecular weight appropriate for this toxin class and optimal solubility for functional characterization."}
{"description": "sp|P61230|TXP1_PARSR Kappa-theraphotoxin-Ps1a OS=Paraphysa scrofa OX=269635 PE=1 SV=1", "sequence": "YCQKWMWTCDSARKCCEGLVCRLWCKKII", "prompt": "Design a novel animal toxin protein sequence that mimics the biological activity and structural characteristics of kappa-theraphotoxin-Ps1a from the tarantula Paraphysa scrofa. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). As a voltage-gated potassium channel (Kv) modulator, the toxin should exhibit high-affinity binding to specific Kv channel subtypes, likely through interactions with the channel's voltage-sensing domain or pore region. The sequence must include the characteristic ICK motif with six conserved cysteine residues forming the knotted disulfide core, which provides exceptional thermal and proteolytic stability. The toxin should function as a potent neurotoxin that disrupts neuronal excitability by altering potassium conductance, leading to modulation of synaptic transmission and potential paralysis in prey organisms. Incorporate key functional residues that mediate target specificity and binding affinity while maintaining the compact, globular fold typical of spider venom peptides. The final protein should demonstrate the hallmark stability and target selectivity of tarantula-derived ICK toxins while exhibiting novel sequence features within this conserved structural framework."}
{"description": "sp|Q90220|VM2H1_GLOHA Zinc metalloproteinase/disintegrin OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "MIQVLLITICLAVFPFQGSSIVLDSGNLNEFEVVYPEKVTALPRAAVKNKYEDAMQYEFKVNGEPLLLHLERNKGLFSDDYSEIHYSPDAREISAYPSVEDHCFYHGRVENDADSTASLSACDGLKAHFKIQGEMYLIEPLEVSDTDAHAVFKYENVEKEDEPPKMCGVTQNWESYESTKKASQLNVSPDQQRFPQRFIKLAIYVDHGMYTKYAGNSERITKRVHQMINNINMMCRALNIVTSLSVLRIWSEKDLITVNASAPSSLTLFGAWRETVLLNRTSHDHAQLMTATIFNGNVIGRAPVGGMCDPKRSVAIVRDHNAILFIVAVTMTHEMGHNLGMHHDEDKCNCNTCIMSKVLSRQPSYEFSDCNENEYQTYVTDHSPQCILNDPLRPDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKKGTVCRIARGDDMDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence from the Siberian pit viper (Gloydius halys) that functions as a zinc metalloproteinase-disintegrin fusion toxin. This protein should exhibit dual functionality: first, as a zinc-dependent metalloproteinase capable of hydrolyzing extracellular matrix components like collagen, fibronectin, and laminin through its catalytic zinc-binding motif; second, as a disintegrin domain that specifically inhibits platelet aggregation by blocking integrin receptors such as αIIbβ3 on platelets. The protein should adopt a modular architecture with distinct metalloproteinase and disintegrin domains connected by appropriate linker regions. The metalloproteinase domain should feature the conserved zinc-binding motif HEXXHXXGXXH and maintain the characteristic metzincin fold with an active site cleft. The disintegrin domain should present the canonical RGD (Arg-Gly-Asp) or related integrin-binding motif in an exposed loop conformation for optimal receptor interaction. The overall structure should facilitate synergistic activity where metalloproteinase-mediated tissue damage enhances disintegrin access to cellular targets. The sequence should include appropriate cysteine residues for structural stabilization through disulfide bonding, particularly in the disintegrin domain where the characteristic cysteine pattern supports the integrin-binding loop conformation. This toxin represents a sophisticated venom adaptation for prey immobilization through combined hemorrhagic and anti-coagulant mechanisms."}
{"description": "sp|P23806|SL9A_PROFL Snaclec coagulation factor IX/factor X-binding protein subunit A OS=Protobothrops flavoviridis OX=88087 PE=1 SV=2", "sequence": "MGRFIFMSFGLLVVAASLRGTGADCLSGWSSYEGHCYKAFEKYKTWEDAERVCTEQAKGAHLVSIESSGEADFVAQLVTQNMKRLDFYIWIGLRVQGKVKQCNSEWSDGSSVSYENWIEAESKTCLGLEKETDFRKWVNIYCGQQNPFVCEA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the habu snake (Protobothrops flavoviridis) that functions as a coagulation factor IX/factor X-binding protein. This protein should act as an anticoagulant toxin by specifically binding to and inhibiting the coagulation factors IX and X, thereby disrupting the intrinsic and common pathways of the blood coagulation cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that form the core structural scaffold. The sequence should include key residues for calcium-independent ligand binding, with a putative binding interface involving loops that mediate protein-protein interactions with coagulation factors. The biological context involves venom from a viperid snake, where this protein contributes to prey immobilization by preventing blood clot formation through targeted inhibition of key coagulation enzymes."}
{"description": "sp|P0DJC8|SLA_BOTAS Snaclec aspercetin subunit alpha (Fragment) OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "DCPSGWSSYEGHCYRFFHPPKDWADAERFCTEQAKGGALVSIQRFGEEDFVSNLITKNLQRG", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the venom of Bothrops asper, a highly venomous pit viper species. This protein should function as the alpha subunit of aspercetin, a heterodimeric snaclec that acts as a platelet receptor antagonist. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain the conserved calcium-binding motifs and carbohydrate recognition domain (CRD) characteristic of C-type lectins, but evolved for protein-protein interactions rather than carbohydrate binding. The molecular target should be platelet membrane receptors, specifically interfering with platelet aggregation through competitive inhibition of receptor-ligand interactions. The structural scaffold should feature the conserved beta-sheet core with alpha-helical elements and surface loops that mediate specific binding to platelet receptors. The protein should exhibit the characteristic stability and specificity of viperid snaclecs, contributing to the hemorrhagic and anticoagulant effects of Bothrops asper venom by disrupting normal hemostasis."}
{"description": "sp|A8QL56|VSP1_OPHHA Alpha- and beta-fibrinogenase OhS1 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MALIRVLASLLILQLSYAVTPFDRIIGGFECNEYEHRSLVHLYNSSGFFCSGTLLNHEWVLTAAHCNRDDIQIKLGVHNVSVNYEDEQIRVPKEKLCCHSTNNCTQLGQDIMLIRLNSSVNYSEHIAPLSLPSNRPSMGSVCRVMGWGLLTSPEVTFPKVPHCVDINILHIQVCQAAYPSMSENYLLCAGVLEGGKDSCKGDSGGPLICNREIQGIVSWGGFPCAQLLEPGVYTKVFDYIDWIEGIIAGNTSVTCPSDNF", "prompt": "Design a protein sequence for a snake venom metalloproteinase (SVMP) from the king cobra (Ophiophagus hannah) that functions as an alpha- and beta-fibrinogenase. This toxin should exhibit potent fibrinogenolytic activity, specifically cleaving the Aα and Bβ chains of fibrinogen to prevent fibrin clot formation and induce anticoagulation. The protein should adopt the characteristic SVMP structural fold with a conserved zinc-binding motif (HEXXHXXGXXH) in the catalytic domain, coordinating a zinc ion essential for proteolytic activity. Include a disintegrin-like domain that may mediate interactions with platelet integrins, and a cysteine-rich domain that could contribute to substrate recognition. The mature toxin should contain multiple disulfide bridges to stabilize its multi-domain architecture, with the catalytic domain featuring the typical metzincin topology characterized by a long central alpha-helix and a five-stranded beta-sheet. This fibrinogenase should efficiently target circulating fibrinogen in the bloodstream, disrupting the coagulation cascade and promoting hemorrhage through its specific proteolytic action on key fibrinogen subunits."}
{"description": "sp|Q2VBN9|3SXQ_OPHHA Short neurotoxin SNTX26 OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTFLVVTIVCLDLGYTLICHQVHGLQTCEPAQKFCQKRTTMFFPNHPVLLMGCTYNCPTERYSVCCSTDKCNK", "prompt": "Design a short neurotoxin protein sequence that mimics the biological activity and structural characteristics of snake venom neurotoxins from the king cobra (Ophiophagus hannah). This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework C-C-CC-C-C. The structure should feature the conserved functional loop II that mediates specific binding to the α-δ and α-γ interfaces of muscle-type nicotinic acetylcholine receptors. The sequence should maintain the key pharmacophore residues responsible for receptor recognition and blockade while preserving the compact, stable globular architecture essential for venom efficacy. The resulting protein should exhibit high affinity binding to neuromuscular junctions and potent inhibition of acetylcholine-induced muscle contraction."}
{"description": "sp|P0CC12|KAX85_ODODO Potassium channel toxin alpha-KTx 8.5 OS=Odontobuthus doriae OX=342590 PE=1 SV=2", "sequence": "MSRLYAIILIALVLNVIMTIMPDSKVEAVSCEDCPEHCSTQKARAKCDNDKCVCESV", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Odontobuthus doriae. This toxin belongs to the alpha-KTx family 8.5, specifically targeting voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker that disrupts neuronal signaling and neuromuscular transmission by binding to the pore region of Kv channels, thereby inhibiting potassium efflux and prolonging action potentials. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with the conserved cysteine framework C1-X(3-9)-C2-X(3-14)-C3-X(0-4)-C4-X(4-12)-C5-X(1-4)-C6, where the C1-C4, C2-C5, and C3-C6 disulfide connectivity creates a stable globular core. The protein should include a functional dyad comprising a critical lysine residue that inserts into the potassium channel selectivity filter and an adjacent aromatic residue (tyrosine or phenylalanine) that enhances binding affinity through hydrophobic interactions. The sequence should contain approximately 30-40 amino acids with a high proportion of basic residues (lysine and arginine) to facilitate electrostatic interactions with the negatively charged channel vestibule. The overall structure should comprise a short N-terminal helix and an anti-parallel beta-sheet, forming a compact, stable molecule resistant to proteolytic degradation, typical of scorpion venom toxins that rapidly induce paralysis in prey."}
{"description": "sp|P0CC13|O16B_CONCN Delta-conotoxin-like CnVIB OS=Conus consors OX=101297 PE=1 SV=1", "sequence": "DECFSPGTFCGTKPGLCCSARCFSFFCISLEF", "prompt": "Design a novel animal toxin protein sequence inspired by the delta-conotoxin-like peptide family from the venom of the marine cone snail Conus consors. This venom component should function as a potent neurotoxin that targets voltage-gated ion channels, likely sodium channels, to disrupt neuronal signaling and induce paralysis in prey. The protein should adopt a compact, disulfide-rich scaffold characteristic of conotoxins, with a conserved cysteine framework (typically C-C-CC-C-C for delta-conotoxins) that forms three disulfide bridges stabilizing an inhibitory cysteine knot (ICK) fold. Key structural features include a rigid, globular core with exposed loops for target interaction, high thermal and proteolytic stability, and molecular recognition surfaces tailored for selective binding to ion channel pore domains or voltage-sensing elements. The sequence must encode functional residues for precise target engagement, such as hydrophobic patches and charged side chains, while maintaining the overall fold integrity through the cysteine pattern. The biological context should reflect the venom's role in prey immobilization, with the toxin acting to block channel inactivation or modulate gating kinetics, leading to sustained depolarization and neuromuscular failure."}
{"description": "sp|P0CE77|CM3B_CONST Mu-conotoxin SIIIB OS=Conus striatus OX=6493 PE=1 SV=1", "sequence": "QNCCNGGCSSKWCKGHARCC", "prompt": "Generate the amino acid sequence for a mu-conotoxin from the marine cone snail Conus striatus, specifically the SIIIB variant. This toxin functions as a potent and selective antagonist of voltage-gated sodium channels, playing a critical role in the venom's paralytic strategy by blocking neuromuscular transmission. The toxin should adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges. This arrangement supports a stable three-dimensional structure with defined loops that mediate high-affinity binding to site 1 of the skeletal muscle sodium channel Nav1.4, effectively inhibiting channel activation and preventing action potential propagation. The sequence must include key residues for target specificity and potency, reflecting the toxin's role in rapid prey immobilization."}
{"description": "sp|P0CAR5|3S1E3_MICPY Weak neurotoxin E3 (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "LICFNDFSPTARTLEYCQIGITTYNPS", "prompt": "Design a protein sequence for a weak neurotoxin from the venom of the Argentinian coral snake (Micrurus pyrrhocryptus). This toxin belongs to the three-finger toxin (3FTx) superfamily, characterized by a conserved structural scaffold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should adopt the classic three-finger fold architecture with predominantly beta-sheet secondary structure. As a weak neurotoxin, it functions as a postsynaptic neurotoxin that binds with moderate affinity to nicotinic acetylcholine receptors at the neuromuscular junction, causing reversible neuromuscular blockade through competitive antagonism. The molecular mechanism involves specific interactions with the alpha-delta or alpha-gamma subunit interfaces of the muscle-type nicotinic acetylcholine receptor, disrupting acetylcholine binding and preventing depolarization of the postsynaptic membrane. The toxin should exhibit the characteristic pharmacological profile of weak neurotoxins - slower onset of action and reversible effects compared to potent neurotoxins, making it evolutionarily optimized for subjugating small vertebrate prey. The sequence should maintain the conserved structural determinants of the three-finger toxin fold while incorporating the specific molecular recognition motifs that confer its weak neurotoxic activity and target specificity."}
{"description": "sp|Q1PBD1|VM2DI_GLOHA Zinc metalloproteinase/disintegrin OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "MIQVLLVIICLAVPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKGLFSKDYIETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSNSEAHAVYKYEDVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPAHQRYIELVIVADHGMFTKYDSNLDTIRTWVHELVNSINEFYRSLNIDVSLTELEIWSNEDLINVQPAAPHTLDSFGKWRERDLLHRIHHDNAMLLTAIDFDEPTIGLAYVGTMCNPKGSTGVVQDHSTINLRVAVTMAHEIGHNLGIHHDTGSCSCGGYSCIMSPVISHEPSKYFSDCSYTQCWDFIMNQKPQCILNKPLRTDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKKGTVCRIARGDDMDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of viperid snake venoms like those from Gloydius halys (Siberian pit viper). This multifunctional toxin should exhibit the following biological characteristics: The zinc metalloproteinase domain should contain the conserved HEXXHXXGXXH zinc-binding motif and function as a hemorrhagic toxin that degrades extracellular matrix components, particularly basement membrane proteins like type IV collagen and fibronectin, leading to tissue damage and hemorrhage. The disintegrin domain should adopt the characteristic disintegrin fold with the RGD (Arg-Gly-Asp) or related integrin-binding motif that specifically inhibits platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors on platelets. The protein should maintain the typical modular architecture of snake venom metalloproteinases, with proper domain organization and disulfide bonding patterns that stabilize both functional domains. The mature protein should facilitate localized tissue destruction while simultaneously preventing blood clot formation, creating synergistic effects that enhance venom spread and prey immobilization. The structural scaffold should ensure proper folding and presentation of both catalytic and inhibitory domains for maximal biological activity in envenomation."}
{"description": "sp|P0DX36|MAST2_POLRT Polistes-mastoparan-R2 OS=Polistes rothneyi OX=30208 PE=1 SV=1", "sequence": "LNFKALAALAKKIL", "prompt": "Design a novel peptide toxin sequence inspired by mastoparan-R2 from the venom of the paper wasp Polistes rothneyi. This peptide should adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan family peptides. The sequence must exhibit potent membrane-disrupting activity through non-specific interactions with phospholipid bilayers, leading to cell lysis and mast cell degranulation. Key structural features to incorporate include: a predominantly cationic character with strategically placed lysine and arginine residues to facilitate membrane binding, hydrophobic residues distributed to create a distinct hydrophobic face for membrane insertion, and a length of approximately 14-16 amino acids. The peptide should demonstrate calcium-independent cytolytic activity against various cell types and exhibit hemolytic properties. The structural scaffold should enable pore formation in lipid membranes through a barrel-stave or carpet mechanism, with the amphipathic helix aligning parallel to the membrane surface during initial binding stages. The designed sequence should maintain the characteristic mastoparan biological activity profile while optimizing for stability and potency."}
{"description": "sp|C0HJC2|K1B1_BUNCI Kappa-actitoxin-Bcs3a OS=Bunodosoma caissarum OX=31165 PE=1 SV=1", "sequence": "ACIDRFPTGTCKHVKKGGSCKNSQKYRINCAKTCGLCH", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-actitoxin derived from the sea anemone Bunodosoma caissarum, functioning as a potent neurotoxin that targets voltage-gated potassium channels (Kv channels). This toxin belongs to the sea anemone type 1 potassium channel toxin family and should exhibit the characteristic structural scaffold of this group, featuring a conserved triple-stranded beta-sheet stabilized by a specific disulfide bridge pattern (cysteine framework I/II: C1-C4, C2-C5, C3-C6). The core mechanism of action involves binding to the pore region of Kv channels, particularly Kv1 subtypes, leading to delayed repolarization and prolonged neuronal excitation. The structural fold should include an inhibitor cysteine knot (ICK) motif, contributing to exceptional stability and resistance to proteolytic degradation. The molecular target interface should involve key residues that interact with the channel's voltage-sensor domain or pore loop, ensuring high affinity and selectivity. The biological significance lies in its role in the sea anemone's venom for prey immobilization and defense, disrupting neuromuscular signaling through potassium channel blockade. The sequence must reflect these functional and structural attributes, with appropriate length and residue conservation typical of sea anemone potassium channel toxins."}
{"description": "sp|B8XH38|KAX_BUTIS Potassium channel toxin-like Tx677 OS=Buthus israelis OX=2899555 PE=3 SV=1", "sequence": "MKISALVMITLLICSMMILCQGQKILSNRCNNSSECIPHCIRIFGTRAAKCINRKCYCYP", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Buthus israelis. This toxin functions as a potent modulator of voltage-gated potassium channels (Kv channels), specifically targeting and blocking these channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved structural scaffold characteristic of scorpion venom toxins targeting potassium channels, featuring a compact, stable fold stabilized by multiple disulfide bridges—typically with a cysteine framework of C-C-CC-C-C or similar, forming three to four disulfide bonds that confer rigidity and resistance to proteolysis. The core structure is expected to include an alpha-helix and anti-parallel beta-sheets, arranged in an inhibitor cysteine knot (ICK) motif, which enhances binding affinity and specificity. Key functional residues should be positioned in loops and surface-exposed regions to interact with the pore region or voltage-sensing domains of Kv channels, such as Kv1.1, Kv1.2, or Kv1.3, leading to channel inhibition and prolonged action potentials. The toxin's mechanism involves binding to the external vestibule of the channel, physically obstructing ion permeation and causing hyperexcitability, paralysis, or prey immobilization. Ensure the sequence reflects high specificity for potassium channels over sodium or calcium channels, with conserved hydrophobic and basic residues critical for target recognition. The biological significance lies in its role in the scorpion's predatory and defensive strategies, where it contributes to rapid prey subjugation by disrupting nervous system function."}
{"description": "sp|X5IFZ1|CAI19_CONGE Conotoxin G1.9 OS=Conus geographus OX=6491 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSRRGPKSRRGEPVPTTVINYGECCKDPSCWVKVKDFQCPGASPPN", "prompt": "Design a novel conotoxin sequence inspired by Conus geographus venom, specifically targeting the α9α10 nicotinic acetylcholine receptor subtype. This toxin should function as a potent and selective antagonist, blocking neurotransmission through competitive inhibition at the orthosteric binding site. The sequence must adopt the conserved α-conotoxin fold, characterized by a compact globular structure stabilized by two disulfide bonds in a CysI-CysIII, CysII-CysIV connectivity pattern (framework I). The mature peptide should be approximately 16-20 residues in length, featuring the characteristic α-conotoxin cysteine spacing with well-defined α-helical and β-sheet elements forming a stable tertiary structure. The molecular surface should present key pharmacophore residues for high-affinity binding to the α9α10 nAChR interface, while maintaining selectivity against other nicotinic receptor subtypes. The toxin should exhibit the paralytic activity typical of Conus geographus venom components, potentially useful for neurological research and pain management applications."}
{"description": "sp|P42717|BRK_PARID Waspkinin OS=Parapolybia indica OX=31921 PE=1 SV=1", "sequence": "QZKRPPGFSPFRK", "prompt": "Design a wasp venom peptide sequence that functions as a potent bradykinin-like toxin, mimicking the inflammatory and pain-inducing properties of endogenous bradykinin. This peptide should be derived from the predatory wasp Parapolybia indica, whose venom components are evolutionarily optimized for prey immobilization and defense through targeted modulation of mammalian pain pathways. The core mechanism of action involves competitive binding to bradykinin B2 receptors on sensory neurons and vascular endothelial cells, triggering pro-inflammatory signaling cascades, increased vascular permeability, and potent nociceptive responses. Structurally, this linear peptide should adopt a flexible, extended conformation stabilized by key hydrophobic and charged residue interactions rather than disulfide bridges, allowing for optimal receptor engagement. Critical functional motifs must include a conserved N-terminal sequence for receptor recognition, a central region with specific residue substitutions that enhance receptor affinity and proteolytic stability compared to endogenous bradykinin, and a C-terminal extension that may confer additional receptor subtype selectivity or prolonged half-life. The peptide should demonstrate high specificity for bradykinin receptors over related GPCRs, with particular potency in inducing pain and inflammation through direct sensory neuron activation and indirect vascular effects."}
{"description": "sp|Q90391|VM1AB_CROAT Snake venom metalloproteinase atrolysin-B OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASDLNLNPDQQNLPQRYIELVVVADHRVFMKYNSDLNIIRKRVHELVNTINGFYRSLNIDVSLTDLEIWSDQDFITVQSSAKNTLNSFGEWREADLLRRKSHDHAQLLTAINFEGKIIGRAYTSSMCNPRKSVGIVKDHSPINLLVGVTMAHELGHNLGMNHDGDKCLRGASLCIMRPGLTPGRSYEFSDDSMGYYQSFLNQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE", "prompt": "Design a snake venom metalloproteinase protein sequence that mimics the toxic activity and structural characteristics of atrolysin-B from the Western diamondback rattlesnake (Crotalus atrox). This enzyme should function as a potent hemorrhagic toxin that degrades key components of the basement membrane and extracellular matrix, particularly targeting type IV collagen, laminin, and fibronectin. The protein should feature the characteristic zinc-binding motif HEXXHXXGXXH in its catalytic domain, which coordinates the catalytic zinc ion essential for proteolytic activity. Include the conserved methionine turn downstream of the active site. The structure should contain the typical metalloproteinase domains: a prodomain that maintains latency, a catalytic domain with the reprolysin family signature, and a disintegrin-like domain that may mediate specific interactions with integrins or other cellular receptors. The cysteine framework should support proper folding with disulfide bridges stabilizing the multidomain architecture. The mature toxin should exhibit calcium-dependent stability and optimal activity at physiological pH, contributing to the rapid tissue damage and hemorrhage characteristic of viperid snake envenomation by disrupting vascular integrity and promoting bleeding."}
{"description": "sp|C0HKB2|KA241_PANIM Potassium channel toxin alpha-KTx 24.1 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "VAKCSTSECGHACQQAGCRNSGCRYGSCICVGC", "prompt": "Design a potassium channel toxin protein from the venom of the emperor scorpion Pandinus imperator. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by disulfide bridges. The expected cysteine framework follows the pattern C-Xn-C-Xn-C-Xn-C, where the disulfide connectivity creates the structural scaffold essential for channel binding. The toxin should specifically target and inhibit potassium channels, likely through interaction with the channel's pore region or voltage-sensing domains, disrupting neuronal excitability and neuromuscular transmission. The biological significance lies in its role in the scorpion's predatory arsenal, where it immobilizes prey by modulating ion channel function. The sequence should include key residues for potassium channel recognition and binding, maintaining the compact, stable globular structure required for venom efficacy."}
{"description": "sp|Q6T627|OXLA_BITGA L-amino-acid oxidase (Fragment) OS=Bitis gabonica OX=8694 PE=2 SV=1", "sequence": "GPMRIPEKHRIVREYIRKFGLQLNEFVQETENAWYYIKNIRKKVHEVKKDPGLLKYPVKP", "prompt": "Generate a protein sequence for a venom-derived L-amino-acid oxidase from the Gaboon viper (Bitis gabonica). This enzyme represents a key component of viperid venom that contributes to prey immobilization and tissue damage through oxidative mechanisms. The protein should function as a flavin adenine dinucleotide (FAD)-dependent oxidase that catalyzes the stereospecific oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The generated hydrogen peroxide mediates cytotoxic effects including induction of apoptosis, platelet aggregation inhibition, and local tissue damage through oxidative stress. The protein should adopt the characteristic L-amino-acid oxidase fold with a conserved FAD-binding domain featuring Rossmann-fold architecture and a substrate-binding domain that confers substrate specificity. The sequence should contain the essential catalytic residues for FAD cofactor binding and substrate recognition, with conserved glycine-rich motifs in the FAD-binding region. The structural scaffold should facilitate dimerization through extensive interface contacts, as typical for snake venom L-amino-acid oxidases. The enzyme should exhibit optimal activity at physiological pH and demonstrate preferential substrate specificity toward hydrophobic L-amino acids, contributing to its role in venom-induced pathophysiology including hemorrhage, edema, and prey debilitation."}
{"description": "sp|Q9I8X0|VSP3_DEIAC Snake venom serine protease Dav-KN OS=Deinagkistrodon acutus OX=36307 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLLNEEWVLTAAHCNGKDMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRIMGWGSITPVEVTFPDVPYCANINLLDDVECKPGYPELLPEYKTLCAGILEGGIDTCGFDSGAPLISNGQFQGIVSWGGDPCAQPREPGVYTNVFDHLDWIKGIIAGNTDVTCPP", "prompt": "Design a snake venom serine protease from the Chinese hundred-pacer viper (Deinagkistrodon acutus) that functions as a potent hemostatic toxin. This enzyme should exhibit the characteristic trypsin-like serine protease fold with a conserved catalytic triad (His57, Asp102, Ser195) and function as a procoagulant by specifically cleaving fibrinogen to generate fibrin clots. The protein should contain the standard serine protease domain architecture with appropriate substrate-binding pockets for recognizing and processing coagulation cascade components. Include the conserved disulfide bond pattern typical of snake venom serine proteases that stabilizes the globular structure. The enzyme should demonstrate high specificity for fibrinogen cleavage while potentially exhibiting secondary activities on other coagulation factors. Consider structural features that contribute to its stability in venom and efficient interaction with mammalian coagulation systems, including surface loops that mediate substrate recognition and potential exosite interactions with coagulation factors."}
{"description": "sp|B1P1D5|JZT4A_CHIGU Kappa-theraphotoxin-Cg3a 1 OS=Chilobrachys guangxiensis OX=278060 PE=2 SV=1", "sequence": "MKNTSILFILGLALLLVLAFEVQVGESDGECGGFWWKCGSGKPACCPKYVCSPKWGLCNFPMP", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-theraphotoxin derived from the venom of the Chinese earth tiger tarantula (Chilobrachys guangxiensis). This toxin belongs to the inhibitory cystine knot (ICK) structural family, which is characteristic of spider venom peptides. The core function of this toxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The structural scaffold must feature the canonical ICK motif with three conserved disulfide bridges forming a knotted topology that provides exceptional thermal and proteolytic stability. The cysteine framework should follow the pattern C1-C4, C2-C5, C3-C6, creating the characteristic cystine knot that defines this toxin family. The mature peptide should be approximately 30-40 amino acids in length with a compact, globular fold stabilized by the disulfide network. Key structural elements should include beta-hairpin loops that form the channel-blocking interface, with specific residues in these loops responsible for interacting with the pore region of Kv channels. The mechanism involves physically occluding the potassium channel pore, leading to prolonged neuronal depolarization and enhanced neurotransmitter release, ultimately causing paralysis in prey organisms. The protein should exhibit high specificity for particular Kv channel subtypes while maintaining the potent neurotoxic activity characteristic of spider venom peptides used for prey immobilization."}
{"description": "sp|Q9I8W9|VSP4_DEIAC Snake venom serine protease Dav-X OS=Deinagkistrodon acutus OX=36307 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGVECDINEHRFLAAFFKYQPWTFQCAGTLIHEQWVLGAAHCYKRGLNIYLGMHNQSIQFDDEQRRYAIEEHYYRCDEKLTKWEKDVMLLKLNKPVRNSTHIAPLSLPSSPPSIGSFCRVMGWGIMSSTKDILPDVPHCANIKLVNYTECVAPYPNIPVTTRLWCAGVLEGGIDTCHQDSGGPLICDGQFQGIVAFGRYPCAQPRVPALYTKVSNYTDWIQNIIAGKTTTACPP", "prompt": "Design a snake venom serine protease from the venom of the hundred-pace snake (Deinagkistrodon acutus) that functions as a potent hemostatic toxin. This enzyme should exhibit trypsin-like serine protease activity with specificity for cleaving key components of the coagulation cascade, particularly fibrinogen and other plasma proteins involved in hemostasis. The protein should adopt the characteristic chymotrypsin-like fold typical of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His, Asp, Ser) positioned in the active site cleft. Include the conserved disulfide bridge pattern that stabilizes this fold, with cysteine residues forming the characteristic connectivity that maintains structural integrity and enzymatic function. The enzyme should possess substrate specificity determinants that enable selective recognition and cleavage of coagulation factors, potentially contributing to both procoagulant and anticoagulant effects depending on the specific targets cleaved. The structural scaffold should facilitate efficient substrate binding and catalytic efficiency while maintaining stability in the venom environment. This serine protease represents a key component of the viperid venom arsenal, evolved to disrupt vertebrate hemostasis through precise proteolytic targeting of coagulation pathways."}
{"description": "sp|A0A3G3C7S0|CA15_CONAA Alpha-conotoxine-like Am1.5 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFMSGRAFRDRNAAAKVSDLIALKARRPECCSHPACNVDHPEICR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus amadis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold featuring a compact, disulfide-stabilized globular fold with the conserved CC-C-C cysteine framework, where two disulfide bridges create a stable core that supports the presentation of key functional loops. These loops should contain critical residues for receptor recognition and binding, particularly in the conserved pharmacophore region that interacts with the orthosteric site of nAChRs. The sequence should maintain the typical length of 12-20 amino acids with appropriate spacing between cysteine residues to ensure proper folding and disulfide connectivity. The toxin should exhibit high affinity and selectivity for its target nAChR subtypes, potentially contributing to the paralytic effects observed in the cone snail's envenomation strategy for prey capture. The structural design should prioritize stability in the marine environment while maintaining the characteristic alpha-conotoxin fold that enables precise receptor subtype discrimination."}
{"description": "sp|P61542|BDS2_ANTEL Pi-actitoxin-Ael2b OS=Anthopleura elegantissima OX=6110 PE=1 SV=1", "sequence": "GTACSCGNSKGIYWFYRPSCPTDRGYTGSCRYFLGTCCTPAD", "prompt": "Design a protein sequence for a potassium channel-blocking toxin from the sea anemone Anthopleura elegantissima. This toxin belongs to the BDS family (Blood Depressing Substance) and functions as a selective inhibitor of voltage-gated potassium channels, specifically Kv3 channels. The protein should adopt the conserved sea anemone toxin fold characterized by a compact, globular structure stabilized by three disulfide bonds with a C1-C4, C2-C5, C3-C6 connectivity pattern. The structural scaffold should feature a core beta-sheet region with loops extending from this stable framework, where key functional residues for channel interaction are located. The mechanism involves binding to the voltage-sensing domain of Kv3 channels, delaying channel activation and modulating neuronal excitability. This toxin plays a crucial role in the sea anemone's venom arsenal for prey immobilization and defense, specifically targeting the fast-spiking properties of neurons that depend on Kv3 channels. The sequence should include the characteristic cysteine framework of sea anemone potassium channel toxins while maintaining the specific molecular surface features required for selective Kv3 channel recognition and blockade."}
{"description": "sp|A0A2P1BSS8|3SX4_MICMP Mipartoxin-4 OS=Micrurus mipartitus OX=430902 PE=2 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRKCHTKNSPGRETSQACPTGQNICFKKWKKGEIISKGCAVTCPKPKKDETFQCCLKNNCNR", "prompt": "Design a novel animal toxin protein sequence based on the biological profile of Mipartoxin-4 from the red-tailed coral snake (Micrurus mipartitus). This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, specifically inhibiting acetylcholine release from motor nerve terminals. The protein should adopt a three-finger toxin (3FTx) structural scaffold characteristic of elapid snake venom toxins, featuring a conserved core stabilized by four disulfide bridges with the characteristic cysteine framework C-C-CC-C-C. The three-finger topology should consist of three extended beta-stranded loops emerging from a central hydrophobic core, creating a molecular surface capable of high-affinity binding to presynaptic membrane targets. The toxin should exhibit specificity for neuronal targets rather than muscle-type receptors, causing progressive and irreversible neuromuscular blockade leading to flaccid paralysis. The sequence should maintain the characteristic physicochemical properties of neurotoxic 3FTxs, including appropriate distribution of hydrophobic residues in the core and charged/polar residues on the surface for target recognition. The structural fold should enable specific interactions with presynaptic membrane proteins involved in neurotransmitter release machinery."}
{"description": "sp|L8BU87|CA1A_CONLI Alpha-conotoxin LvIA (Fragment) OS=Conus lividus OX=89426 PE=3 SV=1", "sequence": "FRGRDAAAKASGLVGLTDRRGCCSHPACNVDHPEICG", "prompt": "Generate the complete amino acid sequence for alpha-conotoxin LvIA from the marine cone snail Conus lividus. This neurotoxic peptide functions as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in pain signaling pathways. The toxin should adopt the characteristic alpha-conotoxin structural scaffold with the conserved CC-C-C cysteine framework (Framework I), forming two essential disulfide bridges that stabilize a compact, globular fold. The mature peptide should contain the typical alpha-conotoxin structural features: a short, constrained beta-hairpin-like conformation with well-defined loops that mediate receptor interaction. The sequence must include key pharmacophore residues responsible for high-affinity binding to specific nicotinic receptor subunits, particularly those expressed in the central and peripheral nervous systems. The toxin should exhibit the molecular mechanism of competitive antagonism by binding to the orthosteric site of nicotinic receptors, thereby blocking acetylcholine-mediated neurotransmission. The structural design should ensure proper folding into the characteristic inhibitory cysteine knot (ICK) motif, with the disulfide connectivity pattern essential for maintaining structural integrity and biological activity. The generated sequence should reflect the evolutionary optimization of this conotoxin for precise receptor subtype selectivity, contributing to the predatory strategy of Conus lividus through targeted neuromuscular and neuronal disruption."}
{"description": "sp|P0DI84|OXLA_VIPAA L-amino-acid oxidase OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "DRNPLEECFRETDYEEFLEIARNGLKKTSNPKHVVVVGAGMSGLSAAYVLAGAGHKVTVLEASERAGGRVRTHRNSKEGWYANLGPMRIPEKHRIVREYIRKFGLNLNEFSQENDNAWYFIKNIRKRVGEVNKDPGLLKYPVKPSEEGKSAGQLYEESLGSAVKDLKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDQLPTSMYRAIEEKVKFNARVIKIQQNANQVTVTYQTPEKDTSSNTADYVIVCTTSRAARRIQFEPPLPPKKQHALRSVHYRSGTKIFLTCSSKFWEDDGIHGGKSTTDLPSRFIYYPNHNFSTGVGVIIAYGIGDDANFFQALKFKDCADIVFNDLSLIHQLPKEEIQSFCYPSMIQKWSLDKYAMGAITTFTPYQFQRFSEALTAPQGRIFFAGEYTAEAHGWIDSTIKSGLTAARDVNRASEQ", "prompt": "Design a protein sequence for a snake venom L-amino-acid oxidase from the nose-horned viper (Vipera ammodytes ammodytes). This enzyme represents a key component of viperid venom that contributes to prey immobilization and tissue damage through oxidative mechanisms. The protein should function as a flavoenzyme that catalyzes the oxidative deamination of L-amino acids, generating hydrogen peroxide, ammonia, and the corresponding α-keto acid. This enzymatic activity underlies its toxic effects, including induction of apoptosis in various cell types, platelet aggregation inhibition or induction depending on concentration, and contribution to local tissue damage and hemorrhage through oxidative stress. The protein should adopt the characteristic homodimeric structure typical of snake venom L-amino-acid oxidases, with each monomer containing a FAD-binding domain that accommodates the flavin adenine dinucleotide cofactor essential for catalytic activity. The structure should feature the conserved glycine-rich motif for FAD binding and maintain the proper active site architecture for substrate recognition and catalysis. The enzyme should exhibit substrate preference for hydrophobic L-amino acids, particularly L-phenylalanine and L-leucine, which is characteristic of viperid L-amino-acid oxidases. The protein should display the yellow coloration typical of these enzymes due to FAD binding and maintain the quaternary structure necessary for optimal enzymatic activity and stability in the venom milieu."}
{"description": "sp|Q719L8|SL_CRODU Snaclec crotocetin OS=Crotalus durissus terrificus OX=8732 PE=2 SV=1", "sequence": "MGRLVFVSFGLLVVFLSLTGTGAGFCCPLGWSSYEGHCYKVFKQDMTWEDAEKFCTQQHEGSHLVSLQSSEEVDFVISMTAPMLKLGLVWIGLSNIWNECTLEWTNGNKVDYKAWSAEPECIVSKSTDKHWFSRPCSKTHKVVCKFQA", "prompt": "Design a protein sequence for a snake venom C-type lectin (snaclec) from the South American rattlesnake Crotalus durissus terrificus. This toxin functions as a platelet aggregation modulator, specifically targeting platelet receptors such as GPIb or GPVI to either inhibit or activate platelet aggregation through its carbohydrate-recognition domain. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a conserved double-loop structure stabilized by two disulfide bridges with a typical C-C-C-C cysteine framework. The sequence should include key residues for calcium-dependent carbohydrate binding and exhibit the heterodimeric assembly common to snaclecs, with distinct α and β chains that form a functional complex. The structural scaffold should feature the β-sandwich fold with long loop regions that mediate specific interactions with platelet surface receptors, contributing to the venom's hemostatic disruption and prey immobilization mechanisms."}
{"description": "sp|P0C351|CA1B_CONPU Alpha-conotoxin PIB OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "QSPGCCWNPACVKNRC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus purpurascens, the purple cone snail. This toxin should function as a potent and selective antagonist of muscle-type nicotinic acetylcholine receptors (nAChRs), specifically targeting the α/δ subunit interface to induce neuromuscular blockade. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a conserved globular disulfide framework (Cys1-Cys3, Cys2-Cys4 connectivity) stabilized by two disulfide bonds that form a compact, stable fold. The sequence should include the appropriate inter-cysteine loop regions that confer target specificity, with loop 2 being critical for receptor binding affinity and selectivity. The overall structure should exhibit high thermal and proteolytic stability typical of conotoxins, enabling effective disruption of cholinergic signaling at the neuromuscular junction. Incorporate conserved residues that maintain the core structural integrity while allowing for functional specificity through strategic variations in the binding loops."}
{"description": "sp|P0DJC9|SLB_BOTAS Snaclec aspercetin subunit beta (Fragment) OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "DCPSDWSSYEGHCYRVFKPPKDWADAERFCSQQAKGGHLVSIERFGREDFVSNLITKNLQRG", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This protein originates from Bothrops asper, a highly venomous pit viper whose venom contains complex mixtures of toxins that disrupt hemostasis through various mechanisms including coagulation cascade interference and platelet function modulation. As a beta subunit of aspercetin, this snaclec protein should exhibit the characteristic C-type lectin-like domain fold with a conserved structural architecture consisting of two antiparallel beta-sheets and two alpha-helices, stabilized by two conserved disulfide bridges typically formed between cysteine residues in positions that maintain the globular protein structure. The protein should function through specific carbohydrate-recognition domain interactions with platelet surface receptors, potentially targeting glycoprotein receptors involved in platelet adhesion and aggregation. The sequence should maintain key residues for calcium-dependent ligand binding and exhibit the signature loop regions that confer target specificity. The overall structure should be compact and stable, typical of venom C-type lectins, with surface-exposed residues optimized for receptor recognition and functional modulation of platelet activity."}
{"description": "sp|A8YPR6|SVMI_ECHOC Snake venom metalloprotease inhibitor 02D01 OS=Echis ocellatus OX=99586 PE=1 SV=2", "sequence": "MFVSRLAASGLLLLSLLALSLDGKPLPQRQPHHIQPMEQKWLAPDAPPLEQKWLAPDAPPLEQKWLAPAAPPLEQKWLAPDAPPMEQKWLAPDAPPMEQKWLAPDAPPMEQKWLAPDAPPMEQKWLAPDAAPLEQKWLAPDAPPMEQKWLAPDAPPMEQKWQPQIPSLMEQRQLSSGGTTALRQELSPRAEAASGPAVVGGGGGGGGGSKAALALPKPPKAKGAAAATSRLMRDLRPDGKQASQKWGRLVDHDHDHHHHHHPGSSVGGGGGGGGGGARRLKGLAKKGVAKGCFGLKLDRIGSMSGLGC", "prompt": "Design a snake venom metalloprotease inhibitor protein from the West African carpet viper, Echis ocellatus. This protein functions as a potent inhibitor of snake venom metalloproteases (SVMPs), playing a crucial role in the venom's complex cocktail by regulating the activity of hemorrhagic and tissue-damaging enzymes. The inhibitor should adopt a canonical Kunitz-type serine protease inhibitor fold, characterized by a compact, stable beta-trefoil structure with conserved disulfide connectivity. The protein must contain the characteristic Kunitz domain with specific cysteine framework (C-C-C-C-C-C pattern) that forms three disulfide bridges stabilizing the core structure. Key structural elements should include an exposed reactive site loop that presents critical residues for specific binding and inhibition of SVMPs, likely through a mechanism involving competitive inhibition at the enzyme's active site. The inhibitor should demonstrate high specificity for zinc-dependent metalloproteases found in viper venoms, potentially targeting enzymes involved in hemorrhage, coagulation disruption, and extracellular matrix degradation. The protein should exhibit the characteristic stability and resistance to proteolytic degradation typical of Kunitz-type inhibitors, with optimal binding affinity for its metalloprotease targets while maintaining structural integrity in the venom environment."}
{"description": "sp|Q6T6S5|VKT2_BITGA Kunitz-type serine protease inhibitor bitisilin-2 OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSGKKRPDFCYLPADTGPCMANFPRFYYDSASKKCKKFTYGGCHGNANNFETREECRKKCFASAARRPT", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by the venom of the Gaboon viper (Bitis gabonica), specifically emulating the functional and structural characteristics of bitisilin-2. This toxin serves as a potent anticoagulant in the venom, functioning through precise inhibition of key serine proteases in the coagulation cascade, thereby disrupting hemostasis and promoting prey immobilization. The protein should adopt the canonical Kunitz domain fold, characterized by a compact, globular structure stabilized by three conserved disulfide bonds with a C1-C6, C2-C4, C3-C5 connectivity pattern. This scaffold forms a stable β-trefoil-like architecture with exposed loops that constitute the protease-binding interface. The reactive site loop should feature specific residues optimized for high-affinity binding to target serine proteases such as thrombin, factor Xa, or plasma kallikrein, employing a standard mechanism of inhibition where the inhibitor presents a substrate-like sequence that occupies the enzyme's active site without proteolytic cleavage. Key structural elements must include a well-defined binding loop with appropriate P1-P1' residues dictating specificity, supported by a rigid core maintained by the disulfide network. The overall structure should exhibit the characteristic Kunitz domain topology with alternating β-strands and α-helices, ensuring thermodynamic stability and resistance to proteolytic degradation while maintaining precise molecular recognition capabilities for serine protease targets."}
{"description": "sp|Q6PXP0|PA2_ANUPH Phospholipase A2 phaiodactylipin OS=Anuroctonus phaiodactylus OX=246982 PE=1 SV=2", "sequence": "MVKRVSKEEMDALERSCSQPFEEERFLIVSGTKWCGNNNIAANYSDLGFLEADKCCRDHDHCDHIASGETKYGLENKGLFTILNCDCDEAFDHCLKEISNNVTTDIRQKGGAENVWRFYFQWYNANCYRLYCKDEKSARDEACTNQYAVVKKNFTVQ", "prompt": "Design a phospholipase A2 toxin protein sequence that captures the venomous essence of the Mexican scorpion Anuroctonus phaiodactylus. This enzyme should function as a potent presynaptic neurotoxin, targeting neuronal membranes and disrupting synaptic transmission through its catalytic activity. The protein must hydrolyze the sn-2 ester bond of glycerophospholipids, releasing free fatty acids and lysophospholipids that induce membrane damage and neurotransmitter release dysregulation. Incorporate the characteristic pancreatic-type phospholipase A2 fold with conserved catalytic residues including a histidine-aspartate dyad and calcium-binding loop. The structure should feature the hallmark disulfide bridge pattern that stabilizes the globular fold, with conserved cysteine residues forming the characteristic disulfide connectivity. Include the conserved structural elements: the N-terminal α-helix, the calcium-binding loop with conserved glycine residues, the catalytic network, and the β-wing region. The protein should exhibit optimal activity at physiological pH and demonstrate specificity for neuronal membrane phospholipids, contributing to the neurotoxic effects characteristic of scorpion venom phospholipases A2."}
{"description": "sp|M4GX67|SCBTY_OLIMR BmKBT-like peptide OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MKAALLLVISTLMLIGVLTKKSGYPIQHDGCKNWCVFNHFCENICETYGGSGYCYFWKLACWCDNIHNWVPTWSRETNKCRAK", "prompt": "Design a novel animal toxin peptide inspired by the BmKBT-like peptide from the scorpion Olivierus martensii. This peptide should function as a potassium channel modulator, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The peptide should adopt a compact, stable fold stabilized by a conserved cysteine framework characteristic of scorpion toxins, likely with three or four disulfide bridges forming a cysteine-stabilized alpha-beta (CSαβ) motif. Key structural elements should include a short alpha-helix and an antiparallel beta-sheet, creating a molecular surface with charged and hydrophobic residues that mediate specific interactions with the pore region or voltage-sensing domain of Kv channels. The biological context should reflect the venom's role in prey immobilization and defense, with the toxin contributing to paralysis by prolonging neuronal depolarization. Ensure the sequence maintains high stability in the venom milieu and exhibits selectivity for Kv channel subtypes relevant to the scorpion's ecological niche."}
{"description": "sp|Q90WA1|VKT1_PSETT Kunitz-type serine protease inhibitor textilinin-1 OS=Pseudonaja textilis textilis OX=169397 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPDFCELPADTGPCRVRFPSFYYNPDEKKCLEFIYGGCEGNANNFITKEECESTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the Australian eastern brown snake (Pseudonaja textilis), known as textilinin-1. This toxin functions as a potent and specific inhibitor of plasmin, playing a crucial role in the snake's venom by preventing fibrinolysis and promoting hemorrhage through the inhibition of key serine proteases in the coagulation cascade. The protein should adopt the characteristic Kunitz-type fold, featuring a compact, globular structure stabilized by three conserved disulfide bonds with a typical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The sequence must include the canonical reactive site loop that specifically interacts with the active site of plasmin, containing key residues for protease recognition and inhibition. The structural scaffold should maintain the standard β-trefoil topology with anti-parallel β-sheets and short helical segments, ensuring proper presentation of the inhibitory loop for high-affinity binding to target serine proteases while maintaining structural stability through the conserved disulfide framework."}
{"description": "sp|L7XCU0|LATA_LATGE Alpha-latrotoxin-Lg1a (Fragment) OS=Latrodectus geometricus OX=156851 PE=1 SV=1", "sequence": "NEELTLEEKAEICSELELQQKYADIASNIIGDLSSLPMVGKIVGTIAAAAMTVAHVGSGRLDIEQTLLGCSDLPFDQIKEILETRFNEVDRKLESHSAALEEITKLVDKSISAVEKTRKQMNKRFDEVMKSIQDAKVSPIVSKINNFAKYFDAEKERVRGLKLNDYILKLEEPNGILLHFKDVRTPKDDSLQSPLFSIIQERYAIPKTVDDELAFKVLYAILYGTQTYVSVMFFLLEQYSFLANHYYEKGDLEKYDEYFNNLNNVFLDFKSSLVGSGASNNEGLIDNVLQVLMTVKSNEFLGLGKNSLEEMLNEKINLFSKIKEEIEGKQRMTLSETPENFARISFEKDITTPIGDWRDSREVRYAVQYASETLFSKIGHWSDPVSVRAKACPTLRMPVDQTRRNVLVFRKFDNSKPQLVGEITPYQSNFIDIDRDLYNAASNPDSAVGFMEFKKLISNGANIRAVFNQGRTVFHAAAKSGNDKIMIELTFFSKYTDINQPDKKGYTPIHVAADSGNAGIVNLLIRSGISVNSKTYNFLQTPLHLAAQRGFVATFQRLMESPEININERDKDGFTPLHYAVRGGERILEAFINQAGIDVNVKSDKGLTPFHLAVIKNDWPVASTLLRSKKIDINAIDENNMTALHYAAILGFLETTKQLINLKEINANAVSSPGLLSALHYAILYKHDDVALFLLKSSKVNYNLKAFGDITPLHLAVMQGRKQVLSEMFNIGININQKTAEKYTPLHLAAMSKYPELVEILLDQGSNLEAKTITGATPLNLATFKGKSQAALILLKDEVNWREPDENGQMPIHGAAMNGLLDVAQAILYLDATVLDIEDKNLDTPLNLAAQNSHIDMVKYFIDLGAKVNTRNKKGQAPLLAFSKKGNLDMVKYLFDKNANVYIADNDGLNFFYYAVRNGHLNIVKYAMSEKDKFEWSTTDNNRSDGCSGECAISHFAVCDAVQYDKIEIVKYFVGTLGHYSICSPLHQAARYGHIHIVKYLVEEEVLSVDGSKPDTPLCYASENGHLAVVQYLIRNGAKVNHDCANGMTAIDKAITKNQLQVVQILAENGVDFRRKNRLDATPFLTAVASNSYEIAEYLIREKRQNININEQNGNKETALHLAVYYKNLQMIKLLVKYGIDENIRNGYDKTALDIARDNKISSIVEYLQTKSGKFRREYKSSNGEHDLLHENRISNFTDSKNLEYQHQHFINADNDASQSFSNTAANQNIDVIGTLLLIDVLIRRFSKQGYINNKPDSASDGIAQAAALAITEKFEDILNSLHNKSTEEQVDFAEVHRKIYAALRSGRNSQVHQVLCSSLKSISTLKPEDIKKLVSVVLSFQSSISLPEVSASAREVYGETLHLFHES", "prompt": "Generate the complete protein sequence for an alpha-latrotoxin from the brown widow spider (Latrodectus geometricus), a potent neurotoxin that forms calcium-permeable pores in presynaptic membranes. This toxin should exhibit the characteristic structural organization of latrotoxins, featuring multiple domains including an N-terminal domain responsible for membrane insertion, central ankyrin-like repeats that mediate oligomerization into tetrameric complexes, and a C-terminal domain involved in receptor binding. The protein should contain conserved cysteine residues that form essential disulfide bridges stabilizing the tertiary structure, with the characteristic pattern found in latrotoxin family members. The mechanism of action involves binding to specific neuronal surface receptors such as neurexins and latrophilins, triggering massive neurotransmitter release through calcium-dependent and calcium-independent pathways. The structural scaffold should enable the formation of transmembrane pores that disrupt synaptic vesicle recycling, leading to exhaustive neurotransmitter depletion and paralysis. The toxin should possess the high molecular weight and complex domain architecture typical of latrotoxins, with specific structural motifs that facilitate its dual role as both a receptor-binding protein and a pore-forming toxin in vertebrate nervous systems."}
{"description": "sp|P0DJE4|LATA_LATMA Alpha-latrotoxin-Lm1a (Fragment) OS=Latrodectus mactans OX=6924 PE=1 SV=1", "sequence": "IVGTIAAAAMTVTHVASGRLNDYILKLEEPNGILLHFKAPLFSIIQEGYAVPKSSLVGTGTSNNEGLLDRNGVDEMLNEKYAVQYASETLFSKDLYNAASNPDSAVGFKLMESPEININERNDWPVASTLLRSSNVNVNLKNSDTPLNLAYFIDQGADINTRNGHLNIVKYLVEEEDLSVDGSKYGIDMTIRTALDIATDLK", "prompt": "Design a protein sequence for an alpha-latrotoxin from the venom of the black widow spider (Latrodectus mactans). This neurotoxin functions as a potent presynaptic excitatory toxin that triggers massive neurotransmitter release from nerve terminals. The protein should adopt the characteristic latrotoxin structural fold, featuring multiple domains including an N-terminal domain involved in membrane interaction, a central domain with receptor-binding capabilities, and a C-terminal domain that forms calcium-permeable pores in presynaptic membranes. The mechanism of action involves binding to specific neuronal surface receptors (such as neurexins and latrophilins), followed by insertion into the presynaptic membrane to form cation-selective channels. This leads to calcium influx, vesicle fusion, and exhaustive neurotransmitter release, ultimately causing synaptic blockade through transmitter depletion. The structural scaffold should include the conserved cysteine pattern typical of latrotoxins that stabilizes the multi-domain architecture through specific disulfide bridges. The generated sequence must exhibit the hallmark biological activity of inducing massive, calcium-dependent exocytosis at neuromuscular junctions and central synapses, characteristic of black widow spider venom neurotoxicity."}
{"description": "sp|Q1ZY03|PA2B_DEIAC Basic phospholipase A2 DAV-N6 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MRTLWIVAVLLVSVEGHLLQFNKMIKIMTRKNAFPFYTSYGCYCGWGGRGWPKDATDSCCFVHDCCYQKLTGCSPKWDIYPYSWKTGVIICGEGTPCEKEICECDRAAAVCLGENLRTYKTKYMFYPDFLCKKPSKQC", "prompt": "Design a basic phospholipase A2 toxin protein sequence inspired by the venom of Deinagkistrodon acutus (hundred-pace snake), a highly venomous pit viper species. This enzyme should function as a potent toxin with the characteristic catalytic activity of Group II secretory phospholipase A2 enzymes. The protein should exhibit calcium-dependent hydrolysis of the sn-2 acyl bond of glycerophospholipids, leading to membrane disruption, inflammation, and potential hemolytic activity. The structural scaffold should feature the conserved pancreatic-type phospholipase A2 fold with the characteristic calcium-binding loop (YGKYCG) and catalytic network (His-Asp dyad). Include the essential disulfide bridge pattern typical of snake venom phospholipases A2, with conserved cysteine residues forming the structural core. The protein should possess the basic isoelectric point characteristic of many viperid venom phospholipases A2, which contributes to its membrane-binding capabilities and toxic potency. The sequence should maintain the amphipathic character necessary for interfacial activation at lipid membranes while preserving the structural integrity required for catalytic function and stability in the venom environment."}
{"description": "sp|C0HJC4|KV53_BUNCI Kappa-actitoxin-Bcs4a OS=Bunodosoma caissarum OX=31165 PE=1 SV=1", "sequence": "GCKGKYEECTRDSDCCDEKNRSGRKLRCLTQCDEGGCLKYRQCLFYGGLQ", "prompt": "Design a novel animal toxin protein sequence based on the biological profile of kappa-actitoxin-Bcs4a from the sea anemone Bunodosoma caissarum. This toxin belongs to the sea anemone type 3 potassium channel toxin family and functions as a potent neurotoxin that selectively targets and inhibits voltage-gated potassium channels (Kv channels), particularly Kv1 subtypes. The toxin operates through a mechanism involving pore block or gating modification, leading to prolonged neuronal depolarization, enhanced neurotransmitter release, and disruption of neuromuscular signaling. Structurally, it adopts the inhibitor cysteine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key functional residues are located within the beta-hairpin loops, which form the molecular interface for high-affinity binding to the Kv channel pore region. The sequence should reflect the typical length of 35-45 amino acids, include the canonical cysteine framework, and incorporate conserved hydrophobic and polar residues critical for structural integrity and target interaction. The resulting protein should exhibit selective potassium channel blockade, contributing to the paralytic and neurotoxic effects characteristic of sea anemone venom."}
{"description": "sp|A8YPR9|SVMI1_CERCE Snake venom metalloprotease inhibitor 02A10 OS=Cerastes cerastes OX=8697 GN=Svmpi-Cce12 PE=1 SV=1", "sequence": "MSVSRLAASGLLLVSLLALALDGKPVEKWSPWLWPPRPRPPIPPLQQQKWLDPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWLNPPIPQQQKWLNPPIPQQQKWLNPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWLDPPIPQQQKWLDPPIPQQQKWLNPPIPQQQKWQRPLQPEVPSLMELHQERQKQGRMMHHDEDPGDAAEGPRRQKKEPGKPEGNGCFGKKIDRINAGFGCPKLPPSGGH", "prompt": "Design a snake venom metalloprotease inhibitor protein derived from the Saharan horned viper, Cerastes cerastes. This protein functions as a potent and specific inhibitor of snake venom metalloproteases (SVMPs), which are zinc-dependent proteolytic enzymes responsible for the hemorrhagic and tissue-damaging effects of viper venom. The inhibitor should employ a competitive inhibition mechanism, directly binding to the active site of SVMPs to block their proteolytic activity against extracellular matrix components such as collagen, fibronectin, and laminin. Structurally, this protein should adopt a compact, stable fold characteristic of endogenous metalloprotease inhibitors found in viper sera, likely featuring multiple disulfide bridges that confer protease resistance and thermodynamic stability. The binding interface should contain specific residues that coordinate with the catalytic zinc ion and interact with the substrate-binding cleft of target SVMPs, effectively mimicking substrate transition states or employing exosite interactions for high-affinity binding. This inhibitor represents an evolutionary adaptation in venomous snakes for self-protection against their own venom components and should exhibit high specificity for SVMPs over mammalian metalloproteases."}
{"description": "sp|P25660|VKT9_BUNFA Kunitz-type serine protease inhibitor IX OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "KNRPTFCNLLPETGRCNALIPAFYYNSHLHKCQKFNYGGCGGNANNFKTIDECQRTCAAKYGRSS", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the banded krait (Bungarus fasciatus). This toxin functions as a potent serine protease inhibitor that disrupts key physiological processes in prey through targeted protease inhibition. The protein should adopt the characteristic Kunitz-type fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three conserved disulfide bonds in the Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The active site should contain the canonical protease-binding loop with residues optimized for specific inhibition of trypsin-like serine proteases, likely targeting enzymes involved in blood coagulation, fibrinolysis, or neuropeptide processing. The structural scaffold should maintain the compact, globular domain typical of Kunitz inhibitors, with the reactive site loop positioned for optimal protease interaction while maintaining overall structural stability through the conserved disulfide framework."}
{"description": "sp|P81116|SLBB_TRIAB Snaclec alboaggregin-B subunit beta OS=Trimeresurus albolabris OX=8765 PE=1 SV=2", "sequence": "MGRFIFGSFGLLVLFLSLSGTGADCPSDWSSYDLYCYKVFQQRMNWEDAEQFCRQQHTGSHLLSFHSSEEVDFVVSKTLPILKADFVWIGLTDVWSACRLQWSDGTELKYNAWTAESECIASKTTDNQWWTRSCSRTYPFVCKLEV", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the white-lipped pit viper (Trimeresurus albolabris). This protein should function as the beta subunit of the snaclec (snake C-type lectin) complex alboaggregin-B, which plays a critical role in the viper's venom by targeting platelet aggregation pathways. The protein should act as a platelet agonist by binding specifically to the platelet receptor GPIb, part of the GPIb-IX-V complex, thereby initiating platelet activation and aggregation through von Willebrand factor-independent mechanisms. The sequence should feature the characteristic C-type lectin-like domain (CTLD) fold, stabilized by two conserved disulfide bridges with a typical C1-C2, C3-C4 connectivity pattern. The structural scaffold should include the conserved calcium-binding site and the specific loop regions responsible for receptor recognition and binding. The protein should form a heterodimeric complex with the alpha subunit, with the interface stabilized by hydrophobic interactions and additional disulfide bonds between subunits. The overall structure should be compact and globular, typical of snake venom C-type lectins, with the functional epitopes positioned to facilitate high-affinity binding to GPIb and subsequent platelet activation."}
{"description": "sp|E4VP04|KAXU3_MESEU Potassium channel toxin MeuTXKalpha3 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MKNYCGIITLFLAIISATGVFCVDFPNKGGKCDRKECRKTCKKLNYRGKCFPNYCRCFPG", "prompt": "Design a novel potassium channel toxin protein inspired by the venom arsenal of the scorpion Mesobuthus eupeus. This toxin should function as a potent and selective modulator of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the canonical cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a conserved core of an alpha-helix packed against a three-stranded anti-parallel beta-sheet. The cysteine framework should follow the typical pattern (C-C-CC-C-C) with three disulfide bridges that stabilize this compact, globular architecture. Key functional residues should be positioned within the functional surface, often involving a critical lysine or arginine in the beta-sheet region, to facilitate specific interactions with the pore region or voltage-sensing domain of the target potassium channel. The toxin should exhibit high affinity binding to block potassium efflux, leading to prolonged membrane depolarization, increased neurotransmitter release, and ultimately, paralysis or neuroexcitatory effects in prey organisms. Ensure the sequence reflects the evolutionary optimization for rapid action and target specificity seen in scorpion venom peptides."}
{"description": "sp|P43318|PA2_RHONO Toxic phospholipase A2 (Fragment) OS=Rhopilema nomadica OX=42738 PE=1 SV=1", "sequence": "GLIKPGTLWCGMGNNAETYDQLGPFADVDSCK", "prompt": "Design a toxic phospholipase A2 protein fragment derived from the venom of Rhopilema nomadica, a jellyfish species known for its potent venom that causes severe envenomation effects including hemolytic activity, cytotoxicity, and potential neurotoxicity. This enzyme should function as a calcium-dependent hydrolase that specifically cleaves the sn-2 acyl bond of glycerophospholipids, generating lysophospholipids and free fatty acids. The mechanism involves attacking cell membranes to induce membrane disruption, inflammation through eicosanoid production, and potentially contributing to hemolysis. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of disulfide bridges, with the catalytic site containing a conserved His-Asp dyad and calcium-binding loop. Key structural elements include the N-terminal helix, the calcium-binding loop with conserved glycine residues, and the active site pocket with hydrophobic residues for substrate binding. The protein should exhibit the typical PLA2 enzymatic activity with specificity for phospholipid substrates while maintaining the structural stability conferred by the disulfide bond pattern common to toxic PLA2 enzymes from cnidarian venoms."}
{"description": "sp|C0HJD7|3L24_DENPO Alpha-elapitoxin-Dpp2d OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "RTCNKTFSDQSKICPPGENICYTKTWCDAFCSQRGKRVELGCAATCPKVKAGVEIKCCSTDNCNKFQFGKPR", "prompt": "Design a novel alpha-elapitoxin venom peptide derived from the black mamba (Dendroaspis polylepis) that functions as a potent postsynaptic neurotoxin. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet scaffold stabilized by four conserved disulfide bridges with a C1-C5, C2-C3, C4-C6, C7-C8 connectivity pattern. The toxin must specifically target and antagonize nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, competitively inhibiting acetylcholine binding to induce flaccid paralysis. Incorporate key functional residues in the central loop II that mediate high-affinity interaction with the receptor's orthosteric site, while maintaining the conserved hydrophobic core and the three β-stranded finger-like extensions typical of the 3FTx fold. The sequence should exhibit the characteristic signal peptide cleavage pattern and post-translational processing of elapid venom toxins, resulting in a mature peptide of approximately 60-75 amino acids with appropriate isoelectric point and molecular weight for efficient venom delivery and target engagement."}
{"description": "sp|Q719L9|SL1_CRODU Snaclec crotocetin-1 OS=Crotalus durissus terrificus OX=8732 PE=2 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADFDCPSGWSAYDQYCYRVIKQLKTWEDAEWFCTKQAKGAHLVSVESAGEADFVAQLVAENIKQNKYYVWIGLRIQNKGQQCSTKWSDGSSVNYENLLKSYSKKCFGLKKETEFLQWYNTDCEEKNLFVCKFPPQR", "prompt": "Design a novel protein sequence for a C-type lectin-like protein (snaclec) derived from the venom of the South American rattlesnake, Crotalus durissus terrificus. This toxin, known as crotocetin-1, functions as a platelet aggregation modulator, specifically targeting and binding to platelet membrane receptors such as GPIb or GPVI through its carbohydrate recognition domain (CRD). The protein should adopt the characteristic snaclec fold, featuring a compact globular structure stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that form the cysteine framework typical of snake venom C-type lectins. The sequence must include key residues for calcium-dependent carbohydrate binding and receptor recognition, ensuring high specificity for platelet glycoproteins. The structural scaffold should maintain the β-sheet-rich architecture with loops critical for target interaction, enabling its role in disrupting hemostasis by either inhibiting or promoting platelet aggregation, depending on the receptor engagement. The biological significance lies in its contribution to the venom's precoagulant or anticoagulant effects, facilitating prey immobilization through interference with blood coagulation pathways."}
{"description": "sp|P81478|PA2A2_CRAGM Acidic phospholipase A2 2 OS=Craspedocephalus gramineus OX=8767 PE=1 SV=1", "sequence": "NLLQFENMIRNVAGRSGIWWYSDYGCYCGKGGHGRPQDASDRCCFVHDCCYGKVNGCNPKKAVYIYSLENGDIVCGGDDPCRKEVCECDKAAAICFRDNKDTYDNKYWNIPSENCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the green pit viper, Craspedocephalus gramineus. This enzyme should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting disruption of membrane integrity and generation of inflammatory mediators should contribute to the venom's hemotoxic, myotoxic, and pro-inflammatory effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by multiple disulfide bridges in a conserved pattern typical of group II phospholipase A2 enzymes. Key functional residues should include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, with aspartate serving as the catalytic base. The acidic nature of this isoform should be reflected in its amino acid composition, potentially influencing its membrane interaction properties and biological potency. The structural scaffold should enable specific interaction with biological membranes and potentially with protein targets that modulate its activity or tissue specificity."}
{"description": "sp|Q9NDA6|COW3_CONTE Leu-contryphan-Tx OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MGKLTILVLVAAVLLSAQVMVQGDGDQPADRKAVPREDNPGGASGKLMDVLRPKKCVLYPWCG", "prompt": "Design a novel animal toxin protein sequence inspired by the biological characteristics of Leu-contryphan-Tx from the marine cone snail Conus textile. This toxin belongs to the contryphan family, which are small, cyclic peptides known for their unique post-translational modifications and potent neuroactive properties. The protein should function as a selective modulator of voltage-gated calcium channels, specifically targeting neuronal subtypes to disrupt synaptic transmission and induce paralysis in prey. The structural scaffold must feature a compact, cyclic conformation stabilized by a single disulfide bridge between two conserved cysteine residues, forming a rigid backbone that enhances proteolytic stability and target specificity. Key structural elements should include a type I beta-turn motif and a conserved tryptophan residue critical for receptor interaction. The sequence must incorporate a D-amino acid at a specific position, a hallmark of contryphans that confers resistance to enzymatic degradation and influences chiral recognition of ion channels. The overall fold should exhibit a globular, constrained architecture with exposed hydrophobic patches for membrane penetration and a defined electrostatic surface for precise channel binding. The toxin's mechanism should involve allosteric inhibition of calcium influx, leading to impaired neurotransmitter release and neuromuscular blockade, reflecting the predatory ecology of Conus textile venom."}
{"description": "sp|P45639|CTXL_LEIQU Chlorotoxin OS=Leiurus quinquestriatus quinquestriatus OX=6885 PE=1 SV=1", "sequence": "MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR", "prompt": "Design a mature animal toxin protein sequence derived from the venom of the deathstalker scorpion, Leiurus quinquestriatus. This toxin should function as a highly selective chloride channel blocker, specifically targeting glioma-associated chloride channels and small-conductance chloride channels in neuronal tissues. The protein should adopt a compact, stable structure stabilized by four conserved disulfide bonds with a cysteine framework pattern of C-C-CC-C-C-C-C-C, characteristic of the short scorpion toxin family. The structural fold should feature a conserved alpha-helix and anti-parallel beta-sheet arrangement typical of scorpion neurotoxins, creating a molecular surface optimized for high-affinity binding to chloride channel pores. The mechanism of action involves pore blockade that disrupts chloride ion flux, leading to altered cell volume regulation and membrane potential in target cells, which is particularly effective against glioma cells. The toxin should exhibit high stability and specificity, with molecular recognition elements positioned to interact with extracellular loops of the target chloride channels while avoiding off-target effects on other ion channel types."}
{"description": "sp|P0DI90|OXLA2_DABRR L-amino-acid oxidase L2 (Fragment) OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "ADDKNPLEECFCEDDDYCEG", "prompt": "Design a protein sequence for a snake venom L-amino-acid oxidase from Russell's viper (Daboia russelii). This enzyme represents a key component of viperid venom that contributes to prey immobilization through multiple toxic mechanisms. The protein should function as a flavin adenine dinucleotide (FAD)-dependent oxidase that catalyzes the oxidative deamination of L-amino acids, particularly hydrophobic residues like L-phenylalanine and L-leucine, generating hydrogen peroxide, ammonia, and the corresponding α-keto acid as reaction products. The generated hydrogen peroxide induces oxidative stress in prey tissues, leading to cytotoxicity, platelet aggregation inhibition, and hemorrhage potentiation. The protein should adopt the characteristic L-amino-acid oxidase fold with two domains: a FAD-binding domain featuring a Rossmann fold motif and a substrate-binding domain. Include conserved catalytic residues for FAD cofactor binding and substrate recognition. The sequence should maintain the characteristic dimeric quaternary structure observed in snake venom LAOOs, with the active site positioned at the dimer interface. The protein should exhibit the typical glycosylation pattern and demonstrate optimal activity at slightly alkaline pH conditions, consistent with its role in envenomation. The structural scaffold should enable efficient substrate access to the FAD cofactor while maintaining stability in the venom environment."}
{"description": "sp|Q1PS45|VM3AK_DEIAC Zinc metalloproteinase-disintegrin-like agkihagin OS=Deinagkistrodon acutus OX=36307 PE=2 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPEGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADLTASISACNGLKGHFMLQGEMYLIEPLKLSDSEAHAVFKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQSNLTPEQQRYLNAPKFVKLFLVADNIMYLKYGRSLTNVRTRMYDMANILNLIFRRMNIHVAVTDLEIWSDKDKIIVQPSADDTLKSFATWRESVLLKHKSHDNAQLLTGINFNGPTAGLAYLGGICDPMYSTAIVQDHNKIHHLVAIAMAHEMGHNLGIDHDKDTCTCAAKSCVMAGTLSCEASYLFSDCSRKEHRAFLIKNMPQCILKKPSKTDVVSPPVCGNYFVEMGEDCDCGSPATCRDPCCDAATCKLKQGAQCAEGLCCDQCRFKGAGTQCRAAMDECDMADLCTGQSADCTDRFQKNGQPCQNNNGYCYNGTCPTMIKQCTVFFGSNAAVSQDACFQFNLQGNNYGYCRKEQNTKIACEPQNVKCGRLYCTSPEKQNPCNIYYSPSNEDKGMVLPGTKCADGKACSNGQCVDVTTPY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin, characteristic of the venom from Deinagkistrodon acutus (the hundred-pace snake). This protein should exhibit the dual functional domains typical of snake venom metalloproteinases (SVMPs): a metalloproteinase domain containing the conserved zinc-binding motif (HEXXHXXGXXH) that facilitates proteolytic cleavage of extracellular matrix components, and a disintegrin-like domain that mimics the structure of endogenous disintegrins to inhibit platelet aggregation by blocking integrin receptors such as αIIbβ3 on platelets. The protein should adopt a multi-domain architecture, likely with a pro-domain that is cleaved upon activation, and feature the characteristic cysteine-rich regions that form disulfide bonds to stabilize the disintegrin-like fold. The metalloproteinase domain should target proteins like collagen, von Willebrand factor, or other haemostatic components, contributing to haemorrhagic effects, while the disintegrin-like domain should specifically interfere with cell-matrix interactions, promoting anticoagulant and antiplatelet activities. The overall structure should reflect the modular design of SVMPs, with defined secondary structures and tertiary folds that enable its role in prey immobilization through disruption of haemostasis and tissue integrity."}
{"description": "sp|C0HJA8|CA1LB_CONRE Alpha-conotoxin-like RgIB OS=Conus regius OX=101314 PE=1 SV=1", "sequence": "TWEECCKNPGCRNNHVDRCRGQV", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus regius, a marine cone snail species. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha9/alpha10 subtype. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where disulfide bridges connect Cys1-Cys3 and Cys2-Cys4. The structure should display the typical alpha-conotoxin pharmacophore with well-defined alpha-helical and beta-turn elements that create a precise binding interface for the receptor. Key structural elements should include a conserved helical region in the first loop and a receptor-binding motif in the second loop that enables selective interaction with the alpha9/alpha10 nAChR subunit interface. The toxin should exhibit high affinity and specificity for blocking neuronal signaling through this receptor subtype, contributing to the venom's paralytic effects on prey by disrupting cholinergic neurotransmission. The sequence should maintain the characteristic compact, stable structure typical of conotoxins, with appropriate length and residue composition for proper folding and biological activity."}
{"description": "sp|P0CE29|CXAT4_CONMS Alpha-conotoxin-like Ms20.4 OS=Conus mustelinus OX=101309 PE=1 SV=1", "sequence": "MPKLAVVLLVLLILPLSYFDVAGGQAAEGDRRGNGLARYPQRGGRDNEAECQINTPGSSWGKCCMTRMCGTMCCARSGCTCVYHWRRGHGCSCPG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus mustelinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements for nAChR binding, including key residues in the inter-cysteine loops that mediate specific receptor subtype recognition and blockade. The mature toxin should be approximately 12-20 amino acids in length, with the N-terminal region contributing to receptor binding affinity and the central loop regions determining receptor subtype selectivity. The structural motif should exhibit the typical alpha-conotoxin fold characterized by beta-turn elements and a well-defined binding interface that competitively inhibits acetylcholine binding at the receptor's orthosteric site. The toxin should demonstrate high potency and specificity for its target nAChR subtypes, consistent with the pharmacological profile of alpha-conotoxins from marine cone snails that evolved to rapidly immobilize prey through neuromuscular disruption."}
{"description": "sp|P26324|VSPF1_CALRH Thrombin-like enzyme ancrod OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "VIGGDECNINEHRFLVAVYEGTNWTFICGGVLIHPEWVITAEHCARRRMNLVFGMHRKSEKFDDEQERYPKKRYFIRCNKTRTSWDEDIMLIRLNKPVNNSEHIAPLSLPSNPPIVGSDCRVMGWGSINRRIDVLSDEPRCANINLHNFTMCHGLFRKMPKKGRVLCAGDLRGRRDSCNSDSGGPLICNEELHGIVARGPNPCAQPNKPALYTSIYDYRDWVNNVIAGNATCSP", "prompt": "Design a thrombin-like serine protease enzyme from the venom of Calloselasma rhodostoma (Malayan pit viper), known as ancrod. This enzyme functions as a key defibrinogenating agent in the venom, specifically cleaving fibrinogen to produce soluble fibrin monomers that are rapidly cleared from circulation, leading to anticoagulant effects and promoting hemorrhage. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and exhibit substrate specificity for fibrinogen's Aα-chain, preferentially releasing fibrinopeptide A. It should feature the typical disulfide bond pattern of snake venom serine proteases, including conserved cysteine residues that stabilize the dual-barrel structure. The enzyme should demonstrate optimal activity at physiological pH and temperature, with structural adaptations for venom gland storage and efficient delivery upon envenomation. The generated sequence must maintain functional integrity for fibrinogen cleavage while excluding any plasmin-like or thrombin-like activities toward other coagulation factors to ensure specificity."}
{"description": "sp|Q9IAY4|VM1H4_DEIAC Snake venom metalloproteinase H4 (Fragment) OS=Deinagkistrodon acutus OX=36307 PE=2 SV=1", "sequence": "FPYQGSSIMLESGKVNDYEVVYPRKVTALPKGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEGHCYYRGHIRNDADSTASISACNGLKGHFKIQGETYFIESLKLSDSEAHAVFKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEFQRYMEIVIVVDHSMYTKYKGDSDKIKAWVYEMINTISESYRYLYIDIIVSALEMWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDFDGPTIGLAYVASMCDPKRSVGVVQDHSSVNHLVAITLAHEIAHNLGVHHDEGSCSCGSGYTCIMSPVINSEVIKYFLDSK", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that embodies the key structural and functional characteristics of toxins from Deinagkistrodon acutus (hundred-pace snake). This SVMP should function as a potent hemorrhagic toxin, targeting and degrading components of the basement membrane and extracellular matrix to disrupt vascular integrity. The protein must contain the canonical metalloproteinase catalytic domain with the conserved zinc-binding motif HEXXHXXGXXH, which coordinates the catalytic zinc ion essential for proteolytic activity. Include the characteristic metzincin signature sequence downstream of the active site. The sequence should feature multiple disulfide bonds typical of SVMPs to stabilize the protein fold, with conserved cysteine patterns that maintain structural integrity in the venom environment. The protein should exhibit substrate specificity for key extracellular matrix components such as type IV collagen, laminin, and fibronectin. Incorporate any additional domains commonly found in hemorrhagic SVMPs that may contribute to target recognition or potentiate hemorrhagic activity. The overall structure should facilitate efficient proteolytic cleavage of vascular basement membrane components, leading to the characteristic hemorrhagic pathology associated with Deinagkistrodon acutus envenomation."}
{"description": "sp|Q6RY98|SRTXL_ATRMM Long-sarafotoxin (Fragment) OS=Atractaspis microlepidota microlepidota OX=172021 PE=1 SV=1", "sequence": "IWDEPVVVSARDTEEAARVPSPQKRSQPLCSCNDINDKECMYFCHQDVIWDEPVVVSVRDTEEAARVPSPQKRPQPRCSCNDMNDKECMYFCHQDVIWDEPVVVSVRDTEEAARVPSPQKRSQPRCSCNDMNDKECVYFCHLDIIWDEPVVVSVRDTEEATRVPSPQKRSQPLCSCNDINDKECMYFCHQDIIWDEPVVVSVRDTEEAARVPSPQKRSQPLCSCNDINDKECMYFCHQDIIWDEPVVVSVRDTEEAARVPSPQKRSQPLCSCNDINDKECMYFCHQDVIWDEPVVVSVQDTEEAARVPSPQKRSQPLCSCNNMSDKECLNFCNLDIIWENVDTSADPEFLG", "prompt": "Design a protein sequence for a long-sarafotoxin, a potent endothelin-like peptide toxin derived from the venom of Atractaspis microlepidota microlepidota (small-scaled burrowing asp). This toxin functions as a highly selective and potent agonist of endothelin receptors, particularly the ET_B receptor subtype, mimicking the physiological effects of endogenous endothelins but with enhanced potency and duration of action. The mechanism involves binding to and activating endothelin receptors, leading to sustained vasoconstriction, increased blood pressure, and potential cardiotoxic effects, which contribute to the venom's lethality by causing severe hypertension and ischemic damage. Structurally, long-sarafotoxin is characterized by a compact, disulfide-rich scaffold stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4), forming a cysteine-stabilized alpha-helical (CSH) motif that confers stability and receptor-binding specificity. The protein adopts a globular fold with a central alpha-helix critical for interacting with the endothelin receptor binding pocket, facilitated by key hydrophobic and charged residues in the C-terminal region. The molecular target is the endothelin receptor, with high affinity for ET_B, where the toxin binds via a surface-exposed loop and helical domain, engaging in hydrophobic interactions and hydrogen bonding to induce receptor activation. Ensure the sequence reflects these structural features, including the conserved disulfide pattern, alpha-helical propensity, and residues essential for receptor agonism, to replicate the toxin's potent vasoconstrictive activity."}
{"description": "sp|Q6SLM1|PA2B5_BUNCE Basic phospholipase A2 2 (Fragment) OS=Bungarus caeruleus OX=132961 PE=1 SV=1", "sequence": "LVAVCVSLLGAANIPPQPLNLKQFKNMIQCAGTRTWTSYIGYGCYCGYGGSGTPVDELDRCCYTHDHCYNKAANIPGCNPLIKTYSYTCTKPNITCNDTSDSCARFICDCDRTAAICFASAPYNINNIMISASTSCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the common krait, Bungarus caeruleus. This enzyme should function as a potent presynaptic neurotoxin, targeting neuromuscular junctions to induce irreversible blockade of acetylcholine release, leading to flaccid paralysis. The protein must adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG) and a catalytic network centered on histidine and aspartate residues essential for hydrolyzing the sn-2 ester bond of glycerophospholipids. Incorporate the canonical disulfide bridge pattern (typically 6-7 disulfides, e.g., Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, and Cys84-Cys96 in full-length homologs) to stabilize the globular, multi-helical structure. Ensure the sequence includes a basic patch (enriched in lysine/arginine) to facilitate membrane penetration and enhance toxicity. The toxin should exhibit high specificity for neuronal membranes, contributing to the venom's lethality by disrupting synaptic transmission."}
{"description": "sp|M5BGS2|DID_ATHSQ Disintegrin DS-AS OS=Atheris squamigera OX=110225 PE=1 SV=1", "sequence": "MIQVLLVIICLAVFPYQGSCIILESGNVNDYEIVYPKKLIVLPTGAMNSPHPCCDPVTCKPKKGEHCISGPCCRNCKFINSGTICKRARGDDMNDYCTGTTPDCPRNPYKD", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Atheris squamigera, the variable bush viper. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The disintegrin must contain the canonical RGD (Arg-Gly-Asp) tripeptide motif within an extended, flexible loop region that serves as the primary integrin-binding interface. The structural scaffold should feature a compact, disulfide-rich fold stabilized by multiple conserved cysteine residues forming a characteristic disintegrin cysteine pattern, typically with 6-8 cystines creating a rigid core that presents the RGD motif in an optimal conformation for high-affinity integrin recognition. The protein should adopt a small, globular architecture that confers resistance to proteolytic degradation while maintaining specificity for αIIbβ3 integrin on platelets to prevent thrombus formation, with potential cross-reactivity to other RGD-sensitive integrins like αvβ3 involved in cell adhesion and migration processes. The sequence must reflect the evolutionary optimization of viperid venoms for rapid disruption of hemostatic pathways through precise molecular interference with cell-matrix interactions."}
{"description": "sp|J3SBP9|VM28_CROAD Zinc metalloproteinase-disintegrin 8 OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAAQPKYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEASKMCGVTETNWESYEPIKKASQLNLPPEQQRFPQTYIELVVVADHRMYTKYDGDKTEISSIIYEIVNTLTQIFRPLHIRVALIGLEIWSSGELSKVTLSADDTLEAFGEWRETVLMNRKRHDNAQLLTGMIFNETIEGRTYKSGMCNPKHSVGIVRDYRTRRHFVANRMAHELGHNLGIDHDRDSCTCGANSCIMSATVSNEPSSQFSDCSLNKYLNYIVRYQSTTRCLHNEPSETDIVSPPFCGNYFKEVGEDCDCGPPANCQNPCCDAATCKLTTGSQCAEGLCCDQCKFTKKGTACRPARGDWNDDTCTGQSADCPRNGLYG", "prompt": "Design a zinc metalloproteinase-disintegrin toxin from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a key hemorrhagic agent. This toxin should contain two distinct functional domains: a metalloproteinase domain and a disintegrin domain. The metalloproteinase domain must feature a conserved HEXXHXXGXXH zinc-binding motif that coordinates a catalytic zinc ion, enabling proteolytic cleavage of extracellular matrix components such as collagen, laminin, and fibronectin. This domain should adopt a globular metzincin fold with a central five-stranded beta-sheet flanked by alpha-helices. The disintegrin domain should contain an RGD (Arg-Gly-Asp) tripeptide motif that specifically binds to integrin receptors on platelets (e.g., αIIbβ3) and endothelial cells, inhibiting platelet aggregation and disrupting cell-matrix interactions. The overall structure should be stabilized by multiple disulfide bonds, with the disintegrin domain typically containing four conserved disulfide bridges that form a compact, stable fold. The toxin should work synergistically: the metalloproteinase domain degrades basement membranes and vascular integrity, while the disintegrin domain prevents platelet plug formation and interferes with endothelial cell adhesion, collectively promoting severe hemorrhage and tissue damage characteristic of viperid envenomation."}
{"description": "sp|P0DL25|SCXU_TITPA Putative beta-neurotoxin (Fragment) OS=Tityus pachyurus OX=288781 PE=1 SV=1", "sequence": "GGKEGYPLNSSNGCKSGRFAGTNSNENTECKGXDAENGY", "prompt": "Design a protein sequence for a beta-neurotoxin from the venom of the scorpion Tityus pachyurus. This toxin should function as a voltage-gated sodium channel (Nav) modulator, specifically targeting and binding to site 4 of these channels to delay inactivation and prolong action potentials, leading to sustained neurotransmitter release and neurotoxic effects. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion beta-neurotoxins, with a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in long-chain scorpion toxins) that stabilizes the core alpha-helix and beta-sheet regions. Key functional domains should include the conserved 'pharmacophore' region responsible for receptor binding specificity, particularly residues involved in recognizing and interacting with the voltage-sensing domain of Nav channels. The toxin should exhibit high affinity for mammalian neuronal sodium channels, contributing to the venom's role in prey immobilization through disruption of normal neuronal signaling. Ensure the sequence maintains the compact, globular architecture stabilized by disulfide bonds that confers resistance to proteolytic degradation and thermal stability, typical of scorpion venom peptides."}
{"description": "sp|P0CAS8|PA2H1_MICPY Phospholipase A2 homolog A1 (Fragment) OS=Micrurus pyrrhocryptus OX=129468 PE=1 SV=1", "sequence": "NFKQIIKMIQCTNTRPWXNFLDYGCY", "prompt": "Design a protein sequence for a phospholipase A2 homolog from the venom of the Argentinian coral snake, Micrurus pyrrhocryptus. This protein belongs to the phospholipase A2 (PLA2) superfamily but functions as a toxin homolog, meaning it has lost catalytic activity while retaining structural integrity and potentially gaining novel toxic functions. The protein should adopt the characteristic PLA2 fold: a conserved three-finger scaffold stabilized by multiple disulfide bonds, typically with a cysteine framework pattern of C-C-C-C-C-C. The structure should feature a central beta-sheet core flanked by two alpha-helices, forming a compact, globular domain. As a homolog, it lacks the canonical calcium-binding loop and catalytic histidine-aspartate dyad required for phospholipid hydrolysis. Instead, it may exert toxicity through alternative mechanisms, such as membrane disruption, receptor binding, or allosteric modulation of ion channels. The biological significance lies in its role in the venom arsenal of coral snakes, contributing to prey immobilization via potential presynaptic or postsynaptic targeting, leading to neuromuscular blockade. The sequence should reflect conserved PLA2 family motifs while incorporating substitutions that ablate enzymatic activity, emphasizing structural stability and potential protein-protein interaction surfaces for toxic function."}
{"description": "sp|P62903|COW_CONMR Glacontryphan-M OS=Conus marmoreus OX=42752 PE=1 SV=1", "sequence": "MGKLTILVLVAAVLLSTQVMVQGDRDQPADRNAVPRDDNPGRARRKRMKVLNESECPWHPWCG", "prompt": "Design a novel protein sequence for a conotoxin derived from the venom of the marine cone snail Conus marmoreus, specifically belonging to the contryphan family. This toxin should exhibit the characteristic biological activity of contryphans, which function as modulators of voltage-gated calcium channels (VGCCs) and potentially other ion channels, contributing to the predatory and defensive strategies of the snail by disrupting neuromuscular signaling in prey. The protein must adopt a compact, disulfide-rich structural scaffold typical of contryphans, featuring a conserved cysteine framework with a specific pattern of disulfide bridges that stabilize a constrained loop conformation. Key structural elements should include a high proportion of post-translationally modified residues, such as D-tryptophan and hydroxyproline, which are critical for receptor interaction and metabolic stability. The molecular target interface should involve specific binding to VGCC subtypes, with the constrained loop region mediating key interactions. Ensure the sequence reflects the small size and high stability of contryphans, optimized for precise ion channel modulation without database identifiers or accession numbers."}
{"description": "sp|Q6T6T5|VKT1_BITGA Kunitz-type serine protease inhibitor bitisilin-1 OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSGKNRPEFCNLPADTGPCKAYEPRFYYDSVSKECQKFTYGGCKGNSNNFESMDECRKTCVASATRRPT", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the Gaboon viper (Bitis gabonica), known as bitisilin-1. This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, such as factor Xa or plasma kallikrein, thereby disrupting hemostasis and promoting prey immobilization through hemorrhage. The protein should adopt the characteristic Kunitz domain fold, featuring a stable alpha-beta structure with a central antiparallel beta-sheet and two short alpha-helices. It must contain the conserved disulfide bridge pattern typical of Kunitz inhibitors, with three disulfide bonds forming a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity that stabilizes the compact globular structure. The reactive site loop should present the canonical protease-binding motif with specific residues optimized for high-affinity interaction with the target serine protease's active site. The sequence should maintain the essential functional residues for protease inhibition while preserving the structural integrity required for venom stability and efficacy."}
{"description": "sp|C0HLF0|PA2_POROP Basic phospholipase A2 OS=Porthidium ophryomegas OX=44717 PE=1 SV=1", "sequence": "NLFQFRKMIKKMTKKEPVVYYAFYGCYCGKGGRGKPKDATDRCCFVHDCCYEKVTGCNPKWGYYTYSMNKQIVCGGDDPCKKQVCECDKAAAICFRDNLKTYKKKYMSFPNFFCTDPSEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the hognosed pitviper, Porthidium ophryomegas. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements should include the conserved calcium-binding loop (essential for catalytic activity), the interfacial binding surface for membrane association, and the catalytic histidine-aspartate dyad. The basic nature of this toxin suggests potential myotoxic and/or anticoagulant properties, possibly through mechanisms involving membrane disruption, inhibition of coagulation factors, or induction of inflammatory responses. The sequence should maintain the canonical phospholipase A2 cysteine framework with the appropriate disulfide connectivity to ensure proper folding and enzymatic activity."}
{"description": "sp|P0DJE5|LITA_LATHA Alpha-latroinsectotoxin-Lh1a (Fragment) OS=Latrodectus hasselti OX=256736 PE=1 SV=1", "sequence": "LVIETIENIATKLSISISFKTDVTQTLIDITEIDLNAQDKILIRNTNAVINIKSKVGLTPLHLATLQNNLSVSKGAYLNDGDANGMTPLHYAAMTGNLEMVDFLKWTPLHLAILFKQLVIELLAKTFFDLAIENGRLNIVAFAVEKYIAAR", "prompt": "Design a protein sequence for an alpha-latroinsectotoxin from the Australian redback spider (Latrodectus hasselti), a highly potent insect-specific neurotoxin. This toxin functions by forming cation-permeable pores in insect neuronal membranes, leading to massive neurotransmitter release and rapid paralysis. The protein should adopt the latrotoxin structural scaffold characterized by a large multi-domain architecture with extensive beta-sheet content and conserved cysteine residues that form specific disulfide bridges stabilizing the pore-forming domain. The sequence must include the conserved ankyrin-like repeats that mediate membrane insertion and pore formation, along with the receptor-binding domains that target insect-specific neuronal receptors. The toxin should exhibit high specificity for insect voltage-gated calcium channels and glutamate receptors while showing minimal activity against mammalian neuronal targets. The structural fold should enable oligomerization to form the functional pore complex in insect presynaptic membranes, causing irreversible depolarization and synaptic vesicle depletion."}
{"description": "sp|P0DI91|OXLA_NAJOX L-amino-acid oxidase (Fragment) OS=Naja oxiana OX=8657 PE=1 SV=1", "sequence": "DDRRSPLEECFQQNDYEEFLEIARNSQLYQESLREDSSYHLSFIESLKSDALFSYEKKFWEADGIHGGKVINDLSLIHDLPKREIQALCYPSIKK", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase from the Central Asian cobra (Naja oxiana). This enzyme represents a key component of elapid snake venom, functioning as a flavoenzyme that catalyzes the oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The generated hydrogen peroxide contributes to the toxin's cytotoxic, platelet aggregation inhibitory, and edema-inducing effects through oxidative stress mechanisms. The protein should adopt the characteristic homodimeric structure typical of snake venom L-amino-acid oxidases, with each monomer containing a conserved FAD-binding domain featuring a Rossmann fold and a substrate-binding domain. Critical structural elements include the conserved glycine-rich nucleotide-binding motif (GXGXXG) for FAD cofactor binding, the active site residues responsible for substrate specificity toward hydrophobic L-amino acids (particularly L-phenylalanine and L-leucine), and the characteristic N-glycosylation sites that contribute to protein stability and biological activity. The enzyme should exhibit the distinctive yellow coloration due to non-covalently bound FAD cofactor and maintain the proper quaternary structure essential for catalytic efficiency and stability in the venom environment."}
{"description": "sp|C0HJN0|KAX6V_HETLA Potassium channel toxin alpha-KTx 6 hetlaxin OS=Heterometrus laoticus OX=217256 PE=1 SV=2", "sequence": "ISCTGSKQCYDPCKKKTGCPNAKCMNKSCXCYGC", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Heterometrus laoticus, the Indo-Chinese forest scorpion. This toxin should function as a potent and selective blocker of voltage-gated potassium channels (Kv channels), specifically targeting the Kv1 subfamily, which is crucial for modulating neuronal excitability and neurotransmitter release. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should feature a short alpha-helix packed against an antiparallel beta-sheet, forming a compact globular architecture that presents key functional residues in the beta-sheet and loop regions for high-affinity binding to the channel's pore domain. The molecular mechanism involves occlusion of the potassium conduction pathway by inserting a critical lysine or aromatic residue into the selectivity filter, thereby inhibiting potassium ion flux and causing hyperexcitability in target cells. Ensure the sequence includes the signature alpha-KTx functional motifs for channel recognition and blockade, while maintaining the structural integrity required for venom stability and efficacy."}
{"description": "sp|P60263|SCX24_TITDI Toxin TdII-4 (Fragment) OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "KDGYLMEPNGCKLGCLTRPAKYCWXEE", "prompt": "Design a venom-derived peptide toxin from the scorpion Tityus discrepans that functions as a potent sodium channel modulator. This toxin belongs to the beta-toxin family and specifically targets voltage-gated sodium channels, causing a hyperpolarizing shift in the activation voltage and prolonging channel opening. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by four disulfide bridges with the characteristic C-C-CC-C-C connectivity pattern. The structural core consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a molecular surface with distinct functional regions for receptor recognition and modulation. The toxin should exhibit high affinity binding to site 4 of voltage-gated sodium channels, particularly affecting neuronal subtypes, leading to prolonged action potentials and enhanced neurotransmitter release. The molecular mechanism involves allosteric modulation that traps the voltage sensor in its activated state, resulting in sustained neuronal excitation and potential neurotoxic effects. The protein should display the characteristic pharmacological profile of beta-scorpion toxins, with specific interactions mediated by conserved hydrophobic residues and key charged residues that form complementary electrostatic interactions with the sodium channel voltage-sensing domain."}
{"description": "sp|K4RNX9|CA1B_CONTE Alpha-conotoxin TxIB (Fragment) OS=Conus textile OX=6494 PE=3 SV=1", "sequence": "FDGRNTSANNKATDLMALPVRGCCSDPPCRNKHPDLCGGRR", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of Conus textile, a marine cone snail species. This toxin functions as a potent and selective antagonist of alpha6/alpha3 nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). The sequence should feature a compact, stable fold stabilized by these disulfide bridges, presenting key functional loops that mediate high-affinity binding to the orthosteric site of alpha6/alpha3 nAChR subunits. The mechanism of action involves competitive inhibition of acetylcholine binding, leading to blockade of receptor activation and disruption of cholinergic signaling. The toxin should exhibit the typical structural features of alpha-conotoxins, including well-defined alpha-helical elements and beta-turn motifs within the constrained disulfide framework, ensuring target specificity and potency. The biological significance lies in its role in the predatory venom of Conus textile, where it contributes to rapid immobilization of prey through precise targeting of neuronal nAChR subtypes."}
{"description": "sp|Q91507|VSP1_PROMU Beta-fibrinogenase mucrofibrase-1 OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHPFLVLVYYDDYQCGGTLLNEEWVLTAAHCNGKDMEIYLGVHSKKVPNKDVQRRVPKEKFFCDSSKTYTKWNKDIMLIRLDRPVRKSAHIAPLSLPSSPPSVGSVCRVMGWGTITSPQETYPDVPHCANINLLDYEVCRAAYAGLPATSRTLCAGILEGGKDSCVGDSGGPLICNGQFQGIVSWGGDPCAQPREPGVCTNVFDHLDWIKGIIAGNTDVTCPL", "prompt": "Design a snake venom metalloproteinase (SVMP) from the venom of Protobothrops mucrosquamatus, the Taiwanese habu pit viper, that functions as a beta-fibrinogenase. This enzyme should specifically cleave the beta-chain of fibrinogen, thereby preventing fibrin clot formation and exhibiting potent anticoagulant activity. The protein should adopt the characteristic multi-domain architecture of P-I class SVMPs, featuring a catalytic domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn. The catalytic domain should exhibit the typical reprolysin family fold, comprising both upper and lower subdomains that form the active site cleft. The enzyme should possess substrate specificity for fibrinogen's beta-chain, likely recognizing specific sequences within the coiled-coil region. Given its role in the viper's venom, this metalloproteinase should contribute to prey immobilization through hemorrhage and blood coagulation disruption, facilitating prey digestion. The structural scaffold should include the standard SVMP disulfide bonding pattern that stabilizes the catalytic domain fold, with conserved cysteine residues forming the characteristic disulfide bridges that maintain structural integrity and enzymatic function."}
{"description": "sp|A0A3G3C7S9|CA12_CONAA Alpha-conotoxine-like Am1.2 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFMSGRASHGRNAAASDLIALTIKGCCSVPPCTANHPELCG", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus amadis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide must adopt the characteristic globular disulfide-stabilized fold of alpha-conotoxins, featuring the conserved cysteine framework C-C-CC with two disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that constrain the structure into two loops of distinct lengths. The core scaffold should include the signature alpha-helical segment in loop 2, stabilized by the disulfide connectivity, and display surface-exposed residues in the inter-cysteine regions that dictate receptor subtype selectivity and binding affinity. Key structural motifs to incorporate are: a flexible N-terminal tail preceding the first cysteine, a short loop 1 between Cys1 and Cys2, and a longer loop 2 between Cys2 and Cys3 that contains critical pharmacophore elements for nAChR interaction. The molecular mechanism involves competitive inhibition at the orthosteric binding site of nAChRs, disrupting ion channel gating and synaptic signaling. The sequence must reflect the evolutionary conservation of alpha-conotoxins in cone snail venoms, which are optimized for rapid paralysis of prey through neuromuscular blockade or neuronal circuit disruption. Ensure the design emphasizes stability, solubility, and functional potency, with loop residues tailored for high-affinity binding to specific nAChR isoforms while maintaining the compact, stable fold characteristic of this toxin family."}
{"description": "sp|C0HKF6|CA2B_CONER Alpha-conotoxin EIIB OS=Conus ermineus OX=55423 PE=1 SV=2", "sequence": "MGMRMMFIVFLLVVLATTVVSFTLDHVLGLASEGRNAKAIDNALDQRDPKRQTPGCCWHPACGKNRCGRR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus ermineus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form the inhibitory cystine knot motif. The sequence should include the conserved cysteine pattern typical of alpha-conotoxins while incorporating unique pharmacophore residues that confer subtype selectivity and high-affinity binding to the receptor's orthosteric site. The mature toxin should be a small, compact peptide (approximately 12-20 residues) with well-defined secondary structure elements including beta-turns and a stable three-dimensional fold that presents key functional residues for receptor interaction. The design should prioritize structural stability through proper disulfide bonding while maintaining the toxin's biological activity in modulating neuronal signaling pathways through competitive inhibition of acetylcholine binding."}
{"description": "sp|C0HKB3|KKX29_PANIM Potassium channel toxin kappa-KTx 2.9 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "VDACYEACMHHHMNSDDCIEACKNPVPP", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx 2.9 from the Emperor scorpion (Pandinus imperator). This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal signaling and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three or four disulfide bridges in the typical scorpion toxin cysteine framework. The sequence should include key functional motifs for potassium channel binding, particularly the functional dyad consisting of a critical lysine residue that inserts into the channel pore and an aromatic residue that stabilizes binding interactions. The toxin should exhibit high affinity and selectivity for specific Kv channel subtypes, potentially interfering with channel gating or pore occlusion mechanisms. The structural scaffold should maintain the characteristic beta-sheet core stabilized by disulfide connectivity, with surface-exposed loops responsible for target recognition and binding specificity. The resulting protein should demonstrate the potent neurotoxic activity typical of scorpion venom components that modulate ion channel function for prey immobilization and defense."}
{"description": "sp|Q6T6S7|VSPH1_BITGA Snake venom serine protease homolog 1 OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "MVLIRVLANLLLLQLSYAQESSELVIGGDECDINEHPFLVALHTARSKRFHCAGTLLNKEWVLTAARCDRKNIRIKFGVHNKNVQNEDEEMRVPKEKHFCVSSKTYTRWDKDIMLIRLKRPVNDGTHIAPLSLPSNPPSVGSVCRIMGWGSITTTKVTYPDVPHCANIKLFDYSVCRDAYKGLPEKSRTLCAGILEGGIDSCKVDNGGPLICNGQFQGIGSWEGHPCAQPLKPALYTNVFEYTDWIEGIIARNTTVTCPP", "prompt": "Design a snake venom serine protease homolog protein from the venom of the Gaboon viper (Bitis gabonica) that functions as a key component in the venom's complex hemorrhagic arsenal. This protein should exhibit the characteristic features of snake venom serine protease-like proteins, which typically lack catalytic activity due to mutations in the catalytic triad but retain structural integrity and binding capabilities. The protein should adopt the canonical chymotrypsin-like serine protease fold with a two-domain architecture consisting of β-barrel structures stabilized by conserved disulfide bridges. It should contain the characteristic cysteine framework that forms multiple intrachain disulfide bonds to maintain structural stability, including the conserved Cys1-Cys2, Cys3-Cys4, and Cys5-Cys6 patterns typical of serine protease homologs. The protein should function through molecular mimicry, potentially interfering with hemostatic pathways by binding to coagulation factors or platelet receptors without proteolytic cleavage. It may target components of the coagulation cascade such as factor X, prothrombin, or platelet surface receptors, disrupting normal blood clotting mechanisms and contributing to the venom's hemorrhagic and anticoagulant effects. The structural scaffold should maintain the characteristic active site cleft architecture while featuring specific amino acid substitutions that abolish catalytic activity while preserving binding interfaces for molecular recognition and interference with host hemostasis."}
{"description": "sp|Q6T179|PA2A4_NAJSG Acidic phospholipase A2 4 (Fragment) OS=Naja sagittifera OX=195058 PE=1 SV=1", "sequence": "SNRPMPLNIYQFKNMIQCTVPSRSWWDFADYGCYCGRGGSGTPVDDLDRCCQVHDNCYNQAQEITGCRPKWKTYTYECSQGTLTCKGRNNACAATVCDCDRLAAICFAGAPYNDNNYNIDLKARCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the banded cobra (Naja sagittifera). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of glycerophospholipids in cell membranes. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer exceptional thermal and proteolytic stability. Key structural elements should include the conserved calcium-binding loop (Tyr-Gly-Cys-X-X-Gly-Gly) and the catalytic dyad consisting of a histidine residue coordinated with an aspartate. The acidic nature of this toxin (low pI) enhances its membrane penetration and facilitates interaction with specific neuronal and muscular targets, leading to presynaptic neuromuscular blockade and muscle fiber degeneration. The sequence should maintain the characteristic hydrophobic channel that accommodates phospholipid substrates while preserving the interfacial binding surface that mediates membrane association."}
{"description": "sp|Q9N682|SCXB_OLIMR Neurotoxin BmK-M11 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MNYLVMISFALLLMTGVESVRDAYIAKPENCVYHCATNEGCNKLCTDNGAESGYCQWGGKYGNACWCIKLPDDVPIRVPGKCHR", "prompt": "Design a potent neurotoxin protein sequence inspired by the venom arsenal of the scorpion Olivierus martensii (formerly Buthus martensii). This toxin, known as neurotoxin BmK-M11, functions as a highly selective modulator of voltage-gated sodium channels. Its primary mechanism involves binding to site 4 on the alpha-subunit of neuronal sodium channels, specifically Nav1.1, Nav1.2, and Nav1.6 isoforms, leading to a pronounced slowing of channel inactivation. This results in prolonged neuronal depolarization, repetitive firing, and ultimately, neuroexcitatory symptoms. The protein should adopt the conserved structural scaffold characteristic of scorpion beta-toxins, featuring a compact, globular fold stabilized by a core of four disulfide bridges with the cysteine framework C1-C2, C3-C6, C4-C7, C5-C8. Key structural elements include an alpha-helix spanning residues 23-32 and an anti-parallel beta-sheet comprising strands 2-5 and 35-39. The molecular surface should present a conserved 'pharmacophore' region, including a critical dyad of residues (Lys58 and Tyr60) essential for receptor binding and functional activity. The sequence must encode a basic, cysteine-rich polypeptide of approximately 60-65 amino acids, with the disulfide connectivity ensuring proper folding into the ICK (inhibitor cysteine knot) motif. The final protein should exhibit high affinity and specificity for its neuronal sodium channel targets, mimicking the potent neurotoxic effects observed in the native venom."}
{"description": "sp|E4VP41|KAXU4_MESEU Potassium channel toxin MeuTXKalpha4 OS=Mesobuthus eupeus OX=34648 PE=3 SV=1", "sequence": "MSRLLIFILTAVVLSVIIDILNNSKVEGQYCCYTCIPDCSKSCQDSGLRFKACIPYRSCLCQY", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom biology. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.4 channels, which play crucial roles in neuronal excitability and cardiac repolarization. The protein must adopt the conserved structural scaffold characteristic of scorpion short-chain potassium channel toxins, featuring a compact globular fold stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should display the conserved alpha-helix and anti-parallel beta-sheet arrangement typical of this toxin family. The molecular mechanism involves high-affinity binding to the external vestibule of Kv1.4 channels, physically occluding the potassium conduction pathway and thereby inhibiting channel function. The binding interface should contain key residues for channel recognition and blockade, including conserved basic residues that interact with the channel pore region and hydrophobic patches for membrane association. The toxin should exhibit the characteristic functional properties of scorpion potassium channel blockers: rapid onset of action, high target specificity, and potent inhibition of potassium currents. The sequence must maintain the structural integrity required for venom delivery and target engagement while optimizing for expression and stability."}
{"description": "sp|A0A3G3C7T5|CM31_CONAA Mu-conotoxin-like Am3.1 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MMSKLRVLLIICLLLFPLTAVPLDGDQPADRPAERTQDDISSEHHPMFDAVRGCCPALACAMGCRPCCG", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of Conus amadis, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular blockade and paralysis in prey organisms. The protein should adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by three disulfide bonds with the conserved cysteine framework C-C-CC-C-C. The core structure should comprise a well-defined beta-hairpin motif and helical elements that form a precise molecular surface for high-affinity binding to site 1 of the Nav1.4 channel, effectively blocking sodium ion flux by occluding the pore region. Key functional residues should be strategically positioned to mediate specific interactions with the channel's domain II S5-S6 pore loop, ensuring subtype selectivity and potent inhibitory activity. The overall architecture must maintain the stability, solubility, and conformational rigidity typical of conotoxins, enabling efficient folding and biological function in the venom cocktail."}
{"description": "sp|P28881|O16B_CONST Omega-conotoxin SVIB OS=Conus striatus OX=6493 PE=1 SV=2", "sequence": "MKLTCVVIVAVLLLTACQLITADDSRGTQKHRALRSDTKLPMSTRCKLKGQSCRKTSYDCCSGSCGRSGKCG", "prompt": "Design a protein sequence for an omega-conotoxin from the marine cone snail Conus striatus, a highly specific and potent calcium channel blocker. This toxin functions as a selective antagonist of N-type voltage-gated calcium channels (Cav2.2), which are critical for neurotransmitter release at presynaptic terminals in the nervous system. The toxin should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by three conserved disulfide bridges with a C-C-CC-C-C connectivity pattern (cysteine framework IV). The mature peptide is expected to be approximately 25-30 amino acids in length, featuring a compact, globular fold with loops that mediate high-affinity binding to the pore region of the calcium channel. Key structural elements include a beta-hairpin and several flexible loops that confer target specificity. The sequence should include conserved residues critical for channel blockade, such as hydrophobic and positively charged amino acids that interact with the channel's voltage-sensing domain and selectivity filter. The toxin should exhibit high potency and selectivity for neuronal calcium channels, contributing to the paralytic effects of Conus striatus venom by inhibiting synaptic transmission."}
{"description": "sp|P0DJE7|LITD_LATHE Delta-latroinsectotoxin-Lhe1a (Fragment) OS=Latrodectus hesperus OX=256737 PE=1 SV=1", "sequence": "EPSGNSLSSALNELLDKNNNYAIPKVAIIFDDFKSSLTGGDDGLIDNVIEVLNTVKVSINSVTENNNWTPLHFAIYFKKNPAVSAVLILENKDIEARTSIMLIVQKLLLELYNYFINNYAETLDEEALFNRLDEQGKLELALIMHNK", "prompt": "Design a protein sequence for a delta-latroinsectotoxin from the venom of the Western black widow spider (Latrodectus hesperus). This toxin belongs to the latrotoxin family, which are large, pore-forming neurotoxins that target insect nervous systems. The protein should function as a selective insecticidal agent by binding to specific neuronal receptors in insects, triggering massive neurotransmitter release through calcium-dependent pore formation in presynaptic membranes. The structural scaffold should reflect the characteristic features of latrotoxins: a multi-domain architecture with an N-terminal domain for receptor binding, a central pore-forming domain capable of inserting into lipid bilayers, and conserved cysteine patterns that stabilize the tertiary structure through specific disulfide bridges. The protein should exhibit high specificity for insect neuronal targets over mammalian systems, consistent with the spider's predation strategy. The overall fold should facilitate membrane insertion and pore assembly, leading to irreversible synaptic disruption and paralysis in insect prey."}
{"description": "sp|E5AJX3|VKT_VIPNI Kunitz-type serine protease inhibitor ki-VN OS=Vipera nikolskii OX=1808362 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSRDRPKFCYLPAEPGECNAYMPSFYYDSASNKCKKFIYGGCRGNANNFKTRDECHHTCVASGKGIQPRIGSN", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Vipera nikolskii, a member of the Viperidae family. This toxin functions as a potent serine protease inhibitor, specifically targeting and inhibiting key serine proteases involved in hemostasis and coagulation pathways. The protein should adopt the characteristic Kunitz-type fold, consisting of a conserved beta-trefoil structure with alpha-helical elements and a well-defined reactive site loop that mediates protease binding and inhibition. The sequence must contain the canonical Kunitz-type cysteine framework with three conserved disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that stabilize the compact, globular structure. The reactive site loop should present specific residues that form complementary interactions with the active site of target serine proteases, enabling tight-binding inhibition through a substrate-like mechanism. The protein should exhibit the typical thermal and proteolytic stability associated with Kunitz-type inhibitors, maintaining structural integrity in the venom environment while effectively disrupting coagulation cascades through precise protease targeting."}
{"description": "sp|O93422|3NO2H_NAJAT Long neurotoxin homolog OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLALGYTLTCLICPEKYCNKVHTCLNGEKICFKKYDQRKLLGKRYIRGCADTCPVRKPREIVECCSTDKCNH", "prompt": "Generate a protein sequence for a long neurotoxin from the Chinese cobra (Naja atra) venom. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. It should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with connectivity C1-C3, C2-C4, C5-C6, C7-C8. The toxin specifically targets nicotinic acetylcholine receptors at the neuromuscular junction, acting as a competitive antagonist that binds with high affinity to the α-δ and α-γ subunit interfaces, thereby blocking acetylcholine binding and causing flaccid paralysis. The sequence should contain the conserved structural core with extended loops that facilitate receptor interaction, particularly the central loop II which is critical for receptor binding specificity. The molecular mechanism involves irreversible binding that prevents depolarization of the postsynaptic membrane, leading to respiratory failure in envenomated prey. The structural scaffold should maintain the characteristic elongated β-strand arrangement with minimal helical content, typical of long neurotoxins that exhibit enhanced receptor affinity compared to short neurotoxins."}
{"description": "sp|C0HJP9|PLA23_BOTDP Phospholipase A2 3 (Fragment) OS=Bothrops diporus OX=1107943 PE=1 SV=1", "sequence": "NLWQFGRVFVYPDVLCKGCYCGWGGRMDIYTYSRCCFVHDCCYGK", "prompt": "Generate a protein sequence for a phospholipase A2 toxin from the venom of Bothrops diporus, a venomous pit viper. This enzyme plays a critical role in the venom's hemotoxic and myotoxic effects, contributing to prey immobilization through tissue damage and systemic toxicity. The protein should function as a calcium-dependent hydrolase that cleaves the sn-2 acyl bond of phospholipids, releasing lysophospholipids and free fatty acids, which disrupt cellular membranes and trigger inflammatory cascades. The sequence must include the conserved catalytic dyad (histidine and aspartate residues) within the Ca²⁺-binding loop, characteristic of group II phospholipase A2 enzymes from viperid venoms. It should feature the typical phospholipase A2 fold with three long alpha-helices stabilized by multiple disulfide bridges, following the common cysteine pattern (C-C-C-C-C-C) that forms three disulfide bonds essential for structural integrity and enzymatic activity. The protein should exhibit interfacial activation at lipid membranes, with a hydrophobic channel for substrate access to the active site. Key functional motifs should include the conserved 'YGCYC' calcium-binding loop and the catalytic network involving histidine, aspartate, and a water molecule for nucleophilic attack. The generated sequence should reflect the potent enzymatic activity that underlies the venom's ability to induce local tissue damage, hemolysis, and contribute to the complex coagulopathic effects characteristic of Bothrops envenomation."}
{"description": "sp|Q92031|VM1A_AGKCL Snake venom metalloproteinase ACLF OS=Agkistrodon contortrix laticinctus OX=2782196 GN=ACLPREF PE=1 SV=1", "sequence": "MIQVLLVTLCLAAFPYQGSSIILESGNVNDYEVVYPRKVTPVPRGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVYKYENVEKEDEAPKMCGVTQNWESYEPIKKAFQLNLTPEQQGFPQRYVELVIVADHRMNTKYNGDSDKIRQWVHQIVNTINEIYRPLNIRFALVGLEIWSNQDLITVTSVSHDTLASFGNWRETDLLRRQRHDNAQLLTAIDFDGDTVGLAYVGGMCQLKHSTGVIQDHSAINLLVALTMAHELGHNLGMNHDGNQCHCGANSCVMPSVLSDQPSKLFSDCSKKDYQTFLPVNNPQCILNKPLRTDTASTPVSGNELLEA", "prompt": "Design a snake venom metalloproteinase (SVMP) from the broad-banded copperhead (Agkistrodon contortrix laticinctus) that functions as a key hemorrhagic toxin in viperid envenomation. This zinc-dependent metalloprotease should exhibit the characteristic multi-domain architecture of P-I class SVMPs, featuring a catalytic domain with the conserved zinc-binding motif HEXXHXXGXXH and a Met-turn structural element. The protein should adopt the classic metzincin fold with a central five-stranded beta-sheet flanked by alpha-helices, stabilized by multiple disulfide bridges characteristic of snake venom metalloproteinases. The enzyme should specifically target and degrade components of the basement membrane, particularly type IV collagen, laminin, and fibronectin, leading to capillary wall disruption and hemorrhage. The catalytic mechanism should involve zinc-mediated hydrolysis of peptide bonds in extracellular matrix proteins, with substrate specificity determined by the S1' substrate-binding pocket. The protein should display optimal activity at physiological pH and temperature, with calcium ions potentially serving as structural cofactors. The mature toxin should represent the processed form following proteolytic activation from the zymogen precursor."}
{"description": "sp|Q2I2Q5|CM31_CONLT Iota-conotoxin LtIIIA OS=Conus litteratus OX=89445 PE=1 SV=1", "sequence": "MLKMGVLLFTFLVLFPLTTLELDTDRPVERHAAIKQDLKPQERRGIRLHAPRDECCEPQWCDGACDCCS", "prompt": "Generate the amino acid sequence for iota-conotoxin LtIIIA, a potent neurotoxic peptide from the venom of the marine cone snail Conus litteratus. This toxin functions as a selective antagonist of voltage-gated sodium channels, specifically targeting neuronal subtypes to disrupt action potential propagation and cause paralysis in prey. The peptide adopts the characteristic conotoxin fold stabilized by a conserved disulfide bond framework, likely with a globular conformation constrained by multiple intramolecular disulfide bridges. Key structural features include a compact, disulfide-rich scaffold with defined loops that mediate high-affinity binding to the extracellular domains of sodium channels, particularly interfering with channel inactivation kinetics. The sequence should reflect the typical conotoxin signature with appropriate cysteine spacing patterns and conserved residues essential for maintaining structural integrity and target specificity within the conotoxin superfamily."}
{"description": "sp|P81504|SIX5_ANDAU Insect toxin AaHIT5 OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "DGYIKRHDGCKVTCLINDNYCDTECKREGGSYGYCYSVGFACWCEGLPDDKAWKSETNTCD", "prompt": "Design a novel insecticidal neurotoxin protein sequence inspired by the venom arsenal of the North African scorpion Androctonus australis. This toxin should function as a potent insect-selective sodium channel modulator, specifically targeting voltage-gated sodium channels in insect nervous systems to induce rapid paralysis and lethality. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. This structural framework should be maintained by four disulfide bridges with the characteristic C-C-CC-C-C pattern that defines the scorpion toxin superfamily. The core structure should consist of an anti-parallel beta-sheet stabilized by an alpha-helix, creating a molecular surface optimized for specific interaction with insect sodium channel receptor site-4. The toxin should exhibit high binding affinity for insect sodium channels while showing minimal activity against mammalian sodium channels, ensuring target specificity. Key functional residues should be positioned to facilitate allosteric modulation of sodium channel inactivation, causing prolonged channel opening and neuronal hyperexcitability that leads to spastic paralysis in insect prey. The sequence should maintain the characteristic molecular weight and physicochemical properties of scorpion insectotoxins while incorporating evolutionary optimized features for enhanced insecticidal potency and stability in the scorpion venom milieu."}
{"description": "sp|A0A2P1BSS9|3SX2_MICMP Mipartoxin-2 OS=Micrurus mipartitus OX=430902 PE=2 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNSLICYVSREGQTQTCPEGMNLCEKYAVSYFHDGRYFFTYECTSTCHRGDRNVCCSTDLCNK", "prompt": "Design a protein sequence for a three-finger toxin from the venom of the red-tailed coral snake (Micrurus mipartitus) that functions as a postsynaptic neurotoxin. This toxin should adopt the characteristic three-finger toxin fold stabilized by four conserved disulfide bridges with the typical cysteine framework (C-C-CC-C-C). The protein should specifically target and antagonize nicotinic acetylcholine receptors at the neuromuscular junction, leading to competitive inhibition of acetylcholine binding and subsequent neuromuscular blockade. The structural scaffold should feature three extended β-stranded loops emerging from a central hydrophobic core, with key functional residues concentrated in the central loop for receptor interaction. The toxin should exhibit high affinity and selectivity for muscle-type nicotinic receptors, contributing to the neurotoxic paralysis characteristic of coral snake envenomation."}
{"description": "sp|P0CB10|O162_CONAJ Omega-conotoxin-like Ai6.2 OS=Conus ammiralis OX=97188 PE=2 SV=1", "sequence": "MKLTCVMIIAVLFLTAWTFATADDSGNGLENLFSKAHHEMKNPKASKLNKRCTQSGELCDVIDPDCCNNFCIIFFCI", "prompt": "Generate a protein sequence for a marine cone snail venom peptide that functions as an omega-conotoxin-like calcium channel blocker. This toxin originates from Conus ammiralis, a predatory marine gastropod whose venom arsenal contains specialized peptides for immobilizing prey through targeted ion channel modulation. The protein should adopt the characteristic omega-conotoxin structural scaffold, featuring an inhibitory cysteine knot (ICK) motif stabilized by three conserved disulfide bridges with a C-C-CC-C-C connectivity pattern. This compact, globular fold creates a stable molecular framework resistant to proteolytic degradation. The peptide should function as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting neuronal N-type (Cav2.2) calcium channels to disrupt synaptic transmission and induce neuromuscular paralysis. The molecular mechanism involves high-affinity binding to the extracellular pore region of the channel, effectively blocking calcium influx and preventing neurotransmitter release at presynaptic terminals. The sequence should contain the conserved cysteine framework characteristic of conotoxins while displaying unique loop regions that confer target specificity and binding affinity. The structural core should maintain the triple-stranded beta-sheet arrangement typical of ICK-fold peptides, with surface-exposed residues forming the pharmacophore for selective calcium channel interaction."}
{"description": "sp|P0DQN2|PE1B_PHOEV Beta/mu-theraphotoxin-Pe1b OS=Phormingochilus everetti OX=2751878 PE=1 SV=1", "sequence": "ECRYWLGGCSKTGDCCEHLSCSPKWHWCVWDGTF", "prompt": "Design a novel animal toxin protein sequence that embodies the biological and structural characteristics of a beta/mu-theraphotoxin from the tarantula Phormingochilus everetti. This toxin should function as a potent inhibitor of voltage-gated sodium channels (Nav), specifically targeting insect Nav channels to induce rapid paralysis and lethality in prey. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that confers exceptional stability and resistance to proteolytic degradation. Key functional residues should be positioned within the pharmacophore region to mediate high-affinity binding to the domain II voltage sensor of insect Nav channels, thereby impeding channel activation and blocking neuronal transmission. The sequence must include a signal peptide for proper secretion and processing, followed by the mature toxin domain with the characteristic ICK fold. The overall structure should be globular and highly constrained, with surface loops that facilitate target recognition and specificity. This toxin should exemplify the evolutionary adaptation of spider venoms for efficient prey capture through selective ion channel modulation."}
{"description": "sp|Q9NDA7|COW1_CONTE Contryphan-Tx OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MGKLTILVLVAVALLSTQVMVQGDGDQPADRDAVPRDDNPGGMSEKFLNALQRRGCPWQPYCG", "prompt": "Design a novel peptide toxin sequence inspired by the biological context and structural characteristics of contryphan-Tx from the textile cone snail (Conus textile). This venom component exemplifies the remarkable molecular diversity and target specificity of conopeptides. The peptide should function as a potent neurotoxin, likely modulating ion channel activity to disrupt neuronal signaling, consistent with the predatory strategy of Conus snails. Infer the structural scaffold to be a compact, disulfide-rich motif typical of contryphans, characterized by a specific cysteine framework (e.g., C-C-C-C pattern) that forms two disulfide bridges, stabilizing a constrained loop structure. This fold imparts resistance to proteolytic degradation and precise molecular recognition. The sequence should include conserved residues for structural integrity, such as a tryptophan and proline, and a post-translationally modified residue like D-tryptophan or hydroxyproline, which are hallmarks of this family and critical for bioactivity. The molecular target is inferred to be voltage-gated or ligand-gated ion channels in the nervous system, with the peptide binding to modulate channel gating and induce paralysis. Ensure the sequence reflects high specificity and potency, with a length under 20 amino acids, and emphasize the disulfide connectivity (e.g., Cys1-Cys4, Cys2-Cys3) that defines the stable, bioactive conformation. The overall design must capture the essence of a minimalistic yet highly effective toxin for neuroscientific research or therapeutic exploration."}
{"description": "sp|E7CLN7|SCX13_RHOJU Putative alpha-neurotoxin RjAa13 (Fragment) OS=Rhopalurus junceus OX=419285 PE=2 SV=1", "sequence": "KEGYPVDWGNCKYECMSDAYCKDLCVDRKAKSGYCYKLNWSCYCEGLPDDSPIKTNGHCRPGGRRK", "prompt": "Design a protein sequence for a potent alpha-neurotoxin derived from the venom of Rhopalurus junceus, the Caribbean blue scorpion. This toxin functions as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, specifically targeting the alpha-delta and alpha-gamma subunit interfaces of muscle-type nAChRs. The toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework. The molecular mechanism involves high-affinity binding to the orthosteric site of nAChRs, preventing acetylcholine binding and resulting in flaccid paralysis through postsynaptic neuromuscular blockade. Key structural features should include: (1) a central core stabilized by disulfide bonds providing structural rigidity, (2) functional loops responsible for receptor recognition and binding specificity, particularly loop II which contains critical residues for nAChR interaction, and (3) conserved hydrophobic patches that facilitate membrane association. The toxin should exhibit the characteristic pharmacological profile of short-chain alpha-neurotoxins with rapid onset of action and reversible binding kinetics. The sequence should reflect the evolutionary optimization for prey immobilization through precise targeting of vertebrate neuromuscular junctions."}
{"description": "sp|P81508|SLA_CROHD Snaclec CHH-B subunit alpha OS=Crotalus horridus OX=35024 PE=1 SV=1", "sequence": "DLECPSGWSSYDRYCYKPFKQEMTWADAERFCSEQAKGRHLLSVETALEASFVDNVLYANKEYLTRYIWIGLRVQNKGQPCSSIYSENLVDPFDCFMVSRDTRLREWFKVDCEQQHSFICKFTRPRR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This toxin originates from the timber rattlesnake (Crotalus horridus), where it serves as the alpha subunit of the CHH-B complex in the venom arsenal. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved structural scaffold with two antiparallel beta-sheets and two alpha-helices stabilized by disulfide bridges. The cysteine framework should follow the typical snaclec pattern with conserved disulfide bonds that maintain the globular fold. As a snaclec, this protein likely targets platelet surface receptors such as GPIb or GPVI, interfering with hemostatic processes through lectin-like binding interactions. The sequence should encode key residues for carbohydrate recognition domain functionality while maintaining the structural integrity required for venom potency and target specificity in disrupting normal platelet function."}
{"description": "sp|Q6SLM2|PA2A1_BUNCE Acidic phospholipase A2 1 (Fragment) OS=Bungarus caeruleus OX=132961 PE=1 SV=1", "sequence": "LVAVCVSLLGAANIPPQPLNLYQLMNMIQCANTRTWPSYTNYGCYCGKGGSGTPVDDLDRCCYTHDHCYNDAKNIDGCNPVTKTYSYTCTEPTITCNDSKDKCARFVCDCDRTAAICFAKAPYNTSNVMIRSTNSCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from the venom of the common krait, Bungarus caeruleus. This enzyme should exhibit potent neurotoxic activity through its phospholipase A2 mechanism, catalyzing the hydrolysis of the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer structural stability and enzymatic activity. Key catalytic residues should include a conserved histidine-aspartate dyad and a calcium-binding loop essential for substrate binding and catalysis. As an acidic isoform, the protein should have a low isoelectric point and may exhibit presynaptic neurotoxicity by targeting neuronal membranes and disrupting neurotransmitter release. The sequence should maintain the canonical phospholipase A2 structural motifs, including the calcium-binding loop (XCGXGG), the catalytic network, and the hydrophobic substrate-binding channel, while ensuring proper folding and enzymatic efficiency characteristic of elapid snake venom phospholipases A2."}
{"description": "sp|P30834|ACTPB_ACTTE Cytolysin tenebrosin-B OS=Actinia tenebrosa OX=6105 PE=1 SV=2", "sequence": "MNRLIIVFIVVTMICAATALSTKRRINKEEKDEKRSVAVAGAVIEGATLTFNVLQTVLKALGDISRKIAVGIDNESGMTWTAMNTYFRSGTSDIVLPYEVPHGKALLYNGQKDRGPVATGVVGVLAYAMSDGNTLAVLFSIPFDYNLYSNWWNVKVYKGHRRADQRMYEELYYNLSPFRGDNGWHNRDLGYGLTSRGFMNSSGQSILEIHVTKA", "prompt": "Design a protein sequence for a potent cytolysin toxin derived from the venom of Actinia tenebrosa, the waratah anemone. This toxin belongs to the actinoporin family, which are pore-forming toxins that specifically target cell membranes. The protein should function by binding to sphingomyelin-rich lipid membranes, oligomerizing to form stable transmembrane pores that disrupt cellular integrity and cause osmotic lysis. The structural scaffold should feature a conserved beta-sandwich fold stabilized by a core disulfide bridge pattern characteristic of actinoporins, typically involving two conserved cysteine residues forming a single disulfide bond that maintains structural stability. The sequence should include a hydrophobic region responsible for membrane insertion and pore formation, along with surface-exposed residues that mediate specific recognition of sphingomyelin headgroups. The N-terminal region should be capable of undergoing conformational changes to form the functional pore structure. The toxin should exhibit high cytolytic activity against eukaryotic cells, particularly erythrocytes, through this membrane-permeabilizing mechanism."}
{"description": "sp|C0HLF7|PA2B_OPHSH Basic phospholipase A2 sphenotoxin subunit B (Fragment) OS=Ophryacus sphenophrys OX=2340898 PE=1 SV=1", "sequence": "HLLQFNKMIKEETGKNAIPFYAFYGCYCGWGGSGKPKDATDRCCFEHDCCYGKLTNCNTKWDIYSYSLKDGYITCGKGTWCEKEVCECDKCLRRNLRTYKYGYMFYL", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin subunit derived from the venom of the Mexican horned pitviper, Ophryacus sphenophrys. This toxin functions as a key component in the venom's arsenal, contributing to prey immobilization and digestion through its enzymatic activity. The protein should exhibit phospholipase A2 activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, which disrupts cellular membranes and induces inflammation, myotoxicity, and potentially neurotoxicity. The structural scaffold should feature the characteristic phospholipase A2 fold, comprising three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif YGCXCG. The sequence must include the essential catalytic residues, typically a histidine-aspartate dyad, and a network of disulfide bridges that stabilize the compact globular structure—commonly involving 6-7 conserved cysteine residues forming specific pairings such as Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, and Cys44-Cys105 (based on standard PLA2 numbering). The protein should be basic in nature, with a predicted isoelectric point above 7.0, facilitating interactions with anionic membrane surfaces. Key functional motifs to include are the interfacial binding site for membrane association and the active site pocket for substrate hydrolysis. Ensure the sequence reflects venom-specific adaptations for stability and potency in a predatory context."}
{"description": "sp|P0DL34|KA302_SCOJE Potassium channel toxin alpha-KTx 30.2 OS=Scorpiops jendeki OX=587368 PE=2 SV=1", "sequence": "MNKVFPFVVIVATVLILVFDTTDAKGEKKCSNSEECVKFCSEYSDVHPACIGDHCECIRWEGGISI", "prompt": "Design a novel potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx scorpion toxins. This toxin should originate from scorpion venom and function as a potent modulator of voltage-gated potassium channels (Kv channels). The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of the alpha-KTx family, featuring a compact globular structure stabilized by three or four disulfide bridges with the characteristic C1-X(m)-C2-X(n)-C3-X(p)-C4 pattern. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a stable molecular scaffold. The functional mechanism should involve specific interaction with the pore region of Kv channels, particularly through residues in the functional dyad that typically includes a critical lysine residue positioned to interact with the channel's selectivity filter. The toxin should exhibit high affinity and selectivity for specific Kv channel subtypes, potentially blocking channel conductance through physical occlusion of the pore or allosteric modulation. The sequence should include conserved structural motifs that maintain the CSαβ fold integrity while allowing for functional diversification across different potassium channel targets. The molecular surface should present key functional loops that mediate target recognition and binding specificity, with appropriate hydrophobic and electrostatic complementarity to the channel vestibule."}
{"description": "sp|P0DL31|CXQA_CONRG Omega-conotoxin RsXXVIA OS=Conus regularis OX=1333719 PE=1 SV=1", "sequence": "CKGQSCSSCSTKEFCLSKGSRLMYDCCTGSCCGVKTAGVT", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is an omega-conotoxin from the marine cone snail Conus regularis, a predatory gastropod that employs venom for prey capture and defense. As an omega-conotoxin, it functions as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal tissues. The toxin's mechanism involves high-affinity binding to specific subtypes of VGCCs, likely N-type or P/Q-type channels, leading to inhibition of calcium influx, disruption of neurotransmitter release, and ultimately neuromuscular paralysis. The structural scaffold is characterized by a compact, disulfide-rich fold typical of conotoxins, with a conserved cysteine framework (likely CC-C-C-CC for omega-conotoxins) forming three disulfide bridges that stabilize a globular, inhibitory cystine knot (ICK) motif. This knot imparts exceptional stability and resistance to proteolytic degradation. The mature toxin is expected to be a short peptide (approximately 25-30 amino acids) with a well-defined tertiary structure featuring loops that mediate target specificity. Key residues in these loops, particularly those in the second and third loops, are critical for interacting with the channel's pore-forming regions or voltage-sensing domains. The sequence should include a signal peptide for secretion and a propeptide region that is cleaved to yield the active toxin, though the final design should focus on the mature peptide. Ensure the sequence reflects the phylogenetic context of Conus regularis, potentially with unique loop variations that distinguish it from other omega-conotoxins, while maintaining the core functional and structural integrity required for calcium channel antagonism."}
{"description": "sp|Q71RP8|SLAB3_TRIST Snaclec stejaggregin-A subunit beta-3 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGAGAGFCCPLGWSSYDLYCYKVFKQEMNWTDAEKFCTEQHTGSHLVSFHSSEEADFVVNMTYPILKLDFVWIGLSNVWNQCNSEWSDGTKLNYKDWSGESECIASKTIENQWWSRSCSRTHYVVCKFQA", "prompt": "Design a protein sequence for a C-type lectin-like toxin subunit that functions as part of a heterodimeric snake venom protein complex. This protein should serve as the beta-3 subunit of stejaggregin-A, originating from Trimeresurus stejnegeri (Chinese green tree viper). The biological context involves a venom component that targets platelet aggregation mechanisms, specifically functioning as a platelet receptor antagonist. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold with conserved structural features including beta-sheets and alpha-helices arranged in a specific topology. Incorporate the essential calcium-binding motifs and carbohydrate recognition domain characteristics typical of snake venom C-type lectins. The sequence should contain the conserved cysteine framework that forms disulfide bridges stabilizing the CTLD structure, with the characteristic pattern found in snaclec family proteins. The protein should be capable of heterodimerizing with its alpha subunit partner to form the functional stejaggregin-A complex that binds platelet membrane receptors, potentially targeting receptors like GPIb or GPVI to inhibit platelet aggregation through competitive binding. The structural scaffold should maintain the globular CTLD fold with surface-exposed loops responsible for receptor recognition and binding specificity."}
{"description": "sp|P85840|VA5_TITSE Venom allergen 5 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MKGILLLFLKLVVLFVYLCSSVLSECPALYRRYSKEHTFCKTKNQKCNIKRWGVSQDDRNTIINLHNKVRNNIALGQDQSGRLPAAGDMLEMEWDDELAQIAQKLADQCVFKHDCDDCRKVENFDVGQNIFTTTITAVEIPDPFWVDAIRSWYNEIYRFTRDFIKPFTSDHATGHFTQMVWSKTWRVGCGYVLYEKRKDSWTQLYVCNYGPAGNLDDSELYKVDKPCEKCPSNTCCGSHCKKKKSTSYLGLCDVLNGSGPDFDETDFSNYIFNCDFKPESSSDCNNKVEGSNKWQTRQIISDVYKTVVLNGGENTVLKFTSNIQSKDGFCLTVSFRKGPNIAGTNNVGEFDVQLERKGAKPLNFRLDSDGNQFLPYSMGIPMNHPMQINIKFSVPKGAPAQYLDISYIRARPGLCN", "prompt": "Generate a venom allergen protein sequence from the Brazilian yellow scorpion Tityus serrulatus, specifically belonging to the Venom Allergen 5 family. This protein functions as a major allergen in scorpion venom, capable of inducing IgE-mediated hypersensitivity reactions in sensitized individuals. The protein should adopt the classic pathogenesis-related protein family 1 (PR-1) structural fold, characterized by a conserved alpha-beta sandwich architecture with mixed beta-sheets and alpha-helices that create a stable scaffold for allergenicity. Key structural features include conserved cysteine residues that form specific disulfide bridges essential for maintaining the protein's three-dimensional conformation and immunological properties. The sequence should exhibit surface-exposed epitopes that facilitate recognition by the immune system, leading to mast cell degranulation and allergic responses. The protein should be optimized for stability in the venom matrix while maintaining its allergenic potential through conserved structural motifs typical of scorpion venom allergens."}
{"description": "sp|P0DJH8|SCX1_BUTMA Alpha-toxin Bu1 OS=Buthacus macrocentrus OX=1143368 PE=1 SV=1", "sequence": "GVRDAYIADDKNCVYTCAKNSYCNTECTKNGAESGYCQWLGKYGNGCWCIKLPDKVPIRIPGRCRGR", "prompt": "Design a potent alpha-toxin from the scorpion Buthacus macrocentrus that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural scaffold of scorpion alpha-toxins, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold with the typical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure. The protein should contain key functional domains including a conserved 'core' region responsible for sodium channel binding and a variable 'NC' domain that confers specificity. The toxin should bind to neurotoxin receptor site 3 on voltage-gated sodium channels, specifically slowing inactivation and prolonging action potentials, leading to neuronal hyperexcitability. The structure should feature a triple-stranded beta-sheet stabilized by the conserved disulfide framework, with critical residues in the beta-hairpin and C-terminal regions mediating target interaction. The toxin should demonstrate high affinity for mammalian sodium channels, contributing to the paralytic and neurotoxic effects characteristic of Buthacus venom."}
{"description": "sp|P0DQN5|KA12O_SCOPC Potassium channel toxin alpha-KTX 12 Sp2 OS=Scorpiops pococki OX=2766750 PE=3 SV=1", "sequence": "MRLAIILLLMTTIVLTIGSPLHGAKCSSSNQCTRPCRYGGGTHGKCMNGRCRCYG", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. This toxin originates from the venom of Scorpiops pococki, a scorpion species whose venom components have evolved to rapidly immobilize prey through precise ion channel modulation. The protein should adopt the conserved structural scaffold characteristic of the alpha-KTX toxin family, featuring a compact, stable fold stabilized by three disulfide bridges with the characteristic cysteine framework (C1-X(3-9)-C2-X(3-9)-C3-X(0-3)-C4-X(4-12)-C5-X(1-4)-C6). The core structure should comprise an alpha-helix packed against an anti-parallel beta-sheet, forming a classic inhibitor cystine knot (ICK) motif that confers exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves high-affinity binding to the pore region of Kv channels, particularly through a functional dyad consisting of a critical lysine residue that penetrates the channel selectivity filter and an adjacent hydrophobic residue that stabilizes the interaction, effectively blocking potassium ion flux. This blockade leads to prolonged membrane depolarization, increased neurotransmitter release, and ultimately, paralysis. The sequence should include conserved residues essential for the ICK fold stability and the functional dyad, while maintaining the overall compact size (typically 30-40 amino acids) and basic character common to scorpion potassium channel toxins to facilitate initial electrostatic interactions with the channel vestibule."}
{"description": "sp|O13058|VSP3_PROFL Snake venom serine protease 3 OS=Protobothrops flavoviridis OX=88087 GN=TLF3 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGALCGGTLINQEWVLTAAHCDMPNMQIYLGVHSASVPNDDEQARDPEEKYFCLSSNNDTEWDKDIMLIRLNRSVRNSKHIAPLSLPSSPPSVGSVCRIMGWGAITSPNETYPDVPYCANIKLLRYSLCRVYQRMPAQSRILCAGILQGGKGICKGDSGGPLICNGQFQGIVHGGGKTCAQPYEPGLYIKVFDYTDWIQNIIAGNTTATCPP", "prompt": "Design a snake venom serine protease from the habu snake (Protobothrops flavoviridis) that functions as a key hemorrhagic toxin in viperid envenomation. This protein should exhibit the characteristic trypsin-like serine protease activity, specifically targeting and cleaving fibrinogen and other coagulation factors to disrupt hemostasis and promote systemic bleeding. The sequence must contain the conserved catalytic triad of histidine, aspartate, and serine residues arranged in the canonical serine protease fold, along with the essential substrate-binding pocket for recognition of specific peptide bonds in coagulation cascade components. Include the characteristic disulfide bond pattern that stabilizes the chymotrypsin-like β-barrel structure, with cysteine residues forming the conserved scaffold that maintains protease stability in the venom environment. The protein should feature appropriate surface loops and exosite regions that facilitate specific interactions with physiological substrates while resisting endogenous protease inhibitors. The overall architecture should reflect the evolutionary optimization for rapid induction of coagulopathy following envenomation, with structural features enabling efficient proteolytic activity against key hemostatic targets."}
{"description": "sp|P60264|SC29_CENLI Toxin II.9 (Fragment) OS=Centruroides limpidus OX=6876 PE=1 SV=1", "sequence": "KKDGYLVNKYTGCKVNCYKLGENKFCNRE", "prompt": "Design a protein sequence for a scorpion venom toxin from Centruroides limpidus that functions as a potent sodium channel modulator. This toxin should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold common to scorpion beta-toxins, featuring a conserved core alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The toxin should specifically target voltage-gated sodium channels (Nav), binding to receptor site 4 to modulate channel inactivation kinetics by trapping the voltage-sensing domain II in an activated state, thereby delaying channel closure and prolonging action potentials. The structural fold should exhibit the conserved ICK (inhibitor cystine knot) motif with the characteristic 'cystine-stabilized' architecture that provides exceptional thermal and proteolytic stability. Key functional residues should be positioned in the conserved 'pharmacophore' regions to enable high-affinity binding to the extracellular loops of domain II in Nav channels, particularly interacting with the S3-S4 linker region. The toxin should demonstrate the typical molecular mechanism of beta-scorpion toxins: enhancing channel activation at more negative membrane potentials and causing repetitive firing in neuronal and muscular tissues, leading to the characteristic neurotoxic effects observed in scorpion envenomation."}
{"description": "sp|P81599|TO1F_HADVE Omega-hexatoxin-Hv1f OS=Hadronyche versuta OX=6904 PE=1 SV=1", "sequence": "SAVCIPSGQPCPYSKYCCSGSCTYKTNENGNSVQRCD", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Australian funnel-web spider Hadronyche versuta. This toxin belongs to the omega-hexatoxin family and functions as a calcium channel blocker. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The toxin specifically targets insect voltage-gated calcium channels (VGCCs), binding to the channel pore region to inhibit calcium influx and disrupt synaptic transmission, leading to rapid paralysis in insect prey. The sequence should include the characteristic cysteine framework of omega-hexatoxins and maintain key residues for channel binding specificity while excluding any mammalian toxicity determinants."}
{"description": "sp|P0DJ41|KKX51_HETLA Potassium channel toxin kappa-KTx 5.1 OS=Heterometrus laoticus OX=217256 PE=1 SV=1", "sequence": "MKLLPLLFVILIVCAILPDEASCDQSELERKEENFKDESREIVKRSCKKECSGSRRTKKCMQKCNREHGHGR", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx 5.1 from the Vietnamese scorpion Heterometrus laoticus. This toxin belongs to the kappa-KTx family of scorpion toxins that specifically target potassium channels. The protein should function as a potent potassium channel blocker, likely targeting voltage-gated potassium channels (Kv channels) and contributing to the neurotoxic effects of scorpion venom by disrupting neuronal excitability and synaptic transmission. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold common to scorpion toxins, with a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in kappa-KTx toxins) that stabilizes the core structure. The protein should contain a functional dyad consisting of a lysine residue positioned to interact with the potassium channel pore and a nearby aromatic residue that contributes to binding specificity. The sequence should include a beta-sheet core stabilized by the disulfide network, with surface loops that mediate target recognition. The molecular mechanism involves blocking potassium efflux through specific interaction with the channel's outer vestibule, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The protein should exhibit the compact, stable structure typical of scorpion venom peptides, with molecular weight around 3-4 kDa and high thermal stability due to the disulfide-stabilized fold."}
{"description": "sp|P0CG45|CM3J_CONRA Kappa-conotoxin RIIIJ OS=Conus radiatus OX=61198 PE=1 SV=1", "sequence": "LPPCCTPPKKHCPAPACKYKPCCKS", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of kappa-conotoxin RIIIJ from the venomous marine snail Conus radiatus. This toxin belongs to the kappa-conotoxin family, which specifically targets and inhibits voltage-gated potassium channels (Kv channels) in the nervous system. The peptide should function as a potent Kv channel antagonist, binding to the channel's pore region to block potassium ion flux, thereby modulating neuronal excitability and synaptic transmission. The structural scaffold must feature the characteristic conotoxin cysteine framework with a specific disulfide bond pattern (likely CC-C-C for kappa-conotoxins) that forms a compact, stable globular fold. The core structure should include a conserved alpha-helical region and beta-sheet elements stabilized by disulfide bridges, creating a well-defined molecular surface for high-affinity interaction with Kv channels. Key functional residues should be positioned to interact with the channel's voltage-sensing domain or selectivity filter, ensuring specificity for Kv1 subfamily channels. The peptide must exhibit high stability in physiological conditions due to its disulfide-stabilized architecture and maintain the typical conotoxin molecular weight of 2-4 kDa. The sequence should reflect the evolutionary optimization of Conus radiatus venom components for rapid prey immobilization through precise ion channel modulation."}
{"description": "sp|P01399|3NO2D_NAJHA Weak toxin CM-13b OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LTCFNCPEVYCNRFHTCRNGEKICFKRFNERKLLGKRYTRGCAATCPVAKPREIVECCSTDRCNH", "prompt": "Design a protein sequence for a weak toxin from the venom of the snouted cobra, Naja annulifera, specifically the CM-13b variant. This toxin belongs to the three-finger toxin superfamily but exhibits reduced toxicity compared to typical neurotoxins from this family. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. Despite its classification as a weak toxin, it should maintain the ability to interact with various molecular targets, potentially including nicotinic acetylcholine receptors or other membrane proteins, but with lower affinity and potency than strong neurotoxins. The sequence should preserve the three-loop architecture extending from a central globular core, with loop II potentially playing a key role in target recognition. The protein should be water-soluble and stable, reflecting its origin from elapid snake venom, where it may serve auxiliary functions in envenomation or have evolved distinct biological activities."}
{"description": "sp|C0HJJ7|TX1A_GRAIH Beta/kappa-theraphotoxin-Gi1a OS=Grammostola iheringi OX=1496261 PE=1 SV=1", "sequence": "SCQKWMWTCDQKRPCCEDMVCKLWCKIIK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of the tarantula species Grammostola iheringi, a theraphosid spider whose venom contains a diverse arsenal of peptide toxins targeting ion channels in the nervous system of prey. This toxin belongs to the beta/kappa-theraphotoxin family, specifically designated Gi1a, and exhibits a dual functional classification: it acts as both a beta-toxin, which typically inhibits voltage-gated sodium channel inactivation, and a kappa-toxin, which generally blocks voltage-gated potassium channels. The core mechanism of action involves binding to specific voltage-gated ion channels—likely Nav and Kv subtypes—in insect or vertebrate prey, leading to prolonged depolarization, disrupted action potential propagation, and ultimately paralysis or death. The structural scaffold is inferred to be an inhibitor cysteine knot (ICK) motif, a hallmark of spider venom peptides, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, and C3-C6 (cysteine framework III). Key domains include a hydrophobic patch for membrane interaction and a solvent-exposed pharmacophore region responsible for ion channel binding. The molecular target interface involves specific interactions with the voltage-sensing domains or pore regions of sodium and potassium channels, with high affinity and selectivity. Ensure the sequence incorporates these structural and functional elements to replicate the toxin's paralytic activity."}
{"description": "sp|P0DJ42|VM1CR_CROAT Snake venom metalloproteinase crotalin (Fragment) OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "LLRRKSHDHAQNHDGDKCLRGASLGYYQSFLNQYKPQCILNKP", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that captures the essential biological and structural characteristics of a crotalin-like toxin from the Western diamondback rattlesnake (Crotalus atrox). This protein should function as a potent zinc-dependent metalloprotease that plays a critical role in venom-induced tissue damage and hemorrhage. The sequence must include a catalytic zinc-binding motif (HEXXHXXGXXH) within the metalloproteinase domain, which enables proteolytic cleavage of extracellular matrix components such as collagen, laminin, and fibronectin. The structural scaffold should feature multiple disulfide bonds characteristic of SVMPs, stabilizing a multi-domain architecture that may include propeptide, metalloproteinase, and disintegrin-like domains. The protein should exhibit specificity for basement membrane proteins and contribute to the rapid tissue destruction and systemic effects observed in envenomation, facilitating prey immobilization through hemorrhage and impaired tissue integrity. The overall fold should maintain the conserved SVMP tertiary structure, with the active site cleft accessible for substrate binding and proteolysis."}
{"description": "sp|A0A2P1BSU3|3SX3_MICMP Mipartoxin-3 OS=Micrurus mipartitus OX=430902 PE=2 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNSLKCYDKLKKEVTCPEGMKFCHKDVLPATHGNSVLVMGCTYSCGLGPRNMCCSTDLCNK", "prompt": "Design a protein sequence for a snake venom toxin from the coral snake Micrurus mipartitus, specifically a mipartoxin-3 variant. This toxin belongs to the three-finger toxin (3FTx) superfamily, characterized by a conserved structural scaffold comprising three β-stranded loops extending from a central core stabilized by four conserved disulfide bridges with the characteristic cysteine framework C1-C2, C3-C6, C4-C5, C7-C8. The protein should adopt the classic three-finger toxin fold, forming a compact globular structure with the three loops providing the molecular surface for target recognition. As a component of elapid snake venom, this toxin likely functions as a neurotoxin targeting the neuromuscular junction, potentially acting as a postsynaptic antagonist of nicotinic acetylcholine receptors (nAChRs) or modulating other ion channels. The sequence should include key residues in the loop regions that mediate specific interactions with the target receptor, ensuring the toxin disrupts cholinergic signaling and causes paralysis. The structural integrity must be maintained through the conserved disulfide connectivity to preserve the functional conformation required for high-affinity binding and toxic activity."}
{"description": "sp|Q2I2R5|CLE1_CONLT Alpha-conotoxin Lt14.1 OS=Conus litteratus OX=89445 PE=1 SV=2", "sequence": "MKLSVMFIVFLMLTMPMTCAGISRSATNGGEADVRAHDKAANLMALLQERMCPPLCKPSCTNCG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus litteratus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey organisms. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold. Implement the conserved CC-C-C cysteine framework with four cysteine residues forming two essential disulfide bridges that create the stable structural core. The mature toxin should be a short peptide of approximately 14-16 amino acids with the characteristic alpha-conotoxin pharmacophore. Include key structural motifs that enable high-affinity binding to the alpha-delta interface of muscle-type nicotinic acetylcholine receptors, featuring critical residues for receptor subtype selectivity and potent neuromuscular blockade. The sequence should exhibit the typical alpha-conotoxin signature of small size, high cysteine content, and the ability to disrupt cholinergic neurotransmission through competitive inhibition at the acetylcholine binding site."}
{"description": "sp|Q6X5T3|SL5_BITAR Snaclec 5 OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "MGRFIFLSSGLLVVFLSLSGTGADFQCPSEWSAYGQHCYRAFKYEKSWAEAEKFCMEQANDGHLVSIQSIKEANFVAKLVSGIIAYIWIGLRDRRKEQQCTSEWNDGSKVTYVNWREGESQMCQVLAIWSGFKNWVNTDCASHNPFVCKSPA", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the puff adder (Bitis arietans), specifically belonging to the snaclec (snake C-type lectin) family. This toxin functions as a platelet aggregation modulator, typically acting as an antagonist by binding to platelet receptors such as GPIb or GPVI, thereby disrupting normal hemostasis and promoting bleeding in envenomation. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure with two antiparallel beta-sheets and two alpha-helices, stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that form the cysteine framework. Key functional residues should be positioned in the loop regions to mediate specific, high-affinity binding to platelet surface receptors, mimicking the natural toxin's role in inhibiting platelet aggregation and contributing to the venom's hemorrhagic effects."}
{"description": "sp|Q6WGI9|KA113_PARGR Potassium channel toxin alpha-KTx 11.3 OS=Parabuthus granulatus OX=242110 PE=1 SV=1", "sequence": "DEEPKETCSDDMCVIYCKGEEFSTGACDGPQKCKCS", "prompt": "Design a potassium channel toxin protein from the venom of the Parabuthus granulatus scorpion, belonging to the alpha-KTx family. This toxin should function as a selective modulator of voltage-gated potassium channels, specifically targeting Kv1.x subtypes to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. Include key functional motifs: a solvent-exposed beta-sheet region for channel interaction, a conserved 'functional dyad' comprising a critical lysine residue for pore block and an aromatic residue for channel recognition, and a structured alpha-helix for structural stability. The toxin should exhibit high affinity binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway to inhibit potassium efflux and prolong action potentials. Ensure the sequence maintains the hallmark scorpion toxin signature with appropriate hydrophobic core packing and surface charge distribution for target specificity and membrane interaction."}
{"description": "sp|C9X4K8|SCNAA_TITDI Toxin TdNa10 OS=Tityus discrepans OX=57059 PE=2 SV=1", "sequence": "MWTFAIVLAFLLIGLDEGEALDGYPLSKNNYCKIYCPNTEVCKDTCKRRAGATDGECRWDGCYCFNVAPDTKMYPGELPCH", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a sodium channel neurotoxin from the venom of the scorpion Tityus discrepans, designated as TdNa10. This toxin belongs to the beta-toxin class, specifically targeting voltage-gated sodium channels (Nav) and modulating their function by binding to site 4, which alters the voltage-dependent activation and enhances channel opening. The toxin's mechanism involves prolonging action potentials and increasing neuronal excitability, contributing to the venom's neurotoxic effects. Structurally, the protein adopts the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three or four disulfide bridges with a typical cysteine framework (e.g., C-C-C-C or similar patterns). Key structural elements include a short alpha-helix and a beta-sheet core, forming a compact globular structure that facilitates high-affinity binding to the sodium channel's voltage-sensing domain. The molecular target is primarily Nav1.2, Nav1.6, or other neuronal subtypes, with the binding interface involving specific residues that interact with the channel's S3-S4 loop. The biological significance lies in its role in prey immobilization and defense, with potential implications for studying sodium channel physiology and developing therapeutic agents. Ensure the sequence reflects these functional and structural attributes, including conserved motifs for disulfide bonding and residues critical for target specificity."}
{"description": "sp|P0C552|3SOIK_BUNFA Neurotoxin 3FTx-LK OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLKCHTTQFRNIETCQKWETVCFQRAVKPHPSSMIVLRGCTSSCGKGETCCATDLCNR", "prompt": "Design a neurotoxic protein sequence that functions as a three-finger toxin (3FTx) from the krait species Bungarus fasciatus. This toxin should adopt the characteristic three-finger structural fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework C-C-CC-C-C. The protein should exhibit potent neurotoxic activity through postsynaptic targeting, specifically antagonizing nicotinic acetylcholine receptors at the neuromuscular junction. The structural architecture should feature the conserved three-loop finger domain organization with loop I and loop II contributing to receptor binding specificity, while loop III may contain additional functional determinants. The toxin should demonstrate high affinity binding to muscle-type nicotinic receptors, causing reversible neuromuscular blockade through competitive inhibition of acetylcholine binding. The sequence should maintain the essential hydrophobic core residues that stabilize the three-finger scaffold while incorporating the specific pharmacophore residues responsible for receptor recognition and binding potency characteristic of krait neurotoxins."}
{"description": "sp|Q71RQ1|SLAA_TRIST Snaclec stejaggregin-A subunit alpha OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGADFDCPSGWSAYDWYCYKPFNEPQTWDDAERFCTEQAKGGHLVSIESSGEADFVGQLVSENIQRPEIYVWIGLRDRRKEQQCSSEWSDGTSIIYVNWNKGESQMCQGLSKWTNFLKWDNTDCQAKNPFVCKFPPQC", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) from the venom of Trimeresurus stejnegeri, the Chinese green tree viper. This protein functions as the alpha subunit of stejaggregin, a platelet-aggregating complex that contributes to the venom's procoagulant and hemorrhagic effects by targeting platelet membrane receptors. The protein should adopt the characteristic C-type lectin-like fold, consisting of a globular domain with two antiparallel beta-sheets and two alpha-helices, stabilized by conserved disulfide bridges. Key structural features include a long loop region involved in receptor recognition and a calcium-binding site essential for structural integrity. The sequence should contain the conserved C-type lectin domain signature motifs and form heterodimeric interactions with the beta subunit to create the functional complex that binds to platelet glycoprotein receptors, initiating aggregation through outside-in signaling. The protein should exhibit high specificity for platelet membrane components while maintaining the stability required for venom delivery and function."}
{"description": "sp|P67860|VEGFA_PROFL Vascular endothelial growth factor A OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MNFLLTWIHWGLAALLYFHNAKVLQAAPAQGDGDRQQSEVIPFMTVYERSVCRPIETMVDIFQDYPDEVEYILKPPCVALMRCGGCCNDEALECVPTELYNVTMEIMKLKPYQSQHIHPMSFQQHSKCECRPKKETRIIQEKKSKREKGKGQKRKRKRGRYKPQNFHCEPCSERRKHLYKQDPLTCKCSCKFTDSRCKSKQLELNERTCRCEKPRR", "prompt": "Design a novel animal toxin protein sequence based on the vascular endothelial growth factor A (VEGF-A) from the venom of Protobothrops flavoviridis, the habu snake. This toxin represents a remarkable example of venom evolution where a normal physiological growth factor has been co-opted for toxic function. The protein should function as a potent VEGF receptor agonist that disrupts normal vascular homeostasis through excessive angiogenesis and vascular permeability. The sequence should maintain the characteristic VEGF structural fold featuring a cysteine-knot motif with eight conserved cysteine residues forming four disulfide bridges in the pattern C1-C5, C2-C6, C3-C7, and C4-C8, creating a stable, dimeric homodimer structure. The protein should contain the key receptor-binding domains including the receptor-binding loops that interact with VEGF receptor tyrosine kinases (VEGFR-1 and VEGFR-2), particularly the regions responsible for high-affinity binding to the immunoglobulin-like domains of these receptors. The toxin should exhibit enhanced stability and potency compared to mammalian VEGF-A, potentially through optimized receptor interaction surfaces and improved resistance to proteolytic degradation. The mechanism involves pathological activation of endothelial cell proliferation, migration, and survival signaling, leading to vascular leakage, tissue edema, and potentially contributing to prey immobilization through circulatory disruption. The structural scaffold should preserve the anti-parallel β-sheet core and helical elements characteristic of the VEGF family while potentially incorporating venom-specific adaptations that enhance its toxicological profile."}
{"description": "sp|D2CFI7|LA1_OLIMR Venom peptide MmKTx1 OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MSIKISAIALFMLSFTVFVNGIPFFLTKGRIDTCKTLTGETIKIGESWHDPNSCSVYYCEVNSLGAMLIGKTCATVFYPSNCREEPGTGLYPDCCNKVVCGEEEMVVYPYEERSLRRYYFSKF", "prompt": "Design a venom peptide from the scorpion Olivierus martensii that functions as a potassium channel blocker. This peptide should belong to the alpha-KTx toxin family and specifically target voltage-gated potassium channels, particularly Kv1.3 channels, to disrupt neuronal signaling and cause neurotoxic effects. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by three or four disulfide bridges with a typical C1-C5, C2-C6, C3-C4 connectivity pattern. The peptide should include key functional motifs such as a conserved dyad (lysine and tyrosine/phenylalanine) in the beta-sheet region for channel pore block, a hydrophobic patch for membrane interaction, and a positively charged surface for electrostatic guidance to the channel vestibule. The sequence should be 30-40 amino acids long with high stability, solubility, and specificity for potassium channels over sodium or calcium channels."}
{"description": "sp|C0HM68|BDSB2_HETMG Pi/alpha-stichotoxin-Hmg5b OS=Heteractis magnifica OX=38281 PE=1 SV=2", "sequence": "MDYQRLLFLFAVAMVITTTVALPKDTALMDGQLQKRGTPCKCHGYIGVYWFMLAGCPNGYGYNLSCPYFLGICCVKK", "prompt": "Design a novel animal toxin protein sequence inspired by the pi/alpha-stichotoxin family from the magnificent sea anemone Heteractis magnifica. This toxin should function as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the characteristic structural fold of sea anemone type 1/2 toxins, featuring a compact beta-sandwich or beta-grasp motif stabilized by three conserved disulfide bridges with a typical C-C-C-C-C-C cysteine framework. The sequence should include key functional residues for channel interaction, such as a conserved lysine or arginine-rich region for binding to the channel pore, and maintain the overall acidic pI typical of this toxin class. The structural core should be rigid and stable, with surface loops that mediate specific target recognition and high-affinity binding to Kv channels, particularly Kv1 subtypes, to induce paralysis or neurotoxic effects. Ensure the sequence reflects the evolutionary optimization of sea anemone venom for rapid prey immobilization through precise ion channel modulation."}
{"description": "sp|K9MCH1|3S11_MICLL Three-finger toxin A1 OS=Micrurus laticollaris OX=1240351 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGHTRICYNQQSSQPPTTKTCSEGQCYKKTWRDHRGTIIERGCACPNVKPGIQISCCTSDKCNG", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom arsenal of the Mexican coral snake (Micrurus laticollaris). This toxin should adopt the canonical three-finger toxin (3FTx) structural scaffold, characterized by three β-stranded loops extending from a small, globular hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The protein should fold into a compact, flattened β-sandwich structure with the three loops exhibiting conformational flexibility for target recognition. As a member of the three-finger toxin A1 family, this protein should function as a potent neurotoxin targeting nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, likely exhibiting postsynaptic activity that disrupts cholinergic signaling. The sequence should contain key conserved residues for structural integrity while incorporating variable loop regions that enable specific receptor binding and potent biological activity characteristic of elapid snake venom toxins."}
{"description": "sp|P30811|PA2HC_PSETE Acidic phospholipase A2 homolog textilotoxin C chain OS=Pseudonaja textilis OX=8673 PE=1 SV=2", "sequence": "MHPAHLLVLLGVYVSLLGAARIPPLPLNLIQFSNMIKCTIPGSQPLLDYANYGCYCGPGNNGTPVDDVDRCCQAHDECYDEASNHGCYPELTLYDYYCDTGVPYCKARTQCQVFVCGCDLAVAKCLAGATYNDENKNINTGERCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 homolog that functions as the C chain component of textilotoxin, a potent presynaptic neurotoxin complex from the venom of the Australian eastern brown snake (Pseudonaja textilis). This protein should exhibit the characteristic phospholipase A2-like structural fold but with attenuated or absent catalytic activity due to evolutionary adaptations, serving instead as a structural and functional component within the heteromeric textilotoxin complex. The sequence should feature the conserved calcium-binding loop (YGKYCG/XCG) and catalytic network typical of PLA2 enzymes, while incorporating specific mutations that reduce enzymatic function. Include the characteristic disulfide bond pattern common to snake venom PLA2s (typically 6-7 conserved disulfide bridges) that stabilizes the compact, multi-helical globular structure. The protein should be acidic in nature, with a calculated pI below 7.0, and possess surface features that enable specific interactions with other textilotoxin subunits (A and B chains) to form the functional quaternary complex. This complex ultimately targets the presynaptic membrane of neuromuscular junctions, disrupting neurotransmitter release through mechanisms involving membrane binding and potential interference with synaptic vesicle recycling pathways."}
{"description": "sp|P60265|SCX9_CENNO Beta-toxin Cn9 (Fragment) OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "KKDGYPIQENGCKY", "prompt": "Design a beta-toxin protein sequence derived from the venom of the Mexican scorpion Centruroides noxius, a species known for producing potent neurotoxins that target voltage-gated sodium channels. This toxin should function as a beta-toxin, specifically modulating sodium channel gating by binding to site 4 and shifting the voltage dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and causing spontaneous repetitive firing. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, featuring a compact globular structure stabilized by four disulfide bridges with a typical cysteine framework pattern of C-C-CC-C-C. Key structural elements should include an alpha-helix packed against an antiparallel beta-sheet, forming a core stabilized by the disulfide network that ensures thermal and proteolytic stability. The molecular target is likely voltage-gated sodium channels (Nav1.1-Nav1.7 subtypes), with specific residues in the loop regions mediating high-affinity binding to the extracellular S3-S4 linker of domain II. The sequence should reflect the functional specificity for insect or mammalian sodium channels, depending on the ecological role of the venom, and maintain the conserved hydrophobic core and charged surface residues critical for channel interaction and potency."}
{"description": "sp|B1P1D9|JZ11F_CHIGU Kappa-theraphotoxin-Cg1a 6 OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MKVSVLITLAVLGVMFVWASAAELEERGSDQRDSPAWLKSMERIFQSEERECRKMFGGCSVDSDCCAHLGCKPTLKYCAWDGTFGK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a kappa-theraphotoxin derived from the venom of the Chinese earth tiger tarantula (Chilobrachys guangxiensis). This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characteristic of spider venom peptides. The core function of this toxin is to act as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The molecular mechanism involves high-affinity binding to the pore region of Kv channels, preventing potassium efflux and leading to prolonged membrane depolarization, which results in uncontrolled neurotransmitter release and paralysis in prey organisms. The structural scaffold must feature the conserved ICK motif with a characteristic triple-stranded beta-sheet fold stabilized by a specific disulfide bridge pattern. The cysteine framework should follow the pattern C1-C4, C2-C5, C3-C6, forming the inhibitory cysteine knot that provides exceptional thermal and proteolytic stability. Key functional domains include a conserved hydrophobic patch for membrane interaction and a solvent-exposed loop region containing critical residues for channel binding specificity. The mature toxin should be a small, compact peptide of approximately 30-40 amino acids with a high density of basic residues that facilitate interaction with the negatively charged vestibule of potassium channels. The overall structure should exhibit the hallmark rigidity and stability of ICK-fold toxins while maintaining the pharmacological profile of a selective potassium channel modulator with potential insecticidal or vertebrate-targeting activity."}
{"description": "sp|P81630|VM23A_ECHCA Disintegrin EC3A OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "NSVHPCCDPVKCEPREGEHCISGPCCRNCYFLRAGTVCKRAVGDDVDDYCSGITPDCPRNRYKGKED", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Echis carinatus (saw-scaled viper) that functions as a potent inhibitor of platelet aggregation. This protein should adopt the canonical disintegrin fold characterized by a compact, disulfide-stabilized structure with the RGD (Arg-Gly-Asp) motif positioned within an exposed, flexible loop for optimal interaction with integrin receptors. The sequence must incorporate the conserved cysteine framework typical of short-chain disintegrins, forming disulfide bridges that stabilize the core structure while allowing the integrin-binding loop to maintain conformational flexibility. The protein should specifically target and antagonize αIIbβ3 integrin on platelets, preventing fibrinogen binding and thereby inhibiting thrombus formation. Key structural elements should include: a well-defined RGD-containing loop with appropriate flanking residues to enhance binding affinity and specificity; a compact globular domain stabilized by intramolecular disulfide bonds; and surface properties that facilitate specific recognition of the integrin receptor while minimizing off-target interactions. The overall structure should be thermodynamically stable under physiological conditions and exhibit the characteristic potency of viperid disintegrins in disrupting hemostatic processes through precise interference with cell-matrix adhesion mechanisms."}
{"description": "sp|P0CF38|NDB26_ISOMC Im-1 OS=Isometrus maculatus OX=497827 PE=1 SV=1", "sequence": "FSFKRLKGFAKKLWNSKLARKIRTKGLKYVKNFAKDMLSEGEEAPPAAEPPVEAPQ", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the scorpion Isometrus maculatus, specifically the Im-1 toxin. This toxin functions as a beta-type scorpion toxin that selectively targets voltage-gated sodium channels (Nav channels) in the peripheral nervous system. It binds to site 4 on the channel's domain II voltage sensor, inhibiting fast inactivation and causing prolonged channel opening, which leads to sustained neuronal depolarization, spontaneous repetitive firing, and neuroexcitatory symptoms. The toxin adopts the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern (cysteine framework VIII). Key structural elements include a conserved 'pharmacophore' region in the beta-sheet involved in receptor binding, a hydrophobic patch for membrane interaction, and a positively charged surface for electrostatic steering to the channel. The sequence should contain the conserved disulfide-stabilized core, functional residues for Nav channel interaction, and structural motifs ensuring stability in the venom environment while maintaining high potency and selectivity for insect or mammalian sodium channel subtypes."}
{"description": "sp|P0CD69|BOL8_BOMLA Bombolitin-8 OS=Bombus lapidarius OX=30192 PE=1 SV=1", "sequence": "LKLKSILGKLGVILSHLNK", "prompt": "Design a protein sequence for bombolitin-8, a hemolytic peptide toxin from the venom of the red-tailed bumblebee (Bombus lapidarius). This toxin belongs to the bombolitin family of amphipathic, membrane-active peptides that function as potent cytolysins. The protein should adopt an alpha-helical structure with distinct amphipathic character, featuring hydrophobic residues on one face and cationic residues on the opposite face that facilitate membrane interaction. The mechanism involves initial electrostatic attraction to negatively charged phospholipid head groups followed by insertion into lipid bilayers, leading to membrane disruption through pore formation or detergent-like effects. Bombolitin-8 exhibits broad-spectrum hemolytic activity against erythrocytes and cytotoxic effects on various cell types by compromising membrane integrity. The sequence should reflect the characteristic bombolitin features: moderate length (approximately 15-25 residues), absence of disulfide bridges, high helical propensity, and optimal amphipathicity for membrane penetration. The structural scaffold should enable the peptide to transition from soluble to membrane-bound states, with the helical conformation stabilizing upon membrane interaction to execute its pore-forming cytolytic function."}
{"description": "sp|Q6T271|VM2BI_BITGA Zinc metalloproteinase/disintegrin (Fragment) OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "KYENVEKGDEAPKKCGVTHTNLESDEPIEKASQLFGTSEQQRFDPRHIELVIVADHGMVMKHNGDLTAVRTWLHQIGNNLNVMFADLNIRITMAGLEMWSEKDLIDIQSAASETLRLFGEWRERYLLNRRMHDNAQLLTTVNLDGDTVGLAYVGGMCDPKNSVGIVQDHSRIAREVAATMAHELGHNLGMAHDGNQCNCGANGCVMSEEIIERTSYQFSDCSKEEYRTFLDNHNPQRILNEPLRTDTVSTPVYGNVLQNSPHPCCDPVTCKPKAWEHCISGPCCRDCKFLRPGTVCRVARGDWNDDFCTGRSSECESNPWNFWNH", "prompt": "Design a protein sequence for a venom toxin derived from the Gaboon viper (Bitis gabonica) that functions as a zinc metalloproteinase with disintegrin activity. This toxin should exhibit the characteristic multidomain architecture of snake venom metalloproteinases (SVMPs), featuring a metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH for catalytic activity, which enables proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin. The disintegrin domain should adopt a compact, disulfide-rich structure with the RGD (Arg-Gly-Asp) motif or related integrin-binding sequences, facilitating inhibition of platelet aggregation by blocking integrin receptors on cell surfaces. The protein should maintain the typical cysteine framework of SVMPs, with multiple disulfide bridges stabilizing both domains, and the metalloproteinase domain should fold into a metzincin-like structure with a central active-site helix and substrate-binding cleft. This toxin contributes to the hemorrhagic and anticoagulant effects of Gaboon viper venom by degrading basement membranes and disrupting hemostasis through dual mechanisms of proteolysis and integrin antagonism."}
{"description": "sp|P31854|PA2B_VIPBB Basic phospholipase A2 Pla2Vb OS=Vipera berus berus OX=31156 PE=1 SV=2", "sequence": "MRTLWIVAVWLMGVEGNLFQFGNMINHMVGKHAVWSYLSYGCYCGWGGQGKPQDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFQKNMNTYNKKYKNYSSSNCQENSDKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the common European adder, Vipera berus berus. This enzyme should function as a potent venom component with multiple toxic activities, including presynaptic neurotoxicity, myotoxicity, and anticoagulant effects. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. Include the essential catalytic triad residues (histidine, aspartate, tyrosine) required for phospholipid hydrolysis. The sequence should feature the conserved disulfide bond pattern typical of group II phospholipase A2 enzymes, with multiple disulfide bridges stabilizing the compact globular structure. The protein should exhibit basic isoelectric point properties that facilitate membrane interaction and enhance toxicity. The molecular mechanism should involve hydrolysis of membrane phospholipids at the sn-2 position, leading to membrane disruption, inflammation, and potential neuromuscular blockade through presynaptic action at motor nerve terminals. The structural scaffold should enable both enzymatic activity and specific membrane-targeting capabilities characteristic of viperid venom phospholipases A2."}
{"description": "sp|P45660|KA165_LEIHE Potassium channel toxin alpha-KTx 16.5 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "GLIDVRCYDSRQCWIACKKVTGSTQGKCQNKQCRCY", "prompt": "Design a novel animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels). This toxin should be derived from the venom of the yellow scorpion Leiurus hebraeus, a medically significant species known for producing potent neurotoxins that disrupt neuronal signaling through ion channel modulation. The toxin belongs to the alpha-KTx family, characterized by their compact, disulfide-stabilized structure and high affinity for potassium channels. The core mechanism of action involves binding to the pore region of Kv channels, thereby inhibiting potassium ion efflux and prolonging neuronal depolarization, which can lead to hyperexcitability, uncontrolled neurotransmitter release, and potentially severe neurotoxic effects. The structural scaffold should feature the conserved alpha-KTx fold, comprising an alpha-helix and an antiparallel beta-sheet stabilized by three disulfide bridges with a characteristic Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 connectivity pattern (cysteine framework I). The sequence must include key functional residues for potassium channel binding, such as a conserved lysine or arginine in the beta-sheet region that interacts with the channel's selectivity filter, and hydrophobic residues that facilitate docking into the channel vestibule. The overall structure should be globular, with a molecular weight of approximately 3-5 kDa, and exhibit high thermal and proteolytic stability due to the disulfide network. The toxin should specifically target Shaker-type Kv channels (e.g., Kv1.1, Kv1.2, or Kv1.3), with a preference for channels involved in neuronal or muscular excitability, and it should not exhibit cross-reactivity with sodium or calcium channels. Ensure the sequence reflects the evolutionary optimization for rapid and potent channel blockade, which is characteristic of scorpion venom toxins used for prey immobilization and defense."}
{"description": "sp|P60268|CTXI3_MESEU Insectotoxin-I3 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MCMPCFTTDHQTARRCRDCCGGRGRKCFGQCLCGYD", "prompt": "Design a protein sequence for a scorpion venom insectotoxin derived from Mesobuthus eupeus. This toxin should function as a potent insect-selective neurotoxin that specifically targets voltage-gated sodium channels in insect nervous systems. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic cysteine framework C1-C2, C3-C6, C4-C7, C5-C8. The structure should display the classic cysteine-stabilized α-helix/β-sheet (CSαβ) motif, with a core triple-stranded antiparallel β-sheet and a single α-helix. Key functional residues should be positioned to interact with the voltage-sensing domain of insect sodium channels, causing a hyperpolarizing shift in channel activation and delaying inactivation, leading to prolonged neuronal excitation and paralysis. The toxin should exhibit high selectivity for insect sodium channels over mammalian counterparts, reflecting its ecological role in prey immobilization. Include conserved structural motifs typical of scorpion β-toxins, such as the conserved 'pharmacophore' region responsible for receptor binding specificity."}
{"description": "sp|Q71RQ0|SLAB1_TRIST Snaclec stejaggregin-A subunit beta-1 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MGRFIFMSFGFLVVAVSLSGTGAGFCCPLGWSSYDEHCYKVFNQRKTWDDAEKFCTQQHKGSHLLSFHSSEEVDFVVSKTYPILKEDFVWIGLSDVWSECTKEWSDGTKLDYKAWSGESECIASKTTDNQWWSRSCNTTYYVVCKFQA", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) derived from the venom of Trimeresurus stejnegeri, a pit viper species. This protein functions as the beta-1 subunit of stejaggregin-A, a heterodimeric snake venom protein that plays a crucial role in the venom's hemostatic disruption mechanism. The protein should exhibit the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should maintain key structural elements including calcium-binding sites and carbohydrate recognition domains, though this particular snaclec primarily functions in protein-protein interactions rather than carbohydrate binding. As part of the stejaggregin-A complex, this beta subunit contributes to platelet aggregation activity, likely through interaction with platelet surface receptors such as GPIb or other hemostatic targets. The protein should display the signature features of venom snaclecs: compact globular structure, high stability conferred by the disulfide framework, and surface-exposed loops that mediate specific molecular recognition. The design should capture the evolutionary optimization of this protein for rapid target engagement in the context of envenomation, where it contributes to the procoagulant or anticoagulant effects characteristic of viperid venoms."}
{"description": "sp|P0DL35|KA303_SCOJE Potassium channel toxin alpha-KTx 30.3 OS=Scorpiops jendeki OX=587368 PE=2 SV=1", "sequence": "MNKTFFLVVIMATVLVLAFDATDAQTNVRCTNTRDCFSFCSQFTNVHPACLGDYCECLRWEGGISI", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom peptides. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should feature a compact, triple-stranded beta-sheet arrangement with a characteristic alpha-helix running parallel to the beta-sheet, creating a molecular surface optimized for potassium channel pore blockade. The binding interface should include a critical functional dyad consisting of a lysine residue positioned to occlude the potassium selectivity filter and an aromatic residue for hydrophobic interactions with channel vestibule residues. The sequence should maintain the characteristic short length (30-40 residues) of scorpion alpha-KTx toxins while incorporating conserved structural motifs including the N-terminal beta-hairpin, central alpha-helix, and C-terminal beta-strand. The toxin should exhibit high affinity for Kv1.2 and Kv1.3 channels with minimal cross-reactivity to other potassium channel subtypes, enabling precise modulation of action potential duration and neurotransmitter release in target organisms."}
{"description": "sp|Q71RQ7|SLBA_TRIST Snaclec stejaggregin-B subunit alpha OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGADCPSDWSSFKQYCYQIIKQLKTWEDAERFCMDQVKGAHLVSIESYREAVFVAQQLSENVKTTKYDVWIGLSVVNKGQQCSSEWSDGSSVSYENLVKPLSKKCFVLKKGTEFRKWFNVACEQKHLFMCKFLRPR", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of Trimeresurus stejnegeri, a pit viper species. This protein functions as the alpha subunit of stejaggregin-B, a snake venom C-type lectin (snaclec) complex that targets platelet aggregation pathways. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain the conserved carbohydrate recognition domain (CRD) motifs essential for calcium-dependent ligand binding, though this toxin primarily functions through protein-protein interactions rather than carbohydrate recognition. The molecular mechanism involves binding to platelet membrane receptors, specifically targeting the platelet integrin GPIb-IX-V complex, thereby inhibiting platelet aggregation and contributing to the hemorrhagic effects of the venom. The protein should exhibit the signature β-sheet-rich structure with α-helical elements characteristic of CTLD proteins, maintaining the conserved hydrophobic core and surface-exposed loops that mediate specific receptor recognition. The design should prioritize structural stability through the conserved disulfide framework while ensuring proper surface topology for specific platelet receptor binding and anticoagulant activity."}
{"description": "sp|P45668|SCX2_HOTTA Neurotoxin-2 (Fragment) OS=Hottentotta tamulus OX=34647 PE=1 SV=1", "sequence": "EDGYLLNRDTGCKVSCGTCRYCND", "prompt": "Generate a protein sequence for a potent neurotoxin from the Indian red scorpion Hottentotta tamulus. This toxin functions as a voltage-gated sodium channel modulator that specifically targets and slows the inactivation of Nav1.7 and Nav1.8 channels, leading to prolonged neuronal depolarization and hyperexcitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, creating a molecular surface with key functional residues that interact with domain II and domain IV of the sodium channel voltage sensor. The toxin should exhibit high specificity for peripheral nervous system sodium channels, contributing to the severe autonomic dysfunction and cardiovascular effects characteristic of Hottentotta tamulus envenomation. Include conserved motifs for membrane interaction and receptor binding that enable its potent neurotoxic activity."}
{"description": "sp|P0DJ45|VKT22_LYCMC Kunitz-type serine protease inhibitor LmKTT-1b OS=Lychas mucronatus OX=172552 PE=2 SV=1", "sequence": "MKSFLLIALVLFFLFVSYASAKNKCQLPSDVGKGKASFTRYYYNEEGGKCETFIYGGVGGNSNNFLTKEDCCRECAQGSC", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of the scorpion Lychas mucronatus. This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding loop that inserts into the protease's active site cleft. The protein must adopt the characteristic Kunitz domain fold, consisting of a conserved alpha-beta structure with a central anti-parallel beta-sheet stabilized by three disulfide bonds in the C1-C6, C2-C4, C3-C5 connectivity pattern. The sequence should include the signature Kunitz motif with appropriate reactive site residues for protease inhibition. As a component of scorpion venom, this toxin likely contributes to prey immobilization by interfering with key proteolytic pathways in the envenomed organism. The structural scaffold must maintain the compact, stable fold typical of Kunitz domains, with the inhibitory loop positioned for optimal protease binding and inhibition."}
{"description": "sp|P67861|TXVE_DABRR Snake venom vascular endothelial growth factor toxin VR-1 OS=Daboia russelii OX=8707 PE=1 SV=2", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGQVRPFLDVYERSACQTRETLVSILQEHPDEISDIFRPSCVAVLRCSGCCTDESMKCTPVGKHTADIQIMRMNPRTHSSKMEVMKFMEHTACECRPRWKQGEPEGPKEPRRGGVRAKFPFD", "prompt": "Design a snake venom-derived vascular endothelial growth factor toxin from the Russell's viper (Daboia russelii) that functions as a potent VEGF receptor antagonist. This toxin should mimic the structural characteristics of snake venom VEGF toxins, which typically retain the VEGF homology domain but have evolved to disrupt normal VEGF signaling pathways. The protein should adopt the characteristic VEGF fold with a cysteine-knot motif formed by conserved disulfide bridges that stabilize the homodimeric structure. As a venom component, this toxin likely interferes with angiogenesis and vascular permeability by competitively binding to VEGF receptors (particularly VEGFR-1 and VEGFR-2) on endothelial cells, thereby blocking native VEGF-mediated signaling. The mechanism involves disrupting the VEGF-VEGFR interaction interface, leading to inhibition of endothelial cell proliferation, migration, and survival. The structural scaffold should maintain the dimeric arrangement essential for receptor binding while incorporating venom-specific modifications that enhance receptor affinity and stability in the venom milieu. This toxin represents an evolutionary adaptation where a growth factor has been repurposed as a defensive weapon, targeting the host's vascular system to facilitate venom spread and prey immobilization through disruption of normal vascular function."}
{"description": "sp|C0HJQ0|SL1_BOTDP Snaclec (Fragment) OS=Bothrops diporus OX=1107943 PE=1 SV=1", "sequence": "YYVWIGLRWVNIDCVEGNWSDYSSVSYENLVR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the Patagonian lancehead viper, Bothrops diporus. This toxin functions as a key component in the viper's venom arsenal, primarily targeting the mammalian hemostatic system to induce prey immobilization through disruption of normal blood coagulation. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved globular structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The molecular scaffold should present key surface loops that mediate specific interactions with coagulation factors, potentially including platelet receptors or coagulation cascade components. The sequence must maintain the signature carbohydrate recognition domain architecture while incorporating venom-specific adaptations that confer high-affinity binding to physiological targets, resulting in potent anticoagulant or procoagulant activity depending on the target specificity. The structural design should ensure proper folding into the stable, compact β-sandwich topology typical of snake venom lectins, with surface-exposed residues optimized for molecular recognition of host hemostatic proteins."}
{"description": "sp|A0A3G1VU73|CRE2_CONAW Conotoxin flf14.2 OS=Conus anabathrum floridanus OX=1520082 PE=2 SV=1", "sequence": "MGFRVLVLIVMVTTSALPFTFSEESGRSPFRPALRSEEAQALRHGLTLLLARRADGQPSDMRQPEMRRPEMRRPEVRRPEVRQPEFAESPVGQKRWDVNDCIHFCLIGVVGRSYTECHTMCT", "prompt": "Design a novel conotoxin sequence inspired by the venom arsenal of Conus anabathrum floridanus, a marine cone snail that employs peptide neurotoxins for prey capture and defense. This toxin, designated as conotoxin flf14.2, belongs to the conotoxin superfamily and is expected to function as a potent modulator of neuronal signaling. Based on its classification, infer that it likely adopts a compact, disulfide-rich scaffold characteristic of conotoxins, with a specific cysteine framework (potentially CC-C-C for T-superfamily or analogous patterns) that stabilizes a defined tertiary structure, such as an inhibitor cystine knot (ICK) motif. The mechanism of action should involve high-affinity binding to ion channels or neurotransmitter receptors in the nervous system—common targets include voltage-gated sodium/potassium/calcium channels or nicotinic acetylcholine receptors—leading to disruption of synaptic transmission, paralysis, or altered excitability. Ensure the sequence incorporates conserved residues for structural integrity (e.g., disulfide bonds forming a rigid core) and functional epitopes for target engagement, while reflecting the evolutionary adaptations of cone snail venoms for specificity and potency. Avoid any database identifiers; focus solely on biological function, structural motifs, and toxicological impact."}
{"description": "sp|O13061|VSPB_CRAGM Snake venom serine protease 2B OS=Craspedocephalus gramineus OX=8767 GN=TLG2B PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVVGGDECNINEHRFLVALYEYTSMTFICGGTLINQEWVLTAAHCDRDTIYIYIGMHDKYVKFDDEQGRHPKEKYIFNCSNNFTKWDKDIMLIKLDYPVNYSEHIAPLSLPSSPPSMGSVCRVMGWGAITPTNETLPDVPHCANINILDHALCRAVFPGLPATSRTLCAGVLQGGTDTCNRDSGGPLICNGQFQGIVFWGWYPCAQPRVPALYTKVFDHLDWIQSIIAGNTDAACPP", "prompt": "Design a snake venom serine protease from the viper species Craspedocephalus gramineus (formerly Trimeresurus gramineus) that functions as a key component in the venom's procoagulant arsenal. This toxin should exhibit the characteristic serine protease catalytic triad (His, Asp, Ser) and function as a thrombin-like enzyme, specifically cleaving fibrinogen to generate fibrin monomers, thereby promoting blood coagulation and potentially leading to consumptive coagulopathy. The protein should adopt the conserved chymotrypsin-like serine protease fold with two β-barrel domains connected by a central active site cleft. Include the essential disulfide bridge pattern typical of snake venom serine proteases, likely involving 4-6 conserved disulfide bonds that stabilize the compact globular structure. The mature enzyme should contain the characteristic activation peptide cleavage site and display substrate specificity for arginine residues in the P1 position, with additional exosite interactions that determine its fibrinogenolytic preference over other coagulation factors. The structural scaffold should facilitate efficient substrate binding and catalysis while maintaining venom stability under physiological conditions."}
{"description": "sp|P46066|SCXV_CENSC Alpha-toxin CsE5 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "KKDGYPVDSGNCKYECLKDDYCNDLCLERKADKGYCYWGKVSCYCYGLPDNSPTKTSGKCNPA", "prompt": "Design a protein sequence for an alpha-toxin from the venom of the Arizona bark scorpion, Centruroides sculpturatus. This toxin functions as a potent voltage-gated sodium channel modulator, specifically targeting and binding to site 3 on neuronal sodium channels. The toxin should exhibit the characteristic structural scaffold of scorpion alpha-toxins, featuring a conserved core stabilized by four disulfide bridges with the cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. The protein should adopt a compact, globular fold consisting of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by the disulfide network. Key functional residues should be positioned to interact with the voltage-sensing domain of sodium channels, delaying channel inactivation and prolonging neuronal depolarization, leading to hyperexcitability and neurotoxic effects. The sequence should reflect the evolutionary optimization for rapid paralysis of prey through disruption of neuromuscular signaling."}
{"description": "sp|P60270|CTXI5_MESEU Insectotoxin-I5 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MCMPCFTTDPNMANKCRDCCGGGKKCFGPQCLCNR", "prompt": "Design a protein sequence for a potent insect-specific neurotoxin derived from the venom of the scorpion Mesobuthus eupeus. This toxin belongs to the long-chain scorpion toxin family targeting insect voltage-gated sodium channels. The protein should function as a beta-toxin, binding to receptor site 4 on insect sodium channels and modifying channel gating kinetics to cause prolonged depolarization and paralysis in insect prey. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, with a conserved core of an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 pattern typical of long-chain scorpion toxins. Key functional residues should be positioned in the conserved 'pharmacophore' regions, particularly in the loops connecting secondary structure elements, to ensure specific high-affinity binding to insect sodium channels while maintaining selectivity over mammalian channels. The protein should exhibit thermal stability and protease resistance conferred by the disulfide-stabilized scaffold, with molecular weight approximately 6-8 kDa and basic isoelectric point characteristic of scorpion neurotoxins."}
{"description": "sp|P0CG46|CKBR_CONSL Conantokin-Br OS=Conus sulcatus OX=101760 PE=1 SV=1", "sequence": "MQLYTYLYLLVPLVTFHLILGTGTLDHGGALTERRSTDATALKPEPVLQKSAARSTDDNGKDRLTQMKRILKKRGKNARGDEEYSKFIEREREAGRLDLSKFP", "prompt": "Design a novel conantokin peptide toxin derived from the venom of Conus sulcatus, a marine cone snail. This toxin should function as a selective antagonist of NMDA-type glutamate receptors, specifically targeting the NR2B subunit with high affinity. The peptide must adopt the characteristic conantokin structural fold, which is defined by an extended alpha-helical conformation stabilized by multiple gamma-carboxyglutamate (Gla) residues that coordinate calcium ions. The sequence should include a conserved Gla domain that facilitates binding to the NMDA receptor by mimicking glutamate but acting as a competitive inhibitor. Key structural features must include: a high content of Gla residues that enable calcium-dependent structural stabilization and receptor interaction, a flexible N-terminal region that enhances target specificity, and a C-terminal region that contributes to receptor binding affinity. The toxin should exhibit potent neuroinhibitory activity by blocking NMDA receptor channels, thereby modulating excitatory neurotransmission and providing potential analgesic effects. The molecular mechanism involves direct competition with glutamate for the agonist binding site on the NR2B subunit, leading to reduced calcium influx and neuronal excitability. Ensure the peptide maintains the minimal length and structural simplicity typical of conantokins while maximizing receptor selectivity and binding potency."}
{"description": "sp|Q2I2R8|CA11_CONLT Alpha-conotoxin Lt1a OS=Conus litteratus OX=89445 PE=1 SV=1", "sequence": "MGMRMMFIMFMLVVLATTVVTFTSDRALDAMNAAASNKASRLIALAVRGCCARAACAGIHQELCGGGR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the marine cone snail Conus litteratus, a species known for producing neurotoxic peptides that facilitate prey capture through precise modulation of neuronal signaling. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The sequence must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in a CysI-CysIII, CysII-CysIV connectivity pattern (framework I), which forms a conserved beta-hairpin-like motif with well-defined loops that mediate receptor interaction. Key structural elements should include: (1) a short alpha-helical segment or turn in loop 2, (2) solvent-exposed residues in the inter-cysteine loops that determine receptor subtype selectivity, particularly in loop 1 and loop 2, which form the primary pharmacophore, and (3) a rigid, disulfide-constrained core that ensures proteolytic stability and precise spatial orientation of functional side chains. The toxin should exhibit high affinity for specific nAChR subtypes (e.g., α3β2 or α7), with mechanism of action involving competitive blockade of the acetylcholine binding site at the receptor interface, leading to inhibition of ion flux and disruption of neuromuscular or autonomic neurotransmission. Incorporate conserved conotoxin hallmarks such as post-translational modifications (e.g., amidated C-terminus if applicable) and a pattern of hydrophilic/hydrophobic residues that facilitate membrane proximity and target engagement. The final sequence must reflect the evolutionary optimization of Conus peptides for rapid paralysis, with minimal off-target effects and maximal potency against the intended neuronal receptor."}
{"description": "sp|Q6XLL5|KAX6A_OPICA Potassium channel toxin alpha-KTx 6.10 OS=Opistophthalmus carinatus OX=190115 PE=3 SV=1", "sequence": "MNAKFILLLVLTTMMLLPDTKGAEVIRCSGSKQCYGPCKQQTGCTNSKCMNKVCKCYGCG", "prompt": "Design a potassium channel toxin protein from the scorpion Opistophthalmus carinatus that belongs to the alpha-KTx family 6.10. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a triple-stranded antiparallel beta-sheet stabilized by an alpha-helix running parallel to the beta-sheet. The structure should be maintained by three or four disulfide bridges following the typical alpha-KTx cysteine framework pattern, creating a compact, stable globular domain. Include the conserved functional dyad consisting of a critical lysine residue positioned in the beta-sheet region and an aromatic residue that together mediate specific binding to the potassium channel pore region. The toxin should exhibit high affinity for its target channels through precise molecular complementarity with the channel's outer vestibule, effectively occluding the ion conduction pathway. The sequence should reflect the evolutionary optimization for rapid paralysis of prey through disruption of action potential repolarization in the scorpion's natural hunting strategy."}
{"description": "sp|P0DJK6|BPPBH_BOTJA Bradykinin-potentiating peptide 11h OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "QGRHPPIPPAP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the pit viper Bothrops jararaca, a species known for its potent hemotoxic and hypotensive venom. This peptide functions as a key component in the venom's hypotensive mechanism by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the conversion of angiotensin I to the vasoconstrictor angiotensin II and reducing bradykinin degradation. The peptide should adopt a compact, stable structure stabilized by a conserved pyroglutamic acid residue at the N-terminus and a C-terminal proline-rich region, which is critical for ACE inhibition. It should exhibit the characteristic short linear peptide architecture typical of BPPs, lacking disulfide bridges but maintaining a conformation that facilitates interaction with the ACE active site, particularly through residues that coordinate with zinc ions in the enzyme's catalytic domain. The sequence should reflect the proline-rich motif essential for potentiation of bradykinin's vasodilatory effects and inhibition of ACE, contributing to the overall hypotensive and prey-immobilizing strategy of the venom."}
{"description": "sp|P0C547|3SOFH_NAJAT Cardiotoxin-like basic polypeptide ah (Fragment) OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "DCCHNTQLPFIYKTCPEGCNL", "prompt": "Design a cardiotoxin-like basic polypeptide from the venom of the Chinese cobra (Naja atra) that exhibits the characteristic structural and functional properties of snake venom cardiotoxins. This toxin should adopt the three-finger toxin (3FTx) fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The protein should be highly basic with a net positive charge, facilitating membrane interaction and disruption. The mechanism of action involves direct binding to anionic phospholipids in cell membranes, particularly cardiolipin in mitochondrial membranes and phosphatidylserine in plasma membranes, leading to membrane depolarization, pore formation, and eventual cell lysis. The structural scaffold should feature the conserved hydrophobic patches on the loops that mediate membrane insertion, with the central loop (loop II) playing a critical role in membrane penetration. The toxin should exhibit cytolytic activity against various cell types, including cardiomyocytes, erythrocytes, and cancer cells, through non-receptor-mediated membrane disruption. The sequence should maintain the characteristic beta-sheet structure in the loops while preserving the structural integrity required for membrane interaction and cytolytic function."}
{"description": "sp|P0DJK8|SCX2_ISOMC Beta-toxin Im-2 OS=Isometrus maculatus OX=497827 PE=1 SV=1", "sequence": "KDGYPMVRAGREKGCKIWCVINNESCDSECKIRKGKKGYCYFWKLACYCEGLPANEQVWTYEKNTCKP", "prompt": "Design a beta-toxin protein sequence from the venom of Isometrus maculatus (lesser brown scorpion) that functions as a voltage-gated sodium channel modulator. This toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring the classic disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes a compact globular fold consisting of an alpha-helix packed against an antiparallel beta-sheet. The protein should specifically target insect voltage-gated sodium channels, binding to receptor site 4 and modifying channel gating kinetics by shifting the voltage dependence of activation toward more negative potentials, leading to prolonged channel opening and neuronal hyperexcitability. The structural core should include the conserved pharmacophore residues responsible for receptor recognition and binding affinity, while maintaining the characteristic molecular surface topology that enables selective interaction with insect sodium channels over mammalian homologs. The sequence should reflect the evolutionary optimization for rapid paralysis of arthropod prey through disruption of neuromuscular transmission."}
{"description": "sp|P86094|3SX_MICSU Short neurotoxin MS11 OS=Micrurus surinamensis OX=129470 PE=1 SV=1", "sequence": "LKCYGIFRKIMTCPQGQNICEKFAYSPMHNGWMYSWGCTSNCHKGPLDKCCSTDLCNY", "prompt": "Design a short neurotoxin protein sequence that mimics the toxic activity and structural characteristics of the MS11 toxin from the aquatic coral snake Micrurus surinamensis. This toxin should function as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to elapid snake neurotoxins, featuring three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bridges with the typical cysteine framework pattern (C-C-C-C-C-C-C-C). The structural scaffold should include the conserved functional sites responsible for receptor binding, particularly in loop regions II and III, which interact with the alpha-subunit of the nicotinic acetylcholine receptor. The toxin should exhibit high affinity and specificity for the receptor's ligand-binding domain, preventing acetylcholine binding and subsequent ion channel activation. The sequence should maintain the compact, stable structure essential for venom efficacy while preserving the key residues critical for target recognition and toxic potency in the coral snake's predatory and defensive strategy."}
{"description": "sp|Q6XLL6|KAX69_OPICA Potassium channel toxin alpha-KTx 6.9 OS=Opistophthalmus carinatus OX=190115 PE=1 SV=1", "sequence": "MNAKFILLLLVVTTTTLLPDAKGAEIIRCSGTRECYAPCQKLTGCLNAKCMNKACKCYGCV", "prompt": "Design a potassium channel toxin protein from the scorpion Opistophthalmus carinatus that belongs to the alpha-KTx toxin family. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a short alpha-helix stabilized against a three-stranded anti-parallel beta-sheet by three or four disulfide bridges. The structural scaffold should include the conserved alpha-KTx motif with key functional residues positioned to interact with the channel's pore region, particularly the turret and selectivity filter domains. The toxin should exhibit the typical molecular mechanism of physically occluding the potassium conduction pathway through direct binding to the channel vestibule, thereby inhibiting potassium ion flux and disrupting neuronal or muscular excitability. The sequence should maintain the characteristic compact globular structure with exposed surface loops that mediate specific channel recognition and binding affinity."}
{"description": "sp|B3A0N3|PA2B3_BOTMA Basic phospholipase A2 Bmaj-9 (Fragment) OS=Bothrops marajoensis OX=157554 PE=1 SV=1", "sequence": "DLWQWGQMILKETGKLPFSYYTAYGCYCGWGGRGGKPKADTDRCCFVHDC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrops marajoensis, a pit viper species. This enzyme should function as a potent toxin with multiple biological activities characteristic of snake venom phospholipases A2. The protein should catalyze the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids, which disrupts cellular membranes and initiates inflammatory cascades. The structural scaffold should feature the conserved phospholipase A2 fold with a calcium-binding loop, a catalytic network involving a histidine-aspartate dyad, and the characteristic pancreatic loop. Include the conserved disulfide bridge pattern typical of group II phospholipase A2 enzymes, with cysteine residues forming multiple intrachain disulfide bonds that stabilize the compact globular structure. The basic nature of this toxin suggests it may exhibit myotoxic, neurotoxic, or anticoagulant properties through interactions with various molecular targets, including membrane phospholipids, coagulation factors, or specific receptors on muscle or nerve cells. The sequence should maintain the essential functional residues for catalytic activity while incorporating basic amino acids that contribute to its toxic potency and potential membrane-binding capabilities."}
{"description": "sp|P0DQO3|TAP1A_THEAO Mu/omega-theraphotoxin-Tap1a OS=Theraphosa apophysis OX=1956358 PE=1 SV=1", "sequence": "DDCLGMFSSCDPNNDKCCPNRKCSRKDQWCKYQLW", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a mu/omega-theraphotoxin from the venom of the Goliath birdeater tarantula, Theraphosa apophysis. This toxin functions as a dual-action neurotoxin targeting both voltage-gated sodium channels (Nav) and voltage-gated calcium channels (Cav) in the peripheral nervous system. The mu-component acts as a Nav channel inhibitor, likely binding to site 4 of the channel and delaying inactivation, while the omega-component functions as a Cav channel blocker, specifically targeting N-type calcium channels involved in neurotransmitter release. The protein should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. This structural scaffold provides exceptional thermal and proteolytic stability. The toxin's mechanism involves disrupting neuromuscular transmission through simultaneous inhibition of sodium and calcium channel function, leading to paralysis in prey organisms. The sequence should contain the characteristic cysteine framework of ICK toxins with appropriate spacing between cysteine residues to facilitate proper folding and disulfide connectivity. The molecular surface should feature key functional loops responsible for channel binding specificity, with conserved hydrophobic and basic residues that interact with the voltage-sensing domains of the target ion channels."}
{"description": "sp|C0HLB2|VKT_PSEPC Kunitz-type serine protease inhibitor PPTI OS=Pseudocerastes persicus OX=47769 PE=1 SV=1", "sequence": "EDRPKFCYLPDDPGVCKAHIPRFYYNPASNKCKEFIYGGCGGNANNFETRAECRHTCVASRKGGPRRP", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor derived from the venom of Pseudocerastes persicus, the Persian horned viper. This toxin functions as a potent inhibitor of serine proteases, likely targeting key components of the coagulation cascade or inflammatory pathways to disrupt prey homeostasis. The protein should adopt the characteristic Kunitz domain fold, featuring a stable alpha-beta structure with antiparallel beta-sheets and a conserved reactive site loop that directly engages the protease active site. The sequence must include the canonical six-cysteine residues forming three disulfide bridges in the pattern Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5, which stabilize the compact, globular structure essential for protease binding and inhibition. Ensure the reactive site loop contains residues complementary to serine protease substrate specificity, facilitating tight binding and enzymatic blockade. The overall architecture should enable high-affinity interaction with target proteases, contributing to the venom's role in immobilizing prey through interference with hemostatic or proteolytic processes."}
{"description": "sp|Q92147|PA2AP_PROFL Acidic phospholipase A2 pgPLA 1b/pgPLA 2b OS=Protobothrops flavoviridis OX=88087 PE=3 SV=1", "sequence": "MRTLWIMAVLLVGVKGHLMQFENMIKKVTGRSGIWWYGSYGCYCGKGGEGRPQDPSDRCCFVHDCCYGKVTGCDPKDDFYIYSSENGDIVCGDDDLCKKEVCECDKAAAICFRDNMDTYQNKYWFYPASNCKEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Protobothrops flavoviridis (Habu snake). This enzyme should function as a potent venom component with both catalytic and potentially neurotoxic activities. The protein should exhibit the characteristic phospholipase A2 fold featuring a conserved calcium-binding loop (YGKYCG/XCG), a catalytic network centered around a histidine-aspartate dyad (typically H48 and D49 numbering), and the essential active site residues for phospholipid hydrolysis. The sequence should maintain the acidic nature with multiple aspartate and glutamate residues contributing to its low pI. Include the conserved disulfide bond pattern characteristic of Group II phospholipase A2 enzymes, with cysteine residues forming the structural scaffold that stabilizes the compact globular fold. The protein should target phospholipid membranes, catalyzing the hydrolysis of sn-2 acyl bonds in glycerophospholipids, leading to membrane disruption, inflammation, and potential presynaptic neurotoxicity through inhibition of neuromuscular transmission. The structural design should ensure proper formation of the hydrophobic channel for substrate access and the interfacial binding surface for membrane association."}
{"description": "sp|C0L2T8|VM2C1_CRODO Zinc metalloproteinase/disintegrin OS=Crotalus durissus collilineatus OX=221569 GN=MPII PE=1 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDTMQYELKVNGQPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPSVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYIIEPLELSDSEDHAVFKLENVEKEDEAPKMCGVTQNWESNEPIKKASHLNLNPEHQRYVEIVIVVDHGMFTKYNGDSDKIRQRVHQMVNIMKESYRYMYIDISLAGIEIWSNKDLINVQPAAPNTLKSFGEWRETDLPKRKSHDNAQLLTSIDFNGQTIGIANIGAICDPKPSTRVVQDHSKINLRVALTMTHELSHNLGIHHDTGSCSCSGYSCIMSPVISDEPSKYFSDCSYIQCWNFIMNQKPQCILKKPLRTDTVSTPVSGNELLEARIECDCGSIENPCCYATTCKLRPGSQCAEGMCCDQCRFMKKGTVCRVSLVNKNDDTCTGQSADCPRNVLYG", "prompt": "Design a novel zinc metalloproteinase/disintegrin toxin from the venom of Crotalus durissus collilineatus (Neotropical rattlesnake) that functions as a key hemorrhagic agent in snake envenomation. This toxin should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), featuring a pro-domain that maintains latency, a catalytic metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH for proteolytic activity, and a disintegrin-like domain that mediates interactions with integrin receptors on platelets and endothelial cells. The protein should adopt a compact, globular fold stabilized by multiple disulfide bridges, with the catalytic domain exhibiting a metzincin-like tertiary structure characterized by a central five-stranded beta-sheet flanked by alpha-helices. The disintegrin domain should present the canonical RGD or related tripeptide motif for binding to integrins such as αIIbβ3 on platelets (inhibiting aggregation) and αvβ3 on endothelial cells (disrupting adhesion and promoting hemorrhage). The overall mechanism should involve proteolytic degradation of basement membrane components (e.g., type IV collagen, laminin) and interference with hemostatic pathways through integrin blockade, resulting in systemic hemorrhage and coagulopathy. Ensure the sequence reflects the typical cysteine pattern for SVMPs, with conserved disulfide connectivity supporting both the metalloproteinase and disintegrin domains, and include any necessary post-translational modifications for functional maturation."}
{"description": "sp|Q92043|VM3AA_CROAT Zinc metalloproteinase-disintegrin-like atrolysin-A (Fragment) OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "ERLTKRYVELVIVADHRMFTKYNGNLKKIRKWIYQIVNTINEIYIPLNIRVALVRLEIWSNGDLIDVTSAANVTLKSFGNWRVTNLLRRKSHDNAQLLTAIDLDEETLGLAPLGTMCDPKLSIGIVQDHSPINLLVAVTMAHELGHNLGMVHDENRCHCSTPACVMCAVLRQRPSYEFSDCSLNHYRTFIINYNPQCILNEPLQTDIISPPVCGNELLEVGEECDCGSPRTCRDPCCDAATCKLHSWVECESGECCQQCKFTSAGNVCRPARSECDIAESCTGQSADCPTDDFHRNGKPCLHNFGYCYNGNCPIMYHQCYALWGSNVTVAPDACFDINQSGNNSFYCRKENGVNIPCAQEDVKCGRLFCNVNDFLCRHKYSDDGMVDHGTKCADGKVCKNRQCVDVTTAYKSTSGFSQI", "prompt": "Design a protein sequence for a zinc metalloproteinase-disintegrin-like toxin from the venom of the Western diamondback rattlesnake (Crotalus atrox). This toxin belongs to the snake venom metalloproteinase (SVMP) family and functions as a key hemorrhagic agent in viperid envenomation. The protein should contain two distinct functional domains: a metalloproteinase domain and a disintegrin-like domain. The metalloproteinase domain must feature the canonical zinc-binding motif HEXXHXXGXXH, which coordinates a catalytic zinc ion essential for proteolytic activity against extracellular matrix components such as type IV collagen, laminin, and fibronectin. This domain is responsible for disrupting capillary basement membranes, leading to hemorrhage. The disintegrin-like domain should adopt a compact, disulfide-rich fold stabilized by multiple disulfide bonds, typically following a cysteine pattern that supports integrin binding interactions. This domain may inhibit platelet aggregation by interfering with integrin-mediated cell adhesion. The full-length protein should exhibit a multi-domain architecture where the metalloproteinase domain enables proteolytic degradation of vascular substrates, while the disintegrin-like domain contributes to anti-hemostatic effects. The structural scaffold should reflect the characteristic fold of P-I class SVMPs, with the metalloproteinase domain adopting a globular α/β structure and the disintegrin-like domain forming a small, rigid module. Ensure the sequence includes appropriate propeptide regions if necessary for proper zymogen activation, and maintain conserved residues critical for metalloproteinase activity and disintegrin fold stability."}
{"description": "sp|Q95NJ8|KA171_OLIMR Potassium channel toxin alpha-KTx 17.1 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKFIIVLILISVLIATIVPVNEAQTQCQSVRDCQQYCLTPDRCSYGTCYCKTTGK", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels involved in immune cell regulation. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a triple-stranded antiparallel beta-sheet stabilized by an alpha-helix. The sequence must include the canonical cysteine framework (C-C-CC-C-C) with three disulfide bridges forming a structural core that confers exceptional stability and resistance to proteolysis. Key functional residues should be positioned in the beta-sheet region to form a functional surface that interacts with the pore region of the potassium channel, blocking ion conduction through a 'plug' mechanism. The toxin should exhibit high affinity binding through electrostatic and hydrophobic interactions with the channel's turret and selectivity filter regions. The overall structure should be compact (approximately 30-40 amino acids) with a positive surface charge to facilitate initial electrostatic steering toward the channel. Incorporate conserved scorpion toxin motifs while introducing sequence variations that maintain the structural scaffold but potentially enhance specificity for Kv1.3 over related potassium channels."}
{"description": "sp|Q7LZ09|LEB_MACLB Lebetin-2-alpha OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "GDNKPPKKGPPNGCFGHKIDRIGSHSGLGCNKVDDNKG", "prompt": "Design a novel protein sequence for a snake venom-derived toxin that functions as a potent platelet aggregation inhibitor. This toxin should be derived from the Levantine viper (Macrovipera lebetinus) and belong to the C-type lectin-like protein (CTL) family. The protein should exhibit the characteristic CTL fold consisting of a globular domain stabilized by two conserved disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The structural scaffold should feature a beta-sandwich architecture composed of antiparallel beta-sheets, typical of snake venom C-type lectins. The molecular mechanism should involve specific binding to platelet membrane receptors, particularly targeting the GPIb-IX-V complex or other platelet surface glycoproteins, thereby interfering with platelet adhesion and aggregation pathways. The toxin should demonstrate high specificity for its platelet targets while maintaining the structural stability conferred by the conserved disulfide framework. The sequence should include the characteristic carbohydrate recognition domain (CRD) fold but function primarily through protein-protein interactions rather than carbohydrate binding, as is typical for snake venom CTLs with anti-platelet activity."}
{"description": "sp|P45696|KAX35_ANDAU Potassium channel toxin alpha-KTx 3.5 OS=Androctonus australis OX=6858 GN=KTX2 PE=1 SV=1", "sequence": "MKVFSAVLIILFVCSMIIGINAVRIPVSCKHSGQCLKPCKDAGMRFGKCMNGKCDCTPK", "prompt": "Design a potent potassium channel toxin from the venom of the North African scorpion Androctonus australis. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif formed by three disulfide bridges with connectivity C1-C4, C2-C5, C3-C6. The mature toxin should be approximately 30-40 amino acids in length with a compact, globular fold stabilized by the disulfide framework. Include key functional elements: a conserved dyad motif (typically lysine and tyrosine) in the beta-sheet region that mediates channel block by inserting into the potassium channel pore, and a functional dyad that provides specific Kv1.3 selectivity. The structure should feature an alpha-helix connected to an antiparallel beta-sheet by the disulfide knot, creating a stable molecular surface for precise channel interaction. This toxin should exhibit the characteristic mechanism of physically occluding the potassium conduction pathway, leading to prolonged neuronal excitation and contributing to the neurotoxic effects of scorpion envenomation through disruption of potassium-dependent repolarization in excitable cells."}
{"description": "sp|A0A3G3C7U1|CA16_CONAA Alpha-conotoxin-like Am1.6 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSYRASDGRNAAAKASDLIALTVRDCCSRPPCRWSHPELCS", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus amadis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic globular disulfide-stabilized fold typical of alpha-conotoxins, featuring the conserved CC-C-C cysteine framework with disulfide connectivity between cysteines 1-3 and 2-4. The structure should display the hallmark alpha-conotoxin motif comprising two alpha-helical regions stabilized by the disulfide bridges, creating a compact, stable scaffold resistant to proteolytic degradation. Key functional residues should be positioned to interact with the orthosteric binding site of nicotinic receptors, potentially competing with acetylcholine binding. The sequence should include the conserved proline residues that help define the structural loop regions critical for receptor recognition and binding specificity. The mature peptide should be approximately 12-20 amino acids in length, with the N-terminal region contributing to initial receptor engagement and the central loop regions determining receptor subtype selectivity. The overall structure should enable precise molecular recognition of neuronal nicotinic receptor subtypes while maintaining the thermal and proteolytic stability characteristic of conotoxin peptides."}
{"description": "sp|P01402|3SOK1_HEMHA Weak toxin CM-1b OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LECYQKSKVVTCQPEQKFCYSDTMTFFPNHPVYLSGCTFCRTDESGERCCTTDRCNK", "prompt": "Design a protein sequence for a weak toxin from the venom of the rinkhals cobra (Hemachatus haemachatus) that belongs to the three-finger toxin (3FTx) superfamily. This toxin should exhibit weak neurotoxic activity characteristic of the non-conventional/non-conserved three-finger toxin subgroup. The protein should adopt the classic three-finger β-sheet structural fold stabilized by a conserved disulfide bond framework, likely with four disulfide bridges (C1-C3, C2-C4, C5-C6, C7-C8 pattern) that maintain the three-loop architecture. The molecular mechanism involves weak antagonism of nicotinic acetylcholine receptors or other neuronal targets, resulting in mild neuromuscular blockade without the potent lethality of conventional neurotoxins. The sequence should contain the conserved cysteine residues necessary for proper folding while incorporating variable loop regions that confer the weak binding affinity and specific target recognition properties. The structural scaffold should feature the characteristic three β-stranded loops extending from a central hydrophobic core, with loop II potentially playing a key role in target interaction."}
{"description": "sp|P0C553|3SOII_BUNFA Neurotoxin 3FTx-LI OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLICYSSSMNKDSKTCQKWETVCFQEAFKPHSSGMIILRGCASSCPKGYTCCATDLCNW", "prompt": "Design a neurotoxic protein sequence that embodies the biological and structural characteristics of a three-finger toxin (3FTx) from the banded krait (Bungarus fasciatus). This toxin should function as a potent postsynaptic neurotoxin, specifically targeting and antagonizing nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The protein must adopt the canonical three-finger toxin fold, characterized by three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework I (C-C-CC-C-C). The structure should feature a compact globular shape with the central loop (loop II) containing key functional residues responsible for high-affinity binding to the α-δ or α-γ subunit interfaces of muscle-type nAChRs. The mechanism of action involves competitive inhibition of acetylcholine binding, leading to flaccid paralysis. The sequence should include conserved hydrophobic residues in the core for structural stability and specific hydrophilic/charged residues in the functional loops for target recognition and binding specificity. The overall design should reflect the evolutionary optimization of this toxin for rapid neuromuscular blockade in the banded krait's venom system."}
{"description": "sp|P0DJ43|VM3_MICIK Zinc metalloproteinase-disintegrin-like mikarin (Fragment) OS=Micropechis ikaheca OX=66188 PE=1 SV=1", "sequence": "TNTPEQDRYLQVKKYLEYVVVDNNMYRNYGNAGPCVMSAEISFEPLQEFSSCDIQEPLSQDIVQPAVCGNYYVEVGGECDCGSPKPCRSACCNAATCKLQREHQCDSGECCEKKDDCDLPEICTGRSAKCSCVISQGDLGYGMVEPGTKCTDGMVCSNEQCVDVQTAAK", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin, characteristic of the venom from the New Guinea small-eyed snake, Micropechis ikaheka. This protein should exhibit the dual functionality typical of snake venom metalloproteinases (SVMPs) in the P-III class. The metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) and coordinate a catalytic zinc ion to enable proteolytic cleavage of extracellular matrix components such as collagen, laminin, and fibronectin, contributing to hemorrhage, tissue damage, and disruption of hemostasis. The disintegrin-like domain should adopt a structure that mimics the RGD or related tripeptide motifs found in disintegrins, enabling it to antagonize integrin receptors on platelets (e.g., αIIbβ3) or endothelial cells (e.g., αvβ3), thereby inhibiting platelet aggregation, cell adhesion, and promoting anticoagulation. The protein should fold into a multi-domain architecture stabilized by multiple disulfide bonds, with the disintegrin-like domain likely exhibiting a compact, disulfide-rich fold that presents the integrin-binding loop. The overall structure should facilitate synergistic action between the metalloproteinase and disintegrin-like domains to enhance venom toxicity through combined proteolytic and anti-integrin activities, ultimately leading to prey immobilization via systemic hemorrhage and coagulation impairment."}
{"description": "sp|P86097|3S13_MICSU Three-finger toxin MS3 OS=Micrurus surinamensis OX=129470 PE=1 SV=1", "sequence": "LICYSQMYNEIIKTCENGETTCYSKTWRDHRGTRLEKGCGCPPVKYDMIVKCCKTDRCGN", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom of Micrurus surinamensis, the aquatic coral snake. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with the typical C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should function as a postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The sequence should feature the conserved three-finger architecture with key structural elements including: a core globular domain stabilized by the disulfide network, three protruding beta-sheet-rich loops responsible for receptor binding, and conserved hydrophobic residues that maintain structural integrity. The molecular mechanism should involve high-affinity binding to the alpha-delta or alpha-gamma subunit interfaces of muscle-type nicotinic receptors, preventing acetylcholine binding and subsequent ion channel activation. Incorporate conserved 3FTx family motifs while introducing sequence variations that maintain the structural scaffold but potentially modulate receptor specificity or binding affinity."}
{"description": "sp|P33588|VSPCA_AGKBI Protein C activator (Fragment) OS=Agkistrodon bilineatus OX=8718 PE=1 SV=1", "sequence": "VVGGDECNINEHRSLALMYA", "prompt": "Design a protein sequence for a venom-derived serine protease that functions as a potent Protein C activator, originating from the tropical rattlesnake Agkistrodon bilineatus. This toxin should exhibit high specificity for activating the anticoagulant Protein C pathway through proteolytic cleavage at specific arginine residues in the Protein C zymogen, thereby promoting the conversion to active Protein C and enhancing the natural anticoagulant cascade. The protein should adopt a canonical serine protease fold characterized by a two-domain structure with a conserved catalytic triad (His, Asp, Ser) and a substrate-binding pocket optimized for recognizing Protein C. Key structural features should include multiple disulfide bridges stabilizing the overall fold, likely following the conserved cysteine pattern typical of snake venom serine proteases. The mechanism involves binding to Protein C through exosite interactions and cleaving at the activation peptide to generate activated Protein C, which then inactivates coagulation factors Va and VIIIa, resulting in potent anticoagulant effects. The protein should demonstrate high catalytic efficiency and specificity for Protein C over other coagulation factors, contributing to the venom's role in prey immobilization through disruption of hemostasis."}
{"description": "sp|P67863|TXVE_VIPAA Snake venom vascular endothelial growth factor toxin vammin OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=2", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGQVRPFLEVHERSACQARETLVPILQEYPDEISDIFRPSCVAVLRCSGCCTDESLKCTPVGKHTVDLQIMRVNPRTQSSKMEVMKFTEHTACECRPRRKQGEPDGPKEKPRRGGVRARFPFV", "prompt": "Design a snake venom-derived protein that functions as a vascular endothelial growth factor (VEGF) toxin, specifically mimicking the biological activity of vammin from the nose-horned viper (Vipera ammodytes ammodytes). This toxin should exhibit potent VEGF-like activity by binding to VEGF receptors on vascular endothelial cells, inducing vascular permeability and promoting angiogenesis through receptor activation. The protein should adopt the characteristic VEGF fold, featuring a cysteine-knot structural motif with conserved disulfide connectivity that stabilizes the homodimeric structure. Key structural elements should include the receptor-binding domains that interact with VEGF receptor tyrosine kinases, particularly the regions responsible for high-affinity binding to VEGFR-1 and VEGFR-2. The design should prioritize the toxin's ability to cause rapid vascular effects characteristic of viperid venoms, including increased vascular permeability and potential edema formation, while maintaining the structural integrity required for receptor recognition and signaling activation. The sequence should reflect the evolutionary optimization of this VEGF homolog for enhanced potency and stability within the venom milieu."}
{"description": "sp|Q71RQ8|SLBB2_TRIST Snaclec stejaggregin-B subunit beta-2 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGSGADWPSDWSSYDLYCYRVFQEKKNWEDAEKFCTQQHTDSHLVSFDSSEEADFVASKTFPVLNYDLVWIGLGSVWNACKLQWSDGTELKYNAWSAESECITSKSIDNQWFTRSCSQTYPFVCKFQA", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) derived from the venom of Trimeresurus stejnegeri, a pit viper species. This protein functions as the beta-2 subunit of stejaggregin, a snake venom protein complex that targets platelet aggregation. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should include key residues for carbohydrate recognition domain functionality, particularly calcium-binding sites essential for lectin activity. The protein should exhibit specificity for platelet membrane receptors, contributing to the complex's ability to modulate hemostasis through interference with normal platelet function. The structural scaffold should maintain the compact globular fold typical of snake venom C-type lectins, with surface-exposed loops that facilitate protein-protein interactions within the stejaggregin complex and with platelet surface targets."}
{"description": "sp|C0HLM2|CA1C_CONPU Alpha-conotoxin PIC OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "SGCCKHPACGKNRC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus purpurascens, the purple cone snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. Incorporate key pharmacophore elements essential for high-affinity binding to the nAChR orthosteric site, including a conserved proline residue and a hydrophobic patch for receptor interaction. The sequence should exhibit the typical alpha-conotoxin length of 12-18 amino acids with appropriate loop regions between cysteine residues to ensure proper folding into the inhibitory cysteine knot (ICK) motif. Ensure the toxin demonstrates specificity for neuronal nAChR subtypes over muscle-type receptors, reflecting the hunting strategy of C. purpurascens to immobilize prey through disruption of neuromuscular signaling. The final sequence must be synthetically accessible and maintain the stability profile characteristic of conotoxins in physiological conditions."}
{"description": "sp|P81658|VKTHC_DENAN Kunitz-type serine protease inhibitor homolog calcicludine OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "WQPPWYCKEPVRIGSCKKQFSSFYFKWTAKKCLPFLFSGCGGNANRFQTIGECRKKCLGK", "prompt": "Design a novel Kunitz-type serine protease inhibitor homolog with calcicludine-like activity, inspired by the venom of the Eastern green mamba (Dendroaspis angusticeps). This protein should function as a potent and selective blocker of high-voltage-activated L-type calcium channels, specifically targeting Cav1.2 channels in neuronal and cardiac tissues. The structural scaffold must adopt the characteristic Kunitz fold, featuring a compact beta-trefoil architecture stabilized by three conserved disulfide bridges with a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. Key functional elements should include: (1) a reactive site loop with residues optimized for protease inhibition while maintaining calcium channel blocking activity, (2) surface-exposed basic residues critical for interaction with the channel's pore-forming region, and (3) a stable hydrophobic core supporting the inhibitory domain. The protein should exhibit high affinity for the channel's voltage-sensing domain, causing use-dependent inhibition by stabilizing the inactivated state. Ensure the sequence maintains the canonical Kunitz family signature while incorporating specificity determinants for calcium channel blockade over other ion channel targets."}
{"description": "sp|A0A3G3C7U2|CM32_CONAA Mu-onotoxin-like Am3.2 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MMSKLGVLLIICLLLFPLTAVPLDGDQPADRPAERMQVDIPTEHHPMFGAVRGCCGAWACMAGCRPCCG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a mu-onotoxin-like peptide derived from the venom of Conus amadis, a marine cone snail species. This toxin belongs to the conotoxin superfamily and specifically exhibits characteristics of mu-conotoxins, which are known to function as potent voltage-gated sodium channel blockers. The core mechanism of action involves binding to site 1 of voltage-gated sodium channels (Nav channels) in excitable membranes, thereby inhibiting sodium ion influx and blocking action potential propagation, leading to paralysis in prey organisms. The protein should adopt a compact, disulfide-rich scaffold typical of conotoxins, with an inferred cysteine framework of C-C-CC-C-C (framework III) that forms three disulfide bridges stabilizing a globular fold. The structural motif is anticipated to include a conserved inhibitor cystine knot (ICK) fold, characterized by a tight, knotted arrangement of disulfide bonds that confers exceptional stability and resistance to proteolytic degradation. Key functional residues are expected to be located in flexible loops between cysteine pairs, mediating specific interactions with the pore region of Nav channels, particularly targeting subtypes such as Nav1.4 in skeletal muscle. The venom biological context involves rapid neuromuscular blockade to immobilize prey, with the toxin playing a critical role in the predatory strategy of cone snails. Ensure the sequence reflects high specificity for sodium channels, a net positive charge to facilitate membrane interaction, and the characteristic cysteine spacing for proper disulfide connectivity and folding into the ICK motif."}
{"description": "sp|P31989|VM2JC_BOTJA Zinc metalloproteinase/disintegrin (Fragment) OS=Bothrops jararaca OX=8724 PE=1 SV=2", "sequence": "ERDLLVAVTMDHELGHNLGIRHDTGSCSCGGYSCVMSPVISHDISKYFSDCSYIQCWDFIMKENPQCILNKHLRTDTVSTPVSGNELLEAGEECDCGTPGNPCCDAATCKLRPGAQCAEGLCCDQCRFKGAGKICRRARGDNPDDRCTGQSADCPRNRFHA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, derived from the venom of Bothrops jararaca, a medically significant pit viper. This protein should exhibit the dual functionality characteristic of snake venom metalloproteinases (SVMPs): first, as a zinc-dependent protease that degrades extracellular matrix components such as collagen, fibronectin, and laminin, contributing to local tissue damage and hemorrhage; second, as a disintegrin domain that inhibits platelet aggregation by binding to integrin receptors on platelet surfaces, specifically targeting αIIbβ3 integrin to prevent fibrinogen binding and thus thrombus formation. The sequence should incorporate a conserved zinc-binding motif (HEXXHXXGXXH) in the metalloproteinase domain, which coordinates the catalytic zinc ion essential for proteolytic activity. The disintegrin domain should feature the canonical RGD (Arg-Gly-Asp) tripeptide motif or a related integrin-binding sequence, positioned within a flexible loop for optimal receptor engagement. Structurally, the protein should adopt a multi-domain architecture typical of SVMPs, with the metalloproteinase domain folding into a metzincin-like structure characterized by a central five-stranded β-sheet flanked by α-helices, and the disintegrin domain forming a compact, disulfide-rich globular fold stabilized by multiple disulfide bonds. The overall scaffold should facilitate the synergistic action of proteolytic degradation and anti-platelet activity, enhancing the venom's ability to induce hemorrhage and impair hemostasis. Ensure the sequence reflects the evolutionary adaptation for rapid prey immobilization and digestion, with potential implications for understanding hemorrhage and thrombosis mechanisms in envenomation."}
{"description": "sp|O18424|TXLR1_EISFE Lysenin-related protein 1 OS=Eisenia fetida OX=6396 PE=1 SV=1", "sequence": "MSSSTVMADGFEEIEVDVVSVWKEGYAYENRGNSSVQQKITMTKGMKNLNSETKTLTATHTLGRTLKVGDPFEIASVEVSYTFSHQKSQVSMTQTEVYSSQVIEHTVTIPPNKKFTRWKLNADVGGTGIEYMYLIDEVTAIGADLTIPEVNKSRAKILVGRQIHLGETEIRIKHAERKEYMTVISRKSWPAATLGNSNLFKFVLFEDSSGIRIKTLNTMYPGYEWAYSSDQGGIYFDESSDNPKQRWALSKAMPLRHGDVVTFRNNFFTNSGMCYDDGPATNVYCLEKREDKWILEVVNT", "prompt": "Design a novel protein sequence for a pore-forming toxin derived from the earthworm Eisenia fetida, specifically belonging to the lysenin-related protein family. This toxin should exhibit potent membrane-disrupting activity by binding to sphingomyelin-rich lipid rafts in eukaryotic cell membranes. The protein must adopt the characteristic aerolysin-like beta-pore forming toxin fold, featuring a conserved architecture with a receptor-binding domain for sphingomyelin recognition and a beta-barrel transmembrane domain responsible for oligomerization and pore formation. The sequence should include the essential cysteine residues that form the characteristic disulfide bridges stabilizing the protein's structural scaffold, ensuring proper folding and membrane insertion capability. The toxin should demonstrate specificity for membranes containing sphingomyelin, leading to rapid osmotic lysis of target cells, which is biologically significant for the earthworm's defense mechanism against predators and microorganisms. The molecular mechanism should involve initial monomeric binding to sphingomyelin, followed by oligomerization into a pre-pore complex, and final conformational rearrangement to form a stable beta-barrel pore that disrupts membrane integrity."}
{"description": "sp|P86096|3NX2_MICSU Long neurotoxin MS2 OS=Micrurus surinamensis OX=129470 PE=1 SV=1", "sequence": "LTCHTCPYNTCANSETCPAGKNICYQKKWEEHQGERIERRCVANCPKLGSNDKSLLCCRRDDCN", "prompt": "Design a long neurotoxin protein sequence that mimics the biological activity and structural characteristics of Micrurus surinamensis (aquatic coral snake) venom components. This toxin should function as a potent postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework C-C-CC-C-C. The extended C-terminal tail, characteristic of long neurotoxins, should contribute to enhanced receptor binding affinity and specificity. The molecular mechanism should involve competitive antagonism of acetylcholine binding, leading to reversible neuromuscular blockade through steric hindrance at the receptor's ligand-binding site. The structural scaffold should maintain the conserved hydrophobic core while displaying variable loop regions that determine target specificity. The toxin should exhibit high affinity for muscle-type nicotinic acetylcholine receptors, with the central loop playing a crucial role in receptor recognition and binding. The overall architecture should ensure proper folding into the stable, compact three-finger motif that is resistant to proteolytic degradation while maintaining the functional epitopes necessary for effective receptor interaction and neurotoxic activity."}
{"description": "sp|Q7LZ61|VM3CX_DABSI Coagulation factor X-activating enzyme heavy chain OS=Daboia siamensis OX=343250 PE=1 SV=2", "sequence": "MMQVLLVTISLAVFPYQGSSIILESGNVNDYEVVYPQKVTALPKGAVQQPEQKYEDTMQYEFEVNGEPVVLHLEKNKILFSEDYSETHYYPDGREITTNPPVEDHCYYHGRIQNDAHSSASISACNGLKGHFKLRGEMYFIEPLKLSNSEAHAVYKYENIEKEDEIPKMCGVTQTNWESDKPIKKASQLVSTSAQFNKIFIELVIIVDHSMAKKCNSTATNTKIYEIVNSANEIFNPLNIHVTLIGVEFWCDRDLINVTSSADETLNSFGEWRASDLMTRKSHDNALLFTDMRFDLNTLGITFLAGMCQAYRSVEIVQEQGNRNFKTAVIMAHELSHNLGMYHDGKNCICNDSSCVMSPVLSDQPSKLFSNCSIHDYQRYLTRYKPKCIFNPPLRKDIVSPPVCGNEIWEEGEECDCGSPANCQNPCCDAATCKLKPGAECGNGLCCYQCKIKTAGTVCRRARDECDVPEHCTGQSAECPRDQLQQNGKPCQNNRGYCYNGDCPIMRNQCISLFGSRANVAKDSCFQENLKGSYYGYCRKENGRKIPCAPQDVKCGRLFCLNNSPRNKNPCNMHYSCMDQHKGMVDPGTKCEDGKVCNNKRQCVDVNTAYQSTTGFSQI", "prompt": "Design a protein sequence for a snake venom metalloproteinase (SVMP) from the viper species Daboia siamensis that functions as a potent procoagulant toxin. This enzyme should specifically activate blood coagulation factor X through proteolytic cleavage, converting it to its active form (factor Xa) and thereby initiating the coagulation cascade. The protein should adopt the characteristic SVMP structural fold with a metalloproteinase catalytic domain containing the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn. It should feature multiple disulfide bridges typical of SVMPs that stabilize the proteinase domain structure. As a P-III class SVMP, it should contain additional domains including disintegrin-like and cysteine-rich domains that may mediate interactions with platelet receptors or extracellular matrix components. The enzyme should exhibit high specificity for factor X cleavage while being resistant to endogenous plasma protease inhibitors, enabling it to rapidly deplete coagulation factors and promote consumptive coagulopathy characteristic of viper envenomation. The structural design should ensure proper folding, disulfide connectivity, and catalytic efficiency appropriate for a venom component that contributes to the hemorrhagic and procoagulant effects of Russell's viper venom."}
{"description": "sp|P0DQO4|TAP2A_THEAO Mu/omega-theraphotoxin-Tap2a OS=Theraphosa apophysis OX=1956358 PE=1 SV=1", "sequence": "DCLGFMKPCDINNDKCCSSYVCGRNNHWCKFHL", "prompt": "Design a novel animal toxin protein sequence based on mu/omega-theraphotoxin-Tap2a from the Goliath birdeater tarantula Theraphosa apophysis. This toxin should function as a dual-action voltage-gated sodium channel modulator, exhibiting both mu-theraphotoxin (inhibitor cystine knot pore blocker) and omega-theraphotoxin (calcium channel blocker) characteristics. The protein should adopt the inhibitor cystine knot (ICK) structural scaffold with the characteristic cysteine framework C-C-CC-C-C, forming three disulfide bridges that create a stable, compact globular fold. The toxin should specifically target neuronal voltage-gated sodium channels (Nav1.2, Nav1.6, or Nav1.7) through pore-blocking mechanisms while also modulating voltage-gated calcium channels. The sequence should include conserved ICK motif residues that facilitate membrane penetration and receptor binding, with surface-exposed loops optimized for high-affinity interaction with channel pore regions. The toxin should exhibit potent neurotoxic activity typical of tarantula venom components, causing paralysis through disruption of neuronal signaling. Include appropriate hydrophobic patches for membrane association and charged residues for specific channel recognition. The overall structure should maintain the thermostable, protease-resistant properties characteristic of ICK-fold toxins from spider venoms."}
{"description": "sp|P0DQQ1|3L23_NAJME Long neurotoxin Tx-NM2 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "KRCYRTPDLKSQTCPPGEDLCYTKKWCADWCTSRGKVIELGCVATCPTVKPYEEITCCSTDNCNPHPKMPKP", "prompt": "Design a protein sequence for a long neurotoxin from the venom of the forest cobra (Naja melanoleuca), a species known for producing potent neurotoxic venom that causes rapid paralysis by targeting the neuromuscular junction. This toxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the postsynaptic membrane, specifically binding with high affinity to the alpha-delta and alpha-gamma subunit interfaces to prevent acetylcholine binding and subsequent ion channel opening. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The structure should feature a long central loop that is critical for receptor binding and specificity. Key functional residues should be positioned in loop II to facilitate precise interaction with the receptor's ligand-binding domain, while maintaining the overall structural stability typical of snake venom neurotoxins that induce flaccid paralysis through neuromuscular blockade."}
{"description": "sp|M1JBC0|SCX4_ANDCR Sodium channel alpha-toxin Acra4 OS=Androctonus crassicauda OX=122909 PE=1 SV=1", "sequence": "VRDGYIVDDKNCVYHCIPPCDGLCKKNGGKSGSCSFLVPSGLACWCKALPDNVPIKDPSYKCHKR", "prompt": "Generate the amino acid sequence for a potent sodium channel alpha-toxin from the venom of the fat-tailed scorpion Androctonus crassicauda. This toxin should function as a voltage-gated sodium channel modulator that binds to neurotoxin receptor site 3, causing delayed channel inactivation and prolonged action potentials in excitable cells. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion long-chain toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should contain a conserved core beta-sheet flanked by alpha-helical elements, with key functional residues concentrated in the 'pharmacophore' region responsible for receptor site 3 recognition and binding. The toxin should exhibit high specificity for mammalian voltage-gated sodium channels, particularly Nav1.2, Nav1.4, and Nav1.6 isoforms, with the molecular mechanism involving stabilization of the channel's voltage-sensing domain II in the activated state. This neurotoxin contributes to the potent paralytic effects of A. crassicauda venom by disrupting neuronal signaling through sustained sodium influx, leading to neurotransmitter release abnormalities and ultimately neuromuscular blockade."}
{"description": "sp|P46111|KAX32_LEIHE Potassium channel toxin alpha-KTx 3.2 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "GVPINVSCTGSPQCIKPCKDAGMRFGKCMNRKCHCTPK", "prompt": "Design a potent animal toxin protein sequence that functions as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv1 family). This toxin should originate from the venom of the yellow scorpion Leiurus hebraeus, where it serves as a key neurotoxic component that disrupts neuronal signaling by inhibiting potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact, globular fold with an alpha-helix and anti-parallel beta-sheets, presenting a functional surface with key residues for high-affinity binding to the pore region of Kv channels. Ensure the toxin exhibits specificity for Shaker-type potassium channels, contributing to its role in prey immobilization through neuromuscular disruption."}
{"description": "sp|P46110|KAX34_LEIHE Potassium channel toxin alpha-KTx 3.4 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "GVPINVKCTGSPQCLKPCKDAGMRFGKCINGKCHCTPK", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. This toxin originates from the venom of the yellow scorpion Leiurus hebraeus, where it serves as a key neurotoxic component that disrupts neuronal signaling by inhibiting potassium efflux, leading to prolonged action potentials and enhanced neurotransmitter release. The protein should adopt the conserved alpha-KTx structural scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern (cysteine framework I). The structure should include an alpha-helix packed against an anti-parallel beta-sheet, forming a stable core that presents a functional surface with key residues for channel blockade. The molecular target is the pore region of Kv1.x family channels, where the toxin binds via electrostatic and hydrophobic interactions, occluding the channel and preventing potassium ion conduction. Incorporate conserved residues critical for binding, such as a lysine-rich patch for docking to the channel vestibule and hydrophobic residues for interaction with the pore helix. Ensure the sequence maintains the characteristic high density of basic residues that facilitate target recognition while preserving the structural integrity required for venom stability and potency."}
{"description": "sp|P0CE74|CA12_CONBN Alpha-conotoxin-like Bn1.2 (Fragment) OS=Conus bandanus OX=72279 PE=2 SV=1", "sequence": "KECCTHPACHVSHPELCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus bandanus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form a compact, stable fold. The sequence should include the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. The molecular mechanism should involve competitive inhibition at the acetylcholine binding site, preventing neurotransmitter activation and leading to synaptic blockade. The structural core should exhibit the hallmark alpha-conotoxin fold with well-defined beta-turns and a constrained conformation that enables high-affinity receptor interaction while maintaining proteolytic stability. The design should reflect the evolutionary optimization of cone snail venoms for precise neuronal targeting and rapid prey immobilization through disruption of cholinergic signaling pathways."}
{"description": "sp|C0HJR6|VSP2_CRODO Thrombin-like enzyme collinein-2 (Fragment) OS=Crotalus durissus collilineatus OX=221569 PE=1 SV=1", "sequence": "TALPQLRLPATSRILCAGVLEGGIDTCNR", "prompt": "Design a thrombin-like serine protease toxin derived from the venom of the neotropical rattlesnake Crotalus durissus collilineatus. This enzyme functions as a key component in the snake's predatory and defensive arsenal by selectively cleaving fibrinogen to generate fibrin monomers, thereby inducing a consumptive coagulopathy that leads to hypofibrinogenemia and potential hemorrhage in prey. The protein should adopt the characteristic chymotrypsin-like fold common to snake venom serine proteases, featuring a two-domain structure with the canonical catalytic triad of His, Asp, and Ser residues positioned within the active site cleft. The sequence must include the conserved motifs surrounding the catalytic residues and maintain the disulfide bond pattern typical of SVSPs, which stabilizes the overall fold and ensures proper orientation of the substrate-binding exosites. These exosites should confer specificity for fibrinogen over other physiological serine protease substrates, potentially through electrostatic complementarity with the fibrinogen α-chain. The enzyme should exhibit optimal activity at physiological pH and temperature, with kinetics favoring the cleavage of fibrinogen to fibrin while minimizing inhibition by endogenous serine protease inhibitors. The structural scaffold should ensure the protease is secreted as a stable, soluble protein capable of withstanding the venom gland environment and rapidly acting upon envenomation."}
{"description": "sp|P0C554|3SO3_BUNFA Neurotoxin 3FTx-RK OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLELGYTRKCLTKYSQDNESSKTCPSGQKLCFKKWETGKLLGTKVKRGCVATCPQPKKEWIIQCCAKDKCNK", "prompt": "Design a novel neurotoxin protein sequence based on the three-finger toxin (3FTx) family from the banded krait (Bungarus fasciatus). This toxin should function as a potent postsynaptic neurotoxin that targets nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to competitive antagonism and subsequent flaccid paralysis. The protein must adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework I-IV, II-V, III-VI. Key structural features should include: (1) a central loop (loop II) responsible for receptor binding, containing conserved hydrophobic and cationic residues that interact with the nAChR α-subunit; (2) a conserved 'three-finger' topology with β-sheet structure in each loop; (3) the globular core stabilized by disulfide connectivity that confers structural rigidity and resistance to proteolysis. The toxin should exhibit high affinity for muscle-type nAChRs, with specific molecular recognition mediated through key residues in the functional loop that insert into the receptor binding site. The sequence should maintain the evolutionary conserved scaffold of elapid snake neurotoxins while incorporating natural variation observed in krait venom toxins for enhanced specificity and potency."}
{"description": "sp|Q2UXR0|VM3E1_ECHOC Zinc metalloproteinase-disintegrin-like Eoc1 OS=Echis ocellatus OX=99586 GN=Svmp3-Eoc1 PE=2 SV=1", "sequence": "MQVLLITISLAVLPYLGSSIILESGIVNDYEVVNPQKVTAMLKGAVKQPEQKYEDTMQYEFKVKGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSSASISACNGLKGHFKLRGEMYFIEPLKIPDSEAHAVYKYENIEEEDEAPKMCGVKHTNRESDKSIKKASQLNLTPEQQRYLNTPKHIKVAIVADYLIFRKYGRNLFTIRAKIYEILNILNEIYKAFNIHVALVFLEIWSNGDKINLFPAANVTLDLFGKWRERDLMNRKNHDNTQLLTGMNFDGPTAGLGYVGTMCHPQFSAAVVQDHNKINFLVALAMAHELGHNLGMTHDEQFCTCGAKSCIMSATLSCEGSYRFSNCSREENRRYLINKMPQCILIKPSRTDIVSPPVCGNSLVEVGEDCDCGSPGYCRNPCCNAATCKLTPGSQCADGECCDQCRFTRAGTECRPARDECDKADLCTGQSAECPADQFQRNGQPCQNNSGYCYNGICPVMRNQCISLFGSRAIVAEDACFQFNSLGIDYGYCRKENGRKIPCAPEDVKCGRLYCFDNLPEHKNPCQIFYTPRDEDKGMVDPGTKCENGKVCINGKCVDVNTAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin from the venom of the West African carpet viper, Echis ocellatus. This toxin belongs to the snake venom metalloproteinase (SVMP) class P-III family, characterized by a multi-domain architecture comprising a pro-domain, a metalloproteinase domain, and a disintegrin-like domain. The metalloproteinase domain should feature a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling proteolytic cleavage of extracellular matrix components such as collagen, laminin, and fibronectin. This domain adopts a metzincin-like fold with a central five-stranded β-sheet and surrounding α-helices. The disintegrin-like domain should contain an ECD motif instead of the RGD motif found in standalone disintegrins, enabling inhibition of integrin-mediated platelet aggregation by binding to αIIbβ3 integrin receptors. The protein should be synthesized as a zymogen with an N-terminal pro-domain that is proteolytically removed for activation. The mature toxin should facilitate hemorrhage, inflammation, and coagulopathy by degrading basement membranes and disrupting hemostasis, reflecting the potent hemotoxic and pro-coagulant effects of Echis ocellatus venom. Ensure the sequence includes appropriate cysteine residues for disulfide bonding to stabilize the multi-domain structure, with a pattern consistent with SVMP P-III family members."}
{"description": "sp|P0DL66|O16A_CONTS Delta-conotoxin TsVIA OS=Conus tessulatus OX=101317 PE=1 SV=1", "sequence": "CAAFGSFCGLPGLVDCCSGRCFIVCLL", "prompt": "Design a novel delta-conotoxin protein sequence inspired by Conus tessulatus venom, specifically emulating the functional and structural characteristics of delta-conotoxin TsVIA. This toxin belongs to the delta-conotoxin family, which are known for their role in prey immobilization through delayed inactivation of voltage-gated sodium channels (Nav). The protein should function as a gating modifier toxin that inhibits fast inactivation of Nav channels, particularly targeting tetrodotoxin-sensitive subtypes, leading to prolonged action potentials and neuronal hyperexcitability. The structural scaffold must feature the conserved cysteine framework characteristic of delta-conotoxins (C-C-CC-C-C), forming three disulfide bridges that stabilize an inhibitor cystine knot (ICK) fold. This fold typically results in a compact, globular structure with defined loops that mediate interaction with the voltage-sensing domain IV of Nav channels. The sequence should include key residues for membrane interaction and channel binding, ensuring high affinity and specificity. The overall design must reflect the biological context of cone snail venom, where such toxins facilitate rapid prey capture by disrupting neuromuscular signaling."}
{"description": "sp|C6EVG7|VNHP_HELSC Natriuretic and helokinestatin peptides OS=Heloderma suspectum cinctum OX=537493 PE=1 SV=1", "sequence": "MNPRLACSTWLPLLLVLFTLDQGRANPVERGQEYRSLSKRFDDDSTELILEPRASEENGPPYQPLVPRASDENVPPAYVPLVPRASDENVPPPPLQMPLIPRASEQKGPPFNPPPFVDYEPRAANENALRKLIKRSFERSPGRNKRLSPGDGCFGQKIDRIGAVSGMGCNSVSSQGKK", "prompt": "Design a novel venom peptide sequence that combines natriuretic and helokinestatin peptide activities, inspired by the venom of the banded Gila monster (Heloderma suspectum cinctum). This peptide should function as a dual-action toxin targeting cardiovascular and smooth muscle systems. The natriuretic component should mimic the biological activity of atrial natriuretic peptide (ANP), promoting diuresis, natriuresis, and vasodilation through guanylyl cyclase-A receptor activation, potentially leading to hypotension. The helokinestatin component should exhibit bradykinin receptor antagonism, specifically blocking B2 receptors to produce smooth muscle relaxation and anti-nociceptive effects. Structurally, anticipate a small, compact peptide (approximately 20-40 amino acids) with multiple disulfide bridges forming a stable cysteine-knot or inhibitor cysteine-knot (ICK) motif, characteristic of many bioactive venom peptides. The sequence should include conserved cysteine residues arranged in a pattern that enables proper folding and stabilization of the dual functional domains. The peptide should demonstrate resistance to proteolytic degradation and maintain structural integrity in physiological conditions, reflecting its evolutionary optimization for venom delivery and target specificity."}
{"description": "sp|Q95NK7|KA142_OLIMR Potassium channel toxin alpha-KTx 14.2 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKIFFAILLILAVCSMAIWTVNGTPFAIKCATDADCSRKCPGNPPCRNGFCACT", "prompt": "Generate the amino acid sequence for a potassium channel toxin from the scorpion Olivierus martensii, classified within the alpha-KTx family. This toxin functions as a selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1 subfamily channels such as Kv1.1, Kv1.2, or Kv1.3, which are critical for neuronal excitability and immune cell function. The toxin operates by binding to the channel's outer vestibule, physically obstructing potassium ion permeation and thereby prolonging action potentials and enhancing neurotransmitter release. Structurally, it adopts the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by a short alpha-helix packed against a three-stranded antiparallel beta-sheet, stabilized by three or four disulfide bridges following the common alpha-KTx cysteine framework (C-X(3-7)-C-X(3-7)-C-X(0-4)-C-X(1-4)-C-X(4-12)-C). Key functional residues are located in the beta-sheet region, forming a functional dyad where a lysine or arginine residue inserts into the potassium selectivity filter, while surrounding hydrophobic and aromatic residues mediate additional interactions with the channel turret. The sequence should reflect high affinity and specificity for potassium channels, with a compact, stable structure typical of scorpion venom peptides that disrupt ion channel function to induce neurotoxic or immunomodulatory effects."}
{"description": "sp|Q71QH5|VSP08_TRIST Snake venom serine protease KN8 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVVGGLPCNINEHRFLVLVYSDGIQCGGTLINKEWMLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKKKYFFPCSKNFTKWDKDIMLIRLNHPVNNSTHIAPLSLPSKPPSQDTVCNIMGWGTISPTKEIYPDVPHCAYINIVDHAVCRAFYPGLLEKSKTLCAGILEGGKDTCQGDSGGPLICNGQIQGIVSVGGDPCAEPRVSVLYTKVFDHLDWIKSIIAGNTAATCPL", "prompt": "Design a snake venom serine protease from the venomous pit viper Trimeresurus stejnegeri, a species known for its potent hemotoxic venom that disrupts hemostasis through proteolytic cleavage of key coagulation factors. This serine protease functions as a major toxin component that targets the blood coagulation cascade, likely exhibiting either procoagulant or anticoagulant activity through specific cleavage of fibrinogen, coagulation factors, or platelet aggregation receptors. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad of histidine, aspartate, and serine residues arranged in the canonical geometry for efficient proteolysis. It should contain the standard disulfide bridge pattern typical of snake venom serine proteases, stabilizing the two-barrel structural domain organization. The mature protein should feature appropriate surface loops and substrate-binding pockets that confer specificity for its physiological targets in the coagulation system, potentially including exosite interactions for macromolecular substrate recognition. The structural scaffold should enable efficient zymogen activation and maintain stability in the venom environment while exhibiting the characteristic selectivity and potency of viperid venom serine proteases in disrupting vertebrate hemostasis."}
{"description": "sp|C0HJS9|KAX1I_RHOJU Potassium channel toxin alpha-KTx 1.18 OS=Rhopalurus junceus OX=419285 PE=1 SV=1", "sequence": "IVIDVPCTVSKECWSACKKAVGTDRGKCMGKKCKCYP", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Caribbean blue scorpion Rhopalurus junceus. This toxin should function as a selective inhibitor of voltage-gated potassium channels (Kv channels), specifically blocking the pore region to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold with an alpha-helix and anti-parallel beta-sheets, presenting a functional surface with key residues for potassium channel recognition and pore occlusion. Include a beta-hairpin structural element that inserts into the channel vestibule to physically obstruct potassium ion conduction. The toxin should exhibit high affinity for specific Kv channel subtypes while maintaining the thermostability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|P0CE75|CA4A_CONSE Conotoxin SmIVA OS=Conus stercusmuscarum OX=89452 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSIPSDRASDGRNAAVNERQTWLVPSTITTCCGYDPGTMCPTCMCDNTCKPKPKKSGRRND", "prompt": "Design a novel conotoxin sequence based on the biological profile of Conotoxin SmIVA from the venom of Conus stercusmuscarum. This toxin belongs to the δ-conotoxin family, which functions as voltage-gated sodium channel inhibitors. The protein should exhibit the characteristic cysteine framework IV (C-C-CC-C-C) with six conserved cysteine residues forming three disulfide bridges that stabilize the compact, globular fold typical of conotoxins. The molecular mechanism involves binding to site 4 of voltage-gated sodium channels, delaying channel inactivation and prolonging action potentials, leading to excitatory neurotoxicity. The structural scaffold should feature a well-defined inhibitory cysteine knot (ICK) motif, with the disulfide connectivity pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) creating a stable triple-stranded β-sheet core. The toxin should specifically target neuronal sodium channels, contributing to the predatory strategy of Conus stercusmuscarum by inducing rapid paralysis in prey through sustained neuronal excitation. Ensure the sequence includes appropriate inter-cysteine loop lengths and conserved residues critical for sodium channel binding and functional activity."}
{"description": "sp|Q71RR4|SLA_TRIST Snaclec coagulation factor IX/factor X-binding protein subunit A OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MGRFIFVSFGLLVVAASLSGTGADCLSGWSSYEGHCYKAFELYKTWEDAESFCMEGVKGGHLVSIESSGEADFVAQLISENMKRLDFFVWIGLRVQGDEKQCNSEWSDGSSVSYENWIESESKTCLGLEQQTKFRKWVNLYCGQRIPFVCEA", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of Trimeresurus stejnegeri, a pit viper species. This protein functions as the A subunit of a snaclec (snake C-type lectin) complex that specifically targets the blood coagulation cascade. The protein should act as a coagulation factor IX/factor X-binding protein, forming heterodimeric complexes with its B subunit to simultaneously bind and inhibit both coagulation factors IX and X. This dual-binding mechanism effectively disrupts the intrinsic tenase complex and prothrombinase complex assembly, leading to potent anticoagulant activity by preventing thrombin generation and subsequent fibrin clot formation. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold common to snake venom snaclecs, featuring a conserved structural scaffold with two alpha-helices and several beta-strands arranged in a specific topology. The sequence should include the conserved calcium-binding motifs and carbohydrate recognition domain (CRD) structural elements typical of C-type lectins, though this protein primarily recognizes protein targets rather than carbohydrates. Key structural features should include the characteristic disulfide bond pattern that stabilizes the CTLD fold, with conserved cysteine residues forming the structural core. The binding interface should contain specific loops and surface residues that enable high-affinity, simultaneous interaction with both coagulation factors IX and X, effectively competing with their physiological partners in the coagulation cascade. The overall structure should be compact and stable, optimized for venom delivery and function in the prey's circulatory system."}
{"description": "sp|O13062|VSPC_CRAGM Snake venom serine protease 2C OS=Craspedocephalus gramineus OX=8767 GN=TLG2C PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGHPCNINEHPFLVLVYHDGYQCGGTLINEEWVLTAAHCDGKKMKLQFGLHSKNVPNKDKQTRVPKEKFFCLSSKNFIKWGKDIMLIRLNRSVNNSTHIAPLSLPSSPPSQNTVCNIMGWGTISPTKEIYPDVPHCANINILDHAVCRAFYPGLLEKSKTLCAGILQGGKDICQGDSGGPLICNGQIQGIVSVGGNPCAEPRVPAIYTKVFDHLDWIKSIIAGNTAATCPL", "prompt": "Design a snake venom serine protease from the viper species Craspedocephalus gramineus (green pit viper) that functions as a potent hemostatic toxin. This enzyme should exhibit trypsin-like serine protease activity with specificity for cleaving key coagulation factors in the blood clotting cascade. The protein should adopt the characteristic chymotrypsin-like fold typical of snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His, Asp, Ser) positioned in the active site cleft. Include the conserved disulfide bridge pattern that stabilizes this fold, with cysteine residues forming the structural scaffold essential for protease stability and function. The enzyme should target fibrinogen and other coagulation factors, promoting either procoagulant or anticoagulant effects through selective proteolysis of specific peptide bonds. The molecular mechanism should involve binding to substrates through extended exosite interactions beyond the active site, enhancing substrate specificity. The structural design should ensure optimal catalytic efficiency while maintaining the thermostability required for venom function in the predator-prey context."}
{"description": "sp|P34079|TX22A_PLETR Omega-plectoxin-Pt1a OS=Plectreurys tristis OX=33319 PE=1 SV=1", "sequence": "ADCSATGDTCDHTKKCCDDCYTCRCGTPWGANCRCDYYKARCDT", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the spider Plectreurys tristis. This toxin should function as an insecticidal agent, specifically targeting the neuromuscular junctions of insect prey. The core mechanism of action should involve potent and selective blockade of insect calcium channels, disrupting calcium influx and thereby inhibiting neurotransmitter release, leading to rapid paralysis. The structural scaffold must be characteristic of spider venom toxins targeting ion channels, featuring a compact, disulfide-rich fold stabilized by multiple intramolecular disulfide bonds that confer both stability and the precise three-dimensional architecture required for target engagement. The sequence should include the conserved cysteine pattern typical of such toxins, forming a stable inhibitory cysteine knot (ICK) motif that defines the structural core. The molecular surface should present key functional loops and residues optimized for high-affinity binding to insect-specific calcium channel subtypes, ensuring species selectivity and efficacy as a paralytic agent. The overall protein should exhibit properties suitable for venom deployment, including solubility, protease resistance conferred by the disulfide framework, and the ability to fold into a stable, bioactive conformation."}
{"description": "sp|O13069|VSP2_BOTJA Thrombin-like enzyme KN-BJ 2 OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKASELIIGGRPCDINEHRSLALVKYGNFQCSGTLINQEWVLSAAHCDGEKMKIHLGVHSKKVPNKDKQTRVAKEKFFCLSSKNYTKWDKDIMLIRLDSPVKNSAHIAPISLPSSPPIVGSVCRIMGWGTISTSKVILSDVPHCANINLLNYTVCRAAYPELPATSRTLCAGILQGGKDTCVGDSGGPLICNGQFQGIVSWGSDVCGYVLEPALYTKVSDYTEWINSIIAGNTTATCPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of Bothrops jararaca, a pit viper species whose venom components are evolutionarily optimized for prey immobilization through disruption of hemostatic pathways. This enzyme should function as a key coagulotoxic agent that mimics the proteolytic activity of mammalian thrombin but with distinct substrate specificity, preferentially cleaving fibrinogen to generate fibrin clots while potentially evading natural anticoagulant mechanisms. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and the structural features typical of snake venom serine proteases, including multiple disulfide bridges that stabilize the compact globular structure. The molecular target is fibrinogen, with specific cleavage at preferred sites that differ from endogenous thrombin, leading to either procoagulant or anticoagulant effects depending on the cleavage pattern. The enzyme should exhibit optimal activity under physiological conditions and possess surface features that facilitate interaction with fibrinogen while maintaining stability in the venom milieu."}
{"description": "sp|Q7SID6|PA2A_DEIAC Acidic phospholipase A2 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=2", "sequence": "SLIQFETLIMKVVKKSGMFWYSAYGCYCGWGGHGRPQDATDRCCFVHDCCYGKVTGCDPKMDSYTYSEENGDIVCGGDDPCKREICECDRVAAVCFRDNLDTYNSDTYWRYPTKNCQEEPDPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the sharp-nosed viper, Deinagkistrodon acutus. This enzyme should exhibit the characteristic catalytic activity of hydrolyzing the sn-2 acyl bond of glycerophospholipids, releasing free fatty acids and lysophospholipids, which contributes to the venom's hemolytic, myotoxic, and pro-inflammatory effects. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices and a beta-wing region, with the catalytic histidine-aspartate dyad properly positioned in the active site. Include the characteristic calcium-binding loop (YXCGXGG) essential for catalytic function. The sequence should maintain the typical disulfide bond pattern of group II phospholipase A2 enzymes, with multiple conserved cysteine residues forming stabilizing cross-links. As an acidic isoform, the overall charge should be appropriately balanced. The protein should demonstrate membrane-binding capability through its interfacial activation surface and exhibit the tissue-damaging properties characteristic of viperid snake venom phospholipases A2."}
{"description": "sp|P01405|3SOB6_DENVI Toxin 4.9.6 OS=Dendroaspis viridis OX=8621 PE=1 SV=1", "sequence": "MICYSHKTPQNSATITCEEKTCYKFVTKLPGVILARGCGCPKKEIFRKSIHCCRSDKCNE", "prompt": "Design a protein sequence for a neurotoxin from the green mamba (Dendroaspis viridis) that functions as a potent postsynaptic alpha-neurotoxin. This toxin should exhibit high affinity binding to nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta subunit interface to competitively antagonize acetylcholine binding. The structural scaffold should feature the characteristic three-finger toxin fold with three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges in the C1-C5, C2-C6, C3-C7, C4-C8 connectivity pattern. The protein should maintain the conserved structural motif where loop I contributes to receptor binding specificity, loop II contains critical functional residues for receptor interaction, and loop III provides structural stability. The sequence should include the conserved cysteine framework and key functional residues that enable selective binding to muscle-type nicotinic receptors, resulting in reversible neuromuscular blockade. The overall structure should be compact and globular with the characteristic 'three-finger' appearance, maintaining thermal stability and resistance to proteolytic degradation typical of elapid snake venom toxins."}
{"description": "sp|Q2YHJ4|PA2HB_CRABR Basic phospholipase A2 homolog Tbo-K49 OS=Craspedocephalus borneensis OX=3147914 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGSVIELGKMILQETGKNPVTYYSAYGCNCGPLGRRKPLDATDRCCFMHKCCYKKLTDSNPIKDSYSYSWENKAIVCKEKNPRLKEMCECDKAVAICFRENMGTYNKKERINTKIFCKKTSEPC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the Bornean pit viper (Craspedocephalus borneensis). This protein belongs to the K49 phospholipase A2-like toxin family, characterized by the substitution of the catalytic aspartate residue at position 49 with lysine, rendering it enzymatically inactive while retaining toxic functions. The protein should adopt the canonical phospholipase A2 fold, featuring three long alpha-helices stabilized by seven conserved disulfide bonds with the characteristic C-C-C-C-C-C-C pattern. Despite lacking enzymatic activity, this homolog exerts myotoxic effects through membrane disruption and pore formation, leading to local tissue damage, edema, and cytotoxicity. The mechanism involves direct interaction with membrane phospholipids and potential engagement with specific receptors on muscle cells, causing calcium influx and cell death. The sequence should include key structural motifs such as the calcium-binding loop and the hydrophobic membrane-interaction surface, while maintaining the basic character that facilitates interaction with anionic membrane components. The protein should exhibit stability and specificity for its pathophysiological role in envenomation, contributing to the venom's prey immobilization and digestion functions."}
{"description": "sp|P0CJ40|OXLA_BOTMA L-amino-acid oxidase (Fragment) OS=Bothrops marajoensis OX=157554 PE=1 SV=1", "sequence": "AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV", "prompt": "Design a protein sequence for a venom-derived L-amino-acid oxidase fragment from the Bothrops marajoensis pit viper. This enzyme represents a key component of viperid venom systems, where it contributes to prey immobilization through hydrogen peroxide generation during oxidative deamination of L-amino acids. The generated reactive oxygen species induce local tissue damage, hemorrhage, and apoptosis in envenomed organisms. The protein should exhibit the characteristic flavin adenine dinucleotide (FAD) binding domain architecture typical of L-amino-acid oxidases, featuring conserved glycine-rich motifs for FAD cofactor interaction. Include the substrate-binding pocket residues that confer specificity for hydrophobic L-amino acids. The structural scaffold should maintain the homodimeric quaternary organization common to snake venom L-amino-acid oxidases, with the characteristic (α/β)8 TIM barrel fold in the FAD-binding domain. The sequence should preserve the catalytic residues essential for the oxidative deamination mechanism, particularly those involved in substrate recognition and the redox-active FAD cofactor coordination. The protein should demonstrate the glycosylation pattern typical of secreted venom proteins, which modulates its stability and biological activity in the envenomation context."}
{"description": "sp|P0DJK9|SIX3_ISOMC Beta-insect depressant toxin Im-3 OS=Isometrus maculatus OX=497827 PE=1 SV=1", "sequence": "KEGYGVGKDGCKISCVIGNEFCNKECKYSQKGTGGYCWTWGLACWCQGLPENAKVWESSTNTC", "prompt": "Design a beta-insect depressant toxin from the venom of Isometrus maculatus (lesser brown scorpion) that functions as a potent insect-selective neurotoxin. This toxin should belong to the beta-toxin class of scorpion venom peptides, specifically targeting insect voltage-gated sodium channels. The mechanism of action involves binding to receptor site 4 on the extracellular domain of insect sodium channels, causing a hyperpolarizing shift in the voltage dependence of activation. This results in prolonged channel opening and repetitive firing, leading to neurotransmitter depletion and ultimately paralysis in insect prey. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should contain a conserved core beta-sheet flanked by an alpha-helix, with key functional residues concentrated in the 'pharmacophore' region responsible for receptor recognition and binding. The toxin should exhibit high selectivity for insect sodium channels over mammalian counterparts, making it an effective insecticidal agent while maintaining low vertebrate toxicity. Include conserved structural motifs such as the 'conserved hydrophobic surface' and the 'pharmacophore loop' that are essential for target recognition and biological activity."}
{"description": "sp|Q75WH1|TXPT6_MACGS Mu-hexatoxin-Mg1c (Fragment) OS=Macrothele gigas OX=223896 PE=2 SV=2", "sequence": "TSQGTTPDKVQLEVNCISNLPNNEVEETDLLRELEMIEENLFGKELSFVPEENRNSRHKRCMGYDIECNERLHCCADLECVKTSGRWWYKKTYCRRKSG", "prompt": "Design a protein sequence for a mu-hexatoxin derived from the venom of the funnel-web spider Macrothele gigas. This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce paralysis through modification of channel gating kinetics. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom toxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a rigid, knotted core. Key structural elements should include a solvent-exposed pharmacophore region comprising specific loops responsible for channel interaction, particularly the beta-hairpin loops that form the functional interface with sodium channel voltage-sensing domains. The toxin should exhibit high selectivity for insect over mammalian sodium channels, with molecular determinants of this specificity encoded in surface-exposed residues within the receptor-binding loops. The sequence should maintain the canonical cysteine framework of spider ICK toxins while incorporating evolutionary conserved hydrophobic patches and polar residues that contribute to structural stability and target recognition. The overall architecture should enable precise modulation of sodium channel inactivation processes, leading to prolonged channel opening and subsequent neuromuscular blockade in insect prey."}
{"description": "sp|P68425|VKT1A_CYRSC Kunitz-type kappaPI-theraphotoxin-Hs1a OS=Cyriopagopus schmidti OX=29017 PE=1 SV=2", "sequence": "MGIARILSAVLFLSVLFVVTFPALLSADHHDGRIDTCRLPSDRGRCKASFERWYFNGRTCAKFIYGGCGGNGNKFPTQEACMKRCAKA", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a Kunitz-type serine protease inhibitor toxin from the venom of the Chinese bird spider, Cyriopagopus schmidti. The venom serves to immobilize prey through disruption of neural signaling pathways. The core function of this toxin is to act as a potent and selective inhibitor of voltage-gated potassium channels, specifically Kv1 subtypes, thereby prolonging neuronal depolarization and enhancing neurotransmitter release. The protein should adopt the characteristic Kunitz-type fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a C1-C6, C2-C4, C3-C5 connectivity pattern. This fold features a well-defined beta-hairpin and several loop regions that form the functional interface. The molecular target is the pore domain of voltage-gated potassium channels, with key binding interactions mediated through a conserved functional loop that inserts into the channel vestibule to physically block potassium ion conduction. The sequence must include the canonical Kunitz protease inhibitor domain with appropriate cysteine spacing to form the stable disulfide framework, along with specific residues in the functional loops that confer potassium channel blocking activity while maintaining the structural integrity of the Kunitz fold."}
{"description": "sp|P0DJL0|CLKTX_ISOMC Potassium channel toxin KTx1 (Fragment) OS=Isometrus maculatus OX=497827 PE=2 SV=1", "sequence": "FLVLLLVSLMCYAEIAEGSQPTECKYGRPCNSDRDCCWEYRCLSSGREYTCKQDPGP", "prompt": "Design a functional potassium channel toxin derived from the venom of Isometrus maculatus, commonly known as the lesser brown scorpion. This toxin should specifically target and inhibit voltage-gated potassium channels (Kv channels), particularly Kv1.1, Kv1.2, and Kv1.3 subtypes, through high-affinity binding to the channel's pore region. The toxin must adopt the conserved structural scaffold of scorpion potassium channel toxins, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the characteristic alpha-helix and anti-parallel beta-sheet structural elements that define this fold. The molecular mechanism involves physically occluding the potassium conduction pathway, thereby preventing potassium ion efflux and modulating neuronal excitability. This toxin represents a key component of scorpion venom used for prey immobilization and defense, functioning as a potent neurotoxin that disrupts normal electrical signaling in excitable cells."}
{"description": "sp|P0DJE9|VSP1_BOTMA Thrombin-like enzyme TLBm OS=Bothrops marajoensis OX=157554 PE=1 SV=1", "sequence": "VIGGDECNINESPFLAFLYSQLLSSRRYFCGMTLINQEWVLTAAHCNLYPDRKDMNWWLLIKLGKHSGSTRRWVANYDEQVRYWPKEKFIWWYCPNKKKDVINNYVWVWWDKDILLWELWMLIRLNRPVKYSEHIAPLSLPSSPPSAKWWHVGSVCRIMGWGQITETWWNSEDTLPDVPRCANINLFNYEVCRAYNQRWWRGLPAKTLCAGDLEGIIRGGWDTCVGDSGGPLICDGQYQGIAYWGSKPCAEPDEPAAYSKVFDHLDWSQSVIAGGTWWRGDDTCP", "prompt": "Design a serine protease enzyme from the venom of Bothrops marajoensis, a pit viper species. This thrombin-like enzyme functions as a key component in the snake's venom arsenal, contributing to prey immobilization through its specific proteolytic activity. The enzyme should exhibit selective cleavage of fibrinogen, preferentially releasing fibrinopeptide A to generate fibrin monomers that spontaneously polymerize into unstable clots, leading to consumptive coagulopathy. This mechanism depletes fibrinogen levels in the victim's bloodstream, resulting in anticoagulant effects through defibrination syndrome. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad of His, Asp, and Ser residues. It should contain the appropriate disulfide bridge pattern typical of snake venom serine proteases, stabilizing the compact globular structure. The enzyme should demonstrate substrate specificity distinct from mammalian thrombin, potentially showing reduced activity toward other thrombin substrates like protein C or PAR receptors. The structural scaffold should include the standard two-domain architecture of serine proteases with the active site cleft between domains, maintaining the characteristic β-barrel fold while incorporating venom-specific loop regions that may contribute to its unique substrate recognition profile."}
{"description": "sp|P0DJE2|VM3A_VIPAA Zinc metalloproteinase-disintegrin-like ammodytagin (Fragment) OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=3", "sequence": "KSAAXVTLDLFGDWRAKRHDNAQLLTGINLNGQTLGIAFMSKXSVGLIQDYXKSYLLVASVMAHELGHNLGMEHDDGNCICPAKCIDNKPLRTDIVSPAVCGNYFVELTPGSQCADGVCCDQCRKAGVTVAPDLCFDYNQLGTEDKFTHSPDDPDYGMVDLGTKCADGKVCNSNRQCVDVNTAY", "prompt": "Design a protein sequence for a snake venom zinc metalloproteinase-disintegrin-like toxin from the European nose-horned viper (Vipera ammodytes ammodytes). This toxin belongs to the reprolysin family of snake venom metalloproteinases (SVMPs) and functions as a key hemorrhagic agent in viper envenomation. The protein should contain a catalytic zinc-binding domain with the characteristic HEXXHXXGXXH zinc-binding motif, where histidine residues coordinate a catalytic zinc ion essential for proteolytic activity. This metalloproteinase domain enables the cleavage of extracellular matrix components, particularly basement membrane proteins like type IV collagen and fibronectin, leading to vascular damage and hemorrhage. Additionally, incorporate a disintegrin-like domain that mimics the structure of endogenous disintegrins, containing the conserved ECD motif that potentially interferes with integrin-mediated platelet aggregation and cell adhesion. The protein should adopt the typical SVMP fold with a multi-domain architecture, featuring a pro-domain (likely cleaved upon activation), metalloproteinase domain with the metzincin topological arrangement, and disintegrin-like domain. Include the appropriate cysteine framework for disulfide bond formation to stabilize the protein structure, with conserved cystines in both the metalloproteinase and disintegrin-like domains. The generated sequence should exhibit the characteristic structural features that enable this toxin to simultaneously degrade vascular basement membranes and disrupt hemostatic processes through its dual metalloproteinase and disintegrin-like functionalities."}
{"description": "sp|P0DQQ3|3SUC1_NAJME Muscarinic toxin-like protein Tx-NM3-2 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "LICVKEKFLFSETTETCPDGQNVCFNQAHLIYPGKYKRTRGCAATCPKLQNRDVIFCCSTDKCNL", "prompt": "Design a novel muscarinic toxin-like protein inspired by the venom of the forest cobra (Naja melanoleuca). This protein should function as a selective antagonist of muscarinic acetylcholine receptors, specifically targeting neuronal subtypes to modulate cholinergic neurotransmission. The toxin should adopt a three-finger toxin (3FTx) structural scaffold characterized by three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C1-C3, C2-C5, C4-C6, C7-C8 connectivity pattern. The molecular mechanism involves high-affinity binding to the orthosteric site of muscarinic receptors, competitively inhibiting acetylcholine signaling and potentially inducing downstream effects such as altered autonomic function. Key structural elements should include: (1) a conserved three-finger fold with rigid, elongated loops rich in β-sheet structure; (2) specific residues in the central loop responsible for receptor subtype selectivity and binding affinity; (3) a hydrophobic core essential for structural stability; and (4) surface-exposed cationic residues that facilitate electrostatic interactions with the receptor. The protein should exhibit thermal stability and protease resistance typical of snake venom toxins, with a molecular weight of approximately 6-8 kDa. Ensure the sequence reflects the evolutionary optimization for rapid target engagement and potency within the elapid venom system."}
{"description": "sp|Q2YHJ5|PA2AB_CRAPU Acidic phospholipase A2 Tpu-E6b OS=Craspedocephalus puniceus OX=3147916 PE=1 SV=1", "sequence": "SLMQFETMIMKVAGRSGVWWYGSYGCYCGKGGQGQPQDASDRCCFVHDCCYGKVNGCDPKDDFYTYSSENGDVVCEEDNPCTKEICECDKAAAICFRDNMDTYQNKYWFYPTKYCKEESEPC", "prompt": "Design a novel acidic phospholipase A2 toxin protein sequence inspired by the venom of Craspedocephalus puniceus (the flat-nosed pit viper). This enzyme should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 acyl bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid as a precursor for inflammatory mediators. The protein should adopt the characteristic phospholipase A2 fold featuring three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the YGCXCG motif essential for catalytic activity. Include the conserved catalytic dyad of histidine and aspartate residues within the active site pocket. The sequence should maintain the characteristic disulfide bond pattern typical of group II phospholipase A2 toxins, with 6-7 conserved disulfide bridges stabilizing the compact globular structure. As an acidic isoform, the protein should have a calculated pI below 7.0, contributing to its specific toxicological profile in viper venom, which may include myotoxic, anticoagulant, or pro-inflammatory effects through disruption of cellular membranes and signaling pathways. The protein should demonstrate thermal stability and resistance to proteolytic degradation characteristic of snake venom phospholipases."}
{"description": "sp|P69391|PMTXA_ANOSM Alpha-pompilidotoxin OS=Anoplius samariensis OX=200614 PE=1 SV=2", "sequence": "MFKQLILLALAAVFLLINISSAEPAAEPNANAEPLAEASAEPRIKIGLFDQLSKLG", "prompt": "Design a protein sequence for an alpha-pompilidotoxin from the spider wasp Anoplius samariensis. This neurotoxin functions as a potent excitatory agent by selectively blocking voltage-gated potassium channels, particularly Kv1-type channels, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The toxin should adopt a compact, globular fold stabilized by a specific disulfide bond pattern characteristic of inhibitor cystine knot (ICK) motifs, typically involving three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity that forms a rigid, triple-stranded beta-sheet core. Key structural elements include a conserved beta-hairpin region responsible for channel blockade by inserting into the potassium channel pore, disrupting ion conductance. The molecular target interface involves interactions with the channel's voltage-sensing domain and pore region, with specific residues likely engaging in electrostatic and hydrophobic contacts to achieve high-affinity binding. The biological significance lies in the wasp's venom system, where this toxin facilitates prey immobilization by inducing uncontrolled neuronal excitation and muscle spasms in insects, reflecting its role as a key predatory adaptation."}
{"description": "sp|Q71QH9|VSP14_TRIST Snake venom serine protease KN14 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDVSSGDFRGSGTLINPEWVLTAAHCETEEMKLQFGLHSKRVPNKDKQTRVSKEKFFCESNENYTKWNKDIMLIKLNRPVKNSAHIEPLSLPSSPPSVGSVCRIMGWGTLSDTEMILPDVPHCANINLLNYSDCQAAYPELPAKSRTLCAGILEGGKDTCSGDSGGPLICNGTFQGIASWGGTLCGYVREPGSYTKVFDHLDWIQSIIAGNTNVTCPL", "prompt": "Design a snake venom serine protease protein from the venom of Trimeresurus stejnegeri, a pit viper species. This toxin functions as a key component in the venom's hemorrhagic arsenal, targeting the host's coagulation cascade. The protein should exhibit trypsin-like serine protease activity with a canonical catalytic triad (His, Asp, Ser) and function as a procoagulant by cleaving fibrinogen or other coagulation factors, potentially leading to consumptive coagulopathy and hemorrhage. The structural scaffold should feature a chymotrypsin-like fold with two β-barrel domains connected by a conserved active site cleft. Include the characteristic disulfide bond pattern that stabilizes this fold, with conserved cysteine residues forming multiple intra-chain disulfide bridges that maintain structural integrity and catalytic function. The protein should possess substrate specificity pockets (S1, S2, etc.) that determine its target selectivity within the coagulation cascade, potentially exhibiting preferential cleavage of fibrinogen or specific coagulation factors. The mature protein should be secreted as a zymogen that requires activation through proteolytic cleavage to expose the active site. The overall structure should maintain the compact, globular architecture typical of snake venom serine proteases, with surface loops that may contribute to substrate recognition and specificity."}
{"description": "sp|P0DJF0|VSP48_BOTJR Thrombin-like enzyme BJ-48 (Fragment) OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "VVGGDCIPQVPFLAFLYSEYFC", "prompt": "Design a thrombin-like serine protease enzyme fragment derived from Bothrops jararacussu venom that functions as a key coagulant toxin. This enzyme should mimic the substrate specificity and catalytic activity of mammalian thrombin but operate within the context of snake venom to induce rapid coagulation and prey immobilization. The protein should feature a characteristic serine protease fold with a catalytic triad (His, Asp, Ser) and exhibit preferential cleavage of fibrinogen to generate fibrin clots. Include conserved structural elements typical of snake venom thrombin-like enzymes, such as appropriate disulfide bonding patterns that stabilize the protease domain, and ensure the sequence reflects the functional specialization for venom-induced coagulopathy, targeting key components of the mammalian coagulation cascade to promote thrombosis and disrupt hemostasis."}
{"description": "sp|C0HJT0|KAX2J_RHOJU Potassium channel toxin alpha-KTx 2.19 OS=Rhopalurus junceus OX=419285 PE=1 SV=1", "sequence": "TVIDVKCTSPKQCVPACKAAMGTVRAKCMNGKCKCYI", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Caribbean blue scorpion Rhopalurus junceus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal signaling and neuromuscular transmission. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with connectivity pattern C1-C4, C2-C5, C3-C6. The structural core should feature a compact, triple-stranded beta-sheet arrangement with a characteristic alpha-helix running anti-parallel to the beta-sheet. The molecular mechanism involves high-affinity binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway through specific interactions with conserved pore region residues. The toxin should exhibit the characteristic functional surface comprising a conserved functional dyad (typically involving a lysine residue for pore insertion and an aromatic residue for channel interaction) and a pharmacophore region responsible for channel subtype selectivity. The sequence should maintain the signature cysteine framework of alpha-KTx toxins while incorporating residues that confer both potency and selectivity for Kv1 channels, reflecting the evolutionary optimization of this scorpion venom component for rapid prey immobilization through disruption of potassium-dependent membrane repolarization."}
{"description": "sp|P46115|SCX5_TITSE Alpha-toxin Ts5 OS=Tityus serrulatus OX=6887 PE=1 SV=1", "sequence": "KKDGYPVEGDNCAFACFGYDNAYCDKLCKDKKADDGYCVWSPDCYCYGLPEHILKEPTKTSGRC", "prompt": "Generate the amino acid sequence for a potent alpha-toxin from the Brazilian yellow scorpion Tityus serrulatus. This toxin functions as a voltage-gated sodium channel modulator that specifically targets and slows the inactivation of neuronal sodium channels, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The toxin should adopt the conserved cysteine-stabilized alpha-beta scaffold characteristic of scorpion alpha-toxins, featuring the classic disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core alpha-helix and beta-sheet structural elements. The molecular mechanism involves binding to neurotoxin receptor site 3 on the extracellular domain of voltage-gated sodium channels, particularly Nav1.2, Nav1.6, and Nav1.7 subtypes, through a conserved pharmacophore that includes key residues in the beta-hairpin and C-terminal regions. The structural fold should consist of a triple-stranded antiparallel beta-sheet connected to a single alpha-helix by the disulfide network, creating a compact globular protein of approximately 60-70 amino acids. This toxin contributes to the neurotoxic venom profile of Tityus serrulatus by causing autonomic nervous system dysfunction, pain, and potentially lethal effects in envenomation victims through its selective action on neuronal sodium channel gating kinetics."}
{"description": "sp|P86099|3NX5_MICSU Long neurotoxin MS5 OS=Micrurus surinamensis OX=129470 PE=1 SV=1", "sequence": "LTCHTCPYNTCANSETCPAGKNICYQKKWEEHRGERIERSCVANCPEFESSHTSLLCCTTANCD", "prompt": "Design a long neurotoxin protein sequence that mimics the biological activity and structural characteristics of Micrurus surinamensis (Surinam coral snake) venom toxin MS5. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the typical cysteine framework pattern of C-C-CC-C-C-C-C-C. As a long neurotoxin, it should feature an extended central loop (loop II) that provides additional structural elements for enhanced receptor binding specificity. The molecular target is the nicotinic acetylcholine receptor at the neuromuscular junction, where it acts as a competitive antagonist by binding to the receptor's α-subunit interface, preventing acetylcholine binding and causing flaccid paralysis. The toxin should exhibit high affinity for muscle-type nicotinic receptors while maintaining the characteristic structural stability and target specificity of coral snake neurotoxins. The sequence should preserve the conserved hydrophobic core and the functional epitopes responsible for receptor recognition and binding, particularly in the central loop region that distinguishes long neurotoxins from their short-chain counterparts."}
{"description": "sp|P0CF15|TA2GV_AGEOR U2-agatoxin-Ao1v (Fragment) OS=Agelena orientalis OX=293813 PE=2 SV=1", "sequence": "LLLISAMVGSMIAAVPEEESLQLSEDERGGCLPHNRFCNALSGPRCCSGLTCKELNIWASKCL", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U2-agatoxin-Ao1v, functions as a selective voltage-gated calcium channel (VGCC) antagonist, specifically targeting insect P/Q-type calcium channels. The toxin should adopt the inhibitory cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. This scaffold confers exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves high-affinity binding to the voltage-sensing domain of insect P/Q-type calcium channels, blocking ion flux and disrupting synaptic transmission, leading to rapid paralysis and death in insect prey. The toxin should exhibit specificity for insect over mammalian calcium channels, reflecting its evolutionary role in prey capture. Key structural elements include a hydrophobic patch and basic residues critical for channel interaction, with surface loops that determine target selectivity. The sequence should encode the canonical ICK fold with appropriate length and cysteine spacing to ensure proper folding and biological activity."}
{"description": "sp|Q7SYF1|VSPP_CERCE Thrombin-like enzyme cerastocytin OS=Cerastes cerastes OX=8697 PE=1 SV=1", "sequence": "MVLISVLASLLVLQLSYAQKSSELVIGGAECNINEHRSLVLLYNSSRLFGGGTLINKEWVLSAAHCDGENMKIYLGLHHFRLPNKDRQIRVAKEKYFCRDRKSIVDKDIMLIKLNKPVNNSTHIAPLSLPSSPPSVGSDCRIMGWGTITSPNDTYPKVPHCANINILEHSLCERAYNDLSASSRTLCAGIEKGGIDTCKGDSGGPLICNGQIQGIVSWGDEVCGKPNKPGVYTKVFDYTDWIRNIIAGNTAATCPQ", "prompt": "Design a serine protease enzyme from the venom of the Saharan horned viper (Cerastes cerastes) that functions as a thrombin-like enzyme. This toxin should mimic the coagulant activity of mammalian thrombin by specifically cleaving fibrinogen to generate fibrin monomers, leading to clot formation and contributing to the viper's prey immobilization strategy. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a catalytic triad of His, Asp, and Ser residues. Include the conserved structural features of snake venom serine proteases, such as the S1 substrate specificity pocket that determines cleavage preference. The enzyme should exhibit optimal activity at physiological pH and temperature, with appropriate substrate recognition loops that enable selective fibrinogen cleavage while avoiding broad-spectrum proteolytic activity. Consider the disulfide bond pattern typical of venom serine proteases that stabilizes the compact globular structure and ensures functional integrity in the venom milieu."}
{"description": "sp|A0A5H1ZR48|SCX29_CENNO Peptide Cn29 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "LCLSCRGGDYDCRVKGTCENGKCVCGS", "prompt": "Design a novel scorpion toxin peptide sequence that mimics the biological activity and structural characteristics of the Cn29 toxin from the venom of Centruroides noxius, the Mexican scorpion. This toxin belongs to the scorpion toxin beta-family, which specifically targets voltage-gated sodium channels (Nav channels) in the peripheral nervous system. The peptide should function as a beta-toxin, binding to site 4 of Nav channels and modifying channel gating by shifting the voltage dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and causing spontaneous firing. This mechanism underlies the neurotoxic symptoms observed in envenomation, including severe pain, autonomic dysfunction, and potentially life-threatening neuromuscular effects. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against an antiparallel beta-sheet, stabilized by a specific disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in beta-toxins). The sequence must include the appropriate cysteine framework for this fold, along with conserved residues critical for structural integrity and target interaction, such as those forming the functional surface that engages with the channel's voltage-sensing domain. The overall architecture should be compact and globular, with the core stabilized by disulfide bonds and the functional loops displaying the pharmacophore necessary for high-affinity binding to site 4 of Nav channels, ensuring potent modulation of sodium channel function."}
{"description": "sp|P0C5G5|NA11_RADCR Delta-stichotoxin-Hcr3a OS=Radianthus crispa OX=3122430 PE=1 SV=1", "sequence": "GVPCRCDSDGPSVHGNTLSGTIWVGSCETGWHKCNTEHNLFHECCKQ", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the sea anemone Radianthus crispa, belonging to the delta-stichotoxin family. This toxin functions as a voltage-gated sodium channel (Nav) modulator, specifically targeting site 3 on the channel's domain IV S3-S4 loop. It delays channel inactivation, leading to prolonged action potentials and sustained neurotransmitter release, resulting in paralysis. The protein adopts the conserved sea anemone toxin fold characterized by a compact beta-sandwich structure stabilized by three disulfide bonds in a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements include a core beta-hairpin motif and a flexible C-terminal region critical for receptor binding. The toxin should exhibit high affinity for mammalian neuronal sodium channels, particularly Nav1.1, Nav1.2, and Nav1.6 subtypes, with the binding interface involving conserved hydrophobic residues and charged surface patches that interact with the channel's voltage-sensing domain."}
{"description": "sp|A0A3G3C7V6|O266_CONAA Gamma-conotoxin-like Am6.6 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MEKLTILLLVAAILMSTQALNQEQRQQAKINLLSKKKPSAERWRRGCTWWFGRCAEDGECCSNSCDQTYCELYAFPSRAI", "prompt": "Design a novel gamma-conotoxin-like peptide derived from the venom of Conus amadis, a marine cone snail species. This toxin should function as a potent modulator of neuronal signaling, specifically targeting voltage-gated calcium channels or related ion channels in the peripheral nervous system. The peptide should adopt the characteristic gamma-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (typically C-C-CC-C-C pattern) that forms three disulfide bridges. The structure should exhibit the hallmark gamma-conotoxin fold with a well-defined globular core and exposed loops that mediate target recognition. Key structural elements should include: a stable beta-hairpin motif, constrained loops with specific residue patterns for target engagement, and surface-exposed residues critical for binding specificity. The molecular mechanism should involve high-affinity binding to specific ion channel subtypes, leading to modulation of neuronal excitability and synaptic transmission. The peptide should demonstrate the typical conotoxin properties of high potency, target selectivity, and structural stability characteristic of cone snail venom peptides used for prey immobilization and defense."}
{"description": "sp|P34128|NGFV_BUNMU Venom nerve growth factor OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPAKSDFSDTNCAQTHEGLKTSRNTDQHHPTPKKSEDQELGSAANIIVDPKLFQKRRFQSPRVLFSTQPPPLSRDEQSVKFLDTEDTLNRNIWANNENHPVHNQGEHSVCDSISVWVTNKTKATDIKGNTVTVMVDVNLNNEVYKQYFFETKCRNPNPVPSGCRGIDSRHWNSYCTTTDTFVKALTMEGNRASWRFIRIDTACVCVISRKTENF", "prompt": "Design a venom-derived nerve growth factor (NGF) protein from the many-banded krait (Bungarus multicinctus) that functions as a neurotrophic toxin. This protein should adopt the classic NGF beta-fold structure characterized by a cysteine knot motif with three conserved disulfide bridges (Cys15-Cys80, Cys58-Cys108, Cys68-Cys110 in human NGF numbering) that stabilize the characteristic β-sheet-rich tertiary structure. The protein should function as a high-affinity ligand for the TrkA receptor (tyrosine kinase receptor A), binding to its extracellular domain with nanomolar affinity to initiate downstream signaling cascades including MAPK/ERK and PI3K/Akt pathways. However, as a venom component, this NGF homolog should exhibit enhanced stability and potentially modified receptor binding kinetics compared to mammalian NGF, contributing to the neurotoxic effects of krait venom by modulating neuronal survival, differentiation, and potentially enhancing the potency of other neurotoxins in the venom cocktail. The sequence should preserve the conserved NGF family signature residues involved in receptor binding while incorporating venom-specific adaptations that maintain structural integrity in the harsh extracellular environment of envenomation."}
{"description": "sp|B2BRQ6|3L22A_AUSLA Alpha-elapitoxin-Al2a OS=Austrelaps labialis OX=471292 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDSLRCYMGPKTPRTCPPGENLCFTKTWCDPRCSLLGKLVKLGCAATCPIPKSYEDVTCCSTDNCNRFPKWERSRPRPRGLLSSIMDHP", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the Australian lowland copperhead snake (Austrelaps labialis) belonging to the alpha-elapitoxin family. This toxin functions as a postsynaptic alpha-neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The structural scaffold should feature the typical three-finger morphology with loop I containing the key functional residues responsible for high-affinity binding to the alpha-delta interface of the nicotinic receptor. The toxin should exhibit specificity for the muscle-type receptor over neuronal subtypes, with conserved hydrophobic residues and cationic side chains mediating receptor interaction. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade characteristic of elapid snake venoms, with appropriate length and secondary structure elements consistent with the three-finger toxin superfamily."}
{"description": "sp|P60277|SCX1_HOTTA Neurotoxin BTN OS=Hottentotta tamulus OX=34647 PE=1 SV=1", "sequence": "GEDGYIADGDNCTYICTFNNYCHALCTDKKGDSGACDWWVPYGVVCWCEDLPTPVPIRGSGKCR", "prompt": "Design a potent neurotoxin protein sequence derived from the venom of the Indian red scorpion, Hottentotta tamulus. This toxin should function as a beta-type neurotoxin that specifically targets voltage-gated sodium channels, acting as a channel modulator to delay inactivation and prolong action potentials, leading to hyperexcitability of the nervous system. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion beta-toxins, featuring a compact globular architecture stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a molecular surface with distinct functional regions for channel recognition and modulation. Key structural elements should include a conserved 'pharmacophore' region responsible for binding to neurotoxin receptor site 4 on domain II of voltage-gated sodium channels, particularly affecting the channel's voltage-sensing mechanism. The toxin should exhibit high specificity for mammalian sodium channels, contributing to the potent neurotoxic effects observed in envenomation, including autonomic nervous system dysfunction and cardiovascular effects. The sequence should maintain the characteristic molecular weight and physicochemical properties typical of scorpion beta-neurotoxins while ensuring proper folding into the stable, disulfide-rich scaffold essential for biological activity."}
{"description": "sp|O42138|VM3AD_AGKCL Zinc metalloproteinase-disintegrin-like ACLD OS=Agkistrodon contortrix laticinctus OX=2782196 PE=2 SV=1", "sequence": "MIQVLLVTLCLAVFPYQGSSIILESGNVNDYEVVYPRKVTVLPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKQLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIDPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQLNLTPEQQAYLDAKKYVEFVVVLDHGMYTKYKDNLDKIKTRIFEIVNTMNEMFIPLNIRVALICLEIWSDKDKFNMTSAANVTSISFRNWRATDLLKRKSHDNAQLLTVIDFDGPTIGKAYMASMCDPKRSVGIIQDHSTINLMMAVTMAHEMGHNLGMDHDEKYCTCGAKSCVMAKALSRQPSKLFSNCSQEDYRKYLIKRRPKCILNEPNGTDIVSPPVCGNELLEVGEECDCGSPTNCQNPCCDAATCKLTPGSQCADGVCCDQCRFTRAGTECRQAKDDCDMADLCTGQSAECPTDRFQRNGHPCLNDNGYCYNRTCPTLKNQCIYFFGPNAAVAKDSCFKGNQKSNNHTYCRKENGKKIPCAPQDIKCGRLYCFRNLPGKKNICSVIYTPTDEDIGMVLPGTKCEDGKVCSNGHCVDVNIAYKSTTGFSQI", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like protein from the venom of the broad-banded copperhead snake (Agkistrodon contortrix laticinctus) that embodies the characteristic structural and functional features of snake venom metalloproteinases (SVMPs). This protein should contain a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that facilitates proteolytic activity against extracellular matrix components such as collagen, fibronectin, and laminin, contributing to local tissue damage and hemorrhage. The disintegrin-like domain should adopt a cysteine-rich fold stabilized by multiple disulfide bonds, typically featuring a conserved disintegrin loop with an ECD motif that may interfere with integrin-mediated cell adhesion, potentially affecting platelet aggregation or cell migration. The overall structure should exhibit the multi-domain architecture common to SVMPs, with the metalloproteinase domain adopting a metzincin-like fold characterized by a central five-stranded β-sheet and surrounding α-helices, and the disintegrin-like domain forming a compact, disulfide-stabilized subdomain. The protein should function synergistically within the venom to promote prey immobilization through hemorrhage, tissue degradation, and potential disruption of hemostatic processes, reflecting the evolutionary adaptation of viperid venoms for rapid prey subjugation."}
{"description": "sp|Q3BER1|DIS_ECHOC Disintegrin ocellatusin OS=Echis ocellatus OX=99586 PE=1 SV=1", "sequence": "MIPVLLVTICLAVFPFQGSSIILESGNINDYEIVYPKKVAVLPTGAMNSAHPCYDPVTCQPKEKEDCESGPCCDNCKFLKEGTICKMARGDNMHDYCNGKTCDCPRNPYKGEHDPMEWPAPAKGSVLM", "prompt": "Generate a protein sequence for a disintegrin toxin from the venom of the West African carpet viper, Echis ocellatus. This toxin, known as ocellatusin, functions as a potent anti-platelet agent by specifically targeting and inhibiting integrin receptors on the surface of platelets. The core mechanism involves high-affinity binding to the αIIbβ3 integrin (glycoprotein IIb/IIIa), thereby blocking fibrinogen binding and preventing platelet aggregation - a critical step in thrombus formation. Structurally, this disintegrin adopts the characteristic disintegrin fold stabilized by a conserved disulfide bridge pattern, typically featuring a C-C-C-C framework that creates a stable, compact structure. The active binding motif is centered around the canonical RGD (Arg-Gly-Asp) tripeptide sequence presented in an optimal conformation within a flexible loop region, allowing for specific recognition of the integrin receptor's binding pocket. The protein should exhibit the typical disintegrin characteristics: relatively small size (approximately 50-80 amino acids), high cysteine content for structural stability, and the conserved RGD motif positioned for maximal receptor interaction. The overall structure should facilitate rapid binding to platelet integrins while maintaining stability in the venom milieu."}
{"description": "sp|Q3BER3|DID4A_ECHOC Disintegrin EO4A OS=Echis ocellatus OX=99586 PE=1 SV=2", "sequence": "MIPVLLVTICLAVFPFQGSSIILESGNINDYEIVYPKKVNVLPTGAMNSAHPCCDPVTCQPKQGEHCISGPCCRNCKFLNSGTICKRARGDNLHDYCTGISSDCPRNPYKGKYDPMKWPAAAKGSVLM", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Echis ocellatus, the West African carpet viper. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The disintegrin should adopt the characteristic disintegrin fold, featuring the conserved RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to integrin receptors such as αIIbβ3 (glycoprotein IIb/IIIa) on platelets, thereby preventing fibrinogen binding and subsequent thrombus formation. The sequence should include the appropriate cysteine framework typical of disintegrins, forming multiple disulfide bonds that stabilize the compact, globular structure and ensure proper presentation of the RGD loop for optimal receptor engagement. The protein should exhibit high specificity for its target integrins, contributing to the hemorrhagic effects observed in envenomation by disrupting hemostasis. Ensure the sequence reflects the evolutionary adaptations of viperid venoms for prey immobilization through anticoagulant and antiplatelet activities."}
{"description": "sp|O42189|PA2A5_GLOHA Acidic phospholipase A2 BA1 OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "SLIQFEKMIKKMTGKEPVVSYAFYGCYCGSGGQGKPKDATDRCCFVHDCCYEKVTGCDPKWDDYTYSWKDGDIVCGGDDPCKKEICECDRAAAICFRDNLNTYNDRKYWAFGAKNCPQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Siberian pit viper (Gloydius halys). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for anionic phospholipid substrates. The structural scaffold should feature the characteristic phospholipase A2 fold consisting of three major alpha-helices, two antiparallel beta-sheets, and a conserved calcium-binding loop with the YGCYCG motif. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic elapid loop region. The sequence should maintain the conserved disulfide bridge pattern (typically 6-7 disulfide bonds) that stabilizes the compact globular structure. The acidic nature should be reflected in the overall charge distribution, with surface-exposed acidic residues contributing to the protein's low isoelectric point. The toxin should demonstrate membrane-binding capability through hydrophobic residues and basic residues that interact with anionic membrane surfaces. Ensure the sequence encodes all functional elements necessary for both enzymatic activity and neurotoxic potency, including regions involved in presynaptic membrane targeting and interference with vesicle fusion machinery."}
{"description": "sp|P0CJ38|MASTE_EUMRB Eumenine mastoparan-ER OS=Eumenes rubrofemoratus OX=1035770 PE=1 SV=1", "sequence": "FDIMGLIKKVAGAL", "prompt": "Design a novel peptide toxin sequence inspired by eumenine mastoparan-ER from the solitary wasp Eumenes rubrofemoratus. This peptide should function as a potent mastoparan-like cytolytic toxin that disrupts biological membranes through amphipathic alpha-helical structure. The sequence must adopt a characteristic mastoparan fold with strong amphipathic character, allowing it to insert into lipid bilayers and form pores that lead to cell lysis. Incorporate key structural features including: a predominantly alpha-helical conformation spanning approximately 14-16 residues, optimal amphipathic moment for membrane interaction, and cationic residues strategically positioned to facilitate initial electrostatic interactions with anionic membrane surfaces. The peptide should exhibit broad-spectrum cytolytic activity against various cell types, with potential secondary effects on G-protein signaling pathways due to mastoparan's known ability to activate heterotrimeric G proteins. Ensure the sequence maintains the characteristic mastoparan physicochemical profile with appropriate hydrophobicity distribution and net positive charge for effective membrane disruption while preserving structural stability in aqueous and membrane environments."}
{"description": "sp|D2DGD8|I361_CONPL Conotoxin Pu6.1 OS=Conus pulicarius OX=93154 PE=3 SV=1", "sequence": "MKLVLAIVLILMLVSLSTGAEESGQEISMVGPPLYIWDPIPPCKQLDEDCGYGYSCCEDLSCQPLIEPDTMEITALVCQIESA", "prompt": "Design a novel conotoxin sequence inspired by the venom of the marine cone snail Conus pulicarius, specifically emulating the functional and structural characteristics of the Pu6.1 conotoxin. This toxin should function as a potent modulator of neuronal ion channels, likely targeting voltage-gated sodium channels or nicotinic acetylcholine receptors based on the pharmacological profile of Conus pulicarius venom. The sequence must adopt a stable disulfide-constrained fold characteristic of conotoxins, with a cysteine framework that enables proper oxidative folding into a compact, bioactive conformation. The structural scaffold should facilitate high-affinity binding to specific receptor subtypes, resulting in either channel blockade or modulation that disrupts neuronal signaling. The mature toxin should exhibit the typical conotoxin features: small size (10-30 amino acids), multiple disulfide bonds creating a rigid tertiary structure, and surface-exposed loops that mediate target recognition. The sequence must maintain conserved residues critical for structural integrity while incorporating variable regions that determine target specificity and potency. The final protein should demonstrate thermal stability, protease resistance, and selective toxicity toward the intended molecular target."}
{"description": "sp|P0DQQ5|CA1C_CONCT Alpha-conotoxin CIC OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "ASGADTCCSNPACQVQHSDLC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus catus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential cysteine residues at positions corresponding to this framework, with intervening loops that determine receptor subtype specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that form the receptor binding interface, particularly targeting the orthosteric site at the nAChR subunit interface. The toxin should exhibit high affinity binding through complementary electrostatic and hydrophobic interactions with conserved receptor residues. The overall structure should be rigid and protease-resistant due to the disulfide-stabilized core, with molecular weight typically under 2 kDa. Include appropriate post-translational modifications common in conotoxins, such as C-terminal amidation and hydroxylation of proline residues if present. The designed sequence should demonstrate selective antagonism toward specific nAChR subtypes while maintaining the characteristic pharmacological profile of alpha-conotoxins from Conus catus."}
{"description": "sp|D2Y1X6|H1A01_CYRHA Mu-theraphotoxin-Hhn2b 1 OS=Cyriopagopus hainanus OX=209901 PE=1 SV=1", "sequence": "MKASMFLALAGLVLLFVVCYASESEEKEFPRELISKIFAVDDFKGEERECKGFGKSCVPGKNECCSGYACNSRDKWCKVLLGK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This toxin belongs to the mu-theraphotoxin family, specifically mu-theraphotoxin-Hhn2b, originating from the Chinese bird spider Cyriopagopus hainanus. As a component of this spider's venom, it functions to immobilize prey through potent neurotoxic activity. The toxin operates as a voltage-gated sodium channel modulator, likely inhibiting channel inactivation to prolong neuronal depolarization and induce paralysis. Structurally, it is anticipated to adopt the inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in a C-C-CC-C-C framework). Key residues for target interaction, such as those forming a functional surface patch, should be preserved to ensure high-affinity binding to site 4 on domain II of voltage-gated sodium channels. The sequence must reflect these structural and functional constraints, incorporating the ICK fold, correct disulfide connectivity, and target-specific pharmacophore elements to achieve the desired neurotoxic effect."}
{"description": "sp|P81742|DIDAA_ERIMA Disintegrin EMF10A OS=Eristicophis macmahoni OX=110227 PE=1 SV=1", "sequence": "MNSANPCCDPITCKPKKGEHCVSGPCCRNCKFLNPGTICKKGRGDNLNDYCTGVSSDCPRNPWKSEEED", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Eristicophis macmahoni, a viper species whose venom components are evolutionarily optimized to disrupt cellular adhesion processes critical for hemostasis and tissue integrity. This disintegrin should function as a potent inhibitor of integrin-mediated platelet aggregation and cell migration by specifically targeting and blocking the RGD (Arg-Gly-Asp) recognition motif-binding site on various integrin receptors, particularly αIIbβ3 on platelets and αvβ3 on endothelial cells. The protein must adopt the canonical disintegrin fold characterized by a compact, globular structure stabilized by multiple disulfide bridges that confer exceptional stability and resistance to proteolytic degradation. The core scaffold should feature the conserved cysteine framework typical of short-chain disintegrins, with precisely spaced cysteine residues forming disulfide bonds that create a rigid, well-defined loop structure presenting the bioactive RGD tripeptide motif at an exposed, solvent-accessible tip for optimal integrin engagement. The sequence must include the critical RGD motif positioned within a flexible, protruding loop that enables high-affinity binding to integrin receptors, disrupting their interaction with extracellular matrix proteins like fibrinogen and vitronectin. The overall structure should exhibit the characteristic disintegrin topology with a central β-sheet core surrounded by loops and turns, maintaining the compact molecular size (approximately 5-8 kDa) and high disulfide density that provide venom disintegrins with their remarkable stability and target specificity. The designed protein should effectively mimic the natural disintegrin's mechanism of competitive inhibition at integrin ligand-binding sites, thereby exhibiting anti-thrombotic and potential anti-metastatic activities through interference with cell adhesion signaling pathways."}
{"description": "sp|Q7SZE1|VSPSX_GLOIT Thrombin-like enzyme saxthrombin OS=Gloydius intermedius OX=44732 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHCDNTNFQMKLGVHSKKVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPLSLPSSPPSVGSVCHIMGWGSITPIKVTYPDVPYCAYINLLDDAVCQAGYPELLTEYRTLCAGILEGGKDTCGGDSGGPLICNGQFQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIAGNTTVTCPQ", "prompt": "Design a thrombin-like enzyme protein sequence inspired by saxthrombin from the venom of Gloydius intermedius, the Central Asian pit viper. This enzyme should function as a key serine protease in the snake's venom arsenal, specifically targeting the mammalian coagulation cascade. The protein must exhibit selective fibrinogenolytic activity, cleaving fibrinogen to generate fibrin monomers while sparing other critical coagulation factors, thereby promoting consumptive coagulopathy and potential hemorrhage in prey. Incorporate the characteristic catalytic triad of serine proteases (His, Asp, Ser) within a chymotrypsin-like fold. Include appropriate disulfide bridges to stabilize the compact, globular structure typical of snake venom serine proteases, ensuring thermal and proteolytic stability in the venom milieu. The sequence should reflect adaptation for rapid action in envenomation, with surface loops potentially mediating substrate specificity toward fibrinogen over other physiological serine protease targets. The overall architecture should facilitate efficient secretion and function in the complex venom mixture, contributing to the viper's predatory efficacy by disrupting hemostasis."}
{"description": "sp|P81744|TOG3B_AGEAP Omega-agatoxin-Aa3b OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "SCIDFGGDCDGEKDDCQCCRSNGYCSCYNLFGYLKSGCKCEVGTSAEFRRICRRKAKQCYNSDPDKCVSVYKPKRR", "prompt": "Design a protein sequence for a potent neurotoxin from the funnel-web spider Agelenopsis aperta that functions as a selective calcium channel blocker. This toxin should belong to the omega-agatoxin family and specifically target P/Q-type voltage-gated calcium channels (Cav2.1) in the mammalian central nervous system. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves high-affinity binding to the voltage-sensing domain of Cav2.1 channels, effectively blocking neurotransmitter release at presynaptic terminals and causing paralysis. The toxin should contain key functional residues for channel recognition and binding, including surface-exposed loops that mediate target specificity while maintaining the core ICK scaffold stability. The biological significance lies in its role as a defensive and predatory venom component that rapidly immobilizes prey through disruption of neuromuscular transmission."}
{"description": "sp|O42192|PA2A8_GLOHA Acidic phospholipase A2 A' OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "SLMQFKTLIMKIAGRSGIWYYGSYGCYCGGGGQGRPQDASDRCCFVHDCCYGKVTGCNPKMDVYTYTEENGAIVCGGDDPCKKQICECDKDAAICFRDNIDTYDNKYWFFPAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Siberian pit viper, Gloydius halys. This enzyme should function as a potent toxin by catalyzing the hydrolysis of the sn-2 acyl bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the venom's hemotoxic, myotoxic, and pro-inflammatory effects. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Key structural elements must include the conserved Ca²⁺ binding loop (Tyr-Gly-Cys), the catalytic dyse (His-Asp), and the interfacial binding surface that mediates membrane association. The acidic nature of this isoform should be reflected in its amino acid composition, with elevated aspartate and glutamate residues contributing to its pI. The enzyme should exhibit specificity for phospholipid substrates and demonstrate calcium-dependent catalytic activity typical of Group II phospholipase A2 enzymes found in viperid venoms."}
{"description": "sp|Q964Q0|IXOSP_IXOSC Ixolaris OS=Ixodes scapularis OX=6945 PE=1 SV=1", "sequence": "MRAVSCFLYYGVAWIALGSWGASSSAERVSEMDIYEFESWVSCLDPEQVTCESQEGTHASYNRKTGQCEEQKGTECGGGENHFETLLKCNESCNDAPKPPCSLEVDYGVGRANIPRWYYDTNNATCEMFTYGGITGNKNNFESEEECKETCKGFSLLKKVNVTIN", "prompt": "Design a protein sequence for Ixolaris, a potent anticoagulant toxin from the black-legged tick Ixodes scapularis. This protein functions as a tissue factor pathway inhibitor (TFPI) mimetic that specifically targets and inhibits factor Xa (fXa) and the factor VIIa/tissue factor (fVIIa/TF) complex, thereby blocking the initiation phase of the blood coagulation cascade. The protein should adopt a Kunitz-type domain architecture, featuring two tandem Kunitz domains that mediate its anticoagulant activity through direct binding to the active sites of these coagulation factors. Each Kunitz domain should contain the characteristic disulfide bond pattern (Cys1-Cys4, Cys2-Cys3) that stabilizes the compact, globular fold. The first Kunitz domain should exhibit high-affinity binding to fXa, while the second domain should interact with the fVIIa/TF complex. The overall structure should be stabilized by these conserved disulfide bridges, forming a rigid, protease-resistant scaffold typical of Kunitz-type inhibitors. The protein should demonstrate high specificity for its coagulation factor targets without significant off-target protease inhibition, reflecting its evolutionary optimization for hematophagous feeding in tick saliva."}
{"description": "sp|P36983|TX22G_PLETR U1-plectoxin-Pt1a OS=Plectreurys tristis OX=33319 PE=1 SV=2", "sequence": "MKHLIFSSALVCALVVCTFAEEQVNVPFLPDERAVKCIGWQETCNGNLPCCNECVMCECNIMGQNCRCNHPKATNECESRRR", "prompt": "Design a protein sequence for a neurotoxic peptide from the venom of the spider Plectreurys tristis, commonly known as the plectoxin family. This toxin functions as a potent insecticidal agent by selectively targeting and modulating voltage-gated sodium channels in insect nervous systems, leading to paralysis and death. The protein should adopt a compact, stable fold stabilized by a conserved disulfide bridge framework typical of spider venom peptides, likely featuring an inhibitor cysteine knot (ICK) motif that provides exceptional structural stability and resistance to proteolytic degradation. The molecular mechanism involves binding to specific sites on insect sodium channels, altering channel gating kinetics and disrupting normal neuronal signaling. The sequence should include key residues for target recognition and binding affinity while maintaining the characteristic cysteine pattern that forms the structural scaffold. The overall architecture should be a small, globular peptide optimized for venom delivery and target specificity against insect prey."}
{"description": "sp|B3EWF8|3SX1_MICMP Mipartoxin-1 OS=Micrurus mipartitus OX=430902 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGNSLKCYVSREGKTQTCPEGEKLCEKYAVSYFHDGRWRYRYECTSACHRGPYNVCCSTDLCNK", "prompt": "Design a novel animal toxin protein sequence based on the biological profile of Mipartoxin-1 from the red-tailed coral snake (Micrurus mipartitus). This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, specifically inhibiting acetylcholine release from motor nerve terminals. The protein should adopt a three-finger toxin (3FTx) structural scaffold characteristic of elapid snake venoms, featuring the conserved beta-sheet-rich fold with three protruding loops that mediate target recognition. The sequence should contain the canonical cysteine framework with four disulfide bridges that stabilize the three-finger architecture. The molecular mechanism should involve high-affinity binding to presynaptic membranes, potentially targeting specific ion channels or receptors involved in neurotransmitter release, leading to progressive paralysis. The toxin should exhibit the typical thermal stability and resistance to proteolytic degradation observed in three-finger toxins, with surface-exposed residues optimized for target specificity while maintaining the conserved hydrophobic core that defines this toxin family. The design should capture the evolutionary optimization of this toxin for rapid immobilization of prey through disruption of neuromuscular transmission."}
{"description": "sp|A0A3G3C7U7|O165_CONAA Omega-conotoxin-like Am6.5 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MCILIVAVLFLTAWTFVMADDPRDEPDTVVRGGKLFSRARDEMNPAASKLNERDCVEVDYFCGIPFVFNGLCCSGNCVFVCTPQG", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an omega-conotoxin-like peptide derived from the venom of Conus amadis, a marine cone snail species. As a member of the omega-conotoxin family, it should function as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal tissues. The toxin should exhibit high affinity for N-type (Cav2.2) calcium channels, leading to inhibition of neurotransmitter release and resulting in paralytic effects on prey. The structural scaffold should feature the characteristic cysteine framework of omega-conotoxins, typically with a C-C-CC-C-C pattern forming three disulfide bridges that stabilize a compact, globular fold. The 3D structure should adopt an inhibitor cystine knot (ICK) motif, characterized by a tight, knotted arrangement of disulfide bonds that confers exceptional stability and resistance to proteolytic degradation. Key functional residues should be positioned in loop regions to mediate specific interactions with the pore-forming region of the calcium channel, ensuring selective blockade. The sequence should include conserved hydrophobic core residues and surface-exposed polar residues that facilitate solubility in aqueous venom. The overall length should be approximately 25-30 amino acids, with the disulfide connectivity directing the formation of a rigid, bioactive conformation essential for high-potency neurotoxicity."}
{"description": "sp|O73800|VSPSN_GLOHA Snake venom serine protease salmobin OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "MVLIKVLANHLILQLSYAQKSSELVIGGDECNINEHRFLVALYHSRSRTFLCGGTLINQEWVLTAAHCDRFLMYIRLGMHNKNVKFDDEQRRFPKEKYFFACSNNFTKWDKDIMLIRLNRPVNNSEHIAPLSLPSNPPSVGSVCRVMGWGTITSPNETLPDVPHCANINLLHYSVCQAAYPKLPVTRRLLCAGILEGGIDSCHRDSGGPLICNGQFQGIVSWGRYPCAQPRVPGIYIKVFDYTDWIQSIIAGNTAVNCPP", "prompt": "Design a snake venom serine protease from the venom of the Siberian pit viper (Gloydius halys) that functions as a potent thrombin-like enzyme. This toxin should exhibit the characteristic trypsin-like serine protease catalytic triad (His, Asp, Ser) and possess the conserved structural fold of snake venom serine proteases, featuring a two-domain architecture with the catalytic domain adopting a chymotrypsin-like fold. The protein should contain the appropriate disulfide bridge pattern typical of this toxin family to stabilize its tertiary structure. As a key component of viper venom, this protease should specifically target the mammalian coagulation cascade, primarily cleaving fibrinogen to fibrin, thereby promoting coagulopathy and contributing to the prey immobilization strategy of this pit viper species. The enzyme should demonstrate substrate specificity for fibrinogen while avoiding broad-spectrum proteolytic activity that might compromise venom stability."}
{"description": "sp|P0DQQ9|VKT1_PALCA Kunitz-like toxin PcKuz1 OS=Palythoa caribaeorum OX=134933 PE=3 SV=1", "sequence": "CMEPKKVGPCRAAMPRFYFNSASNKCEGFTYGGCDANHNNFQSEADCKKAC", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the zoanthid Palythoa caribaeorum, a cnidarian species known for producing potent venom components with defensive and predatory functions. This toxin should function as a high-affinity inhibitor of trypsin-like serine proteases through a canonical mechanism where the reactive site loop inserts into the protease's active site cleft, forming stable enzyme-inhibitor complexes. The protein should adopt the characteristic Kunitz domain fold consisting of a twisted anti-parallel beta-sheet stabilized by three conserved disulfide bonds in a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The structural scaffold should feature the typical Kunitz topology with well-defined secondary structure elements including beta-strands and alpha-helices arranged around a hydrophobic core. The reactive site loop should contain appropriate protease recognition residues optimized for trypsin specificity, with key residues positioned for optimal interaction with the protease's catalytic triad and substrate-binding pocket. The overall structure should maintain the compact, globular nature characteristic of Kunitz domains while incorporating sequence variations that confer high potency and specificity toward serine proteases relevant to cnidarian venom function."}
{"description": "sp|O42207|VSPE2_GLOUS Thrombin-like enzyme CPI-enzyme 2 OS=Gloydius ussuriensis OX=35671 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLALVFNSSGFLCSGTLINQEWVLTAAHCDMENMRIYLGVHNESVQYDDEQTRVPEEKFFCLRSNNDTKWDKDIMLIRLDSPVNNSAHIAPLNLPFNPPMLGSVCRIMGWGAITSPNEIYSSVPHCANINVLHYSMCRAVYPGMPAQTRILCAGIQTGGIDTCSGDSGGPLICNGQFQGIVSWGRYPCAKPRAPGLYTRVFDYTDWIENIIAGNTDASCPP", "prompt": "Design a thrombin-like serine protease enzyme from the venom of the Ussuri pit viper (Gloydius ussuriensis) that functions as a key hemostatic toxin. This enzyme should exhibit selective proteolytic activity toward fibrinogen, specifically cleaving fibrinopeptide A from the Aα chain to generate fibrin monomers, thereby promoting clot formation and contributing to the venom's procoagulant effects. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and possess the typical two-chain structure common to snake venom thrombin-like enzymes, connected by disulfide bridges. Include structural features essential for substrate recognition and cleavage specificity, such as exosite interactions for fibrinogen binding, while maintaining the overall stability through multiple disulfide bonds characteristic of viperid venom serine proteases. The enzyme should demonstrate high specificity for its physiological substrate while exhibiting the thermal stability and pH resilience required for venom function in diverse environments."}
{"description": "sp|D2X8K2|PA2_CONGI Phospholipase A2 A2-actitoxin-Cgg2a OS=Condylactis gigantea OX=47073 PE=1 SV=1", "sequence": "GVWQFAYMIAKYTGRNPLDYWGYGCWCGLGGKGNPVDAVDRCCYVHDVCYNSITQGPRPTCSRIAPYHKNYYFTGKKCSTGWLTSKCGRAICACDIAAVKCFRRNHFNKKYRLYKKNIC", "prompt": "Generate a phospholipase A2 toxin sequence from the giant Caribbean anemone Condylactis gigantea. This protein should function as a potent cytolytic and neurotoxic venom component that targets biological membranes through its enzymatic activity. The toxin should hydrolyze the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids that disrupt cellular membrane integrity and trigger inflammatory responses. The sequence must contain the conserved phospholipase A2 catalytic triad (typically involving histidine, aspartate, and tyrosine residues) and maintain the characteristic calcium-binding loop essential for enzymatic function. The structural scaffold should adopt the classic phospholipase A2 fold with multiple disulfide bridges that stabilize the compact globular structure, featuring the conserved cysteine framework pattern common to snake venom and anemone phospholipase A2 toxins. The protein should exhibit the characteristic interfacial activation mechanism, where it binds to lipid-water interfaces to access its phospholipid substrates. Include conserved structural elements such as the β-wing region and the elapid loop that contribute to membrane binding and substrate specificity. The generated sequence should reflect the dual functionality of this toxin - both as a direct membrane-disrupting agent and as an initiator of inflammatory cascades through eicosanoid production from liberated arachidonic acid."}
{"description": "sp|O42257|3L27_NAJSP Long neurotoxin 7 OS=Naja sputatrix OX=33626 PE=1 SV=1", "sequence": "MKTLLLTLVLVTIMCLDLGYTIRCFITPDVTSTDCPNGHVCYTKTWCDGFCSSRGRRVELGCAATCPTVKPGVDIQCCSTDNCNPFPTRP", "prompt": "Design a long neurotoxin protein sequence that mimics the potent neurotoxic activity found in cobra venom from the Naja genus. This toxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta and alpha-gamma subunit interfaces of muscle-type nAChRs. The protein should adopt the characteristic three-finger toxin fold with three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bonds in the C1-C5, C2-C6, C3-C7, C4-C8 connectivity pattern. The sequence should feature the extended C-terminal tail characteristic of long neurotoxins, which enhances receptor binding affinity and duration of action. Key functional residues should be positioned in loop II for primary receptor interaction, with additional stabilizing residues in loops I and III. The toxin should exhibit high specificity for muscle-type over neuronal nicotinic receptors, causing reversible neuromuscular blockade through competitive inhibition of acetylcholine binding. The structural scaffold should maintain the characteristic beta-sheet organization and disulfide-stabilized core that provides exceptional thermal and proteolytic stability typical of elapid snake venom neurotoxins."}
{"description": "sp|Q7SZV0|SLA_GLOHA Snaclec coagulation factor IX-binding protein subunit A (Fragment) OS=Gloydius halys OX=8714 PE=2 SV=1", "sequence": "YEGHCYQTFKLFKTWADAESFCTEQAKGGHLVSIESDGEADFVAQLVAENIQKTEIYVWVGLRVQGKEQQCSSEWSDGSSVSYQNWIEAESKTCLGLQKETEFRKWFNIYCGERNPFVCEA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a coagulation factor IX-binding protein. This toxin originates from the venom of Gloydius halys (Siberian pit viper), where it plays a critical role in disrupting the blood coagulation cascade by specifically targeting coagulation factor IX. The protein should function as an anticoagulant by binding to factor IX with high specificity, thereby interfering with the intrinsic pathway of coagulation and preventing the formation of the tenase complex. The structural scaffold should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by two conserved disulfide bridges with a typical C-C-C-C cysteine framework. The protein should feature key structural elements including a long loop region and a hydrophobic core that facilitates target recognition. The binding interface should contain conserved residues that enable specific interaction with the Gla domain or other functional regions of coagulation factor IX, effectively blocking its activation or interaction with cofactors. The overall architecture should maintain the dimeric assembly typical of snaclec proteins, where this subunit pairs with its complementary subunit to form the functional heterodimeric complex that exhibits high-affinity binding to its coagulation target."}
{"description": "sp|P0CF77|DEF_TITDI Tddefensin OS=Tityus discrepans OX=57059 PE=3 SV=1", "sequence": "RYCPRNPEACYNYCLRTGRPGGYCGGRSRITCFCFR", "prompt": "Design a defensin-like toxin protein derived from the venom of the scorpion Tityus discrepans. This toxin belongs to the scorpion defensin family, which are small cationic peptides that typically function as antimicrobial agents and ion channel modulators. The protein should adopt a conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a triple-stranded antiparallel beta-sheet, stabilized by three or four disulfide bridges in a specific connectivity pattern (commonly C1-C4, C2-C5, C3-C6 for scorpion defensins). The molecular mechanism involves binding to microbial membranes via electrostatic interactions with negatively charged lipid components, leading to membrane disruption and cell lysis. Additionally, scorpion defensins may modulate voltage-gated potassium or sodium channels, contributing to neurotoxic effects. The sequence should include key conserved residues for structural stability and functional activity, such as a glycine-rich loop involved in membrane interaction and a conserved cationic patch for target recognition. The overall structure should be compact and globular, with the disulfide bridges providing exceptional thermal and proteolytic stability, making it effective in the hostile environment of prey envenomation."}
{"description": "sp|B2BS84|VKT_AUSLA Putative Kunitz-type serine protease inhibitor OS=Austrelaps labialis OX=471292 PE=2 SV=1", "sequence": "MTREKSLALLITLAAALAAAESPPGRCHSPKTVGPCRASFHRWRYNATSQMCQEFIFGGCKGNANNFVSKQDCFQTCIRGGAAEATVVPSGPATEVATPRAGHLPEAYENRPGFREFCAAPRVVGPCRASFLRWYFDLESRMCKMFIYGGCRGNKNNYLFEEHCWSQCTGDGEITEEPGDAGAQPPLPSEPFSFSTRAVVLAVLPAILVTILLGSMGVFFVKICRKNPELSVGTVWSTLDDKEYLMSNAYTL", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein derived from the venom of the Australian pygmy copperhead snake (Austrelaps labialis). This toxin should function as a potent and selective serine protease inhibitor, characteristic of the Kunitz-type structural family. The protein must adopt the conserved Kunitz domain fold, featuring a stable alpha-beta structure with a characteristic disulfide bond pattern (typically Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 in Kunitz domains) that stabilizes the inhibitory loop region. The active site should contain a canonical protease-binding loop with residues optimized for specific serine protease recognition and inhibition, likely targeting key proteases involved in hemostasis or inflammatory pathways. The molecular mechanism should involve tight binding to the protease active site through standard mechanism inhibition, forming a stable enzyme-inhibitor complex that blocks protease function. The structural scaffold must maintain the compact, globular fold typical of Kunitz domains, with the inhibitory loop positioned for optimal protease interaction while maintaining overall thermal and proteolytic stability. The protein should exhibit the characteristic pharmacological profile of snake venom Kunitz-type inhibitors, potentially affecting coagulation cascades or other serine protease-dependent physiological processes."}
{"description": "sp|P0DJJ9|PA2B2_PROFL Basic phospholipase A2 BP-II OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVDGSLVQLWKMIFQETGKEAAKNYGLYGCNCGVGRRGKPKDATDSCCYVHKCCYKKVTGCNPKMDSYSYSWKNKAIVCGEKNPPCLKQVCECDKAVAICLRENLGTYNKKYTIYPKPFCKKADTC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the habu snake, Protobothrops flavoviridis. This enzyme should function as a potent toxin with both presynaptic and myotoxic activities. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG) and a catalytic network centered around histidine and aspartate residues essential for hydrolyzing the sn-2 ester bond of glycerophospholipids. Include the canonical disulfide bond pattern (typically 6-7 disulfide bridges) that stabilizes the compact, multi-helical structure. The sequence should exhibit basic properties to facilitate membrane interaction and enhance toxicity. As a venom component, it should contribute to prey immobilization through mechanisms such as disrupting neuromuscular transmission and inducing muscle damage via membrane phospholipid degradation."}
{"description": "sp|P86120|PA22_OPICY Phospholipase A2 2 (Fragment) OS=Opisthacanthus cayaporum OX=573324 PE=1 SV=1", "sequence": "FMKVIDPGTKWCGPGNKAADDTDNGKN", "prompt": "Design a phospholipase A2 toxin sequence derived from the venom of the scorpion Opisthacanthus cayaporum. This enzyme should function as a potent membrane-disrupting toxin that hydrolyzes the sn-2 ester bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges in the conserved pattern typical of group III phospholipase A2 enzymes from scorpion venoms. Include the conserved calcium-binding loop (YGKYCG/XCG) essential for catalytic activity and the interfacial binding surface that enables membrane association. The toxin should exhibit both enzymatic activity and potential myotoxic, hemolytic, or pro-inflammatory effects through the generation of lipid mediators. Maintain the structural integrity required for venom function in prey immobilization and defense, with appropriate surface residues for membrane interaction while preserving the catalytic triad residues (histidine, aspartate) characteristic of this enzyme family."}
{"description": "sp|P86116|KAX6H_OPICY Potassium channel toxin alpha-KTx 6.17 OS=Opisthacanthus cayaporum OX=573324 PE=1 SV=2", "sequence": "IRCQGSNQCYGHCREKTGCMNGKCINRVCKCYGC", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from scorpion venom. This toxin should originate from the scorpion species Opisthacanthus cayaporum and function as a potent and selective blocker of voltage-gated potassium channels, particularly Kv1-type channels. The mechanism of action involves high-affinity binding to the channel's pore region, thereby inhibiting potassium ion efflux and disrupting neuronal or muscular excitability, which underlies its paralytic and neurotoxic effects. The structural scaffold must feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a triple-stranded anti-parallel beta-sheet, stabilized by three or four disulfide bridges with a characteristic C-X(3-7)-C-X(3-7)-C-X(0-4)-C-X(1-4)-C-X(4-12)-C pattern. Key functional residues should include a dyad or triad of critical lysine and aromatic residues (e.g., lysine and tyrosine/phenylalanine) that mediate channel block by inserting into the selectivity filter. The mature toxin should be compact, approximately 30-40 amino acids in length, with a net positive charge to facilitate electrostatic interactions with the negatively charged channel vestibule. Ensure the sequence reflects the high specificity and potency typical of scorpion potassium channel toxins, contributing to the venom's role in prey immobilization and defense."}
{"description": "sp|Q71QI3|VSP5_TRIST Snake venom serine protease CL5 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQRSSELVIGGDECNINEHRFLALVYTDRFQCGGTLINPEWVLTAAHCDRRYMHIYLGVHNESVQYDDEQRRFPKKKYFCLSSKNYTRWDKDIMLIRLNRPVRNSAHIAHLSLPSKPPSVGSVCRVMGWGTITSPNETLPDVPRCANINLFNYTVCRGVFPWLPARSRILCAGVLQGGIDTCKRDSGGPLICNGQFQGIVSWGPKPCAQPREPALYTKVFDHLDWIQSIIAGNTTVTCPP", "prompt": "Design a snake venom serine protease from the venom of Trimeresurus stejnegeri, a pit viper species. This toxin belongs to the serine protease family and functions as a key component in the venom's hemorrhagic and coagulopathic arsenal. The protein should exhibit trypsin-like or thrombin-like protease activity, specifically targeting components of the coagulation cascade such as fibrinogen, factor X, or other plasma proteins to disrupt hemostasis and promote bleeding. The structural scaffold should feature a canonical serine protease fold with a two-domain architecture: an N-terminal domain and a C-terminal catalytic domain containing the conserved catalytic triad of histidine, aspartate, and serine residues. The protein should include the characteristic disulfide bond pattern common to snake venom serine proteases, typically involving 6-8 conserved cysteine residues that stabilize the fold and maintain enzymatic activity. The molecular surface should present substrate-binding exosites and loops that confer specificity for its physiological targets, enabling selective proteolysis in the prey's circulatory system. The overall structure should be compact and stable, optimized for rapid action in venom-induced prey immobilization."}
{"description": "sp|Q71QI2|VSP2_TRIST Snake venom serine protease CL2 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MVLIRVLANLLIIQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGALCGGTLINQEYVLAAAHCDMPNMQILLGVHSASVLNDDEQARDPEEKYFCLSSNNDTKWDKDIMLIRLNRPVNNSVHIAPLSLPSSPPSVGSVCRIMGWGKTIPTQETHPDVPHCANIKLFHYSLCRAVYVGMPAQSRILCAGILQGGIGSCQGDSGGPLICNGQFQGIVSATSKPCAHSLMPALYIKVFDYTDWIKSIIAGNTTVTCPP", "prompt": "Design a snake venom serine protease from the venom of Trimeresurus stejnegeri, a highly potent and specific serine protease toxin. This enzyme functions as a key component in the viper's venom arsenal, primarily targeting the host's hemostatic system through precise proteolytic cleavage of coagulation factors. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) arranged in the canonical geometry for efficient substrate hydrolysis. It should feature the typical two-domain structure composed of six-stranded beta-barrels with connecting loops that determine substrate specificity. Include the essential disulfide bridge network that stabilizes the protease fold, particularly the conserved pattern that maintains the active site architecture. The enzyme should exhibit high specificity for fibrinogen or other coagulation cascade components, leading to coagulopathy through either procoagulant or anticoagulant mechanisms depending on its natural substrate preference. The surface loops surrounding the active site cleft should be optimized for selective recognition of protein substrates in the blood coagulation pathway, with appropriate charge distribution and hydrophobic patches for efficient target binding and catalytic turnover."}
{"description": "sp|Q98989|STXA_SYNHO Stonustoxin subunit alpha OS=Synanceia horrida OX=13279 PE=1 SV=3", "sequence": "MSSDLVMPALGRPFTLGMLYDARREKLIPGFSLFGDETLQKYQSSNAQRSSEFKIVASDSTESKSSAMDIEASLGVSFLGGLVEVGGSAKYLNNTKKYQNQSRVTLKYKATTVYKQFTAPPGTVTVQETAITEKGLATHVVTSILYGANAFFVSDSDKVEDTNLQDIQGKMEAAIKKIPTISIEGSASVQLTDEEKSLASNLSCKFHGDFLLESLPTTFEDAVKTYQTLPTLIGEDGANSVPMKVWLAPLKSYNSKAQQLIQEINVSKVRRIHTTLEELHKLKRRANEAMDVKLVQRIPLIHDKISNFQQIFQDYMLTVQKKIAEKLPLVRAGTESEQSLQKIIDDRAQSPFSNEKVSKWLDAVEREIAVLKSCAGMVEGTQAKFVSNQTELDREVLVGKVKHAVCFIFTSVERNDPYLKVLSDYWESPPSNNAKDVAPSTEDKWCFSTEVVLKMQQRAQTFCDHVNDFEKSRNVGFFITALENGKFQGASIYYYKEGSLATQDFTFPRMPFVQGYKKRSDLLWYACDLTFDRNTINNWISLSDNDTFAASEHGKRQNYPKHPERFVSFNQVLCNEGLMGKHYWEVEWNGYIDVGIAYISIPRKEIDFASAFGYNTYSWVLSYNPKIGYIERHKKREYNVRAPNPGFKRLGLFLDWRYGSISFYAVSSDEVHHLHTFKTKFTEPVYPAFSIGPAGNHGTLRLL", "prompt": "Design a protein sequence for the alpha subunit of stonustoxin, a potent cytolytic toxin from the venom of the stonefish (Synanceia horrida). This toxin plays a critical role in the stonefish's predatory and defensive mechanisms, causing severe pain, tissue necrosis, and systemic effects in envenomated prey or humans. The protein functions as a pore-forming toxin that disrupts cell membranes through a mechanism involving oligomerization into transmembrane pores, leading to osmotic lysis and cell death. It belongs to the perforin-like/MACPF (membrane attack complex/perforin) superfamily, characterized by a conserved MACPF domain that facilitates membrane insertion and pore formation. The structure is anticipated to feature a central β-sheet core surrounded by α-helices, with conserved regions involved in membrane binding and oligomerization. Key structural elements include a cholesterol-binding motif and hydrophobic regions that interact with lipid bilayers. The molecular target is the plasma membrane of various cell types, with binding interfaces involving specific lipid components and potential protein receptors that facilitate initial attachment and subsequent pore assembly. The sequence should reflect these functional and structural characteristics, ensuring proper folding into the MACPF domain architecture and maintenance of cytolytic activity."}
{"description": "sp|D2Y1X9|H3A01_CYRHA Hainantoxin-III 1 OS=Cyriopagopus hainanus OX=209901 PE=1 SV=1", "sequence": "MKASMFLALAGLVLLFVVGYASESEEKEFPRELLSKIFAVDDFKGEERGCKGFGDSCTPGKNECCPNYACSSKHKWCKVYLGK", "prompt": "Design a protein sequence for a neurotoxic peptide from the venom of the Chinese bird spider, Cyriopagopus hainanus, that functions as a potent inhibitor of voltage-gated sodium channels. This toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The protein must specifically target the voltage-sensing domain of Nav1.2 and Nav1.7 sodium channel subtypes, binding to site 4 to impede channel activation and inhibit neuronal excitability. Incorporate key residues for molecular recognition, including a hydrophobic patch for membrane interaction and basic residues for electrostatic steering to the channel's voltage sensor. The sequence should exhibit high affinity and selectivity for neuronal sodium channels, contributing to the spider's predatory strategy by inducing rapid paralysis in insect prey through disruption of action potential generation."}
{"description": "sp|P0C5H3|SCB1_LEIHE Beta-mammal/insect toxin Lqhb1 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "MKIIIFLIVSSLMLIGVKTDNGYLLNKATGCKVWCVINNASCNSECKLRRGNYGYCYFWKLACYCEGAPKSELWAYATNKCNGKL", "prompt": "Design a beta-mammal/insect toxin protein sequence inspired by the venom of the deathstalker scorpion (Leiurus hebraeus). This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting both mammalian and insect sodium channel subtypes. The protein should adopt the conserved beta-toxin structural scaffold characteristic of scorpion venom toxins, featuring a compact globular fold stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The core structure should consist of an alpha-helix packed against an anti-parallel beta-sheet, with key functional residues positioned in the 'core' and 'NC' domains to mediate specific receptor binding. The molecular mechanism involves binding to neurotoxin receptor site 4 on voltage-gated sodium channels, causing a shift in the voltage-dependence of activation toward more negative potentials and delaying channel inactivation, leading to prolonged neuronal depolarization and neuroexcitatory effects. The toxin should exhibit dual activity against both mammalian central nervous system sodium channels and insect sodium channels, making it effective for prey immobilization through disruption of neuromuscular transmission. Include conserved structural motifs such as the cysteine-stabilized alpha-helix/beta-sheet (CSαβ) fold and maintain the characteristic molecular surface features that enable specific receptor recognition while preserving the thermal and proteolytic stability typical of scorpion venom peptides."}
{"description": "sp|P01413|3SP1_DENJA Toxin S5C1 OS=Dendroaspis jamesoni kaimosae OX=8619 PE=1 SV=1", "sequence": "RICYNHLGTKPPTTECTQEDSCYKNIWRNITFDNIRRGCGCFTPRGDMPGPYCCESDKCNL", "prompt": "Design a venom toxin protein from the Jameson's mamba (Dendroaspis jamesoni kaimosae) that functions as a potent short-chain alpha-neurotoxin. This toxin should specifically target and antagonize muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to postsynaptic blockade and flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the cysteine framework C-C-CC-C-C. The structure should feature the typical three-finger morphology with loop I containing key functional residues for receptor binding. The toxin should exhibit high affinity binding to the alpha-delta interface of the nicotinic acetylcholine receptor, competitively inhibiting acetylcholine binding through key aromatic and basic residues in the central loop. The protein should maintain the compact, stable globular structure characteristic of this toxin family, with the disulfide network providing exceptional thermal and proteolytic stability essential for venom function in prey immobilization."}
{"description": "sp|A0A3G3C7V7|CM33_CONAA Mu-conotoxin-like Am3.3 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "MMSKLGVLLTICLLLFPLTAVPLDGDQPADRPAERMQDDISSENHPMFDAIRGCCMPLSCMLLCEPCCG", "prompt": "Design a novel mu-conotoxin protein sequence inspired by the venom arsenal of Conus amadis, a predatory marine cone snail. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels (NaV channels), specifically targeting the skeletal muscle subtype NaV1.4 to induce rapid neuromuscular paralysis in prey. The molecular mechanism involves high-affinity binding to site 1 of the NaV channel, which is typically occupied by tetrodotoxin or saxitoxin, thereby blocking sodium ion flux and preventing action potential generation in muscle fibers. The structural scaffold must adopt the inhibitor cystine knot (ICK) motif, characterized by a compact, disulfide-stabilized globular fold with triple-stranded beta-sheets. The cysteine framework should follow the conserved mu-conotoxin pattern (C-C-CC-C-C) with disulfide connectivity of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, ensuring structural rigidity and functional integrity. Key residues for target specificity and potency, such as those forming the functional epitope for NaV1.4 interaction, must be incorporated. The sequence should exhibit high hydrophobicity and positive charge density to facilitate membrane proximity and binding to the channel's pore region. Avoid any promiscuous activity against neuronal or cardiac NaV subtypes to maintain specificity. The final protein should be 22-26 amino acids in length, reflecting the typical size of mu-conotoxins, and optimized for stability in marine environments."}
{"description": "sp|Q3BK13|DID2A_MACLB Disintegrin lebein-2-alpha OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPFHGSSIILESGNVNDYEVVYPKKVTLLPTGAMNSANPCCDPITCKPRKGEHCVSGPCCRNCKFLNPGTICKRTMLDGLNDYCTGITSDCPRNPWKSEEDEMKWSATAKGSVLM", "prompt": "Design a protein sequence for a disintegrin toxin derived from the venom of Macrovipera lebetinus (Levantine viper). This toxin belongs to the disintegrin family, which are small, non-enzymatic proteins that play a critical role in the viper's venom by disrupting cell-matrix interactions and inhibiting platelet aggregation. The core function of this disintegrin is to act as a potent antagonist of integrin receptors, specifically targeting receptors such as αIIbβ3 (glycoprotein IIb/IIIa) on platelets, thereby preventing fibrinogen binding and thrombus formation. It may also inhibit other integrins involved in cell adhesion and migration, such as αvβ3, contributing to anti-angiogenic and anti-metastatic effects. The protein is expected to adopt a compact, disulfide-rich structure stabilized by multiple disulfide bridges, typically following a cysteine pattern common to short-chain disintegrins (e.g., Cys-X-Cys or similar motifs), which form a rigid scaffold supporting the integrin-binding loop. This loop contains a canonical RGD (Arg-Gly-Asp) or related tripeptide motif that directly interacts with the integrin receptor's ligand-binding site, mimicking endogenous ligands to block adhesion. The 3D structure is anticipated to be characterized by a globular fold with exposed functional loops, ensuring high affinity and specificity for its molecular targets. The sequence should reflect these structural and functional attributes, emphasizing the disulfide framework and integrin-binding motif to achieve the desired toxic activity of inhibiting hemostasis and promoting hemorrhage."}
{"description": "sp|Q3BK14|DIS_MACLB Disintegrin lebestatin OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MIQVLLVIICLAVFPFQGSSKTLKSGNVNDYEVVNPGTVTGLPKGAVEEKHEPMKGNTLQKFPLCTTGPCCRQCKLKPAGTTCWKTSRTSHYCTGKSCDCPSYPGNG", "prompt": "Design a novel disintegrin protein sequence derived from Macrovipera lebetinus (Levantine viper) venom that functions as a potent inhibitor of platelet aggregation and angiogenesis. This disintegrin should adopt the characteristic short-chain disintegrin fold with the canonical RGD (Arg-Gly-Asp) integrin-binding motif positioned within an exposed, flexible loop for optimal receptor engagement. The sequence must include the conserved cysteine framework typical of disintegrins, forming disulfide bridges that stabilize the compact, globular structure essential for biological activity. The protein should specifically target and antagonize αvβ3 and α5β1 integrins on endothelial and tumor cells, disrupting cell adhesion, migration, and signaling pathways critical for thrombus formation and neovascularization. Incorporate structural elements that confer resistance to proteolytic degradation while maintaining high affinity for integrin receptors, reflecting the evolutionary optimization of viper venom disintegrins for rapid incapacitation of prey through hemostatic disruption."}
{"description": "sp|C0HLN4|TX1_POEVT Beta/delta/mu-theraphotoxin-Pv1 OS=Poecilotheria vittata OX=2053141 PE=1 SV=1", "sequence": "AGCKYLFGSCKEDSDCCKHLGCRRKAPQYCGWDGTF", "prompt": "Design a venom-derived peptide toxin from the Sri Lankan ornamental tarantula Poecilotheria vittata that functions as a potent neurotoxin targeting voltage-gated ion channels. This toxin should exhibit a mixed pharmacological profile characteristic of beta/delta/mu-theraphotoxins, simultaneously modulating sodium (NaV), potassium (KV), and potentially calcium channel function. The peptide should adopt the inhibitor cysteine knot (ICK) structural motif, a hallmark of spider venom toxins, stabilized by a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6) that creates a rigid, triple-stranded beta-sheet scaffold. The molecular mechanism should involve high-affinity binding to voltage-sensing domains of ion channels, causing either inhibition or modulation of channel gating kinetics. Key structural elements should include: a well-defined hydrophobic core, surface-exposed residues forming the pharmacophore for ion channel interaction, and conserved beta-hairpin loops that mediate target recognition. The toxin should demonstrate paralytic activity through disruption of neuronal signaling, consistent with the defensive/offensive role of tarantula venom in prey capture and predator deterrence. The sequence should maintain the characteristic compact globular fold (~30-40 residues) with optimal surface properties for membrane penetration and target engagement."}
{"description": "sp|P0DJL4|SLA_DABPA Snaclec VP12 subunit A (Fragment) OS=Daboia palaestinae OX=1170828 PE=1 SV=1", "sequence": "DQDCLPGWSFYEGNCYKAFDEPKSWVDAEKFCQKQSNGKHLASIEGLGKANFVAKLVSEDQSETLREPQIHVWIGLRDQSERQQCSSHWTDGSAVSYECGLAYPFIC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent anticoagulant toxin. This protein originates from the venom of Daboia palaestinae (Palestine viper), where it serves as the alpha subunit of the VP12 heterodimeric complex. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The molecular mechanism involves specific binding to coagulation factor IX or factor X through a surface-exposed recognition site, thereby inhibiting the coagulation cascade and preventing blood clot formation. The sequence should include key residues for calcium-independent carbohydrate recognition domain functionality and maintain the distinctive beta-sheet rich tertiary structure typical of snake venom lectins that target hemostatic pathways."}
{"description": "sp|P69657|CA1A_CONBU Alpha-conotoxin BuIA OS=Conus bullatus OX=89438 PE=1 SV=1", "sequence": "MFTVFLLVVLTTTVVSFPSDRASDGRNAAANDKASDVVTLVLKGCCSTPPCAVLYCGRRR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus bullatus, a marine cone snail species. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the α3β2 subtype with high affinity. The peptide must adopt the characteristic alpha-conotoxin fold stabilized by two disulfide bonds in a globular C-C-C-C cysteine framework (Cys1-Cys3, Cys2-Cys4 connectivity), forming a compact, disulfide-constrained scaffold. The structure should feature a short alpha-helical segment and beta-turn elements that contribute to receptor binding. Key residues in the loop regions, particularly in the second loop, should mediate specific interactions with the α3β2 receptor interface, blocking acetylcholine binding and inhibiting neuronal signaling. The toxin should exhibit high stability due to its disulfide bonds and minimal secondary structure, typical of conotoxins, and should be optimized for potency and selectivity against the α3β2 subtype over other nicotinic receptor subtypes. The sequence must reflect the conserved structural motifs of alpha-conotoxins while incorporating unique residues that confer the desired receptor specificity and toxic activity."}
{"description": "sp|D2N116|3L2A_BUNCE Alpha-delta-bungarotoxin-4 (Fragment) OS=Bungarus caeruleus OX=132961 PE=3 SV=1", "sequence": "YTLLCHTTSTSPISTVTCPSGENLCYTKMWCDAFCSSRGKVIELGCVATCPQPKPYEEVTCCSTDKCNPHPKQRPG", "prompt": "Design a protein sequence for an alpha-delta-bungarotoxin from the Indian krait (Bungarus caeruleus), a highly potent neurotoxin that functions as a postsynaptic antagonist at the neuromuscular junction. This toxin belongs to the three-finger toxin superfamily and exhibits dual specificity, targeting both nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors, contributing to its profound paralytic effects. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8, forming a compact, rigid structure. The central 'finger' (loop II) and C-terminal region are critical for nAChR binding, interacting with the agonist-binding site of muscle-type nAChRs to block acetylcholine signaling, while distinct epitopes mediate muscarinic receptor antagonism. Incorporate key functional residues that confer high affinity and selectivity, such as aromatic and cationic residues in the binding loops, and ensure the sequence reflects the typical length and hydrophobicity pattern of elapid snake neurotoxins. The resulting protein should exhibit slow dissociation kinetics from its targets, leading to sustained neuromuscular blockade and respiratory paralysis, mimicking the lethal neurotoxicity of krait venom."}
{"description": "sp|P0CY52|FAXD_NOTSN Venom prothrombin activator notanarin-D (Fragment) OS=Notechis scutatus niger OX=1027870 PE=1 SV=1", "sequence": "SNSLFEEVRPIVNGMDCKLG", "prompt": "Design a venom-derived protein sequence that functions as a potent prothrombin activator, originating from the highly toxic venom of the Australian black tiger snake (Notechis scutatus niger). This toxin should exhibit the characteristic activity of notanarin-D, serving as a key component in the snake's venom arsenal that initiates the coagulation cascade by specifically converting prothrombin to thrombin. The protein should adopt a structural scaffold typical of snake venom prothrombin activators, likely featuring multiple domains including metalloproteinase-like and disintegrin-like domains, with conserved cysteine frameworks that form specific disulfide bridge patterns essential for structural stability and functional integrity. The generated sequence should demonstrate high specificity for prothrombin binding and activation, potentially through exosite interactions and catalytic domain functionality, resulting in rapid thrombin generation and subsequent fibrin clot formation. The structural architecture should support both substrate recognition and enzymatic activity, with appropriate surface loops and binding interfaces that facilitate efficient prothrombin conversion while maintaining venom stability."}
{"description": "sp|P0DJG3|VSP1_BOTAN Thrombin-like enzyme TLBan (Fragment) OS=Bothrocophias andianus OX=1144373 PE=1 SV=1", "sequence": "VIGGDECNINEHPFLVALYYSTFFCGMTLINQEWVLTAAHESEKFPKEKYFIFCPNNKDIMLIRLDKPVSNSEHIAPLSLPSSPPSVGSVCRKPALYTKVFDYLLWIQSIIAGNTATCP", "prompt": "Design a thrombin-like enzyme protein sequence derived from the venom of Bothrocophias andianus, a venomous pit viper. This enzyme should function as a key component in the snake's venom arsenal, primarily targeting the mammalian coagulation cascade. The protein should exhibit serine protease activity with high specificity for fibrinogen, cleaving fibrinogen to form fibrin clots, thereby inducing consumptive coagulopathy and potentially leading to thrombosis or hemorrhage in prey. The sequence should feature a catalytic triad typical of serine proteases (His, Asp, Ser) and maintain the chymotrypsin-like fold common to snake venom thrombin-like enzymes. Include conserved structural elements such as the S1 pocket for substrate specificity and appropriate disulfide bridges to stabilize the tertiary structure. The enzyme should demonstrate preferential cleavage at specific arginine or lysine residues in fibrinogen, mimicking the procoagulant activity of thrombin while potentially evading natural anticoagulant mechanisms. Ensure the sequence reflects the evolutionary adaptations for rapid action in envenomation, with optimal stability in the venom milieu and efficient interaction with host coagulation factors."}
{"description": "sp|P0DI86|OXLA_BOTAL L-amino-acid oxidase (Fragment) OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "ADVRNPLEEFRETDYEVL", "prompt": "Generate the complete amino acid sequence for a venom L-amino-acid oxidase from the venom of Bothrops alternatus, a medically important pit viper species. This enzyme represents a key toxic component in viperid venoms, functioning as a flavin adenine dinucleotide (FAD)-dependent oxidoreductase that catalyzes the stereospecific oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The generated protein should exhibit the characteristic structural architecture of snake venom L-amino-acid oxidases, featuring a conserved FAD-binding domain with Rossmann fold topology and a substrate-binding domain that creates the active site cavity. The enzyme should possess the typical homodimeric quaternary structure stabilized by non-covalent interactions, with each monomer containing approximately 500-550 amino acids. Key functional residues should include the conserved histidine and arginine residues essential for FAD binding and catalytic activity, along with the characteristic glycine-rich nucleotide-binding motif. The protein should demonstrate substrate preference for hydrophobic L-amino acids, particularly L-leucine and L-phenylalanine, and generate hydrogen peroxide as a key mediator of its diverse toxic effects, including induction of apoptosis, platelet aggregation inhibition, edema formation, and hemorrhage through oxidative damage to tissues and cell membranes. The structural scaffold should maintain the conserved three-domain organization and the characteristic elongated, saddle-shaped morphology that facilitates substrate access to the deeply buried active site."}
{"description": "sp|P68515|BNP_BOTIN Bradykinin-potentiating and C-type natriuretic peptides OS=Bothrops insularis OX=8723 PE=1 SV=2", "sequence": "MVLSRLAASGLLLLALLALSVDGKPVQQWAQGGWPRPGPEIPPLKVQQWAQGGWPRPGPEIPPLTVQQWAQNWPHPQIPPLTVQQWAQLGPPPRPQIPPLEVQQWAQGRAPHPPIPPAPLQKWAPVQKWAPLLQPHESPASGTTALREELSLGPEAASGVPSAGAEVGRSGSKAPAAPHRLSKSKGAAATSAASRPMRDLRPDGKQARQNWGRMVHHDHHAAVGGGGGGGGGGARRLKGLAKKGAAKGCFGLKLDRIGTMSGLGC", "prompt": "Design a novel protein sequence that functions as a bradykinin-potentiating and C-type natriuretic peptide derived from Bothrops insularis venom. This toxin should exhibit dual biological activities: (1) potentiation of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby enhancing bradykinin's vasodilatory and hypotensive effects, and (2) natriuretic activity through activation of the natriuretic peptide receptor, promoting diuresis and natriuresis. The protein should adopt a compact, stable structure typical of small venom peptides, likely stabilized by disulfide bridges in a characteristic cysteine framework. Given its origin from Bothrops insularis venom, the toxin should be optimized for rapid systemic effects upon envenomation, contributing to prey immobilization through profound hypotension. The sequence should reflect the evolutionary adaptation of pit viper venoms to modulate cardiovascular homeostasis in prey organisms, with high specificity for mammalian ACE and natriuretic peptide receptors. Structural predictions should indicate a folded conformation that presents key functional motifs for receptor interaction while maintaining protease resistance appropriate for venom deployment."}
{"description": "sp|Q71QJ4|VSPH4_TRIST Snake venom serine protease homolog KN4 OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELIIGGDECNINEHRFLVALYTFRSRRFHCGGTLINQEWVLSAARCDRKNIRIKLGMHSTNVTNEDEQRRVPKEKFFCLSSKTYTQWNKDIMLIRLNSPVNNSTHIAPLSLPSNPPFVGSVCRIMGWGTITSPNETYPDVPHCANINLFNYTVCHGAHAGLPATSRTLCAGVLEGGKDTCKGDSGGPLICNGQFQGIVSWGGDPCAQPREPGVYTKVFDHLDWIQNIIAGNTTATCPL", "prompt": "Design a snake venom serine protease homolog protein that mimics the structural and functional characteristics of serine proteases but lacks catalytic activity, serving as a venom component from the pit viper Trimeresurus stejnegeri. This protein should adopt the characteristic chymotrypsin-like serine protease fold with a two-domain β-barrel structure, featuring the conserved catalytic triad residues (His, Asp, Ser) in a spatial arrangement that maintains the structural scaffold while being functionally inactive. The protein should contain the characteristic disulfide bond pattern typical of snake venom serine proteases, likely including conserved cysteine residues that form stabilizing bridges to maintain structural integrity. As a serine protease homolog, it should retain the ability to bind to physiological targets involved in hemostasis, potentially interfering with coagulation cascades or platelet function through non-enzymatic mechanisms such as substrate mimicry or receptor binding. The protein should exhibit the molecular surface properties and electrostatic potential appropriate for interacting with blood coagulation factors or other hemostatic components, contributing to the venom's overall hemorrhagic or pro-coagulant effects. The structural design should ensure proper folding stability in the venom environment while maintaining the characteristic β-barrel architecture and surface loops that mediate target recognition."}
{"description": "sp|P0DQR1|VKT3_PALCA Kunitz-like toxin PcKuz3 OS=Palythoa caribaeorum OX=134933 PE=3 SV=1", "sequence": "CQQPVKPGLCEAYIPRFFYNTSSKQCEKFIYGGCGGNSNRFLTMKACQDKC", "prompt": "Design a novel Kunitz-type toxin protein sequence inspired by the venom arsenal of the zoanthid Palythoa caribaeorum, a cnidarian known for its potent neurotoxic and cytolytic venom components that function in prey capture and defense. This toxin should adopt the canonical Kunitz domain fold characterized by a compact, disulfide-stabilized beta-trefoil structure with an alpha-helix, stabilized by three conserved disulfide bonds in a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The protein should function as a serine protease inhibitor, specifically targeting trypsin-like enzymes through a solvent-exposed binding loop that inserts into the protease active site, mimicking the standard mechanism of Kunitz domain inhibitors. Key structural elements must include the characteristic Kunitz inhibitory loop with appropriate P1 residue (e.g., Lys or Arg) for trypsin specificity, conserved hydrophobic core maintaining structural integrity, and surface loops adapted for potential ion channel modulation given the neurotoxic context of zoanthid venoms. The sequence should reflect the typical 50-60 residue length of Kunitz toxins, with conserved cysteine spacing and the hallmark Kunitz family signature motifs while incorporating sequence variations consistent with cnidarian toxin evolution."}
{"description": "sp|P37045|TX23B_AGEAP Omega-agatoxin-Aa4b OS=Agelenopsis aperta OX=6908 PE=1 SV=2", "sequence": "MKLCMTLLITAIAVVTFVVATQEESAEFNEVEESREDNCIAEDYGKCTWGGTKCCRGRPCRCSMIGTNCECTPRLIMEGLSFA", "prompt": "Design a protein sequence for a potent neurotoxin derived from the venom of the funnel-web spider Agelenopsis aperta. This toxin belongs to the omega-agatoxin family, specifically functioning as a selective and high-affinity antagonist of P/Q-type voltage-gated calcium channels (Cav2.1). The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. This scaffold confers exceptional stability and resistance to proteolytic degradation. The toxin's mechanism involves binding to the extracellular pore region of P/Q-type calcium channels, effectively blocking calcium influx into presynaptic nerve terminals, which inhibits neurotransmitter release and leads to neuromuscular paralysis. Key functional residues should be positioned within flexible loops extending from the ICK core to mediate specific interactions with the channel's voltage-sensing domain and selectivity filter. The sequence must include the characteristic cysteine framework of spider neurotoxins and maintain the hydrophobic core essential for structural integrity, while surface-exposed loops should contain charged and polar residues critical for target recognition and binding affinity."}
{"description": "sp|P01424|3S11_NAJME Short neurotoxin 1 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "MECHNQQSSQPPTTKTCPGETNCYKKQWSDHRGTIIERGCGCPSVKKGVKINCCTTDRCNN", "prompt": "Design a protein sequence for a short neurotoxin from the forest cobra (Naja melanoleuca) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and antagonize muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, causing reversible paralysis by competitively blocking acetylcholine binding. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C5, C2-C6, C3-C7, C4-C8. The structural scaffold should feature the typical globular shape with loop I containing the critical functional residues for receptor binding, particularly in the central loop which forms the primary pharmacophore. The toxin should exhibit high affinity for the α-δ and α-γ subunit interfaces of the nicotinic receptor, with key binding determinants including conserved aromatic residues and basic amino acids that interact with complementary acidic residues on the receptor. The protein should maintain the characteristic thermal stability and protease resistance conferred by the dense disulfide network, while exhibiting the rapid onset of neuromuscular blockade typical of elapid snake neurotoxins used for prey immobilization."}
{"description": "sp|O46028|KA101_CENNO Potassium channel toxin alpha-KTx 10.1 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "MEGIAKITLILLFLFVTMHTFANWNTEAAVCVYRTCDKDCKRRGYRSGKCINNACKCYPYGK", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Centruroides noxius, a medically significant species known for producing potent neurotoxins that target ion channels. This toxin belongs to the alpha-KTx family, specifically designated as alpha-KTx 10.1, and functions as a selective blocker of voltage-gated potassium channels (Kv channels). Its mechanism involves high-affinity binding to the pore region of Kv channels, thereby inhibiting potassium ion efflux, prolonging neuronal action potentials, and enhancing neurotransmitter release, leading to neurotoxic effects. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by disulfide bridges. Infer the disulfide connectivity pattern as C1-C4, C2-C5, C3-C6, based on the alpha-KTx family framework, with key residues in the beta-sheet region forming the functional dyad (typically involving a lysine and a hydrophobic residue) essential for channel block. The molecular target is likely Kv1.x subtypes, with binding mediated by electrostatic and hydrophobic interactions at the channel vestibule. Ensure the sequence reflects the compact, stable structure (approximately 30-40 residues) with the defined scaffold, conserved family motifs, and functional residues for potassium channel inhibition."}
{"description": "sp|P0CH22|M34_CONPL Conotoxin Pu3.4 (Fragment) OS=Conus pulicarius OX=93154 PE=2 SV=1", "sequence": "LGVLLPICLLLFPLTALPLDGDQPADRPAERMQDDFITEQHPLFDPVKRCCDWPCNAGCVPCCF", "prompt": "Design a conotoxin sequence from the marine cone snail Conus pulicarius that functions as a potent neurotoxin. This toxin should exhibit the characteristic cysteine framework and structural scaffold typical of conotoxins, with specific disulfide bridge connectivity that stabilizes a compact, globular fold. The protein should act as a selective antagonist of neuronal nicotinic acetylcholine receptors, binding with high affinity to specific receptor subtypes to disrupt synaptic transmission. Incorporate conserved structural motifs that facilitate precise molecular recognition and target engagement, while maintaining the overall stability and solubility profile characteristic of conopeptides. The sequence should reflect the evolutionary optimization for rapid paralysis of prey through targeted interference with neuromuscular signaling pathways."}
{"description": "sp|P01516|MAST_VESCR Mastoparan-C OS=Vespa crabro OX=7445 PE=1 SV=1", "sequence": "LNLKALLAVAKKIL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the European hornet, Vespa crabro. This amphipathic tetradecapeptide should adopt an alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan family peptides. The sequence must exhibit potent mast cell degranulation activity through direct activation of heterotrimeric G proteins, particularly Gi/o subtypes, by mimicking intracellular G protein-coupled receptor loops. The peptide should demonstrate strong hemolytic activity against erythrocyte membranes and antimicrobial properties against Gram-positive and Gram-negative bacteria via membrane disruption. Key structural features should include: a predominantly cationic N-terminal region for membrane interaction, a central hydrophobic core for membrane insertion, and amphipathic character enabling both membrane binding and protein interactions. The peptide should preferentially interact with phospholipid membranes and exhibit calcium-independent mast cell activation. The sequence should maintain the characteristic mastoparan length of 14 amino acids with appropriate charge distribution for optimal biological activity."}
{"description": "sp|A0A5Q0MUM5|BRKPS_AGASP [Ser6, Val10, Asp11]-phyllokinin OS=Agalychnis spurrelli OX=317303 PE=1 SV=1", "sequence": "MSFLKKSLLLVLFLGLVSFSICEEEKRETEEEENEDDMDEESEEKKRESPDRPPGFSPFRVD", "prompt": "Design a bradykinin-potentiating peptide derived from the skin secretions of the gliding leaf frog, Agalychnis spurrelli. This peptide belongs to the phyllokinin family, characterized by the specific amino acid substitutions [Ser6, Val10, Asp11] relative to canonical bradykinin. The peptide should function as a potent vasoactive agent that enhances bradykinin-mediated effects through inhibition of angiotensin-converting enzyme (ACE), leading to prolonged hypotension and increased vascular permeability. The structural scaffold should be a linear non-disulfide bonded peptide approximately 11 amino acids in length, maintaining the characteristic bradykinin core sequence while incorporating the specified substitutions that enhance receptor binding affinity and metabolic stability. The peptide should exhibit high specificity for bradykinin B2 receptors and ACE inhibition, with the Asp11 substitution potentially contributing to improved pharmacokinetic properties. The overall conformation should adopt a flexible extended structure capable of engaging both enzymatic and receptor targets simultaneously."}
{"description": "sp|Q98UF9|VM3H3_BOTJA Zinc metalloproteinase-disintegrin-like HF3 OS=Bothrops jararaca OX=8724 PE=1 SV=3", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVVYARKVTALPKGAVQPKYEDTMQYELKVNGEPVVLHLEKNKQLFSKDYSETHYSPDGREITTYPPVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYFIEPLKLPNSEAHAVFKYENVEKEDEVPKMCGVTQTNWESDEPIKKASQLVVTAEQQRYNHYKYIELVILADYRMVTKNNGDLGKIRTKIYEIVNILNEIFRYLYIRIALVGIEIWSNADLSNVTLSADDTLASFGTWRGTVLLKRKSHDNAQLLTAIDFDGQTIGIANIASMCNQNKSVGVVMDYSPINLVVAVIMAHEMGHNLGINHDTGSCSCGGYSCIMAPEISDQPSKLFSNCSKQAYQRYINYYKPQCILNEPLRTDIVSPPVCGNELLEMGEECDCGSPRNCRDPCCDAATCKLHSWVECESGECCDQCRFKGAGTECRAARSECDIAESCTGQSADCPTDDFKRNGQPCLHNYGYCYNGNCPIMYHQCYALFGSNATVAEDGCFEFNENGDKYFYCRKQSGVNIPCAQEDVKCGRLFCHTKKHPCDYKYSEDPDYGMVDNGTKCADGKVCSNGHCVDVATAY", "prompt": "Design a mature venom protein sequence from the pit viper Bothrops jararaca that functions as a potent zinc metalloproteinase-disintegrin-like toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), comprising a propeptide domain, a catalytic metalloproteinase domain, and a disintegrin-like domain. The metalloproteinase domain must contain the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, facilitating proteolytic activity against key components of the extracellular matrix such as fibrinogen, collagen, and basement membrane proteins, thereby contributing to hemorrhage, coagulopathy, and tissue damage. The disintegrin-like domain should feature the canonical ECD motif instead of the RGD motif found in free disintegrins, enabling inhibition of integrin-mediated platelet aggregation and cell adhesion. The protein should adopt a compact, multi-domain structure stabilized by multiple disulfide bonds, with the metalloproteinase domain folding into a typical metzincin-like architecture and the disintegrin-like domain forming a small, rigid loop. The overall structure should facilitate synergistic actions between the proteolytic and anti-adhesive domains, enhancing the toxin's potency in prey immobilization and digestion through localized tissue destruction and systemic hemostatic disruption."}
{"description": "sp|O76200|TX20A_PHONI Kappa-ctenitoxin-Pn1a OS=Phoneutria nigriventer OX=6918 PE=1 SV=1", "sequence": "MWFKIQVLVLAITLITLGIQAEPNSSPNNPLIVEEDRAECAAVYERCGKGYKRCCEERPCKCNIVMDNCTCKKFISELFGFGK", "prompt": "Design a venom-derived neurotoxin protein sequence from the armed spider Phoneutria nigriventer, specifically belonging to the kappa-ctenitoxin family. This toxin functions as a potent potassium channel blocker, primarily targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and synaptic transmission. The protein should adopt the inhibitor cysteine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key functional residues should be positioned within flexible loops to facilitate high-affinity binding to the channel's pore region, inducing prolonged channel blockade. The sequence must reflect the typical molecular weight (~4-8 kDa) and basic pI common to spider venom ICK toxins, ensuring stability in the venom milieu and selective activity against neuronal potassium channels to produce paralytic effects in prey."}
{"description": "sp|Q3SAE5|VNPB_HOPST Natriuretic peptide HsNP-b (Fragment) OS=Hoplocephalus stephensii OX=196418 PE=2 SV=1", "sequence": "SGSKTAKIGDGCFGVPIDHIGSTTDLGCGRPRPKPTPRGS", "prompt": "Design a natriuretic peptide toxin derived from the venom of Stephens' banded snake (Hoplocephalus stephensii). This peptide should function as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) to induce diuresis, natriuresis, and vasodilation. The peptide should adopt a conserved natriuretic peptide fold characterized by a central alpha-helical region stabilized by a disulfide-bonded loop structure, typically with a 1-3, 2-4 cysteine connectivity pattern forming a ring-like scaffold essential for receptor binding. Key functional motifs should include the receptor-binding domain with conserved aromatic and hydrophobic residues that interact with the NPR-A extracellular domain, facilitating cyclic GMP production and subsequent physiological effects. The peptide should exhibit high affinity and specificity for natriuretic peptide receptors while resisting proteolytic degradation, contributing to the snake's venom strategy of inducing hypotension and disrupting cardiovascular homeostasis in prey."}
{"description": "sp|Q9BPA9|O26_CONTE TxMEKL-P2 OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MEKLTILLLVAAVLTSTQALIQGGGDERQKAKINFLSRSDRDCRGYDAPCSSGAPCCDWWTCSARTNRCF", "prompt": "Design a novel protein sequence for a conotoxin derived from the venom of the marine cone snail Conus textile, specifically targeting the α9α10 nicotinic acetylcholine receptor (nAChR) subtype. This toxin should function as a potent and selective antagonist of the α9α10 nAChR, which is implicated in pain pathways, making it a potential therapeutic candidate for neuropathic pain. The sequence must adopt the conserved structural framework of α-conotoxins, characterized by a disulfide connectivity pattern of Cys1-Cys3 and Cys2-Cys4, forming two disulfide bridges that stabilize a compact, globular fold. The core structure should include a short α-helical segment and well-defined loops that mediate receptor interaction. Key functional residues should be positioned to interact with the orthosteric binding site of the α9α10 nAChR, likely involving aromatic or hydrophobic residues for binding specificity and charged residues for affinity. The venom of Conus textile is known for its diversity of conotoxins that target ion channels and receptors, and this toxin should reflect the high selectivity and potency typical of conotoxins. Ensure the sequence includes the characteristic cysteine framework and predicted pharmacophore elements for α9α10 nAChR blockade, while maintaining stability and minimal immunogenicity."}
{"description": "sp|O73795|VM2MB_GLOBR Zinc metalloproteinase/disintegrin OS=Gloydius brevicauda OX=3148161 PE=2 SV=2", "sequence": "MIQVLLVIICLAAFPYQGTSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLPKNKALPSKDYIETHYSPDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSNSEAHAVYKYEDVEKEDEAPKMCGVTQNWESYEPIKYEDVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPAHQRYIELVIVADHGMFTKYNGDSDKIREWVRQMVNTVDEIYSYMYIDVALAGLQIWSNEDLINVQPAAPHTLDSFGKWRERDLLHRIHHDNAMLLTAIDFDGPTIGLAYVGTMSNPKGSTGVVQDHSTINFRVAVTMAHEIGHNLGIHHDTGSCSCGGYSCIMSPVISHEPSKYFSDCSYTQCWDFIMNQKPQCILNKPLRTDTVSTPVSGNELLEAGEECDCGSPGNPCCDAATCKLRQGAQCAEGLCCDQCRFMKEGTICRRGRGDDLDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence from the short-tailed mamushi snake (Gloydius brevicauda) that functions as a zinc metalloproteinase and disintegrin. This protein should exhibit the characteristic dual functionality of snake venom metalloproteinases (SVMPs). The metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) and coordinate a catalytic zinc ion to enable proteolytic activity against extracellular matrix components such as fibrinogen, collagen, and von Willebrand factor, contributing to hemorrhage and tissue damage. The disintegrin domain should adopt the typical disintegrin fold with the RGD (Arg-Gly-Asp) or related integrin-binding motif exposed in a flexible loop, enabling specific inhibition of platelet aggregation by blocking αIIbβ3 integrin receptors. The protein should maintain the multi-domain architecture common to SVMPs, with proper folding of both domains and appropriate cysteine residues for disulfide bond formation to stabilize the structure. The overall protein should reflect the hemorrhagic and anti-coagulant properties characteristic of viperid venoms, facilitating prey immobilization through disruption of hemostasis."}
{"description": "sp|C0HJV4|CTX23_LACTA Cytoinsectotoxin-2c OS=Lachesana tarabaevi OX=379576 PE=1 SV=1", "sequence": "SWDSIWKSAKNKMDKIMRQKVAKWMAKKEGKSVEEVQAKVDAMSKKDIRMHVISHYGKKAFEQLSKSLEE", "prompt": "Design a novel cytolytic insecticidal toxin protein inspired by the venom arsenal of the Central Asian spider Lachesana tarabaevi. This protein should function as a potent cytotoxin with specific insecticidal activity, capable of disrupting cellular membranes in insect prey. The mechanism of action should involve pore formation or membrane destabilization, leading to osmotic lysis and rapid paralysis of insect nervous systems. The structural scaffold should feature a compact, globular fold stabilized by multiple disulfide bridges, characteristic of spider venom cytotoxins. Key structural elements should include an amphipathic surface topology with hydrophobic patches for membrane insertion and cationic regions for initial electrostatic interactions with anionic phospholipid headgroups. The protein should exhibit high specificity for insect cell membranes over mammalian systems, potentially through selective recognition of lipid composition or membrane protein receptors unique to arthropods. The sequence should encode conserved cysteine residues forming a specific disulfide connectivity pattern that constrains the tertiary structure into a stable, protease-resistant conformation optimized for venom delivery and target engagement."}
{"description": "sp|P0DJL5|SLB_DABPA Snaclec VP12 subunit B OS=Daboia palaestinae OX=1170828 PE=1 SV=1", "sequence": "DQDCLPGWSYFEKYCYKVFQVKKNWEDAEKFCTEEVKDGHLISLHSNEEVEFMTSLAFPILKYDIVWMGLRNFWRDCPWKWSDDAKLDYKAWSDEPNCYGAMTTDYQWLRWNCNDPRYFVCKSPA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent anticoagulant toxin. This protein originates from the venom of the Palestine viper (Daboia palaestinae), where it plays a crucial role in prey immobilization by disrupting the blood coagulation cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two essential disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The molecular mechanism involves specific binding to coagulation factor IX or factor X through a well-defined carbohydrate recognition domain (CRD)-like interface, effectively inhibiting the coagulation cascade at key steps. The structural scaffold should maintain the typical β-sheet core with flanking α-helices that create a stable platform for target recognition. Key functional residues should be positioned to mediate calcium-independent protein-protein interactions with coagulation factors, mimicking the natural anticoagulant activity observed in viper venoms. The overall architecture should ensure proper folding into a compact, globular structure that maintains stability in the venom milieu while exhibiting high specificity for its hemostatic targets."}
{"description": "sp|P04098|SCX8_BUTOC Neurotoxin 8 (Fragment) OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "VRDAYIAQNYNCVYTCFKNDYCNDICTKNGAXXGYC", "prompt": "Design a neurotoxin protein sequence derived from the venom of Buthus occitanus tunetanus, a scorpion species known for producing potent neurotoxins that target voltage-gated ion channels in the nervous system of prey. This toxin should function as a sodium channel modulator, specifically interacting with site 3 of voltage-gated sodium channels to delay channel inactivation and prolong action potentials, leading to sustained neuronal excitation and paralysis. The protein should adopt the conserved structural scaffold typical of scorpion β-toxins, characterized by a compact, globular fold stabilized by a specific disulfide bridge pattern—likely a cysteine framework with four disulfide bonds (C-C-C-C) that form a core structural motif. Key structural elements should include an α-helix and several β-strands arranged in a βαββ topology, with the functional epitope for receptor binding located in loops connecting these secondary structures. The sequence must include conserved residues critical for target recognition and binding affinity, ensuring the toxin's specificity for insect or mammalian sodium channels as relevant to its ecological role in prey immobilization."}
{"description": "sp|O76201|TX20B_PHONI Omega-ctenitoxin-Pn1a OS=Phoneutria nigriventer OX=6918 PE=1 SV=1", "sequence": "MWLKIQVFLLAITLITLGIQAEPNSSPNNPLIEEEARACAGLYKKCGKGASPCCEDRPCKCDLAMGNCICKKKFIEFFGGGK", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the Brazilian wandering spider (Phoneutria nigriventer), specifically an omega-ctenitoxin. This toxin functions as a calcium channel blocker, primarily targeting voltage-gated calcium channels (VGCCs) in the peripheral nervous system. It should exhibit the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, triple-stranded beta-sheet scaffold. The toxin's mechanism involves high-affinity binding to the pore-forming alpha1 subunit of Cav2.2 (N-type) calcium channels, leading to inhibition of neurotransmitter release and causing severe pain, priapism, and autonomic dysfunction in envenomation. The sequence should reflect the compact, globular fold typical of ICK toxins, with key residues in the beta-hairpin loops responsible for target specificity and potency."}
{"description": "sp|Q75WG5|TXM14_MACGS Delta-hexatoxin-Mg1b OS=Macrothele gigas OX=223896 PE=1 SV=1", "sequence": "MKILEKALLENDSAAEEESRNLRTKRCARKRAWCEKTENCCCPMKCIYAWYNGQSSCDHTISTIWTSCPK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a delta-hexatoxin derived from the venom of the funnel-web spider Macrothele gigas. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, which is characterized by a highly stable triple-stranded beta-sheet fold stabilized by a conserved disulfide bond pattern (C1-C4, C2-C5, C3-C6). The core function of this toxin is to act as a voltage-gated sodium channel (Nav) modulator, specifically targeting insect sodium channels to induce paralysis. The mechanism involves binding to site 4 of the channel, which alters the voltage-dependent activation or inactivation kinetics, leading to disrupted neuronal signaling. The protein should contain the canonical ICK motif with six cysteine residues forming the characteristic knot, and it should exhibit high selectivity for insect over mammalian sodium channels, reflecting the spider's predatory adaptation. The structural scaffold should include a compact, globular fold with exposed loops that mediate target recognition and binding. The sequence must maintain the conserved cysteine framework and key residues for Nav channel interaction while incorporating novel variations to enhance insecticidal potency and stability."}
{"description": "sp|P81798|SLR_ECHML Snaclec multactivase regulatory subunit (Fragment) OS=Echis multisquamatus OX=93050 PE=1 SV=1", "sequence": "DCLPGWSVYEGRCYKVFNQKTWKAAEKFC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a multactivase regulatory subunit. This toxin originates from the venom of Echis multisquamatus (saw-scaled viper), where it plays a crucial role in regulating the procoagulant activity of snake venom metalloproteinases by binding to and modulating the activity of coagulation factors. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The structural scaffold should feature a globular domain with beta-sheets and alpha-helices arranged in a specific spatial orientation that facilitates protein-protein interactions. Key functional residues should be positioned to enable calcium-independent binding to coagulation factors, particularly through surface-exposed loops that mediate specific recognition of blood coagulation components. The sequence should maintain the conserved structural motifs of snaclecs while incorporating the specific binding interface required for its regulatory function in the venom's hemotoxic arsenal."}
{"description": "sp|P69502|A1XA_LOXGA Dermonecrotic toxin LgSicTox-alphaI-Loxn-A (Fragment) OS=Loxosceles gaucho OX=58216 PE=1 SV=2", "sequence": "ADNRRPIWVMGHMVNSLAQIDEFVNLGANSIETDVSFDRNCQVLVVFDLKTGHRWQFGGITNKVLNEAAYK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the South American brown spider Loxosceles gaucho. This toxin belongs to the sphingomyelinase D family and functions as a phospholipase D enzyme that specifically hydrolyzes sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The toxin's mechanism involves cleaving the phosphodiester bond, generating ceramide-1-phosphate and choline, which triggers a cascade of inflammatory responses, endothelial cell damage, platelet aggregation, and complement activation, ultimately leading to dermonecrosis and potential systemic effects. The protein should adopt the conserved (α/β)8 TIM barrel fold characteristic of sphingomyelinase D enzymes, with the active site containing conserved histidine and glutamic acid residues that coordinate a catalytic metal ion (typically Mg²⁺ or Mn²⁺). The structure should feature the characteristic disulfide bond pattern that stabilizes the TIM barrel architecture. The toxin should specifically target endothelial cells and erythrocytes, with molecular recognition elements that facilitate binding to membrane lipid components. The venom's biological significance lies in its role in spider defense and prey immobilization, with this particular toxin being a major contributor to the characteristic necrotic lesions associated with Loxosceles envenomation."}
{"description": "sp|Q7T2I1|3S110_LATLA Short neurotoxin OKI-10 (Fragment) OS=Laticauda laticaudata OX=8630 PE=3 SV=1", "sequence": "KTLLLTLVVVTIVCLDLGYTRRCFNQQSSEPQTNKSCPPGENSCYRKQWRDHRGTIIERGCGCPTVKPGVKLRCCESEDCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the banded sea krait (Laticauda laticaudata), specifically the OKI-10 variant. This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. As a short-chain neurotoxin, it should specifically target and antagonize muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, competitively inhibiting acetylcholine binding and causing reversible neuromuscular blockade. The sequence should contain the conserved functional loop regions typical of three-finger toxins, with loop II being particularly critical for receptor binding specificity. The toxin should exhibit high affinity for the α-δ and α-γ subunit interfaces of the muscle nAChR, leading to flaccid paralysis through disruption of neuromuscular transmission. The structural scaffold should maintain the compact, globular architecture characteristic of short neurotoxins, with the core stabilized by the conserved disulfide framework and the functional loops projecting from this stable core to facilitate precise receptor interaction."}
{"description": "sp|P37300|O17C_CONMA Omega-conotoxin MVIIC (Fragment) OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "TRCKGKGAPCRKTMYDCCSGSCGRRGKCG", "prompt": "Generate the complete amino acid sequence for omega-conotoxin MVIIC from the marine cone snail Conus magus. This neurotoxic peptide functions as a potent and selective calcium channel blocker, specifically targeting N-type voltage-gated calcium channels (Cav2.2) in the presynaptic terminals of neurons. The toxin operates by binding to the pore-forming α1 subunit of these channels, effectively inhibiting neurotransmitter release and causing neuromuscular paralysis. Omega-conotoxin MVIIC belongs to the O-superfamily of conotoxins, characterized by a conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges, stabilizing a compact, globular fold. The structural scaffold is defined by an inhibitor cystine knot (ICK) motif, which confers exceptional stability and resistance to proteolytic degradation. The mature toxin is expected to be 26-31 amino acids in length, with the disulfide connectivity pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) critical for its high-affinity binding and biological activity. The sequence should include key residues involved in target recognition, such as hydrophobic and charged amino acids that interact with the channel's extracellular loops. This conotoxin is part of the predatory venom arsenal of Conus magus, used to immobilize prey by blocking synaptic transmission."}
{"description": "sp|A0A3G5BID2|KAZL2_DOLGE U-Kazal-Dg21.2 OS=Dolopus genitalis OX=2488630 PE=1 SV=1", "sequence": "MKYFLWSAVTIFAIVNVVGAKNSDFDPRCLRACTAIYRPVCGFDGKQYRIFASECVMAFENCNLLLKSQKAFQKTLMSFCQVEEDFDSDFCPEVCPLLYKPVCGSYGDIKKIFPNECELKRANCKFGEAWEKINMDICRNISFKSELIDPKKKCLKPCNLNWDPICAFDGEKYFTFGNRCDMEIQTCLRSEKNWTLIRKGEC", "prompt": "Design a serine protease inhibitor protein from the venom of the Australian blue bottle fly (Dolopus genitalis) that belongs to the Kazal-type inhibitor family. This toxin should function as a potent anticoagulant by specifically targeting and inhibiting key serine proteases in the blood coagulation cascade, likely including thrombin, factor Xa, or other coagulation factors. The protein should adopt the characteristic Kazal-type fold consisting of a compact, globular structure stabilized by three conserved disulfide bonds with the canonical Cys1-Cys5, Cys2-Cys4, Cys3-Cys6 connectivity pattern. The inhibitory activity should be mediated by a canonical binding loop that presents the P1 residue in an optimal conformation for insertion into the protease active site, with the specific P1 residue determining target protease selectivity. The structure should feature the typical Kazal domain architecture with an alpha-helix and anti-parallel beta-sheets, maintaining the conserved structural scaffold while allowing for functional specialization through sequence variation in the reactive site loop. This venom component likely serves to prevent host blood clotting during feeding, facilitating hematophagy by disrupting hemostatic mechanisms."}
{"description": "sp|C0HM18|SCX5_CENHU Beta-toxin Chui5 (Fragment) OS=Centruroides huichol OX=2911785 PE=1 SV=1", "sequence": "KEGYIVNYHDGCKYECYKLGDNDYCLRECRLRYGKGAGGYCYAFGCWCTHLYEQAVVWPLKNKTCN", "prompt": "Design a beta-toxin protein sequence derived from the venom of the scorpion Centruroides huichol. This toxin functions as a voltage-gated sodium channel modulator, specifically targeting and binding to site 4 on the extracellular domains of neuronal sodium channels. The mechanism involves altering channel gating kinetics to delay inactivation, leading to prolonged neuronal depolarization and enhanced neurotransmitter release, which results in neurotoxic effects. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion beta-toxins, with a disulfide bridge pattern that stabilizes the core structure—typically involving four disulfide bonds arranged in a specific connectivity pattern that supports the globular fold. Key structural elements include a short alpha-helix and an antiparallel beta-sheet, forming a compact, stable domain. The molecular target interface should include residues critical for interacting with the voltage-sensing domain of sodium channels, ensuring high affinity and specificity. The sequence must reflect the biological context of scorpion venom, where such toxins aid in prey immobilization through disruption of neuromuscular signaling."}
{"description": "sp|P69747|CA1A_CONVC Alpha-conotoxin Vc1a OS=Conus victoriae OX=319920 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSSTSGRREFRGRNAAAKASDLVSLTDKKRGCCSDPRCNYDHPEICG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus victoriae. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha9alpha10 subtype. The peptide must adopt the characteristic alpha-conotoxin fold stabilized by two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming a compact globular structure with well-defined alpha-helical elements. The sequence should include conserved framework residues that facilitate proper folding and receptor binding, while incorporating specific loop regions that confer high affinity and selectivity for the alpha9alpha10 nAChR subtype. The toxin should exhibit analgesic properties through its modulation of cholinergic signaling in pain pathways, representing a potential therapeutic lead for neuropathic pain conditions. Ensure the peptide maintains the typical 16-20 amino acid length range of alpha-conotoxins and displays the signature cysteine pattern that defines this toxin family."}
{"description": "sp|Q7T046|VM3CX_MACLB Coagulation factor X-activating enzyme heavy chain OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MMQVLLVTISLAVFPYQGSSIILESGNVNDYEVVYPQKITALPEEAVQQPEQKYEDTMQYEFEVNGEPVVLHLEKNKDLFSEDYSETRYSPDGRETTTKPPVQDHCYYHGRIQNDAYSSASISACNGLKGHFKLQGETYLIEPLKIPDSEAHAVYKYENIEKEDEAPKMCGVTQTNWESDEPIKKASQLVATSAKRKFHKTFIELVIVVDHRVVKKYDSAATNTKIYEIVNTVNEIFIPLNIRLTLIGVEFWCNRDLINVTSSADDTLDSFGEWRGSDLLNRKRHDNAQLFTDMKFDLSTLGITFLDGMCQAYRSVGIVQEHGNKNFKTAVIMAHELGHNLGMYHDRKNCICNDSSCIMSAVLSSQPSKLFSNCSNHDYRRYLTTYKPKCILNPPLRKDIASPPICGNEIWEEGEECDCGSPKDCQNPCCDAATCKLTPGAECGNGLCCEKCKIKTAGTVCRRARDECDVPEHCTGQSAECPADGFHANGQPCQNNNGYCYNGDCPIMTKQCISLFGSRATVAEDSCFQENQKGSYYGYCRKENGRKIPCAPQDIKCGRLYCLDNSPGNKNPCKMHYRCRDQHKGMVEPGTKCEDGKVCNNKRQCVDVNTAY", "prompt": "Design a protein sequence for a snake venom metalloproteinase that functions as a coagulation factor X-activating enzyme, derived from the venom of Macrovipera lebetinus (Levantine viper). This enzyme plays a critical role in the venom's procoagulant activity by specifically activating coagulation factor X in the blood clotting cascade, leading to rapid thrombin generation and potentially causing consumptive coagulopathy in envenomed prey. The protein should feature a heavy chain structure characteristic of snake venom metalloproteinases (SVMPs), containing a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates catalytic zinc ions essential for proteolytic activity. The heavy chain should also include disintegrin-like and cysteine-rich domains that may contribute to substrate recognition and interaction with coagulation factors. The enzyme should exhibit high specificity for factor X cleavage, converting it to its active form (factor Xa) through precise proteolytic processing. The structural scaffold should maintain the typical SVMP fold with appropriate disulfide bonding patterns to stabilize the multidomain architecture and ensure proper enzymatic function. The generated sequence must reflect the potent procoagulant properties that make this enzyme a key component in viper venom for prey immobilization through disruption of normal hemostasis."}
{"description": "sp|Q3SAF0|VNPB_PSEPO Natriuretic peptide PpNP-b (Fragment) OS=Pseudechis porphyriacus OX=8671 PE=2 SV=1", "sequence": "SGSKTANIGDGCFGVRLDHIGTTSGMGCGRPRPKPTPGGS", "prompt": "Design a natriuretic peptide toxin derived from the venom of the Australian red-bellied black snake (Pseudechis porphyriacus). This peptide should function as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) to induce hypotension, natriuresis, and diuresis in prey. The sequence should contain the conserved 17-amino acid disulfide-bonded ring structure characteristic of natriuretic peptides, formed by two cysteine residues that create a cyclic domain essential for receptor binding and biological activity. The peptide should adopt a stable, compact globular fold stabilized by this single disulfide bridge, with the cyclic region presenting key hydrophobic and charged residues for specific interaction with the NPR-A extracellular domain. The mechanism should involve competitive binding to NPR-A, activating particulate guanylyl cyclase and increasing intracellular cGMP levels, leading to smooth muscle relaxation and renal effects. The overall structure should be small (approximately 30-40 amino acids) and exhibit high stability in biological fluids, typical of snake venom natriuretic peptides that enhance venom potency by disrupting cardiovascular homeostasis."}
{"description": "sp|Q7SZN0|FA5V_PSETE Venom prothrombin activator pseutarin-C non-catalytic subunit OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MGRYSVSPVPKCLLLMFLGWSGLKYYQVNAAQLREYHIAAQLEDWDYNPQPEELSRLSESDLTFKKIVYREYELDFKQEEPRDALSGLLGPTLRGEVGDSLIIYFKNFATQPVSIHPQSAVYNKWSEGSSYSDGTSDVERLDDAVPPGQSFKYVWNITAEIGPKKADPPCLTYAYYSHVNMVRDFNSGLIGALLICKEGSLNANGSQKFFNREYVLMFSVFDESKNWYRKPSLQYTINGFANGTLPDVQACAYDHISWHLIGMSSSPEIFSVHFNGQTLEQNHYKVSTINLVGGASVTADMSVSRTGKWLISSLVAKHLQAGMYGYLNIKDCGNPDTLTRKLSFRELMKIKNWEYFIAAEEITWDYAPEIPSSVDRRYKAQYLDNFSNFIGKKYKKAVFRQYEDGNFTKPTYAIWPKERGILGPVIKAKVRDTVTIVFKNLASRPYSIYVHGVSVSKDAEGAIYPSDPKENITHGKAVEPGQVYTYKWTVLDTDEPTVKDSECITKLYHSAVDMTRDIASGLIGPLLVCKHKALSVKGVQNKADVEQHAVFAVFDENKSWYLEDNIKKYCSNPSAVKKDDPKFYKSNVMYTLNGYASDRTEVLRFHQSEVVQWHLTSVGTVDEIVPVHLSGHTFLSKGKHQDILNLFPMSGESATVTMDNLGTWLLSSWGSCEMSNGMRLRFLDANYDDEDEGNEEEEEDDGDIFADIFIPSEVVKKKEEVPVNFVPDPESDALAKELGLIDDEGNPIIQPRREQTEDDEEQLMKASMLGLRSFKGSVAEEELKHTALALEEDAHASDPRIDSNSARNPDDIAGRYLRTINRGNKRRYYIAAEEVLWDYSPIGKSQVRSRAAKTTFKKAIFRSYLDDTFQTPSTGGEYEKHLGILGPIIRAEVDDVIEIQFKNLASRPYSLHAHGLLYEKSSEGRSYDDKSPELFKKDDAIMPNGTYTYVWQVPPRSGPTDNTEKCKSWAYYSGVNPEKDIHSGLIGPILICQKGMIDKYNRTIDIREFVLFFMVFDEEKSWYFPKSDKSTCEEKLIGVQSLHTFPAINGIPYQLQGLTMYKDENVHWHLLNMGGPKDIHVVNFHGQTFTEEGREDNQLGVLPLLPGTFASIKMKPSKIGTWLLETEVGENQERGMQALFTVIDKDCKLPMGLASGIIQDSQISASGHVGYWEPKLARLNNTGKYNAWSIIKKEHEHPWIQIDLQRQVVITGIQTQGTVQLLQHSYTVEYFVTYSEDGQNWITFKGRHSETQMHFEGNSDGTTVKENHIDPPIIARYIRLHPTKFYNRPTFRIELLGCEVEGCSVPLGMESGAIKNSEITASSYKKTWWSSWEPSLARLNLEGGTNAWQPEVNNKDQWLQIDLQHLTKITSIITQGATSMTTSMYVKTFSIHYTDDNSTWKPYLDVRTSMEKVFTGNINSDGHVKHFFKPPILSRFIRIIPKTWNQYIALRIELFGCEVF", "prompt": "Design a protein sequence for the non-catalytic subunit of pseutarin-C, a potent prothrombin activator from the venom of the Eastern brown snake (Pseudonaja textilis). This protein functions as a critical component in the snake's venom arsenal, facilitating rapid prey immobilization through the induction of systemic coagulopathy. The non-catalytic subunit acts as a cofactor that dramatically enhances the catalytic efficiency of the enzymatic subunit by forming a stable complex with prothrombin, the precursor to thrombin in the coagulation cascade. This interaction occurs through specific binding domains that recognize and bind to prothrombin, effectively positioning it for optimal cleavage by the catalytic subunit. The protein is expected to adopt a multi-domain architecture characteristic of venom-derived coagulation factors, featuring several epidermal growth factor (EGF)-like domains that mediate calcium-dependent interactions and potentially a gamma-carboxyglutamic acid (Gla) domain for membrane binding, although the latter may be modified or absent in the venom isoform. The structure should include a series of disulfide bridges stabilizing each EGF-like domain in a conserved pattern (typically Cys1-Cys3, Cys2-Cys4, Cys5-Cys6 for individual domains), contributing to a compact, stable fold resistant to proteolytic degradation. The molecular target is prothrombin (Factor II), with binding likely involving exosite interactions that do not interfere with the active site but enhance substrate recognition and turnover. The overall scaffold should reflect a venom-adapted version of mammalian coagulation factors, optimized for rapid action and high specificity in the context of envenomation."}
{"description": "sp|P0DJL6|CT5A_CONCN Tau-conotoxin CnVA OS=Conus consors OX=101297 PE=1 SV=1", "sequence": "ECCHRQLLCCLRFV", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a tau-conotoxin from the marine cone snail Conus consors, a highly specialized predator that employs complex venom cocktails for prey capture and defense. This toxin functions as a potent voltage-gated sodium channel modulator, specifically targeting neuronal sodium channel subtypes to disrupt action potential generation and propagation in the nervous system. The protein should adopt the characteristic conotoxin structural framework with a conserved disulfide connectivity pattern typical of the conotoxin superfamily, featuring multiple disulfide bridges that stabilize a compact, globular fold. The structural scaffold should exhibit high thermal and proteolytic stability due to extensive cross-linking, presenting key functional loops that mediate specific interactions with sodium channel pore regions or voltage-sensing domains. The molecular mechanism involves binding to specific sodium channel isoforms with high affinity, potentially causing channel inhibition or modulation that leads to neurological dysfunction in prey organisms. The sequence should include conserved cysteine residues arranged in the appropriate framework to form the essential disulfide bonds, along with functional residues in exposed loops that determine target specificity and potency. The overall architecture should enable precise molecular recognition of sodium channel extracellular domains while maintaining the compact, stable fold characteristic of conopeptides."}
{"description": "sp|D2Y2D7|H4A03_CYRHA Mu-theraphotoxin-Hhn1b 3 OS=Cyriopagopus hainanus OX=209901 PE=1 SV=1", "sequence": "MKASMFLALTGLALLFVVCYASESEEKEFSNELLSSVLAVDDNSKGEERECLGFGKGCNPSNDQCCKSSNLVCSRKHRWCKYEIGK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a mu-theraphotoxin from the venom of the Chinese earth tiger tarantula (Cyriopagopus hainanus), a theraphosid spider whose venom contains diverse peptide toxins that modulate ion channels to immobilize prey. As a mu-theraphotoxin, it functions as a voltage-gated sodium channel (NaV) modulator, specifically inhibiting channel inactivation to prolong action potentials and induce excitotoxicity, leading to paralysis. The toxin is expected to adopt an inhibitory cysteine knot (ICK) structural fold, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (cysteine framework I: C-C-CC-C-C) with disulfide connectivity typically C1-C4, C2-C5, C3-C6. It likely targets insect or mammalian NaV subtypes (e.g., NaV1.1–NaV1.9) with high affinity, binding to site 4 on the channel's domain II S3–S4 loop to trap the voltage sensor in an activated state. The sequence should include key residues for structural stability (e.g., hydrophobic core, beta-sheet forming regions) and functional motifs for NaV interaction, such as a basic or aromatic surface patch for receptor engagement. Ensure the design reflects a small, stable, disulfide-rich peptide (∼30–40 residues) optimized for venom efficacy and target specificity."}
{"description": "sp|P04567|MCDP_BOMPE Mast cell degranulating peptide OS=Bombus pensylvanicus OX=28643 PE=1 SV=1", "sequence": "MCICKNGKPLPGFIGKICRKICMMQQTH", "prompt": "Design a mast cell degranulating peptide from the venom of Bombus pensylvanicus (bumblebee) that functions as a potent immunomodulatory toxin. This peptide should exhibit the characteristic structural features of bee venom mast cell degranulating peptides, including a compact beta-hairpin fold stabilized by two disulfide bridges in a C1-C4, C2-C3 connectivity pattern. The peptide should specifically target and activate mast cells through interaction with G-protein coupled receptors or direct membrane perturbation, leading to calcium influx and subsequent degranulation. Key structural elements should include: an amphipathic structure with both hydrophobic and cationic regions for membrane interaction, conserved aromatic residues critical for mast cell recognition, and a well-defined beta-sheet core. The sequence should be approximately 20-25 amino acids in length with the characteristic cysteine framework of insect venom peptides. The resulting peptide should demonstrate high potency in inducing histamine release from mast cells while maintaining the thermal and proteolytic stability typical of disulfide-rich venom peptides."}
{"description": "sp|P0DQR6|SHKL1_NEMVE Neurotoxin ShK-like1 OS=Nematostella vectensis OX=45351 PE=1 SV=1", "sequence": "MSRKLLAVLMVCTFFLIAASMGTNALPFHEGIERRAAKCVDKMPFVCMRKDIPAICKNRNHRSYAFIMDVCRKTCGQCT", "prompt": "Design a novel neurotoxin protein sequence inspired by the ShK-like toxin family from the starlet sea anemone Nematostella vectensis. This toxin should function as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv1.x family) to disrupt neuronal excitability and synaptic transmission. The protein must adopt the canonical ShK structural fold characterized by a compact, globular domain stabilized by three conserved disulfide bonds with a C-C-CC-C-C connectivity pattern. Incorporate key functional residues for channel blockade, including a critical lysine residue that penetrates the channel pore and interacts with the selectivity filter, along with surrounding hydrophobic and aromatic residues that mediate specific interactions with channel vestibule residues. The sequence should maintain the characteristic short alpha-helix and two-stranded anti-parallel beta-sheet structural elements typical of ShK-family toxins, with appropriate loop regions for target recognition. Ensure the toxin exhibits high affinity and selectivity for potassium channels while maintaining stability in the marine environment, reflecting its origin from a cnidarian venom system where such toxins serve both predatory and defensive functions by rapidly paralyzing prey through disruption of action potential generation and propagation."}
{"description": "sp|P0DJ50|VKT31_OLIMR Kunitz-type serine protease inhibitor BmKTT-2 OS=Olivierus martensii OX=34649 PE=1 SV=2", "sequence": "MMNVITVVGIILSVVCTISDAEGVDCTLPSDTGRCKAYFIRYFYNQKAGECQKFVYGGCEGNSNNFLTKSDCCKQCSPGKC", "prompt": "Design a novel Kunitz-type serine protease inhibitor toxin derived from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding loop that inserts into the protease's active site cleft. The protein must adopt the characteristic Kunitz domain fold, consisting of a conserved alpha-beta structure with a central anti-parallel beta-sheet stabilized by three disulfide bonds in the Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The sequence should include the signature Kunitz motif with appropriate reactive site residues for protease inhibition, while maintaining the compact, globular structure typical of scorpion venom Kunitz-type toxins. The molecule should exhibit high affinity and specificity for its serine protease targets, contributing to the venom's role in prey immobilization and digestion interference through disruption of key proteolytic pathways."}
{"description": "sp|Q9BPE9|CTA1_CONPE Chi-conotoxin PnID OS=Conus pennaceus OX=37335 PE=1 SV=1", "sequence": "MRCLPVFVILLLLTASGPSVDAKVHLKTKGDGPLSSFRDNAKSTLQRLQDKSTCCGYRMCVPCG", "prompt": "Design a novel peptide toxin sequence that captures the biological essence of Chi-conotoxin PnID from the marine cone snail Conus pennaceus. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting alpha3beta2 and/or alpha3beta4 subtypes to disrupt cholinergic neurotransmission. The peptide must adopt the characteristic alpha-conotoxin structural framework with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where disulfide bridges connect Cys1-Cys3 and Cys2-Cys4 to form a compact, stable scaffold. The sequence should include the signature two-alpha-helical motif stabilized by these disulfide bonds, creating a well-defined binding interface capable of high-affinity interaction with the orthosteric site of neuronal nAChRs. Incorporate key pharmacophore residues that confer subtype selectivity while maintaining the overall compact size typical of alpha-conotoxins (approximately 13-18 amino acids). The toxin should exhibit the paralytic activity characteristic of Conus pennaceus venom, functioning through precise blockade of neuronal signaling pathways without cross-reactivity to muscle-type nAChRs."}
{"description": "sp|B7S4N9|VKT_OXYSC Kunitz-type serine protease inhibitor taicotoxin OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCHLPPKPGPCRAAIPRFYYNPHSKQCEKFIYGGCHGNANSFKTPDECNYTCLGVSLPK", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of the coastal taipan (Oxyuranus scutellatus scutellatus), known as taicotoxin. This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, particularly targeting enzymes like thrombin, factor Xa, or plasmin to disrupt hemostasis and promote prey immobilization through hemorrhage. The protein should adopt the characteristic Kunitz domain fold, featuring a stable alpha-beta structure with antiparallel beta-sheets stabilized by three conserved disulfide bonds in the cysteine framework C1-C6, C2-C4, C3-C5. The active site should include a canonical protease-binding loop with residues optimized for tight, specific inhibition of serine proteases, mimicking the natural toxin's role in venom to incapacitate prey by interfering with coagulation pathways."}
{"description": "sp|C0HM16|SCX3_CENHU Beta-toxin Chui3 (Fragment) OS=Centruroides huichol OX=2911785 PE=1 SV=1", "sequence": "KEGYLVELGTGCKYECFKLGDNDYCLRECKARYGKGAGGYCYAFGCWCTQLYEQAVVWPLKNKTCR", "prompt": "Design a beta-toxin protein sequence derived from the venom of the scorpion Centruroides huichol. This toxin should function as a voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce excitatory neurotoxicity. The protein should adopt the conserved structural scaffold characteristic of scorpion beta-toxins, featuring a compact, globular fold stabilized by a cysteine framework with four disulfide bridges (C1-C4, C2-C5, C3-C6, C7-C8 pattern). Key structural elements should include an alpha-helix and anti-parallel beta-sheets, forming a core inhibitory cystine knot (ICK) motif that confers stability and precise molecular recognition. The toxin's mechanism of action involves binding to site 4 of voltage-gated sodium channels, shifting the voltage-dependence of activation toward more negative potentials and delaying channel inactivation, leading to prolonged neuronal depolarization and paralysis in prey. The sequence should contain conserved residues critical for interaction with the channel's voltage-sensing domain, particularly in regions corresponding to the 'pharmacophore' surface that mediates high-affinity binding and species selectivity. The overall structure must enable efficient folding and secretion as part of the scorpion's venom arsenal for prey immobilization."}
{"description": "sp|B6CQR5|PA2A2_MACLB Acidic phospholipase A2 2 OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MRTLWIVAVWLTGVEGDLSQFGDMINKKTGTFGLFSYIYYGCYCGWGGKGKPQDATDRCCFVHDCCYGSVNGCDPKLSTYSYSFQNGDIVCGDDDPCLRAVCECDRVAAICSGENMNTYDKKYMLYSLFDCKEESEKC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Macrovipera lebetinus (Levantine viper). This enzyme should function as a potent toxin with multiple biological activities characteristic of snake venom phospholipases A2. The protein should exhibit calcium-dependent catalytic activity that hydrolyzes the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids. This enzymatic activity should contribute to various toxic effects including membrane disruption, hemolysis, anticoagulation, and potential neurotoxicity or myotoxicity. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif YGCXCG. Include the essential catalytic residues - a histidine-aspartate dyad for the catalytic mechanism and tyrosine for substrate binding. The sequence should contain the characteristic pattern of 6-8 conserved cysteine residues that form 3-4 disulfide bridges stabilizing the compact globular structure. The acidic nature of this phospholipase A2 should be reflected in the overall amino acid composition, with a calculated isoelectric point below 7.0. The protein should be capable of interacting with various biological membranes and potentially form complexes with other venom components to enhance toxicity. Ensure the structural integrity allows for proper folding into the stable, compact globular architecture typical of secreted phospholipases A2, with the active site cleft properly positioned for substrate access and catalysis."}
{"description": "sp|P81897|K1B_ACTEQ Kappa-actitoxin-Aeq4a OS=Actinia equina OX=6106 PE=1 SV=1", "sequence": "GCKDNFSANTCKHVKANNNCGSQKYATNCAKTCGKC", "prompt": "Design a protein sequence for a potent neurotoxin from the sea anemone Actinia equina, belonging to the kappa-actitoxin family. This toxin functions as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) in the peripheral nervous system. The protein should adopt the conserved structural fold characteristic of sea anemone toxins, featuring a compact beta-sheet core stabilized by three disulfide bridges with the cysteine framework C1-C4, C2-C5, C3-C6. The molecular mechanism involves binding to the extracellular pore region of Kv channels, inhibiting potassium efflux and prolonging neuronal depolarization, leading to enhanced neurotransmitter release and potential paralysis in prey organisms. The structure should include key functional residues for channel recognition and binding affinity, maintaining the typical molecular weight and isoelectric point profile of sea anemone neurotoxins while ensuring proper folding and stability through the conserved disulfide connectivity."}
{"description": "sp|Q7T1M3|BNP_BOTJR Bradykinin-potentiating and C-type natriuretic peptides isoform 2 (Fragment) OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "MVLSRLAASGLLLLALLALSVDGKPVQQWAQSWPGPNIPQLLVQQWAQGGWPRPGPEIPPLTVQQWAQNWPHPQIPPLTVQQWAQGRPPGPPIPPLTVQQWAQARPPHPPIPPAPLQKWAPVQKWAPVQKWAPVQKWAPLLQPT", "prompt": "Design a venom-derived peptide from the pit viper Bothrops jararacussu that functions as a dual-activity toxin with bradykinin-potentiating and C-type natriuretic peptide properties. This peptide should exhibit the characteristic structural features of snake venom bradykinin-potentiating peptides, including a compact globular fold stabilized by disulfide bridges, likely following the C-C-C-C cysteine framework pattern common to these toxins. The peptide must function as a potent inhibitor of angiotensin-converting enzyme (ACE), thereby preventing bradykinin degradation and enhancing its vasodilatory and pro-inflammatory effects. Simultaneously, it should possess C-type natriuretic peptide activity, binding to natriuretic peptide receptors to stimulate cyclic GMP production, promoting vasodilation, natriuresis, and diuresis. The structural scaffold should enable both functions through distinct molecular interfaces: one domain optimized for ACE active site inhibition through competitive binding, and another domain mimicking endogenous natriuretic peptides for receptor activation. The peptide should demonstrate the characteristic stability and resistance to proteolytic degradation typical of venom peptides, with a compact tertiary structure that facilitates rapid systemic distribution and prolonged biological activity following envenomation."}
{"description": "sp|P0DJN7|PA2B3_CROLL Basic phospholipase A2 Cll-N6 OS=Crotalus lepidus lepidus OX=992932 PE=1 SV=2", "sequence": "MRTFWIVAVLLVGVEGNLLQFNKMIKIMTKKNAIPFYTSYGCYCGWGGRGRPKDATDRCCFVHDCCYEKLTDCSPKTARYSYSWKSGVIICGEGTPCEKQICECDRAAAVCFGANLSTYKKRYMFYPDLLCTDPSEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the rock rattlesnake (Crotalus lepidus lepidus) venom. This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity to hydrolyze the sn-2 ester bond of membrane phospholipids, generating lysophospholipids and free fatty acids. The resulting membrane disruption leads to presynaptic neuromuscular blockade, muscle necrosis, and systemic effects including edema and inflammation. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges with the pattern Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, and Cys84-Cys96. Include a conserved calcium-binding loop (Tyr28, Gly30, Gly32, Asp49) and a catalytic dyad (His48, Asp99) essential for enzymatic activity. The basic nature of the protein should facilitate interaction with anionic membrane surfaces, enhancing its membrane penetration and pharmacological potency. The structural scaffold should maintain the characteristic phospholipase A2 interfacial activation site and hydrophobic substrate-binding channel."}
{"description": "sp|Q7T2I3|3L2L_LATLA Long neurotoxin LlLong (Fragment) OS=Laticauda laticaudata OX=8630 PE=3 SV=1", "sequence": "KTLLLTLVVVTIICLDFGYTRICFKTPYVKSETCPPGQELCYTKTWCDRFCSIRGKVIELGCTATCPRAEPKEDTTCCSKDNCNPHP", "prompt": "Design a protein sequence for a long neurotoxin from the sea krait Laticauda laticaudata, a highly venomous marine elapid snake. This toxin functions as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis and respiratory failure in prey. The toxin should adopt the characteristic three-finger toxin fold common to snake neurotoxins, featuring three extended beta-stranded loops emerging from a central globular core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The molecular mechanism involves high-affinity binding to the alpha-subunit of muscle-type nicotinic acetylcholine receptors, competitively inhibiting acetylcholine binding and preventing depolarization of the postsynaptic membrane. The structure should exhibit the elongated morphology typical of long neurotoxins, with an additional fifth disulfide bridge in the central loop that enhances structural stability and target specificity. Key functional residues should be positioned in loop regions to facilitate precise molecular recognition and binding to the receptor's ligand-binding domain."}
{"description": "sp|A0A3S9V8K6|INS2_CONKI Con-Ins K2 OS=Conus kinoshitai OX=376876 PE=3 SV=1", "sequence": "MTTSSYFLLVALGLLLYVCQSSFGNPHTRDSGTTPDRDHSCGGELVDRLVKLCPSNRKRRGFPSMLKARAKRNEAFLLQRDGRVIVGDCCDNYCTDERLKGYCASLLGL", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conus kinoshitai, a marine cone snail species. This protein should function as a con-Insulin (Con-Ins) analog, specifically mimicking the Con-Ins K2 variant, which exhibits insulin-like activity but with potential toxic or modulatory effects distinct from mammalian insulin. The sequence should adopt the characteristic insulin superfamily fold, comprising two polypeptide chains (A and B) linked by disulfide bridges. The A-chain should contain an intra-chain disulfide bond stabilizing its helical structure, while the B-chain should facilitate receptor binding. The protein must retain key residues for insulin receptor interaction but incorporate cone snail-specific mutations that alter potency, selectivity, or stability compared to human insulin, potentially enhancing binding to insulin-like growth factor receptors or inducing hypoglycemic effects in prey. The structural scaffold should include the conserved cysteine framework (e.g., CysA6-CysA11, CysA7-CysB7, and CysA20-CysB19 in human insulin numbering) to maintain proper folding, with modifications in loop regions to confer venom-specific bioactivity. The protein should be soluble and stable in venom secretory environments, supporting its role in prey immobilization via metabolic disruption."}
{"description": "sp|P0DQR7|CAIA_CONGE Alpha-conotoxin GIA OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "ECCNPACGRHYSCGK", "prompt": "Design a novel alpha-conotoxin peptide with the precise toxic activity and structural characteristics of Conus geographus venom components. This neurotoxic peptide should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting the neuromuscular junction to induce paralysis. The peptide must adopt the characteristic alpha-conotoxin fold stabilized by two conserved disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the globular disulfide framework typical of this toxin family. The structure should feature a compact, well-defined three-dimensional conformation with exposed loops that mediate specific receptor binding. Key structural elements should include conserved alpha-helical tendencies in certain regions and beta-turn motifs that present critical pharmacophore residues for receptor interaction. The molecular mechanism involves competitive inhibition at the acetylcholine binding site of muscle-type nicotinic receptors, blocking neurotransmission and causing flaccid paralysis. The peptide should exhibit the characteristic pharmacological profile of Conus geographus alpha-conotoxins, displaying high potency and selectivity for specific nicotinic receptor subtypes. The sequence must maintain the essential cysteine framework while incorporating variable regions that determine receptor subtype specificity and binding affinity. This toxin represents the sophisticated biochemical arsenal developed by cone snails for rapid prey immobilization through targeted disruption of neuromuscular signaling."}
{"description": "sp|A0A3S9V8L7|INS1_CONKI Con-Ins K1 OS=Conus kinoshitai OX=376876 PE=3 SV=1", "sequence": "MTTSSYFLLVALGLLLYVCQSSFGSPHTSDSGTTLVRRRLCGSELVTYLGELCLGNRKRRGFPSMLKARAKRNEAFLLQRDGRGIVEDCCYNDCTDEKLKEYCHTLQG", "prompt": "Design a novel insulin-like toxin protein sequence inspired by the venom of Conus kinoshitai, a marine cone snail species. This toxin should function as a con-Insulin (con-Ins) analog, specifically Con-Ins K1, which exhibits insulin-like activity but operates through a distinct mechanism from endogenous insulin. The protein should adopt the characteristic insulin superfamily fold, featuring two polypeptide chains (A and B) stabilized by three conserved disulfide bridges with the connectivity pattern: A6-A11, A7-B7, and A20-B19. The A-chain should contain an N-terminal helical segment and the B-chain should include a central α-helix, with both chains folding into a compact globular structure. As a conotoxin, this insulin-like molecule should target insulin receptors or related signaling pathways in prey organisms, potentially inducing hypoglycemic effects through receptor binding at sites analogous to the classical insulin binding interface. The sequence should maintain key residues for structural stability while incorporating conotoxin-specific variations that confer its toxic function, such as enhanced receptor affinity or altered signaling properties that disrupt normal metabolic regulation in target organisms."}
{"description": "sp|O93472|3SA2C_NAJSP Cytotoxin 2c OS=Naja sputatrix OX=33626 PE=3 SV=1", "sequence": "MKTLLLTLVLVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMYMVATPKVPVKRGCIDVYPKSSLLVKYVCCNTDRCN", "prompt": "Generate the amino acid sequence for a cytotoxin from the venom of the Javan spitting cobra (Naja sputatrix), specifically the cytotoxin 2c isoform. This protein belongs to the three-finger toxin superfamily and functions as a potent cytolytic agent that targets cell membranes. The toxin should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a rigid, three-loop scaffold. The molecular mechanism involves binding to anionic phospholipids in cell membranes, particularly phosphatidylserine, leading to membrane disruption, pore formation, and eventual cell lysis. Key structural features include three extended loops (loop I, II, and III) emanating from a central hydrophobic core, with loop II often containing hydrophobic residues critical for membrane insertion. The toxin should exhibit specificity for certain cell types, potentially with enhanced activity against cancer cells due to their exposed phosphatidylserine. The sequence should maintain the conserved cysteine framework and structural determinants necessary for membrane interaction while incorporating isoform-specific variations that confer its distinct cytolytic potency within the cytotoxin family."}
{"description": "sp|P0DKU2|PA2_PANIM Phospholipase A2 phospholipin OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "MVDLARRCSGSTEGRFLMWECTKWCGPGNNAKCESDLGPLEADKCCRTHDHCDYIASGETKYGITNYAFFTKLNCKCEEAFDRCLTEAYNKEEKESAKSSTKRLQNFYFGTYSPECYVVTCNSKRSGRDAGCENGVATWKKSYKD", "prompt": "Design a phospholipase A2 toxin from the venom of the emperor scorpion (Pandinus imperator) that functions as a potent neurotoxin and cytotoxin. This enzyme should catalyze the hydrolysis of the sn-2 ester bond in glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of 6-8 disulfide bridges that create a rigid, compact structure. Include the conserved calcium-binding loop (YXCGXGG) essential for catalytic activity and the interfacial binding surface that targets membrane phospholipids. The active site should contain the catalytic histidine-aspartate dyad and the conserved water molecule network. The toxin should exhibit both presynaptic neurotoxic effects through disruption of neurotransmitter release and myotoxic activity via membrane damage. Incorporate venom-specific structural adaptations that enhance membrane penetration and substrate accessibility while maintaining stability in the scorpion venom environment."}
{"description": "sp|A0A6B9L1F0|PR13A_PLARH Kazal peptide Pr13a OS=Platymeris rhadamanthus OX=1134088 PE=1 SV=1", "sequence": "MKYIILFLVLIGLQANLALGSKCKCDCTKYPYSPVCAKELKTGDTETFNNVCQLQCYNCTHMKNYVVIYSGSC", "prompt": "Design a novel Kazal-type serine protease inhibitor peptide toxin derived from the venom of the assassin bug Platymeris rhadamanthus. This toxin should function as a potent anticoagulant by specifically targeting and inhibiting key serine proteases in the mammalian coagulation cascade, particularly thrombin or factor Xa. The peptide must adopt the canonical Kazal domain fold characterized by a compact, disulfide-stabilized structure with a well-defined reactive site loop. The cysteine framework should follow the conserved Kazal pattern (typically C-X(7)-C-X(6)-C-X(3)-C-X(10)-C-X(4)-C) forming three disulfide bridges that create a stable scaffold. The reactive site loop should contain the characteristic P1 residue that determines protease specificity, with optimal positioning for precise enzyme inhibition. The overall structure should be small (approximately 50-60 amino acids), thermostable, and exhibit the typical β-hairpin and α-helical elements common to Kazal domains. The toxin should demonstrate high affinity and specificity for its target protease, effectively disrupting hemostasis through precise molecular recognition at the enzyme's active site."}
{"description": "sp|P0C615|I2BA_CONSP Kappa-conotoxin SrXIA OS=Conus spurius OX=192919 PE=1 SV=1", "sequence": "CRTEGMSCEENQQCCWRSCCRGECEAPCRFGP", "prompt": "Design a novel kappa-conotoxin protein sequence inspired by Conus spurius venom, specifically emulating the biological characteristics of kappa-conotoxin SrXIA. This toxin should function as a selective antagonist of voltage-gated potassium channels, particularly Kv1 subtypes, to induce neuromuscular blockade by inhibiting potassium efflux and prolonging neuronal excitation. The sequence must adopt the conserved conotoxin structural framework with a characteristic inhibitor cystine knot (ICK) motif, featuring four disulfide bridges in a C-C-C-C pattern that forms a compact, triple-stranded beta-sheet stabilized by the knotted disulfide connectivity. Incorporate key functional residues for high-affinity binding to the potassium channel pore region, including surface-exposed loops critical for target specificity. The structural scaffold should be globular and rigid, with the disulfide core conferring proteolytic resistance and thermal stability typical of cone snail toxins. Ensure the toxin mimics the role of Conus spurius venom in prey immobilization through precise ion channel modulation."}
{"description": "sp|C0HM65|KAX48_CENMA Potassium channel toxin alpha-KTx 4.8 OS=Centruroides margaritatus OX=29018 PE=1 SV=1", "sequence": "TFINHKCKSSSECLPACKAAIGRASGKCINSTCKCYY", "prompt": "Design a novel potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from Centruroides margaritatus scorpion venom. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif formed by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature the signature alpha-helix and antiparallel beta-sheet secondary structure elements that create a compact, stable globular fold. Include the conserved functional motifs responsible for potassium channel recognition and pore blockade, particularly the critical lysine-rich region that interacts with the channel's selectivity filter. The toxin should maintain the characteristic molecular surface topology that enables high-affinity binding to the extracellular vestibule of potassium channels while preserving the structural stability required for venom deployment and target engagement. Ensure the sequence reflects the evolutionary optimization for rapid onset of channel blockade and resistance to proteolytic degradation typical of scorpion venom peptides."}
{"description": "sp|P0DKR6|3SX1_DENPO Mambalgin-1 OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "MKTLLLTLLVVTIVCLDLGYSLKCYQHGKVVTCHRDMKFCYHNTGMPFRNLKLILQGCSSSCSETENNKCCSTDRCNK", "prompt": "Design a protein sequence for a potent animal toxin with the following precise biological and structural specifications: This toxin, known as Mambalgin-1, originates from the venom of the black mamba snake (Dendroaspis polylepis), a highly neurotoxic species. The protein functions as a selective acid-sensing ion channel (ASIC) inhibitor, specifically targeting ASIC1a and ASIC1b subtypes in the central and peripheral nervous systems. Its mechanism involves binding to the extracellular domain of ASIC channels, stabilizing them in a closed state and thereby blocking proton-gated sodium currents, which results in potent analgesic effects by inhibiting pain signaling pathways. Structurally, this toxin adopts a three-finger toxin (3FTx) fold, characterized by three beta-stranded loops extending from a central core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The protein exhibits a globular, compact architecture with the second and third loops containing key functional residues essential for ASIC channel interaction. The molecular target binding interface involves specific hydrophobic and electrostatic interactions with the ASIC1 channel thumb domain. The sequence should reflect these structural constraints while maintaining the characteristic three-finger topology and the precise disulfide connectivity required for proper folding and biological activity."}
{"description": "sp|P46114|KAX41_TITSE Potassium channel toxin alpha-KTx 4.1 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MKAFYGILIIFILISMIDLSKQVFINAKCRGSPECLPKCKEAIGKAAGKCMNGKCKCYP", "prompt": "Design a potassium channel toxin protein from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves binding to the pore region of Kv1.x family potassium channels, specifically interacting with the channel's selectivity filter and voltage-sensing domains to physically occlude potassium ion conduction. Key structural elements should include a functional dyad consisting of a critical lysine residue that penetrates the channel pore and an aromatic residue that stabilizes binding through hydrophobic interactions. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes, contributing to the neurotoxic effects of Tityus serrulatus venom by disrupting neuronal excitability and neurotransmitter release. The overall structure should be compact and globular, approximately 30-40 amino acids in length, with the characteristic scorpion toxin fold that provides exceptional stability and target specificity."}
{"description": "sp|P0DJ94|EXE1_HELHO Exendin-1 OS=Heloderma horridum horridum OX=8552 PE=1 SV=1", "sequence": "HSDATFTAEYSKLLAKLALQKYLESILGSSTSPRPPSS", "prompt": "Design a protein sequence for a bioactive peptide toxin derived from the venom of the Mexican beaded lizard (Heloderma horridum horridum). This toxin, known as Exendin-1, functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking the activity of the endogenous incretin hormone GLP-1. The mechanism involves potent and selective binding to the GLP-1 receptor on pancreatic beta cells, stimulating insulin secretion in a glucose-dependent manner while inhibiting glucagon release and gastric emptying. Structurally, Exendin-1 is expected to adopt an alpha-helical conformation stabilized by specific disulfide bridges, characteristic of the exendin peptide family. The sequence should include the conserved cysteine framework necessary for proper folding and receptor engagement, with key residues for receptor binding affinity and metabolic stability. The toxin's biological significance lies in its role in the lizard's venom for prey immobilization through metabolic disruption, and it serves as a template for therapeutic agents in type 2 diabetes management due to its prolonged half-life and potent insulinotropic effects compared to native GLP-1."}
{"description": "sp|D3TTC1|VM3KL_NAJAT Zinc metalloproteinase-disintegrin-like kaouthiagin-like OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACDGLKGHFEHQGETYFIEPLKISNSEAHAIYKDENVENEDETPEICGVTETTWESDESIEKTSQFTNTPEQDRYLQDKKYIEFYVIVDNRMYRYYNNDKPAIKIRVYEMINAVNTKFRPLKIHIALIGLEIWSNKDKFEVKPAASVTLKSFGEWRETVLLPRKRNDNAQLLTGIDFNGNTVGRAYIGSLCKTNESVAIVQDYNRRISLVASTITHELGHNLGIHHDKASCICIPGPCIMLKKRTAPAFQFSSCSIREYREYLLRDRPQCILNKPLSTDIVSPPICGNYFVEVGEECDCGSPQACQSACCNAATCQFKGAETECRVAKDDCDLPELCTGQSAECPTDSLQRNGHPCQNNQSYCYNGTCPTLTNQCITLLGPHFTVSPKGCFDLNMRGDDGSFCRMEDGTKIPCAAKDVKCGRLYCTEKNTMSCLIPPNPDGIMAEPGTKCGDGMVCSKGQCVDVQTAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin inspired by the venom composition of the Chinese cobra (Naja atra). This multifunctional toxin should exhibit the characteristic modular architecture of snake venom metalloproteinases (SVMPs), comprising a metalloproteinase domain and a disintegrin-like domain. The metalloproteinase domain must feature a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling proteolytic activity against extracellular matrix components such as collagen, laminin, and fibronectin. This domain should adopt a globular fold stabilized by disulfide bonds, typical of the reprolysin family. The disintegrin-like domain should mimic the structure of endogenous disintegrins, containing an integrin-binding loop with a potential RGD or related motif that antagonizes platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors. The overall protein should exhibit procoagulant or anticoagulant effects through its dual mechanisms: metalloproteinase-mediated degradation of hemostatic factors and disintegrin-mediated inhibition of platelet aggregation. Ensure the sequence includes appropriate cysteine residues for disulfide bonding to stabilize both domains, with the disintegrin-like domain likely adopting a compact, disulfide-rich fold. The toxin should reflect the evolutionary adaptation of elapid venoms to disrupt hemostasis and cause tissue damage, contributing to the prey immobilization and digestion strategy of Naja atra."}
{"description": "sp|E0Y419|VSPBF_MACLB Beta-fibrinogenase OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MVLIRVLANLLLLQLSHAQKSSELVVGGDECNINEHRSLVFLYNSSFGCGGTLINQEWVLSAAHCDMENMRIYLGWHNFSLPNMNQKRRVAKEKFFCLSSKNYTEWDKDIMLIKMNRPVTYSTHVAPLSLPSSPPSVGSVCRIMGWGAITSPNETYPDVPHCANINILNYTVCRAAHPWLPAQSRTLCAGILQGGIDTCKGDSGGPLICNGQIQGIVSWGDNPCAQPLKPGHYTNVFDYTDWIQSIIAGNTTATCPP", "prompt": "Design a protein sequence for a beta-fibrinogenase toxin from the blunt-nosed viper (Macrovipera lebetinus), a medically significant venomous snake found in North Africa and the Middle East. This toxin functions as a key component of the viper's hemorrhagic venom arsenal, specifically targeting the blood coagulation cascade by cleaving fibrinogen. As a snake venom metalloproteinase (SVMP) of the P-III class, it should contain a multi-domain architecture comprising a propeptide, metalloproteinase, disintegrin-like, and cysteine-rich domains. The catalytic domain must feature a conserved zinc-binding motif (HEXXHXXGXXH) essential for proteolytic activity, along with a methionine turn that contributes to structural stability. The disintegrin-like domain should mediate interactions with platelet integrins, while the cysteine-rich domain facilitates binding to extracellular matrix components. The protein should adopt a globular fold stabilized by multiple disulfide bonds, particularly within the cysteine-rich domain, which typically exhibits a disulfide pattern characteristic of ADAM-like proteins. This beta-fibrinogenase specifically hydrolyzes the Bβ chain of fibrinogen, preventing fibrin clot formation and contributing to systemic coagulopathy and hemorrhage. The mechanism involves binding to fibrinogen via exosite interactions and cleaving at specific sites within the Bβ chain, leading to impaired thrombin-induced clotting and anticoagulant effects. The structural scaffold should reflect the typical P-III SVMP fold, with the metalloproteinase domain adopting a reprolysin-like structure and the ancillary domains supporting target recognition and inhibition of hemostasis."}
{"description": "sp|Q7T1T4|VM1B2_BOTJR Snake venom metalloproteinase BjussuMP-2 (Fragment) OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "TELPKGAVQPKYEDAMQYEFKGNGEPVVLHLEKNKGLFSEDYSETHYSPDGRQIITYPPFEDHCYYHGRIENDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTETNWESYEPIKKASPSNLTPEQQKFSPRYIEVAVVADHRMFKKYNSNLNTIRKWVHEMVNSMNGVYRSMDVHLSLANLEVWSKKDLINVQKDSRETLKSFGEWRERDLLPRISHDNAQLLTAVVFDQQTIGRAYIAGMCDPRHSVGVVMDHSKENLQVAVTMAHELGHNLGMEHDENQCHCDAPSCVMASVLSVVLSYEFSDCSQNQYQTYLTKHNPQCILNEPLLTVSGNELLEAGE", "prompt": "Design a snake venom metalloproteinase (SVMP) sequence fragment that embodies the proteolytic and hemorrhagic characteristics typical of Bothrops jararacussu venom. This toxin should function as a zinc-dependent metalloproteinase, targeting key components of the extracellular matrix and hemostatic system. The protein must contain the conserved zinc-binding motif HEXXHXXGXXH in its catalytic domain, which coordinates the catalytic zinc ion essential for proteolytic activity. It should exhibit specificity for basement membrane components such as collagen IV, laminin, and fibronectin, contributing to local tissue damage and hemorrhage. The structural scaffold should include the characteristic metzincin fold with an active-site cleft optimized for substrate binding and cleavage. As a P-I class SVMP, it should lack additional disintegrin-like and cysteine-rich domains, focusing purely on proteolytic function. The mechanism involves disrupting capillary integrity through degradation of structural proteins and potentially interfering with platelet aggregation via cleavage of von Willebrand factor or other coagulation factors. The protein should maintain the thermolysin-like fold common to SVMPs, with appropriate surface loops for substrate recognition and the conserved methionine turn beneath the active site. This metalloproteinase represents a key virulence factor in Bothrops envenomation, causing local tissue damage, edema, and hemorrhage through targeted extracellular matrix degradation."}
{"description": "sp|Q3HLQ4|PA2HB_PROMU Basic phospholipase A2 homolog TM-N49 OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGNLLQFRKMIKKMTGKEPILSYATYGCNCGMAGVGQPVDGTDRCCFVHNCCYEKVTSCSPKWDQYIYSWENGNIVCGEKNPCKKQICECDKAAAMCFRDNVKTYKKRNIFYPKSSCTEPTDTC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the Taiwanese habu snake, Protobothrops mucrosquamatus. This protein, designated TM-N49, represents a specialized venom component that has evolved to retain the structural scaffold of phospholipase A2 enzymes while exhibiting modified or alternative biological activities distinct from canonical phospholipase function. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved core structure with three long alpha-helices stabilized by multiple disulfide bridges. The anticipated disulfide connectivity pattern should follow the typical phospholipase A2 framework with conserved cysteine residues forming the structural scaffold. While maintaining this enzymatic fold, the protein likely functions through non-enzymatic mechanisms, potentially acting as a presynaptic neurotoxin or myotoxin that disrupts neuromuscular transmission through receptor binding interactions. The basic nature of the protein suggests electrostatic interactions may play a role in target recognition and membrane association. The sequence should reflect evolutionary optimization for venom function, with specific adaptations in surface residues that enable high-affinity binding to molecular targets while preserving the stable phospholipase A2 structural core essential for proper folding and venom stability."}
{"description": "sp|O76963|SIXI_ORTSC Insect toxin OsI1 OS=Orthochirus scrobiculosus OX=6892 PE=1 SV=1", "sequence": "DGYPKQKDGCKYSCTINHKFCNSVCKSNGGDYGYCWFWGLACWCEGLPDNKMWKYETNTCGGKK", "prompt": "Design a protein sequence for an insect-specific neurotoxin derived from the venom of Orthochirus scrobiculosus, a scorpion species. This toxin, known as OsI1, functions as a potent insecticidal agent by selectively targeting and modulating voltage-gated sodium channels in insect nervous systems. The toxin should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion long-chain toxins, featuring a conserved core of alpha-helical and beta-sheet structural elements stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The molecular mechanism involves binding to site 3 on insect sodium channels, delaying channel inactivation and causing prolonged neuronal excitation that leads to paralysis and death. Key functional residues should be positioned in the conserved 'pharmacophore' regions responsible for receptor recognition and specificity, particularly in the loops connecting secondary structural elements. The sequence must maintain high selectivity for insect over mammalian sodium channels, reflecting the evolutionary adaptation for prey capture. Incorporate appropriate hydrophobic patches and electrostatic surfaces that facilitate membrane interaction and target binding while ensuring structural stability through the disulfide framework."}
{"description": "sp|C0HJW1|KAX2F_CENTE Potassium channel toxin alpha-KTx 2.15 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "IFINVKCSSPQQCLKPCKKAFGQHAGGKCINGKCKCYP", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from Centruroides tecomanus scorpion venom. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved functional dyad comprising a critical lysine residue positioned to insert into the potassium channel pore and an aromatic residue that stabilizes binding through hydrophobic interactions. The structural scaffold should consist of a short alpha-helix packed against an antiparallel beta-sheet, creating a stable molecular surface optimized for high-affinity interaction with the extracellular vestibule of Kv1 channels. The toxin should exhibit the typical molecular weight range of 3-5 kDa and maintain the characteristic pharmacological profile of alpha-KTx family members, showing nanomolar affinity for its target channels while displaying selectivity among potassium channel subtypes."}
{"description": "sp|B8K1W0|VM3DK_DABRR Zinc metalloproteinase-disintegrin-like daborhagin-K OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "MMQVLLVTICLAVFPYHGSSIILESGNVNDYEVVYPQKVTAMPKEAVKQPEQKYEDAMQYKFEVNGEPVLLHLEKNKDLFSEDYSETHYSPDGREITTKPLVQDHCYYHGHIQNDAHSSASISACNGLKGHFKLRGEMYLIEPLKLSDSEAHAVYKYENVEKEDEALKMCGVTQTNWESDEPIKKASLLVATSERNRYFNPYSYVELIITVDHSMVTKYKNDLTAIRTWVFELVNTINEIFKYLYIRVPLVGLEIWKNRDLINVTSAANVTLDLFGEWRKSYLLPRKIHDNSQLLTAIDLNGLTIGMAYVSTMCQSKYSVGVVQDHSKINLRVAVTMAHEIGHNLGLTHDGVYCTCGGYSCIMSAVLGDQPSKYFSNCSYNQYRRFLTEHNPECIINPPLRTDIVSPPACGNELLERGEECDCGSPENCRDPCCDAASCKLHSWVECESGKCCNQCRFKRAGTECRPARDECDKAEQCTGRSANCPVDEFHENGRPCLHNFGYCYNGKCPIMYHQCHALFGQNVTGVQDSCFQYNRLGVYYAYCRKENGRKIPCAPKDEKCGRLYCSYKSPGNQIPCLPYYIPSDENKGMVDHGTKCGDGKVCSNGQCVDLNIAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from Russell's viper (Daboia russelii). This protein should exhibit the characteristic dual functionality of SVMPs (snake venom metalloproteinases) by combining proteolytic activity with integrin-binding capability. The sequence must contain a catalytic zinc-binding motif (HEXXHXXGXXH) within the metalloproteinase domain that enables hemorrhagic activity through degradation of extracellular matrix components like collagen and fibrinogen. Additionally, it should feature a disintegrin-like domain with the canonical RGD or related tripeptide motif that mediates potent inhibition of platelet aggregation by blocking integrin receptors (particularly αIIbβ3 and αvβ3) on cell surfaces. The protein should adopt a modular architecture with distinct metalloproteinase and disintegrin domains connected by appropriate linker regions, maintaining the conserved cysteine patterns that stabilize each domain through specific disulfide bridges. The overall structure should facilitate the synergistic hemorrhagic and anti-coagulant effects characteristic of Russell's viper venom, which rapidly induces systemic bleeding and prevents blood clotting through combined proteolytic cleavage of hemostatic proteins and disruption of platelet adhesion mechanisms."}
{"description": "sp|P0C616|PA2HA_BOTAS Basic phospholipase A2 homolog 4a OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "MRTLWIVTVLLVGVEGSLVELGKMILQETGKNPLTSYGVYGCNCGVGGRHKPKDGTDRCCYVHKCCYKKMTDCDPKKDRYSYSWKDKTIVCDENNPCLKELCECDKAVAICLRENLDTYNKKYKIYPKFFCKKAEPC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of Bothrops asper, a highly venomous pit viper species. This protein should function as a venom component with phospholipase A2-like structural characteristics but lacking catalytic activity, serving as a myotoxic agent that disrupts skeletal muscle tissue through non-enzymatic mechanisms. The sequence should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved disulfide bridge pattern typical of group II phospholipase A2 enzymes, with seven conserved disulfide bonds maintaining structural integrity. Key structural elements should include a calcium-binding loop, an interfacial binding surface for membrane interaction, and a conserved catalytic site architecture despite the absence of enzymatic function. The protein should exhibit basic isoelectric point properties and demonstrate specific interactions with muscle cell membranes, leading to membrane disruption and myonecrosis through direct physical interaction rather than phospholipid hydrolysis. The structural scaffold should maintain the characteristic phospholipase A2 three-finger toxin-like architecture while functioning as a pure toxin through protein-membrane interactions."}
{"description": "sp|P69496|I22_CONIM Conotoxin Im11.2 OS=Conus imperialis OX=35631 PE=2 SV=1", "sequence": "MMFRLTSVSCFLLVIVCLNLVVLTNACRLEGSSCRRSYQCCHKSCCIRECKFPCRWDGKRATFQ", "prompt": "Generate a protein sequence for a conotoxin from the marine cone snail Conus imperialis, specifically the Im11.2 variant. This toxin belongs to the I2-superfamily of conotoxins and functions as a potassium channel blocker, likely targeting voltage-gated potassium channels (Kv) to disrupt neuronal excitability and contribute to the venom's paralytic effects. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by three disulfide bonds. The cysteine framework is C-C-CC-C-C, with disulfide connectivity typically forming a knot-like topology that confers exceptional stability. Key structural features include a conserved globular fold with exposed loops critical for channel binding, and the sequence should reflect high specificity for potassium channels over other ion channels. The toxin's mechanism involves binding to the pore region or voltage-sensing domain of Kv channels, inhibiting potassium efflux and prolonging action potentials, leading to neuromuscular blockade. Ensure the sequence includes appropriate signal and propeptide regions if context requires, but prioritize the mature toxin's functional and structural integrity."}
{"description": "sp|Q7YT61|SCX5C_CENLI Toxin Cll5c OS=Centruroides limpidus OX=6876 PE=2 SV=1", "sequence": "MNSLLMITACLVLFGTVWAKEGYLVNKSTGCKYGCFWLGKNENCDMECKAKNQGGSYGYCYSFACWCEGLPDSTPTYPLPNKSCSKK", "prompt": "Design a novel scorpion toxin protein sequence based on the biological profile of Toxin Cll5c from the Mexican scorpion Centruroides limpidus. This toxin belongs to the beta-toxin family of scorpion venom peptides, which specifically target voltage-gated sodium channels (Nav channels) in the peripheral nervous system. The protein should function as a beta-toxin that modifies sodium channel gating by shifting the voltage-dependence of activation toward more negative potentials, leading to enhanced neuronal excitability and spontaneous repetitive firing. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure consisting of an alpha-helix packed against an antiparallel beta-sheet. The molecular target is likely Nav1.7 or Nav1.6 channels, with key functional residues concentrated in the 'pharmacophore' region responsible for receptor binding and channel modulation. The sequence should include conserved hydrophobic patches and positively charged residues that facilitate membrane interaction and specific channel recognition. The overall architecture should maintain the compact, globular structure typical of scorpion beta-toxins, approximately 60-70 amino acids in length, with the characteristic functional surface that enables selective sodium channel modulation while maintaining structural stability through the conserved disulfide framework."}
{"description": "sp|O93515|VM2S3_GLOBR Zinc metalloproteinase-disintegrin salmosin-3 (Fragment) OS=Gloydius brevicauda OX=3148161 PE=2 SV=1", "sequence": "SCPCDANSCIMSATLSNEPSSRFSDCSFSLPSRFSDCSFNQYSSDIIHYHECLLNEPSRTDIVSPPVCGNYYPEVGEDCDCGPPANCQNPCCDAATCGLTTGSQCAEGLCCDQCRLKKAGTICRKARGDNPDDRCTGQSGVCPRNT", "prompt": "Design a venom-derived protein sequence that functions as a zinc metalloproteinase-disintegrin, specifically representing salmosin-3 from the venom of Gloydius brevicauda (short-tailed mamushi). This protein should exhibit the characteristic dual functionality of snake venom metalloproteinases (SVMPs). The metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) that coordinates catalytic zinc ions, enabling proteolytic activity against extracellular matrix components such as collagen, fibronectin, and laminin. The disintegrin domain should adopt the typical cysteine-rich structure with the RGD (Arg-Gly-Asp) motif that specifically targets and inhibits integrin receptors on platelets and other cells, disrupting cell-matrix interactions and potentially causing hemorrhage and anticoagulation effects. The overall structure should maintain the multi-domain architecture typical of SVMPs, with proper disulfide bonding patterns stabilizing both domains. The protein should demonstrate the characteristic hemorrhagic and anti-platelet activities associated with viperid venoms, contributing to prey immobilization through disruption of vascular integrity and hemostasis."}
{"description": "sp|P07526|3L23_OPHHA Long neurotoxin 3 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "TKCYVTPDVKSETCPAGQDLCYTETWCVAWCTVRGKRVSLTCAAICPIVPPKVSIKCCSTDACGPFPTWPNVR", "prompt": "Design a long neurotoxin protein sequence that mimics the potent neurotoxic activity found in king cobra (Ophiophagus hannah) venom. This toxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta and alpha-gamma subunit interfaces to induce postsynaptic blockade and flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold with three extended beta-stranded loops radiating from a central hydrophobic core stabilized by four conserved disulfide bridges (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8). Incorporate key functional residues in the central loop that mediate high-affinity binding to the acetylcholine receptor, including conserved aromatic and basic residues that interact with the receptor's complementary surface. The sequence should maintain the elongated structure typical of long neurotoxins, with extended loops that enhance receptor binding specificity and potency compared to short-chain neurotoxins. Ensure the protein exhibits the characteristic thermal stability and protease resistance conferred by the robust disulfide framework, while preserving the conformational flexibility necessary for optimal receptor interaction and biological activity."}
{"description": "sp|Q7Z090|I1B3_CONRA Iota-conotoxin-like R11.3 OS=Conus radiatus OX=61198 PE=2 SV=2", "sequence": "MKLCLTFLLVLMILASVTGEKLSEQTLRRAARKNKGPRCWVGRVHCTYHKDCCPSVCCFKGRCKPQSWGCWSGPT", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an iota-conotoxin from the marine cone snail Conus radiatus, a species known for producing complex venom peptides that target neuronal ion channels with high specificity. This toxin belongs to the conotoxin superfamily and is functionally classified as an iota-conotoxin, which typically act as voltage-gated sodium channel modulators. The core mechanism of action involves binding to and modulating specific subtypes of voltage-gated sodium channels, potentially causing altered neuronal excitability through effects on channel gating kinetics. The structural scaffold should feature the characteristic conotoxin cysteine framework with a conserved disulfide bridge pattern (likely CC-C-C for iota-conotoxins) that forms a stable, compact tertiary structure. The protein should adopt a small, globular fold stabilized by disulfide bonds, with surface-exposed loops containing key residues for target recognition and binding. The molecular target interface should include specific interactions with voltage-sensing domains or pore regions of neuronal sodium channels. The sequence must maintain the essential pharmacophore elements required for sodium channel modulation while exhibiting the typical conotoxin properties of high stability, target specificity, and potent biological activity characteristic of Conus radiatus venom peptides."}
{"description": "sp|Q3SAF2|VNPD_PSEAU Natriuretic peptide PaNP-d (Fragment) OS=Pseudechis australis OX=8670 PE=2 SV=1", "sequence": "SGSKTAEIDDGCFGLPLDPIGSTSGMGCRSVPKPIPGGS", "prompt": "Design a natriuretic peptide toxin derived from the venom of the Australian king brown snake (Pseudechis australis). This peptide functions as a potent vasoactive toxin that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) in vascular smooth muscle and renal tissues. The mechanism involves binding to the extracellular domain of NPR-A, activating particulate guanylyl cyclase to increase intracellular cGMP levels, resulting in vasodilation, natriuresis, and diuresis. Structurally, it should adopt the characteristic natriuretic peptide fold stabilized by a conserved disulfide bond pattern (Cys1-Cys6, Cys2-Cys5, Cys3-Cys4) forming a ring structure essential for receptor recognition. The peptide should contain key functional motifs including the N-terminal tail, central ring domain with receptor-binding residues, and C-terminal tail, exhibiting amphipathic properties with both hydrophilic receptor-interacting surfaces and hydrophobic core-stabilizing regions. The mature toxin should be approximately 30-40 amino acids in length with the canonical natriuretic peptide cysteine framework and demonstrate high affinity for NPR-A while resisting proteolytic degradation in the circulatory system."}
{"description": "sp|P80719|KAX62_SCOPA Potassium channel toxin alpha-KTx 6.2 OS=Scorpio palmatus OX=1662106 PE=1 SV=1", "sequence": "VSCTGSKDCYAPCRKQTGCPNAKCINKSCKCYGC", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker from the venom of the scorpion Scorpio palmatus. This toxin belongs to the alpha-KTx family 6.2, which specifically targets voltage-gated potassium channels (Kv channels) with high affinity and selectivity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring an alpha-helix packed against a three-stranded antiparallel beta-sheet stabilized by three or four disulfide bridges in the typical alpha-KTx cysteine framework pattern. The molecular mechanism involves binding to the pore region of Kv channels, physically occluding the ion conduction pathway and preventing potassium efflux, leading to neuronal hyperexcitability, prolonged action potentials, and disrupted cellular signaling. Key structural elements should include: a functional dyad consisting of a critical lysine residue that penetrates the channel pore and an adjacent aromatic residue that stabilizes binding through hydrophobic interactions; conserved beta-hairpin motifs that interact with the channel vestibule; and surface-exposed residues that confer specificity for particular Kv channel subtypes. The toxin should exhibit the characteristic compact, globular structure stabilized by disulfide bonds that provides exceptional thermal and proteolytic stability, enabling effective envenomation and prey immobilization through disruption of neuromuscular transmission and autonomic nervous system function."}
{"description": "sp|D3TTC2|VM3H_NAJAT Zinc metalloproteinase-disintegrin-like atragin OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MIQALLVIICLAVFPHQGSSIILESGNVNDYEVVYPQKVPALLKGGVQNPQPETKYEDTMRYEFQVNGEPVVLHLERNKGLFSEDYTETHYAPDGREITTSPPVQDHCYYHGYIQNEADSSAVISACDGLKGHFEHQGETYFIEPLKISNSEAHAIYKDENVENEDETPEICGVTETTWESDESIEKTSQLTNTPEQDRYLQAKKYIEFYVVVDNIMYRHYKRDQPVIKRKVYEMINTMNMIYRRLNFHIALIGLEIWSNINEINVQSDVRATLNLFGEWREKKLLPRKRNDNAQLLTGIDFNGTPVGLAYIGSICNPKTSAAVVQDYSSRTRMVAITMAHEMGHNLGMNHDRGFCTCGFNKCVMSTRRTKPAYQFSSCSVREHQRYLLRDRPQCILNKPLSTDIVSPPICGNYFVEVGEECDCGSPADCQSACCNATTCKLQHEAQCDSEECCEKCKFKGARAECRAAKDDCDLPELCTGQSAECPTDVFQRNGLPCQNNQGYCYNGKCPIMTNQCIALRGPGVKVSRDSCFTLNQRTRGCGLCRMEYGRKIPCAAKDVKCGRLFCKRRNSMICNCSISPRDPNYGMVEPGTKCGDGMVCSNRQCVDVKTAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin protein sequence inspired by atragin from the Chinese cobra (Naja atra) venom. This protein should function as a key hemorrhagic toxin in elapid snake venom, targeting the mammalian vascular system through dual enzymatic and anti-adhesive activities. The sequence must incorporate a zinc-dependent metalloproteinase domain with the canonical HEXXHXXGXXH zinc-binding motif that cleaves extracellular matrix components like type IV collagen and fibronectin, disrupting basement membrane integrity. Additionally, include a disintegrin-like domain featuring the characteristic RGD or related tripeptide motif that competitively inhibits integrin receptors (particularly αvβ3 and α5β1 integrins) on platelets and endothelial cells, preventing cell adhesion and migration. The protein should adopt a modular multi-domain structure typical of snake venom metalloproteinases (SVMPs), with the metalloproteinase domain folding into a conserved metzincin-like globular structure stabilized by multiple disulfide bridges, and the disintegrin-like domain forming an independent structural unit. Ensure the sequence maintains appropriate cysteine frameworks for proper disulfide bonding patterns that confer stability in the venom milieu and resistance to proteolytic degradation. The overall architecture should facilitate synergistic hemorrhagic activity through combined proteolytic degradation of vascular basement membranes and inhibition of platelet aggregation and endothelial cell adhesion, leading to efficient bleeding and tissue damage characteristic of viperid and elapid envenomation."}
{"description": "sp|P0DJO5|KA15S_CHATC Potassium channel toxin alpha-KTx Ctri9577 OS=Chaerilus tricostatus OX=1055734 PE=3 SV=1", "sequence": "MKLVMRILLTCFLLTTLVIKAEGQIHTNQPCTSNNTRCRTYCIKVHKINSGKCMNSKCVCHP", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Chaerilus tricostatus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif formed by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold stabilized by this disulfide framework, with a functional dyad comprising a critical lysine residue in the beta-hairpin region that penetrates the channel pore and an aromatic residue that provides complementary interactions. The mature toxin should be approximately 30-40 amino acids in length with a high density of basic residues to facilitate electrostatic steering toward the channel vestibule. The structural core must maintain the characteristic triple-stranded beta-sheet arrangement typical of scorpion potassium channel toxins, ensuring proper presentation of the pore-blocking residues while maintaining structural stability in the venom milieu."}
{"description": "sp|B2KJ30|O168_CONST Delta-conotoxin-like S6.8 OS=Conus striatus OX=6493 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTFVTADDSRNGLKNLFPKARHEMKNPDASKLNKRDGCSNAGGFCGIHPGLCCSEICLVWCT", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The protein is a delta-conotoxin-like peptide derived from the venom of the marine cone snail Conus striatus. This toxin belongs to the conotoxin superfamily and is classified within the O1-gene superfamily, specifically exhibiting similarity to delta-conotoxins. The biological significance of this venom component lies in its role as a potent neurotoxin that targets voltage-gated sodium channels in the nervous system of prey organisms. The core function of this toxin is to inhibit sodium channel inactivation, leading to prolonged depolarization and repetitive firing of action potentials, resulting in paralysis and ultimately death of the target organism. The molecular mechanism involves binding to site 6 of voltage-gated sodium channels, specifically interfering with the fast inactivation gate. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif common to conotoxins, with a compact, globular fold stabilized by multiple disulfide bridges. Based on the delta-conotoxin classification, the cysteine framework is expected to follow the C-C-CC-C-C pattern (framework VI/VII), forming three disulfide bonds that create the stable knotted core structure. The mature peptide should be approximately 25-35 amino acids in length with a high density of cysteine residues. The structural characteristics include a triple-stranded beta-sheet arrangement and several tight turns, creating a well-defined binding surface for sodium channel interaction. The binding interface should contain key hydrophobic and positively charged residues that facilitate specific recognition of the voltage-sensing domain of sodium channels. The protein should exhibit high specificity for neuronal sodium channel subtypes, with particular affinity for Nav1.2 and Nav1.6 isoforms commonly found in the central nervous system."}
{"description": "sp|C0HJW6|KAX2G_CENTE Potassium channel toxin alpha-KTx 2.16 OS=Centruroides tecomanus OX=1028682 PE=1 SV=1", "sequence": "TIINVKCTSPKQCLKPCKDLYGPHAGEKCMNGKCKCYKI", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Centruroides tecomanus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels (Kv channels), specifically targeting the external vestibule of the channel pore to inhibit potassium ion efflux and disrupt neuronal and muscular electrical signaling. The structural scaffold must be a classic alpha-KTx family fold, characterized by a compact, disulfide-stabilized core with an alpha-helix and anti-parallel beta-sheet arrangement. The cysteine framework should follow the conserved C1-X(4-7)-C2-X(2-5)-C3-X(3-8)-C4 pattern, forming two essential disulfide bridges (C1-C4 and C2-C3) that confer structural stability and define the functional dyad. The functional dyad, comprising a critical lysine residue positioned in the beta-sheet region and a nearby aromatic residue, is essential for inserting into the potassium channel selectivity filter. The sequence should include a conserved functional dyad where a lysine residue protrudes to physically occlude the channel pore, supported by surrounding hydrophobic and polar residues that mediate specific interactions with channel turret and pore helix residues. The overall structure should be highly stable, resistant to proteolysis, and exhibit the characteristic molecular surface features that facilitate high-affinity binding to Kv1.x family channels, leading to prolonged action potential duration and neuroexcitatory effects typical of scorpion venom toxins."}
{"description": "sp|P0DQU0|DEF5_OLIMR Defensin BmKDfsin5 OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MKVIALFFLFAFIFCTLEVAIVEAGFGCPLNQGACHRHCLSIRRRGGYCSGFFKQTCTCYRN", "prompt": "Design a defensin-like toxin protein derived from the venom of Olivierus martensii (Chinese scorpion). This defensin should function as a potent antimicrobial and/or insecticidal agent, characteristic of scorpion venom defensins. The protein should adopt the canonical cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three or four disulfide bridges with a conserved cysteine framework (typically C1-Xn-C2-Xn-C3-Xn-C4-Xn-C5-Xn-C6, where n varies). Key structural elements should include an N-terminal alpha-helix and an antiparallel beta-sheet, forming a compact globular structure. The molecular mechanism likely involves disruption of microbial cell membranes via electrostatic interactions, potentially targeting anionic phospholipids or specific ion channels. Incorporate conserved defensin motifs, such as the γ-core motif (GXCXnC) in the beta-hairpin region, which is critical for antimicrobial activity. Ensure the sequence includes appropriate cationic and hydrophobic residues to facilitate membrane binding and pore formation. The protein should exhibit stability under physiological conditions, with the disulfide network conferring resistance to proteolytic degradation."}
{"description": "sp|P0DKL8|VKT_VIPRE Kunitz-type serine protease inhibitor Vur-KIn OS=Vipera renardi OX=927686 PE=1 SV=1", "sequence": "QDHPVFCYLPADPGICKAHKPRFYYNPASNKCKEFFYGGCGGNANNFKTRDECHHTCVASAMGRPT", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Vipera renardi, a viper species. This toxin functions as a potent serine protease inhibitor that disrupts key physiological processes in prey by targeting and inhibiting specific serine proteases involved in hemostasis, such as those in the coagulation cascade or fibrinolysis pathway. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three conserved disulfide bonds in the Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The active site should contain the canonical protease-binding loop with key residues for specific, high-affinity inhibition of target serine proteases, likely through a standard mechanism involving insertion into the protease active site cleft. The sequence must maintain the structural integrity of the Kunitz domain while encoding the functional specificity typical of viper venom Kunitz-type inhibitors, which play a crucial role in the venom's ability to induce coagulopathy and immobilize prey."}
{"description": "sp|P80958|3S1CC_NAJAT Cobrotoxin-b OS=Naja atra OX=8656 PE=1 SV=2", "sequence": "MKTLLLTLLVVTIVCLDLGYTLECHNQQSSQTPTTKTCSGETNCYKKWWSDHRGTIIERGCGCPKVKPGVNLNCCTTDRCNN", "prompt": "Generate the amino acid sequence for a short-chain alpha-neurotoxin from the venom of the Chinese cobra (Naja atra), a member of the three-finger toxin superfamily. This toxin functions as a potent, competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta and alpha-gamma subunit interfaces of muscle-type receptors. The protein should adopt the characteristic three-finger beta-sheet fold stabilized by four conserved disulfide bonds with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The structural core consists of three elongated loops extending from a central globular domain, with the central loop (loop II) containing key functional residues for receptor binding. The toxin should exhibit high affinity binding through aromatic and hydrophobic residues that interact with the receptor's complementary determining regions, leading to reversible postsynaptic neuromuscular blockade. The sequence should reflect the conserved structural scaffold of short-chain neurotoxins while maintaining the specific pharmacological profile characteristic of cobrotoxins from Naja atra venom."}
{"description": "sp|P0DKZ0|CKR1B_CONRO Conantokin Rl-B (Fragment) OS=Conus rolani OX=745791 PE=3 SV=1", "sequence": "MQLYTYLYLLVPLVTFHLILGTGTLDHGDALTERRSTDATALKPEPVLLQKSSARSTNDNGKDTQMKRILKKRGNKARGEEELAEKAPEFARELAN", "prompt": "Design a conantokin neuropeptide toxin derived from the venom of Conus rolani, a marine cone snail species. This toxin belongs to the conantokin family, which are small, γ-carboxyglutamate (Gla)-rich peptides that function as selective antagonists of NMDA-type glutamate receptors in the mammalian central nervous system. The protein should adopt a helical conformation stabilized by multiple Gla residues that coordinate calcium ions, creating a rigid structural scaffold essential for receptor recognition. The mechanism involves competitive inhibition at the glutamate binding site of NMDA receptors, specifically targeting NR2B-containing receptor subtypes, leading to disruption of excitatory neurotransmission and producing potent analgesic and neuroprotective effects. Key structural features include: an N-terminal helical domain rich in Gla residues that mediates calcium-dependent structural stabilization, a conserved Gla domain pattern that facilitates specific receptor interaction, and the absence of disulfide bridges characteristic of this toxin class. The molecular target interface involves specific recognition of the NR2B subunit ligand-binding domain, with conserved hydrophobic and charged residue patterns enabling high-affinity binding and selective antagonism of NMDA receptor function."}
{"description": "sp|Q7T3S7|PA2A1_ECHCA Acidic phospholipase A2 EC-I OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "MKTLWIVAVWLIAVEGNLYQFGRMIWNRTGKLPILSYGSYGCYCGWGGQGPPKDATDRCCLVHDCCYTRVGDCSPKMTLYSYRFENGDIICDNKDPCKRAVCECDREAAICLGENVNTYDKKYKSYEDCTEEVQEC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the saw-scaled viper, Echis carinatus. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should exhibit the characteristic structural features of group I phospholipase A2 enzymes, including a conserved calcium-binding loop (YGKYCGXXXXGC motif), a catalytic network with a histidine-aspartate dyad, and multiple disulfide bridges (typically 6-7 disulfide bonds) that stabilize the compact, globular fold. The acidic nature should be reflected in the isoelectric point, with surface-exposed acidic residues contributing to its net negative charge. The toxin should target biological membranes, inducing hemolysis, myotoxicity, and potentially anticoagulant effects through disruption of platelet and coagulation factor functions. The structural scaffold should maintain the classic phospholipase A2 fold with distinct hydrophobic and interfacial binding surfaces for membrane interaction and substrate recognition."}
{"description": "sp|B2KTG2|VKTH1_BUNFA Kunitz-type serine protease inhibitor homolog beta-bungarotoxin BF B1 chain OS=Bungarus fasciatus OX=8613 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWTELTPVSSRERHPDCDKPPDTGRCRKNVRAFYYKPSAKRCVQFIYGGCNANGNHFKSDHLCRCECLEYP", "prompt": "Design a protein sequence for a neurotoxic component from the venom of the banded krait (Bungarus fasciatus). This protein represents the B1 chain of beta-bungarotoxin, which functions as a presynaptic neurotoxin that causes irreversible blockade of neuromuscular transmission. The protein adopts a Kunitz-type serine protease inhibitor fold, characterized by a conserved tertiary structure stabilized by three disulfide bridges in the characteristic C1-C6, C2-C4, C3-C5 connectivity pattern. While retaining the structural scaffold of Kunitz-type inhibitors, this toxin homolog has evolved to primarily function as a phospholipase A2-dependent neurotoxin rather than as a potent protease inhibitor. The protein likely interacts with presynaptic membranes at neuromuscular junctions, where it facilitates the entry of the associated phospholipase A2 subunit to disrupt neurotransmitter release. Generate a sequence that maintains the essential Kunitz fold architecture while incorporating evolutionary adaptations that support its neurotoxic function in snake venom."}
{"description": "sp|P0DL37|KAX6L_UROYA Potassium channel toxin alpha-KTx 6.21 OS=Urodacus yaschenkoi OX=1273102 PE=1 SV=1", "sequence": "MNAKLIYLLLVVTTMMLTFDTTQAGDIKCSGTRQCWGPCKKQTTCTNSKCMNGKCKCYGCVG", "prompt": "Design a potassium channel toxin protein from the venom of the Australian scorpion Urodacus yaschenkoi. This toxin belongs to the alpha-KTx family 6.21 and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern typical of scorpion potassium channel toxins. The structural scaffold consists of a short N-terminal alpha-helix followed by an antiparallel beta-sheet, creating a compact globular structure. The molecular mechanism involves specific binding to the voltage-sensing domain or pore region of Kv1.x family potassium channels, leading to channel blockade and disruption of neuronal excitability. The toxin should contain key functional residues in the beta-hairpin region that mediate target recognition and binding affinity. This toxin represents an evolutionarily optimized molecular tool for studying potassium channel physiology and developing therapeutic leads for neurological disorders."}
{"description": "sp|P81996|SLB_ECHCS Snaclec echicetin subunit beta OS=Echis carinatus sochureki OX=124223 PE=1 SV=1", "sequence": "NCLPDWSVYEGYCYKVFKERMNWADAEKFCMKQVKDGHLVSFRNSKEVDFMISLAFPMLKMELVWIGLSDYWRDCYWEWSDGAQLDYKAWDNERHCFAAKTTDNQWMRRKCSGEFYFVCKCPA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor. This protein should be the beta subunit of echicetin, derived from the venom of the saw-scaled viper Echis carinatus. The protein must adopt the characteristic C-type lectin-like fold consisting of a globular domain with two antiparallel beta-sheets and two alpha-helices, stabilized by two conserved disulfide bridges with connectivity Cys1-Cys4 and Cys2-Cys3. The sequence should contain the conserved carbohydrate recognition domain (CRD) motif but function as a protein-binding toxin rather than a carbohydrate-binding lectin. The molecular mechanism involves binding specifically to platelet membrane glycoprotein Ib (GPIb) with high affinity, thereby blocking the interaction between GPIb and von Willebrand factor and preventing platelet adhesion and aggregation - a key hemorrhagic mechanism in saw-scaled viper envenomation. The protein should exhibit the typical snaclec heterodimeric architecture where this beta subunit pairs with an alpha subunit to form the functional complex, though this prompt focuses on generating the beta subunit sequence. Include conserved residues critical for maintaining the structural integrity of the C-type lectin fold and those involved in the protein-protein interaction interface with GPIb."}
{"description": "sp|A0A4P8XV20|CA1B_CONVE Alpha-conotoxin VnIB (Fragment) OS=Conus ventricosus OX=117992 PE=1 SV=2", "sequence": "ASDGRNAAADDKASDPIALTVRGGCCSHPVCYTKNPNCGGRR", "prompt": "Design a protein sequence for an alpha-conotoxin derived from the venom of Conus ventricosus, a marine cone snail. This toxin functions as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds with a Cys1-Cys3, Cys2-Cys4 connectivity pattern (framework I). The sequence should include conserved cysteine residues that form these disulfide bridges, creating a stable core that supports the presentation of key functional loops responsible for receptor binding and specificity. The molecular mechanism involves competitive inhibition at the orthosteric binding site of nAChRs, disrupting cholinergic signaling. The structural design must prioritize the ICK (inhibitor cysteine knot) motif, ensuring the toxin exhibits high affinity, selectivity, and stability typical of conotoxins, with potential applications in neuroscience research or therapeutic targeting of nAChR-related disorders."}
{"description": "sp|P49344|TX1AB_ECTTU Omega/M-ectatotoxin-Et1a subunit B OS=Ectatomma tuberculatum OX=39300 PE=1 SV=1", "sequence": "WSTIVKLTICPTLKSMAKKCEGSIATMIKKKCDK", "prompt": "Design a protein sequence for a neurotoxic peptide derived from the venom of the ant species Ectatomma tuberculatum. This toxin belongs to the omega-ectatotoxin family and functions as a potent modulator of voltage-gated calcium channels. The protein should adopt a stable structural scaffold characteristic of insect-derived neurotoxins, likely featuring an inhibitor cysteine knot (ICK) motif with a conserved disulfide bridge pattern (C-C-C-C-C-C connectivity) that confers exceptional thermal and proteolytic stability. The core mechanism involves high-affinity binding to presynaptic calcium channels, specifically Cav2 family channels, leading to disrupted neurotransmitter release and neuromuscular paralysis. The structural fold should include well-defined beta-sheets stabilized by the cysteine knot, with key functional loops responsible for target recognition and binding specificity. The mature toxin should be a compact, globular peptide of approximately 60-80 amino acids with surface-exposed residues optimized for selective interaction with calcium channel pore-forming subunits. The biological significance lies in its role as a defensive venom component that rapidly immobilizes prey or predators through precise interference with neuronal excitability and synaptic transmission."}
{"description": "sp|P47797|VSPF2_CALRH Thrombin-like enzyme ancrod-2 OS=Calloselasma rhodostoma OX=8717 PE=2 SV=1", "sequence": "MVLIRVLANLVILQLSYAQKSSELVIGGDECNINEHRFLVALYDSTTRNFLCGGVLIHPEWVITAKHCNKKSMVLYLGKHKQSVKFDDEQERFPKEKHFIRCNKPRTRWGEDIMLIRLNKPVNNSEHIAPLSLPSNPPIVGSVCRVMGWGSINKYIDVLPDEPRCANINLYNYTVCRGVFPRIPKKSKILCAGDLQGRLDSCHCDSGGPLICSEEFHGIVYRGPNPCAQPDKPALYTNIFDHLHWILSIMAGNATCYP", "prompt": "Design a serine protease enzyme from the venom of the Malayan pit viper (Calloselasma rhodostoma) that functions as a thrombin-like enzyme with defibrinogenating activity. This toxin should exhibit selective proteolytic activity toward fibrinogen, specifically cleaving fibrinopeptide A from the Aα chain while sparing fibrinopeptide B, thereby generating unstable fibrin monomers that form abnormal clots rapidly cleared from circulation. The enzyme should possess a trypsin-like serine protease catalytic triad (His, Asp, Ser) within a chymotrypsin family fold, featuring the characteristic β-barrel structure with two six-stranded β-barrels and the conserved activation domain. Include the essential disulfide bond pattern typical of snake venom serine proteases that stabilizes the tertiary structure, particularly the conserved Cys1-Cys2, Cys3-Cys4, and Cys5-Cys6 pairings that maintain structural integrity. The protein should demonstrate substrate specificity distinct from mammalian thrombin, with enhanced affinity for fibrinogen over other coagulation factors, contributing to its anticoagulant effect through consumption of circulating fibrinogen. The mature enzyme should be glycosylated at appropriate asparagine residues to ensure stability in the venom and proper folding. This defibrinogenating agent represents a key component of viper venom that disrupts hemostasis by depleting fibrinogen levels, leading to anticoagulation and potential hemorrhagic effects in envenomation."}
{"description": "sp|E0Y421|VSPY_MACLB Chymotrypsin-like protease VLCTLP OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MVLIRVLANLLLLQLSYAQKSSELVVGGDECNINEHRSLVFLYNSSFGCGGTLINQQWVLSAAHCDMENVQIYLGLHNLRLRNQDEQIRVAEEKFFCLSNKSYTKWDKDIMLIRLNSSVTYNTHIAPLSLPSSPPRVGSVCRIMGWGAITSPNETFPNVPHCANINILRYSVCRAAYRGLPAQSRTLCAGILQGGIGSCMGDSGGPLICNGEIQGIVSWGDDICAQPHKPVHYTKVFDYSDWIQSIIAGNTTATCPL", "prompt": "Design a novel chymotrypsin-like serine protease venom component inspired by the Levantine viper (Macrovipera lebetinus). This toxin should function as a key digestive and tissue-damaging enzyme within viperid venom, facilitating prey immobilization through targeted proteolysis of extracellular matrix components and plasma proteins. The protein must adopt the canonical chymotrypsin-like serine protease fold characterized by two β-barrel domains with the catalytic triad (His57, Asp102, Ser195 in chymotrypsin numbering) precisely positioned in the active site cleft. Incorporate structural features typical of snake venom serine proteases, including conserved disulfide bridges that stabilize the compact globular structure and potentially unique surface loops that confer substrate specificity toward fibrinogen, complement components, or other hemostatic targets. The enzyme should exhibit preferential cleavage after aromatic residues (Phe, Tyr, Trp) characteristic of chymotrypsin-like specificity, while potentially displaying the enhanced stability and specific inhibition profiles observed in viper venom proteases. Ensure the structural scaffold maintains the characteristic charge distribution and surface topology that enables efficient interaction with physiological substrates in the envenomation context."}
{"description": "sp|O77463|SCX4_TITSE Toxin Ts4 OS=Tityus serrulatus OX=6887 PE=1 SV=1", "sequence": "MKRMILFISCLLLIDIVVGGREGYPADSKGCKITCFLTAAGYCNTECTLKKGSSGYCAWPACYCYGLPDSVKIWTSETNKCGKK", "prompt": "Design a protein sequence for a beta-toxin from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the Nav1.6 subtype with high affinity. The protein should adopt the conserved CSαβ structural fold characteristic of scorpion beta-toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The molecular mechanism involves binding to site 4 of the sodium channel, shifting the voltage-dependence of activation toward more negative potentials and enhancing channel excitability. Key functional residues should be positioned in the conserved 'pharmacophore' regions to mediate specific interactions with the channel's voltage-sensing domain. The toxin should exhibit the typical compact, globular architecture of scorpion venom peptides, approximately 60-70 amino acids in length, with the core scaffold maintaining the structural integrity required for target recognition and biological activity in neuronal systems."}
{"description": "sp|P69497|I23_CONIM Conotoxin Im11.1 OS=Conus imperialis OX=35631 PE=2 SV=1", "sequence": "MMFRLTSVSCFLLVIACLNLVVLTNACLRDGQSCGYDSDCCRYSCCWGYCDLTCLINGKRATFQ", "prompt": "Design a novel conotoxin sequence inspired by the Im11.1 conotoxin from the venomous marine snail Conus imperialis. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The sequence must adopt the characteristic alpha-conotoxin structural framework with a globular disulfide connectivity pattern (C-C-C-C) stabilized by two disulfide bridges between cysteine residues 1-3 and 2-4. Incorporate key pharmacophore residues that mediate high-affinity binding to the receptor's orthosteric site, particularly those interacting with complementary subunits. The mature peptide should exhibit a compact, stable fold with a well-defined beta-hairpin motif and surface-exposed loops critical for target recognition. Ensure the sequence reflects the evolutionary optimization of Conus imperialis venom components for precise neurological targeting while maintaining structural integrity through conserved cysteine spacing and appropriate hydrophobic core formation."}
{"description": "sp|Q7T3T5|PA2AB_DABSI Acidic phospholipase A2 daboiatoxin B chain (Fragment) OS=Daboia siamensis OX=343250 PE=1 SV=1", "sequence": "MCLIGVEGNLFQFARLIDAKQEAFSFFKYISYGCYCGWGGQGTPKDATDRCCFVHDCCYARVKGCNPKLVEYSYSYRTGKIVCGGDDPCLRAVCECDRVAAICFRENMNTYDKKYMLYSIFDCKEESDQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin component derived from the venom of Daboia siamensis (Russell's viper). This protein functions as the B chain of daboiatoxin, a heterodimeric presynaptic neurotoxin that exhibits potent phospholipase A2 activity. The toxin should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG), a catalytic network centered around histidine and aspartate residues for ester bond hydrolysis, and a hydrophobic substrate-binding channel. The sequence must include the canonical disulfide bridge pattern (CysI-CysIV, CysII-CysV, CysIII-CysVI) that stabilizes the globular, multi-helical structure. As an acidic isoform, the protein should display a net negative charge at physiological pH, contributing to its role in synergistically enhancing the neurotoxic effects of the A chain by facilitating membrane penetration and enzymatic degradation of phospholipids in neuronal membranes. The mechanism involves hydrolysis of sn-2 acyl bonds in glycerophospholipids, leading to membrane disruption, inflammation, and presynaptic blockade of neurotransmitter release. Ensure the sequence reflects the evolutionary adaptations for venom function, including surface-exposed loops for target recognition and stability in the venom milieu."}
{"description": "sp|O93516|VM2S2_GLOBR Zinc metalloproteinase/disintegrin (Fragment) OS=Gloydius brevicauda OX=3148161 PE=2 SV=1", "sequence": "NEYQTYLTDRNPQCILNEPLRTDTVSTPVSGNELLEAGKECDCGAPANPCCDAATCKLRPGEQCAEGLCCDQCRFMKEGTICQEAKGDWNDDTCTGQSADCPRNGFYG", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of the venom from the short-tailed mamushi, Gloydius brevicauda. This protein should exhibit the dual functionality typical of snake venom metalloproteinases (SVMPs), combining proteolytic activity with anti-platelet and anti-adhesive properties. The metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling cleavage of extracellular matrix components such as collagen, laminin, and fibronectin. The disintegrin domain should present the canonical RGD (Arg-Gly-Asp) or related tripeptide motif that competitively inhibits integrin receptors on platelet surfaces, specifically targeting αIIbβ3 integrin to prevent platelet aggregation and thrombus formation. The protein should adopt the characteristic SVMP fold with a metalloproteinase domain featuring a central twisted β-sheet surrounded by α-helices, and a disintegrin domain with a compact, disulfide-rich structure. The cysteine framework should include multiple disulfide bridges that stabilize both domains, with conserved patterns for structural integrity. This protein represents a key component in viperid venom that facilitates prey immobilization through hemorrhage induction and inhibition of hemostatic mechanisms."}
{"description": "sp|C0HJW8|PA2HA_BOTNI Phospholipase A2 homolog nigroviriditoxin acidic subunit A (Fragment) OS=Bothriechis nigroviridis OX=88079 PE=1 SV=1", "sequence": "SPENCQGESQPCGCYCDAEGQGWPQDAEENGDIVCGEXTPC", "prompt": "Design a protein sequence for a phospholipase A2 homolog toxin from the venom of Bothriechis nigroviridis, the black-speckled palm-pitviper. This protein functions as a nigroviriditoxin acidic subunit A, representing a catalytically inactive PLA2-like toxin that has evolved to exert toxic effects through mechanisms distinct from enzymatic phospholipase activity. The toxin likely operates via a membrane-disrupting mechanism, potentially causing pore formation or membrane perturbation that leads to cytotoxicity, myotoxicity, or other pathophysiological effects characteristic of viperid snake venoms. Structurally, it should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices stabilized by a conserved network of disulfide bridges. The cysteine framework should follow the typical viperid PLA2 pattern with 6-7 conserved disulfide bonds maintaining the compact, stable globular structure. Key structural elements include the calcium-binding loop region (though catalytically inactive), the hydrophobic membrane-interaction face, and conserved surface residues that facilitate oligomerization or target recognition. The protein should exhibit the acidic pI characteristic of PLA2 homologs and maintain the overall dimensions and surface topology that enable its specific toxic functions while lacking catalytic residues for phospholipid hydrolysis."}
{"description": "sp|B2KTG3|VKTH2_BUNFA Kunitz-type serine protease inhibitor homolog beta-bungarotoxin BF B2 chain OS=Bungarus fasciatus OX=8613 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISSRERHPDCDKPPDTGRCGNNVRAFYYKPSTNKCVQFIYGGCNANGNHFKSDHLCRCQCREND", "prompt": "Design a protein sequence for a beta-bungarotoxin B2 chain from the banded krait (Bungarus fasciatus), a highly potent presynaptic neurotoxin that functions as a Kunitz-type serine protease inhibitor homolog. This toxin component is part of the heterodimeric beta-bungarotoxin complex, which exhibits phospholipase A2 activity in combination with its Kunitz-type chain. The protein should adopt the characteristic Kunitz-type fold, a compact globular structure stabilized by three conserved disulfide bridges with a C1-C6, C2-C4, C3-C5 connectivity pattern. The sequence should contain the canonical Kunitz domain with key residues for serine protease inhibition, particularly targeting trypsin-like proteases through a well-defined binding loop. As part of the beta-bungarotoxin complex, this chain contributes to the toxin's presynaptic neuromuscular blocking activity by interfering with neurotransmitter release at motor nerve terminals. The structural scaffold should maintain the stable beta-trefoil topology typical of Kunitz inhibitors, with anti-parallel beta-sheets and short helical segments, ensuring proper folding and biological activity within the venom's neurotoxic cocktail."}
{"description": "sp|E5D3Z8|A31_LOXLA Dermonecrotic toxin OS=Loxosceles laeta OX=58217 PE=1 SV=1", "sequence": "MYVHLALILGCWTVVLQGAETDVGERADNRRPIWNLAHMVNAVKQIPTFLDLGANALEADVTFKGSVPTYTYHGTPCDFGRDCIRWEYFNVFLKTLREYTTPGNAKYRDGFILFVLDLKTGSLSNDQVRPAGENVAKELLQNYWNNGNNGGRAYVVLSLPDIGHYEFVRGFKEVLKKEGHEDLLEKVGYDFSGPYLPSLPTLDATHEAYKKAGVDGHIWLSDGLTNFSPLGDMARLKEAIKSRDSANGFINKIYYWSVDKYSTTRTALDVGVDGIMTNYPNVLIDVLNEDGYKDNYRLATYDDNPWETYKK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles laeta. This toxin should function as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The protein should adopt the characteristic TIM barrel fold typical of sphingomyelinase D toxins, with conserved catalytic residues responsible for magnesium ion coordination and substrate binding. Include the conserved histidine and aspartic acid residues essential for the hydrolytic mechanism. The toxin should exhibit the ability to induce dermonecrosis through endothelial cell damage, complement activation, and platelet aggregation, leading to the characteristic necrotic lesions associated with loxoscelism. The sequence should maintain the structural stability required for venom delivery and tissue penetration, with appropriate surface properties for membrane interaction and enzymatic activity in the extracellular environment."}
{"description": "sp|Q3SAX8|VNPD_OXYSC Natriuretic peptide OsNP-d (Fragment) OS=Oxyuranus scutellatus scutellatus OX=8667 PE=2 SV=1", "sequence": "PAAGLSDPKIGNGCFGFPIDRIGSVSGLGCNRLVQNPPKPISGES", "prompt": "Generate a natriuretic peptide sequence from the venom of the coastal taipan (Oxyuranus scutellatus) that functions as a potent vasoactive toxin. This peptide should exhibit the characteristic structural organization of venom natriuretic peptides, featuring a conserved 17-amino acid ring structure formed by a disulfide bridge between two cysteine residues. The sequence should include the canonical natriuretic peptide motif that enables binding to natriuretic peptide receptors, particularly NPR-A, leading to activation of guanylyl cyclase and subsequent cGMP production. The resulting biological effects should include potent vasodilation, natriuresis, and diuresis, contributing to prey immobilization through cardiovascular collapse. The structural scaffold should maintain the amphipathic nature typical of this peptide family, with hydrophobic and hydrophilic regions properly positioned for receptor interaction and stability in the venom milieu. The peptide should demonstrate high specificity for natriuretic peptide receptors while exhibiting resistance to proteolytic degradation, consistent with its role as a fast-acting venom component."}
{"description": "sp|P69499|I2_CONST conotoxin S11.3 OS=Conus striatus OX=6493 PE=2 SV=1", "sequence": "MMFRLTSVSCFLLVIVCLNLFQVVLTRRCVPPSRYCTRHRPCCRGTCCSGLCRPMCNLWYGKRATFQE", "prompt": "Generate the amino acid sequence for a conotoxin from the marine cone snail Conus striatus, specifically the S11.3 variant. This toxin belongs to the conotoxin superfamily and is expected to function as a neurotoxin targeting ion channels or receptors in the prey's nervous system, contributing to the venom's paralytic and immobilizing effects. The sequence should feature a conserved cysteine framework characteristic of conotoxins, likely with multiple disulfide bonds that stabilize a compact, globular fold. Infer the disulfide connectivity pattern based on the conotoxin family's typical arrangements, such as the inhibitor cystine knot (ICK) motif, which confers structural rigidity and resistance to proteolysis. The molecular target may include voltage-gated sodium channels, potassium channels, or ligand-gated ion channels, with specific binding interfaces that modulate neuronal excitability. Ensure the sequence reflects the toxin's role in disrupting synaptic transmission or action potential propagation, leading to rapid prey incapacitation. Include key functional residues for target interaction, such as hydrophobic patches or charged groups, while maintaining the structural integrity required for venom efficacy."}
{"description": "sp|Q9DEF8|SLAB_DEIAC Snaclec anticoagulant protein subunit B OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVLFLSLSGTAADCPSDWSSYEGHCYKPFNEPKNWADAENFCTQQHTGSHLVSFQSTEEADFVVKLAFQTFDYGIFWMGLSKIWNQCNWQWSNAAMLKYTDWAEESYCVYFKSTNNKWRSITCRMIANFVCEFQA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent anticoagulant. This toxin originates from the venom of Deinagkistrodon acutus (hundred-pace snake), a medically significant pit viper whose venom components have evolved to disrupt hemostasis in prey. The protein should function as the B subunit of a heterodimeric anticoagulant complex, specifically targeting and inhibiting key coagulation factors in the blood clotting cascade. The molecular mechanism involves binding to coagulation factor IX, factor X, or other serine protease zymogens in the coagulation pathway, thereby preventing their activation and subsequent thrombin generation. The protein should adopt the characteristic C-type lectin-like fold with a conserved β-sandwich structure stabilized by two intrachain disulfide bridges following the typical C-type lectin cysteine pattern. Key structural elements should include calcium-binding sites characteristic of C-type lectins and specific surface loops that mediate high-affinity binding to coagulation factors. The sequence should contain conserved residues for carbohydrate recognition domain functionality while maintaining specificity for proteinaceous coagulation targets rather than carbohydrates. The overall structure should be compact and globular, with surface-exposed residues optimized for precise molecular recognition of coagulation cascade components to achieve potent anticoagulant activity through targeted inhibition of the intrinsic or common coagulation pathways."}
{"description": "sp|P0DQX0|CDKA1_CONFE Alpha-conotoxin FrXXA OS=Conus fergusoni OX=257326 PE=1 SV=1", "sequence": "MPKLEMMLLVLLILPLSYFDSAGGQAVKVDGHGDGMDRYLQRDDREARITCQPRGRSKWGRCCLTQMCGNFCCPRYGCRCVYRSGRGHGCSC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of the marine cone snail Conus fergusoni. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junction subtypes to induce paralysis in prey. The peptide must adopt the characteristic globular disulfide-stabilized fold of alpha-conotoxins, featuring the conserved CC-C-C cysteine framework with two disulfide bridges that constrain the structure into a compact, stable conformation. Key structural elements should include a short alpha-helical segment and beta-turn motifs that form the receptor-binding interface. The sequence must contain the appropriate spacing between cysteine residues typical of alpha-conotoxins, with conserved hydrophobic core residues that maintain structural integrity and variable loop regions that confer target specificity. The mature toxin should be approximately 12-20 amino acids in length, exhibiting high affinity for nicotinic acetylcholine receptor subtypes while maintaining the characteristic potency and rapid action essential for the predatory function of cone snail venoms."}
{"description": "sp|P0CH58|NDB52_MESEU Meucin-25 OS=Mesobuthus eupeus OX=34648 PE=2 SV=1", "sequence": "MFRIEYSLVQLLLRNVTIPLLLIIQMHIMSSVKLIQIRIWIQYVTVLQMFSMKTKQ", "prompt": "Design a novel peptide toxin sequence inspired by the biological characteristics of Meucin-25 from the venom of the scorpion Mesobuthus eupeus. This peptide should function as a potent antimicrobial agent with broad-spectrum activity against both Gram-positive and Gram-negative bacteria, reflecting the evolutionary role of scorpion venom components in host defense. The mechanism of action should involve disruption of bacterial membrane integrity through electrostatic interactions and pore formation, leading to rapid bacterial cell lysis. Structurally, the peptide should adopt an amphipathic alpha-helical conformation when interacting with lipid membranes, with a well-defined hydrophobic face and a cationic face rich in lysine and arginine residues that facilitate initial binding to negatively charged bacterial membranes. The sequence should be approximately 25 amino acids in length and exhibit the characteristic features of cationic antimicrobial peptides, including a net positive charge and appropriate hydrophobicity balance for selective toxicity toward bacterial versus mammalian cells. The structural scaffold should enable membrane permeabilization while maintaining stability in physiological conditions."}
{"description": "sp|P54135|SCX8_OLIMR Alpha-mammal toxin BmK-M8 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "GRDAYIADSENCTYFCGSNPYCNDVCTENGAKSGYCQWAGRYGNACYCIDLPASERIKEPGKCG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be an alpha-mammal toxin derived from the scorpion Olivierus martensii (commonly known as the Chinese scorpion or Manchurian scorpion). This organism's venom contains a complex mixture of neurotoxins that specifically target mammalian nervous systems, primarily functioning as sodium channel modulators. The core mechanism of action involves binding to voltage-gated sodium channels (Nav channels) in mammalian neurons, specifically interacting with site 3 of the channel to inhibit fast inactivation. This results in prolonged sodium influx, leading to sustained neuronal depolarization, repetitive firing, and ultimately neurotoxic effects. The protein should adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion alpha-toxins, featuring a conserved structural fold with a compact core stabilized by four disulfide bridges in a C1-C4, C2-C5, C3-C6, C4-C7 pattern. The 3D structure should display a conserved triple-stranded antiparallel beta-sheet connected by loops and stabilized by the disulfide network. Key functional domains include the conserved 'pharmacophore' region responsible for receptor binding specificity, particularly residues in the beta2-beta3 loop that interact with the sodium channel's voltage-sensor domain. The molecular target is mammalian voltage-gated sodium channels (primarily Nav1.2, Nav1.4, and Nav1.6 subtypes), with binding occurring at neurotoxin receptor site 3 located on the extracellular S3-S4 loop of domain IV. The binding interface involves specific electrostatic and hydrophobic interactions that confer mammalian selectivity over insect sodium channels. The toxin should exhibit high affinity and specificity for mammalian neuronal targets while maintaining the structural stability characteristic of scorpion venom peptides."}
{"description": "sp|P0DQV8|LEC4_SCOPL C-type isolectin Sp-CL4 OS=Scorpaena plumieri OX=274700 PE=1 SV=1", "sequence": "DAEPPSPAEECAAVKMESCGDDWLYIDENRKVKYFETPKTFQEAQDHCESEDGNLVAMHTEFQKYVVACLSWIYNHKLHRMWIGAGRSEGETQNIDGSDFDYAKWKGGQPDNFGGNEDCIEANFIDWGYLNDVECSEKLPFMCA", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the spotted scorpionfish (Scorpaena plumieri). This toxin belongs to the C-type lectin family and functions as a potent isolectin with carbohydrate-binding activity. The protein should adopt the characteristic C-type lectin fold, featuring a conserved carbohydrate recognition domain (CRD) stabilized by two to three disulfide bridges. The structural scaffold should include the essential calcium-binding site within the CRD, which mediates specific interactions with glycan targets such as galactose or mannose residues on cell surfaces. The toxin likely exerts its biological effects by binding to glycoproteins or glycolipids on host cells, potentially leading to hemagglutination, platelet aggregation, or modulation of immune responses. The sequence should include key residues for calcium coordination (typically involving Glu, Asn, Asp, and two backbone carbonyls) and the conserved motifs for sugar binding (e.g., EPN or QPD motifs depending on specificity). Ensure the protein exhibits the dual-domain architecture common to venom C-type lectins, with a compact globular structure dominated by β-sheets and loops, and include the characteristic long-loop region that confers target specificity. The final sequence should reflect the isolectin nature, implying potential variations in sugar-binding specificity while maintaining the core structural integrity and toxic functionality inherent to scorpionfish venom lectins."}
{"description": "sp|P0DJE3|LATA_LATHE Alpha-latrotoxin-Lhe1a OS=Latrodectus hesperus OX=256737 PE=1 SV=2", "sequence": "MIFVGETMERANHSLVRLRREGEELTLDEKAEICSELELQQKYVDIASNIIGDLSSLPMVGKIVGTIAAAAMTVTHVASGRLDIEQTLLGCSDLPFDQIKEVLEKRFNEVDRKLESHSAALEEITKLVEKSISAVEKTRKQMNKRFDEVMKSIQDAKVSPIVSKINNFARYFDTEKERIRGLKLNDYILKLEEPNGILLHFKESRTPKDDSLQAPLFSIIQEGYAVPKSIDDESAFKVLYALLYGTQTYISVMFFLLEQYSFLANHYYEKGDLEKYDEYFNSLNNVFLDFKSSLVGTGTSNNEGLIDKVLQVLMTFKNSEFLGLGKNGVDEMLNEKINLFNKIKEEIESKQRMTMSETPENFAQISFDKDITTPIGDWRDGREVRYAVQYASETLFSKIGHWSDPVSVREKACPTLRMPVDQTRRNVLVFRKFDNSKPQLVGEITPYLSNFIDIDRDLYNAASNPDSAVGFKEFTKLNYDGANIRATFDQGRTIFHAVAKSGNDKILFGLTFLVKSTELNQPDKKGYTPIHVAADSGNAGIVNLLIQRGVSINSKTYHFLQTPLHLAAQRGFVNTFQRLMESSEININERDKDGFTPLHYAVRGGERILEAFMNQIGIDVNAKSNKGLTPFHLAIIKNDWQVASTLLRNKKVDINAVDENNMTALHYAAILGYLETTKQLINLKEINANVVSSPGLLSALHYAILYKHDDVASFLLRSSNVNVNLKALGGITPLHLAVMQGRKQVLSLMFNIGVNIEQQTDEKYTPLHLAAMSKYPELIQILLDQDSNFEAKTNSGATPLHLATFKGKSQAALILLNNEVNWRDTDENGQMPIHGAATTGLLDVAQAIISIDATVLDIEDKNSDTPLNLAAQNSHIDAVKYFIDQGADINTRNKNGHAPLLAFSKKGNLDMVKYLFDKNANVYIADNNGMNFFYYAVRNGHLNIIKYAMSEKDKFEWSNIDNNRRDECPKEECAISHFAVCDAVQFDKIEIVKFFIGTLGNFNICGPLHQAARYGHLHIVKYLVEEEVLSVDGSKTDTPLCYASENGHLAVVQYLVSNGAKVNHDCANGMTAIDKAITKNHLQVVQFLAANGVDFRRKNSRGATPFLTAVAENAFDIAEYLIREKRQDININEQNVDKETALHLAVYYKNLQMIKLLVKYGIDVTIRNAYDKTVLDIATDAKFSNIVKYLKKNSGKFRREYKSSYGEHSFLQTNEISRFIDGKSIEHDHPQFINADNESSQLFSGTASKIDVIGTLLLIDVLIRYFSKQGYISKESDSASDGITQAAALSITEKFEDVLNSLPNKSAKEQVDLADVHGKVYAALKSGRNSQIHQILCSSLKSISTLKPEDMEKLVSVIMNSHSSLSMPEATDSANEAYGETLHLFGESCRHSEDYISQKFSTNPFSFESEKKIQKISI", "prompt": "Design a protein sequence for an alpha-latrotoxin from the venom of the Western black widow spider (Latrodectus hesperus). This neurotoxin functions as a potent presynaptic excitatory toxin that triggers massive neurotransmitter release from vertebrate nerve terminals. The protein should adopt the characteristic large latrotoxin structure with multiple domains, including an N-terminal domain involved in membrane interaction, a central receptor-binding domain that targets specific neuronal surface receptors (such as neurexins and latrophilins/CIRL), and a C-terminal domain that forms calcium-permeable pores in the presynaptic membrane. The mechanism involves initial receptor-mediated binding followed by insertion into the lipid bilayer to form tetrameric pores, leading to calcium influx and exhaustive vesicle exocytosis. The sequence should contain the conserved cysteine residues characteristic of latrotoxins that form disulfide bridges stabilizing the multi-domain architecture, with the overall fold enabling both receptor recognition and pore-forming capabilities. The structural scaffold should facilitate the dual functionality of specific neuronal targeting and membrane disruption that underlies the toxin's potent neurotoxic effects."}
{"description": "sp|Q7YT39|MTX4_GRARO M-theraphotoxin-Gr1a OS=Grammostola rosea OX=432528 PE=1 SV=1", "sequence": "MKTSVVFVIAGLALLSVVCYASELKEQSSVNEVLSTIFHFEQPEERGCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSFGK", "prompt": "Design a novel protein sequence for a theraphotoxin from the Chilean rose tarantula (Grammostola rosea) venom. This toxin belongs to the M-theraphotoxin family and functions as a potent modulator of neuronal ion channels. The protein should adopt a stable, compact tertiary structure stabilized by a conserved disulfide bridge framework characteristic of inhibitory cysteine knot (ICK) motif toxins. The core structural scaffold should feature a triple-stranded antiparallel beta-sheet arrangement, with the disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) essential for maintaining structural integrity and biological activity. The toxin should specifically target voltage-gated potassium channels (Kv channels) or other neuronal ion channels, with key functional residues positioned in flexible loops to mediate high-affinity binding and modulation of channel gating. The sequence must include conserved hydrophobic patches and surface-exposed polar residues that facilitate membrane interaction and receptor recognition. The overall molecular weight should be approximately 4-5 kDa, with the folded structure exhibiting high thermal and proteolytic stability typical of spider venom peptides. The toxin should exhibit paralytic activity through precise interference with neuronal excitability, reflecting its role in prey immobilization for this theraphosid spider."}
{"description": "sp|P49369|PA1_VESVU Phospholipase A1 OS=Vespula vulgaris OX=7454 PE=1 SV=1", "sequence": "MEENMNLKYLLLFVYFVQVLNCCYGHGDPLSYELDRGPKCPFNSDTVSIIIETRENRNRDLYTLQTLQNHPEFKKKTITRPVVFITHGFTSSASETNFINLAKALVDKDNYMVISIDWQTAACTNEAAGLKYLYYPTAARNTRLVGQYIATITQKLVKHYKISMANIRLIGHSLGAHASGFAGKKVQELKLGKYSEIIGLDPARPSFDSNHCSERLCETDAEYVQIIHTSNYLGTEKTLGTVDFYMNNGKNQPGCGRFFSEVCSHSRAVIYMAECIKHECCLIGIPKSKSSQPISSCTKQECVCVGLNAKKYPSRGSFYVPVESTAPFCNNKGKII", "prompt": "Design a phospholipase A1 toxin protein sequence derived from the venom of the common wasp, Vespula vulgaris. This enzyme should function as a potent lipolytic toxin that specifically hydrolyzes the sn-1 acyl ester bond of phospholipids, producing lysophospholipids and free fatty acids. The protein should adopt the canonical α/β hydrolase fold characteristic of phospholipase A1 enzymes, featuring a central β-sheet surrounded by α-helices, with a catalytic triad typically composed of serine, aspartate, and histidine residues. The active site should contain a conserved GXSXG motif around the nucleophilic serine residue. As a venom component, this phospholipase A1 should contribute to the wasp's predatory and defensive capabilities by disrupting cell membranes, potentially inducing hemolysis, and triggering inflammatory responses through the release of lipid mediators like arachidonic acid. The protein should exhibit optimal activity at physiological pH and temperature, with structural stability maintained by appropriate disulfide bonding patterns common to venom phospholipases. The sequence should reflect the evolutionary optimization for rapid membrane disruption and potent enzymatic activity characteristic of hymenopteran venom toxins."}
{"description": "sp|P0C6A4|DID5B_ECHOC Disintegrin EO5B OS=Echis ocellatus OX=99586 PE=1 SV=1", "sequence": "NSAHPCCDPVTCQPKKGEHCISGPCCRNCKFLNSGTVCKRAVGDDMDDYCSGITTDCPRNPYKGKD", "prompt": "Design a novel disintegrin protein derived from the venom of Echis ocellatus, the West African carpet viper. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on platelet surfaces. The disintegrin should adopt the characteristic disintegrin fold stabilized by a conserved disulfide bond pattern, typically featuring multiple disulfide bridges that maintain the protein's compact, stable structure. The active site should contain the canonical RGD (Arg-Gly-Asp) motif or a related integrin-binding sequence that mediates high-affinity binding to platelet integrins such as αIIbβ3, thereby preventing fibrinogen binding and subsequent platelet aggregation. The protein should exhibit the typical structural features of viperid disintegrins, including a well-defined binding loop that presents the integrin-recognition motif for optimal receptor engagement. This design aims to replicate the natural anticoagulant properties of Echis ocellatus venom disintegrins, which play a crucial role in the snake's predatory strategy by inducing hemorrhage and preventing blood clotting in prey."}
{"description": "sp|Q3HXX8|NGFV1_TROCA Venom nerve growth factor 1 OS=Tropidechis carinatus OX=100989 PE=2 SV=1", "sequence": "MSMLCYTLIIAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPKKAEDQELGSAANIIVDPKLFQKRRFQSSRVLFSTQPPPLSRDEQSVEFLDNEDALNRNIRAKRETHPVHNRGEHSVCDSISVWVANKTNATDIKGNMVTVMVDVNLNNEVYMQYFFETKCRNPNPNPVPSGCRGIDSRHWNSYCTTTQAYVRALTMEGNRASWRFIRIDTACVCVIIRKTDNF", "prompt": "Design a venom-derived nerve growth factor protein from the rough-scaled snake (Tropidechis carinatus) that functions as a neurotrophic toxin. This protein should adopt the characteristic beta-sandwich fold typical of the nerve growth factor family, consisting of anti-parallel beta-strands arranged in a jelly-roll topology. The sequence must include the conserved cysteine residues that form the characteristic disulfide bridge pattern essential for structural stability and biological activity. As a venom component, this nerve growth factor likely functions to modulate neuronal development and survival pathways in envenomed prey, potentially through interaction with TrkA receptors and p75 neurotrophin receptors. The protein should exhibit the dimeric quaternary structure common to functional nerve growth factors, with the receptor-binding interfaces properly configured for high-affinity interactions. The structural scaffold must maintain the conserved beta-hairpin loops that mediate receptor recognition while preserving the overall neurotrophin fold architecture critical for its neurotrophic activity within the venom context."}
{"description": "sp|Q7Z0A3|I1BX_CONRA Iota-conotoxin-like R11.13 (Fragment) OS=Conus radiatus OX=61198 PE=2 SV=1", "sequence": "GHVPCGKDGRKCGYHADCCNCCLSGICKPSTSWTGCSTSTFLLTR", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an iota-conotoxin-like peptide derived from the venom of Conus radiatus, a marine cone snail species. As a member of the conotoxin family, it functions as a potent neurotoxin that targets ion channels in the nervous system of prey organisms. The protein should adopt the characteristic conotoxin structural scaffold with a compact, disulfide-stabilized fold. Based on the iota-conotoxin classification, it likely contains the conserved cysteine framework CC-C-C-CC, forming three disulfide bridges that create a stable, globular structure. The mature peptide is expected to be relatively short (approximately 20-40 residues) and rich in cysteine residues that define its structural integrity. The protein should exhibit high specificity for voltage-gated sodium channels (Nav channels), potentially modulating channel gating kinetics or acting as a channel blocker to disrupt neuronal signaling. The structural fold should enable precise molecular recognition of specific Nav channel subtypes, with surface-exposed loops and turns contributing to target binding specificity. The sequence should maintain the characteristic conotoxin features including proper spacing of cysteine residues, conserved structural motifs, and appropriate post-translational processing signals for proper folding and biological activity."}
{"description": "sp|P0CH59|HN131_CYRHA Hainantoxin F1-31.97 (Fragment) OS=Cyriopagopus hainanus OX=209901 PE=1 SV=1", "sequence": "ECKWYLGTCSKDGDCCKHLQCHSNYE", "prompt": "Design a protein sequence for a spider venom toxin that functions as a potent voltage-gated sodium channel inhibitor. This toxin originates from the Chinese earth tiger tarantula (Cyriopagopus hainanus), where it contributes to the rapid immobilization of prey through disruption of neuronal signaling. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). This scaffold enables precise interaction with the voltage-sensing domain of neuronal sodium channels, particularly Nav1.7 and Nav1.2 subtypes, leading to channel inhibition and blockade of action potential propagation. The sequence must include key residues for membrane penetration and target engagement, with a molecular weight around 4 kDa. The functional outcome should be paralysis through selective modulation of sodium channel gating."}
{"description": "sp|P80963|PA2H_BOTSC Basic phospholipase A2 homolog Bsc-K49 OS=Bothriechis schlegelii OX=44725 PE=1 SV=2", "sequence": "MRTLWIVAVLLVGVEGSMYELGKMILLETGKNAATSYIAYGCNCGVGRRGQPLDATDRCCYVHKCCYKKLTGCNPLTDRYSHSLKNKTIVCGENKPCLKEMCECDKALAICLGKNVNTYNKNYKITMKMFCKKPDAC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of Bothriechis schlegelii, the eyelash viper. This toxin belongs to the phospholipase A2 (PLA2) superfamily but functions as a catalytically inactive homolog due to the characteristic lysine substitution at position 49 (K49) in the calcium-binding loop, which abolishes enzymatic activity. The protein should adopt the conserved PLA2 structural fold, featuring three long alpha-helices stabilized by seven conserved disulfide bonds with the characteristic cysteine pattern C1-C11, C2-C7, C3-C17, C4-C10, C5-C15, C6-C14, and C8-C9. Despite lacking phospholipase activity, this K49-PLA2 homolog exerts potent myotoxic effects through a non-enzymatic mechanism involving membrane disruption and pore formation. The protein should contain a cationic heparin-binding site that facilitates interaction with sulfated glycosaminoglycans on muscle cell membranes, leading to sarcolemma damage, calcium influx, and eventual myonecrosis. The sequence should include key functional motifs: the conserved 'pancreatic loop' for structural integrity, the calcium-binding loop with the critical K49 substitution, and the C-terminal region implicated in membrane binding and myotoxicity. The overall structure should be compact and highly stable, typical of snake venom PLA2s, with surface-exposed basic residues that mediate electrostatic interactions with anionic membrane components."}
{"description": "sp|P50985|CA1B_CONPE Alpha-conotoxin PnIB OS=Conus pennaceus OX=37335 PE=1 SV=2", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRASDDGNAAASDLIALTIKGCCSLPPCALSNPDYCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus pennaceus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting the neuromuscular junction to induce paralysis in prey. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). It should feature a compact, stable fold stabilized by these disulfide bridges, presenting key functional residues in loop regions that mediate high-affinity binding to the alpha-delta subunit interface of muscle-type nicotinic acetylcholine receptors. The sequence should include conserved cysteine residues at appropriate positions to maintain the disulfide pattern, along with specific pharmacophore residues that confer receptor subtype selectivity and potent blocking activity. The overall structure should be small (typically 12-20 amino acids), highly stable due to the disulfide cross-links, and exhibit the typical alpha-conotoxin fold that enables precise molecular recognition of its target receptor."}
{"description": "sp|C0HMB2|PA2A_LACAO Acidic phospholipase A2 OS=Lachesis acrochorda OX=1170830 PE=1 SV=1", "sequence": "HLLQFGDLINKIARRNGILYYGFYGCYCGLGGRGRPQDATDRCCFVHDCCYGKVTGCDPKNDIYTYSEENGAIVCGGDNPCKKEICECDRDAAICFRDNLDTYDNKYWFFPRKYCKEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Chocoan bushmaster, Lachesis acrochorda. This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmission. The protein must exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, ultimately disrupting cellular membrane integrity and triggering inflammatory responses. Incorporate key structural features including the conserved pancreatic phospholipase A2 fold with a central beta-sheet core flanked by alpha-helices, a calcium-binding loop (YGKYCG) coordinating a catalytic calcium ion, and the characteristic catalytic triad (His48, Asp49, Tyr52) essential for enzymatic activity. Include the conserved disulfide bridge pattern (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, Cys84-Cys96) that stabilizes the globular structure. Ensure the sequence maintains an overall acidic isoelectric point through strategic placement of aspartic and glutamic acid residues. The protein should possess a hydrophobic channel for substrate access to the active site and exhibit enhanced membrane-binding capacity through surface-exposed hydrophobic residues. This phospholipase A2 should demonstrate high specificity for neuronal membranes and potent myotoxic effects characteristic of viperid snake venom toxins."}
{"description": "sp|Q7Z0A1|I1BG_CONRA Iota-conotoxin-like R11.16 OS=Conus radiatus OX=61198 PE=2 SV=1", "sequence": "GHVPCGKDGRKCGYHTHCCNCCLSGICKPSTSLIGCSTSSFT", "prompt": "Design a novel conotoxin sequence inspired by the iota-conotoxin family from the marine cone snail Conus radiatus. This venom component should function as a potent neurotoxin targeting voltage-gated sodium channels, specifically Nav1.2 and Nav1.6 subtypes, to modulate neuronal excitability. The protein should adopt the characteristic iota-conotoxin fold with a conserved cysteine framework (C-C-CC-C-C) forming three disulfide bridges that stabilize a compact, globular structure. Incorporate key structural motifs including a beta-hairpin region and flexible loops that facilitate precise interaction with the voltage-sensing domain of the sodium channel. The sequence should maintain the typical iota-conotoxin length of approximately 25-35 amino acids with appropriate hydrophobic core residues and surface-exposed charged residues for target recognition. Ensure the toxin exhibits high affinity binding to site 4 of voltage-gated sodium channels, causing delayed channel inactivation and prolonged neuronal depolarization, consistent with the hunting strategy of Conus radiatus for immobilizing prey."}
{"description": "sp|O77091|SIXP_OLIMR Beta-insect excitatory toxin BmK IT-AP OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKFFLIFLVIFPIMGVLGKKNGYAVDSSGKVAECLFNNYCNNECTKVYYADKGYCCLLKCYCFGLADDKPVLDIWDSTKNYCDVQIIDLS", "prompt": "Design a novel beta-insect excitatory toxin protein sequence inspired by the venom arsenal of the Chinese scorpion Olivierus martensii (formerly Buthus martensii). This toxin should function as a potent insect-selective excitatory neurotoxin, specifically targeting voltage-gated sodium channels in the insect nervous system. The protein must adopt the conserved beta-toxin structural scaffold characterized by a compact, triple-stranded antiparallel beta-sheet core stabilized by a specific disulfide bridge pattern. The cysteine framework should follow the classic C-C-C-C pattern with disulfide connectivity of C1-C4 and C2-C3, forming the stable core fold essential for sodium channel interaction. Key structural elements should include a conserved 'pharmacophore' region responsible for binding to neurotoxin receptor site 4 on insect voltage-gated sodium channels, leading to prolonged channel opening, repetitive firing, and ultimately paralysis. The sequence should maintain the characteristic molecular surface features that confer insect selectivity while avoiding mammalian sodium channel activity. The overall tertiary structure should exhibit the typical beta-toxin globular fold with exposed loops that mediate specific receptor recognition and binding affinity."}
{"description": "sp|P0DQX1|CDKA2_CONFE Alpha-conotoxin FrXXA 2 OS=Conus fergusoni OX=257326 PE=1 SV=1", "sequence": "MPKLEMMLLVLLILPLPYFDAAGGQAVQGDGHGDGMDRYLQRDDREARITCQPRGRSKWGRCCLTQMCGNYCCYKHGCRCVYHSWRGHGCSC", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of the marine cone snail Conus fergusoni. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes to modulate synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form a compact, stable fold. The sequence should include the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. Key structural elements should include a beta-hairpin motif and well-defined loops that facilitate precise molecular recognition of the receptor's ligand-binding domain. The toxin should exhibit high affinity binding to its target receptor through complementary surface interactions, potentially involving key residues in loop regions that mediate receptor subtype selectivity. The overall structure should be compact, disulfide-rich, and resistant to proteolytic degradation, characteristic of conotoxins that evolved for rapid and potent neurotoxic activity in marine predation."}
{"description": "sp|P0DL39|CA1A_CONAV Alpha-conotoxin AusIA OS=Conus australis OX=1519798 PE=1 SV=1", "sequence": "SCCARNPACRHNHPCV", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of Conus australis, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (CC-C-C framework). The sequence should include the essential cysteine residues at positions 3, 4, 10, and 15 (or equivalent spacing) to form these disulfide bridges, creating a stable inhibitory cysteine knot (ICK) motif. Key functional residues should be strategically positioned in loop regions to mediate high-affinity binding to the orthosteric site of target nAChRs, competitively blocking acetylcholine binding and inhibiting receptor activation. The toxin should exhibit specificity for α3β2 or α3β4 nAChR subtypes, with loop 2 containing critical hydrophobic and polar residues that interact with complementary receptor surfaces. The overall structure must be compact (12-20 amino acids), highly stable due to the disulfide cross-linking, and enriched in small and polar amino acids to facilitate solubility and precise molecular recognition. Ensure the sequence reflects the evolutionary optimization of cone snail venoms for rapid and selective neuronal targeting, resulting in a peptide that potently disrupts cholinergic signaling."}
{"description": "sp|Q3HTN1|VM3SA_TRIST Zinc metalloproteinase-disintegrin-like stejnihagin-A OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTTLPKGALQQNYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNEADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVFKYENVVKEDEAPKMCGVTETNWKSDEPIKKASQLVVTAEQQRFPRRYVKLAIVADRRMYMKHQKNLKPWVFQMVNSVHQIYRSMNVLIALVYLNIWKKNDKITVQSASDVTLDLFAEWRETVLLRRKKHDCAHLLTAIDFDGPTIGRAHIASMCNSKLSVGIVQNYTEINLVNAIVMAHELGHNLGISHDGNQCNCHTCIMSAVISNPPSERFSNCSEDYHQSFLTAYNPQCILNAPSKTDIITPPVCGNELLEEGEECDCGSPENCQYQCCDAASCKLHSWVKCESGECCDQCRFTSAGTECRAARSECDIAESCTGQSADCPTDDFHRNGQPCLSNHGYCYNGNCPVMHYQCIALFGSNAIVGQDECFDFNMKGEQYFYCRKEYEKYIPCAQEDVKCGRLFCFYTNNMDICRYNYSDIGIVDHGTKCADGKVCNSNRHCVDVTTVY", "prompt": "Design a novel snake venom metalloproteinase-disintegrin-like protein inspired by stejnihagin-A from Trimeresurus stejnegeri, the Chinese green tree viper. This protein should function as a potent hemorrhagic toxin that disrupts hemostasis through dual mechanisms: proteolytic degradation of basement membrane components in blood vessels via its zinc-dependent metalloproteinase domain, and inhibition of platelet aggregation through its disintegrin-like domain that antagonizes integrin receptors on platelet surfaces. The protein should adopt a modular multi-domain architecture characteristic of snake venom metalloproteinases (SVMPs), featuring a pro-domain, metalloproteinase domain with conserved zinc-binding motif (HEXXHXXGXXH), and disintegrin-like domain. The metalloproteinase domain should contain the catalytic zinc ion coordinated by three histidine residues and exhibit specificity for extracellular matrix proteins like collagen IV, fibronectin, and laminin. The disintegrin-like domain should display the characteristic RGD or related tripeptide motif for integrin binding, enabling interference with platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin. The protein should maintain the conserved cysteine pattern of P-III class SVMPs with multiple disulfide bridges stabilizing both domains, and exhibit the characteristic reprolysin family fold. The overall structure should facilitate hemorrhagic activity through synergistic action of proteolytic vessel wall degradation and anti-platelet effects, representing the typical biological strategy of viperid venoms to induce prey immobilization through blood loss and coagulation impairment."}
{"description": "sp|P80966|PA2A1_OPHHA Acidic phospholipase A2 1 OS=Ophiophagus hannah OX=8665 PE=1 SV=2", "sequence": "MNPAHLLVLSAVCVSLLGASSIPPQPLHLIQFGNMIQCTVPGFLSWIKYADYGCYCGAGGSGTPVDKLDRCCQVHDNCYTQAQKLPACSSIMDSPYVKIYSYDCSERTVTCKADNDECAAFICNCDRVAAHCFAASPYNNNNYNIDTTTRC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the king cobra (Ophiophagus hannah). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and potential myotoxicity. Incorporate the conserved structural features of group IA secretory phospholipase A2 enzymes, including the canonical pancreatic lipase fold with the characteristic calcium-binding loop (YXCGXGG motif), catalytic dyad (histidine-aspartate pair), and the interfacial binding surface for membrane association. Include the essential disulfide bridge pattern that stabilizes the compact globular structure, typically with 6-7 conserved cysteine residues forming specific cross-links. The sequence should reflect the acidic isoelectric point through appropriate amino acid composition while maintaining the amphipathic nature required for membrane interaction. Ensure the protein contains the conserved active site residues and the hydrophobic channel that accommodates the phospholipid substrate, with structural elements that facilitate both catalytic efficiency and target specificity characteristic of elapid snake venom phospholipases A2."}
{"description": "sp|A0A4P1LYC9|3SX9_DENPO Dendroaspis polylepis MT9 OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "TICHIQISKTHGILKTCEENSCYKMSVRGWIIGRGCGCPSAVRPRQVQCCTSDKCNY", "prompt": "Design a novel protein sequence for a muscarinic toxin (MT9) derived from the venom of the black mamba (Dendroaspis polylepis), a highly potent neurotoxin that selectively targets muscarinic acetylcholine receptors. This toxin functions as a competitive antagonist, binding with high affinity to specific muscarinic receptor subtypes to disrupt cholinergic signaling in the autonomic nervous system, leading to parasympathetic inhibition and potential cardiovascular effects. The protein should adopt a three-finger toxin (3FTx) structural fold, characterized by three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges with a Cys1-Cys3, Cys2-Cys5, Cys4-Cys6, Cys7-Cys8 connectivity pattern. Key structural elements include the central loop II, which typically contains the receptor-binding interface with critical residues for subtype selectivity and binding affinity. The sequence should maintain the characteristic three-finger topology with appropriate beta-sheet content and loop flexibility to enable specific receptor engagement while preserving the structural stability conferred by the conserved disulfide framework."}
{"description": "sp|Q3YED1|O163_CONMR Conotoxin MaIr193 OS=Conus marmoreus OX=42752 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTLVTADGTRDGLKNRFPKARLEMKNSEAPRSRGRCRPPGMVCGFPKPGPYCCSGWCFAVCLPV", "prompt": "Generate the amino acid sequence for a conotoxin from the marine cone snail Conus marmoreus, specifically the MaIr193 variant. This toxin belongs to the conotoxin family, which are small, disulfide-rich peptides that target ion channels and receptors in the nervous system. The protein should function as a neurotoxin, likely targeting specific neuronal receptors or ion channels to disrupt synaptic transmission, consistent with the hunting strategy of Conus marmoreus. The sequence must include a conserved cysteine framework, typically with multiple disulfide bridges forming a stable, compact structural scaffold, such as the inhibitor cystine knot (ICK) motif. The 3D structure should exhibit a globular fold stabilized by disulfide bonds, enabling precise molecular recognition and high-affinity binding to its target. The mechanism of action involves binding to and modulating the activity of its molecular target, leading to paralysis or neurological disruption in prey. Ensure the sequence reflects the characteristic features of conotoxins, including a signal peptide region, propeptide region, and mature toxin region with the appropriate cysteine pattern for disulfide bond formation."}
{"description": "sp|Q9DEF9|SLAA_DEIAC Snaclec anticoagulant protein subunit A OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVYLSLSGTAADCSSSWSSYEGHCYKAFKQSKTWADAESFCTKQVNGGHLVSIESSGEADFVAHLIAQKIKSAKIHVWIGLRAQNKEKQCSIEWSDGSSISYENWIEEESKKCLGVHKATGFRKWENFYCEQRDPFVCEA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the hundred-pace pit viper (Deinagkistrodon acutus) that functions as an anticoagulant toxin. This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The protein should form a heterodimeric complex with its partner subunit B, creating a functional anticoagulant unit. The mechanism of action involves specific binding to coagulation factors, particularly targeting the blood coagulation cascade to inhibit clot formation. The structural scaffold should feature the conserved β-sheet core and α-helices characteristic of CTLD proteins, with surface loops optimized for high-affinity interaction with its molecular targets in the coagulation pathway. The protein should exhibit the typical snaclec characteristics of being calcium-independent and functioning through protein-protein interactions rather than enzymatic activity."}
{"description": "sp|P0C173|KA161_HOTTA Potassium channel toxin alpha-KTx 16.1 OS=Hottentotta tamulus OX=34647 PE=1 SV=1", "sequence": "DLIDVKCISSQECWIACKKVTGRFEGKCQNRQCRCY", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. This toxin should originate from the venom of the Indian red scorpion Hottentotta tamulus, where it serves as a key neurotoxic component that disrupts neuronal excitability and neuromuscular transmission by inhibiting potassium efflux, leading to prolonged action potentials and excessive neurotransmitter release. The protein should adopt the conserved alpha-KTx structural scaffold characteristic of scorpion potassium channel toxins, featuring a compact, stable fold stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structure should include an alpha-helical domain and an anti-parallel beta-sheet region, forming a molecular surface with a functional dyad or triad of key residues (typically involving a lysine and aromatic residues) that directly interact with the pore region of Kv channels. The sequence must contain the cysteine framework common to alpha-KTx toxins and maintain the conserved structural motifs required for proper folding, stability in venom, and specific binding to potassium channels to exert its neurotoxic effects."}
{"description": "sp|Q7YXD3|SCX8_ANDMA Alpha-toxin Amm8 OS=Androctonus mauritanicus mauritanicus OX=6860 PE=1 SV=1", "sequence": "MNYLVMISLALLFMTGVESLKDGYIVNDINCTYFCGRNAYCNELCIKLKGESGYCQWASPYGNSCYCYKLPDHVRTKGPGRCNDR", "prompt": "Design a potent alpha-toxin from the North African scorpion Androctonus mauritanicus mauritanicus that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural scaffold of scorpion alpha-toxins, featuring a conserved core stabilized by four disulfide bridges with the cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. The protein should adopt a compact, globular fold consisting of an alpha-helix packed against an anti-parallel beta-sheet, typical of the CSαβ structural motif. The toxin should specifically target voltage-gated sodium channels in excitable membranes, binding to neurotoxin receptor site 3 and modifying channel gating kinetics by slowing inactivation, leading to prolonged neuronal depolarization and neurotoxic effects. Key functional residues should be strategically positioned in the conserved 'pharmacophore' regions to ensure high-affinity binding to the channel's voltage-sensing domain. The sequence should maintain the characteristic hydrophobic core and surface-exposed charged residues that mediate target recognition and membrane interaction, resulting in a stable, bioactive neurotoxin optimized for paralytic activity in scorpion venom."}
{"description": "sp|P0DJF6|VSPC_TRIAB Thrombin-like enzyme chitribrisin OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "MMLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLVVLFNSSGALCGGTLINQEYVLTAAHCDMPNMQILLGVHSASVLNDDEQARDPEEKYFCLSSNNDTKWDKDIMLIRLNRPVNNSVHIAPLTLPSSPPRLGAICRIMGWGAITSPNETYPDASQCANINILRYSLCQAVYRGMPAQSRIVCAGILRGGKGSCKGDSGGPLICNAQLQGIVSAGGDPCAQPRVPVLYIRVFDYTDWIQSIIEGNRTVTCPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of the white-lipped pit viper (Trimeresurus albolabris) that functions as a key component in prey immobilization through its fibrinogenolytic activity. This enzyme should exhibit selective proteolytic cleavage of fibrinogen, specifically targeting the Aα and Bβ chains to generate fibrin monomers while sparing the γ chain, thereby inducing defibrination and consumptive coagulopathy in prey. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) arranged in the canonical geometry for efficient substrate hydrolysis. Incorporate structural elements typical of snake venom thrombin-like enzymes, including multiple disulfide bridges that stabilize the compact globular structure and contribute to thermal stability in the venom environment. The enzyme should display substrate specificity distinct from mammalian thrombin, lacking the thrombomodulin-dependent protein C activation capacity and exhibiting delayed fibrin polymerization kinetics. Include appropriate surface loops and exosite regions that mediate fibrinogen recognition and binding, while maintaining the overall structural integrity required for venom storage and delivery. The final sequence should represent a functionally optimized toxin that contributes to the viper's predatory success through rapid induction of hypofibrinogenemia."}
{"description": "sp|P55902|SIX1_BUTOC Alpha-insect toxin BotIT1 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "VRDAYIAQNYNCVYFCMKDDYCNDLCTKNGASSGYCQWAGKYGNACWCYALPDNVPIRIPGKCHS", "prompt": "Design a novel alpha-insect toxin protein sequence inspired by BotIT1 from the scorpion Buthus occitanus tunetanus. This toxin should function as a potent insecticidal agent by selectively targeting and modulating insect voltage-gated sodium channels. The protein must adopt the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion alpha-toxins, featuring a conserved core alpha-helix packed against an antiparallel beta-sheet. The sequence should include the canonical disulfide bridge pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) that stabilizes this compact globular fold. Key structural elements must include a conserved 'pharmacophore' region responsible for receptor binding, likely involving specific loops that interact with domain IV of insect sodium channels to slow inactivation. The toxin should exhibit high specificity for insect over mammalian sodium channels, contributing to its role in the scorpion's predatory venom arsenal for immobilizing insect prey. Ensure the sequence maintains the overall compact size (~60-70 residues) and basic character common to this toxin family, with appropriate surface residues for solubility and stability in venom."}
{"description": "sp|C0HM79|PA2B1_AGKPL Basic phospholipase A2 (Fragment) OS=Agkistrodon piscivorus leucostoma OX=459671 PE=1 SV=1", "sequence": "NLFQFEKLIKKSGMLWYSAYGCYCGWGGQGRPKDATDRCCFVHDCCYGKVTGCNPKCGGTNPCKKQICECDRAAAICFRDNLKTYDSKTYWKYPK", "prompt": "Generate a protein sequence for a basic phospholipase A2 toxin from the venom of the western cottonmouth (Agkistrodon piscivorus leucostoma). This enzyme belongs to the snake venom group IIA phospholipase A2 family and functions as a potent toxin with multiple biological activities. The protein should exhibit calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids. This enzymatic activity leads to membrane disruption, inflammation, and potential neurotoxic, myotoxic, or anticoagulant effects. The structural scaffold should feature the characteristic phospholipase A2 fold with three long alpha-helices stabilized by seven conserved disulfide bonds in the pattern C11-C77, C27-C126, C44-C105, C51-C98, C61-C91, C84-C96, and C29-C45. Include the conserved calcium-binding loop (Tyr28, Gly30, Gly32, and Asp49) and catalytic residues (His48 and Asp99). The basic nature of this isoform suggests potential for enhanced membrane binding and myotoxic activity. The protein should maintain the hydrophobic substrate-binding channel and exhibit the characteristic interfacial activation mechanism when interacting with lipid membranes."}
{"description": "sp|C0HJE7|OXLA_CRODU L-amino acid oxidase bordonein-L OS=Crotalus durissus terrificus OX=8732 PE=1 SV=2", "sequence": "MNVFFMFSLLFLAALGSCAHDRNPLEECFRETDYEEFLEIARNGLTVTSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERVGGRVRTYRKKDWYANLGPMRLPTKHRIVREYIRKFGLQLNEFFQENENAWYFIKNIRKRVREVKNNPGILEYPVKPSEEGKSAAQLYVESLRKVVKELKRTNCKYILDKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFGYEKRFDEIVGGMDQLPTSMYEAIKEKVQVHFNARVIEIQQNDRETKVTYQTSANEMSSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCKRKFWEDDGIRGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHQLPKEDIQTFCRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPFKRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEF", "prompt": "Design a novel L-amino acid oxidase (LAAO) venom protein inspired by the biological context of the South American rattlesnake, Crotalus durissus terrificus. This enzyme should function as a key toxic component in the venom, contributing to prey immobilization and digestion through its oxidative activity. The protein must exhibit the characteristic flavin adenine dinucleotide (FAD) binding domain and catalyze the oxidative deamination of L-amino acids, generating hydrogen peroxide, ammonia, and the corresponding α-keto acid as reactive byproducts. The hydrogen peroxide produced should induce oxidative stress in target tissues, leading to apoptosis, platelet aggregation, and local tissue damage, which are hallmarks of LAAO toxicity. Structurally, the protein should adopt a conserved homodimeric fold typical of snake venom LAAOs, with each monomer comprising a FAD-binding domain, a substrate-binding domain, and a helical interface domain that facilitates dimerization. The active site must include key residues for FAD coordination and substrate recognition, ensuring specificity for L-amino acids. The overall architecture should feature a multi-domain arrangement that supports efficient electron transfer and oxidative catalysis, contributing to the venom's hemorrhagic and cytotoxic effects. The generated sequence must reflect these functional and structural attributes, enabling the protein to integrate into the venom's synergistic toxicity network."}
{"description": "sp|Q76CA0|NA2G3_STIGI Delta-stichotoxin-Sgt3a OS=Stichodactyla gigantea OX=230562 PE=1 SV=1", "sequence": "MAYLKIVLVALMLVVAVSAMRLSDQEDQDISVAKRAACKCDDDGPDIRSATLTGTVDLGSCNEGWEKCASFYTILADCCRRPRG", "prompt": "Design a protein sequence for a potent neurotoxin derived from the sea anemone Stichodactyla gigantea. This toxin belongs to the delta-stichotoxin family, specifically the Sgt3a isoform, which functions as a voltage-gated sodium channel (Nav) modulator. The protein should adopt the characteristic sea anemone toxin structural fold, featuring a compact beta-sandwich core stabilized by three conserved disulfide bridges with a C-C-C-C-C-C connectivity pattern. Key structural elements include a well-defined beta-hairpin loop that mediates interaction with the voltage-sensing domain (VSD) of Nav channels, particularly Nav1.1, Nav1.2, and Nav1.6 subtypes. The mechanism of action involves binding to site 3 on the channel, slowing inactivation kinetics and prolonging action potentials, leading to sustained neurotransmitter release and neuromuscular excitation. The toxin should exhibit high affinity for its target channels while maintaining the typical small, stable globular architecture (6-8 kDa) common to sea anemone neurotoxins, with surface-exposed residues critical for channel recognition and binding specificity."}
{"description": "sp|B3EWT6|TXC2A_CUPSA Cupiennin-2a OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "GFGTILKALAKIAGKVVKKLATKPGATYMLKENLK", "prompt": "Design a novel peptide toxin sequence inspired by the biological characteristics of Cupiennin-2a from the venom of the wandering spider Cupiennius salei. This peptide should function as a potent cytolytic and antimicrobial agent, primarily targeting bacterial membranes through a carpet-like mechanism of action. The sequence must adopt an amphipathic alpha-helical conformation when interacting with lipid bilayers, featuring a distinct segregation of hydrophobic and cationic residues along the helical face to facilitate membrane disruption. Key structural elements should include: a predominantly alpha-helical fold with minimal secondary structure in aqueous solution, a net positive charge optimized for interaction with anionic bacterial membranes, and appropriate length (approximately 25-35 residues) for efficient pore formation or membrane disintegration. The peptide should exhibit broad-spectrum antimicrobial activity while maintaining selectivity against eukaryotic cells through its specific membrane composition preference. Incorporate conserved motifs that enable the transition from soluble monomer to membrane-bound oligomer, facilitating the destabilization of lipid bilayers characteristic of this class of spider venom peptides."}
{"description": "sp|P0C6A7|VM27B_VIPBB Disintegrin VB7B OS=Vipera berus berus OX=31156 PE=1 SV=1", "sequence": "ELLQNSGNPCCDPVTCKPREGEHCISGPCCRNCKFKRAGTVCLDAKGDWMNNYCTGISSDCPRN", "prompt": "Design a novel disintegrin protein derived from the venom of the common European adder, Vipera berus berus. This toxin should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The protein should adopt the canonical disintegrin fold characterized by a compact, disulfide-rich structure with the characteristic cysteine framework that forms multiple intramolecular disulfide bonds stabilizing the RGD (Arg-Gly-Asp) motif in an exposed, bioactive loop conformation. This RGD motif should be positioned for optimal interaction with the ligand-binding site of integrins such as αIIbβ3 (glycoprotein IIb/IIIa) on platelets, preventing fibrinogen binding and thus inhibiting thrombus formation. The overall structure should be small (approximately 5-10 kDa), highly stable due to its disulfide network, and exhibit the typical disintegrin features of high affinity for integrin receptors and anti-adhesive properties. The protein should lack enzymatic activity and function purely as a receptor antagonist through its RGD-containing loop."}
{"description": "sp|Q7ZTA6|PA2AB_CROVV Acidic phospholipase A2 Cvv-E6b OS=Crotalus viridis viridis OX=8742 PE=1 SV=1", "sequence": "MRTLWILAVLLLGVEGNLVQFELLIMKVAKRSGLLSYSAYGCYCGWGGYGRPQDATDRCCFVHDCCYGKVTDCNPKTASYTYSEENGEIVCGGDDPCKKQVCECDRVAAICFRDNIPSYDNKYIQFPAKNCQEKPEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the prairie rattlesnake, Crotalus viridis viridis. This enzyme should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the toxin's local tissue damage, inflammation, and potential systemic effects characteristic of viperid snake envenomation. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate) within the conserved calcium-binding loop that coordinates a calcium ion cofactor required for enzymatic activity. As an acidic isoform, the sequence should reflect an overall negative charge distribution while maintaining the structural integrity necessary for membrane interaction and substrate binding. The protein should demonstrate stability under physiological conditions and exhibit the characteristic interfacial activation mechanism where catalytic efficiency increases upon binding to lipid membranes or interfaces."}
{"description": "sp|P86270|KA211_TITSE Potassium channel toxin alpha-KTx 21.1 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MQFSGVVLILISMTLVNFVFFETKVEAGKFGKCKPNICAKTCQTEKGKGMGYCNKTECVCSEW", "prompt": "Design a potassium channel toxin protein from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a short alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges with the characteristic C1-X(3-9)-C2-X(3-14)-C3-X(1-5)-C4 pattern. The molecular mechanism involves specific binding to the pore region or voltage-sensing domain of Kv1.x family potassium channels, leading to channel blockade and disruption of neuronal or muscular excitability. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes, contributing to the neurotoxic effects of Tityus serrulatus venom through impairment of action potential repolarization. Key structural elements should include a functional dyad or triad of residues responsible for channel recognition and binding, with appropriate surface charge distribution and hydrophobic patches for membrane interaction. The overall structure should be compact and stable, with the disulfide network providing structural rigidity essential for maintaining the bioactive conformation."}
{"description": "sp|P0C167|KAX14_CENLM Potassium channel toxin alpha-KTx 1.4 OS=Centruroides limbatus OX=244936 PE=1 SV=1", "sequence": "VFIDVSCSVSKECWAPCKAAVGTDRGKCMGKKCRCYX", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Centruroides limbatus, a scorpion species. This toxin should function as a potent and selective blocker of voltage-gated potassium channels (Kv channels), specifically targeting the Kv1 subfamily, which plays a critical role in neuronal excitability and neuromuscular transmission. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, with a disulfide bridge pattern of C1-C4, C2-C5, and C3-C6, stabilizing a compact globular structure comprising an alpha-helix packed against an antiparallel beta-sheet. Key functional residues should be positioned in the beta-sheet region to interact with the channel's pore domain, blocking potassium ion conduction by physically occluding the selectivity filter. The sequence should include a signal peptide for secretion, followed by a mature toxin of approximately 30-40 amino acids, rich in basic residues (e.g., lysine, arginine) to facilitate electrostatic interactions with the negatively charged channel vestibule. Ensure the toxin exhibits high affinity and specificity for Kv1 channels, contributing to the venom's neurotoxic effects by inducing hyperexcitability and paralysis in prey."}
{"description": "sp|P0DL68|CA1A_CONLM Alpha-conotoxin LsIA OS=Conus limpusi OX=1967283 PE=1 SV=1", "sequence": "SGCCSNPACRVNNPNIC", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus limpusi, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements for high-affinity binding to the nAChR orthosteric site, with appropriate loop regions between cysteine residues that determine receptor subtype selectivity. The mature toxin should be approximately 12-18 amino acids in length, exhibiting the typical alpha-conotoxin structural motif of short, constrained loops that create a precise molecular surface for receptor interaction. The design should prioritize structural stability through proper disulfide bridge formation while maintaining the biological activity profile characteristic of alpha-conotoxins from the Conus genus."}
{"description": "sp|P86271|KA20_TITSE Potassium channel toxin Ts16 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MHSSVFILILFSLAVINPIFFDMKVEAGCMKEYCAGQCRGKVSQDYCLKHCKCIPRFI", "prompt": "Design a potassium channel toxin from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The core structural motif consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a molecular surface with key functional residues that interact with the channel's pore region. The toxin should contain the conserved functional dyad comprising a critical lysine residue that penetrates the channel pore and a hydrophobic residue that stabilizes binding to the channel vestibule. The sequence should include the characteristic scorpion toxin signature with appropriate spacing of cysteine residues to form the stable CSαβ scaffold. The molecular mechanism involves high-affinity binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway and preventing potassium efflux, leading to prolonged membrane depolarization, enhanced neurotransmitter release, and ultimately causing paralysis in prey organisms."}
{"description": "sp|P00607|PA2H1_NOTSC Basic phospholipase A2 homolog 1 OS=Notechis scutatus scutatus OX=70142 PE=1 SV=1", "sequence": "NLVQFSNMIQCANHGSRPSLAYADYGCYCSAGGSGTPVDELDRCCKTHDDCYARATKSYSCTPYWTLYSWQCIEKTPTCDSKTGCQRFVCDCDATAAKCFAKAPYNKENYNIDPKKRCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the tiger snake (Notechis scutatus scutatus). This protein should function as a potent neurotoxin and myotoxin, exhibiting phospholipase A2 activity that catalyzes the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The mechanism involves calcium-dependent binding to membrane interfaces, leading to disruption of cellular membranes, neuromuscular blockade, and potential presynaptic neurotoxicity. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved catalytic triad (histidine, aspartate, and a water molecule coordinated by tyrosine), stabilized by multiple disulfide bridges (typically 6-7 conserved cysteine residues forming 3-4 disulfide bonds). The protein should adopt a compact, globular structure with distinct calcium-binding and membrane-interaction loops. Key domains include the N-terminal helix, the conserved active site pocket, and interfacial binding surfaces that facilitate membrane penetration. The molecular target includes neuronal and muscle cell membranes, with potential specificity for presynaptic terminals at neuromuscular junctions. The sequence should reflect the basic isoelectric point characteristic of this venom component, enhancing its interaction with anionic membrane surfaces."}
{"description": "sp|O93426|SLA_CRODU Snaclec convulxin subunit alpha OS=Crotalus durissus terrificus OX=8732 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVLFLSLSGTGAGLHCPSDWYYYDQHCYRIFNEEMNWEDAEWFCTKQAKGAHLVSIKSAKEADFVAWMVTQNIEESFSHVSIGLRVQNKEKQCSTKWSDGSSVSYDNLLDLYITKCSLLKKETGFRKWFVASCIGKIPFVCKFPPQC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet activator. This protein should be derived from the venom of Crotalus durissus terrificus (South American rattlesnake), where it serves as the alpha subunit of the convulxin complex, a key component responsible for the venom's procoagulant and thrombotic effects. The protein must function as a platelet glycoprotein VI (GPVI) agonist, specifically binding to and activating the GPVI receptor on platelet surfaces through its lectin domain, thereby triggering strong platelet aggregation and contributing to the venom's ability to induce systemic coagulopathy and convulsions. The sequence should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C-C-C-C cysteine framework pattern. The protein should exhibit the hallmark β-sandwich architecture composed of two antiparallel β-sheets, with key functional residues in the recognition loops that mediate specific GPVI binding. The structural scaffold should maintain the calcium-independent carbohydrate recognition domain typical of snake venom lectins, with conserved hydrophobic core packing and surface-exposed loops that determine target specificity. The protein should form a heterodimeric complex with the beta subunit through non-covalent interactions, creating the functional convulxin complex that exhibits significantly enhanced platelet activation potency compared to either subunit alone."}
{"description": "sp|P00984|VKTE_DENPO Kunitz-type serine protease inhibitor dendrotoxin E OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "LQHRTFCKLPAEPGPCKASIPAFYYNWAAKKCQLFHYGGCKGNANRFSTIEKCRHACVG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor dendrotoxin from the venom of the black mamba (Dendroaspis polylepis polylepis). This toxin functions as a potent potassium channel blocker that enhances neurotransmitter release at nerve terminals, leading to hyperexcitability and paralysis. The protein should adopt the characteristic Kunitz-type fold consisting of a compact globular domain stabilized by three conserved disulfide bridges with a C1-C6, C2-C4, C3-C5 connectivity pattern. The structure should feature a well-defined reactive site loop that mediates specific inhibition of serine proteases while maintaining high-affinity binding to voltage-gated potassium channels, particularly Kv1.1 and Kv1.2 subtypes. The sequence should include the canonical Kunitz domain architecture with appropriate secondary structure elements including beta-sheets and alpha-helices arranged in the typical inhibitor fold. The molecular surface should present key functional residues for both protease inhibition and channel blockade activities, with the reactive site loop positioned for optimal target engagement while maintaining the structural integrity required for venom stability and potency."}
{"description": "sp|P81165|PA2H2_CERGO Basic phospholipase A2 homolog GodMT-II OS=Cerrophidion godmani OX=44722 PE=1 SV=1", "sequence": "SMYQLWKMILQETGKNAVPSYGLYGCNCGVGSRGKPKDATDRCCFVHKCCYKKLTDCSPKTDSYSYSWKDKTIVCGDNNPCLQEMCECDKAVAICLRENLDTYNKNYKIYPKPLCKKADAC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog toxin from the Godmani montane pitviper (Cerrophidion godmani). This protein belongs to the phospholipase A2 (PLA2) toxin family but functions as a homolog with likely attenuated or altered enzymatic activity while retaining toxic properties characteristic of viperid venoms. The protein should adopt the canonical PLA2 structural fold characterized by three long alpha-helices stabilized by a conserved disulfide bridge pattern typically involving 6-8 cysteine residues forming 3-4 disulfide bonds. Key structural elements should include the conserved calcium-binding loop (essential for catalytic activity in true PLA2 enzymes), the interfacial binding surface for membrane interaction, and the characteristic pancreatic loop. As a basic PLA2 homolog, the protein may exhibit neurotoxic, myotoxic, or anticoagulant properties through mechanisms distinct from phospholipid hydrolysis, potentially involving direct receptor binding or membrane disruption. The sequence should reflect the evolutionary adaptation of this toxin for prey immobilization in pitviper venom, with appropriate surface charge distribution and molecular recognition features optimized for targeting specific physiological systems in prey organisms while maintaining the structural integrity of the PLA2 scaffold."}
{"description": "sp|P55927|KAX71_PANIM Potassium channel toxin alpha-KTx 7.1 (Fragment) OS=Pandinus imperator OX=55084 GN=PTX-1 PE=1 SV=2", "sequence": "RGSVDYKDDDDKTISCTNPKQCYPHCKKETGYPNAKCMNRKCKCFGR", "prompt": "Design a potassium channel toxin protein sequence based on the venom of the Emperor scorpion (Pandinus imperator). This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a short alpha-helix packed against an antiparallel beta-sheet. The cysteine framework should follow the pattern C-X(3-7)-C-X(3-7)-C-X(4-12)-C, forming two disulfide bridges that stabilize the core structure. Key functional residues should be positioned in the beta-sheet region to interact with the pore region of potassium channels, blocking ion conduction through direct occlusion. The toxin should exhibit high affinity and selectivity for Kv1 channels, contributing to the neurotoxic effects of scorpion venom by disrupting neuronal excitability and neurotransmitter release. The sequence should maintain the compact, globular architecture typical of scorpion toxins, with molecular weight around 3-4 kDa, and include conserved hydrophobic patches that facilitate membrane association and target recognition."}
{"description": "sp|P0DJJ4|VM3_NAJOX Zinc metalloproteinase oxiagin (Fragment) OS=Naja oxiana OX=8657 PE=1 SV=1", "sequence": "TNTPEQQCYLQAKCYIEFYVVV", "prompt": "Design a venom zinc metalloproteinase enzyme fragment that exhibits the characteristic proteolytic activity found in the venom of the Central Asian cobra, Naja oxiana. This toxin should function as a hemorrhagic agent by degrading key extracellular matrix components, particularly type IV collagen and other basement membrane proteins, leading to tissue damage and facilitating venom spread. The protein should adopt the canonical reprolysin-like metalloproteinase fold with the conserved zinc-binding motif HEXXHXXGXXH in the catalytic domain, where the three histidine residues coordinate the catalytic zinc ion and the glutamate serves as the catalytic base. The structure should feature the characteristic metzincin 'Met-turn' motif downstream of the active site that provides structural stability. Include appropriate cysteine residues to form disulfide bridges that stabilize the protein's tertiary structure against the harsh extracellular environment. The enzyme should display optimal activity at physiological pH and temperature, with specificity for cleavage sites that disrupt vascular integrity. Consider incorporating any potential exosite regions that might enhance substrate recognition while maintaining the compact, stable structure required for venom delivery and function."}
{"description": "sp|C0HJL8|PA2B_BOTNI Phospholipase A2 nigroviriditoxin basic subunit B OS=Bothriechis nigroviridis OX=88079 PE=1 SV=1", "sequence": "NLLQFNRMIKLETKKNAVPFYAFYGCYCGWGGQGQPKDATDRCCFEHDCCYGKLTKCNTKSDLYSYSSKYGFLLCGKGTWCEEQICECDRIAATCLRRSLDTYKLKYMFYLDSYCKGPSEKC", "prompt": "Generate a protein sequence for a phospholipase A2 toxin from the black-speckled palm-pitviper (Bothriechis nigroviridis) venom. This toxin functions as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release through its phospholipase A2 activity. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic triad (His/Asp/Tyr) essential for hydrolyzing the sn-2 ester bond of membrane phospholipids. Include the typical disulfide bridge pattern (6-7 conserved disulfide bonds) that stabilizes the compact, multi-stranded β-sheet structure with α-helical segments. The sequence should exhibit basic properties to facilitate membrane interaction and contain key residues for interfacial activation and substrate binding. As a component of the nigroviriditoxin complex, this subunit contributes to the heterodimeric assembly that enhances neurotoxic potency through synergistic action with the accompanying subunit."}
{"description": "sp|Q9DF56|PA2A_OPHHA Acidic phospholipase A2 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MNPAHLLVLSAVCVSLLGASSIPPQPLNLLQFNYMIQCTIPGSRPFLDYMDYGCYCGTGVAGHPVDELDRCCQTHDLCYSKAEEQPKCSSLLNSPLMKKYSYTCSGGTLTCNDDNDECGAFICNCDRAARICFAGAPYNKENKELDIATRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the king cobra (Ophiophagus hannah). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, ultimately disrupting cellular membranes and triggering inflammatory responses. Incorporate the conserved structural features of group I phospholipase A2 toxins, including the canonical pancreatic lipase fold with a conserved calcium-binding loop (YGKYCGxxxxGC motif) and catalytic dyad (histidine and aspartate residues). Include the characteristic disulfide bond pattern that stabilizes the globular structure, with conserved cysteine residues forming bridges that maintain the active site geometry. The sequence should reflect the acidic isoelectric point typical of neurotoxic PLA2 variants from elapid snakes, with surface charge distribution optimized for membrane interaction and target specificity. Ensure the protein adopts the stable, compact beta-sheet-rich structure with the hydrophobic substrate-binding channel and interfacial activation surface required for efficient membrane penetration and phospholipid hydrolysis."}
{"description": "sp|O93427|SLB_CRODU Snaclec convulxin subunit beta OS=Crotalus durissus terrificus OX=8732 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGSEAGFCCPSHWSSYDRYCYKVFKQEMTWADAEKFCTQQHTGSHLVSFHSTEEVDFVVKMTHQSLKSTFFWIGANNIWNKCNWQWSDGTKPEYKEWHEEFECLISRTFDNQWLSAPCSDTYSFVCKFEA", "prompt": "Design a protein sequence for a snake venom C-type lectin (snaclec) that functions as the beta subunit of convulxin, a potent platelet-activating complex from the South American rattlesnake Crotalus durissus terrificus. This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The protein must form a heterodimeric complex with the alpha subunit through non-covalent interactions, creating the functional convulxin complex that specifically binds to platelet glycoprotein VI (GPVI) receptors. The binding interface should contain key residues for recognizing GPVI, triggering strong platelet activation and aggregation through collagen receptor signaling pathways. The sequence should maintain the conserved structural features of snake venom C-type lectins while encoding the specific molecular recognition properties that make convulxin one of the most potent platelet-activating compounds in viperid venoms, contributing to the procoagulant and thrombotic effects characteristic of this rattlesnake's venom."}
{"description": "sp|P0DQY1|CA1B_CONOB Alpha-conotoxin OIB OS=Conus obscurus OX=89447 PE=1 SV=1", "sequence": "ICCNPACGPKYSC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus obscurus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic globular disulfide-stabilized fold of alpha-conotoxins, featuring the conserved CC-C-C cysteine framework with disulfide connectivity between Cys1-Cys3 and Cys2-Cys4. Incorporate key structural motifs including a beta-hairpin loop stabilized by the disulfide bonds, which forms the primary receptor-binding interface. The sequence should include conserved residues critical for nAChR binding specificity and potency, while maintaining the compact 12-18 amino acid length typical of this toxin family. Ensure the peptide exhibits high affinity for its target nAChR subtype through precise loop length optimization and strategic placement of pharmacologically important residues that mediate receptor interaction and blockade. The resulting toxin should demonstrate the characteristic paralytic activity of alpha-conotoxins through competitive inhibition of acetylcholine binding at the receptor orthosteric site."}
{"description": "sp|P69750|O16A_CONCN Delta-conotoxin-like CnVIA OS=Conus consors OX=101297 PE=2 SV=2", "sequence": "MKLTCMMIVAVLFLTAWTFVTADDSRNGLENLSPKARHEMKNPEASKSNKRYECYSTGTFCGINGGLCCSNLCLFFVCLTFS", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a delta-conotoxin-like peptide derived from the venom of Conus consors, a marine cone snail species. This toxin belongs to the conotoxin superfamily, which are small, disulfide-rich peptides that target ion channels and receptors in the nervous system. The biological significance of this venom component lies in its role in prey immobilization through disruption of neuronal signaling, specifically by targeting voltage-gated sodium channels. The core function of this delta-conotoxin-like peptide is to act as a gating modifier toxin, inhibiting the inactivation of voltage-gated sodium channels, leading to prolonged depolarization and hyperexcitability in neurons. The mechanism of action involves binding to site 6 on the voltage-gated sodium channel, stabilizing the open state and preventing normal channel closure. The protein is expected to adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, globular fold stabilized by three disulfide bridges forming a knotted topology. The cysteine framework is inferred to be C-C-CC-C-C (framework VI), with disulfide connectivity of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, creating a stable scaffold resistant to proteolytic degradation. The molecular target is the voltage-gated sodium channel, with binding likely occurring at the extracellular S3-S4 linker region of domain IV, interfering with the voltage-sensing mechanism. The protein should exhibit high affinity and selectivity for specific sodium channel subtypes, contributing to its potent neurotoxic effects. The sequence must include conserved residues critical for structural integrity and target interaction, while maintaining the characteristic small size and disulfide-stabilized architecture typical of conotoxins."}
{"description": "sp|Q3SAE9|VNPA_TROCA Natriuretic peptide TcNPa (Fragment) OS=Tropidechis carinatus OX=100989 PE=1 SV=1", "sequence": "SGSETAKIGDGCFGLPIDRIGSASGMGCGSVPKPTPGGS", "prompt": "Design a natriuretic peptide toxin derived from the rough-scaled snake (Tropidechis carinatus), a highly venomous Australian elapid. This toxin, TcNPa, functions as a potent vasoactive peptide that mimics endogenous natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A). The mechanism involves binding to the extracellular domain of NPR-A, activating particulate guanylyl cyclase to increase intracellular cGMP levels, resulting in vasodilation, natriuresis, diuresis, and inhibition of the renin-angiotensin-aldosterone system. Structurally, it should feature the characteristic 17-amino acid ring structure formed by a disulfide bond between two conserved cysteine residues, creating the essential cyclic domain required for receptor binding and biological activity. The peptide should exhibit the conserved FDR/I sequence motif critical for receptor recognition and possess an amphipathic character with both hydrophobic and hydrophilic regions. The N-terminal and C-terminal regions should flank the central cyclic domain, with the C-terminal tail likely contributing to stability and receptor interaction specificity. This toxin represents an evolutionary adaptation where venom components hijack endogenous regulatory pathways to induce cardiovascular collapse in prey."}
{"description": "sp|C0JAQ5|A1IA1_LOXHI Dermonecrotic toxin LhSicTox-alphaIA2ai (Fragment) OS=Loxosceles hirsuta OX=571525 PE=2 SV=1", "sequence": "WIMGHMVNAIYQIDEFVNLGANSIETDVSFDDNANPEYTYHGIPCDCGRSCLKWENYNDFLKGLRSATTPGNSKYQSKLILVVFDLKTGSLYDNQASEAGKKLAKNLLKHYWNNGNNGGRAYIVLSIPDLNHYPLIKGFTDTLKQEGHPELLEKVGYDFSGNDAVGDVAKAYKKAGVSGHVWQSDGITNCLLRGLTRVKEAVANRDSGNGYINKVYYWTVDKRATTRDALDAGVDGVMTNYPDVIADVMNEAAYKNKVRLATYEDSPWVTFKK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles hirsuta. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, endothelial cell damage, platelet aggregation, and complement activation, ultimately leading to characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold characteristic of the phospholipase D superfamily, with the active site containing the conserved HKD motifs that coordinate catalytic magnesium ions. The sequence should include the essential histidine and aspartate residues responsible for phosphodiesterase activity, along with appropriate structural elements for membrane interaction and substrate recognition. The toxin should exhibit specificity for mammalian cell membranes while maintaining structural stability through proper hydrophobic core packing and potential disulfide bonding patterns consistent with spider venom toxins."}
{"description": "sp|P0C6B4|DIDLA_ECHCA Disintegrin schistatin-like subunit A OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "SVNPCCDPVICKPRDGEHCISGPCCNNCKFLNSGTICQRARGDGNHDYCTGITTDCPRNRYN", "prompt": "Design a protein sequence for a disintegrin toxin derived from the venom of the saw-scaled viper, Echis carinatus. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The disintegrin should adopt the characteristic disintegrin fold, featuring the RGD (Arg-Gly-Asp) motif or a related tripeptide motif that mediates high-affinity binding to integrins such as αIIbβ3 (GPIIb/IIIa) on platelets, thereby preventing fibrinogen binding and thrombus formation. The sequence should include a conserved cysteine framework with multiple disulfide bonds that stabilize the compact, globular structure typical of disintegrins, ensuring proper folding and biological activity. The protein should exhibit high specificity for its integrin targets, contributing to the hemorrhagic effects of the venom by disrupting hemostasis. The structural scaffold should be robust, with disulfide connectivity that confers stability in the venom and upon delivery to the prey or victim, aligning with the toxin's role in predation and defense."}
{"description": "sp|Q7Z1K9|SCX3_CENLI Toxin Cll3 OS=Centruroides limpidus OX=6876 PE=2 SV=1", "sequence": "MNSLLMITACLAVIGTVWAKEGYIVNYYDGCKYACLKLGENDYCLRECKARYYKSAGGYCYAFACWCTHLYEQAVVWPLPNKTCYGK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Centruroides limpidus, a scorpion species known for producing potent neurotoxins that target voltage-gated ion channels. This toxin belongs to the beta-toxin family, specifically targeting sodium channels (Nav) and functioning as a gating modifier. The core mechanism involves binding to site 4 of voltage-gated sodium channels, thereby altering channel activation kinetics and delaying inactivation, which leads to prolonged neuronal excitation and neurotoxic effects. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by a specific disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in beta-toxins). Key functional residues should include a hydrophobic patch involved in channel interaction and basic residues critical for binding to the channel's voltage-sensing domain. The protein should be compact, with a molecular weight around 6-8 kDa, and exhibit high stability due to the disulfide framework. Ensure the sequence reflects the typical length and residue conservation patterns of scorpion beta-toxins, with appropriate surface loops for target engagement."}
{"description": "sp|Q76CA3|NA1G2_STIGI Delta-stichotoxin-Sgt2a OS=Stichodactyla gigantea OX=230562 PE=1 SV=1", "sequence": "MNRLIILVFAAVFLTLASAEVSEDVNMAKRGVPCRCDSDGPHVRGNTLTGTVWVFGCPSGWHKCQKGSSTCCKQ", "prompt": "Design a novel animal toxin protein sequence inspired by delta-stichotoxin-Sgt2a from the giant Caribbean sea anemone Stichodactyla gigantea. This toxin should function as a potent pore-forming cytolysin that targets cell membranes, characteristic of actinoporins found in sea anemone venom. The protein must adopt the beta-sandwich fold typical of actinoporins, consisting of a core beta-barrel structure flanked by alpha-helices that facilitate membrane insertion. Incorporate the conserved phospholipase A2-like structural motif despite lacking enzymatic activity, which enhances membrane binding and disruption. Include the characteristic tryptophan-rich membrane-binding region that interacts with lipid bilayers and sphingomyelin-rich domains. The sequence should contain the appropriate cysteine framework for disulfide bond formation to stabilize the beta-sandwich scaffold, ensuring proper folding and thermostability. The toxin should demonstrate hemolytic activity through formation of cation-selective pores in eukaryotic cell membranes, leading to osmotic lysis. Maintain the amphipathic character required for both water solubility and membrane insertion capability. The final protein should exhibit the biophysical properties necessary for venom deployment, including resistance to proteolytic degradation and thermal stability in marine environments."}
{"description": "sp|P69752|O16B_CONER Delta-conotoxin-like EVIB OS=Conus ermineus OX=55423 PE=1 SV=1", "sequence": "EACYPPGTFCGIKPGLCCSELCLPAVCVG", "prompt": "Generate a protein sequence for a delta-conotoxin-like peptide from the venom of the marine cone snail Conus ermineus. This toxin belongs to the conotoxin superfamily and is expected to function as a voltage-gated sodium channel modulator, specifically acting as a sodium channel inhibitor that delays channel inactivation, thereby prolonging action potentials and enhancing neurotransmitter release. The peptide should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized globular fold with triple-stranded beta-sheets. It should feature the conserved O1-superfamily cysteine framework (C-C-CC-C-C), forming three disulfide bridges that confer exceptional stability and define the core scaffold. The molecular target is likely neuronal or skeletal muscle voltage-gated sodium channels, with key functional residues positioned in flexible loops to mediate high-affinity binding and subtype selectivity. The sequence must reflect the venom's role in prey immobilization through neuromuscular disruption, with precise loop lengths and pharmacophore residues optimized for target engagement. Ensure the sequence is synthetically feasible, maintains the canonical conotoxin fold, and exhibits potent bioactivity consistent with delta-conotoxin mechanisms."}
{"description": "sp|B3EWU9|TXC5A_CUPSA Cupiennin-5a OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "KFGKVLKFLAKTLAKHLAKKQAQS", "prompt": "Design a novel peptide toxin sequence inspired by the biological profile of Cupiennin-5a from the venom of the wandering spider Cupiennius salei. This peptide should function as a potent cytolytic and antimicrobial agent, characteristic of the cupiennin family. The sequence must adopt an amphipathic alpha-helical structure when interacting with lipid membranes, enabling its primary mechanism of action: non-receptor-mediated disruption of cell membranes through pore formation. This membrane-permeabilizing activity underlies its broad-spectrum antibacterial effects against both Gram-positive and Gram-negative bacteria, as well as its hemolytic and cytotoxic properties. The peptide should exhibit the typical physicochemical features of cupiennins, including a net positive charge to facilitate initial electrostatic interactions with negatively charged microbial membranes, and a balanced hydrophobic moment for optimal insertion into lipid bilayers. The structural scaffold should be predominantly alpha-helical with the capacity for membrane-induced conformational changes, allowing for the formation of transmembrane pores that lead to rapid cell lysis. The design should prioritize the characteristic membrane-targeting mechanism of cupiennins, which distinguishes them from receptor-targeting neurotoxins and makes them effective against diverse microbial pathogens through physical disruption of membrane integrity."}
{"description": "sp|P0DQH1|TXF1A_ETHRU U-scoloptoxin(15)-Er1a OS=Ethmostigmus rubripes OX=62613 PE=3 SV=1", "sequence": "MQNKGVVLTLFLVVSMAIVISSTKEKRAVIQKKYVDFKDRKYPWKEECFETCARTFTNGDQSKVSEVVPDYFKCICYVLI", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a U-scoloptoxin derived from the venom of Ethmostigmus rubripes, commonly known as the giant centipede. This toxin belongs to the scoloptoxin family, which are key components in centipede venom that facilitate prey capture through potent neurotoxic activity. The core function of this toxin is to disrupt neuronal signaling by targeting voltage-gated ion channels, likely potassium channels (Kv) or sodium channels (Nav), leading to paralysis in prey organisms. The mechanism involves high-affinity binding to specific extracellular domains of these ion channels, inhibiting or modulating their gating properties and thereby blocking action potential propagation. Structurally, the protein is anticipated to adopt a compact, globular fold stabilized by multiple disulfide bridges, characteristic of the scoloptoxin family. The cysteine framework is inferred to follow a conserved pattern, such as C-C-CC-C-C or similar, forming a rigid scaffold that defines the inhibitory cysteine knot (ICK) motif. This motif contributes to exceptional stability against proteolytic degradation and thermal denaturation, which is essential for venom efficacy. Key structural elements include short loops between cysteine residues that form the molecular surface for target interaction, with specific residues in these loops critical for binding specificity and potency. The molecular target is likely voltage-gated potassium channels (e.g., Kv1.x subtypes) or sodium channels in insect or small vertebrate nervous systems, with binding occurring at the channel pore or voltage-sensing domains to alter ion conductance. The biological significance lies in its role in the venom of Ethmostigmus rubripes, where it synergizes with other toxins to induce rapid immobilization of prey, highlighting its evolutionary adaptation for predation. Generate a protein sequence that embodies these functional and structural attributes, ensuring it includes the inferred disulfide connectivity, ICK fold, and target-binding residues for neurotoxic activity."}
{"description": "sp|P00985|VKT2_HEMHA Kunitz-type serine protease inhibitor 2 OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "RPDFCELPAETGLCKAYIRSFHYNLAAQQCLQFIYGGCGGNANRFKTIDECRRTCVG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the rinkhals cobra (Hemachatus haemachatus). This toxin functions as a potent serine protease inhibitor, likely targeting key proteases involved in hemostasis and inflammation pathways. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The active site should contain a canonical protease-binding loop with residues optimized for specific, high-affinity inhibition of serine proteases such as trypsin, chymotrypsin, or coagulation factors. The sequence must include the conserved Kunitz motif and maintain the structural integrity required for protease binding and inhibition, contributing to the venom's role in prey immobilization and defense through disruption of proteolytic cascades."}
{"description": "sp|P86297|TLP15_PHONI Tachykinin-like peptide-XV OS=Phoneutria nigriventer OX=6918 PE=1 SV=1", "sequence": "QKKDKKDRFPNGLV", "prompt": "Design a novel tachykinin-like peptide toxin derived from the venom of the armed spider Phoneutria nigriventer, a medically significant species known for producing neurotoxic components that target the mammalian nervous system. This peptide should function as a potent modulator of tachykinin receptors, particularly neurokinin-1 (NK1) and/or neurokinin-2 (NK2) receptors, which are G-protein coupled receptors involved in pain transmission, neurogenic inflammation, and smooth muscle contraction. The mechanism of action should involve competitive or allosteric modulation of these receptors, potentially leading to hyperexcitability or dysregulation of nociceptive pathways. The peptide must adopt a compact, disulfide-stabilized structure typical of spider venom peptides, likely featuring an inhibitor cystine knot (ICK) motif with a conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges, creating a rigid, triple-stranded beta-sheet fold resistant to proteolytic degradation. Key structural elements should include a solvent-exposed pharmacophore region containing critical residues for receptor interaction, such as a C-terminal amidation motif and conserved hydrophobic or charged residues involved in binding to the extracellular domains of tachykinin receptors. The sequence should exhibit high affinity and selectivity for tachykinin receptors over other neuropeptide receptors, with potential implications for understanding pain pathways or developing novel analgesic agents."}
{"description": "sp|P00595|PA2B1_HEMHA Basic phospholipase A2 DE-1 OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "NLYQFKNMIKCTVPSRSWWHFANYGCYCGRGGSGTPVDDLDRCCQTHDNCYSDAEKISGCRPYFKTYSYDCTKGKLTCKEGNNECAAFVCKCDRLAAICFAGAHYNDNNNYIDLARHCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the ringhals cobra (Hemachatus haemachatus). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein must exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, ultimately disrupting synaptic vesicle recycling and causing flaccid paralysis. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and a catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact, multi-looped globular structure. The sequence should contain basic residues that facilitate membrane association and contribute to the neurotoxic potency through interactions with presynaptic membranes. The overall architecture should maintain the characteristic three long alpha-helices and two antiparallel beta-sheets that define the phospholipase A2 superfamily."}
{"description": "sp|P0DJL1|SLB_TRIAB Snaclec alboluxin subunit beta (Fragment) OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "NFSCPPDWYAYD", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This toxin originates from the white-lipped pit viper (Trimeresurus albolabris), where it contributes to the venom's hemorrhagic and anticoagulant properties by disrupting normal hemostasis. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by conserved disulfide bridges. The core scaffold should feature the typical snaclec cysteine framework with specific disulfide connectivity that maintains structural integrity. The molecular mechanism involves binding to platelet surface receptors, particularly glycoprotein receptors involved in platelet adhesion and aggregation pathways, effectively blocking platelet activation and aggregation. The protein should exhibit high specificity for its platelet targets while maintaining the characteristic beta-sheet rich structure with alpha-helical elements that define the CTLD fold. The binding interface should contain key residues for receptor recognition and inhibition, contributing to the venom's prey immobilization strategy through disruption of blood coagulation."}
{"description": "sp|Q3HTN2|VM3SB_TRIST Zinc metalloproteinase-disintegrin-like stejnihagin-B OS=Trimeresurus stejnegeri OX=39682 PE=2 SV=1", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTAVPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKELFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNEADSTASISACNGLKGHFKLQGETYLIEPLKLPDSEAHAVFKYENVEKEEEAPKMCGVTETNWKSDEPIKKASQLVVTAEQQRFPRRYVKLAIVADHRMYTKHKKNLKPWVFQMVNSVHQIYRSMNVLIALVYLNIWKKNDKITAQSASNVTLDLFGNWRETVLLKRKRHDCAQLLTAIDFDGPTIGRAHVSSVCDPKRSTGIVQNYTEINLVNAVIMAHELGHNLGMDHDGNQCNCHACIMSAVINNPPSERFSGCSMGYYQTFLTAYNPQCILNALSKRDIITPPVCGNELLEEGEECDCGSPENCQYQCCNATTCKLHSWVECESGECCEQCRFKKAGAVCRAARTECDIPENCTDQSADCPTDSFHRNGQPCLYNHGYCYNGNCPVMHYQCYGLFGPNATVGQDGCFDANDRGDEYFYCRKENEKYIPCAQEDVKCGRLFCTYIYDINLCRYDYSANGMVAQGTKCADGKVCNSNRQCADVNTAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from the venom of Trimeresurus stejnegeri, a pit viper species. This protein should exhibit the characteristic dual functionality of SVMP (snake venom metalloproteinase) toxins: (1) A metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH, which enables proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin, contributing to tissue damage and hemorrhage. (2) A disintegrin-like domain that mimics the structure of endogenous disintegrins, featuring the canonical RGD or related integrin-binding motif that specifically targets platelet integrin receptors (particularly αIIbβ3 and αvβ3), thereby inhibiting platelet aggregation and promoting anticoagulant effects. The protein should adopt the multi-domain architecture typical of SVMPs, with the metalloproteinase domain exhibiting the metzincin fold characterized by a conserved methionine turn and the disintegrin-like domain maintaining the disulfide-rich, compact structure that enables high-affinity integrin binding. The cysteine framework should support the formation of multiple disulfide bridges that stabilize both domains, with the disintegrin-like domain typically containing 4-6 conserved cysteine residues forming specific disulfide connectivity patterns. This toxin contributes to the overall hemorrhagic and anticoagulant properties of Trimeresurus venom by simultaneously degrading vascular basement membranes and preventing clot formation, facilitating prey immobilization through blood loss and circulatory disruption."}
{"description": "sp|A0A7S8MU59|SCX18_TITSE Putative sodium channel toxin Ts18 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MNFRFPFLLMITISLIGAVLTFGNDVRPRNQYGNEIFCPHQGFNQKCNAICKRKKYLLGFCDQKTCLCKVRP", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to induce hyperexcitability and prolonged action potentials. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with distinct functional regions: a conserved 'core' domain responsible for structural stability and a 'pharmacophore' region containing key residues for sodium channel interaction. The toxin should specifically bind to site 3 of voltage-gated sodium channels, delaying fast inactivation through allosteric modulation of the channel's voltage-sensing domain IV. Key functional residues should be strategically positioned to interact with the S3-S4 loop of domain IV, stabilizing the activated state of the voltage sensor and preventing normal channel closure. The molecular surface should feature both hydrophobic patches for membrane association and charged residues for specific recognition of sodium channel extracellular loops. The overall structure should exhibit high thermal and proteolytic stability typical of scorpion venom peptides, with molecular weight approximately 6-8 kDa and basic isoelectric point to facilitate interaction with negatively charged channel surfaces."}
{"description": "sp|D2Y2F2|H10B1_CYRHA Hainantoxin-X-2 OS=Cyriopagopus hainanus OX=209901 PE=2 SV=1", "sequence": "MKTAIFTVVLALAVFAVLCLVVSTHAERHSKTDMEDSPMIQERKGLPPGKPCYGATQKIPCCGVCSHNNCT", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the venom of Cyriopagopus hainanus (a tarantula species), specifically representing a hainantoxin. This toxin should function as a potent voltage-gated sodium channel modulator, likely exhibiting inhibitory activity that disrupts neuronal signaling by binding to site 4 of domain II of the channel, thereby impeding action potential propagation. The structural scaffold should feature the inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in a C-C-CC-C-C framework). The sequence should include key residues for target interaction, such as a hydrophobic patch for membrane association and basic residues for channel binding, while maintaining the ICK fold's stability and specificity. The overall length should be approximately 30-40 amino acids, with the cysteine framework ensuring proper knot formation and functional integrity. The toxin should reflect the evolutionary adaptation of spider venoms for prey immobilization through sodium channel blockade."}
{"description": "sp|P55966|CTXL8_LEIHE Toxin Lqh 8/6 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "RCSPCFTTDQQMTKKCYDCCGGKGKGKCYGPQCICAPY", "prompt": "Design a novel animal toxin protein sequence inspired by the biological characteristics of Toxin Lqh 8/6 from the deathstalker scorpion Leiurus hebraeus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically exhibiting activity on insect sodium channels to facilitate prey immobilization. The protein should adopt the conserved structural scaffold typical of scorpion beta-toxins, characterized by a compact globular fold stabilized by four disulfide bridges with a cysteine framework pattern of C-C-CC-C-C. The core structure should feature an inhibitor cystine knot (ICK) motif that provides exceptional thermal and proteolytic stability. Key structural elements should include a conserved hydrophobic patch for membrane interaction and a functional surface containing critical residues for specific receptor binding and channel modulation. The toxin should demonstrate selective affinity for insect sodium channels while maintaining the characteristic delayed inactivation mechanism of beta-toxins. The sequence should preserve the essential pharmacophore regions responsible for target recognition while incorporating natural variation observed within the scorpion toxin family. The final protein should exhibit the typical molecular weight range of 6-8 kDa and maintain the overall charge distribution pattern that facilitates proper folding and biological activity."}
{"description": "sp|P55963|CA4A_CONPU Alpha-conotoxin PIVA OS=Conus purpurascens OX=41690 PE=1 SV=2", "sequence": "MFTVFLLVVLATTVVSFTSDRASDDRNTNDKASRLLSHVVRGCCGSYPNAACHPCSCKDRPSYCGQGR", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus purpurascens, the magician's cone snail, known for its potent neurotoxic venom used for rapid prey immobilization. This toxin should function as a selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuromuscular subtypes to induce paralysis through competitive inhibition of acetylcholine binding. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-stabilized fold, featuring the conserved CC-C-C cysteine framework where disulfide bridges connect Cys1-Cys3 and Cys2-Cys4 to form a compact, stable core. The sequence should include the signature two-loop architecture common to alpha-conotoxins, with Loop1 typically containing 4 residues and Loop2 containing 7 residues, though these can be optimized for enhanced receptor specificity. Key structural elements should include a well-defined beta-hairpin motif stabilized by the disulfide network, creating a rigid molecular surface for precise receptor interaction. The molecular target interface should feature complementary electrostatic and hydrophobic patches that enable high-affinity binding to the alpha-delta subunit interface of muscle-type nAChRs, with specific residues in both loops contributing to target recognition and binding affinity. The overall structure should exhibit the characteristic alpha-conotoxin pharmacophore with appropriate spatial arrangement of functional groups for optimal receptor blockade while maintaining the thermal stability and protease resistance typical of conotoxin scaffolds."}
{"description": "sp|Q802B2|3NO2A_NAJSP Weak neurotoxin 10 OS=Naja sputatrix OX=33626 GN=WNTX10 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCLNCPEVFCKKFQTCRNGEKICFKKFDERKLFGKRYRRGCAATCPEAKPREIVQCCSTDRCNR", "prompt": "Design a protein sequence for a weak neurotoxin from the venom of the cobra species Naja sputatrix. This toxin belongs to the three-finger toxin superfamily and functions as a weak neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger β-sandwich fold stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming the core structural scaffold. The toxin should exhibit weak antagonistic activity against muscle-type nicotinic acetylcholine receptors, potentially through competitive or allosteric modulation, leading to mild neuromuscular blockade without the potent lethality of strong neurotoxins. The sequence should include key functional loops responsible for receptor interaction, with conserved hydrophobic and cationic residues in loop regions that mediate target recognition. The structural integrity should be maintained by the disulfide-stabilized β-sheet arrangement typical of three-finger toxins, ensuring proper folding and functional specificity for weak neurotoxic activity in snake venom."}
{"description": "sp|Q805A2|PA2BN_PROFL Basic phospholipase A2 PLA-N OS=Protobothrops flavoviridis OX=88087 PE=1 SV=2", "sequence": "MRTLWIMAVLLVGVEGNLLQFNKMIKIMTKKNGFPFYTSYGCYCGWGGRGKPKDATDRCCFVHDCCYEKLTDCSPKSDIYSYSWKTGVIICGEGTECEKQICECDRAAAVCFGQNLRTYKKKYMFYPDFLCTDPTEKC", "prompt": "Design a basic phospholipase A2 (PLA2) toxin from the venom of Protobothrops flavoviridis, the habu snake. This enzyme should function as a potent toxin with multiple pathophysiological effects, primarily through hydrolysis of membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids, including arachidonic acid that can be metabolized to inflammatory mediators. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the signature YGCXCG motif. Include the essential catalytic dyad of histidine and aspartate residues within the active site. As a basic PLA2, the protein should exhibit net positive charge that enhances membrane interaction and may contribute to presynaptic neurotoxicity through binding to specific receptors. The structure should be stabilized by the conserved disulfide bond pattern typical of group II snake venom PLA2s, with 6-7 disulfide bridges maintaining the compact, stable scaffold. The toxin should demonstrate both enzymatic activity and potential receptor-mediated effects, contributing to local tissue damage, inflammation, and systemic toxicity characteristic of viperid snake venoms."}
{"description": "sp|P0DM15|CO6A_CONMF MuO-conotoxin MfVIA OS=Conus magnificus OX=257332 PE=1 SV=1", "sequence": "RDCQEKWEYCIVPILGFVYCCPGLICGPFVCV", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications: This protein is a muO-conotoxin from the marine cone snail Conus magnificus, a predatory species that employs venom for prey capture and defense. As a member of the muO-conotoxin family, this peptide functions as a potent voltage-gated sodium channel (NaV) antagonist, specifically targeting tetrodotoxin-sensitive sodium channels in the peripheral nervous system. The toxin operates by binding to site 1 of NaV channels, which inhibits channel activation and prevents action potential propagation, leading to paralysis in prey organisms. Structurally, this conotoxin is expected to adopt the inhibitor cystine knot (ICK) motif, a stable triple-stranded beta-sheet fold stabilized by three disulfide bonds. The cysteine framework is inferred to be C-C-CC-C-C, with disulfide connectivity pattern I-IV, II-V, III-VI, contributing to its compact globular structure and resistance to proteolytic degradation. Key structural elements include well-defined beta-hairpins and a conserved hydrophobic core that facilitates target interaction. The molecular target interface involves specific loops that engage with the pore-forming region of NaV channels, particularly interacting with domain II S5-S6 segments to occlude ion permeation. The sequence should reflect these functional and structural characteristics while maintaining the pharmacological profile of a selective sodium channel blocker."}
{"description": "sp|P81383|OXLA_OPHHA L-amino-acid oxidase OS=Ophiophagus hannah OX=8665 PE=1 SV=3", "sequence": "MNDFLLLLLVLFLGVPRSENHVINLEECFQEPEYENWLATASHGLTKTLNPKKIVIVGAGISGLTAAKLFREAGHEVVILEASDRVGGRIKTHREDGWYVDVGPMRVPQTHRIVREYIKKFNISLNPFRQTDENAWYLIKHVRQKMSANNPENFGYQLNPNERGKSASQLFDETLDKVTDDCTLQKEKYDSFSTKEYLIKEGKLSTGAVEMIGDFLNEEAGFHNSFLISVMDHFLFLNNSFDEITGGFDQLPERFFKDMDSIVHLNSTVEKIVHINNKVTVFYEGLSTNMRLVADYVLITATARATRLIKFVPPLSIPKTRALRSLIYASATKIILVCTDKFWEKDGIHGGRSITDLPSRVIYYPNHDFTNGIGVLLASYTWYSDSEFYTTLSDEKCVDVVMDDLVEIHNVSKDYLKSVCGKHVVQKWALDQYSMGAFSTYTPYQITHYSQMLAQNEGRIYFAGEYTAHPHGWIETSMKSAIREAINIHNA", "prompt": "Design a protein sequence for a snake venom L-amino-acid oxidase from the king cobra (Ophiophagus hannah) that functions as a key enzymatic toxin in this elapid's venom arsenal. This flavoenzyme should catalyze the oxidative deamination of L-amino acids, particularly hydrophobic residues like L-phenylalanine and L-leucine, generating hydrogen peroxide, ammonia, and the corresponding α-keto acid as reaction products. The generated hydrogen peroxide contributes to the toxin's cytotoxic, platelet aggregation inhibitory, and edema-inducing effects through oxidative stress mechanisms. The protein should adopt the classic L-amino-acid oxidase fold with two distinct domains: a FAD-binding domain containing a Rossmann fold motif for cofactor binding, and a substrate-binding domain that forms the active site cavity. Include conserved catalytic residues for substrate recognition and oxidation, with the FAD cofactor covalently bound through histidine or cysteine residues. The structure should feature the characteristic dimeric assembly observed in snake venom LAOOs, with the dimer interface stabilizing the active conformation. The enzyme should exhibit optimal activity at slightly basic pH and demonstrate substrate specificity preferences typical of elapid venom LAOOs. Incorporate appropriate glycosylation sites as these enzymes are often glycoproteins that contribute to stability in the venom milieu. The overall architecture should enable efficient substrate access to the buried active site while maintaining the structural integrity required for the enzyme's multiple toxic functions in prey immobilization and digestion."}
{"description": "sp|P00600|PA2A2_NAJME Acidic phospholipase A2 DE-II OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "NLYQFKNMIQCTVPNRSWWHFANYGCYCGRGGSGTPVDDLDRCCQIHDNCYGEAEKISGCWPYIKTYTYESCQGTLTSCGANNKCAASVCDCDRVAANCFARATYNDKNYNIDFNARCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the forest cobra (Naja melanoleuca). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and neurotransmitter release inhibition. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The sequence should maintain the characteristic interfacial binding surface for membrane association while exhibiting the acidic properties typical of presynaptic neurotoxins from this species. The protein should demonstrate high specificity for neuronal membranes while maintaining thermal stability and resistance to proteolytic degradation characteristic of snake venom phospholipases."}
{"description": "sp|Q3YED6|O167_CONMR Omega-conotoxin-like MaIr137 OS=Conus marmoreus OX=42752 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTFVTAVPHSSDVLENLYLKALHETENHEASKLNVRDDECEPPGDFCGFFKIGPPCCSGWCFLWCA", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the venomous marine snail Conus marmoreus. This toxin should function as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal tissues to disrupt synaptic transmission and induce paralysis in prey. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, featuring a compact, triple-stranded beta-sheet stabilized by a conserved disulfide connectivity pattern (C-C-CC-C-C framework) that confers exceptional thermal and proteolytic stability. Key structural elements must include: a well-defined beta-hairpin loop responsible for target specificity, a rigid core constrained by three disulfide bridges forming the ICK knot, and surface-exposed residues optimized for high-affinity binding to the pore region of VGCCs. The sequence should exhibit evolutionary hallmarks of conotoxins, such as a signal peptide region for venom gland expression, a propeptide region for proper folding, and a mature toxin domain with precisely spaced cysteine residues. The final protein must demonstrate selective activity against neuronal calcium channels while maintaining the compact, stable fold typical of conopeptides that enables rapid onset of neurotoxic effects in marine prey organisms."}
{"description": "sp|C0JAT9|A1H1_LOXSP Dermonecrotic toxin LspaSicTox-alphaIA1i (Fragment) OS=Loxosceles spadicea OX=571530 PE=2 SV=1", "sequence": "WIMGHMVNAIGQIDEFVNLGANSIETDVSFDSNANPEYTYHGIPCDCGRNCKKWENFNDFLKGLRSATTPGDSKYKEKLVLVVFDLKTGSLYDNQANDAGKKLAKNLLQHYWNNGNNGGRAYIVLSIPDLNHYPLIKGFTDTLKQEGHPELLDKLGYDFSGNDAIGDVANAYKKAGVSGHVWQSDGITNCLLRGLTRVREAVANRDSGKGYINKVYYWTVDKRASTRDALDAGVDGIMTNYPDVITDVLNEAAYKSKFRVATYDDNPWETFKK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles spadicea. This toxin belongs to the SicTox-alpha family and functions as a potent phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving phospholipids to generate ceramide-1-phosphate and lysophosphatidic acid, which trigger inflammatory responses, platelet aggregation, hemolysis, and endothelial cell damage leading to characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing conserved histidine and lysine residues essential for catalytic activity. Key structural features include a hydrophobic membrane-binding interface and the characteristic HxKx4D motif responsible for magnesium coordination and substrate binding. The toxin should exhibit optimal activity at neutral to slightly acidic pH and demonstrate specificity for membrane phospholipids in mammalian tissues, contributing to the spider's venom-induced pathology through localized tissue destruction and systemic effects."}
{"description": "sp|E7CLP2|SX12F_RHOJU Putative beta-neurotoxin RjAa12f OS=Rhopalurus junceus OX=419285 PE=1 SV=1", "sequence": "MKILIFIIASFMLIGVECKEGYPMGRDGCKISCVINNNFCKVECQAKWRQSDGYCYFWGLSCYCTNLPEDAQVWDSSTNKCGG", "prompt": "Design a beta-neurotoxin protein sequence inspired by the venom of Rhopalurus junceus, the Caribbean blue scorpion. This toxin should function as a potent neurotoxin targeting voltage-gated sodium channels, characteristic of scorpion beta-neurotoxins. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold, stabilized by four disulfide bridges with the characteristic C-C-CC-C-C pattern. Key structural elements should include a compact core formed by an alpha-helix packed against an antiparallel beta-sheet, creating a stable scaffold that presents critical functional residues for receptor interaction. The toxin should specifically bind to site 4 of voltage-gated sodium channels, delaying channel inactivation and prolonging neuronal depolarization, leading to sustained neurotransmitter release and neuroexcitatory effects. Include conserved motifs for membrane interaction and receptor recognition, with surface-exposed residues optimized for high-affinity binding to the voltage-sensing domain of the sodium channel. The sequence should maintain the characteristic compact globular structure typical of scorpion beta-neurotoxins, approximately 60-70 amino acids in length, with proper spacing of cysteine residues to ensure correct disulfide connectivity and structural stability."}
{"description": "sp|Q86QT8|KGX45_CENEX Potassium channel toxin gamma-KTx 4.5 OS=Centruroides exilicauda OX=6879 PE=3 SV=1", "sequence": "DRDSCVDKSQCAKYGYYYQCDECCKKAGDRAGTCEYFKCKCNP", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Arizona bark scorpion (Centruroides exilicauda), a species known for producing neurotoxins that target voltage-gated potassium channels to disrupt neuronal signaling and cause paralysis in prey. This toxin should function as a potent blocker of Kv1.x family potassium channels, specifically binding to the channel pore with high affinity to inhibit potassium efflux and prolong neuronal depolarization. The protein must adopt the conserved structural scaffold of gamma-KTx toxins, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include key functional residues in the beta-hairpin region that mediate channel interaction, particularly a dyad or triad of basic and hydrophobic residues critical for docking into the channel vestibule. The overall fold should comprise a compact, triple-stranded beta-sheet stabilized by the disulfide knot, with the functional loops displaying the appropriate geometry for selective Kv1 channel blockade. Ensure the sequence reflects the evolutionary optimization for rapid onset and sustained channel inhibition, typical of scorpion venom toxins used for prey immobilization."}
{"description": "sp|P0C6B5|DIDLB_ECHCA Disintegrin schistatin-like subunit B OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "NSVNPCCDPQTCKPIEGKHCISGPCCENCYFLRSGTICQRARGDGNNDYCTGITPDCPRNRYN", "prompt": "Design a novel disintegrin protein inspired by schistatin-like subunit B from the venom of the saw-scaled viper, Echis carinatus. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The protein must adopt the canonical disintegrin fold characterized by a compact, disulfide-rich structure stabilized by multiple conserved disulfide bonds, typically featuring the characteristic RGD (Arg-Gly-Asp) or related integrin-binding motif within an exposed, flexible loop that serves as the primary receptor interaction site. The structural scaffold should ensure high affinity and selectivity for integrins such as αIIbβ3 (glycoprotein IIb/IIIa) on platelets, thereby preventing fibrinogen binding and subsequent thrombus formation. The sequence must include the essential cysteine residues arranged in the conserved disintegrin framework to form the stabilizing disulfide network, which confers protease resistance and structural integrity within the venom milieu. The overall architecture should facilitate rapid systemic distribution and efficient receptor engagement upon envenomation, contributing to the hemorrhagic and anticoagulant effects characteristic of viperid snake venoms."}
{"description": "sp|P01381|3L22_HYDST Alpha-elapitoxin-Ast2b OS=Hydrophis stokesii OX=355677 PE=1 SV=1", "sequence": "LSCYLGYKHSQTCPPGENVCFVKTWCDAFCSTRGERIVMGCAATCPTAKSGVHIACCSTDNCNIYTKWGSGR", "prompt": "Design a protein sequence for an alpha-elapitoxin from the venom of Hydrophis stokesii (Stokes' sea snake), a highly potent neurotoxin that functions as a postsynaptic alpha-neurotoxin. This toxin should exhibit the characteristic three-finger toxin (3FTx) structural fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I pattern (C1-C3, C2-C4, C5-C6, C7-C8). The toxin should specifically target and antagonize muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, binding with high affinity to the alpha-delta subunit interface to competitively block acetylcholine binding. This mechanism results in flaccid paralysis and respiratory failure in prey organisms. The structural scaffold should feature the conserved three-loop architecture with the central loop (loop II) containing key functional residues for receptor recognition and binding. The protein should maintain the characteristic compact, globular structure stabilized by the disulfide network, with surface-exposed residues in the loop regions mediating specific receptor interactions."}
{"description": "sp|Q7LZF5|VSPC1_CROAT Thrombin-like enzyme catroxobin-1 (Fragment) OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "VVGGDECNINEHRSLVAIFVSTEFDCGGDLINVEWVLTAAHCTLCAGIPEGGLDTCGGDSGGPLICDGKPDGITS", "prompt": "Design a thrombin-like serine protease enzyme derived from the venom of the Western diamondback rattlesnake (Crotalus atrox), known as catroxobin-1. This enzyme functions as a key component of the snake's venom arsenal, primarily targeting the vertebrate blood coagulation cascade to induce defibrinogenation and promote hemorrhage. Catroxoxin-1 exhibits selective proteolytic activity toward fibrinogen, cleaving fibrinopeptide A from the Aα chain to form unstable fibrin clots that are rapidly cleared from circulation, leading to consumptive coagulopathy and impaired hemostasis in prey. The enzyme belongs to the snake venom serine protease (SVSP) family and shares the characteristic chymotrypsin-like fold with a conserved catalytic triad (His, Asp, Ser) and structural disulfide bridges that stabilize the globular protease domain. It likely contains multiple disulfide bonds following the typical SVSP pattern, including conserved Cys residues that form the structural core. The enzyme operates through a substrate-specific mechanism distinct from mammalian thrombin, showing preferential cleavage at specific arginine residues in fibrinogen while avoiding activation of other coagulation factors like Factor XIII or protein C. Design this enzyme with the precise substrate specificity and catalytic efficiency required for its defibrinogenating activity, maintaining the structural integrity necessary for venom stability and target recognition in the context of snake envenomation."}
{"description": "sp|C0HJM9|SCX2_TITFA Toxin Tf2 OS=Tityus fasciolatus OX=203543 PE=1 SV=1", "sequence": "MKRFLLFISILMMIGTIVVGKEGYAMDHEGCKFSCFIRPSGFCDGYCKTHLKASSGYCAWPACYCYGVPSNIKVWDYATNKCGK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the Brazilian scorpion Tityus fasciolatus. This toxin should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav channels) to disrupt neuronal signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by a specific cysteine framework with four disulfide bridges (C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern). The core structure should comprise an α-helix packed against an antiparallel β-sheet, forming a stable core that presents key functional loops for receptor interaction. These loops should contain conserved residues for binding to site 4 of Nav channels, typically involving a critical 'pharmacophore' region that interacts with the voltage-sensing domain of the channel. The mechanism of action should involve altering channel gating kinetics, leading to prolonged action potentials, repetitive firing, and ultimately neuroexcitatory effects. The sequence should maintain the hallmark compactness and stability of scorpion toxins while incorporating specific molecular recognition elements for high-affinity binding to mammalian neuronal sodium channels."}
{"description": "sp|P0DJF7|VSPP_TRIPP Thrombin-like enzyme purpurase (Fragment) OS=Trimeresurus purpureomaculatus OX=101163 PE=1 SV=1", "sequence": "VVGGDECNINDHRSLVRIF", "prompt": "Design a protein sequence for a thrombin-like enzyme toxin derived from the venom of Trimeresurus purpureomaculatus, the mangrove pit viper. This enzyme functions as a purpurase, exhibiting serine protease activity that specifically targets the coagulation cascade by cleaving fibrinogen to generate fibrin, thereby promoting blood clot formation and contributing to the venom's potent procoagulant effects. The protein should adopt a chymotrypsin-like serine protease fold, characterized by a two-domain structure with a conserved catalytic triad (His, Asp, Ser) and a substrate-binding pocket that confers specificity for fibrinogen. It likely contains multiple disulfide bridges to stabilize the tertiary structure, with a cysteine framework typical of snake venom serine proteases (SVSPs), such as the conserved pattern found in thrombin-like enzymes. The molecular target is fibrinogen, with binding and cleavage occurring at specific sites analogous to thrombin's action, leading to fibrin polymerization and potential defibrination syndrome. The sequence should reflect the functional attributes of a fragment that retains enzymatic activity, with appropriate signal peptide processing if applicable, and maintain the structural integrity required for efficient substrate recognition and catalysis in the context of venom-induced coagulopathy."}
{"description": "sp|P0CI04|TX132_APHSP Omega-theraphotoxin-Asp3a OS=Aphonopelma sp. OX=29932 PE=1 SV=1", "sequence": "CLGENVPCDKDRPNCCSKYECLEPTGYGRCYASYYSYKKKTL", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin is an omega-theraphotoxin from the venom of Aphonopelma sp., a tarantula species. This toxin functions as a potent voltage-gated calcium channel blocker, specifically targeting Cav2.2 (N-type) and/or Cav2.1 (P/Q-type) calcium channels in the peripheral and central nervous systems. The mechanism involves high-affinity binding to the voltage-sensing domain of these channels, inhibiting calcium influx and thereby disrupting neurotransmitter release, which leads to paralysis in prey. The structural scaffold is characterized by the inhibitor cystine knot (ICK) motif, a hallmark of spider venom peptides, featuring a compact, triple-stranded beta-sheet stabilized by three disulfide bridges with a conserved C-C-CC-C-C cysteine framework. The 3D structure is expected to be globular and highly stable due to the ICK fold, with key residues in the beta-hairpin loops mediating target specificity and binding affinity. The biological significance lies in its role in the tarantula's predatory venom, where it synergizes with other toxins to immobilize insects or small vertebrates. Ensure the sequence reflects these functional and structural attributes, including the precise disulfide connectivity and surface-exposed loops critical for channel interaction."}
{"description": "sp|P86362|CAEA_CONTS Alpha-conotoxin-like ts14a OS=Conus tessulatus OX=101317 PE=1 SV=1", "sequence": "DGCPPHPVPGMHPCMCTNTC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus tessulatus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the defining cysteine framework (CC-C-C) typical of alpha-conotoxins, with inter-cysteine loops of appropriate length to confer target specificity. Key structural elements should include a beta-hairpin motif and well-defined alpha-helical tendencies in specific regions, ensuring proper presentation of pharmacophore residues for high-affinity binding to the orthosteric site of nAChRs. The toxin should exhibit high potency and selectivity, contributing to the paralytic arsenal of Conus tessulatus venom by disrupting cholinergic signaling through competitive inhibition of acetylcholine binding. Ensure the sequence reflects the evolutionary optimization for rapid neuromuscular blockade while maintaining the structural stability required for venom deployment."}
{"description": "sp|C0HJQ2|KA192_BUTOC Potassium channel toxin alpha-KTx 19.2 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "AACYSSDCRVKCRAMGFSSGKCIDSKCKCYK", "prompt": "Design a novel animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. This toxin should belong to the alpha-KTx family, characterized by the conserved structural fold known as the inhibitor cysteine knot (ICK) motif. The ICK scaffold is stabilized by three disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern, forming a compact, triple-stranded beta-sheet structure that confers exceptional stability and resistance to proteolytic degradation. The molecular mechanism involves high-affinity binding to the pore region of Kv channels, particularly through interactions with conserved residues in the channel's turret and selectivity filter, leading to channel blockade and subsequent prolongation of action potentials. This results in hyperexcitability, uncontrolled neurotransmitter release, and potential paralysis in prey organisms. The toxin should exhibit the biological context of scorpion venom from the Buthus genus, where such peptides play a critical role in prey immobilization and defense by selectively targeting ion channels in the peripheral nervous system. Ensure the sequence includes the hallmark alpha-KTx family features: a short, cationic peptide (approximately 30-40 residues) with a well-defined pharmacophore surface containing key functional residues for channel interaction, while maintaining the ICK structural integrity through the conserved cysteine framework."}
{"description": "sp|P0DM51|PA2B1_BOTPA Basic phospholipase A2 BnpTX-1 (Fragment) OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "DLWQFGKMILKVAGKLPFPYYGAYGCYCGWGGRGKPKDPTDRCCFVHDCC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrops pauloensis, a venomous pit viper. This toxin functions as a potent enzymatic toxin that hydrolyzes phospholipids at the sn-2 position of cell membranes, leading to membrane disruption, inflammation, and tissue damage. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. The sequence should include the canonical catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) essential for enzymatic activity. As a basic phospholipase A2, it should exhibit enhanced membrane binding affinity due to its positive surface charge, facilitating interaction with anionic phospholipid headgroups. The toxin likely contributes to the hemotoxic and myotoxic effects typical of Bothrops venoms, causing local tissue damage, edema, and potentially systemic effects. Ensure the structural scaffold maintains the compact, stable globular fold characteristic of secreted phospholipases A2, with the calcium-binding loop and hydrophobic substrate-binding channel properly formed for catalytic efficiency."}
{"description": "sp|P86311|TLP14_PHONI Tachykinin-like peptide-XIV OS=Phoneutria nigriventer OX=6918 PE=1 SV=1", "sequence": "QKKDKKDRFYGLF", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a tachykinin-like peptide derived from the venom of the wandering spider Phoneutria nigriventer. This venom component functions as a neurotoxin that modulates pain signaling and sensory neurotransmission through interaction with tachykinin receptors, particularly neurokinin receptors (NK1, NK2, NK3). The peptide should adopt the characteristic tachykinin structural fold, featuring a conserved C-terminal amidation motif and a well-defined amphipathic alpha-helical region in the C-terminal segment that mediates receptor binding. The core functional domain should include the canonical tachykinin signature sequence F-X-G-L/M-NH2 at the C-terminus, which is essential for receptor activation and biological activity. The protein should exhibit high affinity for mammalian tachykinin receptors, potentially causing neurogenic inflammation, pain sensitization, and smooth muscle contraction through substance P-like mechanisms. The structural scaffold should maintain the typical tachykinin peptide characteristics of 10-15 amino acids with appropriate hydrophobic and charged residue distribution to ensure proper receptor docking and signal transduction. The sequence should demonstrate evolutionary conservation with known tachykinin family members while incorporating Phoneutria-specific modifications that enhance receptor specificity and potency in mammalian systems."}
{"description": "sp|P56710|O16A_CONNI Delta-conotoxin NgVIA OS=Conus nigropunctatus OX=1520089 PE=1 SV=1", "sequence": "SKCFSPGTFCGIKPGLCCSVRCFSLFCISFE", "prompt": "Design a novel delta-conotoxin protein sequence inspired by Conus nigropunctatus venom, specifically targeting voltage-gated sodium channels. This toxin should function as a potent sodium channel inhibitor that delays channel inactivation, thereby prolonging action potentials and enhancing neurotransmitter release at synapses. The protein should adopt the conserved conotoxin structural framework with four disulfide bonds arranged in a C-C-C-C-C-C-C-C cysteine pattern, forming a compact, stable globular fold stabilized by these crosslinks. The sequence must include key functional residues for binding to site 6 of voltage-gated sodium channels, particularly in domains where it modulates inactivation kinetics without blocking the pore. The structural scaffold should feature a well-defined core stabilized by disulfide connectivity, with surface loops presenting the pharmacophore for specific interaction with neuronal sodium channel subtypes. The overall architecture should reflect the typical conotoxin fold—small, cysteine-rich, and highly structured—to ensure biological activity as a neurotoxin that disrupts normal electrical signaling in the nervous system."}
{"description": "sp|P56219|KAX42_TITSE Potassium channel toxin alpha-KTx 4.2 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MKVLYGILIIFILCSMFYLSQEVVIGQRCYRSPDCYSACKKLVGKATGKCTNGRCDC", "prompt": "Design a potassium channel toxin protein from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix stabilized against an antiparallel beta-sheet by three or four disulfide bridges. The specific cysteine framework should follow the typical alpha-KTx pattern (C-C-CC-C-C) with disulfide connectivity that maintains structural stability while allowing for target specificity. The toxin should exhibit high-affinity binding to potassium channels, likely through interactions with the channel's pore region or voltage-sensing domains, leading to channel blockade or modulation that disrupts neuronal excitability and neuromuscular transmission. The structural scaffold should include key functional residues for target recognition while maintaining the compact, stable globular architecture essential for venom efficacy. The protein should be approximately 30-40 amino acids in length with appropriate hydrophobic core packing and surface-exposed residues optimized for potassium channel interaction."}
{"description": "sp|P56409|KUNI_ORNMO Ornithodorin OS=Ornithodoros moubata OX=6938 PE=1 SV=1", "sequence": "LNVLCNNPHTADCNNDAQVDRYFREGTTCLMSPACTSEGYASQHECQQACFVGGEDHSSEMHSSCLGDPPTSCAEGTDITYYDSDSKTCKVLAASCPSGENTFESEVECQVACGAPIEG", "prompt": "Design a protein sequence for a thrombin inhibitor toxin derived from the soft tick Ornithodoros moubata. This protein should function as a potent and specific inhibitor of thrombin, a key serine protease in the blood coagulation cascade, thereby acting as an anticoagulant to facilitate blood feeding in the tick. The protein should adopt a Kunitz-type structural fold, characterized by a compact, stable domain with a central anti-parallel beta-sheet and one or two alpha-helices. It should contain the canonical Kunitz domain disulfide bridge pattern, typically involving three disulfide bonds with a conserved connectivity (e.g., Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 in standard numbering) that stabilizes the fold. The sequence should include a reactive site loop that directly interacts with the active site of thrombin, featuring residues critical for specificity and inhibition, such as those forming a canonical binding interface. The protein should exhibit high affinity and selectivity for thrombin over other serine proteases, leveraging the Kunitz scaffold's adaptability for precise molecular recognition. Ensure the sequence reflects the evolutionary adaptation for hematophagy, with optimized stability and inhibitory potency suitable for a venom-derived anticoagulant."}
{"description": "sp|A0A7S8MU78|SCX40_TITSE Putative sodium channel toxin Ts40 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MTALFYLLFLTSVIIETHQECDMEKLDGDFPRQNNGYLYVCKDVETCFHICEERDLNRNHAKCCYENCFCEHLHGEKIRKQNVSLKI", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal or cardiac isoforms to induce excitatory neurotoxicity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by four disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements should include an alpha-helix packed against an antiparallel beta-sheet, forming a molecular surface with a conserved 'pharmacophore' region responsible for channel recognition. The toxin should bind to site 3 or site 4 of voltage-gated sodium channels, delaying inactivation and promoting persistent sodium currents, leading to prolonged depolarization and hyperexcitability in target cells. Incorporate conserved residues involved in channel interaction, such as a hydrophobic patch and charged residues for electrostatic steering, while maintaining the structural integrity of the CSαβ fold. The sequence should reflect the high specificity and potency typical of Tityus serrulatus toxins, contributing to the venom's role in prey immobilization and defense mechanisms."}
{"description": "sp|A0A7S8MU85|SCX35_TITSE Putative sodium channel toxin Ts35 (Fragment) OS=Tityus serrulatus OX=6887 PE=2 SV=1", "sequence": "QDEVGLGSCSVIFVVGNEEGEAKDGYAVGGDRCRVRCSPLGKNKDCETACRKKAGSYYGYCYLWFCYCENVSESAVVWGNPTLGPCLSDG", "prompt": "Design a protein sequence for a sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting and prolonging the action potential by inhibiting channel inactivation. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact globular fold stabilized by a core of four disulfide bridges with the characteristic cysteine framework (C-C-CC-C-C). The structure should display the typical CSαβ motif consisting of an alpha-helix packed against an antiparallel beta-sheet. The molecular mechanism involves binding to site 4 on voltage-gated sodium channels, particularly Nav1.4 and Nav1.6 isoforms, through specific surface residues that interact with the channel's voltage-sensing domain II. This interaction traps the voltage sensor in an activated state, preventing fast inactivation and leading to prolonged neuronal and muscular excitation. The toxin should exhibit high affinity and selectivity for mammalian sodium channels, contributing to the neurotoxic effects observed in envenomation, including autonomic nervous system dysfunction and muscle paralysis."}
{"description": "sp|P00602|PA2A1_NAJMO Acidic phospholipase A2 CM-I OS=Naja mossambica OX=8644 PE=1 SV=1", "sequence": "NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTAVDDLDRCCQVHDNCYGEAEKLGCWPYLTLYKYECSQGKLTCSGGNNKCEAAVCNCDLVAANCFAGAPYIDANYNVNLKERCQ", "prompt": "Generate a protein sequence for an acidic phospholipase A2 toxin from the venom of the Mozambique spitting cobra (Naja mossambica). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should exhibit high specificity for hydrolyzing the sn-2 acyl bond of glycerophospholipids in neuronal membranes. The sequence must contain 14 conserved cysteine residues forming 7 disulfide bridges that stabilize the compact, multi-looped tertiary structure. The protein should have an acidic pI due to abundant aspartate and glutamate residues, and it should demonstrate both enzymatic activity and direct neurotoxic effects through membrane disruption and interference with vesicle fusion mechanisms at nerve terminals."}
{"description": "sp|P0DKQ9|CM31_CONTU Mu-conotoxin-like T3.1 OS=Conus tulipa OX=6495 PE=2 SV=1", "sequence": "MSKLGVLLTICLLLFPLTALPMDGDEPADRPAERMQDNISSEQHPLFEERHGCCKGPEGCSSRECRPQHCCGRR", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the marine cone snail Conus tulipa. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular paralysis in prey. The peptide should adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by three disulfide bonds with the conserved cysteine framework C-C-CC-C-C (Framework III). The structure should exhibit the typical globular conformation stabilized by these disulfide bridges, forming a stable core that presents key functional loops for receptor interaction. These loops should contain conserved residues critical for binding to the neurotoxin receptor site 1 on the voltage-gated sodium channel, effectively blocking ion conductance by binding to the pore region. The toxin should demonstrate high affinity and specificity for Nav1.4 over other sodium channel isoforms, contributing to the predatory efficacy of Conus tulipa venom by rapidly immobilizing small fish through disruption of action potential propagation at the neuromuscular junction. The sequence should reflect the evolutionary optimization of cone snail toxins for precise molecular targeting, with appropriate hydrophobicity and electrostatic surface properties to facilitate membrane approach and receptor engagement."}
{"description": "sp|Q805F7|DIDA_AGKCO Disintegrin acostatin-alpha OS=Agkistrodon contortrix contortrix OX=8713 PE=1 SV=1", "sequence": "MIQVLLVTLCLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAIQPKNPCCDAATCKLTPGSQCAEGLCCDQCKFIKAGKICRRARGDNPDYRCTGQSGDCPRKHFYA", "prompt": "Design a novel disintegrin protein sequence inspired by acostatin-alpha from the venom of Agkistrodon contortrix contortrix (Southern copperhead snake). This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on platelet surfaces. The sequence must contain the canonical RGD (Arg-Gly-Asp) integrin-binding motif that mediates high-affinity binding to αIIbβ3 integrin (GPIIb/IIIa) on platelets, thereby preventing fibrinogen binding and subsequent platelet aggregation. The structural scaffold should adopt the characteristic disintegrin fold—a compact, cysteine-rich domain stabilized by multiple disulfide bonds that confer rigidity and precise presentation of the RGD loop for optimal receptor engagement. The protein should exhibit high specificity for platelet integrins with minimal off-target effects on other RGD-dependent integrins. Incorporate conserved cysteine residues in the appropriate framework to ensure proper folding and disulfide connectivity, resulting in a stable, bioactive molecule suitable for investigating anti-thrombotic mechanisms or therapeutic development."}
{"description": "sp|C0JAU5|A1L_LOXDE Dermonecrotic toxin LdSicTox-alphaIB2 (Fragment) OS=Loxosceles deserta OX=424440 PE=2 SV=1", "sequence": "LIMGHMVNAIYQIDEFVNLGANSIEIDVSFDDSANPEYTYHGIPCDCRRWCTKWEYFNGFLKALRKATTPGDSKYHEKLVLVVFDLKTNSLYNYQAYDAGKKLAENLLQHYWNNGNNGGRAYIVLSIPNLAHYKLITGFKETLKNKGHPELMEKVGHDFSGNDNLDQVAKAYKKAGVTGHVWQSDGITNCIASFIRGIDRAKKAVANRDSSNGFINKVYYWTVDKYSTTREALDAGVDGIMTNYPDVIANVLNESAYKTKFRLATYADNPWETFKN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the desert recluse spider (Loxosceles deserta). This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, and endothelial cell damage that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing conserved histidine and aspartate residues that coordinate catalytic metal ions. The sequence should include the characteristic HxKx4D motif essential for phosphodiesterase activity. As a member of the SicTox-alphaIB2 subfamily, it should exhibit specific membrane-targeting properties that enhance its dermonecrotic potency. The structural scaffold should facilitate efficient substrate binding and catalysis while maintaining stability in the venom environment."}
{"description": "sp|B3EWY0|KAX3F_MESGB Potassium channel toxin alpha-KTx 3.15 (Fragment) OS=Mesobuthus gibbosus OX=123226 PE=1 SV=1", "sequence": "GSPLTYPCHSAQCEQPCKDANMRFGXCMN", "prompt": "Design a functional potassium channel toxin derived from the scorpion Mesobuthus gibbosus. This toxin belongs to the alpha-KTx family 3.15 and specifically targets voltage-gated potassium channels (Kv channels). The toxin should function as a pore-blocker, binding to the external vestibule of Kv channels and physically occluding the potassium conduction pathway. This mechanism results in prolonged neuronal excitation and enhanced neurotransmitter release, contributing to the neurotoxic effects of scorpion venom. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a three-stranded antiparallel beta-sheet. The cysteine framework is expected to follow the typical alpha-KTx pattern (C-C-CC-C-C) with three disulfide bridges that stabilize this compact globular structure. Key functional residues should be positioned in a conserved functional dyad, typically involving a lysine residue that projects into the potassium channel pore and interacts with key residues in the channel's selectivity filter. The toxin should exhibit high affinity and selectivity for specific Kv channel subtypes, contributing to the prey immobilization and defensive functions of scorpion venom."}
{"description": "sp|P69753|O16A_CONMA Delta-conotoxin-like MVIA OS=Conus magus OX=6492 PE=2 SV=2", "sequence": "MKLTCVMIVAVLFLTTWTFVTADDSRYGLKNLFPKARHEMKNPEASKLNKRDGCYNAGTFCGIRPGLCCSEFCFLWCITFVDSG", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a delta-conotoxin-like peptide derived from the venom of the marine cone snail Conus magus. As a component of this predatory snail's venom cocktail, this toxin functions to immobilize prey through modulation of voltage-gated ion channels. Specifically, this delta-conotoxin analog acts as a potent inhibitor of voltage-gated sodium channels, particularly targeting Nav1.2 and Nav1.6 subtypes in the central nervous system. The toxin employs a 'gating modifier' mechanism, binding to neurotoxin receptor site 6 and delaying channel inactivation, leading to prolonged neuronal depolarization and disrupted action potential propagation. Structurally, this peptide adopts the conserved conotoxin fold characterized by a compact, disulfide-stabilized globular architecture. It features the O1-superfamily cysteine framework with a C-C-CC-C-C pattern, forming three disulfide bridges that create a stable, triple-loop scaffold. The mature toxin exhibits an inhibitor cystine knot (ICK) motif with characteristic beta-hairpin and beta-turn elements. Key functional residues are concentrated in flexible loops between cysteine pairs, particularly in loops 2 and 4, which form the primary pharmacophore for sodium channel interaction. The N-terminal region contains critical hydrophobic and basic residues essential for membrane association and target recognition. Generate a sequence that captures this specific pharmacological profile, structural stability, and target selectivity while maintaining the characteristic compactness and disulfide connectivity of delta-conotoxin-like peptides from cone snail venoms."}
{"description": "sp|Q7LZF6|VSPE2_CROAT Kallikrein-like EII (Fragment) OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "HVGGDECNINEHRSLVAIFVFTEFF", "prompt": "Design a venom-derived serine protease toxin fragment from the Western diamondback rattlesnake (Crotalus atrox) that functions as a kallikrein-like enzyme. This toxin should exhibit the characteristic catalytic triad (His, Asp, Ser) and conserved structural fold of serine proteases, featuring a two-domain architecture with a predominantly beta-barrel structure. The protein should possess specific substrate recognition properties typical of kallikrein enzymes, potentially targeting components of the kinin-kallikrein system to induce hypotensive effects, inflammation, or coagulation disturbances. Incorporate the conserved disulfide bonding pattern characteristic of snake venom serine proteases to stabilize the tertiary structure. The toxin should demonstrate selective proteolytic activity against specific plasma protein substrates, contributing to the complex hemorrhagic and hypotensive pathology of Crotalus atrox envenomation. Ensure the sequence maintains the essential structural motifs for proper folding and catalytic function while exhibiting the evolutionary adaptations that distinguish it from mammalian kallikreins."}
{"description": "sp|Q805F4|VM2PB_AGKPI Zinc metalloproteinase/disintegrin OS=Agkistrodon piscivorus piscivorus OX=8716 PE=1 SV=1", "sequence": "MIQVLLVTLCLAAFPYQGNSIILESGNVNDYEVLYPQKVTALPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSSDGRKITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDKPIKKASQLNLTPEQQRFPQRYIELVVVADHRMFTKYNGNLNTIRIWVHELVNTMNVFYRPLNIHVSLTDLEVWSDQDLINVQPAAADTLEAFGDWRETVLLNRISHDNAQLLTAIELDGETIGLANRGTMCDPKLSTGIVQDHSAINLWVAVTMAHEMGHNLGISHDGNQCHCDANSCIMSEELRQQLSFEFSDCSQNQYQTFLTDHNPQCMLNEPLRTDIVSTPVSGNELWETGEESDFDAPANPCCDAATCKLTPGSQCAEGLCCDQCKFMKEGTVCHRAKGDDLDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of the venom from the Eastern cottonmouth (Agkistrodon piscivorus piscivorus). This protein should exhibit the dual functionality typical of snake venom metalloproteinases (SVMPs), combining proteolytic activity with anti-platelet effects. The metalloproteinase domain must contain the conserved zinc-binding motif (HEXXHXXGXXH) that coordinates the catalytic zinc ion, enabling proteolytic cleavage of extracellular matrix components such as collagen, fibrinogen, and von Willebrand factor, thereby contributing to hemorrhage and tissue damage. The disintegrin domain should feature the canonical RGD (Arg-Gly-Asp) or related tripeptide motif that competitively inhibits integrin receptors (e.g., αIIbβ3 on platelets and αvβ3 on endothelial cells), disrupting cell-matrix interactions and preventing platelet aggregation. The protein should adopt a multi-domain architecture, with the metalloproteinase domain folding into a typical metzincin-like structure characterized by a central five-stranded β-sheet and surrounding α-helices, and the disintegrin domain forming a compact, disulfide-rich fold stabilized by multiple conserved cysteine bridges. The overall structure should be stabilized by disulfide bonds, with specific connectivity patterns conserved in SVMPs, including those between the metalloproteinase and disintegrin domains. The protein's mechanism involves initial proteolytic disruption of vascular integrity followed by integrin blockade, synergistically promoting bleeding and impairing hemostasis."}
{"description": "sp|Q86DU6|CM3A_CONST Mu-conotoxin SIIIA OS=Conus striatus OX=6493 PE=1 SV=1", "sequence": "MMSKLGVLLTVCPLLFPLTALPPDGDQPADRPAERMQDDISSDEHPLFDKRQNCCNGGCSSKWCRDHARCCGR", "prompt": "Design a novel mu-conotoxin protein sequence inspired by Conus striatus venom components, specifically targeting voltage-gated sodium channels. This toxin should function as a potent sodium channel blocker that inhibits neuronal excitability by binding to site 1 of voltage-gated sodium channels, thereby preventing action potential propagation. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of conotoxins, featuring a compact, triple-stranded beta-sheet stabilized by a conserved disulfide connectivity pattern (C-C-CC-C-C framework). Key structural elements should include: a well-defined beta-hairpin region responsible for channel interaction, a hydrophobic core maintaining structural integrity, and surface-exposed residues optimized for high-affinity binding to the sodium channel pore domain. The sequence should exhibit specificity for tetrodotoxin-sensitive sodium channel subtypes while maintaining the characteristic stability and folding efficiency of conus venom peptides. Include conserved cysteine residues at appropriate positions to form the essential disulfide bonds that define the ICK scaffold, with intervening loops of varying lengths that contribute to target specificity and binding affinity."}
{"description": "sp|P81428|FAXD_TROCA Venom prothrombin activator trocarin-D OS=Tropidechis carinatus OX=100989 PE=1 SV=2", "sequence": "MAPQLLLCLILTFLWSLPEAESNVFLKSKVANRFLQRTKRSNSLFEEIRPGNIERECIEEKCSKEEAREVFEDNEKTETFWNVYVDGDQCSSNPCHYRGTCKDGIGSYTCTCLPNYEGKNCEKVLYQSCRVDNGNCWHFCKRVQSETQCSCAESYRLGVDGHSCVAEGDFSCGRNIKARNKREASLPDFVQSQKATLLKKSDNPSPDIRIVNGMDCKLGECPWQAVLINEKGEVFCGGTILSPIHVLTAAHCINQTKSVSVIVGEIDISRKETRRLLSVDKIYVHTKFVPPNYYYVHQNFDRVAYDYDIAIIRMKTPIQFSENVVPACLPTADFANEVLMKQDSGIVSGFGRIQFKQPTSNTLKVITVPYVDRHTCMLSSDFRITQNMFCAGYDTLPQDACQGDSGGPHITAYRDTHFITGIISWGEGCARKGKYGVYTKVSKFIPWIKKIMSLK", "prompt": "Design a venom-derived prothrombin activator protein from the rough-scaled snake (Tropidechis carinatus), a highly venomous Australian elapid. This toxin functions as a potent coagulopathic agent that directly activates prothrombin to thrombin, initiating the coagulation cascade and leading to systemic thrombosis and consumptive coagulopathy. The protein should adopt a structural architecture characteristic of snake venom group D prothrombin activators, featuring multiple domains including a metalloproteinase-like domain, a disintegrin-like domain, and a cysteine-rich domain. The metalloproteinase domain likely contains the catalytic zinc-binding motif (HEXXHXXGXXH) responsible for the proteolytic cleavage of prothrombin. The protein should exhibit a complex disulfide bonding pattern typical of snake venom serine proteinases, with multiple conserved cysteine residues forming stabilizing bridges that maintain structural integrity. The molecular target is prothrombin (Factor II), with specific recognition and cleavage at Arg271-Thr272 and Arg320-Ile321 bonds to generate active α-thrombin. The protein should demonstrate calcium-dependent activity and potentially interact with coagulation factor Va to enhance catalytic efficiency. The structural fold should maintain the characteristic serine proteinase β-barrel architecture while incorporating venom-specific adaptations for enhanced stability and target specificity in the envenomation context."}
{"description": "sp|P56640|CA1B_CONAL Alpha-conotoxin AuIB OS=Conus aulicus OX=89437 PE=1 SV=2", "sequence": "MFTVFLLVVLATTVVSFTSDRASDGRKDAASGLIALTMKGCCSYPPCFATNPDCGRRR", "prompt": "Design a novel alpha-conotoxin sequence derived from the venom of the marine cone snail Conus aulicus. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the alpha3beta4 subtype. The protein should adopt the characteristic alpha-conotoxin fold stabilized by two conserved disulfide bonds forming the globular cysteine framework (Cys1-Cys3, Cys2-Cys4). The mature peptide should be approximately 15-20 amino acids in length with a compact, disulfide-constrained structure that facilitates high-affinity binding to the receptor's orthosteric site. The sequence should include the conserved cysteine pattern while incorporating specific loop residues that confer selectivity for alpha3beta4 nAChRs over other nicotinic receptor subtypes. The toxin should exhibit the typical biological function of disrupting cholinergic neurotransmission in the autonomic nervous system, potentially leading to neuromuscular effects consistent with cone snail envenomation strategies."}
{"description": "sp|P00604|PA2B3_NAJMO Basic phospholipase A2 CM-III OS=Naja mossambica OX=8644 PE=1 SV=1", "sequence": "NLYQFKNMIHCTVPSRPWWHFADYGCYCGRGGKGTPVDDLDRCCQVHDNCYEKAGKMGCWPYFTLYKYKCSQGKLTCSGGNSKCGAAVCNCDLVAANCFAGARYIDANYNINFKKRCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Mozambique spitting cobra (Naja mossambica). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity to hydrolyze the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer exceptional stability. Key structural elements should include the conserved calcium-binding loop (Tyr-Gly-Cys), the catalytic dyse (His-Asp), and the interfacial binding surface that facilitates membrane penetration. The toxin should specifically target neuronal and muscle cell membranes, disrupting membrane integrity and inducing cytotoxicity through both enzymatic and non-enzymatic mechanisms. The sequence should reflect the basic isoelectric point typical of neurotoxic phospholipases A2 from elapid snakes, with surface-exposed cationic residues that may contribute to membrane association and presynaptic neurotoxicity."}
{"description": "sp|P56641|CA1C_CONAL Alpha-conotoxin AuIC OS=Conus aulicus OX=89437 PE=1 SV=1", "sequence": "GCCSYPPCFATNSGYC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus aulicus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting the neuromuscular junction to induce paralysis in prey. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3 and Cys2-Cys4 connectivity pattern, forming the classic cysteine framework I (CC-C-C). The sequence should include the essential pharmacophore residues responsible for high-affinity binding to the alpha-delta subunit interface of muscle-type nAChRs, with key interfacial residues positioned to block acetylcholine binding and channel activation. Incorporate conserved alpha-conotoxin structural motifs, such as a beta-hairpin loop and a helical turn, to ensure proper folding and stability. The final sequence must exhibit the typical alpha-conotoxin length of 12-18 amino acids, with precise disulfide connectivity critical for maintaining the inhibitory cysteine knot (ICK) motif, ensuring potent neuromuscular blockade and prey immobilization."}
{"description": "sp|P0C6S1|VM1B2_BOTPA Snake venom metalloproteinase BnP2 (Fragment) OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "YIELAVVADHGMFTKYNSNIDTIRVHEMVNTVDGFFRSMNVDASIANIEVWSKTITSFGEWRERDIIPR", "prompt": "Design a snake venom metalloproteinase protein sequence that embodies the key structural and functional characteristics of Bothrops pauloensis venom toxins. This protein should function as a potent hemorrhagic toxin capable of degrading extracellular matrix components, particularly basement membrane proteins like type IV collagen, laminin, and fibronectin. The sequence must include the conserved zinc-binding motif HEXXHXXGXXH characteristic of the reprolysin family of metalloproteinases, along with the methionine turn that coordinates the catalytic zinc ion. Incorporate the typical multi-domain architecture including a pro-domain for latency control, a catalytic domain with the zinc-binding site, and a disintegrin-like domain that may mediate protein-protein interactions. The structural scaffold should feature extensive beta-sheet organization in the catalytic domain and maintain the characteristic 'adamalysin' fold. As a Bothrops species toxin, this metalloproteinase should exhibit the hemorrhagic potency typical of pit viper venoms, contributing to prey immobilization through blood vessel degradation and tissue damage. The protein should be optimized for efficient proteolytic activity against key vascular basement membrane components while maintaining the structural stability required for venom delivery and function."}
{"description": "sp|C0JAX2|A1MB_LOXDE Dermonecrotic toxin LdSicTox-alphaIB3b (Fragment) OS=Loxosceles deserta OX=424440 PE=2 SV=1", "sequence": "WIMGHMVNAIAQIDEFVNLGANSIETDVSFDKNANPEYTYHGIPCDCGRTCTKSEKFNDFLQGLQKATTPGDSKYQEKLVLVVFDLKSSSLYDNQASDAGKKLAKSLLQNYWKNGNNGGRAYIVLSIPNLAHYKLITGFKETLKTEGHPELMEKVGYDFSGNDDIDQVAKAYKKAGVTGHVWQSDGITNCLPRGLDRVKQAVANRDSSNGFINKVYYWTVDKRSTTRGALDAGVDGVMTNYPDVIADVLSESAYKSKFRIATYEDNPWETFKN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the desert recluse spider (Loxosceles deserta) venom. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, and endothelial cell damage that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing the conserved HxKxxxxD motif essential for catalytic activity. The structural scaffold should include the characteristic N-terminal signal peptide for secretion, followed by the mature toxin domain with proper disulfide bonding to stabilize the barrel structure. The toxin should specifically target mammalian cell membranes, with particular affinity for endothelial cells and erythrocytes, contributing to the spider's defensive venom arsenal through localized tissue destruction and potential systemic effects."}
{"description": "sp|Q86QU2|KGX51_CENSC Potassium channel toxin gamma-KTx 5.1 OS=Centruroides sculpturatus OX=218467 PE=3 SV=1", "sequence": "DRDSCVDKSRCAKYGYYGQCEVCCKKAGHNGGTCMFFKCMCVNSKMN", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of gamma-KTx 5.1 from the venom of the Arizona bark scorpion (Centruroides sculpturatus). This toxin belongs to the gamma-KTx family of scorpion toxins that specifically target voltage-gated potassium channels. The protein should function as a potent potassium channel blocker, binding to the pore region of Kv channels to inhibit potassium ion flux and disrupt neuronal and muscular electrical signaling. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, with a disulfide bridge pattern that stabilizes the core structure. The sequence should include key functional residues for channel recognition and binding, particularly in the beta-sheet regions that interact with the channel vestibule. The toxin should exhibit the typical compact globular architecture with well-defined secondary structure elements: an alpha-helix connected to an antiparallel beta-sheet by the conserved disulfide framework. The molecular mechanism involves specific interactions with the channel's turret and pore helix regions, blocking potassium conduction through physical occlusion of the ion conduction pathway. The designed protein should maintain the thermostability and protease resistance typical of scorpion venom peptides while exhibiting selective activity against specific potassium channel subtypes relevant to the scorpion's predatory and defensive strategies."}
{"description": "sp|P69754|O16B_CONMA Delta-conotoxin-like MVIB OS=Conus magus OX=6492 PE=2 SV=2", "sequence": "MKLTCVMIVAVLFLTAWTFVTADDSRYGLKDLFPKERHEMKNPEASKLNQREACYNAGSFCGIHPGLCCSEFCILWCITFVDSG", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a delta-conotoxin-like peptide from the venom of the marine cone snail Conus magus. As a component of this predatory snail's venom arsenal, this toxin functions to rapidly immobilize prey through modulation of voltage-gated ion channels. Specifically, this delta-conotoxin-like peptide is inferred to target voltage-gated sodium channels, acting as a gating modifier that inhibits channel inactivation, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of conotoxins, featuring a compact, disulfide-stabilized globular fold with high thermal and proteolytic stability. It should contain the conserved cysteine framework IV (C-C-CC-C-C) with three disulfide bridges forming the characteristic knot topology. The sequence should include key structural elements: a beta-hairpin motif, tight turns stabilized by disulfide connectivity, and a surface-exposed pharmacophore region responsible for channel interaction. The molecular target interface should involve specific loops that interact with voltage-sensing domains of sodium channels, particularly domains II and IV. The overall structure should be small (approximately 25-35 residues), highly basic due to numerous lysine and arginine residues facilitating membrane approach, and exhibit the characteristic conotoxin fold that enables precise targeting of neuronal ion channels while maintaining venom potency and specificity."}
{"description": "sp|P81755|CT5AS_CONTE Epsilon-conotoxin TxVA OS=Conus textile OX=6494 PE=1 SV=2", "sequence": "MRCFPVFIILLLLIASAPCFDARTKTDDDVPLSSLRDNLKRTIRTRLNIRECCEDGWCCTAAPLTGR", "prompt": "Design a novel epsilon-conotoxin protein sequence derived from the venom of the textile cone snail, Conus textile. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype implicated in pain signaling. The protein must adopt the characteristic epsilon-conotoxin structural scaffold, featuring a conserved cysteine framework (C-C-CC-C-C) that forms three disulfide bridges stabilizing a compact, globular fold. The sequence should include key functional residues for high-affinity binding to the domain IV S3-S4 extracellular loop of the sodium channel, effectively inhibiting channel activation and blocking neuronal excitability. Incorporate conserved hydrophobic patches and polar residues that mediate target recognition while maintaining the toxin's stability in the venom milieu. The final sequence should exhibit the hallmark pharmacological profile of epsilon-conotoxins: rapid onset of action, subtype selectivity, and potent inhibition of sodium currents, contributing to the textile cone snail's predatory strategy by immobilizing prey through neuromuscular blockade."}
{"description": "sp|P86398|KAX9A_MESEU Potassium channel toxin alpha-KTx 9.10 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "VGCEECPMHCKGKNAVPTCDNGVCNCNA", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the lesser Asian scorpion Mesobuthus eupeus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels which play crucial roles in immune cell function and neuronal excitability. The toxin must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif formed by three disulfide bridges with the connectivity pattern C1-C4, C2-C5, C3-C6. The structure should feature a compact, triple-stranded beta-sheet core stabilized by this disulfide framework, with key functional residues concentrated in a bioactive surface that directly interacts with the channel's pore region. The molecular mechanism involves precise occlusion of the potassium conduction pathway through specific interactions with conserved residues in the channel's selectivity filter and voltage-sensing domain, resulting in effective blockade of potassium efflux and disruption of cellular membrane potential. The sequence should include the characteristic alpha-KTx signature motif and maintain the conserved structural elements necessary for both folding stability and target specificity."}
{"description": "sp|Q45Z25|PA2A6_TROCA Acidic phospholipase A2 6 OS=Tropidechis carinatus OX=100989 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGAASIPARPLNLYQFGNMIQCANHGRRPTWHYMDYGCYCGKGGSGTPVDELDRCCQIHDDCYGEAEKLPACNYMMSGPYYNTYSYECNEGELTCKDNNDECKAFICNCDRTAAICFARTPYNDANWNIDTKTRC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the rough-scaled snake (Tropidechis carinatus). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting presynaptic activity that disrupts neuromuscular transmission by hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and catalytic histidine-aspartate dyad. Include the essential structural features: multiple disulfide bridges (typically 6-7 conserved cysteines) that stabilize the compact globular structure, an interfacial binding surface for membrane association, and the characteristic pancreatic loop. The toxin should display acidic isoelectric properties and target presynaptic nerve terminals, causing irreversible blockade of acetylcholine release. Incorporate conserved residues for catalytic activity (histidine, aspartate) and calcium coordination while maintaining the overall structural stability required for venom function in prey immobilization."}
{"description": "sp|F8QN53|PA2A2_VIPRE Acidic phospholipase A2 Vur-PL2B OS=Vipera renardi OX=927686 PE=1 SV=1", "sequence": "MRILWIVAVCLIGVEGNLYQFGKMIRYKTGKSALLSYSDYGCYCGWGGQGKPKDATDRCCFVHDCCYGRVNGCDPKLTIYSYSFENGDIVCGGDDSCKRAVCECDRVAAICFGENLNTYDKKYKNYPSSQCTETEQC", "prompt": "Design a novel acidic phospholipase A2 toxin from the venom of Vipera renardi, a viper species whose venom components play crucial roles in prey immobilization and digestion through potent hemotoxic and myotoxic activities. This phospholipase A2 functions as a key enzymatic toxin that catalyzes the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing free fatty acids and lysophospholipids. The resulting membrane disruption leads to significant pathophysiological effects including hemolysis, inflammation, edema, and potential neurotoxicity through presynaptic or postsynaptic mechanisms. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the essential catalytic histidine-aspartate dyad. It must contain the highly conserved active site motif with the catalytic histidine residue and the calcium-binding loop sequence (Tyr-Gly-Cys). The structure should feature the characteristic disulfide bond pattern common to group II phospholipase A2 enzymes, with multiple conserved cysteine residues forming a stable structural scaffold. As an acidic isoform, the protein should exhibit a net negative charge at physiological pH. The enzyme should demonstrate substrate specificity for phospholipid membranes and require calcium ions for catalytic activity. The generated sequence should maintain the conserved structural elements while incorporating sequence variations that confer the acidic properties and specific toxic activities characteristic of viperid phospholipase A2 toxins."}
{"description": "sp|Q3YEE1|O164_CONMR Conotoxin MaIr94 OS=Conus marmoreus OX=42752 PE=2 SV=1", "sequence": "MKLTCVLIITVLFLTACQLTAAGNSRDKQEDPVVRSSGEVQRSEDIKLAKRCLESGSLCFAGYGHSSCCSGACLDYGGLGVGACR", "prompt": "Design a novel conotoxin sequence derived from the venom of the marine cone snail Conus marmoreus, a predatory gastropod that employs complex peptide toxins for prey capture and defense. This conotoxin should function as a potent neurotoxin targeting ion channels in the nervous system of prey organisms. The sequence must adopt a stable, compact disulfide-rich scaffold characteristic of conotoxins, featuring a conserved cysteine framework that forms multiple intramolecular disulfide bridges to constrain the peptide into a well-defined three-dimensional structure. The structural fold should exhibit the typical conotoxin architecture with defined loops between cysteine residues that mediate specific molecular recognition. The toxin should demonstrate high affinity and selectivity for its ion channel target, likely voltage-gated sodium, potassium, or calcium channels, based on the pharmacological diversity of Conus marmoreus venom. The molecular mechanism should involve precise binding to extracellular domains of the target channel, modulating ion flux and disrupting neuronal signaling. The designed sequence must maintain the evolutionary optimized properties of conotoxins, including protease resistance, thermal stability, and efficient folding, while exhibiting the characteristic pharmacological potency that makes these molecules valuable tools for neuroscience research and potential therapeutic development."}
{"description": "sp|Q45Z11|3S11_OXYSC Short neurotoxin 1 OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCYNQQSSEAKTTTTCSGGVSSCYKKTWSDGRGTIIERGCGCPSVKKGIERICCRTDKCNN", "prompt": "Design a protein sequence for a short neurotoxin from the coastal taipan (Oxyuranus scutellatus), a highly venomous Australian elapid snake. This toxin functions as a potent postsynaptic neurotoxin that specifically targets and irreversibly blocks muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The mechanism involves competitive antagonism where the toxin binds with high affinity to the orthosteric binding site of the α-subunit, preventing acetylcholine from activating the receptor and thereby causing flaccid paralysis. Structurally, this toxin belongs to the three-finger toxin (3FTx) superfamily characterized by a conserved β-sheet-rich fold consisting of three extended loops emerging from a central hydrophobic core. The cysteine framework follows the classic 3FTx pattern with four conserved disulfide bridges (C1-C3, C2-C4, C5-C6, C7-C8) that stabilize the three-loop architecture. Key functional residues are located primarily in the central loop (loop II), which forms the major pharmacophore for receptor binding. The protein should exhibit the characteristic compact globular structure with the three finger-like loops extending from the core, and possess the typical molecular weight of 6-8 kDa. The sequence should maintain the conserved hydrophobic core and the specific structural motifs required for high-affinity binding to the α-δ interface of the muscle nAChR."}
{"description": "sp|A0A7S8MU86|SCX38_TITSE Putative sodium channel toxin Ts38 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKHLKFYSILFLFSIFVYKVNALQKILDGYFLSDEEGLFLSCKHKFDEYFCLEKCVESGAKDGYCVGHSFICFCKYEVGSSPRHFMF", "prompt": "Generate the amino acid sequence for a potent sodium channel toxin from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a site-3 neurotoxin that specifically targets voltage-gated sodium channels (Nav), particularly Nav1.2 and Nav1.6 isoforms, causing a pronounced slowing of fast inactivation and a hyperpolarizing shift in the voltage dependence of activation. The resulting prolonged sodium influx leads to sustained neuronal depolarization, repetitive firing, and ultimately neuroexcitatory symptoms. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, with a cysteine framework of C-C-CC-C-C forming three disulfide bridges that stabilize a compact globular structure comprising an alpha-helix packed against an antiparallel beta-sheet. The molecular mechanism involves binding to receptor site-3 on the extracellular loops of domain IV of the sodium channel alpha subunit, with key functional residues likely located in the conserved 'pharmacophore' region responsible for the allosteric modulation of channel gating. The toxin should exhibit high affinity and selectivity for mammalian neuronal sodium channels, contributing to the potent neurotoxic effects observed in Tityus serrulatus envenomation."}
{"description": "sp|Q9I840|SLYB_CALRH Snaclec rhodocytin subunit beta OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADCPSGWSSYEGHCYKPFNEPKNWADAERFCKLQPKHSHLVSFQSAEEADFVVKLTRPRLKANLVWMGLSNIWHGCNWQWSDGARLNYKDWQEQSECLAFRGVHTEWLNMDCSSTCSFVCKFKA", "prompt": "Design a protein sequence for the beta subunit of rhodocytin, a C-type lectin-like protein (snaclec) from the venom of the Malayan pit viper (Calloselasma rhodostoma). This toxin functions as a potent platelet activator by specifically binding to the platelet receptor CLEC-2, triggering downstream signaling that leads to platelet aggregation and thrombus formation. The protein should adopt the characteristic snaclec fold, featuring a compact globular structure stabilized by conserved disulfide bridges. The sequence must include the canonical C-type lectin-like domain with appropriate cysteine residues for proper disulfide bonding, maintaining the structural integrity required for receptor recognition. Key functional residues should be positioned to facilitate specific interaction with CLEC-2, enabling the protein to act as a strong agonist that mimics physiological platelet activation pathways. The overall architecture should reflect the heterodimeric nature of rhodocytin, with this beta subunit contributing critically to the functional assembly and biological activity of the complete toxin complex."}
{"description": "sp|P56529|CM3E_CONPU Psi-conotoxin PIIIE OS=Conus purpurascens OX=41690 PE=1 SV=3", "sequence": "MSKLGALLTICLLLFPITALLMDGDQPADRPAERMDYDISSEVHRLLERRHPPCCMYGRCRRYPGCSSASCCQGG", "prompt": "Design a novel peptide toxin sequence that captures the biological essence of Psi-conotoxin PIIIE from the venomous marine snail Conus purpurascens. This toxin belongs to the conotoxin superfamily, specifically the psi-class, which are known to selectively target and inhibit neuronal voltage-gated sodium channels. The venom of Conus purpurascens, the purple cone snail, is a complex mixture used for prey capture and defense, with components that rapidly immobilize prey through modulation of ion channels. Psi-conotoxins function as non-competitive antagonists of voltage-gated sodium channels, binding to site 4 and stabilizing the inactivated state, thereby blocking neuronal excitability and synaptic transmission. The sequence should feature the characteristic cysteine framework IV (C-C-CC-C-C) with three disulfide bonds forming a compact, stable globular fold. The structural scaffold is expected to adopt an inhibitor cystine knot (ICK) motif, common to many conotoxins, providing exceptional stability and resistance to proteolysis. Key conserved residues within the inter-cysteine loops should be optimized for high-affinity interaction with the voltage-sensing domain of neuronal sodium channels, particularly Nav1.2 and Nav1.6 subtypes. The molecular target interface involves binding to the S3-S4 extracellular loop of domain II, interfering with voltage-dependent activation. The designed sequence must maintain the precise disulfide connectivity (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) critical for the ICK fold and biological activity, while incorporating loop variations that confer subtype selectivity and potent channel blockade."}
{"description": "sp|P01384|3L21_NOTSC Alpha-elapitoxin-Nss2a OS=Notechis scutatus scutatus OX=70142 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGDSLICYMGPKTPRTCPRGQNLCYTKTWCDAFCSSRGKVVELGCAATCPIAKSYEDVTCCSTDNCNPFPVRPRPHP", "prompt": "Design a novel alpha-elapitoxin protein sequence that captures the essential biological and structural characteristics of snake venom neurotoxins from the tiger snake (Notechis scutatus scutatus). This toxin should function as a potent postsynaptic neurotoxin targeting the neuromuscular junction. The protein must adopt the characteristic three-finger toxin (3FTx) fold, consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework C-C-CC-C-C. The structural scaffold should feature the signature three-loop architecture where loop II contains the critical functional residues for high-affinity binding to nicotinic acetylcholine receptors at the α-γ or α-δ subunit interfaces. The toxin should exhibit competitive antagonism by physically occluding the acetylcholine binding site, leading to neuromuscular blockade and paralysis. Incorporate conserved hydrophobic residues in the core to maintain structural integrity and exposed aromatic/hydrophobic residues in the functional loops for receptor interaction. The sequence should reflect the evolutionary optimization for rapid onset of action and target specificity characteristic of elapid snake venoms, while maintaining the compact, stable three-finger topology that enables efficient diffusion to neuromuscular junctions."}
{"description": "sp|P0DKR4|PA2AB_PSEFE Acidic phospholipase A2 CbIbeta (Fragment) OS=Pseudocerastes fieldi OX=1355908 PE=1 SV=1", "sequence": "DCCYGRVNGCNPKMADKNYE", "prompt": "Generate a protein sequence for an acidic phospholipase A2 toxin from the venom of the Field's horned viper (Pseudocerastes fieldi). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 acyl bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGNYCG) and catalytic network involving a histidine-aspartate dyad. It should feature the typical disulfide bridge pattern of group II phospholipase A2 toxins (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8) that stabilizes the globular structure. As an acidic isoform, it should preferentially target neuronal membranes and skeletal muscle tissue, causing presynaptic neurotoxicity through disruption of neurotransmitter release and direct myotoxicity via membrane damage. The sequence should include conserved functional motifs including the interfacial binding surface for membrane association and the hydrophobic channel for substrate access to the active site."}
{"description": "sp|P0DJK0|SRTX1_ATRIR Sarafotoxin-i1 OS=Atractaspis irregularis OX=512568 PE=1 SV=1", "sequence": "MALLPRLAAGGLLLLLALAALDGKPAPPKLLQKLMDGGQRRSEDQAAAGRIIDYEDGDEPVAVSVGDTKQAARALSPLRKPQPLCSCTDMSDLECMNFCHKDVIWINRNRKPSPIQSS", "prompt": "Design a protein sequence for a highly potent sarafotoxin from the venom of the irregular burrowing asp, Atractaspis irregularis. This toxin belongs to the endothelin/sarafotoxin family and functions as a potent vasoconstrictor through selective agonism of endothelin receptors, particularly the ETB receptor subtype. The protein should adopt the characteristic sarafotoxin fold stabilized by two conserved disulfide bridges with a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming a compact, globular structure with an N-terminal extended region and a C-terminal alpha-helical domain. The sequence must include the critical pharmacophore residues responsible for receptor binding and activation, including conserved aromatic and hydrophobic residues that interact with the endothelin receptor binding pocket. The toxin should exhibit high affinity for endothelin receptors, triggering sustained vasoconstriction and contributing to the rapid cardiovascular collapse characteristic of Atractaspis envenomation. The structural scaffold should maintain the characteristic cysteine knot-like topology common to this toxin family while ensuring proper folding and biological activity."}
{"description": "sp|Q86QT3|KGX11_CENNO Potassium channel toxin gamma-KTx 1.1 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "MKVLILIMIIASLMIMGVEMDRDSCVDKSRCAKYGYYQECQDCCKNAGHNGGTCMFFKCKCA", "prompt": "Design a potassium channel toxin protein sequence derived from the venom of the scorpion Centruroides noxius. This toxin belongs to the gamma-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The toxin should contain key functional motifs that enable specific binding to the pore region of Kv1.x family potassium channels, blocking ion conduction through competitive inhibition at the channel vestibule. The molecular mechanism involves disrupting neuronal excitability and synaptic transmission by preventing potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The sequence should include conserved residues in the functional dyad (typically involving a lysine or arginine residue positioned to interact with the channel pore) and maintain the characteristic beta-sheet secondary structure elements connected by flexible loops that facilitate target recognition. The overall structure should be thermostable and resistant to proteolytic degradation, reflecting its evolutionary optimization for venom delivery and target specificity."}
{"description": "sp|C0HK18|VSP4_CRODO Thrombin-like enzyme collinein-4 (Fragment) OS=Crotalus durissus collilineatus OX=221569 PE=1 SV=1", "sequence": "GGDECNINEHRSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGILEGGKDTCHR", "prompt": "Design a thrombin-like serine protease toxin derived from the venom of Crotalus durissus collilineatus, a subspecies of the tropical rattlesnake. This enzyme functions as a key component in the snake's predatory and defensive arsenal by selectively cleaving fibrinogen to generate fibrin monomers, thereby promoting localized coagulation and potentially leading to consumptive coagulopathy in envenomed prey. The protein should adopt the characteristic chymotrypsin-like fold common to snake venom serine proteases, featuring a two-domain structure with the catalytic triad (His, Asp, Ser) positioned within the active site cleft. Incorporate the conserved structural elements including multiple disulfide bridges that stabilize the compact globular architecture, with specific cysteine pairings typical of SVSPs that constrain the substrate-binding loops and ensure precise specificity for fibrinogen cleavage over other coagulation factors. The molecular mechanism involves binding to fibrinogen's Aα and Bβ chains and cleaving at specific Arg-Gly bonds to release fibrinopeptides A and/or B, mimicking thrombin's procogulant activity while potentially exhibiting altered kinetics or secondary fibrinolytic effects. Include surface loops and exosite regions that confer selectivity for fibrinogen over other physiological serine protease substrates, contributing to the toxin's role in disrupting hemostasis through controlled induction of thrombosis."}
{"description": "sp|Q7Z1K5|SCX6_CENLI Toxin Cll6 OS=Centruroides limpidus OX=6876 PE=2 SV=1", "sequence": "MNSLLMIIGCLVLIGTVWTKEGYLVNMKTGCKYGCYELGDNGYCDRKCKAESGNYGYCYTVGCWCEGLPNSKPTWPLPGKSCSGK", "prompt": "Design a novel scorpion toxin protein sequence based on the biological profile of Toxin Cll6 from the Mexican scorpion Centruroides limpidus. This toxin belongs to the beta-KTx scorpion toxin family and functions as a potent potassium channel blocker. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix stabilized against an antiparallel beta-sheet by disulfide bridges. The cysteine framework should follow the C-X(3-7)-C-X(3-7)-C-X(0-4)-C-X(1-4)-C-X(4-13)-C pattern, forming three disulfide bonds with connectivity C1-C4, C2-C5, C3-C6. The functional core should include a functional dyad composed of a critical lysine residue positioned to interact with the channel pore and a hydrophobic residue that aids in binding specificity. The toxin should specifically target voltage-gated potassium channels (Kv channels), particularly Kv1.2 and Kv1.3 subtypes, blocking ion conduction by physically occluding the channel pore. The mechanism involves binding to the channel's outer vestibule, with the functional lysine residue inserting into the selectivity filter to prevent potassium ion permeation. The structural scaffold should maintain the compact, globular architecture typical of scorpion neurotoxins, with the functional dyad properly positioned on the molecular surface for effective channel interaction. The sequence should reflect the evolutionary optimization for rapid paralysis of insect prey through disruption of neuronal excitability."}
{"description": "sp|C0JAZ4|A1OB1_LOXVA Dermonecrotic toxin LvSicTox-alphaIC1bi (Fragment) OS=Loxosceles variegata OX=571533 PE=2 SV=1", "sequence": "WIMGHMVNNIKQIDEFVNLGSNAIETDVSFDKKANPEYTYHGTPCDCGRDCLRWEYFNDFVKALRTATTPGNSKYDKLFLVVFDLKTGSLYDYQASEAGTKLAKNLLQHYWNNGNNGGRAYIILSIPNLKHYKLITGFQQTLKDEGHAELLDKVGYDFSGNDDIGDVQKTYEKAGVTGHVWQSDGITNCLLRGFTRINAAVANRDSANGIINKVYYWTVDKRQTTRDTLDANVDGIMTNYPDITVEILNEDAYKTKFRIATYEDNPWETFKE", "prompt": "Generate the complete amino acid sequence for a dermonecrotic toxin from the recluse spider Loxosceles variegata. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, endothelial cell damage, platelet aggregation, and complement activation, leading to the characteristic dermonecrotic lesions and systemic effects observed in loxoscelism. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold characteristic of the phospholipase D superfamily, with the catalytic histidine and other essential residues properly positioned in the active site pocket to coordinate the magnesium cofactor and facilitate substrate binding and hydrolysis. The sequence should include the N-terminal signal peptide for secretion and the mature toxin domain with appropriate length and structural elements to maintain enzymatic activity and stability in the venom gland and upon delivery to prey or human victims."}
{"description": "sp|A0A7S8MUG8|SCX34_TITSE Putative sodium channel toxin Ts34 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MNLPLLLLITILIEIHALKDGYVIYKNSNCKYSCNINEKWKYCSPLCQKKHGKTGYCYFFACWCTDLPNDVPIYGETGSYCWSNK", "prompt": "Design a novel animal toxin protein sequence that functions as a sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should exhibit the characteristic biological activity of modulating voltage-gated sodium channels, likely acting as a beta-toxin that shifts the voltage dependence of activation to more negative potentials, thereby enhancing neuronal excitability and contributing to the venom's neurotoxic effects. The protein should adopt a compact, stable structural scaffold typical of scorpion toxin beta-family members, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold. This fold is characterized by an alpha-helix packed against an antiparallel beta-sheet, stabilized by a specific disulfide bridge pattern, typically with four disulfide bonds in a C-C-C-C framework (e.g., C1-C4, C2-C5, C3-C6, C7-C8 for an eight-cysteine toxin). The molecular target is the voltage-gated sodium channel, with the toxin binding to site 4 on the channel's domain II voltage sensor, interfering with channel inactivation and prolonging action potentials. The sequence should include key functional residues for receptor interaction, such as a conserved hydrophobic patch and charged residues involved in electrostatic interactions with the channel. The overall structure should be highly stable, resistant to proteolysis, and exhibit the typical molecular weight and isoelectric point range of scorpion neurotoxins."}
{"description": "sp|P0C7I1|CM3E_CONPI Psi-conotoxin PrIIIE OS=Conus parius OX=505247 PE=1 SV=1", "sequence": "MSKLGVLLTICLLLFPITALPVDGDQPADRPVERMQDNISSEQHPFFEKRAARCCTYHGSCLKEKCRRKYCCGR", "prompt": "Design a novel peptide toxin sequence that embodies the biological and structural characteristics of Psi-conotoxin PrIIIE from the marine cone snail Conus parius. This toxin belongs to the conotoxin superfamily, specifically the psi-conotoxin family, which is known for its unique mechanism of action targeting voltage-gated sodium channels. The peptide should function as a potent modulator of neuronal sodium channels, likely exhibiting inhibitory effects that interfere with action potential generation and propagation in the nervous system. Structurally, it should adopt the characteristic conotoxin fold stabilized by a specific disulfide bond framework—anticipated to follow the globular cysteine pattern (C-C-CC-C-C) typical of many conotoxins, forming a compact, stable scaffold with defined loops that mediate target interaction. The molecular target is expected to be specific subtypes of voltage-gated sodium channels, with binding likely occurring at site 1 or site 4, influencing channel gating or inactivation. The sequence should reflect the evolutionary adaptation of Conus parius venom for prey capture, emphasizing high affinity and selectivity for sodium channels to ensure rapid neurotoxic effects. Key structural motifs may include an inhibitor cystine knot (ICK) fold or similar, with well-defined beta-sheets and loops that confer target specificity. Ensure the design captures the essence of a small, disulfide-rich venom peptide optimized for stability, potency, and precise molecular targeting in a marine predatory context."}
{"description": "sp|B3EWT7|TXC2B_CUPSA Cupiennin-2b OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "AFGTILKALAKIAAKVVKKLATKPGATYMLKQNLQ", "prompt": "Design a novel peptide toxin sequence inspired by the biological characteristics of Cupiennin-2b from the wandering spider Cupiennius salei. This peptide should function as a potent cytolytic and antimicrobial agent, mimicking the natural toxin's mechanism of membrane disruption. The sequence must adopt an amphipathic alpha-helical conformation when interacting with lipid bilayers, characterized by a clear segregation of hydrophobic and hydrophilic residues along the helical axis. The hydrophobic face should facilitate insertion into biological membranes, while the cationic hydrophilic face enables initial electrostatic interactions with anionic phospholipid headgroups. The peptide should exhibit broad-spectrum activity against both Gram-positive and Gram-negative bacteria through membrane permeabilization, while also demonstrating hemolytic activity against eukaryotic cells via similar membrane-disruptive mechanisms. The structural scaffold should maintain the characteristic features of spider venom cytolytic peptides, with optimal length for helical formation and membrane insertion, and appropriate residue composition to balance antimicrobial efficacy with potential therapeutic applications. The final sequence should represent a functional analog of natural Cupiennin peptides, capturing their essential membrane-active properties and structural organization."}
{"description": "sp|P0C7J7|BPP11_BOTAL Bradykinin-potentiating peptide 11 OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "QWPDPSSDIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of Bothrops alternatus, a pit viper species. This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and promoting vasodilation. The peptide should adopt a compact, stable structure stabilized by disulfide bonds, characteristic of the BPP family, with a conserved cysteine framework that forms specific disulfide bridges essential for its biological activity. The sequence should include key residues involved in ACE inhibition, such as a C-terminal pyroglutamate residue and proline-rich regions that contribute to its stability and resistance to proteolytic degradation. The overall structure should be optimized for high affinity binding to the active site of ACE, effectively blocking its catalytic function and leading to prolonged bradykinin-mediated vasodilation, which is crucial for the venom's role in prey immobilization through hypotension."}
{"description": "sp|F8QN54|PA2B_VIPRE Basic phospholipase A2 vurtoxin OS=Vipera renardi OX=927686 PE=1 SV=1", "sequence": "MRTLWIVAVCLIGVEGSLLEFGMMILEETGKNPLTSYSFYGCYCGVGGKGTPKDATDRCCFVHDCCYGNLPDCNPKIDRYKYHRKNGAIVCGKGTSCENRICECDRAAAICFRKNLKTYNHIYKYYPDFLCKKESEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Vipera renardi (renard's viper). This toxin, known as vurtoxin, functions as a key venom component that targets biological membranes through phospholipid hydrolysis. The protein should exhibit the characteristic phospholipase A2 enzymatic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, inflammation, and potential hemolytic or myotoxic effects. The structural scaffold must include the conserved phospholipase A2 fold, featuring three long alpha-helices stabilized by a central beta-wing and multiple disulfide bridges. The sequence should contain the essential catalytic dyad (histidine and aspartate residues) within the conserved calcium-binding loop, along with the characteristic elapidic loop region. The protein should be basic in nature, facilitating interactions with anionic membrane surfaces. Key structural elements include the N-terminal helix, the calcium-binding loop with the YGCXCG motif, and the C-terminal extension. The molecular target is primarily phospholipid membranes, with potential specificity for neuronal or muscular tissues, and the binding interface involves the interfacial recognition surface surrounding the active site. The toxin should exhibit stability through multiple disulfide bonds characteristic of group II phospholipase A2 enzymes from viperid venoms."}
{"description": "sp|C0HK19|VSP3_CRODO Thrombin-like enzyme collinein-3 (Fragment) OS=Crotalus durissus collilineatus OX=221569 PE=1 SV=1", "sequence": "WDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRPHCANINLLDYEVCRTAHPQFRLPATSRILCAGVLEGGIDTCHR", "prompt": "Design a thrombin-like serine protease toxin derived from the venom of the South American rattlesnake Crotalus durissus collilineatus. This enzyme functions as a key component in the snake's predatory arsenal by mimicking the activity of mammalian thrombin, specifically cleaving fibrinogen to generate fibrin monomers that polymerize into unstable clots. This procoagulant mechanism leads to consumptive coagulopathy and hemorrhage in prey. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and exhibit specificity for arginine residues at the P1 position. It should feature the canonical serine protease activation mechanism with an N-terminal propeptide that is proteolytically removed to generate the mature, active enzyme. The structure should include the characteristic two-barrel domain architecture with substrate-binding pockets that confer its thrombin-like specificity while lacking the full regulatory functions of endogenous thrombin. Key structural elements should include the oxyanion hole for transition state stabilization and disulfide bridges that stabilize the protease fold, typically including conserved Cys-Cys pairs that maintain structural integrity in the venom gland environment. The enzyme should demonstrate preferential cleavage of fibrinogen over other coagulation factors, contributing to the defibrination syndrome characteristic of viperid envenomations."}
{"description": "sp|P81382|OXLA_CALRH L-amino-acid oxidase OS=Calloselasma rhodostoma OX=8717 PE=1 SV=2", "sequence": "MNVFFMFSLLFLAALGSCADDRNPLAECFQENDYEEFLEIARNGLKATSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERPGGRVRTYRNEEAGWYANLGPMRLPEKHRIVREYIRKFDLRLNEFSQENDNAWYFIKNIRKKVGEVKKDPGLLKYPVKPSEAGKSAGQLYEESLGKVVEELKRTNCSYILNKYDTYSTKEYLIKEGDLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVDGMDKLPTAMYRDIQDKVHFNAQVIKIQQNDQKVTVVYETLSKETPSVTADYVIVCTTSRAVRLIKFNPPLLPKKAHALRSVHYRSGTKIFLTCTTKFWEDDGIHGGKSTTDLPSRFIYYPNHNFTNGVGVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKKDIQSFCYPSVIQKWSLDKYAMGGITTFTPYQFQHFSDPLTASQGRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNLASENPSGIHLSNDNEL", "prompt": "Generate the amino acid sequence for a potent L-amino-acid oxidase toxin from the venom of the Malayan pit viper, Calloselasma rhodostoma. This enzyme should function as a key venom component that catalyzes the oxidative deamination of L-amino acids, producing hydrogen peroxide, ammonia, and the corresponding α-keto acid. The resulting hydrogen peroxide contributes to local tissue damage, hemorrhage, and inflammation at the bite site, while the depletion of essential amino acids may disrupt cellular metabolism. The protein should adopt the classic flavin adenine dinucleotide (FAD)-binding fold characteristic of L-amino-acid oxidases, with conserved residues for FAD cofactor binding and substrate recognition. It should exhibit the typical homodimeric quaternary structure in its active form, with each monomer containing the essential catalytic domain that facilitates the redox reaction. The sequence should include key structural motifs for dimerization, FAD binding pockets, and substrate access channels that confer specificity for L-amino acids over their D-enantiomers. This toxin plays a crucial role in the viper's predatory and defensive strategy by inducing local necrosis and potentiating the effects of other venom components."}
{"description": "sp|P56678|SCL3_LEIHE Alpha-like toxin Lqh3 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "VRDGYIAQPENCVYHCFPGSSGCDTLCKEKGGTSGHCGFKVGHGLACWCNALPDNVGIIVEGEKCHS", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by Leiurus hebraeus (Yellow Israeli scorpion) venom components. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the channel's voltage-sensing domain to delay inactivation and prolong action potentials, leading to neuronal hyperexcitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved beta-sheet core stabilized by the disulfide network, with flexible loops that mediate specific interactions with the sodium channel's domain IV voltage sensor. The molecular target should be mammalian neuronal sodium channels (Nav1.1-Nav1.7), with particular affinity for channels involved in pain pathways. The toxin should exhibit the typical molecular weight range of 6-8 kDa and maintain the evolutionary conserved pharmacophore residues responsible for channel recognition and binding affinity, while incorporating sequence variations that enhance specificity for pathological sodium channel isoforms."}
{"description": "sp|P0DKQ3|M7E_CONCN Omega-conotoxin-like CnVIIE OS=Conus consors OX=101297 PE=1 SV=2", "sequence": "MKLTCVVIVAVLLLTACQLITADDSRGTQKHRALRSDTKLSMSTRCKGTGKPCSRIAYNCCTGSCRSGKCG", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus consors. This venom component should function as a potent calcium channel blocker, specifically targeting neuronal voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and induce neurotoxic effects. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern (C-C-CC-C-C) that forms a compact, triple-stranded beta-sheet fold. Key structural elements must include a rigid, knotted core with well-defined loops that mediate target specificity, particularly the omega-loop region critical for channel pore occlusion. The sequence should encode a mature peptide of approximately 25-30 residues, rich in basic amino acids to facilitate membrane interaction, and include conserved pharmacophore residues for high-affinity binding to Cav2.2 (N-type) calcium channels. Ensure the toxin exhibits selective ion channel inhibition, contributing to the predatory venom arsenal of Conus consors by paralyzing prey through presynaptic blockade of neurotransmitter release."}
{"description": "sp|Q7LZG5|PA2_NOTSC Phospholipase A2 II-5b (Fragment) OS=Notechis scutatus scutatus OX=70142 PE=1 SV=1", "sequence": "NLIQLSNMIKCAIPGSQPLF", "prompt": "Design a protein sequence for a phospholipase A2 toxin derived from the venom of Notechis scutatus scutatus (Tiger Snake), a highly venomous elapid snake native to Australia. This toxin belongs to the group II secreted phospholipase A2 family, which plays a critical role in the venom's neurotoxic, myotoxic, and pro-inflammatory effects. The protein should function by hydrolyzing the sn-2 ester bond of glycerophospholipids in cell membranes, releasing lysophospholipids and free fatty acids such as arachidonic acid, which can be metabolized into pro-inflammatory eicosanoids. This enzymatic activity contributes to membrane disruption, presynaptic neurotoxicity at neuromuscular junctions, and systemic effects including hemolysis and tissue damage. The structural scaffold should feature the characteristic phospholipase A2 fold, comprising three long alpha-helices stabilized by a conserved network of disulfide bridges. Key structural elements include a conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, an interfacial binding surface for membrane association, and a hydrophobic channel leading to the active site. The active site should contain the canonical catalytic dyad of histidine and aspartate residues, with surrounding residues forming the oxyanion hole. The protein should exhibit the typical compact, globular structure of secreted phospholipase A2 enzymes, with molecular weight around 13-15 kDa. Ensure the sequence includes the conserved pattern of 6-8 disulfide bonds that stabilize the core structure, particularly those critical for maintaining the catalytic site geometry and membrane-binding interface."}
{"description": "sp|P56854|TX482_HYSGI Omega-theraphotoxin-Hg1a OS=Hysterocrates gigas OX=118972 PE=1 SV=1", "sequence": "GVDKAGCRYMFGGCSVNDDCCPRLGCHSLFSYCAWDLTFSD", "prompt": "Design a protein sequence for an animal venom toxin with the following precise biological and structural specifications: This toxin is an omega-theraphotoxin from the tarantula species Hysterocrates gigas, commonly known as the Cameroon red baboon tarantula. As a member of the inhibitor cystine knot (ICK) toxin superfamily, it functions as a potent voltage-gated calcium channel (Cav) antagonist, specifically targeting presynaptic Cav2.2 (N-type) channels in the vertebrate nervous system. The toxin achieves its neurotoxic effects by binding to the channel's voltage-sensing domain with high affinity, thereby inhibiting neurotransmitter release and causing paralysis in prey. The structural scaffold must feature the characteristic ICK motif with a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming a stable, triple-stranded beta-sheet fold stabilized by the cystine knot. This compact, globular structure includes key functional loops—particularly the pharmacophore loop—that mediate target specificity and binding affinity. The sequence should reflect the typical length and physicochemical properties of spider venom ICK toxins, including a high density of basic residues that facilitate interaction with the negatively charged channel surfaces. The resulting protein must exhibit selective Cav2.2 channel blockade, contributing to the venom's role in prey immobilization."}
{"description": "sp|P0DKQ6|M7J_CONCN Omega-conotoxin-like CnVIIJ OS=Conus consors OX=101297 PE=1 SV=2", "sequence": "MKLTCVVIVAVLLLTACQLITADDSRGTQKHRSLRSTTKVSKSTSCMKAGSYCRSTTRTCCGYCAYFGKFCIDFPSN", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications: This protein is an omega-conotoxin-like peptide derived from the venom of the marine cone snail Conus consors. As a component of this predatory gastropod's venom arsenal, this toxin functions to immobilize prey through targeted modulation of neuronal signaling pathways. The protein belongs to the conotoxin superfamily and specifically exhibits structural and functional homology to omega-conotoxins, which are known to selectively block voltage-gated calcium channels (VGCCs), particularly N-type (Cav2.2) and/or P/Q-type (Cav2.1) calcium channels in the nervous system. Its mechanism of action involves high-affinity binding to the pore-forming α1 subunit of these channels, thereby inhibiting calcium influx and disrupting neurotransmitter release at presynaptic terminals, leading to flaccid paralysis. The protein is expected to adopt the conserved inhibitory cysteine knot (ICK) motif characteristic of omega-conotoxins, stabilized by a specific disulfide bridge connectivity pattern (cysteine framework I: C-C-CC-C-C) that forms a compact, triple-stranded beta-sheet structure. Key structural elements include a well-defined beta-hairpin and loops that mediate target recognition, with the second and third loops being critical for channel binding specificity. The sequence should encode a small, disulfide-rich peptide (approximately 25-30 amino acids) with the appropriate cysteine spacing to facilitate correct folding into the ICK scaffold. Ensure the design incorporates conserved residues known to be essential for stabilizing the knot structure and for interacting with the channel's extracellular domains, while allowing for sequence variations that confer the omega-conotoxin-like activity profile."}
{"description": "sp|P00606|PA2A_BUNMU Acidic phospholipase A2 OS=Bungarus multicinctus OX=8616 PE=1 SV=2", "sequence": "MNPAHLLILSAVCVSLLGAANVPPQHLNLYQFKNMIVCAGTRPWIGYVNYGCYCGAGGSGTPVDELDRCCYVHDNCYGEAEKIPGCNPKTKTYSYTCTKPNLTCTDAAGTCARIVCDCDRTAAICFAAAPYNINNFMISSSTHCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bungarus multicinctus (many-banded krait). This enzyme plays a critical role in the potent neurotoxicity of krait venom by hydrolyzing the sn-2 ester bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The resulting membrane disruption and generation of bioactive lipid mediators contribute to presynaptic neurotoxicity, muscle paralysis, and tissue damage. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges with the pattern Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, and Cys13-Cys14. Include the canonical calcium-binding loop (Tyr-Gly-Cys) and catalytic dyad (His-Asp) essential for enzymatic activity. The acidic nature should be reflected through a predominance of aspartic and glutamic acid residues, particularly in surface-exposed regions. The structure should feature a hydrophobic channel for substrate access to the active site and maintain the interfacial activation mechanism characteristic of venom phospholipases A2."}
{"description": "sp|P56708|O16A_CONMR Mu-conotoxin MrVIA OS=Conus marmoreus OX=42752 PE=1 SV=2", "sequence": "MKLTCMMIVAVLFLTAWTLVMADDSNNGLANHFSKSRDEMEDPEASKLEKRACRKKWEYCIVPIIGFIYCCPGLICGPFVCV", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the marine cone snail Conus marmoreus. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the Nav1.4 subtype predominantly expressed in skeletal muscle. The mechanism of action involves high-affinity binding to site 1 of the sodium channel, effectively blocking sodium ion flux and inducing rapid neuromuscular paralysis. The structural scaffold must adhere to the characteristic mu-conotoxin framework, featuring a compact, globular fold stabilized by three disulfide bridges with a conserved C-C-CC-C-C connectivity pattern. The core structure should include a well-defined beta-hairpin motif and several reverse turns that create a stable molecular surface for precise interaction with the sodium channel pore domain. Key functional residues should be positioned to form critical electrostatic and hydrophobic contacts with the channel's selectivity filter and surrounding regions. The overall architecture should exhibit high thermal and proteolytic stability typical of conotoxins, with a molecular weight under 4 kDa. The sequence must encode the appropriate cysteine spacing and framework to ensure proper oxidative folding into the native bioactive conformation."}
{"description": "sp|P69755|O16C_CONMA Delta-conotoxin-like MVIC OS=Conus magus OX=6492 PE=2 SV=2", "sequence": "MKLTCVMIVAVLFLTTWTFVTADDSRYGLKNLFPKARHEMKNPEASKLNKRDECYPPGTFCGIKPGLCCSAICLSFVCISFDF", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a delta-conotoxin-like peptide derived from the venom of the marine cone snail Conus magus. As a component of this predatory snail's venom cocktail, this toxin functions to immobilize prey through modulation of voltage-gated ion channels. Specifically, this delta-conotoxin-like peptide is inferred to act as a voltage-gated sodium channel modulator, potentially delaying channel inactivation to prolong neuronal excitation and induce paralysis. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif common to conotoxins, featuring a compact, disulfide-stabilized globular fold. It should contain the conserved cysteine framework IV (C-C-CC-C-C) with three disulfide bridges forming the structural core that provides exceptional stability and defines the bioactive surface. The mature peptide should be approximately 25-35 amino acids in length with the cysteine residues positioned to create the proper ICK fold. The molecular surface should present specific loops and residues optimized for interaction with voltage-gated sodium channels, particularly those expressed in neuromuscular systems of the snail's prey. The sequence should maintain the characteristic hydrophobicity patterns and secondary structure elements typical of conotoxins, including beta-sheets and tight turns that create the functional binding interface."}
{"description": "sp|Q86QU7|KGX47_CENLI Potassium channel toxin gamma-KTx 4.7 OS=Centruroides limpidus OX=6876 PE=3 SV=1", "sequence": "DRDSCVDKSKCAKYGYYGQCDECCKKAGDRAGNCVYLKCKCNQ", "prompt": "Design a potassium channel toxin protein from the venom of the Mexican scorpion Centruroides limpidus. This toxin belongs to the gamma-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by three or four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet. The molecular mechanism involves specific binding to the voltage-sensing domain or pore region of Kv1.x family potassium channels, effectively blocking potassium ion flux and disrupting neuronal excitability. Include key functional residues in the beta-hairpin and loop regions that mediate target recognition and binding affinity. The toxin should exhibit the typical molecular weight range of 3-8 kDa and maintain the high thermal and proteolytic stability conferred by the disulfide-stabilized framework. This toxin contributes to the scorpion's predatory and defensive arsenal by causing paralysis through inhibition of potassium channel function in prey organisms."}
{"description": "sp|Q8AWI5|VM3HA_GLOHA Zinc metalloproteinase-disintegrin-like halysase OS=Gloydius halys OX=8714 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVPALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFTLQGETYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQNWESYEPIKKASQSNLTPEQQRYLNAKKYVKLVMVADYIMYLKYDRNLTTVRTRMYDIVNVINVIYQRMNIHVALVGLEIWSNKDKFILRSAADVTLKLFATWRETDLLKRKSHDNAQLLTGINFNGPTAGLGYLGGICNPMYSAGIVQDHNKIHHLVAIAMAHEMGHNLGIDHDKDTCTCGAKSCVMAGTLSCEASYLFSDCSRKEHQAFLIKDMPQCILKKPLKTDVVSPPVCGNYFVEVGEDCDCGSPATCRDSCCDAATCKLRQGAQCAEGLCCDQCRFKGAGTECRAATDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNGKCPIMTDQCIALFGPNAAVSEDACFQFNLEGNHYGYCRKEQNTKIACEPQNVKCGRLYCIDSSPANKNPCNIYYSPGDEDKGMVLPGTKCADGKACSNGQCVDVNRAS", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin from the venom of the Siberian pit viper (Gloydius halys) that functions as a potent hemorrhagic agent. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), comprising a pro-domain, a metalloproteinase domain containing the conserved zinc-binding motif HEXXHXXGXXH for catalytic activity, and a disintegrin-like domain. The disintegrin-like domain should feature the canonical RGD or related tripeptide motif to mediate inhibition of platelet aggregation by antagonizing integrin receptors on platelets and endothelial cells, thereby contributing to the hemorrhagic and anticoagulant effects. The protein should adopt a compact, globular fold stabilized by multiple disulfide bridges, typical of SVMPs, with the metalloproteinase domain exhibiting a metzincin-like tertiary structure characterized by a central five-stranded β-sheet and surrounding α-helices. The overall structure should facilitate proteolytic cleavage of basement membrane components such as collagen IV and laminin, leading to vascular damage and hemorrhage. Ensure the sequence reflects the evolutionary adaptations for rapid tissue penetration and systemic dissemination observed in viperid venoms."}
{"description": "sp|P0DMB6|PA11_VESVE Phospholipase A1 verutoxin-1 (Fragment) OS=Vespa velutina OX=202808 PE=1 SV=1", "sequence": "GLLPKVKLVPEQISFILSTRENR", "prompt": "Design a protein sequence for a phospholipase A1 toxin from the venom of Vespa velutina (Asian hornet). This toxin should function as a potent verutoxin-1, exhibiting strong phospholipase A1 activity that specifically hydrolyzes the sn-1 ester bond of membrane phospholipids, leading to membrane disruption, hemolysis, and potent cytotoxic effects. The protein should adopt the canonical phospholipase A1 fold characterized by a conserved α/β hydrolase structure with a catalytic triad typically consisting of Ser-Asp-His residues. The active site should feature a hydrophobic substrate-binding pocket optimized for recognizing and cleaving phospholipid substrates. The structural scaffold should include the characteristic N-terminal β-sheet domain and C-terminal α-helical bundle, stabilized by multiple disulfide bridges that confer stability in the venom environment. This phospholipase A1 should be evolutionarily optimized for rapid membrane penetration and efficient catalytic activity, contributing to the hornet's defensive and predatory capabilities through tissue damage, inflammation induction, and potential neurotoxic effects via secondary messenger pathways."}
{"description": "sp|A0A7S8MV32|SCX39_TITSE Putative sodium channel toxin Ts39 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKTLNFCLFLVIISSLTVRVFCLNDRFLTVNDNYVICLYINKSFVNCENLCKAYMNAKDGFCRQPHCFCTDVE", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus, a medically significant species known for producing potent neurotoxins that target voltage-gated sodium channels. This toxin should function as a specific modulator of sodium channel gating, likely exhibiting beta-type scorpion toxin characteristics that alter channel activation kinetics and enhance neuronal excitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by three or four disulfide bridges with a characteristic C-C-CC-C-C connectivity pattern. The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with distinct functional loops responsible for receptor recognition. The toxin should specifically interact with voltage-sensing domains of neuronal sodium channels, particularly Nav1.2, Nav1.3, or Nav1.6 isoforms, through electrostatic and hydrophobic interactions that modify channel voltage dependence. The molecular surface should present key functional residues in strategic loops that form the pharmacophore, including conserved basic residues for electrostatic steering and hydrophobic patches for membrane association. The overall structure should maintain the characteristic compactness and stability of scorpion neurotoxins, with molecular weight around 6-8 kDa and high thermal stability due to the extensive disulfide network."}
{"description": "sp|P58296|SCXB_CENNO Toxin Cn11 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "ARDGYPVDEKGCKLSCLINDKWCNSACHSRGGKYGYCYTGGLACYCEAVPDNVKVWTYETNTC", "prompt": "Design a potent animal toxin protein sequence that mimics the biological activity and structural characteristics of toxin Cn11 from the venom of the Mexican scorpion Centruroides noxius. This toxin belongs to the beta-toxin family of scorpion venom peptides that specifically target voltage-gated sodium channels. The protein should function as a beta-toxin, binding to site-4 of voltage-gated sodium channels (Nav channels) and modifying channel gating kinetics to cause prolonged action potential duration and enhanced neurotransmitter release. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core globular structure consisting of an alpha-helix packed against an anti-parallel beta-sheet. The molecular mechanism involves binding to the voltage-sensing domain of Nav channels, particularly affecting channel inactivation and causing hyperexcitability in neuronal and muscular tissues. The toxin should exhibit high specificity for mammalian sodium channel subtypes, contributing to the neurotoxic effects characteristic of Centruroides noxius envenomation, which includes intense pain, autonomic dysfunction, and potentially life-threatening neurological symptoms. The sequence must maintain the conserved structural motifs and functional residues necessary for sodium channel interaction while preserving the compact, stable fold typical of scorpion beta-toxins."}
{"description": "sp|Q9I841|SLYA_CALRH Snaclec rhodocytin subunit alpha OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "GLEDCDFGWSPYDQHCYQAFNEQKTWDEAEKFCRAQENGAHLASIESNGEADFVSWLISQKDELADEDYVWIGLRAQNKEQQCSSEWSDGSSVSYENLIDLHTKKCGALEKLTGFRKWVNYYCEQMHAFVCKLLPY", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the Malayan pit viper (Calloselasma rhodostoma) that functions as a potent platelet activator. This toxin should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure with two antiparallel beta-sheets flanked by alpha-helices. The protein must contain the conserved disulfide bond pattern typical of snake venom C-type lectins, with specific cysteine residues forming intramolecular bridges that stabilize the fold. The molecular mechanism involves binding to the platelet receptor CLEC-2 via its carbohydrate recognition domain-like interface, triggering downstream signaling that leads to platelet aggregation and thrombus formation. The sequence should maintain key residues for receptor recognition and dimerization with its beta subunit partner, while preserving the structural integrity required for its pro-thrombotic activity in viper envenomation."}
{"description": "sp|P01385|3L21_ACAAN Alpha-elapitoxin-Aa2b OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "VICYRGYNNPQTCPPGENVCFTRTWCDAFCSSRGKVVELGCAATCPIVKSYNEVKCCSTDKCNPFPVRPRRPP", "prompt": "Design a novel alpha-elapitoxin protein sequence that captures the potent neurotoxic activity characteristic of death adder (Acanthophis antarcticus) venom. This toxin should function as a postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the classic three-finger toxin fold, characterized by three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a C-C-C-C-C-C-C-C cysteine framework. Key structural elements should include: (1) a central core with the conserved disulfide pattern typical of short-chain neurotoxins, (2) functional loops containing critical residues for receptor binding specificity, particularly in loop II which forms the primary pharmacophore, and (3) appropriate surface charge distribution for targeting the α-γ/δ subunit interface of the nicotinic receptor. The sequence should maintain the compact globular architecture (~60-70 residues) with proper spacing of hydrophobic residues in the core and conserved glycine residues facilitating tight turns. Ensure the design incorporates the characteristic three-finger toxin structural motif while optimizing for high-affinity binding to the acetylcholine binding site, effectively blocking neurotransmission and inducing paralysis."}
{"description": "sp|P01386|3L22_OPHHA Long neurotoxin 2 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "TKCYVTPDATSQTCPDGQDICYTKTWCDGFCSSRGKRIDLGCAATCPKVKPGVDIKCCSTDNCNPFPTWKRKH", "prompt": "Design a protein sequence for a long neurotoxin from the venom of the king cobra (Ophiophagus hannah) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and irreversibly block nicotinic acetylcholine receptors at the neuromuscular junction, causing flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C5, C2-C6, C3-C7, and C4-C8. The structure should feature a long, flexible central loop that facilitates deep penetration into the receptor binding site, distinguishing it from short-chain neurotoxins. Key functional residues should be positioned in loop II to enable high-affinity binding to the α-subunit of the muscle-type nicotinic acetylcholine receptor, competitively inhibiting acetylcholine binding. The toxin should exhibit the typical structural stability conferred by the disulfide-rich scaffold while maintaining the specific molecular surface topology required for selective receptor recognition and potent neuromuscular blockade."}
{"description": "sp|P86399|CLML_MESEU Neurotoxin lambda-MeuTx OS=Mesobuthus eupeus OX=34648 PE=1 SV=2", "sequence": "MSTFIVVFLLLTAILCHAEHAIDETARGCNRLNKKCNSDADCCRYGERCISTGVNYYCRPDFGP", "prompt": "Design a neurotoxic peptide from the venom of the scorpion Mesobuthus eupeus that functions as a potent sodium channel modulator. This toxin should belong to the beta-toxin family, specifically targeting voltage-gated sodium channels in the mammalian nervous system. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion neurotoxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, creating a molecular surface optimized for binding to neurotoxin receptor site 4 on domain II of voltage-gated sodium channels. The mechanism of action involves altering sodium channel gating kinetics by inhibiting fast inactivation, leading to prolonged action potentials, neuronal hyperexcitability, and ultimately neuromuscular paralysis. Key functional residues should be strategically positioned in the conserved 'pharmacophore' regions to ensure high-affinity binding and potent neurotoxic activity. The overall molecular architecture should exhibit the characteristic thermostability and protease resistance typical of scorpion venom peptides, with molecular weight in the 6-8 kDa range."}
{"description": "sp|P81375|OXLA_MACLB L-amino-acid oxidase (Fragment) OS=Macrovipera lebetinus OX=3148341 PE=1 SV=2", "sequence": "ADDKNPLEECFREDDYEEFLEIAKNGLEGWYANLGPMRYPVKPSEEGKHDDIFAYEKFDEIVGGMDKKFWEDDGIHGGKETFCYSPMIQKPYQFQHFSEALTAPVGR", "prompt": "Generate the amino acid sequence for a venom L-amino-acid oxidase from the Levant viper (Macrovipera lebetinus), a highly potent enzymatic toxin that plays a crucial role in the snake's predatory and defensive arsenal. This enzyme functions as a flavoprotein that catalyzes the oxidative deamination of L-amino acids, producing hydrogen peroxide, ammonia, and the corresponding α-keto acid. The resulting hydrogen peroxide contributes to significant tissue damage, hemorrhage, and cytotoxicity through oxidative stress mechanisms. The protein should adopt the characteristic two-domain structure of snake venom L-amino-acid oxidases, featuring a FAD-binding domain with a Rossmann fold and a substrate-binding domain. The sequence must include conserved catalytic residues for FAD cofactor binding and substrate recognition, along with the characteristic glycosylation sites that modulate its stability and biological activity. The enzyme should exhibit the typical homodimeric quaternary structure observed in viperid L-amino-acid oxidases, with the active site positioned at the interface between domains to facilitate efficient substrate turnover and potent toxic effects through localized oxidative damage to tissues and cells."}
{"description": "sp|P0C1T9|CM3A_CONCN Mu-conotoxin CnIIIA OS=Conus consors OX=101297 PE=1 SV=1", "sequence": "GRCCDVPNACSGRWCRDHAQCC", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of the marine cone snail Conus consors. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce neuromuscular blockade. The protein must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by a conserved cysteine framework (C-C-CC-C-C) with three intramolecular disulfide bonds forming a globular, inhibitor cystine knot (ICK) motif. Key structural elements should include a well-defined beta-hairpin region and loops that mediate high-affinity binding to the neurotoxin receptor site 1 on the voltage sensor domain of Nav1.4, effectively blocking sodium ion flux and preventing action potential propagation in muscle fibers. The sequence should exhibit the typical length and physicochemical properties of mu-conotoxins, with a net positive charge to facilitate interaction with the negatively charged channel pore, and include conserved residues critical for target specificity and potency. The overall structure should be highly stable and resistant to proteolytic degradation, reflecting its role in the predatory venom arsenal of Conus consors for rapid prey immobilization."}
{"description": "sp|Q8AXY1|PA2A_BOTJR Acidic phospholipase A2 BthA-1 OS=Bothrops jararacussu OX=8726 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGSLWQFGKMINYVMGESGVLQYLSYGCYCGLGGQGQPTDATDRCCFVHDCCYGKVTGCDPKIDSYTYSKKNGDVVCGGDDPCKKQICECDRVATTCFRDNKDTYDIKYWFYGAKNCQEKSEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops jararacussu, a medically important pit viper. This enzyme should function as a potent catalytic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network involving His48, Asp49, and Tyr52. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfides) that stabilizes the compact globular structure. The acidic nature should be reflected in the amino acid composition, with surface-exposed acidic residues contributing to its pI. The toxin should exhibit membrane-binding capability through hydrophobic surface patches and demonstrate both enzymatic activity and potential myotoxic effects through membrane disruption. The sequence should maintain the conserved structural elements required for catalytic function while incorporating venom-specific adaptations that enhance stability and target interaction in the context of snake envenomation."}
{"description": "sp|Q86QV1|KGX52_CENGR Potassium channel toxin gamma-KTx 5.2 OS=Centruroides gracilis OX=217898 PE=3 SV=1", "sequence": "DRDSCVDKSRCQKYGPYGQCTDCCKKAGHTGGTCIYFKCKCGAESGR", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the gamma-KTx family from the venom of Centruroides gracilis, the Florida bark scorpion. This toxin should function as a selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1 subfamily channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved structural scaffold of scorpion potassium channel toxins, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include a beta-sheet core and a functional surface loop responsible for channel block by physically occluding the potassium conduction pore. Key residues for channel recognition and binding affinity should be preserved, particularly in the pharmacophore region that interacts with the channel's turret and pore domains. The overall structure should be compact and stable, typical of scorpion venom peptides, enabling precise modulation of potassium flux and contributing to the venom's neurotoxic effects."}
{"description": "sp|P0DQZ2|TXM1A_PTEMU Mu/omega-theraphotoxin-Pmu1a OS=Pterinochilus murinus OX=1184495 PE=1 SV=1", "sequence": "ECRWFWGGCNNDADCCKHLECKRKWPHICLWDGTFT", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a mu/omega-theraphotoxin from the venom of the Mombasa golden starburst tarantula (Pterinochilus murinus), a theraphosid spider whose venom contains complex peptide toxins that modulate neuronal ion channels to immobilize prey. This toxin functions as a dual-acting modulator, exhibiting both mu-theraphotoxin activity (inhibiting voltage-gated sodium channels, particularly Nav1.7 and Nav1.4, to block action potential propagation) and omega-theraphotoxin activity (inhibiting voltage-gated calcium channels, primarily Cav2.2/N-type channels, to reduce neurotransmitter release). The mechanism involves high-affinity binding to specific receptor sites on these ion channels, leading to potent neuromuscular blockade and paralysis. The structural scaffold is based on the inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (cysteine framework I: C-C-CC-C-C) with disulfide connectivity C1-C4, C2-C5, C3-C6. Key structural elements include a beta-hairpin region involved in channel binding, a hydrophobic core maintaining structural integrity, and surface loops that mediate target specificity. The molecular target interface involves interactions with the voltage-sensing domain and pore region of sodium channels and the extracellular loops of calcium channels. The sequence should include conserved residues for ICK fold stability, functional residues for channel binding (including aromatic and basic residues for channel interaction), and appropriate length (30-40 amino acids) typical of spider venom ICK toxins."}
{"description": "sp|P00613|PA2B4_LATSE Basic phospholipase A2 4 OS=Laticauda semifasciata OX=8631 PE=1 SV=1", "sequence": "NLVQFSYLIQCANTGKRASYHYADYGCYCGAGGSGTPVDELDRCCKIHDNCYGQAEKMGCYPKLTMYNYYCGTQSPTCDNKTGCQRYVCACDLEAAKCFARSPYNNKNYNIDTSKRCK", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the banded sea krait, Laticauda semifasciata. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for anionic phospholipid membranes. The structural scaffold should feature the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bridges, creating a rigid, compact globular structure. Include the conserved catalytic dyad of histidine and aspartate residues within the active site groove, along with a calcium-binding loop containing essential glycine residues. The basic nature of this toxin should be reflected in its surface charge distribution, facilitating interaction with anionic membrane surfaces. The protein should maintain the characteristic pancreatic loop region and exhibit the interfacial activation mechanism typical of venom phospholipases A2, where catalytic efficiency increases upon binding to lipid-water interfaces. The overall structure should enable specific membrane penetration and substrate access while maintaining stability in the venom environment."}
{"description": "sp|Q8AY79|VSPS2_TRIST Beta-fibrinogenase stejnefibrase-2 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MELIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVAIFNSTGFFCSGTLINQEWVVTAAHCDSKNFKMKFGAHSKKLLNEDEQIRNPKEKFICPNKKNNDVLDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSDCRIIGWGSITPIEVTYPDVPYCANINLLDDAECKPGYPELLPEYRTLCAGIVEGGKDTCGGDSGGPLICNGQFHGIVSYGGHPCGQSLKPGIYTKVFDYNDWMKSIIAGNTAATCPP", "prompt": "Design a snake venom serine protease from Trimeresurus stejnegeri that functions as a potent beta-fibrinogenase. This enzyme should specifically cleave the beta chain of fibrinogen, thereby preventing fibrin clot formation and exhibiting anticoagulant activity. The protein should adopt the characteristic chymotrypsin-like serine protease fold, featuring a two-domain structure with the catalytic triad (His, Asp, Ser) positioned in the active site cleft. It should contain the conserved disulfide bond pattern typical of snake venom serine proteases, including the essential Cys191-Cys220 disulfide bridge that stabilizes the active site region. The structural scaffold should include the characteristic six-stranded beta-barrel domains connected by surface loops that determine substrate specificity. The enzyme should demonstrate high specificity for fibrinogen while maintaining stability in the venom environment, with surface residues optimized for efficient diffusion through tissues. The mature protein should be approximately 25-30 kDa with optimal pH activity in the physiological range."}
{"description": "sp|P0DMB4|PA11_VESAF Phospholipase A1 1 OS=Vespa affinis OX=882735 PE=1 SV=1", "sequence": "MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII", "prompt": "Design a phospholipase A1 toxin from the venom of the Asian hornet, Vespa affinis. This enzyme should function as a potent hemolytic and myotoxic agent, targeting biological membranes through hydrolysis of the sn-1 ester bond of glycerophospholipids. The protein should adopt the canonical α/β-hydrolase fold characteristic of secreted phospholipases, featuring a central β-sheet surrounded by α-helices and a conserved catalytic triad (Ser-Asp-His) within the active site. Include the characteristic Ca²⁺ binding site essential for substrate binding and catalytic activity. The structure should contain multiple disulfide bridges to stabilize the compact globular fold, with conserved cysteine patterns typical of venom phospholipases. The mature protein should exhibit optimal activity at neutral to slightly basic pH and demonstrate specificity for phosphatidylcholine substrates, generating lysophospholipids and free fatty acids that disrupt membrane integrity and contribute to the venom's cytotoxic, inflammatory, and pain-inducing effects."}
{"description": "sp|P0DM89|VM32A_GLOBR Zinc metalloproteinase-disintegrin-like brevilysin H2a OS=Gloydius brevicauda OX=3148161 PE=1 SV=1", "sequence": "QQRYLNAKRYVKLAIVADRSMVTKHNGKLKKLRKWIYRIVNTINEVYRSLNILVALVYLEIWSKEDLINVTSAAKDTLASFGNWRATDLLKRRSHDAAHLLTNIKFDGTTVGKAYVASMCQQDSSVGINQDHSKINLLVALTMAHELGHNLGMSHDVVNTEKQCNCGTCVMAPTISDQISKLFSNCSKNDYENFLTLYKPQCILNEPSKTDIVSPPVCGNELLEVGEECDCGSPETCQNPCCDAATCKLTSGSQCAKGLCCDQCKFSKSGTECRAAKDDCDIAESCTGQSADCPTDDLQRNGKPCQNNAGYCYNGKCPIMLNQCISFYGSNATVAPDICFNYNLKGEGNFYCRKEQATIFPCAQKDKKCGRLFCVLGPTGKRISCKNTYSEDDPNYGMVDLGTKCEDGKVCNSNRECVDVNTAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin, specifically representing the brevilysin H2a variant from the short-tailed pit viper Gloydius brevicauda. This protein should embody the dual functionality characteristic of snake venom metalloproteinases (SVMPs), integrating both proteolytic and anti-adhesive activities. The core metalloproteinase domain must feature a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling proteolytic cleavage of extracellular matrix components such as fibrinogen, collagen, and von Willebrand factor, thereby promoting hemorrhage and disrupting hemostasis. Adjacent to this, the disintegrin-like domain should adopt a structured fold that mimics the RGD motif or related integrin-binding sequences, facilitating competitive inhibition of platelet integrins (e.g., αIIbβ3) to prevent platelet aggregation and induce anticoagulation. The protein should exhibit a multi-domain architecture typical of P-III class SVMPs, including propeptide, metalloproteinase, disintegrin-like, and cysteine-rich domains, stabilized by multiple disulfide bridges that confer rigidity and resistance to proteolytic degradation. The structural scaffold should reflect the reprolysin family fold, with the metalloproteinase domain adopting a metzincin-like conformation characterized by a deep active-site cleft and a methionine-containing Met-turn. The disintegrin-like domain is expected to form a compact, disulfide-stabilized subdomain that presents surface loops for integrin engagement. Ensure the sequence encodes appropriate signal peptides and propeptide regions for proper zymogen activation, and incorporate conserved cysteine residues to form the complex disulfide connectivity that defines the stability and functional integrity of brevilysin H2a. The overall design should yield a protein that synergistically combines fibrinogenolytic, hemorrhagic, and antiplatelet activities, mimicking the pathophysiological effects observed in envenomation by Gloydius brevicauda."}
{"description": "sp|Q86QV2|KGX34_CENGR Potassium channel toxin gamma-KTx 3.4 OS=Centruroides gracilis OX=217898 PE=3 SV=1", "sequence": "DRDSCVDKSRCQKYGNYAQCTACCKKAGHNKGTCDFFKCKCT", "prompt": "Design a potassium channel toxin protein sequence that embodies the venomous arsenal of the bark scorpion Centruroides gracilis. This toxin should function as a potent modulator of voltage-gated potassium channels, specifically targeting Kv1 subfamily members to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved structural scaffold of gamma-KTx toxins, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact, globular fold with a well-defined beta-sheet core and flexible loops that mediate high-affinity binding to the channel's voltage-sensing domain or pore region. Key functional residues should be strategically positioned to interact with conserved channel residues, enabling selective blockade or modulation of potassium efflux. The toxin must exhibit the characteristic pharmacological profile of scorpion venom peptides, contributing to prey immobilization through precise interference with potassium-dependent repolarization phases of action potentials."}
{"description": "sp|A0A7S8MVA6|SCX33_TITSE Putative sodium channel toxin Ts33 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKTAFFILLIFSIFYGKAKGAEDREGFPVNRFGCTYPCYYGEDTEKCRRLCRETLGADYGYCFWYACYCENLPENVRRIKSQGFFGCSNGWWVVSTTTRKPK", "prompt": "Generate the amino acid sequence for a sodium channel toxin from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin, designated Ts33, functions as a potent modulator of voltage-gated sodium channels, specifically targeting and altering the gating kinetics to induce prolonged neuronal excitation and disrupt normal electrical signaling. The toxin should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, triple-stranded antiparallel beta-sheet stabilized by four disulfide bridges in a C-C-C-C pattern, with key residues in the functional surface forming a bioactive interface that interacts with domain II or IV of the sodium channel. The sequence must include the cysteine framework essential for proper folding and bioactivity, along with conserved hydrophobic and polar residues critical for binding and specificity. The resulting protein should exhibit high affinity for neuronal sodium channels, contributing to the venom's neurotoxic effects by causing repetitive firing, paralysis, or pain."}
{"description": "sp|P56711|O27A_CONPE Gamma-conotoxin PnVIIA OS=Conus pennaceus OX=37335 PE=1 SV=2", "sequence": "MEKLTILLLVAAVLMSTQAQNQEQRQQAKINFLSKRKPSAERWRRDCTSWFGRCTVNSECCSNSCDQTYCELYAFPSFGA", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications: This protein is a gamma-conotoxin from the marine cone snail Conus pennaceus, a predatory mollusk whose venom contains complex peptide cocktails for prey capture and defense. As a gamma-conotoxin, it functions as a specific inhibitor of voltage-gated calcium channels, primarily targeting neuronal N-type (Cav2.2) calcium channels. The toxin likely adopts the conserved conotoxin structural framework characterized by a compact, disulfide-stabilized fold. Based on the gamma-conotoxin family, it should contain the characteristic cysteine framework IV (C-C-CC-C-C) with three disulfide bridges that form a stable, globular structure. The anticipated 3D structure is a small, rigid scaffold with loops that mediate precise interaction with the pore-forming region of N-type calcium channels, blocking calcium influx and thereby inhibiting neurotransmitter release at synapses. The molecular mechanism involves high-affinity binding to the extracellular domain of Cav2.2 channels, leading to presynaptic blockade and neuromuscular paralysis. The protein should exhibit the typical conotoxin properties of high specificity, potency in the nanomolar range, and stability conferred by the disulfide network. Ensure the sequence reflects the compact size (approximately 25-35 amino acids) and includes the conserved cysteine pattern while maintaining the functional residues necessary for calcium channel blockade."}
{"description": "sp|Q9I8X2|VSP1_DEIAC Thrombin-like enzyme acutobin OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGVECDINEHRFLVALYELTSMTFLCGGTLINQEWVVTAAHCDRLQLYLYIGMHDKYVKFDDEQGREPIEKYFYNCSNNLTTRDKDIMLIRLDRPVDNSTHIAPLSLPSRPPSVGSVCRVMGWGAISPSRDVLPDVPHCVNINLVNNAECRRAYPRLPATSRTLCAGVMQGGIDSCNRDSGGPLICDGQFQGVVNWGGNPCAQPNMPALYTKVYDYNDWIRSITAGNTTAACPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of the hundred-pace snake (Deinagkistrodon acutus) that functions as a key component in the snake's predatory arsenal. This enzyme should exhibit selective proteolytic activity toward fibrinogen, specifically cleaving fibrinopeptide A from the Aα chain to generate fibrin monomers, thereby promoting blood coagulation and potentially causing thrombosis in prey. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and a well-defined substrate-binding pocket that confers specificity for fibrinogen over other coagulation factors. It should contain the canonical disulfide bond pattern typical of snake venom serine proteases, stabilizing the overall structure while allowing for functional flexibility. The enzyme should demonstrate optimal activity at physiological pH and temperature, with potential glycosylation sites that may influence its stability and immunogenicity. The structural scaffold should enable efficient substrate recognition and cleavage while maintaining resistance to endogenous protease inhibitors, ensuring its efficacy in envenomation."}
{"description": "sp|P86401|CTXL_MESEU Chlorotoxin-like peptide MeuClTx (Fragment) OS=Mesobuthus eupeus OX=34648 PE=1 SV=2", "sequence": "TEAMCMPCFTTDHNMAKKCRDCCGGNGKCFGYQCLCNRG", "prompt": "Design a chlorotoxin-like peptide derived from the venom of the scorpion Mesobuthus eupeus, a species known for producing neurotoxins that target ion channels in the central nervous system. This peptide should function as a potent and selective inhibitor of chloride channels, particularly small-conductance chloride channels in glioma cells, contributing to its potential as a therapeutic agent for targeting tumor cells. The core mechanism involves binding to and blocking chloride ion flux, which disrupts cellular volume regulation and may induce apoptosis in malignant cells. Structurally, the peptide should adopt a compact, stable fold stabilized by four disulfide bridges with a cysteine framework pattern of C-C-CC-C-C, characteristic of the chlorotoxin family. This scaffold forms an inhibitor cysteine knot (ICK) motif, providing exceptional stability against proteolytic degradation and thermal denaturation. The 3D structure should feature a well-defined beta-hairpin and alpha-helical regions, with key residues in the binding interface interacting with the extracellular domains of the chloride channel. The sequence must include conserved hydrophobic and basic residues critical for membrane interaction and target specificity, ensuring high affinity for glioma-specific chloride channels while minimizing off-target effects on other ion channels."}
{"description": "sp|Q8I0L5|KA152_OLIMR Potassium channel toxin alpha-KTx 15.2 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKFSSIILLTLLICSMSKFGNCQVETNVKCQGGSCASVCRKAIGVAAGKCINGRCVCYP", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin should function as a potent and selective modulator of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include a well-defined beta-sheet core and a functional dyad comprising a critical lysine residue positioned to interact with the channel's pore region and a hydrophobic residue that enhances binding affinity. Ensure the toxin exhibits high specificity for potassium channels over other ion channels, contributing to its role in prey immobilization through blockade of potassium efflux and subsequent prolongation of action potentials. The structural integrity should rely on the ICK fold for stability in the venom environment, with surface loops tailored for target recognition and minimal immunogenicity."}
{"description": "sp|Q8AY81|VSPST_TRIST Thrombin-like enzyme stejnobin OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MMLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDFWSGDFLCGGTLINQEYVLTAAHCKTRNMYIYLGMHNKSVQFDDEQRRYPKKKYFFRCRNNFTRWDKDIMLIRLNRPVRNSAHIAPLSLPSSPPTVGSVCRVMGWGTITSPNETLPDVPRCANINLFNYTVCHGVFPWLPARSRILCAGVLQGGIDTCKRDSGGPLICNGQFQGIVSWGPKPCAQPRKPALYTKVFDHLDWIQSIIAGNTTVTCPP", "prompt": "Design a serine protease enzyme with thrombin-like activity derived from the venom of Trimeresurus stejnegeri, a pit viper species. This enzyme should function as a key component in the snake's venom arsenal, facilitating prey immobilization through its procogulant effects on the mammalian blood coagulation cascade. The protein should specifically mimic thrombin's enzymatic activity by cleaving fibrinogen to form fibrin clots, but with distinct substrate specificity that prevents effective regulation by natural anticoagulant pathways. The structural scaffold should feature a trypsin-like serine protease fold with the characteristic catalytic triad of histidine, aspartate, and serine residues. Include appropriate disulfide bonding patterns typical of snake venom serine proteases to stabilize the compact globular structure. The enzyme should exhibit optimal activity at physiological pH and temperature, with molecular recognition elements that favor fibrinogen cleavage over other physiological substrates, contributing to the disseminated intravascular coagulation phenotype observed in envenomation."}
{"description": "sp|F8S114|VSPCR_CROAD Thrombin-like enzyme crotalase OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYDYWSQSFLCGGTLINEEWVLTAKHCDRTHILIYVGVHDRSVQFDKEQRRFPKEKYFFDCSNNFTKWDKDIMLIRLNKPVSYSEHIAPLSLPSSPPIVGSVCRAMGWGQTTSPQETLPDVPHCANINLLDYEVCRTAHPQFRLPATSRTLCAGVLEGGIDTCNRDSGGPLICNGQFQGIVFWGPDPCAQPDKPGLYTKVFDHLDWIQSIIAGEKTVNCPP", "prompt": "Design a thrombin-like serine protease enzyme from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a key component in the snake's predatory and defensive arsenal. This enzyme should exhibit selective proteolytic activity similar to mammalian thrombin, specifically cleaving fibrinogen to generate fibrin monomers, thereby promoting localized coagulation and potentially causing systemic coagulopathy in prey. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (likely His-Asp-Ser) and maintain the canonical structural features of snake venom serine proteases, including multiple disulfide bridges that stabilize the compact globular structure. The enzyme should possess substrate specificity that distinguishes it from endogenous thrombin, potentially showing preferential cleavage at specific arginine residues in fibrinogen while avoiding inhibition by natural serine protease inhibitors. The structural scaffold should include the characteristic two-domain architecture with the active site situated in the cleft between domains, stabilized by a conserved pattern of disulfide bonds that maintain the proper orientation of the catalytic residues and substrate-binding exosites."}
{"description": "sp|P0C7J8|BPP11_BOTJA Bradykinin-potentiating peptide 11 OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "QGGAGWPPIPP", "prompt": "Generate the amino acid sequence for a bradykinin-potentiating peptide (BPP) from the venom of Bothrops jararaca, the jararaca pit viper. This peptide functions as a potent vasoactive toxin that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and the conversion of angiotensin I to angiotensin II. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of the BPP family, which typically contains a pyroglutamic acid residue at the N-terminus and a C-terminal proline-rich region. The sequence should reflect the conserved cysteine framework that forms the disulfide connectivity essential for maintaining the bioactive conformation required for ACE inhibition. This molecular mechanism contributes to the venom's overall hypotensive and pro-inflammatory effects, facilitating prey immobilization through cardiovascular shock."}
{"description": "sp|Q9I9R4|VM1N_BOTPA Snake venom metalloproteinase neuwiedase (Fragment) OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "QQRFFPQRYIELVIVADRRMYTKYNSDSNKIRTRVHELVNTVNGFFRSMNVDASLANLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLRRKSHDNAQLLTAIDFNGNTIGRAYLGSMCNPKRSVGIVQDHSPINLLVGVTMAHELGHNLGMEHDGKDCLCGASLCIMSPGLTDGPSYEFSDCSKDYYQTFLTNHNPQ", "prompt": "Design a snake venom metalloproteinase (SVMP) sequence fragment that embodies the proteolytic and hemorrhagic characteristics typical of neuwiedase from Bothrops pauloensis. This toxin should function as a zinc-dependent metalloproteinase, targeting and degrading key components of the extracellular matrix and basement membranes, such as fibronectin, laminin, and type IV collagen, to disrupt vascular integrity and induce hemorrhage. The sequence must include the conserved zinc-binding motif (HEXXHXXGXXH) within the catalytic domain, which coordinates the catalytic zinc ion essential for proteolytic activity. Incorporate appropriate cysteine residues to form disulfide bonds that stabilize the metalloproteinase domain fold, characteristic of the reprolysin family. The structural scaffold should facilitate substrate access to the active site while maintaining stability in the venom milieu. Ensure the protein exhibits specificity for extracellular matrix proteins, contributing to the rapid tissue damage and systemic effects observed in envenomation by Bothrops species."}
{"description": "sp|P69756|O16D_CONMA Delta-conotoxin-like MVID OS=Conus magus OX=6492 PE=2 SV=1", "sequence": "EACYNAGTFCGIKPGLCCSAICLSFVCISFDF", "prompt": "Design a novel delta-conotoxin-like peptide derived from the venom of the marine cone snail Conus magus. This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting and inhibiting the inactivation of neuronal sodium channels to prolong action potentials and enhance neurotransmitter release. The peptide should adopt the conserved structural framework characteristic of delta-conotoxins, featuring a disulfide connectivity pattern of Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 (framework VI/VII) that stabilizes a compact, triple-stranded beta-sheet fold with loops of variable length that mediate target specificity. Key structural elements should include a well-defined hydrophobic core stabilized by the disulfide scaffold, solvent-exposed residues in the loop regions critical for channel interaction, and a C-terminal amidation to enhance stability against proteolytic degradation. The molecular target should be mammalian voltage-gated sodium channels, particularly Nav1.2 or Nav1.6 subtypes, with binding mediated through interactions with the channel's S3-S4 linker in domain IV, which is crucial for fast inactivation. The biological significance lies in its role as a defensive and predatory tool for Conus magus, enabling rapid immobilization of prey through disruption of neuronal excitability, and it holds potential as a pharmacological probe for studying sodium channel function and developing novel analgesics or anticonvulsants."}
{"description": "sp|P56714|O17_CONTE Omega-conotoxin TxVII OS=Conus textile OX=6494 PE=1 SV=2", "sequence": "MKLTCMMIVAVLFLTAWTFATADDSGNGLENLFPKAHHEMKNPEASKLNKRCKQADEPCDVFSLDCCTGICLGVCMW", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The protein is an omega-conotoxin derived from the venom of the marine cone snail Conus textile, a predatory species that employs venom for prey capture and defense. This toxin functions as a potent calcium channel antagonist, specifically targeting N-type voltage-gated calcium channels (Cav2.2) in the nervous system. Its mechanism involves high-affinity binding to the channel's pore-forming α1 subunit, thereby blocking calcium influx, inhibiting neurotransmitter release, and inducing paralysis. The structural scaffold is characterized by the inhibitor cystine knot (ICK) motif, featuring a compact, triple-stranded beta-sheet stabilized by three disulfide bridges with a conserved C-C-CC-C-C cysteine framework. Key residues include a hydrophobic core, solvent-exposed loops critical for target interaction, and a conserved 'omega-conotoxin signature' loop that mediates channel specificity. The protein is expected to exhibit high stability, low immunogenicity, and selective activity against neuronal calcium channels, making it a model for neuropharmacological applications."}
{"description": "sp|P86420|3S11_MICFR Frontoxin I (Fragment) OS=Micrurus frontalis OX=129461 PE=1 SV=1", "sequence": "MICYNHQSSEPPTTKTCSEGQCYKKSWSDHRGTIIERGCACPNVKPGVKIICCRSC", "prompt": "Design a protein sequence for a neurotoxic three-finger toxin derived from the venom of the coral snake Micrurus frontalis. This toxin should function as a postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-CC-C-C. The structure should feature the typical globular conformation with the central loop containing key functional residues for receptor binding. The molecular target is the muscle-type nicotinic acetylcholine receptor, with specific binding to the α-δ and α-γ subunit interfaces. The toxin should exhibit high affinity and selectivity for the neuromuscular junction, contributing to the rapid prey immobilization strategy characteristic of elapid snake venoms."}
{"description": "sp|P00620|PA2A_BITGA Acidic phospholipase A2 OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "DLTQFGNMINKMGQSVFDYIYYGCYCGWGGKGKPIDATDRCCFVHDCCYGKMGTYDTKWTSYNYEIQNGGIDCDEDPQKKELCECDRVAAICFANNRNTYNSNYFGHSSSKCTGTEQC", "prompt": "Generate a protein sequence for an acidic phospholipase A2 toxin from the venom of the Gaboon viper (Bitis gabonica). This enzyme plays a critical role in the venom's potent hemotoxic and myotoxic effects by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to systemic inflammation, tissue damage, and coagulopathy. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges (typically 6-7 cysteines with a pattern such as Cys1-Cys4, Cys2-Cys5, Cys3-Cys6). Key functional residues include a conserved histidine-aspartate catalytic dyad and a calcium-binding loop essential for enzymatic activity. The acidic nature (low pI) enhances its stability in venom and may modulate interactions with endogenous inhibitors. The toxin likely targets neuronal or muscular membranes, exacerbating neurotoxicity and myonecrosis through phospholipid degradation and subsequent generation of pro-inflammatory mediators."}
{"description": "sp|Q45Z42|PA2PA_OXYMI Basic phospholipase A2 paradoxin-like alpha chain OS=Oxyuranus microlepidotus OX=111177 PE=1 SV=1", "sequence": "MHPAHLLVLLAVCVSLLGASDIPPLPLNLAQFGFMIKCANHRSRPVSHYMDYGCYCGKGGSGTPVDELDRCCQVHDECYGEAEKRFKCVPYMTLYSWKCYGTAPSCNTKTDCQRFVCNCDAKAAECFARSPYQNKNWNINTKARCK", "prompt": "Design a protein sequence for a highly potent basic phospholipase A2 toxin from the venom of the inland taipan (Oxyuranus microlepidotus), the world's most venomous terrestrial snake. This toxin, known as paradoxin-like alpha chain, functions as a presynaptic neurotoxin that targets the neuromuscular junction. The protein should exhibit calcium-dependent phospholipase A2 activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids. This enzymatic activity disrupts neurotransmitter release by damaging presynaptic membranes and interfering with synaptic vesicle recycling. The sequence must contain the conserved phospholipase A2 active site motif with histidine, aspartate, and tyrosine residues essential for catalytic function. Include the characteristic calcium-binding loop with conserved glycine residues and the elapid phospholipase A2 signature pattern. The protein should adopt the classic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. Incorporate the appropriate disulfide bond pattern characteristic of group IA phospholipase A2 toxins, with conserved cysteine residues forming the structural scaffold. The toxin should exhibit basic isoelectric point properties to facilitate membrane interaction and potent neurotoxic effects through presynaptic blockade. The overall structure should maintain the compact, stable globular fold typical of snake venom phospholipase A2 enzymes while preserving the specific neurotoxic determinants that make this one of the most potent presynaptic neurotoxins in nature."}
{"description": "sp|Q45Z46|PA2HB_OXYMI Neutral phospholipase A2 paradoxin-like beta chain OS=Oxyuranus microlepidotus OX=111177 PE=1 SV=1", "sequence": "MHPAHLLVLLAVCVSLLGASDIPPLPLNLLQFGFMIECAIRNRQPALDFMNYGCYCGTVGHGTPVDDLDRCCKTRNECYAEAEKHGCYPSLTTYRWQCGRVGLHCNSKTQCEVFVCACDLAAAKCLAQEDYNPAHFNINTKARCR", "prompt": "Design a protein sequence for a paradoxin-like beta chain from the venom of the inland taipan (Oxyuranus microlepidotus), one of the world's most venomous snakes. This protein functions as a neutral phospholipase A2 (PLA2) toxin that plays a critical role in the venom's potent neurotoxic and myotoxic effects. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid, which can initiate inflammatory cascades. The sequence must incorporate the conserved PLA2 structural fold characterized by three long alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the motif YGCXCG. Include the catalytic dyad of histidine and aspartate residues essential for enzymatic activity. The protein should feature the characteristic disulfide bond pattern of group II PLA2 enzymes, with 6-7 conserved disulfide bridges stabilizing the compact globular structure. This paradoxin-like beta chain likely functions synergistically with other venom components to enhance membrane disruption, contribute to presynaptic neurotoxicity at neuromuscular junctions, and induce myonecrosis through interactions with specific membrane receptors. The protein should maintain optimal stability at physiological pH while exhibiting specificity for neuronal and muscle cell membranes."}
{"description": "sp|Q86QV5|KGX32_CENEL Potassium channel toxin gamma-KTx 3.2 OS=Centruroides elegans OX=217897 PE=3 SV=1", "sequence": "DRDSCVDKSRCAKYGYYQQCEICCKKAGHRGGTCEFFKCKCKV", "prompt": "Design a potassium channel toxin protein derived from the venom of Centruroides elegans, a scorpion species. This toxin belongs to the gamma-KTx family and specifically functions as a potent blocker of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves high-affinity binding to the pore region of Kv1.x family potassium channels, physically obstructing potassium ion flux and disrupting neuronal excitability. Key structural elements should include a solvent-exposed beta-hairpin loop containing critical residues for channel interaction, a conserved hydrophobic core, and specific charged residues that facilitate electrostatic steering toward the channel vestibule. The toxin should exhibit nanomolar affinity for its target channels while maintaining the thermal stability and protease resistance typical of disulfide-rich venom peptides."}
{"description": "sp|C0JAZ9|A1O_LOXAM Dermonecrotic toxin LamSicTox-alphaIC1 (Fragment) OS=Loxosceles amazonica OX=571517 PE=2 SV=1", "sequence": "WIMGHMVNNINQIEEFVSLGANSIETDVSFDKKANPEYTYHGTPCDCGRDCLRWEYFKDFLNGLRKATTPGDAKYREKLILVVFDLKTGSLYDNQAYDAGKSLAKNLLEYYWNNGNNGGRAYIVLSIPNLAHYKLVTGFKETLKDEGHEDLLEKVGHDFSGNDDIPDIESAYKKAGVTGHVWQSDGITNCLPRTLKRVILAIANRDSGSGIINKVYYWTVDKRSTTRDSLEAGVDGIMTNYPDVIADVLSEAAYKDKYRIATYDDNPWETFKA", "prompt": "Generate the amino acid sequence for a dermonecrotic toxin from the venom of the South American spider Loxosceles amazonica. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage, ultimately leading to localized tissue necrosis characteristic of loxoscelism. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of SicTox family members, with the active site containing the essential catalytic histidine and coordinating residues required for Mg²⁺-dependent phosphodiesterase activity. The sequence should include the characteristic N-terminal signal peptide for secretion and the conserved motifs involved in substrate binding and catalysis. The structural scaffold should facilitate efficient membrane interaction and substrate accessibility while maintaining the thermal stability and pH tolerance required for effective envenomation pathology."}
{"description": "sp|P56712|O16A_CONPE Omega-conotoxin PnVIA OS=Conus pennaceus OX=37335 PE=1 SV=2", "sequence": "MKLTCMMIIAVLFLTAWTFVMADDPRDEPEARDEMNPAASKLNERGCLEVDYFCGIPFANNGLCCSGNCVFVCTPQGK", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications: This protein is an omega-conotoxin from the marine cone snail Conus pennaceus, a predatory mollusk that employs venom for prey capture and defense. As an omega-conotoxin, it functions as a potent neurotoxin by selectively blocking voltage-gated calcium channels (VGCCs), specifically N-type calcium channels (Cav2.2), which are critical for neurotransmitter release at presynaptic terminals. This blockade disrupts synaptic transmission, leading to paralysis in prey organisms. The protein is expected to adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (cysteine framework I: C-C-CC-C-C). Key structural elements include a rigid, knotted core formed by three disulfide bonds that confer exceptional stability against thermal and proteolytic degradation, along with flexible loops that mediate target specificity. The molecular target is the pore-forming alpha1 subunit of N-type calcium channels, with binding likely occurring at extracellular loops such as those in domains III and IV, interfering with ion permeation. The sequence should reflect high affinity and selectivity for Cav2.2, incorporating conserved residues for disulfide bonding and variable loop regions for targeted interaction, while excluding any database identifiers. Focus on creating a functional toxin with precise neurotoxic activity, structural integrity, and evolutionary relevance to Conus venoms."}
{"description": "sp|P0DOC5|TX1B_HETMC Delta-theraphotoxin-Hm1b OS=Heteroscodra maculata OX=268413 PE=1 SV=1", "sequence": "ECRYLFGGCKTTADCCKHLGCRTDLYYCAWDGTF", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a delta-theraphotoxin originating from the venom of Heteroscodra maculata (togo starburst tarantula), a theraphosid spider whose venom contains neurotoxins that target ion channels to immobilize prey. This toxin functions as a voltage-gated sodium channel modulator, specifically inhibiting channel inactivation to prolong action potentials and cause sustained neuronal excitation, leading to paralysis. The structural scaffold should feature the inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence must include conserved cysteine residues forming this knot, along with key functional residues in the loops between cystines that mediate interaction with the voltage-sensing domain of sodium channels, particularly targeting site 4. The molecular mechanism involves binding to domain II of the sodium channel, delaying inactivation and enhancing persistent currents. Ensure the design reflects a stable, disulfide-rich mini-protein with high affinity for insect or mammalian sodium channels, as typical for spider venom toxins, and include hydrophobic patches and basic residues critical for membrane proximity and target engagement."}
{"description": "sp|P82851|KKX11_CHEFU Potassium channel toxin kappa-KTx 1.2 OS=Chersonesometrus fulvipes OX=141248 PE=1 SV=1", "sequence": "GHACYRNCWREGNDEETCKERCG", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx 1.2 from the Indian black scorpion Chessonestrus fulvipes. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal signaling and muscle function. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved functional dyad consisting of a critical lysine residue positioned to interact with the potassium channel pore and an aromatic residue that contributes to binding specificity. The structural scaffold should comprise a short alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a stable molecular surface for channel interaction. The toxin should exhibit high affinity for specific Kv channel subtypes, potentially blocking channel conductance by physically occluding the pore region, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The molecular mechanism should involve specific interactions with the channel's turret region and selectivity filter, disrupting potassium ion flux and causing neurotoxic effects through altered action potential propagation."}
{"description": "sp|P01388|3L22_NAJME Long neurotoxin 2 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "IRCFITPDVTSQICADGHVCYTKTWCDNFCASRGKRVDLGCAATCPTVKPGVNIKCCSTDNCNPFPTRNRP", "prompt": "Generate a protein sequence for a long neurotoxin from the forest cobra (Naja melanoleuca) that functions as a potent postsynaptic neurotoxin. This toxin should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C5, C2-C6, C3-C7, and C4-C8. The toxin should specifically target and irreversibly bind to the α-δ and α-γ interfaces of muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, acting as a competitive antagonist that blocks acetylcholine binding and prevents postsynaptic depolarization. The sequence should feature the conserved structural motif of the long neurotoxin family, including an extended central loop with additional disulfide stabilization that enhances receptor binding affinity and specificity. The protein should exhibit high structural stability through its disulfide framework while maintaining the functional epitopes necessary for selective interaction with nicotinic receptor subtypes, contributing to the neurotoxic paralysis characteristic of elapid snake envenomation."}
{"description": "sp|P0C1U1|CM3A_CONCT Mu-conotoxin CIIIA OS=Conus catus OX=101291 PE=2 SV=1", "sequence": "GRCCEGPNGCSSRWCKDHARCC", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications: This protein is a mu-conotoxin derived from the venom of the marine cone snail Conus catus, a predatory species that employs its venom for rapid prey immobilization through potent neurotoxicity. The toxin functions as a selective antagonist of voltage-gated sodium channels, specifically targeting the Nav1.4 subtype predominantly expressed in skeletal muscle. Its mechanism involves high-affinity binding to site 1 of the sodium channel, which obstructs the channel pore and inhibits sodium ion influx, thereby blocking action potential propagation and inducing flaccid paralysis. Structurally, the protein adopts a compact, disulfide-rich scaffold characteristic of conotoxins, with a cysteine framework of C-C-CC-C-C (framework III) that forms three disulfide bridges stabilizing a globular fold. The core structure is anticipated to feature a combination of beta-sheets and reverse turns, creating a stable molecular surface for precise target engagement. Key conserved residues within the inter-cysteine loops are critical for channel recognition and binding specificity. The sequence must encode these structural elements to ensure proper folding, disulfide connectivity, and biological activity, resulting in a potent neurotoxin effective in neuromuscular blockade."}
{"description": "sp|P0C1U2|CM3A_CONMA Mu-conotoxin MIIIA OS=Conus magus OX=6492 PE=1 SV=1", "sequence": "QGCCNVPNGCSGRWCRDHAQCC", "prompt": "Generate the amino acid sequence for a potent neurotoxic peptide from the venom of the marine cone snail Conus magus. This peptide belongs to the mu-conotoxin family and functions as a selective antagonist of voltage-gated sodium channels, specifically targeting neuronal subtypes to block action potential propagation. The toxin should adopt the characteristic inhibitor cystine knot (ICK) structural motif stabilized by three disulfide bridges with a C-C-CC-C-C connectivity pattern. The mature peptide should be approximately 22 amino acids in length with a compact, globular fold that presents key functional residues for high-affinity binding to the extracellular pore region of sodium channels. The sequence should include conserved cysteine residues at positions that form the structural core, along with specific hydrophobic and charged residues that mediate target recognition and channel blockade. The resulting peptide should exhibit potent neurotoxic activity through selective inhibition of sodium channel function, contributing to the paralytic effects of Conus magus venom on prey organisms."}
{"description": "sp|P0DKR3|PA2AA_PSEFE Acidic phospholipase A2 CbIalpha OS=Pseudocerastes fieldi OX=1355908 PE=1 SV=1", "sequence": "NLFQFGEMIFEKTGKEAVHSYAIYGCYCGWGGQGRAMDATDRCCFVHDCCYGRVNGCNPKMATYSTSFQNGDIVCGDNDLCLRAVCECDRAAAICLGQNVNTYNKNYEHYSISHCMEESEQC", "prompt": "Design a novel acidic phospholipase A2 toxin from the venom of the Persian horned viper (Pseudocerastes fieldi) that exhibits potent neurotoxic and myotoxic activity. This enzyme should function as a calcium-dependent hydrolase that specifically targets and cleaves the sn-2 acyl bond of glycerophospholipids in neuronal and muscle cell membranes, leading to membrane disruption, inflammation, and cell death. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, Cys84-Cys96) that create a rigid, stable scaffold. Include the canonical catalytic triad residues (His48, Asp49, Tyr52) in the active site pocket, with Asp49 serving as the critical calcium-coordinating residue. The acidic nature should be reflected through a calculated pI below 5.0, achieved by strategic placement of aspartate and glutamate residues on the surface. The protein should contain both the conserved 'pancreatic loop' and 'elapid loop' regions that contribute to membrane binding specificity. Incorporate structural features that enhance membrane penetration, including hydrophobic patches and a conserved interfacial binding surface. The mature toxin should be approximately 120-140 amino acids in length and exhibit optimal activity at physiological pH and temperature conditions."}
{"description": "sp|P82896|PA2A5_TRIST Acidic phospholipase A2 5 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "NLMQFELLIMKVAGRSGIVWYSDYGCFCGKGGHGRPQDATDRCCFVHDCCYGKVTECDPKMDFYRYSSNNGDIVCEANNPCTKEICECDKAAAICFRDNKDTYDNKYWNIPMEGCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Trimeresurus stejnegeri, a venomous pit viper. This enzyme should function as a potent toxin that hydrolyzes the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can subsequently lead to inflammatory responses and membrane disruption. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. Include the essential catalytic residues, typically a histidine-aspartate pair, within the active site to ensure enzymatic activity. The acidic nature of this toxin should be reflected in its amino acid composition, with a predominance of acidic residues contributing to its overall negative charge. The protein should exhibit calcium-dependent activity, with a calcium-binding loop essential for catalytic function. Consider the structural stability conferred by the disulfide pattern common to snake venom phospholipases A2, which typically includes multiple conserved cysteine pairs. The toxin should be capable of interacting with biological membranes and potentially exhibiting myotoxic, hemolytic, or pro-inflammatory effects consistent with viperid venom phospholipases A2."}
{"description": "sp|P01389|3L21_NAJAC Long neurotoxin 1 OS=Naja anchietae OX=263737 PE=1 SV=1", "sequence": "IRCFITPDVTSQACPDGQNICYTKTWCDNFCGMRGKRVDLGCAATCPTVKPGVDIKCCSTDNCNPFPTRERS", "prompt": "Design a protein sequence for a long neurotoxin from the Anchieta's cobra (Naja anchietae) venom. This toxin should function as a potent, competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta and alpha-epsilon subunit interfaces of the postsynaptic muscle-type receptor. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The structure should feature a long, flexible third loop that facilitates deep penetration into the receptor binding pocket, with key functional residues concentrated in the central loop for high-affinity binding that prevents acetylcholine from activating the receptor. The toxin should exhibit the typical structural stability and target specificity of elapid snake long neurotoxins, contributing to rapid neuromuscular paralysis through postsynaptic blockade."}
{"description": "sp|Q8JIR2|VM3HA_PROFL Zinc metalloproteinase/disintegrin-like HR1a OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILGSGNVNDYEVVYPRKVTAVPKGAVQPKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLRFSDSEAHAVFKYENVEKEDEAPKMCGVTQTNWESDEPIKKASKLVVTAEQQRYLNNFRFIELVIVADYRMFTKFNSNLNEVKTWVYEIVNTLNEIYRYLYVRVALVALEVWSNGDLSSVTLSAYDTLDSFGEWRKRDLLKRKSHDNAQLLTAIDFNGTIIGLAHVASMCDPKCSTGIVQDYSSRNLVVAVIMAHEMGHNLGIRHDRENCTCHANSCIMSAVISDQPSKYFSNCSHVQYWNYINDDEPQCILNEPLRTDIVSPPVCGNELLEVGEECDCGSPATCRYPCCDAATCKLHSWVECESGECCEQCRFRTAGTECRARRSECDIAESCTGHSADCPTDRFHRNGQPCLHNFGYCYNGNCPIMYHQCYALWGANATVAKDSCFEDNQKGNDYGYCRKENGRKIPCEPQDVKCGRLYCSLGNQLPCRFFYTPTDENIGMVDTGTKCGDKKVCSNRQCVDVNTAY", "prompt": "Design a novel zinc metalloproteinase/disintegrin-like toxin protein sequence inspired by the venom composition of Protobothrops flavoviridis, the habu snake. This protein should function as a key hemorrhagic toxin, targeting the extracellular matrix and vascular integrity through its dual functional domains. The N-terminal metalloproteinase domain must contain the canonical zinc-binding motif HEXXHXXGXXH, coordinating a catalytic zinc ion essential for proteolytic activity against basement membrane components such as type IV collagen, laminin, and fibronectin. This domain should adopt a metzincin-like fold with a central five-stranded beta-sheet and surrounding alpha-helices, facilitating the degradation of capillary walls and promoting hemorrhage. The C-terminal disintegrin-like domain should feature the characteristic disintegrin loop sequence, typically rich in cysteine residues that form multiple disulfide bonds stabilizing its structure, enabling inhibition of integrin-mediated platelet aggregation and cell adhesion. The full-length protein should exhibit a multi-domain architecture, with the metalloproteinase and disintegrin-like domains connected by a flexible linker, and maintain overall structural stability through conserved disulfide connectivity. The generated sequence must reflect the potent hemorrhagic activity typical of snake venom metalloproteinases, contributing to prey immobilization through systemic bleeding and tissue damage."}
{"description": "sp|P0CI41|CUG6A_CONCL Omega-conotoxin Cl16a OS=Californiconus californicus OX=1736779 PE=1 SV=1", "sequence": "NCPAGCRSQGCCM", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of omega-conotoxin Cl16a from the venom of the marine cone snail Californiconus californicus. This toxin belongs to the omega-conotoxin family, which are known for their potent and selective blockade of voltage-gated calcium channels (VGCCs), specifically N-type calcium channels (Cav2.2). The peptide should function as a calcium channel antagonist, binding to the pore-forming α1 subunit of Cav2.2 channels with high affinity to inhibit neurotransmitter release at presynaptic terminals, leading to neuromuscular paralysis. Structurally, it should adopt the characteristic inhibitor cystine knot (ICK) motif, stabilized by three disulfide bridges with a conserved cysteine framework (C-C-CC-C-C). The sequence must include key residues for target specificity, such as those forming the functional loop regions that interact with the channel's extracellular domains, and maintain the compact, globular fold typical of conotoxins. The toxin should exhibit high stability and selectivity, reflecting its role in the predatory venom of C. californicus for immobilizing prey."}
{"description": "sp|A0A7S8MVF3|SCX36_TITSE Putative sodium channel toxin Ts36 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MFKLAIILAFLFLGARAVRDGYPILKNGCSCTCQPLLENPKCGAICKSKVGISKAYCYMWACRLILHRYSEEYRPY", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian scorpion Tityus serrulatus, a medically significant species known for producing potent neurotoxins that target voltage-gated sodium channels. This toxin should function as a site-3 modulator, specifically binding to the voltage-sensing domain IV of Nav channels to inhibit fast inactivation, thereby prolonging action potentials and enhancing neuronal excitability. The protein should adopt a compact, stable fold characteristic of scorpion β-toxins, featuring a conserved cysteine-stabilized α-helix/β-sheet (CSαβ) scaffold with a disulfide bridge pattern of C1-C4, C2-C5, C3-C6. Key structural elements must include a conserved 'pharmacophore' region responsible for receptor recognition, comprising a solvent-exposed hydrophobic patch and critical basic residues that interact with the channel's S3-S4 loop in domain IV. The sequence should exhibit high affinity for mammalian Nav1.2, Nav1.4, or Nav1.6 isoforms, with minimal effects on insect sodium channels, reflecting the toxin's role in vertebrate predation and defense. Ensure the core β-sheet and C-terminal region are optimized for target engagement and thermodynamic stability in the venom milieu."}
{"description": "sp|P0DMD9|TXP3_BRAAI Omega-theraphotoxin-Ba1c OS=Brachypelma albiceps OX=503929 PE=2 SV=1", "sequence": "MRSLTLAAVLACSLLLVFHTSAAEEHEAQEGYLMNPGDTDTALATVDDERILECVFSCDIEKEGKPCKPKGEKKCTGGWKCKIKLCLKI", "prompt": "Design a novel animal venom toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-theraphotoxin from the tarantula species Brachypelma albiceps, belonging to the inhibitor cystine knot (ICK) structural family. This toxin functions as a potent voltage-gated calcium channel antagonist, specifically targeting Cav2.2 (N-type) channels in the peripheral nervous system. The molecular mechanism involves high-affinity binding to the channel's voltage-sensing domain, inhibiting calcium influx and thereby blocking neurotransmitter release at presynaptic terminals, which results in paralysis of prey. The structural scaffold must feature the characteristic ICK motif with a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6, forming a stable, triple-stranded beta-sheet globular fold. Key functional residues should include a hydrophobic patch for membrane interaction and basic residues for channel recognition. The sequence should exhibit high stability, specificity for Cav2.2 channels, and minimal off-target effects, reflecting the evolutionary adaptation of Brachypelma venom for rapid immobilization of arthropod prey."}
{"description": "sp|P82114|PA2H1_BOTMO Basic phospholipase A2 homolog MjTX-I OS=Bothrops moojeni OX=98334 PE=1 SV=2", "sequence": "MRTLWIMAVLLVGVEGSLVELGKMILQETGKNPVTSYGAYGCNCGVLGRGKPKDATDRCCYVHKCCYKKLTDCNPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLDTYNKKYKNNYLKPFCKKADPC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog toxin from the venom of Bothrops moojeni, a medically significant pit viper. This toxin functions as a myotoxic agent that induces skeletal muscle necrosis through a catalytically independent mechanism, as it lacks the conserved calcium-binding and catalytic residues required for phospholipase A2 enzymatic activity. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved core of three long alpha-helices stabilized by seven disulfide bonds with the canonical cysteine pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, Cys13-Cys14). Despite its enzymatic inactivity, the toxin retains membrane-binding capabilities and exerts its toxic effects by disrupting sarcolemma integrity, leading to calcium influx, mitochondrial dysfunction, and muscle cell death. The sequence should include a basic isoelectric point to facilitate interaction with negatively charged phospholipid head groups on muscle cell membranes. Incorporate key structural motifs such as the conserved 'PLA2 domain' architecture, the hydrophobic membrane-interaction face, and the characteristic beta-wing region, while ensuring the absence of functional residues in the catalytic network (e.g., His/Asp dyad). The resulting protein should be structurally stable, exhibit high affinity for muscle cell membranes, and demonstrate potent myotoxicity without phospholipid hydrolysis activity."}
{"description": "sp|Q8JH85|VSPA_MACLB Alpha-fibrinogenase OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MVLIRVLANLVMLHLSYGEKSSELVIGGRPCNINQHRSLALLYNSSGFLCGGTLINQQWVLSAAHCDMENMQIYLGLHNFSLPNMDQKRRVAEEKFFCLSNKSYTKWDKDIMLIKLNRRVKTSTHIAPLSLPSNPPRLRSVCRIMGWGSITSPRETLPYVPHCANIMILRYWVCRAIYGSLPAKSRTLCAGVPRRRIGSCLGDSGGPLICNGQIQGIASWGSDPCVNHGAPGVYTKVFDYNDWIQSIIAGNTAATCPP", "prompt": "Generate the amino acid sequence for an alpha-fibrinogenase toxin from the venom of Macrovipera lebetinus (Levantine viper). This snake venom metalloproteinase (SVMP) belongs to the P-III class of SVMPs, characterized by a multi-domain architecture comprising a catalytic zinc-dependent metalloproteinase domain, a disintegrin-like domain, and a cysteine-rich domain. The toxin functions as a potent anticoagulant by specifically cleaving the Aα-chain of fibrinogen, preventing fibrin clot formation and thereby disrupting the coagulation cascade. The catalytic domain features the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, which coordinates the catalytic zinc ion essential for proteolytic activity. The disintegrin-like and cysteine-rich domains mediate interactions with platelet integrins and other vascular targets, contributing to the toxin's hemorrhagic and antiplatelet activities. The protein is expected to adopt a globular fold stabilized by multiple disulfide bonds, with the cysteine-rich domain particularly enriched in disulfide bridges that confer stability in the venom milieu. The mature toxin likely undergoes post-translational processing to remove a pro-domain, resulting in an active enzyme that targets key components of hemostasis, making it a crucial factor in the viper's predatory and defensive strategies."}
{"description": "sp|P56743|SCX6_ANDAU Toxin Aah6 OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "GRDGYVVKNGTNCKYSCEIGSEYEYCGPLCKRKNAKTGYCYAFACWCIDVPDDVKLYGDDGTYCSS", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should originate from the North African scorpion Androctonus australis, a species known for producing potent neurotoxins that target voltage-gated sodium channels in prey and predators. This toxin belongs to the beta-toxin family, specifically characterized by its ability to modify sodium channel gating kinetics by shifting the voltage dependence of activation toward more negative potentials, thereby enhancing neuronal excitability and causing spontaneous firing. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet, stabilized by four disulfide bridges with a characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern (cysteine framework III). Key structural elements must include a conserved 'pharmacophore' region responsible for binding to neurotoxin receptor site 4 on voltage-gated sodium channels (e.g., Nav1.2, Nav1.6), involving specific residues that interact with the channel's S3-S4 loop in domain II. The toxin should exhibit high affinity for insect sodium channels, contributing to the venom's paralytic effect, while maintaining structural stability through hydrophobic core packing and disulfide-mediated rigidity. Ensure the sequence reflects the typical length of 60-70 amino acids, with appropriate conservation of functional residues critical for target recognition and channel modulation, without incorporating any database identifiers."}
{"description": "sp|P0DKR5|PA2B2_PSEFE Basic phospholipase A2 CbII OS=Pseudocerastes fieldi OX=1355908 PE=1 SV=1", "sequence": "NLFQFTKMINGKLGAFAVLNYISTGCYCGWGGQGTPKDATDRCCFVHDCCYGRVKGCNPKLAIYSYSFQKGNIVCGKNNGCLRDICECDRVAANCFHQNKNTYNRNYRFLSSSRCRQTSEQC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Persian horned viper (Pseudocerastes fieldi). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, two antiparallel beta-sheets, and a conserved calcium-binding loop with the motif YGCXCG. Include the essential catalytic triad residues (His48, Asp49, Tyr52) and maintain the characteristic disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The basic nature of this toxin should facilitate its interaction with anionic membrane surfaces and contribute to its presynaptic neurotoxic effects by disrupting neurotransmitter release at neuromuscular junctions. The sequence should reflect the evolutionary optimization for rapid membrane penetration and efficient substrate hydrolysis while maintaining structural stability in the venom gland environment."}
{"description": "sp|P00621|PA2A2_BITNA Acidic phospholipase A2 CM-II OS=Bitis nasicornis OX=8695 PE=1 SV=1", "sequence": "DLTQFGNMINKMGQSVFDYIYYGCYCGWGGQGKPRDATDRCCFVHDCCYGKMGTYDTKWTSYKYEFQDGDIICGDKDPQKKELCECDRVAAICFANSRNTYNSKYFGYSSSKCTETEQC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the rhinoceros viper, Bitis nasicornis. This enzyme should function as a potent toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) required for calcium-dependent enzymatic activity. The sequence should exhibit the acidic nature typical of viperid phospholipases A2, with a pI below 7.0, and contain the conserved calcium-binding loop motif. The toxin should demonstrate membrane-binding capability through hydrophobic residues and potentially exhibit presynaptic neurotoxic activity by disrupting neurotransmitter release at neuromuscular junctions. The structural scaffold should maintain the compact, stable globular architecture characteristic of secreted phospholipase A2 enzymes, with the active site located in a conserved groove that accommodates phospholipid substrates."}
{"description": "sp|P56973|CA1A_CONCN Alpha-conotoxin CnIA OS=Conus consors OX=101297 PE=1 SV=2", "sequence": "MGMRMMFTVFLLVVLTTTVVSFPSDSASDGRDDEAKDERSDIYESKRNGRCCHPACGKYYSCGR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus consors, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the CC-C-C framework typical of alpha-conotoxins. The sequence should include the essential cysteine residues at positions 1, 2, 3, and 4 to maintain this disulfide bridge architecture, which confers structural stability and enables precise receptor binding. Key structural elements should include a beta-hairpin motif and loop regions that mediate specific interactions with the nAChR ligand-binding domain, particularly through residues in the inter-cysteine loops that determine receptor subtype selectivity. The toxin should exhibit high affinity for its target receptors, blocking acetylcholine binding and inhibiting ion channel activation, thereby disrupting synaptic signaling. The overall structure should be small, stable, and resistant to proteolytic degradation, with surface-exposed residues optimized for target engagement while maintaining the core alpha-conotoxin fold essential for biological activity."}
{"description": "sp|G8XQX1|OXLA_DABRR L-amino-acid oxidase OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "MNVFFMFSLLFLATLGSCADDKNPLEECFREDDYEEFLEIAKNGLKKTSNPKHIVIVGAGMSGLSAAYVLAGAGHKVTVLEASERPGGRVRTHRNVKEGWYANLGPMRVPEKHRIIREYIRKFGLKLNEFVQETENGWYFIKNIRKRVGEVKKDPGLLKYPVKPSEAGKSAGQLYQESLGKAVEELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDQLPTSMYRAIEESVHFKARVIKIQQNAEKVTVTYQTTQKNLLLETADYVIVCTTSRAARRITFKPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIQGGKSTTDLPSRFIYYPNHNFTTGVGVIIAYGIGDDANFFQALNLNECADIVFNDLSSIHQLPKKDLQTFCYPSIIQKWSLDKYAMGAITTFTPYQFQHFSEALTAPVGRIFFAGEYTANAHGWIDSTIKSGLTAARDVNRASEL", "prompt": "Design a protein sequence for an L-amino-acid oxidase toxin from the Russell's viper (Daboia russelii), a medically significant snake species whose venom contains potent enzymatic toxins that contribute to its hemorrhagic, coagulopathic, and cytotoxic effects. This enzyme functions as a flavin adenine dinucleotide (FAD)-dependent oxidase that catalyzes the oxidative deamination of L-amino acids, generating hydrogen peroxide, ammonia, and corresponding α-keto acids as reactive byproducts. The resulting oxidative stress and hydrogen peroxide production induce apoptosis, platelet aggregation inhibition, and tissue damage through lipid peroxidation and cellular membrane disruption. The protein should adopt the classic L-amino-acid oxidase fold characterized by a two-domain structure: a FAD-binding domain with a Rossmann fold topology and a substrate-binding domain that forms the active site cavity. Conserved structural elements include the FAD-binding motif with characteristic glycine-rich loops, the substrate recognition residues that confer specificity for hydrophobic L-amino acids, and the catalytic base responsible for proton abstraction. The enzyme likely functions as a homodimer in its active form, with the dimer interface stabilizing the active site conformation. Key functional residues should include histidine and tyrosine residues involved in the catalytic mechanism, along with conserved acidic residues that coordinate substrate binding and orientation. The generated sequence must maintain the characteristic secondary structure composition with alternating α-helices and β-strands that form the characteristic TIM barrel-like substrate-binding domain and the classical Rossmann fold for FAD cofactor binding."}
{"description": "sp|Q4LCS8|TXA25_ANDAU Beta-insect toxin AaBTxL1 OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "MMKLVLFSVIVILFSLIGSIHGADVPGNYPLDRSGKKYPCTITWKKNPSCIQICKKHGVKYGYCFDFQCWCEIFGRLKTFKI", "prompt": "Design a beta-insect toxin protein sequence derived from the venom of the North African scorpion Androctonus australis. This toxin should function as a potent insecticidal agent by selectively targeting and modulating insect voltage-gated sodium channels. The protein should adopt the characteristic beta-toxin structural scaffold, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should comprise a short alpha-helix packed against an antiparallel beta-sheet, creating a compact, stable globular architecture resistant to proteolytic degradation. Key functional residues should be positioned within the conserved 'pharmacophore' region to enable specific interaction with insect sodium channel domain II voltage-sensor, potentially causing a hyperpolarizing shift in channel activation or inhibiting fast inactivation. The sequence should maintain the signature beta-toxin molecular surface features that confer insect selectivity while avoiding mammalian sodium channel interactions. The resulting protein should exhibit high thermal stability and solubility typical of scorpion venom toxins, suitable for potential biopesticide applications."}
{"description": "sp|C0JB00|A1OB_LOXRU Dermonecrotic toxin LruSicTox-alphaIC1b (Fragment) OS=Loxosceles rufescens OX=571528 PE=2 SV=1", "sequence": "WIMGHMVNSIAQIDEFVNLGANSIETDVSFDKQANPEYMYHGTPCDCGRDCLHWENFNDFLKGLRKATTPGDSKYHEKLILVVFDLKTGSLYDNQAYDAGTKLAKNLLEHYWNNGNNGGRAYIVLSIPNLNHYKLIAGFKDTLKNEGHEDLLEKVGHDFSGNDDIPDVEKAYKNAGVTGHVWQSDGITNCLPRGLSRVKLAIANRDSGSGIINKVYYWTVDKRSTTRNSLDAGVDGIMTNYPGVIADVLSESAYKNKYKIATYEDNPWETFKP", "prompt": "Design a protein sequence for a dermonecrotic toxin from the Mediterranean recluse spider, Loxosceles rufescens. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, and endothelial cell damage that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold characteristic of the phospholipase D superfamily, with the catalytic histidine and other essential residues positioned in the active site pocket to coordinate the hydrolysis reaction. The sequence should include the conserved HxK(x)4D motif essential for catalytic activity and maintain the structural integrity required for membrane interaction and substrate binding. The toxin should exhibit specificity for mammalian cell membranes while maintaining stability in the venom environment."}
{"description": "sp|P0C7K0|BP11B_CROAD Bradykinin-potentiating peptide 11b OS=Crotalus adamanteus OX=8729 PE=1 SV=1", "sequence": "QGGWPRNPIPP", "prompt": "Design a bradykinin-potentiating peptide from the venom of the Eastern diamondback rattlesnake (Crotalus adamanteus) that functions as a potent vasoactive toxin. This peptide should act by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced bradykinin-mediated vasodilation, hypotension, and increased vascular permeability. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of the bradykinin-potentiating peptide family, with a cysteine framework that likely follows a C-C-C-C pattern forming two disulfide bonds. The structure should feature a small, globular fold with exposed residues critical for ACE inhibition, potentially including a proline-rich region that confers resistance to proteolytic degradation. The molecular target is the zinc-metallopeptidase active site of ACE, with key interactions involving coordination to the zinc ion and blocking the substrate-binding pocket. The biological significance lies in the venom's use of this peptide to induce circulatory shock in prey by amplifying endogenous bradykinin signaling, facilitating prey immobilization through severe hypotension."}
{"description": "sp|Q8QGR0|3SIM7_DENAN Muscarinic toxin 7 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK", "prompt": "Design a novel muscarinic toxin protein derived from the venom of the Eastern green mamba (Dendroaspis angusticeps). This three-finger toxin (3FTx) should function as a selective muscarinic acetylcholine receptor antagonist, specifically targeting and modulating muscarinic receptor subtypes with high affinity. The protein must adopt the characteristic three-finger toxin fold stabilized by a conserved disulfide bridge framework (typically 4-6 disulfide bonds with a C-C-CC-C-C pattern) that creates the stable, elongated β-sheet-rich structure. The core scaffold should feature three extended loops projecting from a central globular domain, with key functional residues concentrated in the central loop that mediates receptor binding and specificity. The toxin should exhibit the typical thermal stability and protease resistance conferred by the dense disulfide network, while maintaining precise molecular recognition capabilities for muscarinic receptors to interfere with parasympathetic nervous system signaling. The sequence should reflect the evolutionary optimization for rapid neuromuscular effects while avoiding non-specific interactions with other receptor types."}
{"description": "sp|Q8QG87|PA2A_BOTIN Acidic phospholipase A2 BITP01A OS=Bothrops insularis OX=8723 PE=1 SV=1", "sequence": "MRTLWIMAVLLVGVEGNLWQFGKMMNYVMGQSVVYKYFYYGCYCGWGGIGQPRDATDRCCFVHDCCYGKVTGCDPKTDSYTYSKENGDVVCGGDDPCKKQICECDRVAATCFRDNKDTYDMKYWLYGAKNCQEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Bothrops insularis, the golden lancehead pit viper. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing membrane phospholipids at the sn-2 position to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bonds that confer exceptional thermal and pH stability. Key structural elements should include the conserved calcium-binding loop (YXCGXGG sequence motif) essential for catalytic activity, the interfacial binding surface for membrane association, and the catalytic histidine-aspartate dyad. As an acidic isoform, the protein should have a calculated pI below 7.0. The toxin should exhibit both enzymatic and pharmacological activities typical of viperid phospholipases A2, including myotoxicity, edema formation, and potential neurotoxic or anticoagulant effects through disruption of cellular membranes and generation of pro-inflammatory lipid mediators. The sequence should maintain the characteristic N-terminal helix, beta-wing region, and C-terminal extension common to group II phospholipase A2 enzymes from snake venoms."}
{"description": "sp|C0HKZ7|SLMB_MACLB Snaclec macrovipecetin subunit beta OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "DQDCLPGWSFYEGHCYKVFDVKKTWEDAEKFCTEQMSGGHLVSFHSSEEVDFMIKLASPILKFDLVWIGLSNFWRDCHWGWSDGVKLDYKAWSDKPNCYVAKTVDPQWLHRDCSRTYKFVCKSRVPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation modulator. This protein should originate from Macrovipera lebetinus (Levantine viper) venom, where such snaclecs typically act as antagonists of platelet receptors, disrupting hemostasis through competitive inhibition. The sequence must adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two intra-chain disulfide bonds with a typical C1-C4, C2-C3 connectivity pattern. The protein should form a heterodimeric complex with an alpha subunit, creating a functional snaclec complex that binds specifically to platelet membrane receptors such as GPIb or GPVI. Include key structural elements: a calcium-binding site with conserved acidic residues, a hydrophobic core that maintains domain stability, and surface-exposed loops that mediate specific protein-protein interactions with platelet receptors. The sequence should exhibit the hallmark features of viperid snaclecs - high stability, specific receptor targeting, and potent anti-hemostatic activity through interference with platelet adhesion and activation pathways."}
{"description": "sp|P56972|KBX3_PANIM Scorpine OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "MNSKLTALIFLGLIAIAYCGWINEEKIQKKIDERMGNTVLGGMAKAIVHKMAKNEFQCMANMDMLGNCEKHCQTSGEKGYCHGTKCKCGTPLSY", "prompt": "Design a novel antimicrobial and antiparasitic peptide derived from the venom of the Emperor scorpion (Pandinus imperator), a species known for producing potent bioactive compounds with dual defensive and predatory functions. This peptide should function as a broad-spectrum cytolytic agent capable of disrupting microbial membranes through pore formation, while also exhibiting specific antiparasitic activity against Plasmodium falciparum, the causative agent of malaria. The structural scaffold should feature a characteristic scorpine-like architecture consisting of an N-terminal region with alpha-helical amphipathic character responsible for membrane interaction and disruption, connected to a C-terminal region containing a cysteine-stabilized alpha-beta (CSαβ) motif typical of scorpion defensins. The cysteine framework should follow the conserved pattern C1-Xn-C2-Xn-C3-Xn-C4-Xn-C5-Xn-C6, forming three disulfide bridges (C1-C4, C2-C5, C3-C6) that stabilize the compact globular fold. The peptide should demonstrate cationic properties with a net positive charge to facilitate electrostatic interactions with negatively charged microbial membranes, while maintaining selective toxicity toward pathogens over mammalian cells. The alpha-helical domain should contain hydrophobic and hydrophilic residues arranged in an amphipathic pattern to enable membrane insertion and pore formation, while the CSαβ domain contributes to structural stability and may mediate specific molecular recognition. The resulting peptide should exhibit potent antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as significant antiparasitic effects against malaria parasites through membrane disruption mechanisms."}
{"description": "sp|Q86QV7|KGX42_CENNO Potassium channel toxin gamma-KTx 4.2 OS=Centruroides noxius OX=6878 PE=3 SV=1", "sequence": "DRDSCVDKSKCGKYGYYQECQDCCKNAGHNGGTCVYYKCKCNP", "prompt": "Design a potassium channel toxin protein sequence derived from the venom of the scorpion Centruroides noxius. This toxin belongs to the gamma-KTx family and specifically targets voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker, binding to the pore region of Kv channels and inhibiting potassium ion flux, thereby disrupting neuronal excitability and neuromuscular transmission. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with a conserved cysteine framework (C-C-CC-C-C). The sequence should include key functional residues for channel recognition and binding, particularly in the beta-sheet region that interacts with the channel vestibule. The toxin should exhibit high affinity and selectivity for specific Kv channel subtypes, contributing to the neurotoxic effects of the scorpion venom by prolonging action potentials and causing hyperexcitability in target cells."}
{"description": "sp|Q9BP99|O163_CONAE Omega-conotoxin-like ArMKLT1-02 OS=Conus arenatus OX=89451 PE=2 SV=1", "sequence": "MKVTCMMIVAVLFLTAWTFVTADDSISALEDLFAKAHDKMENSEASPLNERDCRALGEYCGLPYVHNSRCCSQLCGFICVPESP", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This is an omega-conotoxin-like peptide derived from the venom of Conus arenatus, the sand-dwelling cone snail. As a member of the conotoxin superfamily, this peptide functions as a potent neurotoxin that targets voltage-gated calcium channels (VGCCs) in the nervous system. The protein should adopt the characteristic inhibitory cysteine knot (ICK) structural motif, stabilized by a conserved disulfide bridge framework typical of omega-conotoxins (likely C-C-C-C pattern with disulfide connectivity I-III, II-IV). The sequence should contain the appropriate cysteine spacing and conserved residues that facilitate precise binding to specific VGCC subtypes, potentially N-type or P/Q-type calcium channels, leading to synaptic transmission blockade. The structural scaffold should feature a compact, globular fold with well-defined loops that form the pharmacophore interface for high-affinity channel interaction. Include key functional residues that confer target specificity and potent inhibitory activity while maintaining the structural stability characteristic of conopeptides."}
{"description": "sp|C0HKZ6|SLMA_MACLB Snaclec macrovipecetin subunit alpha OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "DCPSDWSSHEEHCYKVFRLFKTWEEAEKFCTQQVNGWHLASIESVEEANFLAELVPKTLIKSKYHVWIGLRDQSERQQCSSHWTDGSAVSYEKVVRFTKCFGLNKDKGYLEWVTLPCEDKNPFICKSWVPH", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a platelet aggregation inhibitor. This protein originates from Macrovipera lebetinus (Levantine viper) venom, where it contributes to the hemorrhagic and anticoagulant effects by targeting blood coagulation pathways. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should contain the essential calcium-binding motifs and carbohydrate recognition domain (CRD) elements that mediate specific interactions with platelet surface receptors, particularly glycoprotein Ib (GPIb) or other coagulation factors, leading to inhibition of platelet adhesion and aggregation. The structural scaffold should feature the conserved beta-sheet core with alpha-helical segments, maintaining the overall globular conformation critical for its anticoagulant function in viper envenomation."}
{"description": "sp|G9I930|PA2HB_MICTN Basic phospholipase A2 homolog MitTx-beta OS=Micrurus tener tener OX=1114302 PE=1 SV=1", "sequence": "MDKMNPAHLLVLAAVCVSLLGASSIPPQALNLNQFRLMIKCTNDRVWADFVDYGCYCVARDSNTPVDDLDRCCQAQKQCYDEAVKVHGCKPLVMFYSFECRYLASDLDCSGNNTKCRNFVCNCDRTATLCILTATYNRNNHKIDPSRCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog toxin component from the venom of the Texas coral snake (Micrurus tener tener). This protein functions as the beta subunit of the MitTx toxin complex, which acts as a potent pain-inducing agent through selective agonism of acid-sensing ion channels (ASICs). The protein should adopt the characteristic phospholipase A2-like fold despite lacking catalytic activity, featuring the conserved pancreatic phospholipase A2 structural scaffold with the calcium-binding loop and catalytic site residues evolutionarily modified. The sequence should contain the typical phospholipase A2 disulfide bond pattern (C-C-C-C-C-C framework) that stabilizes the globular, multi-helical structure. As part of the heterodimeric MitTx complex, this beta subunit works synergistically with the alpha subunit (a Kunitz-type protease inhibitor homolog) to dramatically potentiate ASIC1 activation, causing sustained channel opening and intense pain sensation. The protein should exhibit basic isoelectric point characteristics and maintain the structural elements necessary for proper heterodimer formation and target recognition."}
{"description": "sp|P82935|3NO2_NAJKA Tryptophan-containing weak neurotoxin OS=Naja kaouthia OX=8649 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCLNCPEMFCGKFQICRNGEKICFKKLHQRRPLSWRYIRGCADTCPVGKPYEMIECCSTDKCNR", "prompt": "Design a snake venom neurotoxin protein sequence that exhibits weak neurotoxic activity, characteristic of the three-finger toxin family from cobra venoms. This protein should function as a postsynaptic neurotoxin that binds with moderate affinity to nicotinic acetylcholine receptors at the neuromuscular junction, causing partial blockade of neurotransmission. The structural scaffold must adopt the classic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the characteristic C-C-C-C cysteine framework pattern. Incorporate a conserved tryptophan residue that is essential for receptor binding and functional activity. The protein should maintain the characteristic structural features of weak neurotoxins from Naja kaouthia venom, including appropriate loop lengths and conserved residues that contribute to its specific receptor recognition profile while exhibiting reduced potency compared to more potent alpha-neurotoxins. The sequence should reflect the evolutionary optimization for prey immobilization through reversible neuromuscular blockade."}
{"description": "sp|A0A7S8RFI7|SCX37_TITSE Putative sodium channel toxin Ts37 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MAGEWACLLVSLVLLWGAAGSRDGFLLDRNFCRIKCSFLGSNSMCADRCTVLGASAGHCNNYACFCTDLRDRVKIWGDSVRCRKP", "prompt": "Design a novel animal toxin protein sequence that functions as a sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should exhibit the characteristic structural and functional properties of scorpion β-toxins, which typically target voltage-gated sodium channels (Nav) and modulate their gating kinetics by binding to site 4, leading to delayed inactivation and prolonged neuronal excitation. The protein should adopt a conserved cysteine-stabilized α/β (CSαβ) fold, stabilized by four disulfide bridges with a characteristic cysteine framework (C1-C4, C2-C5, C3-C6, C7-C8) that forms a compact globular structure with a core β-sheet and one or two α-helices. Key functional residues should be located in the flexible C-terminal region and loops, which are critical for receptor recognition and binding specificity. The toxin should demonstrate high affinity for mammalian Nav channels, particularly those expressed in the central and peripheral nervous systems, contributing to the venom's neurotoxic effects such as pain, paralysis, and autonomic dysfunction. Ensure the sequence reflects the evolutionary adaptations of Tityus serrulatus venom for prey immobilization and defense, with optimal stability under physiological conditions and potential isoform selectivity among sodium channel subtypes."}
{"description": "sp|P0DKT6|PA2B_BITAR Phospholipase A2 bitanarin (Fragment) OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "SLIEFGKMITEETNRPVFPYEATIVVCDCGNGNGS", "prompt": "Design a phospholipase A2 toxin protein sequence derived from the venom of Bitis arietans, commonly known as the puff adder. This toxin should function as a potent enzymatic toxin that catalyzes the hydrolysis of the sn-2 acyl bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The generated sequence must exhibit the characteristic structural features of secreted phospholipase A2 enzymes, including the conserved calcium-binding loop (YGKYCG/XCG) essential for catalytic activity, the catalytic histidine-aspartate dyad, and the hydrophobic substrate-binding channel. The protein should adopt the classic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and the calcium-binding loop, stabilized by multiple conserved disulfide bridges typically following the pattern Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8 in group II phospholipase A2 enzymes. The toxin should demonstrate membrane-disrupting activity, contributing to local tissue damage, inflammation, and systemic effects through the generation of pro-inflammatory lipid mediators. The sequence should include characteristic venom phospholipase A2 features such as an extended C-terminal region and surface-exposed residues that may contribute to anticoagulant or myotoxic activities commonly observed in viperid snake venom phospholipase A2 enzymes."}
{"description": "sp|P58504|KA102_CENNO Potassium channel toxin alpha-KTx 10.2 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "VACVYRTCDKDCTSRKYRSGKCINNACKCYPY", "prompt": "Design a novel potassium channel toxin protein sequence that captures the essential biological and structural characteristics of alpha-KTx 10.2 from the venom of the Mexican scorpion Centruroides noxius. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved functional dyad consisting of a critical lysine residue positioned in the beta-sheet region and an aromatic residue that together mediate channel block by physically occluding the potassium conduction pore. The structural fold should feature a compact, triple-stranded antiparallel beta-sheet stabilized by the disulfide core, with the functional dyad presented on an exposed loop region for optimal channel interaction. The toxin should exhibit the characteristic pharmacological profile of blocking potassium efflux, leading to prolonged neuronal depolarization and enhanced neurotransmitter release, consistent with the neurotoxic effects observed in scorpion envenomation. Ensure the sequence maintains the typical 30-40 amino acid length range characteristic of scorpion potassium channel toxins while preserving the essential structural and functional determinants for specific Kv1 channel blockade."}
{"description": "sp|P86402|CTXL1_MESEU Chloride channel toxin-like peptide MeuClTx-1 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MCMPCFTTRPDMAQQCRDCCGGNGKCFGYQCLCNR", "prompt": "Design a novel animal toxin peptide sequence that functions as a chloride channel toxin, inspired by the venom arsenal of the scorpion Mesobuthus eupeus. This toxin should exhibit potent and selective modulation of chloride ion channels, likely targeting specific subtypes such as chloride channels or GABA-gated chloride channels to disrupt neuronal or muscular excitability. The peptide should adopt a compact, stable structural fold characteristic of scorpion venom toxins, stabilized by a conserved disulfide bridge framework—typically involving three or four disulfide bonds arranged in a specific connectivity pattern (e.g., C1-C4, C2-C5, C3-C6 for a four-disulfide scaffold) that confers rigidity and resistance to proteolysis. Key structural motifs may include an inhibitor cysteine knot (ICK) or related β-sheet-rich domains, with surface-exposed loops critical for target recognition and binding. The molecular mechanism should involve high-affinity interaction with the extracellular domains of chloride channels, leading to either blockade or potentiation of chloride flux, thereby inducing paralysis, convulsions, or other neurotoxic effects. Ensure the sequence reflects evolutionary conservation of functional residues (e.g., hydrophobic patches, charged residues for channel interaction) while maintaining the physicochemical properties (e.g., low molecular weight, basic pI) typical of scorpion toxin peptides. The final design must prioritize biological activity, structural integrity, and target specificity, without incorporating any database identifiers."}
{"description": "sp|Q9NII5|KAX16_OLIMR Potassium channel toxin alpha-KTx 1.6 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKISFLLLLAIVICSIGWTEAQFTNVSCSASSQCWPVCKKLFGTYRGKCMNSKCRCYS", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels which play crucial roles in immune cell function and neuronal excitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a functional surface rich in basic residues that mediates specific interactions with the potassium channel pore region. Key structural elements must include: a well-defined beta-hairpin motif that inserts into the channel vestibule, a conserved 'functional dyad' comprising a critical lysine residue that projects into the selectivity filter and an aromatic residue that stabilizes the binding interface through hydrophobic interactions, and a structurally conserved 'gamma-core' motif involved in channel recognition. The toxin should exhibit high affinity binding through electrostatic complementarity with the negatively charged extracellular turret regions of Kv1.3 channels while maintaining selectivity against other potassium channel subtypes. The sequence should preserve the characteristic molecular weight of approximately 4-5 kDa and maintain the structural stability required for venom deployment and target engagement."}
{"description": "sp|P01393|3L21_DENJA Alpha-elapitoxin-Djk2a OS=Dendroaspis jamesoni kaimosae OX=8619 PE=1 SV=1", "sequence": "RTCYKTYSDKSKTCPRGEDICYTKTWCDGFCSQRGKRVELGCAATCPKVKTGVEIKCCSTDYCNPFPVWNPR", "prompt": "Design a protein sequence for an alpha-elapitoxin from the Jameson's mamba (Dendroaspis jamesoni kaimosae) venom. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. It should exhibit high affinity binding to nicotinic acetylcholine receptors at the neuromuscular junction, specifically antagonizing muscle-type nAChRs to cause flaccid paralysis. The structural scaffold must feature the characteristic three-finger fold stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The protein should adopt a compact beta-sheet-rich structure with three protruding loops that form the receptor binding interface. Key functional residues should be concentrated in the central loop for specific receptor recognition and competitive inhibition of acetylcholine binding. The sequence should maintain the conserved hydrophobic core and display the characteristic pharmacological profile of short-chain alpha-neurotoxins from mamba venoms, contributing to rapid prey immobilization through neuromuscular blockade."}
{"description": "sp|P0C7K1|BP11A_CROVV Bradykinin-potentiating peptide 11a OS=Crotalus viridis viridis OX=8742 PE=1 SV=1", "sequence": "QGPSPRHPIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the prairie rattlesnake, Crotalus viridis viridis. This peptide functions as a potent vasoactive agent by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced vasodilation, hypotension, and increased vascular permeability. The peptide should adopt a compact, stable structure stabilized by a conserved pyroglutamic acid residue at the N-terminus, which confers resistance to aminopeptidase degradation, and a C-terminal proline-rich region that is critical for ACE binding and inhibition. The sequence should be relatively short (approximately 5-15 amino acids) and exhibit the characteristic motif of BPPs, including the presence of proline residues that contribute to structural rigidity and functional potency. The overall fold should be optimized for high affinity interaction with the active site of ACE, effectively blocking its catalytic activity and amplifying the physiological effects of bradykinin in prey envenomation."}
{"description": "sp|Q4LCS9|TXA22_ANDAU Beta-toxin KAaH2 OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "MMKLMLFSIIVILFSLIGSIHGADVPGNYPLDSSDDTYLCAPLGENPSCIQICRKHGVKYGYCYAFQCWCEYLEDKNVKI", "prompt": "Design a novel beta-toxin protein sequence inspired by the venom of the North African scorpion Androctonus australis. This toxin should function as a voltage-gated sodium channel modulator, specifically targeting insect sodium channels with high affinity while exhibiting reduced activity toward mammalian channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, with key functional residues positioned in the 'core' and 'NC' domains to mediate specific interactions with the voltage-sensing domain II of insect sodium channels. The mechanism should involve trapping the voltage sensor in its activated state, leading to prolonged channel opening, membrane depolarization, and ultimately paralysis in insect prey. Incorporate conserved hydrophobic patches and polar residues critical for membrane association and target recognition, while maintaining the typical 60-70 amino acid length and basic isoelectric point common to this toxin family to ensure proper folding, stability, and biological activity."}
{"description": "sp|Q9NBW2|SCBT_OLIMR Toxin BmKBT OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKAALLLVIFSLMLIGVLTKKSGYPTDHEGCKNWCVLNHSCGILCEGYGGSGYCYFWKLACWCDDIHNWVPTWSRATNKCRAK", "prompt": "Design a novel scorpion toxin protein sequence inspired by Toxin BmKBT from the Manchurian scorpion (Olivierus martensii, formerly Mesobuthus martensii). This toxin should function as a beta-type scorpion toxin targeting voltage-gated sodium channels (Nav channels). The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by four disulfide bridges with the characteristic C-C-CC-C-C pattern. The core structural motif consists of an alpha-helix packed against an antiparallel beta-sheet. The toxin should exhibit high affinity binding to site-4 of voltage-gated sodium channels, specifically modulating channel inactivation by delaying or inhibiting fast inactivation, leading to prolonged neuronal excitation and neurotoxic effects. The molecular mechanism involves binding to extracellular loops of Nav channel domains, particularly interacting with the S3-S4 linker of domain II. The sequence should contain the conserved structural elements necessary for this activity while maintaining the characteristic molecular weight and physicochemical properties of scorpion beta-toxins. The venom from Olivierus martensii serves as a rich source of neurotoxins that modulate ion channel function, and this particular toxin should reflect the evolutionary optimization for prey immobilization through precise sodium channel modulation."}
{"description": "sp|P00622|PA2B_BITCA Basic phospholipase A2 caudoxin OS=Bitis caudalis OX=8693 PE=1 SV=1", "sequence": "NLIQFGNMISAMTGKSSLAYASYGCYCGWGGKGQPKDDTDRCCFVHDCCYGKADKCSPKMILYSYKFHNGNIVCGDKNACKKKVCECDRVAAICFAASKHSYNKNLWRYPSSKCTGTAEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the horned adder (Bitis caudalis) venom. This enzyme should function as a presynaptic neurotoxin that specifically targets the neuromuscular junction. The protein should exhibit calcium-dependent catalytic activity, hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for phosphatidylcholine substrates. The structural scaffold should feature the characteristic phospholipase A2 fold, consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) within the conserved calcium-binding loop (YGKYCGXXXXG). The protein should maintain the characteristic interfacial activation site that recognizes and binds to phospholipid membranes. As a basic phospholipase, ensure the sequence has an overall positive charge to facilitate interaction with negatively charged neuronal membranes. The toxin should demonstrate presynaptic specificity by binding to specific receptors at motor nerve terminals, ultimately causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The structure should maintain the compact, stable globular fold typical of group I phospholipase A2 enzymes from elapid and viperid venoms."}
{"description": "sp|B4XSY4|SLA1_MACLB Snaclec A1 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MGRSISVSFGLLVVFLSLSGTGADQDCLPGWSSHEGHCYKVFNLDKTWEDAEKFCTEQANSGHLVSIDSKKEANFVAELVSQNIKETRRTDFVWIGLRAEDKRQHCSSEWSDGSSINYQNWIEAESKKCLGLEKQTRYRKWVNLNCGQPYRFTCEI", "prompt": "Design a novel protein sequence for a C-type lectin-like toxin derived from the venom of Macrovipera lebetinus (Levantine viper). This protein should function as a snaclec (snake C-type lectin) with potent platelet-aggregating activity, characteristic of the A1 subtype found in viperid venoms. The protein must adopt the canonical C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with the characteristic C1-C4 and C2-C3 connectivity pattern. The molecular mechanism should involve specific calcium-dependent binding to platelet membrane receptors, particularly targeting glycoprotein Ib (GPIb) or other platelet surface glycoproteins, leading to platelet activation and aggregation through outside-in signaling. The structural scaffold should maintain the β-sheet-rich core typical of CTLDs, with key residues in the carbohydrate recognition domain (CRD) adapted for protein-protein interactions rather than sugar binding. The protein should exhibit the heterodimeric assembly common to snake venom snaclecs, forming a functional complex that enhances avidity and specificity for its platelet targets. This toxin contributes to the profound coagulopathic effects of Levantine viper venom by promoting thrombocytopenia and disrupting normal hemostasis through platelet consumption and microthrombi formation."}
{"description": "sp|P0DPS3|VASP1_VIPAA Snake venom serine protease VaSP1 (Fragment) OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "VIGGDECNINEHPFLVALHTARXXRFYCAGTLINQEWVLTAARCDRXXXXXILGVHSKXXXXXXXXXXXXXXXXXXXXXXTYTRWDKDIMLIRLKRXXXXXXXXXXXXXXXXXXXXXXXXXIMGWGTITTTKVTYPDVPHCADINMFDYSVCQKXXXKLPEKSRTLCAGILQGGIDSCKGISGGPLICNGEIQGIVSYGK", "prompt": "Design a snake venom serine protease protein fragment that mimics the biological activity and structural characteristics of Vipera ammodytes ammodytes venom components. This toxin should function as a potent serine protease with procoagulant or anticoagulant activity, targeting key components of the vertebrate hemostatic system. The protein should adopt the characteristic trypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) arranged in the canonical geometry. Include the essential structural elements: a two-domain architecture with predominantly beta-barrel organization, the characteristic activation domain containing the substrate binding pocket, and conserved disulfide bridges that stabilize the tertiary structure. The protein should exhibit substrate specificity for coagulation factors such as fibrinogen, factor X, or other plasma proteins, leading to disruption of normal blood coagulation through either hypercoagulation or anticoagulation pathways. Incorporate venom-specific adaptations that enhance stability in the venom gland and optimize target recognition, including potential exosite interactions that confer specificity for particular coagulation cascade components. The structural scaffold should maintain the characteristic serine protease fold while incorporating venom-specific sequence features that modulate potency, specificity, and resistance to endogenous protease inhibitors."}
{"description": "sp|Q4JHE1|OXLA_PSEAU L-amino-acid oxidase OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "MNVFFMFSLLFLAALGSCADDRRRPLEECFREADYEEFLEIAKNGLQRTSNPKRVVVVGAGMAGLSAAYVLAGAGHQVTLLEASERVGGRVNTYRNEKDGWYVNLGPMRLPERHRIIREYIRKFGLELNEFIQENDNAWYFIKNIRKRVSEVKKDPGVFKYPVKPSEEGKSASQLYRESLQKVIEELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSSYYLSFIESLKSDDIFSYEKRFDEIVGGFDQLPRSMYQAIAEKVHLNAQVIKIQQNAEDVRVTYQTPAKTLSYVIADYVIVCSTSRAARRIHFEPPLPPKKAHALRSIHYRSSTKIFLTCSQKFWEADGIHGGKSTTDLPSRFIYYPNHSFTSGIGVIVAYTLADDTDFFQALDIETSADIVINDLSLIHQLPKEQIQALCYPSKIQKWSLDEYAMGAITSFTPYQFQDFFEIVAAPVGRIYFAGEYTASVHGWLDSTIKSGLTAARDVNLASQKPSRIQLSNDNEL", "prompt": "Design a novel L-amino-acid oxidase toxin protein with the biological characteristics and structural features derived from king brown snake (Pseudechis australis) venom. This enzyme should function as a key venom component that catalyzes the oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The generated hydrogen peroxide contributes to the toxin's cytotoxic, hemolytic, and pro-apoptotic effects, while the α-keto acid byproducts may induce local tissue damage and inflammation. The protein should adopt the classic flavin-dependent oxidase fold with a conserved FAD-binding domain featuring Rossmann-fold architecture and a substrate-binding domain that accommodates various L-amino acid substrates. Include critical catalytic residues for FAD cofactor binding and substrate recognition, maintaining the characteristic dimeric quaternary structure typical of snake venom L-amino-acid oxidases. The enzyme should exhibit optimal activity at physiological pH and temperature, with structural stability provided by multiple disulfide bridges that maintain the proper orientation of active site residues. The final sequence should reflect the evolutionary optimization for rapid substrate turnover and resistance to proteolytic degradation in the venom environment, enabling efficient prey immobilization through multiple cytotoxic mechanisms."}
{"description": "sp|P58427|TXHP3_HETVE Kappa-sparatoxin-Hv1c OS=Heteropoda venatoria OX=152925 PE=1 SV=1", "sequence": "ECGTLFSGCSTHADCCEGFICKLWCRYERTW", "prompt": "Generate the amino acid sequence for a spider venom toxin from Heteropoda venatoria (huntsman spider) that functions as a kappa-sparatoxin. This neurotoxin should exhibit potent insecticidal activity by selectively targeting and modulating insect voltage-gated calcium channels, particularly Cav2-type channels, which are crucial for synaptic transmission in the insect nervous system. The toxin should adopt a robust structural scaffold stabilized by an inhibitor cystine knot (ICK) motif, characterized by a conserved disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) that creates a compact, triple-stranded beta-sheet fold. This structural framework provides exceptional thermal and proteolytic stability while presenting key functional loops for target interaction. The toxin's mechanism involves high-affinity binding to the extracellular domains of insect calcium channels, leading to disruption of neurotransmitter release and ultimately paralysis or death in insect prey. The sequence should include the characteristic cysteine spacing pattern of ICK toxins and maintain the hydrophobic core essential for structural integrity, while displaying surface-exposed residues optimized for specific insect calcium channel recognition and minimal cross-reactivity with vertebrate channels."}
{"description": "sp|P0DPS4|PA2B_CERCE Basic phospholipase A2 Cc2-PLA2 OS=Cerastes cerastes OX=8697 PE=1 SV=1", "sequence": "NLYQFGKMINHMVGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFGENVNTYDKKFLSSSRCRQTSEQC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Saharan horned viper, Cerastes cerastes. This enzyme should function as a potent toxin with both presynaptic neurotoxic and myotoxic activities. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and cell damage. The structural scaffold should feature the characteristic pancreatic phospholipase A2 fold, consisting of three major alpha-helices and a two-stranded antiparallel beta-sheet, stabilized by a conserved network of seven disulfide bonds. Include the conserved catalytic triad of histidine, aspartate, and tyrosine residues essential for enzymatic activity. The protein should possess a basic character to facilitate interaction with anionic membrane surfaces and contain specific molecular determinants for presynaptic targeting at neuromuscular junctions. The overall structure should maintain the characteristic phospholipase A2 calcium-binding loop and the interfacial binding surface required for membrane association and substrate recognition."}
{"description": "sp|P0DKT7|PA2CA_OXYSA Basic phospholipase A2 cannitoxin alpha chain (Fragment) OS=Oxyuranus scutellatus canni OX=183720 PE=1 SV=1", "sequence": "NLLQFGYMIRCANGRSRPVW", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the coastal taipan (Oxyuranus scutellatus), specifically the cannitoxin alpha chain. This enzyme should exhibit potent neurotoxic and myotoxic activity characteristic of snake venom phospholipases A2. The protein should function by hydrolyzing the sn-2 acyl bond of membrane phospholipids, leading to membrane disruption, inflammation, and potential presynaptic neurotoxicity. The structural scaffold should feature the conserved phospholipase A2 fold with a calcium-binding loop (YXCGXGG motif), catalytic histidine-aspartate dyad, and characteristic disulfide bridge pattern (typically 6-7 conserved disulfide bonds). The sequence should include the essential catalytic residues (histidine, aspartate) and calcium-coordinating residues. As a basic phospholipase A2, it should have an overall positive charge at physiological pH, contributing to its membrane-binding affinity and potent toxicity. The protein should adopt the characteristic phospholipase A2 three-finger-like structure with alpha-helical content and beta-sheet regions, maintaining the conserved structural elements that enable its enzymatic activity and toxic functions in snake venom."}
{"description": "sp|C0JB04|A1P_LOXRU Dermonecrotic toxin LruSicTox-alphaIC2 (Fragment) OS=Loxosceles rufescens OX=571528 PE=2 SV=1", "sequence": "WIMGHMVNGISQIDQFVNLGANSIETDVSFDKQANPEKTHHGVPCDCGRNCRYQTKFPDFLKALRKATTPGDSNYHEKLILVVFDLKTGKLSENQAYDAGTKMARNLLQHYWNNGDNGGRAYIVLSIPYLKHYGLITGFKEALKNEGHEELLEKVGYDFSGNDYLSDVKEAYRKAGVTGHVWQSDGITNCWLRGFKRVKQAVANRDSADGFINKVYYWTVDKRVTTRKSLNAGVDGIMTNYPDVINSVLNESAYKTKFRVATYDDNPWETFKN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the Mediterranean recluse spider, Loxosceles rufescens. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, and endothelial cell damage that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the catalytic histidine and other essential residues properly positioned in the active site pocket. The sequence should include the characteristic N-terminal signal peptide for secretion and the mature toxin domain with the conserved HKD motifs required for enzymatic activity. The structural scaffold should facilitate membrane association and substrate binding while maintaining the thermostability required for venom function. The generated protein should exhibit specific activity against mammalian cell membranes while maintaining the structural integrity necessary for venom delivery and tissue penetration."}
{"description": "sp|P0DKW9|3L22E_ACAAN Alpha-elapitoxin-Aa2e OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "VICYVGYNNPQTCPPGGNVCFTKTWCDARCHQLGKRVEMGCATTCPKVNRGVDIKCCSTDKCNPFPKTTPPWKRPRGKP", "prompt": "Design a novel alpha-elapitoxin protein sequence that captures the potent neurotoxic activity characteristic of death adder (Acanthophis antarcticus) venom. This toxin should function as a postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the classic three-finger toxin (3FTx) structural fold, characterized by three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The structural scaffold should feature the characteristic triple-finger topology with the central loop typically containing key functional residues for receptor binding. The molecular target is the alpha-delta interface of the muscle nicotinic acetylcholine receptor, with specific interactions likely involving conserved aromatic and basic residues in loop II that facilitate high-affinity binding to the receptor's orthosteric site. The protein should exhibit the typical 60-75 amino acid length range of short-chain neurotoxins and maintain the structural stability required for venom delivery while achieving potent receptor blockade through precise molecular recognition elements."}
{"description": "sp|C0JB05|A21_LOXSP Dermonecrotic toxin LspaSicTox-alphaII1 (Fragment) OS=Loxosceles spadicea OX=571530 PE=2 SV=1", "sequence": "WIMGHMVNAIWQIDQFMDLGVNSIEFDINFDKSANPIYTYHGVPCDCFRSCLKWEYFGDFLTALRHRTTPGDKLYKEKLILFVFDMKTNSLYDNQAYTAGVNMANNIFKYYWNNGNNGGRSYFILSIPNLNHYNLIKGFQETIKSKGHPELLEKVGYDFSANDDIPDVEKAYQKVGVTGHVWQSDGITNCLPRTLTRVQAAVKERDSGGVINKVYYWTADKYSTTRDALDAGVDGIMTNYPYVLNDVLKENAYKNKFRLANYEDNPWVTFKP", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles spadicea. This toxin belongs to the SicTox-alpha family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, neutrophil recruitment, and endothelial cell damage, ultimately causing localized tissue necrosis, hemolysis, and the characteristic dermonecrotic lesion. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of the phospholipase D superfamily, with the active site containing the conserved HxK(x)4D motif essential for catalytic activity. Key structural elements include a hydrophobic membrane-binding interface for substrate recognition and a stable core stabilized by disulfide bridges that maintain structural integrity in the venom gland. The toxin should exhibit specificity for mammalian cell membranes while avoiding non-specific cytotoxicity, reflecting its role in spider envenomation where it facilitates prey immobilization and tissue digestion."}
{"description": "sp|C0HL40|BDS4_ANTEL Kappa-actitoxin-Ael2e OS=Anthopleura elegantissima OX=6110 PE=1 SV=1", "sequence": "GTTCYCGKTIGIYWFGKYSCPTNRGYTGSCPYFLGICCYPVD", "prompt": "Design a protein sequence for a sea anemone toxin with potent neurotoxic activity. This toxin belongs to the kappa-actitoxin family, specifically kappa-actitoxin-Ael2e, derived from the aggregating anemone Anthopleura elegantissima. The protein should function as a voltage-gated potassium channel blocker, specifically targeting Kv3 subfamily channels to modulate neuronal excitability and synaptic transmission. The structural scaffold should feature the characteristic sea anemone toxin fold, consisting of a compact beta-sandwich core stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements should include a well-defined beta-hairpin loop that forms the functional epitope for channel interaction, specifically binding to the voltage-sensing domain of Kv3 channels to inhibit channel opening. The sequence should contain the conserved cysteine framework typical of type 1 sea anemone toxins, with appropriate spacing between cysteine residues to enable proper folding. The molecular mechanism involves binding to the extracellular side of potassium channels, trapping them in a closed conformation and prolonging action potential duration in target neurons. The protein should exhibit high specificity for Kv3 channels while maintaining the thermal stability and protease resistance characteristic of sea anemone venom peptides."}
{"description": "sp|P0DKY6|ANF_CRODC Natriuretic peptide NP2 OS=Crotalus durissus cascavella OX=184540 PE=1 SV=1", "sequence": "VSTSRGSQGCFGLKLDRIGAASGLGCWRRIVDS", "prompt": "Design a natriuretic peptide toxin from the venom of the South American rattlesnake Crotalus durissus cascavella. This toxin functions as a potent vasoactive peptide that mimics endogenous natriuretic peptides, primarily targeting the natriuretic peptide receptor-A (NPR-A) in vascular smooth muscle and renal tissues. The protein should adopt the characteristic natriuretic peptide fold consisting of a conserved 17-amino acid disulfide-bonded ring structure formed by two cysteine residues, with flexible N- and C-terminal extensions. The core mechanism involves binding to the extracellular domain of NPR-A, activating particulate guanylyl cyclase activity, leading to increased cyclic GMP production, resulting in vasodilation, natriuresis, and diuresis. This contributes to the venom's hypotensive effects by reducing blood pressure through vascular relaxation and enhanced renal sodium excretion. The structural scaffold should feature the essential disulfide bridge stabilizing the bioactive loop region critical for receptor recognition and activation."}
{"description": "sp|P0DKY5|VSP_CRODC Thrombin-like enzyme F202 (Fragment) OS=Crotalus durissus cascavella OX=184540 PE=1 SV=1", "sequence": "VVGGDECNINEHRFLVALYANSSLLCGGTLINQEWVLIAAHCDR", "prompt": "Design a thrombin-like serine protease enzyme derived from the venom of the South American rattlesnake, Crotalus durissus cascavella. This enzyme functions as a key component of the snake's venom arsenal, primarily targeting the mammalian coagulation cascade to induce consumptive coagulopathy and prey immobilization through defibrination. The protein should exhibit selective proteolytic activity toward fibrinogen, cleaving fibrinopeptide A (and potentially fibrinopeptide B) to generate soluble fibrin monomers that form unstable clots, leading to systemic hypofibrinogenemia. As a serine protease, it must contain the canonical catalytic triad (His, Asp, Ser) within a chymotrypsin-like fold, but with evolved specificity distinct from human thrombin to avoid inhibition by natural anticoagulants. The structure should feature characteristic serine protease domains, likely with venom-specific loops that confer substrate recognition and regulate catalytic efficiency. Conserved disulfide bridges typical of snake venom serine proteases should stabilize the core structure, facilitating stability in the venom gland and upon envenomation. The enzyme may possess exosite interactions for fibrinogen binding, alongside potential glycosylation sites that influence circulatory half-life and immune evasion. Design this toxin to embody the functional and structural hallmarks of crotalid thrombin-like enzymes, prioritizing its role in disrupting hemostasis through precise fibrinogenolysis."}
{"description": "sp|P0C1V9|CA11_CONCB Alpha-conotoxin-like Ca1.1 OS=Conus caracteristicus OX=89440 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRASDGRNAAANAFDLIALIARQNCCSIPSCWEKYKCS", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus caracteristicus, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting Cav1.1 (L-type calcium channel) subtypes. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework consisting of four conserved cysteine residues forming two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern. The 3D structure should feature a compact, stable fold stabilized by these disulfide bridges, with well-defined loops that mediate specific interactions with the pore-forming region of Cav1.1 channels. The molecular mechanism should involve high-affinity binding to the channel's voltage-sensing domain or pore region, effectively blocking calcium ion flux and disrupting neuromuscular transmission. The toxin should exhibit the typical alpha-conotoxin pharmacological profile of rapid onset and reversible blockade, contributing to the predatory strategy of Conus caracteristicus by immobilizing prey through inhibition of calcium-dependent neurotransmitter release at neuromuscular junctions."}
{"description": "sp|Q4TUA4|SCA4_OLIMR Alpha-toxin 4 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MNYLVFFSLALLLMTGVESVRDGYIADDKNCAYFCGRNAYCDDECKKKGAESGYCQWAGVYGNACWCYKLPDKVPIRVPGRCNGG", "prompt": "Design a novel alpha-toxin protein sequence derived from the venom of Olivierus martensii (commonly known as the Chinese scorpion), which functions as a potent neurotoxin targeting voltage-gated sodium channels. This toxin should exhibit the characteristic structural scaffold of scorpion alpha-toxins, featuring a conserved core stabilized by four disulfide bridges with the typical cysteine framework (C1-C4, C2-C5, C3-C6, C7-C8) that forms a compact, triple-stranded beta-sheet fold. The protein should specifically bind to site 3 of voltage-gated sodium channels, thereby inhibiting channel inactivation and prolonging action potentials, leading to sustained neuronal excitation and paralysis. Incorporate key functional residues known to mediate receptor interaction, particularly in the loops connecting the beta-strands, which are critical for the toxin's high affinity and selectivity. Ensure the sequence reflects the evolutionary adaptations of scorpion venom toxins for rapid prey immobilization, with optimal stability and minimal immunogenicity for potential therapeutic applications in neuropharmacology."}
{"description": "sp|Q90WA8|PA2B2_BUNFA Basic phospholipase A2 2 OS=Bungarus fasciatus OX=8613 PE=1 SV=2", "sequence": "MNPAHLLVLLAVCVSLLAAANIPPQSLNLLQFKNMIECAGTRTWMAYVKYGCYCGPGGTGTPLDELDRCCQTHDQCYDNAKKFGNCIPYFKTYVYTCNKPDITCTGAKGSCGRTVCDCDRAAALCFAAAPYNLANFGINKETHCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the banded krait (Bungarus fasciatus). This enzyme should function as a potent neurotoxin that targets presynaptic nerve terminals, causing irreversible blockade of neuromuscular transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, ultimately disrupting cell membrane integrity and triggering neurotransmitter release failure. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and a catalytic network centered around histidine and aspartate residues. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact, multi-looped globular structure. The protein should possess a basic pI to facilitate interaction with anionic membrane surfaces and contain key functional motifs for interfacial activation, substrate binding, and membrane penetration. The sequence should reflect the characteristic N-terminal helix, β-wing region, and C-terminal extension common to snake venom phospholipases A2, with appropriate surface loops for target recognition and membrane association."}
{"description": "sp|A0A7S8RFY1|SCX30_TITSE Putative sodium channel toxin Ts30 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MFKLAIILALLFFGARAGAVRDGYPILSDGCKYTCKPLGENQNCSRICKEKAGSWYGYCYMWACYCTDVSKKAVLFGDSGTPECHVWIK", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus, a medically significant species known for producing potent neurotoxins that target voltage-gated sodium channels. This toxin should function as a specific modulator of voltage-gated sodium channels, likely exhibiting beta-toxin activity that alters channel gating kinetics by binding to receptor site 4. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion sodium channel toxins, featuring a compact globular fold stabilized by four disulfide bridges with a typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should display a core alpha-helix packed against a three-stranded antiparallel beta-sheet, with key functional residues concentrated in the 'pharmacophore' regions—particularly the beta-hairpin loops—that mediate specific interactions with the voltage-sensing domain of domain II of neuronal sodium channels. The toxin should demonstrate selectivity for specific sodium channel subtypes, potentially favoring TTX-sensitive channels involved in pain signaling or neuromuscular transmission, and exhibit thermal and proteolytic stability conferred by its disulfide-rich architecture. The sequence must include the conserved cysteine framework and maintain the structural determinants essential for high-affinity binding to sodium channels while enabling the allosteric modulation of channel inactivation."}
{"description": "sp|P0C7K2|BP11B_CROVV Bradykinin-potentiating peptide 11b OS=Crotalus viridis viridis OX=8742 PE=1 SV=1", "sequence": "QGGAPWNPIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the prairie rattlesnake (Crotalus viridis viridis) that functions as a potent vasoactive peptide. This peptide should act as a dual-function toxin by inhibiting angiotensin-converting enzyme (ACE) to prevent the degradation of bradykinin while simultaneously enhancing bradykinin's vasodilatory effects. The peptide should adopt a compact, stable structure stabilized by a characteristic pyroglutamic acid residue at the N-terminus and a C-terminal proline-rich region. It should exhibit the typical structural features of BPPs, including a small molecular weight (approximately 5-15 amino acids), lack of disulfide bridges, and an overall extended conformation that facilitates ACE binding. The peptide should specifically target the active site of ACE, competing with angiotensin I for binding and thereby modulating the renin-angiotensin system to produce hypotension. The sequence should reflect the evolutionary optimization for rapid onset of action and high potency characteristic of rattlesnake venom peptides used for prey immobilization through cardiovascular collapse."}
{"description": "sp|Q8UVG0|VM3BE_BOTER Zinc metalloproteinase-disintegrin-like berythractivase OS=Bothrops erythromelas OX=44710 PE=1 SV=1", "sequence": "MIQVLLVIICLEAFPYQGSSIILESGNVNDYEVVYPRKVTALSKGAVHPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSEIHYSPDGREITTYPLVEDHCYYHGRIQNDADSSASISACNGLKGHFKLQGEMYLIEPFKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKKASLLNLTPEQQAYLDAKKYVEFVVVLDHGMYKKYKDDLDKIKRRIYEIVNTMNEMFIPLNICVALTGLEIWSKGDKINVTSESWFTLILFTNWRGADLLKRKSHDNAQLLTNTDFDGSTIGRAHIGSMCHPYLSVGIIQDYSPVNLLVASTMAHEMGHNLGMHHDNDTCTCGAPSCVMAAAISKDPSKLFSNCSQEYQRKYLIKNRPQCLLNKPLRTDIISPPVCGNELLEVGEECDCGTPENCRDPCCNATTCKLTPGSQCVEGLCCDQCRFRKTGTECRAAKHDCDLPESCTGQSADCPMDDFQRNGHPCQNNNGYCYNGKCPTMENQCIDLVGPKATVAEDSCFKDNQKGNDYGYCRKENGKKIPCEPQDVKCGRLYCNDNSPGQNNPCKCIYFPRNEDRGMVLPGTKCADGKVCSNRHCVDVATAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin from the venom of Bothrops erythromelas, a medically significant pit viper endemic to northeastern Brazil. This protein should function as a key hemorrhagic toxin that disrupts hemostasis through dual mechanisms: (1) proteolytic cleavage of extracellular matrix components in capillary basement membranes via its zinc-dependent metalloproteinase domain, which contains the conserved HEXXHXXGXXH zinc-binding motif and exhibits substrate specificity for type IV collagen and fibronectin, and (2) inhibition of platelet aggregation through its disintegrin-like domain that antagonizes integrin receptors on platelet surfaces. The protein should adopt a modular architecture typical of snake venom metalloproteinases (SVMPs), featuring a pro-domain, metalloproteinase domain with catalytic zinc ion coordinated by three histidine residues, and disintegrin-like domain characterized by the presence of an RGD or related integrin-binding motif. The mature toxin should exhibit the P-I class SVMP structural characteristics with molecular weight around 20-30 kDa, maintaining the conserved methionine turn and Met-turn supporting the active site architecture. The protein should demonstrate calcium-dependent stability and optimal activity at physiological pH, with the disintegrin-like domain folding into a compact, cysteine-rich structure stabilized by multiple disulfide bonds that present the integrin-recognition epitope in a conformationally constrained loop. The generated sequence should reflect the evolutionary optimization for rapid tissue penetration and potent hemorrhagic activity characteristic of Bothrops venoms, which cause severe local tissue damage and systemic bleeding in envenomation victims."}
{"description": "sp|P86422|3S13_MICFR Frontoxin III OS=Micrurus frontalis OX=129461 PE=1 SV=1", "sequence": "LTCFNDFSPTAHTVEDCQRGITTCYMKTWRVHRETVIERGCGCPKVKPGIRLKCCTGNTCNY", "prompt": "Generate the amino acid sequence for a three-finger toxin from the venom of Micrurus frontalis (South American coral snake), specifically a frontoxin III variant. This toxin belongs to the short-chain alpha-neurotoxin family and functions as a potent postsynaptic neurotoxin. It should adopt the characteristic three-finger protein fold stabilized by four conserved disulfide bonds in the C1-C5, C2-C6, C3-C7, C4-C8 connectivity pattern. The toxin acts as a competitive antagonist of muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, binding with high affinity to the alpha-delta subunit interface and causing flaccid paralysis by blocking neurotransmission. The sequence should feature the conserved structural core with three beta-stranded loops extending from a central globular domain, with key functional residues concentrated in the central loop responsible for receptor binding specificity. The toxin should exhibit the typical pharmacological profile of coral snake neurotoxins, showing selective targeting of skeletal muscle receptors over neuronal subtypes."}
{"description": "sp|Q86QV8|KGX4B_CENNO Potassium channel toxin gamma-KTx 4.11 OS=Centruroides noxius OX=6878 PE=3 SV=1", "sequence": "DRDSCVDKSQCGKYGYYGQCDECCKKAGERVGTCVYYKCKCNP", "prompt": "Design a potassium channel toxin protein from the venom of the Mexican scorpion Centruroides noxius. This toxin belongs to the gamma-KTx family and specifically targets voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker that binds to the pore region of Kv channels, disrupting potassium ion flux and leading to neuronal hyperexcitability. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with the conserved cysteine framework C1-X(3-9)-C2-X(3-14)-C3-X(0-4)-C4-X(1-5)-C5-X(4-13)-C6. The core structure should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a compact, stable molecular architecture resistant to proteolytic degradation. The molecular surface should present key functional residues for specific interaction with Kv channel vestibules, particularly residues that form complementary electrostatic and hydrophobic interactions with channel pore residues. The toxin should exhibit high affinity and selectivity for specific Kv channel subtypes, contributing to the neurotoxic effects characteristic of scorpion venom that facilitate prey immobilization through disruption of neuronal signaling."}
{"description": "sp|P81031|3SIM3_DENAN Muscarinic toxin 3 OS=Dendroaspis angusticeps OX=8618 PE=1 SV=2", "sequence": "LTCVTKNTIFGITTENCPAGQNLCFKRWHYVIPRYTEITRGCAATCPIPENYDSIHCCKTDKCNE", "prompt": "Generate the amino acid sequence for a muscarinic toxin from the Eastern green mamba (Dendroaspis angusticeps) venom. This toxin belongs to the three-finger toxin superfamily and specifically functions as a selective muscarinic acetylcholine receptor antagonist. The protein should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular structure. The toxin should exhibit high affinity and selectivity for muscarinic receptor subtypes, likely interacting with the receptor's extracellular loops to competitively inhibit acetylcholine binding and disrupt parasympathetic nervous system signaling. The sequence should contain the conserved cysteine framework typical of three-finger toxins and maintain the functional loops that mediate receptor recognition and binding specificity."}
{"description": "sp|P0DKY9|CKR1A_CONRO Conantokin R1-A OS=Conus rolani OX=745791 PE=1 SV=1", "sequence": "MQLYTYLYLLVPLVTFHLILGTGTLDHGGALTERRSTDATALKPEPVLQKSAARSTDDNGKDRLTQMKRILKKRGNNPRADEEYLKFIEEQRKQGKLDPTKFP", "prompt": "Generate the amino acid sequence for conantokin R1-A, a conantokin peptide neurotoxin from the marine cone snail Conus rolani. This toxin functions as a selective and potent antagonist of N-methyl-D-aspartate (NMDA) receptors, specifically targeting the NR2B subunit. The protein should exhibit the characteristic conantokin structural features: a highly gamma-carboxyglutamate (Gla)-rich composition that facilitates calcium-dependent binding to NMDA receptors, a relatively short linear peptide scaffold without disulfide bridges, and an alpha-helical conformation stabilized by Gla residues that enables specific interaction with the glutamate binding site of NR2B-containing NMDA receptors. The sequence should reflect the conantokin family's unique post-translational modification pattern with multiple Gla residues critical for receptor binding and biological activity, resulting in selective inhibition of neuronal excitability through NMDA receptor blockade."}
{"description": "sp|P58464|PA2H3_BOTPI Basic phospholipase A2 homolog piratoxin-3 OS=Bothrops pirajai OX=113192 PE=1 SV=1", "sequence": "DLWQFGQMILKETGKLPFPYYTYGGCYCGVGGRRGLGTKDDRCCYVHDCCYKKLTGCPKTDDRYSYSWLDLTIVCGEDDPCKELCECDKAIAVCFRENLGTYNKKYRYHLKPCKKADKPC", "prompt": "Generate the amino acid sequence for a basic phospholipase A2 homolog toxin from the venom of Bothrops pirajai, a pit viper species. This protein should function as a venom component with phospholipase A2-like structural characteristics but potentially reduced or altered enzymatic activity, as is typical for PLA2 homologs in snake venoms. The sequence should feature the conserved phospholipase A2 structural fold characterized by three long alpha-helices and a beta-wing region, along with the characteristic calcium-binding loop and catalytic network. Include the conserved cysteine framework that forms disulfide bridges essential for structural stability, typically involving 6-7 disulfide bonds that maintain the compact, stable protein core. The protein should exhibit basic isoelectric point properties and possess surface features that facilitate interaction with biological membranes or specific protein targets, potentially contributing to myotoxic, neurotoxic, or other pathophysiological effects characteristic of Bothrops venoms. The structural scaffold should maintain the overall PLA2 fold while potentially incorporating sequence variations that modulate its functional specificity and potency within the complex venom mixture."}
{"description": "sp|I2G9B4|VKT_MACLN Kunitz-type serine protease inhibitor PIVL OS=Macrovipera lebetina transmediterranea OX=384075 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSQDRPKFCYLPADPAECNAYMPRFYYDSASNKCKEFIYGGCRGNANNFKNRAECRHTCVASRKGIQPRIASN", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of Macrovipera lebetina transmediterranea (Levantine viper). This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, likely targeting factors such as thrombin, factor Xa, or plasma kallikrein. The protein should adopt the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds in a C1-C6, C2-C4, C3-C5 connectivity pattern. This structural scaffold forms a stable beta-trefoil motif with alternating beta-strands and loops, where the inhibitory activity is mediated by a solvent-exposed binding loop that inserts into the active site of the target protease. The sequence should include the canonical Kunitz-type protease inhibitor signature and maintain the conserved cysteine framework essential for proper folding and functional integrity. The resulting protein should exhibit high specificity and potency as a serine protease inhibitor, contributing to the hemorrhagic effects of viper venom by disrupting hemostasis."}
{"description": "sp|P0CI46|KA172_LYCMC Potassium channel toxin alpha-KTx 17.2 OS=Lychas mucronatus OX=172552 PE=2 SV=1", "sequence": "MKTIIVLLLLTIVAAAVVESSPKARRQTECQIKNDCQRYCQSVKECKYGKCYCNYAG", "prompt": "Design a potassium channel toxin protein sequence derived from the venom of the scorpion Lychas mucronatus. This toxin belongs to the alpha-KTx family 17.2, which specifically targets voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker, binding to the pore region of Kv channels to inhibit potassium ion efflux, thereby modulating neuronal excitability and neuromuscular transmission. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with a conserved cysteine framework (C1-X3-5-C2-X3-7-C3-X1-3-C4-X8-14-C5-X1-4-C6). The mature toxin is expected to be a small, compact polypeptide of approximately 30-40 amino acids, with a well-defined alpha-helix packed against an antiparallel beta-sheet. Key functional residues should be positioned to interact with the channel's selectivity filter and voltage-sensing domains, ensuring high affinity and specificity for Kv1 subfamily channels. The sequence must include the conserved functional dyad (lysine and aromatic residue) critical for channel block, and maintain the structural integrity required for venom efficacy in prey immobilization and defense."}
{"description": "sp|C0HL51|KTIL_BOTSC Kazal-type inhibitor-like protein OS=Bothriechis schlegelii OX=44725 PE=1 SV=1", "sequence": "MKVNCKGYPTKFCFGKPLPHCASDGKTYPNRCRFCNAFVKSHGLITLRYYGKCK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The protein is a Kazal-type inhibitor-like toxin derived from Bothriechis schlegelii (the eyelash viper), a venomous pit viper. This toxin functions as a serine protease inhibitor, playing a critical role in the viper's venom by disrupting prey homeostasis through interference with key proteolytic pathways involved in coagulation, fibrinolysis, and inflammation. The core mechanism involves tight, reversible binding to the active site of target serine proteases (such as trypsin, chymotrypsin, or coagulation factors), effectively blocking their catalytic activity. The structural scaffold must feature the characteristic Kazal-type domain fold, comprising approximately 50-60 amino acids with a well-defined alpha-helix and anti-parallel beta-sheet arrangement stabilized by three conserved disulfide bridges in a CysI-CysVI, CysII-CysIV, CysIII-CysV connectivity pattern (cysteine framework: C-C-C-C-C-C). The reactive site loop, located between the second beta-strand and the alpha-helix, should contain the canonical P1 residue (typically Lys or Arg for trypsin inhibition) that determines protease specificity. The overall structure is compact and globular, with the disulfide network conferring high stability against proteolytic degradation and environmental extremes. Ensure the sequence includes the essential Kazal-type signature motifs and conserved cysteine spacing to maintain the inhibitory function and structural integrity."}
{"description": "sp|Q90282|VM3VB_CROAT Zinc metalloproteinase-disintegrin-like VAP2B OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGNVNDYEVIYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLGKNKGLFSKDYSETHYSPDGREITTYPLVEDHCYYHGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLKLPDSEAHAVYKYENVEKEDEALKMCGVTQNWESYEPIKKASQLVVTAEHQKYNPFRFVELFLVVDKAMVTKNNGDLDKIKTRMYEIVNTVNEIYRYMYIHVALVGLEIWSNEDKITVKPEAGYTLNAFGEWRKTDLLTRKKHDNAQLLTAIDLDRVIGLAYVGSMCHPKRSTGIIQDYSEINLVVAVIMAHEMGHNLGINHDSGYCSCGDYACIMRPEISPEPSTFFSNCSYFECWDFIMNHNPECILNEPLGTDIISPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYDLFGADVYEAEDSCFERNQKGNYYGYCRKENGNKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNEDEHKGMVLPGTKCADGKVCSNGHCVDVATAY", "prompt": "Design a novel zinc metalloproteinase-disintegrin-like toxin protein sequence inspired by snake venom, specifically from the Western diamondback rattlesnake (Crotalus atrox). This protein should function as a key component of viperid venom, contributing to prey immobilization and tissue damage through proteolytic activity. The sequence must incorporate a zinc-dependent metalloproteinase domain characterized by the conserved HEXXHXXGXXH zinc-binding motif, which facilitates the hydrolysis of extracellular matrix components such as collagen, fibronectin, and laminin. Additionally, include a disintegrin-like domain that mimics the structure of endogenous disintegrins, featuring a cysteine-rich framework with a pattern typical of snake venom metalloproteinases (e.g., C-C-C-C disulfide bridges) to mediate interactions with integrin receptors on platelets or other cell surfaces, potentially inhibiting cell adhesion or promoting hemorrhage. The overall architecture should adopt a multi-domain fold common to venom metalloproteinases, with the metalloproteinase domain forming a globular structure centered around the catalytic zinc ion and the disintegrin-like domain presenting surface loops for target engagement. Ensure the sequence reflects the biological role in envenomation, where proteolytic degradation of basement membranes and interference with hemostatic pathways enhance venom spread and prey subjugation."}
{"description": "sp|P01395|3L22_DENVI Alpha-elapitoxin-Dv2a OS=Dendroaspis viridis OX=8621 PE=1 SV=1", "sequence": "RTCYKTPSVKPETCPHGENICYTETWCDAWCSQRGKRVELGCAATCPKVKAGVGIKCCSTDNCNPFPVWNPRG", "prompt": "Design a protein sequence for an alpha-elapitoxin from the green mamba (Dendroaspis viridis) venom. This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a postsynaptic neurotoxin. It should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular structure. The toxin acts as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, specifically targeting the α-δ subunit interface to block acetylcholine binding and induce flaccid paralysis. The sequence should include the conserved functional loop II responsible for receptor binding, featuring key residues for interaction with the nAChR ligand-binding domain. The protein should be approximately 60-70 amino acids in length and exhibit the typical three-loop architecture extending from a central core, with loop II being the primary determinant of receptor specificity and potency."}
{"description": "sp|P82972|VNP_PSEPC Natriuretic peptide PNP OS=Pseudocerastes persicus OX=47769 PE=1 SV=1", "sequence": "GENEPPKKKAPDGCFGHKIDRIGSHSGLGCNKFKPGH", "prompt": "Design a natriuretic peptide toxin from the venom of the Persian horned viper (Pseudocerastes persicus) that functions as a potent vasoactive agent. This toxin should exhibit the characteristic structural features of snake venom natriuretic peptides, including a conserved 17-amino acid disulfide-bonded loop formed by two cysteine residues that create a single disulfide bridge, stabilizing a compact globular fold essential for receptor binding. The peptide should act as an agonist at natriuretic peptide receptors, particularly the NPR-A receptor, mimicking endogenous natriuretic peptides to induce vasodilation, diuresis, and natriuresis by activating guanylyl cyclase and increasing cyclic GMP production. The sequence should include the conserved catalytic core motif [CFGXXXDRIXXXSGLGC] within the disulfide loop, which is critical for receptor recognition and biological activity. The overall structure should be small (approximately 40-45 amino acids) with an N-terminal signal peptide region and a mature peptide domain exhibiting the characteristic natriuretic peptide fold, enabling potent hypotensive effects through disruption of cardiovascular homeostasis in envenomed prey."}
{"description": "sp|P0CI47|KA126_LYCMC Potassium channel toxin alpha-KTx 12.6 OS=Lychas mucronatus OX=172552 PE=2 SV=1", "sequence": "MKMKIFIITIVIALFITSIVEAQNKLDVKCVRLETCREPCKKQLCLLPMKCMNGKCVCSPSRKIC", "prompt": "Design a potassium channel toxin protein sequence that embodies the biological characteristics of alpha-KTx 12.6 from the venom of the scorpion Lychas mucronatus. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature the signature CSαβ fold consisting of an alpha-helix packed against a triple-stranded anti-parallel beta-sheet. Include key functional residues in the beta-sheet region that form the molecular interface for potassium channel binding, particularly conserved aromatic and basic residues that interact with the channel's pore region. The toxin should exhibit the typical compact globular structure of scorpion toxins, approximately 30-40 amino acids in length, with the disulfide framework providing exceptional thermal and proteolytic stability. The biological function should involve precise modulation of neuronal excitability through potassium channel blockade, contributing to the venom's paralytic effects on prey by disrupting action potential repolarization."}
{"description": "sp|B4XSY5|SLAA_MACLB Snaclec A10 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MGRSISVSFGLLVVFLSLSGIGADFDCPSGWSAYDQHCYQAVDEPKSWADAEKFCTEQANGGHLVSIDSKKEANFVAELVSQNIKETRRTDFVWIGLRAEDKRQHCSSEWSDGSSINYQNWIEAESKKCLGLEKQTRYRKWVNLNCGQPYRFTCEI", "prompt": "Generate the amino acid sequence for a C-type lectin-like protein (snaclec) from the venom of Macrovipera lebetinus (Levantine viper). This toxin belongs to the snaclec family, specifically the A10 subtype, and functions as a platelet aggregation modulator. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure with two alpha-helices and two antiparallel beta-sheets stabilized by conserved disulfide bridges. The sequence must include the essential calcium-binding motifs and carbohydrate-recognition domains typical of C-type lectins, enabling specific interactions with platelet surface receptors such as glycoprotein Ib or integrins. The structural scaffold should feature the conserved long-loop region implicated in target binding, with key residues for receptor recognition and modulation of hemostatic pathways. The toxin's mechanism involves disrupting normal platelet function through receptor binding, leading to either inhibition or potentiation of aggregation, contributing to the viper's prey immobilization and digestive strategies."}
{"description": "sp|A0A7S8RGC8|SCX27_TITSE Probable sodium channel toxin Ts27 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MYNMVSLFIVAVLLLTYANVEGSDVTGGFPVNSNNCIYPCYSTQDEIQCEEFCEKLNGRLGYCRRDACYCEHLPESVKQITNSKTFDCSNGPWDLSTV", "prompt": "Design a novel sodium channel toxin protein sequence inspired by the venom arsenal of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal or cardiac isoforms to induce prolonged channel opening or altered inactivation kinetics, characteristic of scorpion beta-toxins. The protein must adopt the conserved structural scaffold of scorpion toxins, featuring a compact, globular fold stabilized by a core of four disulfide bridges with a characteristic cysteine framework (C-C-CC-C-C). The sequence should include key functional residues for receptor site 4 binding on sodium channels, such as a conserved hydrophobic patch and polar residues for specific interactions with domain II voltage-sensor segments. The structural motif should exhibit an alpha-helix packed against an anti-parallel beta-sheet, typical of the CSαβ fold, ensuring stability in the venom milieu and efficient target engagement. The toxin must demonstrate high affinity and selectivity, contributing to the neurotoxic effects of Tityus serrulatus venom, which includes autonomic excitation and pain, by disrupting sodium channel gating mechanisms."}
{"description": "sp|P01412|3S11A_OPHHA Weak toxin DE-1 OS=Ophiophagus hannah OX=8665 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYSLICFNQETYRPETTTTCPDGEDTCYSTFWNDHHGVKIERGCGCPRVNPPISIICCKTDKCNN", "prompt": "Design a protein sequence for a weak toxin from the king cobra (Ophiophagus hannah) venom that belongs to the three-finger toxin superfamily. This toxin should exhibit the characteristic three-finger structural fold stabilized by a conserved disulfide bond pattern, typically with four disulfide bridges arranged in a specific cysteine framework. The protein should function as a weak neurotoxin with low toxicity compared to other snake venom toxins, potentially acting as a modulator of nicotinic acetylcholine receptors or other neuronal targets. The sequence should maintain the structural integrity of the three elongated loops extending from a central core, with appropriate hydrophobic and hydrophilic residue distribution for membrane interaction and receptor binding. The toxin should demonstrate the typical molecular weight and physicochemical properties of weak three-finger toxins, featuring surface-exposed residues that enable specific but weak interactions with target receptors while maintaining the overall structural stability characteristic of this toxin family."}
{"description": "sp|Q90495|VM3E_ECHCA Zinc metalloproteinase-disintegrin-like ecarin OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "MIQILLVIICLAVFPYQGCSIILGSGNVNDYEVVYPQKVTALPKGAVQQPEQKYEDAMQYEFEVKGEPVVLHLEKNKELFSEDYSETHYSSDDREITTNPSVEDHCYYHGRIQNDAESTASISACNGLKGHFKLRGETYFIEPLKIPDSEAHAVYKYENIENEDEAPKMCGVTQDNWESDEPIKKTLGLIVPPHERKFEKKFIELVVVVDHSMVTKYNNDSTAIRTWIYEMLNTVNEIYLPFNIRVALVGLEFWCNGDLINVTSTADDTLHSFGEWRASDLLNRKRHDHAQLLTNVTLDHSTLGITFVYGMCKSDRSVELILDYSNITFNMAYIIAHEMGHSLGMLHDTKFCTCGAKPCIMFGKESIPPPKEFSSCSYDQYNKYLLKYNPKCILDPPLRKDIASPAVCGNEIWEEGEECDCGSPADCRNPCCDAATCKLKPGAECGNGECCDKCKIRKAGTECRPARDDCDVAEHCTGQSAECPRNEFQRNGQPCLNNSGYCYNGDCPIMLNQCIALFSPSATVAQDSCFQRNLQGSYYGYCTKEIGYYGKRFPCAPQDVKCGRLYCLDNSFKKNMRCKNDYSYADENKGIVEPGTKCEDGKVCINRKCVDVNTAY", "prompt": "Design a venom protein sequence from the saw-scaled viper (Echis carinatus) that functions as a zinc metalloproteinase-disintegrin-like toxin. This protein should exhibit the characteristic multi-domain architecture of snake venom metalloproteinases (SVMPs), specifically belonging to the P-III class. The protein must contain a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, enabling proteolytic activity against extracellular matrix components such as collagen, laminin, and fibronectin. Following the metalloproteinase domain, include a disintegrin-like domain that adopts a cysteine-rich fold with the characteristic disulfide bond pattern (typically 6-8 conserved disulfide bridges) that enables inhibition of integrin-mediated platelet aggregation, particularly targeting αIIbβ3 and αvβ3 integrins. The C-terminal region should feature a cysteine-rich domain that may facilitate additional protein-protein interactions. The overall structure should maintain the characteristic reprolysin family fold, with the metalloproteinase domain exhibiting the typical metzincin topology. This toxin contributes to the hemorrhagic, pro-coagulant, and tissue-damaging effects of saw-scaled viper venom by simultaneously degrading vascular basement membranes and disrupting platelet aggregation through integrin blockade."}
{"description": "sp|P58782|CA4A_CONER Alpha-conotoxin EIVA OS=Conus ermineus OX=55423 PE=1 SV=1", "sequence": "GCCGPYPNAACHPCGCKVGRPPYCDRPSGG", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus ermineus, a predatory marine snail. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) that forms a compact, stable fold stabilized by two disulfide bonds. The sequence should include the conserved cysteine pattern that enables proper folding into the inhibitory cysteine knot (ICK) motif, creating a rigid three-dimensional structure ideal for precise receptor binding. Key structural elements should include a short alpha-helical region and beta-turn motifs that present critical pharmacophore residues for high-affinity interaction with the acetylcholine binding site on muscle-type nicotinic receptors. The toxin should exhibit specificity for alpha-delta subunit interfaces while minimizing off-target effects on neuronal subtypes. Incorporate conserved hydrophobic core residues that maintain structural integrity and surface-exposed polar residues that mediate target recognition and binding affinity. The final sequence must be compatible with oxidative folding in the venom duct to achieve the native, biologically active conformation."}
{"description": "sp|Q3YEF3|O1661_CONTE Omega-conotoxin-like TeA61 OS=Conus textile OX=6494 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTFATADDSSNGLGNLFLKAHHEMKNPEASKLNERCLDAGEVCDIFFPTCCGYCILLFCA", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus textile. This venom component should function as a potent calcium channel blocker, specifically targeting neuronal voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and induce neurotoxic effects. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern (C-C-CC-C-C framework) that forms a compact, triple-stranded beta-sheet scaffold. Key structural elements should include a well-defined hydrophobic core, solvent-exposed loops for target recognition, and a rigid, knotted topology that confers protease resistance and thermal stability. The molecular mechanism should involve high-affinity binding to specific VGCC subtypes, likely through interactions with pore-forming or voltage-sensing domains, leading to channel inhibition and impaired neurotransmitter release. The sequence must encode appropriate signal peptides for venom gland expression and post-translational modifications typical of conotoxins, while maintaining the precise cysteine spacing and loop lengths essential for the ICK fold and target specificity."}
{"description": "sp|P58498|KAX64_PANIM Potassium channel toxin alpha-KTx 6.4 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "IEAIRCGGSRDCYRPCQKRTGCPNAKCINKTCKCYGCS", "prompt": "Design a potassium channel toxin protein derived from the venom of the emperor scorpion, Pandinus imperator. This toxin belongs to the alpha-KTx family and specifically functions as a potent blocker of voltage-gated potassium channels, particularly Kv1.3 channels, which play crucial roles in immune cell function and neuronal excitability. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by three or four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves high-affinity binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway through specific interactions with conserved channel residues in the selectivity filter and pore region. Key functional residues should be positioned in the beta-sheet regions to form the functional dyad that inserts into the channel pore. The structural scaffold must maintain the compact, globular architecture typical of scorpion toxins, with the disulfide network providing exceptional thermal and proteolytic stability essential for venom efficacy. The generated sequence should exhibit the characteristic molecular surface features that enable specific recognition and nanomolar affinity binding to potassium channels while maintaining the structural integrity required for venom delivery and target engagement."}
{"description": "sp|P82463|3SUC2_NAJKA Muscarinic toxin-like protein 2 OS=Naja kaouthia OX=8649 PE=1 SV=1", "sequence": "LTCVKEKSIFGVTTEDCPDGQNLCFKRWHMIVPGRYKKTRGCAATCPIAENRDVIECCSTDKCNL", "prompt": "Design a muscarinic toxin-like protein derived from the monocled cobra (Naja kaouthia) venom. This protein should function as a selective antagonist of muscarinic acetylcholine receptors, specifically targeting the M1, M3, and/or M4 subtypes to disrupt parasympathetic nervous system signaling. The toxin should adopt a three-finger toxin (3FTx) structural fold characterized by three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a C1-C3, C2-C5, C4-C6, C7-C8 connectivity pattern. Key structural features include: a central globular core with the conserved disulfide framework, three protruding finger-like loops with variable regions responsible for receptor subtype specificity, and conserved hydrophobic residues in the core for structural stability. The molecular mechanism involves competitive binding to the orthosteric site of muscarinic receptors, preventing acetylcholine binding and leading to parasympathetic blockade. The protein should exhibit the characteristic compact, stable structure of three-finger toxins with surface-exposed residues in loop II and loop III critical for receptor recognition and binding affinity. The sequence should maintain the conserved cysteine framework while incorporating variable region residues that confer muscarinic receptor selectivity over nicotinic receptors."}
{"description": "sp|Q9PRG0|PA2A1_AUSSU Acidic phospholipase A2 S1-11 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASDMPPQPLNLVQFSNMIQCANHGRRPTSNYMDYGCYCGKGGSGTPVDELDRCCKIHDDCYGEAEKSQKCAPYWTWYTWKCGSDGPQCDDSETGSRRFVCGYDATAAKCFAKAPYNKENYNIETRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission through hydrolysis of synaptic membrane phospholipids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should exhibit the typical disulfide bridge pattern of group IA snake venom phospholipases A2 (with 6-7 conserved disulfide bonds stabilizing the compact globular structure), and possess an acidic pI due to abundant aspartate and glutamate residues. The sequence should include an extended beta-wing region that may contribute to presynaptic targeting specificity. The toxin should demonstrate high catalytic efficiency toward phosphatidylcholine substrates while maintaining structural stability in the venom environment."}
{"description": "sp|Q8AY42|VKTB_BUNCA Kunitz-type serine protease inhibitor B OS=Bungarus candidus OX=92438 PE=2 SV=2", "sequence": "MSSGGLLLLVGLLTLCAELTPVSSKDRPKFCNVPPEPGRCNANVRAFYYNPRLRKCIEFTYGGCGGNANNFKSGGECKRACGE", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Malayan krait (Bungarus candidus). This toxin functions as a potent serine protease inhibitor, specifically targeting trypsin-like enzymes through a canonical binding loop that inserts into the protease's active site cleft. The protein should adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The reactive site loop should contain key residues for protease recognition and inhibition, particularly at the P1 position which determines specificity. As a component of krait venom, this toxin contributes to prey immobilization by interfering with proteolytic cascades involved in hemostasis and inflammation. The sequence should maintain the structural integrity of the Kunitz domain while optimizing for high-affinity serine protease binding and inhibition."}
{"description": "sp|P0C1W4|CA11_CONST Alpha-conotoxin-like S1.1 OS=Conus striatus OX=6493 PE=2 SV=1", "sequence": "MGMRMMFTVFLLVVLAITVVSFPLDRESDGANAEARTHDHEKHALDRNGCCRNPACESHRCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus striatus, a species known for producing neurotoxic peptides that facilitate prey capture through precise modulation of ion channels. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the conserved alpha-conotoxin structural scaffold characterized by a compact, disulfide-stabilized globular fold with the cysteine framework CC-C-C (two disulfide bridges connecting Cys1-Cys3 and Cys2-Cys4), forming a stable inhibitory cysteine knot (ICK) motif. Key structural elements should include: a short alpha-helical segment or turn regions stabilized by the disulfide core, exposed loops between cysteine residues that mediate receptor binding specificity, and a overall molecular weight under 2 kDa. The binding interface should feature complementary electrostatic and hydrophobic interactions with the orthosteric site of nAChRs, likely involving conserved residues in loop 2 for subtype selectivity. The final sequence must exhibit high proteolytic stability, minimal off-target activity, and the characteristic pharmacophore of alpha-conotoxins—enabling rapid neuromuscular blockade or neuronal silencing through competitive inhibition of acetylcholine binding."}
{"description": "sp|B4XSY9|SLAE_MACLB Snaclec A14 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MGRFIFVRVGLLVVFLSLSGTGADFDCPPDWSAYDQHCYKAFDEPKRSGDAEKFCTQQANGGHLVSIESVEEAEFVAQLISENIKTSADYVWIGLWNQRKAPYCVSKWTDGSSVIYKNVIERFIKNCFGLEKETNYRTWFNLSCGDDYPFVCKSPA", "prompt": "Design a novel snake venom C-type lectin-like protein (snaclec) from the blunt-nosed viper (Macrovipera lebetinus) that functions as a potent platelet aggregation modulator. This protein should adopt the characteristic snaclec fold consisting of a heterodimeric structure with two subunits forming a compact globular domain stabilized by multiple intrachain disulfide bonds. The protein should exhibit the conserved C-type lectin-like domain (CTLD) architecture with a double-loop structure stabilized by two conserved disulfide bridges, typically following the pattern Cys1-Cys2 and Cys3-Cys4. The molecular surface should feature key functional regions for interacting with platelet receptors, likely targeting glycoprotein receptors such as GPIb or GPVI to modulate hemostasis. The protein should demonstrate high specificity for platelet membrane components while maintaining the typical β-sheet-rich secondary structure with connecting loops that confer target recognition specificity. The sequence should reflect the evolutionary optimization for rapid action in viper envenomation, where such proteins disrupt normal coagulation pathways through receptor binding interference."}
{"description": "sp|K8DWB5|CA1D_CONTE Alpha-conotoxin TxID (Fragment) OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "FDGRNAAGNDKMSALMALTTRGCCSHPVCSAMSPICG", "prompt": "Design a functional alpha-conotoxin peptide derived from the venom of the textile cone snail, Conus textile. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes to disrupt synaptic signaling in the prey's nervous system. The peptide must adopt the characteristic alpha-conotoxin fold stabilized by two conserved disulfide bonds forming the CC-C-C cysteine framework, which constrains the peptide into a compact, globular structure with well-defined loops. Key structural elements should include a conserved alpha-helical region and beta-turn motifs that facilitate precise molecular recognition and high-affinity binding to the receptor's orthosteric site. The sequence must contain the appropriate cysteine spacing pattern and conserved residues critical for maintaining structural integrity, receptor selectivity, and biological activity, while exhibiting the typical small size (10-20 amino acids) and high stability characteristic of conotoxins."}
{"description": "sp|C0JB06|A21_LOXVA Dermonecrotic toxin LvSicTox-alphaII1 (Fragment) OS=Loxosceles variegata OX=571533 PE=2 SV=1", "sequence": "WIMGHMVNGIDQIDEFLRLGSNSPEFDINFDKDAKPVYTYHGVPCDCFRSCLRWEYIGDYLTALREVTTPGNPKFRENLSLFVFDLKTNSLYDSQAGKAGENLADDIFKYYWNEGNNGGRAYMIISIPDIEHYDLMTSFKHYFISNGHEELLDFVGFDFSANDNIPDVEKVFEKVRVPGVPDRVWQSDGITNCIMRGLNRVKEAVKVRDAGGIINKVYVWTVDKVPSIKAALDAGVDGVMTNHPDVVVGVLREDGYKDKFRYASYNDNPWETFKAE", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles variegata. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, endothelial cell damage, platelet aggregation, and complement activation, leading to the characteristic dermonecrotic lesions associated with recluse spider envenomation. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing the conserved HxK(x)4D motif essential for catalytic activity. The sequence should include the characteristic N-terminal signal peptide for secretion and the mature toxin domain with appropriate structural elements for membrane interaction and substrate binding. The toxin should exhibit optimal activity at physiological pH and temperature, with specific affinity for mammalian membrane phospholipids while maintaining stability in the venom gland environment."}
{"description": "sp|P0DQH9|OXLAB_CERCE L-amino acid oxidase (Fragment) OS=Cerastes cerastes OX=8697 PE=1 SV=1", "sequence": "ADDKNPLEECFREADYEEFLEIAKVTVLEASERNDKEDWYANLGPMRLPEKLNEFVQETENGWYFIKYPVKPSEEGKSAGQLYEESLRKSAGQLYQESLGKAHDDIFAYEKRFDEIVDGMDKLPTSMYQAIQERINFKPPLPPKKYAMGAITTFTPYQFQHFSEALTAPVGR", "prompt": "Design a protein sequence for an L-amino acid oxidase toxin fragment derived from the venom of Cerastes cerastes, the Saharan horned viper. This enzyme functions as a key toxic component in viperid venoms, catalyzing the oxidative deamination of L-amino acids to produce corresponding α-keto acids, ammonia, and hydrogen peroxide. The generated hydrogen peroxide contributes to local tissue damage, hemorrhage, and apoptosis in envenomed prey through oxidative stress mechanisms. The protein should adopt the characteristic flavin adenine dinucleotide (FAD)-binding fold typical of L-amino acid oxidases, featuring a conserved Rossmann fold domain for FAD cofactor binding and a substrate-binding domain that confers specificity for L-amino acids. Include critical catalytic residues involved in substrate recognition and oxidation, such as histidine and arginine residues that facilitate proton transfer and substrate orientation. The sequence should maintain the dimeric quaternary structure common to snake venom L-amino acid oxidases, with interfacial residues that promote stable homodimer formation. Ensure the presence of N-linked glycosylation sites that modulate stability, solubility, and immunogenic properties, as well as surface-exposed loops that may interact with host tissues to enhance local toxicity and inflammatory responses."}
{"description": "sp|P82981|VSP2_AGKCO Thrombin-like enzyme contortrixobin OS=Agkistrodon contortrix contortrix OX=8713 PE=1 SV=1", "sequence": "VVGGDECNINEHRFLVAIFNSNGFVCSGTLINQEWVLTAAHCDSTDFQIKLGAHSKKVLNEDEQIRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHIAPLSLPSSPPSVGSVCHIMGWGSITPIEVTFPDVPHCAYINLLDDAACQPGYPEVLPEYRTLCAGILEGGKDTCNYDSGGPLICNGQFQGIVSYGAHPCGQSLKPGIYTKVFDYNDWIQSIIAGNTAATCPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of the Southern copperhead snake (Agkistrodon contortrix contortrix) that functions as a potent procoagulant agent. This enzyme should exhibit selective proteolytic activity toward fibrinogen, specifically cleaving fibrinopeptide A from the Aα chain to generate fibrin monomers, thereby promoting rapid clot formation and contributing to the snake's prey immobilization strategy. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His57, Asp102, Ser195) and possess the distinctive structural features of snake venom thrombin-like enzymes, including an extended substrate-binding region that confers fibrinogen specificity while avoiding broader coagulation cascade activation. Incorporate appropriate disulfide bonding patterns typical of snake venom serine proteases to stabilize the compact globular structure. The enzyme should demonstrate optimal activity at physiological pH and temperature, with structural adaptations that enhance stability in the venom milieu while maintaining precise substrate recognition to avoid unintended systemic coagulation effects."}
{"description": "sp|P0DMG7|NGFV_BOTCO Venom nerve growth factor Bco12 (Fragment) OS=Bothrops cotiara OX=8727 PE=1 SV=1", "sequence": "EDHPVHNRGEYSVCDSVNVWV", "prompt": "Design a venom-derived nerve growth factor protein fragment from the venom of Bothrops cotiara, a pit viper species. This toxin represents a nerve growth factor (NGF) component that has been evolutionarily repurposed from its native neurotrophic role into a venom constituent. The protein should adopt the characteristic NGF fold, featuring a cysteine knot structural motif with conserved disulfide connectivity that stabilizes the tertiary structure. As a venom component, this NGF variant likely functions through receptor-mediated mechanisms, potentially interacting with TrkA and p75 neurotrophin receptors to modulate pain signaling, inflammation, or neuronal survival pathways in envenomation. The sequence should maintain key structural elements including beta-sheet arrangements and loop regions critical for receptor binding specificity, while potentially exhibiting venom-adapted modifications that enhance its stability or potency in the toxic context. The protein should reflect the molecular adaptation of a developmental growth factor into a venom component that contributes to the complex pathophysiological effects of viper envenomation."}
{"description": "sp|C0HLB8|PA2_MICLE Phospholipase A2 (Fragment) OS=Micrurus lemniscatus OX=129464 PE=1 SV=1", "sequence": "NRNNRDWWHFADYGCYCGYGGSGTPVDELDRC", "prompt": "Design a phospholipase A2 toxin sequence derived from the venom of Micrurus lemniscatus, a coral snake species whose venom components are critical for rapid prey immobilization through neurotoxic and myotoxic mechanisms. This enzyme should function as a potent secretory phospholipase A2 that catalyzes the hydrolysis of the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, thereby initiating inflammatory cascades and contributing to membrane disruption. The protein should adopt the characteristic phospholipase A2 fold featuring three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the YGCYCG motif essential for catalytic activity. Include the catalytic histidine-aspartate dyad (typically H48 and D49 numbering) within the conserved active site. The sequence should maintain the characteristic disulfide bond pattern common to group I/II phospholipase A2 toxins, with 6-7 conserved disulfide bridges stabilizing the compact globular structure. This toxin likely exhibits presynaptic neurotoxicity by targeting neuronal membranes and may demonstrate myotoxic effects through muscle membrane damage. Ensure the sequence reflects the typical molecular weight range of 13-15 kDa and includes the elapid loop characteristic of elapid snake venom phospholipases A2."}
{"description": "sp|K4LLQ2|VSP_BOTBA Thrombin-like enzyme barnettobin (Fragment) OS=Bothrops barnetti OX=1051630 PE=1 SV=1", "sequence": "APKELQVSYAHKSSELVIGGDECDINEHPFLAFLYSRGNFCGLTLINQEWVLTAAHCDRRFMPIYLGIHTLSVPNDDEVIRYPKDNFICPNNNIIDEKDKDIMLIRLNRPVKNSEHIAPISLPSNLPSVGSVCRVMGWGSITAPNDTFPDVPHCANINLFNDTVCHGAYKRFPVKSRTLCAGVLQGGKDKCMGDSGGPLICNGPFHGILFWGDDPCALPRKPALYTKGFEYPPWIQSIIAKNTTETCPP", "prompt": "Design a thrombin-like serine protease toxin derived from the venom of Bothrops barnetti, a pit viper species. This enzyme functions as a key component in the snake's predatory arsenal by mimicking the activity of mammalian thrombin to induce coagulopathy in prey. The protein should exhibit selective fibrinogen-clotting activity, cleaving fibrinogen to form fibrin clots while typically sparing other coagulation factors like Factor XIII, leading to consumptive coagulopathy and potential hemorrhage. As a serine protease, it should contain the canonical catalytic triad of His, Asp, and Ser residues within a chymotrypsin-like fold. The structure should feature multiple disulfide bridges characteristic of snake venom serine proteases that stabilize the compact globular domain. Key functional elements should include substrate-binding exosites that confer specificity for fibrinogen over other thrombin substrates, and potential glycosylation sites that may influence stability and activity. The enzyme should demonstrate optimal activity at physiological pH and temperature, with structural adaptations for stability in the venom gland environment."}
{"description": "sp|Q91132|VCO3_NAJKA Cobra venom factor OS=Naja kaouthia OX=8649 PE=1 SV=1", "sequence": "MERMALYLVAALLIGFPGSSHGALYTLITPAVLRTDTEEQILVEAHGDSTPKQLDIFVHDFPRKQKTLFQTRVDMNPAGGMLVTPTIEIPAKEVSTDSRQNQYVVVQVTGPQVRLEKVVLLSYQSSFLFIQTDKGIYTPGSPVLYRVFSMDHNTSKMNKTVIVEFQTPEGILVSSNSVDLNFFWPYNLPDLVSLGTWRIVAKYEHSPENYTAYFDVRKYVLPSFEVRLQPSEKFFYIDGNENFHVSITARYLYGEEVEGVAFVLFGVKIDDAKKSIPDSLTRIPIIDGDGKATLKRDTFRSRFPNLNELVGHTLYASVTVMTESGSDMVVTEQSGIHIVASPYQIHFTKTPKYFKPGMPYELTVYVTNPDGSPAAHVPVVSEAFHSMGTTLSDGTAKLILNIPLNAQSLPITVRTNHGDLPRERQATKSMTAIAYQTQGGSGNYLHVAITSTEIKPGDNLPVNFNVKGNANSLKQIKYFTYLILNKGKIFKVGRQPRRDGQNLVTMNLHITPDLIPSFRFVAYYQVGNNEIVADSVWVDVKDTCMGTLVVKGDNLIQMPGAAMKIKLEGDPGARVGLVAVDKAVYVLNDKYKISQAKIWDTIEKSDFGCTAGSGQNNLGVFEDAGLALTTSTNLNTKQRSAAKCPQPANRRRRSSVLLLDSNASKAAEFQDQDLRKCCEDVMHENPMGYTCEKRAKYIQEGDACKAAFLECCRYIKGVRDENQRESELFLARDDNEDGFIADSDIISRSDFPKSWLWLTKDLTEEPNSQGISSKTMSFYLRDSITTWVVLAVSFTPTKGICVAEPYEIRVMKVFFIDLQMPYSVVKNEQVEIRAILHNYVNEDIYVRVELLYNPAFCSASTKGQRYRQQFPIKALSSRAVPFVIVPLEQGLHDVEIKASVQEALWSDGVRKKLKVVPEGVQKSIVTIVKLDPRAKGVGGTQLEVIKARKLDDRVPDTEIETKIIIQGDPVAQIIENSIDGSKLNHLIITPSGCGEQNMIRMAAPVIATYYLDTTEQWETLGINRRTEAVNQIVTGYAQQMVYKKADHSYAAFTNRASSSWLTAYVVKVFAMAAKMVAGISHEIICGGVRWLILNRQQPDGAFKENAPVLSGTMQGGIQGAEEEVYLTAFILVALLESKTICNDYVNSLDSSIKKATNYLLKKYEKLQRPYTTALTAYALAAADQLNDDRVLMAASTGRDHWEEYNAHTHNIEGTSYALLALLKMKKFDQTGPIVRWLTDQNFYGETYGQTQATVMAFQALAEYEIQMPTHKDLNLDITIELPDREVPIRYRINYENALLARTVETKLNQDITVTASGDGKATMTILTFYNAQLQEKANVCNKFHLNVSVENIHLNAMGAKGALMLKICTRYLGEVDSTMTIIDISMLTGFLPDAEDLTRLSKGVDRYISRYEVDNNMAQKVAVIIYLNKVSHSEDECLHFKILKHFEVGFIQPGSVKVYSYYNLDEKCTKFYHPDKGTGLLNKICIGNVCRCAGETCSSLNHQERIDVPLQIEKACETNVDYVYKTKLLRIEEQDGNDIYVMDVLEVIKQGTDENPRAKTHQYISQRKCQEALNLKVNDDYLIWGSRSDLLPTKDKISYIITKNTWIERWPHEDECQEEEFQKLCDDFAQFSYTLTEFGCPT", "prompt": "Design a protein sequence for cobra venom factor from Naja kaouthia (monocled cobra) that functions as a potent complement system inhibitor. This protein should mimic the structure and function of mammalian complement component C3b, acting as a molecular decoy that hijacks the alternative complement pathway. The sequence should contain multiple functional domains including: (1) a C3b-like domain that binds to complement factor B with high affinity, forming a stable C3 convertase complex (C3bBb), (2) regulatory domains that resist inactivation by complement regulatory proteins such as factor H and factor I, allowing prolonged convertase activity, and (3) structural motifs that enable evasion of host immune recognition while maintaining stability in the venom gland and upon injection. The protein should exhibit the characteristic multi-domain architecture of complement proteins with appropriate disulfide bonding patterns to maintain structural integrity. The mechanism involves continuous consumption of complement component C3, leading to complement depletion and profound immunosuppression in envenomed prey. This represents a sophisticated venom adaptation where the snake co-opts host immune proteins for predatory advantage."}
{"description": "sp|C0HLA8|MAMB5_DENJA Mambaquaretin-5 OS=Dendroaspis jamesoni kaimosae OX=8619 PE=1 SV=1", "sequence": "RPSFCNLPVKPGPCSGFFSAFYYSQKTNKCHSFTYSGCRGNGNRFRTIEECRRTCVG", "prompt": "Design a protein sequence for a venom-derived toxin that functions as a potent and selective inhibitor of the acid-sensing ion channel 1a (ASIC1a). This toxin, known as mambaquaretin-5, originates from the venom of Jameson's mamba (Dendroaspis jamesoni), where it contributes to the neurotoxic effects by modulating neuronal excitability through ASIC blockade. The protein should adopt a three-finger toxin (3FTx) structural fold, characterized by three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with a typical C-C-C-C cysteine framework. The sequence must include key functional residues within the central loop that mediate high-affinity binding to the acidic pocket of ASIC1a, thereby inhibiting channel activation by extracellular protons. The overall structure should be compact and globular, with the pharmacophore positioned to achieve subtype selectivity for ASIC1a over other ASIC isoforms, reflecting its role in modulating pain and ischemic neuronal injury pathways."}
{"description": "sp|P0CI48|KA127_LYCMC Potassium channel toxin alpha-KTx 12.7 OS=Lychas mucronatus OX=172552 PE=2 SV=1", "sequence": "MSNMPVLIITLLLFSMYISTAAQKPTEIKCRYPADCHIMCRKVTGRAEGKCMNGKCTCYY", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Lychas mucronatus. This toxin belongs to the alpha-KTx family and specifically functions as a potent blocker of voltage-gated potassium channels, particularly Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a compact, stable molecular scaffold. Key functional residues should be positioned in the beta-sheet region to form a functional surface that selectively binds to the pore region of potassium channels, physically occluding ion conduction. The toxin should exhibit high affinity and specificity for its potassium channel targets, contributing to the neurotoxic effects of the scorpion venom by disrupting neuronal excitability and synaptic transmission. The sequence must maintain the characteristic disulfide framework and structural motifs required for proper folding, stability, and biological activity as a potassium channel blocker."}
{"description": "sp|C0HLB0|MAMB9_DENVI Mambaquaretin-9 OS=Dendroaspis viridis OX=8621 PE=1 SV=1", "sequence": "RPYACELTVAAGPCLRFSAFYYSKGANQCYPFNYSGCGGNANRFSTNQKCRRTCVV", "prompt": "Design a novel protein sequence for a venom-derived peptide toxin that functions as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to modulate neuronal excitability. The toxin should be derived from the green mamba (Dendroaspis viridis) venom system, which is evolutionarily optimized for rapid neurotoxic effects in prey capture. The protein should adopt a compact, stable structural fold characteristic of mambaquaretin family toxins, featuring a conserved disulfide bond framework (likely CC-C-C pattern) that stabilizes a core inhibitory cystine knot (ICK) motif. This structural scaffold should present key functional residues on exposed loops that mediate high-affinity binding to the pore region of Kv channels, effectively blocking potassium ion flux and prolonging action potential duration. The sequence should maintain the characteristic length and physicochemical properties of mambaquaretin peptides, with appropriate hydrophobic patches and charged residues positioned to facilitate specific channel recognition while ensuring solubility and stability in the venom milieu."}
{"description": "sp|Q90ZI3|VM3H1_PROFL Zinc metalloproteinase-disintegrin-like HV1 OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFTVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADLTASISACDGLKGHFKLQGETYIIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTQSNWESDESIKEDSQSNLTPAQQKYLNAKKYVKFFLVADHIMYLKYGRNLTTLRTRMFDTVNIVNQILQRINIHVALIGIEIWSKEDKIIVQSVPDVTLKLFATWRESVLLKRKNHDNAHLLTGINFNGPTAGLAYLGGICKPMYSAGIVQDHNKIHHLVAIAMAHEMGHNLGMDHDKDTCTCRAKACVMAGTLSCDASYLFSDCSRQEHRAFLIKNMPQCILKKPLKTDVVSPPVCGNYFVEVGEDCDCGSPATCRDPCCDAATCKLRQGAQCAEGLCCDQCRFKAAGTECRAATDECDMADLCTGRSAECTDRFQRNGQPCQNNNGYCYNRTCPTMNNQCIALFGPNAAVSQDACFQFNRQGNYYGYCRKEQNTKIACEPQNVKCGRLYCIDSSPAKKNPCNIIYSPNDEDKGMVLPGTKCADGMACNSNGQCVDVNRTY", "prompt": "Generate the amino acid sequence for a zinc metalloproteinase-disintegrin-like toxin from the venom of Protobothrops flavoviridis (Habu snake). This toxin belongs to the snake venom metalloproteinase (SVMP) family and exhibits a complex multi-domain architecture. The protein should contain a metalloproteinase domain with the characteristic zinc-binding motif HEXXHXXGXXH, which facilitates proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin. This domain is responsible for hemorrhagic activity by degrading capillary basement membranes and disrupting hemostasis. The disintegrin-like domain should feature the canonical RGD or related tripeptide motif that enables binding to integrin receptors on platelets and endothelial cells, inhibiting platelet aggregation and cell adhesion. The protein likely adopts a modular structure with these domains connected by linker regions, stabilized by multiple disulfide bonds characteristic of SVMPs. The metalloproteinase domain should fold into a typical metzincin-like structure with a central alpha-helix and beta-strands, while the disintegrin-like domain may form a compact, disulfide-rich globular fold. This toxin contributes to the prey immobilization strategy of Protobothrops flavoviridis by inducing hemorrhage, disrupting coagulation, and interfering with cellular adhesion processes."}
{"description": "sp|B4XSZ1|SLAG_MACLB Snaclec A16 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MGRLISVSFGLLVVFLSLSGTGADQDCLPGWSFYEGHCYKVFNVKKTWEDAEKFCQKQSNGKHLATIEWLGKANFVADLVTLMNSDPDLDWIGLRVEDKRQQCSSHWTDGSAVSYENVVHNTKCFGLDQKTGYRTWVALRCELAYHFICMSRVPRGA", "prompt": "Generate the amino acid sequence for a C-type lectin-like protein (snaclec) from the venom of Macrovipera lebetinus (Levantine viper). This toxin belongs to the snaclec family, specifically functioning as a platelet aggregation modulator. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by two conserved disulfide bridges with a typical C1-C2, C3-C4 connectivity pattern. The sequence should contain the conserved carbohydrate recognition domain (CRD) motifs essential for calcium-dependent ligand binding, though this snaclec primarily targets platelet receptors rather than carbohydrates. The protein likely interacts with platelet membrane receptors such as GPIb or GPVI, disrupting hemostasis through inhibition or activation of platelet aggregation. The structural scaffold should feature the conserved beta-sandwich fold composed of antiparallel beta-strands, with loops responsible for receptor recognition and specificity. The biological function involves interference with the coagulation cascade, contributing to the hemorrhagic or pro-coagulant effects characteristic of viperid venoms."}
{"description": "sp|P81745|TOG3C_AGEAP Omega-agatoxin-Aa3c (Fragment) OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "NCIDFGGDCDGEKDDCQCCXRNGYCSCYNLFGYLKRGCKXEVG", "prompt": "Design a protein sequence for a calcium channel-blocking neurotoxin derived from the venom of the funnel-web spider Agelenopsis aperta. This toxin should function as a potent and selective inhibitor of P/Q-type voltage-gated calcium channels (Cav2.1), specifically targeting presynaptic terminals in the central nervous system to disrupt neurotransmitter release and cause neuromuscular paralysis. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. Key structural elements should include a beta-hairpin loop responsible for channel pore blockade, conserved hydrophobic residues for membrane interaction, and surface-exposed basic residues that facilitate binding to the voltage-sensing domain of Cav2.1 channels. The sequence must exhibit high affinity for the alpha-1A subunit of P/Q-type channels while maintaining selectivity over other calcium channel subtypes to ensure precise neurotoxic activity consistent with the venom's role in prey immobilization."}
{"description": "sp|C0JB07|A21_LOXAP Dermonecrotic toxin LapSicTox-alphaII1 (Fragment) OS=Loxosceles apachea OX=571518 PE=2 SV=1", "sequence": "WIMGHMVNAIYQIQEFVSLGANSIEFDINFDTDANPIYTYHGVPCDCFRSCLHYEYISDFLKALREHTLPGNPKYKENLVLFVFDLKTNSLYDSQAYTAGQKLAENIFQYYWANGEGMPVSGYLVISIPNLQHYDLIKGFRETIKAKGHNELLDRVGYDFSANDNIPDVENAYKKVGVVNHVWQSDGITNCISRGLTRAKEAVSERDGGGVINKVYVWTIDKYQSMRDALDANVDGIMTNYPNILVEVLKEDAYKDRFRLAKNYDDPFVTFEG", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the Apache recluse spider (Loxosceles apachea). This toxin belongs to the Lipocalin/SicTox family and functions as a potent dermonecrotic agent that induces severe local tissue damage through sphingomyelinase D activity. The protein should hydrolyze sphingomyelin to ceramide-1-phosphate, triggering inflammatory responses, platelet aggregation, and complement activation that lead to characteristic necrotic lesions. The structural scaffold should feature the characteristic lipocalin fold with a conserved beta-barrel structure that forms the catalytic pocket for sphingomyelin binding and hydrolysis. Include key catalytic residues (histidine and aspartic acid) essential for the phospholipase D activity, and maintain the conserved cysteine framework that stabilizes the beta-barrel architecture. The toxin should exhibit high specificity for membrane sphingomyelin while avoiding broad-spectrum phospholipase activity, reflecting its role in spider envenomation where localized tissue destruction provides a predatory advantage."}
{"description": "sp|P0C7K3|BP11C_CROVV Bradykinin-potentiating peptide 11c OS=Crotalus viridis viridis OX=8742 PE=1 SV=1", "sequence": "QSAPGNEAIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the prairie rattlesnake (Crotalus viridis viridis) that functions as a potent vasoactive peptide. This peptide should act as a dual-function toxin by inhibiting angiotensin-converting enzyme (ACE) while simultaneously potentiating the hypotensive effects of endogenous bradykinin. The peptide should adopt a characteristic BPP structural scaffold featuring a pyroglutamic acid residue at the N-terminus that confers resistance to aminopeptidase degradation, followed by a proline-rich sequence that facilitates ACE binding through interaction with the enzyme's active site zinc ion. The core structure should include conserved proline residues that maintain a constrained conformation optimal for receptor interaction, with a C-terminal typically ending in a hydrophobic or aromatic residue that enhances membrane association and bioavailability. The peptide should exhibit the compact, extended conformation typical of BPPs, lacking disulfide bridges but maintaining structural rigidity through proline-induced backbone constraints. The molecular mechanism should involve competitive inhibition of ACE's catalytic domain, preventing angiotensin I conversion to angiotensin II while simultaneously protecting bradykinin from degradation, resulting in synergistic vasodilation and blood pressure reduction characteristic of pit viper venom BPPs."}
{"description": "sp|P0DQQ0|PA2B3_BOTBZ Basic phospholipase A2 BbTX-III OS=Bothrops brazili OX=157546 PE=1 SV=1", "sequence": "SLWEWGQMILKETGKNPFPYYGAYGCYCGWGGRRKPKDATDRCCFVHDCCRYKKLTGCPKTNDRYSYSRLDYTIVCGEDDPCKEICECDKAAAVCFRENLRTYNKKYMAHLRVLCKKDKPC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrops brazili, a venomous pit viper. This toxin should function as a potent enzymatic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. Include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) and the calcium-binding site with its characteristic YGCXCG motif. The sequence should contain the conserved disulfide bond pattern typical of group II phospholipase A2 toxins from viper venoms, with 6-7 conserved disulfide bridges stabilizing the compact globular structure. As a basic phospholipase, this toxin may exhibit enhanced membrane binding capabilities and potential myotoxic, neurotoxic, or anticoagulant activities through both enzymatic and non-enzymatic mechanisms. The protein should maintain the characteristic interfacial binding surface that facilitates interaction with lipid membranes and substrate access to the active site."}
{"description": "sp|Q4ZFU1|A1KA1_LOXAR Dermonecrotic toxin LarSicTox-alphaIB1ai (Fragment) OS=Loxosceles arizonica OX=196454 PE=2 SV=1", "sequence": "VRATEKFASMYFFCHSPQSAETDVAERGNKRPVWIMGHMVNAIAQIDEFVNLGANSIETDVSFDSSANPEYTYHGVPCDCGRTCTKWEHFNEFLKGLRKATTPGDSKYHEKLVLVVFDLKTGRLYDNQASDAGKKLAKSLLQNYWNNGNNGGRAYIVLSIPNLAHYKLIAGFKEALTSEGHPELMDKVGYDFSGNDDIGDVANAYKKAGVTGHVWQSDGITNCLLRGLDRVGKAVANRDSSNGYINKVYYWTVDKRQSTRDALDAGVDGIMTNYPDVIADVLNESAYKAKFRIASYDDNPWETYKN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the Arizona brown spider, Loxosceles arizonica. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleavage of phospholipid head groups, leading to inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing conserved histidine and lysine residues essential for catalytic activity. Key structural features include a hydrophobic membrane-binding interface and specific loops that confer substrate specificity. The toxin targets mammalian cell membranes, particularly endothelial cells and erythrocytes, causing hemolysis and tissue necrosis through its enzymatic activity. The sequence should maintain the characteristic disulfide bond pattern that stabilizes the TIM barrel structure while ensuring proper folding and enzymatic function."}
{"description": "sp|P0DL58|HM1B_PHLSP Mu-theraphotoxin-Phlo1b OS=Phlogius sp. OX=1690075 PE=1 SV=1", "sequence": "MKVSVLITLAVLGVMFVWTSAAEQEDHGSDRRDSPALLKSLGRVFQSEERACRELLGGCSKDSDCCAHLECRKKWPYHCVWDWTFGNEKS", "prompt": "Design a novel animal toxin protein sequence based on mu-theraphotoxin-Phlo1b from the Australian tarantula Phlogius species. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, characteristic of spider venom peptides. The protein should function as a voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce paralysis through disruption of neuronal signaling. The sequence must feature the conserved ICK fold stabilized by three disulfide bonds with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural scaffold should comprise a compact, triple-stranded beta-sheet core constrained by the disulfide knot, providing exceptional thermal and proteolytic stability. Include key functional residues for channel interaction, likely involving a surface-exposed pharmacophore region for binding to domain II or IV of insect sodium channels. The toxin should exhibit high selectivity for insect over mammalian sodium channels, reflecting its evolutionary role in prey immobilization. Incorporate conserved hydrophobic patches and polar residues typical of ICK toxins to maintain proper folding and target engagement. The final sequence should represent a potent, stable neurotoxic peptide optimized for insecticidal activity through precise molecular targeting of voltage-gated sodium channel gating mechanisms."}
{"description": "sp|P86424|3NX5_MICFR Frontoxin V OS=Micrurus frontalis OX=129461 PE=1 SV=1", "sequence": "LTCNTCAFKTCANSETCAAGKNICYQRKWNEHHGERIERKCVANCPELGSHDTSLLCCRIPDCN", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a frontoxin V homolog derived from the venom of Micrurus frontalis, the South American coral snake. This toxin functions as a potent presynaptic neurotoxin that targets the neuromuscular junction, specifically inhibiting acetylcholine release from motor nerve terminals through interaction with voltage-gated calcium channels or synaptic vesicle proteins. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C. The mature toxin should be approximately 60-70 amino acids in length with the typical three-finger toxin topology: loop I for membrane interaction, loop II for target recognition, and loop III for structural stability. The sequence should include key conserved residues for structural integrity while incorporating variable regions in the functional loops that determine target specificity. The protein should exhibit high affinity for its presynaptic target, causing irreversible neuromuscular blockade leading to flaccid paralysis, consistent with the clinical effects of coral snake envenomation. The structural scaffold should maintain the characteristic globular shape with the three finger-like projections that define this toxin family."}
{"description": "sp|P0DKZ5|BPPCE_BOTCO Bradykinin-potentiating peptide 12e OS=Bothrops cotiara OX=8727 PE=1 SV=1", "sequence": "QARPRPGPKIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of Bothrops cotiara, a venomous pit viper. This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby increasing bradykinin's half-life and activity. The peptide should adopt a compact, stable structure stabilized by disulfide bonds, characteristic of the BPP family, which typically features a conserved pyroglutamate residue at the N-terminus and a C-terminal proline-rich region. The molecular mechanism involves competitive inhibition of ACE's zinc-dependent catalytic domain, preventing the degradation of bradykinin and leading to prolonged vasodilation, increased vascular permeability, and inflammation. The structural scaffold should include a well-defined conformation with key residues for ACE binding, such as those interacting with the enzyme's active site and substrate-binding pockets. The peptide's biological role in the venom is to synergize with other toxins to induce prey hypotension and circulatory shock, facilitating prey immobilization and digestion."}
{"description": "sp|Q9PSN3|VSP2_AGKBI Thrombin-like enzyme bilineobin OS=Agkistrodon bilineatus OX=8718 PE=1 SV=1", "sequence": "IIGGDECNINEHRFLVALYDVWSGSFLCGGTLINQEWVLTAAHCNMSNIYIYLGMHNQSVQFDDEERRYPKEKYLFRCSKNFTKWDKDIMLIRLNKPVRNSEHIAPLSLPSSPPIVGSVCRVMGWGTITSPNETLPDVPRCVNINLFNYTVCRGVFPRLPERSRILCAGVLEGGIDTCKRDSGGPLICNGQFQGIVSWGPKRCAQPRKPALYSKVFDHLDWIQSIIAGNKTVNCP", "prompt": "Design a thrombin-like serine protease venom toxin from the venom of Agkistrodon bilineatus (tropical cantil), a pit viper species. This enzyme functions as a key component in the snake's predatory and defensive arsenal by mimicking the activity of mammalian thrombin, specifically cleaving fibrinogen to generate fibrin monomers that polymerize into unstable clots. This procoagulant mechanism leads to rapid depletion of fibrinogen in prey, resulting in consumptive coagulopathy and potentially fatal hemorrhage. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and exhibit specificity for arginine residues at the P1 position. It likely contains structural features common to snake venom thrombin-like enzymes, including distinct surface loops that confer substrate specificity differences from true thrombin, potentially reduced exosite interactions, and possible glycosylation sites. The enzyme should demonstrate preferential cleavage of fibrinogen Aα-chains over Bβ-chains, producing fibrin clots that are more susceptible to physiological fibrinolysis. Include appropriate disulfide bonding patterns typical of snake venom serine proteases to stabilize the compact globular structure."}
{"description": "sp|C0JB09|A31_LOXAR Dermonecrotic toxin LarSicTox-alphaIII1 (Fragment) OS=Loxosceles arizonica OX=196454 PE=2 SV=1", "sequence": "WIMGHMVNAVPQIDQFVNLGSNALEMDVTFNKDAMPVYTYHGTPCDCLRDCLRWEHFPVFLQELRKATSPGDAKYHEKLVLLLFDLKTGKINNNQANTAGQNVAKQLLQHYWNYGNNGGRAYVILSIPYVEHYELIRGFRETLKKEGHENLMEKVGYDFSGRHKLDTVREAYKKAGVDGHVWQSDGITNCLPLVDDLPRVREAVRNRDSPDGFINKVYYWTVDKVATTKKALGAGVDGVMTNHPDVIVNVLNESGYNDKYRLATYDDNPWETFRN", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the Arizona brown spider, Loxosceles arizonica. This toxin belongs to the SicTox-alpha family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving the phosphodiester bond, generating ceramide-1-phosphate and choline, which triggers inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage leading to characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing conserved histidine and lysine residues essential for catalytic activity. The structural scaffold should include the characteristic HxKx4D motif that coordinates the catalytic metal ion (likely magnesium) and facilitates substrate binding. The toxin should exhibit high specificity for membrane phospholipids and demonstrate the ability to induce hemolysis and dermonecrosis through its enzymatic activity. The sequence should maintain the proper folding and stability required for venom delivery and target membrane interaction."}
{"description": "sp|P81746|TOG3D_AGEAP Omega-agatoxin-Aa3d (Fragment) OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "SCIKIGEDCDGDKDDCQCCRTNGYCSXYXLFGYLKSG", "prompt": "Design a protein sequence for a highly potent neurotoxin derived from the venom of the funnel-web spider Agelenopsis aperta. This toxin belongs to the omega-agatoxin family, specifically functioning as a selective and high-affinity antagonist of P/Q-type voltage-gated calcium channels (Cav2.1). The toxin should exhibit the characteristic structural scaffold of spider venom toxins targeting calcium channels, featuring an inhibitory cysteine knot (ICK) motif stabilized by a conserved pattern of disulfide bridges, typically with a C-C-CC-C-C connectivity. The protein should adopt a compact, globular fold with defined loops that mediate specific interactions with the extracellular pore region of the P/Q-type calcium channel, effectively blocking calcium influx and disrupting synaptic transmission at presynaptic terminals. This mechanism underlies the toxin's role in immobilizing prey by causing rapid neuromuscular paralysis. The sequence should include key residues for target recognition and binding affinity, while maintaining the structural integrity conferred by the disulfide-stabilized core."}
{"description": "sp|P58846|M3C_CONTE Conotoxin tx3c OS=Conus textile OX=6494 PE=1 SV=2", "sequence": "MFKLGVLLTICLLLFSLNAVPLDGDQPADQPAERLLDDISFENNPFYDPAKRCCRTCFGCTPCCG", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of Conus textile, a marine cone snail species renowned for its complex cocktail of neuroactive peptides that facilitate prey capture through precise modulation of neuronal signaling pathways. This toxin should function as a conotoxin with potent biological activity, specifically targeting and modulating ion channels or neuronal receptors to disrupt normal synaptic transmission. The protein should adopt a compact, disulfide-rich structural scaffold characteristic of conotoxins, featuring a conserved cysteine framework that forms specific disulfide bridges to stabilize the core fold. The sequence must include key pharmacophore residues responsible for high-affinity binding to its molecular target, ensuring selective interaction with specific receptor subtypes. The overall architecture should comprise a well-defined three-dimensional conformation, potentially incorporating beta-sheet elements or loop regions that mediate target engagement, while maintaining stability in the venom milieu. The toxin should exhibit functional specificity, potentially acting as an antagonist or modulator of voltage-gated ion channels or ligand-gated receptors, thereby inducing paralysis or neurological disruption in prey organisms. The design must prioritize molecular precision, incorporating evolutionary conserved motifs and structural determinants that underpin both folding efficiency and target specificity within the conotoxin family."}
{"description": "sp|P0C251|I1B1_CONBE Conotoxin Bt11.1 OS=Conus betulinus OX=89764 PE=2 SV=1", "sequence": "MKLCVAFLLVLVILPSVIGGKPSERTLSGATRRGDRRMCLSLGQRCERHSNCCGYLCCFYDKCVVTAIGCGHY", "prompt": "Design a novel conotoxin sequence inspired by Conus betulinus venom, specifically emulating the functional and structural characteristics of conotoxin Bt11.1. This toxin should exhibit potent neurotoxic activity typical of predatory cone snail venoms, which rapidly immobilize prey through disruption of neuromuscular signaling. The sequence must adopt the I1-conotoxin framework, characterized by a specific cysteine pattern (C-C-CC-C-C) that forms three disulfide bridges stabilizing a compact, globular fold. This structural scaffold enables high-affinity interaction with voltage-gated sodium channels, where the toxin functions as a gating modifier to inhibit channel inactivation, leading to prolonged neuronal excitation and paralysis. Incorporate conserved residues critical for the hydrophobic surface patch that engages with the channel's voltage-sensing domain, while maintaining the β-hairpin and loop regions essential for target specificity. The final sequence should reflect the evolutionary optimization of Conus betulinus toxins for rapid prey subjugation, with precise molecular recognition of sodium channel subtypes."}
{"description": "sp|P58910|KURT_PARTR Kurtoxin OS=Parabuthus transvaalicus OX=170972 PE=1 SV=1", "sequence": "KIDGYPVDYWNCKRICWYNNKYCNDLCKGLKADSGYCWGWTLSCYCQGLPDNARIKRSGRCRA", "prompt": "Design a protein sequence for kurtoxin, a potent neurotoxin from the venom of the scorpion Parabuthus transvaalicus. This toxin functions as a selective modulator of voltage-gated sodium channels, specifically inhibiting the inactivation gate to prolong channel opening and enhance neuronal excitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The structure should include a conserved core beta-sheet stabilized by the disulfide network, with key functional residues positioned in the 'pharmacophore' region to interact with domain IV of voltage-gated sodium channels. The toxin should exhibit high affinity for neuronal sodium channel subtypes, particularly Nav1.2, Nav1.3, and Nav1.6, while showing minimal activity against cardiac and skeletal muscle isoforms. The sequence should encode the characteristic molecular surface features that enable specific recognition of the channel's voltage-sensing module, facilitating the toxin's role in disrupting normal action potential termination and contributing to the scorpion's predatory and defensive capabilities through induction of autonomic and neuromuscular symptoms."}
{"description": "sp|Q9PSN7|VM3H1_CRORU Snake venom metalloproteinase HT-1 (Fragment) OS=Crotalus ruber ruber OX=8736 PE=1 SV=1", "sequence": "LGTDIISPPVCGNELLEVGEECDCGFPRNCRDPCCDATTCKLHSWVECESGECCGQCKFTSAGNECRPARSECDIAESCTGQSADCPMDDFHRNGQPCLNNFGYCYNGNCPILYHQCYALFGSNVYEAEDSCFERNQKGDDDGYCRKENGEKIPCAPEDVKCGRLYCKDNSPGPNDSCKTFNSNEDDHKEMVLPGTKCADGKVCSNGHCVDVASAY", "prompt": "Design a snake venom metalloproteinase protein fragment that functions as a hemorrhagic toxin, specifically representing the HT-1 variant from the red diamond rattlesnake (Crotalus ruber ruber). This zinc-dependent metalloproteinase should exhibit proteolytic activity targeting key components of the basement membrane and extracellular matrix, particularly type IV collagen, laminin, and fibronectin, to disrupt vascular integrity and induce hemorrhage. The protein should feature the characteristic metalloproteinase catalytic domain with the conserved HEXXHXXGXXH zinc-binding motif, where histidine residues coordinate the catalytic zinc ion essential for proteolytic function. Include the methionine turn structural element that contributes to substrate specificity. The protein should demonstrate calcium-dependent stability and optimal activity at physiological pH. As a hemorrhagic toxin, it should preferentially cleave capillary basement membrane components, leading to endothelial cell detachment and extravasation of blood components. The structural scaffold should maintain the typical metalloproteinase fold with both alpha-helices and beta-strands forming the catalytic domain, featuring surface loops that determine substrate recognition and specificity. The protein should exhibit thermal stability appropriate for reptilian venom and resistance to endogenous protease inhibitors through its structural conformation."}
{"description": "sp|P00983|MAMB7_DENPO Mambaquaretin-7 OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "RPYACELIVAAGPCMFFISAFYYSKGANKCYPFTYSGCRGNANRFKTIEECRRTCVV", "prompt": "Design a protein sequence for a venom-derived toxin that functions as a selective potassium channel blocker. This toxin, known as mambaquaretin-7, originates from the venom of the black mamba (Dendroaspis polylepis), a highly potent neurotoxic snake whose venom components target ion channels to induce rapid paralysis. The protein should adopt a characteristic three-finger toxin fold, consisting of three extended loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with a C-C-C-C cysteine framework. This structural scaffold enables precise interaction with voltage-gated potassium channels, particularly Kv1.3 channels, where the toxin binds to the channel's outer vestibule through specific residues in loop II, physically occluding the pore and inhibiting potassium efflux. The mechanism involves allosteric modulation of channel gating kinetics, leading to prolonged neuronal depolarization and disrupted action potential repolarization. Key structural elements should include: a rigid, disulfide-stabilized core providing thermal and proteolytic stability; three finger-like loops with appropriate length and flexibility for target engagement; conserved hydrophobic residues in the core for structural integrity; and charged/polar residues in the binding loops for specific channel recognition. The sequence should reflect the evolutionary optimization for rapid target engagement and high affinity binding characteristic of elapid snake venom toxins."}
{"description": "sp|P58690|ACT22_HETMG Magnificalysin II (Fragment) OS=Heteractis magnifica OX=38281 PE=1 SV=1", "sequence": "SAALAGTIIDGASLGFDILNKV", "prompt": "Design a protein sequence for a potent cytolysin toxin derived from the magnificent sea anemone (Heteractis magnifica). This toxin belongs to the actinoporin family and functions as a pore-forming toxin that specifically targets cell membranes. The protein should adopt the characteristic actinoporin fold consisting of a beta-sandwich core flanked by alpha-helices, with a conserved phosphocholine-binding site for initial membrane recognition. Include the conserved aromatic-rich membrane insertion domain that facilitates pore formation by oligomerizing into stable transmembrane beta-barrel structures. The sequence should contain the characteristic cysteine pattern that stabilizes the core beta-sandwich scaffold, enabling the toxin to create large, non-selective pores in lipid bilayers leading to rapid cell lysis. This cytolysin represents a key defensive component in sea anemone venom, evolved for immobilizing prey and deterring predators through efficient membrane disruption."}
{"description": "sp|P82465|DID6A_ECHCS Disintegrin EC6 subunit alpha OS=Echis carinatus sochureki OX=124223 PE=1 SV=2", "sequence": "MIQVLLVIICLAVFPYQGSSIILESGNINDYEIVYPKKVAVLPTGAMNSVHPCCDPVTCEPREGEHCISGPCCRNCKFLNAGTICKKAMLDGLNDYCTGISSDCPRNRYKGKEDD", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Echis carinatus sochureki (Saw-scaled viper) that functions as a potent inhibitor of platelet aggregation and cell adhesion processes. This disintegrin should adopt the characteristic disintegrin fold with the conserved RGD (Arg-Gly-Asp) integrin-binding motif positioned within an extended, solvent-exposed loop for optimal receptor recognition. The sequence must maintain the canonical cysteine framework typical of snake venom disintegrins, forming multiple disulfide bridges that stabilize the compact, globular structure and ensure proper presentation of the bioactive epitope. The protein should specifically target and antagonize αIIbβ3 integrin on platelet surfaces, thereby blocking fibrinogen binding and preventing thrombus formation, while potentially exhibiting cross-reactivity with other RGD-sensitive integrins such as αvβ3 involved in angiogenesis. Incorporate structural elements that confer resistance to proteolytic degradation in the bloodstream, including tight disulfide connectivity and minimal flexible linkers outside the functional loops. The overall architecture should reflect the evolutionary optimization of viperid disintegrins for rapid, high-affinity interference with hemostatic pathways through competitive inhibition of cell-matrix and cell-cell interactions."}
{"description": "sp|K9USW8|A1O_LOXGA Dermonecrotic toxin LgSicTox-alphaIC1 OS=Loxosceles gaucho OX=58216 PE=1 SV=1", "sequence": "ADNRRPIWVMGHMVNSLAQIDEFVGLGSNSIETDVSFDKQANPEYTYHGIPCDCGRACLHSTKFNDFLKGLRKVTTPGDSKYLEKLILVVFDLKTGSLYDNQAYDAGTKLAKNLLQHYWNNGNNGGRAYIILSIPNLNHYKLITGFKETLKNEGHEELLEKVGTDFSGNDDISDVQKTYNKAGVTGHVWQSDGITNCLLRGLTRVKAAVANRDSGSGIINKVYYWTVDKRQSTRDTLDANVDGIMTNYPDITVEILNEAAYKKKFRIATYEDNPWETFKG", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles gaucho, specifically belonging to the SicTox family. This toxin should function as a phospholipase D enzyme, catalyzing the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes, leading to profound dermonecrotic effects, complement-dependent hemolysis, and platelet aggregation. The protein should adopt the characteristic (α/β)8-barrel (TIM barrel) fold typical of the phospholipase D superfamily, with the conserved catalytic motif HxK(x)4D that coordinates magnesium ions for substrate binding and hydrolysis. The sequence should include the essential residues for membrane interaction and substrate specificity, while maintaining the structural stability required for venom potency. The molecular mechanism involves generating bioactive lipid metabolites like ceramide-1-phosphate that trigger inflammatory cascades, endothelial damage, and tissue necrosis characteristic of loxoscelism envenomation."}
{"description": "sp|P58809|CTAX_CONMR Chi-conotoxin CMrX OS=Conus marmoreus OX=42752 PE=1 SV=2", "sequence": "MRCLPVLIILLLLTASAPGVDVLPKTEDDVPLSSVYGNGKSILRGILRKGICCGVSFCYPC", "prompt": "Generate the amino acid sequence for a chi-conotoxin from the marine cone snail Conus marmoreus. This toxin belongs to the conotoxin family and specifically targets neuronal nicotinic acetylcholine receptors (nAChRs). The biological significance of this venom component lies in its role as a hunting tool for this predatory marine snail, where it disrupts neurotransmission in prey organisms. The toxin functions as a selective antagonist of neuronal nAChRs, particularly those containing alpha3, alpha4, and/or alpha7 subunits, thereby inhibiting cholinergic signaling in the central and peripheral nervous systems. The molecular mechanism involves competitive or non-competitive binding to the orthosteric or allosteric sites of nAChRs, preventing acetylcholine from activating these ligand-gated ion channels and consequently blocking synaptic transmission. The structural scaffold is characterized by a four-disulfide bridge framework (cysteine pattern C-C-C-C-C-C-C-C) that forms a compact, globular fold stabilized by disulfide bonds. The 3D structure is expected to exhibit a small, rigid conformation with defined loops and beta-sheet elements, typical of conotoxins targeting nAChRs. Key domains include the conserved cysteine framework and variable intercysteine loops that determine receptor subtype specificity. The molecular target interface involves interactions with specific extracellular domains of nAChR subunits, with binding affinity mediated by residues in the toxin's loops. The sequence should reflect these structural and functional constraints, including the precise cysteine spacing for correct disulfide connectivity and loop regions optimized for nAChR antagonism."}
{"description": "sp|P00979|VKTH1_DENPO Kunitz-type serine protease inhibitor homolog dendrotoxin I OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=2", "sequence": "QPLRKLCILHRNPGRCYQKIPAFYYNQKKKQCEGFTWSGCGGNSNRFKTIEECRRTCIRK", "prompt": "Design a protein sequence for a dendrotoxin from the black mamba (Dendroaspis polylepis) that functions as a potent potassium channel blocker. This toxin should adopt the characteristic Kunitz-type serine protease inhibitor fold, featuring a conserved beta-trefoil structure with a central alpha-helix stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The protein should specifically target voltage-gated potassium channels, particularly Kv1.1, Kv1.2, and Kv1.6 subtypes, binding to the channel's outer vestibule to block potassium ion conduction. The molecular mechanism involves high-affinity interaction with the channel's pore region, leading to prolonged neuronal excitation and enhanced neurotransmitter release. The structural scaffold should maintain the characteristic Kunitz domain architecture with the reactive site loop properly positioned for channel interaction while lacking significant protease inhibitory activity. The sequence should encode the essential functional residues for potassium channel recognition and blockade, preserving the toxin's role in the black mamba's neurotoxic venom system where it facilitates rapid prey immobilization through enhanced synaptic transmission."}
{"description": "sp|P00987|VKTH1_BUNMU Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B1 chain, major component OS=Bungarus multicinctus OX=8616 PE=1 SV=2", "sequence": "MSSGGLLLLLGLLTLCAELIPVSSRQRHRDCDKPPDKGNCGPVRRAFYYDTRLKTCKAFQYRGCNGNGNHFKTETLCRCECLVYP", "prompt": "Design a protein sequence for a major venom component from the many-banded krait (Bungarus multicinctus) that functions as the B1 chain of beta-bungarotoxin. This protein should adopt a Kunitz-type serine protease inhibitor structural fold, characterized by a compact, globular domain stabilized by three conserved disulfide bridges with a characteristic Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The sequence should maintain the canonical Kunitz-type fold architecture while exhibiting neurotoxic activity through presynaptic phospholipase A2-mediated mechanisms when complexed with the A2 chain. The protein should display typical Kunitz domain features including an exposed reactive site loop that confers protease inhibitory capability, contributing to the toxin's overall pathophysiological effects by interfering with serine protease-mediated processes. The structural scaffold should enable specific molecular recognition and complex formation with the phospholipase A2 component, resulting in potent neuromuscular blockade through inhibition of acetylcholine release at the neuromuscular junction."}
{"description": "sp|P81789|TX21A_PHONI Omega-ctenitoxin-Pn2a (Fragment) OS=Phoneutria nigriventer OX=6918 PE=1 SV=1", "sequence": "GCANAYKSCNGPHTCCWGYNGYKKACICSGXNWK", "prompt": "Design a protein sequence for an omega-ctenitoxin from the Brazilian wandering spider Phoneutria nigriventer that functions as a potent calcium channel blocker. This toxin should exhibit the characteristic structural features of ctenitoxins, including an inhibitor cystine knot (ICK) motif stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a compact, triple-stranded beta-sheet fold. The protein should specifically target and inhibit voltage-gated calcium channels, particularly Cav2.2 (N-type) channels, through high-affinity binding to the channel's pore-forming region, thereby blocking calcium influx and disrupting synaptic transmission. The sequence should maintain key functional residues for channel recognition and blockade while preserving the stable, knotted scaffold essential for venom efficacy in prey immobilization and predator defense."}
{"description": "sp|P82466|VM26B_ECHCS Disintegrin EC6 subunit beta OS=Echis carinatus sochureki OX=124223 PE=1 SV=1", "sequence": "NSVHPCCDPVTCKPKRGKHCASGPCCENCYIVGVGTVCNPARGDWNDDNCTGVSSDCPPNPWNGKPSDN", "prompt": "Design a novel disintegrin protein sequence derived from the venom of Echis carinatus sochureki, the saw-scaled viper. This protein should function as a potent anti-platelet agent by specifically inhibiting platelet aggregation through high-affinity binding to integrin receptors on the platelet surface. The sequence must incorporate the characteristic disintegrin domain architecture featuring the canonical RGD (Arg-Gly-Asp) or related tripeptide motif that serves as the primary integrin recognition sequence. The structural scaffold should adopt the disintegrin fold stabilized by multiple disulfide bridges, typically with a conserved cysteine pattern that forms a compact, stable structure resistant to proteolytic degradation. The protein should exhibit high specificity for platelet integrin αIIbβ3 (GPIIb/IIIa), effectively blocking fibrinogen binding and thus preventing thrombus formation. The molecular mechanism involves competitive inhibition at the integrin receptor's ligand-binding site, disrupting cell-matrix and cell-cell interactions critical for hemostasis and thrombosis. The overall structure should be relatively small (approximately 50-80 amino acids) with a well-defined binding loop presenting the integrin-recognition motif in an optimal conformation for receptor engagement."}
{"description": "sp|P0C253|I1B1_CONEP Conotoxin Ep11.1 OS=Conus episcopatus OX=88764 PE=2 SV=1", "sequence": "MKLCVTFLLILVILPSVTGEKSSKRTLSGAALRGDWGMCSGIGQGCGQDSNCCGDMCCYGQICAMTFAACGP", "prompt": "Design a novel conotoxin sequence inspired by the venom arsenal of the marine cone snail Conus episcopatus, a predatory species that employs a sophisticated cocktail of neuroactive peptides to immobilize prey. This toxin should function as a potent inhibitor of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype implicated in pain signaling pathways. The sequence must adopt the I1-conotoxin structural framework, characterized by a compact, disulfide-stabilized fold with the cysteine pattern C-C-CC-C-C (Framework I) forming three intramolecular disulfide bridges that confer exceptional stability and resistance to proteolytic degradation. The core scaffold should feature a conserved hydrophobic patch and a solvent-exposed loop region responsible for channel pore block by physically occluding ion permeation. The mature peptide should exhibit high affinity and selectivity for the domain IV S3-S4 extracellular loop of Nav1.7, effectively stabilizing the channel in an inactivated state to prevent action potential propagation in nociceptive neurons. Ensure the sequence maintains the hallmark pharmacological profile of I1-conotoxins: slow binding kinetics, use-dependent inhibition, and minimal effects on cardiac or skeletal muscle sodium channel isoforms."}
{"description": "sp|Q56EB0|SLAB_BOTJA Snaclec bothrojaracin subunit beta OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTAADCPPDWSSYEGSCYRVFEQKMNWEDAEKFCTQQQTGGHLVSFQSSEEADFVVSLTSPILRDSFVWTGLSDVWKECSFEWSDGSDLSYKDNYQFVFSEYECVASKTKNNKWRIIPCTKLEYFVCEFQA", "prompt": "Design a protein sequence for a C-type lectin-like protein (CTL) that functions as a potent thrombin inhibitor, derived from the venom of Bothrops jararaca, the jararaca pit viper. This protein should adopt the characteristic heterodimeric structure of snake venom C-type lectins, composed of alpha and beta subunits that assemble into a functional complex. The sequence must include the conserved C-type lectin fold with its characteristic beta-sheet and alpha-helical regions, stabilized by multiple intrachain and interchain disulfide bonds. Specifically, incorporate the canonical cysteine framework of snake venom CTLs with the appropriate disulfide connectivity pattern. The protein should function as a selective thrombin inhibitor by binding to exosite I of thrombin, thereby blocking thrombin's interaction with fibrinogen and other substrates, effectively acting as an anticoagulant. This mechanism mimics the natural bothrojaracin's ability to prolong clotting times by specifically targeting thrombin's anion-binding exosite I. The structural scaffold should maintain the globular, compact fold typical of C-type lectin-like proteins from viper venoms, with key residues positioned to facilitate high-affinity binding to thrombin while avoiding interference with the active site. The resulting protein should exhibit the anticoagulant properties characteristic of this toxin family, contributing to the prey immobilization strategy of Bothrops jararaca venom."}
{"description": "sp|P0DRJ2|TX1A_SELSX Mu-theraphotoxin-Ssp1a OS=Selenotypus sp. OX=3400313 PE=1 SV=1", "sequence": "DCLGWFSGCDPNNNKCCEGYVCHWKYPWCRYDL", "prompt": "Design a novel animal toxin protein sequence based on mu-theraphotoxin-Ssp1a from the Australian tarantula Selenotypus species. This toxin belongs to the inhibitory cysteine knot (ICK) structural family, characteristic of spider venom peptides that target voltage-gated ion channels. The protein should function as a potent modulator of sodium channels (Nav), likely exhibiting subtype selectivity that contributes to the venom's paralytic effects on insect prey. The sequence must feature the conserved ICK motif with a specific cysteine framework (typically C-C-CC-C-C for mu-theraphotoxins) forming three disulfide bridges that create a stable, compact globular structure. The core scaffold should consist of a triple-stranded beta-sheet stabilized by the cysteine knot, with key functional residues displayed on flexible loops for target interaction. The molecular mechanism involves binding to domain II or IV of voltage-gated sodium channels, modulating channel gating kinetics to produce either inhibitory or excitatory effects on neuronal signaling. The structural fold should exhibit high thermal and proteolytic stability due to the constrained disulfide architecture, with molecular weight in the 3-5 kDa range typical of spider venom peptides. Include conserved hydrophobic core residues that maintain the ICK fold integrity while displaying variable surface residues responsible for target specificity and potency."}
{"description": "sp|Q56EB1|SLAA_BOTJA Snaclec bothrojaracin subunit alpha OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "MGRFLFVSFGLLVVFLSLSGTAADCPSDWSSHEGHCYKFFQQKMNWADAERFCSEQAKGGHLVSFQSDGETDFVVNLVTEKIQSTDLYAWIGLRVQNKEKQCSSKWSDGSSVSYENVVGRTVKKCFALEKEQEFFVWINIYCGQQNPFVCKSPPP", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) from the venom of the pit viper Bothrops jararaca, specifically the bothrojaracin alpha subunit. This protein functions as a potent anticoagulant by binding to thrombin exosite I with high affinity, thereby inhibiting thrombin's interaction with fibrinogen and other substrates. The protein should adopt the characteristic C-type lectin-like fold, consisting of a globular domain stabilized by two conserved disulfide bridges (Cys1-Cys3 and Cys2-Cys4) that form the cysteine framework typical of snake venom C-type lectins. The structure should feature a concave surface formed by loops between beta-strands, which mediates specific binding to thrombin. Key residues involved in thrombin recognition, such as those forming salt bridges and hydrophobic interactions with thrombin exosite I, should be conserved. The protein should exhibit calcium-independent lectin-like properties and function as part of a heterodimeric complex with the bothrojaracin beta subunit, though this sequence is for the alpha subunit alone. The biological significance lies in its role in the venom's pre-digestive strategy, causing hypofibrinogenemia and bleeding in envenomed prey through selective inhibition of the coagulation cascade."}
{"description": "sp|P01416|3S11_DENPO Short neurotoxin 1 OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=1", "sequence": "RICYNHQSTTRATTKSCEENSCYKKYWRDHRGTIIERGCGCPKVKPGVGIHCCQSDKCNY", "prompt": "Design a protein sequence for a short neurotoxin from the black mamba (Dendroaspis polylepis) venom. This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with a Cys1-Cys3, Cys2-Cys5, Cys4-Cys6, Cys7-Cys8 connectivity pattern. Key functional residues should be positioned in the central loop (loop II) to facilitate high-affinity binding to the α-δ and α-γ subunit interfaces of the muscle-type nicotinic acetylcholine receptor, effectively blocking acetylcholine binding and neurotransmission. The structure should exhibit the typical compact globular architecture with exposed functional loops that enable specific receptor recognition while maintaining the structural stability conferred by the disulfide framework."}
{"description": "sp|A0A8U0LTN3|TX21B_RHYMT OMEGA-ectatommitoxin(02)-Rm1b OS=Rhytidoponera metallica OX=148364 PE=3 SV=1", "sequence": "MKDSYISIVIAYLMVTFILVSSMPIEGEKGELGPHRLPCPPEYANYCFNGKCVHFVAQDEPGKPCYSCICDKFYIGKRCGTLDLTNPDF", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an omega-ectatommitoxin from the ant species Rhytidoponera metallica, a member of the ectatommitoxin family found in ponerine ant venoms. As an insect-selective neurotoxin, it should function as a potent modulator of voltage-gated ion channels, specifically targeting insect neuronal sodium channels to induce paralysis and prey immobilization. The structural scaffold should feature the characteristic cysteine framework of ectatommitoxins, likely with a disulfide bridge pattern that stabilizes a compact, globular fold optimized for receptor binding. The mature toxin should exhibit high specificity for insect ion channels over mammalian homologs, reflecting its evolutionary role in predatory behavior. Key structural elements include a stable core stabilized by disulfide bonds, surface-exposed loops for target recognition, and conserved residues critical for channel interaction. The sequence should maintain the pharmacological profile of rapid-onset neurotoxicity while preserving the thermal and proteolytic stability typical of ant venom peptides."}
{"description": "sp|C0JB11|A312_LOXS4 Dermonecrotic toxin Ls4SicTox-alphaIII1ii (Fragment) OS=Loxosceles sp. (strain 4 GJB-2008) OX=575961 PE=2 SV=1", "sequence": "WIMGHMVNAVKQIPTSLDLGANALEMDVTFKNEEPTYTYHGVPCDAFRDCIRWEYFNVFAKTLREYTTPGFDKYREQLILLVFDLKTGDMNNAQARTAGVNTAKQLLQYYWNNDNNGGRAYVVLSIPDIAQHELIKGFKETLKKEGHENLLDKVGYDFSGPYLPRLPTLDETHEAFKKAGVEGHVWLSDGLTNFSPLGDMARLKEAIKSRDSANGFINKIYYWSVDKVSTVEKALKVGVDGIMTNHPDVIIGVLNENGFKDKYRLATYDDNPWETFGK", "prompt": "Design a protein sequence for a dermonecrotic toxin from Loxosceles spiders (recluse spiders). This toxin should exhibit the characteristic necrotic activity that causes localized tissue destruction and skin lesions, which is the hallmark of recluse spider envenomation. The protein should function as a sphingomyelinase D, hydrolyzing sphingomyelin in cell membranes to produce ceramide-1-phosphate and choline, leading to complement activation, inflammatory response, and endothelial cell damage. The structural scaffold should feature the conserved TIM barrel fold typical of sphingomyelinase D enzymes, with the characteristic active site containing metal-coordinating residues (likely histidine and aspartate residues) for catalytic activity. The protein should maintain the appropriate surface properties for membrane interaction and substrate binding, with structural stability provided by the conserved beta-barrel architecture. The molecular target is sphingomyelin in mammalian cell membranes, with the binding interface involving the active site pocket that accommodates the sphingomyelin substrate. The toxin should be optimized for stability in the venom environment and efficient catalytic turnover to drive the dermonecrotic pathology characteristic of Loxosceles envenomation."}
{"description": "sp|P00991|VKT1_VIPAA Kunitz-type serine protease inhibitor 1 OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=2", "sequence": "MSSGGLLLLLGLLTLWAELTPVSGQDHPKFCYLPADPGRCKAHIPRFYYDSASNKCNKFIYGGCPGNANNFKTWDECRQTCGASAMGRPT", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor derived from the venom of Vipera ammodytes ammodytes, the nose-horned viper. This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, particularly targeting factors Xa and XIIa, thereby disrupting hemostasis and promoting prey immobilization through hemorrhage. The protein should adopt the characteristic Kunitz domain fold, consisting of a stable alpha-beta structure with a central antiparallel beta-sheet stabilized by three conserved disulfide bonds following the cysteine framework Cys1-Cys6, Cys2-Cys4, Cys3-Cys5. The reactive site loop, located between two beta-strands, should contain the canonical protease-binding motif that confers specificity for serine proteases. The sequence must maintain the conserved hydrophobic core and disulfide connectivity essential for structural integrity while incorporating residues in the binding loop that determine target selectivity and inhibitory potency."}
{"description": "sp|P0C7S3|BPP5_BOTNU Bradykinin-potentiating peptide 5 OS=Bothrops neuwiedi OX=95648 PE=1 SV=1", "sequence": "EEGGSPPPVVI", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of Bothrops neuwiedi, a venomous pit viper. This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and promoting vasodilation. The peptide should adopt a compact, stable structure stabilized by a characteristic pyroglutamic acid residue at the N-terminus, which confers resistance to aminopeptidase degradation, and a C-terminal proline-rich region that is essential for ACE inhibition. The sequence should be relatively short (approximately 5-15 amino acids) with a high proportion of proline residues, particularly in the C-terminal region, to facilitate the inhibition of ACE's zinc-binding domain. The peptide should exhibit the typical BPP fold, characterized by a constrained conformation that optimizes interaction with the active site of ACE, leading to prolonged bradykinin activity and contributing to the overall hypotensive and pro-inflammatory effects of the venom. Ensure the peptide is structurally optimized for stability in the bloodstream and specific targeting of somatic ACE over other zinc metalloproteases."}
{"description": "sp|P0DUG4|PA2TI_NAJHH Phospholipase A2 TI-Nh (Fragment) OS=Naja haje haje OX=8642 PE=1 SV=1", "sequence": "NVYQYRKMLQCAMPNGGPFECCQTHDNCYGEAEKLKACTSTHSSPYFK", "prompt": "Design a protein sequence for a phospholipase A2 toxin derived from the Egyptian cobra (Naja haje haje), a medically significant elapid snake whose venom contains potent neurotoxic and cytotoxic components. This toxin functions as a calcium-dependent secretory phospholipase A2 that catalyzes the hydrolysis of the sn-2 ester bond in glycerophospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The resulting membrane disruption and generation of lipid mediators contribute to its cytotoxic, myotoxic, and potentially neurotoxic effects through presynaptic or postsynaptic mechanisms. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of 6-7 disulfide bridges, with the catalytic histidine-aspartate dyad positioned in the calcium-binding loop for enzymatic activity. Key structural elements include the conserved Ca²⁺-binding loop (Tyr-Gly-Cys), the active site pocket with essential histidine and aspartate residues, and the interfacial binding surface that mediates membrane association. The protein should exhibit specificity for neuronal or muscle cell membranes, potentially targeting presynaptic nerve terminals to inhibit neurotransmitter release or skeletal muscle membranes to induce myonecrosis."}
{"description": "sp|P82601|NTA_CORVA U1-theraphotoxin-Cv1a OS=Coremiocnemis valida OX=129522 PE=1 SV=1", "sequence": "ACSRAGENCYKSGRCCDGLYCKAYVVTCYKP", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a theraphotoxin derived from the venom of Coremiocnemis valida, a tarantula species. This toxin functions as a potent neurotoxin that targets voltage-gated ion channels, likely sodium or calcium channels, to disrupt neuronal signaling and induce paralysis in prey. The protein should adopt a stable, compact tertiary structure stabilized by multiple disulfide bonds, characteristic of inhibitor cystine knot (ICK) motifs commonly found in spider venom peptides. The sequence must include a conserved cysteine framework pattern that enables proper folding into this knotted structure, with key residues positioned to form specific interactions with the target ion channel's voltage-sensing or pore domains. The toxin should exhibit high affinity and selectivity for its molecular target, contributing to the venom's role in prey immobilization. Ensure the sequence reflects the evolutionary adaptations of spider venom peptides for rapid action and stability in the venom gland."}
{"description": "sp|Q56TT9|SCIT_HOTJU Alpha-insect toxin BjaIT OS=Hottentotta judaicus OX=6863 PE=1 SV=1", "sequence": "MNYLVVICFALLLMTGVESGRDAYIADNLNCAYTCGSNSYCNTECTKNGAVSGYCQWLGKYGNACWCINLPDKVPIRIPGACRGR", "prompt": "Design a novel alpha-insect toxin protein sequence inspired by the venom of the scorpion Hottentotta judaicus. This toxin should function as a potent modulator of insect voltage-gated sodium channels, specifically targeting the voltage-sensing domain of domain II to induce a hyperpolarizing shift in channel activation. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion alpha-toxins, featuring a compact globular architecture stabilized by four disulfide bridges with the canonical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements must include a conserved hydrophobic core, an alpha-helix spanning residues 8-18, and an anti-parallel beta-sheet comprising three strands. The molecular surface should present a conserved 'pharmacophore' region rich in aromatic and basic residues critical for binding to the neurotoxin receptor site 3 on insect sodium channels. The toxin should exhibit high selectivity for insect over mammalian sodium channels, with functional activity leading to prolonged channel opening, spontaneous repetitive firing, and eventual paralysis in insect prey. Incorporate conserved motifs for enhanced thermal and proteolytic stability typical of scorpion venom peptides."}
{"description": "sp|P00989|VKTH2_BUNMU Kunitz-type serine protease inhibitor homolog beta-bungarotoxin B2 chain OS=Bungarus multicinctus OX=8616 PE=1 SV=2", "sequence": "MSSGGLLLLLGLLTLCAELTPVSSRKRHPDCDKPPDTKICQTVVRAFYYKPSAKRCVQFRYGGCNGNGNHFKSDHLCRCECLEYR", "prompt": "Design a protein sequence for a neurotoxic component derived from the venom of the many-banded krait (Bungarus multicinctus), specifically the beta-bungarotoxin B2 chain. This toxin functions as a presynaptic phospholipase A2 neurotoxin that forms a heterodimeric complex with a Kunitz-type serine protease inhibitor homolog. The protein should adopt a Kunitz-type fold characterized by a compact, disulfide-stabilized beta-trefoil structure with a conserved alpha-beta-alpha motif. Incorporate the canonical Kunitz domain cysteine framework with three disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern) that confer exceptional stability and protease resistance. The sequence should maintain key functional residues for serine protease inhibition, including the reactive site loop that mimics natural protease substrates, while the phospholipase A2 partner mediates presynaptic membrane disruption at neuromuscular junctions. The toxin specifically targets voltage-gated potassium channels and protease-activated receptors in peripheral neurons, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. Ensure the structural integrity supports both the inhibitory function and the neurotoxic synergy within the heterodimeric complex."}
{"description": "sp|C0JB14|A411_LOXHI Dermonecrotic toxin LhSicTox-alphaIV1i (Fragment) OS=Loxosceles hirsuta OX=571525 PE=2 SV=1", "sequence": "WIMGHMVNEIYQIDEFVDLGANSIETDITFDDNAMEEYSFHGVPCDCRRYCHKWEYTNTFLDGLRRATTPGDSKFRKELALVVFDLKTGDLSSSTANKGGKLFGQKLLQHYWKGGNNGGRAYIILSIPDLDHYAFISGFKEALKTAGHEELLAKVGYDFSGNDDLGSTRTALNKAGVKDREHVWQSDGITNCVSTLFRGLDRVKKAVSNRDSSNGYINKVYHWTVDKYGSVRDALDAGVDGVMTNDPDVIVNVLNESKYKGKLRLATYDDNPWETFKP", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles hirsuta. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide and lysolipid metabolites trigger profound inflammatory responses, endothelial cell damage, platelet aggregation, and complement activation, ultimately leading to characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of SicTox family members, with the active site containing the essential catalytic residues (histidine and aspartate/glutamate pairs) arranged in the characteristic HxKx4D motif. The structure should feature the conserved disulfide bridge pattern that stabilizes the TIM barrel scaffold. The toxin should exhibit high specificity for membrane phospholipids and demonstrate the characteristic temperature-dependent enzymatic activity that underlies the progressive tissue necrosis observed in loxoscelism envenomation."}
{"description": "sp|P0DQN3|TXPR1_BUMPU Beta/omega-theraphotoxin-Bp1a OS=Bumba pulcherrimaklaasi OX=2024411 PE=1 SV=1", "sequence": "ECRYWLGGCSAGQTCCKHLVCSRRHGWCVWDGTFS", "prompt": "Design a venom-derived peptide toxin from the tarantula species Bumba pulcherrimaklaasi that functions as a beta/omega-theraphotoxin. This toxin should exhibit the characteristic dual functional profile of beta/omega-theraphotoxins, combining beta-toxin activity targeting voltage-gated sodium channels with omega-toxin activity targeting voltage-gated calcium channels. The peptide should function as a potent neurotoxin that disrupts neuronal signaling through simultaneous modulation of both sodium and calcium channel gating properties. It should adopt the inhibitor cysteine knot (ICK) structural motif typical of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates the characteristic knotted topology. The structure should include key functional loops responsible for channel interaction, particularly the beta-hairpin loop that mediates sodium channel binding and the omega-toxin loop region that facilitates calcium channel modulation. The toxin should exhibit high affinity for neuronal voltage-gated ion channels, potentially causing either inhibition or modification of channel kinetics to produce paralytic effects. The sequence should maintain the characteristic length and physicochemical properties of theraphotoxins, with appropriate distribution of hydrophobic, polar, and charged residues to support both structural stability and target recognition."}
{"description": "sp|O16846|1AK_HETMG Kappa-stichotoxin-Hmg1a OS=Heteractis magnifica OX=38281 PE=1 SV=2", "sequence": "MKSQMIAAVLLIAFCLCVVVTARMELQDVEDMENGFQKRRTCKDLIPVSECTDIRCRTSMKYRLNLCRKTCGSC", "prompt": "Design a protein sequence for a potent cytolysin toxin derived from the magnificent sea anemone, Heteractis magnifica. This toxin belongs to the kappa-stichotoxin family and functions as a pore-forming cytolysin that disrupts cell membranes through targeted insertion into lipid bilayers. The protein should adopt a stable beta-sheet rich structural scaffold characteristic of actinoporin-like toxins, featuring a conserved hydrophobic membrane-binding domain and a phosphocholine-binding site that facilitates initial recognition of target cell membranes. The sequence must include the characteristic cysteine framework that forms essential disulfide bridges to stabilize the core beta-sandwich fold, enabling the conformational changes required for membrane insertion and pore formation. The toxin should exhibit specificity for membranes containing sphingomyelin, leading to rapid osmotic lysis of target cells through the formation of stable oligomeric pores. The structural design should ensure efficient membrane penetration and pore assembly while maintaining the thermostability typical of sea anemone cytolysins."}
{"description": "sp|P82852|TOT2A_HADVE Omega-hexatoxin-Hv2a OS=Hadronyche versuta OX=6904 PE=1 SV=1", "sequence": "LLACLFGNGRCSSNRDCCELTPVCKRGSCVSSGPGLVGGILGGIL", "prompt": "Design a protein sequence for an animal toxin that functions as an insecticidal peptide from the Australian funnel-web spider Hadronyche versuta. This toxin belongs to the omega-hexatoxin family and specifically targets insect voltage-gated calcium channels. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. The mechanism involves pore block of insect Cav channels, leading to paralysis by disrupting neuromuscular transmission. Key structural elements include a hydrophobic patch for membrane interaction and a solvent-exposed loop region responsible for channel binding specificity. The sequence should reflect the typical length and physicochemical properties of spider venom ICK toxins, with appropriate distribution of cationic and hydrophobic residues to facilitate target engagement while maintaining structural stability through the cystine knot scaffold."}
{"description": "sp|C0JB18|A411_LOXAM Dermonecrotic toxin LamSicTox-alphaIV1i (Fragment) OS=Loxosceles amazonica OX=571517 PE=2 SV=1", "sequence": "WIMGHMVNEIYQIDEFVDLGANSIETDITFDDDAMAEYSYHGVPCDCMRWCHKWEYVNDFLEGLRRATTPGDSKYRKQLILVVFDLKTGDLSSSTAYKGGKLFAEKLLRYYWNGGSNGGRAYIIISIPDIDHYAFISGFRDALKKSGHEDLLAKVGYDFSGNDDLNSIRSALHKAGVKDREHVWQSGGITNCLLRSLDRVNEAVKNRDSSNGYISKMYYWTIEKYATGRDALNAEVDGIMTNYPDVIVNVLNEDSFKNRFRMATFDDNPWELFKR", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles amazonica. This toxin belongs to the SicTox-alpha family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, vascular damage, and tissue necrosis characteristic of loxoscelism. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the catalytic HxK(x)4D motif essential for Mg2+ coordination and phosphodiester bond cleavage. Include the characteristic N-terminal signal peptide for secretion and maintain the proper spacing of key residues in the active site pocket. The toxin should exhibit high specificity for membrane phospholipids at neutral pH, contributing to the severe dermonecrotic lesions and potential systemic effects observed in envenomation cases."}
{"description": "sp|P01417|3S11_DENJA Short neurotoxin 1 OS=Dendroaspis jamesoni kaimosae OX=8619 PE=1 SV=1", "sequence": "RICYNHQSTTPATTKSCGENSCYKKTWSDHRGTIIERGCGCPKVKQGIHLHCCQSDKCNN", "prompt": "Generate the amino acid sequence for a short neurotoxin from the venom of Dendroaspis jamesoni kaimosae (Jameson's mamba). This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. It specifically targets and antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, causing flaccid paralysis by competitively blocking acetylcholine binding. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a C-C-C-C cysteine framework pattern. The structure should feature three extended loops projecting from a central globular core, with key functional residues concentrated in loop II that mediate high-affinity binding to the α-δ and α-γ subunit interfaces of muscle-type nicotinic receptors. The sequence should reflect the compact size typical of short neurotoxins (60-62 amino acids) and maintain the conserved hydrophobic core and β-sheet secondary structure essential for receptor recognition and toxic activity."}
{"description": "sp|P82815|SCBK_OLIMR Bukatoxin OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "VRDGYIADDKNCAYFCGRNAYCDEECIINGAESGYCQQAGVYGNACWCYKLPDKVPIRVSGECQQ", "prompt": "Design a novel protein sequence for a potassium channel blocker toxin derived from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin should function as a potent and selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1.3 channels, which play crucial roles in immune cell function and neuronal excitability. The protein must adopt the conserved structural scaffold characteristic of scorpion toxins targeting potassium channels, featuring a compact, globular fold stabilized by three disulfide bonds with the cysteine framework C1-C4, C2-C5, C3-C6. The core structure should include a well-defined alpha-helix and an antiparallel beta-sheet, forming a molecular surface with key functional residues for channel block. Critical functional motifs should include a dyad or triad of residues (e.g., lysine and aromatic residues) that interact with the channel's pore region, occluding ion conduction. The sequence should maintain high stability and specificity, with surface-exposed loops contributing to target recognition and binding affinity. The overall design should reflect the evolutionary optimization of scorpion venom toxins for rapid and precise modulation of ion channel activity in prey or defense."}
{"description": "sp|P01419|3S110_DENJA Toxin S5C10 OS=Dendroaspis jamesoni kaimosae OX=8619 PE=1 SV=1", "sequence": "RICYNHQSNTPATTKSCVENSCYKSIWADHRGTIIKRGCGCPRVKSKIKCCKSDNCNL", "prompt": "Design a venom toxin protein from the Jameson's mamba (Dendroaspis jamesoni kaimosae) that functions as a potent short-chain alpha-neurotoxin. This toxin should exhibit high-affinity antagonism of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta subunit interface to cause postsynaptic blockade and paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The structural scaffold should feature the typical short-chain alpha-neurotoxin architecture with loop I containing key functional residues for receptor binding, particularly aromatic and cationic residues that mediate specific interactions with the acetylcholine binding site. The toxin should demonstrate selective binding to muscle-type nicotinic receptors over neuronal subtypes, with the conserved functional epitope in loop II contributing to receptor specificity. The protein should exhibit the characteristic stability and resistance to proteolysis typical of three-finger toxins, maintaining biological activity despite the harsh conditions of envenomation and prey digestion."}
{"description": "sp|P58779|SCX5_CENSC Alpha-like toxin CsEv5 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "KDGYPVDSKGCKLSCVANNYCDNQCKMKKASGGHCYAMSCYCEGLPENAKVSDSATNIC", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by the venom of the Arizona bark scorpion (Centruroides sculpturatus). This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting mammalian neuronal sodium channels to induce prolonged action potentials and neuronal hyperexcitability. The protein should adopt the conserved cysteine-stabilized alpha-helix/beta-sheet (CSαβ) fold characteristic of scorpion alpha-toxins, featuring a core beta-sheet stabilized by an alpha-helix and maintained by four conserved disulfide bridges with connectivity pattern C1-C4, C2-C5, C3-C6, C4-C7. Key structural elements must include: a conserved 'core' region responsible for sodium channel binding, the 'conserved hydrophobic surface' involved in receptor interaction, and the 'pharmacophore' region critical for biological activity. The toxin should exhibit high affinity for site 3 of voltage-gated sodium channels, binding to the extracellular S3-S4 loop of domain IV to inhibit fast inactivation. The sequence should maintain the characteristic molecular weight of approximately 7-8 kDa and display the typical basic isoelectric point that facilitates interaction with the negatively charged sodium channel surface. The structural scaffold should ensure proper folding into the compact, globular architecture that enables specific receptor recognition and potent neurotoxic effects characteristic of scorpion alpha-toxins."}
{"description": "sp|P0C7S7|BPPF_PROMU Bradykinin-potentiating peptide TmF OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "QGRPLGPPIPP", "prompt": "Generate the amino acid sequence for a bradykinin-potentiating peptide from the venom of Protobothrops mucrosquamatus (Taiwan habu pit viper). This peptide functions as a potent vasoactive toxin that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and promoting vasodilation. The peptide should adopt a compact, stable structure stabilized by disulfide bridges, characteristic of the bradykinin-potentiating peptide family from viper venoms. It should contain the conserved pyroglutamic acid residue at the N-terminus, which is essential for its biological activity and resistance to aminopeptidase degradation. The sequence should be relatively short (approximately 5-15 amino acids) and rich in proline residues, which contribute to its conformational stability and ACE inhibitory activity. The molecular target is the zinc-metallopeptidase angiotensin-converting enzyme, with the peptide binding to the active site to competitively inhibit the conversion of angiotensin I to angiotensin II and the breakdown of bradykinin, resulting in prolonged vasodilation and reduced blood pressure."}
{"description": "sp|A1X8B9|CA2_CONQU Putative alpha-conotoxin Qc alphaL-2 OS=Conus quercinus OX=101313 PE=5 SV=1", "sequence": "MGMRMMFTMFLLVVLATTVVSFNLDHAFDGRNAAANNKATDLMARTVRGFCSDPSCRFGNPELCDWRR", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form the inhibitory cysteine knot motif. The sequence should contain the appropriate cysteine spacing pattern typical of alpha-conotoxins, with well-defined loop regions between cysteine residues that determine receptor subtype specificity. The mature toxin should exhibit high affinity binding to its target receptor through precise molecular interactions at the orthosteric binding site, effectively blocking acetylcholine-mediated signaling. The structural fold should feature a compact, stable conformation resistant to proteolytic degradation, with surface-exposed residues in the inter-cysteine loops dictating pharmacological specificity and potency. The toxin must demonstrate the characteristic paralytic activity of conotoxins through precise neuromuscular or neuronal circuit disruption."}
{"description": "sp|Q9PUG7|PA2AH_AUSSU Acidic phospholipase A2 S17-58 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MYPAHLLVLLAVCVSLLGASNIPLPSLDFEQFGKMIQCTIPCEESCLAYMDYGCYCGPGGSGTPSDELDRCCQTHDNCYAEAGKLPACKAMLSEPYNDTYSYSCIERQLTCNDDNDECKAFICNCDRAAVICFSGAPYNDSNYDIGTIEHCK", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Key structural elements must include the conserved calcium-binding loop (Tyr-Gly-Cys), the catalytic dyad (His-Asp), and the interfacial binding surface that facilitates membrane association. The acidic nature of this toxin should be reflected in its amino acid composition, with a calculated pI below 5.0. The generated sequence should demonstrate high specificity for neuronal and muscle cell membranes, contributing to the venom's paralytic and tissue-damaging effects through disruption of membrane integrity and induction of inflammatory responses."}
{"description": "sp|P0DUN0|PA23_BOTHY Acidic phospholipase A2 PhTX-III (Fragment) OS=Bothrocophias hyoprora OX=230469 PE=1 SV=1", "sequence": "DLMQFETLIMKSGVWYYGSYGCYCGSGGQFRPQDASDRCCFVHDCCYGKNGDIVCGGDDPCKKQICECDRVAATCFRDNKVTYDNKYWFFPAKFPPQNCKEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from Bothrocophias hyoprora venom. This enzyme should exhibit the characteristic catalytic activity of hydrolyzing the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids, which contributes to membrane disruption, inflammation, and potential myotoxicity. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices stabilized by multiple disulfide bridges typical of group II phospholipase A2 toxins from viperid venoms. Key structural elements should include a conserved calcium-binding loop (YXCGXGG sequence motif) essential for catalytic activity, an interfacial binding surface for membrane association, and an acidic pI consistent with its classification. The enzyme should target cellular membranes, with potential specificity for particular phospholipid head groups, and may exhibit presynaptic neurotoxic or myotoxic effects through secondary mechanisms involving membrane damage and intracellular signaling cascade initiation. Ensure the sequence maintains the characteristic N-terminal helix, beta-wing region, and C-terminal extension common to viperid phospholipase A2 toxins, with appropriate conservation of catalytic residues (histidine, aspartate) within the active site."}
{"description": "sp|P81885|D1B_HADVE Delta-hexatoxin-Hv1b OS=Hadronyche versuta OX=6904 PE=1 SV=1", "sequence": "CSRSDGWCGKTEDCCCPMKCIKAWYKQNGNCQNTISAIWKNC", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Australian funnel-web spider Hadronyche versuta. This toxin belongs to the delta-hexatoxin family and functions as a voltage-gated sodium channel modulator. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The toxin specifically targets insect voltage-gated sodium channels, causing prolonged channel opening and neuronal hyperexcitation that leads to rapid paralysis in insect prey. The molecular mechanism involves binding to neurotoxin receptor site 4 on the sodium channel, disrupting normal channel inactivation kinetics. The sequence should contain the characteristic cysteine framework of delta-hexatoxins and maintain the structural features necessary for high-affinity interaction with insect sodium channels while exhibiting selectivity over mammalian channels. The venom from Hadronyche versuta contains this toxin as a key component for prey immobilization, representing an evolutionary adaptation for efficient predation on insects."}
{"description": "sp|L0PIN3|BRKP1_AGADC [Thr6]-bradykinyl-Val,Asp OS=Agalychnis dacnicolor OX=75988 PE=1 SV=1", "sequence": "MSFLKKSLFLVLFLGFVSFSICEEEKREDEEEENEREENKESEEKRNQEERPPGFTPFRVD", "prompt": "Design a novel bradykinin-potentiating peptide (BPP) derived from the skin secretions of the Mexican giant tree frog (Agalychnis dacnicolor), a species known for producing bioactive peptides with potent cardiovascular effects. This peptide should function as a potent inhibitor of angiotensin-converting enzyme (ACE), thereby blocking the conversion of angiotensin I to angiotensin II and preventing bradykinin degradation, leading to vasodilation and blood pressure reduction. The peptide must incorporate the [Thr6]-bradykinyl-Val,Asp modification, where the sixth position contains threonine instead of the canonical phenylalanine found in mammalian bradykinin, and include C-terminal valine and aspartic acid residues. The sequence should adopt an extended, flexible conformation typical of linear bioactive peptides, lacking disulfide bridges but containing proline-rich regions that confer resistance to proteolytic degradation. Key structural features should include: a conserved N-terminal pyroglutamate residue for metabolic stability; multiple proline residues that induce turns and restrict conformational flexibility; and the critical Thr6 substitution that enhances ACE binding affinity. The molecular target interface should involve specific interactions with the ACE active site zinc ion and substrate-binding pockets, particularly through the C-terminal dipeptide Val-Asp motif that mimics natural ACE substrates. The peptide should demonstrate high specificity for ACE over other proteases and exhibit enhanced plasma stability compared to endogenous bradykinin."}
{"description": "sp|Q9PTA6|PA2BC_BUNMU Basic phospholipase A2 beta-bungarotoxin A-AL3 chain (Fragment) OS=Bungarus multicinctus OX=8616 PE=3 SV=1", "sequence": "LAVCVSLIGAANIPPQHLNLYQFKEMIRYTIPCEKTWLEYTDYGCYCGYGGSGTPVDALDRCCYVHDNCYGDAEKKHKCNPKMQLYSYKLTKRTIICYGAAGTCERIVCDCDRTAALCFGNSEYIERHKNIDTKRYCR", "prompt": "Design a protein sequence for a potent neurotoxin derived from the venom of the many-banded krait (Bungarus multicinctus), specifically a beta-bungarotoxin. This toxin is a heterodimeric complex composed of a basic phospholipase A2 (PLA2) subunit and a Kunitz-type serine protease inhibitor subunit. The PLA2 subunit should exhibit characteristic features of group IA snake venom PLA2s, including a conserved calcium-binding loop (YGKYCGxxxxGC), catalytic network (H48, D49, Y52, D99), and the pancreatic loop. The structural scaffold should maintain the typical PLA2 fold with three major alpha-helices and a two-stranded antiparallel beta-sheet, stabilized by seven conserved disulfide bonds with connectivity: Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, and Cys84-Cys96. The mechanism of action involves initial binding to presynaptic membranes via the Kunitz subunit's interaction with voltage-gated potassium channels, followed by the PLA2 subunit's enzymatic hydrolysis of phospholipids, leading to irreversible blockade of acetylcholine release at neuromuscular junctions and ultimately respiratory paralysis. The protein should exhibit high specificity for neuronal membranes and potent presynaptic neurotoxicity characteristic of beta-bungarotoxins."}
{"description": "sp|P0C7N3|VM3CR_CROVV Zinc metalloproteinase-disintegrin-like crovidisin (Fragment) OS=Crotalus viridis viridis OX=8742 PE=1 SV=1", "sequence": "AMVTKNNGDLDKSGTECRLYCKDNSPGQNNSCKMFYSNEDEHKGMVLPGTK", "prompt": "Design a protein sequence for a zinc metalloproteinase-disintegrin-like toxin fragment derived from the venom of the prairie rattlesnake, Crotalus viridis viridis. This toxin should function as a key component in the snake's venom arsenal, primarily targeting the hemostatic system of prey through dual mechanisms: proteolytic degradation of extracellular matrix components and inhibition of platelet aggregation. The protein must incorporate a zinc-dependent metalloproteinase domain characterized by the conserved HEXXHXXGXXH zinc-binding motif, which facilitates catalytic activity against substrates such as fibrinogen, collagen, or other matrix proteins, leading to hemorrhage and tissue damage. Additionally, it should feature a disintegrin-like domain that mimics the structure of endogenous disintegrins, containing an RGD (Arg-Gly-Asp) or related motif (e.g., KGD, VGD) to competitively bind integrin receptors (e.g., αIIbβ3 on platelets or αvβ3 on endothelial cells), thereby blocking platelet aggregation and disrupting cell adhesion. The sequence should adopt a multi-domain architecture typical of snake venom metalloproteinases (SVMPs), with the disintegrin-like domain stabilized by a pattern of disulfide bridges (e.g., Cys residues forming 4-6 bonds in a conserved arrangement, such as Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 for rigidity). The overall structure should reflect a compact, globular fold for the disintegrin-like region, potentially with a cysteine-rich scaffold, while the metalloproteinase domain may exhibit a typical 'metzincin' fold with a central active-site zinc ion coordinated by histidine residues. Ensure the protein is secreted and functional in a venom context, with optimal stability for rapid action upon envenomation, and emphasize evolutionary conservation of key residues for integrin binding and proteolytic activity."}
{"description": "sp|P01420|3S13_NAJHA Short neurotoxin 3 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "MICYKQQSLQFPITTVCPGEKNCYKKQWSGHRGTIIERGCGCPSVKKGIEINCCTTDKCNR", "prompt": "Generate the amino acid sequence for a short neurotoxin from the venom of the snouted cobra (Naja annulifera), a highly potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction. This toxin belongs to the three-finger toxin superfamily characterized by a conserved structural fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the characteristic cysteine framework I (C-C-C-C-C-C-C-C). The protein should adopt the classic three-finger beta-sheet topology with minimal secondary structure elements beyond the core beta-sheets. As a short-chain neurotoxin, it should exhibit high affinity binding to the alpha-subunit of muscle-type nicotinic receptors, competitively inhibiting acetylcholine binding and causing rapid flaccid paralysis through neuromuscular blockade. The sequence should contain the conserved functional residues responsible for receptor recognition and binding within the central loop region, while maintaining the structural integrity required for target specificity and toxic potency characteristic of elapid snake venom neurotoxins."}
{"description": "sp|Q58L93|FAXD_PSEPO Venom prothrombin activator porpharin-D OS=Pseudechis porphyriacus OX=8671 PE=2 SV=1", "sequence": "MAPQLLLCLILTFLWSLPEAESNVFLKSKEANRFLQRTKRSNSLFEEFRPGNIERECIEEKCSKEEAREIFKDNEKTEAFWNVYVDGDQCSSNPCHYGGTCKDGIGSYTCTCLPNYEGKNCEHLLFKSCRFFNGNCWHFCKPVQNDTQCSCAESYRLGDDGHSCVAEGDFSCGRNIKARNKREASLPDFVQSQNATLLKKSDNPSPDIRIINGMDCKLGECPWQAVLLDKEGDVFCGGTILSPIYVLTAAHCITQSKHISVVVGEIDISRKETRHLLSVDKAYVHTKFVLATYDYDIAIIQLKTPIQFSENVVPACLPTADFANQVLMKQDFGIISGFGHTRSGGQTSNTLKVVTIPYVDRHTCMLSSDFRITPNMFCAGYDTLPRDACQGDSGGPHITAYRDTHFITGIISWGEGCAKKGKYGVYTKVSNFIPWIKAVMRKHQPSTESSTGRL", "prompt": "Design a venom-derived prothrombin activator protein from the Australian red-bellied black snake (Pseudechis porphyriacus) that functions as a potent coagulotoxic enzyme. This protein should act as a true prothrombin activator, directly converting the zymogen prothrombin to active thrombin through specific proteolytic cleavage, thereby initiating the coagulation cascade and promoting rapid fibrin clot formation. The protein should exhibit structural characteristics typical of snake venom serine proteases (SVSPs), featuring a chymotrypsin-like fold with the characteristic His-Asp-Ser catalytic triad. It should contain multiple disulfide bridges that stabilize the compact globular structure, with conserved cysteine patterns that maintain the protease domain's structural integrity. The enzyme should demonstrate high specificity for prothrombin as its physiological substrate, with optimal activity in the presence of calcium ions and phospholipid surfaces that mimic physiological coagulation conditions. The protein should possess surface loops and exosite regions that facilitate specific recognition and binding to prothrombin, distinguishing it from other coagulation factors. This prothrombin activator represents a key component of the snake's venom arsenal, causing consumptive coagulopathy and potentially leading to systemic thrombosis in envenomed prey."}
{"description": "sp|P01379|3L21_LATSE Alpha-elapitoxin-Ls2a OS=Laticauda semifasciata OX=8631 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYTRECYLNPHDTQTCPSGQEICYVKSWCNAWCSSRGKVLEFGCAATCPSVNTGTEIKCCSADKCNTYP", "prompt": "Design a novel alpha-elapitoxin protein sequence derived from the venom of the sea krait Laticauda semifasciata, a highly venomous marine snake. This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to elapid snake venoms, featuring three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bridges with a C-C-C-C-C-C-C-C cysteine framework. The structural scaffold should include the conserved three-finger motif with the central loop containing key functional residues for receptor binding and specificity. The molecular target interface should involve high-affinity binding to the alpha-delta subunit interface of the nicotinic acetylcholine receptor, blocking acetylcholine binding and preventing ion channel activation. The sequence should maintain the structural integrity of the three-finger toxin fold while incorporating specific residues that confer target selectivity and potent neurotoxic activity characteristic of alpha-elapitoxins from sea krait venoms."}
{"description": "sp|A1X8C6|CA11C_CONQU Alpha-conotoxin-like Qc1.1c (Fragment) OS=Conus quercinus OX=101313 PE=3 SV=1", "sequence": "SDGRNTAANDKASNLMALRDDCCPNPPCKASNPDLCDWRS", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide-bonded framework, featuring the conserved CC-C-C cysteine pattern that forms two essential disulfide bridges stabilizing the compact tertiary structure. The core functional motif should include a well-defined pharmacophore region responsible for high-affinity binding to the orthosteric site of nAChRs, effectively blocking acetylcholine-mediated ion channel activation. The sequence must incorporate key residues for target specificity and potency, while maintaining the typical alpha-conotoxin length of 12-20 amino acids with appropriate loop regions between cysteine residues. The structural fold should exhibit the classic alpha-conotoxin three-dimensional architecture, with beta-turn elements and a stable core stabilized by the disulfide connectivity, ensuring resistance to proteolytic degradation and enabling precise molecular recognition of neuronal nAChR subtypes."}
{"description": "sp|C0JB21|A41_LOXRU Dermonecrotic toxin LruSicTox-alphaIV1 (Fragment) OS=Loxosceles rufescens OX=571528 PE=2 SV=1", "sequence": "WIMGHMVNEIYQIDEFVDLGANSIETDVRFDDNAMAEYTFHGVPCDCRRWCHKWEYINTFLEGLRRATTPGDSKYRSELILVVFDLKTSQLSSSNAYKGGKLFAEKLLRYYWNGGNNGGRAYIILSIPKIDHYAFISGFRDALKESKHEDLLAKVGYDFSGNDDLDSIRSALNKAGVKDKEHVWQSDGITNCIARNLNRVREAVQNRDSANGYINKVYYWTIEKYVSVRDALNAEVDGIMTNYPNVIVNVLNEDNFRNRFRMATFEDNPWEHFTR", "prompt": "Design a protein sequence for a dermonecrotic toxin from the Mediterranean recluse spider, Loxosceles rufescens. This toxin belongs to the SicTox family and represents the alphaIV1 isoform. The protein should function as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. This enzymatic activity leads to profound dermonecrosis through multiple mechanisms: direct membrane disruption, induction of complement-mediated hemolysis, platelet aggregation, and inflammatory cascade activation. The toxin should adopt the characteristic (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the conserved catalytic histidine and other essential residues positioned in the active site pocket. The sequence should include the signature HxK(x)4D motif required for phosphodiesterase activity. The protein should be secreted and stable in venom, capable of binding to cell surface receptors to initiate its cytotoxic effects. The structural scaffold should facilitate efficient substrate access to the catalytic site while maintaining venom stability."}
{"description": "sp|O46166|TXI1_ERAAG U1-agatoxin-Ta1a OS=Eratigena agrestis OX=1686644 PE=1 SV=1", "sequence": "MKLQLMICLVLLPCFFCEPDEICRARMTHKEFNYKSNVCNGCGDQVAACEAECFRNDVYTACHEAQKG", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin derived from the venom of the hobo spider, Eratigena agrestis. This toxin belongs to the U1-agatoxin family and functions as a selective antagonist of insect voltage-gated calcium channels, specifically targeting Cav2-type channels. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted topology. Key structural elements include a hydrophobic patch and basic residues critical for high-affinity binding to the channel's pore-forming region, blocking calcium influx and leading to rapid paralysis in insect prey. The sequence should reflect the typical length and physicochemical properties of U1-agatoxins, with surface-exposed loops that mediate target specificity while maintaining the core ICK fold essential for stability in the venom milieu."}
{"description": "sp|P0C257|I1B1_CONMA Iota-conotoxin-like M11.1 (Fragment) OS=Conus magus OX=6492 PE=2 SV=1", "sequence": "GAVPCGKDGRQCRNHADCCNCCPIGTCAPSTNWILPGCSTGQFMTR", "prompt": "Design a protein sequence for a conotoxin from the marine cone snail Conus magus that functions as an iota-conotoxin-like peptide. This toxin should exhibit the characteristic biological activity of iota-conotoxins, which typically target voltage-gated sodium channels, modulating neuronal excitability through specific channel interactions. The protein should adopt the conserved structural framework of conotoxins, featuring a disulfide-rich scaffold with a specific cysteine pattern. Based on conotoxin classification, anticipate a cysteine framework consistent with iota-conotoxins, likely involving multiple disulfide bonds that stabilize a compact, globular fold. The structural motif should enable high-affinity binding to sodium channel subtypes, potentially influencing channel gating or inactivation. The sequence must reflect the venom's role in prey immobilization by disrupting neuromuscular signaling, with precise molecular recognition elements for target engagement. Ensure the design incorporates conserved conotoxin features: small size, high stability from disulfide cross-links, and functional residues for target specificity, while excluding any database identifiers."}
{"description": "sp|Q5K0C7|O161_CONVR Conotoxin Vi6.1 OS=Conus virgo OX=89427 PE=1 SV=1", "sequence": "MKLTCVLIITVLFLTASQLITADYSRDQRQYRAVRLGDEMRNFKGARDCGGQGEGCYTQPCCPGLRCRGGGTGGGVCQL", "prompt": "Design a novel conotoxin sequence derived from the venom of the marine cone snail Conus virgo, specifically belonging to the Vi6.1 conotoxin family. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels (NaV), contributing to the venom's paralytic effects on prey by blocking neuronal signal transmission. The sequence must adopt the characteristic conotoxin structural framework with a conserved disulfide bond pattern, typically involving four cysteine residues forming two disulfide bridges in a C-C-C-C arrangement that stabilizes a compact, globular fold. The mature peptide should be short (approximately 12-20 amino acids) and rich in post-translationally modified residues, such as hydroxyproline or gamma-carboxyglutamate, which are common in conotoxins and critical for target specificity and stability. Ensure the sequence includes key functional motifs for high-affinity binding to NaV channels, particularly those involved in pore block or modulation of channel gating, while maintaining the overall structural integrity typical of conotoxins from this genus."}
{"description": "sp|P58841|M3A_CONQU Conotoxin QcIIIA OS=Conus quercinus OX=101313 PE=1 SV=1", "sequence": "CCSQDCLVCIPCCPN", "prompt": "Design a novel conotoxin sequence inspired by the α-conotoxin QcIIIA from the marine cone snail Conus quercinus. This toxin should function as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors (nAChRs), specifically targeting the α3β2 and/or α3β4 subtypes. The sequence must adopt the characteristic α-conotoxin globular disulfide framework (Cys-Cys-Cys-Cys with disulfide connectivity I-III, II-IV), forming a compact, two-loop structure stabilized by two disulfide bonds. The N-terminal loop should be shorter (4-7 residues) while the C-terminal loop is longer (7-10 residues), with key residues in these loops mediating receptor subtype selectivity through interactions with complementary binding pockets. Incorporate conserved conotoxin features including an amidated C-terminus for enhanced stability and proteolytic resistance, and maintain the typical α-conotoxin molecular weight of ~1.8-2.2 kDa. The toxin should exhibit high affinity binding to its target nAChRs, effectively blocking neurotransmission in autonomic ganglia and central nervous system pathways where these receptor subtypes are expressed, thereby producing the characteristic neurotoxic effects observed in cone snail envenomation."}
{"description": "sp|P01382|3L21_NAJOX Alpha-elapitoxin-Nno2a OS=Naja oxiana OX=8657 PE=1 SV=1", "sequence": "ITCYKTPIPITSETCAPGQNLCYTKTWCDAWCGSRGKVIELGCAATCPTVESYQDIKCCSTDDCNPHPKQKRP", "prompt": "Design a protein sequence for an alpha-elapitoxin from the Central Asian cobra (Naja oxiana) venom. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with connectivity C1-C3, C2-C4, C5-C6, C7-C8, forming a compact globular structure. The core mechanism involves high-affinity binding to nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the α-δ and α-γ subunit interfaces. The functional loop regions, particularly loop II, should contain key residues for receptor recognition and binding that competitively inhibit acetylcholine binding, leading to flaccid paralysis. The sequence should maintain the conserved structural scaffold while incorporating specific residues that confer the characteristic slow dissociation kinetics and high potency typical of elapid snake neurotoxins. The protein should be approximately 60-75 amino acids in length with the appropriate cysteine framework for proper folding and biological activity."}
{"description": "sp|P01404|3SOB8_DENAN Toxin F-VIII OS=Dendroaspis angusticeps OX=8618 PE=1 SV=2", "sequence": "MKTLLLTLLVVTIVCLDLASTMICYSHKTPQPSATITCEEKTCYKKSVRKLPAIVAGRGCGCPSKEMLVAIHCCRSDKCNE", "prompt": "Design a protein sequence for a neurotoxin from the green mamba (Dendroaspis angusticeps) that functions as a postsynaptic alpha-neurotoxin. This toxin should specifically target and antagonize muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The structural scaffold should feature the typical long central loop that is essential for receptor binding and blockade. The toxin should exhibit high affinity binding to the alpha-delta interface of the nicotinic acetylcholine receptor, competitively inhibiting acetylcholine binding and preventing ion channel activation. The sequence should maintain the conserved structural determinants required for proper folding into the three-finger motif while incorporating the specific functional residues necessary for potent neuromuscular blockade characteristic of mamba venom toxins."}
{"description": "sp|P83044|DID8B_CERCE Disintegrin CC8B OS=Cerastes cerastes OX=8697 PE=1 SV=1", "sequence": "NSAHPCCDPVTCKPKRGEHCISGPCCENCKFLTAGTVCLPAWGDFDNDLCTGISSDCPRNPWHKS", "prompt": "Design a novel disintegrin protein sequence derived from the venom of the Saharan horned viper, Cerastes cerastes. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of platelets and other cells. The disintegrin should adopt the characteristic cysteine-rich scaffold typical of viperid disintegrins, featuring the RGD (Arg-Gly-Asp) tripeptide motif in an exposed loop conformation that serves as the primary integrin-binding interface. The structural fold should be stabilized by a conserved pattern of disulfide bridges that maintain the protein's compact, globular architecture and ensure proper presentation of the bioactive RGD motif. The sequence must encode the functional determinants for high-affinity binding to αIIbβ3 integrin on platelets, thereby preventing fibrinogen binding and subsequent thrombus formation, while also potentially interacting with other RGD-sensitive integrins such as αvβ3 involved in cell adhesion and migration processes. The overall molecular architecture should reflect the evolutionary optimization of this toxin family for rapid and specific interference with hemostatic pathways in envenomed prey."}
{"description": "sp|O42187|PA2BB_GLOHA Basic phospholipase A2 B OS=Gloydius halys OX=8714 PE=1 SV=2", "sequence": "MRALWIVAVLLLGVEGSLLQFRKMIKKMTGKEPVVSYAFYGCYCGSGGRGKPKDATDRCCFVHDCCYEKLTGCDPKWDDYTYSWKNGTIVCGGDDPCKKEVCECDKAAAICFRDNLKTYKKRYMTYPNILCSSKSEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Siberian pit viper (Gloydius halys). This enzyme should function as a potent neurotoxin and myotoxin, characteristic of viperid snake venoms. The protein must exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, presynaptic neurotoxicity, and muscle tissue damage. The sequence should include the conserved phospholipase A2 active site motif with histidine, aspartate, and tyrosine residues essential for catalysis, along with a calcium-binding loop. Maintain the characteristic phospholipase A2 structural fold consisting of three long alpha-helices stabilized by seven conserved disulfide bonds in the pattern Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, and Cys13-Cys14. The protein should possess basic isoelectric properties to facilitate interaction with anionic membrane surfaces. Include structural features that enable both enzymatic activity and potential receptor-binding capabilities for enhanced toxicity. The overall architecture should reflect the dual functionality of this toxin: catalytic membrane disruption and specific targeting of neuromuscular junctions."}
{"description": "sp|P0C256|I1B1_CONFI Iota-conotoxin-like Fi11.1 (Fragment) OS=Conus figulinus OX=101301 PE=2 SV=1", "sequence": "GHVSCGKDGRACDYHADCCNCCLGGICKPSTSWIGCSTNVFLTR", "prompt": "Design a novel conotoxin sequence inspired by iota-conotoxin-like peptides from the marine cone snail Conus figulinus. This venom component should function as a potent neurotoxin targeting voltage-gated ion channels, characteristic of the iota-conotoxin family. The sequence must adopt a compact, disulfide-stabilized fold typical of conotoxins, likely featuring a cysteine framework of C-C-CC-C-C or similar, forming three disulfide bridges that confer structural rigidity and resistance to proteolysis. The core scaffold should exhibit an inhibitory cysteine knot (ICK) motif, with well-defined loops between cysteine residues that mediate target specificity. Key structural elements include a stable beta-hairpin or small beta-sheet region stabilized by disulfide bonds, and surface-exposed residues critical for interacting with voltage-gated sodium or calcium channels to modulate neuronal excitability. The toxin should exhibit high affinity for its molecular target, potentially interfering with channel gating or pore block, leading to paralysis or altered neurotransmission. Ensure the sequence reflects the evolutionary adaptations of Conus figulinus venom for prey capture, with optimal physicochemical properties for solubility, stability, and bioactivity in a marine environment."}
{"description": "sp|P0C8B1|DEFBL_ORNAN Venom-like beta-defensin OS=Ornithorhynchus anatinus OX=9258 PE=1 SV=1", "sequence": "MRLLILFLAVVTLLSLAGPGSAEVRRRRRRPPCEDVNGQCQPRGNPCLRLRGACPRGSRCCMPTVAAH", "prompt": "Design a venom-derived beta-defensin protein from the platypus (Ornithorhynchus anatinus), a monotreme mammal known for its unique venom delivery system in males. This protein should function as a cationic antimicrobial peptide with dual toxic and defensive properties, characteristic of platypus venom defensins. The sequence should adopt the conserved beta-defensin fold stabilized by three intramolecular disulfide bonds in the canonical C1-C5, C2-C4, C3-C6 connectivity pattern, forming a compact triple-stranded beta-sheet structure. The mechanism involves membrane disruption through electrostatic interactions with anionic phospholipids in bacterial and eukaryotic cell membranes, leading to pore formation and cell lysis. Key structural features include: an N-terminal flexible region preceding the first cysteine, a conserved beta-defensin cysteine motif (C-X5-16-C-X3-4-C-X9-13-C-X4-7-C-X-C), and a cationic surface patch for membrane targeting. The protein should exhibit broad-spectrum antimicrobial activity while potentially causing pain and inflammation in mammalian targets through mast cell degranulation and histamine release, consistent with platypus venom's effects. Maintain the characteristic amphipathic nature with clustered basic residues for membrane penetration and cytotoxic activity."}
{"description": "sp|P01422|3S12_NAJHA Short neurotoxin 2 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "MICHNQQSSQPPTIKTCPGETNCYKKRWRDHRGTIIERGCGCPSVKKGVGIYCCKTNKCNR", "prompt": "Design a short neurotoxin protein sequence that mimics the biological activity and structural characteristics of snake venom neurotoxins from the Elapidae family, specifically those found in cobra species. This toxin should function as a potent postsynaptic neurotoxin that competitively antagonizes nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The molecular target is the alpha-delta interface of muscle-type nicotinic acetylcholine receptors, with key functional residues located primarily in the central loop (loop II) that mediate high-affinity binding to the receptor's orthosteric site. The toxin should exhibit the typical structural features of short neurotoxins: approximately 60-62 amino acids in length, rich in beta-sheet content, and containing the conserved cysteine framework that defines the three-finger toxin superfamily. The sequence should maintain the essential pharmacophore responsible for receptor blockade while ensuring proper folding into the stable, compact globular structure characteristic of this toxin class."}
{"description": "sp|Q9PVK9|VM2MD_GLOBR Zinc metalloproteinase/disintegrin OS=Gloydius brevicauda OX=3148161 PE=2 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSMILESGNVNDYEVVYPQKVPALPKGAVPQKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGRKITTNPPVEDHCYYHGHIQNDADSTASISACNGLKGHFKHQGEMYLIEPLKLSDSEAHAVYKYENVEKEDEAPKMCGVTQTNWKSDEPIKASQLVVTAEQQRFPQRYIELVVVADHGMFTKYDSNLDTITTWVHELVNNINEFYRSLNVRVSLTELEIWSNQDLINVQSAAADTLEAFGDWRETDLLNRISHDNAQLLTTIDLDGNTIGLAHVGTMCDPKYSVGIVQDHSAINLLVAVTMAHELGHNLGMDHDGNQCHCGANSSVMGDVLRVGVSYEFSDCNENEYQTYVTDHNPQCILNEPLRTDTVSTPVSGNELLEAGVECDCGAPANPCCDAATCKLRPGAQCAEGLCCDQCRFMKEGTICRMARGDDMDDYCNGISAGCPRNPFHA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, derived from the venom of the short-tailed mamushi, Gloydius brevicauda. This protein should exhibit the characteristic dual functionality of snake venom metalloproteinases (SVMPs), specifically belonging to the P-II class, which integrates a metalloproteinase domain with a disintegrin domain. The metalloproteinase domain must contain the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, facilitating proteolytic activity that degrades extracellular matrix components such as collagen, laminin, and fibronectin, thereby inducing hemorrhage and tissue damage. The disintegrin domain should adopt a compact, disulfide-rich fold stabilized by multiple disulfide bonds, typically featuring an RGD (Arg-Gly-Asp) or related motif (e.g., KGD, VGD) that specifically antagonizes integrin receptors (e.g., αIIbβ3 on platelets or αvβ3 on endothelial cells), inhibiting platelet aggregation and cell adhesion. The overall structure should reflect the modular architecture of SVMPs, with the metalloproteinase domain employing a metzincin-like fold and the disintegrin domain assuming a small, rigid conformation conducive to high-affinity integrin binding. This protein's mechanism involves synergistic disruption of hemostasis and tissue integrity, contributing to the venom's prey immobilization and digestion."}
{"description": "sp|C0JB22|A41_LOXAR Dermonecrotic toxin LarSicTox-alphaIV1 (Fragment) OS=Loxosceles arizonica OX=196454 PE=2 SV=1", "sequence": "WIMGHMVNEIYQIDEFVDLGANSIETDITFDENAVAEYSYHGVPCDCRRWCHKWEYVNDFLNALRRATTPGDSKYRRELVLVVFDLKTGDLSSSTANKGGKLFAQKLLQHYWNGGNNGGRAYIIISIPDIDHYAFISGFRNALKEAGHEELLEKVGYDFSGNDDLNSIRNALHKAGVKDKEHVWQSDGITNCILRGLSRVREAVRNRDSSNGYINKVYYWTIEKYVSVRDALDAGVDGIMTNEPDVIVNVLNEKAYKQRFRLANYDDNPWETYQ", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the Arizona brown spider, Loxosceles arizonica. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The mechanism involves cleaving these phospholipids to generate ceramide-1-phosphate and choline, initiating a cascade of inflammatory responses, endothelial cell damage, platelet aggregation, and complement-dependent hemolysis. This leads to the characteristic dermonecrotic lesions and systemic effects observed in loxoscelism. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing the essential catalytic histidine and other conserved residues required for metal ion coordination and substrate binding. The sequence should include the characteristic HxK(x)4D motif and maintain the proper structural integrity for membrane interaction and enzymatic activity. The toxin should be optimized for stability and potency in disrupting mammalian cell membranes and triggering the pathological cascade associated with Loxosceles envenomation."}
{"description": "sp|A1X8D0|CA15_CONQU Alpha-conotoxin-like Qc1.5 (Fragment) OS=Conus quercinus OX=101313 PE=3 SV=1", "sequence": "SDGRNAAADDKASDLIGLAVRGCCSNPACSVNHPELCGRRR", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that constrain the peptide into a compact, stable fold. The sequence should contain the conserved alpha-conotoxin motif with appropriate spacing between cysteine residues to enable proper folding and receptor binding. Key structural elements should include a well-defined beta-hairpin or loop region that mediates specific interactions with the nAChR binding pocket, particularly at the interface between receptor subunits. The toxin should exhibit high affinity and selectivity for its target nAChR subtype, potentially disrupting neuromuscular transmission or neuronal signaling through competitive inhibition of acetylcholine binding. The mature peptide should be approximately 12-20 amino acids in length with appropriate post-translational processing signals, and maintain the characteristic pharmacological profile of cone snail alpha-conotoxins while incorporating sequence features unique to the Conus quercinus lineage."}
{"description": "sp|Q9PW36|VM1AC_DEIAC Snake venom metalloproteinase acutolysin-C OS=Deinagkistrodon acutus OX=36307 PE=2 SV=1", "sequence": "MIQVLLVTICLAALPYQGSSIMLESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGETIVLHLEKNKGLFSKDYSETHYSPDGRKITTYPSVEDHCYYHGRIENYEDSTASISACNGLKGHFKIQGETYFIESLKLSDSEAHAVLKYENVGKEDETHQICGVTLNWKSYDPIKRPSRLNLTPKQQTWPQTSVNLQLIVDHSMYAKYNSNSEKITKTVQERVNIMKEIFKPLNFDITLSGIEMWDKKDLITVKTAATDTLKLFAKWRQTDLLKRIDNDNAQLQTAVDFDGETVGLAFKSTMCDKRYSAGIIQDHSAIPLLMAVTIAHELGHNLGMDHDDTSKCNCNVCIMAPRLNTNPSKTFSDCSNNDYQKFLTDKKPKCIHKKSLKTDTVSTSVSGNEPLDDNVDGFHA", "prompt": "Design a snake venom metalloproteinase (SVMP) sequence that mimics the toxic activity and structural characteristics of acutolysin-C from the hundred-pace snake (Deinagkistrodon acutus). This protein should function as a potent hemorrhagic toxin that degrades basement membrane components, particularly targeting type IV collagen, laminin, and fibronectin in capillary walls. The sequence must include the characteristic SVMP domain architecture: a prodomain for zymogen regulation, a catalytic domain containing the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn for metalloprotease activity, and a disintegrin-like domain that may modulate interactions with integrins or other extracellular matrix receptors. The mature protein should fold into a compact, multi-domain structure stabilized by multiple disulfide bonds, with the catalytic domain adopting a typical metzincin fold featuring a central five-stranded beta-sheet and surrounding alpha-helices. The protein should exhibit calcium-dependent stability and optimal activity at physiological pH, facilitating rapid tissue damage and hemorrhage upon envenomation. Focus on creating a sequence that maintains the precise spatial arrangement of catalytic residues for efficient proteolysis while preserving the structural integrity required for venom dissemination and target substrate recognition in mammalian tissues."}
{"description": "sp|P0C8E3|CKP_CONPU Conantokin-P OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "MQLYTYLYLLVPLVTFHLILSTGTLAHGGTLTERRSTDTTALKPEPVLLQKSDARSTDDNDKDRLTQMKRILKKRGNKARGEEEHSKYQECLREIRVNKVQQEC", "prompt": "Design a conantokin peptide from the venom of the marine cone snail Conus purpurascens, a predatory species that employs this neuroactive component to immobilize fish prey through targeted disruption of the central nervous system. This toxin functions as a highly selective and potent antagonist of the NMDA (N-methyl-D-aspartate) receptor, specifically competing with glycine at the receptor's co-agonist binding site to inhibit ion channel activation and thereby block excitatory neurotransmission. The peptide is characterized by its unique conantokin structural scaffold, which lacks the typical disulfide bridges found in many conotoxins and instead adopts an elongated, helical conformation stabilized by post-translational gamma-carboxylation of multiple glutamate residues to form gamma-carboxyglutamate (Gla). This post-translational modification is critical for calcium-dependent folding and structural integrity, enabling the peptide to maintain an alpha-helical secondary structure that facilitates precise interaction with the NMDA receptor. The molecular target is the GluN1 subunit of the NMDA receptor, with binding primarily mediated through electrostatic and hydrophobic interactions involving the Gla residues and the peptide's helical face. The sequence should reflect a small, linear peptide rich in Gla-modified glutamate residues, with a predicted isoelectric point favoring interaction with the receptor's extracellular domains, and must exhibit the hallmark neuroinhibitory activity through NMDA receptor antagonism, contributing to rapid prey immobilization by suppressing neuronal excitation in the fish central nervous system."}
{"description": "sp|Q9PW66|BV8_BOMVA Prokineticin Bv8 OS=Bombina variegata OX=8348 PE=1 SV=1", "sequence": "MKCFAQIVVLLLVIAFSHGAVITGACDKDVQCGSGTCCAASAWSRNIRFCIPLGNSGEDCHPASHKVPYDGKRLSSLCPCKSGLTCSKSGEKFKCS", "prompt": "Design a protein sequence for a prokineticin-like toxin derived from the yellow-bellied toad (Bombina variegata). This toxin, known as Bv8, is a key component of the amphibian's defensive skin secretion, functioning as a potent modulator of nociception and inflammation. The protein acts as a selective agonist for the G-protein coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2), initiating intracellular signaling cascades that modulate pain perception and inflammatory responses. The mature toxin should adopt a conserved AVIT protein fold characterized by a compact, globular structure stabilized by five disulfide bridges in a specific connectivity pattern (Cys1-Cys5, Cys2-Cys4, Cys3-Cys8, Cys6-Cys7, Cys9-Cys10). This structural scaffold features a central core with exposed loops that mediate receptor binding, particularly through conserved residues in the N-terminal region that are critical for receptor activation. The sequence should include the characteristic prokineticin domain with conserved cysteine spacing and key functional motifs required for receptor recognition and biological activity."}
{"description": "sp|P01425|3S11_HEMHA Short neurotoxin 1 OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LECHNQQSSQPPTTKSCPGDTNCYNKRWRDHRGTIIERGCGCPTVKPGINLKCCTTDRCNN", "prompt": "Generate the amino acid sequence for a short neurotoxin from the venom of the rinkhals cobra (Hemachatus haemachatus), a highly potent postsynaptic neurotoxin that specifically targets and irreversibly blocks nicotinic acetylcholine receptors at the neuromuscular junction. This toxin belongs to the three-finger toxin superfamily characterized by a compact, globular structure stabilized by four conserved disulfide bridges forming the characteristic cysteine framework I (C-C-CC-C-C). The protein should adopt the classic three-finger β-sheet fold with three extended loops projecting from a central hydrophobic core, facilitating high-affinity binding to the α-γ or α-δ subunit interface of muscle-type nicotinic receptors. The mechanism involves competitive antagonism of acetylcholine binding, leading to flaccid paralysis through disruption of neuromuscular transmission. Key structural features include conserved hydrophobic residues in the central loop for receptor interaction, and the characteristic short-chain length (typically 60-62 amino acids) with the disulfide connectivity pattern essential for maintaining structural integrity and biological activity. The generated sequence should reflect the evolutionary optimization for rapid neuromuscular blockade characteristic of elapid snake venoms."}
{"description": "sp|P0DUN1|PA22_BOTHY Basic myotoxic phospholipase A2 PhTX-II OS=Bothrocophias hyoprora OX=230469 PE=1 SV=1", "sequence": "NLLQFNKMILKETGKNAIPFYAFYGCYCGWGGRGKPKDKTDDRCCFVHDCCYGKLTGCPKWDIYPYSLKSGYITCGKGTWCEEQICECDRAAAICFRENLDTYNKYGYMFYPDSRCKGPSEQC", "prompt": "Design a protein sequence for a basic myotoxic phospholipase A2 toxin from the venom of Bothrocophias hyoprora, a pit viper species. This toxin belongs to the phospholipase A2 family and exhibits potent myotoxic activity, causing skeletal muscle damage through mechanisms involving membrane disruption and potential induction of necrosis. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved catalytic triad (typically involving histidine, aspartate, and tyrosine residues) essential for enzymatic activity. It should include the canonical calcium-binding loop (often with a YGC motif) required for catalytic function. The sequence must contain the conserved disulfide bridge pattern characteristic of group II phospholipase A2 enzymes, typically involving 6-7 disulfide bonds that stabilize the compact globular structure. Key structural elements should include the N-terminal helix, the calcium-binding loop, the antiparallel β-wing region, and the C-terminal extension. The toxin should target phospholipid membranes, particularly those of skeletal muscle cells, where its phospholipase activity leads to hydrolysis of membrane phospholipids, resulting in cell lysis and myonecrosis. The basic nature of this toxin (indicated by its pI) likely facilitates interaction with negatively charged membrane surfaces. The protein should exhibit the characteristic pharmacological profile of myotoxic phospholipase A2 toxins, including local tissue damage and potential systemic effects when introduced into prey or envenomed victims."}
{"description": "sp|Q5K0E0|KA157_ANDAM Potassium channel toxin alpha-KTx 15.7 OS=Androctonus amoreuxi OX=112024 PE=1 SV=1", "sequence": "MKFSSIILLTLLICSMSIFGNGQVQTNKKCKGGSCASVCAKEIGVAAGKCINGRCVCYP", "prompt": "Design a novel potassium channel toxin protein derived from the venom of the scorpion Androctonus amoreuxi, a species known for its potent neurotoxic venom that targets ion channels to induce paralysis in prey. This toxin belongs to the alpha-KTx family, specifically characterized by its high affinity and selectivity for voltage-gated potassium channels (Kv channels). The core function of this toxin is to act as a pore-blocker, physically occluding the potassium conduction pathway and thereby inhibiting potassium efflux, leading to prolonged neuronal depolarization, enhanced neurotransmitter release, and ultimately neuromuscular paralysis. The structural scaffold should feature the conserved alpha-KTx fold, comprising a compact, globular domain stabilized by three disulfide bridges with a cysteine framework of C-C-CC-C-C, forming a classic inhibitor cystine knot (ICK) motif. This fold includes a well-defined beta-sheet core and a functionally critical 'functional dyad' composed of a lysine residue that penetrates the potassium channel pore and a nearby aromatic residue (e.g., tyrosine or phenylalanine) that stabilizes binding through hydrophobic interactions. The molecular target is primarily the Kv1.3 channel subtype, with binding occurring at the external vestibule of the channel pore, where the lysine residue mimics potassium ions to block ion conduction. Ensure the sequence includes conserved residues for structural integrity and target specificity, avoiding any database identifiers."}
{"description": "sp|P01442|3SA2_NAJAT Cytotoxin 2 OS=Naja atra OX=8656 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the Chinese cobra (Naja atra), a medically significant elapid snake. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically functioning as a cytotoxin that disrupts cell membranes through direct interaction with lipid bilayers. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements include three extended loops (fingers) projecting from a central globular core, rich in hydrophobic and cationic residues that facilitate membrane insertion and pore formation. The molecular mechanism involves initial electrostatic attraction to anionic phospholipids in target cell membranes, followed by hydrophobic interactions that disrupt membrane integrity, leading to cell lysis and necrosis. This cytotoxin exhibits preferential activity against certain cell types, including cancer cells and cardiomyocytes, contributing to the venom's systemic cytotoxic effects. The sequence should maintain conserved residues critical for the three-finger scaffold stability while incorporating the specific physicochemical properties required for membrane interaction and cytolytic activity."}
{"description": "sp|P0DUN3|PA2A1_BOTBZ Acidic phospholipase A2 braziliase-I (Fragment) OS=Bothrops brazili OX=157546 PE=1 SV=1", "sequence": "NLWQFEMLIMKIALTSGFMFYSSYGCYCGWGGHGRPKDASDRCCFVHDCCYGKVTTCNPKFGVVVCGGDDPCKKQICECDRVAATCFRDNKYWFYGAKXCQEESDPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin derived from Bothrops brazili venom. This enzyme should exhibit the characteristic phospholipase A2 activity that is central to the viperid venom's pre-digestive and cytotoxic effects. The protein must adopt the conserved phospholipase A2 fold featuring the canonical pancreatic lipase superfamily architecture, with the characteristic calcium-binding loop and catalytic dyad (typically histidine and aspartate residues) essential for hydrolyzing the sn-2 acyl bond of membrane phospholipids. Include the conserved disulfide bridge pattern that stabilizes the compact, multi-helical globular structure, typically involving 6-7 disulfide bonds that maintain structural integrity in the venom environment. The sequence should reflect the acidic pI typical of this venom phospholipase subclass, with surface residues contributing to membrane interaction and potential myotoxic or anticoagulant activities. The protein should demonstrate specificity for phospholipid substrates in biological membranes, contributing to the local tissue damage, inflammation, and systemic effects characteristic of Bothrops envenomation."}
{"description": "sp|C0JB25|A421_LOXLA Dermonecrotic toxin LlSicTox-alphaIV2i (Fragment) OS=Loxosceles laeta OX=58217 PE=2 SV=1", "sequence": "WIMGHMVNKIEQINEFLDLGANSIEVDIAFDELGYPEYTYHGVPCDCKRYCTKSEKIDDFIEALSAATTPGNPKFRKELTLVVFDLKTGGFDASRMYKSGKAFAELIQFSYWKGSDDAGRAYIVLSLPKLDHYEFIKAFREHFDTSTFKNLLEERVGYDFSGNEDMGLTRVVLNKAGVNDREHVWQGDGITNCILRSLDRVKAAVAIRDSATGYINKVCFWTIQAYSSVRDALNAEVDGIMTNEPGVIANVLKEDAFKDRFRLATYRDNPWETFKR", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles laeta. This toxin belongs to the SicTox family and specifically represents the alphaIV2i isoform. The protein should function as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. This enzymatic activity leads to profound dermonecrotic effects through the generation of ceramide-1-phosphate and lysophosphatidic acid, which trigger inflammatory cascades, platelet aggregation, and endothelial cell damage. The toxin should adopt the characteristic (α/β)8-barrel (TIM barrel) fold typical of SicTox family members, with conserved catalytic residues including histidine and aspartic acid residues that coordinate a catalytic metal ion. The structure should feature the conserved N-terminal signal peptide for secretion and the mature toxin domain with the canonical phospholipase D active site. The protein should exhibit high specificity for membrane phospholipids and demonstrate the characteristic tissue-destructive properties that make Loxosceles venom clinically significant in human envenomation cases."}
{"description": "sp|Q5Y4U6|T5G1B_AGEOR Mu-agatoxin-Ao1b OS=Agelena orientalis OX=293813 PE=1 SV=1", "sequence": "MKAIIFFCFLSVMVFIVAEASSLEALKIFEGERECVGENGHCRSWYNDCCDGYYCSCMQPPNCICRNNNG", "prompt": "Design a novel animal toxin protein sequence inspired by mu-agatoxin-Ao1b from the funnel-web spider Agelena orientalis. This toxin should function as a potent insecticidal agent by selectively targeting and modulating voltage-gated sodium channels in insect nervous systems. The protein should adopt the inhibitory cysteine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). Incorporate key functional residues that facilitate high-affinity binding to the voltage-sensing domain of insect sodium channels, leading to channel inactivation and paralysis. Ensure the sequence maintains the hydrophobic core and surface-exposed loops critical for target specificity and membrane interaction, while excluding any mammalian sodium channel activity to enhance insect selectivity. The final protein should exhibit thermal stability and protease resistance typical of ICK-fold toxins, suitable for potential biopesticide applications."}
{"description": "sp|P01448|3SA1_NAJME Cytotoxin 1 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "LECNKLVPIAHKTCPAGKNLCYQMYMVSKSTIPVKRGCIDVCPKSSLLVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein from the venom of the forest cobra (Naja melanoleuca) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The protein should exhibit specific cytotoxicity through membrane interaction and pore formation, targeting various cell types including cancer cells. Key structural features should include: three extended β-stranded loops emerging from a central hydrophobic core, conserved hydrophobic residues for membrane insertion, and positively charged surface residues that facilitate initial electrostatic interactions with negatively charged phospholipid head groups. The toxin should demonstrate preferential binding to anionic membranes and induce cell death through membrane permeabilization and disruption of cellular integrity, consistent with the cytotoxic mechanism of snake venom three-finger toxins that target fundamental cellular membrane structures rather than specific protein receptors."}
{"description": "sp|P0C259|I1B2_CONST Iota-conotoxin-like S11.2 (Fragment) OS=Conus striatus OX=6493 PE=2 SV=1", "sequence": "GCKKDRKPCSYQADCCNCCPIGTCAPSTNWILPGCSTGPFMAR", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an iota-conotoxin derived from the venom of the marine cone snail Conus striatus, a species known for its potent neurotoxic venom used for prey capture. As an iota-conotoxin, it functions as a selective antagonist of voltage-gated sodium channels (Nav), specifically targeting neuronal subtypes to disrupt action potential generation and propagation, leading to paralysis. The protein should adopt the characteristic conotoxin structural framework with a conserved disulfide connectivity pattern—typically a four-cysteine framework (CC-C-C) forming two disulfide bridges that stabilize a compact, globular fold. The sequence must include key residues for receptor binding and selectivity, such as hydrophobic and charged amino acids in loop regions that interact with the channel's pore or voltage-sensing domains. The overall structure should be small (approximately 10-30 residues), cysteine-rich, and exhibit high stability due to the disulfide bonds, with predicted beta-sheet or irregular secondary elements common in conotoxins. Ensure the toxin's mechanism involves blocking sodium influx by binding to site 1 or other specific sites on Nav channels, contributing to its neurotoxic effects without off-target activity."}
{"description": "sp|P0C8I8|SL2_BITAR Snaclec bitiscetin-2 (Fragment) OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "DEGCLPDDSSRT", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) derived from the puff adder, Bitis arietans. This toxin functions as a platelet aggregation modulator, specifically targeting platelet receptors through carbohydrate-recognition domains. The protein should adopt the characteristic C-type lectin-like fold consisting of a globular domain with an α-helix and β-sheets stabilized by conserved disulfide bridges. The structural scaffold should feature the typical heterodimeric assembly common to snaclecs, with interchain disulfide bonds maintaining quaternary structure. The binding interface should contain key residues for recognizing specific platelet membrane glycoproteins, likely GPIb or other platelet surface receptors, mediating its pro-aggregatory or anti-aggregatory activity depending on the specific isoform. The sequence should include conserved calcium-binding motifs characteristic of C-type lectins and maintain the hydrophobic core essential for structural stability. The protein should exhibit the dual functionality typical of viperid snaclecs - capable of either promoting or inhibiting platelet aggregation through receptor binding, contributing to the prey immobilization and digestive enhancement functions of puff adder venom."}
{"description": "sp|P0C8I9|SLAB_BOTAL Snaclec bothroalternin subunit alpha/beta (Fragment) OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "DCPSDWSNHEGHCYRVFNEWMNWAD", "prompt": "Generate the amino acid sequence for a snake venom C-type lectin-like protein (snaclec) from the venom of Bothrops alternatus, specifically the bothroalternin heterodimeric complex. This protein functions as a platelet aggregation modulator, likely acting through binding to platelet membrane receptors such as GPIb or GPVI, disrupting normal hemostasis and promoting coagulopathy. The structure should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The protein should contain key structural elements including an N-terminal alpha-helix followed by beta-strands forming the core domain, with conserved calcium-binding motifs and carbohydrate recognition domains that mediate specific protein-protein interactions. The sequence should reflect the heterodimeric nature of snaclecs, with distinct alpha and beta subunits that assemble through non-covalent interactions to form the functional toxin complex. The protein should exhibit the characteristic stability and target specificity of viperid venom lectins, contributing to the prey immobilization and digestive functions typical of Bothrops venom."}
{"description": "sp|C0JB23|A411_LOXLA Dermonecrotic toxin LlSicTox-alphaIV1i (Fragment) OS=Loxosceles laeta OX=58217 PE=2 SV=1", "sequence": "WIMGHMVNKIEQINEFLDLGANSIEVDITFDNLGYAEYTYHGFPCDCKRWCTNQENVKEYLNALSDITTPGNPKFRKELTLVVFDLKTGGIDANRMYEGGKDFAGKILFDYWKGSENAGRAYIIISVPSIDHYKFMKGFRERFDGSAFKDLLLEKDGWDFSGNDDLDATRTAYQNAGIEALNHIWQSDGITNCIPRGLGRVNKAVSNRDSPDAFINKVYVWTVEKYSSVKDALNADVDGIMTNHPNVINGVLKEDEFKDRFKLATYGDNPWTKFKR", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles laeta. This toxin belongs to the SicTox family and specifically represents the alphaIV1i isoform. The protein should function as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. This enzymatic activity leads to profound dermonecrosis through multiple mechanisms: direct membrane disruption, induction of inflammatory responses, platelet aggregation, and complement activation. The toxin should adopt the conserved structural fold characteristic of SicTox family members, featuring a (beta/alpha)8-barrel (TIM barrel) architecture with the active site located at the C-terminal end of the beta-barrel. The catalytic mechanism should rely on a conserved histidine residue within the HKD motif that acts as a nucleophile, with additional conserved residues facilitating metal ion coordination (typically Mg2+ or Ca2+) for optimal enzymatic activity. The protein should exhibit the characteristic structural stability required for venom components, with appropriate surface properties for membrane interaction and substrate accessibility. The sequence should reflect the evolutionary optimization for rapid tissue destruction and systemic effects observed in Loxosceles envenomation, while maintaining the specific functional and structural hallmarks that distinguish the alphaIV1i isoform within the broader SicTox family."}
{"description": "sp|C0JB30|A71_LOXAR Dermonecrotic toxin LarSicTox-alphaVII1 (Fragment) OS=Loxosceles arizonica OX=196454 PE=2 SV=1", "sequence": "WIMGHMVNSISQIKQFVNPGANAIEIDITFDSDAKAEYTYHKVPCDCFRTCGKWEYIDEYLKAVRNATTRGNRKYLRQLVLLIFDLKTSSLNRSTAYDAGKDFAERLLEHYWNNGENGGRAYVVLSIPNVRHYKFIIGFPDALNSEGHSELMQKVGYDFSGNDDLETIRRALRYAGVKGKNHIWQSDGITNCLSRTLKRVRKAVENRDSSDGYINKVYYWTVDKYATIRDTLDAEVDGIMTNYPNRVVDVLKEKCYSSRFRLATYSDNPFETF", "prompt": "Design a protein sequence for a dermonecrotic toxin from the venom of the Arizona brown spider, Loxosceles arizonica. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, and endothelial cell damage that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the catalytic histidine and other essential residues positioned in the active site pocket to coordinate the hydrolysis reaction. The sequence should include the characteristic N-terminal signal peptide for secretion and the conserved motifs required for substrate binding and catalytic activity. The toxin should exhibit specificity for membrane phospholipids and contribute to the systemic effects observed in loxoscelism, including hemolysis and inflammatory responses."}
{"description": "sp|Q9PWJ0|VM2A2_DEIAC Zinc metalloproteinase/disintegrin OS=Deinagkistrodon acutus OX=36307 GN=wbfib4 PE=1 SV=1", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGKVNDYEVVYPQRLAPLPEGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSKDYSEIHYSPDGRRITTHPLVEDHCYYRGHIRNDADSTASISACHGLKGHFKLRGETYLIEPMKISNSEAHAVYKYENVEKEDEAHKMCGVTQNWESYEPIKKASQLIVSTEQQRYMEIVIVVDHSMVKKYNGDSDKIKAWVYEMINTITESYRYLYIDIILSGLEIWSEKDLINVETSAENTLKSFGEWRAKDLIHRISHDNAQLLTATDLDGPTIGLAYVASMCDPKRSVGIVQDHSSVNRLVAITLAHEMAHNLGVRHDEGSCSCGSGYTCIMSPVINPDAMKYFSDCSYIQCWDYIMKENPPCILNKPLRTDTVSTPVSGNELLEAGKDYDRDSSANPCYDAATCKLNQGAQCTAGPCCDQGRFKEEGTICRRARGDDLDDYCNGISADCPRNPYHA", "prompt": "Design a venom protein sequence from the hundred-pace pit viper (Deinagkistrodon acutus) that functions as a zinc metalloproteinase-disintegrin fusion protein. This multifunctional toxin should exhibit the characteristic modular architecture of snake venom metalloproteinases, featuring a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH and a methionine turn, enabling proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin. The disintegrin domain must adopt the typical cysteine-rich fold with the RGD (Arg-Gly-Asp) tripeptide motif exposed on a flexible loop, facilitating high-affinity binding to integrin receptors (e.g., αIIbβ3 on platelets or αvβ3 on endothelial cells) to inhibit platelet aggregation and cell adhesion. The protein should maintain the canonical disulfide bonding pattern characteristic of SVMPs, stabilizing both domains: the metalloproteinase domain with disulfides supporting the catalytic scaffold, and the disintegrin domain with a compact, disulfide-stabilized structure. The overall fold should enable synergistic activity—hemorrhagic disruption of vascular basement membranes by the metalloproteinase domain coupled with anti-thrombotic and anti-angiogenic effects via integrin blockade by the disintegrin domain. Ensure the sequence reflects viperid venom adaptations for rapid prey immobilization through hemorrhage and coagulation interference."}
{"description": "sp|P83112|KAX1A_PARTR Potassium channel toxin alpha-KTx 1.10 OS=Parabuthus transvaalicus OX=170972 PE=1 SV=1", "sequence": "EVDMRCKSSKECLVKCKQATGRPNGKCMNRKCKCYPR", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the South African spitting scorpion Parabuthus transvaalicus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting a functional dyad where a critical lysine residue in the beta-hairpin region interacts directly with the potassium channel pore to physically occlude ion conduction. The molecular surface should display a patch of basic residues that electrostatically guide the toxin to its binding site near the channel selectivity filter. This toxin should exhibit the characteristic pharmacological profile of alpha-KTx family members: high affinity binding, rapid onset of action, and specific blockade of potassium efflux leading to prolonged membrane depolarization and enhanced neurotransmitter release."}
{"description": "sp|C0JB29|A43_LOXLA Dermonecrotic toxin LlSicTox-alphaIV3 (Fragment) OS=Loxosceles laeta OX=58217 PE=2 SV=1", "sequence": "WIMGHMVNEIYQIDEFVDLGANSIETDITFDDDAIAEYTYHGVPCDCKRWCTKWENVNDFLHGLQRATTPGNSKYRPELVLVVFDLKTGDLSSSTAYKAGNMFAQKLFIHYWNAGNNGGRAYIVLSIPDIDHYAFISGFREAFKNSDHADLLDKVGYDFSGNDDLSATRNALNKGGVKDREHVWQSDGITNCIGRGLGRVRDAVANRDSSNGYINKVYVWTIEKYVSVRDAFDAGVDGIMTNEPDVIVDVLNESAYSSKFRMATYEDNPWETFKYK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown recluse spider Loxosceles laeta. This toxin belongs to the SicTox-alpha family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage, ultimately leading to characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing the essential HxK(x)4D motif for catalytic activity. The structure should feature the characteristic N-terminal signal peptide for secretion, followed by the mature toxin domain with appropriate disulfide bonding to stabilize the barrel architecture. The molecular mechanism involves direct interaction with membrane phospholipids, with specific binding interfaces that facilitate substrate recognition and hydrolysis. The generated sequence must maintain the functional integrity required for sphingomyelinase activity while preserving the structural stability needed for venom efficacy."}
{"description": "sp|P58911|TX60A_PHYSE DELTA-alicitoxin-Pse2a OS=Phyllodiscus semoni OX=163701 PE=1 SV=1", "sequence": "MSPYFKLSSALIFLAITMEALCSPIENTSTSNKDNDKETEHIEISAKPSGISRGALGQGFEIHREDLLSKQFEATGEKIFEDLPMDECTVTTTLGTIERDDSFYNSTESLYQSVASSTKISGSLKGAYTLGVSVAAVTNNIASSEEEVQGLSLNLKAYSMSSILKKNCVNTKPLSKDLVSDFEALDSEITKPWKLSSWKKYKVLLEKYGSRIVKESISGSSIYQYVFAKSSQKFNHRSFTVKACVSLAGPTKVGKLSFSGCTGVSQQEIEQSSSQSMIKKLVVRGGKTETRASLIGELDPDQINKFLIEAETDPSPIQYKFEPIWTILKTRYVGTEHFAKAVNLEQFYKGFLHFGCSYLHTTSAENKVAEMQKFDFAKTSDPDAPTYVCKVGPEGCQHHEDCHYRAAFWCECGGPYDLARTCFRHKFKKLKSGLTKKECYPNKESGFAWHGCRLHGLTCWCSAPNRSWEESWSGEDTNNALNDVHQVLMEKKRRDNAQQQY", "prompt": "Generate the amino acid sequence for a delta-alicitoxin from the sea anemone Phyllodiscus semoni, a potent neurotoxin that functions as a voltage-gated sodium channel modulator. This toxin belongs to the sea anemone type 2 sodium channel toxin family and is characterized by a compact, globular fold stabilized by a conserved disulfide bridge pattern. The protein should adopt a beta-defensin-like structural scaffold with three antiparallel beta-strands forming a beta-sheet and a conserved cysteine framework typical of sea anemone toxins. The toxin acts by binding to site 3 of voltage-gated sodium channels, specifically interacting with the S3-S4 extracellular loop of domain IV, which slows channel inactivation and prolongs action potentials. This mechanism leads to sustained neuronal excitation, resulting in paralysis and neurotoxic effects in prey. The sequence should include key residues for sodium channel interaction, particularly those involved in the functional dyad that mediates receptor binding and modulation. The structural core must maintain the characteristic sea anemone toxin fold with appropriate beta-strand organization and disulfide connectivity to ensure proper folding and biological activity."}
{"description": "sp|P0DUN5|PA2_BOTBS Basic phospholipase A2 Bbil-TX (Fragment) OS=Bothrops bilineatus smaragdinus OX=2815652 PE=1 SV=1", "sequence": "HLLQFNKNAIPFYAFYGCYCGWGGRCCFVHDCCYGKWDIYPYSLKSGYITCGKGTWCEEQICECDRVAAECLRRSLSTYKYGYMFYPDSRCRGPSETC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin derived from the venom of Bothrops bilineatus smaragdinus, a venomous pit viper. This toxin should exhibit the characteristic enzymatic activity of hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids, which disrupts cellular membrane integrity and triggers inflammatory responses. The protein should adopt the conserved phospholipase A2 fold, featuring three long alpha-helices stabilized by a network of seven disulfide bridges that confer structural rigidity and thermal stability. Key catalytic residues, including a histidine-aspartate dyad and a conserved calcium-binding loop, should be preserved to ensure enzymatic function. The basic nature of the toxin enhances its affinity for anionic membrane surfaces and may contribute to myotoxic or anticoagulant activities. The sequence should reflect the typical molecular weight range of 13-15 kDa and maintain the structural scaffold essential for membrane penetration and substrate binding."}
{"description": "sp|A1X8D9|CA13_CONPL Alpha-conotoxin-like Pu1.3 (Fragment) OS=Conus pulicarius OX=93154 PE=3 SV=1", "sequence": "SDGRNAGADRKGFGLISQMFKLSCCADPACKHTPGC", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of the marine cone snail Conus pulicarius. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The peptide should adopt the characteristic alpha-conotoxin structural scaffold with a globular fold stabilized by two conserved disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming the classic cysteine framework I (CC-C-C). The sequence should feature the conserved alpha-conotoxin motif with appropriate spacing between cysteine residues to maintain the bioactive conformation. The molecular surface should present key pharmacophore residues for high-affinity binding to the orthosteric site of nicotinic receptors, likely through competitive inhibition of acetylcholine binding. The structural core should exhibit the typical alpha-conotoxin triple-stranded beta-sheet arrangement stabilized by the disulfide network, with flexible N- and C-terminal regions that may contribute to receptor subtype selectivity. This toxin should represent the evolutionary optimization of Conus venoms for rapid neuromuscular targeting and prey immobilization through precise receptor blockade."}
{"description": "sp|P01426|3S11_NAJPA Short neurotoxin 1 OS=Naja pallida OX=8658 PE=1 SV=1", "sequence": "LECHNQQSSQPPTTKTCPGETNCYKKVWRDHRGTIIERGCGCPTVKPGIKLNCCTTDKCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the red spitting cobra (Naja pallida), a species known for its potent neurotoxic venom that causes rapid paralysis in prey through neuromuscular blockade. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically the short-chain neurotoxin subgroup, which typically consists of 60-62 amino acids. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. As a short neurotoxin, it functions as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the postsynaptic membrane, specifically targeting the muscle-type (α1)2β1γδ nAChR subtype. The mechanism involves high-affinity binding to the orthosteric site of the α-subunit, competitively inhibiting acetylcholine binding and preventing cation channel opening, leading to flaccid paralysis. Key structural features include three extended loops (fingers) projecting from a central globular core, with the central loop (loop II) containing critical residues for receptor interaction and specificity. The toxin should exhibit the conserved hydrophobic core and the characteristic 'three-finger' spatial arrangement that enables precise targeting of the receptor binding site. The sequence should reflect the typical molecular weight of ~7 kDa and maintain the structural integrity required for potent neurotoxic activity through specific molecular recognition of the nAChR."}
{"description": "sp|O57413|VM2T3_PROMU Zinc metalloproteinase/disintegrin OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVSALPKGAVQPKYEDAMQYEFKVNGEAVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIHNDADSTASISACDGLKGYFKLQGETYPIEPLELSDSEAHAVFKYENVEKEDEAPKMCGVTQNWESDESIKKASQLYLTPEQQRFPQRYIKLAIVVDHGMYTKYSSNFKKIRKRVHQMVSNINEMCRPLNIAITLALLDVWSEKDFITVQADAPTTAGLFGDWRERVLLKKKNHDHAQLLTDTNFARNTIGWAYVGRMCDEKYSVAVVKDHSSKVFMVAVTMTHELGHNLGMEHDDKDKCKCDTCIMSAVISDKQSKLFSDCSKDYYQTFLTNDNPQCILNAPLRTDTVSTPVSGNEFLEAGEECDCGSPENPCCDAATCKLRPGAQCAEGLCCDQCRFKKKRTICRRARGDNPDDRCTGQSADCPRNGLYG", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase and disintegrin, characteristic of Protobothrops mucrosquamatus (Taiwan habu snake) venom. This protein should exhibit a modular structure typical of snake venom metalloproteinases (SVMPs), comprising a metalloproteinase domain responsible for hydrolyzing extracellular matrix components such as collagen, fibronectin, and laminin, thereby inducing hemorrhage, tissue damage, and inflammation. The metalloproteinase domain must feature a conserved zinc-binding motif (HEXXHXXGXXH) and a methionine turn, adopting a reprolysin-like fold with a central five-stranded β-sheet and surrounding α-helices. Additionally, the protein should include a disintegrin domain that inhibits platelet aggregation by antagonizing integrin receptors (e.g., αIIbβ3 or αvβ3) through an RGD (Arg-Gly-Asp) or related tripeptide motif, disrupting cell-matrix interactions and promoting anticoagulation. The overall structure should be stabilized by multiple disulfide bonds, with the metalloproteinase domain containing 4-5 disulfides and the disintegrin domain featuring a compact, disulfide-rich fold. The protein may also include a cysteine-rich domain if inferred to be a P-III class SVMP, enhancing adhesion to specific targets. Ensure the sequence reflects the biological context of viperid venom, where such proteins facilitate prey immobilization via hemorrhage, coagulopathy, and impaired wound healing."}
{"description": "sp|P01432|3S13_NAJMO Short neurotoxin 3 OS=Naja mossambica OX=8644 PE=1 SV=1", "sequence": "LNCHNQMSAQPPTTTRCSRWETNCYKKRWRDHRGYKTERGCGCPTVKKGIQLHCCTSDNCNN", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the Mozambique spitting cobra (Naja mossambica), a species known for its potent neurotoxic venom that causes rapid paralysis by targeting the neuromuscular junction. This toxin should function as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR) at the postsynaptic membrane, specifically binding with high affinity to the alpha-delta interface of the muscle-type nAChR to block acetylcholine binding and prevent depolarization. The protein should adopt the characteristic three-finger toxin (3FTx) fold, consisting of three beta-stranded loops extending from a central globular core stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The structure should feature a central beta-sheet core and flexible loops, with the functional core residing in loop II, which contains key residues for receptor interaction. The sequence should include conserved hydrophobic residues for structural stability and specific polar/charged residues in the loop regions for target recognition and binding. The overall molecular weight should be approximately 6-8 kDa, with a compact, stable structure resistant to proteolytic degradation in the venom."}
{"description": "sp|Q5Y4V8|T2G3A_AGEOR U3-agatoxin-Ao1a OS=Agelena orientalis OX=293813 PE=1 SV=1", "sequence": "MKAVIFFCLLSVMVFTVIEAVKEEGTKPAEAARECAAKNKRCADWAGPWCCEGLYCSCRSYPGCMCRPNSG", "prompt": "Generate a protein sequence for a potent insecticidal neurotoxin from the funnel-web spider Agelena orientalis. This toxin belongs to the U3-agatoxin family and functions as a selective inhibitor of insect voltage-gated calcium channels, specifically targeting Cav2-type channels in the presynaptic terminals of neuromuscular junctions. The toxin should adopt a stable, compact globular fold stabilized by a conserved disulfide bridge framework characteristic of spider neurotoxins, likely featuring an inhibitor cystine knot (ICK) motif that provides exceptional thermal and proteolytic stability. The molecular mechanism involves high-affinity binding to domain II or III of the insect calcium channel α1-subunit, effectively blocking calcium influx and inhibiting neurotransmitter release, leading to rapid paralysis and death in insect prey. The structural scaffold should include key residues for target recognition and binding specificity, with surface-exposed loops that mediate precise molecular interactions with the channel pore region while maintaining the core hydrophobic stability typical of spider venom peptides."}
{"description": "sp|A1X8D1|CA16_CONQU Alpha-conotoxin-like Qc1.6 (Fragment) OS=Conus quercinus OX=101313 PE=3 SV=1", "sequence": "FDGRNAAASDKASELMALAVRGCCSNPTCAGNNGNICG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus quercinus, the oak cone snail. This marine snail venom component functions as a potent neurotoxin targeting nicotinic acetylcholine receptors in the neuromuscular junction. The toxin should exhibit the characteristic alpha-conotoxin mechanism of action as a competitive antagonist, binding specifically to neuronal or muscle-type nicotinic acetylcholine receptor subtypes to disrupt synaptic transmission and induce paralysis. The structural scaffold must follow the conserved alpha-conotoxin framework with the globular disulfide connectivity pattern (CysI-CysIII, CysII-CysIV) forming two essential disulfide bridges that stabilize the compact three-dimensional fold. The mature toxin should adopt the characteristic alpha-conotoxin fold featuring a small, rigid beta-sheet secondary structure stabilized by the conserved cysteine framework. The sequence must include the appropriate signal peptide and pro-region for proper folding and processing, with the mature toxin containing the essential cysteine residues in the correct spacing pattern typical of alpha-conotoxins. The molecular target interface should include key residues for specific receptor subtype recognition and high-affinity binding, while maintaining the overall compact, stable structure characteristic of conotoxin family members that enables potent biological activity in the nanomolar range."}
{"description": "sp|O57385|PA2H_DEIAC Basic phospholipase A2 homolog acutohaemolysin OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MRALWIVAVLLVGVEGSLFELGKMIWQETGKNPVKNYGLYGCNCGVGGRGEPLDATDRCCFVHKCCYKKLTDCDSKKDRYSYKWKNKAIVCGKNQPCMQEMCECDKAFAICLRENLDTYNKSFRYHLKPSCKKTSEQC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog toxin from the venom of Deinagkistrodon acutus (hundred-pace snake), known as acutohaemolysin. This protein belongs to the snake venom phospholipase A2 (svPLA2) family but functions as a homolog with distinct toxic properties. The venom of Deinagkistrodon acutus is medically significant, causing severe hemotoxic effects including coagulopathy, hemorrhage, and tissue damage. As a basic phospholipase A2 homolog, acutohaemolysin exhibits hemolytic activity through membrane disruption rather than enzymatic phospholipid hydrolysis, due to evolutionary modifications in its catalytic site. The protein should adopt the characteristic svPLA2 fold featuring three long alpha-helices stabilized by a conserved pattern of seven disulfide bridges (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, Cys13-Cys14) that create a rigid, stable scaffold. Key structural elements include a conserved calcium-binding loop (typically YGCXCG) and a hydrophobic channel for membrane interaction, though catalytic residues may be altered to reduce enzymatic activity while maintaining membrane-binding capability. The basic isoelectric point enhances interaction with negatively charged phospholipid head groups on erythrocyte membranes, facilitating pore formation and hemolysis. The protein should contain the characteristic PLA2 active site motif but with substitutions that diminish catalytic efficiency while preserving structural integrity and membrane-targeting functionality."}
{"description": "sp|P58912|TX60B_PHYSE DELTA-alicitoxin-Pse2b OS=Phyllodiscus semoni OX=163701 PE=1 SV=2", "sequence": "MSKPIIFLLTAFVVLTDLGATEDTEKVEVKAKPSKTSRGAIGQGFELHKIDLLSKELQGTGAQVFEELPVEECTTDNKLGTIQKDDTFYSNTESLYNSVASNSKIEPSLKGPFTLGTSVGAVTNNIVSEKSEIQGLSLNLKAYSMIHALKQDCINKKPLAKDLVSDFEALDREVKKPWLKPSWRKYKVFLEKFGTHIVRETMSGSSIYQYVFAKSSESFKQRDFKIKACLSLGGPTQVGKLGISACSDVSKKDVEESSGKEMVKKLVVRGGKSDTRVDLTGELSKNQINKFLKEATTDPSPIQYTFYPVWTILKARYIGKEHYAKATNLEQFYKGYLNFDCAYEKSEKGLELQKFELAEDSDPDAPTYVCKLGPEGCHSDDDCESDDLIYCACCGDSCIRYNNTVLLSTGDTKKVAFINDVDDEFRDHGCGRKGLKCKCKEENKKWGQSWSGDSDADAALRDINAMMLDQNRRDQAKRHHVKKGKSLH", "prompt": "Generate the amino acid sequence for a delta-alicitoxin from the sea anemone Phyllodiscus semoni, a potent neurotoxin that functions as a voltage-gated sodium channel modulator. This toxin belongs to the sea anemone type 2 sodium channel toxin family and is characterized by a compact, stable beta-sheet-rich structure stabilized by three conserved disulfide bonds with a C-C-CC-C-C connectivity pattern. The toxin adopts a conserved three-finger fold common to sea anemone sodium channel toxins, featuring a central beta-hairpin flanked by loops that form the functional epitopes. Its mechanism involves binding to site 3 of voltage-gated sodium channels, specifically interacting with the S3-S4 extracellular loop of domain IV, which slows channel inactivation and prolongs action potentials, leading to sustained neurotransmitter release and neuromuscular paralysis. The toxin's biological role in Phyllodiscus semoni venom is to immobilize prey through disruption of neuronal signaling, with high affinity for mammalian and crustacean sodium channel subtypes. The sequence should reflect the conserved structural scaffold, including the characteristic cysteine framework, and key residues for sodium channel binding and modulation."}
{"description": "sp|P01433|3S12_HEMHA Short neurotoxin 2 OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LECHNQQSSQTPTTQTCPGETNCYKKQWSDHRGSRTERGCGCPTVKPGIKLKCCTTDRCNK", "prompt": "Design a protein sequence for a short neurotoxin from the venom of the ringhals cobra (Hemachatus haemachatus) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and antagonize muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C. The structure should feature the typical short neurotoxin profile with shorter loops compared to long neurotoxins, particularly in the central loop. Key functional residues should be positioned in loop II to enable high-affinity binding to the α-δ and α-γ subunit interfaces of the nicotinic receptor, competitively blocking acetylcholine binding and preventing ion channel activation. The toxin should exhibit the conserved structural motif of three extended fingers with the central loop containing critical functional determinants for receptor recognition and the N-terminal region forming part of the core structural scaffold."}
{"description": "sp|P58914|O16A_CONRA Omega-conotoxin RVIA OS=Conus radiatus OX=61198 PE=1 SV=1", "sequence": "CKPPGSPCRVSSYNCCSSCKSYNKKCG", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of omega-conotoxin RVIA from the venom of Conus radiatus, the radiated cone snail. This toxin functions as a potent and selective antagonist of N-type voltage-gated calcium channels (Cav2.2), which are critical for neurotransmitter release at presynaptic terminals in the central and peripheral nervous systems. The toxin should adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by three disulfide bridges with the conserved cysteine framework C-C-CC-C-C. The resulting structure should feature a compact, globular fold with well-defined beta-sheets and loops that form the pharmacophore responsible for high-affinity binding to the extracellular pore region of Cav2.2 channels. The mechanism of action involves blocking calcium influx through these channels, thereby inhibiting synaptic transmission and producing analgesic effects. The sequence should include key residues for target specificity and potency, while maintaining the overall stability and folding properties typical of conotoxins from the O-superfamily."}
{"description": "sp|Q9U3Z3|I2B_CONBE Kappa-conotoxin BtX OS=Conus betulinus OX=89764 PE=1 SV=1", "sequence": "MMFRVTSVGCLLLVIVFLNLVVPTSACRAEGTYCENDSQCCLNECCWGGCGHPCRHPGKRSKLQEFFRQR", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of kappa-conotoxin BtX from the marine cone snail Conus betulinus. This toxin should function as a potent and selective antagonist of voltage-gated potassium channels, specifically targeting Kv1 subtypes, which are critical for modulating neuronal excitability and neurotransmitter release. The peptide must adopt the conserved structural scaffold characteristic of kappa-conotoxins, featuring a compact, disulfide-stabilized fold with the cysteine framework C-C-CC-C-C (Framework XI), resulting in three disulfide bridges that confer exceptional stability and define the pharmacophore. The 3D structure should exhibit a well-defined globular conformation with exposed loops that mediate high-affinity binding to the pore region of Kv1 channels, blocking potassium ion flux and inducing excitatory effects. Incorporate key residues known to be essential for target recognition and potency, while ensuring the sequence maintains the overall physicochemical properties typical of conotoxins, including a net positive charge to facilitate interaction with the channel's vestibule. The final sequence should reflect the evolutionary optimization of Conus betulinus venom for rapid prey immobilization through disruption of neuromuscular signaling."}
{"description": "sp|Q9TWM7|O16A_CONGL Delta-conotoxin GmVIA OS=Conus gloriamaris OX=37336 PE=1 SV=2", "sequence": "MKLTCMMIVAVLFLTAWTFVTADDSGNGMEILFPKAGHEMENLEVSNRVKPCRKEGQLCDPIFQNCCRGWNCVLFCV", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications: This protein is a delta-conotoxin from the marine cone snail Conus gloriamaris, a species known for its potent venom used in prey capture and defense. As a delta-conotoxin, it functions as a voltage-gated sodium channel modulator, specifically acting as a gating modifier that inhibits channel inactivation, leading to prolonged neuronal depolarization and excitotoxicity. The toxin belongs to the O1 superfamily of conotoxins, characterized by a conserved cysteine framework of C-C-CC-C-C (Framework VI), which forms three disulfide bridges that stabilize a compact, globular fold. The structural scaffold is expected to include an inhibitor cystine knot (ICK) motif, common in conotoxins, providing exceptional stability and resistance to proteolysis. Key structural elements include beta-sheets and turns that form the molecular surface for target interaction. The molecular target is voltage-gated sodium channels, particularly subtypes expressed in the nervous system, where it binds to site 4 on the channel's domain IV S3-S4 loop, altering gating kinetics. The mechanism involves trapping the channel in an open state, causing sustained sodium influx, membrane depolarization, and eventual paralysis or neuronal hyperexcitability. Ensure the sequence includes the conserved cysteine pattern, hydrophobic residues for membrane interaction, and polar/charged residues for specific sodium channel binding, while maintaining the overall ICK fold for functional activity."}
{"description": "sp|A2CJE5|VM2IA_CROAT Disintegrin atroxatin (Fragment) OS=Crotalus atrox OX=8730 PE=2 SV=1", "sequence": "NPCCDAATCKVTPGSQCAEGLCCDQCKFMKEGTVCRPARGDWNDDTCTGQSADCPRKGIYG", "prompt": "Design a protein sequence for a disintegrin toxin fragment derived from the venom of the Western diamondback rattlesnake (Crotalus atrox). This protein should function as atroxatin, a potent disintegrin that specifically inhibits platelet aggregation by antagonizing integrin receptors on the cell surface. The mechanism of action involves high-affinity binding to integrin αIIbβ3 (GPIIb/IIIa) on platelets, thereby blocking fibrinogen binding and preventing thrombus formation. The sequence must feature the canonical disintegrin RGD (Arg-Gly-Asp) motif, which is essential for integrin recognition and binding specificity. Structurally, the protein should adopt a compact, disulfide-rich fold stabilized by multiple conserved cysteine residues forming a characteristic disulfide bridge pattern typical of snake venom disintegrins. The overall conformation should present the RGD loop in an optimal orientation for integrin engagement, with supporting flanking residues that enhance binding affinity and selectivity. This disintegrin plays a critical role in the venom's pre-digestive and anti-hemostatic strategy, facilitating prey immobilization through disruption of hemostasis."}
{"description": "sp|P0C8J0|SLA_OPHHA Snaclec ophioluxin subunit alpha (Fragment) OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "DFKCPSEWYAYDQHCYRIIN", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor. This protein originates from the venom of Ophiophagus hannah (king cobra), where it serves as the alpha subunit of the heterodimeric toxin ophioluxin. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should include key structural elements: a conserved calcium-binding motif, hydrophobic core residues that maintain the globular fold, and surface-exposed loops that mediate specific interactions with platelet receptors. The molecular mechanism involves binding to platelet membrane glycoproteins, particularly interfering with the glycoprotein Ib-IX-V complex or integrin αIIbβ3, thereby disrupting platelet adhesion and aggregation pathways. The protein should exhibit high specificity for human platelet receptors while maintaining the structural stability typical of venom C-type lectins, with a compact globular domain of approximately 130-150 residues that demonstrates resistance to proteolytic degradation in the venom environment."}
{"description": "sp|Q9U6X1|ACT2A_HETMG DELTA-stichotoxin-Hmg2a OS=Heteractis magnifica OX=38281 PE=1 SV=1", "sequence": "MNRLIVLFLIVTMICATIAVPSREELEDQKEYKRSAALAGTIIEGASLGFQILDKVLGELGKVSRKIAVGVDNESGGSWTALNAYFRSGTTDVILPEFVPNQKALLYSGRKDTGPVATGAVAAFAYYMSNGHTLGVMFSVPFDYNFYSNWWDVKVYSGKRRADQGMYEDMYYGNPYRGDNGWHQKNLGYGLRMKGIMTSAGEAILQIRISR", "prompt": "Design a protein sequence for a delta-stichotoxin from the magnificent sea anemone Heteractis magnifica. This toxin functions as a potent cytolysin that creates pores in cell membranes, leading to osmotic imbalance and cell lysis. The protein should adopt a stable beta-sandwich fold characteristic of actinoporins, with a conserved structural architecture consisting of a central beta-sheet core flanked by alpha-helices. The mechanism involves initial binding to membrane sphingomyelin via a phosphocholine-binding site, followed by insertion of an N-terminal amphipathic helix into the lipid bilayer to form transmembrane pores. Key structural elements should include: a conserved aromatic-rich membrane-binding surface, a flexible N-terminal region containing the pore-forming helix, and stabilizing disulfide bridges that maintain the beta-sandwich scaffold. The toxin should exhibit specificity for membranes containing sphingomyelin and demonstrate calcium-independent cytolytic activity typical of sea anemone venom components used for prey immobilization and defense."}
{"description": "sp|P00596|PA2A1_NAJKA Acidic phospholipase A2 CM-II OS=Naja kaouthia OX=8649 PE=1 SV=2", "sequence": "MNPAHLLILAAVCVSPLGAFSNRPMPLNLYQFKNMIQCTVPNRSWWDFADYGCYCGRGGSGTPVDDLDRCCQVHDNCYNEAEKISRCWPYFKTYSYECSQGTLTCKGDNDACAAAVCDCDRLAAICFAGAPYNNNNYNIDLKARCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the monocled cobra (Naja kaouthia) venom. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for anionic phospholipid substrates. The structural scaffold must feature the characteristic phospholipase A2 fold consisting of three long alpha-helices stabilized by a conserved network of seven disulfide bonds. Include the conserved catalytic dyad of histidine and aspartate residues essential for enzymatic activity, along with the calcium-binding loop motif. The protein should possess an acidic isoelectric point and contain surface-exposed hydrophobic residues that facilitate membrane interaction and interfacial activation. Incorporate structural elements that confer presynaptic targeting specificity while maintaining the characteristic low molecular weight and compact globular architecture typical of snake venom phospholipases A2."}
{"description": "sp|P13208|SRTX_ATREN Sarafotoxin OS=Atractaspis engaddensis OX=1343144 PE=1 SV=2", "sequence": "MALLPRLAAGGLLLLLALAALEGKPAPSALSQLLEKRSEDQAAAGRIIDGGDTKQAARDPSPQRNVEPLCSCKDMSDKECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMTDKECLYFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCKDMTDKECLYFCHQGIIWRDTKQAARDPSPQRNVEPLCSCKDMSDKECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCTCNDMTDEECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMTDKECLYFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMSDKECLNFCHQDVIWRDTKQAARDPSPQRNVEPLCSCKDMTDKECLNFCHQDVIWKNADTSANPEFLG", "prompt": "Design a sarafotoxin protein from the venom of the burrowing asp Atractaspis engaddensis. This toxin belongs to the endothelin/sarafotoxin family and functions as a potent vasoconstrictor by acting as an endothelin receptor agonist. The protein should adopt the characteristic sarafotoxin fold stabilized by two conserved disulfide bridges with a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming a compact, globular structure. The core mechanism involves high-affinity binding to endothelin receptors (particularly ET_A subtype) in vascular smooth muscle, triggering sustained vasoconstriction through G-protein coupled receptor activation and intracellular calcium mobilization. Key structural elements include a well-defined N-terminal region critical for receptor engagement, a central alpha-helical segment, and a solvent-exposed C-terminal tail that contributes to receptor specificity. The biological significance lies in its role in the snake's venom for rapid prey immobilization through cardiovascular collapse, mimicking mammalian endothelin physiology but with enhanced potency and receptor selectivity."}
{"description": "sp|P01452|3SA4_NAJMO Cytotoxin 4 OS=Naja mossambica OX=8644 PE=1 SV=1", "sequence": "LKCNKLIPIAYKTCPEGKNLCYKMMLASKKMVPVKRGCINVCPKNSALVKYVCCSTDRCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the Mozambique spitting cobra (Naja mossambica), a species known for its potent cytotoxic venom that causes rapid tissue necrosis and cell death. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically the cytotoxin subgroup, characterized by a conserved structural fold comprising three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The protein should adopt the classic three-finger toxin fold with a compact globular structure, where the three loops (Loop I, II, and III) mediate membrane interaction and cytotoxicity. The mechanism of action involves binding to and disrupting the integrity of cell membranes, particularly targeting lipid bilayers and inducing pore formation or membrane lysis, leading to rapid cell death. Key structural features include a hydrophobic patch on the molecular surface, often enriched with lysine and hydrophobic residues, which facilitates membrane insertion and disruption. The protein should exhibit high affinity for anionic phospholipids in cell membranes, contributing to its cytotoxic activity. The sequence must preserve the conserved disulfide connectivity and the three-finger scaffold to maintain structural stability and biological function, with specific residues in the loops critical for membrane binding and cytotoxic potency."}
{"description": "sp|P01437|3S11_HYDLA Short neurotoxin 1 OS=Hydrophis lapemoides OX=8684 PE=1 SV=1", "sequence": "MTCCNQQSSQPKTTTNCAESSCYKKTWRDFRGTRIERGCGCPQVKPGIKLECCHTNECNN", "prompt": "Design a short neurotoxin protein sequence derived from the annulated sea snake Hydrophis lapemoides. This toxin belongs to the three-finger toxin superfamily and functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, C7-C8. The core mechanism involves competitive antagonism of nicotinic acetylcholine receptors at the neuromuscular junction, specifically binding to the α-δ and α-γ subunit interfaces with high affinity. The structural scaffold should feature three extended β-stranded loops projecting from a central globular core, with the central loop containing key functional residues for receptor recognition and blockade. The toxin should exhibit rapid onset of paralysis through irreversible binding to muscle-type nicotinic receptors, disrupting synaptic transmission and causing flaccid paralysis. The sequence should maintain the conserved cysteine framework and structural motifs characteristic of short-chain neurotoxins while incorporating specific residues for target specificity and potency."}
{"description": "sp|Q5Y4U8|T4G1K_AGEOR U3-agatoxin-Ao1k OS=Agelena orientalis OX=293813 PE=1 SV=1", "sequence": "MRTIISLLLLSAMVFAVIEAISLEEGLQLFEGERGCVGENQQCADWAGLHCCSGYYCTCRYFPKCICRKDSGK", "prompt": "Design a protein sequence for a neurotoxic peptide derived from the venom of the funnel-web spider Agelena orientalis. This toxin, known as U3-agatoxin-Ao1k, functions as a potent calcium channel blocker that specifically targets P/Q-type voltage-gated calcium channels (Cav2.1) in the presynaptic terminals of neurons. The toxin's mechanism involves high-affinity binding to the channel's pore-forming α1 subunit, effectively inhibiting calcium influx and subsequently blocking neurotransmitter release, leading to paralysis in prey organisms. Structurally, this toxin belongs to the ω-agatoxin family and is expected to adopt the inhibitory cysteine knot (ICK) motif, characterized by a compact, disulfide-stabilized globular fold with high thermal and proteolytic stability. The cysteine framework likely follows a C-C-CC-C-C pattern, forming three disulfide bridges that create a stable knotted core, with key functional residues displayed on flexible loops that mediate target recognition and binding. The mature toxin should be a small, cationic peptide optimized for rapid diffusion and target engagement in the synaptic cleft, with surface-exposed hydrophobic and polar residues critical for interacting with specific extracellular domains of the calcium channel. Ensure the sequence reflects the evolutionary optimization for fast-acting neurotoxicity, with conserved motifs for channel selectivity and minimal off-target effects."}
{"description": "sp|P01467|3SA1_NAJMO Cytotoxin 1 OS=Naja mossambica OX=8644 PE=1 SV=1", "sequence": "LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTNKCN", "prompt": "Design a cytotoxin protein from the venom of the Mozambique spitting cobra (Naja mossambica) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet scaffold stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The protein should exhibit specific cytotoxicity through direct interaction with cell membranes, particularly targeting lipid bilayers and potentially inducing cell lysis via pore formation or membrane destabilization. The structural core should consist of a central β-sheet with three protruding loops (loop I, II, and III) that mediate membrane recognition and binding. Key functional residues should be concentrated in the tips of these loops, particularly in loop II, which typically contains hydrophobic and basic residues that facilitate membrane insertion and electrostatic interactions with anionic phospholipids. The protein should demonstrate thermal stability and resistance to proteolytic degradation due to its compact disulfide-stabilized fold. The cytotoxin should exhibit preferential activity against specific cell types, consistent with the venom's role in prey immobilization and tissue damage, without significant neurotoxic or cardiotoxic effects characteristic of other three-finger toxin subfamilies."}
{"description": "sp|C0JB31|A611_LOXHI Dermonecrotic toxin LhSicTox-alphaVI1i (Fragment) OS=Loxosceles hirsuta OX=571525 PE=2 SV=1", "sequence": "WIMGHMVNAIYQIDEFVDLGANAIETDVEFSSSGKAKYTYHGVPCDCFRWCKKWENIDGFLEALRRATTPGDSKYRKELILVVLDLKLDYVYLSDAYDAGKDLAQRLVKHYWNGGRNGGRAYILLSVPVVEYYRLITGFRAHLMNEGYKDLLAKVGYDFSEDTYLSTIHDGFRNAGVRDKDHIWQSDGISNCFARTLTRLKEAVSNRDSTDGYSNKVYYWTVDKETSITDAINAGADGIMTNHPDRVINVPKDDEIKKKFRLARYRDNPWKTFRK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles hirsuta. This toxin belongs to the SicTox family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, endothelial cell activation, platelet aggregation, complement activation, and neutrophil recruitment, ultimately leading to characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of SicTox family members, with the catalytic pocket formed by conserved histidine and glutamic acid residues that coordinate a magnesium ion cofactor. The sequence should include the characteristic N-terminal signal peptide for secretion, followed by the mature toxin domain with the essential HxKx4D motif for phosphodiesterase activity. The structural scaffold should facilitate membrane association and substrate binding while maintaining the thermostability required for venom function. The generated protein should exhibit specific activity against endothelial cells and erythrocytes, contributing to the hemorrhagic and necrotic pathology characteristic of Loxosceles envenomation."}
{"description": "sp|P0C8J1|SLB_OPHHA Snaclec ophioluxin subunit beta (Fragment) OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "GLCCPMRWSSSEG", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a beta subunit in the ophioluxin complex. This protein originates from the venom of Ophiophagus hannah (king cobra), where it contributes to the venom's potent procoagulant and platelet-modulating activities. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. As a beta subunit, it likely forms heterodimeric complexes with alpha subunits to create functional snaclec complexes that target specific components of the hemostatic system. The protein should contain key structural elements including the calcium-binding site motifs and carbohydrate recognition domain (CRD) regions characteristic of venom CTLs, while maintaining the compact globular structure typical of this toxin family. The sequence should reflect the evolutionary optimization for rapid action in envenomation, with surface residues optimized for specific protein-protein interactions in the coagulation cascade or platelet receptor binding interfaces."}
{"description": "sp|O61705|SCXA_OLIMR Neurotoxin BmK-M10 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MNYLVMISFALLLMKGVESVRDAYIAKPENCVYECGITQDCNKLCTENGAESGYCQWGGKYGNACWCIKLPDSVPIRVPGKCQR", "prompt": "Design a neurotoxin protein sequence inspired by the venom of the Chinese scorpion Olivierus martensii (formerly Buthus martensii). This toxin, known as neurotoxin BmK-M10, functions as a potent modulator of voltage-gated sodium channels. It belongs to the long-chain scorpion toxin family and specifically targets neuronal sodium channels, particularly Nav1.3 and Nav1.7 subtypes, through a mechanism involving modification of channel gating properties. The toxin exhibits a conserved structural scaffold characterized by an inhibitor cystine knot (ICK) motif, stabilized by four disulfide bridges with a C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The three-dimensional structure comprises a compact globular fold with a triple-stranded antiparallel beta-sheet and a single alpha-helix, creating a molecular surface with distinct functional regions: a conserved 'core' domain essential for structural integrity and a 'pharmacophore' region containing key residues for receptor binding and specificity. The biological role of this toxin in the scorpion's venom is to immobilize prey by disrupting neuronal excitability, leading to paralysis. Generate a protein sequence that captures this neurotoxic activity, incorporating the characteristic ICK fold, appropriate cysteine framework for disulfide formation, and functional motifs for sodium channel interaction."}
{"description": "sp|Q5YF89|NGFV2_NAJSP Venom nerve growth factor 2 OS=Naja sputatrix OX=33626 PE=2 SV=1", "sequence": "MSMLCYTLITAFLIGIWAAPKSEDNVPLGSPATSDLSDTSCAQTHEGLKTSRNTDQRHPAPQKAEDQELRTAANIIVDPKLFQKRQFQSPRVLFSTQPPLLSRDEESVEFLDNEDSLNRNIRAKREDHPVHNLGEHSVCDSVSAWVTKTTATDIKGNTVTVMENVNLDNKVYKQYFFETKCKNPNPVPSGCRGIDSSHWNSYCTETDTFIKALTMEGNQASWRFIRIDTACVCVITKKTGN", "prompt": "Design a venom nerve growth factor protein from the Javan spitting cobra (Naja sputatrix) that functions as a neurotrophic toxin. This protein should belong to the nerve growth factor (NGF) family and exhibit the characteristic β-NGF fold consisting of three anti-parallel β-sheets arranged in a cystine knot motif. The sequence should contain the conserved cysteine framework with three intramolecular disulfide bridges forming the characteristic cystine knot structure that provides exceptional stability. As a venom component, this NGF homolog should function as a molecular mimic that binds to TrkA receptors and p75 neurotrophin receptors with high affinity, potentially modulating neuronal survival, differentiation, and pain signaling pathways. The protein should maintain the dimeric structure typical of NGF proteins while potentially exhibiting enhanced stability or altered receptor binding properties compared to mammalian NGFs, consistent with its role in snake venom where it may contribute to neurotoxicity, inflammation, or prey immobilization through disruption of normal neurotrophic signaling."}
{"description": "sp|P01478|TXDT1_ATRRO Delta-hexatoxin-Ar1a OS=Atrax robustus OX=6903 PE=1 SV=1", "sequence": "CAKKRNWCGKNEDCCCPMKCIYAWYNQQGSCQTTITGLFKKC", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Sydney funnel-web spider (Atrax robustus) that functions as a delta-hexatoxin. This toxin should adopt the inhibitor cystine knot (ICK) structural fold, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) forming a rigid, knotted core. The protein should specifically target insect voltage-gated sodium channels, binding to site 4 and modifying channel gating to cause prolonged action potentials, leading to paralysis and death in insect prey. The sequence should include key residues for membrane interaction and receptor binding, maintaining the hydrophobic surface patches typical of spider toxins that facilitate interaction with the lipid bilayer and channel recognition. The overall structure should be highly stable, resistant to proteolysis, and exhibit the characteristic molecular surface features that enable selective insecticidal activity while minimizing effects on vertebrate sodium channels."}
{"description": "sp|P0DUN2|PA21_BOTHY Basic phospholipase A2 Ph-TX1 OS=Bothrocophias hyoprora OX=230469 PE=1 SV=1", "sequence": "DLWEFGKMILKETGKNPFPYYGAYGCYCGWGGRGKPKDKTDDRCCFVHDCCRYKKLTGCPKTNDRYSYSWKDLTIVCGEDDPCKELCECDKAAAVCFRENLGTYNKKYRYHLRSLCKKADKPC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrocophias hyoprora, a pit viper species. This toxin should function as a potent enzymatic toxin that hydrolyzes phospholipids at the sn-2 position of membrane phospholipids, leading to membrane disruption, inflammation, and potential neurotoxic or myotoxic effects characteristic of viperid venoms. The protein should adopt the canonical phospholipase A2 fold, featuring a conserved calcium-binding loop (YXCGXGG), a catalytic network with a conserved histidine-aspartate dyad for enzymatic activity, and the characteristic pancreatic loop. The structure should be stabilized by multiple disulfide bridges, typically 6-7 conserved cysteine residues forming a specific connectivity pattern that maintains the enzyme's stable, compact globular structure. The basic nature of this toxin suggests it may have enhanced membrane association capabilities and potential presynaptic neurotoxic activity through interaction with specific neuronal targets. The sequence should reflect the characteristic N-terminal helix, beta-wing region, and C-terminal extension common to group II phospholipase A2 enzymes from snake venoms, with appropriate conservation of residues critical for substrate binding, catalysis, and interfacial activation at membrane surfaces."}
{"description": "sp|P01434|3S11_ACAAN Short neurotoxin 1 OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "MQCCNQQSSQPKTTTTCPGGVSSCYKKTWRDHRGTIIERGCGCPRVKPGIRLICCKTDECNN", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom components of the common death adder, Acanthophis antarcticus. This toxin should function as a postsynaptic neurotoxin that specifically and irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding to cause flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The structure should feature the conserved functional loop II that mediates receptor binding through key aromatic and basic residues that interact with the receptor's ligand-binding domain. The toxin should exhibit high affinity for muscle-type nicotinic acetylcholine receptors while showing minimal activity against neuronal subtypes, consistent with its role in rapid prey immobilization through neuromuscular blockade. The sequence should maintain the compact, stable globular architecture typical of short neurotoxins, with molecular weight around 6-8 kDa, optimized for rapid diffusion and target engagement in envenomation scenarios."}
{"description": "sp|P58915|O16A_CONTU Omega-conotoxin TVIA OS=Conus tulipa OX=6495 PE=1 SV=1", "sequence": "CLSPGSSCSPTSYNCCRSCNPYSRKC", "prompt": "Design a novel protein sequence for an omega-conotoxin derived from the marine cone snail Conus tulipa. This toxin should function as a potent and selective calcium channel blocker, specifically targeting N-type voltage-gated calcium channels (Cav2.2) in the vertebrate nervous system. The protein must adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved cysteine framework with three disulfide bridges arranged in a C-C-CC-C-C pattern. The sequence should include key functional residues for high-affinity binding to the pore-forming α1 subunit of Cav2.2 channels, particularly within loops 2 and 4 that mediate channel blockade. The toxin should exhibit the typical compact, globular fold of conotoxins, with well-defined β-hairpins and a stable core reinforced by the disulfide network. As a component of Conus tulipa's venom, this toxin should facilitate prey immobilization by inhibiting neurotransmitter release at presynaptic terminals, leading to rapid neuromuscular paralysis. Ensure the sequence reflects the evolutionary optimization for fast-acting neurotoxicity while maintaining the structural integrity required for precise target engagement."}
{"description": "sp|P83239|NDB23_PANIM Pandinin-1 OS=Pandinus imperator OX=55084 PE=1 SV=1", "sequence": "GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT", "prompt": "Design a novel scorpion venom-derived antimicrobial peptide that mimics the structural and functional characteristics of Pandinin-1 from the Emperor scorpion (Pandinus imperator). This peptide should exhibit potent antimicrobial activity through membrane disruption, targeting bacterial cell membranes while maintaining selectivity to minimize mammalian cell toxicity. The sequence should adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, with a well-defined hydrophobic face for membrane insertion and a cationic face for initial electrostatic interactions with negatively charged bacterial membranes. Incorporate key structural features including: (1) A linear alpha-helical architecture without disulfide bridges, characteristic of scorpion antimicrobial peptides; (2) Optimal amphipathicity with clear segregation of hydrophobic and hydrophilic residues; (3) Appropriate length (approximately 24-30 residues) for efficient membrane penetration; (4) Cationic character with strategic placement of lysine and arginine residues for bacterial membrane targeting; (5) Conservation of the characteristic Pandinin-1 helical propensity and membrane-interacting motifs. The designed peptide should demonstrate broad-spectrum activity against Gram-positive and Gram-negative bacteria while maintaining the low hemolytic activity profile typical of Pandinin-1 derivatives."}
{"description": "sp|P01441|3SA2_NAJOX Cytotoxin 2 OS=Naja oxiana OX=8657 PE=1 SV=1", "sequence": "LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN", "prompt": "Design a cytotoxin protein from the venom of the Central Asian cobra (Naja oxiana) that functions as a potent membrane-disrupting agent. This three-finger toxin should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with connectivity C1-C3, C2-C5, C4-C6, and C7-C8, forming the classic three-finger toxin scaffold. The protein should contain key functional loops that mediate membrane interaction and cytolytic activity, particularly loop regions rich in hydrophobic and basic residues that facilitate binding to anionic phospholipids in cell membranes. The toxin should exhibit specific cytotoxicity through membrane permeabilization, potentially targeting cardiac cells and erythrocytes, leading to cell lysis via pore formation or detergent-like membrane disruption. The structural design should ensure proper folding of the three elongated β-sheet-rich fingers extending from a central hydrophobic core, with conserved structural motifs that enable specific membrane recognition and insertion. The protein should demonstrate thermal stability and resistance to proteolytic degradation typical of snake venom three-finger toxins, with surface-exposed residues optimized for membrane interaction while maintaining the structural integrity required for toxic function."}
{"description": "sp|P13487|KAX11_LEIHE Potassium channel toxin alpha-KTx 1.1 OS=Leiurus hebraeus OX=2899558 PE=1 SV=4", "sequence": "MKILSVLLLALIICSIVGWSEAQFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv1 family) with high affinity and selectivity. This toxin should originate from the venom of the deathstalker scorpion (Leiurus hebraeus), where it serves as a key neurotoxic component that disrupts neuronal excitability and neuromuscular transmission by inhibiting potassium efflux, leading to prolonged action potentials and enhanced neurotransmitter release. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact, globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting a functional surface with key residues for interacting with the pore region of Kv channels, particularly through a lysine-rich dyad that inserts into the channel selectivity filter. Ensure the toxin exhibits the typical short-chain (30-40 amino acids) length, high thermal and proteolytic stability due to the disulfide framework, and specific binding to Kv1.1, Kv1.2, and Kv1.3 channels while sparing other ion channel types."}
{"description": "sp|P01447|3SA1_NAJNA Cytotoxin 1 OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "LKCNKLIPLAYKTCPAGKNLCYKMYMVSNKTVPVKRGCIDVCPKNSLVLKYECCNTDRCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the Indian cobra (Naja naja), specifically representing the three-finger toxin (3FTx) structural family. This toxin should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8, forming a compact globular structure. The protein must function as a cytotoxin targeting cell membranes, particularly through interactions with lipid bilayers and potential disruption of membrane integrity, leading to cell lysis. Incorporate conserved hydrophobic residues in the loop regions to facilitate membrane insertion and cytolytic activity. Ensure the sequence maintains the structural integrity of the three β-stranded fingers extending from a central core, with appropriate amphipathic character to mediate membrane interaction while preserving the overall stability of the toxin fold."}
{"description": "sp|P58918|O16B_CONCT Omega-conotoxin CVIB OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "CKGKGASCRKTMYDCCRGSCRSGRC", "prompt": "Design a novel protein sequence for an omega-conotoxin derived from the venom of the marine cone snail Conus catus. This toxin should function as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting N-type calcium channels (Cav2.2) in the vertebrate nervous system. The protein must adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved cysteine framework with three disulfide bridges arranged in a C-C-CC-C-C pattern. The sequence should include key residues for high-affinity binding to the pore-forming alpha1 subunit of the channel, particularly in extracellular loop regions involved in channel gating and ion selectivity. The toxin should exhibit paralytic activity by blocking neurotransmitter release at presynaptic terminals, leading to neuromuscular blockade. Incorporate structural elements that confer stability in the marine environment and resistance to proteolytic degradation, including a compact globular fold with defined beta-sheets and turns. Ensure the sequence maintains the phylogenetic signature of conotoxins from the O-superfamily while introducing specificity for Cav2.2 over other calcium channel subtypes."}
{"description": "sp|P00608|PA2B_NOTSC Basic phospholipase A2 notexin OS=Notechis scutatus scutatus OX=70142 PE=1 SV=1", "sequence": "NLVQFSYLIQCANHGKRPTWHYMDYGCYCGAGGSGTPVDELDRCCKIHDDCYDEAGKKGCFPKMSAYDYYCGENGPYCRNIKKKCLRFVCDCDVEAAFCFAKAPYNNANWNIDTKKRCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Australian tiger snake (Notechis scutatus scutatus). This toxin, known as notexin, should function as a potent presynaptic neurotoxin that causes irreversible neuromuscular blockade by hydrolyzing membrane phospholipids at nerve terminals. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by seven conserved disulfide bonds with the pattern Cys1-Cys11, Cys2-Cys7, Cys3-Cys15, Cys4-Cys10, Cys5-Cys14, Cys6-Cys13, and Cys8-Cys9. Include a conserved calcium-binding loop (Tyr-Gly-Cys) essential for catalytic activity, and an interfacial binding surface with hydrophobic residues for membrane association. The sequence should exhibit high basicity to facilitate interaction with anionic membrane surfaces and synaptic targets. Ensure the catalytic triad (His-Asp) is positioned for efficient phospholipid hydrolysis, leading to membrane disruption and neurotransmitter release inhibition."}
{"description": "sp|P0C2L4|TO1B_HADFO Omega-hexatoxin-Hf1a OS=Hadronyche formidabilis OX=426499 PE=1 SV=1", "sequence": "SPTCIRSGQPCPYNENCCSQSCTFKTNENGNTVKRCD", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Australian funnel-web spider Hadronyche formidabilis. This toxin belongs to the omega-hexatoxin family and functions as a calcium channel blocker, specifically targeting insect voltage-gated calcium channels (VGCCs) to disrupt synaptic transmission and neuromuscular function. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a knotted topology. Key structural elements include a hydrophobic core, solvent-exposed loops critical for channel binding and selectivity, and a molecular surface optimized for high-affinity interaction with insect VGCCs, leading to paralysis and lethality in insect prey. The sequence must reflect the evolutionary adaptation of this toxin for efficient predation, with precise positioning of functional residues to ensure target specificity and potent neurotoxic activity."}
{"description": "sp|P0C8J3|SL1C2_VIPAA Snaclec factor X-activator 1 light chain 2 (Fragment) OS=Vipera ammodytes ammodytes OX=8705 GN=LC2 PE=1 SV=1", "sequence": "LFDPPDSXPXY", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent factor X activator. This toxin originates from the venom of Vipera ammodytes ammodytes (nose-horned viper), where it plays a crucial role in the procoagulant arsenal by specifically activating coagulation factor X in the blood clotting cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by a conserved disulfide bridge pattern typical of snaclecs—specifically, two intra-chain disulfide bonds with connectivity Cys1-Cys2 and Cys3-Cys4 that maintain the globular β-sandwich structure. Key functional residues should be positioned to bind calcium ions and interact with the Gla domain of factor X, facilitating its proteolytic activation to factor Xa. The sequence must include a canonical carbohydrate-recognition domain (CRD) motif but function primarily through protein-protein interactions rather than sugar binding. The overall structure should be compact and resistant to proteolysis, enabling efficient disruption of hemostasis in prey through enhanced thrombin generation."}
{"description": "sp|P0CI83|KA272_LYCMC Potassium channel toxin alpha-KTx 27.2 OS=Lychas mucronatus OX=172552 PE=3 SV=1", "sequence": "MKLMWLLFLCVLAFSIAQIYINDTCAGGVHRCYEPCEKKKCRLPHKCINGRCTCYVGRNVCAISSH", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom biology. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an anti-parallel beta-sheet, creating a stable molecular framework. Include the conserved functional dyad comprising a critical lysine residue positioned to penetrate the potassium channel pore and an aromatic residue that facilitates precise docking within the channel vestibule. The sequence should maintain the characteristic cysteine framework (C-C-CC-C-C) that defines the alpha-KTx family while incorporating specific loop regions that confer target selectivity and binding affinity. The toxin should exhibit the typical molecular weight range of 3-5 kDa and demonstrate high thermal and proteolytic stability due to the extensive disulfide network. Design this toxin to effectively modulate potassium flux across excitable membranes, thereby serving as a valuable pharmacological tool for studying potassium channel function and neuronal signaling pathways."}
{"description": "sp|P01480|SCX3_ANDAU Alpha-mammal toxin Aah3 OS=Androctonus australis OX=6858 PE=1 SV=3", "sequence": "MNYLVMISLALLLMTGVESVRDGYIVDSKNCVYHCVPPCDGLCKKNGAKSGSCGFLIPSGLACWCVALPDNVPIKDPSYKCHSR", "prompt": "Design a novel alpha-toxin protein sequence derived from the venom of the North African scorpion Androctonus australis, specifically representing the Aah3 toxin variant. This protein should function as a potent voltage-gated sodium channel modulator, exhibiting the characteristic activity of alpha-scorpion toxins by binding to neurotoxin receptor site 3 on the voltage-sensing domain of sodium channels. The sequence must maintain the conserved structural scaffold of scorpion alpha-toxins, featuring a compact beta-sheet-rich fold stabilized by four disulfide bridges with the characteristic C-C-CC-C-C cysteine framework. The protein should demonstrate high affinity for mammalian neuronal sodium channels, causing prolonged channel opening and delayed inactivation, leading to sustained neuronal excitation and neurotoxic effects. Incorporate key functional residues responsible for receptor recognition and binding specificity, while preserving the overall globular architecture typical of scorpion neurotoxins. The structural design should ensure proper folding into the stable, compact core domain with exposed loops that mediate target interaction, maintaining the evolutionary conserved pharmacophore essential for sodium channel modulation."}
{"description": "sp|O61668|SIX1_OLIMR Beta-insect excitatory toxin BmKIT1 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKFFLIFLVIFPIMGVLGKKNGYAVDSSGKVSECLLNNYCNNICTKVYYATSGYCCLLSCYCFGLDDDKAVLKIKDATKSYCDVQIIG", "prompt": "Design a beta-insect excitatory toxin protein sequence inspired by the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent insect-specific neurotoxin that targets voltage-gated sodium channels in insect nervous systems. The protein should adopt the conserved beta-toxin structural scaffold characterized by a compact, globular fold stabilized by a specific disulfide bridge pattern. The core structure should feature the classic cysteine-stabilized alpha-beta (CSαβ) motif, with the characteristic arrangement of an alpha-helix packed against an antiparallel beta-sheet. The disulfide connectivity should follow the beta-toxin pattern (C1-C4, C2-C5, C3-C6) that defines this structural family. Key functional residues should be positioned to interact with domain II of insect sodium channels, causing prolonged channel activation and excitatory effects leading to paralysis. The sequence should include conserved hydrophobic patches and surface-exposed residues critical for receptor binding specificity while maintaining the structural integrity required for thermal stability and protease resistance typical of scorpion venom toxins. The overall architecture should facilitate rapid binding to insect sodium channels while exhibiting minimal activity against mammalian sodium channels, reflecting the natural insect-selectivity of this toxin class."}
{"description": "sp|Q5ZPJ7|VKT_NAJAT Kunitz-type serine protease inhibitor NACI OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSGRPRFCELAPSAGSCFAFVPSYYYNQYSNTCHSFTYSGCGGNANRFRTIDECNRTCVG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Chinese cobra (Naja atra). This toxin functions as a potent serine protease inhibitor, specifically targeting and inhibiting key proteolytic enzymes involved in physiological processes such as blood coagulation, fibrinolysis, or inflammation. The protein should adopt the characteristic Kunitz-type fold, a compact globular structure stabilized by three conserved disulfide bonds with the canonical cysteine framework (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5). The sequence must include the essential reactive site loop, which presents the canonical protease-binding motif that interacts with the active site of target serine proteases through a substrate-like mechanism, forming a stable enzyme-inhibitor complex. The structural scaffold should feature a twisted beta-hairpin and alpha-helical elements, maintaining the overall stability and specificity required for effective protease inhibition. The biological significance of this toxin lies in its role in the venom's strategy to disrupt host homeostasis, potentially causing anticoagulant, antifibrinolytic, or anti-inflammatory effects by selectively inhibiting proteases such as trypsin, chymotrypsin, or coagulation factors. Ensure the sequence reflects the evolutionary optimization for high affinity and specificity towards its molecular targets, with conserved residues in the binding interface critical for inhibitory activity."}
{"description": "sp|P0C8J2|SL1C1_VIPAA Snaclec factor X-activator 1 light chain 1 (Fragment) OS=Vipera ammodytes ammodytes OX=8705 GN=LC1 PE=1 SV=2", "sequence": "DFDCPXDWVXYDQ", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent factor X activator. This toxin originates from the venom of Vipera ammodytes ammodytes (nose-horned viper), where it plays a crucial role in the procoagulant arsenal by specifically activating coagulation factor X in the blood clotting cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by a conserved disulfide bridge pattern typical of snaclecs—likely involving two disulfide bonds with a C1-C2, C3-C4 connectivity framework. The structural scaffold should feature a globular domain with anti-parallel β-sheets and loops that form the functional interface for binding and activating factor X. Key residues in the calcium-binding site and the carbohydrate-recognition domain (CRD) should be preserved to mediate specific interactions with factor X, facilitating its conversion to factor Xa and thereby promoting thrombin generation and fibrin clot formation. The mechanism involves binding to the γ-carboxyglutamic acid (Gla) domain or other exosites on factor X, enhancing its proteolytic activation by factor IXa or intrinsic tenase complex. Ensure the sequence reflects the heterodimeric nature typical of factor X-activating snaclecs, with this light chain contributing to the functional complex, and include conserved hydrophobic core residues and surface loops critical for target recognition and enzymatic potentiation."}
{"description": "sp|Q9U8D2|KAX82_OLIMR Potassium channel toxin alpha-KTx 8.2 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MSRLYAIILIALVFNVVMTITPDMKVEAATCEDCPEHCATQNARAKCDNDKCVCEPK", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Chinese scorpion Olivierus martensii (formerly Mesobuthus martensii). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels which play critical roles in immune cell function and neuronal excitability. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif formed by three disulfide bridges with the connectivity pattern C1-C4, C2-C5, C3-C6. The sequence should feature a compact globular fold stabilized by this disulfide framework, with a well-defined molecular surface containing a functional dyad - typically consisting of a critical lysine residue positioned near an aromatic amino acid - that mediates high-affinity binding to the channel's pore region. The toxin should exhibit the characteristic beta-sheet secondary structure common to scorpion potassium channel toxins, with the functional dyad located within a solvent-exposed loop that inserts into the channel vestibule to physically occlude potassium ion conduction. The resulting protein should demonstrate selective pharmacological activity against Kv1.3 channels while maintaining the thermal stability and protease resistance typical of scorpion venom peptides."}
{"description": "sp|P01453|3SAA_NAJHA Cytotoxin 10 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LECNQLIPIAHKTCPEGKNLCYKMFMVSTSTVPVKRGCIDVCPKNSALVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the snouted cobra, Naja annulifera, that functions as a potent membrane-disrupting agent. This three-finger toxin should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C5, C4-C6, and C7-C8. The protein should exhibit specific cytotoxicity through direct interaction with cell membranes, likely via hydrophobic patches and basic residues that facilitate membrane insertion and disruption. The structural scaffold should feature three extended loops projecting from a central hydrophobic core, with loop regions containing conserved motifs that mediate target recognition and membrane perturbation. The toxin should demonstrate preferential activity against specific cell types, potentially through recognition of membrane lipid components or surface receptors. The sequence should maintain the characteristic three-finger toxin topology while incorporating residues that confer membrane-binding specificity and cytolytic potency characteristic of elapid snake venom cytotoxins."}
{"description": "sp|O93523|VM3BP_BOTJA Zinc metalloproteinase-disintegrin-like bothropasin OS=Bothrops jararaca OX=8724 PE=1 SV=2", "sequence": "MIEVLLVTICLAAFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPAVEDHCYYHGRIENDADSTASISACNGLKGHFKLQRETYFIEPLKLSNSEAHAVFKYENVEKEDEAPKMCGVTQNWKSYEPIKKASQLVVTAEQQKYNPFRYVELFIVVDQGMVTKNNGDLDKIKARMYELANIVNEILRYLYMHAALVGLEIWSNGDKITVKPDVDYTLNSFAEWRKTDLLTRKKHDNAQLLTAIDFNGPTIGYAYIGSMCHPKRSVAIVEDYSPINLVVAVIMAHEMGHNLGIHHDTDFCSCGDYPCIMGPTISNEPSKFFSNCSYIQCWDFIMKENPQCILNEPLGTDIVSPPVCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFSKSGTECRASMSECDPAEHCTGQSSECPADVFHKNGQPCLDNYGYCYNGNCPIMYHQCYALFGADVYEAEDSCFKDNQKGNYYGYCRKENGKKIPCAPEDVKCGRLYCKDNSPGQNNPCKMFYSNDDEHKGMVLPGTKCADGKVCSNGHCVDVATAY", "prompt": "Design a protein sequence for a snake venom metalloproteinase (SVMP) from the pit viper Bothrops jararaca, specifically belonging to the P-III class SVMPs that contain both metalloproteinase and disintegrin-like domains. This toxin plays a crucial role in the hemorrhagic and tissue-damaging effects of Bothrops jararaca venom, contributing to prey immobilization through disruption of vascular integrity and extracellular matrix degradation. The protein should function as a zinc-dependent endopeptidase that cleaves key components of the basement membrane and extracellular matrix, including type IV collagen, fibronectin, and laminin. It should contain a conserved zinc-binding motif (HEXXHXXGXXH) in the metalloproteinase domain that coordinates the catalytic zinc ion essential for proteolytic activity. The disintegrin-like domain should adopt a characteristic disintegrin fold with the presence of a disintegrin loop but lacking the RGD motif typical of free disintegrins, instead potentially interacting with integrins or other cell surface receptors to modulate cellular adhesion. The protein should exhibit the multidomain architecture typical of P-III SVMPs, including propeptide, metalloproteinase, disintegrin-like, and cysteine-rich domains, with appropriate interdomain connectivity. The structure should maintain the characteristic metzincin fold of the catalytic domain with a central five-stranded beta-sheet and surrounding helices, stabilized by multiple disulfide bonds that confer stability in the venom environment. The protein should target specific extracellular matrix proteins and potentially interact with cell surface receptors to amplify its hemorrhagic effects through both direct proteolytic action and disruption of cell-matrix interactions."}
{"description": "sp|P83244|KA132_ORTSC Potassium channel toxin alpha-KTx 13.2 OS=Orthochirus scrobiculosus OX=6892 PE=1 SV=2", "sequence": "ACGPGCSGSCRQKGDRIKCINGSCHCYP", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of alpha-KTx 13.2 from the scorpion Orthochirus scrobiculosus. This toxin belongs to the alpha-KTx family of scorpion venom peptides that specifically target voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker, binding to the pore region of Kv channels and inhibiting potassium ion flux, thereby disrupting neuronal excitability and neuromuscular transmission. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, with a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structure. The sequence should include a functional dyad consisting of a critical lysine residue that inserts into the potassium channel selectivity filter and an adjacent aromatic residue that contributes to binding affinity. The mature toxin should be approximately 30-40 amino acids in length with a compact, globular fold stabilized by three disulfide bonds. The molecular mechanism involves specific interactions with the Kv1.x subfamily of potassium channels, leading to prolonged action potentials and enhanced neurotransmitter release. The structural design should ensure proper folding into the ICK (inhibitor cysteine knot) motif characteristic of scorpion potassium channel toxins, with a beta-sheet core and flexible loops that mediate target recognition and binding specificity."}
{"description": "sp|P01495|SCX2_CENNO Beta-mammal toxin Cn2 (Fragment) OS=Centruroides noxius OX=6878 PE=1 SV=3", "sequence": "LLIITACLALIGTVWAKEGYLVDKNTGCKYECLKLGDNDYCLRECKQQYGKGAGGYCYAFACWCTHLYEQAIVWPLPNKRCSGK", "prompt": "Design a beta-toxin scorpion venom peptide derived from Centruroides noxius that functions as a potent modulator of voltage-gated sodium channels. This toxin should exhibit the characteristic beta-scorpion toxin fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) within the cysteine-stabilized alpha-beta (CSαβ) structural scaffold. The peptide should specifically target mammalian voltage-gated sodium channels, binding to neurotoxin receptor site 4 and modifying channel gating by shifting the voltage-dependence of activation toward more negative potentials. This mechanism enhances neuronal excitability and contributes to the venom's neurotoxic effects through prolonged channel opening and spontaneous repetitive firing. The structure should feature a compact globular fold with an alpha-helix packed against an antiparallel beta-sheet, maintaining the conserved molecular surface responsible for receptor recognition and binding affinity to sodium channel domain II voltage-sensor segments."}
{"description": "sp|P14418|PA2A_GLOHA Acidic phospholipase A2 OS=Gloydius halys OX=8714 PE=1 SV=1", "sequence": "SLIQFETLIMKVAKKSGMFWYSNYGCYCGWGGQGRPQDATDRCCFVHDCCYGKVTGCDPKMDVYSFSEENGDIVCGGDDPCKKEICECDRAAAICFRDNLTLYNDKKYWAFGAKNCPQEESEPC", "prompt": "Generate the amino acid sequence for an acidic phospholipase A2 toxin from the venom of the Siberian pit viper (Gloydius halys). This enzyme plays a critical role in the venom's toxicity by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to hemolysis, myotoxicity, neurotoxicity, and inflammation. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges (typically 6-7 disulfide bonds with a specific pattern such as Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91, and Cys84-Cys96 in homologous toxins). Include a conserved calcium-binding loop (Tyr-Gly-Cys-X-Gly-Gly) essential for catalytic activity, and an interfacial binding surface that targets anionic phospholipid membranes. The acidic nature (low pI) should be reflected in the sequence composition, with key catalytic residues (typically a conserved histidine-aspartate dyad) and a hydrophobic channel for substrate access. The toxin should exhibit both enzymatic and potential presynaptic neurotoxic activities, characteristic of viperid phospholipases A2."}
{"description": "sp|P14421|PA2N_GLOHA Neutral phospholipase A2 agkistrodotoxin OS=Gloydius halys OX=8714 PE=1 SV=1", "sequence": "NLLQFNKMIKEETGKNAIPFYAFYGCYCGGGGQGKPKDGTDRCCFVHDCCYGRLVNCNTKSDIYSYSLKEGYITCGKGTNCEEQICECDRVAAECFRRNLDTYNNGYMFYRDSKCTETSEEC", "prompt": "Design a protein sequence for a snake venom phospholipase A2 toxin from the Chinese mamushi (Gloydius halys). This toxin should function as a neutral phospholipase A2 (PLA2) with the specific designation agkistrodotoxin. The protein should exhibit the characteristic structural scaffold of group IIA secretory phospholipases, featuring a conserved calcium-binding loop (YGKYCG/XCG) and catalytic network centered around histidine and aspartate residues. The sequence must include the essential disulfide bridge pattern typical of snake venom PLA2s, with conserved cysteine residues forming 6-7 disulfide bonds that stabilize the compact globular fold. The toxin should possess the enzymatic activity to hydrolyze the sn-2 acyl bond of membrane phospholipids, leading to membrane disruption and potential presynaptic neurotoxicity. The molecular mechanism involves calcium-dependent catalytic activity that generates lysophospholipids and free fatty acids, contributing to local tissue damage, inflammation, and potential neuromuscular effects. The structural design should ensure proper folding into the characteristic PLA2 three-finger-like domain with a hydrophobic channel for substrate access to the active site."}
{"description": "sp|P00611|PA2A1_LATSE Acidic phospholipase A2 1 OS=Laticauda semifasciata OX=8631 PE=1 SV=3", "sequence": "MYPAHLLVLLAVCVSLLGATAIPPLPLNLVQFSNLIQCVNKGSRASYHYADYGCYCGAGGSGTPVDELDRCCKIHDDCYGEAEKMGCYPKWTLYTYDCSTEEPNCSTKTGCQGFVCACDLEAAKCFARSPYNNKNYNIDTSKRCK", "prompt": "Generate a protein sequence for an acidic phospholipase A2 toxin from the venom of the banded sea krait, Laticauda semifasciata. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, with preference for anionic phospholipid substrates. The structural scaffold should feature the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. The sequence should possess an overall acidic pI and contain surface-exposed cationic patches that may facilitate membrane interaction and potential receptor binding. The toxin should demonstrate both enzymatic activity and potential for inducing myotoxicity through membrane disruption."}
{"description": "sp|P14615|PA2N3_BUNFA Neutral phospholipase A2 3 OS=Bungarus fasciatus OX=8613 PE=1 SV=2", "sequence": "NLFQFKNMIQCAGTRSWTDYVSYGCYCGKGGSGTPVDQLDRCCKVHDDCYGDAEKIPKCKPYYKTYSYDCSEGKLTCKADNDECAAFICNCDRVAAICFAGAPYNDNNFMIDSKTRCNDI", "prompt": "Design a protein sequence for a neutral phospholipase A2 toxin from the venom of the banded krait (Bungarus fasciatus). This enzyme should function as a key component of the snake's neurotoxic venom system, specifically targeting and hydrolyzing phospholipids in biological membranes. The protein should exhibit the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should possess the typical disulfide bridge pattern common to snake venom phospholipases A2, featuring multiple conserved cysteine residues that stabilize the compact globular structure. The enzyme should demonstrate substrate specificity for phospholipids at the sn-2 position, leading to membrane disruption and potential presynaptic neurotoxicity through interference with neurotransmitter release. The structural scaffold should include the characteristic pancreatic phospholipase A2-like fold with distinct interfacial binding surfaces for membrane interaction. The protein should maintain optimal activity at neutral pH and exhibit stability in the venom environment while being capable of exerting toxic effects through phospholipid hydrolysis in target organisms."}
{"description": "sp|A3F7X1|TXLT4_LASSB U2-theraphotoxin-Lsp1a OS=Lasiodora sp. (strain IBSP 8539) OX=300858 PE=3 SV=1", "sequence": "MNTIQVIIFAVVLVLTVTVGQADEDSPEASLLRKLKEAEASLFGQNLEESRNSRQKRCGGVDAPCDKDRPDCCSYAECLRPSGYGWWHGTYYCYRKRER", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a theraphotoxin derived from the venom of Lasiodora sp. tarantulas, specifically functioning as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic structural features of spider venom peptides, including a compact, disulfide-rich scaffold with an inhibitor cysteine knot (ICK) motif. The cysteine framework should follow the typical pattern for theraphotoxins, with conserved disulfide bridges that stabilize the core fold. The molecular mechanism involves binding to site 3 or site 4 of voltage-gated sodium channels, leading to modulation of channel gating kinetics—potentially causing delayed inactivation or altered activation thresholds, which disrupts neuronal excitability and contributes to prey immobilization. The sequence should include key residues for target interaction, such as surface-exposed loops critical for receptor binding specificity. The overall structure should be globular and stable, with the ICK motif providing resistance to proteolytic degradation. Ensure the design reflects the evolutionary role of this toxin in tarantula venom for rapid subjugation of arthropod or vertebrate prey through precise interference with voltage-gated sodium channel function."}
{"description": "sp|Q66S03|LECG_THANI Galactose-specific lectin nattectin OS=Thalassophryne nattereri OX=289382 PE=1 SV=1", "sequence": "MASVPHFTVFLFLACALGIGANVTRRATSSCPKGWTHHGSRCFTFHRGSMDWASAEAACIRKGGNLASIHNRREQNFITHLIHKLSGENRRTWIGGNDAVKEGMWFWSDGSKFNYKGWKKGQPDKHVPAEHCAETNFKGAFWNNALCKVKRSFLCAKNL", "prompt": "Design a galactose-specific lectin protein derived from the venom of the toadfish Thalassophryne nattereri. This lectin, known as nattectin, functions as a C-type lectin-like protein that binds specifically to galactose residues on cell surfaces. As a venom component, it plays a critical role in the inflammatory and pro-coagulant effects of the venom by interacting with glycoproteins and glycolipids on immune cells, endothelial cells, and platelets. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. Key structural elements include a long loop region responsible for carbohydrate recognition, calcium-binding sites essential for galactose specificity, and a conserved hydrophobic core. The molecular target involves galactose-containing glycoconjugates on cell surfaces, with binding mediated through specific interactions with the hydroxyl groups of galactose via conserved residues in the carbohydrate-recognition domain. The protein should exhibit the biological activities of inducing leukocyte recruitment, promoting inflammation, and potentially modulating coagulation pathways through its lectin-mediated interactions."}
{"description": "sp|P0C8J4|SL2C1_VIPAA Snaclec factor X-activator 2 light chain 1 (Fragment) OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=2", "sequence": "DFDCPPDWSAYDXQCYYAF", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a potent factor X activator. This toxin originates from the venom of Vipera ammodytes ammodytes (nose-horned viper), where it plays a crucial role in the procoagulant arsenal by specifically activating coagulation factor X in the blood clotting cascade. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a compact globular structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence must include key residues for calcium-independent binding to factor X, particularly those forming the functional epitope that recognizes and activates the zymogen through specific exosite interactions. The structural scaffold should maintain the double-loop organization common to snaclecs, with one loop responsible for target recognition and the other providing structural stability. The generated protein should exhibit high specificity for factor X over other coagulation factors, enabling its role in promoting rapid thrombin generation and contributing to the viper's prey immobilization strategy through systemic coagulopathy."}
{"description": "sp|P0C8L2|KA134_TITST Potassium channel toxin alpha-KTx 13.4 OS=Tityus stigmurus OX=50344 PE=1 SV=1", "sequence": "GCRQCGGGCNKHGKCINGKCKCY", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the Brazilian yellow scorpion Tityus stigmurus. This toxin should function as a potent and selective blocker of voltage-gated potassium channels (Kv channels), specifically targeting the external pore region to inhibit potassium ion efflux and thereby modulate neuronal excitability or muscle contraction. The protein should adopt the conserved alpha-KTx family structural scaffold, characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include a well-defined functional dyad comprising a critical lysine residue positioned to insert into the potassium channel selectivity filter and an adjacent aromatic residue that facilitates binding through hydrophobic interactions with the channel vestibule. The overall structure should feature a compact, globular fold with an alpha-helix and anti-parallel beta-sheets, maintaining high stability and resistance to proteolytic degradation. The toxin should exhibit specificity for particular Kv channel subtypes, potentially disrupting action potential repolarization in prey organisms, leading to paralysis or other neurotoxic effects as part of the scorpion's predatory strategy."}
{"description": "sp|Q9XYR5|CONG_CONGE Contulakin-G OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "MQTAYWVMVMMMVWIAAPLSEGGKLNDVIRGLVPDDITPQLILGSLISRRQSEEGGSNATKKPYILRASDQVASGP", "prompt": "Design a protein sequence for Contulakin-G, a neuroactive peptide from the venom of the marine cone snail Conus geographus. This toxin functions as a selective agonist of the neurotensin receptor 1 (NTS1), modulating pain pathways in the central nervous system. Unlike typical conotoxins, Contulakin-G is a glycosylated peptide with an O-glycosylated threonine residue that enhances its stability and receptor binding affinity. The peptide adopts a flexible, extended conformation rather than a rigid disulfide-stabilized fold, allowing it to mimic endogenous neurotensin. Its mechanism involves binding to NTS1 with high affinity, triggering G-protein coupled receptor signaling that results in analgesic effects. The sequence should include the characteristic glycosylation site and maintain the N-terminal glutamate and C-terminal glycine residues critical for receptor recognition and activity. The design should prioritize structural features that facilitate specific NTS1 engagement while avoiding off-target interactions with other neuropeptide receptors."}
{"description": "sp|Q696W1|SLLC2_MACLB Snaclec coagulation factor X-activating enzyme light chain 2 OS=Macrovipera lebetinus OX=3148341 GN=LC2 PE=1 SV=1", "sequence": "MGRSISVSFGLLAVFLSLSGTGAGLDCPPDSSPYRYFCYRVFKEQKNWADAERFCAERPNNGHLVSIESMEEAEFVAQLLSKITGKFITHFWIGLRIEDKKQQCRSEWSDGSSVSYDNLLKREFRKCFGLEKGTGYRSWFNLNCEEPYPFVCKVPPNC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) derived from Macrovipera lebetinus (Levantine viper). This protein functions as the light chain component of a heterodimeric coagulation factor X-activating enzyme complex. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, featuring a conserved double-loop structure stabilized by two disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The sequence should include key calcium-binding residues and maintain the β-sheet-rich scaffold that defines this protein family. As part of the factor X-activating complex, this light chain contributes to the specific recognition and proteolytic activation of coagulation factor X in the blood coagulation cascade, ultimately promoting thrombin generation and facilitating prey immobilization through procoagulant effects. The protein should exhibit the structural features necessary for heterodimer formation with its heavy chain partner and maintain the molecular recognition properties required for its role in the viper's venom system."}
{"description": "sp|P58919|O16C_CONCT Omega-conotoxin CVIC OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "CKGKGQSCSKLMYDCCTGSCSRRGKC", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This is an omega-conotoxin from the marine cone snail Conus catus, a predatory species that employs venom for prey capture. The toxin functions as a potent calcium channel blocker, specifically targeting N-type voltage-gated calcium channels (Cav2.2) in the nervous system. Its mechanism involves binding to the pore-forming alpha1 subunit of these channels, thereby inhibiting calcium influx and neurotransmitter release, which leads to paralysis in prey. The structural scaffold is characterized by the cysteine framework IV (C-C-CC-C-C), forming three disulfide bridges that stabilize a compact, globular fold typical of the conotoxin superfamily. The mature peptide is expected to be short (approximately 25-30 amino acids), with the disulfide connectivity (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) conferring high stability and specificity. Key conserved residues likely contribute to the hydrophobic core and receptor binding interface, including loops between cysteine pairs that determine target selectivity. The overall 3D structure is anticipated to be an inhibitor cystine knot (ICK) motif, enhancing resistance to proteolytic degradation and ensuring efficient venom delivery."}
{"description": "sp|P01455|3SA1_NAJHA Cytotoxin 1 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LKCHKLVPPVWKTCPEGKNLCYKMFMVSTSTVPVKRGCIDVCPKNSALVKYVCCSTDKCN", "prompt": "Design a cytotoxin protein from the venom of the snouted cobra (Naja annulifera) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bonds with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The protein should exhibit strong cytolytic activity through direct interaction with cell membranes, causing pore formation and cell lysis. The molecular mechanism involves binding to anionic phospholipids in the plasma membrane, leading to membrane destabilization and disruption of cellular integrity. Key structural features should include three extended β-stranded loops emerging from a central hydrophobic core, with specific residues in the second and third loops mediating membrane interaction and cytotoxicity. The protein should demonstrate preferential toxicity toward certain cell types, particularly cancer cells, through selective membrane recognition. The overall structure should be compact and thermostable, characteristic of the three-finger toxin superfamily, with surface-exposed hydrophobic patches that facilitate membrane insertion and cytolytic activity."}
{"description": "sp|Q9U8X3|TACA2_TACTR Tachystatin-A2 OS=Tachypleus tridentatus OX=6853 PE=1 SV=1", "sequence": "MKLQNTLILIGCLFLMGAMIGDAYSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRY", "prompt": "Design a novel protein sequence for a potent antimicrobial toxin derived from the Japanese horseshoe crab, Tachypleus tridentatus. This protein should function as a tachystatin, a class of cysteine-rich antimicrobial peptides that play a critical role in the horseshoe crab's innate immune defense system against microbial pathogens. The toxin must exhibit broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria through membrane disruption mechanisms, likely involving electrostatic interactions with negatively charged bacterial membranes leading to pore formation and cell lysis. The structural scaffold should feature the characteristic tachystatin fold with a compact, stable tertiary structure stabilized by three conserved disulfide bridges in a C-C-C-C-C-C connectivity pattern (cysteine framework III). The protein should adopt a beta-sheet rich conformation with potential amphipathic properties, allowing for both structural stability and membrane interaction capabilities. Key structural elements should include well-defined beta-strands arranged in an antiparallel configuration, creating a surface capable of recognizing and binding to microbial membrane components such as lipopolysaccharides in Gram-negative bacteria and teichoic acids in Gram-positive bacteria. The molecular mechanism should involve initial electrostatic attraction to bacterial surfaces followed by insertion into the lipid bilayer and disruption of membrane integrity."}
{"description": "sp|A3FM53|3L22_HYDHA Long neurotoxin 2 OS=Hydrophis hardwickii OX=8781 PE=3 SV=1", "sequence": "MKILLLTLVVVTIVCLDLAYTRTCYRTHPYKPETCPPGQNLCYKKSWCDAFCSSRGKVIELGCTAKCPTVKHGKDINCCATDNCNTVANWKSR", "prompt": "Design a protein sequence for a long neurotoxin from the venom of Hydrophis hardwickii (Hardwick's sea snake) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and irreversibly bind to the alpha-subunit of nicotinic acetylcholine receptors at the neuromuscular junction, causing competitive antagonism that leads to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The structure should feature a long, flexible central loop that enhances receptor binding specificity and affinity. Key functional residues should be positioned in loop II for effective interaction with the acetylcholine binding site, while maintaining the overall structural stability typical of elapid snake neurotoxins. The sequence should exhibit the conserved hydrophobic core and beta-sheet architecture that defines this toxin family, ensuring proper folding and biological activity as a neuromuscular blocking agent."}
{"description": "sp|C0JB41|B1S1_LOXSN Dermonecrotic toxin LspiSicTox-betaIE2i (Fragment) OS=Loxosceles spinulosa OX=571532 PE=2 SV=1", "sequence": "FALAHMVNDFDIMKSYLDEGANGIETDITFSPEGEPESAFHGVPCDCKRWCDRTVSFDSYLQKTSDLSTPGHPDYRENLLIIILELKLNGLSQDALANGGRRLADKLAAHFWTGGRRDQRATFVVSVPQTSQKVFMKTFREEMEAIGMGDMNAKVGFDFTDNGDVSVTKAVYDELGITEHIWASDGITNCVALLFRGTSRLEELIQKRDEGESTYISKVYAWTYDKETSVVLALELGVDGVMTNYADFVISILNKPEHSSKYRLATYEDDPFERFKAV", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles spinulosa. This toxin belongs to the SicTox-betaIE2i family, which are sphingomyelinase D enzymes that catalyze the hydrolysis of sphingomyelin to produce ceramide-1-phosphate and choline. The biological significance of this venom component is to induce dermonecrosis, hemolysis, and platelet aggregation, contributing to the characteristic necrotic lesions associated with recluse spider envenomation. The core function involves hydrolyzing membrane sphingolipids, disrupting cellular membranes, and activating inflammatory pathways. The protein should adopt the conserved (α/β)8 TIM barrel fold typical of sphingomyelinase D enzymes, with the active site containing essential catalytic residues (likely histidine and aspartate/glutamate pairs) for metal ion coordination and substrate binding. The molecular target is sphingomyelin in cell membranes, with the binding interface involving specific loops that recognize the choline head group and the phosphodiester bond. The sequence should include the characteristic disulfide bridge pattern that stabilizes the TIM barrel structure, though the specific cysteine framework for this fragment may be incomplete. The generated protein should exhibit the enzymatic activity and structural stability required for its dermonecrotic function in spider venom."}
{"description": "sp|Q69CK0|3SDC7_OPHHA Beta-cardiotoxin CTX27 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRKCLNTPLPLIYTTCPIGQDKCVKMTIKKLPSKYDVIRGCIDICPKSSADVEVLCCDTNKCNK", "prompt": "Design a beta-cardiotoxin protein sequence inspired by the venom of the king cobra (Ophiophagus hannah). This toxin should function as a potent cardiotoxin that targets and disrupts cardiac muscle function, likely through interaction with specific ion channels or membrane receptors in heart tissue. The protein should adopt the characteristic three-finger toxin (3FTx) structural fold, featuring three extended beta-stranded loops emerging from a central hydrophobic core stabilized by four conserved disulfide bonds with a C-C-C-C cysteine framework. The sequence should include key structural motifs for membrane interaction and receptor binding, with surface-exposed residues that facilitate specific recognition of cardiac targets. The overall architecture should maintain the compact, stable globular structure typical of snake venom cardiotoxins, enabling precise targeting of cardiovascular systems while exhibiting the thermal stability and protease resistance common to elapid venom toxins."}
{"description": "sp|P01458|3SA3_NAJNI Cytotoxin 3 OS=Naja nivea OX=8655 PE=1 SV=1", "sequence": "LKCNQLIPPFWKTCPKGKNLCYNMYMVSTSTVPVKRGCIDVCPKNSALVKYVCCNTDRCN", "prompt": "Design a cytotoxin protein from the Cape cobra (Naja nivea) venom that functions as a potent membrane-disrupting agent. This toxin should exhibit the characteristic three-finger toxin (3FTx) structural scaffold, featuring three extended beta-stranded loops emerging from a conserved hydrophobic core stabilized by four disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8. The protein should adopt a flat, beta-sheet-rich architecture with the three loops arranged in a finger-like configuration. Key functional residues should be concentrated in the central loop (Loop II), which mediates membrane interaction through hydrophobic and cationic patches that facilitate binding to anionic phospholipid headgroups in cell membranes. The mechanism of action involves direct insertion into lipid bilayers, causing membrane permeabilization, disruption of membrane integrity, and induction of cell lysis, particularly targeting erythrocytes and other susceptible cell types. The toxin should demonstrate specificity for mammalian cell membranes while maintaining the structural stability characteristic of snake venom cytotoxins, with the conserved three-finger fold providing the structural framework for its membrane-active properties."}
{"description": "sp|C0JB40|B1O_LOXCS Dermonecrotic toxin LcsSicTox-betaIC1 (Fragment) OS=Loxosceles cf. spinulosa (strain GJB-2008) OX=575952 PE=2 SV=1", "sequence": "WIMGHMVNDISLVDEYLNQGANSLELDVSFNSEGIAEKLYHGYPCDCLRSCTKTVAFSTYLDYIRNITTPGDPKFRNELVLLMLDLKLKQIAPEAAYWAGFDTAEKLLDYYWQNGQSGARAYIILSIEILTHYEFVTGFKHQLQNKGHEEYSAKIGWDFSGNENLEEIHKVMSDLDLKEHIWQGDGITNCLPRGDDRLKEALFRRNTDWYKYIDKVYTWSIDKKSSIRNALRLGVDGVMTNYPERVVEVLQEPEFSSKLRLATYEDDPWARTVL", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles cf. spinulosa, specifically representing the LcsSicTox-betaIC1 fragment. This toxin belongs to the sphingomyelinase D family (also known as phospholipase D), which is the primary toxic component in Loxosceles venom responsible for inducing dermonecrosis, hemolysis, and systemic effects. The protein should function by hydrolyzing sphingomyelin and lysophosphatidylcholine in cell membranes, generating ceramide-1-phosphate and lysophosphatidic acid, respectively, which trigger inflammatory cascades, platelet aggregation, and complement activation. The sequence must adopt the conserved (α/β)8 TIM barrel fold characteristic of sphingomyelinase D enzymes, with a catalytic site featuring a binuclear metal center (typically Mg²⁺ or Mn²⁺) coordinated by conserved histidine and aspartate residues essential for phosphodiesterase activity. Include key structural motifs such as the HxKx4D motif for metal binding and substrate recognition loops that confer specificity for membrane phospholipids. The toxin should exhibit optimal activity at neutral to slightly acidic pH, reflecting its role in envenomation, and maintain stability through hydrophobic core packing and strategic disulfide bonds that stabilize the barrel structure. Ensure the sequence reflects the potent dermonecrotic and hemolytic properties critical for the spider's predatory and defensive venom strategy."}
{"description": "sp|Q9UAC9|SCAS_OLIMR Beta-toxin BmKAS OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKTVIFLIVSSLLLIGVKTDNGYLLDKYTGCKVWCVINNESCNSECKIRGGYYGYCYFWKLACFCQGARKSELWNYNTNKCNGKL", "prompt": "Design a beta-toxin protein from the scorpion Olivierus martensii (formerly known as Buthus martensii) that functions as a potent voltage-gated sodium channel modulator. This toxin should exhibit the characteristic beta-toxin mechanism of action, binding to site 4 on the extracellular domain of voltage-gated sodium channels and shifting the voltage dependence of activation toward more negative potentials, thereby enhancing channel excitability and causing neuronal hyperexcitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. The structure should contain a conserved core beta-sheet stabilized by an alpha-helix running parallel to it, with key functional residues concentrated in the 'pharmacophore' region responsible for sodium channel recognition and binding. The toxin should demonstrate high specificity for mammalian voltage-gated sodium channels, particularly Nav1.2 and Nav1.6 isoforms expressed in the central nervous system, contributing to the neurotoxic effects observed in scorpion envenomation. The sequence should include the conserved functional motifs essential for beta-toxin activity while maintaining the structural integrity required for venom stability and target specificity."}
{"description": "sp|P0DUA8|COW3_CONCL Contryphan-Cal3 OS=Californiconus californicus OX=1736779 PE=3 SV=1", "sequence": "MTRTAVLLLTLLFLVAMAASDKIKTRELCWSERECENGK", "prompt": "Design a novel peptide toxin sequence inspired by the contryphan family from the venom of Californiconus californicus, a marine cone snail species. This peptide should function as a potent neurotoxin targeting voltage-gated calcium channels, specifically Cav2.2 (N-type) channels, to inhibit neurotransmitter release and induce paralysis in prey. The sequence must adopt the characteristic contryphan structural scaffold: a compact, disulfide-rich fold stabilized by two conserved disulfide bonds forming a Cys1-Cys4, Cys2-Cys3 connectivity pattern (cysteine framework IV). Incorporate key structural motifs including a type I β-turn and a γ-turn, with a constrained backbone conformation due to the disulfide cross-links. Include a post-translational modification such as a tryptophan residue with D-configuration at a specific position to enhance receptor binding affinity and metabolic stability. The peptide should exhibit high selectivity for neuronal calcium channels over other ion channel types, with a mechanism involving pore block or allosteric modulation to disrupt calcium influx. Ensure the sequence maintains the typical contryphan length of 10-15 amino acids, with hydrophobic residues for membrane proximity and charged residues for target specificity. The overall structure should be rigid and protease-resistant, suitable for venom-based neuropharmacological applications."}
{"description": "sp|P01514|MAST_VESLE Mastoparan-L OS=Vespula lewisii OX=7452 PE=1 SV=1", "sequence": "INLKALAALAKKIL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the wasp Vespula lewisii. This amphipathic tetradecapeptide functions as a potent cytolytic toxin that disrupts cellular membranes through its strong membrane-permeabilizing activity. The peptide should adopt an alpha-helical conformation in hydrophobic environments, with a characteristic amphipathic structure where hydrophobic residues cluster on one face and cationic residues (primarily lysines) on the opposite face. This structural arrangement enables mastoparan-L to interact with lipid bilayers and G-protein coupled receptors, leading to mast cell degranulation, histamine release, and activation of phospholipase A2. The sequence should contain 14 amino acids with a high proportion of hydrophobic residues (particularly leucine and isoleucine) and multiple lysine residues that contribute to both membrane interaction and cationic charge. The peptide's mechanism involves forming pores in cell membranes and modulating intracellular signaling pathways through G-protein interactions, making it a valuable tool for studying membrane dynamics and cell signaling cascades."}
{"description": "sp|P58927|CM4B_CONPE Mu-conotoxin PnIVB OS=Conus pennaceus OX=37335 PE=1 SV=2", "sequence": "MMSKLGVLLIICLLLCPLTAVPQDGDQPADQPAERMQDDISSEHHPFFDPVKRCCKYGWTCWLGCSPCGC", "prompt": "Design a novel mu-conotoxin protein sequence inspired by the venom of Conus pennaceus, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid neuromuscular blockade and paralysis in prey. The protein should adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, disulfide-rich fold stabilized by three disulfide bonds with the conserved cysteine framework C-C-CC-C-C. This framework supports a well-defined three-dimensional structure comprising multiple loops that form the pharmacophore responsible for channel blockade. The molecular mechanism involves high-affinity binding to site 1 of the Nav1.4 channel, physically occluding the pore and preventing sodium ion flux, thereby inhibiting action potential generation in muscle fibers. The sequence should include key residues for target specificity and potency, such as a hydrophobic patch for membrane interaction and charged residues for channel recognition, while maintaining the overall stability and solubility typical of conotoxins. The final protein should exhibit high selectivity for Nav1.4 over other sodium channel isoforms to minimize off-target effects, reflecting the evolutionary optimization of cone snail venoms for precise neuropharmacological activity."}
{"description": "sp|P58922|O26G_CONTE Conotoxin Gla(1)-TxVI OS=Conus textile OX=6494 PE=1 SV=2", "sequence": "MEKLTILLLVAAVLMSTQALVERAGENHSKENINFLLKRKRAADRGMWGECKDGLTTCLAPSECCSEDCEGSCTMW", "prompt": "Design a novel conotoxin sequence inspired by Gla(1)-TxVI from the textile cone snail (Conus textile), a venomous marine predator. This toxin belongs to the Gla conotoxin family, characterized by post-translational gamma-carboxylation of glutamate residues that enhances calcium-dependent membrane interactions. The protein should function as a potent neurotoxin targeting voltage-gated calcium channels (VGCCs), specifically inhibiting neuronal N-type (Cav2.2) channels to disrupt synaptic transmission and induce paralysis in prey. The structural scaffold should feature the conserved conotoxin cysteine framework IV (C-C-CC-C-C) with three disulfide bridges forming a compact, stable globular fold. Key sequence motifs should include: (1) gamma-carboxyglutamate (Gla) residues in the N-terminal region for membrane association and target specificity, (2) a hydrophobic patch for channel pore interaction, and (3) surface-exposed basic residues for electrostatic steering to the channel's extracellular domains. The mature toxin should be 25-35 amino acids in length with high conformational stability, exhibiting the characteristic 'conotoxin fold' stabilized by disulfide connectivity (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6). The sequence must maintain the pharmacological profile of selective VGCC blockade while optimizing for expression yield and proteolytic stability."}
{"description": "sp|Q4PMW1|IXO39_IXOSC Ixodegrin YY-39 OS=Ixodes scapularis OX=6945 PE=3 SV=1", "sequence": "MNAALIAALLILGALTLDATAYSSTCERIPCTNNSDCHGPDLCQCRPPRGDDFGYFCSEY", "prompt": "Generate a protein sequence for a disintegrin toxin from the black-legged tick Ixodes scapularis. This protein, known as ixodegrin YY-39, functions as a potent anti-platelet agent by specifically targeting and inhibiting integrin receptors on blood platelets. The toxin should adopt the canonical disintegrin fold characterized by an RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to platelet integrin αIIbβ3 (GPIIb/IIIa), thereby blocking fibrinogen binding and preventing platelet aggregation. The sequence must include the conserved cysteine framework typical of short-chain disintegrins, forming disulfide bridges that stabilize a compact, globular structure with the RGD loop exposed for receptor interaction. The protein should exhibit high specificity for the platelet integrin while maintaining structural stability in the extracellular environment, reflecting its role in the tick's hematophagous strategy to facilitate blood feeding by preventing host hemostasis."}
{"description": "sp|A3F7X2|TXTR3_LASSB U3-theraphotoxin-Lsp1a OS=Lasiodora sp. (strain IBSP 8539) OX=300858 PE=2 SV=1", "sequence": "MKLSTFIIMISLAVALATWPSEHIEGSDSETKLNVELGPYALADRAEKGKDDSLNKGEPCQFHCECRGASVLCEAVYGTRSPMYKCMIKRLPISVLDIMYQAERALEKLASSFRCE", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin originates from the venom of Lasiodora sp., a tarantula species whose venom contains diverse peptide toxins that target ion channels to immobilize prey. This toxin belongs to the U3-theraphotoxin family, specifically designated Lsp1a, which typically functions as a voltage-gated ion channel modulator. The core mechanism involves selective inhibition of specific voltage-gated sodium or potassium channels, disrupting neuronal signaling and causing paralysis. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif common to spider venom peptides, with a conserved disulfide bridge pattern of C-C-C-C forming a knotted topology that provides exceptional stability and defines the bioactive surface. The three-dimensional structure should adopt a compact, globular fold stabilized by the cystine knot, with exposed loops that mediate target recognition and binding. The molecular target is likely voltage-gated sodium channels, where the toxin binds to site 4 or related domains to modulate channel gating kinetics, potentially delaying inactivation or shifting voltage dependence. The sequence must include the appropriate cysteine framework for the ICK motif, conserved hydrophobic core residues, and target-specific recognition loops that confer high-affinity binding to neuronal ion channels while maintaining the thermostability and protease resistance typical of spider venom peptides."}
{"description": "sp|P86436|CTXL_ANDAU Chlorotoxin-like peptide AaCtx OS=Androctonus australis OX=6858 PE=1 SV=1", "sequence": "MCIPCFTTNPNMAAKCNACCGSRRGSCRGPQCIC", "prompt": "Design a chlorotoxin-like peptide from the venom of the North African scorpion Androctonus australis. This peptide should function as a potent neurotoxin that selectively targets chloride channels, particularly glioma-specific chloride channels, making it relevant for neurological research and potential therapeutic applications. The peptide should adopt a stable, compact structure stabilized by four disulfide bonds in a specific cysteine framework (C-C-C-C-C-C-C-C) characteristic of scorpion toxin fold. It should feature an inhibitor cystine knot (ICK) motif with a triple-stranded beta-sheet core stabilized by the disulfide network. The molecular mechanism involves high-affinity binding to chloride channels, modulating ion conductance and potentially disrupting cellular volume regulation. The structure should include key functional residues for channel recognition and binding, maintaining the conserved scaffold of scorpion chlorotoxin-like peptides while exhibiting the specific pharmacological profile of Androctonus australis venom components."}
{"description": "sp|P00614|PA2TA_OXYSC Basic phospholipase A2 taipoxin alpha chain OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=1", "sequence": "NLLQFGFMIRCANRRSRPVWHYMDYGCYCGKGGSGTPVDDLDRCCQVHDECYGEAVRRFGCAPYWTLYSWKCYGKAPTCNTKTRCQRFVCRCDAKAAECFARSPYQNSNWNINTKARCR", "prompt": "Design a protein sequence for a potent presynaptic neurotoxin derived from the venom of the coastal taipan (Oxyuranus scutellatus), one of the world's most venomous terrestrial snakes. This toxin should function as the alpha chain of the heterotrimeric taipoxin complex, exhibiting strong basic phospholipase A2 (PLA2) activity. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG) and a catalytic network centered around histidine and aspartate residues essential for hydrolyzing the sn-2 acyl bond of membrane phospholipids. Include the canonical disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact globular structure. As part of the taipoxin complex, this alpha chain should contribute to the potent presynaptic neurotoxicity by disrupting neurotransmitter release at neuromuscular junctions through phospholipid hydrolysis, leading to membrane damage and eventual paralysis. The sequence should reflect the basic isoelectric point characteristic of neurotoxic PLA2s and maintain the structural features necessary for both enzymatic activity and integration into the heterotrimeric toxin complex."}
{"description": "sp|A0A7M6UNN1|PISP_NASVI Small pacifastin protease inhibitor OS=Nasonia vitripennis OX=7425 PE=2 SV=1", "sequence": "MSKVLKVGLLLLLVAVAASAYAVAEENGAPKENKQLPQIDDYGVTNKCPANQPFKWNCNYCTCGPEGKDASCTRMACPQH", "prompt": "Design a small pacifastin protease inhibitor protein from the parasitoid wasp Nasonia vitripennis. This protein should function as a serine protease inhibitor within the venom apparatus, playing a crucial role in regulating proteolytic activity during venom deployment. The inhibitor should adopt the characteristic pacifastin domain fold, featuring a conserved structural motif stabilized by multiple disulfide bridges that confer exceptional stability and resistance to proteolytic degradation. The core scaffold should consist of a compact, globular domain with the canonical pacifastin inhibitor cysteine framework, forming a rigid structural platform that presents key inhibitory loops for target protease binding. These loops should contain the essential reactive site residues that specifically interact with the active site of target serine proteases, forming a stable enzyme-inhibitor complex through complementary surface interactions. The protein should exhibit high specificity for its protease targets while maintaining the thermostability and structural integrity typical of pacifastin family inhibitors, enabling effective protease regulation in the venom environment."}
{"description": "sp|P01497|SIX1_ANDAU Beta-insect excitatory toxin 1 OS=Androctonus australis OX=6858 PE=1 SV=2", "sequence": "MKFLLLFLVVLPIMGVFGKKNGYAVDSSGKAPECLLSNYCNNECTKVHYADKGYCCLLSCYCFGLNDDKKVLEISDTRKSYCDTTIIN", "prompt": "Design a beta-insect excitatory toxin protein sequence derived from the venom of the North African scorpion Androctonus australis. This toxin should function as a potent insect-specific neurotoxin that targets voltage-gated sodium channels in insect nervous systems. The protein should exhibit the characteristic beta-toxin structural scaffold, featuring a conserved cysteine-stabilized alpha-beta (CSαβ) fold stabilized by four disulfide bridges with the typical C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded anti-parallel beta-sheet, creating a compact globular architecture. The toxin should specifically modulate insect sodium channels by binding to receptor site 4, causing a hyperpolarizing shift in the voltage-dependence of activation and slowing channel inactivation. This mechanism results in prolonged neuronal depolarization and repetitive firing, leading to excitatory paralysis in insect prey. The sequence should include conserved structural motifs essential for beta-toxin function, including the conserved 'pharmacophore' region responsible for receptor binding specificity. The protein should demonstrate high selectivity for insect sodium channels over mammalian counterparts, reflecting the evolutionary adaptation for prey capture. The overall architecture should maintain the characteristic compact, disulfide-rich scaffold typical of scorpion beta-toxins, with molecular weight around 6-8 kDa and basic isoelectric point to facilitate interaction with negatively charged channel surfaces."}
{"description": "sp|B4XT00|SLB1_MACLB Snaclec B1 OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "MGRIIFVSFGLLVVFLSLSGTGAALNCASGWSGYDQHCYKVFDKPKSWADAEKFCKKQTSGGHLVSFHSSEETDFVVELVSQTLESQILWMGLSKVWNQCDWGWSNGAKLKYKAWAEESYCVYFSSTKKGWRSRACRLLGHFVCKSPA", "prompt": "Design a novel C-type lectin-like protein (snaclec) from the venom of Macrovipera lebetinus (Levantine viper) that functions as a potent platelet aggregation modulator. This toxin should adopt the characteristic heterodimeric structure composed of alpha and beta subunits, each approximately 15 kDa, stabilized by multiple intrachain disulfide bonds following the conserved C-type lectin fold pattern. The protein should feature the canonical carbohydrate recognition domain (CRD) fold but evolved for specific protein-protein interactions rather than carbohydrate binding. The mechanism of action should involve high-affinity binding to platelet surface receptors, likely targeting glycoprotein receptors such as GPIb or GPVI, thereby interfering with platelet adhesion and aggregation pathways crucial for hemostasis. The structural scaffold should maintain the beta-sandwich architecture typical of C-type lectins, with conserved calcium-binding sites that may contribute to structural stability rather than carbohydrate recognition. The protein should exhibit specificity for human platelet receptors while maintaining the thermal stability and protease resistance characteristic of viperid venom proteins. The final sequence should reflect the evolutionary optimization for rapid disruption of coagulation cascades, with surface-exposed loops adapted for receptor recognition and binding affinity."}
{"description": "sp|C0JB44|B1T1_LOXSN Dermonecrotic toxin LspiSicTox-betaIE3i (Fragment) OS=Loxosceles spinulosa OX=571532 PE=2 SV=1", "sequence": "FALAHMVNDFDILKSYLDEGANGVETDITFSDEGEPEYAFHGVPCDCKRWCRRTVGFNEYLQHVRDLSTPGNPKFREHFIAIVLDLKLNGLSQEALAHGGMRLADKLIAYYWAHGRNATRITFIVSVPKTSEKVFLKTFLEEIKAVGYDDMLSKVAFDFTDNGDFSETQKVFEGLGIHEHIWASDGITNCIPMLFRGTSRLEDLIRQRDVPGYKYISKVYAWTYDKETSVVKALELGVDGVMTNYADFVIGIINKPEHSSKYRLATYQDNPFEKFVKSA", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles spinulosa. This toxin belongs to the SicTox-betaIE3i family, which are key components of Loxosceles venom responsible for causing severe dermonecrosis in envenomation victims. The toxin functions as a phospholipase D that hydrolyzes sphingomyelin and lysophosphatidylcholine in cell membranes, leading to complement activation, platelet aggregation, hemolysis, and extensive tissue damage. The protein should adopt the characteristic (β/α)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the conserved catalytic histidine and other essential residues positioned in the active site pocket. The sequence should include the signature HxK(x)4D motif crucial for phosphodiesterase activity. As a member of the SicTox family, it should exhibit the conserved structural features that enable membrane binding and substrate recognition. The toxin should be stable and soluble, with appropriate surface properties for interacting with mammalian cell membranes. Generate a sequence that captures the potent dermonecrotic activity while maintaining the structural integrity required for this phospholipase D toxin family."}
{"description": "sp|P0DL00|BPPBG_BOTFO Bradykinin-potentiating peptide 11g OS=Bothrops fonsecai OX=157549 PE=1 SV=1", "sequence": "QARPRHPKIPP", "prompt": "Generate the amino acid sequence for a bradykinin-potentiating peptide (BPP) from the venom of Bothrops fonsecai, a pit viper species. This peptide functions as a potent vasoactive toxin that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), thereby prolonging bradykinin's half-life and amplifying its vasodilation and inflammatory responses. The peptide belongs to the BPP family characterized by a pyroglutamylated N-terminus and a C-terminal proline-rich region, typically containing a conserved IPP or similar motif that is critical for ACE inhibition. The structure is expected to be small (approximately 5-15 residues), linear, and lacking disulfide bridges, with a compact conformation stabilized by proline residues that facilitates binding to the active site of ACE. The molecular target is the zinc-metallopeptidase domain of ACE, where the peptide competitively inhibits bradykinin degradation, leading to increased bradykinin-mediated signaling and contributing to the venom's hypotensive and pro-inflammatory effects during envenomation."}
{"description": "sp|P0DL62|KA311_BUTOC Potassium channel toxin alpha-KTx 31.1 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "AGSMDSCSETGVCMKACSERIRQVENDNKCPAGECICTT", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the scorpion Buthus occitanus tunetanus, a member of the medically significant Buthidae family. This toxin should function as a potent and selective inhibitor of voltage-gated potassium channels, specifically targeting Kv1 subfamily channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, which provides exceptional stability through three disulfide bridges arranged in a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold of approximately 30-40 residues, with a well-defined functional surface comprising a critical lysine-rich patch that inserts into the channel pore to physically occlude potassium ion conduction. Include key pharmacophore residues that confer both high-affinity binding to the channel's voltage-sensing domain and subtype selectivity, while maintaining the characteristic beta-sheet secondary structure stabilized by the disulfide core. The toxin should exhibit the typical evolutionary adaptations seen in scorpion venom peptides: minimal molecular weight, protease resistance, and precise molecular targeting to maximize pharmacological potency against invertebrate or vertebrate prey."}
{"description": "sp|P0DL04|BPPBI_BOTJA Bradykinin-potentiating peptide 11i OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "QNGPRPIGIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the pit viper Bothrops jararaca, a medically significant snake responsible for numerous envenomations in South America. This peptide functions as a potent vasoactive toxin by inhibiting angiotensin-converting enzyme (ACE), thereby preventing the degradation of bradykinin and leading to enhanced bradykinin-mediated vasodilation, hypotension, and increased vascular permeability. The peptide should adopt a compact, stable structure stabilized by a characteristic pyroglutamic acid residue at the N-terminus, which confers resistance to aminopeptidase degradation, and a C-terminal proline-rich region that is essential for ACE inhibition. The sequence should be relatively short (approximately 5-15 amino acids) with a high proportion of proline residues, particularly in the C-terminal region, which is critical for binding to the active site of ACE. The overall structure should be linear and flexible, lacking disulfide bridges, to allow for optimal interaction with the enzyme's catalytic domain. The peptide should exhibit high specificity for ACE over other zinc metalloproteases, contributing to its role in potentiating bradykinin's effects and inducing hypotension as part of the snake's predatory and defensive venom arsenal."}
{"description": "sp|P0C8U9|CA15_CONPL Alpha-conotoxin-like Pu1.5 OS=Conus pulicarius OX=93154 PE=3 SV=1", "sequence": "MFTVFLLVILATTVVPFPSDRDPASNHENSKGSNRNAWLTPEECCAAPACREMILEFCLAGEAFAAALDGFRRLPYRLSSE", "prompt": "Design a novel alpha-conotoxin peptide with the following specifications: This toxin originates from the venom of Conus pulicarius, a marine cone snail species. As an alpha-conotoxin, it should function as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes. The peptide should adopt the characteristic alpha-conotoxin fold stabilized by two disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern, forming a compact globular structure. Key structural features should include a conserved cysteine framework (CC-C-C), short inter-cysteine loops with specific loop lengths optimized for nAChR binding, and a well-defined beta-hairpin motif. The molecular mechanism involves high-affinity binding to the orthosteric site of neuronal nAChRs, blocking acetylcholine-mediated neurotransmission. The sequence should contain appropriate post-translational modifications typical of conotoxins, including amidated C-terminus and potential hydroxylation of proline residues. The overall structure should be thermodynamically stable with the disulfide-constrained fold providing resistance to proteolytic degradation, characteristic of cone snail venom peptides that must maintain activity in the hostile environment of the envenomated prey."}
{"description": "sp|B4XT05|SLB6_MACLB Snaclec B6 (Fragment) OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "DCPWDWSSHEGHCYKVFKLRKTWEDAEKFCTEQARGGHLISLKSTEEVDFMIKLAYPILKANLVWIGLRDFWRDCHMGWRDHANLLYKAWSDEPNCSVAKTTDNQWFRRKCNISQYFVCQSRVPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) derived from the blunt-nosed viper (Macrovipera lebetinus). This protein should function as a key component of the viper's venom system, which primarily targets the hemostatic system of prey organisms through interference with platelet function and coagulation pathways. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by two conserved disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The structural scaffold should feature the typical α-β-α sandwich architecture with two antiparallel β-sheets and two α-helices, forming a stable platform for molecular recognition. The protein should specifically interact with platelet membrane receptors, likely glycoprotein receptors such as GPIb or GPVI, through its concave surface formed by the loops connecting secondary structure elements. The binding interface should mediate inhibition or activation of platelet aggregation, contributing to the hemorrhagic or procoagulant effects characteristic of viper venoms. The sequence should include conserved residues for calcium-independent carbohydrate recognition domain functionality and maintain the structural integrity required for target recognition in the context of envenomation."}
{"description": "sp|A0A8B6XS44|ACTL3_HYDVU Hydra actinoporin-like toxin 3 (Fragment) OS=Hydra vulgaris OX=6087 PE=2 SV=2", "sequence": "LEATVSRNKKYKFTMGNVVRSWKCTVENKSNKTLYADGSTPVSGSMATVLTDIAPGGTGVFLWEQSKGAARGAVGVVYYRYEDKILSLMASIPYDWHLYNAWANARVSNKKESFSNLYNGYDGAQQPTIAGNWGEVDGTKFFLTDKSHAEFNVIFSG", "prompt": "Design a protein sequence for an actinoporin-like toxin derived from the freshwater polyp Hydra vulgaris. This toxin should function as a potent pore-forming cytolysin that targets cell membranes, particularly those rich in sphingomyelin. The protein should adopt the characteristic actinoporin structural fold, featuring a stable beta-sandwich core stabilized by conserved disulfide bridges, with a cluster of aromatic and cationic residues in the membrane-binding region that facilitate initial lipid recognition and insertion. Include a functional N-terminal amphipathic helix that undergoes conformational rearrangement to form the transmembrane pore upon membrane binding. The mechanism should involve specific binding to sphingomyelin-rich membrane domains, followed by oligomerization to create stable, cation-selective pores that disrupt cellular osmotic balance and lead to rapid cell lysis. The structural scaffold should maintain the compact, water-soluble conformation typical of actinoporins in solution, with surface-exposed loops that mediate target specificity and membrane interaction."}
{"description": "sp|B4XT07|SLB8_MACLB Snaclec B8 (Fragment) OS=Macrovipera lebetinus OX=3148341 PE=2 SV=1", "sequence": "DCPWDWSSHEGHCYKVFKFATTWEDAEKFCTEQARGGHLISIKSTEEVDFMIKLAYPILKANLVWIGLRVEDFWRDCHMGWRDHANLLSKPGVVHNTKCFGLDQKTGYRTWVALRCELAYHFICMSRVPR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) derived from the blunt-nosed viper (Macrovipera lebetinus). This toxin belongs to the snaclec family, which are non-enzymatic venom components that typically function as platelet aggregation modulators or coagulation factor antagonists. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure stabilized by conserved disulfide bridges. The core scaffold should feature the typical CTLD pattern with multiple disulfide bonds that maintain the stable β-sheet and α-helical secondary structure elements. Functionally, this snaclec likely targets components of the hemostatic system, potentially acting as an anticoagulant by binding to coagulation factors (such as factor IX/X) or as a platelet aggregation inhibitor by interacting with platelet surface receptors like GPIb or integrins. The molecular mechanism involves specific protein-protein interactions mediated by surface loops and conserved residues within the CTLD fold that recognize carbohydrate or protein motifs on target molecules. The sequence should reflect the venom's biological role in prey immobilization through disruption of normal blood coagulation pathways."}
{"description": "sp|Q8JFE6|BM8A_BOMMX Prokineticin Bm8-a OS=Bombina maxima OX=161274 PE=1 SV=1", "sequence": "MKCFAQIVVLLLVIAFSHGAVITGVCDRDAQCGSGTCCAASAFSRNIRFCVPLGNNGEECHPASHKVPYNGKRLSSLCPCNTGLTCSKSGEKFQCS", "prompt": "Design a novel protein sequence for a potent animal toxin derived from the skin secretions of the large-webbed bell toad, Bombina maxima. This toxin belongs to the prokineticin family and should function as a high-affinity agonist for G-protein coupled receptors, specifically targeting the prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). The protein should adopt the characteristic prokineticin structural fold, featuring a compact globular domain stabilized by five conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C-C-C, forming a distinctive five-disulfide knot architecture. The mature toxin should contain approximately 80-90 amino acids and exhibit the conserved AVITGA motif at the N-terminus, which is critical for receptor recognition and activation. The structural core should consist of a three-stranded antiparallel beta-sheet arrangement stabilized by the disulfide network, creating a rigid scaffold that confers exceptional proteolytic stability and thermal resistance. The toxin should function by binding to prokineticin receptors in the central nervous system and peripheral tissues, triggering intracellular calcium mobilization and activating multiple signaling pathways including MAPK/ERK and PI3K/Akt cascades. This should result in potent nociceptive effects, gastrointestinal motility modulation, and potential neuroinflammatory responses, making it a valuable tool for studying pain pathways and gastrointestinal disorders. The sequence should maintain key conserved residues for receptor binding while incorporating species-specific variations that enhance potency and selectivity for mammalian targets."}
{"description": "sp|P0DL23|SCXS_TITPA Putative beta-neurotoxin (Fragment) OS=Tityus pachyurus OX=288781 PE=1 SV=2", "sequence": "IDMVVECNKDGYLMEHDGCKLSCLMKKGTFCAEECQRMKGKDGYCYAWLACYCYNMPDWVKTWSRATNRCGK", "prompt": "Design a beta-neurotoxin protein sequence derived from the venom of Tityus pachyurus, a medically significant scorpion species. This toxin should function as a potent neurotoxin targeting voltage-gated sodium channels, specifically acting to delay channel inactivation and prolong neuronal depolarization, leading to sustained neurotransmitter release and potentially fatal neuroexcitatory effects. The protein should adopt the conserved structural scaffold characteristic of scorpion beta-neurotoxins, featuring a compact globular fold stabilized by a specific disulfide bridge pattern typically involving four conserved cysteine residues forming two disulfide bonds (C1-C4, C2-C3 connectivity). The structure should contain both alpha-helical and beta-sheet elements arranged in a core-insectotoxin domain fold. Key functional residues should be positioned to interact with the voltage-sensing domain of neuronal sodium channels, particularly binding to site 4 on the channel's domain II. The toxin should exhibit high affinity and selectivity for mammalian sodium channel subtypes, contributing to the venom's paralytic and neurotoxic effects through presynaptic action at neuromuscular junctions."}
{"description": "sp|B5G6G6|VKT2_PSEPO Kunitz-type serine protease inhibitor blackelin-2 OS=Pseudechis porphyriacus OX=8671 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEGLTPVSSKDRPDFCELPDDRGPCRGIFHAFYYNPDQRQCLEFIYGGCYGNANNFKTIDECKRTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin from the venom of the Australian red-bellied black snake (Pseudechis porphyriacus). This toxin, known as blackelin-2, should adopt the characteristic Kunitz domain fold—a conserved structural motif comprising an alpha-helix packed against an antiparallel beta-sheet—stabilized by three disulfide bonds in a specific connectivity pattern (typically Cys1-Cys6, Cys2-Cys4, Cys3-Cys5). The protein must function as a potent and selective inhibitor of serine proteases, likely targeting key enzymes in the prey's hemostatic system (such as coagulation factors or kallikreins) to induce anticoagulant effects and disrupt physiological homeostasis. The sequence should include the canonical reactive site loop, which directly interacts with the protease's active site, and maintain the overall structural integrity required for high-affinity binding and inhibitory activity. Emphasize conservation of residues critical for protease recognition and inhibition, while ensuring the protein exhibits the stability and specificity characteristic of snake venom Kunitz-type inhibitors."}
{"description": "sp|P83253|DID1A_MACLB Disintegrin lebein-1-alpha OS=Macrovipera lebetinus OX=3148341 PE=1 SV=2", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEIVYPKKVTVLPTGAMNSGNPCCDPVTCKPRRGEHCVSGPCCRNCKFLNAGTICNRARGDDMNDYCTGISSDCPRNPYKD", "prompt": "Design a protein sequence for a disintegrin toxin from the venom of the Levantine viper (Macrovipera lebetinus). This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on the surface of blood platelets. The mechanism of action involves high-affinity binding to the RGD (Arg-Gly-Asp) recognition site of integrins such as αIIbβ3 (glycoprotein IIb/IIIa), thereby preventing fibrinogen binding and subsequent platelet aggregation, which is crucial for the viper's prey immobilization through disruption of hemostasis. The protein should adopt the characteristic disintegrin fold, featuring a compact, globular structure stabilized by multiple disulfide bonds that confer stability and rigidity. The sequence must include the conserved RGD motif positioned within an exposed, flexible loop that serves as the primary integrin-binding interface. The structural scaffold should be dominated by beta-sheets and loops, with the RGD-containing loop being highly accessible for receptor interaction. The overall fold should ensure the RGD motif is presented in the correct conformation for high-affinity integrin binding, mimicking the natural toxin's role in venom-induced anticoagulation and hemorrhage."}
{"description": "sp|A0A7S8MU55|SCX17_TITSE Putative sodium channel toxin Ts17 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MNYFIFLVVACLLTAGTEGKKDGYPVEGDNCAFACFGYDNAYCDKLCKDKKADSGYCYWVHILCYCYGLPDKEPTKTSGRCKPGKK", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal or cardiac isoforms to induce excitatory neurotoxicity through delayed channel inactivation or altered activation kinetics. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion toxin family 2, featuring a compact globular fold stabilized by four disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements should include an alpha-helix packed against an antiparallel beta-sheet, forming a molecular surface with a conserved 'pharmacophore' region responsible for channel interaction. The toxin should exhibit high affinity binding to the voltage-sensing domain or pore region of sodium channels, leading to prolonged action potentials and neuronal hyperexcitability. Incorporate conserved residues critical for structural integrity and target recognition, while introducing sequence variations that confer the specific functional profile of Ts17-like toxins within the Tityus serrulatus venom arsenal."}
{"description": "sp|P0DL77|CT1A_CORTR U1-theraphotoxin-Ct1a OS=Coremiocnemis tropix OX=1904443 PE=1 SV=1", "sequence": "MKTFTLIAILTCAVLVIFHAAAAEELEVQDVIQPEDTLTGLATLDEDRLFECSFSCDIKKNGKPCKGSGEKKCSGGWRCKMNFCVKV", "prompt": "Design a novel animal toxin protein sequence that mimics the biological activity and structural characteristics of U1-theraphotoxin-Ct1a from the tarantula species Coremiocnemis tropix. This toxin belongs to the theraphotoxin family, which are cysteine-rich peptides typically found in spider venoms that function as modulators of ion channels. The protein should adopt a stable, compact tertiary structure stabilized by a specific pattern of disulfide bridges, characteristic of inhibitory cysteine knot (ICK) motifs commonly observed in spider toxins. The core function of this toxin is likely to involve the selective inhibition or modulation of voltage-gated ion channels, such as sodium (NaV), potassium (KV), or calcium (CaV) channels, contributing to prey immobilization or defense. The sequence must include conserved cysteine residues arranged in a framework that enables the formation of disulfide bonds essential for structural integrity and biological activity. The molecular target interface should facilitate high-affinity binding to specific ion channel subtypes, potentially interfering with channel gating or ion permeation. The overall fold should exhibit a globular, knotted architecture with exposed loops that mediate target recognition and interaction, ensuring the toxin's efficacy in disrupting neuronal or muscular signaling pathways."}
{"description": "sp|Q8JIV8|SL_DEIAC Snaclec clone 2100755 OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTAADCPSGWSSYDGHCYQVFSDLKNWDDAESFCSGQHEGSRLASIHSREEEAFVGKMASRTLKYTSMWLGLNNPWKECKWEWSDDTRLDYKVWTRRPYCTVMVVKTDRIFWFNRGCEKSVSFVCKFKAYSEDAAE", "prompt": "Design a novel snake venom C-type lectin-like protein (snaclec) derived from the venom of Deinagkistrodon acutus, the hundred-pace viper. This protein should function as a key component in the viper's potent hemotoxic venom system, which primarily targets mammalian blood coagulation pathways. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a conserved double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The structural scaffold should feature a globular domain with an α-helix packed against a curved antiparallel β-sheet, forming a functional dimer interface. The protein should specifically target platelet membrane glycoproteins, likely GPIb or GPVI, through its concave surface to inhibit platelet aggregation or coagulation factors to disrupt hemostasis. The sequence should include conserved calcium-binding motifs if functioning as a true C-type lectin, or maintain the structural homology while evolving distinct target specificity. Key structural elements should include the long-loop region responsible for target recognition, conserved hydrophobic core stabilizing the β-sheet platform, and surface-exposed residues mediating protein-protein interactions with hemostatic system components."}
{"description": "sp|P0DM14|TXP1_PHLXX Mu-theraphotoxin-Pspp1 OS=Phlogiellus sp. OX=2211175 PE=1 SV=1", "sequence": "ACLGQWDSCDPKASKCCPNYACEWKYPWCRYKLF", "prompt": "Design a novel animal toxin protein sequence inspired by mu-theraphotoxin-Pspp1 from the tarantula Phlogiellus species. This toxin should function as a potent inhibitor of voltage-gated sodium channels (Nav), specifically targeting the channel's voltage-sensing domain to impede channel activation and inhibit neuronal excitability. The protein must adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that confers exceptional stability and resistance to proteolytic degradation. Incorporate key functional residues for high-affinity binding to Nav channels, including hydrophobic and cationic residues that interact with the channel's S3-S4 linker region. The sequence should reflect the biological role of tarantula venom in prey immobilization through disruption of neuromuscular signaling, with a molecular mechanism involving allosteric modulation of sodium channel gating. Ensure the structural scaffold maintains the ICK fold's rigidity to preserve target specificity and potency, while optimizing for expression feasibility and minimal off-target effects."}
{"description": "sp|P86522|3L2A2_ACAAN Alpha-elapitoxin-Aa2a (Fragment) OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "VICYRGYNYAQPCPPGENVCFTKTWCDARCYQLGK", "prompt": "Generate the amino acid sequence for an alpha-elapitoxin from the common death adder (Acanthophis antarcticus), a potent postsynaptic neurotoxin that functions as a competitive antagonist of muscle-type nicotinic acetylcholine receptors at the neuromuscular junction. This three-finger toxin adopts a characteristic β-stranded fold stabilized by four conserved disulfide bridges forming the C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The toxin's functional core resides in its central loop II, which contains key residues that directly interact with the orthosteric binding site of the α-subunit of the nicotinic receptor, preventing acetylcholine binding and inducing flaccid paralysis. The sequence should reflect the structural hallmarks of the three-finger toxin superfamily while encoding the specific pharmacological profile of alpha-elapitoxins that enables rapid prey immobilization through neuromuscular blockade."}
{"description": "sp|P83255|VM1F_MACLB Snake venom metalloproteinase fibrolase OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "ERFAPRYIELVIVADHSVATKYNDNVTAILSWVHQLVNNIILFYRDLNVHFTLSAVEVWSNGDLINVQPEATVTLNLFGEWRERDLLNRRMHDNAQLLNNVALDDNTIGLAYDEGMCDPKYSVGIVKDHSAINRMVAATMAHEIGHNLGMNHDGSQCNCGGNGCVMSAVLMQQHSYQFSDCSKDEYQRYLTNHNPQCILNQP", "prompt": "Design a snake venom metalloproteinase protein with fibrolase-like activity, derived from Macrovipera lebetinus (Levantine viper). This toxin belongs to the reprolysin family of zinc-dependent metalloproteinases and functions as a fibrinolytic agent that directly degrades fibrin clots, contributing to the hemorrhagic and coagulopathic effects of viper venom. The protein should feature a conserved metalloproteinase domain with the characteristic zinc-binding motif HEXXHXXGXXH, where the three histidine residues coordinate the catalytic zinc ion and the glutamate acts as a catalytic base. The structural scaffold should include the typical metzincin topology with an N-terminal propeptide domain (removed upon activation), a catalytic metalloproteinase domain containing a central five-stranded beta-sheet flanked by alpha-helices, and a C-terminal disintegrin-like domain that may modulate substrate specificity. The protein should exhibit specific cleavage activity against the alpha and beta chains of fibrinogen, leading to rapid defibrination and anticoagulation. Key structural elements include conserved cysteine residues forming disulfide bridges that stabilize the protein fold, particularly around the active site region. The molecular mechanism involves hydrolyzing fibrin and fibrinogen without requiring plasminogen activation, making it a direct-acting fibrinolytic enzyme with potential implications for understanding thrombosis and hemorrhagic pathology."}
{"description": "sp|A0A7S8MVN3|LVA41_TITSE Putative sodium channel toxin Ts41 OS=Tityus serrulatus OX=6887 PE=3 SV=1", "sequence": "MKIGVLFTIISMLCLLEVRKICSKKEGGYPRYFSFGYKCQNWGTNEYCRTVCQLHKGEYGYCYAGDCYCEGLTEENRLFWNVYRKYCKNPLFD", "prompt": "Design a novel sodium channel toxin derived from the venom of the Brazilian yellow scorpion Tityus serrulatus, a medically significant species known for producing potent neurotoxins that target voltage-gated sodium channels. This toxin should function as a beta-type scorpion toxin, specifically modulating sodium channel inactivation by binding to receptor site 4 on the extracellular side of voltage-gated sodium channels, particularly Nav1.4 and Nav1.6 isoforms. The mechanism involves slowing or preventing fast inactivation, leading to prolonged action potentials, repetitive firing, and neuronal hyperexcitability. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, with a core alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges in a C1-C4, C2-C5, C3-C6 pattern. Key functional residues should include a conserved hydrophobic patch for membrane interaction and basic residues in the C-terminal region critical for receptor site 4 binding. The toxin should be approximately 60-70 amino acids in length, with a compact, globular structure and high thermal stability due to the disulfide network. The biological significance lies in its role in prey immobilization through disruption of neuromuscular transmission, making it a valuable tool for studying sodium channel physiology and potential therapeutic applications."}
{"description": "sp|A0SE60|CA11_CONPL Alpha-conotoxin-like Pu1.1 OS=Conus pulicarius OX=93154 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRTSDGRNAAFNAFDLIALTARQNCCNVPGCWAKYKHLCGRKR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus pulicarius, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the defining cysteine framework (CC-C-C) with appropriate inter-cysteine loop lengths that confer high-affinity binding to the orthosteric site of nAChRs, competitively inhibiting acetylcholine binding and disrupting cholinergic signaling. Incorporate key pharmacophore residues that determine receptor subtype selectivity and potent neurotoxic activity, while maintaining the stable, disulfide-constrained conformation essential for target engagement and resistance to proteolytic degradation. The final sequence should represent a functionally optimized conotoxin with potential applications in neuroscience research and pharmacological tool development."}
{"description": "sp|P86538|3SA2A_NAJNA Cytotoxin 2a OS=Naja naja OX=35670 PE=1 SV=2", "sequence": "LQCNKLVPIASKTCPPGKNLCYKMFMVSDLTIPVKRGCIDVCPKNSLLVKYECCNTDRCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the Indian cobra, Naja naja, that functions as a potent membrane-disrupting agent. This three-finger toxin should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C5, C4-C6, and C7-C8. The protein should exhibit strong cytolytic activity through direct interaction with cell membranes, causing pore formation and cell lysis. Key structural features should include three extended β-stranded loops emerging from a central hydrophobic core, with specific residues in loop regions mediating membrane binding and disruption. The toxin should demonstrate preferential cytotoxicity toward certain cell types while maintaining the thermal stability and structural rigidity characteristic of this toxin family. The sequence should contain the conserved cysteine framework and hydrophobic patches essential for membrane interaction and cytolytic function."}
{"description": "sp|B5KL27|VKT3_OXYMI Kunitz-type serine protease inhibitor microlepidin-3 OS=Oxyuranus microlepidotus OX=111177 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELPADIGPCEDFTGAFHYSPREHECIEFIYGGCEGNANNFNTLEECESACAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin from the venom of the inland taipan (Oxyuranus microlepidotus), known as microlepidin-3. This toxin should function as a potent serine protease inhibitor, specifically targeting enzymes involved in hemostasis and coagulation pathways, such as trypsin, chymotrypsin, or kallikrein, thereby disrupting prey homeostasis and facilitating prey immobilization. The protein should adopt the characteristic Kunitz-type fold, featuring a conserved alpha-beta structural motif with a central antiparallel beta-sheet stabilized by three disulfide bonds in a C1-C6, C2-C4, C3-C5 connectivity pattern. The active site should include a canonical protease-binding loop with key residues (e.g., P1 position) critical for specificity and inhibitory activity. Ensure the sequence reflects the compact, stable scaffold typical of Kunitz domains, with hydrophobic core packing and surface-exposed loops optimized for target engagement. The design should prioritize functional efficacy, structural integrity, and venom-typical properties for biomedical or research applications."}
{"description": "sp|B5G6G8|WAPA_OXYSC Scuwaprin-a OS=Oxyuranus scutellatus scutellatus OX=8667 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSGQDRPKKPGLCPPRPQKPPCVKECKNDWSCPGQQKCCSYGCIDECRDPIFVN", "prompt": "Design a venom protein sequence for a potent snake toxin from the coastal taipan (Oxyuranus scutellatus), one of the world's most venomous terrestrial snakes. This protein should function as a weak apoptosis-inducing protein (WAP) domain-containing toxin, specifically classified as a scuwaprin. The toxin should exhibit the characteristic structural features of WAP domain proteins, including a conserved four-disulfide core architecture with the canonical cysteine framework C-X(6)-C-X(5)-C-X(9)-C-X(4)-C-X(6)-C-X(12)-C-X(8)-C. The protein should fold into a compact, globular structure stabilized by these eight cysteine residues forming four disulfide bridges that create a rigid scaffold. As a WAP domain toxin, it should function as a serine protease inhibitor, specifically targeting and inhibiting key proteolytic enzymes involved in physiological processes. The toxin should demonstrate potent biological activity by interfering with hemostatic pathways, potentially through inhibition of coagulation factors or platelet aggregation enzymes. The sequence should include conserved residues critical for protease binding and inhibition, particularly around the reactive site loop. The structural fold should enable specific molecular recognition of target proteases while maintaining stability in the venom milieu. The protein should represent a sophisticated evolutionary adaptation for prey immobilization through disruption of essential proteolytic cascades."}
{"description": "sp|Q8QGP7|VNP2_DENAN Natriuretic peptide DNP-2 OS=Dendroaspis angusticeps OX=8618 PE=3 SV=1", "sequence": "EVKYDPCFGHKIDRINHVSNLGCPSLRDPRPTAPAALRIIRDLHPDSKQSQAA", "prompt": "Generate the amino acid sequence for a natriuretic peptide toxin from the Eastern green mamba (Dendroaspis angusticeps) venom. This peptide belongs to the natriuretic peptide family and functions as a potent vasoactive toxin that targets the natriuretic peptide receptor system. The protein should adopt the characteristic natriuretic peptide fold consisting of a conserved 17-amino acid ring structure formed by a disulfide bridge between two cysteine residues, creating a stable cyclic domain essential for receptor binding. The mature peptide should exhibit the typical natriuretic peptide mechanism of action: binding to natriuretic peptide receptors (primarily NPR-A and NPR-B) in vascular smooth muscle and renal tissues, activating guanylyl cyclase activity, increasing intracellular cGMP levels, and producing vasodilation, natriuresis, and diuresis. The structural scaffold should include the conserved cysteine framework that forms the essential disulfide-bonded ring, flanked by N- and C-terminal extensions that may modulate receptor specificity and potency. The peptide should demonstrate the characteristic biological activity of Dendroaspis natriuretic peptides - causing profound hypotension through potent vasodilation and contributing to prey immobilization through cardiovascular collapse."}
{"description": "sp|B5KF99|KA11M_OLIMR Potassium channel toxin alpha-KTx J123 OS=Olivierus martensii OX=34649 PE=3 SV=1", "sequence": "MNKVYLVAVLVLFLALTINESNEAVPTGGCPFSDFFCAKRCKDMKFGNTGRCTGPNKTVCKCSI", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. Include key functional residues in the beta-sheet region that form the functional dyad for channel block, with a lysine or arginine residue positioned to penetrate the channel pore and interact with conserved residues in the selectivity filter, and surrounding hydrophobic/aromatic residues for complementary surface interactions. The sequence should maintain the compact globular structure (~30-40 residues) with high thermal and proteolytic stability conferred by the disulfide network, while optimizing for selective Kv1 channel blockade over other potassium channel subtypes to enhance its potential as a pharmacological tool for studying neuronal excitability and ion channel function."}
{"description": "sp|P0DL47|KBX3_EUSVA Scorpine-like peptide Ev37 OS=Euscorpiops validus OX=1643527 PE=1 SV=1", "sequence": "MNSKLTVIVLLALITIASCGLINEKKVQQYLDEKLPNGVVKGALKSLVHKAAKNQNLCAFNVDTVGMCDADCKRQGKAKGVCHGTKCKCDVELSYKK", "prompt": "Design a scorpine-like peptide toxin derived from the venom of Euscorpiops validus, a scorpion species. This peptide should exhibit the characteristic dual functional domains of scorpine-family toxins: an N-terminal region with defensin-like antimicrobial activity and a C-terminal region with potassium channel-blocking neurotoxic properties. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) motif typical of scorpion venom peptides, with a disulfide bridge pattern of C1-C4, C2-C5, C3-C6 that stabilizes the compact globular fold. The peptide should function as a potent inhibitor of voltage-gated potassium channels (particularly Kv1.3), disrupting neuronal excitability and neuromuscular transmission through pore-blocking mechanisms. The antimicrobial domain should demonstrate broad-spectrum activity against Gram-positive bacteria via membrane disruption. Ensure the sequence maintains the amphipathic character essential for membrane interactions, with basic residues facilitating target recognition. The overall structure should be stabilized by the disulfide framework, forming a stable, compact molecule resistant to proteolytic degradation, characteristic of scorpion venom peptides evolved for efficient prey immobilization and defense."}
{"description": "sp|A0SE59|CA13_CONMR Alpha-conotoxin-like Mr1.3 OS=Conus marmoreus OX=42752 PE=3 SV=1", "sequence": "MGMRMMFTMCLLVVLATTVISFTSDRASNGRNAAAKDKASDLNALNVRGCCSHPACRVHYPHVCYGRR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of the marine cone snail Conus marmoreus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two conserved disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the signature cysteine framework (CC-C-C) with appropriate inter-cysteine loop lengths that define the receptor subtype selectivity profile. Incorporate key pharmacophore residues in the inter-cysteine loops that mediate high-affinity binding to the orthosteric site of nicotinic receptors, particularly residues that confer specificity for alpha3beta2 or alpha7 receptor subtypes. The toxin should exhibit the typical molecular weight range of 1.5-2.5 kDa and maintain the conserved structural motifs that enable precise receptor blockade while preserving the characteristic beta-sheet elements and tight turns that define the alpha-conotoxin structural family. Ensure the sequence reflects the evolutionary optimization for rapid neuromuscular paralysis while maintaining the stability conferred by the disulfide-constrained framework."}
{"description": "sp|P0DL59|PM2A_PHLSP Mu-theraphotoxin-Phlo2a (Fragment) OS=Phlogius sp. OX=1690075 PE=1 SV=1", "sequence": "SCQKWMWLCDEERKCCEDMVCKLWCK", "prompt": "Design a protein sequence for a theraphosid spider venom toxin that functions as a potent insecticidal agent. This toxin should belong to the inhibitory cysteine knot (ICK) structural family, characterized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6 that forms a stable, triple-stranded beta-sheet scaffold. The protein should act as a voltage-gated sodium channel modulator, specifically targeting insect neuronal sodium channels to induce paralysis through altered channel gating kinetics. The structural core should maintain the compact, globular fold typical of ICK toxins, with surface loops optimized for selective interaction with insect sodium channel isoforms while minimizing mammalian toxicity. The sequence should include key residues for membrane penetration and receptor binding specificity characteristic of spider venom peptides that disrupt insect nervous system function."}
{"description": "sp|P83303|TXH4_CYRSC Huwentoxin-IV OS=Cyriopagopus schmidti OX=29017 PE=1 SV=2", "sequence": "MVNMKASMFLALAGLVLLFVVCYASESEEKEFSNELLSSVLAVDDNSKGEERECLEIFKACNPSNDQCCKSSKLVCSRKTRWCKYQIGK", "prompt": "Design a protein sequence for a neurotoxic peptide derived from the venom of the Chinese earth tiger tarantula, Cyriopagopus schmidti. This toxin functions as a potent and selective inhibitor of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype, which plays a critical role in pain signaling pathways. The toxin operates by binding to the channel's voltage-sensing domain II, stabilizing it in a deactivated state and preventing channel activation, thereby blocking neuronal excitability. Structurally, the peptide adopts an inhibitor cystine knot (ICK) motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by three disulfide bridges with a connectivity pattern of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6. This scaffold confers exceptional stability and resistance to proteolytic degradation. The molecular surface features a conserved hydrophobic patch and key basic residues that mediate high-affinity interaction with the channel's S3-S4 loop in domain II. The toxin should exhibit high selectivity for Nav1.7 over other sodium channel subtypes, making it a valuable tool for studying pain mechanisms. Ensure the sequence reflects these structural and functional constraints, including the precise cysteine framework and residues critical for target engagement."}
{"description": "sp|B5KL30|VKT4_OXYSC Kunitz-type serine protease inhibitor scutellin-4 OS=Oxyuranus scutellatus scutellatus OX=8667 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSKDHPEFCELPADSGPCRGILHAFYYHPVHRTCLGFIYGGCYGNANNFKTIDECKRTCAA", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by scutellin-4 from the venom of the coastal taipan (Oxyuranus scutellatus). This protein should function as a potent serine protease inhibitor, specifically targeting key proteases involved in the coagulation cascade and fibrinolysis pathways. The structural scaffold must adhere to the canonical Kunitz domain fold, characterized by a compact, globular structure stabilized by three conserved disulfide bonds with the characteristic Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The protein should feature the characteristic Kunitz-type inhibitor loop that serves as the primary protease-binding interface, with residues optimized for high-affinity interaction with serine protease active sites. The overall architecture should maintain the stable beta-sheet core typical of Kunitz domains, ensuring proper folding and functional stability. The designed protein should exhibit the dual functionality observed in many snake venom Kunitz-type inhibitors, capable of modulating both coagulation and potentially other physiological processes through serine protease inhibition, reflecting the complex envenomation strategy of elapid snakes."}
{"description": "sp|P0DL33|KA301_SCOR Potassium channel toxin alpha-KTx 30.1 OS=Scorpiops margerisonae OX=856992 PE=2 SV=1", "sequence": "MNTGFFFFVIMATGLVLTFDTIHAEDKLKCTKTDDCAKYCSQFTDVHPACLGGYCECLRWEGGISS", "prompt": "Design a novel potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx toxins from scorpion venom. The protein should be derived from Scorpiops margerisonae, a scorpion species whose venom contains potent ion channel modulators for prey immobilization and defense. This toxin functions as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion potassium channel toxins, featuring an alpha-helix stabilized against a three-stranded anti-parallel beta-sheet by a specific disulfide bridge pattern. The cysteine framework should follow the C1-C2...C3-C4...C5-C6 pattern typical of alpha-KTx family members, with disulfide bonds connecting C1-C4, C2-C5, and C3-C6 to create the stable structural core. Key functional residues should be positioned in the beta-sheet region to form the molecular interface for potassium channel binding, including conserved basic residues that interact with the channel pore region. The protein should maintain the compact globular architecture (~30-40 residues) with high thermal and proteolytic stability conferred by the disulfide network. Include the characteristic functional dyad or triad of residues responsible for channel block specificity and potency. The sequence should reflect evolutionary conservation of the core scaffold while incorporating species-specific variations that maintain or enhance potassium channel blocking activity."}
{"description": "sp|A1X8B6|CA14_CONLE Alpha-conotoxin Lp1.4 OS=Conus leopardus OX=101306 PE=1 SV=1", "sequence": "MGMRMMSIMFMLVVLATTVVSFTSDRALDAMNAAASKKASRLIALAVRGCCSHPACSGNHQELCDGRR", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus leopardus, a marine cone snail predator. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuromuscular junction subtypes to induce rapid paralysis in prey. The protein must adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (Cys-Cys-Cys-Cys connectivity forming two disulfide bonds: Cys1-Cys3 and Cys2-Cys4). The sequence should feature conserved cysteine residues that form this stable disulfide-bonded core, enabling a compact, rigid structure with exposed loops that mediate high-affinity receptor binding. Key structural elements should include a beta-hairpin motif and well-defined loops that interact with the orthosteric binding site of nAChRs, competitively inhibiting acetylcholine binding. The toxin should exhibit high specificity for muscle-type nAChRs (e.g., α1β1γδ subtypes) over neuronal subtypes, leveraging conserved pharmacophore residues in loop regions for target engagement. Ensure the sequence reflects the evolutionary optimization of cone snail venoms for rapid neuromuscular blockade, with minimal off-target effects and stability in the extracellular environment."}
{"description": "sp|B5KL37|VKT6_CRYNI Kunitz-type serine protease inhibitor nigrescinin-6 OS=Cryptophis nigrescens OX=292442 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSTDRPDFCELPEDSGSCKGNFEAFYYNSDQHQCLEFIYGGCDGNANNFKTIEECKLTCAA", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by nigrescinin-6 from the venom of Cryptophis nigrescens (small-eyed snake). This toxin should function as a potent serine protease inhibitor, characteristic of Kunitz-type venom components that disrupt prey homeostasis by interfering with key proteolytic pathways. The protein must adopt the conserved Kunitz domain fold, featuring a stable alpha-beta structure with characteristic disulfide connectivity (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 in typical Kunitz inhibitors) that creates a rigid, protease-resistant scaffold. The active site should contain a canonical protease-binding loop with residues optimized for specific serine protease recognition and inhibition, likely targeting trypsin-like or other coagulation cascade proteases given its snake venom origin. The sequence should maintain the structural hallmarks of Kunitz domains while incorporating venom-optimized features for enhanced stability and inhibitory potency, reflecting its evolutionary role in venom-mediated prey immobilization."}
{"description": "sp|P0DL44|KAX3H_BUTPA Potassium channel toxin alpha-KTx 3.17 OS=Buthus paris OX=1388771 PE=1 SV=1", "sequence": "GVPINVKCSGSRDCLEPCKKAGMRFGKCINRKCHCTPK", "prompt": "Design a novel potassium channel toxin protein sequence that embodies the biological and structural characteristics of alpha-KTx toxins from Buthus paris scorpion venom. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 family channels to disrupt neuronal excitability and neuromuscular signaling. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion potassium channel toxins, featuring a compact globular architecture stabilized by three disulfide bridges with the canonical C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved functional dyad comprising a critical lysine residue positioned to occlude the potassium selectivity filter and an adjacent aromatic residue that facilitates binding to the channel vestibule. Incorporate the signature alpha-helix and anti-parallel beta-sheet structural elements that define this toxin family, with the functional dyad located within the beta-sheet region. The toxin should exhibit high affinity binding to the pore region of Kv1 channels, effectively blocking potassium efflux and prolonging action potential duration. Ensure the sequence maintains the characteristic molecular weight and isoelectric point typical of scorpion alpha-KTx toxins, while preserving the structural stability and target specificity that make these molecules effective neurotoxic agents in scorpion venom for prey immobilization and defense."}
{"description": "sp|P86545|VSP_NAJNA Thrombin-like enzyme TLP (Fragment) OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "IGGFECNEHEHRSLVYLYNSAGFFCAGTLLNHEWVV", "prompt": "Design a protein sequence for a thrombin-like enzyme derived from the venom of the Indian cobra, Naja naja. This enzyme functions as a key component of the snake's venom arsenal, contributing to prey immobilization through disruption of hemostasis. The protein should exhibit serine protease activity, specifically cleaving fibrinogen to generate fibrin monomers, thereby promoting localized coagulation and potentially leading to consumptive coagulopathy. The enzyme should feature a trypsin-like fold characteristic of snake venom serine proteases, with a canonical catalytic triad (His, Asp, Ser) and a substrate-binding pocket that confers specificity for fibrinogen. The structure should include appropriate disulfide bridges to stabilize the fold, typical of SVSPs, with conserved cysteine patterns that maintain the structural integrity required for enzymatic function. The molecular target is fibrinogen, with the enzyme acting on the Aα and/or Bβ chains to release fibrinopeptides A and B, mimicking the action of mammalian thrombin but with potential differences in cleavage specificity and kinetics that underlie its toxicological impact."}
{"description": "sp|P0DL48|TX20A_AGEAP Omega-agatoxin-Aa5a OS=Agelenopsis aperta OX=6908 PE=1 SV=1", "sequence": "EACAGAYKSCDKVKCCHDRRCRCNIAMDNCVCKLFYCELFGTCDRLKP", "prompt": "Design a protein sequence for a potent neurotoxin from the funnel-web spider Agelenopsis aperta that functions as a selective calcium channel blocker. This toxin should belong to the omega-agatoxin family and specifically target P/Q-type voltage-gated calcium channels (Cav2.1) in the mammalian central nervous system. The protein should adopt the inhibitor cystine knot (ICK) structural motif characteristic of spider venom peptides, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves high-affinity binding to the voltage-sensing domain of Cav2.1 channels, effectively blocking synaptic neurotransmitter release and causing paralysis. Key structural elements should include surface-exposed loops critical for channel recognition and binding specificity, with conserved hydrophobic and basic residues that interact with the channel's pore region. The toxin should exhibit the typical molecular weight and physicochemical properties of spider venom peptides, maintaining high stability and potency characteristic of this toxin class."}
{"description": "sp|B5KL39|VKT2_AUSSU Kunitz-type serine protease inhibitor superbin-2 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPISSKDRPKFCELPADTGPCKAIFQAFYYHPVHRTCLKFIYGGCEGNANNFKTIDECKRTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Australian lowland copperhead snake, Austrelaps superbus. This toxin functions as a potent serine protease inhibitor, likely targeting key proteases in the prey's physiological systems to disrupt homeostasis, coagulation cascades, or inflammatory responses. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, and Cys3-Cys5 connectivity pattern. The active site should include a canonical protease-binding loop with residues optimized for specific, high-affinity inhibition of serine proteases such as trypsin, chymotrypsin, or coagulation factors. The sequence must maintain the structural integrity of the Kunitz scaffold while incorporating venom-specific adaptations that enhance stability, target specificity, and inhibitory potency in a predatory context."}
{"description": "sp|B5KL38|VKT1_AUSSU Kunitz-type serine protease inhibitor superbin-1 OS=Austrelaps superbus OX=29156 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPEFCKLPADTGRCKGKFPAFYYHPVHRTCLEFIYGGCKGNPNNFKTIDECERTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This toxin should function as a potent serine protease inhibitor, likely targeting key proteases in the prey's physiological systems to disrupt homeostasis. The protein should adopt the characteristic Kunitz-type fold, featuring a conserved beta-trefoil structure with alpha-helices and beta-strands arranged in a stable globular conformation. Include the canonical Kunitz-type cysteine framework with three disulfide bridges (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity) that stabilize the inhibitory loop region. The active site should contain a reactive center loop with specific residues optimized for serine protease binding and inhibition, potentially targeting coagulation factors or other serine proteases involved in prey defense mechanisms. Ensure the sequence maintains the structural integrity required for venom stability while exhibiting high specificity and potency as a protease inhibitor."}
{"description": "sp|B5KL32|VKT3_NOTSC Kunitz-type serine protease inhibitor tigerin-3 OS=Notechis scutatus scutatus OX=70142 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEILTPVSSKDRPHFCHLPHDTGPCNRNTQAFYYNPVYHTCLKFIYGGCQGNSNNFKTIDECKRTCAA", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: The protein is a Kunitz-type serine protease inhibitor from the venom of the tiger snake, Notechis scutatus scutatus. This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, likely targeting factors such as thrombin, factor Xa, or plasmin, thereby disrupting hemostasis and promoting prey immobilization through hemorrhage. The protein should adopt the characteristic Kunitz domain fold, consisting of a compact globular structure stabilized by three conserved disulfide bonds with a typical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The structural scaffold features a twisted beta-sheet and a short alpha-helix, with the inhibitory loop (P1-P1' residues) forming the primary protease-binding interface. Key functional residues should include a canonical P1 residue (e.g., Lys or Arg for trypsin-like proteases) within the binding loop, which inserts into the protease active site, and additional exosite interactions for enhanced specificity and potency. The sequence must maintain the Kunitz-type inhibitor signature, including conserved cysteine positions for disulfide formation, and exhibit high stability and specificity for serine protease targets relevant to snake venom toxicity."}
{"description": "sp|A1X8B8|CA1_CONQU Putative alpha-conotoxin Qc alphaL-1 OS=Conus quercinus OX=101313 PE=5 SV=1", "sequence": "MGMRMMFTMFLLVVLATTVVSINLDHAFDGRNAAANNKATDLMARTVRRFCSDPPCRISNPESCGWEP", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the defining cysteine framework (CC-C-C) with appropriate inter-cysteine loop regions that confer receptor subtype selectivity. Key structural elements should include: a short N-terminal loop preceding the first cysteine, a well-defined central alpha-helical region between the second and third cysteines, and C-terminal residues critical for receptor binding affinity. The toxin should exhibit high specificity for its neuronal nAChR targets while maintaining the typical conotoxin properties of small size (12-20 amino acids), disulfide-stabilized tertiary structure, and potent neurotoxic activity through competitive inhibition of acetylcholine binding sites. The final sequence must be biologically plausible for cone snail venom and demonstrate the characteristic pharmacological profile of alpha-conotoxins as selective neuromuscular and neuronal nAChR blockers."}
{"description": "sp|Q8UUK0|3SOF3_NAJAT Cytotoxin homolog Clbp-3 OS=Naja atra OX=8656 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRKCHNSPLSLVYQTCPIGQNICFKINVKEAPSIPVKRACAATCPKSSALVKVVCCKTDKCN", "prompt": "Generate a protein sequence for a cytotoxin from the venom of the Chinese cobra (Naja atra), belonging to the three-finger toxin superfamily. This toxin functions as a cytotoxin that disrupts cell membranes through direct interaction with lipid bilayers, leading to cell lysis and tissue damage. The protein should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with a C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural features include three extended loops (fingers) projecting from a central globular core, with the central loop typically enriched in hydrophobic residues critical for membrane interaction. The molecular mechanism involves insertion of hydrophobic regions into cell membranes, causing permeability changes and eventual cell death. The sequence should contain conserved residues for structural stability and functional loops that facilitate membrane binding and cytolytic activity."}
{"description": "sp|P83519|LECG_BOTJR C-type lectin BJcuL OS=Bothrops jararacussu OX=8726 PE=1 SV=2", "sequence": "MGRFLFVASSACWFVFLSLSGAKGNNCPQDWLPMNGLCYKIFNELKAWKDAEMFCRKYKPGCHLASIHLYGESPEIAEYISDYHKGQSEVWIGLCDKKKDFSWEWTDRSCTDYLSWDKNQPDHYQNKEFCVELVSNTGYRLWNDQVCESKNAFLCQCKF", "prompt": "Design a C-type lectin protein from the venom of Bothrops jararacussu, a pit viper species. This toxin functions as a key component in the snake's venom arsenal, primarily targeting the hemostatic system of prey through carbohydrate recognition. The protein should exhibit calcium-dependent carbohydrate binding activity, specifically recognizing galactose or related sugar moieties on platelet glycoproteins and endothelial cell surfaces. This binding interferes with platelet aggregation and coagulation cascades, contributing to the hemorrhagic and anticoagulant effects characteristic of Bothrops envenomation. The structural scaffold must feature a canonical C-type lectin fold with two distinct domains: a carbohydrate recognition domain (CRD) containing conserved calcium-binding motifs (EPN or QPD motifs) and a long alpha-helical coiled-coil region that facilitates dimerization. The protein should form stable homodimers through disulfide bridges, with the characteristic C-type lectin domain fold stabilized by conserved disulfide bonds between cysteine residues. The binding interface should include key residues for calcium coordination and carbohydrate recognition, enabling specific interaction with target glycoproteins involved in hemostasis. The overall structure should be compact and globular, with the CRD presenting the functional binding site for interference with platelet function and coagulation pathways."}
{"description": "sp|P0DM60|A4A1_LOXIN Dermonecrotic toxin LiSicTox-alphaIVA1 OS=Loxosceles intermedia OX=58218 PE=1 SV=1", "sequence": "MLFPTALIFGCWALVIEGADNRRPIWNMGHMVNEVYQIDEFVDLGANSIETDITFDDDAMAEYSYHGVPCDCRRWCHKWEYVNVFLDGLRRATTPGDSKYRPELTLVVFDLKTGDLSSSTAYKGGKLFAQKLLDRYWNGGNNGGRAYIIISIPDIDHYAFITGFREALKNANHEELLDKVGYDFSGNDDLSSTRTALNKAGVKDREHVWQSDGITNCILRGLDRVREAVRNRDSSNGYINKVYYWTIEKYVSVRDALDAGVDGIMTNEPDVIVNVLNEGNYRGRFRLANYDDNPWVTFK", "prompt": "Design a protein sequence for a dermonecrotic toxin from the brown spider Loxosceles intermedia. This toxin belongs to the sphingomyelinase D family and functions as a phospholipase D enzyme that hydrolyzes sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger potent inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage, ultimately causing the characteristic dermonecrotic lesions and systemic effects of loxoscelism. The protein should adopt the conserved (α/β)8 TIM barrel fold typical of sphingomyelinase D enzymes, with the active site containing essential metal-coordinating residues (likely histidine and aspartate residues) for catalytic activity. The structure should maintain the characteristic disulfide bonding pattern that stabilizes the barrel architecture. The toxin should specifically target membrane phospholipids in dermal and vascular tissues, with high affinity for sphingomyelin-rich membrane domains. The sequence should reflect the molecular adaptations that make this enzyme particularly potent in disrupting mammalian cell signaling pathways and causing tissue necrosis."}
{"description": "sp|P0DM49|PA2X1_BOTPA Phospholipase A2 neuwieditoxin-1 (Fragment) OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "DLVQFGQMILKVAGRSLPKSYGAYGCYCGWGGRGK", "prompt": "Generate the amino acid sequence for a phospholipase A2 toxin from the venom of Bothrops pauloensis, a venomous pit viper. This toxin, known as neuwieditoxin-1, functions as a potent myotoxic and neurotoxic agent that targets presynaptic nerve terminals. The protein should exhibit canonical phospholipase A2 activity, hydrolyzing the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and cell damage. The structure should feature the conserved phospholipase A2 fold characterized by three long alpha-helices stabilized by multiple disulfide bridges, typically following the cysteine pattern C-C-C-C-C-C. The catalytic site should include the essential histidine-aspartate dyad for enzymatic activity. The toxin should possess specific molecular determinants for presynaptic targeting, potentially involving surface-exposed cationic residues that facilitate binding to neuronal membranes. The sequence should reflect the characteristic calcium-binding loop required for catalytic function and maintain the hydrophobic substrate-binding channel. The generated protein should demonstrate both enzymatic phospholipid degradation and specific neurotoxic effects consistent with presynaptic blockade at neuromuscular junctions."}
{"description": "sp|A1X8C2|CA18_CONLE Alpha-conotoxin-like Lp1.8 OS=Conus leopardus OX=101306 PE=3 SV=1", "sequence": "MGMRMMFTMFLLVVLTTTVVSFNSDRESNHENRRTSNQITRGVWDECCKDPQCRQNHMQHCPAR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus leopardus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the signature CC-Xm-C-Xn-C motif typical of alpha-conotoxins, with appropriate loop lengths between cysteine residues that determine receptor subtype specificity. The mature toxin should be short (approximately 12-20 amino acids) and highly basic, facilitating interaction with the orthosteric binding site of nAChRs at the interface of alpha and complementary subunits. The structural core should form a stable beta-hairpin-like motif with defined loop regions that mediate target recognition and binding affinity. The toxin should exhibit high potency and selectivity for its neuronal nAChR targets, contributing to the paralytic activity of Conus leopardus venom through disruption of cholinergic signaling in the nervous system of prey organisms."}
{"description": "sp|A2CKF6|3NO28_BUNFA Neurotoxin 3FTx-8a OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCLICPERYCQKVHTCRGEEKLCVKRFYDEKALGWRAKRGCAATCPEAKPKETVECCSTDKCNK", "prompt": "Design a neurotoxic protein sequence that functions as a three-finger toxin (3FTx) from the venom of the banded krait, Bungarus fasciatus. This toxin should adopt the characteristic three-finger structural fold stabilized by a conserved disulfide bond framework, typically featuring four to five disulfide bridges that maintain the three extended loops emerging from a central hydrophobic core. As a member of the 3FTx family, this neurotoxin likely targets specific ion channels or receptors in the nervous system, potentially acting as a postsynaptic neurotoxin that binds with high affinity to nicotinic acetylcholine receptors at the neuromuscular junction, leading to paralysis. The sequence should include key structural motifs such as the three β-stranded loops that facilitate target recognition and binding, conserved cysteine residues forming the disulfide scaffold, and hydrophobic patches critical for structural integrity and interaction with molecular targets. The protein should exhibit high specificity and potency as a neurotoxin, contributing to the predatory and defensive functions of krait venom by disrupting synaptic transmission."}
{"description": "sp|P0DM52|PA2B2_BOTPA Basic phospholipase A2 BnpTX-2 (Fragment) OS=Bothrops pauloensis OX=1042543 PE=1 SV=1", "sequence": "SLWEFAQMILEETKRLPFPYYGAYGCYCGWGGQGQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin derived from Bothrops pauloensis venom. This enzyme should function as a potent toxin with multiple pharmacological activities characteristic of snake venom phospholipases A2. The protein should exhibit calcium-dependent catalytic activity for hydrolyzing the sn-2 ester bond of membrane phospholipids, producing lysophospholipids and free fatty acids that disrupt cellular membrane integrity. The structural scaffold should feature the conserved phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG/XCG) and catalytic network involving a conserved histidine-aspartate dyad. Include the characteristic disulfide bridge pattern that stabilizes the globular structure, with conserved cysteine residues forming the structural core. The protein should possess basic isoelectric properties that may facilitate membrane interaction and potentially contribute to myotoxic, neurotoxic, or anticoagulant activities through both enzymatic and non-enzymatic mechanisms. The sequence should maintain the characteristic N-terminal helix, β-wing region, and C-terminal loop architecture typical of group II phospholipase A2 enzymes from viperid venoms, with appropriate surface residues that may mediate specific protein-protein interactions contributing to its toxicological profile."}
{"description": "sp|P83561|TXMG5_MACGS Beta-hexatoxin-Mg1a OS=Macrothele gigas OX=223896 PE=1 SV=2", "sequence": "MKAPATTLILVMSLISVLWATPDLEEGDLLAELGDLIATDDEYPMKPEERGCKLTFWKCKNKKECCGWNACALGICMPR", "prompt": "Design a beta-hexatoxin protein sequence derived from the venom of the giant funnel-web spider Macrothele gigas. This toxin belongs to the beta-hexatoxin family and functions as a potent insecticidal agent by selectively targeting insect voltage-gated sodium channels. The toxin acts as a gating modifier, binding to the voltage-sensing domain of the channel and stabilizing it in an activated state, leading to prolonged channel opening, membrane depolarization, and ultimately paralysis or death in insect prey. The structural scaffold should feature the characteristic inhibitor cystine knot (ICK) motif, stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a compact, triple-stranded beta-sheet fold. Key structural elements include a hydrophobic patch on the molecular surface that mediates interaction with the lipid-exposed voltage sensor of the sodium channel, and a conserved 'hot spot' region rich in basic residues that facilitates specific binding to the channel's S3-S4 loop. The sequence should maintain the typical length and physicochemical properties of spider venom ICK toxins, with a balanced distribution of hydrophobic, polar, and charged residues to ensure proper folding, stability in the venom gland, and target specificity. The final protein should exhibit high affinity for insect sodium channels while minimizing cross-reactivity with mammalian homologs, reflecting its evolutionary role in prey immobilization."}
{"description": "sp|P86721|BPP12_BOTAT Bradykinin-potentiating peptide 12a OS=Bothrops atrox OX=8725 PE=1 SV=1", "sequence": "QQWPRDPAPIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of Bothrops atrox, a venomous pit viper. This peptide functions as a potent vasoactive agent that enhances the hypotensive effects of bradykinin by inhibiting angiotensin-converting enzyme (ACE), leading to reduced blood pressure and contributing to prey immobilization through cardiovascular shock. The peptide should adopt a characteristic proline-rich structure typical of BPPs, with a pyroglutamic acid residue at the N-terminus that confers resistance to aminopeptidase degradation, and a C-terminal proline or proline-rich sequence that is essential for ACE inhibition. The structure is expected to be relatively linear and flexible due to the high proline content, facilitating interaction with the active site of ACE. The molecular target is angiotensin-converting enzyme, with the peptide binding to the zinc-binding domain of ACE to competitively inhibit the conversion of angiotensin I to angiotensin II, thereby amplifying bradykinin-mediated vasodilation. The sequence should reflect the conserved features of BPPs, including the N-terminal pyroglutamate and proline-rich C-terminus, without disulfide bridges, to ensure functional mimicry of the natural toxin's mechanism in potentiating bradykinin and inducing hypotension."}
{"description": "sp|P0DM77|VM2_DEIAC Disintegrin accutin OS=Deinagkistrodon acutus OX=36307 PE=1 SV=1", "sequence": "QGAQCTAGPCCWPCKFLKEGTICRRARGDDLDDYCNGISADCPRNPYY", "prompt": "Design a novel disintegrin protein sequence inspired by accutin from the venom of the hundred-pacer snake (Deinagkistrodon acutus). This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on platelet surfaces. The sequence must feature the characteristic RGD (Arg-Gly-Asp) motif that mediates high-affinity binding to integrin αIIbβ3 (GPIIb/IIIa), thereby preventing fibrinogen binding and subsequent platelet aggregation. Incorporate a compact, disulfide-rich scaffold typical of snake venom disintegrins, with conserved cysteine residues forming multiple intramolecular disulfide bonds that stabilize the protein's tertiary structure and present the RGD loop in an optimal conformation for receptor interaction. The overall fold should be small (approximately 5-9 kDa) and devoid of enzymatic domains, reflecting the processed nature of mature disintegrins derived from larger precursor proteins. Ensure the sequence includes key residues surrounding the RGD motif that enhance binding specificity and affinity, and maintain the characteristic cysteine framework that defines the disintegrin family's structural integrity."}
{"description": "sp|B5L5Q1|VKT7_PSETT Kunitz-type serine protease inhibitor textilinin-7 OS=Pseudonaja textilis textilis OX=169397 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPKFCELLPDTGSCEDFTGAFHYSTRDRECIEFIYGGCGGNANNFKTLEECESTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the Australian eastern brown snake, Pseudonaja textilis. This toxin, known as textilinin-7, functions as a potent and specific inhibitor of plasmin, playing a crucial role in the snake's venom by preventing fibrinolysis and promoting hemostatic disturbances in envenomed prey. The protein should adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The sequence must include the conserved reactive site loop that specifically targets the active site of plasmin, with key residues for protease recognition and inhibition. The molecular mechanism involves tight-binding inhibition of plasmin's serine protease activity, thereby blocking the degradation of fibrin clots and contributing to the pro-coagulant effects of the venom. The structural scaffold should maintain the compact, globular fold typical of Kunitz-type inhibitors, ensuring proper presentation of the inhibitory loop for specific molecular recognition and high-affinity binding to the plasmin active site."}
{"description": "sp|Q05110|VA5_VESVU Venom allergen 5 OS=Vespula vulgaris OX=7454 PE=1 SV=1", "sequence": "MEISGLVYLIIIVTIIDLPYGKANNYCKIKCLKGGVHTACKYGSLKPNCGNKVVVSYGLTKQEKQDILKEHNDFRQKIARGLETRGNPGPQPPAKNMKNLVWNDELAYVAQVWANQCQYGHDTCRDVAKYQVGQNVALTGSTAAKYDDPVKLVKMWEDEVKDYNPKKKFSGNDFLKTGHYTQMVWANTKEVGCGSIKYIQEKWHKHYLVCNYGPSGNFMNEELYQTK", "prompt": "Design a venom allergen protein from the common wasp Vespula vulgaris that functions as a major allergen in hypersensitivity reactions. This protein belongs to the antigen 5 family of venom allergens and should exhibit the characteristic CAP domain superfamily fold, which consists of an alpha-beta-alpha sandwich structure with conserved disulfide bridges stabilizing the core. The protein should possess allergenic epitopes that trigger IgE-mediated immune responses in sensitized individuals, leading to systemic anaphylaxis in severe cases. The structural scaffold should feature the conserved cysteine framework typical of antigen 5 proteins, maintaining the proper spacing and connectivity of disulfide bonds essential for structural integrity and immunological recognition. The protein should demonstrate thermal stability and resistance to proteolytic degradation, consistent with venom components that must remain functional after injection. The molecular surface should present specific conformational epitopes that interact with immune receptors, while maintaining the overall globular architecture characteristic of this allergen family."}
{"description": "sp|A2CKF7|3NO2_BUNFA Neurotoxin 3FTx-LT OS=Bungarus fasciatus OX=8613 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTLTCLICPEKYCQKVHTCRDGENLCVKRFYEGKRFGKKYPRGCAATCPEAKPHEIVECCSTDKCNK", "prompt": "Design a novel neurotoxin protein sequence based on the three-finger toxin (3FTx) structural family, specifically the long-chain subtype (3FTx-LT) from the banded krait (Bungarus fasciatus). This toxin should adopt the characteristic three-finger β-sheet fold stabilized by four conserved disulfide bonds with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8, forming a compact, globular structure. The protein must function as a potent postsynaptic neurotoxin that targets and antagonizes nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, leading to flaccid paralysis. Incorporate key functional loops, particularly an extended central loop II that enhances receptor binding specificity and affinity. Ensure the sequence includes conserved hydrophobic residues and cationic amino acids critical for interacting with the receptor's ligand-binding domain. The toxin should exhibit high selectivity for neuronal or muscle-type nAChR subtypes, contributing to the venom's role in prey immobilization and defense."}
{"description": "sp|Q8UW28|3L23_HYDHA Alpha-elapitoxin-Lh2a OS=Hydrophis hardwickii OX=8781 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGDSLSCYLGYKRSQTCPPGEKVCFVKSWCDAFCGSRGKRIEMGCAATCPTVKDGIDITCCATDNCNTYANWGSG", "prompt": "Design a novel animal toxin protein sequence based on the following detailed biological specifications: This is an alpha-elapitoxin from the venom of the sea snake Hydrophis hardwickii, belonging to the three-finger toxin (3FTx) superfamily. The protein should adopt the characteristic three-finger structural fold composed of three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the cysteine framework C-C-C-C-C-C-C-C. As a long-chain alpha-neurotoxin, it functions as a potent and selective competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The mechanism involves high-affinity binding to the orthosteric site of muscle-type nAChRs, specifically competing with acetylcholine for binding at the alpha-delta and alpha-gamma subunit interfaces, thereby blocking neurotransmission and causing flaccid paralysis. The structural scaffold should feature the extended central loop typical of long-chain alpha-neurotoxins, which enhances receptor affinity and specificity. The protein should exhibit the characteristic structural stability conferred by the conserved disulfide bonding pattern while maintaining the functional surface residues necessary for specific receptor recognition and binding. This toxin represents a key component of sea snake venom for prey immobilization through neuromuscular blockade."}
{"description": "sp|Q90W98|VKT4_PSETT Kunitz-type serine protease inhibitor textilinin-4 OS=Pseudonaja textilis textilis OX=169397 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDHPKFCELPADTGSCKGNVPRFYYNADHHQCLKFIYGGCGGNANNFKTIEECKSTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the Australian eastern brown snake (Pseudonaja textilis). This toxin, known as textilinin-4, functions as a potent and specific inhibitor of plasmin, playing a crucial role in the snake's venom by preventing fibrinolysis and promoting hemostasis impairment in envenomed prey. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved alpha-beta structure with an antiparallel beta-sheet stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The sequence must include the essential reactive site loop that confers specificity for plasmin, with key residues positioned to interact with the enzyme's active site and exosites to achieve high-affinity inhibition. The structural scaffold should maintain the compact, globular fold typical of Kunitz inhibitors, ensuring thermodynamic stability and resistance to proteolytic degradation while enabling precise molecular recognition of its serine protease target."}
{"description": "sp|P0DL81|TX1A_APHSP Omega-theraphotoxin-Asp1a OS=Aphonopelma sp. OX=29932 PE=1 SV=1", "sequence": "LFECVLSCDIKKNGKPCKPKGEKKCSGGWRCKINFCLKV", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is an omega-theraphotoxin from the venom of Aphonopelma sp. tarantulas, belonging to the inhibitor cystine knot (ICK) structural family. As an omega-theraphotoxin, it functions as a potent voltage-gated calcium channel (Cav) blocker, specifically targeting neuronal Cav2.x subtypes (likely Cav2.2/N-type channels) involved in neurotransmitter release. The protein should adopt the characteristic ICK fold stabilized by a conserved disulfide bridge pattern with a cysteine framework of C-C-CC-C-C, forming three disulfide bonds that create the knotted core structure. This scaffold provides exceptional thermal and proteolytic stability while presenting key functional loops for target interaction. The molecular mechanism involves high-affinity binding to the voltage-sensing domain of Cav channels, effectively inhibiting channel opening and blocking calcium influx into presynaptic terminals, thereby disrupting synaptic transmission and producing neurotoxic effects. The protein should exhibit the typical compact, globular architecture of ICK toxins with exposed loops containing critical residues for channel recognition and binding specificity. The sequence should reflect the evolutionary optimization of tarantula venom for rapid immobilization of prey through precise modulation of neuronal excitability."}
{"description": "sp|B5L5R7|VKT2_HOPST Kunitz-type serine protease inhibitor stephenin-2 OS=Hoplocephalus stephensii OX=196418 PE=3 SV=1", "sequence": "MSSGGLLLLLGLLTLLEILTPVSSKDRPKFCELPADSGSCKGNFQAFYYNPDQHQCLEFIYGGCDGNANNFKTIDECKRTCAA", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Stephens' banded snake (Hoplocephalus stephensii), specifically representing the stephenin-2 toxin. This protein should function as a potent serine protease inhibitor that disrupts hemostatic pathways in prey organisms. The toxin should adopt the characteristic Kunitz-type fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three conserved disulfide bridges in the C1-C6, C2-C4, C3-C5 connectivity pattern. The protein should contain the canonical Kunitz domain with the reactive site loop that specifically targets and inhibits serine proteases involved in blood coagulation, likely through a substrate-like mechanism where the inhibitor mimics the natural substrate of the protease. The structural scaffold should maintain the compact, globular fold typical of Kunitz-type inhibitors, with the inhibitory loop positioned for optimal interaction with the protease active site. The protein should exhibit high specificity and potency characteristic of snake venom Kunitz-type inhibitors, contributing to the prey immobilization effects of Stephens' banded snake venom through interference with coagulation cascades."}
{"description": "sp|P83912|VM2JT_PROJR Zinc metalloproteinase-disintegrin jerdonitin OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNIDDYEVVYPRKVTALPKGAVQQKYEDTMQYEFKVNEEPVVLHLEKNKGLFSKDYSETHYSPDGREITTYPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGETYFIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKKLSQIMIPPEQQRYIELVIVADHRMYTKYDGDKTEISSKIYETANNLNEIYRHLKIHVVLIGLEMWSSGELSKVTLSADETLDSFGEWRERDLLQRKRHDNAQLLTGMIFNEKIEGRAYKESMCDPKRSVGIVRDHRTRPHLVANRMAHELGHNLGFHHDGDSCTCGANSCIMSATVSNEPSSRFSDCSLFQYSSDIIHNPFTSRCLYNEPSKTDIVSPSVCGNYYMEVGEDCDCGPPANCQNPCCDAATCRLTPGSQCADGLCCDQCRFMKKGTICRIARGDDLDDYCNGISAGCPRNPFHA", "prompt": "Design a novel zinc metalloproteinase-disintegrin toxin from the venom of Protobothrops jerdonii, a pit viper species. This multifunctional toxin should exhibit the characteristic modular architecture of snake venom metalloproteinases (SVMPs), comprising a metalloproteinase domain and a disintegrin domain. The metalloproteinase domain must feature a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion, enabling proteolytic cleavage of extracellular matrix components such as fibrinogen, collagen, and von Willebrand factor, thereby promoting hemorrhage and disrupting hemostasis. The disintegrin domain should adopt a compact, disulfide-rich fold stabilized by multiple disulfide bonds, typically including a key RGD (Arg-Gly-Asp) or related tripeptide motif that mediates high-affinity binding to integrin receptors (e.g., αIIbβ3 on platelets or αvβ3 on endothelial cells), inhibiting platelet aggregation and cell adhesion. The overall structure should reflect the P-II class of SVMPs, where the proteinase and disintegrin domains are covalently linked, and the disintegrin may be released proteolytically in vivo. Ensure the sequence encodes appropriate signal peptides and propeptides for proper folding and secretion, and incorporate conserved cysteine residues to form the essential disulfide bridges that stabilize both domains. The toxin should exemplify the evolutionary adaptation of viperid venoms to immobilize prey through dual mechanisms of tissue damage and anticoagulation."}
{"description": "sp|B5U6Y7|SL125_ECHOC Snaclec CTL-Eoc125 OS=Echis ocellatus OX=99586 PE=2 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGIGADQECLPGWSFYEGHCYKVFSEYKNWVDAEQYCTEQENGGHLVSFHNREEVDFVVKLGYTILKADIVWIGLRDFWRECHWEWSNGAQLDYKGWSDEPNCFIAYTVGNKWLRRKCSSTQQFICKARVPH", "prompt": "Design a novel C-type lectin-like protein (snaclec) from the venom of Echis ocellatus, the West African carpet viper, that functions as a potent anticoagulant toxin. This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a conserved double-loop structure stabilized by two conserved disulfide bridges (typically Cys1-Cys3 and Cys2-Cys4 in the canonical pattern). The protein should specifically target and inhibit key components of the mammalian coagulation cascade, particularly binding to coagulation factor IX or factor X with high affinity, thereby disrupting the coagulation pathway and promoting hemorrhage. The sequence should include conserved residues for calcium-independent carbohydrate recognition, hydrophobic core formation, and surface-exposed loops that mediate specific protein-protein interactions with coagulation factors. The structural scaffold should maintain the compact globular fold typical of snake venom C-type lectins, with beta-sheets and alpha-helices arranged to present functional epitopes for precise molecular recognition in hemostatic disruption."}
{"description": "sp|P83655|KKX13_HETSP Potassium channel toxin kappa-KTx 1.3 OS=Heterometrus spinifer OX=118530 PE=1 SV=1", "sequence": "GFGCYRSCWKAGHDEETCKKECS", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of kappa-KTx 1.3 from the venom of the Malaysian forest scorpion Heterometrus spinifer. This toxin should function as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should include the conserved functional dyad or triad responsible for potassium channel pore blockade, typically involving key aromatic and basic residues that interact with the channel's selectivity filter and voltage-sensing domains. The structural scaffold should maintain the stable beta-sheet and alpha-helical elements that provide the rigid framework necessary for precise channel interaction. This toxin should exhibit the typical venom function of disrupting neuronal excitability and neuromuscular transmission through potassium channel inhibition, contributing to the scorpion's predatory and defensive capabilities."}
{"description": "sp|B5U6Y6|SL124_ECHOC Snaclec CTL-Eoc124 OS=Echis ocellatus OX=99586 PE=2 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTGADCLPDWSPYQGHCYRVFNQKMTWADAEKFCTEQANGGHLASFHSSKEVDFMVSLAFPMLKVDFVWIGMSDFWRDCEWKWSDGAKLDYKAWNNELNCFVSKTTDNQWLRWDCSRTNNVACKYPL", "prompt": "Design a novel C-type lectin-like protein (snaclec) from the venom of Echis ocellatus, the West African carpet viper, a medically significant snake responsible for severe hemotoxic envenomation in sub-Saharan Africa. This toxin should function as a platelet-aggregating protein that binds specifically to platelet membrane receptors, likely GPIb or GPVI, through its carbohydrate recognition domain (CRD) in a calcium-independent manner. The protein should adopt the characteristic snaclec fold: a compact, globular structure stabilized by two conserved disulfide bridges (Cys1-Cys4 and Cys2-Cys3) within the cysteine framework typical of snake venom C-type lectins. The structure should feature a β-sheet-rich core with loop regions critical for receptor recognition and binding. The molecular mechanism should involve high-affinity binding to platelet surface glycoproteins, leading to platelet activation, aggregation, and subsequent thrombotic effects, contributing to the procoagulant venom phenotype. Ensure the sequence encodes the conserved residues for the C-type lectin fold and the specific binding determinants for platelet receptors while maintaining the structural integrity required for toxic function in viperid venom."}
{"description": "sp|A5A3H1|TO1B_ATRRO Omega-hexatoxin-Ar1b OS=Atrax robustus OX=6903 PE=2 SV=1", "sequence": "MNTATGFIVLLVLATVLGCIEAGESHVREDAMGRARRGACTPTGQPCPYNESCCSGSCQEQLNENGHTVKRCV", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Sydney funnel-web spider (Atrax robustus) that functions as a voltage-gated calcium channel blocker. This toxin should belong to the ω-hexatoxin family and exhibit the characteristic inhibitory cystine knot (ICK) structural motif. The protein must contain the conserved cysteine framework (C-C-CC-C-C) with three disulfide bridges that stabilize the compact, triple-stranded beta-sheet fold. The molecular mechanism involves selective blockade of insect voltage-gated calcium channels, disrupting synaptic transmission and neuromuscular function, leading to rapid paralysis in insect prey. The structural scaffold should feature the typical ICK topology with a stable, disulfide-constrained core that provides exceptional thermal and proteolytic stability. The binding interface should contain key residues for specific interaction with insect calcium channel pore domains, ensuring high target specificity and potent neurotoxic activity while maintaining the structural integrity characteristic of spider venom toxins."}
{"description": "sp|P0DM87|VM2_TRIST Zinc metalloproteinase-disintegrin stejnitin OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGNSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTYPSVEDHCYYHGRIQNDADLTASISACNGLKGYFKLQGETYLIEPLKLPDSEAHAVFKYENVEKEDEAPKMCGVTETNWESDEPIKKASQLNLTPDEQRFIELVIVADHRMYTKYDGDETEISSKIYEIANDLNVIFRALYIHVALIGLEIWPSGELCNVTLSADDTLDSFAEWTKRDLQKRKRHDNAQLLTGMIFNEKIEGRAYKKTMCHWKRSVGIVRDHRTRPHFVANRMAHGLGHNLGINHDGDSCTCGANSCIMSATVSNDPSSRFSDCSLNQYSSDIIHNPYTSRCLYNGPWKTDIVSPPVCGNYYVEVGEDCDCGPPANCQNRCCDAATCRLTPGSQCAEGLCCEQCRFSTEGKLCREAKGDWNNDYCSGQSGDCPRNPFRA", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin, characteristic of snake venom metalloproteinases (SVMPs) from Trimeresurus stejnegeri (Chinese green tree viper). This protein should exhibit a modular architecture with distinct functional domains. The metalloproteinase domain must contain the conserved zinc-binding motif HEXXHXXGXXH and coordinate a catalytic zinc ion to enable proteolytic cleavage of extracellular matrix components such as collagen, laminin, and fibronectin, facilitating hemorrhage and tissue damage. The disintegrin domain should adopt a compact, disulfide-rich fold stabilized by multiple disulfide bonds, typically featuring an RGD (Arg-Gly-Asp) or related integrin-binding motif that selectively antagonizes platelet aggregation by blocking fibrinogen binding to αIIbβ3 integrin receptors on platelets. The overall structure should reflect the characteristic reprolysin family fold, with the metalloproteinase domain exhibiting a metzincin-like tertiary structure and the disintegrin domain displaying a rigid, loop-rich conformation. The protein should function synergistically to disrupt hemostasis through dual mechanisms: proteolytic degradation of vascular basement membranes and inhibition of platelet aggregation, contributing to the prey immobilization and digestive functions of the venom."}
{"description": "sp|P84035|VM3BA_BOTAS Snake venom metalloproteinase basparin-A (Fragment) OS=Bothrops asper OX=8722 PE=1 SV=1", "sequence": "SHDNAQLLTAIKAYIATMCDPKMAVIMAHEIGHGGYYGYCRKIPCAPEDVKDDDIGMVLPGTK", "prompt": "Design a snake venom metalloproteinase protein sequence that embodies the toxicological profile of basparin-A from Bothrops asper. This protein should function as a zinc-dependent metalloproteinase, characteristic of snake venom hemorrhagic toxins, with enzymatic activity targeting key components of the extracellular matrix and hemostatic system. The sequence must include the conserved zinc-binding motif HEXXHXXGXXH in the catalytic domain, which coordinates the catalytic zinc ion essential for proteolytic activity. Incorporate the methionine turn motif downstream of the active site that contributes to structural stability. The protein should feature the characteristic disulfide bond pattern that stabilizes the metalloproteinase domain, typically involving 4-6 conserved cysteine residues forming specific bridges that maintain the globular fold. The structural scaffold should adopt the typical metzincin fold with a central five-stranded beta-sheet flanked by alpha-helices, creating the active site cleft. Functionally, this metalloproteinase should exhibit proteolytic activity against basement membrane components such as type IV collagen, laminin, and fibronectin, leading to capillary wall degradation and hemorrhage. It should also target fibrinogen and other coagulation factors, contributing to coagulopathy by disrupting the coagulation cascade. The protein may contain ancillary domains that enhance substrate recognition and binding, though the core catalytic function resides in the metalloproteinase domain. This toxin represents a key virulence factor in Bothrops envenomation, causing local tissue damage, hemorrhage, and systemic bleeding disorders through its potent proteolytic activity on vascular and hemostatic targets."}
{"description": "sp|P84646|SCX1_ODODO Alpha-toxin OD1 OS=Odontobuthus doriae OX=342590 PE=1 SV=1", "sequence": "GVRDAYIADDKNCVYTCASNGYCNTECTKNGAESGYCQWIGRYGNACWCIKLPDEVPIRIPGKCR", "prompt": "Design a potent alpha-toxin from the venom of the scorpion Odontobuthus doriae that functions as a voltage-gated sodium channel modulator. This toxin should exhibit the characteristic cysteine-stabilized alpha-beta (CSαβ) scaffold, featuring a conserved structural fold with an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 pattern typical of scorpion alpha-toxins. The protein should specifically target insect voltage-gated sodium channels, binding to receptor site 3 and modifying channel gating kinetics to cause prolonged action potential duration and neuronal hyperexcitability. The structural core should maintain the globular, compact architecture with key functional residues positioned in the conserved 'pharmacophore' regions responsible for receptor recognition and binding affinity. The toxin should demonstrate high specificity for arthropod sodium channels while maintaining the thermal and proteolytic stability characteristic of scorpion venom peptides."}
{"description": "sp|P84507|TX1_CERMR Beta-theraphotoxin-Cm1a OS=Ceratogyrus marshalli OX=316287 PE=1 SV=1", "sequence": "DCLGWFKSCDPKNDKCCKNYTCSRRDRWCKYDL", "prompt": "Design a novel beta-theraphotoxin protein sequence derived from the venom of the African tarantula Ceratogyrus marshalli. This toxin should function as a potent voltage-gated sodium channel modulator, specifically targeting insect sodium channels to induce rapid paralysis through modification of channel gating kinetics. The protein should adopt the inhibitor cystine knot (ICK) structural scaffold characteristic of spider venom peptides, featuring a compact triple-stranded beta-sheet fold stabilized by a conserved disulfide connectivity pattern of C1-C4, C2-C5, C3-C6. The sequence should include key structural motifs: a beta-hairpin region responsible for channel interaction, conserved hydrophobic core residues for structural stability, and surface-exposed loops containing critical pharmacophore residues that determine target specificity. The mature toxin should be approximately 30-40 amino acids in length with high thermal and proteolytic stability. The molecular mechanism should involve binding to neurotoxin receptor site 4 on voltage-gated sodium channels, causing either channel opening inhibition or delayed inactivation to disrupt neuronal signaling. The design should prioritize insect-selective activity while maintaining the characteristic potency and rapid action of spider venom neurotoxins."}
{"description": "sp|Q90W99|VKT3_PSETT Kunitz-type serine protease inhibitor textilinin-3 OS=Pseudonaja textilis textilis OX=169397 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSKDRPNFCKLPAETGRCNAKIPRFYYNPRQHQCIEFLYGGCGGNANNFKTIKECESTCAA", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor from the venom of the Eastern brown snake (Pseudonaja textilis), specifically the textilinin-3 variant. This toxin functions as a potent and selective inhibitor of plasmin, playing a crucial role in the snake's venom by disrupting the host's fibrinolytic system and promoting hemorrhage through the prevention of fibrin clot breakdown. The protein should adopt the characteristic Kunitz domain fold, consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in a specific connectivity pattern (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5). Key functional residues should be positioned within the canonical binding loop to specifically target the active site of plasmin, with high affinity and selectivity over other serine proteases. The sequence must include the conserved Kunitz-type protease inhibitor signature and maintain the structural integrity required for effective plasmin inhibition, contributing to the venom's overall hemostatic disruption and prey immobilization."}
{"description": "sp|Q95P88|DEF_OLIMR Defensin-like peptide TXKs2 OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MTYAILIIVSLLLISDRISNVVDKYCSENPLDCNEHCLKTKNQIGICHGANGNEKCSCMES", "prompt": "Design a defensin-like peptide toxin from the venom of Olivierus martensii (Chinese scorpion) that functions as a potassium channel blocker. This toxin should adopt the canonical cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion defensin peptides, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges in a conserved C1-C4, C2-C5, C3-C6 pattern. The peptide should contain the gamma-core motif (GXC) in the beta-sheet region, which is critical for potassium channel recognition and binding. The molecular mechanism involves blocking voltage-gated potassium channels (particularly Kv1.3 subtype) through interaction with the channel pore region, leading to neuronal hyperexcitability and enhanced neurotransmitter release. The structural scaffold should be compact and globular with the functional epitope presented on the beta-sheet surface for specific channel interaction. The biological significance lies in prey immobilization through disruption of neuronal signaling, a key component of scorpion venom's paralytic arsenal."}
{"description": "sp|P84736|PA2_TRILM Phospholipase A2 trimorphin (Fragment) OS=Trimorphodon lambda OX=356346 PE=1 SV=1", "sequence": "NLYQFSNMIQCTIPGSDPLSDYGNYGCYCGYGGSGTPVDELLRCCQVHDD", "prompt": "Design a phospholipase A2 toxin sequence derived from the lyre snake, Trimorphodon lambda, that exhibits the characteristic enzymatic activity and structural features of snake venom phospholipases A2. This toxin should function as a potent hydrolytic enzyme that specifically cleaves the sn-2 acyl bond of glycerophospholipids, leading to membrane disruption, inflammation, and potential neurotoxic or myotoxic effects. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by a characteristic network of seven disulfide bridges. Include the conserved calcium-binding loop (YXCGXGG) essential for catalytic activity, with the catalytic histidine-aspartate dyad positioned for efficient substrate hydrolysis. The sequence should maintain the hydrophobic substrate-binding channel and exhibit the typical interfacial activation mechanism where catalytic efficiency increases dramatically upon binding to lipid membranes. The toxin should demonstrate preferential activity toward neuronal or muscle cell membranes, consistent with the predatory function of lyre snake venom in subduing vertebrate prey through disruption of cellular membrane integrity and induction of pathological inflammatory responses."}
{"description": "sp|Q072L7|VSP_LACST Snake venom serine protease OS=Lachesis stenophrys OX=88085 PE=2 SV=1", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGDECNINEHRSLALVYITSGFLCGGTLINQQWVLTAAHCDRGNMLIFFDVHSLKGLNKDVQSRVAKEKFICPNRKKDDEKDKDIMLIKLDSPVSNSEHIAPLSLPSNPPSVGSVCRIMGWGAITSPNVTLPGVPHCANINILDYEVCRKAYTGLPATSRTLCAGILEGGKDSCKGDSGGPLICNGQFQGIVSWGAHPCGQSLKPGVYTKVFDYTEWIQSILAGNADATCPP", "prompt": "Generate a snake venom serine protease sequence from the bushmaster species Lachesis stenophrys that functions as a key enzymatic component in the venom's hemorrhagic and coagulopathic arsenal. This toxin should exhibit the characteristic trypsin-like serine protease activity, specifically targeting and cleaving fibrinogen and other plasma coagulation factors to disrupt hemostasis and promote systemic bleeding. The protein should adopt the canonical chymotrypsin-like fold with the conserved catalytic triad of histidine, aspartate, and serine residues arranged in the appropriate spatial configuration for efficient substrate hydrolysis. Include the characteristic disulfide bond pattern that stabilizes the two-domain β-barrel structure, with conserved cysteine residues forming the structural scaffold essential for maintaining enzymatic activity under physiological conditions. The sequence should feature the substrate-binding pocket with specificity determinants that favor cleavage at arginine and lysine residues in coagulation cascade components, contributing to the venom's potent defibrinogenating and anticoagulant effects observed in envenomation."}
{"description": "sp|A5A3H2|TO1C_ATRRO Omega-hexatoxin-Ar1c OS=Atrax robustus OX=6903 PE=2 SV=1", "sequence": "MNTATGVIALLVLATVIGCIEAEDTRADLQGGEAAEKVFRRSPTCIPSGQPCPYNENYCSQSCTFKENENANTVKRCD", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The toxin should be derived from the Sydney funnel-web spider (Atrax robustus), a medically significant Australian arachnid whose venom contains potent neurotoxins targeting vertebrate nervous systems. This protein belongs to the omega-hexatoxin family, specifically functioning as an insecticidal neurotoxin that potently blocks insect voltage-gated calcium channels (VGCCs). The molecular mechanism involves high-affinity binding to insect Cav channels, particularly those in the central nervous system, leading to disrupted synaptic transmission, paralysis, and ultimately death in insect prey. Structurally, the toxin should adopt the inhibitor cystine knot (ICK) motif characteristic of spider toxins, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that creates a rigid, protease-resistant scaffold. Key functional residues should be positioned within the pharmacophore region, typically involving a hydrophobic patch and basic residues that mediate specific interactions with the channel's pore-forming regions or voltage-sensing domains. The mature toxin should be approximately 30-40 amino acids in length with the characteristic cysteine framework of spider ICK toxins, exhibiting high specificity for insect calcium channels over mammalian homologs to ensure selective insecticidal activity while minimizing vertebrate toxicity."}
{"description": "sp|P0DMI6|PA2_HETLA Phospholipase A2 heteromtoxin OS=Heterometrus laoticus OX=217256 PE=1 SV=1", "sequence": "MHTPKHAIRRMSKGEMEFFEGRCQRMGEAERTVWGTKWCGSGNEATSGIDLGYFKNLDSCCRTHDHCDNIPAGETKYGLTNEGIYTMMNCKCESVFKQCLKDVTGVFEGPAAAAVRKIYFDLYGNGCYSVQCPAGGRSARTGGCPNGVATYTGETGYGAWLLNKANG", "prompt": "Design a phospholipase A2 heteromtoxin protein sequence derived from the venom of the Asian forest scorpion Heterometrus laoticus. This toxin should function as a potent heterodimeric complex that exhibits enhanced phospholipase A2 activity compared to monomeric forms. The protein should adopt the characteristic phospholipase A2 fold featuring a conserved calcium-binding loop, a catalytic network centered around a histidine-aspartate dyad, and the distinctive pancreatic loop. The structure should be stabilized by multiple disulfide bridges following the conserved cysteine pattern of group III secretory phospholipases. The toxin should specifically target and hydrolyze phospholipids in biological membranes, leading to membrane disruption, inflammation, and potential neurotoxic effects through the generation of lysophospholipids and free fatty acids. The heterodimeric nature should confer improved stability and target specificity, making it an effective predatory tool in scorpion venom for immobilizing prey through both enzymatic and potential receptor-mediated mechanisms."}
{"description": "sp|A6M934|CA12_CONMR Alpha-conotoxin-like Mr1.2 OS=Conus marmoreus OX=42752 PE=3 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDRGSDGRNAAAKDKASDLVALTVKGCCSNPPCYANNQAYCNGRR", "prompt": "Design a novel alpha-conotoxin-like peptide derived from the venom of the marine cone snail Conus marmoreus. This peptide should function as a potent neurotoxin targeting specific ion channels in the nervous system, consistent with the predatory strategy of cone snails that use venom components for prey capture. The peptide should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The structure should display the typical alpha-conotoxin pharmacophore with well-defined loops that mediate high-affinity binding to nicotinic acetylcholine receptor subtypes. Key structural elements should include a conserved cysteine framework, short inter-cysteine loops with specific amino acid patterns that determine receptor subtype selectivity, and a stable beta-hairpin-like motif. The peptide should exhibit high conformational stability, solubility in aqueous environments, and the ability to selectively modulate neuronal signaling through targeted receptor antagonism. The sequence should reflect the evolutionary optimization of cone snail toxins for rapid neuromuscular blockade and neurological disruption."}
{"description": "sp|P01462|3SA2_NAJHA Cytotoxin 2 OS=Naja annulifera OX=96794 PE=1 SV=1", "sequence": "LKCHKLVPPFWKTCPEGKNLCYKMYMVATPMLPVKRGCIDVCPKDSALVKYMCCNTDKCN", "prompt": "Design a cytotoxin protein from the venom of the snouted cobra (Naja annulifera) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with connectivity C1-C3, C2-C4, C5-C6, and C7-C8, forming a rigid, flattened β-sandwich architecture. The protein should exhibit specific cytotoxicity through direct interaction with cell membranes, particularly targeting anionic phospholipids and inducing membrane permeabilization via pore formation or detergent-like effects. Key functional loops should include a conserved hydrophobic patch in loop II for membrane insertion and basic residues in loop I and III for electrostatic interactions with negatively charged lipid headgroups. The toxin should demonstrate preferential cytotoxicity toward certain cell types, potentially through specific lipid composition recognition, and contribute to the venom's overall tissue-damaging and cytotoxic effects characteristic of cobra venom cytotoxins."}
{"description": "sp|P84776|PA2H_PROMB Basic phospholipase A2 homolog zhaoermiatoxin OS=Protobothrops mangshanensis OX=242058 PE=1 SV=1", "sequence": "SLIELTKMVFQETGKNPVTYYTLYGCNCGVGRRGKPKDATDRCCFVHRCCYKKLTGCDPKKDRYSYSWENKAIVCGEKNPCLKELCECDKAVAICLRKNLGTYDKNYRFTMKFLCDKPEKC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog toxin from the venom of Protobothrops mangshanensis (Mangshan pit viper). This protein should function as a venom component with phospholipase A2-like structural characteristics but potentially altered enzymatic activity typical of PLA2 homologs. The sequence should adopt the conserved phospholipase A2 fold characterized by three long alpha-helices and a beta-wing region, stabilized by the characteristic disulfide bond pattern of snake venom PLA2s (typically 6-7 conserved disulfide bridges). The protein should exhibit basic isoelectric point properties and maintain key structural motifs including the calcium-binding loop and catalytic site architecture, though it may function primarily through non-enzymatic mechanisms such as membrane disruption or receptor binding. The toxin should represent a component of viperid venom that contributes to the complex prey immobilization and digestive functions through interactions with biological membranes and potential modulation of physiological processes."}
{"description": "sp|P0DM97|VM25A_BITAR Zinc metalloproteinase-disintegrin BA-5A OS=Bitis arietans OX=8692 PE=2 SV=1", "sequence": "MMQVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPQKVTALPKGAVQQAEQKYEDAMQYEFEVNGQPVVLHLEKNKDLFSEDYSETHYSPDGKEITTNPPIEDHCYYHGRIQNDAHSTASISACNGLKGHFKLRGETYLIEPLKIPDSEAHAVYKYENIEKEDDAPKMCGVTQTNWESDEPIKEASQLVATSDQQRYYDHFRYIKYFIVVDHRMVEKYNGNLRTIRRRIYQLVNILNEIYLPWNIRAPLVGIEFWNQRDLINVTSSAPYTLDLFGKWRASDLLNRKIHDYTHLLTAIVFVEQILGMAHIATMCHSELSVGLVQDYMPSEHVVAAIMVHEMGHNLGISHDEKYCNCGADSCIMYPQISIPPPVYFSNCSWEQYQNFLTIYKPDCTLIRPSRTDIVSPPVCGNDILEQGEECDCGSPEKCQDPCCDAASCKLHSWIECEFGECCDQCRFKPAGTECRGIRSECDLPEYCTGQSVDCPIDHFHRNGKPCLNNNGAEKGEFQHTGGRY", "prompt": "Design a novel zinc metalloproteinase-disintegrin fusion protein inspired by the venom composition of Bitis arietans, the puff adder. This multifunctional toxin should integrate two distinct functional domains: (1) A zinc-dependent metalloproteinase domain responsible for hemorrhagic activity, featuring a conserved HEXXHXXGXXH zinc-binding motif and a Met-turn structural element that coordinates catalytic zinc ion. This domain should exhibit proteolytic specificity for basement membrane components such as type IV collagen and fibronectin, facilitating tissue damage and hemorrhage. (2) A disintegrin domain characterized by the canonical RGD (Arg-Gly-Asp) integrin-binding motif that specifically targets platelet integrin αIIbβ3, inhibiting platelet aggregation through competitive binding to fibrinogen receptors. The protein should adopt a modular architecture with the metalloproteinase domain likely exhibiting a reprolysin-like fold with a central five-stranded β-sheet flanked by α-helices, while the disintegrin domain should display the characteristic disintegrin loop structure stabilized by disulfide bonds. This dual-domain toxin represents an evolutionary adaptation for efficient prey immobilization through simultaneous induction of hemorrhage and inhibition of hemostatic mechanisms."}
{"description": "sp|Q91516|VSPPA_TRIST Venom plasminogen activator TSV-PA OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MELIRVLANLLILQLSYAQKSSELVFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKILNEDEQTRDPKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYSWRQVANTTLCAGILQGGRDTCHFDSGGPLICNGIFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSIIAGNKDATCPP", "prompt": "Design a venom plasminogen activator protein from the Chinese green tree viper (Trimeresurus stejnegeri) that functions as a potent fibrinolytic agent. This snake venom serine protease should exhibit specific plasminogen activation activity, converting plasminogen to plasmin through proteolytic cleavage. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and the distinctive snake venom serine protease structural features including multiple disulfide bridges that stabilize the compact globular structure. The enzyme should demonstrate substrate specificity for plasminogen while maintaining stability in the venom environment. The molecular mechanism involves binding to plasminogen and cleaving the Arg561-Val562 bond to generate active plasmin, thereby promoting fibrinolysis and contributing to the hemorrhagic effects of the venom. The protein should possess the typical structural elements of viperid venom serine proteases, including appropriate surface loops and binding pockets that confer its specific biological activity in prey immobilization through disruption of hemostasis."}
{"description": "sp|P0DL82|3SXNA_CALBG Delta-elapitoxin-Cb1a OS=Calliophis bivirgatus OX=8633 PE=1 SV=1", "sequence": "LECYDTIFKWHTMTCPEGQNLCFYYFTWRIFLVRGCTATCPVGYSHTHCCDTDKCNN", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is a delta-elapitoxin from the venom of the blue coral snake (Calliophis bivirgatus), a highly venomous elapid species. This toxin functions as a potent neurotoxin that targets voltage-gated sodium channels (Nav channels) in the peripheral nervous system. The mechanism of action involves binding to site 4 of Nav channels, specifically slowing channel inactivation and prolonging action potentials, leading to sustained neurotransmitter release at neuromuscular junctions and consequent muscle fasciculations, paralysis, and potentially respiratory failure. The structural scaffold is characteristic of the three-finger toxin (3FTx) superfamily, featuring a core stabilized by four conserved disulfide bridges with the cysteine framework C-C-C-C-C-C-C-C. The three-finger fold consists of three β-stranded loops extending from a central globular core, with the second loop typically containing key residues for Nav channel interaction. The molecular target specificity is likely toward skeletal muscle Nav channels (e.g., Nav1.4), with binding mediated by hydrophobic and electrostatic interactions in the channel's voltage-sensing domain. Incorporate conserved residues for structural integrity and functional efficacy, ensuring the sequence reflects the compact, stable fold and target engagement profile of delta-elapitoxins."}
{"description": "sp|Q91053|VSP1_GLOUS Thrombin-like enzyme calobin-1 OS=Gloydius ussuriensis OX=35671 PE=1 SV=1", "sequence": "MVLISVLANLLILQLSYAQKSSELVIGGDECNINEHRFLVALYNSRSRTLFCGGTLINQEWVLTAAHCERKNFRIKLGIHSKKVPNEDEQTRVPKEKFFCLSSKNYTLWDKDIMLIRLDSPVSNSEHIAPLSLPSSPPSVGSVCRIMGWGRISPTKETYPDVPHCANINLLEYEMCRAPYPEFGLPATSRTLCAGILEGGKDTCRGDSGGPLICNGQFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIQSIIAGNTDASCPP", "prompt": "Design a thrombin-like serine protease toxin from the venom of the Ussuri pit viper (Gloydius ussuriensis) that functions as a key hemostatic agent in snake envenomation. This enzyme should mimic the substrate specificity and catalytic activity of mammalian thrombin, cleaving fibrinogen to generate fibrin monomers that spontaneously polymerize into insoluble fibrin clots, thereby promoting coagulopathy and potentially causing thrombosis in prey. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad (His, Asp, Ser) and exhibit the typical two-domain structure composed of six-stranded beta-barrels. Include the canonical disulfide bond pattern that stabilizes this fold, with conserved cysteine residues forming specific intramolecular bridges. The enzyme should possess exosite regions for substrate recognition and demonstrate preferential cleavage at Arg-Gly bonds in fibrinogen, similar to thrombin's specificity but potentially with unique kinetic properties optimized for rapid action in venom. The structural scaffold should maintain the characteristic active site cleft and substrate-binding pockets while potentially incorporating venom-specific surface features that enhance stability and function in the extracellular environment."}
{"description": "sp|P84777|KA156_TITDI Potassium channel toxin alpha-KTx 15.6 OS=Tityus discrepans OX=57059 PE=1 SV=2", "sequence": "MKAFYGMLVIFILCSTCYISVDSQIDTNVKCSGSSKCVKICIDRYNTRGAKCINGRCTCYP", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the scorpion Tityus discrepans. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting key functional residues in the beta-hairpin loops that interact with the channel's pore region. The molecular mechanism should involve high-affinity binding to the voltage-sensing domain or pore region of Kv1 channels, leading to prolonged action potentials and enhanced neurotransmitter release. The structural core must maintain the characteristic ICK stability while displaying surface-exposed residues optimized for specific potassium channel subtype recognition and blockade."}
{"description": "sp|P0C8V4|CA1A_CONVE Alpha-conotoxin-like Vn OS=Conus ventricosus OX=117992 PE=1 SV=1", "sequence": "GGCCSYPPCAVSNPQHC", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of the Mediterranean cone snail, Conus ventricosus. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey organisms. The protein must adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two conserved disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the conserved cysteine framework (CC-C-C) typical of alpha-conotoxins, with the inter-cysteine loops optimized for high-affinity binding to the alpha-delta subunit interface of muscle-type nicotinic receptors. Incorporate key pharmacophore residues in the second loop that mediate receptor interaction while maintaining the overall structural stability through the disulfide-constrained beta-hairpin motif. The toxin should exhibit the biological activity of reversible neuromuscular blockade through competitive inhibition of acetylcholine binding, consistent with the hunting strategy of marine cone snails."}
{"description": "sp|Q91453|STXB_SYNHO Stonustoxin subunit beta OS=Synanceia horrida OX=13279 PE=1 SV=3", "sequence": "MPSDILVVAALGRPFTLGMLYDARNDKLIPGFTLWEDEVIEESTLESSQPSSAFEIIASDSTDDKSSLMDIEASLKASFLGGLVEVGGSAKYLNNQKKFKNQSRVTLQYKATTSFKQLMTNLGTKHVEYSELFENIQATHVVIGILYGANAFFVFDSNKVDSTNVQEIQGQMEAVIKKIPSVEISGKASVQLTGEETDITNSFSCEFHGDFFLTTNPTTFEDAVKTYQQLPQMMGKDNAVPMTVWLVPMVNFYSEAPQLMADSSTPILRKVRNTLEAIVQVQMRCNDALDDPTVNLFTEVQKKLSDFQKICDDHMSKLQATIAKKLFAIRSGDEDESALLNLFEENLQSPFNIESLNMWMEFEEREINVLRSCMDILTKAKPKVIFNQGVLFKGLYDSKVKHALCYVFTNVTKNDVFLNVLNEFLDSPQSRPKKLRPSPKDYWYSYDDIPETMREKAYLFRNLAKEMNNRCVHFFVTAIHNPKQEGAGIHYYRESIQIIDEFTKPYMPGVESIKDRRELQWYDCELTLDPETAHQVLTLSEGNKKAVSGNTKSPTDHLEKFSHFQQVMCTKGLSGRHYWELEWSGYVGAGVTYKGIGRKTSTSDSSLGKNEKSWLFEYSTKSGYQQIHNSKKTRVTVSSTGFKLLGVYLDWPAGTLSFYMVNKAWVTHLHTFHTKFNEAVYPAFLIGDAQQKVNGQIKLL", "prompt": "Design a protein sequence for the beta subunit of stonustoxin, a potent pore-forming cytolysin from the venom of the stonefish (Synanceia horrida). This toxin plays a critical role in the stonefish's predatory and defensive strategy, causing rapid tissue necrosis, hemolysis, and severe pain through membrane disruption. The beta subunit functions in concert with the alpha subunit to form a heterodimeric complex that inserts into target cell membranes, creating large transmembrane pores that lead to osmotic lysis and cell death. The protein should adopt a membrane attack complex/perforin (MACPF) domain fold, characterized by a central beta-sheet core surrounded by alpha-helices, which undergoes conformational changes to expose hydrophobic surfaces for membrane insertion. Key structural features include conserved regions for oligomerization with the alpha subunit and membrane-binding motifs that facilitate pore formation. The mechanism involves initial binding to membrane cholesterol or specific lipid components, followed by oligomerization and beta-barrel pore formation that disrupts cellular integrity. The generated sequence should reflect this cytolytic function with appropriate hydrophobic regions for membrane interaction and structural elements supporting the MACPF fold architecture."}
{"description": "sp|P00615|PA2HB_OXYSC Neutral phospholipase A2 homolog taipoxin beta chain 1 OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=2", "sequence": "MHPAHLLVLLAVCVSLLGASDIPPLPLNLVQFGKMIECAIRNRRPALDFMNYGCYCGKGGSGTPVDDLDRCCQVHDECYAEAEKHGCYPSLTTYTWECRQVGPYCNSKTQCEVFVCACDFAAAKCFAQEDYNPAHSNINTGERCK", "prompt": "Generate the amino acid sequence for a beta chain component of taipoxin, a potent presynaptic neurotoxin complex from the coastal taipan (Oxyuranus scutellatus). This protein is a phospholipase A2 homolog that has lost catalytic activity but retains critical structural and binding functions within the heterotrimeric taipoxin complex. The sequence should reflect a Group IA snake venom phospholipase A2 scaffold with the characteristic calcium-binding loop (YGKYCGxxxxGC) and conserved catalytic site residues, though key histidine and aspartate residues may be modified to eliminate enzymatic activity. Include the conserved disulfide bond pattern typical of snake venom PLA2s (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, Cys61-Cys91) that stabilizes the three-finger globular fold. The protein should contain structural motifs for complex assembly with alpha and gamma chains, including interfacial binding surfaces that enable the trimeric complex to target and disrupt presynaptic membranes at neuromuscular junctions. The sequence should maintain the hydrophobic channel and membrane-interacting regions necessary for neurotoxin function while lacking functional phospholipase activity."}
{"description": "sp|P15167|VM1AD_CROAT Snake venom metalloproteinase atrolysin-D OS=Crotalus atrox OX=8730 PE=1 SV=3", "sequence": "MIEVLLVTICLAVFPYQGSSIILESGNVNDYEVVYPRKVTALPKGAVQPKYEDAMQYELKVNGEPVVLHLEKNKELFSKDYSETHYSPDGRKITTNPSVEDHCYYRGRIENDADSTASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKLENVEKEDEAPKMCGVTQNWESYEPIKKASDLNLNPDQQNLPQRYIELVVVADHRVFMKYNSDLNTIRTRVHEIVNFINGFYRSLNIHVSLTDLEIWSNEDQINIQSASSDTLNAFAEWRETDLLNRKSHDNAQLLTAIELDEETLGLAPLGTMCDPKLSIGIVQDHSPINLLMGVTMAHELGHNLGMEHDGKDCLRGASLCIMRPGLTKGRSYEFSDDSMHYYERFLKQYKPQCILNKPLRIDPVSTPVSGNELLEAGEE", "prompt": "Design a snake venom metalloproteinase (SVMP) sequence that functions as a potent hemorrhagic toxin, characteristic of the atrolysin family from the Western diamondback rattlesnake (Crotalus atrox). This enzyme should exhibit the canonical SVMP domain architecture, featuring a prodomain, a catalytic metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH), and a disintegrin-like domain. The catalytic domain must contain the characteristic 'Met-turn' structural element and maintain the typical reprolysin-family fold, which facilitates substrate binding and proteolytic activity. The protein should specifically target and degrade key components of the basement membrane and extracellular matrix, such as type IV collagen, laminin, and fibronectin, leading to disruption of capillary integrity and hemorrhage. The disintegrin-like domain may contribute to interactions with integrins or other cell surface receptors, enhancing the toxin's pathophysiological effects. The sequence should reflect the high specificity and efficiency of SVMPs in cleaving peptide bonds within structural proteins, resulting in the characteristic hemorrhagic syndrome observed in envenomation. Ensure the protein adopts a compact, multi-domain structure stabilized by disulfide bonds, with the catalytic domain featuring the typical active site cleft for substrate recognition and hydrolysis."}
{"description": "sp|A6MFL0|OXLA_DEMVE L-amino-acid oxidase OS=Demansia vestigiata OX=412038 PE=2 SV=1", "sequence": "MNVFFMFSLLFLAALESCADDRRNPLGECFREADYEEFVDIATNGLKQTSNPKRVVVVGAGMAGLSAAYVLAGAGHNVMLLEASERVGGRVNTYRNEQEGWYVNLGPMRLPERHRIVREYIKKFGLQLNQFFQEDEDAWYFIKNIRKKVREVKENPSIFPYPVKPSEKGKSAPQLYRDSLQKIIEEYGRSNCSYILNKYDTYSTKDYLIKEGNLSPGAVDMIGDLLNEGSSYYLSFIESLKSDDIFSYENRFDEIVGGFDLLPKAMYKAIEEKVHLNARVIQIQQNAEGVRVTYQTPAKNLSYVTADYVIVCSTSRAARRIYFEPPLPPEKAHALQSIHYRSATKIFLTCTKKFWEDDGIHGGKSITDRPSRLIHYPNHNFPNGIGVLVIYTIADDADFFLALDNKTIADIVIHDLSLIHQLPKEKIRDLCYVSMIKKWSLDKYSMGSITTFAPYQFQEYFETVAAPVGRIYFAGEYTARAHGWIDSTIKSGLKAARDVNRASQKPSRIQLSNDNEL", "prompt": "Design a novel L-amino-acid oxidase (LAAO) venom protein inspired by the venom arsenal of Demansia vestigiata, a rear-fanged colubrid snake. This enzyme should function as a potent toxin by catalyzing the oxidative deamination of L-amino acids, generating hydrogen peroxide, ammonia, and the corresponding α-keto acid as reaction byproducts. The hydrogen peroxide produced is the primary cytotoxic agent, inducing oxidative stress, apoptosis, and tissue damage in prey organisms. The protein should adopt the classic LAAO structural fold, featuring a conserved FAD-binding domain with a Rossmann-like topology for cofactor binding and a substrate-binding domain that positions the L-amino acid substrate for efficient catalysis. Include the characteristic dimeric quaternary structure stabilized by extensive inter-subunit interactions. The enzyme should exhibit broad substrate specificity for hydrophobic L-amino acids like L-phenylalanine and L-leucine, while maintaining the conserved catalytic residues (typically including a histidine and tyrosine) essential for the oxidative deamination mechanism. The protein should possess the N-glycosylation patterns typical of snake venom LAAOs, which contribute to stability and may influence target recognition. Design this LAAO to function as a multi-faceted toxin capable of inducing hemorrhage, edema, and apoptosis through hydrogen peroxide-mediated pathways, reflecting the complex envenomation strategy of colubrid snakes."}
{"description": "sp|A7KJJ7|KA261_OLIMR Potassium channel toxin alpha-KTx 26.1 OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MSRLFVFILIALFLSAIIDVMSNFKVEGACSKPCRKYCIDKGARNGKCINGRCHCYY", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the venom arsenal of the scorpion Olivierus martensii. This toxin should belong to the alpha-KTx family, specifically exhibiting the functional profile of alpha-KTx 26.1. The core mechanism of action must be potent and selective blockade of voltage-gated potassium channels (Kv channels), thereby disrupting cellular excitability and contributing to the neurotoxic effects of the venom. The structural scaffold should be characteristic of scorpion short-chain potassium channel toxins: a compact, stable fold stabilized by a conserved disulfide bridge framework. This typically involves three disulfide bonds (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) forming a cysteine-stabilized alpha-beta (CSαβ) motif. The anticipated 3D structure is a small globular protein featuring a central alpha-helix packed against a triple-stranded antiparallel beta-sheet. The molecular target interface should include a functional dyad or triad of key residues (often involving a lysine and aromatic residues) positioned to interact with and occlude the potassium channel pore. The sequence must encode these structural determinants to ensure correct folding, stability in the venom milieu, and high-affinity binding to Kv channels, resulting in the intended neurotoxic activity."}
{"description": "sp|C0JB47|B1U2_LOXSN Dermonecrotic toxin LspiSicTox-betaIE4ii (Fragment) OS=Loxosceles spinulosa OX=571532 PE=2 SV=1", "sequence": "FALAHMVNDFEILKSYLDEGANGIESDITFSDEGEPEYTFHGVPCDCRRWCDRSVGIDEYLQHLSDLTTPGNPKFRENLLVVVLDLKLNGLSQDALRQGGLRLADKLAAHYWTGNRKARAYFIISVPKTSESEFMRTFRKELDEINFGDMSAKIGFDFTDNGDFKETQKVYEGLGISEHIWASDGITNCIPLLFRGTDRLEDLTRQRDEPGYKYIDKVYAWTYDKETSVVKALELGVDGVMTNYADFVIKVLNKPEHSSKYRLATYDDNPFEKFTA", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles spinulosa, specifically belonging to the SicTox-betaIE4ii family. This toxin should function as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving phospholipid head groups, leading to complement activation, platelet aggregation, and massive inflammatory response that results in characteristic dermonecrotic lesions. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of sphingomyelinase D toxins, with the active site containing conserved histidine and glutamic acid residues essential for metal ion coordination and catalytic activity. The structural scaffold should include the characteristic N-terminal signal peptide for secretion, followed by the mature toxin domain with the conserved phospholipase D catalytic motif. The molecular target is primarily endothelial cell membranes, with specific affinity for lipid rafts rich in sphingomyelin. The toxin should exhibit the characteristic stability of spider venom proteins, likely maintained by disulfide bridges in the C-terminal region that stabilize the barrel structure. This toxin represents a key virulence factor in recluse spider envenomation, causing the severe cutaneous manifestations characteristic of loxoscelism."}
{"description": "sp|Q9XZC0|LCTA_LATTR Alpha-latrocrustotoxin-Lt1a (Fragment) OS=Latrodectus tredecimguttatus OX=6925 PE=1 SV=2", "sequence": "VSIFIFHFSANILVRNSEMKGKRVISKREMSKADQCTFLSYQSVAYGTLGDVAGDVSSIEGADLVATPIAAGGHLAKGATDAAMIAMDCSSIPFDEIKQQLNQRFNEVDKKLQKGAEALENVTELAEKTYSSVEKMRVEMREGFNHVIATIENANTKQIITGINQIIQYFNDERENINNRQKEDYVAKLQEPASGNFLLYLRKSRTSEDGSLHSLLFKIINQELAIPNNAADNNAIRALFALFYGTQTFISIMFYLVKQYSYLADYHYQNGNLAEFNSNFDHMKTVFQDFKFTLIGINTSNSKPLVNTVLSIIEDVKNKRFIRNLRSNLYQKIIKSTKSLLDLREKITKMDLPIIEDTPKSSVLINFREKSSSVPRIETPILKWTPGTVVKYAIQYEQDGKYSKISKWSNPITVQRLANPYITIDKDRRNRLVFRQFGNEKPELISILDSSQNEFRDIHRDLYNAAQMPYKETALGICRKLIDSGAQVGASFEMGRKSIHASATAGNDDVARLLLAKNNGLLNVPDKNGYTPLHIASERKNNDFVKFLLEKGADVNVRTFANELTPLHLAARQDFTIIVKTLMEKRGIDVNAKERAGFTPLHLSITSNSRAARTLINETPAGINIKSNSGLTPLHLAVLQNNLSAAKVLVKSNKKVKLNEMDNNGMTPLHYASMLGNLEFVKYFTSEQGIDVNAKTKVKNWTPLHLAILFKKFDVAQSLLQVRNIDISTRADQAITPLHLAAATGNSQIVKTILNSGAVVDQETANGFTALHLAIMNPNTETPQFLIAKGANINAKTNDGSTPLHFAAALGKTNIFQLLMDKGANIKAENLINQMPIHEAVVNGHLAIVKMLIEQDSSLMNAKNMRDEYPFYLAAEKRYKDVFNYLESKGADVNEKNNDGNTLLHLFSINGEVEVVQFLIQNGADFRLRNKERKSFFDLAVEFGHAGIVGYAIEENKVDLQEPYRGKTILYHAICDSVKYDRIEVVRYFVETLNEDQCSPLQEAAAYAHLDLVKYFVQERGINPTAFNNDNQVSPLCIAIVGAPCGFVKSCDTPERLDVVEYLVDKTPDINKECDTQQSTPVSSAVYGNKVSILNYLIRNGADPNKKVRGDPPLFIAAMIGQYDIVKSLVEQHKIDVNTRNKEQFTPLHAAASNDHIDVVKYLIQKGADVNAKGDENLKPIDLAGEKSKAYLRSLGRRFFRNESPSKSFEIDKFNAIMPEVSMSGKVSHDSNFIQHISSGTRSKSNFNSAKNKMYAENSHVRSIDVNGALLLLDFMVRVFSNRKMNYAASISGIKSRSNSEAQAEALILTERFEHLLNALIADQSIDSLDFSNVHSRIYKAIINGNPNGISEMLCSYAKEYSELDPEKIEKLLQEFETLTFTKSSEIQINEKFSHALFETCGLNRPTNVLQIK", "prompt": "Generate the complete protein sequence for an alpha-latrocrustotoxin from the venom of the Mediterranean black widow spider, Latrodectus tredecimguttatus. This neurotoxin functions as a potent presynaptic toxin that targets vertebrate nervous systems. It acts by forming pores in presynaptic membranes, causing massive neurotransmitter release that leads to latrodectism symptoms including severe pain, muscle cramps, autonomic disturbances, and potentially life-threatening systemic effects. The toxin belongs to the latrotoxin family and shares the characteristic structural organization of large, multi-domain proteins that form heptameric complexes in target membranes. It should contain the conserved cysteine-rich domains responsible for receptor binding and membrane insertion, with the characteristic disulfide bridge pattern that stabilizes the pore-forming domains. The structural scaffold should facilitate calcium-dependent binding to specific neuronal receptors, followed by oligomerization and pore formation that disrupts synaptic vesicle recycling. The sequence should reflect the high molecular weight and complex domain architecture typical of latrotoxins, with regions responsible for specific receptor recognition, membrane insertion, and the formation of the ion-permeable pore that causes massive exocytosis of neurotransmitters."}
{"description": "sp|P15226|SCX1_TITSE Beta-mammal/insect toxin Ts1 OS=Tityus serrulatus OX=6887 PE=1 SV=2", "sequence": "MKGMILFISCLLLIGIVVECKEGYLMDHEGCKLSCFIRPSGYCGRECGIKKGSSGYCAWPACYCYGLPNWVKVWDRATNKCGKK", "prompt": "Design a beta-mammal/insect toxin from the Brazilian yellow scorpion Tityus serrulatus, a medically significant species whose venom contains potent neurotoxins targeting voltage-gated sodium channels. This toxin functions as a beta-toxin that modifies sodium channel gating by shifting the voltage dependence of activation to more negative potentials and slowing inactivation, resulting in prolonged neuronal excitation and spontaneous repetitive firing. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structure should contain a conserved core beta-sheet flanked by an alpha-helix, with key functional residues concentrated in the 'pharmacophore' region that interacts with the voltage-sensing domain II of mammalian and insect sodium channels. The toxin should exhibit dual specificity, capable of binding both mammalian neuronal sodium channels (particularly Nav1.2, Nav1.6) and insect sodium channels, with the molecular recognition interface involving conserved hydrophobic patches and charged residues that interact with the channel's S3-S4 loop in domain II. The sequence should maintain the characteristic molecular weight of 6-8 kDa and the basic isoelectric point typical of scorpion beta-toxins to facilitate membrane interaction and target recognition."}
{"description": "sp|P0DM88|VM3_PROJR Zinc metalloproteinase-disintegrin-like jerdohagin (Fragment) OS=Protobothrops jerdonii OX=242841 PE=1 SV=1", "sequence": "YLNNFRYLYIRHDREACTCHANSCIMSAYFSNSHVQYENYINDCKPQCILNELHSWVECESGECCEQCRSECDIAESCTNGQPLHNFGYCYNGNCPIMYHQCYLYCYNSLGNQFPCVPYYTPR", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin from Protobothrops jerdonii (Jerdon's pit viper). This toxin belongs to the SVMP (Snake Venom Metalloproteinase) family, specifically the P-III class, characterized by a multi-domain architecture comprising a metalloproteinase domain, a disintegrin-like domain, and a cysteine-rich domain. The protein functions as a key hemorrhagic toxin, disrupting hemostasis through multiple mechanisms: the metalloproteinase domain degrades extracellular matrix components (e.g., collagen, laminin) and clotting factors, while the disintegrin-like domain inhibits platelet aggregation by antagonizing integrin receptors (e.g., α2β1, α5β1). The cysteine-rich domain may mediate additional protein-protein interactions. The structural scaffold includes a conserved zinc-binding motif (HEXXHXXGXXH) in the metalloproteinase domain, which coordinates catalytic zinc ions, and a disintegrin-like loop with an RGD or related motif that mimics endogenous ligands to block integrin function. The protein features a high density of disulfide bonds, typical of SVMPs, stabilizing its modular fold and conferring resistance to proteolytic degradation. The overall structure is anticipated to adopt a compact, multi-domain arrangement, with the metalloproteinase domain exhibiting a metzincin-like fold and the disintegrin-like domain forming an extended loop stabilized by disulfide bridges. This toxin contributes to prey immobilization by inducing hemorrhage, coagulopathy, and tissue damage, reflecting its role in the venom of viperid snakes for subduing vertebrates."}
{"description": "sp|Q09GK0|SLB_PHIOL Snaclec subunit B OS=Philodryas olfersii OX=120305 PE=2 SV=1", "sequence": "MGRSIFVNLGLLVVAFSLRGSEADCPSGWSSYDKYCYKVFDERKNWDEAESFCMEQKTGSHLASILSSEEGSYVANLAFKRVKHPSMWIGLSNIWNQCSWQWSDGSSLGYEAWVEGPDCVMMRLQPGFIDWYSVECKSTLPFTCKFLAKREDPAPE", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the green snake Philodryas olfersii. This protein functions as a heterodimeric toxin composed of alpha and beta subunits, with this sequence representing the B subunit. The protein should adopt the characteristic C-type lectin-like fold with a conserved double-loop structure stabilized by two intrachain disulfide bonds following the C1-C4, C2-C3 connectivity pattern. As a snaclec, this toxin likely targets components of the hemostatic system, potentially acting as an anticoagulant by binding to coagulation factors such as factor IX, factor X, or platelet receptors like GPIb, thereby disrupting normal blood clotting mechanisms. The structure should feature the typical β-sandwich fold with extensive β-sheet formation and calcium-binding capabilities in the carbohydrate recognition domain. The protein should exhibit high specificity for its molecular target through surface-exposed loops that mediate protein-protein interactions, contributing to the venom's prey immobilization strategy by interfering with hemostasis."}
{"description": "sp|P59066|PA2_AUSSU Phospholipase A2 (Fragment) OS=Austrelaps superbus OX=29156 PE=1 SV=1", "sequence": "NLIQFANMIGCANHGSR", "prompt": "Design a phospholipase A2 toxin sequence derived from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This enzyme should function as a potent presynaptic neurotoxin and myotoxin, characteristic of elapid snake venoms. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, inflammation, and neuromuscular blockade. The sequence must include the conserved catalytic dyad (histidine and aspartate residues within the Ca²⁺-binding loop), a conserved calcium-binding motif (YGKYCG/XCG), and the characteristic elapid phospholipase A2 signature pattern. The structure should adopt the typical phospholipase A2 fold with three long alpha-helices stabilized by multiple disulfide bridges (typically 6-7 conserved cysteine residues forming 3-4 disulfide bonds), creating a compact, stable globular domain. The protein should target presynaptic membranes at neuromuscular junctions, disrupting acetylcholine release through phospholipid hydrolysis and potentially exhibiting β-neurotoxin activity. Include conserved residues for membrane interaction and interfacial activation, ensuring the catalytic pocket is properly formed for substrate binding and hydrolysis."}
{"description": "sp|C0HLK1|CA1B_CONBR Alpha-conotoxin BruIB OS=Conus brunneus OX=101289 PE=1 SV=1", "sequence": "DYCCRRPTCIPIC", "prompt": "Design a novel alpha-conotoxin peptide sequence derived from the venom of Conus brunneus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two conserved disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore residues responsible for high-affinity binding to the nAChR orthosteric site, particularly those interacting with the complementary and principal subunits. Incorporate key structural motifs such as a beta-hairpin loop and conserved turn regions that confer receptor subtype selectivity. The toxin should exhibit rapid neuromuscular blockade activity through competitive inhibition of acetylcholine binding, leading to paralysis. Ensure the sequence maintains the typical length of 12-18 amino acids with appropriate hydrophobic core residues that facilitate proper folding and stability in the venom environment."}
{"description": "sp|P83345|3SAS_NAJSG Cytotoxin sagitoxin OS=Naja sagittifera OX=195058 PE=1 SV=1", "sequence": "LKCNKLVPLAYKTCPAGKNLCYKMYMVANKKVPVKRGCIDVCPKKSLLVKYECCNTDRCN", "prompt": "Design a cytotoxin protein from the venom of the banded cobra (Naja sagittifera) that functions as a potent membrane-disrupting toxin. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet structural fold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming the classic three-finger scaffold. The protein should exhibit specific cytolytic activity through membrane interaction and pore formation, targeting cell membranes with particular affinity for cardiac and muscle tissues. The structural core should consist of a central β-sheet from which three β-stranded loops extend, with the second and third loops containing hydrophobic residues critical for membrane insertion and disruption. The protein should demonstrate thermal stability and resistance to proteolytic degradation typical of snake venom cytotoxins, with surface-exposed basic residues that may facilitate initial electrostatic interactions with negatively charged membrane components. The overall architecture should enable specific membrane recognition while maintaining the structural integrity required for cytotoxic function in the context of snake envenomation."}
{"description": "sp|P0DM38|SLDA_TRIAB Snaclec alboaggregin-D subunit alpha OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "MGRFIFGSFGLLVVFLSLSGTGADFDCPPGWSAYDRYCYQAFSEPKTWEDAESFCMEGVKDSHLVSVESSGEADFVAQLVNENIKTSFRYVWIGLRIQNKEQQCRSEWSDASSVSYENLIKKVSKKCYGLKKGTELRTWFNVYCAELNPFICKFPPEC", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the white-lipped pit viper (Trimeresurus albolabris). This protein should function as the alpha subunit of the heterodimeric snaclec complex known as alboaggregin-D, which plays a critical role in the viper's venom by mediating platelet aggregation through specific receptor interactions. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by conserved disulfide bridges typically involving cysteine residues in positions that form two intra-chain disulfide bonds essential for structural integrity. As part of the snaclec family, this subunit should exhibit calcium-independent lectin activity and specifically bind to platelet receptors such as GPIb, facilitating the formation of large platelet aggregates that contribute to the procoagulant and thrombotic effects of the venom. The sequence should reflect the evolutionary adaptations for toxin function, including surface-exposed loops that mediate receptor recognition and dimerization with the beta subunit to form the functional heterodimer. Ensure the structural scaffold supports the biological activity of enhancing platelet aggregation, a key mechanism in the venom's ability to immobilize prey by promoting thrombosis."}
{"description": "sp|P58917|O16A_CONCT Omega-conotoxin CVIA OS=Conus catus OX=101291 PE=1 SV=1", "sequence": "MKLTCVVIVAMLLLTACQLITANDSRGTQKHRALRSDTKLSMSTRCKSTGASCRRTSYDCCTGSCRSGRCG", "prompt": "Design a novel peptide toxin sequence that mimics the biological activity and structural characteristics of omega-conotoxin CVIA from the marine cone snail Conus catus. This toxin functions as a potent and selective antagonist of N-type voltage-gated calcium channels (Cav2.2), which are critical for neurotransmitter release at presynaptic terminals in the central and peripheral nervous systems. The peptide should adopt the characteristic inhibitor cystine knot (ICK) structural fold, stabilized by three disulfide bridges with the conserved cysteine framework C-C-CC-C-C. The core structural motif should feature a compact, triple-stranded beta-sheet arrangement stabilized by the knotted disulfide topology, which confers exceptional thermal and proteolytic stability. Key functional residues should be positioned to interact with the pore-forming region of the Cav2.2 channel, specifically blocking calcium ion flux through high-affinity binding to the channel's extracellular domains. The toxin should exhibit the typical pharmacological profile of omega-conotoxins, including reversible blockade of synaptic transmission and potential analgesic effects through inhibition of pain pathway signaling. The sequence should maintain the conserved hydrophobic core and surface-exposed loops that mediate target specificity while incorporating the unique pharmacophore elements that distinguish CVIA from other omega-conotoxin variants."}
{"description": "sp|P00616|PA2HG_OXYSC Acidic phospholipase A2 homolog taipoxin gamma chain OS=Oxyuranus scutellatus scutellatus OX=8667 PE=1 SV=2", "sequence": "MHPAHLLVLLAVCVSLLGSSEIPQPSLDFEQFSNMIQCTIPCGESCLAYMDYGCYCGPGGSGTPIDDLDRCCKTHDECYAEAGKLSACKSVLSEPNNDTYSYECNEGQLTCNDDNDECKAFICNCDRTAVTCFAGAPYNDLNYNIGMIEHCK", "prompt": "Design a protein sequence for an acidic phospholipase A2 homolog that functions as the gamma chain component of taipoxin, a potent presynaptic neurotoxin complex from the coastal taipan (Oxyuranus scutellatus). This protein should exhibit the characteristic phospholipase A2-like structural fold despite lacking catalytic activity, serving as a structural component that enhances the overall neurotoxicity of the taipoxin complex. The sequence should feature the conserved phospholipase A2 disulfide bridge pattern with multiple intramolecular disulfide bonds stabilizing the characteristic three-finger scaffold. Key structural elements should include the calcium-binding loop, conserved hydrophobic residues for membrane interaction, and surface-exposed regions that facilitate complex formation with the alpha and beta chains of taipoxin. The protein should maintain an overall acidic isoelectric point and possess the ability to interact with neuronal membranes, contributing to the complex's mechanism of presynaptic neuromuscular blockade through disruption of neurotransmitter release at motor nerve terminals."}
{"description": "sp|C0HLL9|SCX1_TITMA Beta-mammal toxin Tma1 OS=Tityus macrochirus OX=2599738 PE=1 SV=1", "sequence": "KKEGYLVGNDGCKYGCFTRPAQYCESECSLRKGTGGYCYAWLACYCYNMPDWVPTWNSAKNRCGK", "prompt": "Design a beta-mammal toxin protein sequence derived from the venom of Tityus macrochirus, a scorpion species. This toxin should function as a potent modulator of voltage-gated sodium channels in mammalian systems, specifically exhibiting beta-toxin activity that alters channel gating kinetics through a voltage-sensor trapping mechanism. The protein should adopt the conserved structural scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with a cysteine pattern of C-C-CC-C-C. The core structure should comprise an alpha-helix packed against an anti-parallel beta-sheet, forming the conserved CSαβ motif. Key functional residues should be positioned within the conserved pharmacophore regions to enable specific interaction with domain II voltage-sensors of Nav channels, resulting in delayed channel inactivation and prolonged neuronal excitation. The sequence should maintain the characteristic molecular surface features that facilitate high-affinity binding to mammalian sodium channels while preserving the structural integrity required for venom stability and target specificity."}
{"description": "sp|P01473|3SOF3_NAJME Cytotoxin homolog 3 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "IKCHNTPLPFIYKTCPEGNNLCFKGTLKFPKKITYKRGCADACPKTSALVKYVCCNTDKCN", "prompt": "Design a cytotoxin protein sequence derived from the venom of the forest cobra, Naja melanoleuca, that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-loop β-sheet scaffold stabilized by four conserved disulfide bridges with the connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular fold. The protein should exhibit specific cytotoxicity through direct interaction with cell membranes, particularly targeting lipid bilayers and potentially inducing cell lysis via pore formation or membrane destabilization. Incorporate conserved hydrophobic residues in the central loop to mediate membrane insertion, while maintaining charged residues in the flanking loops for initial electrostatic interactions with anionic phospholipid headgroups. The structural core should maintain the three-finger topology with β-strands in loops I, II, and III, where loop II typically contains the membrane-interacting pharmacophore. Ensure the sequence reflects the evolutionary optimization for rapid membrane permeabilization, contributing to the neurotoxic and cytotoxic effects characteristic of elapid snake venoms by disrupting cellular integrity and facilitating venom spread."}
{"description": "sp|P0C8V5|O161_CONAH Delta-conotoxin-like Ac6.1 OS=Conus achatinus OX=369967 PE=1 SV=1", "sequence": "MKLTCVVIVAVLFLTAWTFVMADDSRYGLKDLFPKARHEMKNPEASKLNKRDECFSPGTFCGIKPGLCCSAWCYSFFCLTLTF", "prompt": "Design a novel delta-conotoxin-like peptide derived from the venom of Conus achatinus, a marine cone snail. This toxin should function as a potent voltage-gated sodium channel (VGSC) modulator, specifically targeting and inhibiting the inactivation of neuronal sodium channels to prolong action potentials and enhance neurotransmitter release. The peptide should adopt the conserved structural framework characteristic of delta-conotoxins, featuring a compact, disulfide-rich scaffold with a cysteine pattern of C-C-CC-C-C (Framework VI) that forms three disulfide bonds stabilizing an inhibitor cystine knot (ICK) fold. This fold confers exceptional stability and resistance to proteolytic degradation. The molecular target is likely Nav1.2 or Nav1.6 sodium channel subtypes, with binding mediated through interactions with the channel's voltage-sensing domain IV. The toxin should exhibit high affinity and selectivity for its target, contributing to the venom's role in rapid prey immobilization by disrupting neuronal excitability. Ensure the sequence includes key conserved residues for structural integrity and functional activity, such as hydrophobic patches and charged surfaces involved in channel interaction."}
{"description": "sp|P00617|PA2B1_BUNMU Basic phospholipase A2 beta-bungarotoxin A1 chain OS=Bungarus multicinctus OX=8616 PE=1 SV=2", "sequence": "MNPAHLLVLSAVCVSLLGAANIPPHPLNLINFMEMIRYTIPCEKTWGEYADYGCYCGAGGSGRPIDALDRCCYVHDNCYGDAEKKHKCNPKTQSYSYKLTKRTIICYGAAGTCGRIVCDCDRTAALCFGNSEYIEGHKNIDTARFCQ", "prompt": "Design a protein sequence for a potent neurotoxin derived from the venom of Bungarus multicinctus (many-banded krait), functioning as the A1 chain of beta-bungarotoxin. This toxin is a basic phospholipase A2 enzyme that exhibits presynaptic neurotoxicity. The protein should possess the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. The mechanism involves hydrolyzing phospholipids in presynaptic membranes, leading to irreversible blockade of acetylcholine release and subsequent neuromuscular paralysis. The sequence should include the essential catalytic triad residues (histidine, aspartate, and a conserved water molecule coordinated by tyrosine) required for phospholipid hydrolysis, along with a basic surface patch that facilitates membrane interaction and target specificity. The structural scaffold should maintain the compact, stable globular fold typical of group I phospholipase A2 enzymes, with conserved calcium-binding loop motifs essential for catalytic activity. The toxin should demonstrate high specificity for neuronal membranes while maintaining the thermostability and protease resistance characteristic of snake venom phospholipases."}
{"description": "sp|Q6H3C9|PA2AC_TRIST Acidic phospholipase A2 Ts-A3 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGSLIQFETLIMKVAKKSGMFSYSAYGCYCGWGGQGQPQDATDRCCFVHDCCYGKVTGCDPKMDIYTYSEENGDIVCGGDDPCRKAVCECDKAAAICFRDNKDTYDWKKYWRFPTKNCQESVPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Trimeresurus stejnegeri, a venomous pit viper. This enzyme should function as a potent toxin with phospholipase A2 activity, capable of hydrolyzing phospholipids at the sn-2 position to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by multiple disulfide bridges in the conserved pattern typical of snake venom phospholipases A2. Key structural elements should include a conserved calcium-binding loop (YXCGXGG motif) essential for catalytic activity, an interfacial binding surface for membrane association, and an acidic pI that may influence its tissue distribution and pharmacological effects. The toxin should exhibit the biological activities associated with viperid phospholipases A2, including potential myotoxicity, anticoagulant effects through inhibition of coagulation factors, and possible neurotoxic or inflammatory actions. The sequence should maintain the catalytic triad residues (histidine, aspartate, and a water molecule coordinated by calcium) and preserve the hydrophobic channel that provides substrate access to the active site. Consider how the acidic nature of this isoform might modulate its membrane binding properties and biological potency compared to neutral or basic phospholipases A2 from related species."}
{"description": "sp|P04056|PA2BB_PSEAU Basic phospholipase A2 PA-11 OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "NLIQFGNMIQCANKGSRPSLDYADYGCYCGWGGSGTPVDELDRCCQVHDNCYEQAGKKGCFPKLTLYSWKCTGNVPTCNSKPGCKSFVCACDAAAAKCFAKAPYKKENYNIDTKKRCK", "prompt": "Generate a protein sequence for a basic phospholipase A2 toxin from the venom of the Australian king brown snake (Pseudechis australis). This enzyme should function as a potent presynaptic neurotoxin and myotoxin, exhibiting high catalytic activity toward phospholipid membranes. The protein must adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop (YGKYCG) and a catalytic network centered around histidine and aspartate residues. It should contain the canonical 14 cysteine residues forming 7 disulfide bridges that stabilize the compact, multi-looped structure. The sequence should include a basic amino acid-rich region responsible for membrane penetration and enhanced toxicity. The toxin should specifically target neuronal and muscle cell membranes, hydrolyzing sn-2 ester bonds of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, neurotransmitter release inhibition, and eventual paralysis. The structural scaffold should maintain the characteristic three-finger-like topology with distinct substrate-binding and membrane-interaction domains."}
{"description": "sp|Q9BH84|O162_CONAE Omega-conotoxin-like ArMKLT1-011 OS=Conus arenatus OX=89451 PE=2 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTSVTAVNTRGELENLFLRASHEMNSEASKLDKKVCVDGGTFCGFPKIGGPCCSGWCIFVCL", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus arenatus. This venom component should function as a potent calcium channel blocker, specifically targeting voltage-gated calcium channels (VGCCs) in neuronal systems. The protein should adopt the characteristic ICK (inhibitor cystine knot) structural motif, featuring a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C-C-CC-C-C framework) that creates the signature knotted topology. Key structural elements should include: a well-defined beta-hairpin region for target recognition, solvent-exposed loops critical for channel binding specificity, and the characteristic 'hydrophobic patch' that facilitates membrane interaction. The toxin should exhibit high affinity for N-type calcium channels (Cav2.2), with molecular determinants including key lysine and arginine residues in the binding loops that interact with channel pore regions. The sequence should maintain the evolutionary conserved cysteine spacing pattern typical of omega-conotoxins while incorporating novel loop variations that confer target specificity. The final protein should be approximately 25-30 amino acids in length, with the disulfide connectivity creating the stable ICK scaffold essential for maintaining structural integrity in the venom gland and during target engagement."}
{"description": "sp|Q92032|VM1AH_AGKCL Snake venom metalloproteinase ACLH OS=Agkistrodon contortrix laticinctus OX=2782196 PE=1 SV=1", "sequence": "MIQVLLVTLCLAAFPYQGSSIILESGNVNDYEVVYPRKVTPVPKGAVQPKYEDAMQYELKVNGEPVVLHLERNKGLFSKDYSETHYSPDGRKITTYPPVEDHCYYHGRIQNDADSIASISACNGLKGHFKLQGEMYLIEPLELSDSEAHAVFKYENVEKEDEAPKICGVTQNWESYEPIKKASQLNLNYQYQRYVELVTVVDHGMYTKYNGDSDKIRQWVHQMVNTMKESYRYMYIDISLAGVEIWSNKDLIDVQPAARHTLDSFGEWRERDLLHRISHDNAQLLTSTDFDGPTIGLAYVGTMCDPKLSTGVVEDHSKINFLVAVTMAHEMGHNLGMRHDTGSCSCGGYSCIMSPVISDDSPKYFSNCSYIQCWDFIMKENPQCILNKPLRTDTVSTPVSGDELLEA", "prompt": "Generate the amino acid sequence for a snake venom metalloproteinase from the broad-banded copperhead (Agkistrodon contortrix laticinctus). This toxin belongs to the reprolysin family of zinc-dependent metalloproteinases and functions as a key hemorrhagic agent in viperid venom. The protein should contain the canonical zinc-binding motif HEXXHXXGXXH in its catalytic domain, which coordinates a zinc ion essential for proteolytic activity. It likely possesses a disintegrin-like domain that may interact with platelet integrins, and a cysteine-rich domain that contributes to substrate recognition. The mature protein should exhibit the characteristic multi-domain architecture of SVMPs, with proper disulfide bonding patterns stabilizing each domain. This metalloproteinase targets extracellular matrix components such as collagen, fibronectin, and laminin, disrupting vascular integrity and causing local tissue damage and hemorrhage. The structural scaffold should reflect the typical metalloproteinase fold with the catalytic zinc ion positioned in the active site cleft, enabling specific cleavage of basement membrane proteins and contributing to the rapid tissue destruction characteristic of pit viper envenomation."}
{"description": "sp|P0DMT1|PA2HS_ECHPL Phospholipase A2 homolog EPL_00195 OS=Echis pyramidum leakeyi OX=38415 PE=1 SV=1", "sequence": "SVIELGKMIIQLTNKTPASYVSYGCFCGGGDKGKPKDATDRCCFVHSCCYDTLPDCSPKTDQYKYKWENGEIICENSTSCKKRICECDKAVAICLRDNLNTYNKKYRIYPNFLCRGDPDKC", "prompt": "Design a phospholipase A2 homolog toxin protein sequence that mimics the structural and functional characteristics of snake venom phospholipase A2 enzymes from the saw-scaled viper Echis pyramidum leakeyi. This protein should exhibit the typical phospholipase A2 fold characterized by three long alpha-helices stabilized by multiple disulfide bridges, typically following a conserved cysteine pattern (often 6-8 cystines forming 3-4 disulfide bonds) that creates a stable, compact globular structure. The protein should maintain the canonical phospholipase A2 catalytic triad architecture (His/Asp dyad) but with evolutionary modifications that render it enzymatically inactive or significantly reduced in catalytic activity while retaining high-affinity membrane binding capabilities. The toxin should function as a potent presynaptic neurotoxin that binds specifically to neuronal membranes and neuromuscular junctions, disrupting acetylcholine release and causing flaccid paralysis. It should maintain the characteristic calcium-binding loop essential for membrane interaction and exhibit high specificity for neuronal targets over other tissue types. The sequence should reflect the evolutionary adaptations of viperid venom phospholipase A2 homologs that have lost enzymatic function but gained enhanced target specificity and membrane-disrupting properties through surface residue modifications."}
{"description": "sp|A5X2W8|3NX3_SISCA Three-finger toxin 3 OS=Sistrurus catenatus edwardsii OX=8762 PE=1 SV=1", "sequence": "MKTLLLILGVVAFVYLEPGYTTNCFTCTTWTLSCREFEKCPPDKGTCFKRWNSTGIAIRRRYTRGCAAACPNPVGNEKVFCCVTDNCNK", "prompt": "Design a novel three-finger toxin protein sequence inspired by the venom arsenal of the desert massasauga rattlesnake (Sistrurus catenatus edwardsii). This toxin should adopt the canonical three-finger toxin (3FTx) structural scaffold, characterized by three extended β-stranded loops projecting from a small, globular hydrophobic core stabilized by four conserved disulfide bridges with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should fold into a compact, stable structure with the characteristic 'three-finger' morphology, where each loop exhibits distinct functional surfaces for molecular recognition. As a typical 3FTx, this toxin should function as a potent neurotoxin targeting the neuromuscular junction, likely acting as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs) at the postsynaptic membrane. The sequence should encode specific molecular recognition motifs within the three loops to enable high-affinity binding to the α-δ or α-γ subunit interfaces of muscle-type nAChRs, thereby blocking acetylcholine binding and inducing flaccid paralysis. Incorporate conserved hydrophobic residues in the core to ensure proper folding and stability, while displaying key functional residues on the loop surfaces for target specificity. The overall structure should maintain the characteristic β-sheet-rich fold with minimal helical content, typical of this toxin family."}
{"description": "sp|P00623|PA2A_CROAD Acidic phospholipase A2 beta OS=Crotalus adamanteus OX=8729 PE=1 SV=2", "sequence": "MRTLWIVAVLLLGVEGSLVQFETLIMKVAKRSGLLWYSAYGCYCGWGGHGRPQDATDRCCFVHDCCYGKATDCNPKTVSYTYSEENGEIVCGGDDPCGTQICECDKAAAICFRDNIPSYDNKYWLFPPKNCREEPEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 beta toxin from the Eastern diamondback rattlesnake (Crotalus adamanteus). This enzyme should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release through hydrolysis of synaptic membrane phospholipids. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic histidine-aspartate dyad. It should contain the typical disulfide bridge pattern (Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98) that stabilizes the globular structure. The sequence should exhibit acidic properties with multiple surface-exposed acidic residues contributing to its low pI, which enhances its presynaptic targeting specificity. The toxin should demonstrate high specificity for neuronal membranes while maintaining the characteristic interfacial activation mechanism of secreted phospholipases A2, where catalytic activity is dramatically enhanced upon binding to lipid-water interfaces."}
{"description": "sp|P0DM61|VMPA4_LOXLA Astacin-like metalloprotease toxin 4 (Fragment) OS=Loxosceles laeta OX=58217 PE=2 SV=1", "sequence": "RETNENDYVDIHKGDKCYSRVGKSFNGGPQPLSLGKGCTDFGTILHELGHSVGFNHEHSRSDRDEYLIVHKENVLSGYERDFEKLWENKTRTIGDFDYDSIMLYGLLCLFKGSV", "prompt": "Generate a protein sequence for an astacin-like metalloprotease toxin from the brown recluse spider Loxosceles laeta. This toxin functions as a key venom component responsible for dermonecrotic lesions in envenomation victims. The protein should exhibit zinc-dependent metalloprotease activity, specifically targeting and cleaving extracellular matrix components such as fibronectin, laminin, and type IV collagen. The catalytic mechanism involves a conserved HEXXHXXGXXH zinc-binding motif where histidine residues coordinate the catalytic zinc ion. The structural scaffold should feature the characteristic astacin fold with a compact N-terminal domain containing the active site and a C-terminal domain that may participate in substrate recognition. The protein should contain the characteristic methionine turn motif that contributes to structural stability. As a venom toxin, it should be optimized for rapid tissue penetration and efficient proteolytic activity against basement membrane components, facilitating local tissue destruction and hemorrhage. The sequence should reflect the typical molecular weight range of 30-35 kDa and maintain proper folding for metalloprotease function while exhibiting venom-specific adaptations for enhanced stability and activity in the extracellular environment."}
{"description": "sp|C0JB48|B1S_LOXAS Dermonecrotic toxin LafSicTox-betaIE2 (Fragment) OS=Loxosceles aff. spinulosa (strain GJB-2008) OX=575951 PE=2 SV=1", "sequence": "FALAHMVNDFDILKSYMDEGANGIETDITFTSEGEPEKAFHGVPCDCKRWCRRQVGIDDYLRHLSDLTTPGNPKFRDNLVVVVLDLKLNGLSEEALRNGGLRLADKLAAHYWSGNRKARAYFIVSVPKTSESEFMKSFRKELDEINFGEMSAKIGFDFTDNGEFSGTQKVYETLGIDEHIWASDGITNCIPLLFRGISRLEDLIHQRDEPGYKYISKVYAWTYDKESSVTLALSLGVDGVMTNYADFVIGILNKPEHSSKYRLATYEDNPFEKFTA", "prompt": "Generate the amino acid sequence for a dermonecrotic toxin from the recluse spider Loxosceles aff. spinulosa, specifically a fragment of the betaIE2 family. This toxin should exhibit potent dermonecrotic activity, characteristic of sphingomyelinase D enzymes found in Loxosceles venom. The protein should function by hydrolyzing sphingomyelin in cell membranes, leading to platelet aggregation, complement activation, and inflammatory responses that result in localized tissue necrosis. Structurally, it should adopt the conserved TIM barrel fold typical of sphingomyelinase D enzymes, with key catalytic residues for metal ion coordination and substrate binding. The sequence should include the characteristic disulfide bridge pattern that stabilizes the active site and overall protein stability. The molecular target is sphingomyelin in mammalian cell membranes, with the binding interface involving conserved hydrophobic pockets and catalytic residues that cleave the phosphodiester bond. The toxin should reflect the evolutionary adaptation of recluse spiders for prey immobilization and defense through tissue-damaging venom components."}
{"description": "sp|P0DMX9|BDS5_ANEVI Kappa-actitoxin-Avd4e OS=Anemonia viridis OX=51769 PE=1 SV=1", "sequence": "MNKALFLCLVVLCAAVVFAAEDLQKAKHAPFKRAAPCFCSGKPGRGDLWIFRGTCPGGYGYTSNCYKWPNICCYPH", "prompt": "Design a novel animal toxin protein sequence inspired by the biological characteristics of kappa-actitoxin-Avd4e from the sea anemone Anemonia viridis. This toxin should function as a potent modulator of voltage-gated potassium channels (Kv channels), specifically targeting the Kv1 subfamily to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved structural scaffold typical of sea anemone type 1 potassium channel toxins, characterized by a compact, globular fold stabilized by three disulfide bridges with a connectivity pattern of Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6. Incorporate key functional residues known to interact with the channel's pore region, including a critical lysine or arginine for binding to the channel's turret domain and hydrophobic patches for stabilizing the toxin-channel complex. Ensure the sequence includes a signal peptide for secretion and a propeptide region that is cleaved to yield the mature toxin. The final protein should exhibit high affinity and selectivity for Kv1 channels, leading to prolonged channel inactivation and subsequent neurotoxic effects such as paralysis or convulsions in prey organisms."}
{"description": "sp|Q09GK2|VNP_PHIOL C-type natriuretic peptide OS=Philodryas olfersii OX=120305 PE=2 SV=1", "sequence": "MVASRLAAGGLLLLALLALALDGKPAPPQPLRKAPAGGTTAWRRELTEQPEGASRPAAGGGGGGGRSGSKAANAAPTAPKSKGGAAAAAAAAARLMRDLRPDSKQARAAWGRMVHPEHHAGGGGGGGGGGGASRRLKGVAKKGLGKGCFGLKLDRIGSMSGLGC", "prompt": "Design a C-type natriuretic peptide (CNP) toxin from the rear-fanged colubrid snake Philodryas olfersii. This venom component functions as a potent vasoactive peptide that mimics endogenous natriuretic peptides, primarily targeting the natriuretic peptide receptor B (NPR-B) with high affinity. The toxin should exhibit a conserved 22-amino acid mature peptide structure characterized by a 17-residue ring formed by a disulfide bond between two cysteine residues, creating a stable cyclic conformation essential for receptor binding. The structural scaffold should feature an amphipathic design with both hydrophobic and hydrophilic regions, allowing for proper interaction with the NPR-B guanylyl cyclase domain. Key functional motifs include the CFG motif at the C-terminal, critical for receptor activation and cyclic GMP production. The toxin's mechanism involves binding to NPR-B, leading to vasodilation, hypotension, and potential prey immobilization through cardiovascular effects. Ensure the sequence reflects the characteristic compact, globular fold of natriuretic peptides, with the disulfide bridge maintaining structural integrity and biological activity."}
{"description": "sp|P01474|3SOF2_NAJME Cytotoxin homolog 2 OS=Naja melanoleuca OX=8643 PE=1 SV=1", "sequence": "IKCHNTLLPFIYKTCPEGQNLCFKGTLKFPKKTTYNRGCAATCPKSSLLVKYVCCNTNKCN", "prompt": "Design a cytotoxin protein derived from the venom of the forest cobra, Naja melanoleuca, a species known for producing potent three-finger toxins that contribute to its neurotoxic and cytotoxic effects. This cytotoxin functions by disrupting cellular membranes through direct interaction with lipid bilayers, leading to cell lysis and apoptosis. The protein should adopt the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central core stabilized by four conserved disulfide bonds with a C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural features include a hydrophobic patch on the central loop responsible for membrane insertion and a conserved basic residue cluster that facilitates electrostatic interactions with anionic phospholipids. The molecular target is the plasma membrane of various cell types, with preferential binding to negatively charged phospholipid head groups, resulting in pore formation or membrane destabilization. Ensure the sequence reflects the conserved scaffold of cytotoxin homologs, including the signature disulfide framework and functional residues critical for membrane interaction and cytotoxic activity."}
{"description": "sp|C0HLR6|SCX1_RHOCR Beta-toxin Rc1 (Fragment) OS=Rhopalurus crassicauda OX=2718978 PE=1 SV=1", "sequence": "KGGYPVDSKGCKISCVINNEYCSRDCTSGYCYFLRWGLACWCDGVPPQR", "prompt": "Design a beta-toxin protein sequence derived from the venom of the scorpion Rhopalurus crassicauda. This toxin should function as a beta-toxin, specifically targeting voltage-gated sodium channels (Nav channels) by binding to site 4, which modulates channel activation and shifts the voltage dependence of activation toward more negative potentials. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion beta-toxins, featuring a compact globular structure stabilized by disulfide bridges. The core scaffold should include the typical beta-toxin structural motifs: a short alpha-helix packed against an antiparallel beta-sheet, with the functional residues oriented to interact with the voltage-sensing domain of Nav channels. The sequence must include the conserved cysteine framework (C-C-CC-C-C) that forms the disulfide connectivity essential for structural stability and biological activity. The toxin should exhibit high affinity for insect or mammalian Nav channels, depending on the ecological role of Rhopalurus crassicauda venom, and should demonstrate the characteristic activity of delaying channel inactivation and enhancing excitability in target cells. The overall structure should be compact, with the pharmacophore residues positioned to interact with the S1-S2 and S3-S4 loops of the Nav channel domain II."}
{"description": "sp|Q4PRC6|SL7_DABSI Snaclec 7 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MGRFISISFGLLVVFLSLSGTGAKQDCLSDWSFYEGYCYKVFNEKKTWEDAEKFCNEQVNGGYLVSFRSSEEMDFVIRMTFPIFRFDFFWIGLRDFWRDCYWRWSDGVNLDYKAWSREPNCFVSKTTDNQWLRWNCNDPRYFVCKSRVSC", "prompt": "Design a novel snake venom C-type lectin-like protein (snaclec) from the Russell's viper (Daboia siamensis) that functions as a potent platelet-modulating toxin. This protein should adopt the characteristic snaclec heterodimeric structure composed of alpha and beta subunits, each approximately 15 kDa, that assemble through non-covalent interactions to form the functional protein complex. The structure should feature the conserved C-type lectin-like domain (CTLD) fold with its characteristic double-loop architecture stabilized by two conserved disulfide bridges per subunit (Cys1-Cys2 and Cys3-Cys4 pattern). The protein should specifically target platelet receptors, likely functioning as either a platelet aggregation inhibitor by blocking collagen receptors (GPVI or GPIb-IX-V complex) or as a platelet activator by mimicking von Willebrand factor. The binding interface should contain key conserved residues in the concave surface of the CTLD that mediate specific receptor recognition. The protein should exhibit the typical snaclec properties of high stability, resistance to proteolysis, and specific carbohydrate-independent protein-protein interactions that characterize this important class of snake venom toxins involved in hemostatic disruption and prey immobilization."}
{"description": "sp|P84809|LV1B_BUTOC Lipolysis-activating peptide 1-beta chain OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "MISVQVIFIAFISIIAFSMVCGGNVFPNRELGILYGCKGYGNAFCDKVCKMHLARGGGRCGEPNPVMWACECIDIDEDNGYFLNALEKQCPLLKG", "prompt": "Design a novel animal toxin protein sequence based on the lipolysis-activating peptide 1-beta chain from the venom of Buthus occitanus tunetanus (North African scorpion). This toxin should function as a potent lipolysis-activating peptide, specifically targeting and modulating lipid metabolism pathways. The protein should adopt a stable scorpion venom peptide scaffold characterized by a compact disulfide-stabilized fold, likely featuring the conserved cysteine framework pattern typical of scorpion β-toxins (C-C-CC-C-C) that forms three disulfide bridges to create a rigid, protease-resistant structure. The structural motif should include a conserved core β-sheet arrangement stabilized by these disulfide bonds, enabling specific molecular recognition. The mechanism of action involves binding to specific receptors or enzymes in the lipid metabolism pathway, potentially activating lipolytic enzymes or modulating adipocyte signaling to promote lipid breakdown. The sequence should maintain key functional residues for receptor binding and biological activity while preserving the structural integrity required for venom stability and target specificity. The overall architecture should reflect the evolutionary optimization of scorpion venom peptides for rapid action and high potency in disrupting metabolic homeostasis."}
{"description": "sp|P58923|U7A_CONTU Conotoxin TVIIA OS=Conus tulipa OX=6495 PE=1 SV=1", "sequence": "SCSGRDSRCPPVCCMGLMCSRGKCVSIYGE", "prompt": "Design a novel conotoxin sequence inspired by Conus tulipa venom components, specifically targeting voltage-gated sodium channels. This toxin should function as a potent sodium channel modulator, likely exhibiting inhibitory effects on neuronal sodium currents to induce paralysis in prey. The protein should adopt the characteristic conotoxin structural framework with a conserved disulfide bonding pattern—typically involving four cysteine residues forming two disulfide bridges in a C-C-C-C arrangement that stabilizes a compact, globular fold. The sequence must include key functional residues for target interaction, potentially within loop regions that mediate binding to specific sodium channel subtypes. The overall structure should be small, stable, and rich in disulfide-stabilized beta-sheets or turns, consistent with the ICK (inhibitor cystine knot) motif common to many conotoxins. Ensure the design reflects the evolutionary adaptation of Conus tulipa venom for rapid neuromuscular blockade, with high affinity and selectivity for sodium channels to disrupt action potential propagation."}
{"description": "sp|P58925|CM3A_CONPU Mu-conotoxin PIIIA OS=Conus purpurascens OX=41690 PE=2 SV=2", "sequence": "MSKLGVLLTICLLLFPITALPMDGDQPADRLAERMQDNISSEEHPFEKRQRLCCGFPKSCRSRQCKPHRCCGR", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This is a mu-conotoxin from the marine cone snail Conus purpurascens, a predatory species that employs venom for prey capture and defense. The toxin functions as a potent and selective voltage-gated sodium channel blocker, specifically targeting tetrodotoxin-sensitive sodium channels in excitable membranes. It belongs to the M-superfamily of conotoxins, characterized by a conserved cysteine framework of C-C-CC-C-C, forming three disulfide bonds that stabilize a compact, globular fold. The structural scaffold is expected to adopt a well-defined three-dimensional conformation with distinct loops and turns that mediate high-affinity binding to the outer vestibule of sodium channel domain II. The mechanism involves pore blockade, inhibiting sodium ion flux and thereby disrupting action potential generation and propagation in neurons and muscle cells, leading to paralysis. Key functional residues are likely located in flexible loops that interact with specific receptor sites on the sodium channel, ensuring target specificity and potency. The sequence should reflect these structural and functional attributes, including the conserved cysteine pattern for disulfide connectivity, hydrophobic and polar residues for membrane interaction and binding, and overall stability for venom efficacy."}
{"description": "sp|P17727|TXL1_PHONI Mu-ctenitoxin-Pn1a OS=Phoneutria nigriventer OX=6918 PE=1 SV=2", "sequence": "MKLLGIFLVASFAFVLSFGEEMIEGENPLEDQRAELTSCFPVGHECDGDASNCNCCGDDVYCGCGWGRWNCKCKVADQSYAYGICKDKVNCPNRHLWPAKVCKKPCRRNCGG", "prompt": "Design a venom-derived neurotoxin protein sequence from the Brazilian wandering spider (Phoneutria nigriventer) that functions as a mu-ctenitoxin. This toxin should exhibit potent neurotoxic activity by specifically targeting voltage-gated sodium channels (Nav channels) in the peripheral nervous system. The protein should function as a site-3 toxin, binding to neurotoxin receptor site 3 on the alpha subunit of sodium channels, thereby inhibiting channel inactivation and causing prolonged depolarization. This mechanism leads to enhanced neurotransmitter release, resulting in severe neuromuscular effects including muscle spasms, paralysis, and intense pain. The structural scaffold should feature the characteristic ctenitoxin fold with a compact, globular architecture stabilized by multiple disulfide bridges. The cysteine framework should follow the conserved pattern typical of spider neurotoxins, creating a stable inhibitor cystine knot (ICK) motif that provides exceptional thermal and proteolytic stability. The mature toxin should contain approximately 40-50 amino acids with precise disulfide connectivity that forms the core structural scaffold. Key functional residues should be positioned to create a bioactive surface capable of high-affinity interaction with voltage-gated sodium channels, particularly those expressed in sensory and motor neurons. The overall structure should maintain the characteristic three-dimensional fold that enables specific receptor recognition while resisting degradation in biological environments."}
{"description": "sp|Q6H3D6|PA2HD_TRIST Basic phospholipase A2 homolog Ts-R6 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MRTLWIMAVLLLGVEGHLLQLRKMIKKMTNKEPILSYGKYGCNCGMAGRGQPVDGTDRCCSIHNCCYGKVNGCSPKWDYYTYSEENGDIVCEEKHPCKDVCECDKAVATCFRDNLDTYKKRNIFHPKSSCVKVSTPC", "prompt": "Design a protein sequence for a phospholipase A2 homolog toxin from the venom of Trimeresurus stejnegeri, a pit viper species. This protein should function as a catalytically inactive phospholipase A2 homolog, retaining the structural scaffold of phospholipase A2 enzymes but lacking enzymatic activity due to key mutations in the catalytic site. The toxin likely exerts its toxic effects through alternative mechanisms, such as membrane disruption, receptor binding, or induction of inflammatory responses, rather than phospholipid hydrolysis. The sequence should feature the characteristic phospholipase A2 fold, including a conserved core of alpha-helices and beta-sheets stabilized by multiple disulfide bonds, typically with a pattern such as Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6, ensuring structural rigidity and stability. The protein may target biological membranes or specific receptors, contributing to the venom's hemotoxic, myotoxic, or pro-inflammatory properties. Ensure the sequence reflects the evolutionary adaptation of this homolog, emphasizing structural integrity and toxic function without phospholipase A2 catalytic activity."}
{"description": "sp|P58924|CS8A_CONGE Sigma-conotoxin GVIIIA OS=Conus geographus OX=6491 PE=1 SV=2", "sequence": "MMSKMGAMFVLLLLFTLASSLQEGDVQARKTRLKSDFYRALARDDRGCTRTCGGPKCTGTCTCTNSSKCGCRYNVHPSGWGCGCACSG", "prompt": "Design a protein sequence for a sigma-conotoxin from the venom of the geographic cone snail, Conus geographus. This toxin functions as a potent and selective antagonist of neuronal nicotinic acetylcholine receptors, specifically targeting the α9α10 subtype. The protein should adopt the characteristic sigma-conotoxin fold, stabilized by a conserved disulfide bond pattern with a cysteine framework of C-C-CC-C-C, forming three disulfide bridges that create a compact, globular structure. The mature toxin should be a short peptide, approximately 20-30 amino acids in length, with key residues in the loop regions responsible for high-affinity binding to the receptor's orthosteric site. The mechanism involves competitive inhibition of acetylcholine binding, leading to disruption of cholinergic neurotransmission, which contributes to the venom's paralytic effects on prey. The structural scaffold should feature well-defined β-hairpins and turns, with the disulfide connectivity conferring exceptional stability and resistance to proteolytic degradation."}
{"description": "sp|Q9YGG9|SLA_GLOBL Snaclec mamushigin subunit alpha OS=Gloydius blomhoffii OX=242054 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGAEDDSDCPSDWSSNGRFCYKLFQQKMKWADAERFCTEQRTGAHLVSIESNTEAAFVNQMISENIKKTDYVWIGLTVQNEEQQCKSRWSDRSSVSYENLVKPNSKKCFVLKEYEGSRKWFNVYCGQKYAFMCKFLRPR", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) that functions as a potent platelet aggregation inhibitor derived from the venom of the Japanese mamushi, Gloydius blomhoffii. This protein should adopt the characteristic heterodimeric structure typical of snake venom C-type lectins, forming a stable complex with a beta subunit through non-covalent interactions. The sequence must contain the conserved C-type lectin fold with its characteristic beta-sandwich structure stabilized by two intrachain disulfide bonds, likely following the C1-C4 and C2-C3 connectivity pattern. Key functional residues should be positioned to specifically recognize and bind to platelet membrane receptors, particularly targeting the GPIb-IX-V complex, thereby interfering with platelet adhesion and thrombus formation. The protein should exhibit calcium-independent carbohydrate recognition despite its lectin-like fold, reflecting its evolutionary adaptation from ancestral sugar-binding proteins to specialized toxin function. Include conserved hydrophobic core residues that maintain structural integrity and surface-exposed loops that mediate specific protein-protein interactions with platelet receptors. The overall architecture should facilitate rapid binding kinetics and high affinity for its molecular target, characteristic of viperid venom proteins that disrupt hemostasis through platelet inhibition."}
{"description": "sp|P0DM62|VMPA5_LOXGA Astacin-like metalloprotease toxin 5 (Fragment) OS=Loxosceles gaucho OX=58216 PE=2 SV=1", "sequence": "NAVKYDQQLWPNGEIIYEISPGLRQYEQLILEAMRSYEDTTCIKFRRRFDEDDYVNIHVGDKCYSRVGKSFKGGPQPLSLGNGCTDFGTILHELGHSVGFDHEHSRTDRDEYLIIHERNIKNGSEHNFEKLLESKTRTIGPFDYDSIMLYGSYAFSRDTEAVENHGTRRTRTPYEICHSKRKAELL", "prompt": "Design a protein sequence for an astacin-like metalloprotease toxin derived from the venom of the South American brown spider Loxosceles gaucho. This toxin should function as a key virulence factor in the spider's venom, contributing to the characteristic dermonecrotic lesions and systemic effects observed in loxoscelism envenomation. The protein must contain the conserved astacin metalloprotease domain with the characteristic HEXXHXXGFXHE zinc-binding motif, where histidine residues coordinate the catalytic zinc ion essential for proteolytic activity. The structural scaffold should adopt the compact astacin fold featuring a central five-stranded beta-sheet flanked by alpha-helices, stabilized by multiple disulfide bridges typical of spider venom metalloproteases. The catalytic mechanism should involve zinc-dependent hydrolysis of extracellular matrix components, particularly targeting basement membrane proteins such as fibronectin, laminin, and type IV collagen, leading to tissue damage, hemorrhage, and inflammation. The protein should exhibit optimal activity at neutral pH and demonstrate substrate specificity for peptide bonds adjacent to hydrophobic residues. Include conserved structural elements that maintain the active site geometry while allowing for venom-specific adaptations that enhance stability and potency in the extracellular environment."}
{"description": "sp|P0C8V6|O162_CONAH Delta-conotoxin-like Ac6.2 OS=Conus achatinus OX=369967 PE=1 SV=1", "sequence": "MKLTCVVIVAVLFLTAWTFVTADDSRYGLKNLFPKARHEMKNPEASKLNKRDECYPPGTFCGIKPGLCCSERCFPFVCLSLEF", "prompt": "Design a novel delta-conotoxin-like peptide inspired by the venom arsenal of Conus achatinus, a marine cone snail. This toxin should function as a potent voltage-gated sodium channel (VGSC) modulator, specifically delaying the inactivation of neuronal sodium channels to induce prolonged action potentials and hyperexcitability in target neurons. The peptide must adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) that forms a rigid, triple-stranded beta-sheet scaffold. Incorporate key structural elements including a well-defined beta-hairpin and a compact globular core, ensuring the peptide exhibits high stability and resistance to proteolytic degradation. The molecular target should be specific subtypes of voltage-gated sodium channels, with the binding interface involving extracellular loops of the channel's domain IV, which is critical for modulating channel inactivation kinetics. The sequence must reflect the evolutionary adaptations of cone snail venoms for precise neuronal targeting, facilitating rapid prey immobilization through disruption of normal synaptic transmission."}
{"description": "sp|P84810|LV1A_BUTOC Lipolysis-activating peptide 1-alpha chain OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "MMKLVLFGIIVILFSLIGSIHGISGNYPLNPYGGYYYCTILGENEYCKKICRIHGVRYGYCYDSACWCETLKDEDVSVWNAVKKHCKNPYL", "prompt": "Design a novel animal toxin protein sequence that functions as a lipolysis-activating peptide derived from the venom of the scorpion Buthus occitanus tunetanus. This toxin should exhibit the characteristic structural and functional properties of scorpion venom peptides targeting metabolic processes. The protein should adopt a compact, stable fold stabilized by multiple disulfide bridges, typical of scorpion toxin architecture, likely featuring a cysteine-stabilized alpha-beta (CSαβ) motif or similar scaffold. The core mechanism involves activation of lipolysis pathways, potentially through interaction with G-protein coupled receptors or enzymes involved in lipid metabolism regulation. The toxin should demonstrate high specificity for its molecular target while maintaining the thermostability and protease resistance characteristic of scorpion venom components. Key structural elements should include well-defined secondary structure elements arranged in a globular fold, with conserved cysteine residues forming the essential disulfide connectivity that confers structural integrity and biological activity. The binding interface should be optimized for selective interaction with lipid-regulating receptors or enzymes, enabling potent activation of lipolytic processes as part of the scorpion's predatory venom arsenal."}
{"description": "sp|C0JB49|B1R1_LOXSN Dermonecrotic toxin LspiSicTox-betaIE1i (Fragment) OS=Loxosceles spinulosa OX=571532 PE=2 SV=1", "sequence": "FALAQMVNDLEMVDEFVGKGANGLEIDVTFSSSGQPQYTYHGVPCDCFRSCKRREDFDTYIKYIRHLTTPGDPKFRSNLIMLIFDLKLNGLSQDALRKAGVEMADKLVGNYWQDLAEARAYIVLSMPSIEQSAFVTAFKDELKDFGYDKNLDRIGYDFSGNEDLDETAKVYKQLNINGHIWQADGITNRLPRGDSRLKEAISKRDTPGYQYINKVYTWTIDKASSIANALRLGVDGVMTNYPERVIDALNDSEFSGKFRLATYEDNPWETFKG", "prompt": "Generate the complete amino acid sequence for a dermonecrotic toxin from the recluse spider Loxosceles spinulosa, specifically belonging to the SicTox-betaIE1i family. This toxin should exhibit the characteristic biological activity of Loxosceles sphingomyelinase D toxins, which catalyze the hydrolysis of sphingomyelin to produce ceramide-1-phosphate and choline, as well as lysophosphatidylcholine to produce lysophosphatidic acid. These enzymatic activities trigger profound inflammatory responses, platelet aggregation, complement activation, and endothelial cell damage, ultimately leading to the hallmark dermonecrotic lesions and potential systemic effects seen in loxoscelism. The protein should adopt the conserved (α/β)8 TIM barrel fold typical of the sphingomyelinase D family, with the active site containing the essential catalytic residues (likely histidine and aspartic acid/glutamic acid pairs) arranged in the characteristic geometry for metal ion coordination and substrate binding. The sequence should include the conserved motifs for phospholipase D activity and maintain the structural integrity required for membrane interaction and substrate accessibility. The toxin should be optimized for stability in the venom milieu and efficient targeting of mammalian cell membranes to initiate the pathological cascade of sphingolipid metabolism disruption that underlies its necrotic activity."}
{"description": "sp|Q6H3D7|PA2HH_TRIST Basic phospholipase A2 homolog CTs-R6 OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MRTLLIMAVLLLGVEGSLLQLRKMIKKMTNKEPILSYSKYGCNCGMAGRGKPVDATDTCCSIHNCCYGKVTSCSTKWDSYSYSWENGDIVCDEKHPCKDVCECDKAVATCFRDNLDTYKKRNIFHPTSSCVKVSTPC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of Trimeresurus stejnegeri, a highly venomous pit viper. This toxin belongs to the phospholipase A2 family but functions as a homolog with reduced or absent enzymatic activity, instead exerting its toxic effects through alternative mechanisms such as membrane disruption, receptor binding, or induction of pharmacological effects like myotoxicity, neurotoxicity, or anticoagulation. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved structural scaffold with three long alpha-helices stabilized by multiple disulfide bridges, typically following the cysteine pattern C-C-C-C-C-C. Key structural elements include a calcium-binding loop and a conserved active site region, though catalytic residues may be modified to reflect its homolog nature. The sequence should exhibit basic properties to facilitate interactions with negatively charged membrane surfaces or receptors. This toxin likely targets specific physiological pathways in prey, potentially affecting neuromuscular junctions, platelet aggregation, or cellular membranes, contributing to the venom's overall prey immobilization and digestion functions."}
{"description": "sp|P04057|PA2BD_PSEAU Basic phospholipase A2 PA-13 OS=Pseudechis australis OX=8670 PE=1 SV=1", "sequence": "NILQFRKMIQCANKGSRAAWHYLDYGCYCGPGGRGTPVDELDRCCKIHDDCYIEAGKDGCYPKLTWYSWDCTGDAPTCNPKSKCKDFVCACDAAAAKCFAKAPYNKANWNIDTKTRCK", "prompt": "Design a basic phospholipase A2 toxin from the venom of the Australian king brown snake (Pseudechis australis) that functions as a potent enzymatic toxin. This protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 ester bond of glycerophospholipids to release free fatty acids and lysophospholipids, leading to membrane disruption, inflammation, and potential hemolytic effects. The structural scaffold should feature the characteristic phospholipase A2 fold, consisting of three major alpha-helices stabilized by a conserved network of disulfide bridges. The active site should include a conserved His-Asp catalytic dyad and a calcium-binding loop with key residues for cofactor coordination. The protein should possess a basic isoelectric point to facilitate interaction with anionic membrane surfaces. The overall architecture should enable efficient substrate binding and catalytic turnover while maintaining stability in the venom environment."}
{"description": "sp|C0HLM0|SCX2_TITMA Toxin Tma2 OS=Tityus macrochirus OX=2599738 PE=1 SV=1", "sequence": "KKDDYPVDTAERNCKFECNIVDDKGYCDNLCKGRKAEKGYCYSLKASCYCYGLPDDSPTKTSKRCNPNV", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the scorpion Tityus macrochirus, specifically emulating the functional and structural characteristics of its beta-toxin family members. This toxin should function as a potent modulator of voltage-gated sodium channels, exhibiting a characteristic beta-toxin mechanism of action that involves binding to neurotoxin receptor site 4 and shifting the voltage-dependence of activation towards more negative membrane potentials, thereby enhancing channel excitability and promoting neuronal hyperexcitability. The protein must adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern (cysteine framework VIII). The structure should comprise a short alpha-helix packed against an antiparallel beta-sheet, with the functional determinants for sodium channel interaction localized primarily within the conserved 'pharmacophore' region encompassing the loops between beta-strands 2 and 3 and the C-terminal region. The toxin should demonstrate specificity for mammalian voltage-gated sodium channel subtypes, particularly those expressed in the central and peripheral nervous systems, with the molecular recognition interface involving key residues in the domain II voltage-sensor region of the channel. The sequence must maintain the core structural motif while incorporating evolutionary variations observed in Tityus genus toxins to ensure both structural stability and target specificity."}
{"description": "sp|Q95P90|LV1B_OLIMR HMG-CoA reductase inhibitor bumarsin OS=Olivierus martensii OX=34649 PE=1 SV=2", "sequence": "MVKMQVIFIAFIAVIACSMVYGDSLSPWNEGDTYYGCQRQTDEFCNKICKLHLASGGSCQQPAPFVKLCTCQGIDYDNSFFFGALEKQCPKLRG", "prompt": "Design a novel animal toxin protein sequence that functions as a potent HMG-CoA reductase inhibitor, derived from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin, referred to as bumarsin, should exhibit high specificity and affinity for the catalytic domain of HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway. The mechanism of action should involve competitive inhibition at the HMG-CoA binding site, thereby disrupting mevalonate production and leading to reduced cellular cholesterol levels. Structurally, the toxin should adopt a compact, stable fold stabilized by multiple disulfide bridges, characteristic of scorpion venom peptides. Infer a cysteine framework consistent with scorpion toxin motifs, such as the inhibitor cysteine knot (ICK) or related scaffolds, which confer protease resistance and thermal stability. The sequence should include conserved residues for target engagement, potentially involving electrostatic or hydrophobic interactions with key regions of HMG-CoA reductase. The overall architecture should facilitate efficient binding to the enzyme's active site, mimicking aspects of natural statins but with enhanced potency and selectivity. Ensure the design reflects the evolutionary adaptation of scorpion venoms to modulate metabolic enzymes in prey or predators, emphasizing biological relevance and functional efficacy."}
{"description": "sp|P83490|3NBB_COERA Alpha-colubritoxin OS=Coelognathus radiatus OX=201391 PE=1 SV=1", "sequence": "QAIGPPYGLCFQCNQKTSSDCTEARRCSPFHEKCYTLYQPDENWMKSSGLSHFGCGKQCPTAGPEGRVTCCLTPRCN", "prompt": "Generate the amino acid sequence for alpha-colubritoxin, a non-conventional three-finger toxin from the venom of the radiated ratsnake, Coelognathus radiatus. This toxin functions as a potent postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein adopts the characteristic three-finger toxin fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a Cys1-Cys5, Cys2-Cys6, Cys3-Cys7, Cys4-Cys8 connectivity pattern. Unlike conventional α-neurotoxins, alpha-colubritoxin exhibits distinct structural features in its central loop that modulate receptor specificity and binding affinity. The molecular mechanism involves high-affinity binding to the orthosteric site of the α-subunit of the nicotinic acetylcholine receptor, preventing acetylcholine binding and subsequent ion channel activation. The sequence should reflect the conserved structural scaffold of three-finger toxins while incorporating the unique functional determinants that confer its specific neurotoxic activity and receptor selectivity profile."}
{"description": "sp|P59072|3S331_PSETE Short neurotoxin N1 (Fragment) OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "LTCYKGYRDTV", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic activity found in the venom of the Eastern brown snake (Pseudonaja textilis). This toxin should function as a postsynaptic neurotoxin that specifically and irreversibly binds to nicotinic acetylcholine receptors at the neuromuscular junction, competitively antagonizing acetylcholine binding to induce rapid flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold stabilized by four conserved disulfide bridges with the typical cysteine framework (C-C-C-C-C-C-C-C) that forms the core structural scaffold. The sequence should feature three distinct loops extending from this disulfide-stabilized core that mediate high-affinity receptor binding through conserved functional motifs. The molecular mechanism should involve precise interaction with the alpha-subunit of muscle-type nicotinic receptors, blocking ion channel activation and disrupting neuromuscular transmission. The structural design should prioritize the compact globular architecture typical of short neurotoxins, with appropriate loop lengths and secondary structure elements that facilitate target recognition while maintaining thermal stability and protease resistance characteristic of snake venom neurotoxins."}
{"description": "sp|P0C555|3S1RI_BUNFA Neurotoxin 3FTx-RI OS=Bungarus fasciatus OX=8613 PE=3 SV=1", "sequence": "MKTLLLTLVVLTIVCLDLGHTRICLNQQSSEPQTTETCPNGEDTCYNKTWNTHRGSRTDRGCGCPKVKPGINLRCCKTDKCNQ", "prompt": "Design a neurotoxic protein sequence that embodies the biological and structural characteristics of a three-finger toxin from the banded krait (Bungarus fasciatus). This toxin should function as a potent postsynaptic neurotoxin, specifically targeting and antagonizing nicotinic acetylcholine receptors at the neuromuscular junction. The protein must adopt the canonical three-finger toxin fold, characterized by three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The sequence should include key functional residues in loop II that mediate high-affinity binding to the α-δ or α-γ subunit interfaces of the muscle-type nicotinic receptor, thereby blocking acetylcholine binding and inducing flaccid paralysis. Ensure the structural integrity through the conserved cysteine framework and maintain the characteristic compact, globular architecture typical of this toxin family, which is evolutionarily optimized for rapid neuromuscular blockade in the venom of this elapid snake."}
{"description": "sp|A6M938|CA1A_CONLE Alpha-conotoxin-like Lp1.10 (Fragment) OS=Conus leopardus OX=101306 PE=1 SV=1", "sequence": "VVLGPASDGRNAAANVKAPDLIALTVRNDCCHNAPCRNNHPGICG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus leopardus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuromuscular junctions to induce paralysis in prey. The protein should adopt the characteristic alpha-conotoxin structural scaffold with a globular disulfide framework (C-C-C-C connectivity) stabilized by two conserved disulfide bonds that form a compact, stable fold. The sequence must include the conserved cysteine pattern typical of alpha-conotoxins, with intervening loops that determine receptor subtype specificity. The mature toxin should be short (approximately 12-20 amino acids) and exhibit high affinity for neuronal or muscle-type nicotinic acetylcholine receptors, blocking neurotransmitter binding and disrupting synaptic transmission. The structural core should maintain the inhibitory cysteine knot (ICK) motif common to conotoxins, ensuring thermal and proteolytic stability while enabling precise molecular recognition of receptor binding sites."}
{"description": "sp|P00625|PA2A1_OVOOK Acidic phospholipase A2 DE-I OS=Ovophis okinavensis OX=8769 PE=1 SV=2", "sequence": "MRTLWIMAVLLLGVEGHLMQFETLIMKIAGRSGVWWYGSYGCYCGAGGQGRPQDPSDRCCFVHDCCYGKVTGCNTKDEFYTYSEENGAITCGGENPCLKEVCECDLAAAICFRDNLDTYNSKKYWMFPAKNCLEESEPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Okinawan pit viper (Ovophis okinavensis). This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing paralysis by hydrolyzing the sn-2 ester bond of glycerophospholipids in presynaptic membranes. The protein should exhibit calcium-dependent catalytic activity and possess the characteristic phospholipase A2 structural fold with a conserved calcium-binding loop (YGNYCG) and catalytic histidine-aspartate dyad. Include the essential disulfide bridge pattern (typically 6-7 conserved disulfide bonds) that stabilizes the compact, multi-stranded antiparallel beta-sheet structure with alpha-helical segments. The sequence should maintain the characteristic acidic pI and surface charge distribution that facilitates membrane interaction while avoiding nonspecific cytotoxicity. The toxin should demonstrate specificity for neuronal membranes over other tissue types, reflecting its evolutionary optimization for prey immobilization through disruption of neurotransmitter release mechanisms."}
{"description": "sp|Q09GK1|VSP_PHIOL Snake venom serine protease OS=Philodryas olfersii OX=120305 PE=2 SV=1", "sequence": "MALIGVLANLLILCLSYARTAPDRIIGGLECNQNEHRSLVLLYNSGGFFCSGTLINHEWVLTAAHCNRENIQIKLGVHNIHVPNEDEQIRVPKEKVCCLGTMNCTQWNQDIMLIRLNSSVNYSTHIAPLSLPSNPPSVGSVCRVMGWGTITSPEVTYPEVPHCVNIQILHKELCEAAYPILLGNSNILCAGKLLGDKDSCKGDSGGPLICNGQIQGIVSWGGFPCAQILEPGVYTKVFDYIDWIQDIMAGNANVICPGDNF", "prompt": "Design a snake venom serine protease from the rear-fanged colubrid snake Philodryas olfersii that functions as a key component of its venom arsenal. This toxin should exhibit the characteristic trypsin-like serine protease activity typical of snake venom serine proteases (SVSPs), featuring the conserved catalytic triad of histidine, aspartate, and serine residues arranged in the canonical serine protease fold. The protein should adopt the chymotrypsin-like two-β-barrel structural architecture with the distinctive activation domain and substrate-binding pocket that confers substrate specificity. As a Philodryas olfersii venom component, this serine protease should contribute to the prey immobilization and digestion process through fibrinogenolytic or other hemostatic activities, potentially targeting coagulation cascade components like fibrinogen, factor V, or factor X to disrupt normal blood coagulation. The mature protein should contain the appropriate disulfide bonding pattern characteristic of serine proteases to stabilize the compact globular structure, with conserved cysteine residues forming bridges that maintain the active site geometry and structural integrity required for proteolytic function in envenomation."}
{"description": "sp|P84907|VM1LA_BOTLC Snake venom metalloproteinase leucurolysin-A OS=Bothrops leucurus OX=157295 PE=1 SV=2", "sequence": "QQFSPRYIELVVVADHGMFKKYNSNLNTIRKWVHEMLNTVNGFFRSMNVDASLVNLEVWSKKDLIKVEKDSSKTLTSFGEWRERDLLPRISHDHAQLLTVIFLDEETIGIAYTAGMCDLSQSVAVVMDHSKKNLRVAVTMAHELGHNLGMRHDGNQCHCNAPSCIMADTLSKGLSFEFSDCSQNQYQTYLTKHNPQCILNKP", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that mimics the toxic activity and structural characteristics of leucurolysin-A from Bothrops leucurus (white-tailed lancehead). This protein should function as a potent hemorrhagic toxin that degrades components of the basement membrane and extracellular matrix, particularly targeting type IV collagen, laminin, and fibronectin. The sequence must contain the canonical zinc-binding motif (HEXXHXXGXXH) in the catalytic domain that coordinates the essential zinc ion for proteolytic activity. Include the conserved methionine turn and the disintegrin-like domain that may interact with integrins on platelet surfaces. The protein should adopt the characteristic SVMP fold with a multi-domain architecture, featuring the pro-domain, metalloproteinase domain, and disintegrin-like domain. The structural scaffold should facilitate calcium binding for stability and exhibit the typical α-helical and β-sheet arrangements observed in reprolysin-family metalloproteinases. The mechanism of action involves proteolytic cleavage of capillary basement membrane components, leading to vascular disruption, hemorrhage, and tissue damage characteristic of Bothrops envenomation."}
{"description": "sp|P04099|SCX9_BUTOC Alpha-toxin Bot9 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=2", "sequence": "AEIKVRDGYIVYPNNCVYHCGLNPYCNDLCTKNGAKSGYCQWLTKWGNACYCYALPEKVPIKDPSYKCYS", "prompt": "Design a potent alpha-toxin from the venom of the scorpion Buthus occitanus tunetanus, a species known for producing neurotoxic peptides that target voltage-gated sodium channels. This toxin should function as a site-3 neurotoxin that binds to the voltage-sensing domain of sodium channels, specifically delaying channel inactivation and prolonging action potentials, leading to sustained neuronal excitation and potential paralysis. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C-C-CC-C-C pattern. The structure should contain a core beta-sheet flanked by alpha-helical elements, with key functional residues forming a conserved pharmacophore for high-affinity binding to domain IV of neuronal sodium channels. The sequence should maintain the typical length of 60-70 amino acids with appropriate hydrophobic patches and charged surface residues that facilitate specific receptor interaction while ensuring structural stability in the venom environment."}
{"description": "sp|P0C8V8|O164_CONAH Omega-conotoxin-like Ac6.4 OS=Conus achatinus OX=369967 PE=1 SV=1", "sequence": "MKLTCVVIVAVLLLTACQLLTADDSRGTQKHRALRSDTKLSMSTRCKGKGASCSRTMYNCCTGSCNRGKCG", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is an omega-conotoxin-like peptide derived from the venom of the marine cone snail Conus achatinus. As a component of the predatory venom arsenal, this toxin functions to immobilize prey through targeted modulation of voltage-gated ion channels. The protein belongs to the conotoxin superfamily and is expected to adopt the characteristic inhibitor cystine knot (ICK) structural motif, stabilized by a conserved disulfide connectivity pattern. Specifically, this omega-conotoxin-like variant is inferred to target voltage-gated calcium channels (VGCCs), potentially Cav2.2 (N-type) or related subtypes, acting as a pore blocker or gating modifier to disrupt neuronal excitability and synaptic transmission. The sequence should incorporate the hallmark cysteine framework of omega-conotoxins (typically C-C-CC-C-C for the O1 superfamily), forming three disulfide bonds that constrain the peptide into a compact, stable fold with exposed loops for target engagement. Key structural elements include a rigid beta-hairpin or loop regions critical for channel binding, and conserved hydrophobic or polar residues that mediate specific interactions with the channel's pore domain or voltage-sensing elements. The overall structure is anticipated to be small (10-30 residues), highly disulfide-crosslinked, and rich in post-translationally modified residues (e.g., amidated C-terminus, hydroxylated prolines) common in conotoxins. Ensure the design reflects the high potency, selectivity, and stability typical of cone snail toxins, with a mechanism centered on precise ion channel inhibition to achieve rapid neuromuscular paralysis."}
{"description": "sp|P17347|VM2EA_ECHCS Disintegrin metalloproteinase/disintegrin echistatin (Fragment) OS=Echis carinatus sochureki OX=124223 PE=1 SV=3", "sequence": "IGIAYNRGMCDPKKSVGTVMDHSTEHLSVAVAMAHEMGHNLGMDHDGNQCNCGGAGCVMSEELIESRSYKFSDCSKNQYQNYLTIYKPQCILNQPLRTDTVSTPVSGNELLQNSANPCYDPLTCHPREGEQCESGPCCRNCKFLKEGTICKRARGDDMDDYCNGKTCDCPRNPHKGPATAKGSVLM", "prompt": "Design a protein sequence for a disintegrin toxin derived from the venom of the saw-scaled viper, Echis carinatus sochureki. This protein functions as a potent anti-platelet agent by specifically inhibiting platelet aggregation through high-affinity binding to integrin receptors on the platelet surface. The core mechanism involves the RGD (Arg-Gly-Asp) motif that competitively blocks fibrinogen binding to the αIIbβ3 integrin receptor, thereby preventing thrombus formation. The protein should adopt the canonical disintegrin fold characterized by a compact, globular structure stabilized by multiple disulfide bonds, typically with a cysteine framework pattern of C-C-C-C-C-C that forms three intramolecular disulfide bridges creating a stable, rigid scaffold. The RGD tripeptide motif should be positioned within an exposed, flexible loop region that serves as the primary receptor-binding interface. The overall structure should exhibit high stability and resistance to proteolytic degradation due to the extensive disulfide network. The protein should demonstrate specificity for platelet integrins while maintaining the characteristic potency of viper venom disintegrins in disrupting hemostatic processes."}
{"description": "sp|A7X4K7|WAP2_PHIOL Waprin-Phi2 OS=Philodryas olfersii OX=120305 PE=3 SV=1", "sequence": "MKATLLLLLLFAVILPGTISAEQEKPGSCPNVDMPIPPLGLCKTTCSKDSDCSETKKCCKNGCGFMTCTTARP", "prompt": "Design a protein sequence for a waprin toxin from the green snake Philodryas olfersii. This toxin should adopt the characteristic whey acidic protein (WAP) domain fold, stabilized by a conserved four-disulfide core architecture with the canonical cysteine framework C-X5-16-C-X5-9-C-X9-19-C-X6-23-C-X8-23-C-X3-7-C-X6-16-C. The structural scaffold should form a compact, globular domain featuring a central alpha-helix packed against an antiparallel beta-sheet, creating a stable protein core resistant to proteolytic degradation. Functionally, this waprin should exhibit serine protease inhibitory activity, specifically targeting trypsin-like enzymes through a canonical binding loop that inserts into the protease active site. The mechanism involves tight-binding inhibition of key digestive and inflammatory proteases, contributing to the venom's prey immobilization and tissue damage effects. The protein should maintain the essential pharmacological properties of snake venom waprins, including stability in the venom milieu and specific inhibition of mammalian proteases relevant to envenomation pathology."}
{"description": "sp|C0HLU0|SECP1_APIME Secapin-1 OS=Apis mellifera OX=7460 PE=1 SV=1", "sequence": "YIINVPPRCPPGSKFVKNKCRVIVP", "prompt": "Generate the amino acid sequence for secapin-1, a small cationic peptide toxin from the European honey bee (Apis mellifera) venom. This peptide belongs to the secapin family of venom components and functions as a membrane-active cytolytic toxin. The protein should adopt a compact, amphipathic alpha-helical structure that facilitates interaction with biological membranes. Secapin-1 exhibits antimicrobial activity against Gram-positive bacteria through membrane disruption and pore formation, contributing to the bee's defense against microbial pathogens. The peptide may also display weak hemolytic activity against erythrocyte membranes. The sequence should contain characteristic features of secapin peptides, including a high proportion of basic residues (lysine and arginine) that confer cationic character, hydrophobic residues that mediate membrane insertion, and a conserved cysteine framework that stabilizes the helical structure through disulfide bonding. The mature peptide should be approximately 20-25 amino acids in length with a molecular weight around 2.5-3 kDa. The structural scaffold should enable membrane targeting through electrostatic interactions with anionic phospholipid head groups followed by hydrophobic insertion into the lipid bilayer, leading to membrane permeabilization and cell lysis."}
{"description": "sp|P17728|SCXA_LEIHE Alpha-insect toxin LqhaIT OS=Leiurus hebraeus OX=2899558 PE=1 SV=2", "sequence": "MNHLVMISLALLLLLGVESVRDAYIAKNYNCVYECFRDAYCNELCTKNGASSGYCQWAGKYGNACWCYALPDNVPIRVPGKCHRK", "prompt": "Design a novel alpha-insect toxin protein sequence inspired by the venom of the yellow scorpion Leiurus hebraeus. This toxin should function as a potent insecticidal agent by selectively targeting and modulating insect voltage-gated sodium channels. The protein must adopt the conserved structural scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by a specific disulfide bridge pattern with four conserved cysteine residues forming two disulfide bonds (C1-C4, C2-C3 connectivity). The core structure should include an alpha-helix packed against an anti-parallel beta-sheet, with key functional residues positioned to interact with the voltage-sensing domain of insect sodium channels, delaying channel inactivation and causing prolonged neuronal excitation. The sequence should maintain the characteristic pharmacophore responsible for insect selectivity while excluding any mammalian sodium channel activity. Ensure the protein exhibits high thermal stability and protease resistance typical of scorpion venom peptides, with a molecular weight consistent with small cysteine-rich neurotoxins."}
{"description": "sp|Q6J936|TXVE_BOTER Snake venom vascular endothelial growth factor toxin OS=Bothrops erythromelas OX=44710 PE=2 SV=1", "sequence": "MAAYLLAVAILFCIQGWPLGTVQGQVMPFMEVYRHSVCQPRETLVSILEEYPGEIAHIFRPSCVTALRCGGCCTDESLECTATGKRSVGREIMRLSPHKGTSEKEVMQFTEHTDCECRPRSASGVNSRKHKRNPEEGEQRAKFPFV", "prompt": "Design a snake venom-derived vascular endothelial growth factor (VEGF) toxin from the lancehead pit viper Bothrops erythromelas. This protein represents a fascinating evolutionary adaptation where a normal growth factor has been co-opted into a venom component. The toxin functions by binding to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, but unlike mammalian VEGF, it exhibits pathological effects including increased vascular permeability, promotion of edema, and potentially contributing to hemorrhage and inflammation at the envenomation site. The protein should maintain the characteristic VEGF structural fold - a cysteine-knot motif formed by eight conserved cysteine residues that create three intra-chain disulfide bridges (C1-C4, C2-C5, C3-C6 in the typical pattern). This scaffold creates a stable, compact globular structure with exposed receptor-binding loops. The toxin likely binds to VEGF receptors through the same receptor-binding interfaces as endogenous VEGF but with modified affinity or signaling properties that result in dysregulated vascular responses. The sequence should reflect the typical VEGF domain organization with receptor-binding determinants preserved but potentially enhanced for pathological vascular effects."}
{"description": "sp|Q98995|VM2L2_MACLB Zinc metalloproteinase/disintegrin OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MIQVLLVTICLAVFPYQGSSKTLKSGNVNDYEVVNPQAVTGLPKGAVKQPEKKYEDTMQYEFEVNGEPVVLHLEKNRGLFSKDYSETHYSPDGREITTNPAVEDHCYYHGRIQNDADSTASISACNGLKGYFTLRGETYLIEPLKLPDSEAHAVYKYENIEKEDEAPKMCGVTQTNWASDEPIKKASQLNLTPEQQRFEPRYIELVIVADHAMVTKYNGDLAAITTWVHQLVNNINGFYRDLNVHITLSAVEVWTNGDLINVQPAASVTLNLFGEWRERDLLNRRMHDHAQLLTGIDLDDNIIGLAYDDSMCDPRYSVGIVQDHSAIIRLVAVTMAHELGHNLGMNHDGDQCNCGANGCVMSVVLIEQRSYQFSDCSKNKYQTYLTNRNPQCILNQPLRTDTVSTPVSGNELLQNSGNPCCDPVTCQPRRGEHCVSGKCCRNCKFLRAGTVCKRAVGDDMDDYCTGISSDCPRNPYKD", "prompt": "Design a venom protein sequence from the Levant viper (Macrovipera lebetinus) that functions as a zinc metalloproteinase-disintegrin fusion protein. This multifunctional toxin should exhibit the characteristic modular architecture of snake venom metalloproteinases (SVMPs), comprising a metalloproteinase domain followed by a disintegrin domain. The metalloproteinase domain must contain the conserved zinc-binding motif HEXXHXXGXXH and coordinate a catalytic zinc ion to enable proteolytic cleavage of extracellular matrix components such as fibrinogen, collagen, and von Willebrand factor, thereby promoting hemorrhage and anticoagulation. The disintegrin domain should adopt a compact, disulfide-rich fold stabilized by multiple disulfide bonds, typically featuring an RGD (Arg-Gly-Asp) or related integrin-binding motif that selectively antagonizes platelet integrins (e.g., αIIbβ3 or αvβ3) to inhibit platelet aggregation. The overall structure should reflect the P-II class of SVMPs, where the metalloproteinase and disintegrin domains are covalently linked, and the protein may undergo proteolytic processing to release the disintegrin domain. Ensure the sequence encodes appropriate propeptide and cysteine-rich regions, with disulfide connectivity that supports both enzymatic activity and integrin-binding function, ultimately contributing to the venom's prey immobilization through disruption of hemostasis and induction of systemic bleeding."}
{"description": "sp|C0HLM1|SCX3_TITMA Toxin Tma3 OS=Tityus macrochirus OX=2599738 PE=1 SV=1", "sequence": "KKDDYPVDTAKRNCKFPCNVIDKEGYCDNLCKGRKAEKGYCYRLNASCYCYGLPDDSPTKKSGRCNPNL", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the scorpion Tityus macrochirus, specifically emulating the functional and structural characteristics of the Tma3 toxin. This toxin belongs to the beta-toxin class of scorpion venom peptides, which are known to target voltage-gated sodium channels (Nav) and modulate their gating kinetics. The core mechanism of action involves binding to site 4 of Nav channels, typically leading to a hyperpolarizing shift in the voltage dependence of activation and enhancing channel opening at subthreshold potentials, thereby causing prolonged neuronal excitation and potential neurotoxicity. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) motif, characterized by an alpha-helix packed against an antiparallel beta-sheet, stabilized by a specific disulfide bridge pattern (typically C1-C4, C2-C5, C3-C6 in beta-toxins). Key domains include a conserved 'pharmacophore' region responsible for channel recognition, often involving residues in the beta-sheet and loops that interact with the channel's voltage-sensing domain. The molecular target is likely mammalian Nav1.2, Nav1.4, or Nav1.6 isoforms, with binding mediated by electrostatic and hydrophobic interactions at the channel's extracellular loops. Ensure the sequence incorporates the beta-toxin family's hallmark: a compact, globular fold with high stability, facilitated by the disulfide network, and functional residues that confer selectivity and potency for sodium channel modulation."}
{"description": "sp|P0DMT2|PA2HS_ECHCS Phospholipase A2 homolog ECS_00014 OS=Echis carinatus sochureki OX=124223 PE=1 SV=1", "sequence": "SIVELGKMIIQETGKSPFPSYTSYGCFCGGGERGPPLDATDRCCLAHSCCYDTLPDCSPKTDRYKYKRENGEIICENSTSCKKRICECDKAMAVCLRKNLNTYNKKYTYYPNFWCKGDIEKC", "prompt": "Design a phospholipase A2 homolog toxin from the venom of the saw-scaled viper, Echis carinatus sochureki. This protein belongs to the snake venom group II phospholipase A2 family and functions as a potent toxin despite lacking catalytic phospholipase activity. The venom of this viper is medically significant, causing severe coagulopathy, hemorrhage, and tissue damage in envenomation. The toxin likely exerts its effects through non-enzymatic mechanisms, such as binding to specific membrane receptors or disrupting cellular membranes, contributing to the venom's cytotoxic and myotoxic properties. It should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved pattern of seven disulfide bridges (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6, Cys7-Cys8, Cys9-Cys10, Cys11-Cys12, Cys13-Cys14), forming a compact, stable structure. Key structural elements include a conserved calcium-binding loop and a hydrophobic channel, though the catalytic residues (e.g., His/Asp in the active site) may be mutated or absent, rendering it enzymatically inactive. The molecular target is anticipated to be membrane-associated, such as integrins or other receptors on muscle or endothelial cells, leading to pore formation, membrane disruption, or signal interference. Ensure the sequence reflects high stability, specificity for its target, and the typical physicochemical properties of viperid toxins, including basic pI and surface-exposed hydrophobic patches for membrane interaction."}
{"description": "sp|Q4PRC8|SL5_DABSI Snaclec 5 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MGRFISISFGLLVMFLSLSGTGAKQDCLSDWSFYEGYCYKVFNEKKTWEDAEKFCTEQHKGSHLLSLHNIAEADFVLKKTLAMLKDGVIWMGLNDVWNECNWGWTDGAKLDYKAWNEGTNCFVFKIAKNHWSHMDCSSTHNFVCKFRV", "prompt": "Design a protein sequence for a C-type lectin-like toxin from the venom of the Siamese Russell's viper (Daboia siamensis), belonging to the snaclec family. This toxin functions as a platelet aggregation modulator, specifically targeting platelet receptors such as GPIb or GPVI to either inhibit or promote platelet activation, thereby disrupting hemostasis and contributing to the venom's hemorrhagic and procoagulant effects. The protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a globular structure with two antiparallel beta-sheets and two alpha-helices, stabilized by two conserved disulfide bridges (Cys1-Cys2 and Cys3-Cys4) that form the cysteine framework typical of snake venom C-type lectins. The sequence must include key residues for calcium-independent carbohydrate recognition, with a putative binding interface involving loops between beta-strands for specific interaction with platelet glycoproteins. The overall structure should exhibit high stability and specificity for its molecular target, reflecting the toxin's role in venom-induced coagulopathy."}
{"description": "sp|Q9DF52|PA2B_BUNCE Basic phospholipase A2 KPA2 OS=Bungarus caeruleus OX=132961 PE=1 SV=1", "sequence": "MYPAHLLVLVAVCVSLLGAANIPPQPLNLIQFKNMIQCAGTRPWTAYVNYGCYCGKGGSGTPVDELDRCCYTHDNCYNEAEKIPGCNPNIKTYSYTCTEPNLTCTDTADTCARFLCDCDRTAAICFASAPYNSNNVMISSSTNCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the common krait, Bungarus caeruleus. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should contain the typical disulfide bridge pattern common to group I phospholipase A2 enzymes, with conserved cysteine residues forming multiple intrachain disulfide bonds that stabilize the compact globular structure. The sequence should include a basic amino acid-rich region responsible for membrane association and enhanced neurotoxic activity through electrostatic interactions with anionic phospholipid head groups. The protein should exhibit specific molecular recognition for presynaptic membranes at motor nerve terminals, where it hydrolyzes phospholipids to generate lysophospholipids and free fatty acids, disrupting membrane integrity and synaptic vesicle recycling. The structural scaffold should maintain the characteristic pancreatic phospholipase A2-like fold with an N-terminal α-helix, antiparallel β-sheets, and the conserved catalytic network essential for calcium-dependent enzymatic activity."}
{"description": "sp|P59170|PA2A4_ECHCS Acidic phospholipase A2 4 OS=Echis carinatus sochureki OX=124223 PE=2 SV=1", "sequence": "MRTLWIVAVWLVGVEGNLYQFGKMIKNKTGKPAMFSYSAYGCYCGWGGQGKPQDPSDRCCFLHDCCYTRVNNCSPKMTLYSYRFENGDIICGDNDPCRKAVCECDREAAICLGENVNTYDEKYRFYSSSYCTEEESEKC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the saw-scaled viper, Echis carinatus sochureki. This enzyme should function as a potent presynaptic neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 acyl bond of glycerophospholipids in cell membranes. The protein must contain the conserved phospholipase A2 structural fold characterized by three long alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the sequence YGCXCG. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic elapid loop. The sequence should feature the typical disulfide bond pattern common to group II phospholipase A2 enzymes, stabilizing the compact globular structure. This toxin should demonstrate high specificity for neuronal and muscle cell membranes, causing membrane disruption, inflammation, and potentially contributing to the hemorrhagic effects characteristic of viperid venoms. The acidic nature of this phospholipase A2 should be reflected in its amino acid composition, with an overall negative charge that may influence its tissue distribution and pharmacological properties."}
{"description": "sp|P59171|PA2A5_ECHOC Acidic phospholipase A2 5 OS=Echis ocellatus OX=99586 PE=2 SV=1", "sequence": "MRTLWIVAVWLIGVEGSVIEFGTMIIEETGRSPFPFYTSYGCYCGLGGKGKPKDDTDRCCFVHDCCYGSMPDCSPKTDIYRYHRENGEIICESGTSCEKRICECDKAAAVCFRENLKTYKNKYMVYPDSLCKEESEKC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the West African carpet viper, Echis ocellatus. This enzyme should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of nerve transmission. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, initiating inflammatory cascades and membrane disruption. Incorporate the characteristic phospholipase A2 structural fold with a conserved calcium-binding loop (YGKYCG/XCG) and catalytic dyad (histidine-aspartate). Include the appropriate disulfide bridge pattern typical of group II phospholipase A2 toxins, with conserved cysteine residues forming stabilizing cross-links. The sequence should maintain an overall acidic pI while preserving key functional residues for membrane binding, interfacial activation, and specific interaction with presynaptic targets. Ensure the structural scaffold supports both enzymatic activity and neurotoxic specificity, reflecting the dual functionality of this viper venom component in prey immobilization through both direct tissue damage and neurological effects."}
{"description": "sp|P59068|PA2SB_AUSSU Phospholipase A2 superbin b (Fragment) OS=Austrelaps superbus OX=29156 PE=1 SV=1", "sequence": "NLYQFKNMIQCANRGSRHWLAYADYGCYCGWGGSGTPVDELDRCCKTHDDCYTEAGK", "prompt": "Generate a protein sequence for a phospholipase A2 toxin derived from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This toxin belongs to the phospholipase A2 superfamily and functions as a potent presynaptic neurotoxin that targets neuromuscular junctions. The protein should exhibit the characteristic phospholipase A2 catalytic activity, hydrolyzing the sn-2 ester bond of glycerophospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption and neurotoxicity. The structural scaffold should feature the conserved phospholipase A2 fold, characterized by three long alpha-helices stabilized by multiple disulfide bridges. The active site should include the conserved catalytic triad residues (typically histidine, aspartate, and a water molecule coordinated by tyrosine) essential for calcium-dependent enzymatic activity. The toxin should possess specific molecular determinants for presynaptic targeting, potentially involving surface-exposed cationic residues that facilitate binding to neuronal membranes. The sequence should reflect the typical molecular weight range of 13-15 kDa for snake venom phospholipases A2 and maintain the structural integrity required for both enzymatic function and neurotoxic specificity."}
{"description": "sp|Q9BKB7|KGX21_MESEU Potassium channel toxin gamma-KTx 2.1 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "MKISFVLLLTLFICSIGWSEARPTDIKCSESYQCFPVCKSRFGKTNGRCVNGFCDCF", "prompt": "Design a potassium channel toxin from the scorpion Mesobuthus eupeus venom, specifically a gamma-KTx family member. This toxin functions as a potent and selective blocker of voltage-gated potassium channels, particularly Kv1 subfamily channels, which are crucial for neuronal excitability and action potential repolarization. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion potassium channel toxins, featuring a compact globular architecture stabilized by three disulfide bridges with the typical C1-C4, C2-C5, C3-C6 connectivity pattern. The core structural elements include a short alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with key functional residues that mediate high-affinity binding to the channel's pore region. The molecular mechanism involves direct occlusion of the potassium conduction pathway through specific interactions with conserved residues in the channel's selectivity filter and outer vestibule, thereby inhibiting potassium ion flux and prolonging neuronal depolarization. The toxin should exhibit the hallmark pharmacological profile of gamma-KTx toxins: nanomolar affinity for Kv1 channels, rapid binding kinetics, and selectivity among potassium channel subtypes. The structural scaffold must ensure proper folding with the characteristic disulfide-stabilized core that confers both thermodynamic stability and resistance to proteolytic degradation in the venom gland and upon envenomation."}
{"description": "sp|P0DPC2|TXDF1_DAFVA Mu-theraphotoxin-Df1a OS=Davus fasciatus OX=2024242 PE=1 SV=1", "sequence": "ECRWFLGGCSGGQTCCEHLVCHRKHQWCVWDWSF", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is a mu-theraphotoxin from the tarantula species Davus fasciatus, representing a typical spider venom component with neurotoxic activity. This toxin functions as a voltage-gated sodium channel modulator, specifically targeting and inhibiting Nav1.7 and Nav1.2 channel subtypes through interaction with the voltage-sensing domain II. The molecular mechanism involves stabilization of the channel's inactivated state, leading to impaired action potential generation in sensory neurons and resulting in analgesic effects. Structurally, the protein adopts the inhibitor cystine knot (ICK) motif, characterized by a compact triple-stranded beta-sheet fold stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The cysteine framework follows the typical spider toxin pattern with six cysteine residues forming the core structural scaffold. Key functional residues are located within the beta-hairpin loops, particularly loops 2 and 4, which contain the pharmacophore responsible for channel interaction. The mature toxin should be approximately 30-40 amino acids in length with a molecular weight around 3-4 kDa, exhibiting high thermal stability and protease resistance due to the dense disulfide network. The sequence should maintain the characteristic hydrophobic core and surface-exposed polar residues that facilitate specific sodium channel binding while avoiding off-target effects on other ion channel families."}
{"description": "sp|Q9YGJ8|VSPPA_GLOBR Venom plasminogen activator Haly-PA OS=Gloydius brevicauda OX=3148161 PE=1 SV=2", "sequence": "MALIRVLANLLILQLSYAQKSSELVVGGDECNINEHRSLVVLFNSSGLICSGTLINQEWVLTAAHCDSKNFQMLFGVHSKKILNEDEQTRDPKEKFICPNKKKDDEKDKDIMLIRLDSPVSNSEHIAPLSLPSSSPTVDSVCRIMGWGTIKPADETYPDVPHCANINILDHTVCRAAYPVLLAGSSTLCAGTQQGGKDTCVGDSGGPLICNGQIQGIVSWGAHPCGQGSKPGVYTKVFDHLDWIKSIIAGNTAVTCPP", "prompt": "Design a venom-derived plasminogen activator protein from the short-tailed mamushi snake, Gloydius brevicauda. This toxin functions as a key component in the snake's venom arsenal, promoting hemorrhage and systemic disruption by converting plasminogen to plasmin, thereby enhancing fibrinolysis and degrading fibrin clots. The protein should exhibit serine protease activity characteristic of snake venom plasminogen activators, with a catalytic triad (likely His, Asp, Ser) and specificity for plasminogen cleavage. It should adopt a trypsin-like serine protease fold, featuring a two-domain structure with a central beta-barrel and substrate-binding loops that confer target selectivity. The protein may contain conserved disulfide bridges typical of serine proteases to stabilize its tertiary structure, and it should demonstrate efficient plasminogen activation while potentially evading endogenous protease inhibitors to maximize its toxic effects in prey envenomation."}
{"description": "sp|P00630|PA2_APIME Phospholipase A2 OS=Apis mellifera OX=7460 PE=1 SV=3", "sequence": "MQVVLGSLFLLLLSTSHGWQIRDRIGDNELEERIIYPGTLWCGHGNKSSGPNELGRFKHTDACCRTHDMCPDVMSAGESKHGLTNTASHTRLSCDCDDKFYDCLKNSADTISSYFVGKMYFNLIDTKCYKLEHPVTGCGERTEGRCLHYTVDKSKPKVYQWFDLRKY", "prompt": "Design a phospholipase A2 toxin from the venom of the European honey bee (Apis mellifera) that functions as a potent membrane-disrupting enzyme. This toxin should exhibit the characteristic catalytic triad (His/Asp/Tyr) and calcium-binding loop essential for hydrolyzing the sn-2 ester bond of glycerophospholipids in cell membranes, leading to membrane destabilization, inflammation, and pain induction. The protein should adopt the conserved pancreatic-type phospholipase A2 fold with three long alpha-helices stabilized by multiple disulfide bridges (typically 6-7 conserved cystines forming a rigid scaffold). Key structural elements should include the calcium-binding loop (Tyr-Gly-Cys), the catalytic network, and the interfacial binding surface that targets zwitterionic phospholipid membranes. The enzyme should be secreted and exhibit optimal activity at physiological pH, contributing to the defensive and pain-inducing properties of honey bee venom through the generation of lysophospholipids and free fatty acids that amplify inflammatory signaling pathways."}
{"description": "sp|Q9DF33|PA2A2_OPHHA Acidic phospholipase A2 2 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MNPAHLLVLSAVCVSLLGASSIPPQPLHLVQFNGMIRCTIPGSIPWWDYSDYGCYCGSGGSGTPVDELDRCCQVHDNCYTQAQQLTECSPYSKRYSYDCSEGTLTCKADNDECAAFVCDCDRVAAICFAGAPYNKENINIDTTTRC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Ophiophagus hannah (king cobra). This enzyme should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the toxin's cytotoxic, myotoxic, and potentially neurotoxic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Key structural elements must include the conserved calcium-binding loop (YXCGXGG), the catalytic dyse (His-Asp), and the interfacial binding surface that mediates membrane association. As an acidic isoform, the sequence should reflect an overall negative charge at physiological pH. The toxin should demonstrate preferential activity against neuronal or muscle cell membranes, consistent with the potent neurotoxicity and myotoxicity observed in king cobra envenomation, which leads to presynaptic neuromuscular blockade and muscle fiber degradation."}
{"description": "sp|Q0GY43|KIK2_TITDI Potassium channel toxin TdiKIK OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "MVATNRCCVFALLVALLLIHSLAEAGKGKEVLGKIKNKLVEVKEKIKAGWDKLTSKSEYACPVIDKFCEDHCAAKNAIGKCDDFKCQCLNS", "prompt": "Design a potassium channel toxin from the venom of the scorpion Tityus discrepans. This toxin belongs to the scorpion potassium channel toxin family and functions as a potent modulator of voltage-gated potassium channels (Kv channels). The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three or four disulfide bridges with a typical cysteine pattern. It should exhibit high affinity and selectivity for specific Kv channel subtypes, potentially blocking channel conductance by binding to the pore region or voltage-sensing domains, thereby disrupting neuronal excitability and neuromuscular transmission. The structural scaffold should include a beta-sheet core stabilized by alpha-helices, with key functional residues in flexible loops responsible for target recognition and binding. The toxin should contribute to the predatory and defensive arsenal of Tityus scorpion venom by inducing paralysis in prey through inhibition of potassium efflux and membrane depolarization."}
{"description": "sp|P0DMK1|PA23_BOTMT Basic phospholipase A2 BmatTX-III (Fragment) OS=Bothrops mattogrossensis OX=1171125 PE=1 SV=1", "sequence": "DLWELAKMILKETGKNPLPSYGAYGCYCGWGG", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrops mattogrossensis, a pit viper species. This toxin functions as a potent enzymatic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the venom's hemotoxic effects, causing local tissue damage, inflammation, and systemic effects. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, two antiparallel beta-sheets, and a conserved calcium-binding loop essential for catalytic activity. Include the conserved catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic elapid loop region. The sequence should contain the typical pattern of 6-7 conserved disulfide bonds that stabilize the compact globular structure, including the conserved Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, and Cys61-Cys91 disulfide pairs. As a basic phospholipase A2, incorporate positively charged residues that enhance membrane interaction and contribute to the toxin's myotoxic and anticoagulant properties. The protein should target phospholipid membranes and exhibit specificity for glycerophospholipids, with the basic nature facilitating interaction with anionic membrane surfaces."}
{"description": "sp|C0HLZ1|SCX10_TITPA Toxin Tppa2 OS=Tityus pachyurus OX=288781 PE=1 SV=1", "sequence": "KDGYLVGNDGCKYSCLTRPGHYCASECSRVKGKDGYCYAWMACYCYNMPNWVKTWSRATNKCGKRK", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the scorpion Tityus pachyurus, specifically the toxin Tppa2. This toxin belongs to the beta-toxin family and functions as a voltage-gated sodium channel (Nav) modulator. It is a beta-toxin that typically targets site 4 of Nav channels, causing a shift in the voltage dependence of activation towards more negative potentials, leading to prolonged channel opening and enhanced neuronal excitability. The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characteristic of scorpion toxins, with a disulfide bridge pattern of C1-C4, C2-C5, C3-C6 (or similar) stabilizing a compact globular structure comprising an alpha-helix packed against an antiparallel beta-sheet. The molecular target is likely Nav1.4 (skeletal muscle) or Nav1.6 (central nervous system), with key residues in the functional surface forming a hydrophobic patch and charged residues for specific receptor interaction. The biological significance lies in its role in prey immobilization through disruption of neuromuscular transmission, causing paralysis. Ensure the sequence reflects the typical length of 60-70 residues, with the appropriate cysteine framework and conserved structural motifs for beta-toxin activity."}
{"description": "sp|P85013|CA12A_CONRE Alpha-conotoxin RegIIA OS=Conus regius OX=101314 PE=1 SV=2", "sequence": "MGMRMMFTVFLLVVLTTTVVSSTSVRASDGRNAAADNRASDLIAQIVRRGCCSHPACNVNNPHICG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus regius, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting the α3β2 subtype, which is implicated in pain pathways and neurological disorders. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the Cys1-Cys3, Cys2-Cys4 connectivity pattern, corresponding to the CC-C-C framework. The core structure should include a conserved alpha-helical region and beta-turn elements that form the receptor-binding interface. Key residues in the second loop should be optimized for high-affinity binding to the orthosteric site of the α3β2 nAChR, ensuring specificity over other subtypes like α4β2 or muscle-type nAChRs. The toxin's mechanism of action involves competitive inhibition of acetylcholine binding, leading to neuromuscular blockade or modulation of neuronal signaling. Incorporate conserved hydrophobic patches and polar residues critical for membrane penetration and receptor interaction. The final sequence should reflect the evolutionary adaptations of Conus regius venom for prey immobilization, with enhanced stability in physiological conditions due to the disulfide-stabilized fold."}
{"description": "sp|Q9YGJ0|3NO5I_BUNMU Gamma-bungarotoxin OS=Bungarus multicinctus OX=8616 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMQCKTCSFYTCPNSETCPDGKNICVKRSWTAVRGDGPKREIRRECAATCPPSKLGLTVFCCTTDNCNH", "prompt": "Design a protein sequence for gamma-bungarotoxin, a potent neurotoxin from the venom of the many-banded krait (Bungarus multicinctus). This toxin belongs to the three-finger toxin (3FTx) superfamily and functions as a postsynaptic neurotoxin that specifically and irreversibly binds to muscle-type nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The mechanism involves competitive antagonism at the acetylcholine binding site, leading to complete neuromuscular blockade, respiratory paralysis, and potentially fatal envenomation. The structural scaffold should feature the characteristic three-finger fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should adopt a compact, flattened beta-sheet structure with three protruding loops (central, short, and long) that form the functional binding interface. Key structural elements include a conserved hydrophobic core, beta-strands forming the finger-like projections, and specific residues in loop II that mediate high-affinity binding to the alpha-delta interface of the nAChR. The sequence should maintain the characteristic cysteine framework of short-chain alpha-neurotoxins while incorporating conserved hydrophobic and aromatic residues critical for receptor interaction and structural stability."}
{"description": "sp|Q6SLM0|PA2B3_BUNCE Basic phospholipase A2 3 (Fragment) OS=Bungarus caeruleus OX=132961 PE=1 SV=1", "sequence": "LVAVCVSLLGAANIPPQPLNLQQFKNMIQCAGTRTWTAYINYGCYCGKGGSGTPVDKLDRCCYTHDHCYNQADSIPGCNPNIKTYSYTCTQPNITCTRTADACAKFLCDCDRTAAICFASAPYNINNIMISASNSCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the common krait, Bungarus caeruleus. This toxin should function as a potent presynaptic neurotoxin that targets neuromuscular junctions, causing irreversible blockade of acetylcholine release and leading to flaccid paralysis. The protein must adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop (YGKYCG) and catalytic network (His-Asp dyad). It should contain the typical disulfide bridge pattern (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6) that stabilizes the globular structure. The sequence should exhibit basic isoelectric point properties that facilitate membrane interaction and enhance neurotoxic potency. Include key functional residues for substrate binding and hydrolysis, particularly at the interfacial binding surface that recognizes phospholipid membranes. The toxin should demonstrate specific activity against presynaptic nerve terminals while maintaining the structural stability required for venom delivery and target engagement."}
{"description": "sp|Q0GY41|KBX2_HOFGE Potassium channel toxin Hge-beta-KTx OS=Hoffmannihadrurus gertschi OX=380989 PE=1 SV=1", "sequence": "MAKSFFAAFLIIMLISSLVDGKSTVGQKLKKKLNQAVDKVKEVLNKSEYMCPVVSSFCKQHCARLGKSGQCDLLECICS", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the scorpion venom peptide Hge-beta-KTx from Hoffmannihadrurus gertschi. This toxin belongs to the beta-KTx family and functions as a potent modulator of voltage-gated potassium channels, specifically Kv1 subfamily channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular mechanism involves binding to the voltage-sensing domain or pore region of Kv1 channels, leading to channel blockade and disruption of neuronal excitability or muscle contraction. Include key functional residues for potassium channel recognition, such as a conserved dyad of lysine and aromatic residues critical for channel interaction. The structural scaffold should maintain the compact, globular architecture typical of scorpion toxins, with the disulfide network providing exceptional thermal and proteolytic stability. The final sequence should exhibit high specificity for potassium channels while maintaining the venom's evolutionary role in prey immobilization and defense."}
{"description": "sp|A8CG84|PA2BS_DABSI Basic phospholipase A2 DsM-S1 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MRTLWIVAVCLIGVEGSLLEFGKMILEETGKLAIPSYSSYGCYCGWGGKGTPKDATDRCCFVHDCCYGNLPDCNPKSDRYKYKRVNGAIVCEKGTSCENRICECDKAAAICFRQNLNTYSKKYMLYPDFLCKGELRC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Daboia siamensis (Eastern Russell's viper). This enzyme plays a critical role in the venom's potent hemotoxic and myotoxic effects by catalyzing the hydrolysis of sn-2 ester bonds in membrane phospholipids, releasing lysophospholipids and free fatty acids that disrupt cellular membranes and trigger inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that create a rigid, compact structure. Include the canonical catalytic dyad of histidine and aspartate residues within the conserved calcium-binding loop, which is essential for enzymatic activity. The basic nature of this isoform suggests enhanced membrane interaction capabilities, potentially contributing to its presynaptic neurotoxic effects through binding to specific neuronal receptors. The sequence should maintain the conserved structural elements required for substrate binding and catalysis while preserving the overall stability and toxicity profile characteristic of viperid phospholipase A2 toxins."}
{"description": "sp|P0DM39|SLDB_TRIAB Snaclec alboaggregin-D subunit beta OS=Trimeresurus albolabris OX=8765 PE=1 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGAGAGLCCPLDWSSYDLYCYKVFKQQMNWTDAEQFCTQQHTGSHLVSFHSTEEVDFVVQMSYKSLDTTFFWIGVNNIWNGCNWQWSDGTGLDYKEWREQFECLVAKTFDNQWWSMDCNSTYSFVCKFQA", "prompt": "Design a protein sequence for a C-type lectin-like toxin derived from the venom of the white-lipped pit viper (Trimeresurus albolabris). This protein should function as the beta subunit of the heterodimeric snaclec complex known as alboaggregin-D, which plays a critical role in the venom's hemostatic disruption by targeting platelet aggregation. The sequence must adopt the characteristic C-type lectin-like domain (CTLD) fold, stabilized by conserved disulfide bridges typically involving cysteine residues in positions that maintain the double-loop structure. As part of the functional heterodimer, this beta subunit should contribute to the specific recognition and binding to platelet receptors, such as GPIb, facilitating the complex's role as a platelet agonist. The protein should exhibit the typical structural features of snake venom C-type lectins, including a compact globular domain with beta-sheets and alpha-helices, and surface loops that mediate receptor interaction. Ensure the sequence reflects the evolutionary adaptations for toxin function, including key residues for receptor binding and complex formation with the alpha subunit, while maintaining the structural integrity required for stability in the venom milieu."}
{"description": "sp|P59069|PA2SC_AUSSU Phospholipase A2 superbin c (Fragment) OS=Austrelaps superbus OX=29156 PE=1 SV=1", "sequence": "NLIQLSNMIKCAIPGSRPLLHYTDYGCYCGKGGSGTPVDELDRCCK", "prompt": "Design a protein sequence for a phospholipase A2 toxin derived from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This toxin should function as a potent phospholipase A2 enzyme, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids in cell membranes, leading to membrane disruption, inflammation, and potential hemolytic activity. The protein should adopt the characteristic phospholipase A2 structural fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges. The catalytic site should include a conserved histidine-aspartate dyad essential for calcium-dependent enzymatic activity. The toxin should exhibit the typical pharmacological profile of snake venom phospholipase A2 toxins, potentially including presynaptic or postsynaptic neurotoxicity, myotoxicity, or anticoagulant effects through interference with coagulation factors. The structural scaffold should maintain the globular, compact fold typical of secreted phospholipase A2 enzymes, with surface residues optimized for target membrane interaction and potential receptor binding."}
{"description": "sp|P0C8V9|O165_CONAH Omega-conotoxin-like Ac6.5 OS=Conus achatinus OX=369967 PE=1 SV=1", "sequence": "MKLTCVVIVAVLLLTACQLLTADDSRGTQKHRSLRSTTKVSKATDCIEAGNYCGPTVMKICCGFCSPFSKICMNYPQN", "prompt": "Design a novel animal toxin protein sequence inspired by the omega-conotoxin family from the marine cone snail Conus achatinus. This venom component should function as a potent calcium channel antagonist, specifically targeting voltage-gated calcium channels (VGCCs) to disrupt neuronal signaling and induce paralysis in prey. The protein should adopt the characteristic ICK (inhibitor cystine knot) structural motif, stabilized by a conserved cysteine framework with three disulfide bridges forming a compact, triple-stranded beta-sheet fold. Key structural elements must include a rigid, knotted core for protease resistance, surface-exposed loops for target specificity, and conserved residues for calcium channel binding. The sequence should reflect the evolutionary adaptations of cone snail venoms for rapid prey immobilization, with high affinity for neuronal calcium channels to block neurotransmitter release. Ensure the design incorporates family-specific motifs for omega-conotoxins while maintaining biological plausibility for a Conus achatinus-derived toxin."}
{"description": "sp|C0HM08|3S12_NAJNA Alpha-elapitoxin-Nn2a OS=Naja naja OX=35670 PE=1 SV=1", "sequence": "LECHNQQSSQTPTTTDCSGGETNCYKKWWSDHRGTIIERGCGCPTVKKGIELNCCTTDRCNN", "prompt": "Generate the amino acid sequence for a potent postsynaptic neurotoxin from the venom of the Indian cobra (Naja naja), belonging to the three-finger toxin (3FTx) superfamily. This alpha-elapitoxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha-delta and alpha-gamma subunit interfaces of muscle-type nAChRs. The protein should adopt the characteristic three-finger beta-sheet fold stabilized by four conserved disulfide bridges with connectivity pattern C1-C3, C2-C4, C5-C6, and C7-C8, forming a compact globular structure. The functional loops (Loop I, Loop II, and Loop III) should contain key residues for receptor binding and specificity, particularly in the central loop which mediates high-affinity interaction with the receptor's orthosteric site. The toxin should exhibit high structural stability due to the extensive disulfide network while maintaining the flexibility required for target recognition and binding. The sequence should reflect the evolutionary optimization for rapid neuromuscular blockade, contributing to the neurotoxic venom profile characteristic of elapid snakes."}
{"description": "sp|P04205|MAST_VESMA Mastoparan-M OS=Vespa mandarinia OX=7446 PE=1 SV=2", "sequence": "MKNTILILFTAFIALLGFFGMSAEALADPKADPLAGPNPDADPEAINLKAIAALAKKLLG", "prompt": "Design a mastoparan peptide sequence derived from the venom of the Asian giant hornet (Vespa mandarinia), a potent wasp venom component that functions as a cationic amphipathic alpha-helical peptide. This toxin should exhibit characteristic mastoparan activity by acting as a G-protein activator through direct interaction with heterotrimeric G proteins, stimulating phospholipase C and adenylate cyclase pathways. The peptide should adopt a well-defined amphipathic alpha-helical conformation in membrane-mimetic environments, with a typical length of 14 amino acids rich in hydrophobic residues and basic lysine/arginine residues that facilitate membrane interaction. The sequence should demonstrate membrane-disrupting properties through pore formation or detergent-like effects on lipid bilayers, leading to mast cell degranulation, histamine release, and hemolytic activity. The structural scaffold should feature a clear segregation of hydrophobic and hydrophilic faces when folded into an alpha-helix, with the cationic residues positioned to interact with phospholipid head groups while the hydrophobic face embeds into the membrane core. This peptide should represent a potent cytolytic toxin that contributes to the intense pain, inflammation, and tissue damage characteristic of Vespa mandarinia envenomation."}
{"description": "sp|P59067|PA2SA_AUSSU Phospholipase A2 superbin a (Fragment) OS=Austrelaps superbus OX=29156 PE=1 SV=1", "sequence": "NLYQFKNMIQCANHGRRATWHYLDYGCYCGPGGLGTPVDELDRCCKTHDDCYIEAGKKGCFP", "prompt": "Design a protein sequence for a phospholipase A2 toxin derived from the venom of the Australian lowland copperhead snake (Austrelaps superbus). This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad essential for hydrolyzing the sn-2 ester bond of membrane phospholipids. Include the conserved disulfide bridge pattern (typically 6-7 disulfide bonds) that stabilizes the globular structure, with key cysteines forming the structural core. The sequence should feature specific surface-exposed residues that mediate high-affinity binding to presynaptic membranes, enhancing its neurotoxic potency through both enzymatic activity and target-specific interactions. The overall structure should maintain the characteristic three-finger scaffold with distinct substrate-binding and membrane-interaction domains."}
{"description": "sp|C0HM22|KA321_CENMA Potassium channel toxin alpha-KTx 32.1 (Fragment) OS=Centruroides margaritatus OX=29018 PE=1 SV=1", "sequence": "KCRECGNTSPSCYFSGNCVNGKCVCPA", "prompt": "Design a novel potassium channel toxin protein sequence derived from the venom of the scorpion Centruroides margaritatus. This toxin should belong to the alpha-KTx family and function as a potent blocker of voltage-gated potassium channels, specifically targeting Kv1.x subtypes with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a compact globular structure stabilized by three or four disulfide bridges in the typical alpha-KTx pattern (C1-C4, C2-C5, C3-C6). The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, creating a molecular surface with key functional residues that interact with the channel's pore region. The toxin should exhibit selective binding to the voltage-sensing domain or pore region of potassium channels, effectively inhibiting channel conductance and disrupting neuronal or muscular excitability. Include conserved motifs for membrane interaction and receptor binding while maintaining the thermostable, compact architecture essential for venom efficacy. The sequence should reflect the evolutionary optimization for rapid target engagement and resistance to proteolytic degradation in the venom delivery system."}
{"description": "sp|C0JB54|B1V_SICTE Dermonecrotic toxin StSicTox-betaIF1 (Fragment) OS=Sicarius terrosus OX=571544 PE=2 SV=1", "sequence": "WIMGHMVNDLEMVDYYVDKGANGLEIDITFNSNGIAEYTYHGVPCDCFRNCRRNTTLSTYLNYVRQLTTPGDQKFRQNLIFIIMDLKLNRLKSQALFNAGLSIADRLTQYYWKDDGKARAYFLLSVPYVRQAAFIRGFQSRFEEKGLKKYYEKIGWDFSANEDLNRIREAYQKLNISGHIWQSDGITNCLTRRTRRLKEAIRKRDSPGWYINKVYSWSLDRYKSIKYALDLGVDGVMSNYADRLVKILSKGTYKRRFRLATHEDNPWETFTP", "prompt": "Generate the amino acid sequence for a dermonecrotic toxin from the six-eyed sand spider Sicarius terrosus, a highly potent venom component that induces severe tissue necrosis through its cytotoxic activity. This toxin belongs to the sphingomyelinase D family, functioning as a phospholipase that hydrolyzes sphingomyelin and lysophosphatidylcholine in cell membranes, leading to cell lysis, inflammation, and dermonecrosis. The protein is expected to adopt an (α/β)8 TIM barrel fold, characteristic of sphingomyelinase D enzymes, with a conserved active site featuring metal-binding residues (likely coordinating Mg²⁺ or Ca²⁺) essential for catalytic activity. Key structural elements include a central β-barrel surrounded by α-helices, with loops governing substrate specificity and membrane interaction. The toxin's mechanism involves cleaving phospholipid headgroups, generating ceramide-1-phosphate and choline, which trigger complement activation, platelet aggregation, and endothelial damage, mimicking aspects of loxoscelism. Ensure the sequence reflects the canonical sphingomyelinase D domain architecture, with appropriate hydrophobic regions for membrane association and conserved catalytic motifs for enzymatic function."}
{"description": "sp|P01479|SCX1_ANDAU Neurotoxin-1'' OS=Androctonus australis OX=6858 PE=1 SV=3", "sequence": "MNYLVMISLALLLMIGVESKRDGYIVYPNNCVYHCVPPCDGLCKKNGGSSGSCSFLVPSGLACWCKDLPDNVPIKDTSRKCTR", "prompt": "Design a potent neurotoxin protein sequence derived from the venom of the North African scorpion Androctonus australis. This toxin should function as a highly specific voltage-gated sodium channel modulator, exhibiting the characteristic beta-toxin activity that shifts the voltage-dependence of channel activation toward more negative potentials, thereby delaying channel inactivation and prolonging action potentials. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion neurotoxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved alpha-helix packed against an anti-parallel beta-sheet, creating a molecular surface with distinct functional loops responsible for receptor recognition and binding. The toxin should specifically target mammalian voltage-gated sodium channels, particularly Nav1.2 and Nav1.6 isoforms, with high affinity binding to site-4 of the channel's voltage-sensing domain. The molecular interface should feature conserved aromatic and basic residues that interact with the channel's S3-S4 loop region, enabling the toxin to trap the voltage sensor in its activated state. The sequence should maintain the characteristic molecular weight of 6-8 kDa and exhibit the typical thermostability and protease resistance conferred by the extensive disulfide network. This neurotoxin should represent an evolutionarily optimized weapon for prey immobilization through disruption of neuronal excitability, causing sustained neurotransmitter release and eventual paralysis."}
{"description": "sp|P0DPT7|PA21_SCODE Phospholipase A2 SSD387 OS=Scolopendra dehaani OX=2609776 PE=1 SV=1", "sequence": "MSPKFLLFSIIAVWSCAAAIEALFIQPRSLANFLSMTLTAAKRSPQEYDGYGNYCGWGGEGTPVDSIDRCCQVHDNCYGTVNENECGHYIRNVKLIDYDWHMEGTEIVCDPKDDACGRALCKCDKDIIDCFNENDKDYNPEYNKVIG", "prompt": "Design a phospholipase A2 toxin from the venom of the Chinese red-headed centipede Scolopendra dehaani. This enzyme should function as a potent myotoxic and neurotoxic agent, characteristic of centipede venom phospholipases. The protein should exhibit calcium-dependent catalytic activity, specifically hydrolyzing the sn-2 acyl bond of membrane phospholipids to release lysophospholipids and free fatty acids, leading to membrane disruption, inflammation, and potential neuromuscular effects. The structural scaffold should feature the conserved phospholipase A2 fold with three long alpha-helices stabilized by multiple disulfide bridges, typically 6-8 conserved cysteine residues forming a rigid core. Include the conserved calcium-binding loop (YGKYCG) and catalytic network (His/Asp dyad). The protein should target neuronal and muscle cell membranes, with surface residues optimized for membrane penetration and interfacial activation. Ensure the sequence reflects the characteristic signal peptide for venom gland secretion and the mature toxin domain with appropriate propeptide processing."}
{"description": "sp|A6MFK4|3L21_DEMVE Long neurotoxin LNTX-1 OS=Demansia vestigiata OX=412038 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDFGYARTCLKTPEVKSEPCPPGQEVCYTKAWCDRMCSFRGKVIELGCAATCPRQEPGKEITCCSTDDCNTHP", "prompt": "Design a long neurotoxin protein sequence that mimics the biological activity and structural characteristics of snake venom neurotoxins from the species Demansia vestigiata. This toxin should function as a potent postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the typical cysteine framework C-C-C-C-C-C-C-C. The structural scaffold should feature the elongated central loop characteristic of long neurotoxins, which enhances receptor binding affinity and specificity. The molecular mechanism should involve competitive antagonism of acetylcholine binding, leading to neuromuscular blockade and paralysis. Key functional residues should be positioned in loop regions to facilitate specific interactions with the α-δ and α-γ subunit interfaces of muscle-type nicotinic receptors. The toxin should exhibit the typical thermal stability and protease resistance conferred by the dense disulfide network, while maintaining the amphipathic surface properties necessary for both structural integrity and target recognition. The sequence should reflect evolutionary conservation of critical pharmacophore elements while incorporating species-specific variations that define Demansia vestigiata neurotoxin characteristics."}
{"description": "sp|P00981|VKTHK_DENPO Kunitz-type serine protease inhibitor homolog dendrotoxin K (Fragment) OS=Dendroaspis polylepis polylepis OX=8620 PE=1 SV=2", "sequence": "SGHLLLLLGLLTLWAELTPVSGAAKYCKLPLRIGPCKRKIPSFYYKWKAKQCLPFDYSGCGGNANRFKTIEECRRTCVG", "prompt": "Design a protein sequence for a dendrotoxin K homolog from the black mamba (Dendroaspis polylepis) venom. This protein should function as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv1.1, Kv1.2) in the nervous system. The sequence must adopt a Kunitz-type serine protease inhibitor fold, characterized by a compact, stable beta-trefoil structure with a conserved disulfide bond pattern (typically three disulfide bridges forming a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity). The protein should contain the canonical Kunitz domain with a reactive site loop that mediates potassium channel blockade rather than serine protease inhibition. Key structural elements should include a well-defined beta-sheet core and several loop regions that form the channel-binding interface. The molecular mechanism involves binding to the external vestibule of potassium channels, physically occluding the pore and preventing potassium ion efflux, leading to enhanced neuronal excitability and facilitating neurotransmitter release. The protein should exhibit high affinity and selectivity for neuronal potassium channels, contributing to the neurotoxic effects characteristic of black mamba venom."}
{"description": "sp|P59356|SCL6_LEIHE Alpha-like toxin Lqh6 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "VRDGYIAQPENCVYHCIPDCDTLCKDNGGTGGHCGFKLGHGIACWCNALPDNVGIIVDGVKCHK", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by Leiurus hebraeus (Yellow Israeli scorpion) venom components. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting site 3 to inhibit channel inactivation and prolong action potentials, leading to hyperexcitability in neuronal and muscular tissues. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the typical C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. Include key structural elements: a conserved hydrophobic core, an alpha-helix domain for structural integrity, and a beta-sheet region containing the functional epitope responsible for receptor binding. The molecular surface should present specific charged and hydrophobic residues that facilitate high-affinity interaction with the voltage-sensing domain IV of sodium channels. Ensure the sequence maintains the characteristic molecular weight range of 6-8 kDa and exhibits the pharmacological profile of delaying sodium channel inactivation without affecting activation kinetics, consistent with the neurotoxic activity observed in Leiurus hebraeus venom."}
{"description": "sp|P85109|VSP1_GLOBR Thrombin-like enzyme kangshuanmei OS=Gloydius brevicauda OX=3148161 PE=1 SV=1", "sequence": "VIGGDECNINEHRFLVALYHSRSRTFLCGGTLINQEWVLTAAHCDRFFMYIRLGMHNKNVNFDDEQRRSPKEKYFFRCSNNFTKWDKDIMLIRLDSPVNNSAHIAPLSLPSNPPSVGSVCRVMGWGQTTSPQEDLSDVPRCANINLFNFTVCRAAYPWLPATSRVLCAGDMEGGIDTCNRDSGGPLICNGQFQGIVSKGQNLCAQPRKPALYTKVFDHLDWIQSIIAGNKTVTCPP", "prompt": "Design a thrombin-like serine protease enzyme from the venom of the short-tailed pit viper, Gloydius brevicauda. This enzyme functions as a key hemostatic toxin that mimics the activity of mammalian thrombin, specifically cleaving fibrinogen to generate fibrin monomers and promote blood coagulation. The protein should adopt the characteristic chymotrypsin-like serine protease fold with a conserved catalytic triad of His, Asp, and Ser residues. It should contain the distinctive structural features of snake venom serine proteases, including multiple disulfide bridges that stabilize the compact globular structure, typically with a conserved pattern involving 6-8 cysteine residues forming 3-4 disulfide bonds. The enzyme should exhibit substrate specificity for arginine-rich sequences in fibrinogen, particularly cleaving the Aα and Bβ chains to initiate clot formation. The protein should maintain the typical two-domain architecture of serine proteases with the active site located in the cleft between domains, and include structural elements that confer its stability in the venom environment and specific recognition of coagulation cascade components."}
{"description": "sp|Q9I8X1|VSPP_DEIAC Snake venom serine protease Dav-PA OS=Deinagkistrodon acutus OX=36307 PE=1 SV=2", "sequence": "MVLIRVLANLLILQLSYAQKSSELVIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTDFQMQLGVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKDTCGGDSGGPLICNGQFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIAGNTDATCPP", "prompt": "Design a snake venom serine protease protein from the venom of Deinagkistrodon acutus (hundred-pace snake) that functions as a potent thrombin-like enzyme. This toxin should exhibit the characteristic serine protease catalytic triad (His, Asp, Ser) and possess the conserved structural fold typical of trypsin-like serine proteases, featuring a two-domain architecture with a central beta-barrel structure. The protein should contain the appropriate disulfide bonding pattern to stabilize its tertiary structure, likely including conserved cysteine pairs that form essential structural bridges. As a venom component, this serine protease should contribute to the prey immobilization and digestive functions by cleaving key coagulation factors, potentially leading to coagulopathy through fibrinogen cleavage or interference with the coagulation cascade. The enzyme should demonstrate substrate specificity for peptide bonds following basic residues (arginine/lysine), characteristic of trypsin-like serine proteases, and maintain optimal activity under physiological conditions. The structural scaffold should ensure proper orientation of the substrate-binding pocket and catalytic residues for efficient proteolytic activity while maintaining venom stability."}
{"description": "sp|P17935|PA2HL_VIPAA Basic phospholipase A2 homolog ammodytin L OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "MRILWIVAVCLIGVEGSVIEFGKMIQEETDKNPLTSYSFYGCHCGLGNKGKPKDATDRCCFVHSCCYAKLPDCSPKTNRYEYHRENGAIVCGSSTPCKKQICECDRAAAICFRENLKTYNKKYKVYLRFKCKGVSEKC", "prompt": "Generate a protein sequence for a basic phospholipase A2 homolog toxin from the venom of the nose-horned viper (Vipera ammodytes ammodytes). This protein belongs to the group IIA secreted phospholipase A2-like family and functions as a myotoxic agent. Despite its structural similarity to catalytically active phospholipases A2, this homolog lacks enzymatic activity due to key substitutions in the calcium-binding and catalytic sites. The toxin exerts its toxic effects through membrane disruption and pore formation in muscle cells, leading to myonecrosis. It should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by seven conserved disulfide bonds with the typical C-C-C-C-C-C-C pattern. The protein should contain a conserved hydrophobic channel and exhibit a basic isoelectric point to facilitate interaction with negatively charged membrane surfaces. Key structural elements include the calcium-binding loop, the catalytic network (though inactive), and membrane-interacting surfaces that enable its cytolytic activity. The sequence should reflect the evolutionary conservation of the phospholipase A2 scaffold while incorporating the specific mutations that render it enzymatically inactive but maintain its membrane-targeting and myotoxic functions."}
{"description": "sp|P01490|SCXA_MESEU Alpha-toxin BeM10 OS=Mesobuthus eupeus OX=34648 PE=1 SV=1", "sequence": "VRDGYIADDKDCAYFCGRNAYCDEECKKGAESGKCWYAGQYGNACWCYKLPDWVPIKQKVSGKCN", "prompt": "Design a protein sequence for an alpha-toxin from the venom of the scorpion Mesobuthus eupeus, specifically the BeM10 variant. This toxin functions as a potent modulator of voltage-gated sodium channels, primarily targeting the Nav1.7 subtype, which is crucial for pain signaling in the peripheral nervous system. The mechanism involves binding to site 3 of the sodium channel, leading to a delayed inactivation and prolonged channel opening, resulting in hyperexcitability of neurons and neurotoxic effects. The structural scaffold is characterized by a compact, globular fold stabilized by four disulfide bridges in a C-C-C-C pattern, forming a cysteine-stabilized alpha-beta (CSαβ) motif typical of scorpion alpha-toxins. Key structural elements include a conserved beta-sheet core and flexible loops that mediate receptor interaction, with specific residues in the C-terminal region critical for binding affinity and selectivity. The protein should exhibit high specificity for neuronal sodium channels, contributing to the venom's role in prey immobilization and defense."}
{"description": "sp|P59354|SCX4_BUTOM Alpha-like toxin Bom4 OS=Buthus occitanus mardochei OX=6869 PE=1 SV=1", "sequence": "GRDAYIAQPENCVYECAKNSYCNDLCTKNGAKSGYCQWLGKYGNACWCEDLPDNVPIRIPGKCHF", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by the venom arsenal of the scorpion Buthus occitanus mardochei. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting insect sodium channels to induce paralysis through prolonged channel activation or inactivation. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C-C-CC-C-C pattern. Key structural elements should include a conserved core beta-sheet flanked by an alpha-helix, creating a molecular surface with specific loops (particularly loops II and IV) that mediate high-affinity binding to receptor site 3 on the sodium channel alpha-subunit. The sequence should maintain the pharmacological profile of selective insect toxicity while exhibiting the thermostability and protease resistance typical of scorpion venom peptides. Focus on creating a sequence that preserves the critical functional residues for channel interaction while optimizing the structural stability of the CSαβ fold."}
{"description": "sp|P01050|HIRV1_HIRME Hirudin variant-1 OS=Hirudo medicinalis OX=6421 PE=1 SV=1", "sequence": "VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIPEEYLQ", "prompt": "Generate the amino acid sequence for a potent thrombin inhibitor derived from the medicinal leech, Hirudo medicinalis. This protein should function as a highly specific and tight-binding direct thrombin inhibitor, blocking the active site of thrombin with exceptional affinity to prevent fibrin clot formation and exhibit anticoagulant activity. The protein should adopt a compact, globular fold stabilized by three conserved disulfide bonds with the characteristic cysteine framework C-C-C-C-C-C, forming a stable core that resists proteolytic degradation. Key structural elements should include an N-terminal domain that binds to the active site of thrombin with high specificity, a central core maintaining structural integrity, and a negatively charged C-terminal tail that may interact with exosite I of thrombin. The molecular mechanism involves direct inhibition of thrombin's serine protease activity, preventing the conversion of fibrinogen to fibrin and thereby exhibiting potent antithrombotic effects. The protein should demonstrate high specificity for thrombin over other serine proteases and maintain stability in the circulatory environment."}
{"description": "sp|A6MFK6|3S11_DEMVE Short neurotoxin SNTX-1 OS=Demansia vestigiata OX=412038 PE=3 SV=1", "sequence": "MKTLLLILVVVTIVCLDLVCCSRTCCNQQSSQPKTTTVCPDGEKSCYKKSWRDHRGTRSERGCGCPTVKPGVNRECCDTDECNN", "prompt": "Generate a protein sequence for a short neurotoxin from the venom of Demansia vestigiata, a species of venomous snake. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically the short neurotoxin subtype, which functions as a potent postsynaptic neurotoxin. The protein should adopt the characteristic three-finger β-sandwich fold, stabilized by four conserved disulfide bridges with a cysteine framework pattern of C-C-CC-C-C-C-C-C. The core mechanism of action involves high-affinity binding to the α-subunit of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, competitively inhibiting acetylcholine binding and leading to flaccid paralysis. The structural scaffold should feature three extended loops (fingers) projecting from a central globular core, with key functional residues concentrated in the central loop for receptor interaction. The sequence should reflect the compact size typical of short neurotoxins, optimized for rapid diffusion and efficient receptor blockade, contributing to the venom's neurotoxic potency in prey immobilization."}
{"description": "sp|A8HDJ4|3S11_PSEPO Alpha-elapitoxin-Ppr1 OS=Pseudechis porphyriacus OX=8671 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTMTCCNQQSSQPKTTTTCAGGESSCYKKTWSDHRGSRTERGCGCPHVKPGIKLTCCETDECNN", "prompt": "Generate the amino acid sequence for a potent neurotoxin from the venom of the Australian red-bellied black snake (Pseudechis porphyriacus), specifically an alpha-elapitoxin. This toxin functions as a postsynaptic neurotoxin that competitively antagonizes muscle-type nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold common to elapid snake venoms, featuring three beta-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with a C-C-C-C-C-C-C-C cysteine framework. The molecular mechanism involves high-affinity binding to the alpha-subunit of the nicotinic acetylcholine receptor, blocking acetylcholine binding and preventing depolarization of the postsynaptic membrane. The structural scaffold should include the conserved hydrophobic core, flexible loops responsible for receptor interaction, and surface residues that confer specificity for the neuromuscular junction subtype of nicotinic receptors over neuronal subtypes. This toxin represents a key component of the snake's venom for prey immobilization through rapid neuromuscular blockade."}
{"description": "sp|Q9BJV7|TOT2B_ATRIL Omega-hexatoxin-Asp2b OS=Atrax sp. (strain Illawarra) OX=153482 PE=3 SV=1", "sequence": "MKFSKLSITLAVILTQAVFVLCGMKNEDFMEKGLESNELHDAIKKPVNSGKPDTERLLDCVLSRVCSSDANCCGLTPTCKMGLCVPKVGGLLGGLLGGIL", "prompt": "Design a protein sequence for an animal venom toxin that functions as a potent insecticidal neurotoxin. This toxin originates from the venom of Atrax sp. (strain Illawarra), a funnel-web spider species whose venom components target insect nervous systems with high specificity. The protein should adopt the structural scaffold characteristic of the omega-hexatoxin family, which typically features an inhibitor cystine knot (ICK) motif. This structural fold is stabilized by a conserved disulfide bridge pattern, likely involving three disulfide bonds with a specific connectivity (e.g., C1-C4, C2-C5, C3-C6) that confers exceptional stability and resistance to proteolytic degradation. The toxin's mechanism of action involves selective antagonism of insect voltage-gated calcium channels, particularly Cav channels in synaptic terminals, leading to disrupted neurotransmitter release and paralysis. Key structural elements should include a compact, globular core defined by the ICK motif, with surface loops that mediate high-affinity binding to the channel's pore-forming or voltage-sensing domains. The sequence should incorporate conserved residues critical for target recognition and potency, while maintaining the hydrophobic core and disulfide framework essential for folding and stability. The overall architecture should enable precise molecular interactions with insect-specific channel isoforms, minimizing cross-reactivity with vertebrate homologs."}
{"description": "sp|P01486|SCXB_BUTOC Alpha-toxin Bot11 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "LKDGYIVDDRNCTYFCGTNAYCNEECVKLKGESGYCQWVGRYGNACWCYKLPDHVRTVQAGRCRS", "prompt": "Design a potent alpha-toxin from the venom of the scorpion Buthus occitanus tunetanus, a member of the North African scorpion family known for producing neurotoxic peptides that target voltage-gated sodium channels. This toxin should function as a site-3 neurotoxin that binds to the voltage-sensing domain of sodium channels, specifically delaying channel inactivation and prolonging action potentials, leading to sustained neuronal excitation and potential paralysis. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion alpha-toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include a conserved 'core' region critical for receptor binding, a functional dyad typically involving residues in the beta-sheet that interact with the channel's domain IV voltage sensor, and surface loops that determine specificity for mammalian versus insect sodium channels. The mature toxin should be approximately 60-70 amino acids in length, with the N-terminal region contributing to structural stability and the C-terminal region involved in receptor interaction and potency modulation."}
{"description": "sp|P18965|VSPG_DABSI Factor V activator RVV-V gamma OS=Daboia siamensis OX=343250 PE=1 SV=2", "sequence": "MVLIKVLANLLVLQLSYAQKSSELVVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIRIKLGMHSKNIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRSRGVGSRCRIMGWGKISTTEDTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILKGGRDTCHGDSGGPLICNGEMHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQSIIAGNRTVTCPP", "prompt": "Design a protein sequence for a snake venom Factor V activator from the Russell's viper (Daboia siamensis), specifically the RVV-V gamma subunit. This toxin functions as a potent procoagulant enzyme that initiates the blood coagulation cascade by selectively activating coagulation Factor V to Factor Va. The protein should exhibit serine protease activity with high specificity for Factor V cleavage, characteristic of snake venom metalloproteinase-disintegrin-like complexes. The structural scaffold should include a metalloproteinase domain with the conserved zinc-binding motif (HEXXHXXGXXH) for catalytic activity, followed by a disintegrin-like domain that may facilitate substrate recognition. The mature protein likely contains multiple disulfide bridges to stabilize its tertiary structure, with a characteristic cysteine pattern common to snake venom metalloproteinases. The enzyme operates through calcium-dependent proteolytic cleavage of Factor V at specific sites, converting it to its active form and dramatically accelerating thrombin generation, leading to disseminated intravascular coagulation and contributing to the hemotoxic effects of Russell's viper envenomation. The sequence should reflect the high substrate specificity for Factor V over other coagulation factors, with appropriate catalytic residues and structural motifs that enable efficient proteolytic activation while maintaining stability in the venom gland environment."}
{"description": "sp|Q0GY44|KBX1_TITDI Potassium channel toxin Tdi-beta-KTx OS=Tityus discrepans OX=57059 PE=1 SV=1", "sequence": "MERKLALLLLLGMITLASSGLREKHVQKLVTLIPNDTLRSIMKTIVHKLAKTQFGCPAYEGYCMNHCQDIERHDGSCHGFKCKCEKS", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Tityus discrepans. This toxin belongs to the beta-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by disulfide bridges. The cysteine framework is expected to follow the pattern C1-X3-9-C2-X3-6-C3-X9-19-C4-X0-2-C5-X3-9-C6, with disulfide connectivity C1-C4, C2-C5, and C3-C6. The toxin should specifically target and inhibit potassium channels, likely through interaction with the channel's voltage-sensing domain or pore region, leading to altered neuronal excitability and contributing to the venom's paralytic and neurotoxic effects. Key functional residues should be positioned in the beta-sheet and loop regions to facilitate high-affinity binding and selectivity for potassium channels over other ion channels."}
{"description": "sp|Q4PRC9|SL4_DABSI Snaclec 4 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MGRFISISFGLLVVFLSLSGTEAAFCCPSGWSAYDQNCYKVFTEEMNWADAEKFCTEQKKGSHLVSLHSREEEKFVVNLISENLEYPATWIGLGNMWKDCRMEWSDRGNVKYKALAEESYCLIMITHEKVWKSMTCNFIAPVVCKF", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) from the venom of the Siamese Russell's viper (Daboia siamensis). This toxin functions as a platelet aggregation modulator, specifically targeting platelet receptors such as GPIb or GPVI to either inhibit or activate platelet aggregation, thereby contributing to the venom's hemorrhagic and coagulopathic effects. The protein should adopt a characteristic C-type lectin-like fold, consisting of a heterodimeric structure with alpha and beta subunits stabilized by conserved disulfide bridges. Each subunit should contain the canonical C-type lectin domain with a double-loop structure, featuring key residues for carbohydrate recognition and receptor binding. The sequence must include the essential cysteine framework for proper disulfide bonding, typically with 4-6 conserved cysteines forming intra-chain bridges that maintain the globular fold. The molecular surface should present specific loop regions responsible for high-affinity binding to platelet membrane receptors, potentially mimicking endogenous ligands to disrupt hemostasis. The overall structure should be compact and stable, resistant to proteolytic degradation in the bloodstream, with surface-exposed residues optimized for target specificity while maintaining the structural integrity characteristic of snake venom C-type lectins."}
{"description": "sp|P59070|PA2SD_AUSSU Phospholipase A2 superbin d (Fragment) OS=Austrelaps superbus OX=29156 PE=1 SV=1", "sequence": "NLVQFSNMIQCANHGSRPTRHYVDYGCYCGWGGSGTPVDELDRCCQTH", "prompt": "Design a protein sequence for a phospholipase A2 toxin derived from the venom of the Australian lowland copperhead snake, Austrelaps superbus. This toxin should function as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmission. The protein should adopt the characteristic phospholipase A2 structural fold, featuring a conserved catalytic network including a His-Asp dyad for calcium-dependent hydrolysis of membrane phospholipids. Include the canonical disulfide bridge pattern typical of snake venom phospholipases A2, with conserved cysteine residues forming the structural scaffold that stabilizes the compact, multi-stranded β-sheet core surrounded by α-helices. The sequence should contain specific molecular determinants for high-affinity binding to presynaptic membranes, facilitating access to phospholipid substrates while exhibiting minimal postsynaptic activity. Incorporate structural features that confer resistance to proteolytic degradation and thermal stability, consistent with the functional requirements of a venom component in an elapid snake species."}
{"description": "sp|Q4PRD0|SL3_DABSI Snaclec 3 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MGRFISVSFGLLVVFLSLSGTEAAFCCPSGWSAYDQNCYKVFTEEMNWADAEKFCTEQHKGSHLLSLHNIAEADFVLKKTLAMLKDGVIWMGLNDVWNECNWGWTDGAKLDYKAWNEGTNCFVFKIAKNHWSHMDCSSTHNFVCKFRV", "prompt": "Design a protein sequence for a C-type lectin-like protein (snaclec) from the venom of Daboia siamensis, the Eastern Russell's viper. This toxin functions as a venom component that disrupts hemostasis through its carbohydrate-recognition domain. The protein should adopt the characteristic C-type lectin-like fold, consisting of a globular domain stabilized by conserved disulfide bridges. The structure should feature the typical α-helical and β-sheet elements of this fold, with key residues in the carbohydrate-binding site that mediate interactions with glycoprotein targets involved in coagulation pathways. The sequence must include the appropriate cysteine framework to form the essential disulfide bonds that maintain structural integrity and functional specificity. This snaclec likely targets platelet receptors or coagulation factors, contributing to the venom's potent anticoagulant or platelet-aggregating effects, which are critical for prey immobilization and digestion in viper envenomation."}
{"description": "sp|P0DMD6|TSNP_TITSE Natriuretic peptide TsNP OS=Tityus serrulatus OX=6887 PE=1 SV=1", "sequence": "KLSGCFGFKLDRIGTMSGLGC", "prompt": "Design a natriuretic peptide toxin from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin functions as a potent vasoactive peptide that mimics mammalian natriuretic peptides, specifically targeting the natriuretic peptide receptor-A (NPR-A) in the cardiovascular system. The peptide should exhibit the characteristic structural scaffold of scorpion natriuretic toxins, featuring a conserved 17-amino acid ring structure formed by a disulfide bridge between two cysteine residues that stabilizes the bioactive conformation. The core mechanism involves binding to NPR-A with high affinity, activating particulate guanylyl cyclase to increase cyclic GMP levels, resulting in vasodilation, natriuresis, and diuresis. This contributes to the scorpion's envenomation syndrome by causing hypotension and fluid imbalance. Ensure the sequence includes the essential residues for receptor interaction, such as those forming the receptor-binding loop within the disulfide-stabilized ring, and maintains the overall compact, globular fold typical of this toxin family. The design should prioritize biological activity, structural stability, and specificity for NPR-A over other natriuretic peptide receptors."}
{"description": "sp|Q6T178|PA2_HOTTA Phospholipase A2 OS=Hottentotta tamulus OX=34647 PE=1 SV=1", "sequence": "MHTPKHAIRRMSKGEMEFFEGRCQRMGEAKRTMWGTKWCGSGNEAINYTDLGYFSNLDSCCRTHDHCDSIPAGETKYGLTNEGKYTMMNCKCESAFEKCLRDVRGILEGKAAAAVRKTYFDLYGNGCFNVKCPSGARSARSEECTNGMATYTGETGYGAWAINKLNG", "prompt": "Design a phospholipase A2 toxin protein sequence from the venom of the Indian red scorpion, Hottentotta tamulus. This enzyme should exhibit potent neurotoxic and cardiotoxic activity through its catalytic function of hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of 6-8 disulfide bridges that maintain structural integrity. Key catalytic residues should include a conserved histidine-aspartate dyad and a calcium-binding loop essential for enzymatic activity. The toxin should preferentially target neuronal and cardiac cell membranes, disrupting membrane integrity and triggering inflammatory responses through eicosanoid production. Include conserved structural motifs such as the pancreatic loop and elapid loop characteristic of group I/II phospholipase A2 enzymes, with surface-exposed hydrophobic residues that facilitate membrane interaction and substrate binding. The protein should demonstrate thermal stability and resistance to proteolytic degradation typical of scorpion venom phospholipases."}
{"description": "sp|P01499|MCDP_APIME Mast cell degranulating peptide OS=Apis mellifera OX=7460 PE=1 SV=2", "sequence": "MISMLRCTFFFLSVILITSYFVTPTMSIKCNCKRHVIKPHICRKICGKNG", "prompt": "Design a mast cell degranulating peptide from the venom of the European honey bee (Apis mellifera) that functions as a potent immunomodulatory toxin. This peptide should exhibit the characteristic structural features of apamin-like bee venom peptides, including a compact globular fold stabilized by two disulfide bridges with a C1-C4, C2-C3 connectivity pattern. The peptide should adopt a stable alpha-helical conformation in its core region, facilitating specific interaction with mast cell membranes to induce rapid degranulation and histamine release. The molecular mechanism involves perturbation of mast cell membrane integrity through a combination of hydrophobic interactions and electrostatic forces, leading to calcium influx and subsequent exocytosis of inflammatory mediators. The structural scaffold should maintain the conserved bee venom peptide architecture while optimizing for high-affinity binding to mast cell surface components, resulting in potent pro-inflammatory activity characteristic of this class of venom peptides."}
{"description": "sp|P05486|CESS_CONGE Conopressin-conophysin OS=Conus geographus OX=6491 PE=1 SV=2", "sequence": "MTRSAMQMGRLTLVLCLLLLLLLTTQACFIRNCPKGGKRDVDERYLFKACMSCSFGQCVGPRICCGPRGCEMGTAEANRCIEEDEDPIPCQVVGQHCDLNNPGNIHGNCVANGICCVDDTCTIHTGCL", "prompt": "Design a neuropeptide hormone precursor protein from the venom of the geography cone snail (Conus geographus) that functions as a conopressin-conophysin complex. This protein should serve as a precursor to vasopressin-like neuropeptides that modulate neuronal signaling and physiological processes in prey organisms. The sequence should include both the conopressin peptide domain, which acts as a vasopressin/oxytocin receptor agonist to influence fluid balance, blood pressure, and social behaviors, and the conophysin domain, which serves as a neurophysin-like carrier protein that stabilizes and facilitates the proper folding and processing of the conopressin moiety. The mature conopressin component should adopt a cyclic conformation stabilized by a disulfide bridge between two conserved cysteine residues, forming a compact ring structure characteristic of vasopressin-family peptides. The overall precursor should exhibit the typical organization of neurophysin-associated peptides, with appropriate cleavage sites for proteolytic processing to release the active conopressin hormone. The structural scaffold should ensure proper hormone-carrier interactions that maintain bioactivity and facilitate targeted delivery within the venom's neuropharmacological arsenal."}
{"description": "sp|C0HM73|KA104_CENBO Potassium channel toxin alpha-KTx 10.5 (Fragment) OS=Centruroides bonito OX=3035065 PE=1 SV=1", "sequence": "NVACVHRTCDSNCKRNGYKSGKCINRKCNCYPH", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom toxins. This toxin should function as a selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels with high affinity. The protein should adopt the conserved alpha-KTx structural scaffold characteristic of scorpion toxins, featuring a compact globular fold stabilized by three disulfide bridges in the C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core should consist of an alpha-helix packed against an anti-parallel beta-sheet, creating a molecular surface with key functional residues for channel blockade. Include the conserved functional dyad consisting of a critical lysine residue positioned for deep insertion into the potassium channel pore and an aromatic residue that facilitates binding through hydrophobic interactions. The toxin should exhibit the typical molecular weight range of 3-5 kDa and maintain the characteristic cysteine-stabilized alpha-beta (CSαβ) motif. The sequence should reflect evolutionary optimization for rapid neuromuscular paralysis in the scorpion's predatory strategy, with specific residues tailored for selective potassium channel inhibition while maintaining structural stability in the venom environment."}
{"description": "sp|P59357|SCL7_LEIHE Alpha-like toxin Lqh7 OS=Leiurus hebraeus OX=2899558 PE=1 SV=1", "sequence": "VRDGYIAKPENCAHHCFPGSSGCDTLCKENGGTGGHCGFKVGHGTACWCNALPDKVGIIVDGVKCH", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by the venom of the yellow scorpion Leiurus hebraeus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the channel's voltage-sensing domain to delay inactivation and prolong action potentials, leading to hyperexcitability in neuronal and muscular tissues. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion alpha-toxins, featuring a compact globular architecture stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C7-C8 connectivity pattern. Key structural elements should include a conserved beta-sheet core stabilized by the disulfide framework, with flexible loops extending from this core that mediate specific interactions with sodium channel domain IV. The molecular mechanism should involve binding to neurotoxin receptor site 3 on voltage-gated sodium channels, preferentially affecting mammalian neuronal subtypes. The sequence should maintain the hallmark pharmacological profile of Leiurus hebraeus toxins—high potency, selective sodium channel modulation, and the ability to induce repetitive firing and spontaneous neurotransmitter release. Critical functional residues should be preserved in the receptor-binding interface to ensure target specificity and biological activity."}
{"description": "sp|P0DQH4|3SBB_HEMHA Hemextin B (Fragment) OS=Hemachatus haemachatus OX=8626 PE=1 SV=1", "sequence": "LKCKNKVVPFLKCKNKVVPFLCYKMTLKKVTPKIKRG", "prompt": "Design a protein sequence for a snake venom toxin derived from the rinkhals (Hemachatus haemachatus) that functions as a potent anticoagulant through specific inhibition of blood coagulation factor Xa. This toxin belongs to the three-finger toxin (3FTx) family and should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bridges with a C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The protein should contain the conserved three-loop architecture extending from a central hydrophobic core, with loop II likely containing key residues for direct interaction with the active site of factor Xa. The mechanism involves competitive inhibition that prevents factor Xa from activating prothrombin to thrombin, thereby disrupting the coagulation cascade and preventing fibrin clot formation. The structural scaffold should maintain the globular, compact fold typical of three-finger toxins while incorporating specific surface residues that confer high affinity and selectivity for the factor Xa serine protease domain."}
{"description": "sp|C0JB55|B1V_SICCD Dermonecrotic toxin SdSicTox-betaIF1 (Fragment) OS=Sicarius cf. damarensis (strain GJB-2008) OX=575956 PE=2 SV=1", "sequence": "WIMGHMVDDIAMVDDFLDNGANGLELDISFDSNGKAEYTYHGTPCDCFRSCTRYESFDKYMEYVREISTPGNQKFRKSLIMLIMYLKLNSLYANQLYTAGSDIADQLARHYWKDDGAARAYMVLSLPSITQTEFIRGFKNRMESQGLQKYYAKIGWDFTGNEDLDDIEATYKKLNITEHIWQSDGITNCLNRGTDRLEDAIRRRDKPGNKYINKVYLWSIDKMSSIRDALDKGVDGIMVNYADRFIDVLKESKYSSKYRLATYEDNPWETFRP", "prompt": "Design a protein sequence for a dermonecrotic toxin from the six-eyed sand spider Sicarius cf. damarensis. This toxin belongs to the SdSicTox-betaIF1 family and functions as a potent cytolytic agent that induces severe tissue necrosis through membrane disruption. The toxin likely operates via a sphingomyelinase-like mechanism, hydrolyzing sphingomyelin in cell membranes to generate ceramide, which triggers apoptotic signaling pathways and inflammatory responses leading to localized tissue destruction. The structural scaffold should feature a conserved beta-sandwich fold characteristic of sphingomyelinase D enzymes, stabilized by multiple disulfide bridges in a pattern typical for this toxin family (likely involving 4-6 cysteine residues forming 2-3 disulfide bonds). The protein should contain key catalytic residues for enzymatic activity, including histidine and aspartic acid residues in the active site, and maintain surface-exposed hydrophobic patches for membrane interaction. The target interface involves binding to lipid bilayers, particularly those rich in sphingomyelin, with specificity for mammalian cell membranes. The sequence should reflect the venom's ecological role in prey immobilization and defense, producing rapid local tissue damage and systemic effects in envenomation scenarios."}
{"description": "sp|Q9NBG9|KA162_OLIMR Potassium channel toxin alpha-KTx 16.2 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKIFSILLVALIICSISICTEAFGLIDVKCFASSECWTACKKVTGSGQGKCQNNQCRCY", "prompt": "Design a potassium channel toxin protein from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The venom of this scorpion contains a complex mixture of neurotoxins that target ion channels to disrupt neuronal signaling and induce paralysis in prey. The core mechanism of action involves high-affinity binding to the pore region of Kv1-type potassium channels, effectively blocking potassium ion flux and prolonging neuronal depolarization, leading to hyperexcitability and neuromuscular dysfunction. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against a three-stranded anti-parallel beta-sheet stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements include a functional dyad comprising a critical lysine residue in the beta-sheet region that inserts into the channel pore and a nearby aromatic residue that stabilizes the interaction. The molecular target is specifically Kv1.3 or related Kv1 subfamily potassium channels, with binding occurring at the external vestibule where the toxin occludes the ion conduction pathway. The sequence should contain the signature pattern of scorpion alpha-KTx toxins with appropriate spacing of cysteine residues and conserved residues essential for channel recognition and blockade."}
{"description": "sp|Q52SK6|HLYS3_HYDVD Hydralysin-3 OS=Hydra viridissima OX=6082 GN=Hln-3 PE=2 SV=3", "sequence": "MGKELLTFSDLRWLDSSPDTVRSAFTREYGTTPDGIALNSEGYFGYHSPPITEQYGRPCYKQTGETKITSQDLSAPTDDVLGSSAAINRGDSPITLTFGVEGVFQMGGEFSLTVSVRKSGSSSVEKTSTSSVQVTVPPRSKVVVSMVGIMKKEKVFFEVPVTVDGSFGANFSSTVQGHYFWFMDARSCLNKTSGVIKGTIDHANVFDVSVEVGPSEPL", "prompt": "Design a novel protein sequence for a cytolytic toxin derived from the green hydra, Hydra viridissima, that functions as a pore-forming toxin in the hydralysin family. This toxin should exhibit potent membrane-disrupting activity through the formation of β-pore structures in target cell membranes, leading to osmotic lysis and cell death. The protein should adopt a conserved β-trefoil fold characteristic of the aerolysin-like toxin superfamily, featuring a central β-barrel pore-forming domain and receptor-binding regions. Key structural elements should include: a pre-pore soluble conformation that undergoes oligomerization upon membrane binding, a transmembrane β-hairpin region that inserts into lipid bilayers, and conserved hydrophobic patches for membrane interaction. The mechanism should involve binding to specific membrane components (likely glycosphingolipids or cholesterol-rich domains), followed by oligomerization into a ring-shaped pore complex that permits uncontrolled ion flux. The sequence should maintain the characteristic disulfide bonding pattern that stabilizes the β-trefoil core while allowing for conformational flexibility during the pre-pore to pore transition. The resulting protein should demonstrate broad-spectrum cytolytic activity against various cell types, consistent with the predatory function of hydra venom in immobilizing prey."}
{"description": "sp|A8QL53|VSP1_NAJAT Snake venom serine protease NaSP (Fragment) OS=Naja atra OX=8656 PE=2 SV=1", "sequence": "MVLIRVLASLLILQLSYSKSLDDGAKESAYDDEIQQSSWGNSTVNTTLTETVVIQLIMGGSECYKSKHPFLVYLYNSAGFFCSGTLLNHEWVLTAAHCNRDDIQLKLGVHNVHVHYEDEQIRVPKEKLCCLSTKNCTQWSQDIMLIRLNSSVNNSKHIEPLSLPSRPPSMGSDCTVMGWGTITSPKVTYPKVPHCVDIKILHNPVCQAAYPTMSRKNILCAGVLEGGKDSCKGDSGGPLICDGQIQGIVSWGRFPCAQLLEPGVYTKVFDYIDWIRGIIAGN", "prompt": "Design a snake venom serine protease protein fragment from the Chinese cobra (Naja atra) that functions as a potent hemostatic toxin. This protein should exhibit the characteristic serine protease catalytic triad (His, Asp, Ser) and function as a thrombin-like enzyme, promoting coagulation by cleaving fibrinogen to form fibrin clots. The protein should adopt the conserved chymotrypsin-like fold typical of snake venom serine proteases, featuring a two-domain structure with the active site located in the cleft between domains. Include the characteristic disulfide bond pattern that stabilizes this fold, with conserved cysteine residues forming multiple intra-chain disulfide bridges. The protein should possess substrate specificity for fibrinogen, preferentially cleaving fibrinopeptides A and/or B, and may exhibit additional kallikrein-like activity affecting blood pressure regulation. The structural scaffold should maintain the standard SVSP topology with appropriate surface loops that mediate substrate recognition and potential interactions with coagulation factors. This toxin contributes to the prey immobilization strategy of elapid snakes by disrupting normal hemostasis through pro-coagulant mechanisms."}
{"description": "sp|P01021|BNP_GLOBL Bradykinin-potentiating and C-type natriuretic peptides OS=Gloydius blomhoffii OX=242054 PE=1 SV=4", "sequence": "MFVSRLAASGLLLLALMALSLDGKPVQQWSQGRPPGPPIPRLVVQQWSQGLPPGPPIPRLVVQQWSQGLPPGPPIPPLVVQQWSQGLPPRPKIPPLVVQQWSQGLPPRPKIPPLVVQKWDPPPVSPPLLLQPHESPAGGTTALREELSLGPEAASGPAAAGADGGRSGSKAPAALHRLSKSKGASATSASASRPMRDLRTDGKQARQNWARMVNPDHHAVGGCCCGGGGGGARRLKGLVKKGVAKGCFGLKLDRIGTMSGLGC", "prompt": "Generate a protein sequence for a venom-derived peptide from the Japanese mamushi snake (Gloydius blomhoffii) that functions as a dual-activity toxin with both bradykinin-potentiating and C-type natriuretic peptide activities. This peptide should exhibit the characteristic structural features of snake venom peptides, including a compact, stable fold stabilized by multiple disulfide bonds, likely following the typical cysteine pattern found in natriuretic peptide precursors. The bradykinin-potentiating function should involve inhibition of angiotensin-converting enzyme (ACE), thereby preventing bradykinin degradation and enhancing its vasodilatory and pro-inflammatory effects. Simultaneously, the C-type natriuretic peptide domain should bind to natriuretic peptide receptors, particularly NPR-B, activating guanylyl cyclase and increasing cyclic GMP levels to promote vasodilation, natriuresis, and diuresis. The resulting peptide should have a molecular architecture that enables both enzymatic inhibition and receptor binding activities, contributing to the snake's predatory strategy by inducing hypotension, increased vascular permeability, and prey immobilization through synergistic cardiovascular effects."}
{"description": "sp|A8N286|3SO8_OPHHA Haditoxin OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVYLDLGYTTKCYNHQSTTPETTEICPDSGYFCYKSSWIDGREGRIERGCTFTCPELTPNGKYVYCCRRDKCNQ", "prompt": "Design a protein sequence for a novel neurotoxin from the king cobra (Ophiophagus hannah) venom that functions as a potent, reversible antagonist of both muscle-type and neuronal nicotinic acetylcholine receptors. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, stabilized by a conserved disulfide bridge pattern with four intramolecular bonds (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8) that create the signature three-loop architecture. The protein should exhibit dual specificity, binding to the orthosteric site of α7 neuronal nAChRs with high affinity while also effectively blocking muscle-type (α1β1γδ) nAChRs at the neuromuscular junction. Key structural elements should include: Loop I for initial receptor recognition, Loop II containing critical residues for receptor subtype discrimination and binding affinity, and Loop III contributing to structural stability and target engagement. The toxin should demonstrate non-competitive antagonism through allosteric modulation, causing paralysis by preventing acetylcholine-mediated ion channel opening. Incorporate conserved hydrophobic core residues that maintain the β-sheet rich scaffold while including variable loop residues that confer the dual receptor specificity. The sequence should reflect the evolutionary optimization of king cobra venom for rapid prey immobilization through comprehensive neuromuscular blockade."}
{"description": "sp|P07037|PA2A2_ASPSC Acidic phospholipase A2 CM-II OS=Aspidelaps scutatus OX=8607 PE=1 SV=1", "sequence": "NLYQFKNMIQCTVPNRSWWHFADYGCFCGYGGSGTPVDELDRCCQTHDNCYSEAEKLSGCKPYIKTYSYDCSQGKLTCSGNDDKCAAFVCNCDRVAAICFAGAPYIDDNYNVDLNERCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the shield-nosed cobra (Aspidelaps scutatus). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of glycerophospholipids in cell membranes. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer exceptional thermal and proteolytic stability. Key structural elements must include the conserved calcium-binding loop (Tyr-Gly-Cys-Tyr-Cys-Gly-X-Gly-Gly) and the catalytic triad (His-Asp-Tyr) essential for enzymatic activity. The acidic nature of this toxin (low pI) enhances its membrane penetration capability and contributes to its presynaptic neurotoxic effects by disrupting neurotransmitter release at neuromuscular junctions. The sequence should maintain the characteristic interfacial binding surface that facilitates interaction with lipid membranes while preserving the structural determinants for specific targeting of neuronal and muscle cell membranes, leading to paralysis and tissue damage."}
{"description": "sp|P85420|VM11_BOTAT Snake venom metalloproteinase atroxlysin-1 OS=Bothrops atrox OX=8725 PE=1 SV=2", "sequence": "TPEQQRYVDLFIVVDHGMFMKYNGNSDKIRRRIHQMVNIMKEAYSTMYIDILLTGVEIWSNKDLINVQPAAPQTLDSFGEWRKTDLLNRKSHDNAQLLTSTDFNGPTIGLAYVGSMCDPKRSTGVIQDHSEQDLMVAITMAHELGHNLGISHDTGSCSCGGYSCIMSPVLSHEPSKYFSDCSYIQCWDFIMKENPQCILNKR", "prompt": "Generate the amino acid sequence for a snake venom metalloproteinase from Bothrops atrox, specifically the atroxlysin-1 isoform. This zinc-dependent metalloproteinase belongs to the reprolysin family and functions as a key hemorrhagic toxin in pit viper venom. The protein should exhibit the characteristic multi-domain architecture of SVMPs, featuring a pro-domain that maintains latency, a catalytic domain containing the conserved zinc-binding motif HEXXHXXGXXH, and a disintegrin-like domain that may facilitate target recognition. The mature enzyme acts by degrading components of the basement membrane, particularly type IV collagen, laminin, and fibronectin, leading to capillary disruption and hemorrhage. It targets endothelial cells and extracellular matrix proteins through specific exosite interactions beyond the catalytic cleft. The structure should reflect the typical metalloproteinase fold with alpha-helices and beta-strands surrounding the active site zinc ion, stabilized by multiple disulfide bonds that confer stability in the venom milieu. The protein should demonstrate calcium-dependent stability and optimal activity at physiological pH, contributing to the rapid tissue damage and prey immobilization characteristic of Bothrops envenomation."}
{"description": "sp|Q9PT41|VSPF5_MACLB Factor V activator OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MVLIRVLANLLVLQLSYAQKSSELVVGGDECDINEHPFLVALYTSSSSTVHCAGTLINQEWVLTAVHCDRKNIRIKLGMHSKNIRNEDEQIRVPRRKFFCLNTKFPNGKDKDIMLIRLRRPVKNSAHIAPISLPSSPSSPRSRCRIMGWGKISTTEETYPDVPHCAKIFIVKHAWCEALYPWVPADSRTLCAGILQGGKDTCEGDSGGPLICNGQIQGIVSGGSDPCGQRLKPAVYTKVFDYTDWIQSIIAGNTTATCP", "prompt": "Design a protein sequence for a snake venom Factor V activator from the blunt-nosed viper Macrovipera lebetinus. This metalloproteinase toxin functions as a potent procoagulant by specifically cleaving and activating coagulation Factor V in the blood plasma, leading to rapid thrombin generation and potentially fatal thrombosis. The protein should exhibit the characteristic structural features of snake venom metalloproteinases (SVMPs), including a conserved zinc-binding catalytic domain with the HEXXHXXGXXH motif that coordinates the catalytic zinc ion, and a disintegrin-like domain that may mediate substrate recognition. The mature toxin likely adopts a compact, globular fold stabilized by multiple disulfide bridges typical of SVMPs, with the catalytic domain forming the active site cleft that selectively recognizes and processes Factor V. The mechanism involves precise proteolytic cleavage at specific sites in Factor V, converting it to its active form (Factor Va) and dramatically accelerating the coagulation cascade. This represents a key offensive strategy in viper envenomation, causing systemic coagulopathy through targeted manipulation of the host's hemostatic system."}
{"description": "sp|C0JB56|B2J1_SICPE Dermonecrotic toxin SpeSicTox-betaIIA3i (Fragment) OS=Sicarius peruensis OX=571541 PE=2 SV=1", "sequence": "WIMGHMVNAIEQVDEFLDLGANAIEFDVDFDDDGVAKYTHHGIPCDCGRLCTKYAVFTEYLDYVRQVTTPGDPKFRKELVLLALDLKLQRISSEKAYAAGVDVATKLLDHYWMRGWNGGRAYILLNIPLVEDYEFIRAFKDTLRKEGHEQYNAKVGINFTGNEDLDEIREVLEKLGEDEHIWQADGITSCFPRGTERLKKALEKRDTPGYKYIPKVYAWTLVRSSIMRRSLRLGVDGVMSNYPDSVVKVLKEKEFSDKFRLATYADNPWEKFTPI", "prompt": "Design a protein sequence for a dermonecrotic toxin from the six-eyed sand spider Sicarius peruensis, specifically representing the SpeSicTox-betaIIA3i variant. This toxin belongs to the sphingomyelinase D family (SMase D) and functions as a potent phospholipase that hydrolyzes sphingomyelin and lysophosphatidylcholine in mammalian cell membranes. The mechanism involves cleaving the phosphodiester bond, generating ceramide-1-phosphate and choline, which triggers inflammatory responses, platelet aggregation, and endothelial cell damage leading to dermal necrosis. The protein should adopt the conserved (α/β)8 TIM barrel fold characteristic of SMase D enzymes, with the active site containing essential catalytic residues (likely histidine and aspartate/glutamate pairs) for metal ion coordination and substrate binding. Key structural features include a hydrophobic membrane-interaction surface and conserved disulfide bridges that stabilize the barrel structure. The toxin targets vascular endothelial cells and dermal tissues, causing localized tissue destruction through complement activation and neutrophil recruitment, consistent with the necrotic pathology observed in Sicarius envenomation."}
{"description": "sp|A8Y7N7|VKTC4_DABSI Kunitz-type serine protease inhibitor C4 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECMAYIRSFYYDSESKKCKEFIYGGCHGNANNFPTRDKCRQTCRAPRKGRHT", "prompt": "Design a Kunitz-type serine protease inhibitor toxin from the venom of Daboia siamensis (Russell's viper). This protein should function as a potent anticoagulant by specifically inhibiting key serine proteases in the coagulation cascade, likely targeting factors Xa, XIa, or plasma kallikrein. The structural scaffold must feature the characteristic Kunitz domain fold consisting of approximately 60 amino acids with a conserved alpha-beta-alpha secondary structure arrangement. The sequence should contain the canonical six cysteine residues forming three disulfide bridges in the C1-C6, C2-C4, C3-C5 connectivity pattern that stabilizes the compact globular structure. The reactive site loop should be positioned between the second beta-strand and the C-terminal alpha-helix, containing the critical P1 residue that determines protease specificity. The protein should exhibit high thermal stability and protease resistance due to its disulfide-stabilized framework. This toxin would contribute to the viper's hemorrhagic venom strategy by disrupting hemostasis through precise inhibition of coagulation factors."}
{"description": "sp|Q52SK7|HLYS_HYDVU Hydralysin OS=Hydra vulgaris OX=6087 GN=Hln PE=2 SV=3", "sequence": "MGKELLTFSDLSWLDSSPDSVRKAFTNSYGRTPDGISVNNETYFNAVKPAITEQYGHYCYKRTGQTKIVSQQLSDPTDAVLGSSIARNRGDSPVTLTVSVAGTWNDSTSWSTSAEAGVTMKSEFEVSGFFKTGAEFSVSVTAGKSGSSSVEKSSTSQIQVTVPPRSKVTVNMVGIMKKEKVCFEVPITVDGSFGANFGSSVQGHYFWFMSTDQALSKTSGIIKGTIDHASVFDVSTEIGPSEPL", "prompt": "Design a novel protein sequence that embodies the biological and structural characteristics of hydralysin, a pore-forming toxin from the freshwater cnidarian Hydra vulgaris. This toxin plays a crucial role in the cnidarian's venom arsenal, facilitating prey capture and defense through rapid membrane disruption. The protein should function as a potent cytolysin, forming stable transmembrane pores in target cell membranes that lead to osmotic lysis and cell death. The mechanism involves oligomerization into a β-barrel pore complex that inserts into lipid bilayers. The structural scaffold should feature a predominantly β-sheet-rich architecture characteristic of the aerolysin-like toxin family, with conserved domains for membrane binding and β-barrel formation. The sequence must include the characteristic cysteine framework for proper disulfide bonding that stabilizes the pore-forming domains. The protein should exhibit specificity for cholesterol-rich membranes and demonstrate calcium-independent cytolytic activity. The molecular target is the plasma membrane of susceptible cells, with binding mediated by specific recognition of lipid components and subsequent oligomerization into functional pores."}
{"description": "sp|P01502|MEL_APIDO Melittin OS=Apis dorsata OX=7462 GN=MELT PE=1 SV=1", "sequence": "GIGAILKVLSTGLPALISWIKRKRQE", "prompt": "Design a protein sequence for melittin, a major hemolytic peptide toxin from the venom of the giant honey bee Apis dorsata. This amphipathic peptide functions as a potent cytolytic agent that disrupts biological membranes through detergent-like mechanisms, forming voltage-dependent ion channels and causing osmotic lysis. The protein should adopt a predominantly alpha-helical structure in hydrophobic environments, with a flexible N-terminal region and a more rigid C-terminal helix. It should exhibit characteristic amphipathicity with hydrophobic residues clustered on one face and hydrophilic residues on the opposite face, enabling membrane insertion and pore formation. The sequence should maintain the typical 26-amino acid length with high content of basic residues (particularly lysine) that facilitate initial electrostatic interactions with negatively charged phospholipid head groups. The molecular mechanism involves binding to lipid bilayers, inducing curvature stress, and ultimately forming transmembrane pores that lead to cell lysis and systemic effects in envenomated organisms."}
{"description": "sp|P59368|TX35D_PHONI Delta-ctenitoxin-Pn1a OS=Phoneutria nigriventer OX=6918 PE=1 SV=2", "sequence": "MKVAIVFLSLLVLAFASESIEENREEFPVEESARCGDINAACKEDCDCCGYTTACDCYWSKSCKCREAAIVIYTAPKKKLTC", "prompt": "Design a novel animal toxin protein sequence based on the following biological specifications: This is a delta-ctenitoxin from the venom of the Brazilian wandering spider, Phoneutria nigriventer. The toxin functions as a potent neurotoxin that specifically targets voltage-gated sodium channels, acting as a site-4 toxin that inhibits channel inactivation, leading to prolonged neuronal depolarization and excitotoxicity. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. Key structural elements include a conserved hydrophobic patch and a solvent-exposed loop region responsible for channel interaction. The molecular mechanism involves binding to the voltage-sensing domain of sodium channels, trapping them in an activated state and disrupting normal action potential termination. The venom from which this toxin originates is medically significant, causing intense pain, autonomic dysfunction, and potentially life-threatening neurological effects in envenomation victims."}
{"description": "sp|P85886|CA1AB_CONSP Alpha-conotoxin SrIA/SrIB OS=Conus spurius OX=192919 PE=1 SV=1", "sequence": "MGMRMMFTVFLLVVLATTVVSFTSDSAFDSRNVAANDKVSDMIALTARRTCCSRPTCRMEYPELCGGRR", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus spurius, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements for nAChR binding, particularly the conserved disulfide-constrained loop regions that mediate receptor interaction. The mature toxin should be approximately 12-18 amino acids in length with a high density of cationic residues that facilitate electrostatic interactions with the receptor's ligand-binding domain. The structural core should exhibit the typical alpha-conotoxin fold characterized by beta-turn elements and constrained loops that provide precise spatial orientation of key functional residues. The toxin should demonstrate high specificity for neuronal nAChR subtypes while maintaining the thermal stability and protease resistance characteristic of conotoxins due to the rigid disulfide framework."}
{"description": "sp|P59854|SCX7_OLIMR Alpha-like toxin BmK-M7 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "VRDGYIALPHNCAYGCLNNEYCNNLCTKDGAKIGYCNIVGKYGNACWCIQLPDNVPIRVPGRCHPA", "prompt": "Design a novel alpha-like neurotoxin protein sequence inspired by the venom of Olivierus martensii (Chinese scorpion). This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting insect sodium channels with high affinity while exhibiting reduced activity toward mammalian channels. The protein should adopt the conserved structural scaffold characteristic of scorpion alpha-toxins, featuring a compact globular fold stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 pattern that forms the core cysteine-stabilized alpha-beta motif. Key structural elements should include an anti-parallel beta-sheet core and several loop regions critical for receptor binding, particularly the 'pharmacophore' loops that interact with domain IV of the sodium channel. The mechanism of action should involve binding to neurotoxin receptor site 3 on voltage-gated sodium channels, thereby inhibiting fast inactivation and prolonging action potentials, leading to hyperexcitability and paralysis in insect prey. The sequence should maintain the characteristic molecular weight of approximately 7-8 kDa and exhibit the typical isoelectric point and surface charge distribution that facilitates specific interaction with insect sodium channels while providing selectivity over mammalian counterparts."}
{"description": "sp|C0HM74|KAX2A_CENBO Potassium channel toxin alpha-KTx 2.10 (Fragment) OS=Centruroides bonito OX=3035065 PE=1 SV=1", "sequence": "IFINVKCSLPQQCLRPCKDRFGQHAGGKCINGKCKCYP", "prompt": "Design a functional potassium channel toxin protein derived from the venom of the scorpion Centruroides bonito. This toxin belongs to the alpha-KTx family 2.10 and functions as a selective blocker of voltage-gated potassium channels, particularly Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a short alpha-helix packed against a three-stranded antiparallel beta-sheet. The cysteine framework follows the pattern C-X(3-7)-C-X(3-7)-C-X(6-12)-C-X(1-4)-C-X(6-12)-C, forming three disulfide bridges that stabilize the compact globular structure. Key functional residues should be positioned in the beta-sheet region to form the functional dyad (typically a lysine and an aromatic residue) that mediates specific interaction with the potassium channel pore. The toxin should exhibit high affinity binding to the external vestibule of Kv1 channels, physically occluding the ion conduction pathway and inhibiting potassium efflux, leading to neuronal hyperexcitability. The molecular mechanism involves precise electrostatic and hydrophobic complementarity with the channel's selectivity filter and surrounding residues. The protein should be approximately 30-40 amino acids in length with the characteristic CSαβ structural motif essential for its neurotoxic activity in scorpion venom."}
{"description": "sp|P0DOZ3|C6G_CONRE Conotoxin reg6(gamma) OS=Conus regius OX=101314 PE=1 SV=1", "sequence": "RVLEPGXEDPDVGEPAGEYEHHLLEX", "prompt": "Design a novel conotoxin sequence that mimics the biological activity and structural characteristics of gamma-conotoxins from Conus regius, a marine cone snail species known for its potent venom used in prey capture. This toxin should function as a voltage-gated sodium channel modulator, specifically targeting neuronal sodium channel subtypes to disrupt action potential generation in the nervous system. The protein should adopt the characteristic conotoxin fold stabilized by a conserved disulfide bonding pattern, likely following the cysteine framework typical for gamma-conotoxins with four disulfide bridges forming a compact, stable tertiary structure. The sequence should contain key functional residues for sodium channel interaction, including conserved hydrophobic patches and charged residues that mediate specific binding to domain II or IV of voltage-gated sodium channels. The structural scaffold should feature a well-defined core stabilized by disulfide bonds, with flexible loops that enable precise interaction with the sodium channel pore region. The toxin should exhibit high affinity and selectivity for specific sodium channel isoforms, potentially causing excitatory or inhibitory effects depending on the binding site. The overall architecture should maintain the compact, cysteine-rich nature characteristic of conopeptides while incorporating the specific pharmacophore elements required for effective sodium channel modulation."}
{"description": "sp|Q9NJC7|SC11_OLIMR BmK AGP-SYPU2 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MNYMVIISLALLVMTGVESVKDGYIADDRNCPYFCGRNAYCDGECKKNRAESGYCQWASKYGNACWCYKLPDDARIMKPGRCNGG", "prompt": "Design a novel animal toxin protein sequence based on the venom peptide BmK AGP-SYPU2 from the scorpion Olivierus martensii (commonly known as the Chinese scorpion). This toxin belongs to the beta-KTx family of scorpion toxins that specifically target voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker, binding to the pore region of Kv1.3 channels with high affinity to modulate neuronal excitability and immune cell function. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The core architecture comprises a short alpha-helix packed against an antiparallel beta-sheet, forming a compact globular structure. Key functional residues should include a conserved dyad of lysine and aromatic residues in the beta-sheet region that mediate channel block by inserting into the potassium selectivity filter. The N-terminal region should be flexible and contribute to target specificity, while the C-terminal should maintain the structural integrity of the beta-sheet. The sequence must exhibit the hallmark scorpion toxin properties of high stability, disulfide-directed folding, and selective ion channel modulation relevant to the scorpion's predatory and defensive strategies."}
{"description": "sp|Q9NII7|KAX36_OLIMR Potassium channel toxin alpha-KTx 3.6 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKVFFAVLITLFICSMIIGIHGVGINVKCKHSGQCLKPCKDAGMRFGKCINGKCDCTPKG", "prompt": "Design a novel potassium channel toxin protein sequence inspired by the alpha-KTx family from the scorpion Olivierus martensii. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1.3 channels which play crucial roles in immune cell function and neuronal excitability. The venom of Olivierus martensii contains a diverse arsenal of potassium channel toxins that have evolved to rapidly immobilize prey by disrupting neuronal signaling through precise channel blockade.\n\nThe protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion potassium channel toxins, featuring an alpha-helix stabilized against a two- or three-stranded anti-parallel beta-sheet by a specific disulfide bridge pattern. The cysteine framework should follow the alpha-KTx pattern with three disulfide bonds connecting C1-C4, C2-C5, and C3-C6, creating a compact, stable globular structure resistant to proteolytic degradation.\n\nKey structural elements must include: a functional dyad consisting of a critical lysine residue positioned in the beta-sheet region that penetrates the channel pore, and an aromatic residue (typically tyrosine or phenylalanine) that contributes to binding specificity through interactions with the channel turret region. The toxin should maintain the characteristic molecular surface with a conserved hydrophobic patch and positively charged residues that interact with the channel's voltage-sensor domain and outer vestibule.\n\nThe mechanism of action involves high-affinity binding to the external pore region of Kv1.3 channels, physically occluding the ion conduction pathway and preventing potassium efflux. This blockade leads to membrane depolarization, prolonged action potentials, and ultimately neurotransmitter release dysregulation in the prey's nervous system. The toxin should exhibit nanomolar affinity for Kv1.3 channels while maintaining selectivity over other potassium channel subtypes through precise molecular recognition elements in its binding interface."}
{"description": "sp|P83588|TOM1A_MISBR Omega-actinopoditoxin-Mb1a OS=Missulena bradleyi OX=230234 PE=1 SV=1", "sequence": "SPVCTPSGQPCQPNTQPCCNNAEEEQTINCNGNTVYRCA", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein is an omega-actinopoditoxin from the venom of Missulena bradleyi, commonly known as the Eastern mouse spider. This toxin belongs to the actinopoditoxin family, which are key components in spider venoms that target vertebrate nervous systems to immobilize prey. The core function of this toxin is to act as a potent inhibitor of voltage-gated calcium channels, specifically targeting Cav2 family channels involved in neurotransmitter release at presynaptic terminals. The mechanism involves high-affinity binding to the channel's pore-forming alpha1 subunit, effectively blocking calcium influx and disrupting synaptic transmission, leading to paralysis. Structurally, this toxin should adopt the inhibitor cystine knot (ICK) motif, a hallmark of spider venom peptides, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. The sequence must include this cysteine framework to ensure proper folding into a rigid, stable scaffold that resists proteolytic degradation. Key structural features include a hydrophobic patch on the molecular surface for channel interaction and a basic residue cluster for electrostatic steering toward the channel's extracellular vestibule. The binding interface should complement the channel's S5-S6 pore loop region, with specific side chains engaging in hydrogen bonding and van der Waals contacts to achieve subtype selectivity, likely favoring Cav2.2 or Cav2.1 channels. Ensure the sequence reflects these functional and structural constraints to produce a bioactive toxin with high potency and specificity for calcium channel blockade."}
{"description": "sp|Q9PTU8|VSP3_BOTJA Snake venom serine protease BPA OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "MVLIRVIANLLILQLSNAQKSSELVIGGDECNITEHRFLVEIFNSSGLFCGGTLIDQEWVLSAAHCDMRNMRIYLGVHNEGVQHADQQRRFAREKFFCLSSRNYTKWDKDIMLIRLNRPVNNSEHIAPLSLPSNPPSVGSVCRIMGWGTITSPNATFPDVPHCANINLFNYTVCRGAHAGLPATSRTLCAGVLQGGIDTCGGDSGGPLICNGTFQGIVSWGGHPCAQPGEPALYTKVFDYLPWIQSIIAGNTTATCPP", "prompt": "Design a snake venom serine protease from the pit viper Bothrops jararaca that functions as a key hemostatic toxin. This enzyme should exhibit trypsin-like or thrombin-like protease activity, targeting specific components of the coagulation cascade to induce consumptive coagulopathy and systemic hemorrhage. The protein should adopt the characteristic chymotrypsin-fold structure with a canonical catalytic triad (His, Asp, Ser) and the conserved structural features of snake venom serine proteases, including appropriate disulfide bonding patterns that stabilize the two-domain β-barrel architecture. The sequence should include specific substrate-binding exosites that confer selectivity for fibrinogen, coagulation factors, or platelet receptors, enabling the toxin to either promote or inhibit clot formation depending on its precise molecular targets. The structural scaffold should facilitate efficient proteolytic activity while maintaining stability in the venom milieu, with surface loops and charge distributions optimized for interacting with mammalian hemostatic proteins to disrupt normal blood coagulation physiology."}
{"description": "sp|P01391|3L21_NAJKA Alpha-cobratoxin OS=Naja kaouthia OX=8649 PE=1 SV=1", "sequence": "IRCFITPDITSKDCPNGHVCYTKTWCDAFCSIRGKRVDLGCAATCPTVKTGVDIQCCSTDNCNPFPTRKRP", "prompt": "Design a protein sequence for a potent neurotoxin from the monocled cobra (Naja kaouthia) venom. This toxin belongs to the three-finger toxin (3FTx) superfamily, specifically the long-chain alpha-neurotoxin subgroup. It functions as a competitive antagonist of nicotinic acetylcholine receptors (nAChRs), with high affinity for the alpha7 and muscle-type (alpha1-beta1-gamma-delta) subtypes. The protein should adopt the characteristic three-finger beta-sandwich fold, stabilized by four conserved disulfide bridges with a Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8 connectivity pattern. Key functional loops (Loop I, II, and III) must be structured to enable specific receptor binding, with Loop II particularly critical for interaction with the nAChR orthosteric site. The sequence should include the conserved 'core' disulfide-stabilized scaffold and functional residues essential for receptor blockade, resulting in neuromuscular paralysis. The overall structure should be compact, with beta-strands forming a rigid, stable framework resistant to proteolysis, typical of elapid snake venom neurotoxins."}
{"description": "sp|P59847|KAX25_CENLM Potassium channel toxin alpha-KTx 2.5 OS=Centruroides limbatus OX=244936 PE=1 SV=1", "sequence": "TVIDVKCTSPKQCLPPCKAQFGIRAGAKCMNGKCKCYPH", "prompt": "Design a potassium channel toxin protein sequence that embodies the functional and structural characteristics of alpha-KTx 2.5 from the bark scorpion Centruroides limbatus. This toxin belongs to the alpha-KTx family of scorpion venom peptides that specifically target voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker, binding to the pore region of Kv1.x family channels with high affinity and selectivity, thereby disrupting neuronal excitability and neuromuscular transmission. Structurally, the toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against a three-stranded antiparallel beta-sheet stabilized by three or four disulfide bridges in the typical C1-C4, C2-C5, C3-C6 pattern. The molecular surface should display a functional dyad consisting of a critical lysine residue that penetrates the potassium channel selectivity filter and adjacent hydrophobic residues that interact with the channel vestibule. The sequence should include the conserved structural motifs that confer stability against proteolytic degradation and thermal denaturation, while maintaining the specific pharmacophore residues responsible for Kv1 channel recognition and blockade. The overall architecture should be compact and globular, approximately 30-40 amino acids in length, with the characteristic scorpion toxin fold that enables precise molecular recognition of potassium channel extracellular domains."}
{"description": "sp|P86100|HYAL1_OLIMR Hyaluronidase-1 OS=Olivierus martensii OX=34649 PE=1 SV=2", "sequence": "MTQNIQMTEMYQIILFASILAAISATSADFKVVWEVPSIMCSKKFKINVTDLLTSHKILVNQEETFNGDKIVIFYESQLGKYPHIESHGDINGGMLQVSDLANHLKIARDNISKFIPDPNFNGVGIIDWEAWRPLWKYNWGRMSEYRDRSKDLVKAKHPDWSPAQIEKVAIEEWENSAKEWMLKTLKLVEDMRPNAAWCYYLFPDCYNYGGKDQPSEYFCKNDIQEANDKLSWLWKQSTALCPSIYMQESHITKYNTSQRAWWIYARLRETIRLSHPNTLIYPYINYILPGTKKTVPSMDFKRVLGQIGSLGLDGAIIWGSSYHVNTEEMCKEMKTYVKDVIAPVASTVIQNVNRCSQQICKGRGNCVWPEEPYTSWKYLIDPKNPTFKHTNISCKCKGGYTGRYCQIAP", "prompt": "Generate the amino acid sequence for a hyaluronidase enzyme from the venom of Olivierus martensii (Chinese scorpion). This enzyme functions as a spreading factor that degrades hyaluronic acid, a major component of the extracellular matrix, thereby facilitating the diffusion of other venom components through tissues and enhancing systemic toxicity. The protein should adopt the classical (α/β)8 TIM barrel fold characteristic of glycosyl hydrolase family 56, with conserved catalytic residues (typically glutamate and aspartate) that mediate acid-base catalysis for the hydrolysis of β-1,4 glycosidic bonds in hyaluronic acid. The sequence should include appropriate signal peptide regions for secretion and maintain structural stability through disulfide bonds that are conserved in scorpion venom hyaluronidases, ensuring optimal enzymatic activity at physiological pH conditions."}
{"description": "sp|Q9YI92|SLB_GLOBL Snaclec mamushigin subunit beta OS=Gloydius blomhoffii OX=242054 PE=1 SV=1", "sequence": "MGRFIFLSFGLLVVFVSLSGTGADCPSDWSSYEGHCYRVFQKEMTWEDAEKFCTQQRKESHLVSFHSSEEVDFVVSMTWPILKYDFVWIGLNNIWNECMVEWTDGTRLSHNAWITESECIAAKTTDNQWLSRPCSRTYNVVCKFQE", "prompt": "Generate the amino acid sequence for a snake venom C-type lectin-like protein (snaclec) from the Japanese mamushi (Gloydius blomhoffii), specifically the beta subunit of mamushigin. This protein functions as a heterodimeric complex with its alpha subunit partner to exert potent anticoagulant activity through binding to coagulation factor IX or factor X, thereby inhibiting the coagulation cascade and promoting hemorrhage. The beta subunit contributes critical binding interfaces for the coagulation factors, with the heterodimer adopting the characteristic C-type lectin-like fold stabilized by conserved disulfide bridges. The structure features a globular domain with beta-sandwich architecture, calcium-binding sites that mediate target recognition, and specific loop regions that determine target specificity. The sequence should reflect the conserved cysteine framework typical of snaclec proteins, forming the essential disulfide bonds that maintain structural integrity and functional conformation. This toxin exemplifies the sophisticated hematoxic strategy of viperid venoms, targeting key components of the hemostatic system to disrupt prey physiology."}
{"description": "sp|A8Y7N9|VKTC6_DABSI Kunitz-type serine protease inhibitor C6 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MSSGGLLLLLGFLTLWAELTPISGQNRPMFCHLPADSGRCKAHIPRFYYNPASNQCQGFTYGGCGGNANNFETRDQCRHTCGASGNVGPRPRIASN", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Daboia siamensis (Russell's viper). This toxin functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, particularly targeting factors like Factor Xa or thrombin. The protein should adopt the characteristic Kunitz domain fold consisting of a conserved beta-trefoil structure with an alpha-helix and anti-parallel beta-sheets stabilized by three disulfide bonds in the C1-C6, C2-C4, C3-C5 connectivity pattern. The canonical protease-binding loop should be positioned between the second and third beta-strands, containing the critical P1 residue that determines specificity. The structural scaffold should maintain the compact, globular fold typical of Kunitz inhibitors, with the reactive site loop presenting the appropriate conformation for tight-binding inhibition of serine proteases. The protein should exhibit high affinity and selectivity for its coagulation cascade targets, contributing to the hemorrhagic effects characteristic of viperid snake venoms."}
{"description": "sp|P20164|VM3HB_PROFL Zinc metalloproteinase-disintegrin-like HR1b OS=Protobothrops flavoviridis OX=88087 PE=1 SV=4", "sequence": "MIQVLLVTICLAVFPYQGSSIILESGNVNDYEVMYPQKVAALPKGAVQQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGRIQNDADSTASISACNGLKGHFKLQGEMYLIEPLKFSDSEAHAVYKYENVEKEEEAPKMCGVTQTNWESDEPIKKASKLVVTAEQQRFPRRYIKLAIVVDHGIVTKHHGNLKKIRKWIYQLVNTINNIYRSLNILVALVYLEIWSKQNKITVQSASNVTLDLFGDWRESVLLKQRSHDCAQLLTTIDFDGPTIGKAYTASMCDPKRSVGIVQDYSPINLVVAVIMTHEMGHNLGIPHDGNSCTCGGFPCIMSPMISDPPSELFSNCSKAYYQTFLTDHKPQCILNAPSKTDIVSPPVCGNELLEAGEECDCGSPENCQYQCCDAASCKLHSWVKCESGECCDQCRFRTAGTECRAAESECDIPESCTGQSADCPTDRFHRNGQPCLYNHGYCYNGKCPIMFYQCYFLFGSNATVAEDDCFNNNKKGDKYFYCRKENEKYIPCAQEDVKCGRLFCDNKKYPCHYNYSEDLDFGMVDHGTKCADGKVCSNRQCVDVNEAYKSTTVFSLI", "prompt": "Generate a protein sequence for a zinc metalloproteinase-disintegrin-like toxin from the venom of Protobothrops flavoviridis (Habu snake). This toxin represents a key component of viperid snake venom with critical roles in prey immobilization and tissue destruction. The protein should function as a hemorrhagic toxin that degrades extracellular matrix components, particularly basement membrane proteins like type IV collagen and laminin, leading to widespread hemorrhage and tissue damage. The sequence must contain a zinc-dependent metalloproteinase domain characterized by the conserved HEXXHXXGXXH zinc-binding motif, which coordinates a catalytic zinc ion essential for proteolytic activity. Additionally, incorporate a disintegrin-like domain that may interfere with integrin-mediated cell adhesion, though this domain in snake venom metalloproteinases typically lacks the RGD motif found in free disintegrins. The structural scaffold should feature multiple disulfide bonds that stabilize both domains, with the metalloproteinase domain adopting a metzincin-like fold featuring a central five-stranded beta-sheet and surrounding alpha-helices. The protein should be synthesized as a pre-pro-enzyme that undergoes activation through proteolytic cleavage to release the mature, active toxin. The generated sequence should reflect the characteristic multidomain architecture of snake venom metalloproteinases while maintaining the specific functional properties that enable this toxin to disrupt vascular integrity and facilitate venom spread through prey tissues."}
{"description": "sp|C0HMA9|SCX36_CENSC Beta-toxin NaTx36 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "KDGYPMRSDGCTIACLFDNDFCNRKCVEQKGKSGYCYFWKQSCYCEGLPDDKVYDSATSKCRA", "prompt": "Design a beta-toxin protein sequence from the venom of the Arizona bark scorpion (Centruroides sculpturatus) that functions as a potent sodium channel modulator. This toxin should specifically target voltage-gated sodium channels (Nav channels) and exhibit the characteristic beta-toxin mechanism of action, where it binds to the voltage-sensing domain of the channel and shifts the voltage dependence of activation toward more negative potentials, leading to enhanced neuronal excitability and spontaneous firing. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold typical of scorpion beta-toxins, featuring a compact globular structure stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. Key structural elements should include an alpha-helix packed against an anti-parallel beta-sheet, with the functional residues concentrated in the 'pharmacophore' region comprising loops between the secondary structure elements. The toxin should preferentially target mammalian Nav1.2, Nav1.6, and Nav1.7 channels, with specific interactions mediated by conserved hydrophobic and basic residues that engage with the S1-S2 and S3-S4 loops of the channel's voltage-sensing domain. The sequence should maintain the core scaffold essential for beta-toxin activity while incorporating the specific molecular recognition features that confer its channel subtype selectivity and potent modulatory effects."}
{"description": "sp|Q0NZX6|VM2JR_BOTJA Zinc metalloproteinase-disintegrin jararin (Fragment) OS=Bothrops jararaca OX=8724 PE=2 SV=1", "sequence": "FVANRMAHELGHNLGIDNDRDSCSCGANSCIMSATVSNEPSSRFSDCSLNQYSSDLINYYGCLLNEPLRTDIVSPPFCGNYYPEVGEDCDCGPPANCQNPCCDAATCKLTTGSQCAEGLCCDQCKFIKARQICRKGRGDNPDDRCTGQSGDCPRNS", "prompt": "Generate the amino acid sequence for a zinc metalloproteinase-disintegrin toxin from the venom of Bothrops jararaca, a medically significant pit viper. This toxin should function as a key hemorrhagic agent by targeting and degrading components of the extracellular matrix, particularly basement membrane proteins like type IV collagen and fibronectin, leading to blood vessel disruption and hemorrhage. The protein must contain a zinc-dependent metalloproteinase domain with the characteristic HEXXHXXGXXH zinc-binding motif, which facilitates proteolytic activity. Additionally, it should include a disintegrin domain that inhibits platelet aggregation by binding to integrin receptors on platelet surfaces, typically through an RGD (Arg-Gly-Asp) or related motif that blocks fibrinogen binding. The structural scaffold should feature multiple disulfide bridges stabilizing both domains, with the metalloproteinase domain adopting a metzincin-like fold and the disintegrin domain forming a compact, disulfide-rich structure. The mature protein should be processed from a larger precursor and exhibit optimal activity at physiological pH, contributing to the rapid tissue damage and coagulopathy characteristic of Bothrops envenomation."}
{"description": "sp|Q6T6T3|DID1_BITGA Disintegrin gabonin-1 OS=Bitis gabonica OX=8694 PE=1 SV=1", "sequence": "MIQVLLVIICLAVFPYQGSSIILESGNVNDYEIVYPKKVTVLPTGAMNSAHPCCDPVTCKPKRGEHCISGPCCRNCKFLNAGTICKRGRGDSLHDYCTGVTPDCPRNPNKGESDELEWSAAATGSVLM", "prompt": "Design a novel disintegrin protein sequence inspired by gabonin-1 from the venom of Bitis gabonica, the Gaboon viper. This protein should function as a potent inhibitor of platelet aggregation by specifically targeting and blocking integrin receptors on platelet surfaces. The sequence must adopt the characteristic disintegrin fold stabilized by a conserved disulfide bridge pattern typical of snake venom disintegrins, featuring the RGD (Arg-Gly-Asp) motif or a related integrin-binding sequence that mediates high-affinity binding to platelet integrins such as αIIbβ3. The structural scaffold should be compact and cysteine-rich, ensuring proper folding and stability through multiple disulfide bonds that confer resistance to proteolytic degradation. The protein's mechanism of action involves competitive inhibition of integrin-ligand interactions, disrupting hemostasis and leading to anticoagulant effects, which is ecologically significant for the viper's predation strategy by preventing prey blood clotting. Ensure the sequence reflects the evolutionary adaptation for rapid and specific targeting of mammalian platelet receptors, with a structure optimized for binding affinity and selectivity."}
{"description": "sp|C0JB71|B2KB1_SICCD Dermonecrotic toxin SdSicTox-betaIIB1bi (Fragment) OS=Sicarius cf. damarensis (strain GJB-2008) OX=575956 PE=2 SV=1", "sequence": "WIMGHMVNAIEQVDEFLNLGANAIELDIDFDKDGIAQITHHGIPCDCGRECTKKAIFTEYLDNIRQVTTPDNPKFREQLVLLALDLKLQRISSAKAYRAGEDVAKKLLDHYWQRGNSRARAYILLNIPLVEDCEFIRAFKDTLKNEGYESYNDKVGINFTGNEDLDKIRDVLEILGIHKQVWQADGITSCFARGTERLKEALEKRDTPGYNYINKVYAWTLVRKSIMRRSLRLGVDGVMSNNPDRVIKVLKEKEFADKFRLATYNDNPWEKFRG", "prompt": "Design a protein sequence for a dermonecrotic toxin from the six-eyed sand spider Sicarius cf. damarensis. This toxin belongs to the SdSicTox-betaIIB1bi family and functions as a potent cytolytic agent that induces severe tissue necrosis through membrane disruption. The toxin likely operates via a sphingomyelinase-like mechanism, hydrolyzing sphingomyelin in cell membranes to generate ceramide, triggering apoptotic and necrotic pathways in endothelial cells and keratinocytes. The structural scaffold should feature the conserved beta-toxin fold characteristic of spider venom phospholipases, with a TIM barrel architecture stabilized by multiple disulfide bridges. The active site should contain conserved catalytic residues for sphingomyelin hydrolysis, including histidine and aspartic acid residues coordinated to a divalent metal ion. The protein should exhibit amphipathic surface properties that facilitate membrane association and insertion. The generated sequence must maintain the characteristic cysteine framework of sicariid dermonecrotic toxins to ensure proper folding and biological activity, with the mature protein displaying optimal stability for venom delivery and tissue penetration."}
{"description": "sp|R4J7Z9|HYAL_LOXIN Hyaluronidase OS=Loxosceles intermedia OX=58218 PE=2 SV=1", "sequence": "MQTILVLTTFLSAWFLAVGFDVFWNVPSQQCKKYGMKFVPLLEQYSILVNKEDNFKGDKITIFYESQLGLYPHIGANDESFNGGIPQLGDLKAHLEKSAVDIRRDILDKSATGLRIIDWEAWRPIWEFNWSSLRKYQDKMKKVVRQFNPTAHESTVAKLAHNEWENSSKSWMLSTLQLGKQLRPNSVWCYYLFPDCYNYDGNSVQEFQCSEAIRKGNDRLKWLWEESTAVCPSIYIKEGQLTNYTLQKRIWFTNGRLQEALRVAQPKARIYPYINYSIKPGMMVPEVEFWRLIAQIASLGMDGAVIWGSSASVGSKNHCAQLMKYIADVLGPATLRIKENVARCSKQACSGRGRCTWPKDTSVIAWKFLVEKEDYDFYLGDIECKCVEGYEGRYCEQKTK", "prompt": "Design a hyaluronidase enzyme from the venom of the brown spider Loxosceles intermedia, a medically significant species responsible for necrotic arachnidism. This enzyme functions as a spreading factor that degrades hyaluronic acid in the extracellular matrix, facilitating the diffusion of other venom components and contributing to tissue damage and dermonecrosis. The protein should adopt the canonical (α/β)8 TIM barrel fold characteristic of glycosyl hydrolase family 56, with conserved catalytic residues (typically glutamate and aspartate) that mediate acid-base catalysis via a retaining mechanism. The active site should accommodate hyaluronic acid binding and cleavage through hydrolysis of β-1,4 linkages between N-acetylglucosamine and glucuronic acid residues. The structure should exhibit optimal stability at physiological pH and temperature, reflecting its role in enhancing venom potency and pathogenesis in mammalian tissues."}
{"description": "sp|P0DOZ4|CKQ_CONQU Conantokin-Qu OS=Conus quercinus OX=101313 PE=1 SV=1", "sequence": "GYEEREVAETVRELDAA", "prompt": "Design a protein sequence for conantokin-Qu, a neuroactive peptide toxin from the marine cone snail Conus quercinus. This toxin belongs to the conantokin family, which are unique among conotoxins for their lack of disulfide bridges and high content of gamma-carboxyglutamic acid (Gla) residues. Conantokin-Qu functions as a potent and selective antagonist of N-methyl-D-aspartate (NMDA) receptors in the mammalian central nervous system. The protein should adopt an alpha-helical secondary structure stabilized by multiple Gla residues that coordinate calcium ions, forming a rigid helical conformation essential for receptor binding. The sequence should contain approximately 17-21 amino acids with 4-5 Gla residues at conserved positions, particularly at the N-terminal region. The mechanism involves competitive inhibition at the glutamate binding site of NMDA receptors, specifically targeting NR2B-containing receptor subtypes with high specificity. The helical structure presents critical acidic residues that interact with the receptor's ligand-binding domain, disrupting excitatory neurotransmission and causing neurological effects. The absence of cysteine residues distinguishes this from typical conotoxins and contributes to its unique structural stability through metal ion coordination rather than disulfide bonding."}
{"description": "sp|A6MFL1|VKT1_DEMVE Kunitz-type serine protease inhibitor vestiginin-1 OS=Demansia vestigiata OX=412038 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSKDRPEFCELPPDRGTCMGFLQAFYYNPSQNKCLPFMFGGCKANPNNFKTLEECKRTCAA", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by the venom composition of the black whip snake, Demansia vestigiata. This toxin, known as vestiginin-1, should function as a potent and selective serine protease inhibitor, contributing to the snake's venom arsenal by disrupting prey homeostasis through interference with key proteolytic cascades such as coagulation, fibrinolysis, or complement activation. The protein must adopt the canonical Kunitz domain fold, characterized by a compact, stable structure comprising an alpha-helix packed against an antiparallel beta-sheet. It should feature the conserved disulfide bond pattern typical of Kunitz-type inhibitors, with three disulfide bridges forming a Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity that stabilizes the core scaffold. The reactive site loop, which confers specificity towards target serine proteases, should be optimized for high-affinity binding, potentially mimicking the inhibitory mechanism of bovine pancreatic trypsin inhibitor (BPTI) but with unique sequence determinants that reflect its reptilian origin. The molecular target is likely a serine protease involved in hemostasis, such as thrombin, factor Xa, or plasmin, with the binding interface involving complementary surface interactions between the inhibitor's loop residues and the protease's active site cleft. The overall structure should exhibit high thermal and proteolytic stability, enabling effective function in the complex environment of envenomation."}
{"description": "sp|P0CV88|SLBH_CROAT Snaclec convulxin subunit beta homolog (Fragment) OS=Crotalus atrox OX=8730 PE=1 SV=1", "sequence": "GFCCPSGWSSYDR", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a convulxin subunit beta homolog from the Western diamondback rattlesnake (Crotalus atrox). This protein should adopt the characteristic C-type lectin-like fold consisting of a globular domain with a conserved β-sandwich structure stabilized by two intrachain disulfide bonds, typically with a C1-C4 and C2-C3 connectivity pattern. The sequence should contain key structural motifs including the calcium-binding site with conserved acidic residues and the carbohydrate recognition domain (CRD) fold. As a component of the convulxin complex, this protein should specifically bind to platelet glycoprotein VI (GPVI) receptors with high affinity, triggering potent platelet activation and aggregation through collagen-like signaling pathways. The protein should exhibit the typical heterodimeric assembly characteristics of snake venom C-type lectins, forming stable complexes with its alpha subunit partner through non-covalent interactions. Include conserved residues critical for maintaining the structural integrity of the CRD fold and those involved in the specific recognition of GPVI receptors on platelet surfaces."}
{"description": "sp|R4GUQ3|KA281_ISOMC Potassium channel toxin alpha-KTx 28.1 OS=Isometrus maculatus OX=497827 PE=1 SV=1", "sequence": "MNFWVTFIRLIVVLSIVFAFQIAVAKAACVTHEDCTLLCYDTIGTCVDGKCKCM", "prompt": "Design a novel potassium channel toxin protein derived from the venom of Isometrus maculatus, the lesser brown scorpion. This toxin belongs to the alpha-KTx family, specifically designated as alpha-KTx 28.1, and functions as a potent modulator of voltage-gated potassium channels. The biological significance of this toxin lies in its role in the scorpion's predatory and defensive arsenal, where it disrupts neuronal excitability and muscle contraction by selectively blocking potassium efflux, leading to prolonged depolarization and potential paralysis in prey or threats. The core mechanism of action involves high-affinity binding to the pore region of Kv1-type potassium channels, effectively inhibiting channel opening and altering action potential repolarization. The protein should adopt the conserved structural scaffold characteristic of scorpion toxins, featuring an inhibitor cysteine knot (ICK) motif stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The anticipated 3D structure includes a compact, globular fold with a triple-stranded beta-sheet and a single alpha-helix, creating a molecular surface rich in basic and hydrophobic residues critical for target engagement. Key functional domains include a conserved functional dyad comprising a lysine residue for pore block and an aromatic residue for channel interaction, along with a solvent-exposed loop region that dictates channel subtype specificity. The molecular target is likely Kv1.1, Kv1.2, or Kv1.3 channels, with binding mediated through electrostatic and van der Waals interactions at the channel vestibule. Ensure the sequence reflects high stability, specificity for potassium channels, and minimal off-target effects, leveraging the evolutionary optimization of scorpion venom peptides for ion channel modulation."}
{"description": "sp|P59869|KAX54_HOTTA Potassium channel toxin alpha-KTx 5.4 OS=Hottentotta tamulus OX=34647 PE=1 SV=1", "sequence": "AFCNLRRCELSCRSLGLLGKCIGEECKCVPY", "prompt": "Design a potassium channel toxin protein from the venom of the Indian red scorpion Hottentotta tamulus. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring a short alpha-helix packed against an antiparallel beta-sheet. The cysteine framework should follow the typical alpha-KTx pattern with three disulfide bridges (C1-C4, C2-C5, C3-C6) that stabilize the compact globular structure. The molecular mechanism involves specific binding to the pore region of Kv1.x family potassium channels, particularly Kv1.3, through a functional dyad consisting of a critical lysine residue that penetrates the channel pore and an aromatic residue that stabilizes the interaction. The toxin should exhibit high affinity and selectivity for its target channels, disrupting neuronal and muscular electrical signaling to induce neurotoxic effects. Include key structural elements such as the conserved beta-hairpin motif that forms the channel-blocking interface and the characteristic molecular surface topography that enables specific receptor recognition."}
{"description": "sp|Q9PT51|VSPB_GLOBL Beta-fibrinogenase brevinase OS=Gloydius blomhoffii OX=242054 PE=1 SV=1", "sequence": "VIGGDECNINEHRFLALLYSERFQCGGTLINEEWVLTAAHCDMGNMYIYLGVHNVSVQYDDEQRRYPKKKYFCLSSRNYNQWDNDIMLIRLNRPVRNSAHIAPLSLPSGPPSVGSVCRVMGWGTITSPNETYPDVPHCANINILDYEVCRAAYAGLPATSRTLCAGILEGGKDSCRGDSGGPLICNGEIQGIVSWGGNICAQPREPGLYTKVFDYIDWIQSIIAGNTTVNCPP", "prompt": "Design a novel snake venom metalloproteinase (SVMP) with potent beta-fibrinogenase activity, inspired by brevinase from the Japanese mamushi (Gloydius blomhoffii). This enzyme should function as a key hemorrhagic toxin in viperid venom, specifically targeting and cleaving the beta-chain of fibrinogen to prevent blood clot formation and promote systemic bleeding. The protein must feature the characteristic multi-domain architecture of P-III SVMPs, comprising a zinc-dependent catalytic domain with the conserved HEXXHXXGXXH metalloproteinase motif, a disintegrin-like domain for potential cell surface interactions, and a cysteine-rich domain that may mediate binding to vascular targets. Incorporate the appropriate cysteine framework to form disulfide bonds that stabilize the protein's tertiary structure, particularly within the cysteine-rich domain. The catalytic domain should adopt a classic metzincin fold with a central five-stranded beta-sheet and surrounding alpha-helices, housing the zinc ion in the active site cleft. Optimize the substrate-binding pockets to recognize and hydrolyze the beta-chain of fibrinogen with high specificity, while ensuring the protein exhibits the stability and solubility required for venom function. The overall structure should facilitate efficient diffusion through tissues to reach circulatory targets, contributing to the venom's hemorrhagic pathology."}
{"description": "sp|P59936|KA121_TITSE Potassium channel toxin alpha-KTx 12.1 OS=Tityus serrulatus OX=6887 PE=1 SV=3", "sequence": "MQVFYGLLLMFILCSTIHLSEQWCSTCLDLACGASRECYDPCFKAFGRAHGKCMNNKCRCYT", "prompt": "Design a potassium channel toxin protein derived from the venom of the Brazilian yellow scorpion Tityus serrulatus. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three disulfide bridges with the cysteine framework C1-X(3-9)-C2-X(3-14)-C3-X(0-4)-C4-X(4-11)-C5-X(1-4)-C6. The functional core includes a beta-sheet region that forms the molecular interface for channel blockade, with key residues in the functional dyad (typically a lysine and an aromatic residue) positioned to interact with the channel's pore region. The toxin should exhibit high affinity and selectivity for potassium channels, contributing to the neurotoxic effects of scorpion venom by disrupting neuronal excitability and neurotransmitter release. The structural scaffold should maintain the compact, globular fold with exposed functional loops that enable specific channel recognition and blockade."}
{"description": "sp|P59863|SIX2_BUTOC Beta-toxin BotIT2 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "DGYIKGYKGCKITCVINDDYCDTECKAEGGTYGYCWKWGLACWCEDLPDEKRWKSETNTC", "prompt": "Design a beta-toxin protein sequence from the scorpion Buthus occitanus tunetanus that functions as a potent voltage-gated sodium channel modulator. This toxin should exhibit the characteristic beta-toxin mechanism of action, binding to neurotoxin receptor site 4 on the voltage sensor of domain II of sodium channels, thereby shifting the voltage dependence of activation toward more negative potentials and enhancing channel excitability. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold typical of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural core should consist of an alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a molecular surface with key functional residues for specific sodium channel interaction. The toxin should demonstrate high selectivity for insect sodium channels over mammalian variants, reflecting its role in the scorpion's predatory venom arsenal for immobilizing prey through neuronal hyperexcitability and spontaneous repetitive firing. Include conserved beta-toxin signature motifs that facilitate the allosteric modulation of sodium channel gating kinetics while maintaining the thermostable, protease-resistant properties essential for venom efficacy."}
{"description": "sp|P01504|MEL_APIFL Melittin OS=Apis florea OX=7463 GN=MELT PE=1 SV=1", "sequence": "GIGAILKVLATGLPTLISWIKNKRKQ", "prompt": "Generate the amino acid sequence for melittin, a major cytolytic peptide toxin from the venom of the dwarf honey bee Apis florea. This 26-residue amphipathic peptide functions as a potent membrane-disrupting agent that targets lipid bilayers through a detergent-like mechanism. The peptide adopts an alpha-helical conformation in membrane environments, with a pronounced amphipathic character where hydrophobic residues cluster on one face and cationic residues (primarily lysines) on the opposite face. This structural arrangement enables melittin to bind to and disrupt biological membranes, leading to cell lysis through pore formation or general membrane disintegration. The mechanism involves initial electrostatic interactions with negatively charged phospholipid head groups, followed by insertion of the hydrophobic face into the lipid bilayer core. Melittin exhibits broad-spectrum cytolytic activity against various cell types and demonstrates hemolytic properties. The sequence should reflect the characteristic N-terminal region rich in hydrophobic residues and a C-terminal segment containing multiple basic residues that facilitate membrane interaction and disruption."}
{"description": "sp|P83608|TDM1A_MISBR Delta-actinopoditoxin-Mb1a OS=Missulena bradleyi OX=230234 PE=1 SV=1", "sequence": "CAKKREWCAKTEDCCCPMKCIYAWYNEQSSCQTTFSGMFKKC", "prompt": "Design a novel animal toxin protein sequence based on the following detailed specifications. The protein is a delta-actinopoditoxin from the venom of Missulena bradleyi, commonly known as the Eastern mouse spider. This toxin belongs to the actinopoditoxin family, which are key components in the predatory arsenal of Australian funnel-web and mouse spiders, functioning to rapidly immobilize prey through potent neurotoxic activity. The core mechanism of action involves selective antagonism of voltage-gated sodium channels, specifically targeting insect sodium channel subtypes to cause paralysis. The protein should adopt the characteristic inhibitor cystine knot (ICK) structural motif, a highly stable scaffold common to spider neurotoxins, featuring a compact triple-stranded beta-sheet stabilized by a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6. This fold creates a molecular surface with exposed loops that mediate high-affinity binding to the voltage-sensing domain of sodium channels, delaying channel inactivation and leading to sustained neuronal excitation. The sequence must include the essential cysteine residues in the appropriate framework to form this disulfide connectivity, along with conserved hydrophobic core residues that maintain the ICK fold stability. The molecular target interface should include key residues for interacting with domain II or IV of insect sodium channels, ensuring species selectivity while maintaining the potent neurotoxic profile characteristic of actinopoditoxins."}
{"description": "sp|C0HMB8|SCX1_CENVL Beta-mammal toxin Cv1 OS=Centruroides villegasi OX=3161195 PE=1 SV=1", "sequence": "KEGYIVNLSTGCKYECYKLGDNDYCLKECKLQYGKGAGGYCYAFGCWCTHLYEQAVVWPLPKKTCN", "prompt": "Design a beta-mammal toxin protein sequence derived from the venom of the scorpion Centruroides villegasi. This toxin should function as a potent modulator of voltage-gated sodium channels in mammalian systems, specifically acting as a beta-toxin that modifies channel gating kinetics. The protein should adopt the conserved cysteine-stabilized alpha-beta scaffold characteristic of scorpion beta-toxins, featuring the canonical disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that stabilizes the core structural fold. The sequence should include key functional motifs for binding to domain II of voltage-gated sodium channels, particularly the receptor site 4, where it enhances channel activation by shifting the voltage dependence toward more negative potentials. The structural architecture should comprise an alpha-helix packed against an antiparallel beta-sheet, with exposed loops critical for target recognition and specificity. The toxin should exhibit the typical molecular weight and physicochemical properties of scorpion beta-toxins, ensuring proper folding and biological activity in envenomation contexts where it contributes to prey immobilization through disruption of neuronal excitability."}
{"description": "sp|Q9PVF2|PA2AE_CALRH Acidic phospholipase A2 H1E6 OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "MRTLWILAVLQVGVEGHLLQFETMIIKMTKQTGLFSYSFYGCYCGWGGHGRPQDPTDRCCFVHDCCYGKVTNCDPKAAAYSYTIENGGIVCGGDDPCKKQICECDRAAAMCFRDNLDTYNYAKYWKFSAKDCQEESDPC", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of Calloselasma rhodostoma (Malayan pit viper). This enzyme plays a critical role in the venom's pre-digestive and cytotoxic effects by catalyzing the hydrolysis of membrane phospholipids at the sn-2 position, releasing lysophospholipids and free fatty acids. The resulting membrane disruption contributes to hemolysis, myotoxicity, and inflammation. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of 6-7 disulfide bridges that confer structural rigidity and resistance to proteolysis. Key catalytic residues include a conserved histidine-aspartate dyad and a calcium-binding loop essential for enzymatic activity. As an acidic isoform, the protein likely exhibits enhanced membrane binding through electrostatic interactions with anionic phospholipid headgroups. The sequence should reflect the typical PLA2 domain architecture with conserved motifs for substrate recognition and interfacial activation."}
{"description": "sp|Q6TPH0|SLOA_PROMU Snaclec mucrocetin subunit alpha OS=Protobothrops mucrosquamatus OX=103944 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGTGADFDCIPGWSAYDRYCYQAFSEPKNWEDAESFCEEGVKTSHLVSIESSGEGDFVAQLVAEKIKTSFQYVWIGLRIQNKEQQCRSEWSDASSVNYENLYKQSSKKCYALKKGTELRTWFNVYCGRENPFVCKYTPEC", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) from the venom of Protobothrops mucrosquamatus, the Taiwanese habu pit viper. This protein, known as mucrocetin subunit alpha, functions as a platelet aggregation modulator within the venom's arsenal for prey immobilization and digestion. As a member of the snaclec family, it should adopt the characteristic C-type lectin-like fold, consisting of a globular domain stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The protein should exhibit a β-sandwich structure composed of antiparallel β-sheets and possess key functional loops responsible for target recognition. Its primary molecular target is platelet membrane receptors, likely glycoprotein Ib (GPIb) or other platelet surface glycoproteins, where it binds with high affinity to either inhibit or promote platelet aggregation depending on the specific isoform. The sequence should include conserved residues for calcium-independent carbohydrate recognition domain (CRD) functionality and maintain the structural integrity required for its role in disrupting hemostasis through interference with normal platelet function."}
{"description": "sp|P08815|KAX21_CENNO Potassium channel toxin alpha-KTx 2.1 OS=Centruroides noxius OX=6878 PE=1 SV=3", "sequence": "TIINVKCTSPKQCSKPCKELYGSSAGAKCMNGKCKCYNN", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Mexican bark scorpion Centruroides noxius. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should feature a compact globular fold with an alpha-helix and anti-parallel beta-sheet arrangement, presenting a functional surface with key residues for interacting with the channel's pore region. The molecular mechanism should involve binding to the external vestibule of potassium channels, physically occluding the ion conduction pathway and preventing potassium efflux, leading to prolonged membrane depolarization and enhanced neurotransmitter release. The structural core must maintain the characteristic ICK stability while displaying variable surface loops that confer target specificity and binding affinity."}
{"description": "sp|P60179|O166_CONAA Delta-conotoxin Am2766 OS=Conus amadis OX=198732 PE=1 SV=1", "sequence": "CKQAGESCDIFSQNCCVGTCAFICIE", "prompt": "Generate the amino acid sequence for a delta-conotoxin from the marine cone snail Conus amadis. This toxin belongs to the conotoxin superfamily and functions as a voltage-gated sodium channel (VGSC) modulator. Specifically, it acts as a sodium channel inhibitor that delays channel inactivation, leading to prolonged neuronal depolarization and enhanced neurotransmitter release. The toxin should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized globular fold with triple-stranded beta-sheets. It will feature the conserved O-superfamily cysteine framework (C-C-CC-C-C), forming three disulfide bridges that confer exceptional stability and define the functional epitopes. The sequence must include key residues for interaction with site 4 of voltage-gated sodium channels, particularly those involved in binding to the domain IV S3-S4 extracellular loop, which is critical for its mechanism of action. This conotoxin contributes to the predatory venom arsenal of Conus amadis by inducing excitatory symptoms in prey through sustained sodium currents, facilitating rapid immobilization."}
{"description": "sp|P0DOZ5|CKC_CONCB Conantokin-Ca2 OS=Conus caracteristicus OX=89440 PE=1 SV=1", "sequence": "GYEEREIAETVRELEEA", "prompt": "Design a protein sequence for conantokin-Ca2, a conantokin peptide neurotoxin from the venom of the marine cone snail Conus caracteristicus. This toxin functions as a selective and potent antagonist of NMDA-type glutamate receptors, specifically targeting the NR2B subunit. The protein should adopt the characteristic conantokin structural fold, which is defined by a high degree of gamma-carboxyglutamic acid (Gla) residues that chelate calcium ions and stabilize an alpha-helical conformation. Unlike typical disulfide-rich conotoxins, conantokins lack cysteine residues and disulfide bridges, instead relying on post-translational gamma-carboxylation of glutamate residues for structural integrity and function. The sequence should include multiple Gla residues positioned to facilitate calcium binding and helical stabilization. The mechanism involves binding to the glutamate recognition site on NMDA receptors, thereby inhibiting receptor activation and providing potent neuroprotective effects through blockade of excitotoxic signaling. The structural scaffold should feature a well-defined alpha-helix stabilized by Gla-Ca2+ interactions, with specific residues mediating high-affinity binding to the NR2B subunit of NMDA receptors."}
{"description": "sp|P01398|3LKB_BUNMU Kappa-bungarotoxin OS=Bungarus multicinctus OX=8616 PE=1 SV=2", "sequence": "MKTLLLTLVVVTIVCLDLGYTRTCLISPSSTPQTCPNGQDICFLKAQCDKFCSIRGPVIEQGCVATCPQFRSNYRSLLCCTTDNCNH", "prompt": "Design a protein sequence for a neurotoxic peptide from the venom of the many-banded krait, Bungarus multicinctus. This toxin belongs to the kappa-bungarotoxin family, which are three-finger toxins (3FTx) that function as potent and selective antagonists of neuronal-type nicotinic acetylcholine receptors (nAChRs). The protein should adopt the characteristic three-finger β-sheet fold stabilized by a conserved disulfide bond framework typical of long-chain α-neurotoxins, with four disulfide bridges (Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, Cys7-Cys8) that confer structural rigidity and target specificity. The molecular mechanism involves high-affinity binding to the α3β2 and/or α4β2 subunit interfaces of neuronal nAChRs in the central nervous system, blocking acetylcholine-mediated synaptic transmission and causing paralysis. The sequence should include functional loops that mediate receptor interaction, with key residues in the central loop II contributing to subtype selectivity and binding affinity. This toxin plays a critical role in the krait's predatory strategy by disrupting neuromuscular signaling and immobilizing prey."}
{"description": "sp|P20474|PA2B3_BOTAS Basic phospholipase A2 myotoxin I OS=Bothrops asper OX=8722 PE=1 SV=2", "sequence": "MRTLWIMAVLLVGVEGSLIEFAKMILEETKRLPFPYYTTYGCYCGWGGQGQPKDATDRCCFVHDCCYGKLSNCKPKTDRYSYSRKSGVIICGEGTPCEKQICECDKAAAVCFRENLRTYKKRYMAYPDLLCKKPAEKC", "prompt": "Generate a protein sequence for a basic phospholipase A2 myotoxin from the venom of Bothrops asper, a highly venomous pit viper. This toxin should function as a potent myotoxin that induces rapid skeletal muscle necrosis through phospholipase A2 activity. The protein should exhibit the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should contain the conserved disulfide bridge pattern typical of group II phospholipase A2 enzymes, with multiple disulfide bonds stabilizing the compact globular structure. The sequence should include key functional residues for membrane phospholipid hydrolysis and myotoxic activity, with basic residues that facilitate interaction with negatively charged muscle cell membranes. The toxin should demonstrate preferential binding to skeletal muscle tissue, causing calcium influx, mitochondrial damage, and eventual muscle fiber degeneration. The structural scaffold should maintain the characteristic three-finger-like topology with distinct substrate-binding and membrane-interaction regions."}
{"description": "sp|P0C612|I1B5_CONLY Iota-conotoxin-like L11.5 OS=Conus lynceus OX=289038 PE=2 SV=1", "sequence": "NWSWCSGSGEGCDYHSECCGERCCIESMCIGDGVACWP", "prompt": "Design a novel animal toxin protein sequence inspired by the iota-conotoxin family from the venomous marine snail Conus lynceus. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting neuronal subtypes to disrupt action potential generation and propagation in prey organisms. The protein should adopt the characteristic iota-conotoxin structural scaffold featuring a compact, disulfide-stabilized fold with the conserved cysteine framework C-C-CC-C-C that forms three intramolecular disulfide bridges, creating a stable, protease-resistant molecular architecture. The sequence should include key functional motifs for sodium channel interaction, particularly residues involved in binding to domain II voltage-sensor regions, while maintaining the overall globular conformation typical of conotoxins. The toxin should exhibit high specificity for sodium channel subtypes expressed in the nervous system, contributing to the paralytic and neurotoxic effects characteristic of Conus lynceus venom in its natural predatory behavior."}
{"description": "sp|P0C8X4|VMP_TITST Venom metalloproteinase (Fragment) OS=Tityus stigmurus OX=50344 PE=1 SV=1", "sequence": "SPXIIIDYLCVTETX", "prompt": "Design a venom metalloproteinase protein sequence that embodies the toxic arsenal of the Brazilian yellow scorpion Tityus stigmurus. This enzyme should function as a zinc-dependent metalloprotease capable of degrading extracellular matrix components and disrupting hemostatic pathways in envenomed prey. The protein must feature the canonical zinc-binding motif HEXXHXXGXXH within its catalytic domain, coordinating a catalytic zinc ion essential for proteolytic activity. Incorporate a disintegrin-like domain with the characteristic Cys-rich pattern to mediate specific interactions with integrin receptors on target cells. The structural scaffold should adopt the metzincin fold, characterized by a conserved methionine turn that positions the active site for substrate recognition. Include the cysteine framework typical of scorpion venom metalloproteinases to ensure proper disulfide bonding that stabilizes the multi-domain architecture. The generated sequence must exhibit substrate specificity for fibrinogen, collagen, and other key components of the coagulation cascade, enabling the hemorrhagic and tissue-damaging effects characteristic of scorpion envenomation. The overall structure should facilitate calcium-dependent conformational stability while maintaining the propeptide region necessary for zymogen activation in the venom gland."}
{"description": "sp|P86092|VM3LB_BOTLC Zinc metalloproteinase leucurolysin-B (Fragment) OS=Bothrops leucurus OX=157295 PE=1 SV=1", "sequence": "DTVLLNRISHDNAQLLAIVFNENVIGKAYTGGMCDPRYSVGVVMDHSPINRLVADTMAHEMGHNLGIHHDTGSCSCGGHSCIMSRVISHQPLQYFSNCSYIEYWDFITKLNPQCILNEPLRTDIVSPPVCGNELLEMGEECDCGSPRNCRDLCCDAATCKLHSWVECESGECCDQCRFIKAGNVCRPPRKECDVAEACTGQSAQCPTDDFKRNGQPCLNNYAYCYQGNCPIMYHQCYALFGSDATMAQDSCFQVNKKGNEYFYCRLENGINIPCAQEDVKCGRLFCHNMKYEQDCNYSDRGMVDNGTKCAEGKVCNSNRQAYQR", "prompt": "Design a zinc metalloproteinase toxin sequence that embodies the proteolytic venom arsenal of Bothrops leucurus, the white-tailed lancehead viper. This toxin should function as a potent hemorrhagic agent by specifically targeting and degrading key components of the basement membrane and extracellular matrix, including type IV collagen, laminin, and fibronectin. The sequence must feature a canonical zinc-binding motif (HEXXHXXGXXH) within its catalytic domain, where the three histidine residues coordinate a catalytic zinc ion and the glutamate serves as the catalytic base. Incorporate a conserved methionine turn downstream of the active site. The structural scaffold should adopt the characteristic metzincin fold with a central five-stranded beta-sheet flanked by alpha-helices, stabilized by multiple disulfide bridges that confer stability in the venom gland and resistance to proteolytic degradation. The molecular mechanism involves hydrolyzing peptide bonds in vascular basement membrane proteins, leading to endothelial cell detachment, hemorrhage, and tissue damage—facilitating prey immobilization through blood loss and shock. Ensure the sequence reflects the typical multidomain architecture of snake venom metalloproteinases, potentially including propeptide, catalytic, and disintegrin-like domains that work in concert to disrupt hemostasis and promote local tissue destruction."}
{"description": "sp|P83621|TXC1C_CUPSA Cupiennin-1c OS=Cupiennius salei OX=6928 PE=1 SV=1", "sequence": "GFGSLFKFLAKKVAKTVAKQAAKQGAKYIANKQTE", "prompt": "Design a novel antimicrobial peptide sequence inspired by the biological context and structural characteristics of cupiennin-1c from the venom of the wandering spider Cupiennius salei. This peptide should function as a cytolytic toxin with broad-spectrum antimicrobial activity, primarily targeting bacterial membranes through a carpet-like mechanism that disrupts lipid bilayers. The peptide should adopt an amphipathic alpha-helical conformation when interacting with membranes, characterized by a clear segregation of hydrophobic and hydrophilic residues along the helical axis. Key structural features should include: a predominantly cationic character with multiple lysine and arginine residues for initial membrane association, a substantial hydrophobic face for membrane insertion, and a length optimized for spanning lipid bilayers. The sequence should lack cysteine residues and disulfide bridges, maintaining the linear, unstructured conformation in aqueous solution that transitions to helical structure upon membrane binding. The antimicrobial mechanism should involve electrostatic attraction to anionic bacterial membranes followed by hydrophobic insertion and pore formation or membrane disintegration. The peptide should exhibit selectivity for prokaryotic membranes over eukaryotic cells, potentially through charge distribution patterns that favor interaction with bacterial phosphatidylglycerol over mammalian membrane components."}
{"description": "sp|P0DMH0|PA2A_BOTFO Basic phospholipase A2 Bfon11 (Fragment) OS=Bothrops fonsecai OX=157549 PE=1 SV=1", "sequence": "NLWQFGMMIQHTTRENPLFKYFSYGCYCGWGGGGPLDATDRCCFVHDCCYG", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin derived from Bothrops fonsecai venom. This enzyme should function as a potent catalytic toxin that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, two antiparallel beta-sheets, and a conserved calcium-binding loop. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic elapid loop region. The sequence should contain the conserved pattern of 6-8 disulfide bonds that stabilize the compact globular structure, with specific connectivity including Cys11-Cys77, Cys27-Cys126, Cys29-Cys45, Cys44-Cys105, Cys51-Cys98, and Cys61-Cys91. The basic nature of this toxin should facilitate membrane interaction and enhance its myotoxic and anticoagulant activities. The protein should exhibit interfacial activation at lipid-water interfaces and demonstrate calcium-dependent catalytic activity. Include conserved residues for substrate binding and catalysis, particularly around the hydrophobic channel that accommodates the phospholipid substrate. The overall structure should be highly stable and resistant to proteolytic degradation, characteristic of snake venom phospholipases that function in prey immobilization through membrane disruption and induction of inflammatory responses."}
{"description": "sp|P0DQJ6|NTA_AVIPU Mu/kappa-theraphotoxin-Ap1a OS=Avicularia purpurea OX=2652666 PE=1 SV=1", "sequence": "GDCHKFWGWCRDEPDPCCEHLTCSTKHGWCVWDGSF", "prompt": "Generate the amino acid sequence for a theraphotoxin from the purple pinktoe tarantula (Avicularia purpurea) that functions as a dual mu/kappa-opioid receptor modulator. This toxin should exhibit the characteristic structural features of theraphotoxins, including an inhibitor cystine knot (ICK) motif stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence should contain the appropriate cysteine framework to form this knotted scaffold, which confers exceptional stability and resistance to proteolytic degradation. The toxin should specifically target both mu-opioid and kappa-opioid receptors in the central nervous system, modulating pain perception pathways through its interaction with these G-protein coupled receptors. The structural core should facilitate high-affinity binding to extracellular domains of these opioid receptors, potentially competing with endogenous opioid peptides. The mature toxin should be a compact, globular polypeptide optimized for crossing biological barriers and exerting potent neuromodulatory effects characteristic of spider venom peptides that target neurotransmitter systems."}
{"description": "sp|Q9TWL9|COMA_CONMA Conodipine-M alpha chain OS=Conus magus OX=6492 PE=1 SV=2", "sequence": "QXPSTAELCKINSNACSVPFSXIPCQKXFLAACDRHDTCYHCGKHFGFKQDDCDDAFFRDMTALCAHGTDDEGXCPX", "prompt": "Design a protein sequence for an animal toxin that functions as a conodipine-M alpha chain from the marine cone snail Conus magus. This toxin belongs to the conodipine family, which are phospholipase A2 (PLA2) enzymes specialized for venom activity. The protein should exhibit calcium-dependent catalytic activity, hydrolyzing phospholipids at the sn-2 position to release lysophospholipids and free fatty acids, contributing to prey immobilization through membrane disruption and potential inflammatory responses. Infer key structural features include a conserved PLA2 fold with a catalytic dyad (typically histidine and aspartate residues), a calcium-binding loop, and multiple disulfide bridges that stabilize the compact, globular structure. The molecular target is phospholipid membranes in neuronal or muscular tissues of prey, with the enzyme interacting at membrane interfaces to exert its toxic effects. Ensure the sequence reflects the venom's role in rapid prey subduction by Cone snails, emphasizing stability, enzymatic efficiency, and specificity for venomous contexts."}
{"description": "sp|P85038|BPP2_GLOHA Bradykinin-potentiating peptide 2 OS=Gloydius halys OX=8714 PE=1 SV=1", "sequence": "QGRPPRPHIPP", "prompt": "Design a bradykinin-potentiating peptide (BPP) from the venom of the Siberian pit viper (Gloydius halys) that functions as a potent inhibitor of angiotensin-converting enzyme (ACE). This peptide should exhibit the characteristic structural features of BPPs, including a pyroglutamic acid residue at the N-terminus that confers resistance to aminopeptidase degradation, and a proline-rich C-terminal sequence that facilitates ACE binding. The peptide must adopt a compact, stable conformation stabilized by a single disulfide bond between two conserved cysteine residues, forming a C-C framework that constrains the active conformation. The core mechanism involves competitive inhibition of ACE's zinc-dependent catalytic domain, thereby preventing the conversion of angiotensin I to angiotensin II and reducing bradykinin degradation, leading to vasodilation and hypotension. The peptide should be 5-15 amino acids in length with high specificity for the somatic isoform of ACE, exhibiting nanomolar affinity while avoiding off-target interactions with other zinc metalloproteases. The structural scaffold should enable oral bioavailability by resisting gastrointestinal proteolysis, a key pharmacological advantage of natural BPPs that inspired the development of captopril and other ACE inhibitor drugs."}
{"description": "sp|P01517|MAST_POLJO Mastoparan-J OS=Polistes jokahamae OX=256662 PE=1 SV=1", "sequence": "VDWKKIGQHILSVL", "prompt": "Design a mastoparan peptide sequence derived from the venom of the Japanese paper wasp Polistes jokahamae. This amphipathic tetradecapeptide should adopt an alpha-helical conformation in membrane-mimetic environments, characteristic of mastoparan family peptides. The sequence must exhibit potent membrane-disrupting activity through direct interaction with phospholipid bilayers, leading to membrane permeabilization and potential cell lysis. As a G-protein activator, the peptide should stimulate phospholipase C activity via direct interaction with G-protein alpha subunits, mimicking receptor-mediated signaling. The structure should feature a cationic N-terminal region and a hydrophobic C-terminal segment that facilitates membrane insertion. The peptide should demonstrate broad-spectrum cytolytic activity against various cell types while maintaining the characteristic mastoparan biological profile of inducing histamine release from mast cells and activating pertussis toxin-sensitive G-proteins."}
{"description": "sp|P60211|KA181_TITOB Potassium channel toxin alpha-KTx 18.1 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MRFTGIILILISMTLIDSFFEMKVEATGPQTTCQAAMCEAGCKGLGKSMESCQGDTCKCKA", "prompt": "Design a potassium channel toxin protein derived from the venom of the scorpion Tityus obscurus. This toxin belongs to the alpha-KTx family and functions as a potent blocker of voltage-gated potassium channels, specifically Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, stabilized by three or four disulfide bridges with a typical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural core consists of an alpha-helix packed against a three-stranded antiparallel beta-sheet. The functional mechanism involves binding to the external vestibule of potassium channels via a conserved functional dyad, typically involving a critical lysine residue that projects into the channel pore to physically occlude potassium ion conduction, thereby disrupting neuronal excitability and neuromuscular transmission. The toxin should exhibit high affinity and selectivity for Kv1 channels, contributing to the venom's paralytic effects on prey. Ensure the sequence includes the appropriate cysteine framework and key residues for structural stability and target interaction."}
{"description": "sp|A6MFL3|VKT3_DEMVE Kunitz-type serine protease inhibitor vestiginin-3 OS=Demansia vestigiata OX=412038 PE=1 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPVSSKDLPEICKLPKEPGPCRSYLLYFYYNSVEHKCQTFHYGGCEGNENRFHTIEECKSTCAE", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by the venom composition of the black whip snake (Demansia vestigiata). This protein should exhibit the characteristic structural features of vestiginin toxins, which are known to modulate hemostasis through precise inhibition of key serine proteases in the coagulation cascade. The protein must adopt the conserved Kunitz domain fold, featuring a stable alpha-beta structure with the canonical disulfide connectivity pattern (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that defines this inhibitor family. The active site should contain a well-defined protease-binding loop that enables specific, high-affinity interaction with target serine proteases such as thrombin, factor Xa, or plasma kallikrein, effectively disrupting coagulation pathways. The overall architecture should maintain the compact, globular nature typical of Kunitz domains, with the reactive site loop positioned for optimal protease engagement while ensuring structural stability through the intricate disulfide network. The resulting protein should demonstrate potent anticoagulant activity by selectively inhibiting its designated serine protease target, mimicking the biological function of natural vestiginin toxins in snake venom."}
{"description": "sp|P59864|SIX6_BUTOC Beta-insect depressant toxin BotIT6 OS=Buthus occitanus tunetanus OX=6871 PE=1 SV=1", "sequence": "DGYPKQKNGCKYDCIINNKWCNGICKMHGGYYGYCWGWGLACWCEGLPEDKKWWYETNKCGR", "prompt": "Design a novel beta-insect depressant toxin protein sequence that mimics the biological activity and structural characteristics of insect-specific neurotoxins from scorpion venom. The protein should originate from Buthus occitanus tunetanus (North African scorpion) and function as a potent insect-selective neurotoxin. Its core mechanism involves binding to voltage-gated sodium channels in insect nervous systems, specifically causing a depressant effect characterized by progressive flaccid paralysis without excitatory symptoms. The toxin should adopt the conserved beta-toxin structural scaffold featuring a cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against an antiparallel beta-sheet stabilized by four conserved disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The molecular target interface should include specific interactions with insect voltage-gated sodium channels, particularly domain II, where it modulates channel gating to produce the characteristic depressant effect. The structural core must maintain the compact, globular architecture typical of scorpion beta-toxins, with the conserved 'pharmacophore' regions responsible for insect selectivity and channel binding preserved. The protein should exhibit high specificity for insect sodium channels over mammalian counterparts, reflecting the evolutionary adaptation of scorpion venom for prey capture while minimizing toxicity to vertebrates."}
{"description": "sp|Q9PVF4|PA2HD_CALRH Basic phospholipase A2 homolog W6D49 OS=Calloselasma rhodostoma OX=8717 PE=1 SV=1", "sequence": "MRTLWILAVLLVSVDGSMFNLWKMIMVMTGKEATKNYGMYGCNCGPMKRGKPKDATDQCCADHDCCYKKLTDCDPKKESYSYKFEKGEILCGETNPCLNQACECDKAVATCFRDNLDTYNKKQQFNTGIFCSKAKAC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of the Malayan pit viper (Calloselasma rhodostoma). This protein represents a catalytically inactive phospholipase A2 homolog that retains structural integrity while lacking enzymatic activity. The venom of Calloselasma rhodostoma is medically significant, causing coagulopathy and tissue damage in envenomation cases. The protein should adopt the characteristic phospholipase A2 fold, featuring a conserved calcium-binding loop, a hydrophobic channel, and the distinctive pancreatic loop. It must contain the canonical phospholipase A2 disulfide bridge pattern with the conserved cysteine framework that stabilizes the compact globular structure. Despite being enzymatically inactive due to key active site substitutions, this homolog likely functions through alternative mechanisms such as membrane disruption, receptor binding, or interference with coagulation pathways. The sequence should reflect the basic isoelectric point characteristic of this venom component and maintain the structural elements necessary for its biological role in venom toxicity, including surface features that may mediate protein-protein interactions or membrane association."}
{"description": "sp|P08873|PA2B2_NOTSC Basic phospholipase A2 notechis 11'2 OS=Notechis scutatus scutatus OX=70142 PE=1 SV=1", "sequence": "MYPAHLLVLLTVCVSLLEASSIPARPLNLYQFGNMIQCANHGRRPTLAYADYGCYCGAGGSGTPVDELDRCCKAHDDCYGEAGKKGCYPTLTLYSWQCIEKTPTCNSKTGCERSVCDCDATAAKCFAKAPYNKKNYNIDTEKRCQ", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the tiger snake (Notechis scutatus scutatus). This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the sequence YGCXCG. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic elapid loop. The structure should be stabilized by the typical seven disulfide bond pattern common to group I phospholipase A2 enzymes. The protein should demonstrate presynaptic neurotoxic activity by targeting neuromuscular junctions and causing irreversible blockade of neurotransmitter release, while also exhibiting myotoxic effects through direct membrane disruption of muscle cells. The basic nature of the protein should facilitate interaction with anionic membrane surfaces and potential receptor binding sites."}
{"description": "sp|U5T7E4|TILVI_BOMIG Venom serine protease inhibitor BiVSPI OS=Bombus ignitus OX=130704 PE=1 SV=1", "sequence": "MSRILFVFLAVMAIFSTSFGQQCGLNEEFKSCGSCEPTCAKPRVTICTMECKIGCQCKSGYLRNGEGTCVLPEKC", "prompt": "Design a venom serine protease inhibitor protein from the bumblebee Bombus ignitus that functions as a key regulatory component in the insect's venom arsenal. This toxin should adopt a canonical Kunitz-type serine protease inhibitor fold characterized by a compact, stable beta-trefoil structure with a well-defined reactive site loop. The protein must contain the conserved disulfide bridge pattern typical of Kunitz domain inhibitors, likely involving three disulfide bonds that stabilize the core scaffold and maintain the proper orientation of the inhibitory loop. The mechanism of action involves tight, specific binding to target serine proteases through a substrate-like interaction at the enzyme's active site, forming a stable enzyme-inhibitor complex that blocks proteolytic activity. This inhibition likely modulates host immune responses by interfering with coagulation cascades, complement activation, or inflammatory pathways in envenomed organisms. The protein should exhibit the characteristic thermodynamic stability and protease resistance conferred by the Kunitz fold, enabling it to function effectively in the hostile environment of envenomation. The sequence should encode all structural elements necessary for proper folding, including the canonical binding loop conformation, beta-sheet secondary structure, and the conserved cysteine framework that defines this inhibitor family."}
{"description": "sp|Q0NZX7|VM3B4_BOTJA Zinc metalloproteinase-disintegrin-like bothrojarin-4 (Fragment) OS=Bothrops jararaca OX=8724 PE=2 SV=1", "sequence": "IVSPPVCGNYFVEVGEECDCGLPRNCQNQCCNATTCKLIPGAQCEDGECCERCQFKGAGNVCRPRRSKCDIAESCTGQSPDCPTDRFRRNGVSCLNN", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin derived from Bothrops jararaca, a medically significant pit viper in South America. This toxin belongs to the SVMP class and functions as a key hemorrhagic agent in envenomation by degrading components of the extracellular matrix and basement membranes, particularly type IV collagen, laminin, and fibronectin, leading to disruption of vascular integrity and hemorrhage. The protein should feature a metalloproteinase domain with a conserved zinc-binding motif (HEXXHXXGXXH) that coordinates a catalytic zinc ion essential for proteolytic activity, followed by a disintegrin-like domain that may inhibit platelet aggregation by interfering with integrin receptors such as αIIbβ3. The structural scaffold should include multiple disulfide bridges stabilizing both domains, with the metalloproteinase domain adopting a metzincin-like fold characterized by a central twisted β-sheet flanked by α-helices, and the disintegrin-like domain exhibiting a compact, disulfide-rich structure. The protein may also contain a cysteine-rich domain C-terminal to the disintegrin-like region, contributing to additional stability and potential functional interactions. The overall architecture should facilitate precise substrate recognition and cleavage within the vascular basement membrane, embodying the potent hemorrhagic activity characteristic of Bothrops jararaca venom."}
{"description": "sp|C0K3N2|TXVE_AGKPI Snake venom vascular endothelial growth factor toxin apiscin OS=Agkistrodon piscivorus piscivorus OX=8716 PE=2 SV=1", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGQAMPFMEVYTRSACQTRETLVSILEEHPHEISHLFKPSCVTVLRCGGCCSDESLTCTSTGKRSVGREIMRVDPHKETSKIEVMQFTEHTDCECRPQSASG", "prompt": "Design a snake venom protein sequence that functions as a vascular endothelial growth factor (VEGF) toxin, specifically derived from the Eastern cottonmouth (Agkistrodon piscivorus piscivorus). This toxin should mimic the structural and functional characteristics of snake venom VEGF toxins, which are homologs of mammalian VEGF but have evolved to disrupt normal vascular function. The protein should adopt the characteristic VEGF fold, consisting of a cysteine-knot motif with eight conserved cysteine residues forming four disulfide bridges that stabilize the homodimeric structure. The core function should involve binding to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, acting as a receptor agonist or antagonist to induce vascular permeability, promote inflammation, and contribute to local tissue damage and prey immobilization. The sequence should include key residues for receptor interaction, particularly in the receptor-binding domains, while maintaining the dimerization interface essential for functional activity. The structural scaffold should ensure proper folding into the VEGF-like tertiary structure, with the cysteine-knot providing exceptional stability against proteolytic degradation in the venom milieu."}
{"description": "sp|P0DQN8|DEL1A_HOTJU Delta-buthitoxin-Hj1a OS=Hottentotta judaicus OX=6863 PE=1 SV=1", "sequence": "EEVRDAYIAQPHNCVYHCFRDSYCNDLCIKHGAESGECKWFTSSGNACWCVKLPKSEPIKVPGKCH", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications. The protein should be a delta-buthitoxin derived from the venom of the scorpion Hottentotta judaicus. This toxin belongs to the scorpion toxin superfamily and specifically targets voltage-gated sodium channels (Nav channels). Its primary mechanism of action involves binding to site 4 on the extracellular domains of Nav channels, leading to delayed inactivation and prolonged channel opening, which results in sustained neuronal excitation and neurotoxic effects. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against an antiparallel beta-sheet. The cysteine framework is expected to follow the typical scorpion toxin pattern with four disulfide bridges (C-C-C-C-C-C-C-C connectivity) that stabilize the core structure. Key functional residues should include those involved in receptor binding, such as hydrophobic and charged residues in the beta-sheet regions that interact with the channel's voltage-sensing domains. The protein should be approximately 60-70 amino acids in length, with a compact, globular shape and high stability due to the disulfide network. Ensure the sequence reflects the evolutionary adaptations of scorpion venoms for rapid prey immobilization through modulation of ion channel function."}
{"description": "sp|P60210|KAX44_TITOB Potassium channel toxin alpha-KTx 4.4 OS=Tityus obscurus OX=1221240 PE=1 SV=1", "sequence": "VFINVKCRGSKECLPACKAAVGKAAGKCMNGKCKCYP", "prompt": "Design a potent animal toxin peptide that functions as a selective potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) in the Shaker-related family. This toxin originates from the venom of Tityus obscurus, a scorpion species whose venom components have evolved to rapidly immobilize prey through disruption of neuronal and muscular excitability. The toxin should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The peptide should fold into a compact, globular structure with a triple-stranded beta-sheet core stabilized by the disulfide knot, presenting a functional surface that selectively binds to the pore region of Kv1.x channels. The binding interface should include a critical lysine-rich patch that inserts into the channel vestibule, physically occluding potassium ion conduction and thereby prolonging neuronal depolarization. The sequence should maintain the characteristic alpha-KTx molecular signature: approximately 30-40 amino acids in length, with strictly conserved cysteine positions forming the structural core, and a functional dyad consisting of a pore-blocking lysine residue positioned adjacent to a hydrophobic anchor residue that enhances binding affinity through complementary interactions with the channel surface. The overall structure should exhibit high thermal and proteolytic stability conferred by the ICK motif, ensuring potent and persistent channel blockade characteristic of scorpion venom toxins that disrupt neuromuscular transmission."}
{"description": "sp|P0C8X9|KAXU2_HOFGE Potassium channel toxin alpha-KTx OS=Hoffmannihadrurus gertschi OX=380989 PE=1 SV=1", "sequence": "MKNIAMKTTVVLTILLLSVLTAINADTMKKRSDYCSNDFCFFSCRRDRCARGDCENGKCVCKNCHLN", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Hoffmannihadrurus gertschi. This toxin belongs to the alpha-KTx family and functions as a potent modulator of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by disulfide bridges. The cysteine framework should follow the typical alpha-KTx pattern with three or four disulfide bonds that confer structural stability and define the functional surface. The molecular mechanism involves specific binding to the pore region or voltage-sensing domain of Kv1.x potassium channels, leading to channel blockade and disruption of neuronal or muscular excitability. This toxin contributes to the scorpion's predatory and defensive strategy by causing paralysis through inhibition of potassium efflux, resulting in prolonged membrane depolarization and enhanced neurotransmitter release. The sequence should include key residues for potassium channel recognition and binding, particularly in the functional loops that interact with channel turrets and selectivity filter regions."}
{"description": "sp|Q6WP39|OXLA_TRIST L-amino-acid oxidase OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARNGLKATSNPKHVVIVGAGMSGLSAAYVLAGAGHEVTVLEASERAGGRVRTYRNDEEGWYANLGPMRLPEKHRIVREYIRKFNLQLNEFSQENDNAWHFVKNIRKTVGEVKKDPGVLKYPVKPSEEGKSAEQLYEESLRKVEKELKRTNCSYILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLMNEDAGYYVSFIESMKHDDIFAYEKRFDEIVDGMDKLPTSMYRAIEEKVHFNAQVIKIQKNAEEVTVTYHTPEKDTSFVTADYVIVCTTSRAARRIKFEPPLPLKKAHALRSVHYRSGTKIFLTCTKKFREDEGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDLKDCGDIVINDLSLIHQLPREEIQTFCYPSMIQKWSLDKYAMGGITTFTPYQFQHFSEALTSHVDRIYFAGEYTAHAHGWIDSSIKSGLTAARDVNRASENPSGIHLSNDDEL", "prompt": "Design a novel L-amino-acid oxidase (LAAO) venom protein inspired by the pit viper Trimeresurus stejnegeri. This enzyme should function as a potent toxin through its catalytic activity, oxidizing L-amino acids to produce hydrogen peroxide and reactive oxygen species that induce oxidative stress in prey. The protein should adopt the classic LAAO structural fold, featuring a conserved FAD-binding domain with Rossmann fold topology and a substrate-binding domain. Key structural elements must include: a dimeric quaternary structure stabilized by non-covalent interactions, conserved catalytic residues for FAD cofactor binding and amino acid oxidation, and proper substrate access channels. The enzyme should exhibit substrate preference for hydrophobic L-amino acids like phenylalanine and leucine. As a venom component, it should contribute to local tissue damage, hemorrhage, and apoptosis through hydrogen peroxide-mediated cytotoxicity and platelet aggregation inhibition. The structural design should ensure proper FAD incorporation, efficient catalytic turnover, and stability in the venom environment while maintaining the characteristic yellow coloration from the flavin cofactor."}
{"description": "sp|P0DOZ6|CKG_CONGL Conantokin-Gm OS=Conus gloriamaris OX=37336 PE=1 SV=1", "sequence": "GAKERNNAEAVRERLEEI", "prompt": "Design a protein sequence for a conantokin neuropeptide toxin derived from the venom of Conus gloriamaris, the Glory of the Sea cone snail. This toxin functions as a selective and potent antagonist of NMDA-type glutamate receptors in the central nervous system, specifically targeting the NR2B subunit. Unlike typical disulfide-rich conotoxins, conantokins are characterized by their lack of cysteine residues and instead rely on post-translational gamma-carboxylation of glutamate residues to form gamma-carboxyglutamate (Gla) residues, which are essential for calcium-dependent structural stabilization and receptor binding. The sequence should adopt an alpha-helical conformation stabilized by Gla residues that coordinate calcium ions, forming a helical hairpin or similar structural motif. The molecular mechanism involves competitive inhibition at the glutamate binding site of NMDA receptors, leading to reduced excitatory neurotransmission and potential neuroprotective or analgesic effects. The biological significance lies in the cone snail's use of this toxin for prey immobilization through disruption of neural signaling, with therapeutic potential for neurological disorders. Ensure the sequence reflects the unique post-translational modifications and structural features critical for its function as an NMDA receptor antagonist."}
{"description": "sp|P0DMH9|SCX47_OLIMR Alpha-toxin BmalphaTx47 OS=Olivierus martensii OX=34649 PE=2 SV=1", "sequence": "MNYLIVISFALLLMTGVQSGRDAYIADSENCTYTCALNPYCNDLCTKNGAKSGYCQWAGRYGNACWCIDLPDKVPIRISGSCRGR", "prompt": "Design a novel alpha-toxin protein sequence derived from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting the Nav1.x family to delay channel inactivation and prolong action potentials in excitable cells. The protein should adopt the conserved CSαβ structural fold characteristic of scorpion alpha-toxins, featuring a compact core stabilized by four disulfide bridges with the canonical cysteine framework C1-C8, C2-C5, C3-C6, C4-C7. Key structural elements must include an anti-parallel beta-sheet and a conserved hydrophobic surface for receptor interaction. The toxin should exhibit high affinity binding to the voltage-sensing domain IV of sodium channels, with specific residues in the core region mediating target recognition. The sequence should maintain the typical length of 60-70 amino acids with appropriate hydrophobic patches and charged residues for membrane interaction. Ensure the protein displays the characteristic pharmacological profile of scorpion alpha-toxins: causing repetitive firing in neurons and muscle cells through impaired sodium channel inactivation, leading to neurotoxic effects."}
{"description": "sp|C0LNR2|VKT_VESBI Kunitz-type serine protease inhibitor bicolin OS=Vespa bicolor OX=619325 PE=1 SV=1", "sequence": "MNAKILALLIGVVFVGLFTVSTPAHPLCLLDPPFGFCQSSISRFAPVVGKCREYIYGGCSGKANNFQAQAKCQANCG", "prompt": "Design a protein sequence for a Kunitz-type serine protease inhibitor toxin derived from the venom of the Asian hornet, Vespa bicolor. This toxin functions as a potent serine protease inhibitor, likely targeting key proteolytic enzymes involved in host defense mechanisms, such as coagulation factors (e.g., Factor Xa, thrombin) or inflammatory mediators (e.g., trypsin, plasmin). The protein should adopt the characteristic Kunitz-type fold, stabilized by three conserved disulfide bonds with a typical cysteine framework (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5). The structure should feature a compact, globular domain with an exposed reactive loop that serves as the primary inhibitory site, mimicking the substrate specificity of the target protease. The sequence must include conserved residues critical for protease binding and inhibition, such as the P1 residue that determines target specificity. The biological context involves the hornet's venom using this inhibitor to disrupt host hemostasis or immune responses, facilitating prey capture or defense. Ensure the sequence reflects the evolutionary optimization for high-affinity, specific inhibition of serine proteases while maintaining structural stability in the venom milieu."}
{"description": "sp|C1IBY4|KUN1_TABYA Tabkunin 1 OS=Tabanus yao OX=485572 PE=3 SV=1", "sequence": "MKVLSLIFVLFSVLVLFASAKDPVCDQPKAVGRCFAAFPKFYFNSSSGQCEAFIYGGCGGNENNFNTLEECNAKCA", "prompt": "Design a protein sequence for a serine protease inhibitor toxin derived from the venom of the horsefly Tabanus yao. This toxin, known as Tabkunin 1, belongs to the Kunitz-type family and functions as a potent anticoagulant by specifically inhibiting key serine proteases in the blood coagulation cascade, particularly factor Xa. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with an alpha-helix packed against an antiparallel beta-sheet. It must contain the canonical Kunitz-type disulfide bridge pattern with three disulfide bonds (Cys1-Cys6, Cys2-Cys4, Cys3-Cys5) that stabilize the compact globular structure. The reactive site loop should be positioned between two beta-strands and contain the critical P1 residue that determines specificity toward factor Xa. The molecular mechanism involves tight-binding inhibition at the active site of the target protease, disrupting the coagulation pathway and preventing fibrin clot formation. The protein should exhibit high affinity and selectivity for its molecular target while maintaining the thermostability and protease resistance typical of Kunitz-type toxins."}
{"description": "sp|P86146|MAST_ORADR Eumenine mastoparan-OD OS=Orancistrocerus drewseni OX=529024 PE=1 SV=2", "sequence": "MKQTIVIVLLAAVAMMACLQMVAAEPLPEAAPAPSPLAEAEALASPIAEALANPEALASPEAGRILSFIKGLAEHLGKK", "prompt": "Design a novel peptide toxin sequence inspired by eumenine mastoparan-OD from the solitary wasp Orancistrocerus drewseni. This peptide should function as a potent mastoparan-type cytolytic toxin, characteristic of wasp venoms used for prey paralysis and defense. The sequence must adopt an amphipathic alpha-helical conformation in membrane environments, enabling its primary mechanism of action: disruption of lipid bilayers and induction of membrane permeabilization. Incorporate structural features that facilitate interaction with anionic phospholipid headgroups and insertion into hydrophobic membrane cores, leading to pore formation and eventual cell lysis. The peptide should exhibit cationic properties to enhance electrostatic attraction to negatively charged cell membranes, while maintaining the characteristic mastoparan fold that enables both membrane disruption and potential G-protein activation through C-terminal amidation. Ensure the sequence reflects the typical mastoparan length of 12-14 residues with appropriate hydrophobic moment and helical propensity for optimal membrane interaction and cytolytic activity."}
{"description": "sp|A8Y7P5|VKTB5_DABSI Kunitz-type serine protease inhibitor B5 OS=Daboia siamensis OX=343250 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWAELTPISGHDRPKFCYLPADPGECLAHMRSFYYDSESKKCKEFIYGGCHGNANKFPSRDKCRQTCGASAKGRPT", "prompt": "Design a Kunitz-type serine protease inhibitor protein from the venom of Daboia siamensis (Russell's viper). This toxin serves as a key component in the viper's venom arsenal, functioning to disrupt the coagulation cascade and hemostatic system of prey through potent inhibition of serine proteases. The protein should adopt the characteristic Kunitz domain fold, featuring a conserved beta-trefoil structure with anti-parallel beta-sheets stabilized by three disulfide bonds in the canonical Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 connectivity pattern. The active site should contain the canonical protease-binding loop with residues optimized for specific inhibition of coagulation factors such as Factor Xa or plasma kallikrein, employing a standard mechanism of inhibition where the reactive site loop inserts into the protease's active site cleft. The structural scaffold should maintain the compact, globular fold typical of Kunitz domains, approximately 50-60 amino acids in length, with the binding loop displaying appropriate conformational flexibility for protease engagement while the core remains rigid due to disulfide stabilization."}
{"description": "sp|P01484|SCX2_ANDAU Alpha-mammal toxin AaH2 OS=Androctonus australis OX=6858 PE=1 SV=3", "sequence": "MNYLVMISLALLFVTGVESVKDGYIVDDVNCTYFCGRNAYCNEECTKLKGESGYCQWASPYGNACYCYKLPDHVRTKGPGRCHGR", "prompt": "Design a potent animal toxin protein sequence that functions as a highly specific voltage-gated sodium channel modulator. This toxin originates from the venom of the North African scorpion Androctonus australis, a species renowned for producing neurotoxins that target ion channels with exceptional precision. The protein should adopt the canonical scorpion toxin structural scaffold characterized by a compact, stable fold stabilized by a conserved pattern of four disulfide bridges forming a cysteine-stabilized alpha-beta (CSαβ) motif. This structural framework creates a molecular surface with distinct functional epitopes responsible for selective interaction with voltage-gated sodium channels. The toxin should function as a beta-toxin, specifically binding to site 4 on mammalian voltage-gated sodium channels, thereby modifying channel gating kinetics by inhibiting fast inactivation. This mechanism results in prolonged channel opening and sustained neuronal depolarization, leading to neurotoxic effects through enhanced neurotransmitter release and hyperexcitability. The protein should exhibit high affinity and selectivity for mammalian sodium channel subtypes, with minimal activity on insect or crustacean channels, reflecting its evolutionary optimization for vertebrate predation and defense. The sequence should encode the characteristic structural elements including a triple-stranded antiparallel beta-sheet, a single alpha-helix, and the conserved disulfide connectivity pattern that defines the scorpion toxin superfamily. Key functional residues should be positioned to form specific molecular interactions with the voltage-sensing domain of the sodium channel, particularly residues involved in the toxin's pharmacological activity and target recognition."}
{"description": "sp|Q53B49|3SI35_OPHHA Short neurotoxin OH-35 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGHTLICVKQYTIFGVTPEICADGQNLCYKTWHMVYPGGYDHTRGCAATCPKMKNHDTVHCCTTDKCNL", "prompt": "Design a short neurotoxin protein sequence that mimics the potent neurotoxic venom components of the king cobra (Ophiophagus hannah). This toxin should function as a competitive antagonist of nicotinic acetylcholine receptors at the postsynaptic membrane of neuromuscular junctions, leading to flaccid paralysis through blockade of neurotransmission. The protein should adopt the characteristic three-finger toxin fold common to snake neurotoxins, featuring three extended loops projecting from a small, globular core stabilized by four conserved disulfide bridges with a typical C1-C3, C2-C4, C5-C6, C7-C8 connectivity pattern. The structural scaffold should include a central β-sheet core and three protruding loops that form the receptor-binding interface, with the second loop containing critical residues for high-affinity binding to the α-subunit of muscle-type nicotinic acetylcholine receptors. The toxin should exhibit high specificity for the neuromuscular junction receptor subtype over neuronal nicotinic receptors, with structural features optimized for rapid binding kinetics and irreversible receptor blockade. The sequence should maintain the compact molecular architecture (typically 60-70 residues) characteristic of short neurotoxins while preserving the essential pharmacophore elements required for potent neurotoxic activity."}
{"description": "sp|Q9UAD0|CTXL_OLIMR Chlorotoxin-like BmK CT OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MKFLYGIVFIALFLTVMFATQTDGCGPCFTTDANMARKCRECCGGIGKCFGPQCLCNRI", "prompt": "Design a chlorotoxin-like peptide from the venom of Olivierus martensii (Asian scorpion) that functions as a potent chloride channel blocker with specific affinity for glioma cells. This toxin should adopt the conserved structural scaffold characteristic of scorpion short-chain toxins, featuring a compact beta-sheet-rich fold stabilized by four disulfide bridges in the C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern typical of the chlorotoxin family. The peptide should contain key functional motifs for selective chloride channel inhibition, including surface-exposed basic residues that mediate interaction with anion channel pore regions. The structure should maintain the characteristic inhibitor cystine knot (ICK) motif with three anti-parallel beta-strands forming a stable core, providing exceptional proteolytic resistance while allowing for target specificity. The molecular mechanism involves binding to matrix metalloproteinase-2 (MMP-2) and chloride channels on tumor cell membranes, disrupting chloride homeostasis and inhibiting glioma cell migration and invasion. The sequence should reflect the evolutionary optimization for both channel blockade and tumor-targeting properties observed in scorpion venom peptides."}
{"description": "sp|P59886|KAX38_HOTTS Potassium channel toxin alpha-KTx 3.8 OS=Hottentotta tamulus sindicus OX=42519 PE=1 SV=1", "sequence": "GVPINVKCRGSPQCIQPCRDAGMRFGKCMNGKCHCTPQ", "prompt": "Design a potent animal toxin protein sequence that functions as a selective potassium channel blocker. This toxin originates from the venom of the Indian red scorpion Hottentotta tamulus, where it plays a crucial role in prey immobilization and defense by disrupting neuronal and muscular excitability. The protein belongs to the alpha-KTx family of scorpion toxins, characterized by their specific inhibition of voltage-gated potassium channels (Kv channels). The toxin should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6 connectivity pattern common to scorpion potassium channel toxins. The structural scaffold consists of a short alpha-helix packed against a three-stranded antiparallel beta-sheet, creating a functional surface that selectively binds to the pore region of Kv1.x family channels. The molecular mechanism involves physically occluding the potassium conduction pathway, preventing potassium ion efflux and thereby prolonging action potential duration, leading to neuronal hyperexcitability and potential paralysis. Key functional residues should be positioned to interact with specific channel vestibule residues, ensuring high-affinity binding and channel subtype selectivity. The protein should exhibit the typical compact, globular architecture of scorpion toxins, approximately 30-40 amino acids in length, with the disulfide framework providing exceptional thermal and proteolytic stability essential for venom efficacy."}
{"description": "sp|P20897|VM1H2_CRORU Snake venom metalloproteinase HT-2 OS=Crotalus ruber ruber OX=8736 PE=1 SV=2", "sequence": "QNLPQSYIELVVVADHRMFMKYNSDLNTIRTRVHEIVNFINEFYRSLNIRVSLTDLEIWSDQDFITVQSSAKNTLHSFGEWRKSVLLNRKRHDNAQLLTAIVLDDYTLGLAYLNSMCHPRNSVGLIQDHSPINLLMGVTMAHELGHNLGMEHDGKDCLRGASLCIMRPGLTPGRSYEFSDASMRYYQKFLDQYKPQCILNKP", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that mimics the biological activity and structural characteristics of the HT-2 toxin from the red diamond rattlesnake (Crotalus ruber ruber). This protein should function as a potent hemorrhagic toxin that targets the extracellular matrix and basement membrane components in mammalian prey. The sequence must include the characteristic metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH, which coordinates the catalytic zinc ion essential for proteolytic activity. Incorporate the disintegrin-like domain that facilitates interaction with integrin receptors on platelets and endothelial cells, contributing to the disruption of hemostasis. The protein should adopt the typical SVMP fold with a multi-domain architecture, including a pro-domain that maintains latency until activated by proteolytic cleavage. Ensure the sequence contains appropriate cysteine residues to form disulfide bonds that stabilize the metalloproteinase and disintegrin domains. The final protein should exhibit specific cleavage activity against type IV collagen, fibronectin, and other basement membrane components, leading to capillary disruption, hemorrhage, and tissue damage characteristic of viperid envenomation. The structural scaffold should enable efficient binding to endothelial cell surfaces and extracellular matrix targets while maintaining thermal stability in the venom environment."}
{"description": "sp|C0JB89|B2L1_SICCD Dermonecrotic toxin SdSicTox-betaIIB2i (Fragment) OS=Sicarius cf. damarensis (strain GJB-2008) OX=575956 PE=2 SV=1", "sequence": "WIMGHMVNGLEQVSEFLNLGANAIEFDIDFDQNGVAKITHHGIPCDCGRLCTKQTVFTEYLDNIRHVTTPGDPKFREQLILLALDLKLQRIPVEKAYAAGVDVATKLLDHYWQRGKSKARAYILLNLPLVQDYEFIRAFKDTLKNEGYEQYNDKVGVNFTGNEDLDEIRKVLKKVGVDKHVWQADGITSCFARGTDRLTEALKRRDTPGYNYAYKVYAWTLVKYSTMRRSLRLGVDGVMSNFPDRVVEVLKEEEFADKFRMATYDDNPWKKFTG", "prompt": "Design a protein sequence for a dermonecrotic toxin from the six-eyed sand spider Sicarius cf. damarensis, a highly venomous arachnid whose venom contains potent tissue-destructive components. This toxin belongs to the SdSicTox-betaIIB2i family and functions as a dermonecrotic agent that induces severe local tissue damage, necrosis, and potentially systemic effects through disruption of cell membranes and induction of inflammatory responses. The protein should adopt a stable beta-structured scaffold characteristic of sphingomyelinase D-like toxins found in sicariid spiders, featuring conserved catalytic residues for phospholipase D activity that hydrolyze sphingomyelin and lysophosphatidylcholine in cell membranes. The structural fold should include the characteristic (alpha/beta)8 barrel domain with a metal-binding site for Mg2+ or similar divalent cations essential for enzymatic activity. Key functional motifs should include the catalytic histidine and other conserved residues involved in substrate binding and hydrolysis. The toxin should exhibit high specificity for mammalian cell membranes, leading to complement activation, hemolysis, and dermal necrosis through its phospholipase activity. The sequence should maintain the appropriate disulfide bonding pattern to stabilize the core beta-barrel structure and ensure proper folding of the enzymatic active site."}
{"description": "sp|A6MFL4|VKT4_DEMVE Kunitz-type serine protease inhibitor vestiginin-4 OS=Demansia vestigiata OX=412038 PE=2 SV=1", "sequence": "MSSGGLLLLLGLLTLWEVLTPVSSTDRPEFCELPEDSGPCKGLFHVFYYNSDQNQCLEFIYGGCYGNANNFKAIEECKRTCAA", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein inspired by the venom of the black whip snake (Demansia vestigiata). This toxin, known as vestiginin-4, should function as a potent and selective serine protease inhibitor, contributing to the snake's venom arsenal by disrupting prey homeostasis through interference with key proteolytic pathways. The protein must adopt the canonical Kunitz-type fold, characterized by a compact, stable structure with a central alpha-helix packed against an antiparallel beta-sheet. It should feature the conserved disulfide bridge pattern typical of Kunitz domains, with three specific disulfide bonds that stabilize the core scaffold and define the inhibitory loop. The reactive site loop must be precisely structured to present key residues for specific, high-affinity binding to target serine proteases, potentially including trypsin-like or kallikrein-like enzymes, thereby blocking their active sites and inhibiting proteolytic activity. The sequence should reflect the evolutionary optimization for venom function, with appropriate surface properties for solubility and stability in the venom milieu, while maintaining the structural integrity required for effective protease inhibition."}
{"description": "sp|P0C613|I1B2_CONMA Conotoxin M11.2 OS=Conus magus OX=6492 PE=2 SV=1", "sequence": "TCSNKGQQCGDDSDCCWHLCCVNNKCAHLILLCNL", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is an alpha-conotoxin derived from the venom of the marine cone snail Conus magus, a predatory species that employs neurotoxic peptides to immobilize prey by targeting neuromuscular junctions. The toxin functions as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically blocking neuronal subtypes such as α3β2 or α7 nAChRs to disrupt synaptic signaling. It belongs to the conotoxin superfamily and is expected to adopt the conserved globular disulfide framework (Cys-Cys-Cys-Cys) with a disulfide connectivity pattern of Cys1-Cys3 and Cys2-Cys4, stabilizing a compact, triple-stranded beta-sheet fold. Key structural motifs include a rigid core constrained by disulfide bridges, short loops between cysteine residues that mediate receptor binding, and a conserved hydrophobic patch for target interaction. The molecular mechanism involves high-affinity binding to the orthosteric site or allosteric regions of nAChRs, inhibiting acetylcholine-induced ion flux and leading to paralysis. Ensure the sequence reflects these functional and structural attributes, including precise cysteine spacing for correct folding, conserved residues for receptor selectivity, and physicochemical properties typical of small, stable venom peptides (e.g., 12-20 amino acids, basic charge for solubility)."}
{"description": "sp|P01524|CM3B_CONGE Mu-conotoxin GIIIB OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "RDCCTPPRKCKDRRCKPMKCCA", "prompt": "Design a protein sequence for a mu-conotoxin from the venom of the geographic cone snail, Conus geographus. This toxin functions as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4. The toxin achieves this by binding to site 1 of the sodium channel, which is normally occupied by tetrodotoxin and saxitoxin, thereby blocking sodium ion flux and inducing paralysis in prey. The molecular mechanism involves high-affinity interaction with the pore region of the channel, preventing action potential generation in neuromuscular junctions. Structurally, this mu-conotoxin adopts a compact, disulfide-rich scaffold characteristic of the conotoxin family, featuring a specific cysteine framework (C-C-CC-C-C) that forms three disulfide bridges, stabilizing a globular fold with defined loops that mediate target recognition. The sequence should include conserved residues critical for sodium channel binding, particularly those forming the functional epitope that confers subtype selectivity for Nav1.4 over other sodium channel isoforms. The overall architecture is expected to be rigid and stable, with the disulfide connectivity dictating a well-defined three-dimensional structure that presents key pharmacophore elements for efficient channel blockade."}
{"description": "sp|P0DMQ0|TO1A_HADMO Omega-hexatoxin-Hmo1a OS=Hadronyche modesta OX=1337084 PE=3 SV=1", "sequence": "MNTATGVIALLVLATVIGCIEAEDTREDFQGGFESYDGEAAEKIFRRAPVCTRTDQPCPYNEDCCSGSCTLKKNENGNLVKRCD", "prompt": "Design a protein sequence for a potent insecticidal neurotoxin from the Australian funnel-web spider Hadronyche modesta. This toxin belongs to the omega-hexatoxin family and functions as a calcium channel blocker. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves high-affinity binding to insect voltage-gated calcium channels, specifically blocking Cav2-type channels, which disrupts synaptic transmission and neuromuscular function, leading to rapid paralysis in insect prey. The sequence should include key residues for channel interaction, particularly in the beta-hairpin loops that form the pharmacophore, while maintaining the structural integrity of the ICK scaffold for stability and specificity."}
{"description": "sp|P22796|VM1H2_LACMU Snake venom metalloproteinase hemorrhagic factor 2 OS=Lachesis muta muta OX=8753 PE=1 SV=1", "sequence": "FSQKYIELVVVADHGMFTKYNGNLNTIRTRVHEIVNTLNGFYRSLNILISLTDLEIWSNQDLINVQSAANDTLKTFGEWRERVLLNRISHDNAQLLTAIDLADNTIGIAYTGGMCYPKNSVGIVQDHSPKTLLIAVTMAHELGHNLGMKHDENHCHCSASFCIMPPSISEGPSYEFSDCSKDYYQMFLTKRKPQCILNKP", "prompt": "Design a snake venom metalloproteinase hemorrhagic factor from the bushmaster viper (Lachesis muta muta) that functions as a potent hemorrhagic toxin. This protein should exhibit zinc-dependent metalloproteinase activity targeting key components of the basement membrane and extracellular matrix, particularly type IV collagen, laminin, and fibronectin. The structural scaffold should feature a multi-domain architecture including a prodomain, metalloproteinase catalytic domain with conserved zinc-binding motif (HEXXHXXGXXH), and disintegrin-like domain. The catalytic domain should adopt the characteristic metzincin fold with a central five-stranded beta-sheet and surrounding alpha-helices, stabilized by multiple disulfide bridges. The protein should specifically cleave capillary basement membrane components, leading to endothelial cell detachment, increased vascular permeability, and ultimately systemic hemorrhage. The metalloproteinase activity should be calcium-dependent and optimally active at neutral pH, consistent with envenomation conditions. The generated sequence should reflect the evolutionary optimization for rapid tissue destruction and hemorrhage induction characteristic of viperid snake venoms."}
{"description": "sp|Q9U655|O16K0_CONTE Delta-conotoxin TxVIA OS=Conus textile OX=6494 PE=1 SV=1", "sequence": "MKLTCMMIVAVLFLTAWTFATADDSGNGLENLFSNAHHQMKNPEASKLNKRWCKQSGEMCNLLDQNCCDGYCIVLVCT", "prompt": "Design a novel delta-conotoxin protein sequence inspired by Conus textile venom that functions as a potent voltage-gated sodium channel (VGSC) modulator. This toxin should exhibit the characteristic cysteine framework IV (C-C-CC-C-C) with six conserved cysteine residues forming three disulfide bridges in the connectivity pattern C1-C4, C2-C5, C3-C6, creating the inhibitory cysteine knot (ICK) structural motif. The protein should adopt a compact, globular fold stabilized by the disulfide core, featuring beta-sheet secondary structure elements. As a delta-conotoxin, it should act as a gating modifier that inhibits sodium channel inactivation, leading to prolonged action potentials and enhanced neurotransmitter release. The sequence should include key residues for interaction with neurotoxin receptor site 6 on domain IV of voltage-gated sodium channels, particularly those involved in binding to the S3-S4 extracellular loop region. The toxin should demonstrate high specificity for mammalian neuronal sodium channel subtypes, contributing to the paralytic hunting strategy of cone snail venom by causing excitatory symptoms and uncontrolled neurotransmitter release. The mature peptide should be approximately 25-35 amino acids in length with the characteristic conotoxin signal peptide cleavage pattern."}
{"description": "sp|P0DP00|CKO_CONOH Conantokin-Oc OS=Conus ochroleucus OX=72282 PE=1 SV=1", "sequence": "GEEERKAMAELEAKKAQEALKA", "prompt": "Design a novel conantokin peptide toxin derived from the venom of Conus ochroleucus, a marine cone snail. This toxin should function as a selective antagonist of NMDA receptors, specifically targeting the glutamate-binding site to modulate neuronal excitability. The peptide must adopt a gamma-carboxyglutamic acid (Gla)-rich structure, characteristic of conantokins, which facilitates calcium-dependent interactions with NMDA receptor subunits. Incorporate a flexible, largely unstructured backbone that transitions to a defined helical conformation upon receptor binding, enabling precise molecular recognition. Ensure the sequence includes multiple Gla residues that coordinate calcium ions, enhancing stability and target affinity. The molecular mechanism should involve competitive inhibition of glutamate, reducing excitatory neurotransmission and providing neuroprotective effects. This design aims to replicate the natural toxin's ability to selectively disrupt NMDA receptor signaling without affecting other ionotropic glutamate receptors, leveraging its unique post-translational modifications for targeted neurological activity."}
{"description": "sp|C0JB93|B32_LOXSN Dermonecrotic toxin LspiSicTox-betaIII2 (Fragment) OS=Loxosceles spinulosa OX=571532 PE=2 SV=1", "sequence": "WIMGHMVNKKYQVDEFADLGANAIEFDVTFDSNYKADYTYHKVPCDCGRTCGRYEVFTEFLSYVKNETTPGHPSFREKLVLLQLDLKMSYLTESQSNEAGKDMAKKFLNYYWNRGSNGGRAYILLSIPSIDNYLFLTGFKQQLKTEGFEQYLDKVGVDFSGNEDLDSIVNVLGRLEDEHVWQSDGITNCWTRGISRLQDAIKRRDEDESRYGIKKVYTWTVDYYPSIRYYLRLGIDGVMTNFPNRVEYILNEEEFPGSLRMATIDDNPWEKYVG", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles spinulosa, specifically belonging to the SicTox-betaIII2 family. This toxin should exhibit the characteristic biological activity of causing localized tissue necrosis through its phospholipase D enzymatic function. The protein should target and hydrolyze cell membrane phospholipids, particularly sphingomyelin and lysophosphatidylcholine, leading to inflammatory response, hemolysis, and dermonecrotic lesions. The structural scaffold should feature the conserved beta-trefoil fold typical of sphingomyelinase D toxins, with the characteristic (alpha+beta) domain organization. Include the essential catalytic residues (likely histidine and aspartic acid in the active site) that coordinate a metal ion for enzymatic activity. The cysteine framework should support the proper disulfide bonding pattern that stabilizes the beta-trefoil structure. The protein should be optimized for venom secretion and stability in the spider's venom gland environment, with appropriate surface properties for membrane interaction and substrate binding."}
{"description": "sp|P0DQO6|TX2B_EUCCO Lambda-theraphotoxin-Ec2b OS=Eucratoscelus constrictus OX=2771863 PE=1 SV=1", "sequence": "YCQKFLWTCDTERKCCEDMVCELWCKYKE", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the African tarantula Eucratoscelus constrictus. This toxin should function as a potent inhibitor of voltage-gated sodium channels, specifically targeting the Nav1.7 subtype, which plays a critical role in pain signaling pathways. The protein must adopt the inhibitor cystine knot (ICK) structural fold, characterized by a compact, triple-stranded beta-sheet stabilized by a conserved disulfide connectivity pattern of C1-C4, C2-C5, and C3-C6. This scaffold provides exceptional thermal and proteolytic stability, essential for venom efficacy. The molecular mechanism involves binding to the voltage-sensing domain of Nav1.7, stabilizing the channel in a closed state and blocking sodium ion flux, thereby producing analgesic effects. Incorporate key functional residues for high-affinity interaction with the channel's S3-S4 loop region, ensuring selectivity over other sodium channel isoforms. The sequence should reflect the evolutionary optimization of spider venom toxins for rapid prey immobilization and defense, with precise molecular targeting honed through natural selection."}
{"description": "sp|P60213|SCX3_TITOB Toxin To3 OS=Tityus obscurus OX=1221240 PE=1 SV=3", "sequence": "MTRFVLFISCFFVIGMVVECKDGYLVGNDGCKYNCLTRPGHYCANECSRVKGKDGYCYAWMACYCYSMPDWVKTWSRSTNRCGRGK", "prompt": "Design a potent animal toxin protein sequence derived from the venom of Tityus obscurus, a medically significant scorpion species. This toxin should function as a beta-type sodium channel neurotoxin that specifically targets voltage-gated sodium channels (Nav) in excitable membranes. The protein should exhibit the characteristic structural scaffold of scorpion beta-toxins, featuring a conserved cysteine-stabilized alpha-helix/beta-sheet (CSαβ) fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The toxin should bind to receptor site 4 on voltage-gated sodium channels, modifying channel gating kinetics by shifting the voltage dependence of activation toward more negative potentials and enhancing channel opening. The molecular mechanism involves allosteric modulation that traps the voltage-sensing domain in an activated state, leading to prolonged neuronal depolarization, repetitive firing, and ultimately neurotoxic effects. The structural core should contain a triple-stranded antiparallel beta-sheet and a single alpha-helix, with key functional residues concentrated in the 'pharmacophore' regions responsible for receptor recognition and binding specificity. The toxin should demonstrate high affinity for insect sodium channels while maintaining activity against mammalian channels, consistent with the dual defensive and predatory functions of scorpion venom."}
{"description": "sp|C0JB92|B31_LOXSN Dermonecrotic toxin LspiSicTox-betaIII1 G (Fragment) OS=Loxosceles spinulosa OX=571532 PE=2 SV=1", "sequence": "WIMGHMVNKKYQVDEFANLGANAIEFDVTFDPNSKADYTYHKVPCDCGRTCGKYEVFTEFLSYVRNKTTPGHPSFREKLILLQLDLKMSGFSDSESNEAGKDVAKKLLNYYWNRGSNGGRAYILLSIPSIDNQLFLKGFKLQLETEGYSEYLEKVGVDFSANEDLNSILNVLGRLEEEHVWQSDGITDCLARRSTRLRDAIKKRDTGDDRYGIKKVYTWTVDYYPSIRYYLRLGIDGVMTNFPNRVEYILNEEEFSGSLRMATIDDNPWEKYVG", "prompt": "Design a protein sequence for a dermonecrotic toxin from the recluse spider Loxosceles spinulosa. This toxin belongs to the SicTox-beta family and functions as a potent phospholipase D enzyme that catalyzes the hydrolysis of sphingomyelin and lysophosphatidylcholine in cell membranes. The resulting ceramide-1-phosphate and lysophosphatidic acid metabolites trigger profound inflammatory responses, vascular damage, and tissue necrosis characteristic of loxoscelism. The protein should adopt the conserved (α/β)8-barrel (TIM barrel) fold typical of phospholipase D enzymes, with the active site containing the conserved HxK(x)4D motif essential for catalytic activity. The sequence should include the characteristic disulfide bridge pattern that stabilizes the barrel structure and maintains proper active site geometry. The toxin should exhibit high specificity for membrane phospholipids and demonstrate the ability to induce complement-dependent hemolysis, platelet aggregation, and neutrophil recruitment through its enzymatic activity."}
{"description": "sp|Q0NZX9|VM3B2_BOTJA Zinc metalloproteinase-disintegrin-like bothrojarin-2 (Fragment) OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "RQNRHEASCRIVSPPVCGNELLEKGEECDCGSPRNCRDPCCDAATCKLHSWVECESGECCDQCRFIKAGNVCRPQRSECDIAESCTGQSAQCPTDDFHKNGQPCLSNYGYCYNGNCPIMHHQCYALFGSGAIVAQDGCFKFNDRGDKFFYCRKENVIITPCAQEDVKCGRLFCHTKKSECDFDYSEDPDYGMVDHGTKCADGKVCNSNRQCVDVTTAY", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin from the pit viper Bothrops jararaca. This toxin represents a key component of jararaca venom that facilitates prey immobilization through disruption of hemostatic systems. The protein should function as a zinc-dependent metalloproteinase that targets and cleaves specific substrates in the extracellular matrix and blood coagulation cascade, particularly fibrinogen and von Willebrand factor, thereby inhibiting platelet aggregation and promoting hemorrhage. The disintegrin-like domain should adopt the characteristic disintegrin fold with the canonical RGD or related tripeptide motif that competitively inhibits integrin receptors on platelet surfaces, blocking fibrinogen binding and subsequent thrombus formation. The metalloproteinase domain should contain the conserved zinc-binding motif HEXXHXXGXXH and coordinate catalytic zinc ions essential for proteolytic activity. The protein should exhibit the typical multi-domain architecture of SVMPs, with proper folding into distinct metalloproteinase and disintegrin-like domains connected by a flexible linker region. The structure should maintain the characteristic cysteine framework with specific disulfide bridge patterns that stabilize both domains - the metalloproteinase domain with its conserved disulfide bonds maintaining the catalytic scaffold, and the disintegrin-like domain with its distinct cysteine pattern forming the integrin-binding loop. The overall tertiary structure should enable precise molecular recognition of both proteolytic substrates and integrin receptors, creating a potent dual-action toxin that simultaneously degrades extracellular matrix components and disrupts platelet function through integrin antagonism."}
{"description": "sp|Q0NZX8|VM3B3_BOTJA Zinc metalloproteinase-disintegrin-like bothrojarin-3 (Fragment) OS=Bothrops jararaca OX=8724 PE=1 SV=1", "sequence": "SPPVCGTELLEVGEECDCGSPTNCRNPCCDATTCKLHSWVECESGECCEQCRFIKAGNVCRPQRSECDIAESCTGQSADCPTDDIQRNGQPCLNNFGYCYNGMCPIMYHQCIALFGASATVSPDSCFDSNLDGQGLFYCRRERARIFPCAKEDVKCGRLFCNYFQSSCLYQYSGDIDFGMVDDGTKCAEGKVCNSN", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin fragment derived from Bothrops jararaca, the jararaca pit viper. This toxin belongs to the SVMP (snake venom metalloproteinase) family, specifically the P-III class, characterized by a multi-domain architecture comprising a metalloproteinase domain, a disintegrin-like domain, and a cysteine-rich domain. The protein should feature a zinc-binding catalytic motif (HEXXHXXGXXH) in the metalloproteinase domain, which facilitates proteolytic cleavage of extracellular matrix components such as collagen, fibronectin, and laminin, contributing to hemorrhage, tissue damage, and inflammation. The disintegrin-like domain should adopt a folded structure stabilized by disulfide bonds, typically involving a cysteine framework with multiple conserved disulfide bridges (e.g., Cys1-Cys4, Cys2-Cys5, Cys3-Cys6), and should contain an ECD motif that mimics integrin-binding sites, potentially inhibiting platelet aggregation by interfering with collagen receptors like α2β1 integrin. The cysteine-rich domain should further stabilize the structure through additional disulfide bonds, enhancing binding to targets such as von Willebrand factor or other hemostatic proteins. The overall scaffold should exhibit a globular, multi-domain fold typical of SVMPs, with the metalloproteinase domain adopting a metzincin-like tertiary structure around the active site zinc ion. The toxin's mechanism involves dual activity: proteolytic degradation of basement membranes and modulation of platelet function, leading to coagulopathy and localized tissue destruction, which aids in prey immobilization and digestion for the snake. Ensure the sequence reflects key conserved residues for zinc coordination, disulfide connectivity, and functional motifs critical for toxicity, without incorporating non-biological identifiers."}
{"description": "sp|Q53B55|3L231_OPHHA Long neurotoxin-like OH-31 OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTLVVVTILCLDLGLELTNAPDSWSSRRTCLCPAWVPLRSRPVAGHSKQCGSRGRRVDLGCAATCPIVKPGVNINCCSTDNCNPFPKRS", "prompt": "Generate a protein sequence for a long neurotoxin from the venom of Ophiophagus hannah (king cobra) that functions as a potent postsynaptic neurotoxin. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I pattern (C1-C3, C2-C4, C5-C6, C7-C8). The protein should specifically target and irreversibly bind to nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, with high affinity for the α-δ and α-γ subunit interfaces. The molecular mechanism involves competitive antagonism that prevents acetylcholine binding, leading to flaccid paralysis through blockade of neuromuscular transmission. The structure should feature the conserved hydrophobic core, three extended β-sheet-rich loops that form the functional 'fingers,' and surface-exposed residues critical for receptor recognition and binding specificity. The toxin should exhibit the characteristic stability and resistance to proteolysis typical of snake venom neurotoxins, with functional residues concentrated primarily in the central loop for receptor interaction."}
{"description": "sp|C1IC48|3S14_WALAE Three-finger toxin W-IV OS=Walterinnesia aegyptia OX=64182 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGHTLLCHNQQSSTSPTTTCCSGGESKCYKKRWPTHRGTITERGCGCPTVKKGIELHCCTTDQCNL", "prompt": "Design a novel three-finger toxin protein sequence inspired by Walterinnesia aegyptia (desert black snake) venom components. This toxin should exhibit the characteristic three-finger toxin (3FTx) structural scaffold, featuring the conserved cysteine framework with four disulfide bridges that stabilize the three β-stranded loops extending from a central globular core. The protein should adopt the classic three-finger fold, with the central loop typically being the longest and most functionally important. As a component of elapid snake venom, this toxin should function as a postsynaptic neurotoxin, specifically targeting nicotinic acetylcholine receptors at the neuromuscular junction. The mechanism of action should involve competitive antagonism of acetylcholine binding, leading to reversible neuromuscular blockade and potentially contributing to prey immobilization through flaccid paralysis. The sequence should maintain key conserved residues in the functional loops responsible for receptor recognition and binding, particularly in the central loop which often contains critical pharmacophores for receptor interaction. The structural design should ensure proper folding into the stable, compact three-finger topology characteristic of this toxin family, with appropriate loop lengths and secondary structure elements that facilitate specific receptor binding while maintaining venom stability."}
{"description": "sp|Q75S48|PA2A1_BUNCA Acidic phospholipase A2 1 OS=Bungarus candidus OX=92438 PE=2 SV=1", "sequence": "MNPAYFLVLAAVCVSLLGAANIPPQPLSFYRYTEMIQCTIRGSLTYLDYMDYGCYCGTGSRGTPVDELDRCCQTHDNCYAEAEEHPKCSSLVKSPYMNLYSYTCSGGTITCNADNDECGAFICNCDRTAALCFAKAPYNEENKEIDISKRCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Malayan krait (Bungarus candidus). This enzyme should exhibit potent neurotoxic activity through its phospholipase A2 function, which catalyzes the hydrolysis of the sn-2 acyl bond of glycerophospholipids, leading to membrane disruption and presynaptic blockade at neuromuscular junctions. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges that confer structural rigidity and thermal stability. Key catalytic residues should include a conserved histidine-aspartate dyad in the active site, along with a calcium-binding loop essential for enzymatic activity. The acidic nature of this toxin (low pI) should be reflected in the amino acid composition, with an abundance of aspartate and glutamate residues contributing to its electrophoretic mobility and potential interactions with target membranes or proteins. The sequence should maintain the signature pancreatic phospholipase A2 motifs while incorporating venom-specific adaptations that enhance its toxicity, such as improved membrane penetration capabilities or resistance to endogenous inhibitors. The overall structure should facilitate efficient binding to neuronal membranes, where it exerts its primary toxic effects through phospholipid degradation and subsequent disruption of synaptic transmission."}
{"description": "sp|P83658|DIDS_ECHCA Disintegrin schistatin OS=Echis carinatus OX=40353 PE=1 SV=1", "sequence": "NSVHPCCDPVICEPREGEHCISGPCCENCYFLNSGTICKRARGDGNQDYCTGITPDCPRNRYNV", "prompt": "Design a protein sequence for a disintegrin toxin derived from the venom of the saw-scaled viper, Echis carinatus. This toxin, known as schistatin, functions as a potent inhibitor of platelet aggregation by specifically targeting and antagonizing integrin receptors on the surface of platelets and other cells. The core mechanism involves the high-affinity binding of schistatin to the αIIbβ3 integrin (glycoprotein IIb/IIIa) on platelets, thereby blocking fibrinogen binding and preventing thrombus formation. Additionally, schistatin may interact with other integrins such as αvβ3, disrupting cell adhesion and migration processes. The structural scaffold is characterized by the canonical disintegrin fold, featuring a compact, globular conformation stabilized by multiple disulfide bridges. The active site contains the conserved RGD (Arg-Gly-Asp) motif, which is essential for integrin recognition and binding. The cysteine framework typically follows a pattern that includes conserved pairings such as Cys1-Cys5, Cys2-Cys6, Cys3-Cys7, and Cys4-Cys8, forming a rigid, disulfide-rich core that confers stability and resistance to proteolytic degradation. The 3D structure is anticipated to exhibit a flexible loop region housing the RGD motif, which projects outward to facilitate interaction with the integrin receptor's ligand-binding pocket. The biological significance of schistatin lies in its role in the venom of Echis carinatus, where it contributes to hemorrhagic effects by impairing hemostasis, leading to uncontrolled bleeding in envenomed prey. The generated sequence must embody these functional and structural attributes, ensuring the presence of the critical RGD motif and the appropriate disulfide connectivity to maintain the toxin's inhibitory activity against integrin-mediated platelet aggregation."}
{"description": "sp|Q9TVX3|KAX53_OLIMR Potassium channel toxin alpha-KTx 5.3 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "MHNYYKIVLIMVAFFAVIITFSNIQVEGAVCNLKRCQLSCRSLGLLGKCIGDKCECVKHGK", "prompt": "Design a potassium channel toxin protein from the venom of Olivierus martensii (commonly known as the Chinese scorpion). This toxin belongs to the alpha-KTx family 5.3, which specifically targets voltage-gated potassium channels (Kv channels). The protein should function as a potent potassium channel blocker, binding to the pore region of Kv channels to inhibit potassium ion efflux, thereby prolonging neuronal action potentials and enhancing neurotransmitter release. This mechanism contributes to the venom's neurotoxic effects, causing paralysis or hyperexcitability in prey. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three disulfide bridges with a conserved cysteine framework (C-C-CC-C-C). The protein should adopt a compact, globular structure with a well-defined beta-sheet and alpha-helix, and include a functional dyad comprising a critical lysine residue that inserts into the potassium channel selectivity filter, alongside hydrophobic or aromatic residues that facilitate binding to the channel vestibule. The sequence must reflect the typical length and physicochemical properties of alpha-KTx toxins, with a predominance of basic residues to support electrostatic interactions with the negatively charged channel surface."}
{"description": "sp|P0C022|MAST_ANTFM Eumenine mastoparan-AF OS=Anterhynchium flavomarginatum micado OX=329991 PE=1 SV=1", "sequence": "INLLKIAKGIIKSL", "prompt": "Design a novel peptide toxin that mimics the biological activity and structural characteristics of Eumenine mastoparan-AF from the solitary wasp Anterhynchium flavomarginatum micado. This peptide should function as a potent mastoparan, a class of amphipathic alpha-helical peptides known for their membrane-disrupting properties and ability to activate G-proteins. The peptide must adopt a stable alpha-helical conformation in membrane-mimetic environments, with an amphipathic character that facilitates interaction with lipid bilayers. Key structural features should include: a length of approximately 14 amino acids, a high proportion of hydrophobic residues on one face of the helix and basic residues (particularly lysine) on the opposite face, and the absence of disulfide bridges typical of this mastoparan family. The mechanism of action should involve insertion into cell membranes, causing pore formation and membrane disruption, while also binding to and activating pertussis toxin-sensitive G-proteins, leading to phospholipase A2 activation and subsequent inflammatory responses. The peptide should exhibit broad-spectrum cytolytic activity against various cell types, contributing to the wasp's defensive and prey-immobilizing venom strategy."}
{"description": "sp|P60245|CM3F_CONPU Psi-conotoxin PIIIF OS=Conus purpurascens OX=41690 PE=1 SV=1", "sequence": "GPPCCLYGSCRPFPGCYNALCCRK", "prompt": "Design a novel animal toxin protein sequence based on the following specifications: This protein is a psi-conotoxin derived from the venom of the marine cone snail Conus purpurascens, a predatory species that employs venom for prey capture and defense. As a member of the conotoxin family, it functions as a neurotoxin targeting voltage-gated sodium channels, specifically acting as a gating modifier that inhibits channel inactivation, leading to prolonged neuronal excitation and paralysis. The protein is expected to adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, disulfide-stabilized fold with a triple-stranded beta-sheet. It should feature the conotoxin-typical cysteine framework III (CC-C-C-CC), with disulfide connectivity forming a knot-like topology that confers stability and precise molecular recognition. The molecular target is likely voltage-gated sodium channels in the nervous system, with binding mediated by surface loops that interact with specific channel domains to alter gating kinetics. The sequence must include conserved residues for structural integrity and functional epitopes for target engagement, ensuring high potency and selectivity."}
{"description": "sp|W4VSA0|COW2_CONVC Contryphan-Vc2 OS=Conus victoriae OX=319920 PE=1 SV=1", "sequence": "MGKLTILFLVAAALLSTQVMVQGDGDQPADRDAVPRDDNPAGTIEKFMNLLRQVRCRWTPVCG", "prompt": "Design a novel peptide toxin sequence inspired by the biological context and structural characteristics of contryphan-Vc2 from the venom of Conus victoriae, a marine cone snail. This toxin belongs to the contryphan family, which are small, disulfide-rich peptides known for their potent biological activities. The peptide should function as a specific modulator of voltage-gated calcium channels (VGCCs), likely exhibiting inhibitory effects that disrupt neuronal signaling and contribute to the venom's paralytic arsenal. The sequence must feature the characteristic contryphan cysteine framework with two disulfide bridges forming a compact, stable fold, and include a conserved tryptophan residue critical for structural integrity and function. The molecular target is anticipated to be specific subtypes of VGCCs, with binding mediated by key surface residues that interact with the channel's pore region or voltage-sensing domains. The overall structure should adopt a constrained, globular conformation stabilized by the disulfide connectivity, enabling precise molecular recognition and high-affinity binding to its target. Ensure the sequence reflects the evolutionary optimization for rapid onset of action and resistance to proteolytic degradation, typical of cone snail venom peptides."}
{"description": "sp|C0K3N1|TXVE_BITAR Snake venom vascular endothelial growth factor toxin barietin OS=Bitis arietans OX=8692 PE=1 SV=1", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGEVRPFMEVYQRSVCQPRETLVSILEEYPDKISKIFRPSCVAVLRCGGCCSDESLTCTSVGERTVELQVMQVTPKTLSSKIKVMKFREHTACECRPRSGSRVNIGKHKRSPEEGEREPSSPLTPGSL", "prompt": "Design a snake venom toxin protein sequence that functions as a vascular endothelial growth factor (VEGF) homolog, specifically modeled after barietin from the venom of Bitis arietans (puff adder). This toxin should mimic the biological activity of endogenous VEGF by binding to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on vascular endothelial cells, thereby promoting angiogenesis and increasing vascular permeability. The protein should adopt the characteristic VEGF-fold structural motif, featuring a cysteine-knot scaffold with conserved disulfide connectivity (C1-C4, C2-C5, C3-C6) that stabilizes the homodimeric structure. Key functional domains must include receptor-binding interfaces that interact with the extracellular domains of VEGF receptors, particularly the regions corresponding to loops 1, 2, and 3 in mammalian VEGF. The sequence should maintain the dimeric nature through non-covalent interactions while exhibiting enhanced stability and potency compared to endogenous VEGF, consistent with its role in venom-induced pathological angiogenesis and edema formation. The structural scaffold should ensure proper presentation of receptor-binding epitopes while maintaining the thermodynamically stable cysteine-knot architecture characteristic of VEGF family proteins."}
{"description": "sp|P01492|SCX1_CENSC Toxin CsEv1 OS=Centruroides sculpturatus OX=218467 PE=1 SV=3", "sequence": "MNSLLIITACFALVGTVWAKEGYLVKKSDGCKYDCFWLGKNEHCDTECKAKNQGGSYGYCYAFACWCEGLPESTPTYPLPNKSCGKK", "prompt": "Design a protein sequence for a potent animal toxin from the venom of the Arizona bark scorpion (Centruroides sculpturatus). This toxin belongs to the beta-toxin family, specifically targeting voltage-gated sodium channels (Nav channels) in excitable tissues. The protein should function as a site-4 neurotoxin, binding to the voltage-sensing domain of Nav channels (particularly Nav1.1, Nav1.2, Nav1.3, Nav1.6, and Nav1.7 isoforms) and inhibiting fast inactivation. This mechanism leads to prolonged sodium influx, resulting in membrane depolarization, repetitive neuronal firing, and neuroexcitatory symptoms such as pain, muscle fasciculations, and autonomic dysfunction. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, characterized by an alpha-helix packed against a triple-stranded antiparallel beta-sheet, stabilized by four disulfide bridges with a characteristic C-C-CC-C-C pattern (cysteine framework II). Key functional residues should include a conserved hydrophobic patch and basic residues critical for interaction with the channel's voltage-sensor domain. The toxin should exhibit high affinity for mammalian Nav channels, contributing to the venom's defensive and predatory efficacy in the scorpion."}
{"description": "sp|P60215|SCX4_TITOB Beta-toxin To4 OS=Tityus obscurus OX=1221240 PE=1 SV=2", "sequence": "MTRFVLFISCFFLIGMIVECKDGYLMEYGGCKMSCLMKKGTFCAEECTRMKGKDGYCYAWLACYCYNMPDWVKIWNRATNKCGKRK", "prompt": "Design a beta-toxin protein sequence from the venom of the Brazilian scorpion Tityus obscurus. This toxin should function as a voltage-gated sodium channel modulator, specifically targeting insect sodium channels with high affinity and selectivity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) scaffold characteristic of scorpion beta-toxins, featuring a compact globular fold stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern. The structural core should consist of an alpha-helix packed against an antiparallel beta-sheet, creating the molecular surface responsible for receptor recognition. The toxin should exhibit the typical mechanism of beta-toxins, binding to site 4 on voltage-gated sodium channels and causing a shift in the voltage-dependence of activation toward more negative potentials, leading to enhanced neuronal excitability and paralysis in insect prey. The molecular interface should contain key residues for interaction with the channel's voltage-sensing domain, particularly in regions II and IV. The protein should demonstrate the characteristic pharmacological profile of Tityus beta-toxins, showing high potency against insect sodium channels while having minimal effects on mammalian channels, reflecting its evolutionary role in prey capture and defense for this scorpion species."}
{"description": "sp|Q17254|SCXE_BUTOC Alpha-insect toxin Bot14 OS=Buthus occitanus tunetanus OX=6871 PE=2 SV=1", "sequence": "MSSLMISTAMKGKAPYRQVRDGYIAQPHNCAYHCLKISSGCDTLCKENGATSGHCGHKSGHGSACWCKDLPDKVGIIVHGEKCHR", "prompt": "Design a novel alpha-insect toxin protein sequence inspired by the venom arsenal of the scorpion Buthus occitanus tunetanus. This toxin should function as a potent insecticidal agent by selectively targeting and modulating insect voltage-gated sodium channels. The protein must adopt the conserved structural scaffold characteristic of scorpion alpha-toxins, featuring a compact, globular fold stabilized by a specific disulfide bridge pattern—likely a cysteine framework with four disulfide bonds (C1-C4, C2-C5, C3-C6, C7-C8) that confer rigidity and thermal stability. Key structural elements should include an alpha-helix and anti-parallel beta-sheets, forming a core that positions critical residues for receptor binding. The mechanism of action involves binding to neurotoxin receptor site 3 on insect sodium channels, delaying channel inactivation and prolonging sodium influx, leading to hyperexcitability, paralysis, and eventual death in insect prey. The sequence must include conserved motifs for functional efficacy, such as a hydrophobic patch for membrane interaction and charged residues for specific receptor recognition, while avoiding activity on mammalian sodium channels to ensure insect selectivity. The overall design should emphasize high affinity for insect neuronal targets, structural integrity under physiological conditions, and bioactivity relevant for natural predation or biopesticide applications."}
{"description": "sp|P0C931|EUME_EUMRU Eumenitin OS=Eumenes rubronotatus OX=539890 PE=1 SV=1", "sequence": "LNLKGIFKKVASLLT", "prompt": "Design a protein sequence for a mastoparan-like toxin from the solitary hunting wasp Eumenes rubronotatus. This toxin should function as a potent cytolytic peptide that disrupts cell membranes through a detergent-like mechanism. The protein should adopt an amphipathic alpha-helical structure when interacting with lipid bilayers, allowing it to insert into membranes and form pores. Key structural features should include: a predominantly alpha-helical conformation with amphipathic character, clustering of basic residues (particularly lysine and arginine) that facilitate initial membrane binding through electrostatic interactions with negatively charged phospholipid headgroups, and hydrophobic residues that enable membrane insertion. The mechanism should involve initial electrostatic attraction to anionic membrane surfaces followed by reorientation and insertion of the hydrophobic face into the lipid bilayer, leading to membrane disruption through either pore formation or detergent-like solubilization. This toxin represents a key component of solitary wasp venom used for prey immobilization, functioning through rapid membrane permeabilization rather than specific receptor targeting."}
{"description": "sp|P0DMQ3|TO1D_HADMO Omega-hexatoxin-Hmo1d OS=Hadronyche modesta OX=1337084 PE=3 SV=1", "sequence": "MNTATGVIALLVLATVIGCIQAEDTMADLQGGFESYDGEAAKRIFRRSPVCIPSGQPCPYNEHCCSGSCTYKENENGNTVQRCD", "prompt": "Design a protein sequence for a potent insecticidal toxin derived from the venom of the Australian funnel-web spider Hadronyche modesta. This toxin belongs to the omega-hexatoxin family and functions as a selective insect calcium channel blocker. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves high-affinity binding to insect voltage-gated calcium channels, specifically blocking Cav2-type channels to disrupt neuromuscular transmission and induce rapid paralysis in insect prey. The structural scaffold should feature the characteristic ICK knotted topology with well-defined loops that form the pharmacophore for target recognition, particularly loops 2 and 4 which are critical for channel binding specificity. The toxin should exhibit the typical molecular weight range of 3-5 kDa and maintain the hydrophobic core common to spider venom ICK toxins while displaying the specific surface residues that confer insect selectivity over mammalian calcium channels."}
{"description": "sp|C1IC52|VKT2_WALAE Kunitz-type serine protease inhibitor spermatin OS=Walterinnesia aegyptia OX=64182 PE=1 SV=1", "sequence": "MSSGCLLLLLGLLTLWAELTPVSGRPRLCELPAESGLCNAYIPSFYYNPHSHKCQKFMYGGCGGNANNFKTIDECHRTCVG", "prompt": "Design a novel Kunitz-type serine protease inhibitor protein derived from the venom of the desert black snake, Walterinnesia aegyptia. This toxin should function as a potent spermatin-like inhibitor, specifically targeting and neutralizing key serine proteases involved in reproductive biology. The protein must adopt the canonical Kunitz domain fold, characterized by a compact, globular structure stabilized by three conserved disulfide bridges with a C1-C6, C2-C4, C3-C5 connectivity pattern. The core scaffold should feature an anti-parallel beta-sheet arrangement with short intervening loops, including a well-defined reactive site loop that presents the critical inhibitory residues for precise protease recognition and binding. The molecular mechanism should involve tight, reversible binding to the active site of target serine proteases, effectively blocking their catalytic function through standard mechanism inhibition. The sequence must encode all structural determinants necessary for proper folding, stability, and specific inhibitory activity while maintaining the evolutionary conserved features of the Kunitz-type toxin family."}
{"description": "sp|P0DQO1|PME2A_POEME Mu/delta-theraphotoxin-Pm2a OS=Poecilotheria metallica OX=1956341 PE=1 SV=1", "sequence": "GCTKFMGSCKTDADCCEHLECYKYKWCGWDGTF", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the Gooty sapphire ornamental tarantula (Poecilotheria metallica), a theraphosid spider whose venom contains a complex cocktail of neuroactive peptides targeting ion channels in the insect and vertebrate nervous system. This toxin belongs to the mu/delta-theraphotoxin family, a class of spider venom peptides known for their dual or promiscuous activity on voltage-gated sodium (NaV) and/or calcium (CaV) channels. The core function of this toxin is to disrupt neuronal excitability and synaptic transmission in prey, leading to rapid paralysis. Its mechanism of action likely involves modulation of NaV channels (potentially inhibiting inactivation to cause prolonged depolarization, consistent with mu-theraphotoxins) and/or CaV channels (possibly blocking presynaptic channels to inhibit neurotransmitter release, consistent with delta-theraphotoxins), resulting in disrupted motor function. The structural scaffold is anticipated to be the inhibitor cystine knot (ICK) motif, a hallmark of spider venom peptides, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (cysteine framework likely C-C-CC-C-C, with disulfide connectivity I-IV, II-V, III-VI forming the knot). This fold confers exceptional stability and precise molecular surface features for target engagement. The molecular target is expected to be voltage-gated sodium channels (e.g., NaV1.7 in pain pathways or insect NaV isoforms) and/or voltage-gated calcium channels (e.g., N-type or L-type CaV channels), with binding mediated by surface loops between cysteine residues that form a pharmacophore interface for channel interaction. Generate a protein sequence that embodies this ICK scaffold, disulfide pattern, and neurotoxic activity, ensuring it is consistent with the structural and functional principles of mu/delta-theraphotoxins from tarantula venoms."}
{"description": "sp|Q53B56|3L257_OPHHA Long neurotoxin OH-57 OS=Ophiophagus hannah OX=8665 PE=3 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGYTRICHKSSFISETCPDGQNLCYLKSWCDIFCGSRGERLEFGCAATCPEVKPGVNIECCSTDNCNPHPKLRP", "prompt": "Design a long neurotoxin protein sequence from the venom of Ophiophagus hannah (king cobra) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and antagonize nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis through competitive inhibition of acetylcholine binding. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework I (C-C-C-C-C-C-C-C). The structure should feature the elongated central loop characteristic of long neurotoxins, which enhances receptor binding affinity and specificity. The molecular mechanism involves high-affinity binding to the α-δ and α-γ subunit interfaces of muscle-type nicotinic receptors, effectively blocking neurotransmission and causing respiratory failure in prey. The sequence should maintain the conserved structural motifs essential for proper folding, receptor recognition, and toxic activity while exhibiting the specific molecular determinants that distinguish long neurotoxins from short-chain variants."}
{"description": "sp|Q9W7J3|PA2A2_PSETE Acidic phospholipase A2 2 OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MHPAHLLVPLGVCVSLLGAARIPPLPLSLVEFRILIKCANHNSRNVLDYADYGCYCGKGGSGTPVDELDRCCQAHDYCYDDAEKLPACNYRFSGPYWNPYSYKCNEGEVTCTDDNDECKAFICNCDRTAAICFAGAPYNDENFMITIKKKNICQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Eastern brown snake (Pseudonaja textilis). This enzyme should exhibit potent phospholipase A2 activity, specifically hydrolyzing the sn-2 acyl bond of glycerophospholipids to release lysophospholipids and free fatty acids, including arachidonic acid. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by multiple disulfide bridges. As an acidic isoform, it should have a calculated pI below 7.0 and contain the conserved catalytic triad (histidine-aspartate-tyrosine) essential for enzymatic activity. The toxin should function as a presynaptic neurotoxin that disrupts neuromuscular transmission by targeting nerve terminals, potentially leading to paralysis. Include structural elements that facilitate membrane binding and interfacial activation, with appropriate surface residues for calcium ion coordination required for catalytic function. The sequence should reflect the typical molecular weight range of 13-15 kDa for snake venom phospholipases A2 and maintain the structural stability necessary for venom delivery and target engagement."}
{"description": "sp|Q0NZY0|VM3B1_BOTJA Zinc metalloproteinase-disintegrin-like bothrojarin-1 (Fragment) OS=Bothrops jararaca OX=8724 PE=2 SV=1", "sequence": "DIVSPPVCGNYFVEVGEECDCGRPGKCQNPCCNATTCKLTPGSQCADGLCCDQCRFKGAGTECRAARSECDIAESCTGQSPECPTDDFQRNGQPCLNNQGYCYNGNCPILDHQCHNLFGAGATVAPDACFNFNRRGQGIYYCRKQNGVTIPCARKDIKCGRLFCVQ", "prompt": "Design a protein sequence for a snake venom metalloproteinase-disintegrin-like toxin derived from Bothrops jararaca, the jararaca pit viper. This toxin belongs to the reprolysin family of zinc-dependent metalloproteinases and functions as a key hemorrhagic agent in the venom. The protein should contain a metalloproteinase domain with the conserved zinc-binding motif HEXXHXXGXXH, which facilitates proteolytic cleavage of extracellular matrix components such as collagen and fibronectin, leading to tissue damage and hemorrhage. Additionally, incorporate a disintegrin-like domain characterized by the presence of a disintegrin loop with the sequence ECD, which inhibits integrin-mediated platelet aggregation by binding to αIIbβ3 integrin receptors on platelets, thereby disrupting hemostasis. The protein should adopt a multi-domain structure typical of SVMPs, with the metalloproteinase domain exhibiting a metzincin-like fold and the disintegrin-like domain forming a compact, cysteine-rich module stabilized by multiple disulfide bonds. Ensure the sequence includes appropriate cysteine residues for disulfide bridge formation to maintain structural integrity and functional specificity. The overall architecture should enable synergistic action between the proteolytic and anti-platelet activities, contributing to the venom's prey immobilization and digestion functions."}
{"description": "sp|P60275|SCXI_TITBA Insect toxin TbIT-1 OS=Tityus bahiensis OX=50343 PE=1 SV=1", "sequence": "GKEGYPVDSRGCKVTCFFTGAGYCDKECKLKKASSGYCAWPACYCYGLPDSVPVYDNASNKCB", "prompt": "Design a novel insecticidal neurotoxin protein sequence inspired by the venom of the Brazilian scorpion Tityus bahiensis. This toxin should function as a potent modulator of insect voltage-gated sodium channels, specifically targeting the central nervous system of insects to induce rapid paralysis and lethality. The protein should adopt a compact beta-sheet rich structural scaffold stabilized by a conserved cysteine framework characteristic of scorpion beta-toxins, featuring four disulfide bridges that confer exceptional thermal and proteolytic stability. Key structural elements should include a conserved core domain with an inhibitor cystine knot (ICK) motif, which facilitates precise interaction with the voltage-sensing domain of insect sodium channels, delaying channel inactivation and causing prolonged neuronal depolarization. The molecular mechanism should involve high-affinity binding to receptor site 4 on insect sodium channels, leading to uncontrolled neurotransmitter release and synaptic disruption. The sequence must maintain the evolutionary conserved pharmacophore residues essential for insect selectivity while excluding mammalian sodium channel activity, ensuring target specificity. The overall architecture should reflect the compact, globular fold typical of scorpion neurotoxins, with surface-exposed loops mediating target recognition and membrane interaction."}
{"description": "sp|C0K3N3|TXVE_CROAT Snake venom vascular endothelial growth factor toxin cratrin OS=Crotalus atrox OX=8730 PE=2 SV=1", "sequence": "MAVYLLAVAILFCIQGWPSGTVQGQAMSFMEVYERSVCQTREMLVSILDEYPSEVAHLFRPSCVTVLRCGGCCTDESLTCTATGKRSVGREIMRVDPRKGTSKIEVMQFTEHTECECRPRSTVNNGKRKKNPKEGEPRAKFPLV", "prompt": "Design a snake venom toxin protein that functions as a vascular endothelial growth factor (VEGF) homolog, specifically derived from the Western diamondback rattlesnake (Crotalus atrox). This toxin should mimic the structure and function of endogenous VEGF but serve as a pathogenic factor in envenomation. The protein should adopt the characteristic VEGF fold, featuring a cysteine-knot motif with conserved disulfide bridges that stabilize the homodimeric structure. Key functional elements must include receptor-binding domains that interact with VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, promoting vascular permeability, angiogenesis, and contributing to localized edema and systemic effects during envenomation. The sequence should maintain the core structural scaffold of VEGF family proteins while incorporating venom-specific adaptations that enhance stability and potency in the toxic context. Focus on preserving the critical residues involved in receptor binding and dimerization, ensuring the toxin effectively disrupts normal vascular homeostasis through pathological VEGF signaling."}
{"description": "sp|P59940|KGX4C_CENSC Potassium channel toxin gamma-KTx 4.12 OS=Centruroides sculpturatus OX=218467 PE=1 SV=1", "sequence": "ERDSCVEKSKCGKYGYYGQCDECCKKAGDRAGTCVYYKCKCNP", "prompt": "Design a potassium channel toxin protein from the venom of the Arizona bark scorpion (Centruroides sculpturatus) that functions as a potent and selective blocker of voltage-gated potassium channels. This toxin should belong to the gamma-KTx family and exhibit the characteristic structural scaffold of scorpion potassium channel toxins. The protein should adopt a compact, globular fold stabilized by a conserved disulfide bridge pattern typical of scorpion toxins, likely featuring three disulfide bonds with a C1-C4, C2-C5, C3-C6 connectivity that forms a stable core structure. The molecular mechanism involves high-affinity binding to the pore region of Kv1.x family potassium channels, effectively blocking potassium ion flux and disrupting neuronal excitability. The toxin should contain a functional dyad consisting of a critical lysine residue that penetrates the channel pore and an aromatic residue that stabilizes binding through hydrophobic interactions. The structural fold should include a conserved alpha-helix and anti-parallel beta-sheet arrangement that positions key functional residues for optimal channel blockade. This toxin contributes to the neurotoxic effects of scorpion venom by prolonging action potentials and enhancing neurotransmitter release at nerve terminals."}
{"description": "sp|Q9W7J4|PA2A1_PSETE Acidic phospholipase A2 1 OS=Pseudonaja textilis OX=8673 PE=1 SV=1", "sequence": "MHPAHLLVLLGVCVSLLGAARIPPLPLSLDDFSNLITCANRGSRSWLDYAHYGCFCGSGGSGTPVDDLDRCCQVHDNCFGDAEKLPACNYLFSGPYWNPYSYKCNEGEITCTDDNDECAAFICNCDRTAAICFAGATYNDENFMVTIKKKNICQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the Eastern brown snake (Pseudonaja textilis). This enzyme plays a critical role in the snake's venom by hydrolyzing the sn-2 acyl bond of glycerophospholipids, releasing lysophospholipids and free fatty acids. The resulting membrane disruption and generation of pro-inflammatory lipid mediators contribute to the venom's potent hemolytic, myotoxic, and neurotoxic effects. The protein should adopt the characteristic phospholipase A2 fold, featuring three long alpha-helices stabilized by a conserved network of disulfide bridges (typically 6-8 cysteine residues forming 3-4 disulfide bonds). Key catalytic residues include a conserved histidine-aspartate dyad and a calcium-binding loop essential for enzymatic activity. The acidic nature of this isoform suggests enhanced interaction with specific membrane components or protein targets, potentially modulating its potency and specificity. The structural scaffold should ensure proper orientation of the hydrophobic channel for substrate access and the interfacial binding surface for membrane association."}
{"description": "sp|B1P1B0|JZ50A_CHIGU U4-theraphotoxin-Cg1a OS=Chilobrachys guangxiensis OX=278060 PE=1 SV=1", "sequence": "MNATIFALLLLLNLAMYNAAEQSSETDMDDTLLIPEINRGRCIEEGKWCPKKAPCCGRLECKGPSPKQKKCTRP", "prompt": "Generate the amino acid sequence for a theraphotoxin from the Chinese earth tiger tarantula (Chilobrachys guangxiensis), specifically the U4-theraphotoxin-Cg1a variant. This toxin belongs to the inhibitor cystine knot (ICK) structural family, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms a rigid, knotted core. The toxin functions as a voltage-gated sodium channel modulator, likely targeting insect or mammalian Nav channels to induce paralysis by altering channel gating kinetics—either through inhibition or persistent activation. The sequence should include the canonical ICK motif with six cysteine residues in the appropriate spacing to form the knot, along with surface loops that mediate target specificity. Key structural features include a hydrophobic patch for membrane interaction and positively charged residues for channel binding. The biological role involves prey immobilization, contributing to the venom's neurotoxic arsenal. Ensure the sequence reflects high stability, protease resistance, and target selectivity inherent to ICK toxins."}
{"description": "sp|P0C909|KAX3B_ODODO Potassium channel toxin alpha-KTx 3.11 OS=Odontobuthus doriae OX=342590 PE=1 SV=1", "sequence": "GVPTDVKCRGSPQCIQPCKDAGMRFGKCMNGKCHCTPK", "prompt": "Design a potent animal toxin peptide that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. This toxin should originate from the venom of Odontobuthus doriae, a scorpion species whose venom components are evolutionarily optimized for rapid neuronal targeting and prey immobilization. The peptide must adopt the conserved alpha-KTx structural scaffold, characterized by a compact, stable fold stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern, forming a classic cysteine-stabilized alpha-beta (CSαβ) motif. The core structure should feature a short alpha-helix packed against an anti-parallel beta-sheet, creating a molecular surface rich in basic residues (e.g., lysine, arginine) that mediate specific interactions with the pore region of Kv channels. The mechanism of action involves physical occlusion of the potassium channel pore, inhibiting potassium ion efflux, leading to prolonged membrane depolarization, enhanced neurotransmitter release, and ultimately neuromuscular paralysis. Key functional residues should be positioned within a conserved functional dyad, typically involving a critical lysine residue that penetrates the channel pore and a neighboring aromatic or hydrophobic residue that stabilizes binding. The peptide must exhibit thermodynamic stability, protease resistance, and nanomolar affinity for its target channels, consistent with the biophysical properties of scorpion venom toxins used in prey subjugation."}
{"description": "sp|P86453|PA2HB_BOTAL Basic phospholipase A2 homolog BaTX OS=Bothrops alternatus OX=64174 PE=1 SV=1", "sequence": "SLFELGKMILQETGKNPAKSYGAYYCYCGWGGQGQPKDATDRCCYVHKCCYKKLTGCNPKKDRYSYSWKDKTIVCGENNSCLKELCECDKAVAICLRENLNTYNKKYRYYLKPLCKKADAC", "prompt": "Design a protein sequence for a basic phospholipase A2 homolog from the venom of Bothrops alternatus (Urutu snake). This toxin represents a catalytically inactive phospholipase A2 homolog that retains membrane-binding capabilities and exhibits myotoxic activity. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices stabilized by a conserved network of seven disulfide bonds. Key structural elements should include the calcium-binding loop, the conserved active site region (though rendered inactive through specific residue substitutions), and the interfacial binding surface that facilitates membrane association. The toxin should demonstrate preferential binding to anionic phospholipid membranes and exert myotoxicity through mechanisms involving membrane disruption rather than enzymatic hydrolysis. The sequence should maintain the overall structural stability and basic character typical of this toxin class, which contributes to its tissue-targeting properties in envenomation."}
{"description": "sp|P59939|KGX31_CENNO Potassium channel toxin gamma-KTx 3.1 OS=Centruroides noxius OX=6878 PE=1 SV=1", "sequence": "GRDSCVNKSRCAKYGYYSQCEVCCKKAGHKGGTCDFFKCKCKV", "prompt": "Design a potassium channel toxin protein sequence that mimics the biological activity and structural characteristics of gamma-KTx 3.1 from the venom of the Mexican scorpion Centruroides noxius. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1 subfamily channels with high affinity. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion potassium channel toxins, featuring a compact globular structure stabilized by three disulfide bridges with the typical C1-C4, C2-C5, C3-C6 connectivity pattern. The structural scaffold should include a short alpha-helix and an antiparallel beta-sheet stabilized by the disulfide network. The functional core should contain key residues in the beta-sheet region that form the molecular interface for channel blockade, interacting with the pore region of Kv1 channels to physically occlude potassium ion conduction. The toxin should exhibit the characteristic pharmacological profile of gamma-KTx toxins, showing preferential blockade of Kv1.2 and Kv1.3 channels while maintaining the thermal and proteolytic stability typical of scorpion venom peptides. The sequence should encode all necessary structural determinants for proper folding, including the conserved cysteine framework and critical functional residues responsible for channel recognition and blockade efficacy."}
{"description": "sp|P0C164|KAX2B_CENEL Potassium channel toxin alpha-KTx 2.11 OS=Centruroides elegans OX=217897 PE=1 SV=1", "sequence": "TIINVKCTSPKQCLLPCKEIYGIHAGAKCMNGKCKCYKI", "prompt": "Design a potassium channel toxin protein from the venom of the scorpion Centruroides elegans, belonging to the alpha-KTx toxin family. This toxin functions as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a short alpha-helix stabilized against a two- or three-stranded anti-parallel beta-sheet by three or four disulfide bridges. The cysteine framework typically follows the pattern C-X(3-7)-C-X(3-7)-C-X(0-4)-C-C-X(4-13)-C-X(1-4)-C, with disulfide connectivity of C1-C4, C2-C5, and C3-C6. The functional core includes a critical dyad or triad of residues (often involving a lysine and aromatic residues) that insert into the potassium channel pore, mimicking the potassium ion and physically occluding ion conduction. The toxin should exhibit high affinity and selectivity for its target potassium channels, contributing to the neurotoxic effects of the venom by disrupting neuronal excitability and synaptic transmission. The structural scaffold must ensure proper folding, stability in the venom milieu, and precise molecular recognition of the potassium channel vestibule."}
{"description": "sp|P60992|TX1A_HETMC Delta-theraphotoxin-Hm1a OS=Heteroscodra maculata OX=268413 PE=1 SV=1", "sequence": "ECRYLFGGCSSTSDCCKHLSCRSDWKYCAWDGTFS", "prompt": "Design a potent animal toxin protein sequence that functions as a delta-theraphotoxin, specifically from the venom of the ornamental baboon tarantula (Heteroscodra maculata). This toxin should act as a selective inhibitor of vertebrate voltage-gated sodium channels, particularly targeting the Nav1.1 subtype. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). The molecular mechanism involves binding to the voltage-sensing domain of the sodium channel, delaying channel inactivation and prolonging action potentials, leading to neuronal hyperexcitability and potent neurotoxic effects. The sequence should include key functional residues for receptor interaction while maintaining the structural integrity of the ICK scaffold essential for thermal stability and protease resistance in the venom environment."}
{"description": "sp|P01496|SCX3_TITSE Alpha-mammal toxin Ts3 OS=Tityus serrulatus OX=6887 PE=1 SV=5", "sequence": "MNYFILLVVVCLLTAGTEGKKDGYPVEYDNCAYICWNYDNAYCDKLCKDKKADSGYCYWVHILCYCYGLPDSEPTKTNGKCKSGKK", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This is an alpha-mammal toxin from the Brazilian yellow scorpion Tityus serrulatus, a medically significant species whose venom contains potent neurotoxins targeting mammalian nervous systems. The toxin functions as a voltage-gated sodium channel modulator, specifically interacting with Nav1.6 and Nav1.7 channel subtypes. Its mechanism involves binding to site 3 of voltage-gated sodium channels, causing a slowing of channel inactivation and prolonging action potentials, leading to sustained neuronal excitation and neurotoxic effects. The protein should adopt the conserved scorpion toxin fold characterized by an inhibitor cystine knot (ICK) structural motif, featuring a compact globular architecture stabilized by four disulfide bridges with a characteristic C-C-CC-C-C cysteine framework. The tertiary structure should display a triple-stranded antiparallel beta-sheet stabilized by the disulfide core, with key functional residues concentrated in flexible loops that form the molecular interface for sodium channel recognition. The binding interface should include conserved aromatic and basic residues that interact with specific extracellular loops of the sodium channel voltage-sensing domain. The sequence should maintain the characteristic molecular weight of approximately 7-8 kDa typical of scorpion alpha-toxins while incorporating the specific pharmacological profile that distinguishes Tityus serrulatus toxins from other scorpion venom components."}
{"description": "sp|C1J5M7|CM3C_CONBU Mu-conotoxin BuIIIC OS=Conus bullatus OX=89438 PE=1 SV=1", "sequence": "MMSKLGVLLTICLLLFPLFALPQDGDQPADRPAERMQDDLSSEQHPLFEKRIVDRCCNKGNGKRGCSRWCRDHSRCCGRR", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of Conus bullatus, a marine cone snail species. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the Nav1.4 subtype predominantly expressed in skeletal muscle. The mechanism of action involves high-affinity binding to site 1 of the sodium channel, effectively blocking sodium ion flux and inducing rapid neuromuscular paralysis. The structural scaffold must feature the characteristic mu-conotoxin cysteine framework (C-C-CC-C-C) with three disulfide bridges forming a compact, globular fold stabilized by extensive beta-sheet secondary structure. Key functional residues should be strategically positioned within loop regions to mediate specific molecular recognition and binding to the extracellular domain of the Nav1.4 channel, ensuring minimal cross-reactivity with other sodium channel isoforms. The overall architecture should exhibit high thermal and proteolytic stability, typical of conopeptides, to maintain efficacy in the hostile environment of the envenomation site."}
{"description": "sp|P83745|TX1_THEBL Kappa-theraphotoxin-Tb1a OS=Theraphosa blondi OX=260533 PE=1 SV=1", "sequence": "AACLGMFESCDPNNDKCCPNRECNRKHKWCKYKLW", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is a kappa-theraphotoxin originating from the venom of the Goliath birdeater tarantula (Theraphosa blondi), a large therapiosid spider whose venom contains diverse neuroactive peptides targeting ion channels. As a kappa-theraphotoxin, this peptide functions as a potent potassium channel blocker, specifically inhibiting voltage-gated potassium channels (likely Kv1 subtypes) to disrupt neuronal repolarization and cause hyperexcitability in the nervous system of prey. The structural scaffold should feature the characteristic inhibitor cysteine knot (ICK) motif common to spider toxins, with a conserved disulfide bridge pattern of C1-C4, C2-C5, C3-C6 that creates a stable, compact triple-stranded beta-sheet fold. The sequence should include key functional residues for potassium channel interaction, particularly a functional dyad or triad involved in channel pore occlusion, with appropriate hydrophobic and basic residues positioned to interact with the channel's voltage-sensing domain and pore region. The mature peptide should be 30-40 amino acids in length with high structural stability and target specificity characteristic of spider venom peptides."}
{"description": "sp|P01501|MEL_APIME Melittin OS=Apis mellifera OX=7460 GN=MELT PE=1 SV=1", "sequence": "MKFLVNVALVFMVVYISYIYAAPEPEPAPEPEAEADAEADPEAGIGAVLKVLTTGLPALISWIKRKRQQG", "prompt": "Design a protein sequence for melittin, a major component of honeybee (Apis mellifera) venom that functions as a potent cytolytic peptide. This toxin exhibits broad-spectrum membrane-disrupting activity through its amphipathic alpha-helical structure, which enables insertion into lipid bilayers and formation of transmembrane pores. The protein should adopt a predominantly alpha-helical conformation with distinct amphipathic character, featuring hydrophobic residues on one face and cationic residues on the opposing face. This arrangement facilitates initial electrostatic interactions with anionic phospholipid head groups followed by hydrophobic insertion into the membrane core. The sequence should include the characteristic N-terminal hydrophobic domain and C-terminal hydrophilic region that together enable toroidal pore formation in eukaryotic cell membranes, leading to osmotic lysis and cell death. The mechanism involves non-specific targeting of various cell types through lipid bilayer disruption rather than receptor-mediated binding, making it a general cytolysin with hemolytic, antimicrobial, and mast cell degranulation activities."}
{"description": "sp|P0DQP6|PA21_CERGO Basic phospholipase A2 (Fragment) OS=Cerrophidion godmani OX=44722 PE=1 SV=1", "sequence": "HLFQFREMIKEMTGKEPVVSYAFYGCYCGKGGRGKPDAT", "prompt": "Design a functional phospholipase A2 toxin fragment derived from the venom of the hognosed pitviper Cerrophidion godmani. This toxin should exhibit the characteristic enzymatic activity of hydrolyzing the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the canonical phospholipase A2 fold featuring three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop with the signature YGCXCG motif. Include the essential catalytic dyad of histidine and aspartate residues within the active site pocket, along with the conserved network of disulfide bridges that stabilize the compact globular structure. The toxin should demonstrate membrane-binding capability through hydrophobic surface patches and exhibit the typical venom PLA2 properties of myotoxicity, neurotoxicity, or anticoagulant activity, depending on specific surface residues that determine target specificity. Maintain the characteristic molecular weight range of 13-15 kDa and the high thermal stability typical of snake venom phospholipases A2."}
{"description": "sp|P23028|PA2HD_PSETE Acidic phospholipase A2 homolog textilotoxin D chain OS=Pseudonaja textilis OX=8673 PE=1 SV=2", "sequence": "MHPAHLLVLLGVCVSLLGAASIPRPSLNIMLFGNMIQCTIPCEQSWLGYLDYGCYCGSGSSGIPVDDVDKCCKTHDECYYKAGQIPGCSVQPNEVFNVDYSYECNEGQLTCNESNNECEMAVCNCDRAAAICFARFPYNKNYWSINTEIHCR", "prompt": "Design a protein sequence for an acidic phospholipase A2 homolog that functions as the D chain component of textilotoxin, a potent presynaptic neurotoxin complex from the venom of the Australian eastern brown snake (Pseudonaja textilis). This protein should adopt the canonical phospholipase A2 fold characterized by three long alpha-helices stabilized by a conserved pattern of seven disulfide bridges, yet it should lack catalytic activity due to critical substitutions in the calcium-binding and catalytic sites that render it enzymatically inactive. As part of the textilotoxin heteropentameric complex, this D chain homolog must exhibit specific protein-protein interaction interfaces to assemble with other subunits while contributing to the toxin's mechanism of presynaptic neuromuscular blockade. The sequence should maintain the structural integrity of the phospholipase A2 scaffold, including the conserved hydrophobic channel and interfacial binding surface, while incorporating the molecular determinants that enable its role as a non-enzymatic component in this synergistic neurotoxin complex that disrupts acetylcholine release at motor nerve terminals."}
{"description": "sp|A6YR23|COC1C_CONCL Mu-conotoxin-like Cal 12.1.1c OS=Californiconus californicus OX=1736779 PE=2 SV=1", "sequence": "DVCDSLVEGRCIHNGCWCDEEAPHGNCCDTAGCTAWWWCPGTKFD", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the California cone snail, Californiconus californicus. This peptide should function as a potent sodium channel blocker, specifically targeting voltage-gated sodium channels in the peripheral nervous system to induce neuromuscular paralysis. The toxin should adopt the characteristic mu-conotoxin structural scaffold featuring a compact, globular fold stabilized by a conserved cysteine framework with the pattern C-C-CC-C-C, forming three intramolecular disulfide bridges that create a stable inhibitory cystine knot (ICK) motif. The structural core should consist of a triple-stranded beta-sheet arrangement with tight turns, providing a rigid platform for precise interaction with sodium channel pore domains. Key functional residues should be strategically positioned in loop regions to facilitate high-affinity binding to site 1 of voltage-gated sodium channels, effectively blocking ion conduction and preventing action potential propagation. The peptide should exhibit specificity for neuronal or skeletal muscle sodium channel subtypes, contributing to the predatory efficiency of the cone snail's venom cocktail by rapidly immobilizing prey through disruption of neuromuscular transmission."}
{"description": "sp|Q9W6M5|VM3AH_DEIAC Zinc metalloproteinase-disintegrin-like acurhagin OS=Deinagkistrodon acutus OX=36307 PE=1 SV=2", "sequence": "MIQVLLVTICLAAFPYQGSSIILESGDVNDYEVVYPRKVTALPKGAVQQKYEDAMQYEFKVNGEPVVLHLEKNKHLFSKDYSETHYSPDGREITINPPVEDHCYYHGRIENDGDSTASISACNGLKGNFKLQGETYLIEPMKLSDSEAHAVFKYENVEKEDEAPKMCGVTQKWKSYEPIKKISQLNLIPEQQIYDPFKYVETVVVVDKAMVTKYNGDLDKIKTKMYEAANNMNEMYRYMFFRVVMVGLIIWTEEDKITVKPDVDYTLNAFAEWRKTYLLAEKKHDNAQLITGIDFRGSIIGYAYIGSMCHPKRSVGIIQDYSPINLVLAVIMAHEMGHNLGIHHDDGYCYCGGYPCIMGPSISPEPSKFFSNCSYIQCWDFIMNHNPECIDNEPLGTDIISPPLCGNELLEVGEECDCGTPENCQNECCDAATCKLKSGSQCGHGDCCEQCKFRTSGTECRASMSECDPAEHCTGQSSECPADVFHKNGEPCLDNYGYCYNGNCPIMYHQCYALFGADIYEAEDSCFESNKKGNYYGYCRKENGKKIPCASEDVKCGRLYCKDDSPGQNNPCKMFYSNDDEHKGMVLPGTKCADGKVCSNGHCVDVTTAY", "prompt": "Design a venom protein sequence that functions as a zinc metalloproteinase-disintegrin-like toxin from the venom of the hundred-pacer snake, Deinagkistrodon acutus. This protein should exhibit the characteristic multi-domain architecture typical of snake venom metalloproteinases (SVMPs), comprising a metalloproteinase domain responsible for proteolytic degradation of extracellular matrix components such as collagen, fibronectin, and laminin, which contributes to hemorrhage and tissue damage. The disintegrin-like domain should mediate inhibition of platelet aggregation by antagonizing integrin receptors on platelet surfaces, thereby disrupting hemostasis. The protein must incorporate the conserved zinc-binding motif (HEXXHXXGXXH) within the metalloproteinase domain for catalytic activity, and maintain the appropriate cysteine framework for disulfide bond formation that stabilizes the protein's tertiary structure. The overall fold should reflect the modular organization of SVMPs, with distinct domains connected by flexible linkers, enabling synergistic toxic effects that facilitate prey immobilization through combined hemorrhagic and anti-coagulant mechanisms."}
{"description": "sp|P86523|PA2AA_ACAAN Phospholipase A2 P-elapitoxin-Aa1a alpha chain (Fragment) OS=Acanthophis antarcticus OX=8605 PE=1 SV=1", "sequence": "NLLQFGFMIRCANKRRRPVWPYEESGC", "prompt": "Design a protein sequence for a potent snake venom phospholipase A2 toxin from the common death adder (Acanthophis antarcticus). This enzyme should function as a presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of acetylcholine release. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad. It should contain the typical pancreatic-type phospholipase A2 disulfide bridge pattern with multiple conserved cysteine residues forming a stable structural scaffold. The toxin should exhibit high affinity for neuronal membranes and demonstrate both enzymatic activity (hydrolyzing the sn-2 acyl bond of glycerophospholipids) and neurotoxic effects through membrane disruption and interference with vesicle fusion machinery. The sequence should reflect the characteristic features of elapid snake venom phospholipases A2, including conserved regions for membrane binding and catalytic efficiency, while maintaining the structural stability required for venom delivery and target engagement."}
{"description": "sp|Q9YGP1|LECG_TRIST C-type lectin TsL OS=Trimeresurus stejnegeri OX=39682 PE=1 SV=1", "sequence": "MGRFIFVSFGLLVVFLSLSGAKGSCCTNDSLPMNGMCYKIFDEPKTWEDAEMFCRKYKPGCHLASFHRLAESLDIAEYISDYHKRQAEVWIGLLDRKKDFSWEWTDRSCTDYLNWDKNQPDHYKDKEFCVELVSLTGYHRWNDQVCESKNSFLCQCKF", "prompt": "Design a novel C-type lectin protein from the venom of Trimeresurus stejnegeri, the Chinese green tree viper. This toxin should function as a potent anticoagulant by specifically binding to coagulation factors in the blood, disrupting the coagulation cascade through calcium-dependent carbohydrate recognition. The protein should adopt the characteristic C-type lectin fold consisting of a globular domain with two alpha-helices and several beta-strands arranged in a beta-sandwich structure. Include the conserved C-type lectin domain with its signature calcium-binding site formed by conserved glutamate and asparagine residues that coordinate calcium ions essential for carbohydrate recognition. The structure should feature the typical disulfide bridge pattern common to snake venom C-type lectins, likely with 4-6 conserved cysteine residues forming 2-3 disulfide bonds that stabilize the globular fold. The molecular surface should present key recognition loops that mediate specific binding to coagulation factors such as factor IX, factor X, or other components of the coagulation system, leading to anticoagulant effects through competitive inhibition or allosteric modulation. The protein should exhibit the characteristic oligomeric state often seen in snake venom C-type lectins, potentially forming heterodimers or higher-order complexes that enhance target recognition and functional potency. The overall architecture should reflect the evolutionary optimization of this scaffold for rapid and specific interference with hemostatic processes in prey organisms."}
{"description": "sp|P23026|PA2BA_PSETE Basic phospholipase A2 textilotoxin A chain OS=Pseudonaja textilis OX=8673 PE=1 SV=3", "sequence": "MHPAHLLVLLGVCVSLLGASDIPPLPLNLVQFSYLIRCANKYKRPGWHYANYGCYCGSGGRGTPVDDVDRCCQAHDKCYEDAEKLGCYPKWTTYYYYCGANGPYCKTRTKCQRFVCNCDVVAADCFASYPYNRRYWFYSNKKRCR", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the Australian eastern brown snake (Pseudonaja textilis), specifically the A chain of textilotoxin. This toxin functions as a potent presynaptic neurotoxin that targets the neuromuscular junction, causing irreversible blockade of neurotransmitter release and leading to progressive paralysis. The protein should adopt the characteristic phospholipase A2 fold with a conserved calcium-binding loop and catalytic histidine-aspartate dyad essential for hydrolyzing the sn-2 ester bond of membrane phospholipids, generating lysophospholipids and free fatty acids that disrupt membrane integrity. Incorporate the canonical disulfide bridge pattern (Cys1-Cys11, Cys2-Cys7, Cys3-Cys17, Cys4-Cys10, Cys5-Cys15, Cys6-Cys14) that stabilizes the globular structure and enables interaction with presynaptic targets. The sequence should exhibit basic residues that facilitate membrane penetration and enhance neurotoxic potency through electrostatic interactions with anionic phospholipid headgroups. Ensure the protein retains the hydrophobic channel for substrate access to the active site and the β-wing region implicated in target specificity, while maintaining the structural stability required for venom delivery and function."}
{"description": "sp|P01500|APAM_APIME Apamin OS=Apis mellifera OX=7460 PE=1 SV=2", "sequence": "MISMLRCIYLFLSVILITSYFVTPVMPCNCKAPETALCARRCQQHG", "prompt": "Design a protein sequence for apamin, a potent neurotoxin from the venom of the European honey bee (Apis mellifera). Apamin is a key component of bee venom that contributes to its neurotoxic effects by selectively blocking small-conductance calcium-activated potassium channels (SK channels) in the central nervous system. This toxin functions as a specific SK channel antagonist, disrupting neuronal excitability and synaptic transmission through inhibition of afterhyperpolarization currents. The protein adopts a compact, globular structure stabilized by two disulfide bonds in a C1-C11, C3-C15 connectivity pattern, forming a characteristic cysteine-stabilized alpha-helix (CSα) motif. The core structural scaffold consists of an alpha-helix spanning residues 6-13, constrained by the disulfide network that confers exceptional thermal and proteolytic stability. Key functional residues include arginine at position 13, which is critical for channel binding and blockade activity. The mature toxin should be 18 amino acids in length with the characteristic bee venom peptide signature, exhibiting high specificity for SK2 and SK3 channel subtypes while sparing other potassium channel families. The sequence must maintain the conserved structural fold that enables precise molecular recognition of the SK channel pore region."}
{"description": "sp|P60163|SCX2_CENGR Toxin Cg2 OS=Centruroides gracilis OX=217898 PE=2 SV=1", "sequence": "KDGYLVNKSTGCKYSCIENINDSHCNEECISSIRKGSYGYCYKFYCYCIGMPDSTQVYPIPGKTCSTE", "prompt": "Design a novel scorpion toxin protein sequence inspired by the beta-toxin family from Centruroides gracilis venom. This toxin should function as a potent voltage-gated sodium channel (Nav) modulator, specifically targeting insect sodium channels to induce excitatory neurotoxicity through a 'beta-toxin' mechanism of action. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) structural fold characteristic of scorpion toxins, featuring a compact globular architecture stabilized by four disulfide bridges with the canonical C-C-CC-C-C connectivity pattern. The core scaffold should consist of an alpha-helix packed against an antiparallel beta-sheet, with key functional residues positioned to interact with receptor site 4 on domain II of voltage-gated sodium channels. The sequence should include the conserved structural motifs that enable the toxin to modify channel gating kinetics by shifting voltage-dependence of activation toward more negative potentials, resulting in spontaneous and repetitive neuronal firing. The molecular surface should present a functional epitope with both hydrophobic and charged residues optimized for high-affinity binding to insect sodium channels while maintaining the thermodynamic stability typical of scorpion venom peptides. The overall design should reflect the evolutionary optimization of this toxin family for rapid paralysis of arthropod prey through disruption of neuromuscular signaling."}
{"description": "sp|P0CAQ6|CA16A_CONLE Alpha-conotoxin-like Lp1.6a OS=Conus leopardus OX=101306 PE=1 SV=1", "sequence": "MGMRMMFIIFLFVVLATTVVSFTSGRASDGRNAPANNKVSDLIRQFCCGHYDCDFIPNVCG", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus leopardus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two conserved disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern (cysteine framework I). The sequence should include the essential pharmacophore elements for nAChR binding, including key residues in the inter-cysteine loops that mediate specific interactions with receptor subunits. The N-terminal region should contribute to receptor subtype selectivity, while the core structure maintains the inhibitory cystine knot (ICK) motif typical of conotoxins, ensuring high stability and resistance to proteolytic degradation. The overall architecture should facilitate precise molecular recognition of nAChR ligand-binding domains, resulting in reversible blockade of ion channel function and modulation of cholinergic signaling pathways."}
{"description": "sp|P0C165|KAX2C_CENEL Potassium channel toxin alpha-KTx 2.12 OS=Centruroides elegans OX=217897 PE=1 SV=1", "sequence": "TIINVKCTSPKQCLPPCKEIYGRHAGAKCMNGKCHCSKI", "prompt": "Design a novel potassium channel toxin protein sequence inspired by scorpion venom biochemistry. This toxin should belong to the alpha-KTx family, specifically emulating the structural and functional characteristics of toxins from Centruroides elegans. The protein must function as a potent and selective blocker of voltage-gated potassium channels, particularly Kv1 family channels, to disrupt neuronal excitability and neuromuscular signaling. The structural scaffold should feature the conserved alpha-KTx fold characterized by an inhibitor cysteine knot (ICK) motif with a beta-sheet-rich core stabilized by three disulfide bridges in a C1-C4, C2-C5, C3-C6 connectivity pattern. The sequence must include a functional dyad comprising a critical lysine residue positioned to occlude the potassium selectivity filter and an adjacent aromatic residue that enhances binding affinity through hydrophobic interactions with the channel vestibule. The N-terminal region should be structured to facilitate initial docking, while the C-terminal tail remains flexible for optimal target engagement. Ensure the protein exhibits high thermal stability and protease resistance typical of scorpion toxins, with molecular recognition properties that confer specificity for potassium channels over other ion channel types."}
{"description": "sp|C3TS08|STX71_ANEVI Delta-actitoxin-Avd2b 1 OS=Anemonia viridis OX=51769 PE=3 SV=1", "sequence": "MMNRLLVFLMLGAAFMLVVSANDAYGDEPAFKDLNQGDESLGKRKSCCPCWLRGNCFWGQNCYPEGCSGPKV", "prompt": "Design a novel animal toxin protein sequence inspired by delta-actitoxin-Avd2b from the sea anemone Anemonia viridis. This toxin should function as a potent modulator of voltage-gated sodium channels, specifically targeting site 3 to delay channel inactivation and prolong action potentials, leading to neuroexcitatory effects and potential paralysis in prey organisms. The protein should adopt a compact, stable beta-sheet-rich fold stabilized by a conserved disulfide bridge pattern characteristic of sea anemone toxins, likely involving three disulfide bonds forming a core structural scaffold that confers resistance to proteolytic degradation and thermal denaturation. Key structural elements should include well-defined loops and surface-exposed residues critical for interacting with the voltage-sensing domain of sodium channels, particularly residues involved in binding to the S3-S4 extracellular loop. The sequence should maintain the typical molecular weight range of 4-6 kDa and exhibit high specificity for vertebrate or invertebrate sodium channel subtypes, depending on the ecological role of the toxin in sea anemone venom for prey capture or defense."}
{"description": "sp|P60164|KA111_PARVI Potassium channel toxin alpha-KTx 11.1 OS=Parabuthus villosus OX=252780 PE=1 SV=1", "sequence": "DEEPKESCSDEMCVIYCKGEEYSTGVCDGPQKCKCSD", "prompt": "Design a potassium channel toxin protein sequence that embodies the venom strategy of the Parabuthus villosus scorpion. This toxin should function as a potent and selective blocker of voltage-gated potassium channels, specifically targeting Kv1-type channels to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved alpha-KTx structural scaffold characterized by an inhibitor cysteine knot (ICK) motif, featuring a compact beta-sheet core stabilized by three disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. Key structural elements should include a functional dyad comprising a critical lysine residue positioned in the beta-sheet region that penetrates the channel pore, and an aromatic residue that stabilizes binding through interactions with the channel vestibule. The sequence should maintain the characteristic alpha-helix and anti-parallel beta-sheet arrangement typical of scorpion potassium channel toxins, with the conserved molecular surface responsible for channel recognition and blockade. The toxin should exhibit high affinity for its potassium channel targets while maintaining the thermal stability and protease resistance conferred by the ICK fold, enabling effective disruption of potassium conductance in prey organisms."}
{"description": "sp|Q1I163|SCX8_TITDI Toxin Td8 OS=Tityus discrepans OX=57059 PE=1 SV=2", "sequence": "MTRFVLFLSCFFLIGMVVECKDGYLVGDDGCKMHCFTRPGHYCASECSRVKGKDGYCYAWLACYCYNMPNWAPIWNSATNRCRGRK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the scorpion Tityus discrepans. This toxin should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav) to disrupt neuronal signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, globular fold stabilized by a cysteine-stabilized α-helix/β-sheet (CSαβ) motif. The core architecture must include four disulfide bridges with the canonical cysteine framework (C-C-CC-C-C) that defines the scorpion toxin superfamily, ensuring proper folding into a stable, triple-stranded antiparallel β-sheet paired with a single α-helix. Key functional residues should be positioned to interact with the S1-S2 and S3-S4 extracellular loops of domain II or IV of Nav channels, inducing a hyperpolarizing shift in channel activation or inhibiting fast inactivation. The sequence must encode a basic, hydrophilic surface patch for initial electrostatic recognition of the channel, while maintaining hydrophobic core residues for structural integrity. Emphasize evolutionary conservation of the inhibitor cysteine knot (ICK) topology, with the disulfide connectivity conferring resistance to proteolytic degradation and thermal denaturation, typical of scorpion venom peptides. The final protein should exhibit high specificity for insect or mammalian Nav isoforms, reflecting the predatory ecology of Tityus species, and demonstrate paralytic activity through prolonged channel opening or altered gating kinetics."}
{"description": "sp|P61409|AF2_GRARO Kappa-theraphotoxin-Gr2c OS=Grammostola rosea OX=432528 PE=1 SV=2", "sequence": "MKAFFVILGLALLCAYSFALEEQDQLSLRNDLLTVMFAENSELTPETEERYCQKWMWTCDEERKCCEGLVCRLWCKKKIEW", "prompt": "Design a novel animal toxin protein sequence that mimics the biological activity and structural characteristics of kappa-theraphotoxin-Gr2c from the Chilean rose tarantula (Grammostola rosea). This toxin belongs to the inhibitory cysteine knot (ICK) structural family and functions as a potassium channel blocker. The protein should adopt the characteristic ICK fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6) that forms the knotted core structure. The toxin should specifically target voltage-gated potassium channels, particularly Kv1.x subtypes, with high affinity binding that modulates neuronal excitability. The sequence should include key functional residues responsible for channel pore occlusion and receptor recognition, while maintaining the compact globular structure typical of spider venom peptides. The mature toxin should be approximately 30-40 amino acids in length with the appropriate cysteine framework to ensure proper folding and biological activity as a neurotoxin that disrupts potassium conductance in prey organisms."}
{"description": "sp|P86535|OXLA1_DABRR L-amino-acid oxidase L1 (Fragment) OS=Daboia russelii OX=8707 PE=1 SV=2", "sequence": "ADDINPKEECFFEDDYYEFE", "prompt": "Generate the amino acid sequence for a potent animal venom toxin with L-amino-acid oxidase (LAAO) activity, derived from Russell's viper (Daboia russelii). This enzyme represents a key component of viperid venom responsible for inducing local tissue damage, hemorrhage, and systemic effects through its catalytic function. The protein should adopt the characteristic LAAO structural fold, featuring a conserved FAD-binding domain with Rossmann-fold topology and a substrate-binding domain that facilitates oxidative deamination of L-amino acids. The catalytic mechanism involves FAD-dependent conversion of L-amino acids to corresponding α-keto acids, producing hydrogen peroxide and ammonia as byproducts. This hydrogen peroxide generation contributes significantly to the toxin's cytotoxic effects, including apoptosis induction, platelet aggregation inhibition, and endothelial cell damage. The protein should exhibit the typical homodimeric quaternary structure common to snake venom LAAOs, with each monomer containing approximately 500-550 amino acids and displaying the conserved glycine-rich nucleotide-binding motif for FAD cofactor attachment. The structural scaffold should enable specific interaction with cell surface targets, potentially including integrins or other membrane receptors that facilitate its localization and cytotoxic action in envenomation."}
{"description": "sp|Q76CA1|GIG1_STIGI OMEGA-stichotoxin-Sgt1a OS=Stichodactyla gigantea OX=230562 PE=1 SV=1", "sequence": "MASFRTLFACVVILCCVLWSSMARYGEDMEVETEMNKRDVGVACTGQYASSFCLNGGTCRYIPELGEYYCICPGDYTGHRCEQMSV", "prompt": "Design a novel marine toxin protein sequence inspired by the omega-stichotoxin family from the giant Caribbean sea anemone Stichodactyla gigantea. This toxin should function as a potent potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The protein should adopt the characteristic structural scaffold of sea anemone type 3 potassium channel toxins, featuring a compact beta-sheet-rich fold stabilized by a conserved disulfide bridge pattern with three intramolecular disulfide bonds (Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 connectivity). Incorporate key functional residues for channel binding, including a conserved arginine-rich region for interaction with the channel pore domain and hydrophobic patches for membrane association. The sequence should maintain the typical molecular weight of 4-5 kDa and exhibit the amphipathic character necessary for both aqueous solubility and membrane interaction. Ensure the structural integrity supports high-affinity binding to Kv1.x channels, leading to prolonged action potential duration and enhanced neurotransmitter release at synapses."}
{"description": "sp|Q53B57|3L256_OPHHA Long neurotoxin OH-56 OS=Ophiophagus hannah OX=8665 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIMCLDLGYTTKCYVTPDVTSQTCPDGQNICYTETWCDAWCGSRGKRVNLGCAATCPKVNPGVDIICCSTDNCNPFPKRS", "prompt": "Design a long neurotoxin protein sequence from the venom of the king cobra (Ophiophagus hannah) that functions as a potent postsynaptic neurotoxin. This toxin should specifically target and irreversibly block nicotinic acetylcholine receptors at the neuromuscular junction, leading to flaccid paralysis. The protein should adopt the characteristic three-finger toxin fold consisting of three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bridges with the typical cysteine framework C-C-CC-C-C. The structure should feature an extended central loop that enhances receptor binding affinity and specificity. The molecular mechanism involves competitive antagonism by binding to the agonist site of muscle-type nicotinic acetylcholine receptors, preventing acetylcholine-mediated signal transduction. The toxin should exhibit high specificity for the α-δ and α-γ interfaces of the receptor. Key structural elements should include a conserved hydrophobic core, flexible loop regions for receptor interaction, and surface-exposed residues critical for receptor recognition and binding kinetics. The protein should maintain the characteristic stability and resistance to proteolysis typical of snake venom neurotoxins."}
{"description": "sp|C0K3N4|VEGFA_AGKPI Vascular endothelial growth factor A OS=Agkistrodon piscivorus piscivorus OX=8716 PE=2 SV=1", "sequence": "MNFLLTWIHWGLAALLYFHNAKVLQAAPAHGDGDRQQSEVIPFMTVYERSVCRPIETMVDIFQEYPDEVEYILKPPCVALMRCGGCCNDEALECVPTELYNVTMEIMKLKPYQSQHIHPMSFQQHSKCECRPKKETRIIQENHCEPCSERRKHLYKQDPLTCKCSCKFTDSRCKSKQLELNERTCRCEKPRR", "prompt": "Design a novel protein sequence for a snake venom-derived toxin that functions as a vascular endothelial growth factor A (VEGF-A) homolog. This protein originates from the venom of Agkistrodon piscivorus piscivorus (eastern cottonmouth), where it serves as a key component of the viperid venom arsenal, contributing to local tissue damage, hemorrhage, and edema formation through disruption of vascular integrity. The core mechanism involves competitive binding to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, thereby modulating angiogenesis and vascular permeability. The protein should adopt a conserved VEGF-like fold characterized by a cysteine-knot motif, with a characteristic disulfide connectivity pattern (C1-C4, C2-C5, C3-C6) that stabilizes the homodimeric structure. Key structural elements include the receptor-binding domains containing critical residues for interaction with VEGFR extracellular domains, particularly in regions corresponding to the receptor-binding loops of mammalian VEGF-A. The sequence should maintain the characteristic β-sheet core structure while incorporating venom-specific modifications that enhance stability and receptor affinity compared to endogenous VEGF. The resulting protein should exhibit potent angiogenic or anti-angiogenic activity depending on its specific receptor interactions, making it a valuable tool for studying vascular biology and potential therapeutic applications."}
{"description": "sp|P0DMR9|KA17G_OLIMR Toxin BmKK16 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "QRQCERLRDCYKYCMSPKRCTYGTCYCEPSP", "prompt": "Design a novel animal toxin protein sequence inspired by the scorpion venom peptide BmKK16 from Olivierus martensii (Mesobuthus martensii). This toxin belongs to the short-chain scorpion toxin family targeting potassium channels. The protein should function as a potent potassium channel blocker, specifically modulating voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular transmission. The structural scaffold should feature the characteristic cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by three conserved disulfide bridges with a C1-C4, C2-C5, C3-C6 connectivity pattern. The core structure comprises a short alpha-helix packed against a three-stranded antiparallel beta-sheet, forming a compact globular domain. Key functional residues should be positioned in the beta-sheet region to interact with the pore domain of Kv channels, facilitating high-affinity binding and channel blockade. The sequence must include the conserved cysteine framework (C-C-CC-C-C) and maintain the hydrophobic core essential for structural stability. The toxin should exhibit specificity for Shaker-type potassium channels, contributing to the paralytic and neurotoxic effects characteristic of scorpion venoms in prey immobilization."}
{"description": "sp|P86408|SCXN1_MESEU Sodium channel neurotoxin MeuNaTxalpha-1 OS=Mesobuthus eupeus OX=34648 PE=1 SV=2", "sequence": "MNSLVMISLALLVMTGVESVRDGYIADDKNCAYFCGRNAYCDEECKKKGAESGYCQWAGQYGNACWCYKLPDKVPIKVSGKCNGR", "prompt": "Design a novel sodium channel neurotoxin from the venom of the scorpion Mesobuthus eupeus, specifically belonging to the alpha-toxin family. This toxin should function as a potent modulator of voltage-gated sodium channels, exhibiting the characteristic mechanism of alpha-scorpion toxins: binding to neurotoxin receptor site 3 on the extracellular domain of voltage-gated sodium channels, thereby inhibiting fast inactivation and prolonging the action potential duration. The resulting hyperexcitability in neuronal and muscular tissues leads to severe neurotoxic effects, including convulsions, paralysis, and potentially lethal respiratory failure. The structural scaffold should feature the conserved cysteine-stabilized alpha-beta (CSαβ) fold, stabilized by four disulfide bridges with the characteristic C1-C4, C2-C5, C3-C6, C4-C7 connectivity pattern common to scorpion alpha-toxins. The core structure should comprise a compact, globular arrangement with an alpha-helix packed against an antiparallel beta-sheet, stabilized by the disulfide network that confers exceptional thermal and proteolytic stability. Key functional residues should be positioned within the conserved 'core' and 'NC' domains to mediate specific interactions with the voltage-sensing domain IV of sodium channels, particularly through aromatic and basic residues that facilitate high-affinity binding to site 3. The toxin should exhibit selectivity for mammalian neuronal sodium channels, with minimal activity on insect channels, reflecting the ecological role of Mesobuthus eupeus venom in prey capture and defense. The overall molecular weight should be approximately 6-8 kDa, with a basic isoelectric point due to the presence of multiple lysine and arginine residues that enhance membrane interaction and target binding affinity."}
{"description": "sp|A6YR28|COC2A_CONCL Mu-conotoxin-like Cal 12.1.2a OS=Californiconus californicus OX=1736779 PE=2 SV=1", "sequence": "DVCDSLVDGRCIHNGCFCERDAPNGNCCDTDGCTARWWCPGTKWD", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the Californiconus californicus marine cone snail. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce neuromuscular blockade. The peptide should adopt the characteristic mu-conotoxin structural scaffold featuring a compact, globular fold stabilized by a conserved disulfide connectivity pattern (C-C-C-C framework with disulfide bonds between Cys1-Cys4, Cys2-Cys5, and Cys3-Cys6). Incorporate key structural elements including a well-defined beta-hairpin motif and surface-exposed loops that mediate specific interactions with the voltage-sensing domain of Nav1.4. The sequence should maintain the canonical mu-conotoxin cysteine framework while displaying appropriate surface residues for high-affinity binding to the receptor's site 1, effectively blocking sodium ion flux and causing paralysis. Ensure the peptide exhibits the typical small size (approximately 22-26 amino acids) and cationic character common to mu-conotoxins, with optimized pharmacophore residues for enhanced potency and selectivity against the target sodium channel subtype."}
{"description": "sp|P0DMR8|KA17C_OLIMR Toxin BmKK12 OS=Olivierus martensii OX=34649 PE=1 SV=1", "sequence": "QRQCQNVQNCYKYCMSPKKCEYGTCYCEPSP", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the Chinese scorpion Olivierus martensii (formerly Mesobuthus martensii). This toxin should function as a potassium channel modulator, specifically targeting voltage-gated potassium channels (Kv channels) to disrupt neuronal excitability and neuromuscular signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion short-chain potassium channel toxins, featuring a compact globular fold stabilized by a specific disulfide bridge pattern. The core architecture should include three disulfide bonds with a C1-C4, C2-C5, C3-C6 connectivity pattern, forming a stable cysteine-stabilized alpha-beta (CSαβ) motif. The structural fold should present a small, rigid core with an exposed functional surface containing key residues for channel interaction, including a conserved dyad or triad involved in channel pore blockade. The sequence should maintain the typical length of 30-40 amino acids with high beta-sheet content and minimal helical regions. The molecular mechanism should involve binding to the external vestibule of Kv channels, physically occluding the ion conduction pathway and inhibiting potassium efflux, leading to prolonged membrane depolarization, enhanced neurotransmitter release, and ultimately causing paralysis in prey organisms. The toxin should exhibit specificity toward particular Kv channel subtypes while maintaining the potent neurotoxic activity characteristic of scorpion venom peptides."}
{"description": "sp|P01522|O16A_CONGE Omega-conotoxin GVIA OS=Conus geographus OX=6491 PE=1 SV=2", "sequence": "MKLTCVVIVAVLLLTACQLITADDSRGTQKHRALGSTTELSLSTRCKSPGSSCSPTSYNCCRSCNPYTKRCYG", "prompt": "Design a protein sequence for a highly potent neurotoxic peptide from the venom of the marine cone snail Conus geographus. This toxin belongs to the omega-conotoxin family and specifically targets voltage-gated calcium channels. The protein should function as a selective and irreversible blocker of N-type calcium channels (Cav2.2), which are critical for neurotransmitter release at presynaptic nerve terminals. The mechanism involves high-affinity binding to the pore-forming alpha1 subunit of the channel, effectively inhibiting calcium influx and disrupting synaptic transmission, leading to paralysis. The structural scaffold should feature the characteristic cysteine framework of omega-conotoxins, with a conserved disulfide connectivity pattern (C-C-CC-C-C) that forms a compact, stable fold stabilized by three disulfide bridges. The anticipated 3D structure includes a small, rigid globular domain with beta-hairpin motifs and loops that are essential for target recognition and binding specificity. Key functional residues should be positioned to interact with the channel's extracellular loops, particularly in domains III and IV of the Cav2.2 channel. The sequence must include conserved hydrophobic and polar residues that contribute to the structural integrity and biological activity, ensuring high potency and selectivity for neuronal calcium channels over other subtypes."}
{"description": "sp|P62375|3SOF5_NAJAT Cytotoxin A5 OS=Naja atra OX=8656 PE=1 SV=1", "sequence": "MKTLLLTMVVVTIVCLDLGYTLKCHNTQLPFIYKTCPEGKNLCFKATLKKFPLKFPVKRGCADNCPKNSALLKYVCCSTDKCN", "prompt": "Design a cytotoxin protein from the venom of the Chinese cobra (Naja atra) that functions as a potent membrane-disrupting agent. This three-finger toxin (3FTx) should adopt the characteristic three-finger β-sheet structural fold stabilized by four conserved disulfide bonds with the cysteine framework C1-C3, C2-C4, C5-C6, C7-C8. The protein should exhibit specific cytotoxicity through membrane interaction and pore formation, targeting various cell types including cancer cells. The structural core should consist of three extended β-sheet-rich loops emerging from a central hydrophobic core, with the tips of the loops containing key residues for membrane binding and disruption. The protein should demonstrate thermal stability and resistance to proteolytic degradation due to its compact disulfide-stabilized architecture. Focus on creating a sequence that maintains the conserved hydrophobic core while incorporating surface-exposed residues that facilitate membrane interaction and cytolytic activity."}
{"description": "sp|P0DQQ6|CA1A_CONMD Alpha-conotoxin MilIA OS=Conus milneedwardsi OX=2825866 PE=1 SV=1", "sequence": "DMCCHPACMNHFNC", "prompt": "Design a novel alpha-conotoxin protein sequence inspired by the venom of Conus milneedwardsi, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The protein must adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern (CC-C-C framework). The sequence should include the essential cysteine residues at positions that enable proper disulfide bridge formation, along with key pharmacophore residues in the intervening loops that mediate high-affinity binding to the nAChR orthosteric site. The mature toxin should be approximately 12-18 amino acids in length, with the N-terminal region and inter-cysteine loops optimized for target specificity and potency. The structural core must exhibit the typical alpha-conotoxin fold, characterized by beta-turn elements and a well-defined binding interface that blocks acetylcholine binding, resulting in neuromuscular or neuronal transmission blockade. Ensure the sequence reflects the evolutionary optimization of cone snail venoms for rapid prey immobilization through precise receptor antagonism."}
{"description": "sp|C1IC45|PA2A2_WALAE Acidic phospholipase A2 PL-II (Fragment) OS=Walterinnesia aegyptia OX=64182 PE=1 SV=1", "sequence": "AVCVSLLGASSIRPLPLHLGQFNNMIKCTIPGSTPWWDFSDYGCYCGYGGSGTPVDQLDRCCQTHDNCYTEAQKFSGCSPYRRKYSYECSEGTLTCKSDNDECAAFVCNCDRLAAICFAGAPYNSNNVDIDLEARCQ", "prompt": "Design a protein sequence for an acidic phospholipase A2 toxin from the venom of the desert black snake, Walterinnesia aegyptia. This enzyme should function as a potent neurotoxin and myotoxin, exhibiting calcium-dependent catalytic activity that hydrolyzes the sn-2 ester bond of membrane phospholipids to release lysophospholipids and free fatty acids. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of seven disulfide bridges. Key structural elements must include the conserved calcium-binding loop (Tyr-Gly-Cys-Tyr-Cys-Gly-X-Gly-Gly) and the catalytic dyad comprising histidine and aspartate residues essential for enzymatic activity. The acidic nature of this toxin should be reflected in its overall negative charge at physiological pH. The protein should target neuronal and muscle cell membranes, causing membrane disruption, inflammation, and potentially presynaptic neurotoxicity through phospholipid hydrolysis. Include conserved residues critical for substrate binding and interfacial activation, ensuring the sequence maintains the structural integrity required for both membrane association and catalytic efficiency."}
{"description": "sp|C4PWC3|CXAT1_CONMS Alpha-conotoxin-like Ms20.1 OS=Conus mustelinus OX=101309 PE=1 SV=1", "sequence": "MLKLEMMLVVLLILPLFYFDAGGQVVQRDWRSDGLARYLQRGDRDVRECNINTPGSSWGKCCLTRMCGPMCCARSGCTCVYHWRRGHGCSCPG", "prompt": "Design a novel alpha-conotoxin protein sequence derived from the venom of Conus mustelinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The protein should adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the signature cysteine framework (CC-C-C) typical of alpha-conotoxins, with inter-cysteine loops of appropriate lengths to form the receptor-binding interface. The mature toxin should be approximately 12-20 amino acids in length, exhibiting high structural stability through the disulfide network while maintaining the pharmacophore residues essential for receptor recognition and blockade. The protein should demonstrate specificity for neuronal nicotinic receptors rather than muscle-type receptors, reflecting the hunting strategy of Conus mustelinus for small fish prey. The structural motif should include a beta-hairpin or similar secondary structure elements that present key functional residues for receptor interaction."}
{"description": "sp|W5XCJ6|SLCIB_MACLB Snaclec lebecin subunit beta OS=Macrovipera lebetinus OX=3148341 PE=1 SV=1", "sequence": "MGRIIFVSFGLLVVFLSLSGTGADCPSDWSSDEEHCYYVFFLLFTWEEAAKFCTQQANGGHLVSIESVEEAEFVAQLISENIKTSADYVWIGLWNQRKAPYCVSKWTDGSSVIYKNVIERFIKNCFGLEKETNYRTWFNLSCGDDYPFVCKSPA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a beta subunit in the lebecin complex from the blunt-nosed viper (Macrovipera lebetinus). This protein should adopt the characteristic C-type lectin-like domain (CTLD) fold, consisting of a double-loop structure stabilized by two conserved disulfide bridges with a typical C1-C4, C2-C3 connectivity pattern. The protein should form heterodimeric complexes with alpha subunits to create functional lebecin, which acts as a platelet aggregation modulator in the venom. The sequence should include key structural elements: a conserved calcium-binding motif (when present), hydrophobic core residues that maintain the globular fold, and surface-exposed loops that mediate protein-protein interactions with platelet receptors. The protein should exhibit the typical snaclec characteristics of being a non-enzymatic, carbohydrate-binding protein that interferes with hemostasis through receptor binding, potentially targeting platelet membrane glycoproteins to either inhibit or promote platelet aggregation as part of the viper's envenomation strategy to disrupt prey coagulation systems."}
{"description": "sp|P60993|TX2_HETMC Kappa-theraphotoxin-Hm2a OS=Heteroscodra maculata OX=268413 PE=1 SV=1", "sequence": "ECRYFWGECNDEMVCCEHLVCKEKWPITYKICVWDRTF", "prompt": "Design a novel animal toxin protein sequence based on the following comprehensive biological specifications: This protein is a kappa-theraphotoxin from the venom of the ornamental baboon tarantula (Heteroscodra maculata), a theraphosid spider whose venom contains diverse peptide toxins that modulate neuronal signaling. The toxin functions as a potent and selective inhibitor of voltage-gated potassium channels, specifically Kv1-type channels, which are crucial for regulating neuronal excitability and action potential repolarization. The mechanism involves high-affinity binding to the channel's pore region, blocking potassium ion flux and thereby prolonging action potential duration, leading to enhanced neurotransmitter release and potential neuroexcitatory effects. Structurally, this toxin adopts the inhibitor cysteine knot (ICK) motif, a compact and stable triple-stranded beta-sheet fold stabilized by three conserved disulfide bonds with a characteristic C1-C4, C2-C5, C3-C6 connectivity pattern. The molecular surface features a conserved functional dyad comprising a critical lysine residue that projects into the channel pore and an adjacent hydrophobic residue that interacts with the channel vestibule, along with other key residues in the beta-hairpin loops that determine channel subtype selectivity and binding affinity. The sequence should encode a mature peptide of approximately 30-40 amino acids with the canonical ICK cysteine framework and physicochemical properties typical of spider venom peptides, including a net positive charge for interaction with the negatively charged channel exteriors."}
{"description": "sp|P0DMV6|3SA12_DABRR 7.2 kDa cytotoxin RVV-7 (Fragment) OS=Daboia russelii OX=8707 PE=1 SV=1", "sequence": "LECNKLVDIAYITCPAGKNL", "prompt": "Design a cytotoxin protein sequence derived from Russell's viper (Daboia russelii) venom that functions as a potent membrane-disrupting agent. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, featuring a compact globular core stabilized by four conserved disulfide bridges with the typical cysteine framework (C-C-C-C-C-C-C-C). The protein should exhibit cytolytic activity through direct interaction with cell membranes, likely via amphipathic loops that facilitate membrane insertion and pore formation. The structural scaffold should consist of three beta-stranded loops extending from a central core, with conserved hydrophobic residues positioned for membrane interaction. The toxin should demonstrate specificity for disrupting cellular integrity, potentially through phospholipid binding or membrane perturbation mechanisms characteristic of snake venom cytotoxins. The sequence should maintain the structural stability and functional efficiency required for rapid membrane disruption while preserving the evolutionary conserved motifs of viperid cytotoxins."}
{"description": "sp|U3FAE1|3SXA_MICFL Fulditoxin OS=Micrurus fulvius OX=8637 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGNSLKCYSSRTETMTCPEGEDKCEKYAVGLMHGSFFFIYTCTSKCHEGAYNVCCSTDLCNKSSTSG", "prompt": "Design a novel protein sequence for a potent neurotoxin derived from the venom of the Eastern coral snake, Micrurus fulvius. This toxin should function as a presynaptic phospholipase A2 neurotoxin that specifically targets the neuromuscular junction. The protein must exhibit the characteristic structural features of a group IA phospholipase A2 toxin, including a conserved calcium-binding loop (YGKYCGXGG), a catalytic network centered around histidine and aspartate residues, and the distinctive pancreatic loop. The sequence should incorporate the essential disulfide bond pattern that stabilizes the three-finger toxin fold, with cysteine residues forming bridges that maintain the protein's structural integrity and functional specificity. The toxin should demonstrate high affinity binding to presynaptic membranes, where it hydrolyzes phospholipids to disrupt acetylcholine release, leading to progressive flaccid paralysis. The design should prioritize structural stability while maintaining the potent neurotoxic activity characteristic of coral snake venoms, with appropriate surface residues for target recognition and membrane interaction."}
{"description": "sp|A6YR31|COC2D_CONCL Mu-conotoxin-like Cal 12.1.2d OS=Californiconus californicus OX=1736779 PE=2 SV=1", "sequence": "DVCDSLVGGRCIHNGCWCERSAPHGNCCNTSGCTARWWCPGTKFD", "prompt": "Design a novel mu-conotoxin-like peptide derived from the venom of the Californiconus californicus marine cone snail. This peptide should function as a potent and selective sodium channel blocker, specifically targeting voltage-gated sodium channels involved in neuromuscular transmission. The peptide must adopt the characteristic mu-conotoxin structural scaffold, featuring a compact, globular fold stabilized by a conserved disulfide bonding pattern. The core structure should include the hallmark cysteine framework common to mu-conotoxins, forming multiple intramolecular disulfide bridges that confer stability and define the bioactive conformation. The molecular architecture should present key functional residues on surface-exposed loops that mediate high-affinity binding to site 1 of voltage-gated sodium channels, effectively inhibiting channel function and disrupting action potential propagation. The peptide should exhibit the typical physicochemical properties of conotoxins, including small size, high cysteine content, and the ability to fold into a stable, bioactive conformation in physiological environments. The design should reflect the evolutionary optimization of cone snail venoms for rapid prey immobilization through precise targeting of ion channels."}
{"description": "sp|P86780|PA2_BUNCI Phospholipase A2 (Fragment) OS=Bunodosoma caissarum OX=31165 PE=1 SV=1", "sequence": "GATIMPGTLWCGKGNSAADYLQLGVWKDTAHCCRDHDGC", "prompt": "Design a phospholipase A2 toxin fragment derived from the sea anemone Bunodosoma caissarum, a species known for its potent venom used in prey capture and defense. This toxin functions as a calcium-dependent enzyme that hydrolyzes the sn-2 ester bond of membrane phospholipids, releasing lysophospholipids and free fatty acids including arachidonic acid, which can initiate inflammatory cascades. The protein should adopt the characteristic phospholipase A2 fold featuring three long alpha-helices stabilized by a conserved network of disulfide bridges, typically following the C-C-C-C-C-C pattern common to group III secretory PLA2s. The catalytic site should include the conserved calcium-binding loop (YGKYCG/XCG) and the catalytic histidine-aspartate dyad essential for enzymatic activity. The molecular target is the lipid bilayer of cell membranes, with specific interfacial binding domains that allow the toxin to penetrate and disrupt membrane integrity, leading to hemolysis, myotoxicity, and potential neurotoxic effects through secondary inflammatory mediator release. The structural scaffold should maintain the compact, stable globular architecture typical of venom PLA2s, with surface-exposed hydrophobic patches for membrane interaction and conserved residues for catalytic efficiency and calcium coordination."}
{"description": "sp|Q5D228|T7406_ILLWI U1-hexatoxin-Iw1c (Fragment) OS=Illawarra wisharti OX=278061 PE=1 SV=1", "sequence": "LKFVVLICLVIMASTSAQQCGDETCGAGTCCAVFSQNHCRRLSQMYDLCSDHSDASPSGNYLFFCPCEPGLHCDRNTWTCTEGSSRSE", "prompt": "Design a protein sequence for a spider venom toxin that functions as a potent insecticidal agent. This toxin originates from the Australian funnel-web spider Illawarra wisharti and belongs to the U1-hexatoxin family. The protein should adopt the inhibitor cystine knot (ICK) structural motif, characterized by a compact, triple-stranded beta-sheet fold stabilized by a conserved disulfide bridge pattern (C1-C4, C2-C5, C3-C6). As a neurotoxin, it targets insect voltage-gated sodium channels, specifically binding to site 4 to modulate channel gating and induce paralysis. The sequence should include key functional residues for receptor interaction, maintaining the hydrophobic core and surface loops critical for target specificity and potency. Ensure the structural integrity of the ICK scaffold, with disulfide bonds enforcing stability against proteolytic degradation, reflecting its role in predatory venom for immobilizing prey."}
{"description": "sp|P23807|SL9B_PROFL Snaclec coagulation factor IX/factor X-binding protein subunit B OS=Protobothrops flavoviridis OX=88087 PE=1 SV=2", "sequence": "MGRFIFMSFGFLVVFLSLSGTAADCPSDWSSYEGHCYKPFSEPKNWADAENFCTQQHAGGHLVSFQSSEEADFVVKLAFQTFGHSIFWMGLSNVWNQCNWQWSNAAMLRYKAWAEESYCVYFKSTNNKWRSRACRMMAQFVCEFQA", "prompt": "Design a protein sequence for a snake venom C-type lectin-like protein (snaclec) that functions as a coagulation factor IX and factor X-binding protein. This protein originates from the venom of Protobothrops flavoviridis (Habu snake), where it plays a critical role in disrupting the blood coagulation cascade by simultaneously binding to coagulation factors IX and X. The protein should adopt the characteristic C-type lectin-like fold, consisting of a heterodimeric complex with another subunit, forming a stable quaternary structure that enables high-affinity binding to both coagulation factors. The sequence should contain the conserved C-type lectin domain with the appropriate disulfide bonding pattern (typically involving multiple disulfide bridges that stabilize the globular fold), key residues for calcium-independent carbohydrate recognition, and specific surface loops that mediate protein-protein interactions with factors IX and X. The binding interface should involve complementary electrostatic and hydrophobic interactions that competitively inhibit the assembly of the tenase and prothrombinase complexes, thereby exerting potent anticoagulant activity by preventing thrombin generation and subsequent fibrin clot formation."}
{"description": "sp|X5IWS1|O17J_CONGE Mu-conotoxin GVIIJ OS=Conus geographus OX=6491 PE=1 SV=2", "sequence": "MKLTCVVIVAALLLTACQLITALDCGGTQKHRALRSTIKLSLLRQHRGWCGDPGATCGKLRLYCCSGFCDCYTKTCKDKSSA", "prompt": "Design a mu-conotoxin protein sequence derived from the venom of the piscivorous marine cone snail Conus geographus. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the skeletal muscle subtype Nav1.4 to induce rapid paralysis in prey. The protein should adopt the characteristic mu-conotoxin structural framework, featuring a compact, disulfide-rich scaffold stabilized by three disulfide bonds with the conserved cysteine connectivity pattern C-C-CC-C-C (Framework III). The mature toxin should exhibit a well-defined three-dimensional fold dominated by beta-sheet structure, with key functional loops responsible for channel blockade. Critical structural elements must include the conserved inter-cysteine loops that form the pharmacophore for binding to the neurotoxin receptor site 1 on domain II of the Nav1.4 channel, effectively occluding the pore and preventing sodium ion conductance. The sequence should maintain the hallmark mu-conotoxin properties of high affinity, target specificity, and structural stability essential for its paralytic function in the cone snail's venom arsenal."}
{"description": "sp|P60207|CM3A_CONSE Mu-conotoxin SmIIIA (Fragment) OS=Conus stercusmuscarum OX=89452 PE=2 SV=1", "sequence": "PLFDKRQRCCNGRRGCSSRWCRDHSRCCGRR", "prompt": "Design a novel mu-conotoxin protein sequence derived from the venom of Conus stercusmuscarum, the fly-speck cone snail. This toxin should function as a potent and selective antagonist of voltage-gated sodium channels, specifically targeting the Nav1.4 subtype predominantly expressed in skeletal muscle. The mechanism of action involves high-affinity binding to site 1 of the sodium channel alpha subunit, effectively blocking sodium ion flux and inducing neuromuscular paralysis. The structural scaffold must adhere to the mu-conotoxin family framework, characterized by a compact, globular fold stabilized by three disulfide bridges with a C-C-CC-C-C connectivity pattern (framework III). The mature peptide should be approximately 22 amino acids in length, featuring a well-defined beta-hairpin structure and a conserved hydrophobic core that facilitates precise interaction with the sodium channel pore region. Key functional residues should include conserved basic amino acids that mediate electrostatic interactions with the channel's extracellular loops, particularly those involved in the selectivity filter. The overall tertiary structure should exhibit high thermal and proteolytic stability typical of conotoxins, enabling effective prey immobilization through rapid and irreversible neuromuscular blockade."}
{"description": "sp|P04204|EXE2_HELSU Exendin-2-long OS=Heloderma suspectum OX=8554 PE=1 SV=3", "sequence": "MKSILWLCVFGLLIATLFPVSWQMAIKSRLSSEDSETDQRLFESKRHSDAIFTEEYSKLLAKLALQKYLASILGSRTSPPPPSR", "prompt": "Design a protein sequence for a potent toxin derived from the venom of the Gila monster (Heloderma suspectum), specifically representing the exendin-2 isoform. This toxin belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist family and functions as a high-affinity ligand for the GLP-1 receptor. The protein should adopt a stable, predominantly alpha-helical structure characteristic of incretin mimetics, with key residues for receptor binding and activation conserved. The mechanism involves potent and prolonged stimulation of pancreatic beta cells, enhancing glucose-dependent insulin secretion, inhibiting glucagon release, and delaying gastric emptying, which collectively contribute to its metabolic effects. The sequence should reflect the evolutionary optimization for resistance to proteolytic degradation, particularly against dipeptidyl peptidase-4 (DPP-4), ensuring extended in vivo half-life compared to endogenous GLP-1. Include appropriate disulfide bonding to stabilize the tertiary structure, typical of this toxin family, ensuring biological activity and structural integrity."}
{"description": "sp|B6DD52|TX24A_LYCSI U16-lycotoxin-Ls1a OS=Lycosa singoriensis OX=434756 PE=3 SV=1", "sequence": "MSPKVQALLLLVGLITFLAVHAEEELSETVESERSCAKEYQWCDWNTRPCCDNISCICSWIGTNCECKKGIIRTIKDWYKGK", "prompt": "Design a novel animal toxin protein sequence inspired by the venom arsenal of the wolf spider Lycosa singoriensis. This toxin should function as a potent pore-forming cytolysin, specifically targeting and disrupting cell membranes through the formation of stable transmembrane pores. The protein should adopt a compact, amphipathic alpha-helical bundle structure, characteristic of lycotoxin family members, which facilitates membrane insertion and oligomerization. Key structural features must include: a conserved pattern of hydrophobic residues arranged to interact with lipid bilayers, paired with charged residues that confer selectivity and modulate pore stability; a disulfide-stabilized core, likely following a C-C pattern, to maintain structural integrity under physiological conditions; and surface-exposed loops that mediate initial membrane recognition. The mechanism of action should involve reversible binding to lipid membranes, followed by conformational rearrangement into a beta-barrel or helical bundle pore, leading to ion dysregulation and eventual cell lysis. The sequence must reflect the evolutionary optimization for rapid incapacitation of prey, with high specificity for invertebrate neuronal and muscular cell membranes, while maintaining the biophysical properties necessary for venom delivery and stability."}
{"description": "sp|P86803|PA2B1_BOTMA Basic phospholipase A2 BmjeTX-I OS=Bothrops marajoensis OX=157554 PE=1 SV=1", "sequence": "DLWQFGQMILKETGKIPFPYYGAYGCYCGWGGRGGKPKAGTDRCCYVHDCCYGKLTSCPKTDDRYSYSWLDGTIVCGEDDPCKELCECDKKIAVCFRENLGTYNKKYRYHLKSCKKADKPC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of Bothrops marajoensis, a pit viper species. This toxin should function as a potent enzymatic toxin that hydrolyzes phospholipids at the sn-2 position of membrane glycerophospholipids, leading to membrane disruption, inflammation, and potential myotoxicity. The protein should adopt the characteristic phospholipase A2 fold consisting of three major alpha-helices, a beta-wing region, and a conserved calcium-binding loop. Include the essential catalytic dyad of histidine and aspartate residues within the active site, along with the characteristic disulfide bond pattern that stabilizes the compact globular structure. The sequence should exhibit basic isoelectric point properties consistent with its classification, facilitating interactions with anionic membrane surfaces. The toxin should demonstrate specificity for phospholipid substrates while maintaining the structural stability required for venom deployment in predatory and defensive contexts."}
{"description": "sp|V5TBK6|VMH4A_VIPAA Zinc metalloproteinase-disintegrin-like protein H4 subunit A OS=Vipera ammodytes ammodytes OX=8705 PE=1 SV=1", "sequence": "MIQPLLVVTCLVVFPYQVSSIILESGNVNDYEVVYPQKVTSLPKGAVQQPEQKYEDTMQYEFKVNGEPVVLHLEKNKGLFSEDYSETHYSPDGREITTNPPVEDHCYYHGHIQNEADSTASISACNGLKGHFKLQGETYLIEPLKIPESEAHAVYKYENIEKEDEAPKMCGVTETNWESDEPIRKASQLVATSEQRRNIQKYIELVIVVDNVMFRKYTGNSTAIRTRIYEIVNTLNVVFRNVHIFVALVGIEIWNKKDQIKVKSAESVTLDLFGDWREKDLLRRKRHDNAQLLTGIDLNEQTLGIAPMSGMCKPKSSVGLIQDYCKSYLLVAIVMAHELGHNLGMDHDDGNCICREMPCIMSPEAGSKPAFYFSDCSWNQYQKFRNDIKSKCIDNKPLKTDIVSPAFCGNYFVEEGEECDCGFPGNCRNPCCNATTCKLTPGSECGDGECCDQCRIQTAGTECRPAWDECDVPEYCTGQSAECPTDVLQRNGQPCKNNNGYCYNGVCPILTNQCISLFGSSVTVAPDRCFNNNLQGTENFHCGMENGRYIKCKPQDKKCGRLFCVEPPTGGGINCKSIRSEGDPDHGMVDLGTKCADGKVCNSNRQCVDVNTAY", "prompt": "Design a zinc metalloproteinase-disintegrin-like protein from the venom of the nose-horned viper (Vipera ammodytes ammodytes) that functions as a key hemorrhagic toxin. This protein should contain a metalloproteinase domain with a conserved HEXXHXXGXXH zinc-binding motif that enables proteolytic cleavage of basement membrane components, particularly type IV collagen and fibronectin in capillary walls, leading to vascular disruption and hemorrhage. The disintegrin-like domain should adopt a cysteine-rich fold with the characteristic C-C-C-C disulfide bonding pattern found in snake venom metalloproteinases, facilitating protein stability and potential interactions with integrin receptors. The overall structure should exhibit the multi-domain architecture typical of SVMPs, with the metalloproteinase domain containing the catalytic zinc ion coordinated by histidine residues and the disintegrin-like domain displaying surface loops capable of modulating cell adhesion processes. This toxin contributes to the viper's predatory and defensive strategy by inducing tissue damage, facilitating prey immobilization through blood loss, and impairing wound healing mechanisms in envenomed organisms."}
{"description": "sp|C1IC49|3NO25_WALAE Three-finger toxin W-V OS=Walterinnesia aegyptia OX=64182 PE=1 SV=1", "sequence": "MKTLLLTLVLVTIVCLDLGYTLTCLICPKKYCNQVHTCRNGENLCIKTFYEGNLLGKQFKRGCAATCPEARPREIVECCSRDKCNH", "prompt": "Design a novel three-finger toxin protein sequence inspired by Walterinnesia aegyptia (desert black snake) venom components. This toxin should adopt the characteristic three-finger toxin (3FTx) structural scaffold, featuring three extended β-stranded loops projecting from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic C1-C8, C2-C5, C3-C6, C4-C7 connectivity pattern. The protein should fold into a compact, globular structure with the three β-hairpin 'fingers' providing the molecular recognition surface. As a component of elapid snake venom, this toxin should function as a postsynaptic neurotoxin targeting nicotinic acetylcholine receptors at the neuromuscular junction, causing competitive antagonism that leads to flaccid paralysis. The sequence should maintain the conserved cysteine framework while incorporating variable residues in the loop regions that mediate specific receptor binding and potency. The structural core should maintain the characteristic three-finger topology that enables precise molecular targeting while ensuring proper folding and stability in the venom environment."}
{"description": "sp|Q53B61|3NO2_OPHHA Weak neurotoxin OH-72 (Fragment) OS=Ophiophagus hannah OX=8665 PE=2 SV=1", "sequence": "LTLVVVTIVCLDLGYTLTCLICPEEYCKRIHTCRDGENVCFKGFYEGKQLGKQFRRGCAATCPEGKPNEIVQCCSTDECNH", "prompt": "Design a protein sequence for a weak neurotoxin derived from the venom of the king cobra (Ophiophagus hannah), a species known for producing potent neurotoxins that target the neuromuscular junction. This toxin belongs to the three-finger toxin (3FTx) superfamily, characterized by a conserved structural fold comprising three β-stranded loops extending from a central hydrophobic core stabilized by four conserved disulfide bonds with the characteristic cysteine framework I (C-C-C-C). As a weak neurotoxin, it exhibits reduced potency compared to typical α-neurotoxins but retains the ability to modulate nicotinic acetylcholine receptors (nAChRs), particularly the muscle-type (α1β1γδ) or neuronal subtypes, through competitive or allosteric inhibition. The protein should adopt the classic three-finger β-sheet architecture, with the central loop often containing key residues for receptor interaction. Ensure the sequence includes the essential disulfide connectivity (Cys1-Cys3, Cys2-Cys4) to maintain structural integrity and functional specificity. The toxin's mechanism involves binding to the nAChR ligand-binding domain, disrupting acetylcholine signaling and leading to reversible neuromuscular blockade without the high affinity of stronger neurotoxins. Incorporate conserved hydrophobic residues in the core and variable surface residues in the loops to confer target selectivity and weak antagonistic activity."}
{"description": "sp|Q1I179|SCX2_TITDI Toxin Td2 OS=Tityus discrepans OX=57059 PE=1 SV=2", "sequence": "MTRFVLFLNCFFLICMVVECKEGYLMGADGCKRSCLTRPGHYCANECSRVKGTDGYCYAWLACYCYNMPNWVKTWDRATNTCGRGK", "prompt": "Design a novel scorpion toxin protein sequence inspired by Toxin Td2 from the venom of Tityus discrepans. This toxin should function as a potent sodium channel modulator, specifically targeting voltage-gated sodium channels (Nav channels) to disrupt neuronal signaling. The protein should adopt the conserved structural scaffold characteristic of scorpion β-toxins, featuring a compact, globular fold stabilized by a cysteine-stabilized alpha-beta (CSαβ) motif. The sequence must include the canonical disulfide bridge pattern with four conserved cysteine residues forming two disulfide bonds (C1-C4, C2-C3) that confer structural stability and functional integrity. Key structural elements should include a triple-stranded antiparallel beta-sheet and a single alpha-helix, with exposed loops critical for receptor binding and specificity. The toxin should exhibit high affinity for insect sodium channels, contributing to the venom's paralytic and neurotoxic effects, while maintaining the physicochemical properties typical of scorpion venom peptides, such as low molecular weight, basic isoelectric point, and resistance to proteolytic degradation. Ensure the sequence reflects the evolutionary adaptations of Tityus venom components for prey immobilization and defense."}
{"description": "sp|P86802|VM1H1_BOTMA Snake venom metalloproteinase HF-1 OS=Bothrops marajoensis OX=157554 PE=1 SV=1", "sequence": "PCWKGWSEDEQNLWPQRYIQLVVVADHGMFMKYNGDLAAIRKRVHELVNNINGFYRSLNIDVSLTDLEIWSDQDFITVVQSSSAKNTLNSFGEWREADLLRRKSHDHAQLLTAIDLDDDTVGLAYTSSMCNPRKSVAWGQDHSEEPINLLDVGVTMAHELGHNLGMNHDEEKKCHCGASLCIMSPSITEGPSLEFSDDSMGYYQSFLVVVNYNPQCILNKPEDQYYYILSPKHRIYSW", "prompt": "Design a snake venom metalloproteinase (SVMP) protein sequence that mimics the biological activity and structural characteristics of Bothrops marajoensis HF-1. This toxin belongs to the P-I class of SVMPs, characterized by containing only the metalloproteinase domain without additional disintegrin-like or cysteine-rich domains. The protein should feature the canonical zinc-binding motif HEXXHXXGXXH in its catalytic domain, which coordinates a zinc ion essential for proteolytic activity. The structural scaffold should adopt the typical SVMP 'metzincin' fold with a conserved methionine turn and an N-terminal pro-domain that is cleaved upon activation. Key functional residues should include the catalytic glutamate within the HEXXH motif and conserved cysteine residues that form disulfide bonds stabilizing the protein structure. The toxin should exhibit specific proteolytic activity against extracellular matrix components, particularly targeting basement membrane proteins such as type IV collagen, fibronectin, and laminin, contributing to hemorrhage, tissue damage, and inflammation. The mechanism involves disruption of capillary integrity through degradation of endothelial cell adhesion proteins and extracellular matrix components. The protein should maintain the characteristic multi-domain architecture of SVMPs while exhibiting the specific substrate specificity profile associated with Bothrops species venoms, which are known for their potent hemorrhagic and proteolytic activities in envenomation."}
{"description": "sp|P69436|MAST1_AGEPP Agelaia-MPI OS=Agelaia pallipes pallipes OX=313352 PE=1 SV=1", "sequence": "INWLKLGKAIIDAL", "prompt": "Design a protein sequence for a mastoparan-like toxin derived from the venom of the social wasp Agelaia pallipes pallipes. This toxin should function as a potent mast cell degranulating peptide, mimicking the biological activity of mastoparan-1. The protein should adopt an amphipathic alpha-helical conformation in membrane-mimetic environments, characterized by a predominantly hydrophobic face and a cationic face rich in lysine and arginine residues. The helical structure should facilitate insertion into lipid bilayers and subsequent activation of G-proteins, particularly Gi/o subtypes, through direct interaction with their alpha subunits. This mechanism leads to phospholipase C activation, calcium mobilization, and ultimately mast cell degranulation with histamine release. The sequence should include key residues for membrane interaction and G-protein coupling, maintaining the characteristic 14-amino acid length of mastoparan peptides. The structural scaffold should ensure proper amphipathicity with optimal hydrophobic moment for membrane penetration while preserving the cationic nature necessary for initial electrostatic interactions with anionic membrane surfaces. The toxin should exhibit the typical hemolytic and antimicrobial activities associated with mastoparans, reflecting the defensive and predatory functions in wasp venom."}
{"description": "sp|P86805|PA2B9_CRODM Basic phospholipase A2 9 OS=Crotalus durissus cumanensis OX=184542 PE=1 SV=1", "sequence": "SLVQFNKMIKFETRKSGLPFYAAYGCYCGWGGQRPKDATDRCCFVHDCCYGKVAKCNTKWDIYSYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNEYMFYPDSRCREPPEYTC", "prompt": "Design a protein sequence for a basic phospholipase A2 toxin from the venom of the South American rattlesnake, Crotalus durissus cumanensis. This enzyme should exhibit the characteristic catalytic triad (His/Asp/Tyr) and calcium-binding loop essential for phospholipase A2 activity. The protein should adopt the conserved phospholipase A2 fold featuring three long alpha-helices stabilized by seven conserved disulfide bonds that create a rigid, compact structure. As a basic phospholipase, it should possess a net positive charge that facilitates membrane interaction and potential myotoxic activity. The toxin should efficiently hydrolyze the sn-2 ester bond of glycerophospholipids in cell membranes, leading to membrane disruption, inflammation, and potential neurotoxic effects. The sequence should include the characteristic pancreatic loop and elapid loop regions that define snake venom phospholipase A2 architecture. The protein should demonstrate stability in the venom environment and target biological membranes with high specificity, contributing to the rattlesnake's predatory and defensive capabilities through its potent enzymatic activity."}
{"description": "sp|C0LZJ5|VM3LC_MACLN Disintegrin-like leberagin-C OS=Macrovipera lebetina transmediterranea OX=384075 PE=1 SV=1", "sequence": "IVSPPVCGNELLENGEECDCGSPANCRNPCCDAASCRLHSWVECESGECCDQCRFVTAGTECRATRSECDLAGQCTGQSADCPIDRFHRNGQPCLQNYGYCYNGKCPIMHHQCYYLFGANATVAQDACFEENKNGIGDFYCRKQSDRLIPCAPEDVKCGRLFCEILPNTRCKHAPGDNGMVDPGTKCEDKKVCFNRKCVDVNTVY", "prompt": "Design a disintegrin-like protein sequence derived from the venom of Macrovipera lebetina transmediterranea (Levantine viper). This toxin belongs to the disintegrin family, which are non-enzymatic components of viper venoms that play a crucial role in disrupting hemostasis by inhibiting platelet aggregation and cell adhesion processes. The protein should function as a potent antagonist of integrin receptors, specifically targeting platelet integrin αIIbβ3 (GPIIb/IIIa) to prevent fibrinogen binding and subsequent thrombus formation. It may also exhibit activity against other integrins such as αvβ3 involved in angiogenesis and metastasis. The sequence should feature the characteristic disintegrin domain with the canonical RGD (Arg-Gly-Asp) or related tripeptide motif (e.g., KGD, VGD, MVD) positioned within an extended, flexible loop that serves as the primary receptor-binding site. This loop should be stabilized by a conserved disulfide bond framework typical of snake venom disintegrins, likely involving 4-6 cysteine residues forming 2-3 intramolecular disulfide bridges that create a compact, stable fold. The overall structure should adopt a small, globular conformation with the integrin-binding motif exposed for optimal receptor interaction. The protein should lack metalloproteinase activity, consistent with its disintegrin-like nature, and exhibit high affinity and specificity for its target integrins to effectively impair hemostatic mechanisms."}
{"description": "sp|X2JCV5|OXLAA_CERCE L-amino acid oxidase OS=Cerastes cerastes OX=8697 PE=1 SV=1", "sequence": "MNVFFMFSLLFLAALESCADDKNPLEEEFFEADYEEFLLIAKNGLQQTSNPKRVVIVGAGMSGLSAAYVLAKTGHEVILLEASERVGGRVSTYRNDQEGWYANLGPMRLPERHRIVREYIRKFGLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEKGKSAPQLYRDSLQKIIEEYGRSNCSYILNKYDTYSTKDYLIKEGNLSPGAVDMVGDLLNEDSGYYVSFIESLKPDDIFAYENRFDEIVGGFDKLPTSMYQAIQEKVRLNVRVIKIQQDVKEVTVTYQTPAKNLSYVTADYVIVCTTSGAARRIKFEPPLPLKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSITDRPSRLIHYPNHNFPNGIGVLVIFTIADDADFFLALDNKTIADIVIHDLSLIHQLPKEKIRDLCYVSMIQKWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEL", "prompt": "Design a novel L-amino acid oxidase enzyme from the venom of the Saharan horned viper, Cerastes cerastes, that functions as a potent toxin through oxidative deamination of L-amino acids. This flavin adenine dinucleotide (FAD)-dependent enzyme should catalyze the conversion of L-amino acids to their corresponding α-keto acids, producing hydrogen peroxide and ammonia as byproducts. The generated hydrogen peroxide induces oxidative stress in prey tissues, leading to cytotoxicity, apoptosis, and hemorrhage through endothelial cell damage and platelet aggregation inhibition. The enzyme should adopt the classic L-amino acid oxidase fold with a conserved Rossmann-like domain for FAD binding and a substrate-binding pocket that preferentially recognizes hydrophobic L-amino acids like L-phenylalanine or L-leucine. The structure should feature the characteristic dimeric quaternary organization observed in snake venom L-amino acid oxidases, with each monomer containing approximately 500-550 residues organized into distinct FAD-binding, substrate-binding, and helical domains. The active site should contain conserved catalytic residues for substrate orientation and proton transfer, maintaining the enzyme's high specificity for L-enantiomers and its role in the viper's predatory strategy by inducing rapid prey immobilization through systemic oxidative damage and local tissue destruction."}
{"description": "sp|C6JUP3|3SX3_MICCO Three-finger toxin MicTx3 OS=Micrurus corallinus OX=54390 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIMCLDLGYTLVCYTNVLEPPGTLETCPDDFTCVKKWEGGGRRVTQYCSHACAIPASYEFVHCCQTDKCNG", "prompt": "Design a novel three-finger toxin protein sequence inspired by MicTx3 from the venom of the coral snake Micrurus corallinus. This toxin should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three extended β-stranded loops emerging from a conserved hydrophobic core stabilized by four conserved disulfide bonds with the typical cysteine framework (C-C-C-C-C-C-C-C). The protein should function as a potent neurotoxin targeting the neuromuscular junction, likely acting as a postsynaptic antagonist that binds with high affinity and specificity to nicotinic acetylcholine receptors (nAChRs), particularly muscle-type nAChRs, thereby inhibiting acetylcholine binding and inducing flaccid paralysis. The sequence should include key structural motifs: a central globular core stabilized by disulfide bonds, three flexible loops (loop I, II, and III) that mediate receptor interaction, and conserved hydrophobic residues in the core for structural integrity. The molecular mechanism should involve competitive inhibition at the orthosteric site of nAChRs, leading to blockade of neuromuscular transmission. Ensure the sequence reflects the evolutionary optimization of coral snake venom for rapid immobilization of prey through precise targeting of ion channels."}
{"description": "sp|P0CAQ8|CA14A_CONQU Alpha-conotoxin-like Qc1.4a (Fragment) OS=Conus quercinus OX=101313 PE=2 SV=1", "sequence": "SDGRNTAANDKASDLMALRDGCCSNPSCSVNNPDICGGGR", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus quercinus, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors, specifically targeting neuronal subtypes involved in neurotransmission modulation. The peptide should adopt the characteristic alpha-conotoxin structural scaffold featuring a compact globular fold stabilized by two conserved disulfide bonds in a Cys1-Cys3, Cys2-Cys4 connectivity pattern (framework I). The sequence should contain the canonical cysteine framework with appropriate spacing between cysteine residues to facilitate proper disulfide bond formation and structural stability. The mature toxin should exhibit high affinity binding to specific nicotinic receptor subtypes through precise molecular recognition elements, including conserved pharmacophore residues that mediate receptor interaction and subtype selectivity. The structural core should maintain the typical alpha-conotoxin fold with well-defined beta-sheet elements and constrained loops that provide the necessary rigidity for target recognition while allowing for subtype-specific variations. The toxin should demonstrate potent biological activity consistent with conotoxin-mediated neuromuscular or neuronal signaling disruption, with appropriate molecular weight and physicochemical properties characteristic of small, disulfide-rich conopeptides."}
{"description": "sp|C1IC47|3S13_WALAE Three-finger toxin W-III OS=Walterinnesia aegyptia OX=64182 PE=1 SV=1", "sequence": "MKTLLLTLVVVTIVCLDLGHTFVCHNQQSSQPPTTTNCSGGENKCYKKQWSDHRGSITERGCGCPTVKKGIKLHCCTTEKCNN", "prompt": "Design a three-finger toxin protein sequence inspired by the venom of Walterinnesia aegyptia (the desert black snake), specifically representing the W-III toxin variant. This protein should adopt the characteristic three-finger toxin (3FTx) structural fold, consisting of three extended β-stranded loops (fingers) projecting from a small, globular hydrophobic core stabilized by four conserved disulfide bonds. The expected disulfide connectivity pattern is Cys1-Cys3, Cys2-Cys4, Cys5-Cys6, and Cys7-Cys8, forming a rigid scaffold that maintains the functional loops. As a member of the non-conventional three-finger toxin family, this protein likely functions as a postsynaptic neurotoxin, targeting nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction. The mechanism involves high-affinity binding to the α-subunit of muscle-type nAChRs, competitively inhibiting acetylcholine binding and leading to flaccid paralysis. The three loops should contain key residues for receptor interaction, with loop II typically being critical for target specificity and binding affinity. The sequence should maintain the conserved hydrophobic core and disulfide framework while incorporating variable loop regions that confer the specific neurotoxic activity characteristic of Walterinnesia aegyptia venom components."}
{"description": "sp|P0DQX2|CDKA_CONPG Alpha-conotoxin PiXXA OS=Conus princeps OX=101311 PE=1 SV=1", "sequence": "MPKLEMMLLVLLILPLPYFDAAGGQSVHVDGYGDGLARYLQRGERAVKKTCIRSTPGSNWGRCCLTKMCHTLCCARSDCTCVYRSGKGHGCSCTS", "prompt": "Design a novel alpha-conotoxin peptide derived from the venom of Conus princeps, a marine cone snail species. This toxin should function as a potent and selective antagonist of nicotinic acetylcholine receptors (nAChRs), specifically targeting neuronal subtypes involved in synaptic transmission. The peptide should adopt the characteristic alpha-conotoxin structural scaffold, featuring a compact globular fold stabilized by two disulfide bonds in the conserved Cys1-Cys3, Cys2-Cys4 connectivity pattern. The sequence should include the invariant cysteine framework (CC-C-C) typical of alpha-conotoxins, with inter-cysteine loops of appropriate length to confer subtype selectivity. Key structural elements should include a beta-hairpin motif in the second loop that mediates receptor binding, and a well-defined hydrophobic core that ensures stability in the venom gland and upon injection. The toxin should exhibit high affinity for its target nAChR subtype through specific interactions with complementary receptor surfaces, likely involving key residues in the second loop that determine pharmacological specificity. The mechanism of action should involve competitive blockade of acetylcholine binding, leading to disruption of cholinergic signaling. The overall structure should be compact, stable, and resistant to proteolytic degradation, characteristic of conotoxin peptides that have evolved for rapid and precise neurological targeting."}
{"description": "sp|P67862|TXVE_PROFL Snake venom vascular endothelial growth factor toxin TfsvVEGF OS=Protobothrops flavoviridis OX=88087 PE=1 SV=1", "sequence": "MAAYLLAVAILFCIQGWPSGTVQGQVMPFMEVYSRSACQTRETLVPILKEYPDEVSHLFKPSCVPVLRCGGCCSDESLTCTATGKHSVGREIMRVDPHKGTSKMEVMQFKEHTACECRPRSPGDVNNGKDKRNPEEGGPRARFPFV", "prompt": "Design a snake venom-derived protein sequence that functions as a vascular endothelial growth factor (VEGF) toxin, specifically from the venom of Protobothrops flavoviridis (Habu snake). This toxin represents a fascinating example of molecular mimicry where venom components have evolved to target the host's vascular system. The protein should function as a VEGF homolog that competitively binds to VEGF receptors (primarily VEGFR-1 and VEGFR-2) on endothelial cells, disrupting normal angiogenesis and vascular permeability signaling pathways. This interference leads to vascular dysfunction, contributing to the venom's hemorrhagic and edematous effects. The sequence should maintain the characteristic VEGF fold structure, featuring a cysteine-knot motif with conserved disulfide connectivity (C1-C4, C2-C5, C3-C6 pattern) that stabilizes the homodimeric structure. Key structural elements should include the receptor-binding loops that interact with VEGFR domains, particularly the regions corresponding to binding sites I and III in mammalian VEGF. The protein should exhibit the typical VEGF family β-sheet core structure with loop regions that determine receptor specificity. Given its venom origin, the sequence may show evolutionary adaptations that enhance receptor binding affinity or stability compared to endogenous VEGF, potentially contributing to its pathological effects in envenomation."}
{"description": "sp|P0C166|KAX6C_ANUPH Potassium channel toxin alpha-KTx 6.12 OS=Anuroctonus phaiodactylus OX=246982 PE=1 SV=1", "sequence": "QKECTGPQHCTNFCRKNKCTHGKCMNRKCKCFNCK", "prompt": "Design a potassium channel toxin protein from the venom of the black-back scorpion Anuroctonus phaiodactylus. This toxin belongs to the alpha-KTx family 6.12 and functions as a potent blocker of voltage-gated potassium channels. The protein should adopt the conserved cysteine-stabilized alpha-beta (CSαβ) fold characteristic of scorpion toxins, featuring an alpha-helix packed against an antiparallel beta-sheet stabilized by three or four disulfide bridges. The specific cysteine framework should follow the typical alpha-KTx pattern (C1-X3-5-C2-X3-6-C3-X1-3-C4-X8-14-C5-X1-4-C6) that forms the structural core. The molecular mechanism involves binding to the pore region of Kv1.x family potassium channels, physically occluding the ion conduction pathway and preventing potassium efflux, leading to neuronal hyperexcitability and enhanced neurotransmitter release. The functional surface should contain key residues for channel recognition and binding, including a conserved dyad of lysine and aromatic residues that interact with the channel vestibule. The overall structure should be compact and globular, approximately 30-40 amino acids in length, with the disulfide network providing exceptional thermal and proteolytic stability. The toxin should exhibit high affinity and selectivity for specific potassium channel subtypes relevant to the scorpion's predatory strategy."}
{"description": "sp|P24335|WAG13_TROWA Waglerin-3 OS=Tropidolaemus wagleri OX=8770 PE=1 SV=2", "sequence": "SLGGKPDLRPCHPPCHYIPRPKPR", "prompt": "Design a novel venom peptide toxin inspired by the biological characteristics of Waglerin-3 from Tropidolaemus wagleri (Wagler's pit viper). This toxin should function as a potent neuromuscular blocking agent that specifically targets and inhibits muscle-type nicotinic acetylcholine receptors (nAChRs) at the postsynaptic membrane. The peptide should adopt a compact, stable tertiary structure stabilized by multiple disulfide bridges, characteristic of snake venom three-finger toxins. The molecular mechanism should involve competitive or allosteric antagonism of acetylcholine binding, leading to reversible flaccid paralysis by disrupting neuromuscular transmission. Key structural features should include: a core three-finger toxin fold with three protruding β-stranded loops, conserved cysteine framework forming 4-6 disulfide bonds for structural rigidity, and specific residues in the central loop for receptor interaction. The toxin should exhibit high affinity and selectivity for the α-δ and/or α-γ interfaces of muscle nAChRs, with minimal activity on neuronal subtypes. Consider the ecological context: Wagler's pit viper employs this toxin for rapid prey immobilization, requiring fast-onset, reversible action suitable for subduing small vertebrates. The designed sequence should maintain the characteristic compact globular architecture (~6-8 kDa) with surface-exposed functional loops for receptor recognition while ensuring proper folding and oxidative stability through the conserved disulfide pattern."}
{"description": "sp|P05483|U7AB_CONGE Omega-conotoxins GVIIA/GVIIB OS=Conus geographus OX=6491 PE=1 SV=1", "sequence": "CKSPGTPCSRGMRDCCTSCLLYSNKCRRY", "prompt": "Design a novel protein sequence for an omega-conotoxin from the venom of the marine cone snail Conus geographus, a highly specialized predator that employs neurotoxic venom for rapid prey immobilization. This toxin functions as a potent and selective antagonist of voltage-gated calcium channels, specifically targeting N-type calcium channels (Cav2.2) in the presynaptic terminals of neurons. The mechanism involves high-affinity binding to the channel's pore-forming α1 subunit, effectively blocking calcium influx and inhibiting neurotransmitter release, leading to synaptic transmission failure and paralysis. The structural scaffold should feature the characteristic cysteine framework of omega-conotoxins, with a conserved disulfide connectivity pattern (C-C-CC-C-C) forming three disulfide bridges that stabilize a compact, globular fold. The core structure is expected to adopt an inhibitor cysteine knot (ICK) motif, characterized by a tight, triple-stranded beta-sheet and a knotted topology secured by the disulfide network, ensuring exceptional stability and resistance to proteolytic degradation. Key functional residues should be positioned in flexible loops to facilitate precise interaction with the channel's extracellular vestibule, including conserved hydrophobic and polar residues critical for target recognition and binding affinity. The sequence must maintain the hallmark pharmacological properties of omega-conotoxins: high specificity for neuronal calcium channels, sub-nanomolar potency, and minimal off-target effects, reflecting its evolutionary optimization for disrupting neuromuscular signaling in prey."}
{"description": "sp|P60209|KAX94_HOTTA Potassium channel toxin alpha-KTx 9.4 OS=Hottentotta tamulus OX=34647 PE=1 SV=1", "sequence": "VGCAECPMHCKGKMAKPTCENEVCKCNIGKKD", "prompt": "Design a potent animal toxin protein sequence that functions as a potassium channel blocker, specifically targeting voltage-gated potassium channels (Kv channels) with high affinity and selectivity. This toxin should originate from the venom of the Indian red scorpion Hottentotta tamulus, a medically significant species whose venom components are known for their neurotoxic effects on ion channels, causing severe autonomic and neurological symptoms in envenomation victims. The protein must adopt the conserved alpha-KTx structural scaffold characteristic of scorpion potassium channel toxins, featuring a compact, stable fold stabilized by three disulfide bridges with the cysteine framework C1-X(m)-C2-X(n)-C3-X(p)-C4-X(q)-C5-X(r)-C6, where the specific spacing between cysteines should enable the formation of the correct disulfide connectivity (typically C1-C4, C2-C5, C3-C6) that defines the inhibitor cysteine knot (ICK) motif. This ICK motif confers exceptional stability and resistance to proteolytic degradation, essential for venom efficacy. The core functional domain should include a critical pharmacophore region, often involving a conserved dyad or triad of residues (e.g., a lysine or arginine residue positioned to interact with the channel pore, and hydrophobic residues for membrane proximity), which mediates binding to the external vestibule of Kv channels, physically occluding the ion conduction pathway and inhibiting potassium efflux. This mechanism leads to prolonged neuronal depolarization, enhanced neurotransmitter release, and hyperexcitability in target tissues. The molecular target specificity should favor Shaker-related Kv channels (e.g., Kv1.1, Kv1.2, Kv1.3), with key interactions involving the channel's turret and pore helix regions. The sequence must encode a short polypeptide (approximately 30-40 amino acids) with a high proportion of basic residues (e.g., lysine, arginine) to facilitate electrostatic steering toward the negatively charged channel surface, and a well-defined beta-sheet secondary structure stabilized by the disulfide core. Ensure the design reflects the evolutionary optimization for rapid onset and sustained activity in venom, avoiding any non-toxin-like features."}
